PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Kimura, T; Deshpande, GA; Urayama, KY; Masuda, K; Fukui, T; Matsuyama, Y				Kimura, Takeshi; Deshpande, Gautam A.; Urayama, Kevin Y.; Masuda, Katsunori; Fukui, Tsuguya; Matsuyama, Yutaka			Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						body weight gain; non-alcoholic steatohepatitis; prevention and control	BODY-MASS INDEX; CORONARY-HEART-DISEASE; RISK-FACTOR; CARDIOMETABOLIC RISK; METABOLICALLY OBESE; INSULIN-RESISTANCE; NATURAL-HISTORY; POPULATION; PREVALENCE; ADULTS	Background and AimsInterventions for lifestyle diseases including non-alcoholic fatty liver disease (NAFLD) have focused on overweight and obese populations. The impact of adult weight gain on NAFLD development among normal weight individuals remains unclear. MethodsIn this cross-sectional study, we collected data from participants presenting to a health check-up program. Ultrasound-diagnosed NAFLD prevalence was examined over 1-kg increments of weight change since age 20. Relative risks were calculated in men and women stratified by current weight (normal, overweight, and obese). Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) adjusting for potential confounders. ResultsAmong 21496 participants, 3498 cases of NAFLD (16.3%) were observed. Prevalence of NAFLD increased with weight gain since age 20; among the 10.1-11.0kg weight gain group, 41.6% of men and 24.8% of women had NAFLD. Multivariate analysis by quartiles showed that weight change was significantly associated with NAFLD risk in men and women. Risk of NAFLD associated with weight change (10-kg increments) was significantly higher in normal weight individuals (men: OR 7.53, 95% CI: 4.99-11.36, women: OR 12.20, 95% CI: 7.45-19.98) than overweight (men: OR 1.61, 95% CI: 0.91-2.85, women: OR 2.90, 95% CI: 0.99-8.54) and obese (men: OR 4.0, 95% CI: 2.97-5.39, women: OR 2.68, 95% CI: 2.00-3.60). ConclusionsNAFLD is robustly associated with weight change since age 20. This effect appears particularly strong in individuals at normal weight, suggesting an important role for early and longitudinal weight monitoring, even among healthy individuals at normal weight.	[Kimura, Takeshi; Masuda, Katsunori] St Lukes Int Univ, Ctr Prevent Med, Tokyo, Japan; [Kimura, Takeshi; Deshpande, Gautam A.; Urayama, Kevin Y.; Fukui, Tsuguya] St Lukes Life Sci Inst, Ctr Clin Epidemiol, Tokyo 1040044, Japan; [Urayama, Kevin Y.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan; [Matsuyama, Yutaka] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan	Kimura, T (reprint author), St Lukes Life Sci Inst, Ctr Clin Epidemiol, Chuo Ku, 10-1 Akashi Cho, Tokyo 1040044, Japan.	takekimu@luke.ac.jp					Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Hocking S, 2013, ENDOCR REV, V34, P463, DOI 10.1210/er.2012-1041; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Sinn DH, 2012, AM J GASTROENTEROL, V107, P561, DOI 10.1038/ajg.2011.400; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Rexrode KM, 1997, JAMA-J AM MED ASSOC, V277, P1539, DOI 10.1001/jama.277.19.1539; Hamaguchi M, 2005, ANN INTERN MED, V143, P722; Omagari K, 2002, J GASTROEN HEPATOL, V17, P1098, DOI 10.1046/j.1440-1746.2002.02846.x; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; CASEY VA, 1991, AM J CLIN NUTR, V53, P1493; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Arner P, 2011, NATURE, V478, P110, DOI 10.1038/nature10426; Lonardo A, 1997, ITAL J GASTROENTEROL, V29, P351; Church TS, 2006, GASTROENTEROLOGY, V130, P2023, DOI 10.1053/j.gastro.2006.03.019; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Chang Y, 2009, GUT, V58, P1419, DOI 10.1136/gut.2008.161885; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Lee SH, 2011, CLIN ENDOCRINOL, V75, P475, DOI 10.1111/j.1365-2265.2011.04085.x; Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Kaess BM, 2012, DIABETOLOGIA, V55, P2622, DOI 10.1007/s00125-012-2639-5; Conus F, 2007, APPL PHYSIOL NUTR ME, V32, P4, DOI 10.1139/H06-092; Barba C, 2004, LANCET, V363, P157; Chei CL, 2008, INT J OBESITY, V32, P144, DOI 10.1038/sj.ijo.0803686; COLDITZ GA, 1995, ANN INTERN MED, V122, P481; International Diabetes Federation, 2014, GLOB BURD IDF DIAB A; Madeira FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060673; Ministry of Health Labour and Welfare Japan, 2007, OUTL NAT HLTH NUTR S; Thomas EL, 2012, NUTR RES REV, V25, P150, DOI 10.1017/S0954422412000054; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Wakasugi M, 2012, CLIN EXP NEPHROL, V16, P259, DOI 10.1007/s10157-011-0565-3; World Health Organization, WHO GLOB INF BMI OV; World Health Organization/International Association for the Study of Obesity/International Obesity Task Force, 2000, AS PAC PERSP RED OB; Yoong SL, 2014, J GEN INTERN MED, V29, P328, DOI 10.1007/s11606-013-2637-4	43	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	MAY	2015	30	5					909	917		10.1111/jgh.12861		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF8JF	WOS:000352803400019		
J	Endo, K; Hori, T; Jobara, K; Hata, T; Tsuruyama, T; Uemoto, S				Endo, Kosuke; Hori, Tomohide; Jobara, Kanta; Hata, Toshiyuki; Tsuruyama, Tatsuaki; Uemoto, Shinji			Pretransplant replacement of donor liver grafts with recipient Kupffer cells attenuates liver graft rejection in rats	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						bone marrow cells; chimerism; Kupffer cells; liver transplant; xenotransplantation	MARROW-DERIVED CELLS; ENDOTHELIAL-CELLS; PROGENITOR CELLS; HIGH-FREQUENCY; HEMOPHILIA-A; T-CELLS; TRANSPLANTATION; TOLERANCE; INJURY; XENOTRANSPLANTATION	Background and AimRejection of liver grafts is a difficult issue that has not been resolved. Preoperative replacement of liver cells in the graft with cells from the intended recipient may attenuate rejection. We investigated whether preoperative transplant of recipient bone marrow cells (BMCs) to the donor replaced liver allograft cells and attenuated rejection. MethodsWe used a rat model of allogeneic liver transplant (LT) from Dark Agouti (DA) to Lewis (LEW) rats. In BMC group, DA rats received BMC transplants from LacZ-transgenic LEW rats at 1 week before LT. In the control group, DA rats received no preoperative treatment. We evaluated graft damage at 7 days after LT and the survival of the recipient rats. ResultsRats in the BMC group experienced prolonged survival that was abrogated by the administration of gadolinium chloride to donors at 24h before LT. Serum concentrations of total bilirubin and hyaluronic acid on day 7 were significantly lower in the BMC group, and histopathological analyses revealed that rejection of the liver graft was attenuated. X-gal staining and immunohistostaining of the liver graft revealed that BMCs engrafted in the sinusoidal space differentiated into Kupffer cells. ConclusionsPreoperative transplant of recipient BMCs to LT donors replaced donor Kupffer cells and attenuated post-LT rejection, indicating that this strategy may increase the success of LT.	[Endo, Kosuke; Hori, Tomohide; Jobara, Kanta; Hata, Toshiyuki; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat & Transplant Surg, Dept Surg, Kyoto 6068507, Japan; [Tsuruyama, Tatsuaki] Kyoto Univ, Grad Sch Med, Dept Diagnost Pathol, Kyoto 6068507, Japan	Hori, T (reprint author), Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat & Transplant Surg, Dept Surg,Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	kosukee@kuhp.kyoto-u.ac.jp; horit@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science [20249058, 245821]	This work was supported by governmental grants to S. Uemoto (No. 20249058) and K. Endo (No. 245821) from the Japan Society for the Promotion of Science.	KAMADA N, 1983, SURGERY, V93, P64; Ekser B, 2011, XENOTRANSPLANTATION, V18, P158, DOI 10.1111/j.1399-3089.2011.00642.x; Chen Y, 2008, LIVER TRANSPLANT, V14, P823, DOI 10.1002/lt.21450; Iida T, 2005, AM J TRANSPLANT, V5, P1076, DOI 10.1111/j.1600-6143.2005.00799.x; Lee WC, 2013, ANN SURG, V258, P306, DOI 10.1097/SLA.0b013e3182754b8e; Wang L, 2012, J CLIN INVEST, V122, P1567, DOI 10.1172/JCI58789; Follenzi A, 2012, BLOOD, V119, P5532, DOI 10.1182/blood-2011-07-367680; Harb R, 2009, GASTROENTEROLOGY, V137, P704, DOI 10.1053/j.gastro.2009.05.009; Sun ZL, 2003, LIVER TRANSPLANT, V9, P489, DOI 10.1053/jlts.2003.50091; Inoue H, 2005, BIOCHEM BIOPH RES CO, V329, P288, DOI 10.1016/j.bbrc.2005.01.132; You Q, 2008, HEPATOLOGY, V48, P978, DOI 10.1002/hep.22395; Ekser B, 2010, AM J TRANSPLANT, V10, P273, DOI 10.1111/j.1600-6143.2009.02945.x; Voigt MD, 2013, AM J TRANSPLANT, V13, P369, DOI 10.1111/ajt.12000; Hori T, 2010, WORLD J GASTROENTERO, V16, P3120, DOI 10.3748/wjg.v16.i25.3120; Follenzi A, 2008, J CLIN INVEST, V118, P935, DOI 10.1172/JCI32748; Durand F, 2008, LIVER TRANSPLANT, V14, P1694, DOI 10.1002/lt.21668; BAILEY LL, 1985, JAMA-J AM MED ASSOC, V254, P3321, DOI 10.1001/jama.254.23.3321; STARZL TE, 1993, LANCET, V341, P65, DOI 10.1016/0140-6736(93)92553-6; Hata T, 2013, ANN SURG, V257, P542, DOI 10.1097/SLA.0b013e31825c5349; Kleeberger W, 2002, HEPATOLOGY, V35, P110, DOI 10.1053/jhep.2002.30275; Wertheim JA, 2012, CURR OPIN ORGAN TRAN, V17, P235, DOI 10.1097/MOT.0b013e3283534ec9; Gao ZH, 2001, LANCET, V357, P932, DOI 10.1016/S0140-6736(00)04217-3; Yadav N, 2009, BLOOD, V114, P4552, DOI 10.1182/blood-2009-02-202788; Horie M, 2009, STEM CELLS, V27, P878, DOI 10.1634/stemcells.2008-0616; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Breous E, 2009, HEPATOLOGY, V50, P612, DOI 10.1002/hep.23043; Brock LG, 2012, AM J TRANSPLANT, V12, P3272, DOI 10.1111/j.1600-6143.2012.04247.x; Fabrega E, 2000, TRANSPLANTATION, V69, P569; Ge XP, 2008, TRANSPL INT, V21, P49, DOI 10.1111/j.1432-2277.2007.00569.x; Hori T, 2012, MICROSURG, V32, P253, DOI 10.1002/micr.21946; Hori T, 2010, ANN GASTROENTEROL, V23, P270; Hove W Rogier ten, 2003, Liver Transpl, V9, P552, DOI 10.1053/jlts.2003.50116; Idilman R, 2007, CLIN TRANSPLANT, V21, P202, DOI 10.1111/j.1399-0012.2006.00623.x; Jung K, 2012, HEPATOLOGY, V56, P1838, DOI 10.1002/hep.25906; Kienstra KA, 2008, PEDIATR RES, V63, P131; Krause P, 2010, WORLD J GASTROENTERO, V16, P3928, DOI 10.3748/wjg.v16.i31.3928; Liu H, 2007, WORLD J GASTROENTERO, V13, P3133; MAKOWKA L, 1995, TRANSPLANTATION, V59, P1654, DOI 10.1097/00007890-199506270-00002; Neil DAH, 2002, HEPATOLOGY, V35, P639, DOI 10.1053/jhep.2002.31726; Ng IOL, 2003, HEPATOLOGY, V38, P989, DOI 10.1053/jhep.2003.50395; Okabayashi T, 2011, AM J TRANSPLANT, V11, P2046, DOI 10.1111/j.1600-6143.2011.03698.x; Park MT, 2012, J RADIAT RES, V53, P570, DOI 10.1093/jrr/rrs011; Rees MA, 2002, TRANSPLANTATION, V73, P1460, DOI 10.1097/00007890-200205150-00016; STARZL TE, 1994, TRANSPLANT P, V26, P1082; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5; STEINMUL.D, 1974, NATURE, V248, P796, DOI 10.1038/248796a0; Stolz DB, 2007, HEPATOLOGY, V46, P1464, DOI 10.1002/hep.21887; Sun ZL, 2009, HEPATOLOGY, V49, P587, DOI 10.1002/hep.22653; Thomson AW, 2011, IMMUNOL RES, V50, P221, DOI 10.1007/s12026-011-8223-0	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	MAY	2015	30	5					944	951		10.1111/jgh.12872		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF8JF	WOS:000352803400023		
J	Ohkawa, A; Mizumoto, M; Ishikawa, H; Abei, M; Fukuda, K; Hashimoto, T; Sakae, T; Tsuboi, K; Okumura, T; Sakurai, H				Ohkawa, Ayako; Mizumoto, Masashi; Ishikawa, Hitoshi; Abei, Masato; Fukuda, Kuniaki; Hashimoto, Takayuki; Sakae, Takeji; Tsuboi, Koji; Okumura, Toshiyuki; Sakurai, Hideyuki			Proton beam therapy for unresectable intrahepatic cholangiocarcinoma	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						intrahepatic cholangiocarcinoma; proton beam therapy; radiotherapy; unresectable	BILIARY-TRACT CANCER; PHASE-II TRIAL; HEPATOCELLULAR-CARCINOMA; TUMOR THROMBUS; GEMCITABINE; RADIOTHERAPY; CHEMOTHERAPY; EXPERIENCE; CISPLATIN; ADJACENT	Background and AimTreatment for unresectable intrahepatic cholangiocarcinoma (ICC) has not been established. The aim of the study was to evaluate the outcome of proton beam therapy (PBT) for patients with unresectable ICC. MethodsUp to 2010, 20 patients (11 males, 9 females, median age 63 years old) with unresectable ICC (two, seven, seven, and four in stages II, IIIA, IIIC, and IV, respectively) were treated with PBT. The largest dimensions of the tumors ranged from 15 to 140mm (median: 50mm). The intrahepatic region and lymph nodes received median total proton doses of 72.6 GyE in 22 fractions and 56.1 GyE in 17 fractions, respectively. Four patients received concurrent chemotherapy (tegafur, gimeracil, and oteracil; TS-1) during PBT. Twelve patients were treated curatively, and eight were treated palliatively because tumors were present outside the irradiation field. ResultsIn the curative group, nine tumors within the irradiated field were controlled in follow-up of 8.6-62.6 months (median: 20.8 months). Median survival rates in the curative and palliative groups were 27.5 and 9.6 months, respectively, and overall 1- and 3-year survival rates were 82% and 38%, and 50% and 0%, respectively. Eight patients survived for>2 years, and there was no distant metastasis in five of these patients after 2 years. No severe side-effects occurred. ConclusionsThe results suggest that long-term survival can be achieved using PBT for patients with unresectable ICC without distant metastasis. Further studies are required to determine the optimal treatment schedule and best combination of PBT and chemotherapy.	[Ohkawa, Ayako; Mizumoto, Masashi; Ishikawa, Hitoshi; Hashimoto, Takayuki; Sakae, Takeji; Tsuboi, Koji; Okumura, Toshiyuki; Sakurai, Hideyuki] Univ Tsukuba, Dept Radiat Oncol, Tsukuba, Ibaraki 3058575, Japan; [Abei, Masato; Fukuda, Kuniaki] Univ Tsukuba, Dept Gastroenterol, Tsukuba, Ibaraki 3058575, Japan	Sakurai, H (reprint author), Univ Tsukuba, Dept Radiat Oncol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	hsakurai@pmrc.tsukuba.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [24390286, 24659556, 25861064, 24591832]	This work was supported by Grants-in-Aid for Scientific Research (B) (24390286), Challenging Exploratory Research (24659556), Young Scientists (B) (25861064), and Scientific Research (C) (24591832) from the Ministry of Education, Science, Sports and Culture of Japan.	Andre T, 2008, BRIT J CANCER, V99, P862, DOI 10.1038/sj.bjc.6604628; Sugahara S, 2009, STRAHLENTHER ONKOL, V185, P782, DOI 10.1007/s00066-009-2020-x; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Ebata T, 2009, BRIT J SURG, V96, P926, DOI 10.1002/bjs.6655; Kuhlmann JB, 2013, CURR OPIN GASTROEN, V29, P324, DOI 10.1097/MOG.0b013e32835d9dea; Tsunashima Y, 2004, INT J RADIAT ONCOL, V60, P951, DOI 10.1016/j.ijrobp.2004.06.026; Fukumitsu N, 2009, INT J RADIAT ONCOL, V74, P831, DOI 10.1016/j.ijrobp.2008.10.073; Paganetti H, 2002, INT J RADIAT ONCOL, V53, P407, DOI 10.1016/S0360-3016(02)02754-2; Sasaki T, 2010, CANCER CHEMOTH PHARM, V65, P1101, DOI 10.1007/s00280-009-1115-5; Shinohara ET, 2008, INT J RADIAT ONCOL, V72, P1495, DOI 10.1016/j.ijrobp.2008.03.018; Mizumoto M, 2011, INT J RADIAT ONCOL, V81, P1039, DOI 10.1016/j.ijrobp.2010.07.015; Mizumoto M, 2008, INT J RADIAT ONCOL, V71, P462, DOI 10.1016/j.ijrobp.2007.09.056; Kopek N, 2010, RADIOTHER ONCOL, V94, P47, DOI 10.1016/j.radonc.2009.11.004; Riechelmann RR, 2007, CANCER, V110, P1307, DOI 10.1002/cncr.22902; Polistina FA, 2011, RADIOTHER ONCOL, V99, P120, DOI 10.1016/j.radonc.2011.05.016; Wang YZ, 2013, J CLIN ONCOL, V31, P1188, DOI 10.1200/JCO.2012.41.5984; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; Ray CE, 2013, J VASC INTERV RADIOL, V24, P1218, DOI 10.1016/j.jvir.2013.03.019; Park J, 2009, GUT LIVER, V3, P298, DOI 10.5009/gnl.2009.3.4.298; [Anonymous], 2013, COMM TERM CRIT ADV E; Fu Y, 2011, CHINESE J CANCER RES, V23, P295, DOI 10.1007/s11670-011-0295-9; Hata M, 2006, CANCER, V107, P591, DOI 10.1002/cncr.22039; Hata M, 2007, INT J RADIAT ONCOL, V68, P786, DOI 10.1016/j.ijrobp.2006.12.063; Hata M, 2005, CANCER, V104, P794, DOI 10.1002/cncr.21237; Hata M, 2007, INT J RADIAT ONCOL, V69, P805, DOI 10.1016/j.ijrobp.2007.04.016; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim YJ, 2008, ANN ONCOL, V19, P99, DOI 10.1093/annonc/mdm439; Mizumoto M, 2007, JPN J CLIN ONCOL, V37, P459, DOI 10.1093/jjco/hym038; Nakayama H, 2011, INT J RADIAT ONCOL, V80, P992, DOI 10.1016/j.ijrobp.2010.03.015; Nakayama H, 2009, CANCER, V115, P5499, DOI 10.1002/cncr.24619; Ohtsuka Masayuki, 2003, J Hepatobiliary Pancreat Surg, V10, P259, DOI 10.1007/s00534-002-0724-8; Oshiro Y, 2011, RADIOTHER ONCOL, V99, P124, DOI 10.1016/j.radonc.2011.05.009; Sugahara S, 2010, INT J RADIAT ONCOL, V76, P460, DOI 10.1016/j.ijrobp.2009.02.030; Sulpice L, 2013, BRIT J SURG, V99, P1711	34	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	MAY	2015	30	5					957	963		10.1111/jgh.12843		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF8JF	WOS:000352803400025		
J	Otsuka, R; Natsume, T; Maruyama, T; Tanaka, H; Matsuzaki, H				Otsuka, Ryota; Natsume, Toshiyuki; Maruyama, Takashi; Tanaka, Hajime; Matsuzaki, Hiroshi			Antecolic Reconstruction Is a Predictor of the Occurrence of Roux Stasis Syndrome After Distal Gastrectomy	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						Roux stasis syndrome; Delayed gastric emptying; Distal gastrectomy	EN-Y RECONSTRUCTION; GASTRIC-CANCER; CONTROLLED-TRIAL; GASTROJEJUNOSTOMY; ANASTOMOSIS; MOTILITY; LIMB; REFLUX	Roux-en-Y reconstruction after distal gastrectomy can result in delayed gastric emptying, called Roux stasis syndrome (RSS). The cause of RSS has not been completely identified. This study retrospectively investigated the development of RSS. Between April 2008 and March 2014, we performed 138 procedures with distal gastrectomy using Roux-en-Y reconstruction. The development of RSS was analyzed and examined for correlations with the length of the operation, amount of blood loss, and surgical procedure. RSS was observed in 16 of the 138 patients. There were no relationships between the length of the operation or amount of blood loss and the development of RSS according to the Mann-Whitney U test. There were also no significant differences in the development of RSS between the patients treated with laparotomy and laparoscopic surgery, end-to-side, side-to-side, or end-to-end anastomosis or isoperistaltic or antiperistaltic anastomosis, as determined using the chi-square test. However, the development of RSS tended to lower in the patients who underwent laparoscopic surgery, side-to-side anastomosis, and isoperistaltic anastomosis. In addition, there was a significant difference between the patients who received antecolic and retrocolic reconstruction (p = 0.005). Our findings suggest that antecolic reconstruction correlates with a lower likelihood of developing RSS.	[Otsuka, Ryota; Natsume, Toshiyuki; Maruyama, Takashi; Tanaka, Hajime; Matsuzaki, Hiroshi] Funabashi Municipal Med Ctr, Dept Surg, Funabashi, Chiba 2738588, Japan	Otsuka, R (reprint author), Funabashi Municipal Med Ctr, Dept Surg, 1-21-1 Kanasugi, Funabashi, Chiba 2738588, Japan.	antique_ryo2@hotmail.com					Tani M, 2006, ANN SURG, V243, P316, DOI 10.1097/01.sla.0000201479.84934.ca; MIEDEMA BW, 1992, GASTROENTEROLOGY, V103, P1133; Hoya Y, 2009, SURG TODAY, V39, P647, DOI 10.1007/s00595-009-3964-2; BarNatan M, 1996, AM J SURG, V172, P24, DOI 10.1016/S0002-9610(96)00048-7; Bergamaschi R, 2002, SURG LAPARO ENDO PER, V12, P393, DOI 10.1097/00129689-200212000-00002; BRITTON JP, 1987, BRIT J SURG, V74, P900, DOI 10.1002/bjs.1800741010; Fujita T, 2010, J GASTROINTEST SURG, V14, P289, DOI 10.1007/s11605-009-1082-5; Fukuhara K, 2003, WORLD J SURG, V27, P567, DOI 10.1007/s00268-003-6796-z; Fukuhara K, 2002, WORLD J SURG, V26, P1452, DOI 10.1007/s00268-002-6363-z; GUSTAVSSON S, 1988, AM J SURG, V155, P490, DOI 10.1016/S0002-9610(88)80120-X; HERMONTA.J, 1971, GUT, V12, P40, DOI 10.1136/gut.12.1.40; HERRINGTON JL, 1984, ANN SURG, V199, P590, DOI 10.1097/00000658-198405000-00014; Hirao M, 2009, WORLD J SURG, V33, P290, DOI 10.1007/s00268-008-9828-x; Hirono S, 2014, SURGERY, V76, P125; Masui T, 2012, GASTRIC CANCER, V15, P281, DOI 10.1007/s10120-011-0107-4; MATHIAS JR, 1985, GASTROENTEROLOGY, V88, P101; MIEDEMA BW, 1992, ARCH SURG-CHICAGO, V127, P295; Mimae T, 2008, JPN J GASTROENTEROL, V41, P1551; OUUTI K, 1979, AM J SURG, V137, P332, DOI 10.1016/0002-9610(79)90061-8; VANDERMIJLE HCJ, 1993, AM J SURG, V166, P11, DOI 10.1016/S0002-9610(05)80574-4	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	MAY	2015	19	5					821	824		10.1007/s11605-015-2770-y		4	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG3RX	WOS:000353198400004		
J	Kimura, N; Toyoki, Y; Ishido, K; Kudo, D; Yakoshi, Y; Tsutsumi, S; Miura, T; Wakiya, T; Hakamada, K				Kimura, Norihisa; Toyoki, Yoshikazu; Ishido, Keinosuke; Kudo, Daisuke; Yakoshi, Yuta; Tsutsumi, Shinji; Miura, Takuya; Wakiya, Taiichi; Hakamada, Kenichi			Perioperative Blood Transfusion as a Poor Prognostic Factor After Aggressive Surgical Resection for Hilar Cholangiocarcinoma	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						Hilar cholangiocarcinoma; Aggressive surgery; Hepatectomy; Prognosis; Blood transfusion	PORTAL-VEIN EMBOLIZATION; BILE-DUCT CARCINOMA; BILIARY-TRACT CANCER; LONG-TERM SURVIVAL; COLORECTAL-CANCER; HEPATOCELLULAR-CARCINOMA; EXTENDED HEPATECTOMY; HEPATIC RESECTION; LIVER RESECTION; EXTRAHEPATIC CHOLANGIOCARCINOMA	Blood transfusion is linked to a negative outcome for malignant tumors. The aim of this study was to evaluate aggressive surgical resection for hilar cholangiocarcinoma (HCCA) and assess the impact of perioperative blood transfusion on long-term survival. Sixty-six consecutive major hepatectomies with en bloc resection of the caudate lobe and extrahepatic bile duct for HCCA were performed using macroscopically curative resection at our institute from 2002 to 2012. Clinicopathologic factors for recurrence and survival were retrospectively assessed. Overall survival rates at 1, 3, and 5 years were 86.7, 47.3, and 35.7 %, respectively. In univariate analysis, perioperative blood transfusion and a histological positive margin were two of several variables found to be significant prognostic factors for recurrence or survival (P < 0.05). In multivariate analysis, only perioperative blood transfusion was independently associated with recurrence (hazard ratio (HR) = 2.839 (95 % confidence interval (CI), 1.370-5.884), P = 0.005), while perioperative blood transfusion (HR = 3.383 (95 % CI, 1.499-7.637), P = 0.003) and R1 resection (HR = 3.125 (95 % CI, 1.025-9.530), P = 0.045) were independent risk factors for poor survival. Perioperative blood transfusion is a strong predictor of poor survival after radical hepatectomy for HCCA. We suggest that circumvention of perioperative blood transfusion can play an important role in long-term survival for patients with HCCA.	[Kimura, Norihisa; Toyoki, Yoshikazu; Ishido, Keinosuke; Kudo, Daisuke; Yakoshi, Yuta; Tsutsumi, Shinji; Miura, Takuya; Wakiya, Taiichi; Hakamada, Kenichi] Hirosaki Univ, Grad Sch Med, Dept Surg Gastroenterol, Hirosaki, Aomori 0368562, Japan	Kimura, N (reprint author), Hirosaki Univ, Grad Sch Med, Dept Surg Gastroenterol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	norihisa@cc.hirosaki-u.ac.jp					Albores-Saavedra J, 2000, TUMORS GALLBLADDER E; FONG YM, 1994, AM J SURG, V167, P256, DOI 10.1016/0002-9610(94)90087-6; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Miyazaki M, 2007, SURGERY, V141, P581, DOI 10.1016/j.surg.2006.09.016; Liu CL, 2006, BRIT J SURG, V93, P1488, DOI 10.1002/bjs.5482; Hyung WJ, 2002, ANN SURG ONCOL, V9, P5, DOI 10.1245/aso.2002.9.1.5; Klempnauer J, 1997, J CLIN ONCOL, V15, P947; Kooby DA, 2003, ANN SURG, V237, P860; Endo I, 2008, ANN SURG ONCOL, V15, P2104, DOI 10.1245/s10434-008-0003-2; BURROWS L, 1982, LANCET, V2, P662; Shiba H, 2009, J GASTROINTEST SURG, V13, P1636, DOI 10.1007/s11605-009-0963-y; Imamura H, 1999, HEPATOLOGY, V29, P1099, DOI 10.1002/hep.510290415; Neuhaus P, 1999, ANN SURG, V230, P808, DOI 10.1097/00000658-199912000-00010; Igami T, 2010, J HEPATO-BIL-PAN SCI, V17, P449, DOI 10.1007/s00534-009-0209-0; Su CH, 1996, ANN SURG, V223, P384, DOI 10.1097/00000658-199604000-00007; de Boer MT, 2007, DIGEST SURG, V24, P259, DOI 10.1159/000103656; Igami T, 2009, ANN SURG, V249, P296, DOI 10.1097/SLA.0b013e318190a647; STEPHENSON KR, 1988, ANN SURG, V208, P679, DOI 10.1097/00000658-198812000-00002; Shimizu H, 2010, ANN SURG, V251, P281, DOI 10.1097/SLA.0b013e3181be0085; Asahara T, 1999, WORLD J SURG, V23, P676; NAGINO M, 1995, HEPATOLOGY, V21, P434, DOI 10.1016/0270-9139(95)90104-3; Kawasaki S, 2003, ANN SURG, V238, P84, DOI 10.1097/01.SLA.0000074984.83031.02; Ito F, 2008, ANN SURG, V248, P273, DOI 10.1097/SLA.0b013e31817f2bfd; YAMAMOTO J, 1994, SURGERY, V115, P303; Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14; Millikan KW, 1999, AM SURGEON, V65, P618; Nagino M, 2010, ANN SURG, V252, P115, DOI 10.1097/SLA.0b013e3181e463a7; Ebata T, 2003, ANN SURG, V238, P720, DOI 10.1097/01.sla.0000094437.68038.a3; Mullen JT, 2007, J AM COLL SURGEONS, V204, P854, DOI 10.1016/j.jamcollsurg.2006.12.032; KAPLAN J, 1984, BLOOD, V64, P308; Ito F, 2009, ANN SURG, V250, P210, DOI 10.1097/SLA.0b013e3181afe0ab; Wang CC, 2009, ANN SURG ONCOL, V16, P1832, DOI 10.1245/s10434-009-0448-y; Jarnagin WR, 2005, ANN SURG, V241, P703, DOI 10.1097/01.sla.0000160817.94472.fd; Gerhards MF, 2000, SURGERY, V127, P395, DOI 10.1067/msy.2000.104250; Hasegawa S, 2007, WORLD J SURG, V31, P1256, DOI 10.1007/s00268-007-9001-y; GASCON P, 1984, ANN INTERN MED, V100, P173; Abdalla EK, 2002, ARCH SURG-CHICAGO, V137, P675, DOI 10.1001/archsurg.137.6.675; Kneuertz PJ, 2011, ANN SURG ONCOL, V18, P1327, DOI 10.1245/s10434-010-1476-3; Hemming AW, 2005, ANN SURG, V241, P693, DOI 10.1097/01.sla.0000160701.38945.82; Ueda M, 2009, WORLD J SURG, V33, P104, DOI 10.1007/s00268-008-9807-2; KANEDA M, 1987, TRANSFUSION, V27, P375, DOI 10.1046/j.1537-2995.1987.27587320526.x; TARTTER PI, 1992, ANN SURG, V216, P633, DOI 10.1097/00000658-199212000-00004; Nuzzo G, 2012, ARCH SURG-CHICAGO, V147, P26, DOI 10.1001/archsurg.2011.771; Kosuge T, 1999, ANN SURG, V230, P663, DOI 10.1097/00000658-199911000-00008; Goeppert B, 2013, BRIT J CANCER, V109, P2665, DOI 10.1038/bjc.2013.610; Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c; Nakanishi Y, 2010, J HEPATO-BIL-PAN SCI, V17, P166, DOI 10.1007/s00534-009-0127-1; PETERS WR, 1989, DIS COLON RECTUM, V32, P749, DOI 10.1007/BF02562122; GOZZETTI G, 1995, BRIT J SURG, V82, P1105, DOI 10.1002/bjs.1800820833; MAKUUCHI M, 1990, SURGERY, V107, P521; Poon RTP, 2001, ANN SURG, V234, P63, DOI 10.1097/00000658-200107000-00010; Seyama Y, 2003, ANN SURG, V238, P73, DOI 10.1097/01.SLA.0000074960.55004.72; Yeh JJ, 2007, BRIT J SURG, V94, P466, DOI 10.1002/bjs.5488; Uesaka K, 1996, ANN SURG, V223, P77, DOI 10.1097/00000658-199601000-00011; HEISS MM, 1994, J CLIN ONCOL, V12, P1859; Kitagawa Y, 2001, ANN SURG, V233, P385, DOI 10.1097/00000658-200103000-00013; Nagino M, 2005, SURGERY, V137, P148, DOI 10.1016/j.surg.2004.06.006; BLUMBERG N, 1985, BRIT MED J, V290, P1037; BUSCH ORC, 1995, EUR J CANCER, V31A, P1226, DOI 10.1016/0959-8049(95)00174-H; CAMERON JL, 1991, AM J SURG, V161, P120, DOI 10.1016/0002-9610(91)90371-J; FOSTER RS, 1985, CANCER, V55, P1195, DOI 10.1002/1097-0142(19850315)55:6<1195::AID-CNCR2820550610>3.0.CO;2-H; Gomez D, 2008, J SURG ONCOL, V98, P371, DOI 10.1002/jso.21103; International Union Against Cancer, 2009, TNM CLASSIFICATION M; Jarnagin WR, 2001, ANN SURG, V234, P507; Klempnauer J, 1997, CANCER, V79, P26, DOI 10.1002/(SICI)1097-0142(19970101)79:1<26::AID-CNCR5>3.0.CO;2-K; Launois B, 1999, ANN SURG, V230, P266, DOI 10.1097/00000658-199908000-00018; Miyazaki M, 1998, SURGERY, V123, P131, DOI 10.1067/msy.1998.85440; NIMURA Y, 1990, WORLD J SURG, V14, P535; NIMURA Y, 1991, HEPATO-GASTROENTEROL, V38, P170; NIMURA Y, 1991, BRIT J SURG, V78, P727, DOI 10.1002/bjs.1800780629; Ojima H, 2009, CANCER SCI, V100, P62, DOI 10.1111/j.1349-7006.2008.01009.x; OPELZ G, 1978, NEW ENGL J MED, V299, P369, DOI 10.1056/NEJM197808242990801; PARROT NR, 1986, BRIT J SURG, V73, P970, DOI 10.1002/bjs.1800731208; Rea DJ, 2005, ANN SURG, V242, P451, DOI 10.1097/01.sla.0000179678.13285.fa; Regimbeau JM, 2011, J GASTROINTEST SURG, V15, P480, DOI 10.1007/s11605-011-1414-0; Sakamoto Y, 2006, LANGENBECK ARCH SURG, V391, P203, DOI 10.1007/s00423-006-0026-8; Sasaki R, 2007, WORLD J SURG, V31, P1788, DOI 10.1007/s00268-007-9102-7; Todoroki T, 2000, BRIT J SURG, V87, P306, DOI 10.1046/j.1365-2168.2000.01343.x; Tsao JI, 2000, ANN SURG, V232, P166, DOI 10.1097/00000658-200008000-00003; Upile T, 2011, EUR ARCH OTO-RHINO-L, V268, P1789, DOI 10.1007/s00405-011-1525-y; VOOGT PJ, 1987, CANCER, V59, P836, DOI 10.1002/1097-0142(19870215)59:4<836::AID-CNCR2820590430>3.0.CO;2-S; Wakai T, 2005, CANCER, V103, P1210, DOI 10.1002/cncr.20906; WASHBURN WK, 1995, ARCH SURG-CHICAGO, V130, P270; Young AL, 2011, HPB, V13, P483, DOI 10.1111/j.1477-2574.2011.00328.x	84	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	MAY	2015	19	5					866	879		10.1007/s11605-014-2741-8		14	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG3RX	WOS:000353198400010		
J	Murata, A; Mayumi, T; Muramatsu, K; Ohtani, M; Matsuda, S				Murata, Atsuhiko; Mayumi, Toshihiko; Muramatsu, Keiji; Ohtani, Makoto; Matsuda, Shinya			Effect of Hospital Volume on Outcomes of Laparoscopic Appendectomy for Acute Appendicitis: an Observational Study	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						Laparoscopic appendectomy; Acute appendicitis; Hospital volume; Outcomes; Administrative database	NATIONAL ADMINISTRATIVE DATABASE; ENDOSCOPIC SUBMUCOSAL DISSECTION; INPATIENT SAMPLE NIS; GASTRIC-CANCER; SINGLE-INCISION; ACUTE-PANCREATITIS; UNITED-STATES; TIME TREND; EPIDEMIOLOGY; METAANALYSIS	This study investigated the effect of hospital volume on outcomes of laparoscopic appendectomy for acute appendicitis. In total, 30,525 patients who underwent laparoscopic appendectomy for acute appendicitis were referred to 825 hospitals in Japan from 2010 to 2012. We compared appendectomy-related complications, length of stay (LOS), and medical costs in relation to hospital volume. For this study period, hospitals were categorized as low-volume hospitals (LVHs, < 50 cases), medium-volume hospitals (MVHs, 50-100 cases), or high-volume hospitals (HVHs, > 100 cases). Significant differences in appendectomy-related complications were observed among the LVHs, MVHs, and HVHs (6.9, 7.2, and 6.0 %, respectively; p = 0.001). Multiple logistic regression revealed that HVHs were associated with a lower relative risk of appendectomy-related complications than were LVHs and MVHs (odds ratio [OR], 0.84; 95 % confidence interval [CI], 0.74-0.95; p = 0.006). Multiple linear regression showed that HVHs were associated with shorter LOS and lower medical costs than were LVHs and MVHs. The unstandardized coefficient for LOS was -0.92 days (95 % CI, -1.07 to -0.78; p < 0.001), whereas that for medical costs was -aEuro parts per thousand$167.4 (95 % CI, -256.2 to -78.6; p < 0.001). Hospital volume was significantly associated with laparoscopic appendectomy outcomes.	[Murata, Atsuhiko; Muramatsu, Keiji; Ohtani, Makoto; Matsuda, Shinya] Univ Occupat & Environm Hlth, Sch Med, Dept Prevent Med & Community Hlth, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Mayumi, Toshihiko] Univ Occupat & Environm Hlth, Dept Emergency Med, Kitakyushu, Fukuoka 8078555, Japan	Murata, A (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Prevent Med & Community Hlth, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	amurata@med.uoeh-u.ac.jp			Ministry of Health, Labour and Welfare, Japan	This study was funded by Grants-in-Aid for Research on Policy Planning and Evaluation from the Ministry of Health, Labour and Welfare, Japan.	Andersson M, 2014, WORLD J SURG, V38, P2777, DOI 10.1007/s00268-014-2708-7; Andersson RE, 2013, WORLD J SURG, V37, P974, DOI 10.1007/s00268-012-1856-x; Wei B, 2011, SURG ENDOSC, V25, P1199, DOI 10.1007/s00464-010-1344-z; Murata A, 2014, SURG ENDOSC, V28, P1298, DOI 10.1007/s00464-013-3326-4; Markar SR, 2013, BRIT J SURG, V100, P1709, DOI 10.1002/bjs.9296; Murata A, 2014, J THROMB THROMBOLYS, V38, P364, DOI 10.1007/s11239-014-1068-3; Cudnik MT, 2012, RESUSCITATION, V83, P862, DOI 10.1016/j.resuscitation.2012.02.006; Vons C, 2011, LANCET, V377, P1573, DOI 10.1016/S0140-6736(11)60410-8; Eappen S, 2013, JAMA-J AM MED ASSOC, V309, P1599, DOI 10.1001/jama.2013.2773; Murata A, 2012, DIGEST LIVER DIS, V44, P143, DOI 10.1016/j.dld.2011.08.011; Murata A, 2014, J SURG RES, V186, P157, DOI 10.1016/j.jss.2013.09.015; Anderson JE, 2012, WORLD J SURG, V36, P2787, DOI 10.1007/s00268-012-1749-z; Murata A, 2014, GASTRIC CANCER, V17, P294, DOI 10.1007/s10120-013-0282-6; Pisanu A, 2013, J SURG RES, V183, pE49, DOI 10.1016/j.jss.2013.03.038; Buckius MT, 2012, J SURG RES, V175, P185, DOI 10.1016/j.jss.2011.07.017; Lee JH, 2010, J EPIDEMIOL, V20, P97, DOI 10.2188/jea.JE20090011; Moazzez A, 2013, SURG ENDOSC, V27, P1061, DOI 10.1007/s00464-012-2557-0; Mazzaglia G, 2009, CIRCULATION, V120, P1598, DOI 10.1161/CIRCULATIONAHA.108.830299; Murata A, 2011, PANCREAS, V40, P1018, DOI 10.1097/MPA.0b013e31821bd233; Papandria D, 2012, J SURG EDUC, V69, P149, DOI 10.1016/j.jsurg.2011.08.003; Masoomi H, 2012, WORLD J SURG, V36, P573, DOI 10.1007/s00268-011-1417-8; Chu T, 2011, SURG ENDOSC, V25, P1187, DOI 10.1007/s00464-010-1342-1; Casella F, 2011, INTERN EMERG MED, V6, P557, DOI 10.1007/s11739-011-0694-4; Chase DM, 2008, AM J OBSTET GYNECOL, V199, pe1; Emmanuel A, 2011, Ir Med J, V104, P276; Feinberg EJ, 2011, AM SURGEON, V77, P286; Kim MG, 2014, SURG ENDOSC, V28, P1563, DOI 10.1007/s00464-013-3352-2; Kong VY, 2012, WORLD J SURG, V36, P2068, DOI 10.1007/s00268-012-1626-9; Kuwabara K, 2008, CLIN TER, V159, P155; Lin FR, 2001, INT J MED INFORM, V62, P11, DOI 10.1016/S1386-5056(01)00126-5; Masoomi H, 2014, AM SURGEON, V80, P1074; McCartan DP, 2012, COLORECTAL DIS, V14, P243, DOI 10.1111/j.1463-1318.2011.02597.x; Murata A, 2011, MED CARE, V49, P313, DOI 10.1097/MLR.0b013e3182028954; Murata A, 2014, TOHOKU J EXP MED, V233, P9, DOI 10.1620/tjem.233.9; Murata A, 2013, GERIATR GERONTOL INT, V13, P731, DOI 10.1111/j.1447-0594.2012.00938.x; Murata A, 2010, J GASTROENTEROL, V45, P1090, DOI 10.1007/s00535-010-0257-x; Murata A, 2014, J DIGEST DIS, V15, P62, DOI 10.1111/1751-2980.12106; Smink DS, 2004, PEDIATRICS, V113, P18, DOI 10.1542/peds.113.1.18; Varadhan KK, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2156; Wei HB, 2010, SURG ENDOSC, V24, P266, DOI 10.1007/s00464-009-0563-7; Zhan C, 2003, QUAL SAF HLTH CAR S2, V12, pii58	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	MAY	2015	19	5					897	904		10.1007/s11605-015-2746-y		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG3RX	WOS:000353198400013		
J	Wakabayashi, G				Wakabayashi, Go			Systematic reviews from the 2nd International Consensus Conference on Laparoscopic Liver Resection	Journal of Hepato-Biliary-Pancreatic Sciences			English	Editorial Material									Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 0208505, Japan	Wakabayashi, G (reprint author), Iwate Med Univ, Sch Med, Dept Surg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	go324@mac.com					Hasegawa Y, 2015, J HEPATO-BIL-PAN SCI, V22, P335, DOI 10.1002/jhbp.214; Morise Z, 2015, J HEPATO-BIL-PAN SCI, V22, P342, DOI 10.1002/jhbp.215; Otsuka Y, 2015, J HEPATO-BIL-PAN SCI, V22, P363, DOI 10.1002/jhbp.216; Hallet J, 2015, J HEPATO-BIL-PAN SCI, V22, P353, DOI 10.1002/jhbp.220; Lesurtel M, 2014, SURGERY, V155, P390, DOI 10.1016/j.surg.2013.10.003; Scatton O, 2015, J HEPATO-BIL-PAN SCI, V22, P327, DOI 10.1002/jhbp.213; Tranchart H, 2015, J HEPATO-BIL-PAN SCI, V22, P371, DOI 10.1002/jhbp.217; Wakabayashi G, 2015, ANN SURG, V261, P619, DOI 10.1097/SLA.0000000000001180	8	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	MAY	2015	22	5					325	326		10.1002/jhbp.230		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CT	WOS:000353460500001		
J	Scatton, O; Brustia, R; Belli, G; Pekolj, J; Wakabayashi, G; Gayet, B				Scatton, Olivier; Brustia, Raffaele; Belli, Giulio; Pekolj, Juan; Wakabayashi, Go; Gayet, Brice			What kind of energy devices should be used for laparoscopic liver resection? Recommendations from a systematic review	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Energy device; Laparoscopy; Liver surgery; Liver tumor; Sealing; Transection	RADIO-FREQUENCY ABLATION; VESSEL-SEALING DEVICE; PORCINE MODEL; RADIOFREQUENCY; HEPATECTOMY; TRANSECTION; EXPERIENCE; CONSENSUS	Transection methods and hemostasis achievement have an impact on blood loss, and consequently on outcome and survival. However, no consensus exists on parenchymal transection or hemostasis techniques in laparoscopic liver resection (LLR). The aim of this review is to clarify the role of energy devices (ED) in LLR. ED is a generator of mechanic or electric energy transfer to an operating tool, used for transection, sealing or both. Searches were performed in PubMed, PubMed Central, Cochrane, Embase, Google Scholar in human or animal experimental models. Each study quality was graded following the GRADE system. From 1996 to 2014, 30 studies were found: five comparative, one prospective, two case-control, and 16 case series and some case reports, with level of evidence ranging from Moderate to Very Low. Since 2012, the Research and Development of new tools raised quicker than clinical studies could follow. The two main techniques emerged are blind transection versus sharp dissection: due to the low quality and heterogeneity of the studies, no firm conclusion can be drawn, but meticulous dissection of vessels usually never leads to vascular damage. As a matter of fact, ED, though efficient and reliable, cannot replace the basic skills of hepatic surgery: sharp dissection, vascular control and elective sealing.	[Scatton, Olivier; Brustia, Raffaele] Hop La Pitie Salpetriere, Dept Hepatobiliary & Liver Transplantat Surg, F-75013 Paris, France; [Scatton, Olivier; Brustia, Raffaele] Univ Paris 06, Paris, France; [Belli, Giulio] Nuovo Loreto Hosp, Dept Gen HPB & Emergency Surg, Naples, Italy; [Pekolj, Juan] Hosp Italiano Buenos Aires, Dept Gen Surg, Buenos Aires, DF, Argentina; [Wakabayashi, Go] Iwate Med Univ, Dept Surg, Morioka, Iwate, Japan; [Gayet, Brice] Inst Mutualiste Montsouris, Dept Laparoscop Surg, Paris, France	Scatton, O (reprint author), Hop La Pitie Salpetriere, Dept Hepatobiliary & Liver Transplantat Surg, 47-83 Blvd Hop, F-75013 Paris, France.	olivier.scatton@gmail.com					Abdouljods MS, 2008, SURG ENDOSC, V22, P426; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Aldrighetti L, 2008, AM J SURG, V195, P270, DOI 10.1016/j.amjsurg.2007.02.022; Akyildiz HY, 2011, SURG ENDOSC, V25, P1143, DOI 10.1007/s00464-010-1330-5; Lesurtel M, 2005, ANN SURG, V242, P814, DOI 10.1097/01.sla.0000189121.35617.d7; Ikegami T, 2009, J HEPATO-BILIARY-PAN, V16, P394, DOI 10.1007/s00534-008-0039-5; Bachellier P, 2007, AM J SURG, V193, P427, DOI 10.1016/j.amjsurg.2006.06.046; Berber E, 2014, SURG ENDOSC, V28, P974, DOI 10.1007/s00464-013-3262-3; Buell JF, 2013, HPB, V15, P845, DOI 10.1111/hpb.12043; Campagnacci R, 2007, SURG ENDOSC, V21, P2280, DOI 10.1007/s00464-007-9384-8; Croce E, 2003, HEPATO-GASTROENTEROL, V50, P2088; Dulucq JL, 2007, SURG LAPARO ENDO PER, V17, P413; Felekouras E, 2005, SURG ENDOSC, V19, P1237, DOI 10.1007/s00464-004-2260-x; Frenkens C, 2014, JAMA SURG, V149, P941; Gumbs AA, 2008, HPB, V10, P296, DOI 10.1080/13651820802166773; Gurusamy KS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007629; Hompes D, 2007, SURG ENDOSC, V21, P175, DOI 10.1007/s00464-005-0846-6; Imuras S, 2008, SURG ENDOSC, V22, P272; Kamiyama T, 2005, J HEPATO-BILIARY-PAN, V12, P49, DOI 10.1007/s00534-004-0934-3; Matern U, 1996, MINIM INVASIV THER, V5, P5, DOI 10.3109/13645709609153273; Mbah NA, 2012, HPB, V14, P126, DOI 10.1111/j.1477-2574.2011.00414.x; Mortensen MR, 2014, DAN MED J, V61; Nanashima A, 2013, INT J SURG, V11, P891, DOI 10.1016/j.ijsu.2013.07.012; Navarro A, 2008, SURG ENDOSC, V22, P1384, DOI 10.1007/s00464-008-9793-3; Sarpels U, 2012, REPORTS SURG TECHNOL, VXXII; Slakey DP, 2008, HPB, V10, P253, DOI 10.1080/13651820802166880; Somasundar P, 2009, HPB, V11, P145, DOI 10.1111/j.1477-2574.2009.00026.x; Sotiropoulos GC, 2013, WORLD J GASTROENTERO, V19, P5929, DOI 10.3748/wjg.v19.i35.5929; Toyama Y, 2006, J HEPATO-BILIARY-PAN, V13, P317, DOI 10.1007/s00534-005-1071-3; Tsalis K, 2007, SURG LAPARO ENDO PER, V17, P22, DOI 10.1097/01.sle.0000213757.53890.57; Uchiyama H, 2013, SURG LAPARO ENDO PER, V23, pE116, DOI 10.1097/SLE.0b013e3182806535; Wakabayashi G, 2014, J HEPATO-BIL-PAN SCI, V21, P723, DOI 10.1002/jhbp.139; Weber J C, 2003, Surg Endosc, V17, P834; Yaos P, 2007, ANZ J SURG, V77, P480	34	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	MAY	2015	22	5					327	334		10.1002/jhbp.213		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CT	WOS:000353460500002		
J	Hasegawa, Y; Koffron, AJ; Buell, JF; Wakabayashi, G				Hasegawa, Yasushi; Koffron, Alan J.; Buell, Joseph F.; Wakabayashi, Go			Approaches to laparoscopic liver resection: a meta-analysis of the role of hand-assisted laparoscopic surgery and the hybrid technique	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Hand-assisted; Hepatectomy; Hybrid; Laparoscopic liver resection; Laparoscopy-assisted	HEPATIC RESECTION; HEPATECTOMY; FEASIBILITY; LAPAROTOMY; EXPERIENCE; TUMORS	Laparoscopic liver resection has been established as a safe and feasible treatment option. Surgical approaches include pure laparoscopy, hand-assisted laparoscopy (HALS), and the hybrid technique. The role of these three approaches, and their superiority over open laparotomy, is not yet known. A literature review was performed using specific search phrases, relating to hand-assisted or hybrid approaches to laparoscopic liver resection. Surgical results from 18 case series (HALS, nine series; hybrid technique, nine series), each with 10 patients, were analyzed. Results indicated that HALS was associated with a mean operative time of 82-264.5min, an estimated blood loss of 82-300mL, and a complication rate of 3.8-27.1%. Analysis of series involving the hybrid technique indicated a mean operative time of 111-366.5min, an estimated blood loss of 93-936mL, and a complication rate of 3.4-23.5%. In conclusion, there is insufficient evidence to conclude that any single approach is superior to the others, although HALS and the hybrid technique are useful when dealing with difficulties associated with pure laparoscopy. Conversely, the need for these two methods, which can function as a bridge to pure laparoscopic liver resection, may be overcome with appropriate training.	[Hasegawa, Yasushi; Wakabayashi, Go] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 0208505, Japan; [Koffron, Alan J.] William Beaumont Hosp, Div Transplantat, Royal Oak, MI 48072 USA; [Buell, Joseph F.] Tulane Univ Med Ctr Hosp & Clin, Tulane Transplant Inst, New Orleans, LA USA; [Buell, Joseph F.] Louisiana State Univ, Med Ctr, New Orleans, LA USA	Hasegawa, Y (reprint author), Iwate Med Univ, Sch Med, Dept Surg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	hasegawayas@yahoo.co.jp					Klarenbeek BR, 2011, SURG ENDOSC, V25, P1121, DOI 10.1007/s00464-010-1327-0; Hasegawa Y, 2013, J HEPATO-BIL-PAN SCI, V20, P525, DOI 10.1007/s00534-012-0591-x; Huang MT, 2009, J GASTROINTEST SURG, V13, P896, DOI 10.1007/s11605-009-0834-6; Buell JF, 2008, ANN SURG, V248, P475, DOI 10.1097/SLA.0b013e318185e647; Cannon RM, 2011, J AM COLL SURGEONS, V213, P501, DOI 10.1016/j.jamcollsurg.2011.04.032; Vigano L, 2009, ANN SURG, V250, P772, DOI 10.1097/SLA.0b013e3181bd93b2; Dagher I, 2009, ANN SURG, V250, P856, DOI 10.1097/SLA.0b013e3181bcaf46; Nguyen KT, 2009, ANN SURG, V250, P831, DOI 10.1097/SLA.0b013e3181b0c4df; Wakabayashi G, 2009, J HEPATO-BILIARY-PAN, V16, P403, DOI 10.1007/s00534-009-0121-7; Nguyen KT, 2009, ANN SURG, V250, P842, DOI 10.1097/SLA.0b013e3181bc789c; Nitta H, 2010, ANN SURG, V251, P450, DOI 10.1097/SLA.0b013e3181cf87da; Nicholson ML, 2010, BRIT J SURG, V97, P21, DOI 10.1002/bjs.6803; Cardinal JS, 2013, J HEPATO-BIL-PAN SCI, V20, P114, DOI 10.1007/s00534-012-0553-3; Buell JF, 2009, ANN SURG, V250, P825, DOI 10.1097/SLA.0b013e3181b3b2d8; Bryant R, 2009, ANN SURG, V250, P103, DOI 10.1097/SLA.0b013e3181ad6660; Robles R, 2008, SURG ENDOSC, V22, P2357, DOI 10.1007/s00464-008-9770-x; Wakabayashi G, 2009, J HEPATO-BILIARY-PAN, V16, P439, DOI 10.1007/s00534-009-0122-6; Reddy SK, 2011, WORLD J SURG, V35, P1478, DOI 10.1007/s00268-010-0906-5; Yoon YS, 2010, SURG ENDOSC, V24, P1630, DOI 10.1007/s00464-009-0823-6; Takiguchi S, 2013, WORLD J SURG, V37, P2379, DOI 10.1007/s00268-013-2121-7; Bans D, 2014, J HEPATOBILIARY PANC, V21, P745; Buell JF, 2005, J AM COLL SURGEONS, V200, P472, DOI 10.1016/j.jamcollsurg.2004.10.017; Chen YL, 2008, INT SURG, V93, P127; Fans ST, 2011, ANN SURG, V253, P745; Itano O, 2009, J HEPATO-BILIARY-PAN, V16, P711, DOI 10.1007/s00534-009-0141-3; Jain A, 2009, LIVER TRANSPLANT, V15, P1488, DOI 10.1002/lt.21850; Johnson LB, 2012, J AM COLL SURGEONS, V214, P717, DOI 10.1016/j.jamcollsurg.2011.12.044; Johnson LB, 2012, J AM COLL SURGEONS, V214, P723; Kobayashi S, 2013, SURG ENDOSC, V27, P610, DOI 10.1007/s00464-012-2499-6; Koffron AJ, 2007, SURGERY, V142, P463, DOI 10.1016/j.surg.2007.08.006; Koffron AJ, 2007, ANN SURG, V246, P392; Koffron AJ, 2007, ANN SURG, V246, P385, DOI 10.1097/SLA.0b013e318146996c; Lins NC, 2013, ANN SURG, V257, P205; Medbery RL, 2014, J AM COLL SURGEONS, V218, P929, DOI 10.1016/j.jamcollsurg.2014.01.045; Nitta H, 2013, J HEPATO-BIL-PAN SCI, V20, P111, DOI 10.1007/s00534-012-0557-z; Poultsides G, 2007, SURG ENDOSC, V21, P1275, DOI 10.1007/s00464-006-9174-8; Soyama A, 2014, SURG ENDOSC, V28, P203, DOI 10.1007/s00464-013-3159-1; Troisi RI, 2014, HPB, V16, P75, DOI 10.1111/hpb.12077	38	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	MAY	2015	22	5					335	341		10.1002/jhbp.214		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CT	WOS:000353460500003		
J	Morise, Z; Ciria, R; Cherqui, D; Chen, KH; Belli, G; Wakabayashi, G				Morise, Zenichi; Ciria, Ruben; Cherqui, Daniel; Chen, Kuo-Hsin; Belli, Giulio; Wakabayashi, Go			Can we expand the indications for laparoscopic liver resection? A systematic review and meta-analysis of laparoscopic liver resection for patients with hepatocellular carcinoma and chronic liver disease	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Chronic liver disease; Hepatocellular carcinoma; Laparoscopic liver resection; Repeat hepatectomy	OPEN HEPATIC RESECTION; INTERNATIONAL CONSENSUS CONFERENCE; CIRRHOTIC-PATIENTS; OPEN HEPATECTOMY; SURGERY; TERM; MORTALITY; BENIGN; RISK; HCC	Liver resection (LR) for patients with hepatocellular carcinoma (HCC) and chronic liver disease (CLD) poses a high risk of serious postoperative complications and multicentric metachronous lesions requiring repeated treatment. The efficacy of laparoscopic LR (LLR) for such patients has yet to be established. The objective of this study is to test the outcomes of LLR for HCC with the aim of considering potential expansion of the indications for LLR. We performed a systematic review of the pertinent English-language literature. Our search yielded four meta-analyses and 23 comparative studies of LLR for HCC. On the basis of the findings from these studies and our newly conducted meta-analysis, the possibility for expanding the indications for LLR to HCC was examined. The studies show that LLR (vs open) for HCC generally yields better short-term outcomes without compromising long-term outcomes, and that incidences of postoperative ascites and liver failure are decreased with LLR. Several studies show the benefits of LLR for patients with severe CLD and for repeat surgery. Reductions of postoperative ascites and liver failure are among the advantages of LLR. These characteristics of LLR may allow us to expand the indications of LLR to HCC with CLD. (c) Japanese Society of	[Morise, Zenichi] Fujita Hlth Univ, Sch Med, Banbuntane Houtokukai Hosp, Dept Surg,Nakagawa Ku, Nagoya, Aichi 4548509, Japan; [Ciria, Ruben; Wakabayashi, Go] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate, Japan; [Ciria, Ruben] Univ Hosp Reina Sofia, Unit Hepatobiliary Surg & Liver Transplantat, IMIBIC, Cordoba, Spain; [Cherqui, Daniel] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France; [Chen, Kuo-Hsin] Far Eastern Mem Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Belli, Giulio] Loreto Nuovo Hosp, Dept Gen & HPB Surg, Naples, Italy	Morise, Z (reprint author), Fujita Hlth Univ, Sch Med, Banbuntane Houtokukai Hosp, Dept Surg,Nakagawa Ku, 3-6-10 Otobashi, Nagoya, Aichi 4548509, Japan.	zmorise@aol.com					Ais J-H, 2013, PLOS ONE, V8; Alemi F, 2010, AM J SURG, V200, P591, DOI 10.1016/j.amjsurg.2010.07.014; Mirnezami R, 2011, HPB, V13, P295, DOI 10.1111/j.1477-2574.2011.00295.x; Kaneko H, 2005, AM J SURG, V189, P190, DOI 10.1016/j.amjsurg.2004.09.010; Nguyen KT, 2011, ARCH SURG-CHICAGO, V146, P348, DOI 10.1001/archsurg.2010.248; Kanazawa A, 2013, SURG ENDOSC, V27, P2592, DOI 10.1007/s00464-013-2795-9; Aldrighetti L, 2010, J SURG ONCOL, V102, P82, DOI 10.1002/jso.21541; Kanazawa A, 2013, J HEPATO-BIL-PAN SCI, V20, P512, DOI 10.1007/s00534-012-0592-9; Hoeper MM, 2004, LANCET, V363, P1461, DOI 10.1016/S0140-6736(04)16107-2; Croome KP, 2010, ARCH SURG-CHICAGO, V145, P1109, DOI 10.1001/archsurg.2010.227; Sarpel U, 2009, ANN SURG ONCOL, V16, P1572, DOI 10.1245/s10434-009-0414-8; Tranchart H, 2010, SURG ENDOSC, V24, P1170, DOI 10.1007/s00464-009-0745-3; Truant S, 2011, SURG ENDOSC, V25, P3668, DOI 10.1007/s00464-011-1775-1; Zhou YM, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-44; Belghiti J, 2000, J AM COLL SURGEONS, V191, P38, DOI 10.1016/S1072-7515(00)00261-1; Capussotti L, 2009, EJSO-EUR J SURG ONC, V35, P11, DOI 10.1016/j.ejso.2007.06.005; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Xiong JJ, 2012, WORLD J GASTROENTERO, V18, P6657, DOI 10.3748/wjg.v18.i45.6657; Ziser A, 1999, ANESTHESIOLOGY, V90, P42, DOI 10.1097/00000542-199901000-00008; Cheung TT, 2013, ANN SURG, V257, P506, DOI 10.1097/SLA.0b013e31827b947a; Laurent A, 2003, ARCH SURG-CHICAGO, V138, P763, DOI 10.1001/archsurg.138.7.763; Kaneko H, 2009, J HEPATO-BILIARY-PAN, V16, P433, DOI 10.1007/s00534-009-0123-5; Mansour A, 1997, SURGERY, V122, P730, DOI 10.1016/S0039-6060(97)90080-5; Belli G, 2009, BRIT J SURG, V96, P1041, DOI 10.1002/bjs.6680; Zhou YM, 2011, DIGEST DIS SCI, V56, P1937, DOI 10.1007/s10620-011-1572-7; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Hwang S, 2010, J HEPATO-BIL-PAN SCI, V17, P443, DOI 10.1007/s00534-009-0241-0; Laurent A, 2009, J HEPATO-BILIARY-PAN, V16, P310, DOI 10.1007/s00534-009-0063-0; Belli G, 2007, SURG ENDOSC, V21, P2004, DOI 10.1007/s00464-007-9503-6; Belli GL, 2009, SURG ENDOSC, V23, P1807, DOI 10.1007/s00464-009-0344-3; Chas CH, 2003, ANN SURG, V238, P315; Endo Yuichi, 2009, Surg Laparosc Endosc Percutan Tech, V19, pe171, DOI 10.1097/SLE.0b013e3181bc4091; Gagner M, 1992, SURG ENDOSC-ULTRAS, V6, P97; Hibi T, 2014, J HEPATO-BIL-PAN SCI, V21, P737, DOI 10.1002/jhbp.141; Hus B-S, 2011, WORLD J GASTROENTERO, V17, P4725; Kers CG, 2011, INT J HEPATOL, V2011; Kims H, 2014, SURG ENDOSC, V28, P950; Kims HH, 2011, J KOREAN SURG SOC, V80, p412 ; Lais EC, 1995, ANN SURG, V221, P291; Lais ECH, 2009, ARCH SURG-CHICAGO, V144, P143; Laus WY, 2003, ANN SURG, V237, P171; Lees KF, 2011, WORLD J SURG, V35, P2268; Lees KF, 2007, HONG KONG MED J, V13, P442; Lis N, 2012, HEPATOL RES, V42, P51; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Memeo R, 2014, WORLD J SURG, V38, P2919, DOI 10.1007/s00268-014-2659-z; Mizuguchi T, 2011, SURG TODAY, V41, P39, DOI 10.1007/s00595-010-4337-6; Morise Z, 2011, Asian J Endosc Surg, V4, P143, DOI 10.1111/j.1758-5910.2011.00081.x; Raos A, 2012, AM J SURG, V204, P222; Raos A, 2011, SURG ENDOSC, V25, P1603; Ryder S. D., 2003, Gut, V52, P1; Shimada M, 2001, SURG ENDOSC-ULTRAS, V15, P541, DOI 10.1007/s004640080099; Simillis C, 2007, SURGERY, V141, P203, DOI 10.1016/j.surg.2006.06.035; Soubrane O, 2014, HPB, V16, P357, DOI 10.1111/hpb.12142; Soubrane O, 2014, ANN SURG, DOI [10.1097/SLA.0000000000000737, DOI 10.1097/SLA.0000000000000737]; Tomishige Hirokazu, 2013, World J Gastrointest Surg, V5, P173, DOI 10.4240/wjgs.v5.i6.173; Torzilli G, 1999, ARCH SURG-CHICAGO, V134, P984, DOI 10.1001/archsurg.134.9.984; Wakabayashi G, 2014, J HEPATO-BIL-PAN SCI, V21, P723, DOI 10.1002/jhbp.139; Weis M, 2014, PLOS ONE, V9; Yins Z, 2013, ANN SURG ONCOL, V20, P1203	60	6	6	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	MAY	2015	22	5					342	352		10.1002/jhbp.215		11	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CT	WOS:000353460500004		
J	Hallet, J; Gayet, B; Tsung, A; Wakabayashi, G; Pessaux, P				Hallet, Julie; Gayet, Brice; Tsung, Allan; Wakabayashi, Go; Pessaux, Patrick		2 Int Consensus Conference	Systematic review of the use of pre-operative simulation and navigation for hepatectomy: current status and future perspectives	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						3D modeling; Image-guided surgery; Laparoscopic hepatectomy; Navigation; Simulation	LIVER SURGERY; HEPATIC RESECTION; IMPACT; TRANSPLANTATION; RECONSTRUCTION; SEGMENTECTOMY; CARCINOMA; SOFTWARE; GUIDANCE; RISK	Pre-operative simulation using three-dimensional (3D) reconstructions have been suggested to enhance surgical planning of hepatectomy. Evidence on its benefits for hepatectomy patients remains limited. This systematic review examined the use and impact of pre-operative simulation and intraoperative navigation on hepatectomy outcomes. A systematical searched electronic databases for studies reporting on the use and results of simulation and navigation for hepatectomy was performed. The primary outcome was change in operative plan based on simulation. Secondary outcomes included operating time (min), estimated blood loss, surgical margins, 30-day postoperative morbidity and mortality, and study-specific outcomes. From 222 citations, we included 11 studies including 497 patients. All were observational cohort studies. No study compared hepatectomy with and without simulation. All studies performed 3D reconstruction and segmentation, most commonly with volumetrics measurements. In six studies reporting intraoperative navigation, five relied on ultrasound, and one on a resection map. Of two studies reporting on it, the resection line was changed intraoperatively in one third of patients, based on simulation. Virtually predicted liver volumes (Pearson correlation r=0.917 to 0.995) and surgical margins (r=0.84 to 0.967) correlated highly with actual ones in eight studies. Heterogeneity of the included studies precluded meta-analysis.Pre-operative simulation seems accurate in measuring volumetrics and surgical margins. Current studies lack intraoperative transposition of simulation for direct navigation. Simulation appears useful planning of hepatectomies, but further work is warranted focusing on the development of improved tools and appraisal of their clinical impact compared to traditional resection.	[Hallet, Julie; Pessaux, Patrick] IRCAD, Strasbourg, France; [Hallet, Julie; Pessaux, Patrick] Univ Strasbourg, Inst Hosp Univ Strasbourg IHU, Inst Minimally Hybrid Invas Image Guided Surg, Strasbourg, France; [Hallet, Julie] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Div Gen Surg, Toronto, ON M4N 3M5, Canada; [Gayet, Brice] Univ Paris 05, Inst Mutualiste Montsouris, Dept Digest Dis, Paris, France; [Tsung, Allan] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Wakabayashi, Go] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 020, Japan; [Pessaux, Patrick] Hop Univ Strasbourg, Nouvel Hop Civil, Pole Hepatodigestif, Strasbourg, France	Pessaux, P (reprint author), Hop Univ Strasbourg, Nouvel Hop Civil, Pole Hepatodigestif, Strasbourg, France.	patrick.pessaux@chru-strasbourg.fr					Zijlmans M, 2012, MINIM INVASIV THER, V21, P241, DOI 10.3109/13645706.2012.665805; Lamade W, 2000, ARCH SURG-CHICAGO, V135, P1256, DOI 10.1001/archsurg.135.11.1256; Ishizawa T, 2012, ANN SURG, V256, P959, DOI 10.1097/SLA.0b013e31825ffed3; Wigmore SJ, 2001, ANN SURG, V233, P221, DOI 10.1097/00000658-200102000-00011; Mullen JT, 2007, J AM COLL SURGEONS, V204, P854, DOI 10.1016/j.jamcollsurg.2006.12.032; Wang Y, 2012, DIGEST SURG, V29, P99, DOI 10.1159/000336289; Chen G, 2010, INT J SURG, V8, P72, DOI 10.1016/j.ijsu.2009.11.005; Lang HK, 2005, ARCH SURG-CHICAGO, V140, P629, DOI 10.1001/archsurg.140.7.629; Kingham TP, 2013, J GASTROINTEST SURG, V17, P1274, DOI 10.1007/s11605-013-2214-5; Martin RCG, 2010, J AM COLL SURGEONS, V210, P627, DOI 10.1016/j.jamcollsurg.2009.12.022; Dagher I, 2010, J AM COLL SURGEONS, V211, P16, DOI 10.1016/j.jamcollsurg.2010.03.012; Takamoto T, 2013, AM J SURG, V206, P530, DOI 10.1016/j.amjsurg.2013.01.041; Leung KL, 2004, LANCET, V363, P1187, DOI 10.1016/S0140-6736(04)15947-3; Saito S, 2005, HEPATOLOGY, V41, P1297, DOI 10.1002/hep.20684; Buchs NC, 2013, J SURG RES, V184, P825, DOI 10.1016/j.jss.2013.04.032; Lujan J, 2013, SURG ENDOSC, V27, P295, DOI 10.1007/s00464-012-2444-8; Yamanaka J, 2006, J HEPATO-BILIARY-PAN, V13, P363, DOI 10.1007/s00534-005-1075-z; Lamata P, 2010, SURG ENDOSC, V24, P2327, DOI 10.1007/s00464-010-0915-3; Begin A, 2014, SURG ENDOSC, V28, P3408, DOI 10.1007/s00464-014-3611-x; Gauss T, 2013, LANGENBECK ARCH SURG, V398, P277, DOI 10.1007/s00423-012-1028-3; Higginss JPT, 2011, COCHRANE HDB SYSTEMA; Kamiyama T, 2006, WORLD J SURG, V30, P400, DOI 10.1007/s00268-005-0383-4; Lamata P, 2008, INT J COMPUT ASS RAD, V3, P299, DOI 10.1007/s11548-008-0226-5; Lange T., 2008, INT J COMPUTER ASSIS, V4, P79; Langes T, 2006, CANCER RES, V167, P13; Mutters D, 2008, SURG ENDOSC, V23, P432; Sauerland S, 2010, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD001546.PUB3; Soler L, 2000, Stud Health Technol Inform, V70, P316; Yamanaka J, 2009, J HEPATO-BILIARY-PAN, V16, P808, DOI 10.1007/s00534-009-0112-8	29	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	MAY	2015	22	5					353	362		10.1002/jhbp.220		10	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CT	WOS:000353460500005		
J	Otsuka, Y; Kaneko, H; Cleary, SP; Buell, JF; Cai, XJ; Wakabayashi, G				Otsuka, Yuichiro; Kaneko, Hironori; Cleary, Sean P.; Buell, Joseph F.; Cai, Xiujun; Wakabayashi, Go			What is the best technique in parenchymal transection in laparoscopic liver resection? Comprehensive review for the clinical question on the 2nd International Consensus Conference on Laparoscopic Liver Resection	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Energy device; Laparoscopy; Liver surgery; Stapling device; Technique; Transection	VESSEL-SEALING DEVICE; GLISSONIAN APPROACH; HEPATIC LOBECTOMY; RIGHT HEPATECTOMY; EXPERIENCE; CHOLANGIOCARCINOMA; MANEUVER; SEALER	The continuing evolution of technique and devices used in laparoscopic liver resection (LLR) has allowed successful application of this minimally invasive surgery for the treatment of liver disease. However, the type of instruments by energy sources and technique used vary among each institution. We reviewed the literature to seek the best technique for parenchymal transection, which was proposed as one of the important clinical question in the 2nd International Consensus Conference on LLR held on October 2014. While publications have described transection techniques used in LLR from 1991 to June 2014, it is difficult to specify the best technique and device for laparoscopic hepatic parenchymal transection, owing to a lack of randomized trials with only a small number of comparative studies. However, it is clear that instruments should be used in combination with others based on their functions and the depth of liver resection. Most authors have reported using staplers to secure and divide major vessels. Preparation for prevention of unexpected hemorrhaging particularly in liver cirrhosis, the Pringle's maneuver and prompt technique for hemostasis should be performed. We conclude that hepatobiliary surgeons should select techniques based on their familiarity with a concrete understanding of instruments and individualize to the procedure of LLR. (c) Japanese Society of Hepato-Biliary-Pancreatic Surgery	[Otsuka, Yuichiro; Kaneko, Hironori] Toho Univ, Fac Med, Deparment Surg, Ota Ku, Tokyo 1438541, Japan; [Cleary, Sean P.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Buell, Joseph F.] Tulane Univ, Dept Surg, Tulane Transplant Inst, New Orleans, LA 70118 USA; [Buell, Joseph F.] Loiusiana State Univ, Sch Med, New Orleans, LA USA; [Cai, Xiujun] Zhejiang Univ, Inst Minimally Invas Surg, Dept Gen Surg, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Wakabayashi, Go] Iwate Med Univ, Dept Surg, Morioka, Iwate 020, Japan	Kaneko, H (reprint author), Toho Univ, Fac Med, Deparment Surg, Ota Ku, 6-11-1 Omorinishi, Tokyo 1438541, Japan.	hironori@med.toho-u.ac.jp					Machado MA, 2011, SURG ENDOSC, V25, P2020, DOI 10.1007/s00464-010-1483-2; Herman P, 2013, SURG ENDOSC, V27, P1840, DOI 10.1007/s00464-012-2681-x; Toyama Y, 2013, SURG LAPARO ENDO PER, V23, pE194, DOI 10.1097/SLE.0b013e31828b8602; Buell JF, 2008, ANN SURG, V248, P475, DOI 10.1097/SLA.0b013e318185e647; Aldrighetti L, 2008, AM J SURG, V195, P270, DOI 10.1016/j.amjsurg.2007.02.022; Schmidbauer S, 2002, ANN SURG, V235, P27, DOI 10.1097/00000658-200201000-00004; Belli G, 2006, J HEPATO-BILIARY-PAN, V13, P149, DOI 10.1007/s00534-005-1023-y; Nissen NN, 2007, AM SURGEON, V73, P987; REICH H, 1991, OBSTET GYNECOL, V78, P956; Kaneko H, 2008, HPB, V10, P219, DOI 10.1080/13651820802166831; Zacharoulis D, 2013, J LAPAROENDOSC ADV S, V23, P549, DOI 10.1089/lap.2012.0464; O'Rourke N, 2004, J GASTROINTEST SURG, V8, P213, DOI 10.1016/j.gassur.2003.11.008; Wang L, 2013, HEPATO-GASTROENTEROL, V60, P217, DOI 10.5754/hge12502; Wakabayashi G, 2009, J HEPATO-BILIARY-PAN, V16, P439, DOI 10.1007/s00534-009-0122-6; Boggi U, 2009, MINIM INVASIV THER, V18, P306, DOI 10.1080/13645700903201001; Buells JF, 2013, HPB OXFORD, DOI [10.1111/hpb.12043, DOI 10.1111/HPB.12043]; Chopra SS, 2009, PHOTOMED LASER SURG, V27, P281, DOI 10.1089/pho.2008.2305; Dulucq JL, 2007, SURG LAPARO ENDO PER, V17, P413; Eguchi D, 2006, SURG ENDOSC, V20, P1326, DOI 10.1007/s00464-005-0723-3; Eiriksson Kristinn, 2009, Surg Endosc, V23, P1038, DOI 10.1007/s00464-008-0115-6; Gumbs AA, 2008, HPB, V10, P296, DOI 10.1080/13651820802166773; Honda G, 2014, J GASTROINTEST SURG, V18, P1379, DOI 10.1007/s11605-014-2538-9; Hos CM, 2013, SURG ENDOSC, V27, P1820; Jersenius U, 2007, SURG ENDOSC, V21, P315, DOI 10.1007/s00464-006-0758-0; Machado MA, 2011, SURG ENDOSC, V25, P3930, DOI 10.1007/s00464-011-1812-0; Matern U, 1996, MINIM INVASIV THER, V5, P5, DOI 10.3109/13645709609153273; Raus HG, 2008, HPB OXFORD, V10, P275; Saidi Reza F, 2007, HPB (Oxford), V9, P440, DOI 10.1080/13651820701658219; Sarpel Umut, 2012, Surg Technol Int, V22, P33; Slakey DP, 2008, HPB, V10, P253, DOI 10.1080/13651820802166880; Somasundar P, 2009, HPB, V11, P145, DOI 10.1111/j.1477-2574.2009.00026.x; Sotiropoulos GC, 2013, WORLD J GASTROENTERO, V19, P5929, DOI 10.3748/wjg.v19.i35.5929; Takahashi M, 2013, SURG ENDOSC, V27, P4732, DOI 10.1007/s00464-013-3202-2; Tokunaga Y, 2009, HEPATO-GASTROENTEROL, V56, P1714; Uchiyama H, 2013, SURG LAPARO ENDO PER, V23, pE116, DOI 10.1097/SLE.0b013e3182806535; Yaos P, 2007, ANZ J SURG, V77, P480	36	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	MAY	2015	22	5					363	370		10.1002/jhbp.216		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CT	WOS:000353460500006		
J	Tranchart, H; O'Rourke, N; Van Dam, R; Gaillard, M; Lainas, P; Sugioka, A; Wakabayashi, G; Dagher, I				Tranchart, Hadrien; O'Rourke, Nicholas; Van Dam, Ronald; Gaillard, Martin; Lainas, Panagiotis; Sugioka, Atsushi; Wakabayashi, Go; Dagher, Ibrahim			Bleeding control during laparoscopic liver resection: a review of literature	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Bleeding control; Blood loss; Hepatectomy; Laparoscopy; Liver resection	LEFT LATERAL SECTIONECTOMY; CARBON-DIOXIDE EMBOLISM; CENTRAL VENOUS-PRESSURE; OPEN HEPATIC RESECTION; HEPATOCELLULAR-CARCINOMA; PRINGLE MANEUVER; BLOOD-LOSS; MALIGNANT-TUMORS; HEPATECTOMY; METAANALYSIS	Despite the established advantages of laparoscopy, bleeding control during laparoscopic liver resection (LLR) is a liver-specific improvement. The 2nd International Consensus Conference on Laparoscopic Liver Resection was held in October 2014 at Morioka, Japan. One of the most capital questions was: What is essential in bleeding control during LLR? In order to correctly address this question, we conducted a comprehensive review of the literature. Essential points based on personal experience of the expert panel are also discussed. A total of 54 publications were identified. Based on this analysis, the working group built these recommendations: (1) a pneumoperitoneum of 10-14mmHg should be used as it allows a good control of the bleeding without significant modifications of hemodynamics; (2) a low central venous pressure (<5mmHg) should be used; (3) laparoscopy facilitates inflow and outflow control; and (4) surgeons should be experienced with the use of all surgical devices for liver transection and should master laparoscopic suture before starting LLR. Precoagulation with radiofrequency can be useful, particularly in cases of atypical resection. These recommendations are mostly based on experts' opinions and on B or C quality of evidence grade studies. More prospective data are required to confirm these results.	[Tranchart, Hadrien; Gaillard, Martin; Lainas, Panagiotis; Dagher, Ibrahim] Antoine Beclare Hosp, Dept Minimally Invas Digest Surg, Clamart, France; [Tranchart, Hadrien; Gaillard, Martin; Lainas, Panagiotis; Dagher, Ibrahim] Univ Paris 11, Orsay, France; [O'Rourke, Nicholas] Wesley Med Ctr, Dept Surg, Auchenflower, Qld, Australia; [Van Dam, Ronald] Maastricht Univ, Med Ctr, Dept Surg, NL-6200 MD Maastricht, Netherlands; [Sugioka, Atsushi] Fujita Hlth Univ, Dept Hepatobiliary Surgey, Toyoake, Aichi, Japan; [Wakabayashi, Go] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 020, Japan	Dagher, I (reprint author), Antoine Beclare Hosp, Dept Minimally Invas Digest Surg, Clamart, France.	ibrahim.dagher@abc.aphp.fr					Mirnezami R, 2011, HPB, V13, P295, DOI 10.1111/j.1477-2574.2011.00295.x; Gayet B, 2007, AM J SURG, V194, P685, DOI 10.1016/j.amjsurg.2006.11.044; Kanazawa A, 2013, SURG ENDOSC, V27, P2592, DOI 10.1007/s00464-013-2795-9; Aldrighetti L, 2010, J SURG ONCOL, V102, P82, DOI 10.1002/jso.21541; Tranchart H, 2014, WORLD J SURG, V38, P2904, DOI 10.1007/s00268-014-2679-8; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Cannon RM, 2011, J AM COLL SURGEONS, V213, P501, DOI 10.1016/j.jamcollsurg.2011.04.032; Tranchart H, 2013, AM J SURG, V205, P8, DOI 10.1016/j.amjsurg.2012.04.015; Honda G, 2013, J HEPATO-BIL-PAN SCI, V20, P435, DOI 10.1007/s00534-012-0586-7; Aldrighetti L, 2008, AM J SURG, V195, P270, DOI 10.1016/j.amjsurg.2007.02.022; STEPHENSON KR, 1988, ANN SURG, V208, P679, DOI 10.1097/00000658-198812000-00002; Croome KP, 2010, ARCH SURG-CHICAGO, V145, P1109, DOI 10.1001/archsurg.2010.227; Tranchart H, 2010, SURG ENDOSC, V24, P1170, DOI 10.1007/s00464-009-0745-3; Troisi RI, 2011, SURG ENDOSC, V25, P79, DOI 10.1007/s00464-010-1133-8; Nissen NN, 2007, AM SURGEON, V73, P987; Zhou YM, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-44; Katz SC, 2009, ANN SURG, V249, P617, DOI 10.1097/SLA.0b013e31819ed22f; Xiong JJ, 2012, WORLD J GASTROENTERO, V18, P6657, DOI 10.3748/wjg.v18.i45.6657; Zacharoulis D, 2013, J LAPAROENDOSC ADV S, V23, P549, DOI 10.1089/lap.2012.0464; Kobayashi S, 2011, SURG ENDOSC, V25, P3590, DOI 10.1007/s00464-011-1764-4; Cheung TT, 2013, ANN SURG, V257, P506, DOI 10.1097/SLA.0b013e31827b947a; Melendez JA, 1998, J AM COLL SURGEONS, V187, P620, DOI 10.1016/S1072-7515(98)00240-3; Packiam V, 2012, J GASTROINTEST SURG, V16, P2233, DOI 10.1007/s11605-012-2040-1; Zhou YM, 2011, DIGEST DIS SCI, V56, P1937, DOI 10.1007/s10620-011-1572-7; Akyildiz HY, 2011, SURG ENDOSC, V25, P1143, DOI 10.1007/s00464-010-1330-5; Lesurtel M, 2005, ANN SURG, V242, P814, DOI 10.1097/01.sla.0000189121.35617.d7; Ikeda M, 2009, ANN SURG, V250, P199, DOI 10.1097/SLA.0b013e3181a334f9; Wakabayashi G, 2009, J HEPATO-BILIARY-PAN, V16, P439, DOI 10.1007/s00534-009-0122-6; Bazin JE, 1997, BRIT J ANAESTH, V78, P570; Belli GL, 2009, SURG ENDOSC, V23, P1807, DOI 10.1007/s00464-009-0344-3; Chao YJ, 2012, SURG ENDOSC, V26, P2681, DOI 10.1007/s00464-012-2210-y; Chos A, 2009, SURG ENDOSC, V23, P906; Costi R, 2012, J LAPAROENDOSC ADV S, V22, P425, DOI 10.1089/lap.2011.0334; Dagher I, 2014, J HEPATO-BIL-PAN SCI, V21, P732, DOI 10.1002/jhbp.140; Decailliot F, 2005, ANESTH ANALG, V100, P617, DOI 10.1213/01.ANE.0000144592.20499.12; Haberstroh J, 1996, EUR SURG RES, V28, P8, DOI 10.1159/000129434; Herman P, 2010, J LAPAROENDOSC ADV S, V20, P35, DOI 10.1089/lap.2009.0215; Jarnagin William R, 2002, Ann Surg, V236, P397; Jaskille A, 2005, J TRAUMA, V59, P1305, DOI 10.1097/01.ta.0000198374.16218.ca; Jayaraman S, 2009, SURG ENDOSC, V23, P2369, DOI 10.1007/s00464-009-0359-9; Jis WB, 2011, ANN SURG, V253, P342; Jis ZL, 2004, CHIR GASTROENTEROL, V20, P308; Kers CG, 2011, INT J HEPATOL, V2011; Komedas K, 2013, SURG LAPARO ENDO PER, V23, P103; Lees KF, 2007, HONG KONG MED J, V13, P442; Lis N, 2012, HEPATOL RES, V42, P51; Mbah NA, 2012, HPB, V14, P126, DOI 10.1111/j.1477-2574.2011.00414.x; Mizuguchi T, 2011, SURG TODAY, V41, P39, DOI 10.1007/s00595-010-4337-6; Navarro A, 2008, SURG ENDOSC, V22, P1384, DOI 10.1007/s00464-008-9793-3; Pais M, 2008, HPB OXFORD, V10, P261; Park EY, 2012, YONSEI MED J, V53, P459, DOI 10.3349/ymj.2012.53.3.459; Patriti Alberto, 2012, Updates Surg, V64, P87, DOI 10.1007/s13304-012-0144-5; Patritis A, 2011, SURG LAPARO ENDO PER, V21, P242; Pringles JH, 1908, ANN SURG, V48, P541; Raos A, 2012, AM J SURG, V204, P222; Raos A, 2011, SURG ENDOSC, V25, P1603; Raos AM, 2013, COCHRANE DB SYST REV, V5; Saidi Reza F, 2007, HPB (Oxford), V9, P440, DOI 10.1080/13651820701658219; Schmandra Thomas C, 2004, Surg Technol Int, V12, P137; Simillis C, 2007, SURGERY, V141, P203, DOI 10.1016/j.surg.2006.06.035; Smyrniotis V, 2003, J AM COLL SURGEONS, V197, P949, DOI 10.1016/j.jamcollsurg.2003.07.009; Somasundar P, 2009, HPB, V11, P145, DOI 10.1111/j.1477-2574.2009.00026.x; Soubranes O, 2014, ANN SURG; Tans J, 2012, J LAPAROENDOSC ADV A, V22, P343; Toyama Y, 2006, J HEPATO-BILIARY-PAN, V13, P317, DOI 10.1007/s00534-005-1071-3; Troisi RI, 2012, DIGEST SURG, V29, P463, DOI 10.1159/000345996; Uchiyamas H, 2013, BICLAMP SURG LAPAROS, V23, P116; vans Dams RM, 2012, TRIALS, V13, P54; Weis M, 2014, PLOS ONE, V9; Yaos P, 2007, ANZ J SURG, V77, P480; Yins Z, 2013, ANN SURG ONCOL, V20, P1203; Zhen ZJ, 2010, WORLD J SURG, V34, P314, DOI 10.1007/s00268-009-0320-z	72	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	MAY	2015	22	5					371	378		10.1002/jhbp.217		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CT	WOS:000353460500007		
J	Katanuma, A; Itoi, T; Baron, TH; Yasuda, I; Kin, T; Yane, K; Maguchi, H; Yamazaki, H; Sano, I; Minami, R; Sen-yo, M; Ikarashi, S; Osanai, M; Takahashi, K				Katanuma, Akio; Itoi, Takao; Baron, Todd H.; Yasuda, Ichiro; Kin, Toshifumi; Yane, Kei; Maguchi, Hiroyuki; Yamazaki, Hajime; Sano, Itsuki; Minami, Ryuki; Sen-yo, Manabu; Ikarashi, Satoshi; Osanai, Manabu; Takahashi, Kuniyuki			Bench-top testing of suction forces generated through endoscopic ultrasound-guided aspiration needles	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Bench-top test; Endoscopic ultrasound-guided fine needle aspiration; Fine needle aspiration needle; Negative pressure; Slow pull method	RANDOMIZED CONTROLLED-TRIAL; PANCREATIC LESIONS; SOLID MASSES; FNA; ULTRASONOGRAPHY; DIAGNOSIS; 22-GAUGE; UTILITY; CANCER; BIOPSY	BackgroundAdequate needle size and tissue acquisition techniques for endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) need further elucidation. Moreover, the actual negative pressure and suction forces of FNA needles remain unknown. We evaluated the suction forces of 19-gauge, 22-gauge, and 25-gauge conventional FNA needles and side hole aspiration needles using conventional negative pressure and the slow pull technique. MethodsUsing a manometer, we determined the mean (SD) negative pressure and suction force for needle gauge, aspiration volume, and aspiration technique. We also evaluated the time to reach the maximum negative pressure. ResultsSuction force was comparatively higher in the 19-gauge needle when 50ml of negative pressure was applied. Suction force using the slow pull method was very weak at 5% of pressure found with conventional methods. With the use of a 20-ml syringe, the time to reach the maximum negative pressure was 4s in the 19-gauge needle, 11s in the 22-gauge needle, and 80s in the 25-gauge needle. ConclusionsBench-top testing showed that suction force increases with a larger gauge needle and larger aspiration volume. The slow pull method produces a very weak suction force. The time to reach the maximum negative pressure was longest in the 25-gauge needle.	[Katanuma, Akio; Kin, Toshifumi; Yane, Kei; Maguchi, Hiroyuki; Yamazaki, Hajime; Sano, Itsuki; Minami, Ryuki; Sen-yo, Manabu; Ikarashi, Satoshi; Osanai, Manabu; Takahashi, Kuniyuki] Teine Keijinkai Hosp, Ctr Gastroenterol, Teine Ku, Sapporo, Hokkaido 0068555, Japan; [Itoi, Takao] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan; [Baron, Todd H.] Univ N Carolina, Adv Therapeut Endoscopy, Chapel Hill, NC USA; [Yasuda, Ichiro] Teikyo Univ, Mizonokuchi Hosp, Dept Gastroenterol, Kawasaki, Kanagawa, Japan	Katanuma, A (reprint author), Teine Keijinkai Hosp, Ctr Gastroenterol, Teine Ku, 1-40-1-12 Maeda, Sapporo, Hokkaido 0068555, Japan.	akatanuma@gmail.com					Wallace MB, 2001, GASTROINTEST ENDOSC, V54, P441, DOI 10.1067/mge.2001.117764; Micames C, 2003, GASTROINTEST ENDOSC, V58, P690, DOI 10.1016/S0016-5107(03)02009-1; Iwashita T, 2013, GASTROINTEST ENDOSC, V77, P909, DOI 10.1016/j.gie.2013.01.001; VILMANN P, 1992, GASTROINTEST ENDOSC, V38, P172, DOI 10.1016/S0016-5107(92)70385-X; Yusuf TE, 2009, ENDOSCOPY, V41, P445, DOI 10.1055/s-0029-1214643; Sakamoto H, 2009, J GASTROEN HEPATOL, V24, P384, DOI 10.1111/j.1440-1746.2008.05636.x; Song TJ, 2010, AM J GASTROENTEROL, V105, P1739, DOI 10.1038/ajg.2010.108; Nakai Y, 2014, DIGEST DIS SCI, V59, P1578, DOI 10.1007/s10620-013-3019-9; Siddiqui UD, 2009, GASTROINTEST ENDOSC, V70, P1093, DOI 10.1016/j.gie.2009.05.037; Puri R, 2009, SCAND J GASTROENTERO, V44, P499, DOI 10.1080/00365520802647392; Bhutani MS, 1997, ENDOSCOPY, V29, P854, DOI 10.1055/s-2007-1004321; Chang KJ, 1997, GASTROINTEST ENDOSC, V45, P387, DOI 10.1016/S0016-5107(97)70149-4; Cahn M, 1996, AM J SURG, V172, P470, DOI 10.1016/S0002-9610(96)00222-X; Chen J, 2012, J CANCER RES CLIN, V138, P1433, DOI 10.1007/s00432-012-1268-1; DeWitt J, 2007, CLIN GASTROENTEROL H, V5, P609, DOI 10.1016/j.cgh.2006.11.021; Ferber Reed, 2013, J Diabetes Sci Technol, V7, P1167; GIOVANNINI M, 1995, ENDOSCOPY, V27, P171, DOI 10.1055/s-2007-1005657; Hasan Muhammad K, 2012, Gastrointest Endosc Clin N Am, V22, P155, DOI 10.1016/j.giec.2012.04.016; Itoi T, 2009, GASTROINTEST ENDOSC, V69, P509, DOI 10.1016/j.gie.2008.07.017; Larghi A, 2005, GASTROINTEST ENDOSC, V62, P768, DOI 10.1016/j.gie.2005.05.014	20	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	MAY	2015	22	5					379	385		10.1002/jhbp.201		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CT	WOS:000353460500008		
J	Miyazawa, M; Kawai, M; Hirono, S; Okada, K; Shimizu, A; Kitahata, Y; Yamaue, H				Miyazawa, Motoki; Kawai, Manabu; Hirono, Seiko; Okada, Ken-ichi; Shimizu, Atsushi; Kitahata, Yuji; Yamaue, Hiroki			Preoperative evaluation of the confluent drainage veins to the gastrocolic trunk of Henle: understanding the surgical vascular anatomy during pancreaticoduodenectomy	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Gastrocolic trunk of Henle; Pancreaticoduodenectomy; Surgical vascular anatomy	CT	BackgroundThe aim of this study was to classify the variations of the anatomical tributaries of the colic drainage veins into the gastrocolic trunk of Henle detected by three-dimensional multidetector computed tomography to understand the surgical vascular anatomy during pancreaticoduodenectomy. MethodsOne hundred and twenty patients who underwent three-dimensional multidetector computed tomography studies before pancreaticoduodenectomy were retrospectively reviewed. ResultsThe gastrocolic trunk of Henle was identified in 100 patients (83.3%) by three-dimensional multidetector computed tomography. The anatomical tributaries of the gastrocolic trunk of Henle described by three-dimensional multidetector computed tomography were classified into four types based on the number of veins (superior right colic vein, right colic vein and middle colic vein) that drained into the gastrocolic trunk of Henle, as follows: Type-0 (no colic drainage veins), -I (one colic drainage vein), -II (two colic drainage veins) and -III (three colic drainage veins). The frequencies of Type-0, Type-I, Type-II and Type-III were 7% (n=7), 71% (n=71), 20% (n=20) and 2% (n=2), respectively. ConclusionsThree-dimensional multidetector computed tomography can provide clinically useful information about the confluent colic drainage veins to gastrocolic trunk of Henle during pancreaticoduodenectomy.	[Miyazawa, Motoki; Kawai, Manabu; Hirono, Seiko; Okada, Ken-ichi; Shimizu, Atsushi; Kitahata, Yuji; Yamaue, Hiroki] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama 6418510, Japan	Yamaue, H (reprint author), Wakayama Med Univ, Sch Med, Dept Surg 2, 811-1 Kimiidera, Wakayama 6418510, Japan.	yamaue-h@wakayama-med.ac.jp					Yamaguchi S, 2002, DIS COLON RECTUM, V45, P1337, DOI 10.1097/01.DCR.0000027284.76452.84; Sakaguchi T, 2010, AM J SURG, V200, P15, DOI 10.1016/j.amjsurg.2009.05.017; Horiguchi A, 2010, J HEPATO-BIL-PAN SCI, V17, P523, DOI 10.1007/s00534-009-0261-9; Ignjatovic D, 2004, Tech Coloproctol, V8, P19, DOI 10.1007/s10151-004-0045-9; Ignjatovic D, 2004, TECH COLOPROCTOL, V8, P21; Ignjatovic D, 2010, AM J SURG, V199, P249, DOI 10.1016/j.amjsurg.2009.03.010; Jins G, 2006, AM J SURG, V191, P100; Kawai M, 2008, WORLD J SURG, V32, P82, DOI 10.1007/s00268-007-9305-y; Kims HJ, 2007, SURG RADIOL ANAT, V29, P67; Kimura W, 2000, J Hepatobiliary Pancreat Surg, V7, P473, DOI 10.1007/s005340070017; Lange J F, 2000, J Hepatobiliary Pancreat Surg, V7, P401, DOI 10.1007/s005340070035; Shioyama Y, 2001, ABDOM IMAGING, V26, P234, DOI 10.1007/s002610000165; Spasojevic M, 2011, SURG ENDOSC, V25, P1883, DOI 10.1007/s00464-010-1480-5; Yamaue H, 2012, J HEPATO-BIL-PAN SCI, V19, P95, DOI 10.1007/s00534-011-0476-4	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	MAY	2015	22	5					386	391		10.1002/jhbp.205		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CT	WOS:000353460500009		
J	Tazuma, S; Kanno, K; Kubota, K; Tsuyuguchi, T; Kamisawa, T; Isayama, H; Nakagohri, T; Inui, K				Tazuma, Susumu; Kanno, Keishi; Kubota, Keiichi; Tsuyuguchi, Toshio; Kamisawa, Terumi; Isayama, Hiroyuki; Nakagohri, Toshio; Inui, Kazuo		Japan Biliary Assoc	Report on the 2013 national cholelithiasis survey in Japan	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Cholelithiasis; Endoscopic sphincterotomy; Laparoscopic cholecystectomy; National survey		Background and aimsThe Academic Committee of the Japan Biliary Association conducted a national survey of cholelithiasis and analyzed its current management centering on epidemiology. MethodsTo allow comparison with previous results, a prospective survey was performed on the treatment of cholelithiasis during the month of August 2013, using the same questionnaire as that used for the 1997 Cholelithiasis Survey Project by the Japan Biliary Association. A personal questionnaire was sent to 71 institutions, and 612 individual survey sheets were collected from 56 institutions as treated during August 2013. Results and conclusionsCompared with the results obtained in 1997, the gender ratio was reversed in 2013 with male predominance. There were increases in the mean age, asymptomatic ratio, use of magnetic resonance cholangiopantreatography for diagnosis, and cholesterol stone type was also increased. Laparoscopic cholecystectomy was performed for 79.8% of gallbladder stones, and treatment of common bile duct stones generally involved endoscopic procedures, among which endoscopic sphincterotomy (EST) was performed more often compared with endoscopic papillary balloon dilation (EPBD), suggesting that EST is the mainstream treatment for common bile duct stones.	[Tazuma, Susumu; Kanno, Keishi] Hiroshima Univ, Dept Gen Internal Med, Hiroshima, Japan; [Kubota, Keiichi] Dokkyo Med Univ, Dept Surg Gastroenterol, Mibu, Tochigi, Japan; [Tsuyuguchi, Toshio] Chiba Univ Hosp, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan; [Kamisawa, Terumi] Tokyo Metropolitan Komagome Hosp, Dept Internal Med, Tokyo, Japan; [Isayama, Hiroyuki] Univ Tokyo, Dept Gastroenterol, Tokyo, Japan; [Nakagohri, Toshio] Tokai Univ Hosp, Dept Surg Gastroenterol, Tokyo, Japan; [Inui, Kazuo] Fujita Hlth Univ, Teaching Hosp 2, Dept Gastroenterol, Nagoya, Aichi, Japan	Tazuma, S (reprint author), Hiroshima Univ Hosp, Dept Gen Internal Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	stazuma@hiroshima-u.ac.jp					Japanese Society of Gastroenterology, 2009, PRACT GUID CHOL 2009; Kamedas H, 1990, TANDO, V4, P396; Tanimuras H, 1997, TANDO, V11, P133; Tanimuras H, 1998, TANDO, V12, P276	4	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	MAY	2015	22	5					392	395		10.1002/jhbp.206		4	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CT	WOS:000353460500010		
J	Naitoh, I; Nakazawa, T; Ban, T; Okumura, F; Hirano, A; Takada, H; Togawa, S; Hayashi, K; Miyabe, K; Shimizu, S; Kondo, H; Nishi, Y; Yoshida, M; Yamashita, H; Umemura, S; Hori, Y; Kato, A; Sano, H; Joh, T				Naitoh, Itaru; Nakazawa, Takahiro; Ban, Tesshin; Okumura, Fumihiro; Hirano, Atsuyuki; Takada, Hiroki; Togawa, Shozo; Hayashi, Kazuki; Miyabe, Katsuyuki; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Yoshida, Michihiro; Yamashita, Hiroaki; Umemura, Shuichiro; Hori, Yasuki; Kato, Akihisa; Sano, Hitoshi; Joh, Takashi			8-mm versus 10-mm diameter self-expandable metallic stent in bilateral endoscopic stent-in-stent deployment for malignant hilar biliary obstruction	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Bilateral stent; Hilar malignant biliary obstruction; Re-intervention; Self-expandable metallic stent; Stent-in-stent	PLACEMENT; DRAINAGE	BackgroundWe aimed to clarify the clinical benefits of using 8-mm versus 10-mm diameter self-expandable metallic stent (SEMS) in bilateral endoscopic stent-in-stent (SIS) deployment for malignant hilar biliary obstruction (MHBO). MethodsA total of 72 consecutive patients with MHBO treated by endoscopic bilateral SIS deployment were enrolled. The 8-mm and 10-mm diameter SEMSs were used in 37 patients (8-mm group) and 35 patients (10-mm group), respectively. We retrospectively compared technical success, functional success, complications, successful re-intervention, time to recurrent biliary obstruction (RBO) and survival time between two groups. ResultsThere were no significant inter-group differences in terms of technical success (8-mm vs. 10-mm group, both 100%), functional success (96% vs. 100%), early (5% vs. 9%) and late (19% vs. 14%) complications other than RBO, and successful endoscopic re-intervention (94% vs. 100%), respectively. Time to RBO (median: 198 days vs. 222 days; log-rank, P=0.440) and survival time (median: 186 days vs. 235 days; log-rank, P=0.883) did not differ significantly between the two groups. However, the success rate of endoscopic bilateral revisionary stent insertion for RBO was significantly higher in the 10-mm compared to the 8-mm group (68% vs. 31%; P=0.044). ConclusionsThe 10-mm diameter SEMS is more suitable with regard to endoscopic re-intervention.	[Naitoh, Itaru; Nakazawa, Takahiro; Hayashi, Kazuki; Miyabe, Katsuyuki; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Yoshida, Michihiro; Yamashita, Hiroaki; Umemura, Shuichiro; Hori, Yasuki; Kato, Akihisa; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan; [Ban, Tesshin] Nagoya Daini Red Cross Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Okumura, Fumihiro; Sano, Hitoshi] Gifu Prefectural Tajimi Hosp, Dept Gastroenterol, Tajimi, Japan; [Hirano, Atsuyuki] Nagoya City West Med Ctr, Dept Gastroenterol, Nagoya, Aichi, Japan; [Takada, Hiroki] Kasugai Municipal Hosp, Dept Gastroenterol, Kasugai, Aichi, Japan; [Togawa, Shozo] Japan Community Healthcare Org Chukyo Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan	Naitoh, I (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan.	inaito@med.nagoya-cu.ac.jp					De Palma GD, 2001, GASTROINTEST ENDOSC, V53, P547, DOI 10.1067/mge.2001.113381; Naitoh I, 2009, J GASTROEN HEPATOL, V24, P552, DOI 10.1111/j.1440-1746.2008.05750.x; Perdue DG, 2008, J CLIN GASTROENTEROL, V42, P1040, DOI 10.1097/MCG.0b013e31815853e0; Mukai T, 2013, J HEPATO-BIL-PAN SCI, V20, P214, DOI 10.1007/s00534-012-0508-8; Loew BJ, 2009, GASTROINTEST ENDOSC, V70, P445, DOI 10.1016/j.gie.2008.11.018; WAGNER HJ, 1993, ENDOSCOPY, V25, P213, DOI 10.1055/s-2007-1010295; Dumonceau JM, 2012, ENDOSCOPY, V44, P277, DOI 10.1055/s-0031-1291633; Dumas R, 2000, GASTROINTEST ENDOSC, V51, P334, DOI 10.1016/S0016-5107(00)70364-6; Hwang JC, 2011, SCAND J GASTROENTERO, V46, P326, DOI 10.3109/00365521.2010.536253; Isayama H, 2015, DIGEST ENDOSC, V27, P259, DOI 10.1111/den.12379; Iwano H, 2011, DIGEST ENDOSC, V23, P43, DOI 10.1111/j.1443-1661.2010.01036.x; Kawakami H, 2015, J HEPATO-BIL-PAN SCI, V22, pE12, DOI 10.1002/jhbp.186; Kawakubo K, 2015, J HEPATO-BIL-PAN SCI, V22, P79, DOI 10.1002/jhbp.170; Kims KM, 2012, HEPATO-GASTROENTEROL, V59, P341; Kogure H, 2011, SURG ENDOSC, V25, P463, DOI 10.1007/s00464-010-1194-8; Kogure H, 2014, DIGEST ENDOSC, V26, P93, DOI 10.1111/den.12055; Lees JH, 2007, GASTROINTEST ENDOSC, V66, P364; Lees TH, 2014, CLIN ENDOSC, V47, P440; Lees TH, 2013, DIGEST DIS SCI, V58, P547; Liberato MJA, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-103; Naitoh I, 2012, DIGEST DIS SCI, V57, P3279, DOI 10.1007/s10620-012-2270-9; Sherman S, 2001, GASTROINTEST ENDOSC, V53, P681, DOI 10.1067/mge.2001.114714	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	MAY	2015	22	5					396	401		10.1002/jhbp.219		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CT	WOS:000353460500011		
J	Eid, N; Ito, Y; Otsuki, Y				Eid, Nabil; Ito, Yuko; Otsuki, Yoshinori			Right hepatic artery forming caterpillar hump, perforating Calot's triangle into the cystic plate and associated with a variant branching pattern of the parent vessel	Journal of Hepato-Biliary-Pancreatic Sciences			English	Editorial Material									[Eid, Nabil; Ito, Yuko; Otsuki, Yoshinori] Osaka Med Coll, Dept Anat & Cell Biol, Div Life Sci, Takatsuki, Osaka 5698686, Japan	Eid, N (reprint author), Osaka Med Coll, Dept Anat & Cell Biol, Div Life Sci, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	nabil@art.osaka-med.ac.jp					Strasberg SM, 2010, J AM COLL SURGEONS, V211, P132, DOI 10.1016/j.jamcollsurg.2010.02.053; Badagabettu Satheesha Nayak, 2012, N Am J Med Sci, V4, P376, DOI 10.4103/1947-2714.99525; Kelly MD, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-19; Yamagami T, 2007, ACTA RADIOL, V48, P280, DOI 10.1080/02841850601182188	4	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	MAY	2015	22	5					402	403		10.1002/jhbp.231		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CT	WOS:000353460500012		
J	Gomi, H; Morikawa, S; Shinmura, N; Moki, H; Yasui, T; Tsukise, A; Torii, S; Watanabe, T; Maeda, Y; Hosaka, M				Gomi, Hiroshi; Morikawa, Satomi; Shinmura, Naoki; Moki, Hiroaki; Yasui, Tadashi; Tsukise, Azuma; Torii, Seiji; Watanabe, Tsuyoshi; Maeda, Yoshinori; Hosaka, Masahiro			Expression of Secretogranin III in Chicken Endocrine Cells: Its Relevance to the Secretory Granule Properties of Peptide Prohormone Processing and Bioactive Amine Content	JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY			English	Article						adrenal medulla; chicken endocrine system; chromogranin; gastrointestinal endocrine cells; pancreatic islets; proteolytic processing; prohormone; secretogranin; secretory granules; ultimobranchial glands	ENTEROCHROMAFFIN EC CELLS; CHROMOGRANIN-A; IMMUNOCYTOCHEMICAL LOCALIZATION; CARBOXYPEPTIDASE-E; SORTING RECEPTOR; PITUITARY-CELLS; MESSENGER-RNA; GH4C1 CELLS; SUBSTANCE-P; MALE RATS	The expression of secretogranin III (SgIII) in chicken endocrine cells has not been investigated. There is limited data available for the immunohistochemical localization of SgIII in the brain, pituitary, and pancreatic islets of humans and rodents. In the present study, we used immunoblotting to reveal the similarities between the expression patterns of SgIII in the common endocrine glands of chickens and rats. The protein-protein interactions between SgIII and chromogranin A (CgA) mediate the sorting of CgA/prohormone core aggregates to the secretory granule membrane. We examined these interactions using co-immunoprecipitation in chicken endocrine tissues. Using immunohistochemistry, we also examined the expression of SgIII in a wide range of chicken endocrine glands and gastrointestinal endocrine cells (GECs). SgIII was expressed in the pituitary, pineal, adrenal (medullary parts), parathyroid, and ultimobranchial glands, but not in the thyroid gland. It was also expressed in GECs of the stomach (proventriculus and gizzard), small and large intestines, and pancreatic islet cells. These SgIII-expressing cells co-expressed serotonin, somatostatin, gastric inhibitory polypeptide, glucagon-like peptide-1, glucagon, or insulin. These results suggest that SgIII is expressed in the endocrine cells that secrete peptide hormones, which mature via the intragranular enzymatic processing of prohormones and physiologically active amines in chickens.	[Gomi, Hiroshi; Morikawa, Satomi; Shinmura, Naoki; Moki, Hiroaki; Yasui, Tadashi; Tsukise, Azuma] Nihon Univ, Coll Bioresource Sci, Dept Vet Anat, Fujisawa, Kanagawa 2520880, Japan; [Torii, Seiji] Gunma Univ, Inst Mol & Cellular Regulat, Lab Secret Biol, Maebashi, Gumma 371, Japan; [Watanabe, Tsuyoshi] Asahikawa Med Coll, Dept Microscop Anat & Cell Biol, Asahikawa, Hokkaido 078, Japan; [Maeda, Yoshinori; Hosaka, Masahiro] Akita Prefectural Univ, Dept Biotechnol, Lab Mol Life Sci, Akita, Japan	Gomi, H (reprint author), Nihon Univ, Coll Bioresource Sci, Dept Vet Anat, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	gomi.hiroshi@nihon-u.ac.jp		Watanabe, Tsuyoshi/0000-0002-6094-7728	Japan Society for the Promotion of Science [25450471, 24390050, 25440052]; Institute for Molecular and Cellular Regulation, Gunma University [12026]; Akita Prefectural University	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by Grants-in-Aid from the Japan Society for the Promotion of Science #25450471 (to HG), #24390050 (to ST), and #25440052 (to MH). It was also supported in part by the joint research program of the Institute for Molecular and Cellular Regulation, Gunma University (no. 12026, to HG and ST) and the Akita Prefectural University President's Research Project Fund (to MH).	Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Gomi H, 2013, J HISTOCHEM CYTOCHEM, V61, P156, DOI 10.1369/0022155412466872; Tolmachova T, 2004, MOL BIOL CELL, V15, P332; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Zhang KX, 2006, DIABETES OBES METAB, V8, P621, DOI 10.1111/j.1463-1326.2006.00575.x; PortelaGomes GM, 1997, J HISTOCHEM CYTOCHEM, V45, P815; Salvi E, 1996, ANAT EMBRYOL, V194, P89; Prasad P, 2008, J IMMUNOL, V181, P5024; Bartolomucci A, 2011, ENDOCR REV, V32, P755, DOI 10.1210/er.2010-0027; ANOUAR Y, 1992, MOL CELL ENDOCRINOL, V88, P97, DOI 10.1016/0303-7207(92)90013-V; Bataille D, 2007, J MOL MED, V85, P673, DOI 10.1007/s00109-007-0167-4; Courel M, 2010, J BIOL CHEM, V285, P10030, DOI 10.1074/jbc.M109.064196; DOPAZO A, 1993, J MOL NEUROSCI, V4, P225, DOI 10.1007/BF02821554; El Fadil F A, 1997, Endocrinology, V138, P4989; FRANCIS BH, 1990, GASTROENTEROLOGY, V99, P1283; Fujita T, 1977, INT REV CYTOL      S, P187; Han L, 2008, MOL ENDOCRINOL, V22, P1935, DOI 10.1210/me.2008-0006; Holthuis JCM, 1996, J BIOL CHEM, V271, P17755; Hosaka M, 2004, J BIOL CHEM, V279, P3627, DOI 10.1074/jbc.M310104200; Hosaka M, 2005, J CELL SCI, V118, P4785, DOI 10.1242/jcs.02608; Hosaka M, 2010, ENDOCR J, V57, P275; Hosaka M, 2002, MOL BIOL CELL, V13, P3388, DOI 10.1091/mbc.E02-03-0040; Hotta K, 2009, J ENDOCRINOL, V202, P111, DOI 10.1677/JOE-08-0531; HUTTNER WB, 1991, TRENDS BIOCHEM SCI, V16, P27, DOI 10.1016/0968-0004(91)90012-K; Isshiki Y., 1975, Japanese Poultry Science, V12, P71; IWANAGA T, 1993, BIOMED RES-TOKYO, V14, P1; KINGSLEY DM, 1990, EMBO J, V9, P395; Kuramoto H, 2007, ARCH HISTOL CYTOL, V70, P235, DOI 10.1679/aohc.70.235; Osaka M, 1971, ARCH HISTOL JAPON, V35, P235; OTTIGER HP, 1990, J NEUROSCI, V10, P3135; Paco S, 2010, CEREB CORTEX, V20, P1386, DOI 10.1093/cercor/bhp202; PEARSE AGE, 1975, HISTOCHEMISTRY, V41, P373, DOI 10.1007/BF00490081; Portela-Gomes GM, 2010, REGUL PEPTIDES, V165, P12, DOI 10.1016/j.regpep.2010.02.011; RAVAZZOLA M, 1983, P NATL ACAD SCI-BIOL, V80, P215, DOI 10.1073/pnas.80.1.215; Sakai Y, 2004, ARCH HISTOL CYTOL, V67, P57, DOI 10.1679/aohc.67.57; Sakai Y, 2003, J HISTOCHEM CYTOCHEM, V51, P227; SCAMMELL JG, 1990, J HISTOCHEM CYTOCHEM, V38, P949; Schoonderwoert VTG, 2000, EUR J BIOCHEM, V267, P5646, DOI 10.1046/j.1432-1327.2000.01648.x; SOKOLSKI KN, 1984, J HISTOCHEM CYTOCHEM, V32, P1066; Stridsberg M, 2008, J ANAT, V212, P229, DOI 10.1111/j.1469-7580.2008.00857.x; Sun M, 2013, TRAFFIC, V14, P205, DOI 10.1111/tra.12029; Takayanagi M, 1996, TISSUE CELL, V28, P495, DOI 10.1016/S0040-8166(96)80035-8; Takeuchi Toshiyuki, 2008, Curr Diabetes Rev, V4, P31, DOI 10.2174/157339908783502406; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; THOMPSON ME, 1992, ENDOCRINOLOGY, V131, P318, DOI 10.1210/en.131.1.318; Watanabe T, 1998, ENDOCRINOLOGY, V139, P2765, DOI 10.1210/en.139.6.2765	47	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0022-1554	1551-5044		J HISTOCHEM CYTOCHEM	J. Histochem. Cytochem.	MAY	2015	63	5					350	366		10.1369/0022155415575032		17	Cell Biology	Cell Biology	CG9KO	WOS:000353634100005		
J	Ariga, K; Ji, QM; Nakanishi, W; Hill, JP				Ariga, Katsuhiko; Ji, Qingmin; Nakanishi, Waka; Hill, Jonathan P.			Thin Film Nanoarchitectonics	Journal of Inorganic and Organometallic Polymers and Materials			English	Article						Langmuir-Blodgett film; Layer-by-layer assembly; Nanoarchitectonics; Self-assembled monolayer; Thin films	LAYER-BY-LAYER; AIR-WATER-INTERFACE; SELF-ASSEMBLED MONOLAYERS; MESOPOROUS NANOCOMPARTMENT FILMS; ULTRATHIN MULTILAYER FILMS; SOL-GEL PROCESS; MOLECULAR RECOGNITION; AQUEOUS DIPEPTIDES; GLUCOSE-OXIDASE; DRUG-DELIVERY	A paradigm shift from nanotechnology to nanoarchitectonics is necessary. Individual nano-objects are required to be constructed into functional nanoarchitectures in order to develop this field and its potential applications. According to nanoarchitectonic strategies, materials are formed based on manipulation of atoms, molecules, or their assemblies and through synergetic combinations of chemical nanofabrication, self-organization, and field-controlled organization. In this review, nanoarchitectonics involving films are summarized, in which both nano-level material (i.e. molecular) interactions and external stimuli are utilized in a harmonized manner. In film nanoarchitectonics, three major strategies are used for thin film preparation: self-assembled monolayer (SAM) technique, Langmuir-Blodgett (LB) method, and layer-by-layer (LbL) assembly. The SAM method is a powerful and precise strategy for surface nanoarchitectures that is advantageous for introduction of functionality to device structures and for preparation of biocompatible surfaces. LbL assembly and LB techniques both provide effective methods for preparing controlled layered nanoarchitectures. LbL assembly is somewhat more versatile being useful for preparing a wide range of layered nanoarchitectures and has been rapidly taken up for various applications. On the other hand, the LB method is unique for its utilization of a dynamic interface in production processes. Thin film nanoarchitectonics is an excellent prototypical method for formation of three-dimensional nanoarchitectures.	[Ariga, Katsuhiko; Ji, Qingmin; Nakanishi, Waka; Hill, Jonathan P.] Natl Inst Mat Sci NIMS, WPI Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan	Ariga, K (reprint author), Natl Inst Mat Sci NIMS, WPI Ctr Mat Nanoarchitecton MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	ARIGA.Katsuhiko@nims.go.jp	ARIGA, Katsuhiko/H-2695-2011		World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan	This work was partly supported by World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan.	LINFORD MR, 1995, J AM CHEM SOC, V117, P3145, DOI 10.1021/ja00116a019; Sangeeth CSS, 2014, J AM CHEM SOC, V136, P11134, DOI 10.1021/ja505420c; Ji QM, 2010, ANGEW CHEM INT EDIT, V49, P9737, DOI 10.1002/anie.201004929; Lvov Y, 2001, NANO LETT, V1, P125, DOI 10.1021/nl0100015; Ariga K, 2005, LANGMUIR, V21, P976, DOI 10.1021/la0477845; Park JW, 2014, J AM CHEM SOC, V136, P1907, DOI 10.1021/ja4097384; Xiao FX, 2014, J AM CHEM SOC, V136, P1559, DOI 10.1021/ja411651e; OKAHATA Y, 1986, LANGMUIR, V2, P538, DOI 10.1021/la00070a028; Lefaux CJ, 2004, J POLYM SCI POL PHYS, V42, P3654, DOI 10.1002/polb.20209; Ariga K, 2013, LANGMUIR, V29, P8459, DOI 10.1021/la4006423; Fujii N, 2010, MACROMOLECULES, V43, P3947, DOI 10.1021/ma100473j; Krishnan V, 2011, CURR OPIN COLLOID IN, V16, P459, DOI 10.1016/j.cocis.2011.08.005; Wanunu M, 2005, J AM CHEM SOC, V127, P17877, DOI 10.1021/ja0556676; Such GK, 2006, J AM CHEM SOC, V128, P9318, DOI 10.1021/ja063043+; Aono M, 2012, ADV MATER, V24, P150, DOI 10.1002/adma.201104614; Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023; Osada M, 2012, ADV MATER, V24, P210, DOI 10.1002/adma.201103241; Michinobu T, 2011, PHYS CHEM CHEM PHYS, V13, P4895, DOI 10.1039/c0cp01990a; Lvov Y, 1996, LANGMUIR, V12, P3038, DOI 10.1021/la951002d; Kalblein D, 2014, ACS NANO, V8, P6840, DOI 10.1021/nn501484e; Lvov Y, 1997, LANGMUIR, V13, P6195, DOI 10.1021/la970517x; Ariga K, 2012, CHEM SOC REV, V41, P5800, DOI 10.1039/c2cs35162e; Ramanathan M, 2013, PHYS CHEM CHEM PHYS, V15, P10580, DOI 10.1039/c3cp50620g; Ariga K, 2011, EXPERT OPIN DRUG DEL, V8, P633, DOI 10.1517/17425247.2011.566268; Rydzek G, 2014, ACS NANO, V8, P5240, DOI 10.1021/nn501306y; Ariga K, 2009, SOFT MATTER, V5, P3562, DOI 10.1039/b909397d; Sukhishvili SA, 2000, J AM CHEM SOC, V122, P9550, DOI 10.1021/ja002410t; Gandra N, 2014, ANGEW CHEM INT EDIT, V53, P866, DOI 10.1002/anie.201308516; Avinash MB, 2014, NANOSCALE, V6, P13348, DOI 10.1039/c4nr04340e; Cha X, 1996, J AM CHEM SOC, V118, P9545, DOI 10.1021/ja961526f; Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202; Howorka S, 2013, LANGMUIR, V29, P7344, DOI 10.1021/la3045785; Dreaden EC, 2014, ACS NANO, V8, P8374, DOI 10.1021/nn502861t; NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063; Ji Q, 2008, J AM CHEM SOC, V130, P2376, DOI 10.1021/ja076139s; Yan Y, 2014, CHEM MATER, V26, P452, DOI 10.1021/cm402126n; Serizawa T, 2004, NATURE, V429, P52, DOI 10.1038/nature02525; Otte FL, 2014, J AM CHEM SOC, V136, P11248, DOI 10.1021/ja505563e; Onda M, 1996, J AM CHEM SOC, V118, P8524, DOI 10.1021/ja960991+; Ariga K, 2007, PHYS CHEM CHEM PHYS, V9, P2319, DOI 10.1039/b700410a; Golberg D, 2010, ACS NANO, V4, P2979, DOI 10.1021/nn1006495; Wen CY, 2014, ACS NANO, V8, P941, DOI 10.1021/nn405744f; Katagiri K, 2002, J AM CHEM SOC, V124, P7892, DOI 10.1021/ja0259281; Ariga K, 2011, J NANOSCI NANOTECHNO, V11, P1, DOI 10.1166/jnn.2011.3839; Zhang H, 2003, J PHYS CHEM B, V107, P8, DOI 10.1021/jp025910c; Chen XQ, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/4/044604; Zhuk I, 2014, ACS NANO, V8, P7733, DOI 10.1021/nn500674g; Ariga K, 2011, ADV DRUG DELIVER REV, V63, P762, DOI 10.1016/j.addr.2011.03.016; Joseph N, 2014, POLYM CHEM-UK, V5, P1817, DOI 10.1039/c3py01262j; Ariga K, 2010, ADV COLLOID INTERFAC, V154, P20, DOI 10.1016/j.cis.2010.01.005; Govindaraju T, 2012, NANOSCALE, V4, P6102, DOI 10.1039/c2nr31167d; Hod I, 2014, ADV MATER, V26, P6295, DOI 10.1002/adma.201401940; Caruso F, 1998, LANGMUIR, V14, P4559, DOI 10.1021/la971288h; Mori T, 2013, LANGMUIR, V29, P7239, DOI 10.1021/la304293z; Qiu XP, 2001, LANGMUIR, V17, P5375, DOI 10.1021/la010201w; Ariga K, 2013, CHEM SOC REV, V42, P6322, DOI 10.1039/c2cs35475f; Fakhrullin RF, 2012, CHEM SOC REV, V41, P4189, DOI 10.1039/c2cs15264a; Hamoudi H, 2014, RSC ADV, V4, P22035, DOI 10.1039/c4ra02846e; Kim Y, 2014, ACS NANO, V8, P2419, DOI 10.1021/nn405988d; Konig TAF, 2014, ACS NANO, V8, P6182, DOI 10.1021/nn501601e; Ariga K, 2014, NEW J CHEM, V38, P5149, DOI 10.1039/c4nj00864b; Katagiri K, 2002, LANGMUIR, V18, P6709, DOI 10.1021/la025772i; Shinkai S, 2001, ACCOUNTS CHEM RES, V34, P494, DOI 10.1021/ar000177y; Onda M, 1999, J BIOSCI BIOENG, V87, P69, DOI 10.1016/S1389-1723(99)80010-3; Kinbara K, 2005, CHEM REV, V105, P1377, DOI 10.1021/cr030071r; Lvov Y, 1998, J BIOMAT SCI-POLYM E, V9, P345; SHINKAI S, 1981, J AM CHEM SOC, V103, P111, DOI 10.1021/ja00391a021; Pei RJ, 2001, BIOMACROMOLECULES, V2, P463, DOI 10.1021/bm0001289; Gole A, 2005, CHEM MATER, V17, P1325, DOI 10.1021/cm048297d; Ji QM, 2009, ADV FUNCT MATER, V19, P1792, DOI 10.1002/adfm.200801762; Shimazaki Y, 1998, LANGMUIR, V14, P2768, DOI 10.1021/la9713457; Ikeda A, 2001, J AM CHEM SOC, V123, P4855, DOI 10.1021/ja015596k; Wu ZS, 2014, ADV MATER, V26, P4552, DOI 10.1002/adma.201401228; Lee SS, 2001, MACROMOLECULES, V34, P5358, DOI 10.1021/ma0022304; Ariga K, 1998, ACCOUNTS CHEM RES, V31, P371, DOI 10.1021/ar970014i; Stockton WB, 1997, MACROMOLECULES, V30, P2717, DOI 10.1021/ma9700486; Zerkoune L, 2014, NANOMATERIALS-BASEL, V4, P741, DOI 10.3390/nano4030741; Shrestha LK, 2013, CHEM-ASIAN J, V8, P1662, DOI 10.1002/asia.201300247; Ji QM, 2009, J AM CHEM SOC, V131, P4220, DOI 10.1021/ja9010354; Ariga K, 2012, J MATER CHEM, V22, P2369, DOI 10.1039/c1jm14101e; Tsargorodska A, 2014, ACS NANO, V8, P7858, DOI 10.1021/nn5014319; SAGIV J, 1980, J AM CHEM SOC, V102, P92, DOI 10.1021/ja00521a016; Wu SM, 2011, ADV FUNCT MATER, V21, P93, DOI 10.1002/adfm.201001520; Ramanathan M, 2014, J NANOSCI NANOTECHNO, V14, P390, DOI 10.1166/jnn.2014.8766; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Ma RZ, 2010, ADV MATER, V22, P5082, DOI 10.1002/adma.201001722; Bottari G, 2012, COORDIN CHEM REV, V256, P2453, DOI 10.1016/j.ccr.2012.03.011; Nakanishi W, 2014, NANO TODAY, V9, P378, DOI 10.1016/j.nantod.2014.05.002; Ma LX, 2012, LANGMUIR, V28, P9849, DOI 10.1021/la301553w; Hamoudi H, 2014, RSC ADV, V4, P39657, DOI 10.1039/c4ra05476h; Li M, 2013, CHEM COMMUN, V49, P6879, DOI 10.1039/c3cc43629b; Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n; Lvov YM, 1998, J AM CHEM SOC, V120, P4073, DOI 10.1021/ja9737984; Jiang L, 2014, J AM CHEM SOC, V136, P1982, DOI 10.1021/ja411116n; Ariga K, 2014, CHEM LETT, V43, P36, DOI 10.1246/cl.130987; Takada K, 2013, LANGMUIR, V29, P7538, DOI 10.1021/la3045253; SPRINGS B, 1977, BIOORG CHEM, V6, P181, DOI 10.1016/0045-2068(77)90019-0; Ichinose I, 1996, CHEM LETT, P831, DOI 10.1246/cl.1996.831; Sakakibara K, 2011, SMALL, V7, P1288, DOI 10.1002/smll.201002350; Li M, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/5/053001; Kraus-Ophir S, 2014, ANGEW CHEM INT EDIT, V53, P294, DOI 10.1002/anie.201305962; Sasaki T, 2001, CHEM MATER, V13, P4661, DOI 10.1021/cm010478h; Ariga K, 2014, APL MATER, V2, DOI 10.1063/1.4868177; Balzani V, 1998, ACCOUNTS CHEM RES, V31, P405, DOI 10.1021/ar970340y; Koumura N, 1999, NATURE, V401, P152; Chen B, 2013, CHEM COMMUN, V49, P10136, DOI 10.1039/c3cc46008h; LEE H, 1988, J AM CHEM SOC, V110, P618, DOI 10.1021/ja00210a062; Ariga K, 2012, B CHEM SOC JPN, V85, P1, DOI 10.1246/bcsj.20110162; Ford WE, 2014, ACS NANO, V8, P9173, DOI 10.1021/nn502794z; Ishihara S, 2014, PHYS CHEM CHEM PHYS, V16, P9713, DOI 10.1039/c3cp55431g; Luther JM, 2008, NANO LETT, V8, P3488, DOI 10.1021/nl802476m; Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q; SASAKI DY, 1991, J AM CHEM SOC, V113, P9685, DOI 10.1021/ja00025a051; LVOV Y, 1995, J CHEM SOC CHEM COMM, P2313, DOI 10.1039/c39950002313; LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Mamedov AA, 2002, NAT MATER, V1, P190, DOI 10.1038/nmat747; Zaba T, 2014, J AM CHEM SOC, V136, P11918, DOI 10.1021/ja506647p; Yoo D, 1998, MACROMOLECULES, V31, P4309, DOI 10.1021/ma9800360; Nishiguchi A, 2011, ADV MATER, V23, P3506, DOI 10.1002/adma.201101787; DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A; Ariga K, 2014, CHEM MATER, V26, P519, DOI 10.1021/cm401999f; Ariga K, 2012, ADV MATER, V24, P158, DOI 10.1002/adma.201102617; Acharya S, 2009, ADV MATER, V21, P2959, DOI 10.1002/adma.200802648; Ariga K, 2008, ANGEW CHEM INT EDIT, V47, P7254, DOI 10.1002/anie.200802820; Tamagawa H, 1997, J PHYS CHEM B, V101, P4817, DOI 10.1021/jp9700600; Ichinose I, 1997, CHEM MATER, V9, P1296, DOI 10.1021/cm970008g; Ariga K, 1997, J AM CHEM SOC, V119, P2224, DOI 10.1021/ja963442c; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; Park JY, 2011, SOFT MATTER, V7, P9829, DOI 10.1039/c1sm05750b; Ariga K, 2012, CHEM MATER, V24, P728, DOI 10.1021/cm202281m; Shiratori SS, 2002, COLLOID SURFACE A, V198, P415, DOI 10.1016/S0927-7757(01)00953-0; KURIHARA K, 1991, J AM CHEM SOC, V113, P5077, DOI 10.1021/ja00013a063; Izquierdo A, 2005, LANGMUIR, V21, P7558, DOI 10.1021/la047407s; Wang HJ, 2012, J AM CHEM SOC, V134, P10819, DOI 10.1021/ja303773z; Wu ZG, 2014, ACS NANO, V8, P6097, DOI 10.1021/nn501407r; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; Sukhorukov GB, 1998, POLYM ADVAN TECHNOL, V9, P759, DOI 10.1002/(SICI)1099-1581(1998100)9:10/11<759::AID-PAT846>3.0.CO;2-Q; Sakakibara K, 2012, ANGEW CHEM INT EDIT, V51, P9643, DOI 10.1002/anie.201203402; Ariga K, 2000, J AM CHEM SOC, V122, P7835, DOI 10.1021/ja000924m; Ariga K, 2010, ADV POLYM SCI, V229, P51, DOI 10.1007/12_2009_42; Matsui J, 2014, J AM CHEM SOC, V136, P842, DOI 10.1021/ja4107786; Onda M, 1996, BIOTECHNOL BIOENG, V51, P163, DOI 10.1002/(SICI)1097-0290(19960720)51:2<163::AID-BIT5>3.0.CO;2-H; Aono Masakazu, 2000, 1 INT S NAN US SUPR; Ariga K, 2005, LANGMUIR, V21, P4578, DOI 10.1021/la0467887; Ariga K, 2012, SOFT MATTER, V8, P15, DOI 10.1039/c1sm06832f; Ariga K, 2011, CHEM SCI, V2, P195, DOI 10.1039/c0sc00300j; Ariga K, 2013, ADV MATER, V25, P6477, DOI 10.1002/adma.201302283; Ariga K, 1999, LANGMUIR, V15, P3875, DOI 10.1021/la981047p; Ariga K, 2014, THIN SOLID FILMS, V554, P32, DOI 10.1016/j.tsf.2013.05.060; Ariga K, 2012, NPG ASIA MATER, V4, DOI 10.1038/am.2012.30; Ariga K, 2009, COLLOID SURFACE B, V74, P426, DOI 10.1016/j.colsurfb.2009.07.035; Ariga K, 2004, J NANOSCI NANOTECHNO, V4, P23, DOI 10.1166/jnn.2004.048; Ariga K, 2011, PHYS CHEM CHEM PHYS, V13, P4802, DOI 10.1039/c0cp02040k; Ariga K, 2011, CHEM REC, V11, P199, DOI 10.1002/tcr.201100004; Ariga K, 2006, SOFT MATTER, V2, P465, DOI 10.1039/b602732f; Beilis E, 2014, J AM CHEM SOC, V136, P6151, DOI 10.1021/ja410754t; Castleberry SA, 2014, ACS NANO, V8, P6580, DOI 10.1021/nn501963q; CHA XA, 1995, J AM CHEM SOC, V117, P11833, DOI 10.1021/ja00153a003; Chen JY, 1999, LANGMUIR, V15, P7208, DOI 10.1021/la981668i; Cheng Y.Y., 2014, CHEM SOC REV, V43, P2680; Cordier S, 2015, J INORG ORGANOMET P, V25, P189, DOI 10.1007/s10904-014-0112-2; DECHER G, 1991, MAKROMOL CHEM-M SYMP, V46, P321, DOI 10.1002/masy.19910460145; Dierendonck M, 2014, SOFT MATTER, V10, P804, DOI 10.1039/c3sm52202d; Gao YX, 2014, CHEM COMMUN, V50, P10448, DOI 10.1039/c4cc04788e; Geng F, 2011, CHEM COMMUN, V47, P8533, DOI 10.1039/c1cc12396c; Hamoudi H, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-287; Harada A, 2001, ACCOUNTS CHEM RES, V34, P456, DOI 10.1021/ar000174l; Hecht S, 2003, ANGEW CHEM INT EDIT, V42, P24, DOI 10.1002/anie.200390045; Hill JP, 2006, CHEM COMMUN, P2320, DOI 10.1039/b517668a; Hill JP, 2007, J PHYS CHEM C, V111, P16174, DOI 10.1021/jp0745945; Hoshi T, 2002, LANGMUIR, V18, P7024, DOI 10.1021/la0203685; Hu XG, 2005, J PHYS CHEM B, V109, P19385, DOI 10.1021/jp052706r; IKEURA Y, 1991, J AM CHEM SOC, V113, P7342, DOI 10.1021/ja00019a035; Jang HJ, 2014, ACS NANO, V8, P7192, DOI 10.1021/nn502199z; Jurow M., 2010, COORDIN CHEM REV, V254, P19; KAMINO A, 1995, COLLOID SURFACE A, V103, P183, DOI 10.1016/0927-7757(95)03244-8; KAWAHARA T, 1992, CHEM LETT, P1839, DOI 10.1246/cl.1992.1839; KITANO H, 1985, B CHEM SOC JPN, V58, P2826, DOI 10.1246/bcsj.58.2826; Komatsu H., DIP IMAGING IN PRESS; Kong B.-S., 2009, CHEM COMMUN, V16, P2174; KOTOV NA, 1995, J PHYS CHEM-US, V99, P13065, DOI 10.1021/j100035a005; Kujawa P, 2013, LANGMUIR, V29, P7354, DOI 10.1021/la4014619; Kujawa P, 2014, POLYM INT, V63, P377, DOI 10.1002/pi.4663; KURIHARA K, 1991, J AM CHEM SOC, V113, P444, DOI 10.1021/ja00002a010; Lee KG, 2014, ADV MATER, V26, P6119, DOI 10.1002/adma.201401246; Li M, 2012, CHEM LETT, V41, P383, DOI 10.1246/cl.2012.383; LVOV Y, 1994, CHEM LETT, P2323, DOI 10.1246/cl.1994.2323; Miller MS, 2014, J AM CHEM SOC, V136, P4212, DOI 10.1021/ja411140j; Mori T, 2010, J AM CHEM SOC, V132, P12868, DOI 10.1021/ja106653a; Netzer NL, 2014, ANGEW CHEM INT EDIT, V53, P10965, DOI 10.1002/anie.201406733; Oishi Y, 1997, LANGMUIR, V13, P519, DOI 10.1021/la960112x; Onda M, 1996, J FERMENT BIOENG, V82, P502, DOI 10.1016/S0922-338X(97)86992-9; Otsuki J, 2010, COORDIN CHEM REV, V254, P2311, DOI 10.1016/j.ccr.2009.12.038; Pan H, 2015, J INORG ORGANOMET P, V25, P179, DOI 10.1007/s10904-014-0073-5; Pandeeswar M, 2015, J INORG ORGANOMET P, V25, P293, DOI 10.1007/s10904-014-0144-7; Pandey AP, 2014, J NANOSCI NANOTECHNO, V14, P828, DOI 10.1166/jnn.2014.9014; Puscasu CM, 2015, J INORG ORGANOMET P, V25, P259, DOI 10.1007/s10904-014-0132-y; Rajendran R, 2015, J INORG ORGANOMET P, V25, P267, DOI 10.1007/s10904-014-0102-4; Rajendran R, 2014, J MATER CHEM A, V2, P18480, DOI 10.1039/c4ta03996c; Sakakibara K, 2014, PHYS CHEM CHEM PHYS, V16, P10286, DOI 10.1039/c3cp55078h; SAKURAI M, 1995, CHEM LETT, P1001, DOI 10.1246/cl.1995.1001; Sakurai M, 1997, J PHYS CHEM B, V101, P4810, DOI 10.1021/jp9700591; SASAKI DY, 1992, J AM CHEM SOC, V114, P10994, DOI 10.1021/ja00053a065; Serizawa T, 2000, J AM CHEM SOC, V122, P1891, DOI 10.1021/ja9913535; Takada K, 2015, J INORG ORGANOMET P, V25, P205, DOI 10.1007/s10904-014-0127-8; Wang KL, 2008, P IEEE, V96, P212, DOI 10.1109/JPROC.2007.911055; Yang L, 2005, ACCOUNTS CHEM RES, V38, P933, DOI 10.1021/ar040242u; Yoon HJ, 2014, J AM CHEM SOC, V136, P16, DOI 10.1021/ja409771u	209	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1574-1443	1574-1451		J INORG ORGANOMET P	J. Inorg. Organomet. Polym. Mater.	MAY	2015	25	3					466	479		10.1007/s10904-015-0179-4		14	Polymer Science	Polymer Science	CG7FQ	WOS:000353468400015		
J	Ahmed, Z; Kawamura, T; Shimada, S; Piguet, V				Ahmed, Zahra; Kawamura, Tatsuyoshi; Shimada, Shinji; Piguet, Vincent			The Role of Human Dendritic Cells in HIV-1 Infection	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; CYCLIC GMP-AMP; INNATE IMMUNE RECOGNITION; HUMAN LANGERHANS CELLS; EX-VIVO INFECTION; DC-SIGN; TRANS-INFECTION; ENVELOPE GLYCOPROTEINS; GASTROINTESTINAL-TRACT	Dendritic cells (DCs) and their subsets have multifaceted roles in the early stages of HIV-1 transmission and infection. DC studies have led to remarkable discoveries, including identification of restriction factors, cellular structures promoting viral transmission including the infectious synapse or the interplay of the C-type lectins, Langerin on Langerhans cells (LCs), and dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin on other DC subsets, limiting or facilitating HIV transmission to CD4(+) T cells, respectively. LCs/DCs are also exposed to encountering HIV-1 and other sexually transmitted infections (herpes simplex virus-2, bacteria, fungi), which reprogram HIV-1 interaction with these cells. This review will summarize advances in the role of DCs during HIV-1 infection and discuss their potential involvement in the development of preventive strategies against HIV-1 and other sexually transmitted infections.	[Ahmed, Zahra; Piguet, Vincent] Cardiff Univ, Dept Dermatol, Inst Infect & Immun, Sch Med,Univ Hosp Wales, Cardiff CF14 4XN, S Glam, Wales; [Kawamura, Tatsuyoshi; Shimada, Shinji] Univ Yamanashi, Fac Med, Dept Dermatol, Yamanashi, Japan	Piguet, V (reprint author), Cardiff Univ, Dept Dermatol & Acad Wound Healing, Inst Infect & Immun, Sch Med,Univ Hosp Wales, Glamorgan House,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	piguetv@cardiff.ac.uk					Fahrbach KM, 2007, J VIROL, V81, P6858, DOI 10.1128/JVI.02472-06; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Lambert AA, 2011, BLOOD, V117, P6589, DOI 10.1182/blood-2011-01-331363; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Ballweber L, 2011, J VIROL, V85, P13443, DOI 10.1128/JVI.05615-11; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1081/jem.20061519; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; de Jong MAWP, 2008, J CLIN INVEST, V118, P3440, DOI 10.1172/JCI34721; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; LENZ A, 1993, J CLIN INVEST, V92, P2587, DOI 10.1172/JCI116873; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Moris A, 2006, BLOOD, V108, P1643, DOI 10.1182/blood-2006-02-006361; Peressin M, 2014, AIDS, V28, P667, DOI 10.1097/QAD.0000000000000193; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Altfeld M, 2011, NAT REV IMMUNOL, V11, P176, DOI 10.1038/nri2935; Harman AN, 2013, REV MED VIROL, V23, P319, DOI 10.1002/rmv.1753; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Blanchet FP, 2010, IMMUNITY, V32, P654, DOI 10.1016/j.immuni.2010.04.011; Valladeau J, 1999, EUR J IMMUNOL, V29, P2695, DOI 10.1002/(SICI)1521-4141(199909)29:09<2695::AID-IMMU2695>3.0.CO;2-Q; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Matsuzawa T, 2013, J INVEST DERMATOL, V133, P2803, DOI 10.1038/jid.2013.215; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Kawamura T, 2000, J EXP MED, V192, P1491, DOI 10.1084/jem.192.10.1491; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Cottrell ML, 2014, J CLIN PHARMACOL, V54, P603, DOI 10.1002/jcph.292; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Ogawa Y, 2009, BLOOD, V113, P5157, DOI 10.1182/blood-2008-10-185728; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Mohanram V, 2013, J IMMUNOL, V190, P3346, DOI 10.4049/jimmunol.1201184; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Ganor Y, 2013, J EXP MED, V210, P2161, DOI 10.1084/jem.20122349; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; Izquierdo-Useros N, 2009, BLOOD, V113, P2732, DOI 10.1182/blood-2008-05-158642; Nikolic DS, 2011, BLOOD, V118, P4841, DOI 10.1182/blood-2010-09-305417; Andrews CD, 2014, SCIENCE, V343, P1151, DOI 10.1126/science.1248707; Manches O, 2012, P NATL ACAD SCI USA, V109, P14122, DOI 10.1073/pnas.1204032109; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Chu CC, 2012, J EXP MED, V209, P935, DOI 10.1084/jem.20112583; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Harman AN, 2013, J IMMUNOL, V190, P66, DOI 10.4049/jimmunol.1200779; Ganor Y, 2010, MUCOSAL IMMUNOL, V3, P506, DOI 10.1038/mi.2010.32; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; de Jong MAWP, 2010, MOL IMMUNOL, V47, P1216, DOI 10.1016/j.molimm.2009.12.016; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Engering A, 2002, J IMMUNOL, V168, P2118; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Turville S, 2003, J LEUKOCYTE BIOL, V74, P710, DOI 10.1189/jlb.0503208; NESTLE FO, 1993, J IMMUNOL, V151, P6535; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Romani N, 2012, J INVEST DERMATOL, V132, P872, DOI 10.1038/jid.2011.437; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; de Jong MAWP, 2010, J IMMUNOL, V185, P1633, DOI 10.4049/jimmunol.0904137; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Pollara J, 2014, J VIROL, V88, P7715, DOI 10.1128/JVI.00156-14; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Ogawa Y, 2013, CELL HOST MICROBE, V13, P77, DOI 10.1016/j.chom.2012.12.002; Schmidt B, 2005, VIROLOGY, V343, P256, DOI 10.1016/j.virol.2005.09.059; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; van den Berg LM, 2013, ADV EXP MED BIOL, V762, P45, DOI 10.1007/978-1-4614-4433-6_2; Cunningham AL, 2008, EUR J IMMUNOL, V38, P2377, DOI 10.1002/eji.200838521; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Battivelli E, 2011, J VIROL, V85, P7828, DOI 10.1128/JVI.00648-11; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Manches O, 2014, TRENDS IMMUNOL, V35, P114, DOI 10.1016/j.it.2013.10.003; Blanchet FP, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-6; Bloch N, 2013, AIDS RES HUM RETROV, V30, P195; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0090004; Coleman CM, 2011, RETROVIROLOGY, V8, DOI [10.1186/1742-4690-8-26, 10.1186/1742-4690-8]; Garcia E, 2008, TRAFFIC, V9, P200, DOI 10.1111/j.1600-0854.2007.00678.x; Granelli-Piperno A, 2006, J IMMUNOL, V176, P991; Groot F, 2006, BLOOD, V108, P1957, DOI 10.1182/blood-2006-03-010918; Gummuluru S, 2003, J VIROL, V77, P12865, DOI 10.1128/JVI.77.23.12865-12874.2003; Hatch SC, 2009, J VIROL, V83, P3496, DOI 10.1128/JVI.02249-08; Iwasaki A, 2012, IMMUNITY, V37, P389, DOI 10.1016/j.immuni.2012.08.011; Izquierdo-Useros N, 2007, J VIROL, V81, P7559, DOI 10.1128/JVI.02572-06; Kawamura T, 2001, EUR J IMMUNOL, V31, P360, DOI 10.1002/1521-4141(200102)31:2<360::AID-IMMU360>3.0.CO;2-X; Laguette N, 2012, TRENDS IMMUNOL, V33, P26, DOI 10.1016/j.it.2011.11.002; Matsuzawa T, 2014, J INVEST DERMATOL, V134, P1158, DOI 10.1038/jid.2013.467; MEYLAN PRA, 1993, VIROLOGY, V193, P138, DOI 10.1006/viro.1993.1110; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; O'Brien M, 2011, J CLIN INVEST, V121, P1088, DOI 10.1172/JCI44960; PAVLI P, 1993, IMMUNOLOGY, V78, P132; Pion M, 2007, J INVEST DERMATOL, V127, P319, DOI 10.1038/sj.jid.5700518; Popov S, 2005, J VIROL, V79, P602, DOI 10.1128/JVI.79.1.602-608.2005; Puryear WB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003291; Sandgren KJ, 2013, J IMMUNOL, V191, P60, DOI 10.4049/jimmunol.1202489; Trumpfheller C, 2003, INT IMMUNOL, V15, P289, DOI 10.1093/intimm/dxg030; Zhou ZC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002100	129	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135	5					1225	1233		10.1038/jid.2014.490		9	Dermatology	Dermatology	CG1CQ	WOS:000353011000008		
J	Kato, M; Shimizu, A; Yokoyama, Y; Kaira, K; Shimomura, Y; Ishida-Yamamoto, A; Kamei, K; Tokunaga, F; Ishikawa, O				Kato, Madoka; Shimizu, Akira; Yokoyama, Yoko; Kaira, Kyoichi; Shimomura, Yutaka; Ishida-Yamamoto, Akemi; Kamei, Kiyoko; Tokunaga, Fuminori; Ishikawa, Osamu			An Autosomal Recessive Mutation of DSG4 Causes Monilethrix through the ER Stress Response	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							RECURRENT INTRAGENIC DELETION; DESMOGLEIN-4 GENE; DESMOSOMAL CADHERINS; MISSENSE MUTATION; HAIR FOLLICLE; HYPOTRICHOSIS; IDENTIFICATION; KERATINOCYTES; PLAKOGLOBIN; DISEASE	Monilethrix is a hair shaft anomaly characterized by beaded hair with periodic changes in hair thickness. Mutations in the desmoglein 4 (DSG4) gene reportedly underlie the autosomal recessive form of the disease. However, the pathogenesis and cellular basis for the DSG4 mutation induced monilethrix remained largely unknown. We report a Japanese female patient with monilethrix. Observation of her hair shaft by means of transmission electron microscopy showed fewer desmosomes and abnormal keratinization. Genetic analysis revealed a homozygous mutation, c.2119delG (p.Asp707Ilefs*109), in the DSG4 gene, which was predicted to cause a frameshift and premature termination in the intracellular region of the DSG4 protein. The mutation has not been reported previously. In the patient's hair shaft, we detected reduced but partial expression of the mutant DSG4 protein. Cellular analyses demonstrated that the mutant DSG4 lost its affinity to plakoglobin and accumulated in the endoplasmic reticulum (ER). The amounts of mutant DSG4 were increased by proteasome inhibitor treatment, and the expression of an ER chaperone, GRP78/BiP, was elevated in the patient's skin. Collectively, these results suggest that the dysfunctional mutated DSG4, tethered in the ER, undergoes ER-associated degradation, leading to unfolded protein response induction, and thus ER stress may have a role in the pathogenesis of monilethrix.	[Kato, Madoka; Shimizu, Akira; Yokoyama, Yoko; Ishikawa, Osamu] Gunma Univ, Grad Sch Med, Dept Dermatol, Maebashi, Gunma 3718511, Japan; [Kaira, Kyoichi] Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Gunma, Japan; [Shimomura, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Lab Genet Skin Dis, Niigata, Japan; [Ishida-Yamamoto, Akemi] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan; [Kamei, Kiyoko; Tokunaga, Fuminori] Gunma Univ, Inst Mol & Cellular Regulat, Lab Mol Cell Biol, Gunma, Japan	Shimizu, A (reprint author), Gunma Univ, Grad Sch Med, Dept Dermatol, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	shimizuakira@gunma-u.ac.jp					Al-Jassar Caezar, 2013, J Mol Biol, V425, P4006, DOI 10.1016/j.jmb.2013.07.035; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Moss C, 2004, J INVEST DERMATOL, V123, P607, DOI 10.1111/j.0022-202X.2004.23311.x; Djabali K, 2003, CLIN EXP DERMATOL, V28, P206, DOI 10.1046/j.1365-2230.2003.01196.x; TROYANOVSKY SM, 1994, J CELL BIOL, V127, P151, DOI 10.1083/jcb.127.1.151; Zlotogorski A, 2006, J INVEST DERMATOL, V126, P1292, DOI 10.1038/sj.jid.5700251; Shimomura Y, 2006, J INVEST DERMATOL, V126, P1281, DOI 10.1038/sj.jid.5700113; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; Messenger AG, 2005, J INVEST DERMATOL, V125, P1077, DOI 10.1111/j.0022-202X.2005.23903.x; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Winter H, 1997, NAT GENET, V16, P372, DOI 10.1038/ng0897-372; Ishida-Yamamoto A, 2014, J DERMATOL SCI, V74, P99, DOI 10.1016/j.jdermsci.2014.02.005; van Steensel MAM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.021030; Spindler V, 2014, CELL COMMUN ADHES, V21, P77, DOI 10.3109/15419061.2013.877000; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Bazzi H, 2005, J INVEST DERM SYMP P, V10, P222, DOI 10.1111/j.1087-0024.2005.10110.x; Bazzi H, 2006, DIFFERENTIATION, V74, P129, DOI 10.1111/j.1432-0436.2006.00061.x; Celli A, 2011, BRIT J DERMATOL, V164, P16, DOI 10.1111/j.1365-2133.2010.10046.x; Farooq M, 2011, BRIT J DERMATOL, V165, P425, DOI 10.1111/j.1365-2133.2011.10373.x; GUMMER CI, 1981, BRIT J DERMATOL, V105, P529, DOI 10.1111/j.1365-2133.1981.tb00796.x; ITO M, 1990, J INVEST DERMATOL, V95, P186, DOI 10.1111/1523-1747.ep12477967; ITO M, 1984, J CUTAN PATHOL, V11, P513, DOI 10.1111/j.1600-0560.1984.tb00412.x; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; MATHUR M, 1994, J BIOL CHEM, V269, P14075; Meyer B, 2004, DIFFERENTIATION, V72, P541, DOI 10.1111/j.1432-0436.2004.07209007.x; Oeffner F, 2009, AM J HUM GENET, V84, P459, DOI 10.1016/j.ajhg.2009.03.014; Rafiq MA, 2004, J INVEST DERMATOL, V123, P247, DOI 10.1111/j.0022-202X.2004.22715.x; Savignac M, 2014, J INVEST DERMATOL, V134, P1961, DOI 10.1038/jid.2014.8; Schaffer JV, 2006, INVEST DERMATOL, V126, P1286; Sugiura K, 2009, J INVEST DERMATOL, V129, P2126, DOI 10.1038/jid.2009.51; Whittock NV, 2003, J INVEST DERMATOL, V120, P523, DOI 10.1046/j.1523-1747.2003.12113.x	32	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135	5					1253	1260		10.1038/jid.2015.12		8	Dermatology	Dermatology	CG1CQ	WOS:000353011000011		
J	Rupp, DE; Hoffman, BJ; Bischof, D; Byham, W; Collins, L; Gibbons, A; Hirose, S; Kleinmann, M; Kudisch, JD; Lanik, M; Jackson, DJR; Kim, M; Lievens, F; Meiring, D; Melchers, KG; Pendit, VG; Putka, DJ; Povah, N; Reynolds, D; Schlebusch, S; Scott, J; Simonenko, S; Thornton, G				Rupp, Deborah E.; Hoffman, Brian J.; Bischof, David; Byham, William; Collins, Lynn; Gibbons, Alyssa; Hirose, Shinichi; Kleinmann, Martin; Kudisch, Jeffrey D.; Lanik, Martin; Jackson, Duncan J. R.; Kim, Myungjoon; Lievens, Filip; Meiring, Deon; Melchers, Klaus G.; Pendit, Vina G.; Putka, Dan J.; Povah, Nigel; Reynolds, Doug; Schlebusch, Sandra; Scott, John; Simonenko, Svetlana; Thornton, George		International Taskforce Assessment	Guidelines and Ethical Considerations for Assessment Center Operations	JOURNAL OF MANAGEMENT			English	Article						assessment center; assessment centers; assessment; behavioral assessment; assessment technology; assessors; validation; assessor training; developmental assessment centers	ASSESSMENT-CENTER RATINGS; METAANALYSIS; VALIDITY		[Rupp, Deborah E.] Purdue Univ, W Lafayette, IN 47907 USA; [Hoffman, Brian J.] Univ Georgia, Athens, GA 30602 USA; [Byham, William; Reynolds, Doug] Dev Dimens Int, Pittsburgh, PA USA; [Gibbons, Alyssa; Thornton, George] Colorado State Univ, Ft Collins, CO 80523 USA; [Hirose, Shinichi] Int Univ Japan, Tokyo, Japan; [Kleinmann, Martin] Univ Zurich, CH-8006 Zurich, Switzerland; [Kudisch, Jeffrey D.] Univ Maryland, College Pk, MD USA; [Jackson, Duncan J. R.] Univ London, London WC1E 7HU, England; [Kim, Myungjoon] Assesta, Seoul, South Korea; [Lievens, Filip] Univ Ghent, B-9000 Ghent, Belgium; [Meiring, Deon] Univ Pretoria, ZA-0002 Pretoria, South Africa; [Melchers, Klaus G.] Univ Ulm, D-89069 Ulm, Germany; [Scott, John] APTMetrics, Darien, CT USA; [Simonenko, Svetlana] Detech, Moscow, Russia	Rupp, DE (reprint author), Purdue Univ, Purdue Dept Psychol Sci, 703 Third St, W Lafayette, IN 47907 USA.	ruppd@purdue.edu		Jackson, Duncan/0000-0001-9233-4232			American Educational Research Association American Psychological Association & National Council on Measurement in Education, 2014, STAND ED PSYCH TEST; American Psychological Association, 2002, AM PSYCHOL, V47, P1060, DOI DOI 10.1037/0003-066X.57.12.1060; American Psychological Association Council of Representatives, 1990, APA GUID PROV PSYCH; American Psychological Association Public Interest Directorate and Council of Representatives, 2002, GUID MULT ED TRAIN R; Arthur W, 2003, PERS PSYCHOL, V56, P125, DOI 10.1111/j.1744-6570.2003.tb00146.x; BRAY DW, 1966, PSYCHOL MONOGR, V80, P1; Brummel B., 2009, PERS PSYCHOL, V62, P135; BYHAM WC, 1970, HARVARD BUS REV, V48, P150; Council of the International Test Commission, 2012, INT GUID TEST US VER; Dean MA, 2008, J APPL PSYCHOL, V93, P685, DOI [10.1037/0021-9010.93.3.685, 10.1037/0021-9010-93.3.685]; Equal Employment Opportunity Commission Civil Service Commission Department of Labor & Department of Justice, 1978, FED REG, V43, P38290; Haertel E. H., 2006, ED MEASUREMENT, P65; International Test Commission, 2005, ITC GUID COMP BAS IN; International Test Commission, 2014, INT GUID SEC TESTS E; International Test Commission, 2005, INT GUID TEST AD; Jackson D. J. R., 2012, PSYCHOL ASSESSMENT C, V4th; Kirkpatrick D., 1994, EVALUATING TRAINING; Lanik M., 2011, PSYCHOL MANAGER J, V14, P221; Lievens F, 2009, RES PERS H, V28, P99, DOI 10.1108/S0742-7301(2009)0000028006; Meriac J. P., 2014, J MANAGEMENT; Povah N, 2011, ASSESSMENT CENTRES AND GLOBAL TALENT MANAGEMENT, P1; Putka DJ, 2010, HDB EMPLOYEE SELECTI, P9; Quinones M. A., 2003, HUMAN RESOURCES PROG, P225; Society for Industrial and Organizational Psychology, 2003, PRINC VAL US PERS SE; Thornton III G. C., 2003, DEV ORG SIMULATIONS; Thornton III G. C, 2015, ASSESSMENT CTR PERSP; Thornton III G. C, 2005, ASSESSMENT CTR HUMAN; Woehr DJ, 2003, J MANAGE, V29, P231, DOI 10.1177/014920630302900206	28	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0149-2063	1557-1211		J MANAGE	J. Manag.	MAY	2015	41	4					1244	1273		10.1177/0149206314567780		30	Business; Psychology, Applied; Management	Business & Economics; Psychology	CG7EP	WOS:000353465500009		
J	Kodama, S				Kodama, Satoshi			Tsunami-tendenko and morality in disasters	JOURNAL OF MEDICAL ETHICS			English	Article								Disaster planning challenges our morality. Everyday rules of action may need to be suspended during large-scale disasters in favour of maxims that that may make prudential or practical sense and may even be morally preferable but emotionally hard to accept, such as tsunami-tendenko. This maxim dictates that the individual not stay and help others but run and preserve his or her life instead. Tsunami-tendenko became well known after the great East Japan earthquake on 11 March 2011, when almost all the elementary and junior high school students in one city survived the tsunami because they acted on this maxim that had been taught for several years. While tsunami-tendenko has been praised, two criticisms of it merit careful consideration: one, that the maxim is selfish and immoral; and two, that it goes against the natural tendency to try to save others in dire need. In this paper, I will explain the concept of tsunami-tendenko and then respond to these criticisms. Such ethical analysis is essential for dispelling confusion and doubts about evacuation policies in a disaster.	Kyoto Univ, Grad Sch Letters, Dept Eth, Sakyo Ku, Kyoto 6068501, Japan	Kodama, S (reprint author), Kyoto Univ, Grad Sch Letters, Dept Eth, Sakyo Ku, Kyoto 6068501, Japan.	satoshikodama-tky@umin.ac.jp					Uscher-Pines L, 2007, HASTINGS CENT REP, V37, P32, DOI 10.1353/hcr.2007.0064; [Anonymous], 2012, YOMIURI SHIMBUN 0123; [Anonymous], 2011, DAILY YOMIURI   0818; [Anonymous], 2011, MAINICHI SHIMBU 0703; [Anonymous], 2012, ASAHI SHIMBUN E 0214; [Anonymous], 2011, YOMIURI SHIMBUN 1115; Aono Y, 2011, MAINICHI SHIMBU 0925; Futagi K, 2011, MAINICHI SHIMBU 0706; Ishizuka T, 2011, MAINICHI SHIMBU 0923; Jonsen A R, 1986, Law Med Health Care, V14, P172; Komine S, 2011, YOMIURI SHIMBUN 0529; Nagano H, 2011, MAINICHI SHIMBU 0425; Nemoto T, 2011, MAINICHI SHIMBU 0812; Shishido M, 2011, MAINICHI SHIMBU 0419; Yamashita F, 2008, TSUNAMI TENDENKO HIS	15	4	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-6800	1473-4257		J MED ETHICS	J. Med. Ethics	MAY	2015	41	5					361	363		10.1136/medethics-2012-100813		3	Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical	Social Sciences - Other Topics; Medical Ethics; Social Issues; Biomedical Social Sciences	CG6EL	WOS:000353388900001		
J	Asai, A				Asai, Atsushi			Tsunami-tendenko and morality in disasters	JOURNAL OF MEDICAL ETHICS			English	Editorial Material									Kumamoto Univ, Grad Sch Hlth Sci, Dept Bioeth, Kumamoto 8608556, Japan	Asai, A (reprint author), Kumamoto Univ, Grad Sch Hlth Sci, Dept Bioeth, Kumamoto 8608556, Japan.	aasai@kumamoto-u.ac.jp					Asai A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-9; Kodama S, 2015, J MED ETHICS, V41, P361, DOI 10.1136/medethics-2012-100813; Savulescu J, 2013, J MED ETHICS, V39, P129, DOI 10.1136/medethics-2013-101384; Yamori K, 2012, J JPN SOC NAT DISAST, V31, P35	4	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-6800	1473-4257		J MED ETHICS	J. Med. Ethics	MAY	2015	41	5					365	366		10.1136/medethics-2013-101629		2	Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical	Social Sciences - Other Topics; Medical Ethics; Social Issues; Biomedical Social Sciences	CG6EL	WOS:000353388900003		
J	Juhr, M; Haux, R; Suzuki, T; Takabayashi, K				Juhr, Maren; Haux, Reinhold; Suzuki, Takahiro; Takabayashi, Katsuhiko			Overview of Recent Trans-Institutional Health Network Projects in Japan and Germany	JOURNAL OF MEDICAL SYSTEMS			English	Article						Health data; Health information exchange; Regional health information systems; Community networks; Health information technology; Cross-institutional	LOWER SAXONY BANK; INFORMATION EXCHANGE; CARE; OUTCOMES; SYSTEMS; RECORDS; DESIGN; IMPACT	Worldwide populations are aging and countries have to prepare for the effects of demographic change in health care. Health information exchange (HIE), which is the process of moving patient information across health care providers electronically, can help overcome health data fragmentation and open opportunities to improve patient care in terms of quality, economy and efficiency. Since Japan and Germany are among the first countries strongly impacted by demographic changes of aging populations, we report on current developments about health information systems carrying out HIE based on case studies in both countries. Four projects that address the improvement of HIE within a defined region have been selected and investigated: the German project of the Lower Saxony Bank of Health and the Japanese projects Chiba ITnet, Nagasaki AjisaiNet and the National Disaster and Backup System of Japan. The project descriptions are based on relevant English publications, on-site visits and interviews with developers and users. The projects are introduced in terms of their basic architecture and implementation, their present status and future objectives. The projects' developments are still in progress and all have to cope with significant challenges before they will be able to provide a fully working trans-institutional health network solution.	[Juhr, Maren; Haux, Reinhold] Tech Univ Carolo Wilhelmina Braunschweig, Peter L Reichertz Inst Med Informat, D-38106 Braunschweig, Germany; [Juhr, Maren; Haux, Reinhold] Hannover Med Sch, D-38106 Braunschweig, Germany; [Suzuki, Takahiro; Takabayashi, Katsuhiko] Chiba Univ Hosp, Div Med Informat & Management, Chiba, Japan	Juhr, M (reprint author), Tech Univ Carolo Wilhelmina Braunschweig, Peter L Reichertz Inst Med Informat, Muehlenpfordtstr 23, D-38106 Braunschweig, Germany.	m.juhr@tu-bs.de; reinhold.haux@plri.de; takaba@ho.chiba-u.ac.jp			International Academy of Lifesciences; Chiba University Hospital; Chiba University	We want to thank all the people who provided insights into their work and information about the particular regional health networks. This involves the staff of the Medical Informatics and Management Department at Chiba University Hospital, Kengo Miyo from Tokyo University Hospital, Takehiro Matsumoto and Masayuki Honda from Nagasaki University Hospital and Markus Wagner from the Peter L. Reichertz Institute. We acknowledge the support of Professor Kulikowski, Rutgers University, who kindly agreed to review and improve our English. Finally, we want to thank for the project support on the part of International Academy of Lifesciences, Chiba University and Chiba University Hospital.	Kimura M, 2011, METHOD INFORM MED, V50, P131, DOI 10.3414/ME10-01-0015; Chaudhry B, 2006, ANN INTERN MED, V144, P742; Vest JR, 2011, J AM MED INFORM ASSN, V18, P143, DOI 10.1136/jamia.2010.004812; Johnson KB, 2011, J AM MED INFORM ASSN, V18, P690, DOI 10.1136/amiajnl-2011-000308; Bouamrane MM, 2015, METHOD INFORM MED, V54, P1, DOI 10.3414/ME15-10-0001; Dodd B., 1997, BRIT J HEALTHC COMP, V14, P33; Geissbuhler A, 2004, ST HEAL T, V107, P1048; Gusew N, 2012, METHOD INFORM MED, V51, P199, DOI 10.3414/ME11-02-0010; Hafen E, 2014, METHOD INFORM MED, V53, P82, DOI 10.3414/ME13-02-0051; Hincapie A, 2011, APPL CLIN INFORM, V2, P499, DOI 10.4338/ACI-2011-05-R-0027; Ishikawa T, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-41; Japanese Telemedicine and Telecare Association, 2013, TEL JAP 2013; Kluge F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108501; Kopetsch T., 2007, GERMAN HLTH SYSTEM R; Lapsia V, 2012, INT J MED INFORM, V81, P821, DOI 10.1016/j.ijmedinf.2012.08.008; Maenpaa T, 2009, INT J MED INFORM, V78, P757, DOI 10.1016/j.ijmedinf.2009.07.001; Nomura Kyoko, 2011, Nihon Eiseigaku Zasshi, V66, P22, DOI 10.1265/jjh.66.22; OECD, 2014, OECD FACTB 2014 EC E, DOI [10.1787/factbook-2014-105-en, DOI 10.1787/FACTBOOK-2014-105-EN]; OECD, 2014, OECD FACTB 2014 EC E, DOI [10.1787/factbook-2014-103-en, DOI 10.1787/FACTBOOK-2014-103-EN]; Plischke M, 2014, METHOD INFORM MED, V53, P73, DOI 10.3414/ME13-02-0003; Schwartze J, 2013, STUD HEALTH TECHNOL, V192, P318, DOI 10.3233/978-1-61499-289-9-318; Shabo A, 2006, METHOD INFORM MED, V45, P498; Shabo A, 2014, METHOD INFORM MED, V53, P63, DOI 10.3414/ME13-02-0048; United Nations, 2013, WORLD POP AG 2013; Vest J., 2012, ADV HLTH CARE MANAG, DOI [10.1108/S1474-8231(2012)0000012005, DOI 10.1108/S1474-8231(2012)0000012005]; Vest JR, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9987-7; Vest JR, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-78; Yasnoff WA, 2014, METHOD INFORM MED, V53, P66, DOI 10.3414/ME13-02-0030; Yeager VA, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0078-1	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0148-5598	1573-689X		J MED SYST	J. Med. Syst.	MAY	2015	39	5							50	10.1007/s10916-015-0234-2		8	Health Care Sciences & Services; Medical Informatics	Health Care Sciences & Services; Medical Informatics	CF8OR	WOS:000352821900009		
J	Yin, XX; Xu, BL; Jiang, CH; Fu, YF; Wang, ZD; Li, HY; Shi, G				Yin, Xuxian; Xu, Baolei; Jiang, Changhao; Fu, Yunfa; Wang, Zhidong; Li, Hongyi; Shi, Gang			Classification of Hemodynamic Responses Associated With Force and Speed Imagery for a Brain-Computer Interface	JOURNAL OF MEDICAL SYSTEMS			English	Article						Functional near-infrared spectroscopy (fNIRS); Brain-computer interface (BCI); Joint mutual information (JMI); Extreme learning machine (ELM); Force/speed imagery	NEAR-INFRARED SPECTROSCOPY; EXTREME LEARNING-MACHINE; MOTOR IMAGERY; SIGNALS; NIRS; BCI; SYSTEM; COMMUNICATION; STIMULI; SSVEP	Functional near-infrared spectroscopy (fNIRS) is an emerging optical technique, which can assess brain activities associated with tasks. In this study, six participants were asked to perform three imageries of hand clenching associated with force and speed, respectively. Joint mutual information (JMI) criterion was used to extract the optimal features of hemodynamic responses. And extreme learning machine (ELM) was employed to be the classifier. ELM solved the major bottleneck of feedforward neural networks in learning speed, this classifier was easily implemented and less sensitive to specified parameters. The 2-class fNIRS-BCI system was firstly built with an average accuracy of 76.7%, when all force and speed tasks were categorized as one class, respectively. The multi-class systems based on different levels of force and speed attempted to be investigated, the accuracies were moderate. This study provided a novel paradigm for establishing fNIRS-BCI system, and provided a possibility to produce more degrees of freedom in BCI system.	[Yin, Xuxian; Xu, Baolei; Wang, Zhidong; Li, Hongyi; Shi, Gang] Chinese Acad Sci, State Key Lab Robot, Shenyang Inst Automat SIA, Shenyang 110016, Peoples R China; [Yin, Xuxian] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Jiang, Changhao] Capital Inst Phys Educ, Key Lab Motor & Brain imaging, Beijing 100088, Peoples R China; [Wang, Zhidong] Chiba Inst Technol, Dept Adv Robot, Chiba 2750016, Japan; [Li, Hongyi] Northeastern Univ, Sch Mech Engn & Automat, Shenyang, Peoples R China; [Fu, Yunfa] Kunming Univ Sci & Technol, Sch Automat & Informat Engn, Kunming 650500, Peoples R China	Xu, BL (reprint author), Chinese Acad Sci, State Key Lab Robot, Shenyang Inst Automat SIA, Shenyang 110016, Peoples R China.	blxu@sina.cn			National Natural Science Foundation (NNSF) of China [61203368, 81470084, 61463024]; General Reserve Department of PLA [9140A26060214ZK63424]	This work is supported by National Natural Science Foundation (NNSF) of China under Grant 61203368, 81470084 and 61463024 and General Reserve Department of PLA under Grant 9140A26060214ZK63424.	Li YQ, 2013, IEEE T BIO-MED ENG, V60, P3156, DOI 10.1109/TBME.2013.2270283; Kimura Y, 2013, IEEE T BIO-MED ENG, V60, P2831, DOI 10.1109/TBME.2013.2265260; Everdell NL, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2038567; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Sitaram R, 2009, NEURAL NETWORKS, V22, P1320, DOI 10.1016/j.neunet.2009.05.009; Sitaram R, 2007, NEUROIMAGE, V34, P1416, DOI 10.1016/j.neuroimage.2006.11.005; Naseer N, 2013, NEUROSCI LETT, V553, P84, DOI 10.1016/j.neulet.2013.08.021; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Coyle SM, 2007, J NEURAL ENG, V4, P219, DOI 10.1088/1741-2560/4/3/007; Huppert TJ, 2006, NEUROIMAGE, V29, P368, DOI 10.1016/j.neuroimage.2005.08.065; DUNCAN A, 1995, PHYS MED BIOL, V40, P295, DOI 10.1088/0031-9155/40/2/007; Naseer N, 2014, EXP BRAIN RES, V232, P555, DOI 10.1007/s00221-013-3764-1; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; Huang GB, 2010, NEUROCOMPUTING, V74, P155, DOI 10.1016/j.neucom.2010.02.019; Cui Xu, 2011, Neuroimage, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; Zhang L, 2010, J MED SYST, V34, P51, DOI 10.1007/s10916-008-9215-z; Coyle S, 2004, PHYSIOL MEAS, V25, P815, DOI 10.1088/0967-3334/25/4/003; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Matthews F, 2008, IEEE SIGNAL PROC MAG, V25, P87, DOI [10.1109/MSP.2008.4408445, 10.1109/MSP2007.909011]; Chen M, 2011, J MED SYST, V35, P1323, DOI 10.1007/s10916-011-9696-z; Cope M., 1991, DEV NEAR INFR SPECTR; Egger J, 2012, J MED SYST, V36, P2097, DOI 10.1007/s10916-011-9673-6; Gottemukkula V, 2011, I IEEE EMBS C NEUR E, P72; Hong KS, 2015, NEUROSCI LETT, V587, P87, DOI 10.1016/j.neulet.2014.12.029; Khan MJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00244; Luu S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016003; Muller-Putz G., 2008, INT J BIOELECTROMAGN, V10, P52; Naseer N., 2015, FRONT HUM NEUROSCI, DOI [10.3389/fnhum.2015.00003._9(3), DOI 10.3389/FNHUM.2015.00003._9(3)]; POWER SD, 2010, J NEURAL ENG, V7, DOI DOI 10.1088/1741-2560/; Rodriguez-Bermudez G, 2012, J MED SYST, V36, pS51, DOI 10.1007/s10916-012-9893-4; Sen B, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0018-0; Xu B., 2014, J BIOMIM BIOMAT TISS, V19, P1; Yang HH, 1999, NIPS, V12, P687	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0148-5598	1573-689X		J MED SYST	J. Med. Syst.	MAY	2015	39	5							UNSP 53	10.1007/s10916-015-0236-0		8	Health Care Sciences & Services; Medical Informatics	Health Care Sciences & Services; Medical Informatics	CF8OR	WOS:000352821900012		
J	Hang, CY; Kitahashi, T; Parhar, IS				Hang, Chong Yee; Kitahashi, Takashi; Parhar, Ishwar S.			Brain area-specific diurnal and photic regulation of val-opsinA and val-opsinB genes in the zebrafish	JOURNAL OF NEUROCHEMISTRY			English	Article						light-sensitive; non-image-forming; non-visual photoreceptor; rhythmic	MESSENGER-RNA EXPRESSION; VERTEBRATE ANCIENT OPSIN; MAMMALIAN NEURAL TISSUE; PINEAL-GLAND; DEEP BRAIN; MELATONIN PRODUCTION; CIRCADIAN-RHYTHMS; MELANOPSIN; CELLS; PHOTORECEPTOR	Zebrafish possess two isoforms of vertebrate ancient long (VAL)-opsin, val-opsinA (valopa) and val-opsinB (valopb), which probably mediate non-visual responses to light. To understand the diurnal and light-sensitive regulation of the valop genes in different cell groups, the current study used real-time quantitative PCR to examine the diurnal changes of valopa and b mRNA levels in different brain areas of adult male zebrafish. Furthermore, effects of the extended exposure to light or dark condition, luminous levels and the treatment with a melatonin receptor agonist or antagonist on valop transcription were examined. In the thalamus, valop mRNA levels showed significant diurnal changes; valopa peaked in the evening, while valopb peaked in the morning. The diurnal change of valopa mRNA levels occurred independent of light conditions, whereas that of valopb mRNA levels were regulated by light. A melatonin receptor agonist or antagonist did not affect the changes of valop mRNA levels. In contrast, the midbrain and hindbrain showed arrhythmic valop mRNA levels under light and dark cycles. The differential diurnal regulation of the valopa and b genes in the thalamus and the arrhythmic expression in the midbrain and hindbrain suggest involvement of deep brain VAL-opsin in time-and light-dependent physiology.	[Hang, Chong Yee; Kitahashi, Takashi; Parhar, Ishwar S.] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Brain Res Inst, Bandar Sunway, Malaysia	Kitahashi, T (reprint author), Niigata Univ, Fac Sci, Sado Marine Biol Stn, 87 Tassha, Niigata 9522135, Japan.	tkitahas@cc.niigata-u.ac.jp		Hang, Chong Yee/0000-0002-7969-0467	Monash University Malaysia [M-3-08, TK-10-01]; Malaysian Ministry of Higher Education [FRGS/2/2010/SG/MUSM/02/2, ERGS/1/2011/STG/MUSM/02/6]; International Society for Neuroethology (ISN)	This work was supported by grants from the Monash University Malaysia, M-3-08 and TK-10-01 (to T.K. and I.S.P.) and the Malaysian Ministry of Higher Education, FRGS/2/2010/SG/MUSM/02/2 and ERGS/1/2011/STG/MUSM/02/6 (to T.K. and I.S.P). In recognition of the current work, H.C.Y. was funded by the International Society for Neuroethology (ISN) to present the work in a poster at the 2014 ICN congress, under the Developing Neuroethology Award.	Rawashdeh O, 2007, SCIENCE, V318, P1144, DOI 10.1126/science.1148564; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; Cahill GM, 2002, CELL TISSUE RES, V309, P27, DOI 10.1007/s00441-002-0570-7; Cahill GM, 1996, BRAIN RES, V708, P177, DOI 10.1016/0006-8993(95)01365-2; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Chaurasia SS, 2005, J NEUROCHEM, V92, P158, DOI 10.1111/j.1471-4159.2004.02874.x; Halstenberg S, 2005, VISUAL NEUROSCI, V22, P135, DOI 10.1017/S09522523805222022; Kojima D, 2000, J NEUROSCI, V20, P2845; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Weger M, 2013, DEV BIOL, V380, P259, DOI 10.1016/j.ydbio.2013.04.035; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Ziv L, 2007, EXP EYE RES, V84, P92, DOI 10.1016/j.exer.2006.09.004; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Nakane Y, 2014, CURR BIOL, V24, pR596, DOI 10.1016/j.cub.2014.05.038; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Kojima D, 2008, J NEUROCHEM, V104, P1364, DOI 10.1111/j.1471-4159.2007.05093.x; Kokel D, 2013, J NEUROSCI, V33, P3834, DOI 10.1523/JNEUROSCI.3689-12.2013; Li P, 2005, J EXP BIOL, V208, P497, DOI 10.1242/jeb.01424; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; DUBOCOVICH ML, 1988, J PHARMACOL EXP THER, V246, P902; Fernandes A. M., 2012, CURR BIOL, V22, P1; Fischer RM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001585; Frisch K.V., 1911, PFLUGERS ARCH GES PH, V138, P319, DOI DOI 10.1007/BF01680752; Grone BP, 2007, J BIOL RHYTHM, V22, P558, DOI 10.1177/0748730407308285; Hang CY, 2014, J COMP NEUROL, V522, P3847, DOI 10.1002/cne.23645; Holthues H, 2005, BIOCHEM BIOPH RES CO, V326, P160, DOI 10.1016/j.bbrc.2004.11.022; Illnerova H, 1997, J BIOL RHYTHM, V12, P547, DOI 10.1177/074873049701200609; Jenkins A, 2003, CURR BIOL, V13, P1269, DOI 10.1016/S0960-9822(03)00509-8; Li P, 2008, J BIOL CHEM, V283, P31673, DOI 10.1074/jbc.M803875200; Minamoto T, 2002, BIOCHEM BIOPH RES CO, V290, P280, DOI 10.1006/bbrc.2001.6186; Moore HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086176; Morse D, 2002, TRENDS NEUROSCI, V25, P632, DOI 10.1016/S0166-2236(02)02274-9; Moutsaki P, 2000, FEBS LETT, V473, P316, DOI 10.1016/S0014-5793(00)01550-7; Nakane Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3108; Soni BG, 1997, FEBS LETT, V406, P279, DOI 10.1016/S0014-5793(97)00287-1; Takanaka Y, 1998, J NEUROCHEM, V70, P908; Yanez J, 2009, NEUROSCIENCE, V164, P1712, DOI 10.1016/j.neuroscience.2009.09.043	37	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAY	2015	133	4					501	510		10.1111/jnc.13084		10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CG8PD	WOS:000353569800003		
J	Uruha, A; Hayashi, YK; Oya, Y; Mori-Yoshimura, M; Kanai, M; Murata, M; Kawamura, M; Ogata, K; Matsumura, T; Suzuki, S; Takahashi, Y; Kondo, T; Kawarabayashi, T; Ishii, Y; Kokubun, N; Yokoi, S; Yasuda, R; Kira, J; Mitsuhashi, S; Noguchi, S; Nonaka, I; Nishino, I				Uruha, Akinori; Hayashi, Yukiko K.; Oya, Yasushi; Mori-Yoshimura, Madoka; Kanai, Masahiro; Murata, Miho; Kawamura, Mayumi; Ogata, Katsuhisa; Matsumura, Tsuyoshi; Suzuki, Shigeaki; Takahashi, Yukako; Kondo, Takayuki; Kawarabayashi, Takeshi; Ishii, Yuko; Kokubun, Norito; Yokoi, Satoshi; Yasuda, Rei; Kira, Jun-ichi; Mitsuhashi, Satomi; Noguchi, Satoru; Nonaka, Ikuya; Nishino, Ichizo			Necklace cytoplasmic bodies in hereditary myopathy with early respiratory failure	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							TIBIAL MUSCULAR-DYSTROPHY; FN3 119 DOMAIN; DILATED CARDIOMYOPATHY; TITIN MUTATIONS; HMERF; GENE; TTN	Background In hereditary myopathy with early respiratory failure ( HMERF), cytoplasmic bodies ( CBs) are often localised in subsarcolemmal regions, with necklace-like alignment ( necklace CBs), in muscle fibres although their sensitivity and specificity are unknown. Objective To elucidate the diagnostic value of the necklace CBs in the pathological diagnosis of HMERF among myofibrillar myopathies ( MFMs). Methods We sequenced the exon 343 of TTN gene ( based on ENST00000589042), which encodes the fibronectin-3 ( FN3) 119 domain of the A-band and is a mutational hot spot for HMERF, in genomic DNA from 187 patients from 175 unrelated families who were pathologically diagnosed as MFM. We assessed the sensitivity and specificity of the necklace CBs for HMERF by re-evaluating the muscle pathology of our patients with MFM. Results TTN mutations were identified in 17 patients from 14 families, whose phenotypes were consistent with HMERF. Among them, 14 patients had necklace CBs. In contrast, none of other patients with MFM had necklace CBs except for one patient with reducing body myopathy. The sensitivity and specificity were 82% and 99%, respectively. Positive predictive value was 93% in the MFM cohort. Conclusions The necklace CB is a useful diagnostic marker for HMERF. When muscle pathology shows necklace CBs, sequencing the FN3 119 domain of A-band in TTN should be considered.	[Uruha, Akinori; Hayashi, Yukiko K.; Mitsuhashi, Satomi; Noguchi, Satoru; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Dept Clin Dev, Translat Med Ctr, Kodaira, Tokyo 1878502, Japan; [Uruha, Akinori; Hayashi, Yukiko K.; Mitsuhashi, Satomi; Noguchi, Satoru; Nonaka, Ikuya; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; [Uruha, Akinori] Univ Yamanashi, Dept Educ, Interdisciplinary Grad Sch Med & Engn, Yamanashi, Japan; [Hayashi, Yukiko K.] Tokyo Med Univ, Dept Neurophysiol, Tokyo 1608402, Japan; [Oya, Yasushi; Mori-Yoshimura, Madoka; Kanai, Masahiro; Murata, Miho] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Dept Neurol, Kodaira, Tokyo 1878502, Japan; [Kawamura, Mayumi] Wakayama Med Ctr, Japanese Red Cross Soc, Dept Neurol, Wakayama, Japan; [Ogata, Katsuhisa; Nonaka, Ikuya] Higashisaitama Hosp, Natl Hosp Org, Dept Neurol, Inst Clin Res, Saitama, Japan; [Matsumura, Tsuyoshi] Toneyama Natl Hosp, Natl Hosp Org, Dept Neurol, Osaka, Japan; [Suzuki, Shigeaki] Keio Univ, Sch Med, Dept Neurol, Tokyo, Japan; [Takahashi, Yukako] Osaka Red Cross Hosp, Dept Neurol, Osaka, Japan; [Takahashi, Yukako; Kondo, Takayuki] Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto, Japan; [Kawarabayashi, Takeshi] Hirosaki Univ, Dept Neurol, Inst Brain Sci, Grad Sch Med, Aomori, Japan; [Ishii, Yuko; Kokubun, Norito] Dokkyo Med Univ, Dept Neurol, Shimotsuke, Tochigi, Japan; [Yokoi, Satoshi] Nagoya Univ, Dept Neurol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Yasuda, Rei] Maizuru Med Ctr, Natl Hosp Org, Dept Neurol, Kyoto, Japan; [Kira, Jun-ichi] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan	Nishino, I (reprint author), Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Natl Inst Neurosci, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878502, Japan.	nishino@ncnp.go.jp	Suzuki, Shigeaki/N-9555-2013		JSPS KAKENHI [24659437]; Ministry of Health, Labour and Welfare of Japan; NCNP [23-5, 26-8]	This study was supported partly by JSPS KAKENHI Grant Number of 24659437; partly by Research on Rare and Intractable Diseases, Comprehensive Research on Disability Health and Welfare and Applying Health Technology from the Ministry of Health, Labour and Welfare of Japan; and partly by Intramural Research Grant 23-5 and 26-8 for Neurological and Psychiatric Disorders of NCNP.	Carmignac V, 2007, ANN NEUROL, V61, P340, DOI 10.1002/ana.21089; Pfeffer G, 2012, BRAIN, V135, P1695, DOI 10.1093/brain/aws102; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Tasca G, 2010, NEUROMUSCULAR DISORD, V20, P730, DOI 10.1016/j.nmd.2010.07.269; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; EDSTROM L, 1990, J NEUROL SCI, V96, P211, DOI 10.1016/0022-510X(90)90134-9; Schroder R, 2009, BRAIN PATHOL, V19, P483, DOI 10.1111/j.1750-3639.2009.00289.x; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Satoh M, 1999, BIOCHEM BIOPH RES CO, V262, P411, DOI 10.1006/bbrc.1999.1221; Ohlsson M, 2012, BRAIN, V135, P1682, DOI 10.1093/brain/aws103; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2; Pfeffer G, 2014, J NEUROL NEUROSUR PS, V85, P331, DOI 10.1136/jnnp-2012-304728; Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448; Palmio J, 2014, J NEUROL NEUROSUR PS, V85, P345, DOI 10.1136/jnnp-2013-304965; Cho A, 2014, J NEUROL NEUROSUR PS, V85, P912, DOI 10.1136/jnnp-2013-305587; Fisher D, 2008, NEUROLOGY, V71, P758; Haravuori H, 1998, AM J HUM GENET, V62, P620, DOI 10.1086/301752; Hedberg C, 2014, BRAIN, V137, DOI 10.1093/brain/awt305; Izumi R, 2013, J HUM GENET, V58, P259, DOI 10.1038/jhg.2013.9; Lange S, 2014, BRAIN, V137, pE279, DOI 10.1093/brain/awu033; MACDONAL.RD, 1969, ACTA NEUROPATHOL, V14, P99; Toro C, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-29; Uruha A, 2014, J NEUROL NEUROSUR PS, V85, P248, DOI 10.1136/jnnp-2013-305394; Vasli N, 2012, ACTA NEUROPATHOL, V124, P273, DOI 10.1007/s00401-012-0982-8	24	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAY	2015	86	5					483	489		10.1136/jnnp-2014-309009		7	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CF8BR	WOS:000352780800004		
J	Kinoshita, M; Taniguchi, M; Takagaki, M; Seike, N; Hashimoto, N; Yoshimine, T				Kinoshita, Manabu; Taniguchi, Mai; Takagaki, Masatoshi; Seike, Nobuhisa; Hashimoto, Naoya; Yoshimine, Toshiki			Development of a non-tissue adherent neurosurgical patty and an ex vivo testing system to evaluate adherent characteristics	JOURNAL OF NEUROSURGERY			English	Article						neurosurgical patty; neurosurgical device; surgical device; surgical technique		Neurosurgical patties are the most frequently used instruments during neurosurgical procedures, and their high performance is required to ensure safe operations. They must offer cushioning, water-absorbing, water-retaining, and non tissue adherent characteristics. Here, the authors describe a revised neurosurgical patty that is superior in all respects to the conventional patty available in Japan. Patty characteristics were critically and scientifically evaluated using various in vitro assays. Moreover, a novel ex vivo evaluation system focusing on the adherent characteristics of the neurosurgical patty was developed. The proposed assay could provide benchmark data for comparing different neurosurgical patties, offering neurosurgeons objective data on the performance of patties. The newly developed patty was also evaluated in real neurosurgical settings and showed superb performance during various neurosurgical procedures.	[Kinoshita, Manabu; Takagaki, Masatoshi] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Neurosurg, Osaka 5378511, Japan; [Taniguchi, Mai; Seike, Nobuhisa] Kawamoto Corp, Osaka, Japan; [Kinoshita, Manabu; Hashimoto, Naoya; Yoshimine, Toshiki] Osaka Univ, Grad Sch Med, Dept Neurosurg, Osaka, Japan	Kinoshita, M (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Neurosurg, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	mail@manabukinoshita.com					Hernesniemi J, 2005, SURG NEUROL, V64, P195, DOI 10.1016/j.surneu.2005.04.031; Marquardt G, 2001, NEUROSURG REV, V24, P41, DOI 10.1007/PL00011966; Menovsky T, 2009, SURG NEUROL, V71, P326, DOI 10.1016/j.surneu.2007.12.018	3	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2015	122	5					1180	1184		10.3171/2014.9.JNS14347		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG5XP	WOS:000353369500028		
J	Hide, T; Yano, S; Shinojima, N; Kuratsu, J				Hide, Takuichiro; Yano, Shigetoshi; Shinojima, Naoki; Kuratsu, Jun-ichi			Usefulness of the indocyanine green fluorescence endoscope in endonasal transsphenoidal surgery	JOURNAL OF NEUROSURGERY			English	Article						indocyanine green fluorescence endoscope; endoscopic endonasal transsphenoidal surgery; pituitary adenoma; meningioma; craniopharyngioma; chordoma; surgical technique	ANEURYSM SURGERY; 5-AMINOLEVULINIC ACID; INTRAOPERATIVE ASSESSMENT; PITUITARY-ADENOMAS; CLINICAL ARTICLE; MALIGNANT GLIOMA; TECHNICAL NOTE; BLOOD-FLOW; ANGIOGRAPHY; VIDEOANGIOGRAPHY	OBJECT To avoid disorientation during endoscopic endonasal transsphenoidal surgery (ETSS), the confirmation of anatomical landmarks is essential. Neuronavigation systems can be pointed at exact sites, but their spatial resolution power is too low for the detection of vessels that cannot be seen on MR images. On Doppler ultrasonography the shape of concealed arteries and veins cannot be visualized. To address these problems, the authors evaluated the clinical usefulness of the indocyanine green (ICG) endoscope. METHODS The authors included 38 patients with pituitary adenomas (n = 26), tuberculum sellae meningiomas (n = 4), craniopharyngiomas (n = 3), chordomas (n = 2), Rathke's cleft cyst (n = 1), dermoid cyst (n = 1), or fibrous dysplasia (n = 1). After opening the sphenoid sinus and placing the ICG endoscope, the authors injected 12.5 mg of ICG into a peripheral vein as a bolus and observed the internal carotid arteries (ICAs), cavernous sinus, intercavernous sinus, and pituitary. RESULTS The ICA was clearly identified by a strong fluorescence signal through the dura mater and the covering thin bone. The intercavernous and cavernous sinuses were visualized a few seconds later. In patients with tuberculum sellae meningiomas, the abnormal tumor arteries in the dura were seen and the vague outline of the attachment was identified. At the final inspection after tumor removal, perforators to the brain, optic nerves, chiasm, and pituitary stalk were visualized. ICG fluorescence signals from the hypophyseal arteries were strong enough to see and spread to the area of perfusion with the passage of time. CONCLUSIONS The ICA and the patent cavernous sinus were detected with the ICG endoscope in real time and at high resolution. The ICG endoscope is very useful during ETSS. The authors suggest that the real-time observation of the blood supply to the optic nerves and pituitary helps to predict the preservation of their function.	[Hide, Takuichiro; Yano, Shigetoshi; Shinojima, Naoki; Kuratsu, Jun-ichi] Kumamoto Univ, Grad Sch Med Sci, Dept Neurosurg, Kumamoto 8608556, Japan	Hide, T (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Neurosurg, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	thide@fc.kuh.kumamoto-u.ac.jp					Akdemir H, 2006, MINIM INVAS NEUROSUR, V49, P312, DOI 10.1055/s-2006-954577; Raabe A, 2005, J NEUROSURG, V103, P982, DOI 10.3171/jns.2005.103.6.0982; Eljamel MS, 2009, J NEURO-ONCOL, V92, P417, DOI 10.1007/s11060-009-9820-9; Kassam AB, 2011, J NEUROSURG, V114, P1544, DOI 10.3171/2010.10.JNS09406; McLaughlin N, 2013, J NEUROSURG, V118, P613, DOI 10.3171/2012.11.JNS112020; Litvack ZN, 2012, J NEUROSURG, V116, P935, DOI 10.3171/2012.1.JNS11601; BARROW DL, 1992, NEUROSURGERY, V30, P153; Ritz R, 2011, J NEUROSURG, V114, P1410, DOI 10.3171/2010.11.JNS10250; Komotar RJ, 2012, WORLD NEUROSURG, V77, P329, DOI 10.1016/j.wneu.2011.07.011; Desmettre T, 2000, SURV OPHTHALMOL, V45, P15, DOI 10.1016/S0039-6257(00)00123-5; Stummer W, 1998, NEUROSURGERY, V42, P518, DOI 10.1097/00006123-199803000-00017; Koutourousiou M, 2013, J NEUROSURG, V118, P621, DOI 10.3171/2012.11.JNS121190; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Washington CW, 2013, J NEUROSURG, V118, P420, DOI 10.3171/2012.10.JNS11818; Bruneau M, 2013, NEUROSURG REV, V36, P77, DOI 10.1007/s10143-012-0419-9; WROBEL CJ, 1994, NEUROSURGERY, V35, P970; Mielke Dorothee, 2014, Neurosurgery, V10 Suppl 3, P418, DOI 10.1227/NEU.0000000000000345; Nishiyama Y, 2012, J NEUROSURG, V117, P302, DOI 10.3171/2012.5.JNS112300; Schuette AJ, 2010, NEUROSURGERY, V67, P658, DOI 10.1227/01.NEU.0000374721.84406.7F; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.neu.0000317304.31579.17, 10.1227/01.NEU.0000297118.47076.5F]; Suzuki K, 2007, J NEUROSURG, V107, P68, DOI 10.3171/JNS-07/07/0068; Tamura Y, 2007, J NEUROSURG, V106, P507, DOI 10.3171/jns.2007.106.3.507	22	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2015	122	5					1185	1192		10.3171/2014.9.JNS14599		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG5XP	WOS:000353369500029		
J	Takada, S; Isake, F; Nakakuki, T; Mitsuno, Y; Kaneko, T				Takada, Shigeki; Isake, Fumiaki; Nakakuki, Takuya; Mitsuno, Yuto; Kaneko, Takaaki			Torcular dural arteriovenous fistula treated via stent placement and angioplasty in the affected straight and transverse sinuses: case report	JOURNAL OF NEUROSURGERY			English	Article						torcular dural arteriovenous fistula; stent placement; angioplasty; vascular disorders	INTRACRANIAL VASCULAR MALFORMATIONS; SUPERIOR SAGITTAL SINUS; TECHNICAL CASE-REPORT; SIGMOID SINUS; TRANSARTERIAL EMBOLIZATION; BALLOON ANGIOPLASTY; RECANALIZATION	The successful obliteration of torcular dural arteriovenous fistula (DAVF) with a diffuse shunt in the affected sinus may require complex treatment strategies. Therapeutic goals include the preservation of normal venous drainage and complete obliteration of shunt flow. The authors report the case of a torcular DAVF. The treatment of this type of AVF may require a combined approach with transarterial and transvenous embolization, open surgery, or radiosurgery and is associated with many problems. Stent placement and angioplasty in the affected sinus result in compression of the fistulous dural wall of the sinus and decrease shunt flow. In cases in which there is a diffuse shunt in the affected sinus and no evident shunt point, such as in AVFs involving venous pouches and parasinuses, sealing the fistula orifice with self-expandable stents and angioplasty (balloon inflation) is considered the best treatment option to preserve normal cerebral venous sinus drainage and obliterate shunt flow. In such cases, the authors recommend using one or more self-expandable and closed-cell stents and using angioplasty to avoid endoleakage into the gap between the stent graft and the vessel wall.	[Takada, Shigeki; Isake, Fumiaki; Nakakuki, Takuya; Mitsuno, Yuto; Kaneko, Takaaki] Hikone Municipal Hosp, Dept Neurosurg, Hikone, Shiga 5228539, Japan	Takada, S (reprint author), Hikone Municipal Hosp, Dept Neurosurg, 1882 Hassaka Cho, Hikone, Shiga 5228539, Japan.	tshigekidesu@gmail.com					NEWTON TH, 1969, RADIOLOGY, V93, P1071; Kakarla UK, 2007, NEUROSURGERY, V61, P447, DOI 10.1227/01.NEU.0000280007.72190.F1; Al-Shahi R, 2003, STROKE, V34, P1163, DOI 10.1161/01.STR.0000069018.90456.C9; Malek AM, 1999, NEUROSURGERY, V44, P896, DOI 10.1097/00006123-199904000-00133; Liebig T, 2005, NEURORADIOLOGY, V47, P543, DOI 10.1007/s00234-005-1377-5; Ohara N, 2012, INTERV NEURORADIOL, V18, P333; Levrier O, 2006, J NEUROSURG, V104, P254, DOI 10.3171/jns.2006.104.2.254; NISHIJIMA M, 1992, J NEUROSURG, V76, P600, DOI 10.3171/jns.1992.76.4.0600; Brown RD, 1996, NEUROLOGY, V46, P949; Choi BJ, 2009, NEUROSURGERY, V65, P994, DOI 10.1227/01.NEU.0000351772.45417.92; Hamada Y, 1997, NEUROSURGERY, V40, P452, DOI 10.1097/00006123-199703000-00005; Murphy KJ, 2000, NEUROSURGERY, V46, P497, DOI 10.1097/00006123-200002000-00048; Pan DHC, 2002, J NEUROSURG, V96, P823, DOI 10.3171/jns.2002.96.5.0823; Spiotta AM, 2012, J STROKE CEREBROVASC, V21, P283, DOI 10.1016/j.jstrokecerebrovasdis.2010.08.009; Troffkin NA, 2003, J NEUROSURG, V99, P579, DOI 10.3171/jns.2003.99.3.0579	15	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2015	122	5					1208	1213		10.3171/2014.12.JNS141374		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG5XP	WOS:000353369500034		
J	Ogiwara, H				Ogiwara, Hideki			Bed rest after filum surgery Response	Journal of Neurosurgery-Pediatrics			English	Editorial Material									Natl Ctr Child Hlth & Dev, Div Neurosurg, Tokyo, Japan	Ogiwara, H (reprint author), Natl Ctr Child Hlth & Dev, Div Neurosurg, Tokyo, Japan.							0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAY	2015	15	5					460	460				1	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CG5XM	WOS:000353369200002		
J	Ogiwara, H; Joko, M; Takado, M; Uematsu, K; Kameda, M; Sasaki, N; Kitagawa, M; Morota, N				Ogiwara, Hideki; Joko, Masahiro; Takado, Michiko; Uematsu, Kodai; Kameda, Masahiro; Sasaki, Natsu; Kitagawa, Masashi; Morota, Nobuhito			Duration of the horizontal decubitus position for prevention of cerebrospinal fluid leakage following transection of a tight filum terminale	Journal of Neurosurgery-Pediatrics			English	Article						tight filum terminale; untethering; cerebrospinal fluid leakage; spine	TETHERED CORD SYNDROME; CHILDREN	OBJECT The untethering of a tethered spinal cord in patients with a tight filum terminale is a relatively simple procedure that can prevent or improve neurological symptoms. Postoperatively, patients are usually kept in the horizontal decubitus position to prevent a CSF leak. However, the optimal period for keeping patients flat has not been determined yet. The authors compared 2 cohorts with different periods of horizontal decubitus; one with 72 hours and the other with 8 days. METHODS The authors retrospectively analyzed surgical results in 2 cohorts of pediatric patients who had tethered spinal cord with a tight filum terminale. One cohort was maintained flat for 8 days and the other cohort for 72 hours post-operatively. The patients' charts were reviewed for demographic data, clinical presentation, surgical therapy, and clinical course. RESULTS Three hundred fifty-four patients underwent sectioning of a tight filum terminale. Of those, 238 were kept lying flat for 8 days postoperatively, and 116 were maintained flat for 72 hours: Magnetic resonance imaging was performed 1 to 2 weeks after the surgery. None of the patients in either cohort developed a CSF leak. Pseudomeningocele, which was confirmed by MRI, developed in 1 patient who had been kept flat for 8 days. The occurrence rates of a CSF leak and pseudomeningocele were not significantly different in either cohort. CONCLUSIONS Keeping patients flat for longer than 72 hours did not change the rate of postoperative CSF leakage or pseudomeningocele. Seventy-two hours or less would be an appropriate period for maintaining patients flat after transection of a tight filum terminale.	[Ogiwara, Hideki; Joko, Masahiro; Takado, Michiko; Uematsu, Kodai; Kameda, Masahiro; Sasaki, Natsu; Kitagawa, Masashi; Morota, Nobuhito] Natl Ctr Child Hlth & Dev, Div Neurosurg, Tokyo, Japan	Ogiwara, H (reprint author), Okura 2-10-1,Setagaya Ku, Tokyo 1578535, Japan.	hidelci_o@d5.dion.ne.jp					PANG D, 1982, J NEUROSURG, V57, P32, DOI 10.3171/jns.1982.57.1.0032; Ostling LR, 2012, WORLD NEUROSURG, V77, P187, DOI 10.1016/j.wneu.2011.05.017; Milhorat TH, 2009, SURG NEUROL, V72, P20, DOI 10.1016/j.surneu.2009.03.008; Nazar GB, 1995, PEDIATR NEUROSURG, V23, P228, DOI 10.1159/000120965; Yong RL, 2011, NEUROSURGERY, V68, P1594, DOI 10.1227/NEU.0b013e31821246c6; Wehby MC, 2004, PEDIATR NEUROSURG, V40, P51, DOI 10.1159/000078908; Cornips EMJ, 2012, EUR J PAEDIATR NEURO, V16, P103, DOI 10.1016/j.ejpn.2011.07.002; Chern JJ, 2011, J NEUROSURG-PEDIATR, V8, P35, DOI 10.3171/2011.4.PEDS10502; Chern JJ, 2011, SPINE, V36, pE944; Khoury AE, 1990, J UROLOGY, V144; LaMarca F, 1997, PEDIATR NEUROSURG, V26, P8, DOI 10.1159/000121155; Ogiwara Hideki, 2012, Surg Neurol Int, V3, P113, DOI 10.4103/2152-7806.101802; ZIDE BM, 1987, J NEUROSURG, V67, P59, DOI 10.3171/jns.1987.67.1.0059	13	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAY	2015	15	5					461	464		10.3171/2014.9.PEDS14289		4	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CG5XM	WOS:000353369200003		
J	Iwama, J; Ogiwara, H; Kiyotani, C; Terashima, K; Matsuoka, K; Iwafuchi, H; Morota, N				Iwama, Junya; Ogiwara, Hideki; Kiyotani, Chikako; Terashima, Keita; Matsuoka, Kentaro; Iwafuchi, Hideto; Morota, Nobuhito			Neoadjuvant chemotherapy for brain tumors in infants and young children	Journal of Neurosurgery-Pediatrics			English	Article						neoadjuvant chemotherapy; infantile brain tumors; second-look surgery; oncology	EXPERIENCE CLINICAL ARTICLE; 2ND-LOOK SURGERY; CHILDHOOD	OBJECT Because of their large size and high vascularity, complete removal of brain tumors in infants and young children is often difficult. In most cases the degree of resection is associated with prognosis. Neoadjuvant chemotherapy may facilitate resection by reducing the vascularity of the tumor. The authors evaluated the effectiveness of neoadjuvant chemotherapy in the management of these tumors. METHODS The authors performed a retrospective review of infants and young children who underwent tumor removal after neoadjuvant chemotherapy. RESULTS Nine consecutive patients underwent resection after neoadjuvant chemotherapy during the period February 2004 to December 2012. The mean age at diagnosis was 18 months (range 2-50 months). The average largest tumor diameter was 71 mm (range 30-130 mm) at initial surgery. Five patients underwent partial resection, and 4 underwent biopsy as the initial surgery. The histopathological diagnoses were ependymoma in 2 patients, anaplastic ependymoma in 1, primitive neuroectodermal tumor (PNET) in 2, choroid plexus carcinoma in 1, atypical teratoid/rhabdoid tumor (AT/RT) in 1, glioblastoma in 1, and embryonal tumor with abundant neuropil and true rosettes in 1. After 2-4 courses of multiagent chemotherapy (mainly with vincristine, cyclophosphamide, etoposide, and cisplatin), the second-look surgery was performed. In 1 patient with a PNET, intratumoral hemorrhage was observed after 2 courses of chemotherapy. The mean interval between the initial and the second-look surgery was 3 months. The tumor volume was reduced to varying degrees in 5 patients (56%) after chemotherapy. Intraoperatively, the vascularity of the tumor was considerably reduced, and the tumor was more circumscribed in all cases. Gross-total resection was achieved in 8 patients (89%) and near-total resection in 1 (11%). Histopathological examination demonstrated fibrotic tissue circumscribing the tumor in 6 of 9 cases (67%). The average blood loss was 20% of the estimated blood volume, and 3 patients (33%) required a blood transfusion. There was no surgical mortality. One patient had transient dysphasia postoperatively. The mean follow-up period was 28 months. At the last follow-up, 2 patients (22%) had died (1 died of tumor progression and 1 of sepsis), and 4 patients (44%) had no tumor recurrence. CONCLUSIONS Neoadjuvant chemotherapy for brain tumors in infants and young children was effective in reduction of tumor vascularity and clarification of the tumor-brain interface, which significantly facilitated maximal tumor resection.	[Iwama, Junya; Ogiwara, Hideki; Morota, Nobuhito] Natl Ctr Child Hlth & Dev, Div Neurosurg, Tokyo 1578535, Japan; [Kiyotani, Chikako; Terashima, Keita] Natl Ctr Child Hlth & Dev, Div Neurooncol, Tokyo 1578535, Japan; [Matsuoka, Kentaro; Iwafuchi, Hideto] Natl Ctr Child Hlth & Dev, Div Pathol, Tokyo 1578535, Japan	Ogiwara, H (reprint author), Natl Ctr Child Hlth & Dev, Div Neurosurg, Setagaya Ku, Okura 2-10-1, Tokyo 1578535, Japan.	hideki_o@d5.dion.ne.jp					Van Poppel M, 2011, J NEUROSURG-PEDIATR, V8, P251, DOI 10.3171/2011.6.PEDS11158; Lafay-Cousin L, 2009, ONCOLOGIST, V14, P433, DOI 10.1634/theoncologist.2008-0193; Duffner P K, 1999, Neuro Oncol, V1, P152, DOI 10.1215/15228517-1-2-152; DUFFNER PK, 1991, PEDIATR NEUROL, V7, P237, DOI 10.1016/0887-8994(91)90038-M; Foreman NK, 1997, NEUROSURGERY, V40, P856, DOI 10.1097/00006123-199704000-00042; Heideman RL, 1997, CANCER-AM CANCER SOC, V80, P497; Latay-Cousin L, 2010, J NEUROSURG PEDIAT, V5, P615; Massimino M, 2011, J NEUROSURG-PEDIATR, V8, P246, DOI 10.3171/2011.6.PEDS1142; SANFORD RA, 1989, CONCEPTS PEDIAT NEUR, V9, P139	9	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAY	2015	15	5					488	492		10.3171/2014.11.PEDS14334		5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CG5XM	WOS:000353369200009		
J	Hayashi, T; Daubs, MD; Suzuki, A; Scott, TP; Phan, KH; Ruangchainikom, M; Takahashi, S; Shiba, K; Wang, JC				Hayashi, Tetsuo; Daubs, Michael D.; Suzuki, Akinobu; Scott, Trevor P.; Phan, Kevin H.; Ruangchainikom, Monchai; Takahashi, Shinji; Shiba, Keiichiro; Wang, Jeffrey C.			Motion characteristics and related factors of Modic changes in the lumbar spine	JOURNAL OF NEUROSURGERY-SPINE			English	Article						Modic changes; lumbar spine; kinematic analysis; magnetic resonance imaging; logistic regression analysis; degenerative disc disease	DEGENERATIVE DISK DISEASE; SEGMENTAL MOBILITY; INSTABILITY; MARROW	OBJECT Most studies of Modic changes (MCs) have focused on investigating the relationship between MCs and low-back pain, whereas the kinematic characteristics and degenerative disc disease associated with MCs are not well understood. To the authors' knowledge, no previous study has reported on the kinematics of MCs. The purpose of this study was to elucidate the relationship of MCs to segmental motion and degenerative disc disease. METHODS Four hundred fifty symptomatic patients underwent weight-bearing lumbar kinematic MRI in the neutral, flexion, and extension positions. Segmental displacement and intervertebral angles were measured in 3 positions using computer analysis software. Modic changes, disc degeneration, disc bulging, spondylolisthesis, angular motion, and translational motion were recorded, and the relationship of MCs to these factors was analyzed using a logistic regression model. To control the influence of disc degeneration on segmental motion, angular and translational motion were analyzed according to mild and severe disc degeneration stages. The motion characteristics and disc degeneration among types of MCs were also evaluated. RESULTS Multivariate analysis revealed that age, disc degeneration, angular motion, and translational motion were factors significantly related to MCs. In the severe disc degeneration stage, a significant decrease of angular motion and significant increase of translational motion were found in segments with MCs, indicating that a disorder of the endplate had an additional effect on segmental motion. Disc degeneration increased and angular motion decreased significantly and gradually as the type of MC increased. Translational motion was significantly increased with Type 2 MCs. CONCLUSIONS Age, disc degeneration, angular motion, and translational motion were significantly linked to MCs in the lumbar spine. The translational motion of lumbar segments increased with Type 2 MCs, whereas angular motion decreased as the type of MC increased, indicating that Type 2 MCs may have translational instability likely due to degenerative changes. A disorder of the endplates could play an important role in spinal instability.	[Hayashi, Tetsuo; Daubs, Michael D.; Suzuki, Akinobu; Scott, Trevor P.; Phan, Kevin H.; Ruangchainikom, Monchai; Takahashi, Shinji; Wang, Jeffrey C.] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90024 USA; [Hayashi, Tetsuo; Shiba, Keiichiro] Japan Labour Hlth & Welf Org, Spinal Injuries Ctr, Dept Orthopaed Surg, Izuka City, Fukuoka 8208508, Japan	Hayashi, T (reprint author), Japan Labour Hlth & Welf Org, Spinal Injuries Ctr, Dept Orthopaed Surg, 550-4 Igisu, Izuka City, Fukuoka 8208508, Japan.	tetsuo884hayashi@yahoo.co.jp					Zhao FD, 2005, SPINE, V30, P2621, DOI 10.1097/01.brs.0000188203.71182.c0; MODIC MT, 1988, RADIOLOGY, V168, P177; Tan YL, 2012, EUR SPINE J, V21, P2673, DOI 10.1007/s00586-012-2387-8; Kong MH, 2009, SPINE, V34, P2537, DOI 10.1097/BRS.0b013e3181b353ea; Wu HL, 2012, SPINE, V37, P1958, DOI 10.1097/BRS.0b013e31825bfb85; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Zou J, 2008, SPINE, V33, pE140, DOI 10.1097/BRS.0b013e3181657f7e; Keorochana G, 2011, SPINE, V36, P893, DOI 10.1097/BRS.0b013e3181f4d212; [Anonymous], 1982, CLIN ORTHOPAEDICS; Jensen TS, 2010, EUR SPINE J, V19, P129, DOI 10.1007/s00586-009-1184-5; TOYONE T, 1994, J BONE JOINT SURG BR, V76B, P757; MODIC MT, 1988, RADIOLOGY, V166, P193; Zhang YH, 2008, EUR SPINE J, V17, P1289, DOI 10.1007/s00586-008-0758-y; Mann E, 2011, SPINE, V36, P1081, DOI 10.1097/BRS.0b013e3181ef6a1e; Kjaer P, 2006, EUR SPINE J, V15, P1312, DOI 10.1007/s00586-006-0185-x; Thompson KJ, 2009, RADIOLOGY, V250, P849, DOI 10.1148/radiol.2503080474; Buttermann G R, 1997, Eur Spine J, V6, P115, DOI 10.1007/BF01358743; LANG P, 1990, SPINE, V15, P581, DOI 10.1097/00007632-199006000-00028; Pfirrmann CW, 2001, SPINE, V26, P1873; Zou J, 2009, SPINE, V34, P2545, DOI 10.1097/BRS.0b013e3181b32998	20	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	MAY	2015	22	5					511	517		10.3171/2014.10.SPINE14496		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG5XN	WOS:000353369300011		
J	Yamaguchi, S; Hida, K; Takeda, M; Mitsuhara, T; Morishige, M; Yamada, N; Kurisu, K				Yamaguchi, Satoshi; Hida, Kazutoshi; Takeda, Masaaki; Mitsuhara, Takafumi; Morishige, Mizuki; Yamada, Naoto; Kurisu, Kaoru			Visualization of regional cerebrospinal fluid flow with a dye injection technique in focal arachnoid pathologies	JOURNAL OF NEUROSURGERY-SPINE			English	Article						dorsal arachnoid web; focal adhesive arachnoiditis; lysis; gentian violet; technique	SYRINGOMYELIA; WEB	Surgical lysis of the thickened arachnoid membrane is the first choice of treatment in spinal arachnoid pathologies that cause flow disturbances or blockage of CSF. However, it is important to consider that while extensive lysis of the arachnoid may temporarily provide a wide pathway for CSF, an extensive lytic procedure may later cause secondary adhesion. Thus, it is ideal for the proper extent of the arachnoid lysis to be determined after careful analysis of regional CSF flow. The authors report their limited experience with intraoperative visualization of CSF flow in spinal arachnoid pathologies. Two patients with a dorsal arachnoid web (DAW) with cervical syringomyelia and 1 patient with focal adhesive arachnoiditis causing edema of the spinal cord were surgically treated at the authors' institution between 2007 and 2013. In all cases, the presence of a DAW or focal adhesive arachnoiditis was suspected from the findings on MRI, namely 1) an indentation on the upper thoracic spinal cord and 2) syringomyelia and/or edema of the spinal cord above the indentation. Exploratory surgery disclosed a transversely thickened arachnoid septum on the dorsal side of the indented cord. To prove blockage of the CSF by the septum and to decide on the extent of arachnoid lysis, regional,CSF flow around the arachnoid septum was visualized by subarachnoid injection of gentian violet solution close to the web. Injected dye stagnated just close to the arachnoid septum in all cases, and these findings dooumented CSF blockage by the septum. In 2 cases, a 2-minute observation showed that the injected dye stayed close to the web without diffusion. The authors performed not only resection of the web itself but also lysis of the thickened arachnoid on both sides of the spinal cord to make a CSF pathway on the ventral side. In the third case, the dye stagnated close to the web at first but then diffused through the nerve root to the ventral CSF space. The lysis procedure was completed after exclusive removal of the dorsal web. Postoperative MR images confirmed reduction of the syrinx and/or improvement of the edema in all cases, suggesting that the extent of arachnoid lysis was optimal in each case. No adverse effect was observed after subarachnoid injection of gentian violet. The authors believe that their technique of visualizing regional CSF flow will be helpful to decide the optimal extent of lysis in some local arachnoid pathologies.	[Yamaguchi, Satoshi; Takeda, Masaaki; Mitsuhara, Takafumi; Yamada, Naoto; Kurisu, Kaoru] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurosurg, Hiroshima 7348551, Japan; [Morishige, Mizuki] Hiroshima Univ Hosp, Div Clin Engn, Hiroshima, Japan; [Hida, Kazutoshi] Sapporo Azabu Neurosurg Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan	Yamaguchi, S (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurosurg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	satoya@hiroshima-u.ac.jp					Mauer UM, 2008, NEUROSURGERY, V63, P1139, DOI 10.1227/01.NEU.0000334411.93870.45; Maley AM, 2013, EXP DERMATOL, V22, P775, DOI 10.1111/exd.12257; Reardon MA, 2013, AM J NEURORADIOL, V34, P1104, DOI 10.3174/ajnr.A3432; Brodbelt AR, 2003, ACTA NEUROCHIR, V145, P707, DOI 10.1007/s00701-003-0071-9; Griessenauer CJ, 2014, J NEUROSURG-SPINE, V20, P30, DOI 10.3171/2013.9.SPINE1323; Ishizaka S, 2012, NEUROL MED-CHIR, V52, P686; KAMIYAMA H, 1993, NEUROSURGERY, V33, P1109; Ohata K, 2001, J CLIN NEUROSCI, V8, P40, DOI 10.1054/jocn.2000.0731; Paramore CG, 2000, J NEUROSURG, V93, P287, DOI 10.3171/spi.2000.93.2.0287; Sridharan A, 2009, NEUROSURGERY, V65, P216, DOI 10.1227/01.NEU.0000348007.84175.FA; Tseng SH, 1997, CLIN NEUROL NEUROSUR, V99, P256, DOI 10.1016/S0303-8467(97)00086-3	11	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	MAY	2015	22	5					554	557		10.3171/2014.10.SPINE1446		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG5XN	WOS:000353369300016		
J	Murakami, K; Hori, S; Yamaguchi, Y; Mercuri, LG; Harayama, N; Maruo, S; Takahashi, T				Murakami, KenIchiro; Hori, Shinsuke; Yamaguchi, Yoshinori; Mercuri, Louis G.; Harayama, Naota; Maruo, Syouta; Takahashi, Tsuneo			Synovial Plicae and Temporomandibular Joint Disorders: Surgical Findings	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							KNEE	Purpose: Synovial plicae and their relation to pain and disability have been reported in the orthopedic literature in association with the knee and other extremity joints. However, the occurrence of synovial plicae in the temporomandibular joint (TMJ) have rarely been reported. This report describes the surgical appearance, distribution, and histologic findings of synovial plicae in patients with TMJ recurrent dislocation and internal derangement. Materials and Methods: Twenty consecutive patients, 16 with recurrent dislocation and 4 with internal derangement, who underwent open TMJ surgery by the same surgeon from 2010 to 2013 were studied retrospectively. Results: Synovial plicae were detected in 18 of 28 joints (64.3%). Synovial plicae were observed in 15 of 24 joints (62.5%) with recurrent dislocation and in 3 of 4 joints (75%) with internal derangement. Histologic findings of these plicae were consistent with dense fibrous or cartilaginous tissues, with some exhibiting a synovial lining. Conclusions: Although the role of synovial plicae in TMJ disorders is unknown and unstudied, consideration should be given to investigating the possible relation of these structures to the signs and symptoms of TMJ disorders. (c) 2015 American Association of Oral and Maxillofacial Surgeons	[Murakami, KenIchiro] Ako City Hosp, Dept Oral & Maxillofacial Surg, Ako City, Hyogo 6780232, Japan; [Hori, Shinsuke; Maruo, Syouta] Kyotango City Kumihama Hosp, Dept Oral & Maxillofacial Surg, Kyotango, Japan; [Yamaguchi, Yoshinori] Kusatsu Gen Hosp, Dept Oral & Maxillofacial Surg, Kusatsu, Japan; [Mercuri, Louis G.] TMJ Concepts, Ventura, CA USA; [Harayama, Naota] Kyoto City Hosp, Dept Oral & Maxillofacial Surg, Kyoto, Japan; [Harayama, Naota] Ako City Hosp, Dept Oral & Maxillofacial Surg, Ako, Japan; [Takahashi, Tsuneo] Kanagawa Dent Univ, Dept Imaging Anat 3D, Ako, Japan	Murakami, K (reprint author), Ako City Hosp, Dept Oral & Maxillofacial Surg, Nakahiro 1090, Ako City, Hyogo 6780232, Japan.	murakeny@yahoo.co.jp					AAOMS ParCare, 2012, J ORAL MAXILLOFAC S3, V70, pe1; Jee WH, 1998, J COMPUT ASSIST TOMO, V22, P814, DOI 10.1097/00004728-199809000-00028; Garcia-Valtuille R, 2002, RADIOGRAPHICS, V22, P775; de Luzuriaga BCR, 2013, SKELETAL RADIOL, V42, P675, DOI 10.1007/s00256-012-1523-1; Dupont JY, 1997, CLIN SPORT MED, V16, P87, DOI 10.1016/S0278-5919(05)70009-0; Funk L, 2006, J SHOULDER ELB SURG, V15, P697, DOI 10.1016/j.jse.2006.03.009; Kent M, 2010, KNEE, V17, P97, DOI 10.1016/j.knee.2009.07.009; Kirk WS, 2013, INT J ORAL MAX SURG, V42, P229, DOI 10.1016/j.ijom.2012.11.002; Moses JJ, 1989, ORAL MAXILLOFAC SURG, V1, P165; MURAKAMI K-I, 1982, Okajimas Folia Anatomica Japonica, V58, P745; MURAKAMI KI, 1985, ANAT ANZEIGER, V160, P167; OHMURA Y, 1984, Journal of the Stomatological Society Japan, V51, P465; RICHMOND JC, 1983, CLIN ORTHOP RELAT R, P185; Schindler OS, 2004, CURR ORTHOPAED, V18, P210, DOI 10.1016/j.cuor.2004.03.005	14	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	MAY	2015	73	5					827	833		10.1016/j.joms.2014.12.018		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CG3AL	WOS:000353148700012		
J	Yoshida, M; Shiiba, S; Sago, T; Nunomaki, M; Harano, N; Watanabe, S				Yoshida, Mitsuhiro; Shiiba, Shunji; Sago, Teppei; Nunomaki, Masahito; Harano, Nozomu; Watanabe, Seiji			Comparison of Pain Tolerance Thresholds of Upper Limb to Identify the Most Appropriate Venipuncture Site	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							NEUROPATHY; NEUROMETER; CHILDREN; VEINS	Purpose: Venipuncture is often accompanied by pain, which can compromise dental care and foment distrust toward dental care providers. The aim of the present study was to identify sites on the forearm and hand that have the greatest pain tolerance threshold (PTT) during venipuncture. Materials and Methods: The PTT was estimated in 20 healthy volunteers using a noninvasive nerve conduction threshold device. The subjects self-stimulated 5 sites (median cubital vein, cephalic vein at the cubitus, basilic vein, cephalic vein at the carpus, and superficial dorsal vein) at 2 kHz, 250 Hz, and 5 Hz. We measured the stimulation intensity before the subject deactivated the device. Differences in the average PTT values at each site were compared using the Kruskal-Wallis and Scheffe tests. P <. 05 was considered to indicate statistical significance. Results: The PTT was significantly greater at the superficial dorsal vein than at the basilic vein for all 3 noninvasive nerve conduction threshold frequencies (P <.05). The estimated PTT was significantly greater at the superficial dorsal vein than at the median cubital vein and cephalic vein at the carpus in response to 250-Hz stimulation (P <.05). Conclusions: The greater PTT of the superficial dorsal vein suggests that venipuncture at this site should result in the lowest pain intensity among all upper limb sites. (c) 2015 American Association of Oral and Maxillofacial Surgeons	[Yoshida, Mitsuhiro; Shiiba, Shunji; Sago, Teppei; Nunomaki, Masahito; Harano, Nozomu; Watanabe, Seiji] Kyushu Dent Univ, Div Dent Anesthesiol, Dept Control Phys Funct, Kitakyushu, Fukuoka 8038580, Japan	Yoshida, M (reprint author), Kyushu Dent Univ, Div Dent Anesthesiol, Dept Control Phys Funct, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	mh.yoshida@gmail.com					Akdas O, 2014, IRISH J MED SCI, V183, P517, DOI 10.1007/s11845-013-1037-4; Wallace MS, 1996, PAIN, V66, P69, DOI 10.1016/0304-3959(96)02980-6; VEVES A, 1994, DIABETES CARE, V17, P1200, DOI 10.2337/diacare.17.10.1200; Taddio A, 2010, CAN MED ASSOC J, V182, pE843, DOI 10.1503/cmaj.101720; Kiso T, 2001, J PHARMACOL EXP THER, V297, P352; Fetzer S J, 1999, J Perianesth Nurs, V14, P95, DOI 10.1016/S1089-9472(99)80024-0; Furuya A, 2009, J CLIN ANESTH, V21, P190, DOI 10.1016/j.jclinane.2008.07.005; Gross PR, 1992, BEHAV RES THER, V30, P73; HARDY JD, 1952, P SOC EXP BIOL MED, V80, P425; Khalili S, 2014, INT J APPL BASIC MED, V4, P46; LIU S, 1995, ANESTHESIOLOGY, V82, P60, DOI 10.1097/00000542-199501000-00009; Malamed SF, 2009, SEDATION; MASSON EA, 1989, DIABETOLOGIA, V32, P724, DOI 10.1007/BF00274531; Mironer YE, 2000, PAIN MED, V1, P110, DOI 10.1046/j.1526-4637.2000.00019.x; NITESCU P, 1990, ACTA ANAESTH SCAND, V34, P120; PITEI DL, 1994, DIABETIC MED, V11, P872; Raj P P, 2001, Pain Pract, V1, P53, DOI 10.1046/j.1533-2500.2001.01007.x; Shimazu H, 2005, T JPN SOC MED BIOL E, V43, P117; Torebjork E, 1974, J NEUROL NEUROSUR PS, V37, P653; Yamada K, 2008, CLIN ANAT, V21, P307, DOI 10.1002/ca.20622	20	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	MAY	2015	73	5					850E1	850E5		10.1016/j.joms.2015.01.027		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CG3AL	WOS:000353148700015		
J	Kobayashi, W; Teh, BG; Kimura, H; Kakehata, S; Kawaguchi, H; Takai, Y				Kobayashi, Wataru; Teh, Beng Gwan; Kimura, Hiroto; Kakehata, Sinya; Kawaguchi, Hideo; Takai, Yoshihiro			Comparison of Osteoradionecrosis of the Jaw After Superselective Intra-arterial Chemoradiotherapy Versus Conventional Concurrent Chemoradiotherapy of Oral Cancer	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; STAGE-IV HEAD; NECK-CANCER; RADIATION-THERAPY; DENTAL-CARE; RADIOTHERAPY; CHEMOTHERAPY; TRIAL; PREVENTION	Purpose: The purpose of the present study was to compare the incidence of osteoradionecrosis between superselective intra-arterial chemoradiotherapy and intravenous chemoradiotherapy and to verify the risk factors for osteoradionecrosis. Materials and Methods: Of the 79 patients with oral cancer, 40 were treated with intra-venous chemoradiotherapy and 39 were treated with superselective intra-arterial chemoradiotherapy. The incidence of, and risk factors for, osteoradionecrosis were evaluated using statistical analysis. Results: Of the 79 patients, 4 (10%) of 40 in the intravenous chemoradiotherapy and 7 (17.9%) of 39 in the superselective intra-arterial chemoradiotherapy group developed osteoradionecrosis of the jaw. No significant difference was found between the 2 groups. Although the chemoradiotherapy methods, anatomic tumor location, smoking behavior, alcohol consumption, condition of teeth, teeth extraction before radiation, and progression of dental caries were considered predisposing factors for the occurrence of osteoradionecrosis, only progressive dental caries resulted in a significant difference for osteoradionecrosis. Conclusions: The present study is the first report comparing the incidence of osteoradionecrosis between superselective intra-arterial chemoradiotherapy and intravenous chemoradiotherapy. The administration methods of anticancer drugs were not related to the incidence of osteoradionecrosis in our study. From our study, dental caries is the most important risk factor for osteoradionecrosis; therefore, a radiation caries prevention program is crucial to control osteoradionecrosis. (c) 2015 American Association of Oral and Maxillofacial Surgeons	[Kobayashi, Wataru; Kimura, Hiroto] Hirosaki Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Hirosaki, Aomori 0368562, Japan; [Teh, Beng Gwan] Misawa City Hosp, Dept Oral & Maxillofacial Surg, Misawa, Japan; [Kakehata, Sinya; Kawaguchi, Hideo; Takai, Yoshihiro] Hirosaki Univ, Grad Sch Med, Dept Radiol, Hirosaki, Aomori 0368562, Japan	Kobayashi, W (reprint author), Hirosaki Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	wako@cc.hirosaki-u.ac.jp					Bensadoun RJ, 2006, INT J RADIAT ONCOL, V64, P983, DOI 10.1016/j.ijrobp.2005.09.041; EPSTEIN JB, 1987, J ORAL MAXIL SURG, V45, P104, DOI 10.1016/0278-2391(87)90399-5; Wahl MJ, 2006, INT J RADIAT ONCOL, V64, P661, DOI 10.1016/j.ijrobp.2005.10.021; DREIZEN S, 1977, J DENT RES, V56, P99, DOI 10.1177/00220345770560022101; Robbins KT, 2005, J CLIN ONCOL, V23, P1447, DOI 10.1200/JCO.2005.03.168; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Semrau R, 2006, INT J RADIAT ONCOL, V64, P1308, DOI 10.1016/j.ijrobp.2005.10.039; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Tsai CJ, 2013, INT J RADIAT ONCOL, V85, P415, DOI 10.1016/j.ijrobp.2012.05.032; Kielbassa AM, 2006, LANCET ONCOL, V7, P326, DOI 10.1016/S1470-2045(06)70658-1; Nabil S, 2012, OR SURG OR MED OR PA, V113, P54, DOI 10.1016/j.tripleo.2011.07.042; MARX RE, 1987, ORAL SURG ORAL MED O, V64, P379, DOI 10.1016/0030-4220(87)90136-8; JANSMA J, 1992, CANCER, V70, P2171, DOI 10.1002/1097-0142(19921015)70:8<2171::AID-CNCR2820700827>3.0.CO;2-S; Kobayashi W, 2010, ORAL ONCOL, V46, P860, DOI 10.1016/j.oraloncology.2010.10.001; RANKOW RM, 1971, ANN OTO RHINOL LARYN, V80, P603; Le QT, 2006, CANCER, V106, P1940, DOI 10.1002/cncr.21785; Wendt TG, 1998, J CLIN ONCOL, V16, P1318; Gomez DR, 2011, INT J RADIAT ONCOL, V81, pE207, DOI 10.1016/j.ijrobp.2011.02.003; Budach V, 2005, J CLIN ONCOL, V23, P1125, DOI 10.1200/JCO.2005.07.010; Ben-David MA, 2007, INT J RADIAT ONCOL, V68, P396, DOI 10.1016/j.ijrobp.2006.11.059; Moller P, 2004, ORAL SURG ORAL MED O, V97, P173, DOI 10.1016/S1079-2104(03)00473-6; Bartelink H, 2002, EUR J CANCER, V38, P667, DOI 10.1016/S0959-8049(01)00425-7; COX FL, 1976, ORAL SURG ORAL MED O, V42, P679, DOI 10.1016/0030-4220(76)90218-8; Johnson RP, 1997, J ORAL MAXIL SURG, V55, P545, DOI 10.1016/S0278-2391(97)90479-1; MAIN JHP, 1983, CAN MED ASSOC J, V128, P1062; Mitsudo K, 2011, INT J RADIAT ONCOL, V79, P1428, DOI 10.1016/j.ijrobp.2010.01.011; Oshiro Maki, 2007, J Oral Sci, V49, P115, DOI 10.2334/josnusd.49.115; SOLOMON H, 1968, AM J SURG, V115, P349, DOI 10.1016/0002-9610(68)90158-X; Teh BG, 2007, ASIAN J ORAL MAXILLO, V19, P210	29	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	MAY	2015	73	5					994	1002		10.1016/j.joms.2014.11.016		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CG3AL	WOS:000353148700032		
J	Sakakibara, A; Minamikawa, T; Hashikawa, K; Sakakibara, S; Hasegawa, T; Akashi, M; Furudoi, S; Komori, T				Sakakibara, Akiko; Minamikawa, Tsutomu; Hashikawa, Kazunobu; Sakakibara, Shunsuke; Hasegawa, Takumi; Akashi, Masaya; Furudoi, Shungo; Komori, Takahide			Does Salivary Duct Repositioning Prevent Complications After Tumor Resection or Salivary Gland Surgery?	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article								Purpose: Tissue that is resected for the treatment of oral tumors often includes salivary gland ducts. At their institution, the authors conserve and transfer as much of the salivary duct as possible during these procedures to avoid obstructive complications. Differentiating these obstructive complications from a metastatic node can be challenging and can confound subsequent oncologic management. This study compared and examined the effectiveness of salivary duct repositioning in decreasing the incidence of obstructive complications. Materials and Methods: Cases of oromandibular disease treated with salivary duct resection at Kobe University Graduate School of Medicine from 2008 to 2013 were retrospectively analyzed. Thirty-two cases (25 patients) of Wharton duct resection and 31 cases (31 patients) of Stensen duct resection were included. The incidence of complications after salivary duct repositioning, duct ligation, and retention of the sublingual gland around the Wharton duct was compared. Results: Wharton ducts were repositioned in 30 cases and ligated in 2 cases. Complications, including oral swelling at the Wharton duct, were observed in 5 cases of repositioning and 2 cases of ligation. Stensen ducts were repositioned in 9 cases and ligated in 22 cases. The only complication reported was a single case of salivary fistula after ligation. Conclusions: Salivary duct repositioning is performed to prevent blockage of physiologic salivary discharge. Complications were more frequently associated with Wharton ducts than with Stensen ducts because of the unique physiologic and anatomic characteristics of the Wharton duct. Repositioning of the salivary duct is a suitable method for preventing complications associated with the Wharton duct. (c) 2015 American Association of Oral and Maxillofacial Surgeons	[Sakakibara, Akiko; Minamikawa, Tsutomu; Hasegawa, Takumi; Akashi, Masaya; Furudoi, Shungo; Komori, Takahide] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo 6500017, Japan; [Hashikawa, Kazunobu; Sakakibara, Shunsuke] Kobe Univ, Grad Sch Med, Dept Plast Surgery, Kobe, Hyogo 6500017, Japan	Sakakibara, A (reprint author), Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo 6500017, Japan.	oguni@med.kobe-u.ac.jp		Sakakibara, Shunsuke/0000-0001-5644-4549			Cotrim AP, 2007, MOL THER, V15, P2101, DOI 10.1038/sj.mt.6300296; YOSHIMURA Y, 1989, J ORAL MAXIL SURG, V47, P704; Scott J, 1999, J DENT RES, V78, P1711; Fehrenbach MJ, 2012, ILLUSTRATED ANATOMY, P156; Harrison JD, 2010, HEAD NECK-J SCI SPEC, V32, P1310, DOI 10.1002/hed.21326; ISACSSON G, 1981, ARCH OTO-RHINO-LARYN, V232, P91, DOI 10.1007/BF00661007; LEPPI TJ, 1967, J DENT RES, V46, P359, DOI 10.1177/00220345670460020801; Nanci A, 2013, 10 CATES ORAL HISTOL, P255; Ord RA, 1996, J ORAL MAXIL SURG, V54, P1075, DOI 10.1016/S0278-2391(96)90163-9; Shehata EA, 2008, ANN PEDIAT SURG, V4, P89	10	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	MAY	2015	73	5					1003	1007		10.1016/j.joms.2014.12.006		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CG3AL	WOS:000353148700033		
J	Konopnicki, S; Sharaf, B; Resnick, C; Patenaude, A; Pogal-Sussman, T; Hwang, KG; Abukawa, H; Troulis, MJ				Konopnicki, Sandra; Sharaf, Basel; Resnick, Cory; Patenaude, Adam; Pogal-Sussman, Tracy; Hwang, Kyung-Gyun; Abukawa, Harutsugi; Troulis, Maria J.			Tissue-Engineered Bone With 3-Dimensionally Printed beta-Tricalcium Phosphate and Polycaprolactone Scaffolds and Early Implantation: An In Vivo Pilot Study in a Porcine Mandible Model	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							MESENCHYMAL STEM-CELLS; PCL-TCP SCAFFOLD; DEFECTS; VITRO; RECONSTRUCTION; AUGMENTATION; CONDYLE; SURGERY; CULTURE; GRAFTS	Purpose: Deep bone penetration into implanted scaffolds remains a challenge in tissue engineering. The purpose of this study was to evaluate bone penetration depth within 3-dimensionally (3D) printed beta-tricalcium phosphate (beta-TCP) and polycaprolactone (PCL) scaffolds, seeded with porcine bone marrow progenitor cells (pBMPCs), and implanted early in vivo. Materials and Methods: Scaffolds were 3D printed with 50% beta-TCP and 50% PCL. The pBMPCs were harvested, isolated, expanded, and differentiated into osteoblasts. Cells were seeded into the scaffolds and constructs were incubated in a rotational oxygen-permeable bioreactor system for 14 days. Six 2- x 2-cm defects were created in eachmandible (N= 2 minipigs). In total, 6 constructs were placed within defects and 6 defects were used as controls (unseeded scaffolds, n = 3; empty defects, n = 3). Eight weeks after surgery, specimens were harvested and analyzed by hematoxylin and eosin (H&E), 4',6-diamidino-2-phenylindole (DAPI), and CD31 staining. Analysis included cell counts, bone penetration, and angiogenesis at the center of the specimens. Results: All specimens (N = 12) showed bone formation similar to native bone at the periphery. Of 6 constructs, 4 exhibited bone formation in the center. Histomorphometric analysis of the H& E-stained sections showed an average of 22.1% of bone in the center of the constructs group compared with 1.87% in the unseeded scaffolds (P <.05). The 2 remaining constructs, which did not display areas of mature bone in the center, showed massive cell penetration depth by DAPI staining, with an average of 2,109 cells/0.57 mm(2) in the center compared with 1,114 cells/0.57 mm(2) in the controls (P <.05). CD31 expression was greater in the center of the constructs compared with the unseeded scaffolds (P <.05). Conclusion: 3D printed beta-TCP and PCL scaffolds seeded with pBMPCs and implanted early into porcine mandibular defects display good bone penetration depth. Further study with a larger sample and larger bone defects should be performed before human applications. (c) 2015 American Association of Oral and Maxillofacial Surgeons	[Konopnicki, Sandra] Massachusetts Gen Hosp, Dept Oral & Maxillofacial Surg, Skeletal Biol Res Ctr, Boston, MA 02114 USA; [Konopnicki, Sandra] Lille Univ Hosp, Dept Oral & Maxillofacial Surg, Lille, France; [Sharaf, Basel] Mayo Clin, Dept Surg, Div Plast Surg, Rochester, MN USA; [Resnick, Cory] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA USA; [Resnick, Cory] Harvard Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Boston, MA 02115 USA; [Resnick, Cory; Troulis, Maria J.] Harvard Univ, Sch Med, Boston, MA USA; [Patenaude, Adam; Pogal-Sussman, Tracy; Troulis, Maria J.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Hwang, Kyung-Gyun] Hanyang Univ, Coll Med, Dept Dent Oral & Maxillofacial Surg, Seoul 133791, South Korea; [Abukawa, Harutsugi] Tokyo Med Univ Hosp, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Troulis, Maria J.] Massachusetts Gen Hosp, Dept Oral & Maxillofacial Surg, Minimally Invas Oral & Maxillofacial Surg & Resid, Skeletal Biol Res Ctr, Boston, MA 02114 USA	Konopnicki, S (reprint author), Massachusetts Gen Hosp, Dept Oral & Maxillofacial Surg, 55 Fruit St,Warren 1201, Boston, MA 02114 USA.	sandra.konopnicki@gmail.com		Resnick, Cory/0000-0002-6391-9618	Massachusetts General Hospital Department of Oral and Maxillofacial Surgery Education and Research Fund (Boston, MA); La Fondation des Gueules Cassees (Paris, France) [40-2013]; Hanson Foundation (Boston, MA); Massachusetts Pediatric Sugery (Boston, MA); Francine and Roger Jean Foundation Education and Research in OMFS Fund; Lynn Foundation	This work was funded in part by the Massachusetts General Hospital Department of Oral and Maxillofacial Surgery Education and Research Fund (Boston, MA), La Fondation des Gueules Cassees (Paris, France) (Grant 40-2013), Hanson Foundation (Boston, MA), Massachusetts Pediatric Sugery (Boston, MA), the Francine and Roger Jean Foundation Education and Research in OMFS Fund, and the Lynn Foundation.	Curodeau A, 2000, J BIOMED MATER RES, V53, P525, DOI 10.1002/1097-4636(200009)53:5<525::AID-JBM12>3.0.CO;2-1; Abukawa H, 2004, J ORAL MAXIL SURG, V62, P601, DOI 10.1016/j.joms.2003.11.010; Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550; Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Khojasteh A, 2013, J BIOMED MATER RES B, V101B, P848, DOI 10.1002/jbm.b.32889; Ringe J, 2002, CELL TISSUE RES, V307, P321, DOI 10.1007/s00441-002-0525-z; Abukawa H, 2003, J ORAL MAXIL SURG, V61, P94, DOI 10.1053/joms.2003.50015; Payne KFB, 2014, BRIT J ORAL MAX SURG, V52, P7, DOI 10.1016/j.bjoms.2013.03.005; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Kuboki T, 1997, J DENT RES, V76, P1760; Ishaug SL, 1997, J BIOMED MATER RES, V36, P17; Ma JL, 2009, J TISSUE ENG REGEN M, V3, P615, DOI 10.1002/term.203; Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.0.CO;2-7; Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8; Kinoshita Y, 2013, SCI WORLD J, DOI 10.1155/2013/863157; Rai B, 2007, J ORAL MAXIL SURG, V65, P2195, DOI 10.1016/j.jams.2006.11.026; Terai H, 2002, MAT SCI ENG C-BIO S, V20, P3, DOI 10.1016/S0928-4931(02)00006-1; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sharaf B, 2012, J ORAL MAXIL SURG, V70, P647, DOI 10.1016/j.joms.2011.07.029; Sandor GK, 2014, STEM CELL TRANSL MED, V3, P530, DOI 10.5966/sctm.2013-0173; DELUSTRO F, 1990, CLIN ORTHOP RELAT R, P263; Eklou-Kalonji E, 1999, J NUTR, V129, P188; Ferri J, 1997, J ORAL MAXIL SURG, V55, P440, DOI 10.1016/S0278-2391(97)90685-6; Henkel KO, 2005, J CRANIO MAXILL SURG, V33, P45, DOI 10.1016/j.jcms.2004.08.005; KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505; Ruehe B, 2009, ORAL SURG ORAL MED O, V108, P699, DOI 10.1016/j.tripleo.2009.06.037; Temple JP, 2014, J BIOMED MATER RES A, V102, P4317, DOI 10.1002/jbm.a.35107; Tessier P, 2005, PLAST RECONSTR SURG, V116, p6S, DOI 10.1097/01.prs.0000173862.20563.12; Troulis MJ, 2000, J ORAL MAXIL SURG, V58, P507, DOI 10.1016/S0278-2391(00)90012-0; Yeo A, 2012, CLIN ORAL IMPLAN RES, V23, P1322, DOI 10.1111/j.1600-0501.2011.02366.x	31	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	MAY	2015	73	5					1016E1	1016E11		10.1016/j.joms.2015.01.021		11	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CG3AL	WOS:000353148700035		
J	Rokutanda, S; Yanamoto, S; Yamada, S; Naruse, T; Inokuchi, S; Umeda, M				Rokutanda, Satoshi; Yanamoto, Souichi; Yamada, Shin-ichi; Naruse, Tomofumi; Inokuchi, Satoshi; Umeda, Masahiro			Application of Polyglycolic Acid Sheets and Fibrin Glue Spray to Bone Surfaces During Oral Surgery: A Case Series	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							SKIN-GRAFTS; SEALANT; FELT	Purpose: Previous studies have described the use of a combination of polyglycolic acid (PGA) sheets (a resorbable biomaterial) and fibrin glue spray to treat open soft tissue wounds during oral surgery, which have produced good results. However, there have not been any detailed investigations of the use of these materials to treat exposed hard tissue wounds. This study investigated the combination of PGA sheets and fibrin glue spray to treat exposed bone surfaces during oral surgery. Materials and Methods: PGA sheets and fibrin glue spray were applied to exposed bone surfaces after lesion resection in 8 patients (10 sites) who had been diagnosed with malignant tumors. The sheets were cut into pieces (width, 5 to 10 mm) and applied to the exposed bone surface. Results: PGA adhesion was confirmed for the final time on postoperative days 28 to 56 (mean, 35.8 days), and there were no cases in which the PGA sheets fell off the wound prematurely. Epithelialization of the wound surface occurred gradually and was complete by postoperative weeks 4 to 5, regardless of the size of the wound. Conclusion: This method was considered very effective at preventing postoperative bleeding, alleviating postoperative pain, and promoting epithelialization during the reconstruction of bone surfaces after tumor resection in the oral cavity. (c) 2015 American Association of Oral and Maxillofacial Surgeons	[Rokutanda, Satoshi; Yanamoto, Souichi; Yamada, Shin-ichi; Naruse, Tomofumi; Inokuchi, Satoshi; Umeda, Masahiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, Nagasaki 8528588, Japan	Rokutanda, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	satoshi6@nagasaki-u.ac.jp					Takimoto K, 2014, DIGEST ENDOSC, V26, P46, DOI 10.1111/den.12280; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; Kobayashi S, 2011, SURG ENDOSC, V25, P3590, DOI 10.1007/s00464-011-1764-4; Doyama N, 2014, DIGEST ENDOSC, V26, P41; HALL HD, 1970, J ORAL SURG, V28, P565; Maniwa Tomohiro, 2009, Interact Cardiovasc Thorac Surg, V8, P697, DOI 10.1510/icvts.2008.201814; Ochiai T, 2010, J GASTROINTEST SURG, V14, P884, DOI 10.1007/s11605-009-1149-3; Qureshi SS, 2005, J SURG ONCOL, V89, P102, DOI 10.1002/jso.20192; SCHRAMM VL, 1980, ARCH OTOLARYNGOL, V106, P528; Shinozaki T, 2013, JPN J CLIN ONCOL, V43, P33, DOI 10.1093/jjco/hys186; Takeuchi J, 2013, J ORAL MAXIL SURG, V71, pE126, DOI 10.1016/j.joms.2012.08.012; Yonezawa H, 2012, BR J ORAL MAXILLOFAC, V50, P43	12	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	MAY	2015	73	5					1017E1	1017E6		10.1016/j.joms.2015.01.014		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CG3AL	WOS:000353148700036		
J	Ito, A; Aoyama, T; Iijima, H; Tajino, J; Nagai, M; Yamaguchi, S; Zhang, XK; Kuroki, H				Ito, Akira; Aoyama, Tomoki; Iijima, Hirotaka; Tajino, Junichi; Nagai, Momoko; Yamaguchi, Shoki; Zhang, Xiangkai; Kuroki, Hiroshi			Culture Temperature Affects Redifferentiation and Cartilaginous Extracellular Matrix Formation in Dedifferentiated Human Chondrocytes	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						chondrocyte; temperature; extracellular matrix; differentiation; pellet culture	ARTICULAR-CARTILAGE; KNEE; HEAT; REGENERATION; HYPERTHERMIA; EXPRESSION; ALGINATE; DEFECTS; DAMAGE; CELLS	To date, there have been few studies on how temperature affects the phenotype and metabolism of human chondrocytes. Thus, the purpose of this study was to elucidate the effects of culture temperature on chondrocyte redifferentiation and extracellular matrix (ECM) formation using dedifferentiated mature human chondrocytes in vitro. Dedifferentiated chondrocytes were cultured in a pellet culture system for up to 21days. The pellets were randomly divided into three groups with different culture temperature (32, 37, and 41 degrees C). Chondrocyte redifferentiation and ECM formation were evaluated by wet weight, messenger ribonucleic acid (mRNA), histological, and biochemical analyses. The results showed that the wet weight and the mRNA expressions of collagen type II A1 and cartilage oligomeric matrix protein at 37 degrees C were higher than the corresponding values at 32 degrees C. The histological and biochemical analyses revealed that the syntheses of type II collagen and proteoglycan were promoted at 37 degrees C compared to those at 32 degrees C, whereas they were considerably inhibited at 41 degrees C. In conclusion, the results obtained herein indicated that temperature affects chondrocyte redifferentiation and ECM formation, and modulation of temperature might thus represent an advantageous means to regulate the phenotype and biosynthetic activity of chondrocytes. (c) 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 33:633-639, 2015.	[Ito, Akira; Iijima, Hirotaka; Tajino, Junichi; Nagai, Momoko; Yamaguchi, Shoki; Zhang, Xiangkai; Kuroki, Hiroshi] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Dept Motor Funct Anal, Kyoto, Japan; [Ito, Akira; Yamaguchi, Shoki] Japan Soc Promot Sci, Tokyo, Japan; [Aoyama, Tomoki] Kyoto Univ, Grad Sch Med, Dept Dev & Rehabil Motor Funct, Human Hlth Sci, Kyoto, Japan	Kuroki, H (reprint author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Dept Motor Funct Anal, Kyoto, Japan.	kuroki.hiroshi.6s@kyoto-u.ac.jp			JSPS KAKENHI [25242055, 25560258];  [25-3611]	Grant sponsor: Grant-in-Aid for JSPS Research Fellows; Grant number: 25-3611; Grant sponsor: JSPS KAKENHI Grant-in-Aid for Scientific Research (A); Grant number: 25242055.; Grant sponsor: JSPS KAKENHI Grant-in-Aid for Challenging Exploratory Research; Grant number: 25560258.	Dewhirst MW, 2003, INT J HYPERTHER, V19, P267, DOI 10.1080/0265673031000119006; WHEATLEY DN, 1989, INT J HYPERTHER, V5, P145, DOI 10.3109/02656738909140444; Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477; OOSTERVELD FGJ, 1994, SEMIN ARTHRITIS RHEU, V24, P82, DOI 10.1016/S0049-0172(05)80002-2; Mollon B, 2013, OSTEOARTHR CARTILAGE, V21, P1824, DOI 10.1016/j.joca.2013.08.024; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; DEWEY WC, 1977, RADIOLOGY, V123, P463; Changoor A, 2011, OSTEOARTHR CARTILAGE, V19, P126, DOI 10.1016/j.joca.2010.10.010; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091561; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Freyria AM, 2012, INJURY, V43, P259, DOI 10.1016/j.injury.2011.05.035; Mouw JK, 2005, OSTEOARTHR CARTILAGE, V13, P828, DOI 10.1016/j.joca.2005.04.020; KIM HKW, 1991, J BONE JOINT SURG AM, V73A, P1301; Becher C, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-46; Elder SH, 2006, J ORTHOP RES, V24, P740, DOI 10.1002/jor.20086; Iijima H, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-101; Ito A, 2012, ULTRASOUND MED BIOL, V38, P1726, DOI 10.1016/j.ultrasmedbio.2012.06.005; Ito A, 2014, INT J HYPERTHER, V30, P210, DOI 10.3109/02656736.2014.906048; Ito A, 2014, INT J HYPERTHER, V30, P96, DOI 10.3109/02656736.2014.880857; Kocaoglu B, 2011, ARTHROSCOPY, V27, P526, DOI 10.1016/j.arthro.2010.10.019; PELTONEN L, 1980, P NATL ACAD SCI-BIOL, V77, P162, DOI 10.1073/pnas.77.1.162; Sanchez-Inchausti G, 2005, ARTHROSCOPY, V21, P552, DOI 10.1016/j.arthro.2005.01.011; Tekari A, 2014, J ORTHOP RES, V32, P1503, DOI 10.1002/jor.22690; Tonomura H, 2008, J ORTHOP RES, V26, P34, DOI 10.1002/jor.20421	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	MAY	2015	33	5					633	639		10.1002/jor.22808		7	Orthopedics	Orthopedics	CG6NB	WOS:000353417300004		
J	Yoshii, Y; Ishii, T; Tung, WL				Yoshii, Yuichi; Ishii, Tomoo; Tung, Wen-lin			Ultrasound Assessment of the Effectiveness of Carpal Tunnel Release on Median Nerve Deformation	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						median nerve; deformation; displacement; carpal tunnel release; ultrasound	CANAL PRESSURES; SURGICAL-TREATMENT; FINGER; TENDON; DISPLACEMENT; SONOGRAPHY; DIAGNOSIS; WRIST	To assess the biomechanical effect of carpal tunnel release (CTR), we evaluated the deformation and displacement patterns of the median nerve before and after CTR in carpal tunnel syndrome (CTS) patients. Sixteen wrists of 14 idiopathic CTS patients who had open CTR and 26 wrists of 13 asymptomatic volunteers were evaluated by ultrasound. Cross-sectional images of the carpal tunnel during motion from full finger extension to flexion were recorded. The area, perimeter, aspect ratio of a minimum enclosing rectangle, and circularity of the median nerve were measured in finger extension and flexion positions. Deformation indices, determined by the flexion-extension ratio for each parameter, were compared before and after CTR. After CTR, the deformation indices of perimeter and circularity became significantly larger and the aspect ratio became significantly smaller than those before CTR (p<0.05). Those differences were more obvious when comparing the values between the patients before CTR and the controls. Since the deformation indices after CTR are similar to the patterns of normal subjects, the surrounding structures and environment of the median nerve may be normalized upon CTR. This may be a way to tell how the median nerves recover after CTR. (c) 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 33:726-730, 2015.	[Yoshii, Yuichi; Ishii, Tomoo] Tokyo Med Univ, Ibaraki Med Ctr, Dept Orthopaed Surg, Ami, Ibaraki 3000395, Japan; [Tung, Wen-lin] Ibaraki Prefectural Univ Hlth Sci, Dept Rehabil, Ami, Ibaraki, Japan	Yoshii, Y (reprint author), Tokyo Med Univ, Ibaraki Med Ctr, Dept Orthopaed Surg, Ami, Ibaraki 3000395, Japan.	yy12721@yahoo.co.jp			Japanese Society for Surgery of the Hand	Grant sponsor: Japanese Society for Surgery of the Hand.	ALQATTAN MM, 1994, J HAND SURG-BRIT EUR, V19B, P622, DOI 10.1016/0266-7681(94)90130-9; BROWN RA, 1993, J BONE JOINT SURG AM, V75A, P1265; BUCHBERGER W, 1992, AM J ROENTGENOL, V159, P793; Tuzuner S, 2004, NEUROSURGERY, V54, P1155, DOI 10.1227/01.NEU.0000119232.57668.98; WERNER CO, 1983, ACTA ORTHOP SCAND, V54, P312; Ugbolue UC, 2005, CLIN BIOMECH, V20, P50, DOI 10.1016/j.clinbiomech.2004.08.006; GELBERMAN RH, 1981, J BONE JOINT SURG AM, V63, P380; KULICK MI, 1986, J HAND SURG-AM, V11A, P59; Duncan I, 1999, AM J ROENTGENOL, V173, P681; Brown RK, 2000, J HAND SURG-AM, V25A, P112; Cobb TK, 1996, ERGONOMICS, V39, P103, DOI 10.1080/00140139608964437; GOLDSTEIN SA, 1987, J BIOMECH, V20, P1, DOI 10.1016/0021-9290(87)90261-2; HARRIS CM, 1979, J BONE JOINT SURG AM, V61, P93; HYBBINETTE CH, 1975, ACTA ORTHOP SCAND, V46, P610; Lee CH, 2005, ANN PLAS SURG, V54, P20, DOI 10.1097/01.sap.0000141942.27182.55; NAGLE D, 1994, ARTHROSCOPY, V10, P259, DOI 10.1016/S0749-8063(05)80108-2; OKUTSU I, 1989, J BONE JOINT SURG AM, V71A, P679; Phalen G S, 1972, Clin Orthop Relat Res, V83, P29, DOI 10.1097/00003086-197203000-00007; Schuind F, 2002, J HAND SURG-AM, V27A, P1019, DOI 10.1053/jhsu.2002.36541; Simmons BP, 1981, HAND, V1, P377; SZABO RM, 1989, J HAND SURG-AM, V14A, P624, DOI 10.1016/0363-5023(89)90178-0; van Doesburg MHM, 2012, J ORTHOP RES, V30, P643, DOI 10.1002/jor.21562; Werner R, 1997, CLIN BIOMECH, V12, P44, DOI 10.1016/S0268-0033(96)00044-7; Yoshii Y, 2013, J ORTHOP RES, V31, P1876, DOI 10.1002/jor.22462; ZEISS J, 1989, AM J ROENTGENOL, V153, P533	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	MAY	2015	33	5					726	730		10.1002/jor.22843		5	Orthopedics	Orthopedics	CG6NB	WOS:000353417300016		
J	Tsuchiya, H				Tsuchiya, Hiroyuki			Introduction: The 18th Annual Meeting of the Japanese Research Society of Ultrasound Stimulation for Fracture Repair	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article									Japanese Res Soc Ultrasound Stimulat Fracture Rep, Tokyo, Japan	Tsuchiya, H (reprint author), Japanese Res Soc Ultrasound Stimulat Fracture Rep, Tokyo, Japan.							0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	MAY	2015	29	5					S1	S1		10.1097/BOT.0000000000000339		1	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CG4GE	WOS:000353242600014		
J	Bito, S; Yamamoto, T; Tominaga, H				Bito, Seiji; Yamamoto, Tetsuo; Tominaga, Harumi		JAPOAN Investigators	Prospective Cohort Study Comparing the Effects of Different Artificial Nutrition Methods on Long-Term Survival in the Elderly: Japan Assessment Study on Procedures and Outcomes of Artificial Nutrition (JAPOAN)	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article						artificial nutrition; tube feeding; mortality; survival curves; multicenter cohort study	PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; BLOOD-STREAM INFECTIONS; CRITICALLY-ILL PATIENTS; PARENTERAL-NUTRITION; ENTERAL NUTRITION; ASPIRATION PNEUMONIA; COMPLICATIONS; DYSPHAGIA; THERAPY; PATIENT	Background: The effects of various artificial nutrition methods on the long-term outcomes of elderly patients are still not well known. We aimed to compare the long-term survival of the elderly newly administered with parenteral nutrition (PN) or enteral nutrition. Materials and Methods: This multicenter, prospective, observational cohort study was conducted on 546 elderly patients who were administered artificial nutrition. The main outcome was the survival ratio at 180 and 360 days after initiation of 3 different nutrition methods and estimated mean survival time: PN, nasal tube feeding (EN_N), and percutaneous endoscopic gastrostomy (PEG) feeding (EN_G). The incidence of systemic infection was also compared among different cohorts. Results: At 180 and 360 days after initiation of artificial nutrition, the mortality rates in the PN, EN_N, and EN_G cohorts were 52% and 63%, 32% and 41%, and 22% and 33%, respectively. Multivariate logistic regression analysis showed that, whereas PN nutrition had significant associations with a higher death rate at 180 and 360 days in all samples, there is no significant difference on the main outcome among the 3 cohorts with neurological diseases. A subgroup analysis with neurological diseases showed that the proportional hazard ratios of the PN and EN_N cohorts in comparison with the EN_G cohort were 1.13 (95% confidence interval [CI], 0.66-1.92) and 1.22 (95% CI, 0.82-1.81). Conclusion: There is no significant superiority of PEG feeding compared with nasal tube feeding or PN. Clinicians should consider the choice of nutrition support method, taking into consideration the limitation of the patient's interest.	[Bito, Seiji] NHO Tokyo Med Ctr, Div Clin Epidemiol, Tokyo 1528602, Japan; [Yamamoto, Tetsuo] NHO Yonago Med Ctr, Tottori, Japan; [Tominaga, Harumi] NHO Kure Med Ctr, Dept Surg, Hiroshima, Japan	Bito, S (reprint author), NHO Tokyo Med Ctr, Div Clin Epidemiol, Meguro Ku, 2-5-1 Higashigaoka, Tokyo 1528602, Japan.	bitoseiji@kankakuki.go.jp			National Hospital Organization	This study was supported by a grant from National Hospital Organization (multicenter clinical studies for evidence-based medicine).	Sobotka L, 2009, CLIN NUTR, V28, P461, DOI 10.1016/j.clnu.2009.04.004; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Pontes-Arruda A, 2012, JPEN-PARENTER ENTER, V36, P574, DOI 10.1177/0148607111427040; Staun M, 2009, CLIN NUTR, V28, P467, DOI 10.1016/j.clnu.2009.04.001; Marik PE, 2004, BRIT MED J, V328, P1407, DOI 10.1136/bmj.38118.593900.55; Nicholson FB, 2000, J GASTROEN HEPATOL, V15, P21, DOI 10.1046/j.1440-1746.2000.02004.x; Zhao VM, 2013, NUTRITION, V29, P52, DOI 10.1016/j.nut.2012.03.010; Marik PE, 2003, CHEST, V124, P328, DOI 10.1378/chest.124.1.328; Collins CJ, 2009, CLIN INFECT DIS, V49, P1769, DOI 10.1086/648112; Loser C, 1998, DIGEST DIS SCI, V43, P2549, DOI 10.1023/A:1026615106348; Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700; Guyomard V, 2009, J AM GERIATR SOC, V57, P2101, DOI 10.1111/j.1532-5415.2009.02526.x; GONZALEZHUIX F, 1993, AM J GASTROENTEROL, V88, P227; Smith BM, 2008, SURG ENDOSC, V22, P74, DOI 10.1007/s00464-007-9372-z; Arvanitakis M, 2006, ACTA GASTRO-ENT BELG, V69, P317; ASPEN Board of Directors and the Clinical Guidelines Task Force, 2002, JPEN J PARENTER EN S, V26, p1SA; Attanasio A, 2009, MINERVA MED, V100, P159; Boitano M, 2010, NUTR CLIN PRACT, V25, P663, DOI 10.1177/0884533610385349; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Chernoff Ronni, 2006, Nutr Clin Pract, V21, P142, DOI 10.1177/0115426506021002142; Gomes Jr CA, 2010, COCHRANE DB SYST REV, V11; HODGES MO, 1994, CLIN GERIATR MED, V10, P475; Li G, 2011, JPEN J PARENTER ENTE, V36, P213; MacFie J, 2000, NUTRITION, V16, P606, DOI 10.1016/S0899-9007(00)00249-5; Martins AS, 2012, REV ASSOC MED BRAS, V58, P691, DOI 10.1590/S0104-42302012000600014; SARTORI S, 1994, SUPPORT CARE CANCER, V2, P188, DOI 10.1007/BF00417479; Sato T, 2008, INT SURG, V93, P206; Statistics Bureau and the Director-General for Policy Planning of Japan, 2010, POP CENS; STRONG RM, 1992, JPEN-PARENTER ENTER, V16, P59, DOI 10.1177/014860719201600159; Verschueren A, 2009, AMYOTROPH LATERAL SC, V10, P42, DOI 10.1080/17482960802267480; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Woo K, 1999, Perspectives, V23, P2	32	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0148-6071	1941-2444		JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	MAY	2015	39	4					456	464		10.1177/0148607114522486		9	Nutrition & Dietetics	Nutrition & Dietetics	CG3CW	WOS:000353156000016		
J	Budianto, IR; Obata, S; Kinoshita, Y; Yoshimaru, K; Yanagi, Y; Miyata, J; Nagata, K; Ieiri, S; Taguchi, T				Budianto, Iskandar R.; Obata, Satoshi; Kinoshita, Yoshiaki; Yoshimaru, Koichiro; Yanagi, Yusuke; Miyata, Junko; Nagata, Kouji; Ieiri, Satoshi; Taguchi, Tomoaki			Reevaluation of Acetylcholinesterase Staining for the Diagnosis of Hirschsprung Disease and Allied Disorders	JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION			English	Article						acetylcholinesterase staining; chronic idiopathic intestinal pseudo-obstruction; Hirschsprung disease; intestinal neuronal dysplasia; rectal mucosal biopsy	INTESTINAL NEURONAL DYSPLASIA; RECTAL MUCOSAL BIOPSY; LONG-TERM OUTCOMES; QUALITY-OF-LIFE; PSEUDOOBSTRUCTION; EXPERIENCE; PATHOLOGY; CHILDREN; CRITERIA; JAPAN	Objectives: Acetylcholinesterase (AChE) staining has become the gold standard for definitively diagnosing Hirschsprung disease (HD), although some pitfalls have been reported. We reevaluated a large series at our institute in order to validate the accuracy of AChE staining for detecting HD. Methods: A retrospective study of the rectal mucosal specimens of all of the children with suspected HD during a 13-year period was performed. The specimens were stained according to the modified Karnovsky-Roots method for AChE staining. The final diagnosis, prognosis, and management after the histopathological diagnosis were analyzed with a questionnaire sent to the patient's original hospital. Results: Three hundred and fifty-eight specimens were collected. One hundred twenty-two (34%) specimens were diagnosed as HD, 198 (55%) as nonHD, 25 (7%) as "undetermined,'' and 13 (4%) as "inappropriate.'' The non-HD group contained 190 (96%) specimens with a normal appearance and 8 (4%) specimens with suspected intestinal neuronal dysplasia (IND). Three hundred and six of 358 questionnaires were returned. The final diagnosis showed that no specimens first diagnosed as HD were identified as non-HD and vice versa, for a sensitivity and specificity of 100%. Four cases were finally diagnosed as chronic idiopathic intestinal pseudo-obstruction (CIIP) in the non-HD group. All of the patients with HD underwent radical surgery. Most non-HD patients were managed conservatively, although some continued to have constipation. Conclusions: AChE staining is an accurate tool for differentiating between HD and non-HD with high sensitivity and specificity. CIIP can be included in cases of non-HD; therefore, careful follow-up is mandatory.	[Budianto, Iskandar R.; Obata, Satoshi; Kinoshita, Yoshiaki; Yoshimaru, Koichiro; Yanagi, Yusuke; Miyata, Junko; Nagata, Kouji; Ieiri, Satoshi; Taguchi, Tomoaki] Kyushu Univ, Dept Pediat Surg, Grad Sch Med Sci, Fukuoka 812, Japan	Kinoshita, Y (reprint author), 3-1-1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan.	kinoppy@pedsurg.med.kyushu-u.ac.jp			Ministry of Health, Labour Sciences Research Grants for Research on Intractable Disease	The study was partly supported by the Ministry of Health, Labour Sciences Research Grants for Research on Intractable Disease.	Rudolph CD, 1997, J PEDIATR GASTR NUTR, V24, P102, DOI 10.1097/00005176-199701000-00021; Stanghellini V, 2005, CLIN GASTROENTEROL H, V3, P449, DOI 10.1053/S1.542-3565(04)00675-5; Knowles CH, 2009, ACTA NEUROPATHOL, V118, P271, DOI 10.1007/s00401-009-0527-y; Ieiri S, 2010, J PEDIATR SURG, V45, P2398, DOI 10.1016/j.jpedsurg.2010.08.040; Kapur RP, 2009, SEMIN PEDIAT SURG, V18, P212, DOI 10.1053/j.sempedsurg.2009.07.003; Meier-Ruge WA, 2006, PEDIATR DEVEL PATHOL, V9, P444, DOI 10.2350/06-06-0109.1; Bagdzevicius R, 2011, MED LITH, V47, P374; Suita S, 2005, J PEDIATR SURG, V40, P197, DOI 10.1016/j.jpedsurg.2004.09.052; Friedmacher F, 2013, PEDIATR SURG INT, V29, P855, DOI 10.1007/s00383-013-3351-3; Moore SW, 2005, PEDIATR SURG INT, V21, P255, DOI 10.1007/s00383-005-1383-z; Nakao M, 2001, J PEDIATR SURG, V36, P1357, DOI 10.1053/jpsu.2001.26369; IKEDA K, 1967, SURGERY, V61, P503; Holland SK, 2011, ANN DIAGN PATHOL, V15, P323, DOI 10.1016/j.anndiagpath.2011.02.010; Haricharan RN, 2008, SEMIN PEDIAT SURG, V17, P266, DOI 10.1053/j.sempedsurg.2008.07.005; Castiglia P T, 2001, J Pediatr Health Care, V15, P200, DOI 10.1067/mph.2001.115885; Dasgupta R, 2004, CURR PROB SURG, V41, P949, DOI 10.1067/j.cpsurg.2004.09.004; De la Torre-Mondragon L, 1998, J PEDIATR SURG, V33, P1283, DOI 10.1016/S0022-3468(98)90169-5; Gillick J, 2001, J PEDIATR SURG, V36, P777, DOI 10.1053/jpsu.2001.22959; HIROSE R, 1993, J PEDIATR SURG, V28, P942, DOI 10.1016/0022-3468(93)90703-N; HOLSCHNEIDER AM, 1994, EUR J PEDIATR SURG, V4, P260, DOI 10.1055/s-2008-1066115; IKEDA K, 1984, ANN SURG, V199, P400, DOI 10.1097/00000658-198404000-00005; Ito T, 2008, INTERNAL MED, V47, P421, DOI 10.2169/internalmedicine.47.0275; Kakita Y, 2000, ARCH PATHOL LAB MED, V124, P1314; LAKE BD, 1995, VIRCHOWS ARCH, V426, P537; Lourencao PLTD, 2013, ANN DIAGN PATHOL, V17, P352, DOI 10.1016/j.anndiagpath.2013.04.004; Martucciello Giuseppe, 2005, J Pediatr Surg, V40, P1527, DOI 10.1016/j.jpedsurg.2005.07.053; MEIERRUG.W, 1972, J PEDIATR SURG, V7, P11, DOI 10.1016/0022-3468(72)90394-6; Meier-Ruge WA, 2004, EUR J PEDIATR SURG, V14, P384, DOI 10.1055/s-2004-821120; Meier-Ruge W, 1971, Verh Dtsch Ges Pathol, V55, P506; Montedonico S, 2002, J PEDIATR SURG, V37, P1772, DOI 10.1053/jpsu.2002.36720; Montgomery DF, 2008, J PEDIATR HEALTH CAR, V22, P199, DOI 10.1016/j.pedhc.2008.02.009; Ohkubo H, 2012, DIGESTION, V86, P12, DOI 10.1159/000337528; Puri P, 1997, J PEDIATR SURG, V32, P149, DOI 10.1016/S0022-3468(97)90170-6; Puri Prem, 2003, Semin Pediatr Surg, V12, P259, DOI 10.1053/j.sempedsurg.2003.08.007; RAVITCH MM, 1958, ANN SURG, V147, P781; SACHER P, 1993, EUR J PEDIATR SURG, V3, P228, DOI 10.1055/s-2008-1063549; Schappi MG, 2013, J PEDIATR GASTR NUTR, V57, P677, DOI 10.1097/MPG.0b013e3182a8bb50; Suita S, 1998, J AM COLL SURGEONS, V187, P577, DOI 10.1016/S1072-7515(98)00254-3; Sullivan PB, 1996, CURR PAEDIAT, V6, P97, DOI 10.1016/S0957-5839(96)80070-4; Toyosaka A, 1993, Clin Auton Res, V3, P243, DOI 10.1007/BF01829013	40	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-2116	1536-4801		J PEDIATR GASTR NUTR	J. Pediatr. Gastroenterol. Nutr.	MAY	2015	60	5					606	612		10.1097/MPG.0000000000000664		7	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	CG6LA	WOS:000353410900015		
J	Hagiwara, S; Kubota, M; Sakaguchi, K; Hiwatari, E; Kishimoto, H; Kagimoto, S				Hagiwara, Shin-ichiro; Kubota, Mitsuru; Sakaguchi, Keita; Hiwatari, Erika; Kishimoto, Hiroshi; Kagimoto, Seiichi			Fatal Hepatic Hemorrhage from Peliosis Hepatis with X-linked Myotubular Myopathy	JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION			English	Article									[Hagiwara, Shin-ichiro; Kubota, Mitsuru; Sakaguchi, Keita; Hiwatari, Erika; Kagimoto, Seiichi] Saitama Childrens Med Ctr, Div Gen Pediat, Iwatsuki Ku, Saitama 3398551, Japan; [Kishimoto, Hiroshi] Saitama Childrens Med Ctr, Div Pathol, Iwatsuki Ku, Saitama 3398551, Japan	Hagiwara, S (reprint author), Saitama Childrens Med Ctr, Div Gen Pediat, Iwatsuki Ku, 2100 Magome, Saitama 3398551, Japan.	hagiwara.shinichiro@pref.saitama.lg.jp					Wang SY, 2001, J PEDIATR SURG, V36, P1456, DOI 10.1053/jpsu.2001.26397; Hnia K, 2011, J CLIN INVEST, V121, P70, DOI 10.1172/JCI44021; Samyn M, 2004, J PEDIATR GASTR NUTR, V39, P431, DOI 10.1097/00005176-200410000-00024; Hautekeete ML, 1997, VIRCHOWS ARCH, V430, P195, DOI 10.1007/BF01324802; Hyodo M, 2004, J HEPATO-BILIARY-PAN, V11, P371, DOI 10.1007/s00534-004-0908-5; Terlizzi JP, 2013, J PEDIATR SURG, V48, pE9, DOI 10.1016/j.jpedsurg.2013.06.014; Cui XM, 1998, NAT GENET, V18, P331, DOI 10.1038/ng0498-331; DEANGELIS MS, 1991, J NEUROL SCI, V103, P2, DOI 10.1016/0022-510X(91)90275-C; Herman GE, 1999, J PEDIATR-US, V134, P206, DOI 10.1016/S0022-3476(99)70417-8	9	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-2116	1536-4801		J PEDIATR GASTR NUTR	J. Pediatr. Gastroenterol. Nutr.	MAY	2015	60	5					E45	E46		10.1097/MPG.0000000000000233		2	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	CG6LA	WOS:000353410900004		
J	Igarashi, K; Hori, T; Yamamoto, M; Inazawa, N; Noguchi, H; Suzuki, N; Somekawa, Y; Sasaki, M; Tsutsumi, H; Hatakeyama, N				Igarashi, Keita; Hori, Tsukasa; Yamamoto, Masaki; Inazawa, Natsuko; Noguchi, Hiroko; Suzuki, Nobuhiro; Somekawa, Yukihiro; Sasaki, Mayumi; Tsutsumi, Hiroyuki; Hatakeyama, Naoki			Extramedullary Relapse in RARA Rearrangement-negative Acute Promyelocytic Leukemia Successfully Treated in Combination With Chemotherapy, Local Radiotherapy, and Cord Blood Transplantation	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						acute promyelocytic leukemia; RARA rearrangement; extramedullary relapse; cord blood transplantation	ACUTE MYELOID-LEUKEMIA; SARCOMA; DISEASE; LACKING	RARA rearrangement-negative acute promyelocytic leukemia (APL) is uncommon, and its extramedullary relapse is extremely rare. We report a 5-year-old girl with RARA rearrangement-negative APL, which recurred solely at the external auditory canal and mastoid air cells. She was successfully treated with chemotherapy, local radiotherapy, and unrelated cord blood transplantation. She has maintained complete remission for 24 months after transplantation. The clinical features and our therapeutic strategy in this patient will provide valuable information for extramedullary relapse of RARA rearrangement-negative APL.	[Igarashi, Keita; Hori, Tsukasa; Yamamoto, Masaki; Inazawa, Natsuko; Tsutsumi, Hiroyuki] Sapporo Med Univ, Sch Med, Dept Pediat, Sapporo, Hokkaido 0608543, Japan; [Noguchi, Hiroko] Teine Keijinkai Hosp, Dept Pathol, Sapporo, Hokkaido, Japan; [Suzuki, Nobuhiro] Hokkaido Med Ctr Child Hlth & Rehabil, Sapporo, Hokkaido, Japan; [Somekawa, Yukihiro] JR Sapporo Hosp, Dept Otolaryngol, Sapporo, Hokkaido, Japan; [Sasaki, Mayumi] JR Sapporo Hosp, Dept Pathol, Sapporo, Hokkaido, Japan; [Hatakeyama, Naoki] Asahikawa Med Univ, Dept Pediat, Asahikawa, Hokkaido, Japan	Igarashi, K (reprint author), Sapporo Med Univ, Sch Med, Dept Pediat, Chuo Ku, S1W16, Sapporo, Hokkaido 0608543, Japan.	keita@sapmed.ac.jp					Sainty D, 2000, BLOOD, V96, P1287; Bakst RL, 2011, BLOOD, V118, P3785, DOI 10.1182/blood-2011-04-347229; Chevallier P, 2008, J CLIN ONCOL, V26, P4940, DOI 10.1200/JCO.2007.15.6315; SCOTT AA, 1994, BLOOD, V84, P244; Grimwade D, 2000, BLOOD, V96, P1297; Grimwade D, 2002, LEUKEMIA, V16, P1959, DOI 10.1038/sj.leu.2402721; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Bakst R, 2012, INT J RADIAT ONCOL, V82, P1816, DOI 10.1016/j.ijrobp.2011.02.057; Bradley MB, 2007, BONE MARROW TRANSPL, V40, P621, DOI 10.1038/sj.bmt.1705785; Gruver AM, 2013, DIAGN MOL PATHOL, V22, P10, DOI 10.1097/PDM.0b013e31825b8326; Hori T, 2011, PEDIATR INT, V53, P1070, DOI 10.1111/j.1442-200X.2011.03364.x; Lafayette TCS, 2010, J PEDIAT HEMATOL ONC, V32, P229, DOI 10.1097/MPH.0b013e3181cf7ef3; Specchia G, 2001, J CLIN ONCOL, V19, P4023; Specchia G, 2011, MEDITERR J HEMATOL I, V3; Yagasaki H, 2011, INT J HEMATOL, V93, P566, DOI 10.1007/s12185-011-0835-6	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	MAY	2015	37	4					E234	E237				4	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CG5AR	WOS:000353301600008		
J	Kishimoto, K; Kobayashi, R; Yonemaru, N; Yamamoto, H; Tsujioka, T; Sano, H; Suzuki, D; Yasuda, K; Suzuki, M; Ando, A; Tonoki, H; Iizuka, S; Uetake, K; Kobayashi, K				Kishimoto, Kenji; Kobayashi, Ryoji; Yonemaru, Nozomi; Yamamoto, Hiroshi; Tsujioka, Takao; Sano, Hirozumi; Suzuki, Daisuke; Yasuda, Kazue; Suzuki, Masahiko; Ando, Akiko; Tonoki, Hidefumi; Iizuka, Susumu; Uetake, Kimiaki; Kobayashi, Kunihiko			Refractory Sacrococcygeal Germ Cell Tumor in Schinzel-Giedion Syndrome	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						Schinzel-Giedion syndrome; germ cell tumor; sacrococcygeal region; chemotherapy	HIGH-DOSE CHEMOTHERAPY; TERATOMA; CHILDREN; MUTATIONS; MAKEI-89; SIBS	We describe a boy with Schinzel-Giedion syndrome who developed refractory sacrococcygeal germ cell tumor with elements of embryonal carcinoma and immature teratoma. He developed local recurrence soon after tumor resection. The tumor was highly resistant to platinum-based combination chemotherapy, local irradiation, and salvage chemotherapy. Frequent infections resulted in a delay in treatment, although apparent fragility had not been observed clinically. He died from tumor progression at 32 months of age. Intensification of chemotherapy does not seem to be feasible for tumors in patients with Schinzel-Giedion syndrome.	[Kishimoto, Kenji; Kobayashi, Ryoji; Sano, Hirozumi; Suzuki, Daisuke; Yasuda, Kazue; Kobayashi, Kunihiko] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido 0030006, Japan; [Yonemaru, Nozomi; Tonoki, Hidefumi; Iizuka, Susumu] Tenshi Hosp, Dept Pediat, Sapporo, Hokkaido, Japan; [Yamamoto, Hiroshi] Tenshi Hosp, Dept Pediat Surg, Sapporo, Hokkaido, Japan; [Tsujioka, Takao; Suzuki, Masahiko; Ando, Akiko; Uetake, Kimiaki] Obihiro Kosei Gen Hosp, Dept Pediat, Obihiro, Hokkaido, Japan	Kishimoto, K (reprint author), Sapporo Hokuyu Hosp, Dept Pediat, Shiroishi Ku, 6-6 Higashi Sapporo, Sapporo, Hokkaido 0030006, Japan.	ken@yacht.ocn.ne.jp					ALTMAN RP, 1974, J PEDIATR SURG, V9, P389; Gobel U, 2000, ANN ONCOL, V11, P263, DOI 10.1023/A:1008360523160; Feldman DR, 2010, J CLIN ONCOL, V28, P1706, DOI 10.1200/JCO.2009.25.1561; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Motzer RJ, 2000, J CLIN ONCOL, V18, P2413; Makishima H, 2013, NAT GENET, V45, P942, DOI 10.1038/ng.2696; ANTICH J, 1995, AM J MED GENET, V59, P96, DOI 10.1002/ajmg.1320590119; Beschorner R, 2007, ACTA NEUROPATHOL, V113, P339, DOI 10.1007/s00401-006-0179-0; Burck U, 1982, KLIN GENETIK PAEDIAT, P351; Calaminus G, 2003, J CLIN ONCOL, V21, P781, DOI 10.1200/JCO.2003.03.125; De Giorgi U, 2005, BRIT J CANCER, V93, P412, DOI 10.1038/sj.bjc.6602724; Lehman AM, 2008, AM J MED GENET A, V146A, P1299, DOI 10.1002/ajmg.a.32277; Matsumoto F, 2005, INT J UROL, V12, P1061, DOI 10.1111/j.1442-2042.2005.01213.x; McPherson E, 1998, AM J MED GENET, V79, P62, DOI 10.1002/(SICI)1096-8628(19980827)79:1<62::AID-AJMG13>3.3.CO;2-I; Rescorla F, 2001, J PEDIATR SURG, V36, P12, DOI 10.1053/jpsu.2001.19993; ROBIN NH, 1993, AM J MED GENET, V47, P852, DOI 10.1002/ajmg.1320470611; RODRIGUEZ JI, 1994, AM J MED GENET, V53, P374, DOI 10.1002/ajmg.1320530414; Sandri A, 2003, J PEDIAT HEMATOL ONC, V25, P558, DOI 10.1097/00043426-200307000-00012; SCHINZEL A, 1978, AM J MED GENET, V1, P361, DOI 10.1002/ajmg.1320010402; Schneider DT, 2001, J CLIN ONCOL, V19, P1951	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	MAY	2015	37	4					E238	E241				4	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CG5AR	WOS:000353301600009		
J	Endo, H; Aoki, S; Ito, T; Rees, TD; Allen, EP; Kuyama, K; Yamamoto, H				Endo, Hiroyasu; Aoki, Shinichiro; Ito, Takanori; Rees, Terry D.; Allen, Edward P.; Kuyama, Kayo; Yamamoto, Hirotsugu			Re: A Stab-and-Roll Biopsy Technique to Maintain Gingival Epithelium for Desquamative Gingivitis. Endo H, Rees TD, Allen EP, et al. (J Periodontol 2014; 85: 802-809.) Response	JOURNAL OF PERIODONTOLOGY			English	Letter									[Endo, Hiroyasu; Aoki, Shinichiro; Ito, Takanori] Nihon Univ, Sch Dent, Dept Oral Diag, Matsudo, Chiba 271, Japan; [Rees, Terry D.; Allen, Edward P.] Texas A&M Univ, Baylor Coll Dent, Dept Periodont, Dallas, TX USA; [Kuyama, Kayo; Yamamoto, Hirotsugu] Nihon Univ, Sch Dent, Dept Oral Pathol, Matsudo, Chiba 271, Japan	Endo, H (reprint author), Nihon Univ, Sch Dent, Dept Oral Diag, Matsudo, Chiba 271, Japan.						Leao JC, 2008, ORAL DIS, V14, P556, DOI 10.1111/j.1601-0825.2007.01420.x; Endo H, 2014, J PERIODONTOL, V85, P802, DOI 10.1902/jop.2014.130428; NISENGARD RJ, 1987, J PERIODONTOL, V58, P167	3	0	0	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	MAY	2015	86	5					609	610		10.1902/jop.2015.140722		2	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CG6LE	WOS:000353411400004		
J	Javed, F; Al-Kheraif, AA; Al Amri, MD; Mikami, T; Vohra, F; Warnakulasuriya, S; Romanos, GE				Javed, Fawad; Al-Kheraif, Abdulaziz A.; Al Amri, Mohammad D.; Mikami, Toshinari; Vohra, Fahim; Warnakulasuriya, Saman; Romanos, Georgios E.			Periodontal Parameters and Whole Salivary Cytokine Profiles Among Habitual Gutka Chewers and Non-Chewers	JOURNAL OF PERIODONTOLOGY			English	Article						Cytokines; inflammation; interleukins; matrix metalloproteinases; saliva; tobacco; smokeless	GINGIVAL CREVICULAR FLUID; SYSTEMIC-DISEASES; ORAL-HEALTH; RISK-FACTOR; TOBACCO; DIAGNOSIS	Background: Whole salivary interleukin (IL)-1 beta, IL-6, matrix metalloproteinase (MMP)-8, and MMP-9 levels among habitual gutka chewers and non-chewers (controls) have not been investigated. The aim of the present study is to assess clinical periodontal parameters and whole salivary IL-1 beta, IL-6, MMP-8, and MMP-9 levels among habitual gutka chewers and controls. Methods: Forty-five gutka chewers and 45 controls were included. Demographic information regarding age, sex, duration and daily frequency of gutka chewing, duration of gutka placement in the mouth, and daily toothbrushing habits were collected using a questionnaire. Periodontal parameters, including plaque index (PI), bleeding on probing (BOP), probing depth (PD) > 3 mm, clinical attachment loss (AL), marginal bone loss (MBL), and number of missing teeth, were recorded. Unstimulated whole saliva samples were collected, and unstimulated whole salivary flow rate (UWSFR) was determined. Levels of IL-6, IL-1b, MMP-8, and MMP-9 were measured in UWS using an enzyme-linked immunosorbent assay. Results: PI (P < 0.01), BOP (P < 0.01), PD > 3 mm(P < 0.01), and clinical AL (P < 0.01) were significantly higher in gutka chewers than controls, as were whole salivary IL-6 (P < 0.01), IL-1b (P < 0.01), MMP-8 (P < 0.01), and MMP-9 (P < 0.01) concentrations. There was no significant difference in UWSFR, number of missing teeth, or MBL among habitual gutka chewers and controls. Conclusion: Periodontal inflammatory conditions were worse, and whole salivary IL-6, IL-1b, MMP-8, and MMP-9 levels were higher among gutka chewers than non-chewers.	[Javed, Fawad] Univ Rochester, Eastman Inst Oral Hlth, Div Gen Dent, Rochester, NY 14642 USA; [Al-Kheraif, Abdulaziz A.] King Saud Univ, Coll Appl Med Sci, Dent Biomat Res Chair, Riyadh, Saudi Arabia; [Al Amri, Mohammad D.; Vohra, Fahim] King Saud Univ, Coll Dent, Dept Prosthet Dent Sci, Riyadh, Saudi Arabia; [Mikami, Toshinari] Iwate Med Univ, Div Oral Pathol, Yahaba, Iwate, Japan; [Vohra, Fahim] Jinah Hosp, Div Dent, Karachi, Pakistan; [Warnakulasuriya, Saman] Kings Coll London, Dept Oral Med, London WC2R 2LS, England; [Warnakulasuriya, Saman] World Hlth Org Collaborating Ctr Oral Canc & Prec, London, England; [Romanos, Georgios E.] SUNY Stony Brook, Sch Dent Med, Dept Periodontol, Stony Brook, NY 11794 USA	Javed, F (reprint author), Univ Rochester, Eastman Inst Oral Hlth, Div Gen Dent, 625 Elmwood Ave, Rochester, NY 14642 USA.	fawad_javed@urmc.rochester.edu			Deanship of Scientific Research at King Saud University; Visiting Professor Program at King Saud University, Saudi Arabia; Research Center, College of Applied Medical Sciences	The authors extend their appreciation to the Research Center, College of Applied Medical Sciences, and Deanship of Scientific Research at King Saud University for funding this research. The authors also thank the Visiting Professor Program at King Saud University, Saudi Arabia, for supporting this research project. The authors report no conflicts of interest related to this study.	Warnakulasuriya S, 2002, BRIT MED J, V324, P799, DOI 10.1136/bmj.324.7341.799; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Chiappin S, 2007, CLIN CHIM ACTA, V383, P30, DOI 10.1016/j.cca.2007.04.011; Gilbert AD, 1999, BRIT DENT J, V186, P241, DOI 10.1038/sj.bdj.4800075a; Javed F, 2012, J NUTR HEALTH AGING, V16, P445, DOI 10.1007/s12603-011-0353-5; Javed F, 2009, J ORAL REHABIL, V36, P39, DOI 10.1111/j.1365-2842.2008.01895.x; Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197; Lamster IB, 2007, ANN NY ACAD SCI, V1098, P216, DOI 10.1196/annals.1384.027; AINAMO J, 1975, INT DENT J, V25, P229; Javed F, 2007, J PERIODONTOL, V78, P2112, DOI 10.1902/jop.2007.070186; Aps JKM, 2005, FORENSIC SCI INT, V150, P119, DOI 10.1016/j.forsciint.2004.10.026; Desai R, 2014, J DENT, V42, P84, DOI 10.1016/j.jdent.2013.10.016; Javed F, 2008, ACTA ODONTOL SCAND, V66, P268, DOI 10.1080/00016350802286725; GOODSON JM, 1984, J CLIN PERIODONTOL, V11, P348, DOI 10.1111/j.1600-051X.1984.tb01331.x; Saleem S, 2013, ORAL ONCOL, V49, P818, DOI 10.1016/j.oraloncology.2013.04.004; ARMITAGE GC, 1977, J CLIN PERIODONTOL, V4, P173, DOI 10.1111/j.1600-051X.1977.tb02271.x; Armitage G C, 1996, Ann Periodontol, V1, P37, DOI 10.1902/annals.1996.1.1.37; Attin T, 2005, Oral Health Prev Dent, V3, P135; Bathi RJ, 2009, QUINTESSENCE INT, V40, pE19; Buhlin K, 2002, COMMUNITY DENT ORAL, V30, P431, DOI 10.1034/j.1600-0528.2002.00014.x; Cakic S, 2009, SRP ARK CELOK LEK, V137, P298, DOI 10.2298/SARH0906298C; Changrani Jyotsna, 2005, J Immigr Health, V7, P103, DOI 10.1007/s10903-005-2643-7; Changrani J, 2006, J IMMIGR REFUG STUD, V4, P99, DOI 10.1300/J500v04n01_07; Fiyaz Mohamed, 2013, J Indian Soc Periodontol, V17, P454, DOI 10.4103/0972-124X.118316; Gupta PC, 2012, INDIAN J CANCER, V49, P393, DOI 10.4103/0019-509X.107746; Jacob Pulikkotil Shaju, 2014, J Periodontal Implant Sci, V44, P126, DOI 10.5051/jpis.2014.44.3.126; Javed F, 2014, J INVESTIG CLIN DENT, DOI [10.1111/jicd.12113., DOI 10.1111/JICD.12113]; Javed F, 2010, ORAL SURG ORAL MED O, V109, P857, DOI 10.1016/j.tripleo.2009.12.038; Javed F, 2013, AM J MED SCI, V346, P273, DOI 10.1097/MAJ.0b013e31827333fb; Javed F, 2013, J PERIODONTOL, V84, P1158, DOI 10.1902/jop.2012.120390; Javed F, 2014, INT WOUND J, V11, P79, DOI 10.1111/j.1742-481X.2012.01070.x; Mohamed Roslinda, 2012, Clin Transl Med, V1, P19, DOI 10.1186/2001-1326-1-19; Palipudi KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033466; Panesar SS, 2008, LANCET, V372, P97, DOI 10.1016/S0140-6736(08)61014-4; Rovida T A Saliba, 2014, Oral Health Dent Manag, V13, P842; MUHLEMAN.HR, 1971, HELV ODONTOL ACTA, V15, P107	36	1	1	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	MAY	2015	86	5					689	695		10.1902/jop.2015.140556		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CG6LE	WOS:000353411400013		
J	Ejiri, H; Suhonen, J				Ejiri, H.; Suhonen, J.			GT neutrino-nuclear responses for double beta decays and astro neutrinos	JOURNAL OF PHYSICS G-NUCLEAR AND PARTICLE PHYSICS			English	Article						Gamow-Teller beta decay; beta decay matrix element; double beta decay; astro neutrino response; quenching of g(A); QRPA nuclear matrix element; astro neutrino nucleosynthesis	SINGLE-STATE DOMINANCE; SPIN-ISOSPIN RESPONSES; ELECTRON-CAPTURE; SOLAR NEUTRINOS; TRANSITIONS; NUCLEOSYNTHESIS; SUPPRESSION	Gamow-Teller nuclear matrix elements (NMEs) for pairs of beta(+/-) 1(+) <-> 0(+) ground-state-to-ground-state transitions, in particular their geometric mean NME M-m, are studied. The observed means M-exp(m) in the medium-heavy mass region are compared with the corresponding single-quasiparticle (qp) NMEs and the means M-QRPA(m) calculated by the proton neutron qp random-phase approximation (pnQRPA). The M-m NMEs turn out to be insensitive to the nucleon occupancy/vacancy amplitudes and to the particle-particle interaction parameter g(pp) of the pnQRPA. The observed mean NMEs are found to be reduced by a coefficient k approximate to 0.23 relative to the effective qp NMEs and by a coefficient k(NM) approximate to 0.6 with respect to the pnQRPA NMEs. The reductions associated with the spin isospin correlations and nuclear medium effects, and their impact on nuclear double beta decays and astro-neutrino-nuclear interactions are discussed.	[Ejiri, H.] Osaka Univ, Nucl Phys Res Ctr, Osaka, Japan; [Suhonen, J.] Univ Jyvaskyla, Dept Phys, FI-40014 Jyvaskyla, Finland	Ejiri, H (reprint author), Osaka Univ, Nucl Phys Res Ctr, Osaka, Japan.	ejiri@rcnp.osaka-u.ac.jp			Academy of Finland under the Finnish Centre of Excellence Program (Nuclear and Accelerator Based Program at JYFL)	This work was supported by the Academy of Finland under the Finnish Centre of Excellence Program 2012-2017 (Nuclear and Accelerator Based Program at JYFL). The authors thank Professor D Frekers and Professor F Iachello for valuable discussions.	Ejiri H, 2014, PHYS LETT B, V729, P27, DOI 10.1016/j.physletb.2013.12.051; Kolbe E, 2001, PHYS REV C, V63, DOI 10.1103/PhysRevC.63.025802; Vergados JD, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/106301; Yako K, 2005, PHYS LETT B, V615, P193, DOI 10.1016/j.physletb.2005.04.032; Civitarese O, 1999, NUCL PHYS A, V653, P321, DOI 10.1016/S0375-9474(99)00172-4; SUHONEN J, 1993, NUCL PHYS A, V563, P205, DOI 10.1016/0375-9474(93)90602-T; Barea J, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.014315; Wakasa T, 1997, PHYS REV C, V55, P2909, DOI 10.1103/PhysRevC.55.2909; Cheoun MK, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.065807; Engel J, 1999, PHYS REV C, V60, DOI 10.1103/PhysRevC.60.014302; SUHONEN J, 1988, NUCL PHYS A, V486, P91, DOI 10.1016/0375-9474(88)90041-3; Caurier E, 2012, PHYS LETT B, V711, P62, DOI 10.1016/j.physletb.2012.03.076; Cheoun MK, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.035504; Balasi K G, 2010, J PHYS C SER, V203; Bes DR, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.024314; Bhattacharya M, 1998, PHYS REV C, V58, P1247, DOI 10.1103/PhysRevC.58.1247; Bohr A, 1969, NUCL STRUCTURE, V1; BOHR A, 1981, PHYS LETT B, V100, P10, DOI 10.1016/0370-2693(81)90274-4; Civitarese O, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.044319; Civitarese O, 1998, PHYS REV C, V58, P1535, DOI 10.1103/PhysRevC.58.1535; Dongdong N, 2014, J PHYS G, V41; EJIRI H, 1982, PHYS REV C, V26, P2628, DOI 10.1103/PhysRevC.26.2628; Ejiri H, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.074201; Ejiri H, 2000, PHYS REP, V338, P265, DOI 10.1016/S0370-1573(00)00044-2; EJIRI H, 1983, NUCL PHYS A, V396, pC181; Ejiri H, 1998, PHYS LETT B, V433, P257, DOI 10.1016/S0370-2693(98)00673-X; Ejiri H, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.033201; Ejiri H, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.055501; Firestone R. B., 1999, TABLE ISOTOPES; Frekers D, 2013, COMMUNICATION; Giannaka P G, 2014, ADV HIGH ENERGY PHYS, V2014; Hayakawa T, 2013, ASTROPHYS J LETT, V779, DOI 10.1088/2041-8205/779/1/L9; Heger A, 2005, PHYS LETT B, V606, P258, DOI 10.1016/j.physletb.2004.12.017; Jachowicz N, 2002, PROG PART NUCL PHYS, V48, P39, DOI 10.1016/S0146-6410(02)00109-6; Langanke K, 2014, NUCL PHYS A, V928, P305, DOI 10.1016/j.nuclphysa.2014.04.015; OSET E, 1979, PHYS REV LETT, V42, P47, DOI 10.1103/PhysRevLett.42.47; Singh B., 1998, Nuclear Data Sheets, V84, DOI 10.1006/ndsh.1998.0015; Suhonen J, 2014, NUCL PHYS A, V924, P1, DOI 10.1016/j.nuclphysa.2014.01.004; SUHONEN J, 1988, PHYS LETT B, V202, P174, DOI 10.1016/0370-2693(88)90002-0; Thies JH, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.044309; Vergados JD, 2008, NUCL PHYS B, V804, P144, DOI 10.1016/j.nuclphysb.2008.06.004; VOGEL P, 1986, PHYS REV LETT, V57, P3148, DOI 10.1103/PhysRevLett.57.3148	42	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0954-3899	1361-6471		J PHYS G NUCL PARTIC	J. Phys. G-Nucl. Part. Phys.	MAY	2015	42	5							055201	10.1088/0954-3899/42/5/055201		13	Physics, Nuclear; Physics, Particles & Fields	Physics	CG7CF	WOS:000353459100018		
J	Kiss, GG; Szucs, T; Rauscher, T; Torok, Z; Csedreki, L; Fulop, Z; Gyurky, G; Halasz, Z				Kiss, G. G.; Szuecs, T.; Rauscher, T.; Toeroek, Zs; Csedreki, L.; Fueloep, Zs; Gyuerky, Gy; Halasz, Z.			Measurement of (alpha,n) reaction cross sections of erbium isotopes for testing astrophysical rate predictions	JOURNAL OF PHYSICS G-NUCLEAR AND PARTICLE PHYSICS			English	Article						measured cross section; activation method; astrophysical gamma-process	STATISTICAL-MODEL CALCULATIONS; P-PROCESS; NEUTRON-CAPTURE; S-PROCESS; NUCLEAR; NUCLEOSYNTHESIS; UNCERTAINTIES; SUPERNOVAE; PHYSICS; STARS	The gamma-process in core-collapse and/or type Ia supernova explosions is thought to explain the origin of the majority of the so-called p nuclei (the 35 protonrich isotopes between Se and Hg). Reaction rates for gamma-process reaction network studies have to be predicted using Hauser-Feshbach statistical model calculations. Recent investigations have shown problems in the prediction of alpha-widths at astrophysical energies which are an essential input for the statistical model. It has an impact on the reliability of abundance predictions in the upper mass range of the p nuclei. With the measurement of the Er-164,Er-166(alpha,n) Yb-167,Yb-169 reaction cross sections at energies close to the astrophysically relevant energy range we tested the recently suggested low energy modification of the alpha+nucleus optical potential in a mass region where gamma-process calculations exhibit an underproduction of the p nuclei. Using the same optical potential for the alpha-width which was derived from combined Er-162(alpha,n) and Er-162(alpha,gamma) measurement makes it plausible that a low-energy modification of the optical alpha+nucleus potential is needed.	[Kiss, G. G.; Szuecs, T.; Toeroek, Zs; Csedreki, L.; Fueloep, Zs; Gyuerky, Gy; Halasz, Z.] MTA Atomki, H-4001 Debrecen, Hungary; [Rauscher, T.] Univ Hertfordshire, Sch Phys Astron & Math, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Rauscher, T.] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland; [Halasz, Z.] Univ Debrecen, Dept Theoret Phys, H-4001 Debrecen, Hungary	Kiss, GG (reprint author), RIKEN, Nishina Ctr, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	ggkiss@atomki.mta.hu	Fulop, Zsolt/B-2262-2008; Kiss, Gabor/A-1259-2015; Rauscher, Thomas/D-2086-2009	Rauscher, Thomas/0000-0002-1266-0642	OTKA [K101328, PD104664, K108459]; ENSAR/THEXO European FP7 programme; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; UK STFC grant BRIDGCE [ST/M000958/1]; Swiss NSF; European Research Council	This work was supported by OTKA (K101328, PD104664, K108459) and by the ENSAR/THEXO European FP7 programme. G G Kiss acknowledges support from the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. T Rauscher acknowledges support from the UK STFC grant BRIDGCE (ST/M000958/1), the Swiss NSF and the European Research Council.	Kappeler F, 2011, REV MOD PHYS, V83, P157, DOI 10.1103/RevModPhys.83.157; Rauscher T, 1997, PHYS REV C, V56, P1613, DOI 10.1103/PhysRevC.56.1613; Kertesz Z, 2010, NUCL INSTRUM METH B, V268, P1924, DOI 10.1016/j.nimb.2010.02.103; Arlandini C, 1999, ASTROPHYS J, V525, P886, DOI 10.1086/307938; RAYET M, 1995, ASTRON ASTROPHYS, V298, P517; MCFADDEN L, 1966, NUCL PHYS, V84, P177, DOI 10.1016/0029-5582(66)90441-X; Rauscher T, 2002, ASTROPHYS J, V576, P323, DOI 10.1086/341728; Mohr P, 2007, EUR PHYS J A, V32, P357, DOI 10.1140/epja/i2006-10378-y; Rauscher T, 2014, AIP ADV, V4, DOI 10.1063/1.4868239; Rauscher T, 2000, ATOM DATA NUCL DATA, V75, P1, DOI 10.1006/adnd.2000.0834; Travaglio C, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/93; WOOSLEY SE, 1978, ASTROPHYS J SUPPL S, V36, P285, DOI 10.1086/190501; Baglin C. M., 2000, Nuclear Data Sheets, V90, DOI 10.1006/ndsh.2000.0012; Baglin CM, 2008, NUCL DATA SHEETS, V109, P2033, DOI 10.1016/j.nds.2008.08.001; Glorius J, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.065808; Iliadis C., 2007, NUCL PHYS STARS; Injuk J, 2001, XRAY FLUORESCENCE NO, P151; Kiss GG, 2014, PHYS LETT B, V735, P40, DOI 10.1016/j.physletb.2014.06.011; Kiss GG, 2011, PHYS LETT B, V695, P419, DOI 10.1016/j.physletb.2010.11.052; Koltay E, 2011, HDB NUCL CHEM, V3, P1695; Netterdon L, 2013, NUCL PHYS A, V916, P149, DOI 10.1016/j.nuclphysa.2013.08.002; Rauscher T, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/1/L10; Rauscher T, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.035803; Rauscher T, 2012, COMPUTER CODE SMARAG; Rauscher T, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.015804; Rauscher T, 2012, ASTROPHYS J SUPPL S, V201, DOI 10.1088/0067-0049/201/2/26; Rauscher T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.061104; Rauscher T, 2001, ATOM DATA NUCL DATA, V79, P47, DOI 10.1006/adnd.2001.0863; Sauerwein A, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.045808; Szabo G, 2006, PIXEKLM PROGRAM HDB, P109; Szucs T., 2014, Nuclear Data Sheets, V120, DOI 10.1016/j.nds.2014.07.043; Szucs T, 2014, AIP CONF PROC, V1595, P173, DOI 10.1063/1.4875306; Ziegler J F, 2008, CODE SRIM VERSION 20	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0954-3899	1361-6471		J PHYS G NUCL PARTIC	J. Phys. G-Nucl. Part. Phys.	MAY	2015	42	5							055103	10.1088/0954-3899/42/5/055103		10	Physics, Nuclear; Physics, Particles & Fields	Physics	CG7CF	WOS:000353459100007		
J	Daikoku, E; Saito, M; Ono, F				Daikoku, Eriko; Saito, Masahisa; Ono, Fumihito			Zebrafish mutants of the neuromuscular junction: swimming in the gene pool	Journal of Physiological Sciences			English	Review						Synapse; Zebrafish; Acetylcholine receptor; Mutant	MUSCLE ACETYLCHOLINE-RECEPTOR; IN-VIVO; MYASTHENIC SYNDROME; RAPSYN CLUSTERS; BETA-SUBUNIT; IDENTIFICATION; SYNAPSES; PROTEIN; REVEALS; SLOW	This review provides an overview of zebrafish mutants with dysfunctional acetylcholine receptors or related proteins at the neuromuscular junction (NMJ). The NMJ, which has served as the classical model of the chemical synapse, uses acetylcholine as the neurotransmitter, and mutations of proteins involved in the signaling cascade lead to a variety of behavioral phenotypes. Mutants isolated after random chemical mutagenesis screening are summarized, and advances in the field resulting from these mutants are discussed.	[Daikoku, Eriko; Saito, Masahisa; Ono, Fumihito] Osaka Med Coll, Dept Physiol, Takatsuki, Osaka 5698686, Japan; [Ono, Fumihito] NIAAA, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA	Ono, F (reprint author), Osaka Med Coll, Dept Physiol, Takatsuki, Osaka 5698686, Japan.	onof@art.osaka-med.ac.jp			intramural program at NIAAA	We thank Dr Henry Puhl for critical reading of the manuscript. We thank Ms Kasumi Minamimoto and Ms Chika Murakami for their help with preparation of the figures. This work was supported by the intramural program at NIAAA.	Granato M, 1996, DEVELOPMENT, V123, P399; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Michalk A, 2008, AM J HUM GENET, V82, P464, DOI 10.1016/j.ajhg.2007.11.006; SEGUELA P, 1993, J NEUROSCI, V13, P596; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Ono F, 2001, J NEUROSCI, V21, P5439; Borges LS, 2008, J NEUROSCI, V28, P11468, DOI 10.1523/JNEUROSCI.2508-08.2008; Jing LL, 2009, NEURON, V61, P721, DOI 10.1016/j.neuron.2008.12.025; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Lefebvre JL, 2004, DEVELOPMENT, V131, P2605, DOI 10.1242/dev.01123; Wen H, 2013, J NEUROSCI, V33, P7384, DOI 10.1523/JNEUROSCI.5839-12.2013; BURDEN SJ, 1983, CELL, V35, P687, DOI 10.1016/0092-8674(83)90101-0; Mongeon R, 2011, J GEN PHYSIOL, V138, P353, DOI 10.1085/jgp.201110649; Woods IG, 2006, CURR BIOL, V16, P636, DOI 10.1016/j.cub.2006.02.067; Park JY, 2014, J NEUROSCI, V34, P10211, DOI 10.1523/JNEUROSCI.0426-14.2014; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Ohno K, 2002, AM J HUM GENET, V70, P875, DOI 10.1086/339465; Haffter P, 1996, DEVELOPMENT, V123, P1; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Blanco G, 2001, HUM MOL GENET, V10, P9, DOI 10.1093/hmg/10.1.9; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; CHARNET P, 1992, MOL PHARMACOL, V41, P708; Epley KE, 2008, J NEUROSCI, V28, P13223, DOI 10.1523/JNEUROSCI.2814-08.2008; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; Ikeda H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063318; JENNINGS CGB, 1993, P NATL ACAD SCI USA, V90, P2895, DOI 10.1073/pnas.90.7.2895; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Lee Y, 2009, NEUROSCIENCE, V163, P222, DOI 10.1016/j.neuroscience.2009.05.057; Lefebvre JL, 2007, P NATL ACAD SCI USA, V104, P2483, DOI 10.1073/pnas.0610822104; Marangi PA, 2001, EMBO J, V20, P7060, DOI 10.1093/emboj/20.24.7060; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Ono F, 2002, J NEUROSCI, V22, P6491; Ono F, 2004, J NEUROSCI, V24, P5475, DOI 10.1523/JNEUROSCI.0851-04.2004; Ono F, 2008, SCI SIGNAL, V1; Panzer JA, 2006, J NEUROSCI, V26, P934, DOI 10.1523/JNEUROSCI.3656-05.2006; Papke RL, 2012, BIOCHEM PHARMACOL, V84, P352, DOI 10.1016/j.bcp.2012.04.022; Park JY, 2012, J NEUROSCI, V32, P7356, DOI 10.1523/JNEUROSCI.0397-12.2012; Sepich DS, 1998, GENETICS, V148, P361; Walogorsky M, 2012, P NATL ACAD SCI USA, V109, P17711, DOI 10.1073/pnas.1215858109; Walogorsky M, 2012, J NEUROSCI, V32, P7941, DOI 10.1523/JNEUROSCI.0158-12.2012; Zhang J, 2004, NAT NEUROSCI, V7, P1303, DOI 10.1038/nn1350	43	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	MAY	2015	65	3					217	221		10.1007/s12576-015-0372-9		5	Physiology	Physiology	CG6LB	WOS:000353411100002		
J	Niwa, M; Muramatsu, K; Sasaki, SI				Niwa, Masatoshi; Muramatsu, Ken; Sasaki, Sei-Ichi			Discharge patterns of abdominal and pudendal nerves during induced defecation in anesthetized cats	Journal of Physiological Sciences			English	Article						Abdominal nerve; Defecation; Intra-abdominal pressure; Pudendal nerve	EXTERNAL ANAL-SPHINCTER; MORPHOLOGICAL ANALYSIS; MUSCLES; MOTONEURONS; REFLEX; LOCALIZATION; NEURONS	Defecation is thought to be achieved not only by contraction of the colon, but also by a rise in intra-abdominal pressure. In this study we recorded the discharges of nerves innervating the abdominal (Abd) muscles, diaphragm, external anal sphincter (EAS) muscle and pelvic floor (PF) muscles during induced defecation evoked by distention of an expellable balloon to reveal defecation-related muscle activities. The discharges of the Abd muscle and phrenic (Phr) nerves increased when rectal pressure increased. The discharges of the EAS and PF nerves usually increased in proportion to the pressure in the rectum and maintained a constant activity level, although some trials showed inhibition. The results suggest that activities of these muscles increase the intra-abdominal pressure.	[Niwa, Masatoshi] Kyorin Univ, Dept Occupat Therapy, Tokyo 1928508, Japan; [Muramatsu, Ken] Hlth Sci Univ, Dept Phys Therapy, Yamanashi, Japan; [Sasaki, Sei-Ichi] Ibaraki Prefectural Univ Hlth Sci, Ctr Med Sci, Ibaraki, Japan	Niwa, M (reprint author), Kyorin Univ, Dept Occupat Therapy, 476 Miyashita, Tokyo 1928508, Japan.	mt-niwa@ks.kyorin-u.ac.jp			KAKENHI [22500482]	This work was supported by KAKENHI 22500482. The authors thank Dr. Steve I. Perlmutter for proof reading the manuscript for English language.	ALVA J, 1967, GASTROENTEROLOGY, V53, P101; SCHUSTER MM, 1965, B JOHNS HOPKINS HOSP, V116, P79; GOLDMAN JM, 1987, J NEUROL NEUROSUR PS, V50, P866, DOI 10.1136/jnnp.50.7.866; BISHOP B, 1959, J NEUROPHYSIOL, V22, P679; BISHOP B, 1956, J PHYSIOL-LONDON, V134, P229; BISHOP B, 1964, J APPL PHYSIOL, V19, P224; CAMPBELL EJM, 1953, J PHYSIOL-LONDON, V122, P282; FLOYD WF, 1953, J PHYSIOL-LONDON, V122, P599; FLOYD WF, 1950, J ANAT, V84, P132; HOLSTEGE G, 1987, BRAIN, V110, P1323, DOI 10.1093/brain/110.5.1323; Ihre T, 1974, Scand J Gastroenterol Suppl, V25, P1; Krier J, 1988, AM J PHYSIOL, V255, P772; KRIER J, 1985, J PHYSIOL-LONDON, V368, P471; KUZUHARA S, 1980, NEUROSCI LETT, V16, P125, DOI 10.1016/0304-3940(80)90331-6; MILLER AD, 1987, J NEUROPHYSIOL, V57, P1854; Muramatsu K, 2008, ANAT SCI INT, V83, P247, DOI 10.1111/j.1447-073X.2008.00238.x; Niwa M, 2008, ANAT SCI INT, V83, P17, DOI 10.1111/j.1447-073x.2007.00196.x; Nout YS, 2006, PROG BRAIN RES, V152, P359, DOI 10.1016/S0079-6123(05)52024-7; PORTER N H, 1962, Ann R Coll Surg Engl, V31, P379; RUSSELL JA, 1987, EXP NEUROL, V97, P179, DOI 10.1016/0014-4886(87)90292-5; SASAKI M, 1994, J COMP NEUROL, V349, P269, DOI 10.1002/cne.903490209; SATO M, 1978, BRAIN RES, V140, P149, DOI 10.1016/0006-8993(78)90244-5; SCHUSTER MM, 1975, GASTROENTEROLOGY, V69, P249; UEYAMA T, 1984, J COMP NEUROL, V222, P38, DOI 10.1002/cne.902220104; Vilensky JA, 2004, COLORECTAL DIS, V6, P376, DOI 10.1111/j.1463-1318.2004.00636.x; WATERS RL, 1972, J ANAT, V111, P191	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	MAY	2015	65	3					223	231		10.1007/s12576-015-0362-y		9	Physiology	Physiology	CG6LB	WOS:000353411100003		
J	Munetomo, A; Hojo, Y; Higo, S; Kato, A; Yoshida, K; Shirasawa, T; Shimizu, T; Barron, A; Kimoto, T; Kawato, S				Munetomo, Arisa; Hojo, Yasushi; Higo, Shimpei; Kato, Asami; Yoshida, Kotaro; Shirasawa, Takuji; Shimizu, Takahiko; Barron, Anna; Kimoto, Tetsuya; Kawato, Suguru			Aging-induced changes in sex-steroidogenic enzymes and sex-steroid receptors in the cortex, hypothalamus and cerebellum	Journal of Physiological Sciences			English	Article						Aging; Brain; Cortex; Hypothalamus; Cerebellum; Steroidogenesis; Steroid receptor	AGE-RELATED-CHANGES; MALE-RAT HIPPOCAMPUS; NEUROTROPHIC FACTOR; TESTOSTERONE SYNTHESIS; ANDROGEN RECEPTOR; GENE-EXPRESSION; RHESUS-MONKEYS; MESSENGER-RNA; FEMALE RAT; ESTROGEN	We investigated age-induced changes in mRNA expression profiles of sex-steroidogenic enzymes and sex-steroid receptors in 3-, 12-, and 24-month-old male rat brain subregions [cerebral cortex (CC), hypothalamus (Hy) and cerebellum (CL)]. In many cases, the expression levels of mRNA decreased with age for androgen synthesis enzyme systems, including Cyp17a1, Hsd17b and Srd5a in the CC and CL, but not in the Hy. Estradiol synthase Cyp19a1 did not show age-induced decline in the Hy, and nearly no expression of Cyp19a1 was observed in the CC and CL over 3-24 m. Androgen receptor Ar increased in the Hy but decreased in the CC with age. Estrogen receptor Esr1 increased in the CC and Hy, and did not change in the CL with age. Esr2 did not change in the CC and Hy, but decreased in the CL with age. As a comparison, age-induced changes of brain-derived neurotrophic factor mRNA were also investigated.	[Munetomo, Arisa; Hojo, Yasushi; Higo, Shimpei; Kato, Asami; Yoshida, Kotaro; Barron, Anna; Kimoto, Tetsuya; Kawato, Suguru] Univ Tokyo, Grad Sch Arts & Sci, Dept Biophys & Life Sci, Tokyo 153, Japan; [Shirasawa, Takuji] Juntendo Univ, Grad Sch Med, Dept Aging Control Med, Bunkyo Ku, Tokyo 1130033, Japan; [Shimizu, Takahiko] Tokyo Metropolitan Inst Gerontol, Mol Geront, Itabashi Ku, Tokyo 1730015, Japan; [Shimizu, Takahiko] Chiba Univ, Grad Sch Med, Dept Adv Aging Med, Chuo Ku, Chiba 2608670, Japan	Kawato, S (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Biophys & Life Sci, Komaba 3-8-1, Tokyo 153, Japan.	kawato@bio.c.u-tokyo.ac.jp					Hojo Y, 2009, ENDOCRINOLOGY, V150, P5106, DOI 10.1210/en.2009-0305; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Gore AC, 2002, J NEUROENDOCRINOL, V14, P300, DOI 10.1046/j.1365-2826.2002.00777.x; Hao JD, 2006, J NEUROSCI, V26, P2571, DOI 10.1523/JNEUROSCI.3440-05.2006; Foy MR, 1999, J NEUROPHYSIOL, V81, P925; Mukai H, 2007, J NEUROCHEM, V100, P950, DOI 10.1111/j.1471-4159.2006.04264.x; Wu D, 2009, J COMP NEUROL, V512, P688, DOI 10.1002/cne.21925; Sakamoto H, 2003, ENDOCRINOLOGY, V144, P4466, DOI 10.1210/en.2003-0307; Munetsuna E, 2009, ENDOCRINOLOGY, V150, P4260, DOI 10.1210/en.2008-1644; Silhol M, 2005, NEUROSCIENCE, V132, P613, DOI 10.1016/j.neuroscience.2005.01.008; Hojo Y, 2008, MOL CELL ENDOCRINOL, V290, P31, DOI 10.1016/j.mce.2008.04.017; Perovic M, 2013, AGE, V35, P2057, DOI 10.1007/s11357-012-9495-6; Wilson ME, 2002, MECH AGEING DEV, V123, P593, DOI 10.1016/S0047-6374(01)00406-7; Ooishi Y, 2012, CEREB CORTEX, V22, P926, DOI 10.1093/cercor/bhr164; Midzak AS, 2009, MOL CELL ENDOCRINOL, V299, P23, DOI 10.1016/j.mce.2008.07.016; Sierra A, 2003, EUR J NEUROSCI, V18, P1458, DOI 10.1046/j.1460-9568.2003.02872.x; Rapp PR, 2003, J NEUROSCI, V23, P5708; Kawato S, 2002, METHOD ENZYMOL, V357, P241; CHEN HL, 1994, J ANDROL, V15, P551; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; KERR JE, 1995, ENDOCRINOLOGY, V136, P3213, DOI 10.1210/en.136.8.3213; Ewa BS, 2012, INT J DEV NEUROSCI, V30, P139, DOI 10.1016/j.ijdevneu.2011.12.001; Janmaat S, 2011, AGE, V33, P565, DOI 10.1007/s11357-010-9203-3; Kato A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00149; Katoh-Semba R, 1998, NEUROSCI RES, V31, P227, DOI 10.1016/S0168-0102(98)00040-6; Kimoto T, 2010, ENDOCRINOLOGY, V151, P5795, DOI 10.1210/en.2010-0581; MacKenzie SM, 2008, J ENDOCRINOL, V196, P123, DOI 10.1677/JOE-07-0427; NORMINGTON K, 1992, J BIOL CHEM, V267, P19548; Ota H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029598; Pires RS, 2010, NEUROSCI LETT, V478, P146, DOI 10.1016/j.neulet.2010.05.005; Sorwell KG, 2012, NEUROBIOL AGING, V33, DOI DOI 10.1016/J.NEUR0BI0LAGING.2011.05.0; Yamaguchi-Shima N, 2007, BRAIN RES, V1155, P34, DOI 10.1016/j.brainres.2007.04.016	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	MAY	2015	65	3					253	263		10.1007/s12576-015-0363-x		11	Physiology	Physiology	CG6LB	WOS:000353411100006		
J	Miki, K; Maekura, R; Nagaya, N; Miki, M; Kitada, S; Yoshimura, K; Mori, M; Kangawa, K				Miki, Keisuke; Maekura, Ryoji; Nagaya, Noritoshi; Miki, Mari; Kitada, Seigo; Yoshimura, Kenji; Mori, Masahide; Kangawa, Kenji			Effects of ghrelin treatment on exertional dyspnea in COPD: an exploratory analysis	Journal of Physiological Sciences			English	Article						Dyspnea; Exercise; Pulmonary rehabilitation; Lactate threshold; Underweight	OBSTRUCTIVE PULMONARY-DISEASE; EXERCISE; MECHANISMS; FIBROSIS; CACHEXIA; OXYGEN	A substudy of ghrelin treatment in a multicenter trial previously revealed that administration of ghrelin improves the exercise capacity of underweight COPD patients. To clarify exertional dyspnea more precisely, exploratory analysis was conducted on data from the substudy. Of 20 underweight COPD patients who were randomized to pulmonary rehabilitation with intravenous ghrelin (2 mu g/kg, n = 10) or placebo (n = 10) twice daily for 3 weeks in the substudy, 16 (ghrelin = 9, placebo = 7) could be investigated for dyspnea break-point on the dyspnea-ratio (%) of Delta oxygen uptake () (= peak minus resting ) curve. A significant treatment effect of ghrelin on percentage at the dyspnea break-point to Delta (p = 0.049) was achieved. In conclusion, underweight COPD patients benefitted from ghrelin treatment in terms of shifts to the early exercise phase of the dyspnea break-point during a standardized exercise program.	[Miki, Keisuke; Maekura, Ryoji; Miki, Mari; Kitada, Seigo; Yoshimura, Kenji; Mori, Masahide] Natl Hosp Org Toneyama Natl Hosp, Dept Resp Med, Toyonaka, Osaka 5608552, Japan; [Nagaya, Noritoshi] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Regenerat Med, Suita, Osaka, Japan; [Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biochem, Suita, Osaka, Japan	Miki, K (reprint author), Natl Hosp Org Toneyama Natl Hosp, Dept Resp Med, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan.	mikisuke@toneyama.go.jp			Ministry of Health, Labour and Welfare in Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan; Takeda Scientific Foundation in Japan; Health and Labour Sciences Research Grants, Clinical Research [H20-translational research-general-002]	Funding was received as Research Grants from: the Ministry of Health, Labour and Welfare in Japan; the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan; the Takeda Scientific Foundation in Japan; and Health and Labour Sciences Research Grants, Clinical Research, H20-translational research-general-002. The authors would like to thank Mr K. Tsuguchi (Nihon Ultmarc Inc., Tokyo, Japan) for performing the statistical analysis, Ms Y. Tsuchie (Toneyama National Hospital) for her assistance with this study, and Mr T. Uenishi (Toneyama National Hospital) for obtaining the CPET measurements. They authors would also like to thank the members of the main study that included this sub study at Miyazaki University School of Medicine (Professor M. Nakazato, Dr N. Matsumoto, and Dr Y. Arimura), Nara Medical University (Professor H. Kimura and Dr M. Yoshikawa), and the National Cardiovascular Center Research Institute (Dr K. Yamahara).	Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; Wagner PD, 2008, EUR RESPIR J, V31, P492, DOI 10.1183/09031936.00074807; Wasserman K, 2014, RESP PHYSIOL NEUROBI, V190, P142, DOI 10.1016/j.resp.2013.10.009; Stringer WW, 1997, J APPL PHYSIOL, V82, P908; Matsumura K, 2002, HYPERTENSION, V40, P694, DOI 10.1161/01.HYP.0000034395.51441.10; Nagaya N, 2001, AM J PHYSIOL-REG I, V280, pR1483; Laveneziana P, 2012, EXPERT REV RESP MED, V6, P651, DOI [10.1586/ers.12.70, 10.1586/ERS.12.70]; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; O'Donnell DE, 2002, AM J RESP CRIT CARE, V166, P663, DOI 10.1164/rccm.2201003; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; ODonnell DE, 1997, AM J RESP CRIT CARE, V155, P109; Nagaya N, 2005, CHEST, V128, P1187, DOI 10.1378/chest.128.3.1187; Burki NK, 2010, CHEST, V138, P1196, DOI 10.1378/chest.10-0534; Gagnon P, 2012, AM J RESP CRIT CARE, V186, P606, DOI 10.1164/rccm.201203-0404OC; ITOH H, 1990, Circulation, V81, pII31; Kinugawa T, 1998, CHEST, V114, P1295, DOI 10.1378/chest.114.5.1295; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856; Miki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035708; Miki K, 2009, RESPIROLOGY, V14, P1020, DOI 10.1111/j.1440-1843.2009.01607.x; Miki K, 2012, RESPIROLOGY, V17, P149, DOI 10.1111/j.1440-1843.2011.02086.x; Miki K, 2010, J PHYSIOL SCI, V60, P187, DOI 10.1007/s12576-009-0083-1; Miki K, 2013, RESP PHYSIOL NEUROBI, V185, P653, DOI 10.1016/j.resp.2012.11.008; Miki K, 2013, EUR RESPIR J, V42, p517s; Miki K, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-37; O'Donnell DE, 2009, RESP PHYSIOL NEUROBI, V167, P116, DOI 10.1016/j.resp.2009.01.010	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	MAY	2015	65	3					277	284		10.1007/s12576-015-0366-7		8	Physiology	Physiology	CG6LB	WOS:000353411100008		
J	Sugimoto, K				Sugimoto, Keiko			Plant cell reprogramming as an adaptive strategy	JOURNAL OF PLANT RESEARCH			English	Article						Dedifferentiation; Redifferentiation; Totipotency; Pluripotency; Regeneration; Tissue culture; Wounding	ARABIDOPSIS; REGENERATION; ROOT		RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan	Sugimoto, K (reprint author), RIKEN Ctr Sustainable Resource Sci, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	keiko.sugimoto@riken.jp			Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fisheries;  [22119010]	I thank Masaki Ito and Akira Iwase for comments and suggestions on this manuscript. The work on reprogramming in my laboratory is supported by Grants-in-Aid for Scientific Research on Innovative Areas (Grant No. 22119010) and as a part of the Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fisheries.	Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Atta R, 2009, PLANT J, V57, P626, DOI 10.1111/j.1365-313X.2008.03715.x; Asahina M, 2011, P NATL ACAD SCI USA, V108, P16128, DOI 10.1073/pnas.1110443108; Asahina M, 2015, J PLANT RES, DOI [10. 1007/ s10265- 015- 0705- z, DOI 10.1007/S10265-015-0705-Z]; Cavers F, 1903, NEW PHYTOL, V2, P121, DOI 10.1111/j.1469-8137.1903.tb04960.x; Ishikawa M, 2011, PLANT CELL, V23, P2924, DOI 10.1105/tpc.111.088005; Ishikawa M, 2015, J PLANT RES, DOI [10. 1007/ s10265- 015- 0713- z, DOI 10.1007/S10265-015-0713-Z]; Ito M, 2015, J PLANT RES, DOI [10. 1007/ s10265- 014- 0694-3, DOI 10.1007/S10265-014-0694-3]; Iwase A, 2011, CURR BIOL, V21, P506; Iwase A, 2015, J PLANT RES IN PRESS; Nishihama R, 2015, J PLANT RES, DOI [10. 1007/ s10265- 015- 0724- 9, DOI 10.1007/S10265-015-0724-9]; Ohtani M, 2015, J PLANT RES, DOI [10. 1007/ s10265- 015- 0700- 4, DOI 10.1007/S10265-015-0700-4]; Sugiyama M, 2015, J PLANT RES, DOI [10. 1007/ s10265- 015- 0706- y, DOI 10.1007/S10265-015-0706-Y]	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	MAY	2015	128	3					345	347		10.1007/s10265-015-0718-7		3	Plant Sciences	Plant Sciences	CG5ST	WOS:000353355500001		
J	Sugiyama, M				Sugiyama, Munetaka			Historical review of research on plant cell dedifferentiation	JOURNAL OF PLANT RESEARCH			English	Review						Dedifferentiation; History; Tissue culture; Totipotency	TOBACCO MESOPHYLL PROTOPLASTS; AUXIN-REGULATED GENE; TRACHEARY ELEMENT DIFFERENTIATION; ORGANOGENESIS IN-VITRO; HORDEUM-VULGARE L; SOMATIC EMBRYOGENESIS; TISSUE-CULTURE; ARABIDOPSIS-THALIANA; SHOOT REGENERATION; EXPRESSION PROGRAMS	Plant cell dedifferentiation has long attracted interest as a key process for understanding the plasticity of plant development. In early studies, typical examples of plant cell dedifferentiation were described as physiological and cytological changes associated with wound healing or regenerative development. Subsequently, plant tissue and cell culture techniques, in which exciting progress was achieved after discovery of the hormonal control of cell proliferation and organogenesis in vitro in the 1950s, have been used extensively to study dedifferentiation. The pioneer studies of plant tissue/cell culture led to the hypothesis that many mature plant cells retain totipotency and related dedifferentiation to the initial step of the expression of totipotency. Plant tissue/cell cultures have provided experimental systems not only for physiological analysis, but also for genetic and molecular biological analysis, of dedifferentiation. More recently, proteomic, transcriptomic, and epigenetic analyses have been applied to the study of plant cell dedifferentiation. All of these works have expanded our knowledge of plant cell dedifferentiation, and current research is contributing to unraveling the molecular mechanisms. The present article provides a brief overview of the history of research on plant cell dedifferentiation.	Univ Tokyo, Bot Gardens, Grad Sch Sci, Bunkyo Ku, Tokyo 1120001, Japan	Sugiyama, M (reprint author), Univ Tokyo, Bot Gardens, Grad Sch Sci, Bunkyo Ku, 3-7-1 Hakusan, Tokyo 1120001, Japan.	sugiyama@ns.bg.s.u-tokyo.ac.jp	SUGIYAMA, MUNETAKA/G-4922-2014				Aichinger E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000605; AKAMA K, 1992, PLANT CELL REP, V12, P7, DOI 10.1007/BF00232413; Fan MZ, 2012, CELL RES, V22, P1169, DOI 10.1038/cr.2012.63; Ohtani M, 2013, PLANT CELL, V25, P2056, DOI 10.1105/tpc.113.111922; Xu L, 2014, CURR TOP DEV BIOL, V108, P1, DOI 10.1016/B978-0-12-391498-9.00009-7; STEWARD FC, 1958, AM J BOT, V45, P705, DOI 10.2307/2439728; Motte H, 2014, P NATL ACAD SCI USA, V111, P8305, DOI 10.1073/pnas.1404978111; Nishimura A, 2005, P NATL ACAD SCI USA, V102, P11940, DOI 10.1073/pnas.0504220102; Damri M, 2009, REJUV RES, V12, P435, DOI 10.1089/rej.2009.0887; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; REINERT J, 1959, PLANTA, V53, P318, DOI 10.1007/BF01881795; Schmidt EDL, 1997, DEVELOPMENT, V124, P2049; TAKEBE I, 1971, NATURWISSENSCHAFTEN, V58, P318; Avivi Y, 2004, DEV DYNAM, V230, P12, DOI 10.1002/dvdy.20006; BLOCH R, 1952, BOT REV, V18, P655, DOI 10.1007/BF02957556; Anzola JM, 2010, P NATL ACAD SCI USA, V107, P10308, DOI 10.1073/pnas.0913918107; Mano Y, 2002, THEOR APPL GENET, V105, P708, DOI 10.1007/s00122-002-0992-3; Feher A, 2003, PLANT CELL TISS ORG, V74, P201, DOI 10.1023/A:1024033216561; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.127.3.803; Liu HL, 2010, PLANT GROWTH REGUL, V62, P127, DOI 10.1007/s10725-010-9495-4; Ogas J, 1999, P NATL ACAD SCI USA, V96, P13839, DOI 10.1073/pnas.96.24.13839; MILLER CO, 1955, J AM CHEM SOC, V77, P1392, DOI 10.1021/ja01610a105; Grafi G, 2004, DEV BIOL, V268, P1, DOI 10.1016/j.ydbio.2003.12.027; Raynaud C, 2014, J EXP BOT, V65, P2677, DOI 10.1093/jxb/ert433; Che P, 2006, PLANT PHYSIOL, V141, P620, DOI 10.1104/pp.106.081240; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; CHRISTIANSON ML, 1983, DEV BIOL, V95, P288, DOI 10.1016/0012-1606(83)90029-5; KOMAMINE A, 1992, IN VITRO CELL DEV-PL, V28P, P11; DeKlerk GJ, 1997, BIOL PLANTARUM, V39, P53, DOI 10.1023/A:1000304922507; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200; Chitteti BR, 2008, PROTEOMICS, V8, P4303, DOI 10.1002/pmic.200701149; Namasivayam P, 2007, PLANT CELL TISS ORG, V90, P1, DOI 10.1007/s11240-007-9249-9; VASIL V, 1965, SCIENCE, V150, P889, DOI 10.1126/science.150.3698.889; Grafi G, 2011, PLANTA, V233, P433, DOI 10.1007/s00425-011-1366-3; Child CM, 1912, BIOL BULL-US, V23, P1, DOI 10.2307/1536001; Ogas J, 1997, SCIENCE, V277, P91, DOI 10.1126/science.277.5322.91; Xu K, 2012, GENOMICS, V100, P116, DOI 10.1016/j.ygeno.2012.05.013; Tessadori F, 2007, J CELL SCI, V120, P1200, DOI 10.1242/jcs.000026; NAGATA T, 1970, PLANTA, V92, P301, DOI 10.1007/BF00385097; HEMERLY AS, 1993, PLANT CELL, V5, P1711, DOI 10.1105/tpc.5.12.1711; Jiang FW, 2013, PROTOPLASMA, V250, P1231, DOI 10.1007/s00709-013-0513-z; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; Fukuda H, 1997, PLANT CELL, V9, P1147, DOI 10.1105/tpc.9.7.1147; Demura T, 2002, P NATL ACAD SCI USA, V99, P15794, DOI 10.1073/pnas.232590499; NAGATA T, 1971, PLANTA, V99, P12, DOI 10.1007/BF00392116; Ohbayashi I, 2011, PLANT J, V67, P49, DOI 10.1111/j.1365-313X.2011.04574.x; RAMAGOPAL S, 1994, PLANT CELL REP, V13, P692, DOI 10.1007/BF00231626; Grafi G, 2007, DEV BIOL, V306, P838, DOI 10.1016/j.ydbio.2007.03.023; Mano Y, 1996, BREEDING SCI, V46, P137; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x; Dewitte W, 2003, ANNU REV PLANT BIOL, V54, P235, DOI 10.1146/annurev.arplant.54031902.134836; Takeuchi Y, 2000, CROP SCI, V40, P245; Asahina M, 2011, P NATL ACAD SCI USA, V108, P16128, DOI 10.1073/pnas.1110443108; BACKSHUS.D, 1970, PROTOPLASMA, V70, P49, DOI 10.1007/BF01276841; Blackman FF, 1901, ANN BOT-LONDON, V15, P533; BLOCH ROBERT, 1941, BOT REV, V7, P110, DOI 10.1007/BF02872446; Bloch R, 1935, ANN BOT-LONDON, V49, P651; BLOCH ROBERT, 1926, BER DEUTSCH BOT GES, V44, P308; Bonner J, 1938, PLANT PHYSIOL, V13, P331, DOI 10.1104/pp.13.2.331; BONNETT HT, 1965, PLANT PHYSIOL, V40, P1228, DOI 10.1104/pp.40.6.1228; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; Buvat R, 1989, ONTOGENY CELL DIFFER; Chitteti BR, 2007, PROTEOMICS, V7, P1473, DOI 10.1002/pmic.200600871; CHRISTIANSON ML, 1985, DEV BIOL, V112, P494, DOI 10.1016/0012-1606(85)90423-3; Chupeau MC, 2013, PLANT CELL, V25, P2444, DOI 10.1105/tpc.113.109538; COCKING EC, 1960, NATURE, V187, P962, DOI 10.1038/187962a0; Dudits D, 1995, IN VITRO EMBRYOGENES, P267; English Jr J, 1939, J AM CHEM SOC, V61, P3434, DOI 10.1021/ja01267a059; ENGVILD KC, 1973, PHYSIOL PLANTARUM, V28, P155, DOI 10.1111/j.1399-3054.1973.tb01168.x; FELDMAN LJ, 1977, J CELL SCI, V28, P87; FISCHER HERMANN, 1934, PLANTA, V22, P767, DOI 10.1007/BF01916341; FUKUDA H, 1981, PHYSIOL PLANTARUM, V52, P423, DOI 10.1111/j.1399-3054.1981.tb02711.x; GALUN E, 1981, ANNU REV PLANT PHYS, V32, P237, DOI 10.1146/annurev.pp.32.060181.001321; GAUTHERET R., 1939, COMPT REND ACAD SCI [PARIS], V208, P118; GAUTHERET RJ, 1983, BOT MAG TOKYO, V96, P393, DOI 10.1007/BF02488184; Grafi G, 2014, BBA GENE RE IN PRESS, DOI [10.1016/j.bbagrm.2014.07.015, DOI 10.1016/J.BBAGRM.2014.07.015]; Haberlandt G, 1902, SITZBER KAISER AKAD, VK1, P69; Haberlandt G, 1921, BEITR ALLG BOT, V2, P1; HARADA H, 1990, CURR PLANT SCI BIOT, P129; Heitz E, 1925, Z ZELLFORSCH MIKROSK, V2, P69, DOI 10.1007/BF00373252; HENRY Y, 1994, EUPHYTICA, V79, P45, DOI 10.1007/BF00023575; Iwase A, 2011, CURR BIOL, V21, P506; JORDAN EG, 1987, ANN BOT-LONDON, V59, P525; KAO KN, 1970, EXP CELL RES, V62, P338, DOI 10.1016/0014-4827(70)90563-X; KOMATSUDA T, 1993, THEOR APPL GENET, V86, P713, DOI 10.1007/BF00222661; KOORNNEEF M, 1987, THEOR APPL GENET, V74, P633, DOI 10.1007/BF00288863; KOORNEEF M, 1993, PLANT J, V3, P131, DOI 10.1111/j.1365-313X.1993.tb00016.x; Kostoff D, 1928, AM J BOT, V15, P565, DOI 10.2307/2435772; Lohar DP, 2006, PLANT PHYSIOL, V140, P221; MARTINEZ MC, 1992, P NATL ACAD SCI USA, V89, P7360, DOI 10.1073/pnas.89.16.7360; MELCHERS G, 1978, CARLSBERG RES COMMUN, V43, P203, DOI 10.1007/BF02906548; MILLER CO, 1956, J AM CHEM SOC, V78, P1375, DOI 10.1021/ja01588a032; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; NAGATA T, 1994, INT J DEV BIOL, V38, P321; Nagata T, 1985, CC AGR BIOL ENV, V9, P18; Neelakandan AK, 2011, PLANT CELL REP, V31, P597; Nishiyama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036471; Nobecourt P, 1939, CR SOC BIOL, V130, P1270; Ohtani M, 2005, PLANT J, V43, P479, DOI 10.1111/j.1365-313X.2005.02469.x; Ondrej V, 2009, MOL CELLS, V27, P443, DOI 10.1007/s10059-009-0057-4; Ozawa S, 1998, DEVELOPMENT, V125, P135; RAMAGOPAL S, 1989, J PLANT PHYSIOL, V134, P395; Sachs J, 1887, LECT PHYSL PLANTS; Sakakibara K, 2014, DEVELOPMENT, V141, P1660, DOI 10.1242/dev.097444; SCHRAUDOLF H, 1959, NATURE, V184, P465, DOI 10.1038/184465a0; SONI R, 1995, PLANT CELL, V7, P85, DOI 10.1105/tpc.7.1.85; SUGIYAMA M, 1990, CELL DIFFER DEV, V31, P77, DOI 10.1016/0922-3371(90)90011-K; Sugiyama M, 2000, INT REV CYTOL, V196, P67; Sugiyama M, 2014, PLANT BIOTECHNOL REP, V8, P29, DOI 10.1007/s11816-013-0292-1; TaguchiShiobara F, 1997, THEOR APPL GENET, V95, P828, DOI 10.1007/s001220050632; TAKAHASHI Y, 1989, P NATL ACAD SCI USA, V86, P9279, DOI 10.1073/pnas.86.23.9279; TAKAHASHI Y, 1992, PLANT CELL PHYSIOL, V33, P779; TAKAHASHI Y, 1992, P NATL ACAD SCI USA, V89, P56, DOI 10.1073/pnas.89.1.56; Thome OW, 1879, TXB STRUCTURAL PHYSL; Thorpe T. A., 2001, CURRENT TRENDS EMBRY, P279; Tschirch A, 1889, ANGEWANDTE PFLANZENA; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; WHITE PR, 1946, BOT REV, V12, P521, DOI 10.1007/BF02861802; White PR, 1936, BOT REV, V2, P419, DOI 10.1007/BF02870163; WHITE PHILIP R., 1939, AMER JOUR BOT, V26, P59, DOI 10.2307/2436709; WILLIAMS EG, 1986, ANN BOT-LONDON, V57, P443; Williams L, 2003, DEV DYNAM, V228, P113, DOI 10.1002/dvdy.10348; WOLTER KE, 1968, NATURE, V219, P509, DOI 10.1038/219509a0; ZIMMERMAN DC, 1979, PLANT PHYSIOL, V63, P536, DOI 10.1104/pp.63.3.536; ZIMMERMAN JL, 1993, PLANT CELL, V5, P1411, DOI 10.2307/3869792	126	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	MAY	2015	128	3					349	359		10.1007/s10265-015-0706-y		11	Plant Sciences	Plant Sciences	CG5ST	WOS:000353355500002		
J	Ohtani, M				Ohtani, Misato			Regulation of RNA metabolism is important for in vitro dedifferentiation of plant cells	JOURNAL OF PLANT RESEARCH			English	Article						In vitro dedifferentiation; miRNA; Organogenesis; Pre-mRNA splicing; rRNA biosynthesis; Somatic embryogenesis	TEMPERATURE-SENSITIVE MUTANTS; ALTERNATIVE SPLICING LANDSCAPE; JERUSALEM-ARTICHOKE TUBER; EMBRYONIC STEM-CELLS; ARABIDOPSIS-THALIANA; SNRNA TRANSCRIPTION; GENETIC-ANALYSIS; TISSUE-CULTURE; MICRORNAS; COMPLEXITY	The characteristic high regenerative ability of plants has been exploited to develop in vitro plant regeneration techniques, which are usually initiated by an in vitro dedifferentiation step induced by artificial phytohormone treatment. Recent advances in plant molecular biological and genetic technologies have revealed the importance of the regulation of RNA metabolism, including the control of rRNA biosynthesis, pre-mRNA splicing, and miRNA-based RNA decay, in successful in vitro dedifferentiation. This review provides a brief overview of current knowledge of the roles of RNA metabolism in the dedifferentiation of plant cells in vitro. In addition, the possibility that plant-specific aspects of RNA metabolism regulation are linked closely to their high regenerative ability is discussed.	[Ohtani, Misato] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Ohtani, Misato] RIKEN Ctr Sustainable Resource Sci, Biomass Engn Program Cooperat Div, Yokohama, Kanagawa 2300045, Japan	Ohtani, M (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama Cho, Nara 6300192, Japan.	misato@bs.naist.jp			Nara Institute of Science and Technology; Japan Society for the Promotion of Science [18870028, 24770052, 25114520]	I thank Dr. Munetaka Sugiyama (University of Tokyo) for critical discussions and helpful suggestions. I also thank Dr. Dominique Gagliardi and Dr. Heike Lange (Universite de Strasbourg) for providing the mtr4 mutants, Dr. Kentaro Nakaminami and Dr. Motoaki Seki (RIKEN Center for Sustainable Resource Science) for providing the xrn mutants, and Dr. Taku Demura (Nara Institute of Science and Technology), Dr. Yuichiro Watanabe (University of Tokyo) and Dr. Hiroyasu Motose (Okayama University) for fruitful discussions. This work was supported in part by a Start-up Grant for Women Researchers from the Nara Institute of Science and Technology and by Grants-in-Aid from the Japan Society for the Promotion of Science (Grant numbers 18870028, 24770052, and 25114520 to M.O.).	Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Ohtani M, 2013, PLANT CELL, V25, P2056, DOI 10.1105/tpc.113.111922; Matzke MA, 2014, NAT REV GENET, V15, P394, DOI 10.1038/nrg3683; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; YASUTANI I, 1994, PLANT PHYSIOL, V105, P815; Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Iwakawa H, 2013, MOL CELL, V52, P591, DOI 10.1016/j.molcel.2013.10.033; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; de Almeida SF, 2014, SEMIN CELL DEV BIOL, V32, P2, DOI 10.1016/j.semcdb.2014.03.010; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Mallanna SK, 2010, DEV BIOL, V344, P16, DOI 10.1016/j.ydbio.2010.05.014; Avivi Y, 2004, DEV DYNAM, V230, P12, DOI 10.1002/dvdy.20006; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; Lin SB, 2014, NAT CELL BIOL, V16, P129, DOI 10.1038/ncb2914; Lange H, 2011, PLANT J, V68, P51, DOI 10.1111/j.1365-313X.2011.04675.x; Neelakandan AK, 2012, PLANT CELL REP, V31, P597, DOI 10.1007/s00299-011-1202-z; Konishi M, 2003, DEVELOPMENT, V130, P5637, DOI 10.1242/dev.00794; Zhang SG, 2010, BIOCHEM BIOPH RES CO, V398, P355, DOI 10.1016/j.bbrc.2010.06.056; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Qiao M, 2012, PLANT J, V71, P14, DOI 10.1111/j.1365-313X.2012.04944.x; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200; Luo YC, 2006, FEBS LETT, V580, P5111, DOI 10.1016/j.febslet.2006.08.046; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Tessadori F, 2007, J CELL SCI, V120, P1200, DOI 10.1242/jcs.000026; Shinohara N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00159; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Nodine MD, 2010, GENE DEV, V24, P2678, DOI 10.1101/gad.1986710; Ohbayashi I, 2011, PLANT J, V67, P49, DOI 10.1111/j.1365-313X.2011.04574.x; Wu XM, 2011, PLANTA, V233, P495, DOI 10.1007/s00425-010-1312-9; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Brown SJ, 2012, HUM MOL GENET, V353, pR1; COOKE R, 1981, PLANTA, V152, P1, DOI 10.1007/BF00384976; Feher A, 2015, BBA-GENE REGUL MECH, V1849, P385, DOI 10.1016/j.bbagrm.2014.07.005; FRASER RSS, 1974, J EXP BOT, V25, P847, DOI 10.1093/jxb/25.5.847; FRASER RSS, 1975, EUR J BIOCHEM, V50, P529, DOI 10.1111/j.1432-1033.1975.tb09893.x; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; Hussain A, 2012, RECENT ADV PLANT IN, P1, DOI [10.5772/52760, DOI 10.5772/52760]; James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235; Li TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043451; Lin YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060337; Liu WN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093438; Lodish H., 2000, MOL CELL BIOL; MINOCHA SC, 1979, Z PFLANZENPHYSIOL, V92, P367; Nelles DA, 2010, ADV EXP MED BIOL, V695, P92, DOI 10.1007/978-1-4419-7037-4_7; Ohtani M, 2008, PLANT MOL BIOL, V66, P303, DOI 10.1007/s11103-007-9271-7; Ohtani M, 2015, J PLANT RES IN PRESS; Ohtani M, 2010, PLANT CELL PHYSIOL, V51, P2002, DOI 10.1093/pcp/pcq159; Ohtani M, 2005, PLANT J, V43, P479, DOI 10.1111/j.1365-313X.2005.02469.x; Ozawa S, 1998, DEVELOPMENT, V125, P135; Palmer C.M., 2012, ELS, DOI [http://dx.doi.org/10.1002/9780470015902.a0002092.pub2, DOI 10.1002/9780470015902.A0002092.PUB2]; Pulianmackal AJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00142; Rodriguez-Enriquez J, 2011, TRENDS PLANT SCI, V16, P242, DOI 10.1016/j.tplants.2011.03.002; Sugiyama M, 2014, PLANT BIOTECHNOL REP, V8, P29, DOI 10.1007/s11816-013-0292-1; Tamaki H, 2009, PLANT J, V57, P1027, DOI 10.1111/j.1365-313X.2008.03750.x; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Williams L, 2003, DEV DYNAM, V228, P113, DOI 10.1002/dvdy.10348; Wu J, 2013, POSTTRANSCRIPTIONAL GENE REGULATION: RNA PROCESSING IN EUKARYOTES, P1, DOI 10.1002/9783527665433	64	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	MAY	2015	128	3					361	369		10.1007/s10265-015-0700-4		9	Plant Sciences	Plant Sciences	CG5ST	WOS:000353355500003		
J	Ohtani, M; Takebayashi, A; Hiroyama, R; Xu, B; Kudo, T; Sakakibara, H; Sugiyama, M; Demura, T				Ohtani, Misato; Takebayashi, Arika; Hiroyama, Ryoko; Xu, Bo; Kudo, Toru; Sakakibara, Hitoshi; Sugiyama, Munetaka; Demura, Taku			Cell dedifferentiation and organogenesis in vitro require more snRNA than does seedling development in Arabidopsis thaliana	JOURNAL OF PLANT RESEARCH			English	Article						Cell dedifferentiation; Organogenesis in vitro; snRNA; SRD2	TEMPERATURE-SENSITIVE MUTANTS; NUCLEAR-RNA GENES; PLANT DEVELOPMENT; DNA-BINDING; TATA BOX; TRANSCRIPTION; EXPRESSION; SUBUNIT; SNAP(C); ELEMENT	Small nuclear RNA (snRNA) is a class of non-coding RNAs that processes pre-mRNA and rRNA. Transcription of abundant snRNA species is regulated by the snRNA activating protein complex (SNAPc), which is conserved among multicellular organisms including plants. SRD2, a putative subunit of SNAPc in Arabidopsis thaliana, is essential for development, and the point mutation srd2-1 causes severe defects in hypocotyl dedifferentiation and de novo meristem formation. Based on phenotypic analysis of srd2-1 mutant plants, we previously proposed that snRNA content is a limiting factor in dedifferentiation in plant cells. Here, we performed functional complementation analysis of srd2-1 using transgenic srd2-1 Arabidopsis plants harboring SRD2 homologs from Populus trichocarpa (poplar), Nicotiana tabacum (tobacco), Oryza sativa (rice), the moss Physcomitrella patens, and Homo sapiens (human) under the control of the Arabidopsis SRD2 promoter. Only rice SRD2 suppressed the faulty tissue culture responses of srd2-1, and restore the snRNA levels; however, interestingly, all SRD2 homologs except poplar SRD2 rescued the srd2-1 defects in seedling development. These findings demonstrated that cell dedifferentiation and organogenesis induced during tissue culture require higher snRNA levels than does seedling development.	[Ohtani, Misato; Xu, Bo; Demura, Taku] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Ohtani, Misato; Takebayashi, Arika; Hiroyama, Ryoko; Demura, Taku] RIKEN Ctr Sustainable Resource Sci, Biomass Engn Program Cooperat Div, Yokohama, Kanagawa 2300045, Japan; [Kudo, Toru; Sakakibara, Hitoshi] RIKEN Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Sugiyama, Munetaka] Univ Tokyo, Bot Gardens, Grad Sch Sci, Tokyo 112001, Japan	Ohtani, M (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama Cho, Nara 6300192, Japan.	misato@bs.naist.jp	Sakakibara, Hitoshi/A-6040-2010; SUGIYAMA, MUNETAKA/G-4922-2014; Kudo, Toru/A-2013-2011	Sakakibara, Hitoshi/0000-0001-5449-6492; 	RIKEN Biomass Engineering Program; RIKEN Plant Science Center; Japan Society for the Promotion of Science [18870028, 24770052, 25114520]	We thank Dr. Yoshimi Nakano (Nara Institute of Science and Technology), Ms. Ayumi Ihara, Ms. Nobue Makita, Ms. Tomoko Matsumoto, Ms. Masayo Sekimoto, Ms. Kayo Kitaura, Ms. Akiko Sato, Ms. Nao Kume, Ms. Seiko Nomura, and Ms. Sachiko Ooyama (RIKEN Center for Sustainable Resource Science) for their technical assistance. We also thank Dr. Hiroko Toyooka (University of Tokyo) and Dr. Marcelo Yanovsky (University of Buenos Aires) for the fruitful discussion. This work was supported in part by the RIKEN Biomass Engineering Program and RIKEN Plant Science Center, and by Grants-in-Aid from the Japan Society for the Promotion of Science (Grant no. 18870028, 24770052, and 25114520 to M.O.).	Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Kudo T, 2012, PLANT PHYSIOL, V160, P319, DOI 10.1104/pp.112.196733; Ohtani M, 2013, PLANT CELL, V25, P2056, DOI 10.1105/tpc.113.111922; YASUTANI I, 1994, PLANT PHYSIOL, V105, P815; NAGATA T, 1992, INT REV CYTOL, V132, P1; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Xu B, 2014, SCIENCE, V343, P1505, DOI 10.1126/science.1248417; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Brown JWS, 2003, NUCLEIC ACIDS RES, V31, P432, DOI 10.1093/nar/gkg009; Ohtani M, 2011, PLANT J, V67, P499, DOI 10.1111/j.1365-313X.2011.04614.x; Egloff S, 2008, BIOCHEM SOC T, V36, P590, DOI 10.1042/BST0360590; Henry RW, 1996, EMBO J, V15, P7129; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; Hung KH, 2009, J BIOL CHEM, V284, P22568, DOI 10.1074/jbc.M109.027961; Hung KH, 2011, CRIT REV BIOCHEM MOL, V46, P11, DOI 10.3109/10409238.2010.518136; Jawdekar GW, 2006, J BIOL CHEM, V281, P31050, DOI 10.1074/jbc.M603810200; Kim MK, 2010, MOL CELL BIOL, V30, P2411, DOI 10.1128/MCB.01508-09; Mittal V, 1999, GENE DEV, V13, P1807, DOI 10.1101/gad.13.14.1807; MURPHY S, 1992, MOL CELL BIOL, V12, P3247; Ohtani M, 2008, PLANT MOL BIOL, V66, P303, DOI 10.1007/s11103-007-9271-7; Ohtani M, 2010, PLANT CELL PHYSIOL, V51, P2002, DOI 10.1093/pcp/pcq159; Ohtani M, 2005, PLANT J, V43, P479, DOI 10.1111/j.1365-313X.2005.02469.x; Ozawa S, 1998, DEVELOPMENT, V125, P135; SADOWSKI CL, 1993, GENE DEV, V7, P1535, DOI 10.1101/gad.7.8.1535; Sierro N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4833; Sugiyama M, 2014, PLANT BIOTECHNOL REP, V8, P29, DOI 10.1007/s11816-013-0292-1; VANKAN P, 1989, EMBO J, V8, P3875; VANKAN P, 1988, EMBO J, V7, P791; Wu J, 2012, RNA BIOL, V9, P301; Yu YT, 1999, RNA WORLD, P487	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	MAY	2015	128	3					371	380		10.1007/s10265-015-0704-0		10	Plant Sciences	Plant Sciences	CG5ST	WOS:000353355500004		
J	Asahina, M; Satoh, S				Asahina, Masashi; Satoh, Shinobu			Molecular and physiological mechanisms regulating tissue reunion in incised plant tissues	JOURNAL OF PLANT RESEARCH			English	Article						Tissue reunion; Incision; Phytohormones; Flowering stem; Hypocotyl	GRAFT-UNION DEVELOPMENT; LONG-DISTANCE; GENE-EXPRESSION; XYLEM SAP; VASCULAR DIFFERENTIATION; ARABIDOPSIS-THALIANA; CELL COMMUNICATION; AUXIN TRANSPORT; CUCUMBER; INHIBITION	Interactions among the functionally specialized organs of higher plants ensure that the plant body develops and functions properly in response to changing environmental conditions. When an incision or grafting procedure interrupts the original organ or tissue connection, cell division is induced and tissue reunion occurs to restore physiological connections. Such activities have long been observed in grafting techniques, which are advantageous not only for agriculture and horticulture but also for basic research. To understand how this healing process is controlled and how this process is initiated and regulated at the molecular level, physiological and molecular analyses of tissue reunion have been performed using incised hypocotyls of cucumber (Cucumis sativus) and tomato (Solanum lycopersicum) and incised flowering stems of Arabidopsis thaliana. Our results suggest that leaf gibberellin and microelements from the roots are required for tissue reunion in the cortex of the cucumber and tomato incised hypocotyls. In addition, the wound-inducible hormones ethylene and jasmonic acid contribute to the regulation of the tissue reunion process in the upper and lower parts, respectively, of incised Arabidopsis stems. Ethylene and jasmonic acid modulate the expression of ANAC071 and RAP2.6L, respectively, and auxin signaling via ARF6/8 is essential for the expression of these transcription factors. In this report, we discuss recent findings regarding molecular and physiological mechanisms of the graft union and the tissue reunion process in wounded tissues of plants.	[Asahina, Masashi] Teikyo Univ, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan; [Satoh, Shinobu] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Asahina, M (reprint author), Teikyo Univ, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan.	asahina@nasu.bio.teikyo-u.ac.jp; satoh.shinobu.ga@u.tsukuba.ac.jp			JSPS-KAKENHI [26840098, 24114006]; MEXT [S1311014]; Faculty of Science and Engineering of Teikyo University	We thank Prof. H. Yamane, Prof. T. Yokota and Dr. K. Matsuoka (Teikyo University) for valuable suggestions and technical assistance. This work was supported in part by JSPS-KAKENHI (Grant-in-Aid for Young Scientists B; 26840098 to M.A. and a Grant-in-Aid for Scientific Research on Innovative Areas; 24114006 to S.S.), the MEXT-supported Program for the Strategic Research Foundation at Private Universities (S1311014 to M.A.) and Special grant for promoting education and research at Faculty of Science and Engineering of Teikyo University (to M.A.).	Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Sachs T, 2000, PLANT CELL PHYSIOL, V41, P649; Lolle SJ, 1997, DEV BIOL, V189, P311, DOI 10.1006/dbio.1997.8671; Ye ZH, 2002, ANNU REV PLANT BIOL, V53, P183, DOI 10.1146/annurev.arplant.53.100301.135245; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; LOLLE SJ, 1992, DEV BIOL, V152, P383, DOI 10.1016/0012-1606(92)90145-7; Satoh S, 2006, J PLANT RES, V119, P179, DOI 10.1007/s10265-005-0257-8; Sakuta C, 2000, PLANT CELL PHYSIOL, V41, P627; Mattsson J, 1999, DEVELOPMENT, V126, P2979; Yin H, 2012, J EXP BOT, V63, P4219, DOI 10.1093/jxb/ers109; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Notaguchi M, 2009, J PLANT RES, V122, P201, DOI 10.1007/s10265-008-0209-1; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Notaguchi M, 2008, PLANT CELL PHYSIOL, V49, P1645, DOI 10.1093/pcp/pcn154; Che P, 2006, PLANT PHYSIOL, V141, P620, DOI 10.1104/pp.106.081240; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; [Anonymous], 1991, DEVELOPMENT S; Kehr J, 2008, J EXP BOT, V59, P85, DOI 10.1093/jxb/erm176; Jenks MA, 1996, PLANT PHYSIOL, V110, P377; Matsumoto-Kitano M, 2008, P NATL ACAD SCI USA, V105, P20027, DOI 10.1073/pnas.0805619105; WALKER DB, 1975, AM J BOT, V62, P457, DOI 10.2307/2441952; Sena G, 2009, NATURE, V457, P1150, DOI 10.1038/nature07597; Tabata R, 2010, PLANT CELL PHYSIOL, V51, P164, DOI 10.1093/pcp/pcp176; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Iwase A, 2011, CURR BIOL, V21, P508, DOI 10.1016/j.cub.2011.02.020; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369-5266(02)00003-1; Yamaguchi M, 2008, PLANT J, V55, P652, DOI 10.1111/j.1365-313X.2008.03533.x; Turnbull CGN, 2002, PLANT J, V32, P255, DOI 10.1046/j.1365-313X.2002.01419.x; Asahina M, 2002, PLANT PHYSIOL, V129, P201, DOI 10.1104/pp.010886; Asahina M, 2011, P NATL ACAD SCI USA, V108, P16128, DOI 10.1073/pnas.1110443108; Asahina M., 2007, PLANT BIOTECHNOL, V24, P99, DOI 10.5511/plantbiotechnology.24.99; Asahina M, 2006, J PLANT RES, V119, P337, DOI 10.1007/s10265-006-0278-y; Bainbridge Katherine, 2006, V323, P39; BOSTOCK RM, 1989, ANNU REV PHYTOPATHOL, V27, P343; Davis AR, 2008, CRIT REV PLANT SCI, V27, P50, DOI 10.1080/07352680802053940; Flaishman MA, 2008, J PLANT GROWTH REGUL, V27, P231, DOI 10.1007/s00344-008-9050-y; Ikeuchi M, 2013, PLANT CELL, V2, P3159; Iwase Akira, 2013, Plant Signal Behav, V8, pe27432, DOI 10.4161/psb.27432; Jesko J, 1989, DEV PLANT SOIL SCI, V46, P1; KOLLMANN R, 1985, PROTOPLASMA, V124, P224, DOI 10.1007/BF01290774; LOLLE SJ, 1993, DEV BIOL, V155, P250, DOI 10.1006/dbio.1993.1022; Lolle SJ, 1999, TRENDS PLANT SCI, V4, P14, DOI 10.1016/S1360-1385(98)01353-3; Pitaksaringkarn W, 2014, PLANT J, V80, P604, DOI 10.1111/tpj.12654; Pitaksaringkarn W, 2014, PLANT BIOTECHNOL-NAR, V31, P49, DOI 10.5511/plantbiotechnology.13.1028b; Reid JB, 2011, P NATL ACAD SCI USA, V108, P17241, DOI 10.1073/pnas.1114432108; Richardson FVM, 1996, PLANT GROWTH REGUL, V20, P17, DOI 10.1007/BF00024052; Roberts LW, 1988, VASCULAR DIFFERENTIA, P22; Sasaki K, 2002, PLANT CELL PHYSIOL, V43, P108, DOI 10.1093/pcp/pcf013; Satoh S, 1996, PHYSIOL PLANTARUM, V97, P440, DOI 10.1034/j.1399-3054.1996.970304.x; Satoh S, 1998, J PLANT RES, V111, P541, DOI 10.1007/BF02507789; Smith LG, 2001, NAT REV MOL CELL BIO, V2, P33, DOI 10.1038/35048050; Stobbe H, 2002, ANN BOT-LONDON, V89, P773, DOI 10.1093/aob/mcf137; Tsukaya N., 1993, DEVELOPMENT, V118, P751; VANDERSCHOOT C, 1995, PLANTA, V195, P450; Wang YQ, 1996, J PLANT PHYSIOL, V147, P521; ZIMMERMAN JL, 1993, PLANT CELL, V5, P1411, DOI 10.2307/3869792	58	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	MAY	2015	128	3					381	388		10.1007/s10265-015-0705-z		8	Plant Sciences	Plant Sciences	CG5ST	WOS:000353355500005		
J	Iwase, A; Mita, K; Nonaka, S; Ikeuchi, M; Koizuka, C; Ohnuma, M; Ezura, H; Imamura, J; Sugimoto, K				Iwase, Akira; Mita, Kento; Nonaka, Satoko; Ikeuchi, Momoko; Koizuka, Chie; Ohnuma, Mariko; Ezura, Hiroshi; Imamura, Jun; Sugimoto, Keiko			WIND1-based acquisition of regeneration competency in Arabidopsis and rapeseed	JOURNAL OF PLANT RESEARCH			English	Article						Regeneration; Callus formation; Plant tissue culture; Phytohormones; AP2/ERF transcription factor	SHOOT REGENERATION; GENE-EXPRESSION; EARLY EVENTS; TISSUE-CULTURE; ROOT; PLANT; CELL; TRANSFORMATION; THALIANA; EXPLANTS	Callus formation and de novo organogenesis often occur in the wounded tissues of plants. Although this regenerative capacity of plant cells has been utilized for many years, molecular basis for the wound-induced acquisition of regeneration competency is yet to be elucidated. Here we find that wounding treatment is essential for shoot regeneration from roots in the conventional tissue culture of Arabidopsis thaliana. Furthermore, we show that an AP2/ERF transcription factor WOUND INDUCED DEDIFFERENTIATION1 (WIND1) plays a pivotal role for the acquisition of regeneration competency in the culture system. Ectopic expression of WIND1 can bypass both wounding and auxin pre-treatment and increase de novo shoot regeneration from root explants cultured on shoot-regeneration promoting media. In Brassica napus, activation of Arabidopsis WIND1 also greatly enhances de novo shoot regeneration, further corroborating the role of WIND1 in conferring cellular regenerative capacity. Our data also show that sequential activation of WIND1 and an embryonic regulator LEAFY COTYLEDON2 enhances generation of embryonic callus, suggesting that combining WIND1 with other transcription factors promote efficient and organ-specific regeneration. Our findings in the model plant and crop plant point to a possible way to efficiently induce callus formation and regeneration by utilizing transcription factors as a molecular switch.	[Iwase, Akira; Ikeuchi, Momoko; Ohnuma, Mariko; Sugimoto, Keiko] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Mita, Kento; Koizuka, Chie; Imamura, Jun] Tamagawa Univ, Grad Sch Agr, Machida, Tokyo 1948610, Japan; [Nonaka, Satoko; Ezura, Hiroshi] Univ Tsukuba, Ctr Gene Res, Tsukuba, Ibaraki 3058572, Japan	Iwase, A (reprint author), RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan.	akira.iwase@riken.jp; keiko.sugimoto@riken.jp		Ikeuchi, Momoko/0000-0001-9474-5131	Research and development projects for application in promoting new policy of agriculture, forestry and fisheries - RIKEN Special Postdoctoral Researchers Program; Japan Society for the Promotion of Science [24770053]; RIKEN Plant Transformation Network;  [22119010]	We thank Mariko Mouri, Chika Ikeda, and Yasuko Yatomi for their technical supports. We are also grateful to David Favero for his linguistic advice. This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (Grant No. 22119010) and the Research and development projects for application in promoting new policy of agriculture, forestry and fisheries to Sugimoto K. Iwase A was funded by the RIKEN Special Postdoctoral Researchers Program and a grant from Japan Society for the Promotion of Science (Grant No. 24770053). The tomato resources used in this research were provided by the National BioResource Project (NBRP), Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The production of transgenic rapeseed and tomato plants was supported by the RIKEN Plant Transformation Network.	Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Ledwon A, 2009, PLANT CELL REP, V28, P1677, DOI 10.1007/s00299-009-0767-2; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Che P, 2002, PLANT CELL, V14, P2771, DOI 10.1105/tpc.006668; Motte H, 2014, P NATL ACAD SCI USA, V111, P8305, DOI 10.1073/pnas.1404978111; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Banno H, 2001, PLANT CELL, V13, P2609, DOI 10.1105/tpc.13.12.2609; Sun HJ, 2006, PLANT CELL PHYSIOL, V47, P426, DOI 10.1093/pcp/pci251; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Zhou C, 2012, PLANT CELL TISS ORG, V110, P423, DOI 10.1007/s11240-012-0163-4; Duclercq J, 2011, TRENDS PLANT SCI, V16, P597, DOI 10.1016/j.tplants.2011.08.004; MADEN M, 1976, J EMBRYOL EXP MORPH, V36, P561; Gallois JL, 2004, GENE DEV, V18, P375, DOI 10.1101/gad.291204; Che P, 2006, PLANT PHYSIOL, V141, P620, DOI 10.1104/pp.106.081240; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Ohbayashi I, 2011, PLANT J, V67, P49, DOI 10.1111/j.1365-313X.2011.04574.x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Atta R, 2009, PLANT J, V57, P626, DOI 10.1111/j.1365-313X.2008.03715.x; Iwase A, 2011, CURR BIOL, V21, P508, DOI 10.1016/j.cub.2011.02.020; SANGWAN RS, 1992, PLANTA, V188, P439, DOI 10.1007/BF00192812; Asahina M, 2011, P NATL ACAD SCI USA, V108, P16128, DOI 10.1073/pnas.1110443108; BOSTOCK RM, 1989, ANNU REV PHYTOPATHOL, V27, P343; Chupeau MC, 2013, PLANT CELL, V25, P2444, DOI 10.1105/tpc.113.109538; GUZZO F, 1995, PROTOPLASMA, V185, P28, DOI 10.1007/BF01272751; Ishikawa M, 2011, PLANT CELL, V23, P2924, DOI 10.1105/tpc.111.088005; Iwase Akira, 2011, Plant Signal Behav, V6, P1943, DOI 10.4161/psb.6.12.18266; Iwase Akira, 2013, Plant Signal Behav, V8, pe27432, DOI 10.4161/psb.27432; Iwase A, 2005, BIOTECHNOL LETT, V27, P1097, DOI 10.1007/s10529-005-8456-x; KOHNOMURASE J, 1994, PLANT MOL BIOL, V26, P1115, DOI 10.1007/BF00040693; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Ohtani M, 2005, PLANT J, V43, P479, DOI 10.1111/j.1365-313X.2005.02469.x; Ozawa S, 1998, DEVELOPMENT, V125, P135; Perianez-Rodriguez J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00219; Stobbe H, 2002, ANN BOT-LONDON, V89, P773, DOI 10.1093/aob/mcf137; Tamaki H, 2009, PLANT J, V57, P1027, DOI 10.1111/j.1365-313X.2008.03750.x; Thorpe Trevor, 2012, Methods Mol Biol, V877, P9, DOI 10.1007/978-1-61779-818-4_2; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Vogel G, 2005, SCIENCE, V309, P86, DOI 10.1126/science.309.5731.86; Yadav SR, 2010, CURR BIOL, V20, pR843, DOI 10.1016/j.cub.2010.09.010	41	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	MAY	2015	128	3					389	397		10.1007/s10265-015-0714-y		9	Plant Sciences	Plant Sciences	CG5ST	WOS:000353355500006		
J	Ishikawa, M; Hasebe, M				Ishikawa, Masaki; Hasebe, Mitsuyasu			Cell cycle reentry from the late S phase: implications from stem cell formation in the moss Physcomitrella patens	JOURNAL OF PLANT RESEARCH			English	Article						Cell cycle; DNA synthesis; Physcomitrella; Wounding	RETINOBLASTOMA-RELATED PROTEIN; DEPENDENT KINASE COMPLEX; PRIMORDIAL GERM-CELLS; RIBOSOMAL-RNA GENES; DNA-SYNTHESIS; VICIA-FABA; PLANTS; TRANSCRIPTION; REPLICATION; ARABIDOPSIS	Differentiated cells are in a non-dividing, quiescent state, but some differentiated cells can reenter the cell cycle in response to appropriate stimuli. Quiescent cells are generally arrested at the G0/G1 phase, reenter the cell cycle, and progress to the S phase to replicate their genomic DNA. On the other hand, some types of cells are arrested at the different phase and reenter the cell cycle from there. In the moss Physcomitrella patens, the differentiated leaf cells of gametophores formed in the haploid generation contain approximately 2C DNA content, and DNA synthesis is necessary for reentry into the cell cycle, which is suggested to be arrested at late S phase. Here we review various cell-division reactivation processes in which cells reenter the cell cycle from the late S phase, and discuss possible mechanisms of such unusual cell cycle reentries with special emphasis on Physcomitrella.	[Ishikawa, Masaki; Hasebe, Mitsuyasu] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Ishikawa, Masaki; Hasebe, Mitsuyasu] SOKENDAI Grad Univ Adv Studies, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi 4448585, Japan	Ishikawa, M (reprint author), Natl Inst Nat Sci, Natl Inst Basic Biol, 38 Nishigonaka,Myodaiji Cho, Okazaki, Aichi 4448585, Japan.	ishikam@nibb.ac.jp			Japan Science and Technology Agency ERATO Program; Ministry of Education, Culture, Sports, Science and Technology [25291067]	We thank Drs. Y. Tamada and I. Imai for critical reading of the manuscript, and Liechi Zhang for providing photographs of an excised leaf. This work was partially supported by the Japan Science and Technology Agency ERATO Program and the Ministry of Education, Culture, Sports, Science and Technology (No. 25291067 to M. H. and M. I.).	Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Molyneaux K, 2004, INT J DEV BIOL, V48, P537, DOI 10.1387/ijdb.041833km; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Nakagami H, 2002, PLANT CELL, V14, P1847, DOI 10.1105/tpc.002550; De Veylder L, 2007, NAT REV MOL CELL BIO, V8, P655, DOI 10.1038/nrm2227; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Chen-Kiang S, 2003, IMMUNOL REV, V194, P39, DOI 10.1034/j.1600-065X.2003.00065.x; Cross FR, 2011, PHILOS T R SOC B, V366, P3532, DOI 10.1098/rstb.2011.0078; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Gutierrez C, 2002, CURR OPIN PLANT BIOL, V5, P480, DOI 10.1016/S1369-5266(02)00301-1; Berger C, 2005, NAT CELL BIOL, V7, P56, DOI 10.1038/ncb1203; Shulaev V, 2006, PLANT PHYSIOL, V141, P367, DOI 10.1104/pp.106.077925; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tsubouchi T, 2013, CELL, V152, P873, DOI 10.1016/j.cell.2013.01.012; Planchais S, 2000, FEBS LETT, V476, P78, DOI 10.1016/S0014-5793(00)01675-6; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; ROGERS SO, 1987, PLANT MOL BIOL, V9, P509, DOI 10.1007/BF00015882; ROGERS SO, 1987, GENETICS, V117, P285; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Beeckman T, 2001, J EXP BOT, V52, P403; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; COVE DJ, 1993, PLANT CELL, V5, P1483; ALT FW, 1978, J BIOL CHEM, V253, P1357; Takebayashi S, 2005, EXP CELL RES, V304, P162, DOI 10.1016/j.yexcr.2004.10.024; Singh AM, 2013, STEM CELL REP, V1, P532, DOI 10.1016/j.stemcr.2013.10.009; Menand B, 2007, J EXP BOT, V58, P1843, DOI 10.1093/jxb/erm047; Kaufmann K, 2010, NAT REV GENET, V11, P830, DOI 10.1038/nrg2885; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Menges M, 2005, PLANT J, V41, P546, DOI 10.1111/j.1365-313X.2004.02319.x; Cao LH, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-55; Nakagami H, 1999, PLANT J, V18, P243, DOI 10.1046/j.1365-313X.1999.00449.x; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Petruk S, 2012, CELL, V150, P922, DOI 10.1016/j.cell.2012.06.046; BLAKELY LM, 1979, PLANT SCI LETT, V14, P79, DOI 10.1016/0304-4211(79)90158-5; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; CIONINI PG, 1985, PROTOPLASMA, V124, P213, DOI 10.1007/BF01290772; Cove D, 2006, ANNU REV PLANT BIOL, V57, P497, DOI 10.1146/annurev.arplant.57.032905.105338; Cove DJ, 1992, DEV MOL GENETIC APPR, P179; den Boer BGW, 2000, TRENDS CELL BIOL, V10, P245, DOI 10.1016/S0962-8924(00)01765-7; Gaamouche T, 2010, PLANT J, V64, P26, DOI 10.1111/j.1365-313X.2010.04317.x; Hyldig SMW, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-11; Ishikawa M, 2011, PLANT CELL, V23, P2924, DOI 10.1105/tpc.111.088005; KLEIN G, 1986, CANCER RES, V46, P3211; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kofuji R, 2014, CURR OPIN PLANT BIOL, V17, P13, DOI 10.1016/j.pbi.2013.10.007; Kotogany E, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-5; Lee TJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000982; Matsui Atsuka, 2013, Biomol Concepts, V4, P567, DOI 10.1515/bmc-2013-0026; NATALI L, 1986, CELL DIFFER DEV, V18, P157, DOI 10.1016/0045-6039(86)90081-3; Pajalunga D, 2008, CELL MOL LIFE SCI, V65, P8, DOI 10.1007/s00018-007-7425-z; Polyn S, 2014, CURR OPIN PLANT BIOL, V23, P1; Schween G, 2003, PLANT BIOLOGY, V5, P50, DOI 10.1055/s-2003-37984; Sugiyama M, 1995, J PLANT RES, V85, P351; Surani M A, 2010, Cold Spring Harb Symp Quant Biol, V75, P211, DOI 10.1101/sqb.2010.75.010; Sustar A, 2005, CELL, V120, P383, DOI 10.1016/j.cell.2004.12.008; White EJ, 2004, P NATL ACAD SCI USA, V101, P17771, DOI 10.1073/pnas.0408170101; Zavitz KH, 1997, CURR OPIN CELL BIOL, V9, P773, DOI 10.1016/S0955-0674(97)80077-4; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0	65	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	MAY	2015	128	3					399	405		10.1007/s10265-015-0713-z		7	Plant Sciences	Plant Sciences	CG5ST	WOS:000353355500007		
J	Nishihama, R; Ishizaki, K; Hosaka, M; Matsuda, Y; Kubota, A; Kohchi, T				Nishihama, Ryuichi; Ishizaki, Kimitsune; Hosaka, Masashi; Matsuda, Yoriko; Kubota, Akane; Kohchi, Takayuki			Phytochrome-mediated regulation of cell division and growth during regeneration and sporeling development in the liverwort Marchantia polymorpha	JOURNAL OF PLANT RESEARCH			English	Article						Cell division cycle; Cell shape; Dedifferentiation; Phytochrome; Regeneration; Sugar signaling	MOSS CERATODON-PURPUREUS; PHYSCOMITRELLA-PATENS; GENE-EXPRESSION; LIGHT; CYCLE; ARABIDOPSIS; PROTONEMATA; PLANTS; TRANSFORMATION; PHOTOTROPISM	Light regulates various aspects of development throughout the life cycle of sessile land plants. Photoreceptors, such as the red (R) and far-red (FR) light receptors phytochromes, play pivotal roles in modulating developmental programs. Reflecting high developmental plasticity, plants can regenerate tissues, organs, and whole bodies from varieties of cells. Among land plants, bryophytes exhibit extraordinary competency of regeneration under hormone-free conditions. As an environmental factor, light plays critical roles in regeneration of bryophytes. However, how light regulates regeneration remains unknown. Here we show that using the liverwort Marchantia polymorpha, which contains a single phytochrome gene, the phytochrome regulates re-entry into the cell cycle and cell shape in newly regenerating tissues. Our morphological and cytological observations revealed that S-phase entry of G(1)-arrested epidermal cells around the midrib on the ventral surface of thallus explants was greatly retarded in the dark or under phytochrome-inactive R/FR cycle irradiation conditions, where, nevertheless, small, laterally narrow regenerants were eventually formed. Thus, consistent with earlier descriptions published over a century ago, light is not essential for, but exerts profound effects on regeneration in M. polymorpha. Ventral cells in regenerants grown under R/FR cycle conditions were longer and narrower than those under R cycle. Expression of a constitutively active mutant of M. polymorpha phytochrome allowed regeneration of well grown, widely expanded thalli even in the dark when sugar was supplied, further demonstrating that the phytochrome signal promotes cell proliferation, which is rate-limited by sucrose availability. Similar effects of R and FR irradiation on cell division and elongation were observed in sporelings as well. Thus, besides activation of photosynthesis, major roles of R in regeneration of M. polymorpha are to facilitate proliferation of rounder cells through the phytochrome by mechanisms that are likely to operate in the sporeling.	[Nishihama, Ryuichi; Ishizaki, Kimitsune; Hosaka, Masashi; Matsuda, Yoriko; Kubota, Akane; Kohchi, Takayuki] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan	Nishihama, R (reprint author), Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan.	nishihama@lif.kyoto-u.ac.jp		Ishizaki, Kimitsune/0000-0003-0504-8196	Japan Society for the Promotion of Science [23120516, 25113009, 22770035, 24570048]	We thank John Bowman for information on classical literature and helpful discussion, Tom Dierschke for translating German literature, Sachihiro Matsunaga for the EdU technique, and Keisuke Inoue for experimental supports and discussion. This work was supported by KAKENHI Grant-in-Aids for Scientific Research on Innovative Area (Nos. 23120516 and 25113009 to T.K.), for Young Scientists (B) (No. 22770035 to K.I.), and for Scientific Research (C) (No. 24570048 to R.N.) from the Japan Society for the Promotion of Science.	Althoff F, 2014, TRANSGENIC RES, V23, P235, DOI 10.1007/s11248-013-9746-z; Kubota A, 2013, BIOSCI BIOTECH BIOCH, V77, P167, DOI 10.1271/bbb.120700; HARTMANN E, 1983, PHOTOCHEM PHOTOBIOL, V38, P599, DOI 10.1111/j.1751-1097.1983.tb03388.x; Ito S, 2012, MOL PLANT, V5, P573, DOI 10.1093/mp/sss013; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; Neff MM, 2000, GENE DEV, V14, P257; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Komatsu A, 2014, PLANT PHYSIOL, V166, P411, DOI 10.1104/pp.114.245100; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Prigge MJ, 2010, DEVELOPMENT, V137, P3535, DOI 10.1242/dev.049023; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Lopez-Juez E, 2008, PLANT CELL, V20, P947, DOI 10.1105/tpc.107.057075; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Casal JJ, 2013, ANNU REV PLANT BIOL, V64, P403, DOI 10.1146/annurev-arplant-050312-120221; Xiong Y, 2013, NATURE, V496, P181, DOI 10.1038/nature12030; Riou-Khamlichi C, 2000, MOL CELL BIOL, V20, P4513, DOI 10.1128/MCB.20.13.4513-4521.2000; BAUER L, 1959, PLANTA, V54, P68, DOI 10.1007/BF01916149; Brucker G, 2005, PLANTA, V220, P864, DOI 10.1007/s00425-004-1411-6; Cavers F, 1903, NEW PHYTOL, V2, P121, DOI 10.1111/j.1469-8137.1903.tb04960.x; COVE DJ, 1978, PHOTOCHEM PHOTOBIOL, V27, P249, DOI 10.1111/j.1751-1097.1978.tb07596.x; Dickson H, 1932, ANN BOT-LONDON, V46, P683; Fraikin GY, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1238, DOI 10.1134/S0006297913110047; Furuya M, 1997, PLANT PHYSIOL, V113, P677; Galbraith DW, 2009, CYTOM PART A, V75A, P692, DOI 10.1002/cyto.a.20760; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; GILES K L, 1971, New Zealand Journal of Botany, V9, P689; GILES K. L., 1967, BRYOLO GIST, V70, P312; Goebel K, 1898, FLORA, V85, P69; Goebel K, 1907, FLORA, V97, P192; Hansel V, 1876, SITZUNGSBER KAIS AKA, V73, P89; Heald FdF, 1898, BOT GAZ, V26, P169; Heald FdF, 1898, BOT GAZ, V26, P25; Hu W, 2009, MOL PLANT, V2, P166, DOI 10.1093/mp/ssn086; Ishikawa M, 2011, PLANT CELL, V23, P2924, DOI 10.1105/tpc.111.088005; JENKINS GI, 1983, PLANTA, V157, P39, DOI 10.1007/BF00394538; KADOTA A, 1982, PHOTOCHEM PHOTOBIOL, V35, P533, DOI 10.1111/j.1751-1097.1982.tb02605.x; KAUL KM, 1962, ANN BOT-LONDON, V26, P447; Kreh W, 1909, REGENERATION LEBERMO; Kubota A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4668; Liu HY, 2011, NUCL ENG INT, V56, P16; Mittmann F, 2004, P NATL ACAD SCI USA, V101, P13939, DOI 10.1073/pnas.0403140101; Nakazato T, 1999, PLANT CELL PHYSIOL, V40, P1014; Nishihama R, 2013, CURR OPIN PLANT BIOL, V16, P630, DOI 10.1016/j.pbi.2013.07.006; NJd Necker, 1774, PHYSL MUSEORUM; Okada S, 2000, PLANT J, V24, P421, DOI 10.1046/j.1365-313x.2000.00882.x; Rickett HW, 1920, B TORREY BOT CLUB, V47, P347, DOI 10.2307/2480258; Schostakowitsch W, 1894, FLORA, V79, P350; SONI R, 1995, PLANT CELL, V7, P85, DOI 10.1105/tpc.7.1.85; VALANNE N, 1966, Annales Botanici Fennici, V3, P1; Vochting H, 1885, JB WISS BOT, V16, P367; WADA M, 1989, ANNU REV PLANT PHYS, V40, P169; WADA M, 1985, P ROY SOC EDINB B, V86, P231; WADA M, 1984, PLANT CELL PHYSIOL, V25, P1053	57	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	MAY	2015	128	3					407	421		10.1007/s10265-015-0724-9		15	Plant Sciences	Plant Sciences	CG5ST	WOS:000353355500008		
J	Ito, M; Machida, Y				Ito, Masaki; Machida, Yasunori			Reprogramming of plant cells induced by 6b oncoproteins from the plant pathogen Agrobacterium	JOURNAL OF PLANT RESEARCH			English	Article						Agrobacterium; Crown gall tumor; Epigenetic regulation; Histone chaperone; Histone variants; Oncoprotein 6b; Reprogramming	CROWN-GALL TUMORIGENESIS; TUMEFACIENS AK-6B GENE; RHIZOGENES T-DNA; HISTONE VARIANTS; TRANSGENIC TOBACCO; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; CHROMATIN; ONCOGENE; ROOT	Reprogramming of plant cells is an event characterized by dedifferentiation, reacquisition of totipotency, and enhanced cell proliferation, and is typically observed during formation of the callus, which is dependent on plant hormones. The callus-like cell mass, called a crown gall tumor, is induced at the sites of infection by Agrobacterium species through the expression of hormone-synthesizing genes encoded in the T-DNA region, which probably involves a similar reprogramming process. One of the T-DNA genes, 6b, can also by itself induce reprogramming of differentiated cells to generate tumors and is therefore recognized as an oncogene acting in plant cells. The 6b genes belong to a group of Agrobacterium T-DNA genes, which include rolB, rolC, and orf13. These genes encode proteins with weakly conserved sequences and may be derived from a common evolutionary origin. Most of these members can modify plant growth and morphogenesis in various ways, in most cases without affecting the levels of plant hormones. Recent studies have suggested that the molecular function of 6b might be to modify the patterns of transcription in the host nuclei, particularly by directly targeting the host transcription factors or by changing the epigenetic status of the host chromatin through intrinsic histone chaperone activity. In light of the recent findings on zygotic resetting of nucleosomal histone variants in Arabidopsis thaliana, one attractive idea is that acquisition of totipotency might be facilitated by global changes of epigenetic status, which might be induced by replacement of histone variants in the zygote after fertilization and in differentiated cells upon stimulation by plant hormones as well as by expression of the 6b gene.	[Ito, Masaki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Machida, Yasunori] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Ito, M (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	masakito@agr.nagoya-u.ac.jp; yas@bio.nagoya-u.ac.jp					Amin AD, 2012, BBA-GENE REGUL MECH, V1819, P264, DOI 10.1016/j.bbagrm.2011.07.008; Nashun B, 2010, DEVELOPMENT, V137, P3785, DOI 10.1242/dev.051805; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Shan XY, 2012, CURR OPIN PLANT BIOL, V15, P84, DOI 10.1016/j.pbi.2011.09.006; Ingouff M, 2010, CURR BIOL, V20, P2137, DOI 10.1016/j.cub.2010.11.012; Mallory AC, 2008, TRENDS PLANT SCI, V13, P359, DOI 10.1016/j.tplants.2008.03.007; Geraldo N, 2009, PLANT PHYSIOL, V150, P1611, DOI 10.1104/pp.109.137448; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; MORRIS RO, 1986, ANNU REV PLANT PHYS, V37, P509, DOI 10.1146/annurev.pp.37.060186.002453; SITBON F, 1992, PLANT PHYSIOL, V99, P1062, DOI 10.1104/pp.99.3.1062; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Sagi M, 2004, PLANT CELL, V16, P616, DOI 10.1105/tpc.019398; CARDARELLI M, 1987, MOL GEN GENET, V209, P475, DOI 10.1007/BF00331152; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Coleman-Derr D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002988; Tamaoki M, 1997, PLANT CELL PHYSIOL, V38, P917; Duroux M, 2004, PLANT J, V40, P660, DOI 10.1111/j.1365-313X.2004.02242.x; Kitakura S, 2002, PLANT CELL, V14, P451, DOI 10.1105/tpc.010360; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; CHILTON MD, 1977, CELL, V11, P263, DOI 10.1016/0092-8674(77)90043-5; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Zhu Y, 2011, PLANT J, V66, P443, DOI 10.1111/j.1365-313X.2011.04504.x; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Yelagandula R, 2014, CELL, V158, P98, DOI 10.1016/j.cell.2014.06.006; ESTRUCH JJ, 1991, EMBO J, V10, P3125; Kaplan-Levy RN, 2012, TRENDS PLANT SCI, V17, P163, DOI 10.1016/j.tplants.2011.12.002; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; Zhu J, 2000, J BACTERIOL, V182, P3885, DOI 10.1128/JB.182.14.3885-3895.2000; Shinagawa T, 2014, CELL STEM CELL, V14, P217, DOI 10.1016/j.stem.2013.12.015; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; Wang MM, 2011, GENE DEV, V25, P64, DOI 10.1101/gad.1985511; Zhu Y, 2006, PLANT CELL, V18, P2879, DOI 10.1105/tpc.106.046490; Skene PJ, 2013, DEVELOPMENT, V140, P2513, DOI 10.1242/dev.091439; Canonne J, 2011, PLANT CELL, V23, P3498, DOI 10.1105/tpc.111.088815; Kitakura S, 2008, J PLANT RES, V121, P425, DOI 10.1007/s10265-008-0160-1; Shkryl YN, 2010, PLANTA, V232, P1023, DOI 10.1007/s00425-010-1237-3; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; Balaji S, 2009, MOL BIOSYST, V5, P269, DOI 10.1039/b816424j; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Kakiuchi Y, 2006, PLANTA, V223, P237, DOI 10.1007/s00425-005-0080-4; Terakura S, 2007, PLANT CELL, V19, P2855, DOI 10.1105/tpc.106.049551; Avvakumov N, 2011, MOL CELL, V41, P502, DOI 10.1016/j.molcel.2011.02.013; Zhu Y, 2012, BBA-GENE REGUL MECH, V1819, P343, DOI 10.1016/j.bbagrm.2011.07.012; Nilsson O, 1997, PHYSIOL PLANTARUM, V100, P463, DOI 10.1034/j.1399-3054.1997.1000307.x; Aoki S, 2004, J PLANT RES, V117, P329, DOI 10.1007/s10265-004-0163-5; Bulgakov VP, 2012, PLANT PHYSIOL, V158, P1371, DOI 10.1104/pp.111.191494; CANADAY J, 1992, MOL GEN GENET, V235, P292, DOI 10.1007/BF00279373; Cecchetti V, 2007, PLANT J, V49, P27, DOI 10.1111/j.1365-313X.2006.02934.x; Clement B, 2006, PLANT J, V45, P1017, DOI 10.1111/j.1365-313X.2006.02663.x; ESTRUCH JJ, 1991, EMBO J, V10, P2889; Filippini F, 1996, NATURE, V379, P499, DOI 10.1038/379499a0; Frundt C, 1998, MOL GEN GENET, V259, P559; Galis I, 2004, PHYTOCHEMISTRY, V65, P169, DOI 10.1016/j.phytochem.2003.10.015; Gao MJ, 2009, PLANT CELL, V21, P54, DOI 10.1105/tpc.108.061309; Gremillon L, 2004, PLANT J, V37, P218, DOI 10.1046/j.1365-313X.2003.01956.x; Gutierrez C, 2000, EMBO J, V19, P729; Gutzat R, 2012, TRENDS PLANT SCI, V17, P139, DOI 10.1016/j.tplants.2011.12.001; Helfer A, 2003, PLANT MOL BIOL, V52, P483, DOI 10.1023/A:1023962121894; Helfer A, 2002, MOL GENET GENOMICS, V267, P577, DOI 10.1007/s00438-002-0707-0; HOOYKAAS PJJ, 1988, PLANT MOL BIOL, V11, P791, DOI 10.1007/BF00019519; HUFFMAN GA, 1984, J BACTERIOL, V157, P269; Jullien J, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-17; Kakiuchi Y, 2007, J PLANT RES, V120, P259, DOI 10.1007/s10265-006-0049-9; LEVESQUE H, 1988, PLANT MOL BIOL, V11, P731, DOI 10.1007/BF00019514; Liu ZQ, 2009, PLANT J, V59, P27, DOI 10.1111/j.1365-313X.2009.03844.x; March-Diaz R, 2009, MOL PLANT, V2, P565, DOI 10.1093/mp/ssp019; Metraux JP, 2009, ADV BOT RES, V51, P39, DOI 10.1016/S0065-2296(09)51002-6; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Mohajjel-Shoja H, 2011, MOL PLANT MICROBE IN, V24, P44, DOI 10.1094/MPMI-06-10-0139; Moriuchi H, 2004, PLANT J, V38, P260, DOI 10.1111/j.1365-313X.2004.02041.x; Nashun B, 2011, EPIGENETICS-US, V6, P1489, DOI 10.4161/epi.6.12.18206; Nie X, 2014, BIOL OPEN, V3, P794, DOI 10.1242/bio.20148680; Otero S, 2014, CYTOGENET GENOME RES, V143, P114, DOI 10.1159/000365264; OTTEN L, 1994, MOL GEN GENET, V245, P493, DOI 10.1007/BF00302262; Perianez-Rodriguez J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00219; Ramirez-Parra E, 2007, TRENDS PLANT SCI, V12, P570, DOI 10.1016/j.tplants.2007.10.002; SPANIER K, 1989, MOL GEN GENET, V219, P209; SPENA A, 1987, EMBO J, V6, P3891; Stieger PA, 2004, PLANT PHYSIOL, V135, P1798, DOI 10.1104/pp.104.040899; Terakura S, 2006, PLANT CELL PHYSIOL, V47, P664, DOI 10.1093/pcp/pcj036; TINLAND B, 1990, MOL GEN GENET, V223, P1, DOI 10.1007/BF00315790; TINLAND B, 1989, MOL GEN GENET, V219, P217; Wabiko H, 1996, PLANT PHYSIOL, V112, P939, DOI 10.1104/pp.112.3.939; WHITE FF, 1983, NATURE, V301, P348, DOI 10.1038/301348a0; Wollmann H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002658	87	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	MAY	2015	128	3					423	435		10.1007/s10265-014-0694-3		13	Plant Sciences	Plant Sciences	CG5ST	WOS:000353355500009		
J	Ikeda, H; Yoneta, Y; Higashi, H; Eidesen, PB; Barkalov, V; Yakubov, V; Brochmann, C; Setoguchi, H				Ikeda, Hajime; Yoneta, Yusuke; Higashi, Hiroyuki; Eidesen, Pernille Bronken; Barkalov, Viachenslav; Yakubov, Valentin; Brochmann, Christian; Setoguchi, Hiroaki			Persistent history of the bird-dispersed arctic-alpine plant Vaccinium vitis-idaea L. (Ericaceae) in Japan	JOURNAL OF PLANT RESEARCH			English	Article						Biogeography; Disjunct distribution; Long-distance dispersal; Pleistocene; Range margin	GENETIC-STRUCTURE; HIGH MOUNTAINS; NORTH-AMERICA; HAPLOTYPE RECONSTRUCTION; POPULATION-STRUCTURE; STATISTICAL-METHOD; DNA POLYMORPHISM; GENOTYPE DATA; ICE AGES; PHYLOGEOGRAPHY	Arctic-alpine plants have expanded and contracted their ranges in response to the Pleistocene climate oscillations. Today, many arctic-alpine plants have vast distributions in the circumarctic region as well as marginal, isolated occurrences in high mountains at lower latitudes. These marginal populations may represent relict, long-standing populations that have persisted for several cycles of cold and warm climate during the Pleistocene, or recent occurrences that either result from southward step-wise migration during the last glacial period or from recent long-distance dispersal. In light of these hypotheses, we investigated the biogeographic history of the marginal Japanese populations of the widespread arctic-alpine plant Vaccinium vitis-idaea (Ericaceae), which is bird-dispersed, potentially over long distances. We sequenced three nuclear loci and one plastid DNA region in 130 individuals from 65 localities covering its entire geographic range, with a focus on its marginal populations in Japan. We found a homogenous genetic pattern across its enormous range based on the loci analysed, in contrast to the geographically structured variation found in a previous study of amplified fragment length polymorphisms in this species. However, we found several unique haplotypes in the Japanese populations, excluding the possibility that these marginal populations result from recent southward migration. Thus, even though V. vitis-idaea is efficiently dispersed via berries, our study suggests that its isolated populations in Japan have persisted during several cycles of cold and warm climate during the Pleistocene.	[Ikeda, Hajime] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki 3050005, Japan; [Yoneta, Yusuke] Kyoto Univ, Fac Integrated Human Studies, Sakyo Ku, Kyoto 6068501, Japan; [Higashi, Hiroyuki; Setoguchi, Hiroaki] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Eidesen, Pernille Bronken] Univ Ctr Svalbard, N-9171 Longyearbyen, Norway; [Barkalov, Viachenslav; Yakubov, Valentin] Russian Acad Sci, Inst Biol & Soil Sci, Far East Branch, Vladivostok 690022, Russia; [Brochmann, Christian] Univ Oslo, Nat Hist Museum, N-0318 Oslo, Norway	Ikeda, H (reprint author), Okayama Univ, Inst Plant Sci & Resources, 2-20-1 Chuo, Kurashiki, Okayama 7100046, Japan.	ike@okayama-u.ac.jp	Brochmann, Christian/A-4105-2009; Barkalov, Vyacheslav/P-3751-2015		KAKENHI; Research Council of Norway [150322/720, 170952/V40]	This study was supported by a Grant-in-Aid for Scientific Research (KAKENHI; HS) and by the Research Council of Norway (Grant Nos. 150322/720 and 170952/V40 to C.B.).	AHOKAS H, 1971, Annales Botanici Fennici, V8, P254; Edwards ME, 2000, J BIOGEOGR, V27, P521, DOI 10.1046/j.1365-2699.2000.00426.x; Skrede I, 2006, MOL ECOL, V15, P1827, DOI 10.1111/j.1365-294X.2006.02908.x; Hey J, 2003, NAT REV GENET, V4, P535, DOI 10.1038/nrg1112; Eidesen PB, 2013, NEW PHYTOL, V200, P898, DOI 10.1111/nph.12412; Westergaard KB, 2011, MOL ECOL, V20, P376, DOI 10.1111/j.1365-294X.2010.04928.x; Popp M, 2011, P NATL ACAD SCI USA, V108, P6520, DOI 10.1073/pnas.1012249108; Alsos IG, 2007, SCIENCE, V316, P1606, DOI 10.1126/science.1139178; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Pritchard JK, 2000, GENETICS, V155, P945; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Garcia PE, 2012, MOL ECOL, V21, P1255, DOI 10.1111/j.1365-294X.2012.05456.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Albach DC, 2006, MOL ECOL, V15, P3269, DOI 10.1111/j.1365-294X.2006.02980.x; Aizawa M, 2007, MOL ECOL, V16, P3393, DOI 10.1111/j.1365-294X.2007.03391.x; Winkler M, 2012, MOL ECOL, V21, P4618, DOI 10.1111/j.1365-294X.2012.05705.x; TAJIMA F, 1989, GENETICS, V123, P585; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Abbott RJ, 2003, MOL ECOL, V12, P299, DOI 10.1046/j.1365-294X.2003.01731.x; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Alsos IG, 2005, MOL ECOL, V14, P2739, DOI 10.1111/j.1365-294X.2005.02621.x; Allen GA, 2012, ECOL EVOL, V2, P649, DOI 10.1002/ece3.213; Ronikier M, 2012, MOL ECOL, V21, P5561, DOI 10.1111/mec.12030; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Abbott RJ, 2000, SCIENCE, V289, P1343, DOI 10.1126/science.289.5483.1343; Ikeda H, 2012, NEW PHYTOL, V194, P583, DOI 10.1111/j.1469-8137.2012.04061.x; DeChaine EG, 2008, PLANT ECOL DIVERS, V1, P197, DOI 10.1080/17550870802328660; Eidesen PB, 2007, MOL ECOL, V16, P3902, DOI 10.1111/j.1365-294X.2007.03425.x; Frenzel B., 1992, ATLAS PALEOCLIMATES; FRENZEL B, 1968, SCIENCE, V161, P637, DOI 10.1126/science.161.3842.637; Fujii N, 2006, TAXON, V55, P43; Hirao Akira S., 2011, APG Acta Phytotaxonomica et Geobotanica, V61, P155; Hulten E, 1937, OUTLINE HIST ARCTIC; Ikeda H, 2008, MOL ECOL, V17, P3178, DOI 10.1111/j.1365-294X.2008.03821.x; Ikeda H, 2009, BIOL J LINN SOC, V97, P403, DOI 10.1111/j.1095-8312.2009.01177.x; Ikeda H, 2013, BIOL J LINN SOC, V110, P214, DOI 10.1111/bij.12116; Ikeda H, 2014, BIOL J LINN SOC, V113, P497, DOI 10.1111/bij.12342; Ikeda H, 2007, J BIOGEOGR, V34, P169, DOI 10.1111/j.1365-2699.2006.01577.x; Ikeda H, 2010, MOL ECOL, V19, P2779, DOI 10.1111/j.1365-294X.2010.04700.x; Ikeda H, 2014, NEW PHYTOL, V203, P980, DOI 10.1111/nph.12863; Ikeda H, 2008, PLANT SYST EVOL, V272, P197, DOI 10.1007/s00606-007-0637-8; Ikeda H, 2006, MOL ECOL, V15, P3731, DOI 10.1111/j.1365-294X.2006.03054.x; Kikuchi R, 2013, BIOL J LINN SOC, V108, P278, DOI 10.1111/j.1095-8312.2012.02023.x; Kropf M, 2009, MOL ECOL, V18, P697, DOI 10.1111/j.1365-294X.2008.04053.x; Lihova J, 2010, AM J BOT, V97, P1058, DOI 10.3732/ajb.0900361; MURRAY DF, 1995, ECOL STU AN, V113, P21; Nei M., 1987, MOL EVOLUTIONARY GEN; Ritchie R, 1955, J ECOL, V43, P701; Senni Kei, 2005, APG Acta Phytotaxonomica et Geobotanica, V56, P265; Shimizu T, 1982, NEW ALPINE FLORA JAP, VI; Shimizu T, 1982, NEW ALP FLORA JAPAN, VI, P151; Shimizu T, 1983, NEW ALPINE FLORA JAP, VII; Soltis DE, 1997, PLANT SYST EVOL, V206, P353, DOI 10.1007/BF00987957; Sota T, 2007, J BIOGEOGR, V34, P977, DOI 10.1111/j.1365-2699.2006.01672.x; Tsuda Y, 2005, MOL ECOL, V14, P3929, DOI 10.1111/j.1365-294X.2005.02715.x; UOTILA P, 1985, Acta Botanica Fennica, V130, P1; Wei H, 2005, THEOR APPL GENET, V111, P1347, DOI 10.1007/s00122-005-0064-6	63	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	MAY	2015	128	3					437	444		10.1007/s10265-015-0709-8		8	Plant Sciences	Plant Sciences	CG5ST	WOS:000353355500010		
J	Tobe, H				Tobe, Hiroshi			Floral morphology and structure of Emblingia calceoliflora (Emblingiaceae, Brassicales): questions and answers	JOURNAL OF PLANT RESEARCH			English	Article						Brassicales; Emblingia; Emblingiaceae; Floral anatomy; Floral morphology; Flowers	PHYLOGENY GROUP CLASSIFICATION; FLOWERING PLANTS; EVOLUTIONARY IMPLICATIONS; SYSTEMATIC RELATIONSHIPS; DEVELOPMENTAL EVIDENCE; CORE BRASSICALES; ANATOMY; FAMILIES; PAEONIACEAE; MORINGACEAE	Emblingia calceoliflora, the sole species of the family Emblingiaceae (Brassicales), is a creeping shrub endemic to South Western Australia. The flowers have a characteristic slipper-like corolla (calceolus). Earlier studies using dry specimens have left some questions regarding the flower unresolved. Here I present an anatomical study of fresh flowers to resolve these questions. The flowers are pedicellate, strongly monosymmetric, and pentamerous with the median sepal in the abaxial position. During flower development, a pedicel turns clockwise or anticlockwise, placing the adaxial calceolus (comprising both petals) downward and a transversely dilated androgynophore upward with a large tunnel-like space between them. Two short longitudinal walls develop from the basal part of the petals, enclosing a nectary gland deep in the flower. The vascular anatomy of the androgynophore shows that lateral d,doublement occurs in five stamens, resulting in two pairs of fertile stamens on the adaxial side and (three to) six staminodes as the "hood" on the opposite side. Androecial configuration is obhaplostemony, and the gynoecium is tricarpellate/trilocular. Comparisons with flowers of other Brassicales show that an extrastaminal nectary is a synapomorphy of the core Brassicales including Emblingiaceae. The flower of Emblingia is highly specialized for adaptation to insect-pollination.	Kyoto Univ, Dept Bot, Grad Sch Sci, Kyoto 6068502, Japan	Tobe, H (reprint author), Kyoto Univ, Dept Bot, Grad Sch Sci, Kyoto 6068502, Japan.	tobe@sys.bot.kyoto-u.ac.jp			Japan Society for the Promotion of Science [25440208]	I am grateful to Juliet Wege and Allan Tinker for their assistance in collecting the materials used in the present study and to Tomoki Kadokawa for his assistance in preparing some figures used in the present article. The study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 25440208).	Airy Shaw HK, 1965, KEW B, V18, P249; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; TAKHTAJAN AL, 1980, BOT REV, V46, P225, DOI 10.1007/BF02861558; THORNE RF, 1992, BOT REV, V58, P225, DOI 10.1007/BF02858611; Su JX, 2012, TAXON, V61, P601; DAHLGREN RMT, 1980, BOT J LINN SOC, V80, P91, DOI 10.1111/j.1095-8339.1980.tb01661.x; Ao CQ, 2015, J PLANT RES, V128, P161, DOI 10.1007/s10265-014-0672-9; Bremer B, 2003, BOT J LINN SOC, V141, P399; APG (Angiosperm Phylogeny Group), 1998, ANN MISSOURI BOT GAR, V85, P531; Bremer B, 2009, BOT J LINN SOC, V161, P105; Bentham G, 1862, GENERA PLANTARUM, V1, P968; Chandler Gregory T., 2000, Plant Species Biology, V15, P67, DOI 10.1046/j.1442-1984.2000.00024.x; Cronquist S, 1981, INTEGRATED SYSTEM CL; De Craene LPR, 2010, FLORAL DIAGRAMS AID; DECRAENE LPR, 1991, PLANT SYST EVOL, V178, P179; Decraene LPR, 1999, CAN J BOT, V77, P582; De Craene LPR, 2005, AM J BOT, V92, P752; Decraene LPR, 1995, ACTA BOT NEERL, V44, P439; DECRAENE LPR, 1993, BOT J LINN SOC, V113, P103; De Craene LPR, 2002, BOT J LINN SOC, V139, P29, DOI 10.1046/j.1095-8339.2002.00045.x; De Craene LPR, 2002, CAN J BOT, V80, P443, DOI 10.1139/B02-021; Diels L, 1905, BOT JB, V35, P55; ERDTMAN G, 1969, Botanical Journal of the Linnean Society, V62, P169, DOI 10.1111/j.1095-8339.1969.tb01963.x; Hall JC, 2004, SYST BOT, V29, P654, DOI 10.1600/0363644041744491; HIEPKO P, 1966, BER DEUT BOT GES, V79, P233; Hiepko P, 1964, BER DEUT BOT GES, V77, P427; Hufford L, 1996, AM J BOT, V83, P1471, DOI 10.2307/2446102; Maddison D.R., 2005, MACCLADE; Melchior H, 1964, ENGLERS SYLLABUS PFL, VII, P178; Mueller E, 1860, FRAGMENTA PHYTOGRAPH, V12, P2; Murbeck SV, 1916, LUNDS U ARSSKR, V12, P1; Olson ME, 2003, AM J BOT, V90, P49, DOI 10.3732/ajb.90.1.49; Pax F, 1936, NATURLICHEN PFLANZ B, V17b, P146; Decraene Louis P. Ronse, 1997, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V119, P231; Decraene LPR, 2001, ANN BOT-LONDON, V88, P879, DOI 10.1006/anbo.2001.1525; De Craene LPR, 2006, BOT J LINN SOC, V151, P453; De Craene LR, 2009, ANN BOT-LONDON, V104, P913, DOI 10.1093/aob/mcp170; Decraene LPR, 1998, ANN BOT-LONDON, V82, P273; SAWADA M, 1971, BOT MAG TOKYO, V84, P51; Stevens P.F., 2001, ANGIOSPERM PHYLOGENY; Takhtajan A., 2009, FLOWERING PLANTS; Takhtajan A. L, 1997, DIVERSITY CLASSIFICA; TAMURA M, 1972, BOT MAG TOKYO, V85, P29, DOI 10.1007/BF02489198; Tobe H, 2008, AM J BOT, V95, P1475, DOI 10.3732/ajb.0800218; Tobe H, 1999, TAXON, V48, P277, DOI 10.2307/1224432; Tobe H, 2012, J PLANT RES, V125, P361, DOI 10.1007/s10265-011-0450-x; Watson L., 1992, FAMILIES FLOWERING P	47	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	MAY	2015	128	3					481	495		10.1007/s10265-015-0701-3		15	Plant Sciences	Plant Sciences	CG5ST	WOS:000353355500014		
J	Guo, P; Yoshimura, A; Ishikawa, N; Yamaguchi, T; Guo, Y; Tsukaya, H				Guo, Pin; Yoshimura, Asami; Ishikawa, Naoko; Yamaguchi, Takahiro; Guo, Youhao; Tsukaya, Hirokazu			Comparative analysis of the RTFL peptide family on the control of plant organogenesis	JOURNAL OF PLANT RESEARCH			English	Article						Evolution; Motif patterns; Organogenesis; Plant peptides; RTFL/DVL family	SOYBEAN NODULE DEVELOPMENT; ARABIDOPSIS-THALIANA; SELF-INCOMPATIBILITY; PROTEIN EVOLUTION; SUCROSE SYNTHASE; LOTUS-JAPONICUS; ROOT-GROWTH; LEAF-SHAPE; ENOD40; RECEPTOR	Plant peptides play important roles in various aspects of plant growth and development. The RTFL/DVL family includes small peptides that are widely conserved among land plants. Overexpression of six RTFL genes in Arabidopsis was suggestive of their functions as negative regulators of cell proliferation and as positional cues along the longitudinal axis of the plant body . At this time, few reports are available on RTFL paralogs in other species and the evolutionary relationship of RTFL members among land plants remains unclear. In this study, we compared and analyzed whole amino acid sequences of 188 RTFL members from 22 species among land plants and identified 73 motifs. All RTFL members could be grouped into four clades, and each clade exhibited specific motif patterns, indicative of unique evolutionary traits in the RTFL family. In agreement with this hypothesis, we analyzed two RTFL members from Oryza sativa and Arabidopsis by overexpressing them in Arabidopsis, revealing similar phenotypes suggestive of a conserved function of the RTFL family between eudicots and monocots, as well as different phenotypes and unique functions.	[Guo, Pin; Guo, Youhao] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Guo, Pin; Yoshimura, Asami; Ishikawa, Naoko; Tsukaya, Hirokazu] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan; [Yamaguchi, Takahiro] Acel Inc, Sagamihara, Kanagawa, Japan	Tsukaya, H (reprint author), Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan.	tsukaya@bs.s.u-tokyo.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan; Mitsubishi Foundation	We thank Prof. John L. Bowman (Monash University, Australia) for the RTFL sequence in Marchantia polymorpha, Prof. Hiroyuki Hirano (The University of Tokyo) for supplying us with T65 plants. This work was supported by the Japan Society for the Promotion of Science (Grants-in-Aid for Creative Scientific Research and Scientific Research A), the Ministry of Education, Culture, Sports, Science and Technology, Japan (Scientific Research on Priority Areas and Scientific Research on Innovative Areas), and the Mitsubishi Foundation.	Matsubayashi Y, 2014, ANNU REV PLANT BIOL, V65, P385, DOI 10.1146/annurev-arplant-050312-120122; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; Wen JQ, 2004, PLANT J, V37, P668, DOI 10.1111/j.1365-313X.2003.01994.x; Narvaez-Vasquez J, 2005, P NATL ACAD SCI USA, V102, P12974, DOI 10.1073/pnas.0505248102; Petricka JJ, 2012, ANNU REV PLANT BIOL, V63, P563, DOI 10.1146/annurev-arplant-042811-105501; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Charon C, 1999, PLANT CELL, V11, P1953, DOI 10.1105/tpc.11.10.1953; GAMBORG OL, 1976, IN VITRO CELL DEV B, V12, P473; Bjorklund AK, 2005, J MOL BIOL, V353, P911, DOI 10.1016/j.jmb.2005.08.067; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; Weiner J, 2006, FEBS J, V273, P2037, DOI 10.1111/j.1742-4658.2006.05220.x; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Scheer JM, 2002, P NATL ACAD SCI USA, V99, P9585, DOI 10.1073/pnas.132266499; Li L, 2001, PLANT PHYSIOL, V127, P1414, DOI 10.1104/pp.127.4.1414; Casson SA, 2002, PLANT CELL, V14, P1705, DOI 10.1105/tpc.002618; Rohrig H, 2002, P NATL ACAD SCI USA, V99, P1915, DOI 10.1073/pnas.022664799; Tsukaya H, 2006, ANNU REV PLANT BIOL, V57, P477, DOI 10.1146/annurev.arplant.57.032905.105320; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275; Tsuge T, 1996, DEVELOPMENT, V122, P1589; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; Farrokhi N, 2008, PLANT BIOTECHNOL J, V6, P105, DOI 10.1111/j.1467-7652.2007.00315.x; YANG WC, 1993, PLANT J, V3, P573, DOI 10.1046/j.1365-313X.1993.03040573.x; Yamaguchi Y, 2006, P NATL ACAD SCI USA, V103, P10104, DOI 10.1073/pnas.0603729103; CRESPI MD, 1994, EMBO J, V13, P5099; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Kachroo A, 2001, SCIENCE, V293, P1824, DOI 10.1126/science.1062509; Narita NN, 2004, PLANT J, V38, P699, DOI 10.1111/j.1365-313X.2004.02078.x; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; Valdivia ER, 2012, J EXP BOT, V63, P1405, DOI 10.1093/jxb/err378; Yamaguchi Y, 2011, CURR OPIN PLANT BIOL, V14, P351, DOI 10.1016/j.pbi.2011.05.001; Buljan M, 2009, BIOCHEM SOC T, V37, P751, DOI 10.1042/BST0370751; Chilley PM, 2006, PLANT CELL, V18, P3058, DOI 10.1105/tpc.106.040790; Wan X, 2007, J EXP BOT, V58, P2033, DOI 10.1093/jxb/erm072; Matsubayashi Y, 2006, ANNU REV PLANT BIOL, V57, P649, DOI 10.1146/annurev.arplant.56.032604.144204; Chae YK, 2012, PROTEIN PEPTIDE LETT, V19, P808; Combier Jean-Philippe, 2008, Mol Plant Microbe Interact, V21, P1118, DOI 10.1094/MPMI-21-8-1118; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Fletcher Jennifer C., 1999, Science (Washington D C), V283, P1911, DOI 10.1126/science.283.5409.1911; Golz JF, 2002, PLANT CELL, V14, pS277, DOI 10.1105/tpc.000828; Ikeuchi M, 2010, PLANT CELL PHYSL, V52, P59; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Kastin A, 2013, HDB BIOL ACTIVE PEPT; Katsir L, 2011, CURR BIOL, V21, P356; Kaul S, 2000, NATURE, V408, P796; KOUCHI H, 1993, MOL GEN GENET, V238, P106; Kumagai H, 2006, PLANT CELL PHYSIOL, V47, P1102, DOI 10.1093/pcp/pcj081; Meindl T, 1998, PLANT CELL, V10, P1561; Mihara M, 2009, NUCLEIC ACIDS RES, V38, P835; Narvaez-Vasquez J, 2004, PLANTA, V218, P360, DOI 10.1007/s00425-003-1115-3; Podkowinski J, 2009, ACTA BIOCHIM POL, V56, P89; Rohrig H, 2004, BIOCHEM BIOPH RES CO, V325, P864, DOI 10.1016/j.bbrc.2004.10.100; Sakagami Y, 2007, ELS, DOI [10.1002/9780470015902.a0020110, DOI 10.1002/9780470015902.A0020110]; Takeda N, 2005, PLANT CELL PHYSIOL, V46, P1291, DOI 10.1093/pcp/pci138; Yamaguchi T, 2013, HDB BIOL ACTIVE PEPT, V2nd, P53	56	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	MAY	2015	128	3					497	510		10.1007/s10265-015-0703-1		14	Plant Sciences	Plant Sciences	CG5ST	WOS:000353355500015		
J	Ihara, Y; Ohta, H; Masuda, S				Ihara, Yuta; Ohta, Hiroyuki; Masuda, Shinji			A highly sensitive quantification method for the accumulation of alarmone ppGpp in Arabidopsis thaliana using UPLC-ESI-qMS/MS	JOURNAL OF PLANT RESEARCH			English	Article						Arabidopsis; Chloroplast; Plastid; ppGpp; Stringent response; UPLC-ESI-qMS/MS	PERFORMANCE LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; ESCHERICHIA-COLI; STRINGENT RESPONSE; LAND PLANTS; (P)PPGPP; CHLOROPLASTS; NUCLEOTIDES; ELONGATION; EXPRESSION	Recently, a bacterial second messenger, guanosine 5'-diphosphate 3'-diphosphate (ppGpp), has been detected in chloroplasts. However, because ppGpp concentration in plants is much lower than that in bacteria, detailed analysis of ppGpp in plants has not been performed. A highly sensitive quantification method is required for further characterization of ppGpp function in chloroplasts. Here, we report a new method that allows for the highly sensitive and selective high-throughput quantification of ppGpp by ultra-performance liquid chromatography (UPLC) coupled with a tandem quadrupole mass spectrometer (qMS/MS) equipped with an electrospray interface (ESI). This method requires only similar to 100 mg of plant tissue for ppGpp quantification. We used this method to measure ppGpp levels in Arabidopsis thaliana under different light conditions. A. thaliana accumulated ppGpp during dark periods. This method will be helpful to further characterize the stringent response in higher plants.	[Ihara, Yuta; Ohta, Hiroyuki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Ohta, Hiroyuki; Masuda, Shinji] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 1528551, Japan; [Masuda, Shinji] Tokyo Inst Technol, Ctr Biol Resources & Informat, Yokohama, Kanagawa 2268501, Japan	Masuda, S (reprint author), Tokyo Inst Technol, Ctr Biol Resources & Informat, Nagatsuta Cho 4259 B-66, Yokohama, Kanagawa 2268501, Japan.	shmasuda@bio.titech.ac.jp	Ohta, Hiroyuki/B-1840-2014		MEXT of Japan [25120709]	This study was supported by a Grants-in-Aid for Scientific Research on Innovative Areas from MEXT of Japan (No. 25120709) to SM.	Masuda S, 2008, PLANT CELL PHYSIOL, V49, P135, DOI 10.1093/pcp/pcm177; Kanno Y, 2010, PLANT CELL PHYSIOL, V51, P1988, DOI 10.1093/pcp/pcq158; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Ross W, 2013, MOL CELL, V50, P420, DOI 10.1016/j.molcel.2013.03.021; Ito D, 2012, BIOSCI BIOTECH BIOCH, V76, P2236, DOI 10.1271/bbb.120523; Klawitter J, 2007, ANAL BIOCHEM, V365, P230, DOI 10.1016/j.ab.2007.03.018; Kanjee U, 2011, EMBO J, V30, P931, DOI 10.1038/emboj.2011.5; Struys EA, 2000, CLIN CHEM, V46, P1650; Coulier L, 2006, ANAL CHEM, V78, P6573, DOI 10.1021/ac0607616; Mizusawa K, 2008, PLANTA, V228, P553, DOI 10.1007/s00425-008-0758-5; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Givens RM, 2004, J BIOL CHEM, V279, P7495, DOI 10.1074/jbc.M311573200; Tozawa Y, 2011, PLANT BIOLOGY, V13, P699, DOI 10.1111/j.1438-8677.2011.00484.x; HERNANDEZ VJ, 1993, J BIOL CHEM, V268, P10851; ROJAS AM, 1984, MOL GEN GENET, V197, P36, DOI 10.1007/BF00327920; Sai JQ, 2002, PLANT CELL, V14, P1279, DOI 10.1105/tpc.000653; SCHREIBER G, 1991, J BIOL CHEM, V266, P3760; WINTER H, 1993, PLANTA, V191, P180; Mei H, 2003, RAPID COMMUN MASS SP, V17, P97, DOI 10.1002/rcm.876; Kanjee U, 2012, MOL MICROBIOL, V85, P1029, DOI 10.1111/j.1365-2958.2012.08177.x; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; van der Biezen EA, 2000, P NATL ACAD SCI USA, V97, P3747, DOI 10.1073/pnas.060392397; Wang JD, 2007, CELL, V128, P865, DOI 10.1016/j.cell.2006.12.043; Tozawa Y, 2007, J BIOL CHEM, V282, P35536, DOI 10.1074/jbc.M703820200; Chen P, 2009, PHARM RES-DORD, V26, P1504, DOI 10.1007/s11095-009-9863-9; SVITIL AL, 1993, J BIOL CHEM, V268, P2307; Takahashi K, 2004, P NATL ACAD SCI USA, V101, P4320, DOI 10.1073/pnas.0308555101; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Cohen S, 2009, J CHROMATOGR B, V877, P3831, DOI 10.1016/j.jchromb.2009.09.030; Cashel M, 1996, ESCHERICHIA COLI SAL, V1, P1458; Fung EN, 2001, J CHROMATOGR B, V754, P285, DOI 10.1016/S0378-4347(00)00619-8; GENTRY DR, 1995, J BACTERIOL, V177, P3890; Masuda S., 2012, ADV PHOTOSYNTH FUNDA, P487; Nomura Y, 2012, PLANT MOL BIOL, V78, P185, DOI 10.1007/s11103-011-9858-x; PAYNE SM, 1982, ANAL BIOCHEM, V123, P151, DOI 10.1016/0003-2697(82)90636-4; TOSA T, 1971, J BACTERIOL, V106, P972; Tuytten R, 2002, RAPID COMMUN MASS SP, V16, P1205, DOI 10.1002/rcm.704; Uesugi T, 1997, J CHROMATOGR B, V703, P63, DOI 10.1016/S0378-4347(97)00430-1; Yagi Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00061	39	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	MAY	2015	128	3					511	518		10.1007/s10265-015-0711-1		8	Plant Sciences	Plant Sciences	CG5ST	WOS:000353355500016		
J	Onoda, S; Azumi, S; Miura, Y; Kimata, Y				Onoda, Satoshi; Azumi, Shogo; Miura, Yuki; Kimata, Yoshihiro			Head and Neck Reconstruction by Using Extended Pectoralis Major Myocutaneous Flap	JOURNAL OF RECONSTRUCTIVE MICROSURGERY			English	Article						pectoralis major myocutaneous flap; thoracoacromial vessels; lateral thoracic vessels	CIRCUMFERENTIAL PHARYNGEAL DEFECTS; THORACOACROMIAL VESSELS; VASCULAR TERRITORIES; RECIPIENT VESSELS; ANTERIOR CHEST; ANGIOSOMES; PROSTAGLANDIN-E1; MICROSURGERY; DEFINITION; REPAIR	Background Pectoralis major flaps have been the workhorse in head and neck region reconstructions till date. However, pectoralis major flaps have disadvantages, including limitations regarding flap range and less stable blood flow than that in free flaps. Here, we report on the safe reconstruction to the oral cavity and neck area by using extended pectoralis major flaps. These flaps include both the normal vessels that feed pectoralis major flaps (the thoracoacromial artery and vein) and the lateral thoracic artery and vein to stabilize blood flow and expand flap survival area caudally. Methods Eight patients who had undergone reconstruction with extended pectoralis major flaps after the resection of head and neck cancers from June 2009 to March 2013. In all cases, the pectoralis major flap was elevated with a vascular pedicle comprising the thoracoacromial artery and vein and the lateral thoracic artery and vein. Results No blood-circulation disorders, such as ischemia or congestion, were observed after the flaps were elevated and moved to the resected areas. All flaps were sutured-on without difficulty. The area the flaps were harvested from was closed in a single stage. No postoperative complications such as hematoma, abscess, or fistula were observed. Conclusion Extended pectoralis major flaps have a wide range and more stable blood flow, so they are thought to be useful in situations in which free flaps cannot be used for a variety of reasons.	[Onoda, Satoshi; Azumi, Shogo; Miura, Yuki] Natl Hosp Org, Kure Med Ctr, Dept Plast Surg, Hiroshima, Japan; [Onoda, Satoshi; Azumi, Shogo; Miura, Yuki] Chugoku Canc Ctr, Hiroshima, Japan; [Kimata, Yoshihiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Plast & Reconstruct Surg, Okayama 7008530, Japan	Onoda, S (reprint author), Natl Hosp Org, Kure Med Ctr, Dept Plast Surg, 3-1 Aoyama Cho, Kure, Hiroshima 7370023, Japan.	satoshiprs18@gmail.com					Taylor GI, 1998, PLAST RECONSTR SURG, V102, P599, DOI 10.1097/00006534-199809030-00001; Kiyokawa K, 1998, PLAST RECONSTR SURG, V102, P2336, DOI 10.1097/00006534-199812000-00010; Rikimaru H, 2009, PLAST RECONSTR SURG, V123, P1220, DOI 10.1097/PRS.0b013e31819f2967; TAYLOR GI, 1992, PLAST RECONSTR SURG, V89, P181, DOI 10.1097/00006534-199202000-00001; ARIYAN S, 1979, PLAST RECONSTR SURG, V63, P73, DOI 10.1097/00006534-197901000-00012; Suami H, 2003, PLAST RECONSTR SURG, V112, P1790, DOI 10.1097/01.PRS.0000091161.95599.D8; Taylor GI, 2003, CLIN PLAST SURG, V30, P331, DOI 10.1016/S0094-1298(03)00034-8; Espitalier F, 2012, LARYNGOSCOPE, V122, P2677, DOI 10.1002/lary.23567; ARIYAN S, 1979, PLAST RECONSTR SURG, V64, P605, DOI 10.1097/00006534-197964050-00002; Aycock JK, 2008, PLAST RECONSTR SURG, V121, P88, DOI 10.1097/01.prs.0000293858.11494.96; Burke MS, 2013, ANN PLAS SURG, V71, P649, DOI 10.1097/SAP.0b013e3182583e80; Chang SH, 2011, ANN THORAC SURG, V91, P586, DOI 10.1016/j.athoracsur.2010.07.042; Dolan R, 1996, LARYNGOSCOPE, V106, P1436, DOI 10.1097/00005537-199611000-00026; Hallock GG, 2013, J RECONSTR MICROSURG, V29, P461, DOI 10.1055/s-0033-1343957; Harris JR, 2002, ARCH OTOLARYNGOL, V128, P319; He JX, 2009, ANN THORAC SURG, V88, P288, DOI 10.1016/j.athoracsur.2008.11.030; Hueston JT, 1968, AUST N Z J SURG, V38, P61; Kadlub N, 2013, INT J ORAL MAX SURG, V42, P453, DOI 10.1016/j.ijom.2012.10.038; Kerawala CJ, 2001, HEAD NECK-J SCI SPEC, V23, P879, DOI 10.1002/hed.1127; Kiyokawa K, 2001, J CRANIOFAC SURG, V12, P326, DOI 10.1097/00001665-200107000-00005; Kompatscher P, 2005, PLAST RECONSTR SURG, V115, P77, DOI 10.1097/01.PRS.0000146034.16752.68; Li Z, 2014, J RECONSTR MICROSURG, V30, P497, DOI 10.1055/s-0034-1370359; MARUYAMA Y, 1981, BRIT J PLAST SURG, V34, P157, DOI 10.1016/S0007-1226(81)80085-9; NAKAJIMA H, 1981, BRIT J PLAST SURG, V34, P258, DOI 10.1016/0007-1226(81)90004-7; Onoda S, 2011, MICROSURG, V31, P628, DOI 10.1002/micr.20947; TAYLOR GI, 1987, BRIT J PLAST SURG, V40, P113, DOI 10.1016/0007-1226(87)90185-8; Teo KGW, 2013, J RECONSTR MICROSURG, V29, P449, DOI 10.1055/s-0033-1343832; Vanni CMRS, 2010, EUR ARCH OTO-RHINO-L, V267, P1141, DOI 10.1007/s00405-010-1203-5	28	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0743-684X	1098-8947		J RECONSTR MICROSURG	J. Reconstr. Microsurg.	MAY	2015	31	4					300	304		10.1055/s-0034-1396788		5	Surgery	Surgery	CG5WP	WOS:000353366900009		
J	Sakakibara, S; Onishi, H; Hashikawa, K; Akashi, M; Sakakibara, A; Nomura, T; Terashi, H				Sakakibara, Shunsuke; Onishi, Hiroyuki; Hashikawa, Kazunobu; Akashi, Masaya; Sakakibara, Akiko; Nomura, Tadashi; Terashi, Hiroto			Three-Dimensional Venous Visualization with Phase-Lag Computed Tomography Angiography for Reconstructive Microsurgery	JOURNAL OF RECONSTRUCTIVE MICROSURGERY			English	Article						phase-lag computed tomography angiography; computed tomography angiography; venous anatomy; venous imaging	FLAP BREAST RECONSTRUCTION; ARTERY PERFORATOR FLAP; CT-ANGIOGRAPHY; MR VENOGRAPHY; EXPERIENCE; VESSELS; SURGERY; MDCT	Background Most free flap reconstruction complications involve vascular compromise. Evaluation of vascular anatomy provides considerable information that can potentially minimize these complications. Previous reports have shown that contrast-enhanced computed tomography is effective for understanding three-dimensional arterial anatomy. However, most vascular complications result from venous thromboses, making imaging of venous anatomy highly desirable. Methods The phase-lag computed tomography angiography (pl-CTA) technique involves 64-channel (virtually, 128-channel) multidetector CT and is used to acquire arterial images using conventional CTA. Venous images are three-dimensionally reconstructed using a subtraction technique involving combined venous phase and arterial phase images, using a computer workstation. Results This technique was used to examine 48 patients (12 lower leg reconstructions, 34 head and neck reconstructions, and 2 upper extremity reconstructions) without complications. The pl-CTA technique can be used for three-dimensional visualization of peripheral veins measuring approximately 1 mm in diameter. Conclusion The pl-CTA information was especially helpful for secondary free flap reconstructions in the head and neck region after malignant tumor recurrence. In such cases, radical dissection of the neck was performed as part of the first operation, and many vessels, including veins, were resected and used in the first free-tissue transfer. The pl-CTA images also allowed visualization of varicose changes in the lower leg region and helped us avoid selecting those vessels for anastomosis. Thus, the pl-CTA-derived venous anatomy information was useful for exact evaluations during the planning of free-tissue transfers.	[Sakakibara, Shunsuke; Hashikawa, Kazunobu; Nomura, Tadashi; Terashi, Hiroto] Kobe Univ, Grad Sch Med, Dept Plast Surg, Kobe, Hyogo 6500017, Japan; [Onishi, Hiroyuki] Kobe Circulat Clin, Kobe, Hyogo, Japan; [Akashi, Masaya; Sakakibara, Akiko] Kobe Univ, Grad Sch Med, Dept Oral Surg, Kobe, Hyogo 6500017, Japan	Sakakibara, S (reprint author), Kobe Univ, Grad Sch Med, Dept Plast Surg, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	shunsuke@med.kobe-u.ac.jp		Sakakibara, Shunsuke/0000-0001-5644-4549			Agrawal MD, 2014, J RECONSTRMICROSURG; Betsou S, 1998, BRIT J RADIOL, V71, P634; Karunanithy N, 2011, RADIOGRAPHICS, V31, P1307, DOI 10.1148/rg.315105089; Bui DT, 2007, PLAST RECONSTR SURG, V119, P2092, DOI 10.1097/01.prs.0000260598.24376.e1; Ensat F, 2012, MICROSURG, V32, P605, DOI 10.1002/micr.20835; Rozen WM, 2009, PLAST RECONSTR SURG, V124, P848, DOI 10.1097/PRS.0b013e3181b037a2; Hamdi M, 2009, J PLAST RECONSTR AES, V62, P1127, DOI 10.1016/j.bjps.2007.12.078; Masia J, 2008, ANN PLAS SURG, V60, P29, DOI 10.1097/SAP.0b013e31805003c2; Onoda S, 2013, MICROSURG, V33, P265, DOI 10.1002/micr.22079; Mathes DW, 2010, J RECONSTR MICROSURG, V26, P3, DOI 10.1055/s-0029-1244806; Siebert E, 2009, BRIT J RADIOL, V82, P561, DOI 10.1259/bjr/27721218; Clavero JA, 2008, AM J ROENTGENOL, V191, P670, DOI 10.2214/AJR.07.2515; Masia J, 2010, J RECONSTR MICROSURG, V26, P29, DOI 10.1055/s-0029-1238222; Hattori Yasunori, 2013, J Reconstr Microsurg, V29, P531, DOI 10.1055/s-0033-1351354; Hijjawi JB, 2010, J RECONSTR MICROSURG, V26, P11, DOI 10.1055/s-0029-1244807; Klein S, 2014, J RECONSTR MICROSURG, V30, P47, DOI 10.1055/s-0033-1351667; Lin J, 2005, CARDIOVASC INTER RAD, V28, P795, DOI 10.1007/s00270-004-0054-0; Masia J, 2008, PLAST RECONSTR SURG, V122, p80E, DOI 10.1097/PRS.0b013e31817d5eea; Nagamatsu S, 2010, J PLAST RECONSTR AES, V63, P1736, DOI 10.1016/j.bjps.2010.02.032; Novakovic D, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-33; Ruehm SG, 2000, RADIOLOGY, V215, P421; Sakakibara S, 2013, KEISEI GEKA, V56, P1271; Spritzer Charles E, 2009, Perspect Vasc Surg Endovasc Ther, V21, P105, DOI 10.1177/1531003509337259; Tanju Sumru, 2006, Diagn Interv Radiol, V12, P74; Teunis T, 2013, MICROSURG, V33, P496, DOI 10.1002/micr.22119	25	1	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0743-684X	1098-8947		J RECONSTR MICROSURG	J. Reconstr. Microsurg.	MAY	2015	31	4					305	312		10.1055/s-0034-1400070		8	Surgery	Surgery	CG5WP	WOS:000353366900010		
J	Ryan, DJ; Yoshihara, H; Yoneoka, D; Zuckerman, JD				Ryan, Devon J.; Yoshihara, Hiroyuki; Yoneoka, Daisuke; Zuckerman, Joseph D.			Blood transfusion in primary total shoulder arthroplasty: incidence, trends, and risk factors in the United States from 2000 to 2009	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Total shoulder arthroplasty; blood transfusion; National Inpatient Sample	KNEE ARTHROPLASTY; SPINAL-FUSION; TOTAL HIP; PREDICTORS	Background: Total shoulder arthroplasty (TSA) may be associated with substantial blood loss, and some patients require perioperative blood transfusion. Possible blood transfusion methods include predonated autologous blood transfusion, perioperative autologous blood transfusion, and allogeneic blood transfusion (ALBT). The purposes of the present study were to assess the incidence and recent trends over time of blood transfusion in TSA and analyze patient and hospital characteristics that affect the risk of ALBT. Methods: This study used national hospital discharge data from the National Inpatient Sample between 2000 and 2009. The data were used to generate the overall blood transfusion rate, and linear regression was used to assess trends in transfusion patterns over time. Logistic regression analysis was performed to analyze which patient and hospital characteristics independently influence the likelihood that a given patient undergoes ALBT. Results: The overall blood transfusion rate (ie, the proportion of patients who received at least 1 transfusion of any kind) was 6.7%. This rate increased over time, from 4.9% in 2000 to 7.1% in 2009 (P < .001). Risk factors associated with ALBT included age, gender, race, insurance status, hospital region, and hospital annual caseload. Conclusions: The increase in overall blood transfusion rate in TSA found in the present study may be related to factors specific to TSA, such as the introduction of reverse total shoulder arthroplasty during the study period. A variety of patient and hospital characteristics contribute to the risk of undergoing ALBT. (C) 2015 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Ryan, Devon J.; Zuckerman, Joseph D.] NYU, Hosp Joint Dis, Dept Orthopaed Surg, New York, NY USA; [Yoshihara, Hiroyuki] Nassau Univ, Med Ctr, Dept Orthopaed Surg, E Meadow, NY 11554 USA; [Yoshihara, Hiroyuki] Suny Downstate Med Ctr, Dept Orthopaed Surg, Brooklyn, NY 11203 USA; [Yoneoka, Daisuke] Grad Univ Adv Studies, Sch Adv Sci, Dept Stat Sci, Tachikawa, Tokyo, Japan	Yoshihara, H (reprint author), Nassau Univ, Med Ctr, Dept Orthopaed Surg, 2201 Hempstead Turnpike, E Meadow, NY 11554 USA.	hiroyoshihara55@yahoo.co.jp		Yoneoka, Daisuke/0000-0002-3525-5092			Sperling JW, 2005, J SHOULDER ELB SURG, V14, P599, DOI 10.1016/j.jse.2005.03.006; Domen RE, 2003, ARCH PATHOL LAB MED, V127, P316; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Yoshihara H, 2014, SPINE, V39, P297, DOI 10.1097/BRS.0000000000000122; Leahy MF, 2012, INTERN MED J, V42, P332, DOI 10.1111/j.1445-5994.2012.02717.x; Davenport RD, 2005, SEMIN HEMATOL, V42, P165, DOI 10.1053/j.seminhematol.2005.04.006; Domen RE, 1998, TRANSFUSION, V38, P296, DOI 10.1046/j.1537-2995.1998.38398222875.x; BOVILL DF, 1989, CLIN ORTHOP RELAT R, P137; Ceccherini-Nelli L, 2004, TRANSPLANT P, V36, P680, DOI 10.1016/j.transproceed.2004.03.009; Gruson KI, 2009, J SHOULDER ELB SURG, V18, P225, DOI 10.1016/j.jse.2008.08.005; Hardy JC, 2013, J SHOULDER ELB SURG, V22, P233, DOI 10.1016/j.jse.2012.04.013; Millett PJ, 2006, J BONE JOINT SURG AM, V88A, P1223, DOI 10.2106/JBJS.E.00706; Nuttall G. A., 1996, Transfusion (Bethesda), V36, P144, DOI 10.1046/j.1537-2995.1996.36296181927.x; Project HCUP, 2014, OV NAT INP SAMPL; Schmitges J, 2012, UROLOGY, V79, P332, DOI 10.1016/j.urology.2011.08.079; Schumer RA, 2010, J SHOULDER ELB SURG, V19, P91, DOI 10.1016/j.jse.2009.05.001; Yoshihara H, 2014, J ARTHROPLASTY, V29, P1932, DOI 10.1016/j.arth.2014.04.029; Yoshihara H, 2014, J ARTHROPLASTY, V29, P1736, DOI 10.1016/j.arth.2014.04.026; Yoshihara H, 2014, SPINE, V39, P304, DOI 10.1097/BRS.0000000000000123	19	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	MAY	2015	24	5					760	765		10.1016/j.jse.2014.12.016		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CG3NT	WOS:000353187600019		
J	Saka, M; Yamauchi, H; Hoshi, K; Yoshioka, T; Hamada, H; Gamada, K				Saka, Masayuki; Yamauchi, Hiroki; Hoshi, Kenji; Yoshioka, Toru; Hamada, Hidetoshi; Gamada, Kazuyoshi			Reliability and validity in measurement of true humeral retroversion by a three-dimensional cylinder fitting method	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Humeral retroversion; three-dimensional measurement; cylinder fitting; computed tomography; baseball players; reliability	PROFESSIONAL BASEBALL PITCHERS; POSTERIOR CAPSULE THICKNESS; HEAD RETROVERSION; THROWING SHOULDER; PROXIMAL ULNA; ELBOW; PLAYERS; MOTION; ROTATION; TORSION	Hypothesis and background: Humeral retroversion is defined as the orientation of the humeral head relative to the distal humerus. Because none of the previous methods used to measure humeral retroversion strictly follow this definition, values obtained by these techniques vary and may be biased by morphologic variations of the humerus. The purpose of this study was 2-fold: to validate a method to define the axis of the distal humerus with a virtual cylinder and to establish the reliability of 3-dimensional (3D) measurement of humeral retroversion by this cylinder fitting method. Methods: Humeral retroversion in 14 baseball players (28 humeri) was measured by the 3D cylinder fitting method. The root mean square error was calculated to compare values obtained by a single tester and by 2 different testers using the embedded coordinate system. To establish the reliability, intraclass correlation coefficient (ICC) and precision (standard error of measurement [SEM]) were calculated. Results: The root mean square errors for the humeral coordinate system were <1.0 mm/1.0 degrees for comparison of all translations/rotations obtained by a single tester and <1.0 mm/2.0 degrees for comparison obtained by 2 different testers. Assessment of reliability and precision of the 3D measurement of retroversion yielded an intratester ICC of 0.99 (SEM, 1.0 degrees) and intertester ICC of 0.96 (SEM, 2.8 degrees). Discussion and conclusion: The error in measurements obtained by a distal humerus cylinder fitting method was small enough not to affect retroversion measurement. The 3D measurement of retroversion by this method provides excellent intratester and intertester reliability. (C) 2015 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Saka, Masayuki; Hoshi, Kenji; Gamada, Kazuyoshi] Hiroshima Int Univ, Grad Sch Med Technol & Hlth Welfare Sci, Higashihiroshima, Hiroshima 7392631, Japan; [Yamauchi, Hiroki] Kameda Med Ctr, Dept Rehabil, Chiba, Japan; [Yoshioka, Toru] Saka Midorii Hosp, Dept Orthopaed Surg, Hiroshima, Japan; [Hamada, Hidetoshi] Hamawaki Orthopaed Hosp, Dept Orthopaed Surg, Hiroshima, Japan	Saka, M (reprint author), Hiroshima Int Univ, Grad Sch Med Technol & Hlth Welfare Sci, 555-36 Kurosegakuendai, Higashihiroshima, Hiroshima 7392631, Japan.	sakamasayuki.25@gmail.com					ADAMS JE, 1965, CALIF MED, V102, P127; Whiteley R, 2006, J SCI MED SPORT, V9, P310, DOI 10.1016/j.jsams.2006.05.012; Osbahr DC, 2002, AM J SPORT MED, V30, P347; Crockett HC, 2002, AM J SPORT MED, V30, P20; Myers JB, 2012, AM J SPORT MED, V40, P1155, DOI 10.1177/0363546512436801; Eckhoff D, 2007, CLIN ORTHOP RELAT R, P238, DOI 10.1097/BLO.0b013e318112416b; Myers JB, 2009, CLIN J SPORT MED, V19, P366, DOI 10.1097/JSM.0b013e3181b544f6; Shanley E, 2011, AM J SPORT MED, V39, P1997, DOI 10.1177/0363546511408876; Whiteley RJ, 2009, J ORTHOP SPORT PHYS, V39, P256, DOI 10.2519/jospt.2009.2821; Ciccotti MG, 2014, AM J SPORT MED, V42, P544, DOI 10.1177/0363546513516592; Reagan KM, 2002, AM J SPORT MED, V30, P354; Nishinaka N, 2008, J SHOULDER ELB SURG, V17, P319, DOI 10.1016/j.jse.2007.05.018; Yamamoto N, 2006, J SHOULDER ELB SURG, V15, P571, DOI 10.1016/j.jse.2005.06.009; Boileau P, 2008, CLIN ORTHOP RELAT R, V466, P661, DOI 10.1007/s11999-007-0089-z; Hang DW, 2004, AM J SPORT MED, V32, P79, DOI 10.1177/0095399703258674; Roach NT, 2012, J ANAT, V220, P293, DOI 10.1111/j.1469-7580.2011.01464.x; Thomas SJ, 2012, J SHOULDER ELB SURG, V21, P910, DOI 10.1016/j.jse.2011.05.028; Whiteley RJ, 2010, J SCI MED SPORT, V13, P392, DOI 10.1016/j.jsams.2009.06.001; MORREY BF, 1976, J BONE JOINT SURG AM, V58, P501; Oyama S, 2013, CLIN BIOMECH, V28, P268, DOI 10.1016/j.clinbiomech.2013.01.014; Windisch G, 2007, J SHOULDER ELB SURG, V16, P661, DOI 10.1016/j.jse.2006.12.008; Robertson DD, 2000, J BONE JOINT SURG AM, V82A, P1594; Polster JM, 2013, AM J SPORT MED, V41, P2015, DOI 10.1177/0363546513493249; SHIBA R, 1988, J ORTHOPAED RES, V6, P897, DOI 10.1002/jor.1100060614; KING JW, 1969, CLIN ORTHOP RELAT R, P116; Thomas SJ, 2011, J SHOULDER ELB SURG, V20, P708, DOI 10.1016/j.jse.2010.08.031; Bottlang M, 2000, J ORTHOPAED RES, V18, P821, DOI 10.1002/jor.1100180521; Brownhill JR, 2009, J SHOULDER ELB SURG, V18, P27, DOI 10.1016/j.jse.2008.03.008; Casciaro ME, 2010, IEEE ENG MED BIO, P3946, DOI 10.1109/IEMBS.2010.5627701; DELAND JT, 1987, CLIN ORTHOP RELAT R, P303; Gugenheim J J Jr, 1976, Am J Sports Med, V4, P189, DOI 10.1177/036354657600400501; Harrold F, 2012, J SHOULDER ELB SURG, V21, P612, DOI 10.1016/j.jse.2011.04.005; Johnson JW, 2013, J BONE JOINT SURG AM, V95A, P719, DOI 10.2106/JBJS.J.00085; Kerins Caitlyn M, 2013, Int J Sports Phys Ther, V8, P248; LONDON JT, 1981, J BONE JOINT SURG AM, V63, P529; Myers Joseph B, 2011, Sports Health, V3, P383; Polster JM, 2010, J SHOULDER ELB SURG, V19, P899, DOI 10.1016/j.jse.2009.11.047; Van Roy P, 2005, ERGONOMICS, V48, P1645, DOI 10.1080/00140130500101361; Wyland DJ, 2012, AM J SPORT MED, V40, P1858, DOI 10.1177/0363546512452720; Yoshida M, 2010, J SPORT REHABIL, V19, P149	40	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	MAY	2015	24	5					809	813		10.1016/j.jse.2014.09.041		5	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CG3NT	WOS:000353187600026		
J	Kadonaga, T; Fraser, MW				Kadonaga, Tomoko; Fraser, Mark W.			Child maltreatment in Japan	Journal of Social Work			English	Article						Social work; child abuse; child neglect; children and families; resilience; child welfare; Japan		Over the past 15 years, the number of child maltreatment incidents reported to Child Guidance Centers in Japan has increased more than three fold. Reviewing a wide range of policy white-papers and research reports in Japan, we discuss the prevalence of child maltreatment, its social construction over time, societal factors contributing to child maltreatment, and the development and design of the Japanese child welfare system. We conclude with a discussion of emerging issues and challenges. Findings A variety of risk factors exacerbate maltreatment in Japan. These include the decline of extended familial supports, low paternal involvement in childrearing, and demanding work routines for both men and women who seek professional careers. Throughout the paper, we discuss historically competing social constructions of the child, family, and work. In addition, we discuss the gendered roles of men and women in Japanese society. Japan's legacy of Shintoism and Confucianism, the institutionalization of patriarchy in the Tokugawa and Meiji Periods, and the modern constraints placed on families by Japanese corporations are explored as factors affecting child maltreatment and the services rendered by the child welfare system. Under the Child Welfare Act of 1948 and the Prevention of Child Abuse Act of 2000, approximately 90% of children in need, including maltreated children, receive care in large group home settings in Japan. Compared to other nations, Japan places great reliance on out-of-home care. Preventive systems to strengthen families and avert out of home placements have not be adequately developed. Applications Japanese scholars are re-examining the child welfare system in efforts to design family-based policies and services to both prevent maltreatment and provide alternatives to out-of-home care.	[Kadonaga, Tomoko] Kyoto Womens Univ, Kyoto 6058501, Japan; [Fraser, Mark W.] Univ North Caroline, Chapel Hill, NC USA	Kadonaga, T (reprint author), Kyoto Womens Univ, Higashiyama Ku, 35 Kitahiyoshi Cho, Kyoto 6058501, Japan.	kadonaga@kyoto-wu.ac.jp					Sidebotham P, 2002, CHILD ABUSE NEGLECT, V26, P1243, DOI 10.1016/S0145-2134(02)00415-5; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Cabinet Office National Government of Japan, 2013, NUMB SUIC BAS STAT D; Child Care Conference, 1994, RES CAR CHILDR; Collin-Vezina, 2011, INT J MENT HEALTH AD, V9, P577, DOI [10.1007/s11469-011-9323-8, DOI 10.1007/S11469-011-9323-8]; Committee of Examining Maltreated Children and Children in Need the Child Section of Social Security Committee Ministry of Health Labor and Welfare Japan, 2011, 7 MIN HLTH LAB WELF; Fujiwara T, 2010, PSYCHOLOGIA, V53, P211; Hemmi M., 1994, J JAPAN SOC HIST STU, V37, P99; Hirata M., 2011, JAPANESE J CLIN PSYC, V11, P659; Ihaya T., 2008, JAPANESE J PERSONALI, V17, P39; Ikeda Y., 2002, ANN B CTR CLIN DEV S, V2, P46; Ishikawa Y., 2011, B OSAKA SHOIN WOMENS, V1, P171; Ishinomori S., 1988, JAPAN INC INTRO JAPA; Iwamoto T., 1993, B NATL MUSEUM JAPANE, V54, P73; Kanamaru J., 2010, B HIROSHIMA U, V38, P355; Katada K., 2009, JAPANESE SOC STUDY S, V50, P5; Kikuchi M., 2007, JAPANESE SOC PREVENT, V9, P147; Kobayashi M., 2010, JAPANESE SOC PREVENT, V12, P8; Kohashi A., 2011, B SAPPORO OTANI U SA, V41, P65; Kokubu M., 2011, J CLIN PSYCHOL, V11, P642; MacKenzie MJ, 2011, CHILD YOUTH SERV REV, V33, P1638, DOI 10.1016/j.childyouth.2011.04.018; Masuda S., 2001, B AOMORI U HLTH WELF, V3, P177; Matsumiya Y., 2010, HLTH LABOR WELFARE S, V57, P6; Matsumoto I., 2010, JAPAN INFORM TRAININ, V8, P1; Matsumoto K., 2004, JAPANESE J FAMILY SO, V16, P32; Matsunobu H., 1995, J JAPAN SOC FAMILY S, V7, P47; Ministry of Health Labor and Welfare, 2010, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 2005, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 2000, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 2001, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 1994, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 1996, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 1998, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 1991, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 2004, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 2007, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 2002, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 2005, CHILD WELF SYST JAP; Ministry of Health Labor and Welfare, 1999, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 2006, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 1990, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 1993, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 2011, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 2008, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 1995, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 2011, 7 MIN HLTH LAB WELF; Ministry of Health Labor and Welfare, 2003, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 2009, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 1997, ANN WELF ADM REP; Ministry of Health Labor and Welfare, 2010, NUMB REP CHILD MALTR; Ministry of Health Labor and Welfare, 1992, ANN WELF ADM REP; Ministry of Health Labor and Welfare and the Nissei Research Institute, 2008, FUT SUPP BAL WORK FA; Ministry of Health Labor and Welfare Child Section of Social Security Committee, 2012, 8 MIN HLTH LAB WELF; Ministry of Health Labor and Welfare Japan, 2009, PUBL REL POV RAT CHI; Ministry of Internal Affairs and Communications Japan, 2010, WHIT PAP CHILD AD; Ministry of Internal Affairs and Communications Japan, 2011, POP JAP AG 2011; Ministry of Internal Affairs and Communications Japan, 2000, POP JAP 1990 2000; Ministry of Welfare, 1948, MONTHLY STAT REPORT, V2, P87; Ministry of Welfare, 1947, MONTHLY STAT REPORT, V1, P72; Mitsubishi UFJ Research and Consulting, 2008, COMPR STUD AG SUPP C; Morita Y., 2002, HUM RIGHTS, V171, P66; Morita Y., 2002, HUM RIGHTS, V172, P62; Nakaya N., 2006, JAPANESE J DEV PSYCH, V17, P148; National Council of Social Welfare Tokyo, 2011, FUT ALT CAR ITS AG; National Police Agency, 2011, WHIT PAP NAT POL AG; NHK Broadcasting Culture Research Institute, 2011, NHK SURV LIF CIT YEA; Nishizawa S., 2010, CHILD STUDY, V64, P98; Nobe Y., 2012, RES HOUSEHOLD EC, V93, P58; OHARA K, 1963, Am J Psychiatry, V120, P382; Saimura J., 2007, WELFARE CHILDREN THE, P109; Sankei Newspaper, 2010, SANKEI NEWSPAPER; Shibuya M., 2007, J HLTH WELFARE STAT, V54, P1; Shima N., 1999, ANN REPORT SOCIOLOGY, V12, P26; Shimonishi S., 2005, JAPANESE SOC STUDY S, V46, P3; Shoji J., 2001, CHILD FOSTER CARE CH, P81; Shoji J., 2007, CHILD ABUSE NEGLECT, V9, P162; Takiuchi T., 1972, B KYOTO PREFECTURAL, V24, P47; Tanaka Y., 2011, JAPANESE J CLIN PSYC, V11, P633; Tokunaga M., 2000, J HLTH WELFARE STAT, V47, P3; Uchino A., 2011, J ED SOCIAL WORK, V17, P65; United Nations, 2010, CONS REP SUBM STAT P; Wada M., 2005, STUDIES SOCIOLOGY PS, V60, P15; Watanabe M., 2012, CHILD ABUSE NEGLECT, V14, P28; Watanabe M., 2010, CHILD ABUSE NEGLECT, V12, P99; Yamada M., 1994, MUNICIPAL RES, V85, P51; Yamagata F., 2011, ED MED, V59, P756; Yamamoto K., 2010, B INT PACIFIC U, V3, P111; Yamamoto M, 1999, J COMMUNITY PSYCHOL, V27, P377, DOI 10.1002/(SICI)1520-6629(199907)27:4<377::AID-JCOP2>3.0.CO;2-N; Yamanda T., 2007, CHILD ABUSE NEGLECT, V9, P156; Yoshioka M., 2005, B HIGASHIOSAKA COLL, V2, P29; Yuzawa Y., 2004, INT COMP FOSTER FAMI	91	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1468-0173	1741-296X		J SOC WORK	J. Soc. Work	MAY	2015	15	3					233	253		10.1177/1468017314537424		21	Social Work	Social Work	CG7HQ	WOS:000353474000001		
J	Hasegawa, T; Yamane, H				Hasegawa, Toru; Yamane, Hisanori			Synthesis and crystal structure analysis of Li2NaBP2O8 and LiNa2B5P2O14	JOURNAL OF SOLID STATE CHEMISTRY			English	Article						Borophosphate; Solid-state reaction; Crystal structure	BOROPHOSPHATES; GROWTH; CHEMISTRY; LITHIUM	Single crystals of Li2NaBP2O8 and LiNa2B5P2O14 were prepared at 873-883 K. The XRD reflections of Li2NaBP2O8 single crystal were indexed with triclinic unit-cell parameters of a= 5.4344(3) angstrom, b=7.3793 (4) angstrom, c=7.9840(4) angstrom, alpha=103.243(3)degrees, beta=109.270(4)degrees and gamma=87.391(2)degrees; (space group P (1) over bar (No. 2)). Li2NaBP2O8 consists of one-dimensional (1)(infinity)[BP2O8](3-) chains of BO4 and PO4 tetrahedra in the direction of the c axis, and Li and Na atoms located around the chains. The XRD reflections of the LiNa2B5P2O14 single crystal were indexed with monoclinic unit-cell parameters of a=8.208(3) angstrom, 6=9.151(3) angstrom, c=8.349(3) angstrom and beta=115.709(7)degrees; (space group P2(1)/m (No. 11)). In the crystal structure of LiNa2B5P2O14, BO3 trigonal planer and BO4 and PO4 tetrahedra share O atoms and form two-dimensional sheets of (2)(infinity)[B5P2O14](3-). One Li and two Na atoms are situated at a large triangular space in the sheets. (C) 2014 Elsevier Inc. All rights reserved.	[Hasegawa, Toru; Yamane, Hisanori] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Yamane, H (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	yamane@tagen.tohoku.ac.jp					Wang Y, 2014, DALTON T, V43, P12886, DOI 10.1039/c4dt01199f; Zhao D, 2009, INORG CHEM, V48, P6623, DOI 10.1021/ic900620x; [Anonymous], 2005, RAPID AUTO; Ewald B, 2007, Z ANORG ALLG CHEM, V633, P1517, DOI 10.1002/zaac.200700232; Burla MC, 2005, J APPL CRYSTALLOGR, V38, P381, DOI 10.1107/S002188980403225X; Hasegawa T, 2014, DALTON T, V43, P14525, DOI 10.1039/c4dt01670j; Kniep R, 1998, CHEM MATER, V10, P2930, DOI 10.1021/cm980263g; Wang Y, 2013, CRYSTENGCOMM, V15, P4956, DOI 10.1039/c3ce40394g; Momma K, 2008, J APPL CRYSTALLOGR, V41, P653, DOI 10.1107/S0021889808012016; Zintl E, 1934, Z ELKTROCHEM ANGEW P, V40, P588; MACGILLAVRY CH, 1949, NATURE, V164, P448, DOI 10.1038/164448b0; GURR GE, 1970, ACTA CRYSTALL B-STRU, VB 26, P906, DOI 10.1107/S0567740870003369; Babaryk AA, 2012, CRYSTENGCOMM, V14, P5071, DOI 10.1039/c2ce25451d; BRESE NE, 1991, ACTA CRYSTALLOGR B, V47, P192, DOI 10.1107/S0108768190011041; Farrugia L.J., 1999, J APPL CRYSTALLOGR, V32, P837; Gurbanova OA, 2007, CRYSTALLOGR REP+, V52, P624, DOI 10.1134/S1063774507040098; Hasegawa T, 2014, DALTON T, V43, P2294, DOI 10.1039/c3dt52917g; HAUF C, 1995, Z KRISTALLOGR, V210, P446, DOI 10.1524/zkri.1995.210.6.446; Hauf C, 1998, J SOLID STATE CHEM, V140, P154, DOI 10.1006/jssc.1998.7955; Higashi T., 1999, NUMABS NUMERICAL ABS; Kneip R., 1994, ANGEW CHEM INT EDIT, V33, P749; Li HY, 2013, EUR J INORG CHEM, P3185, DOI 10.1002/ejic.201300009; Li ZH, 2003, J CRYST GROWTH, V255, P119, DOI 10.1016/S0022-0248(03)01234-X; Rahab H, 2007, J CRYST GROWTH, V303, P629, DOI 10.1016/j.jcrysgro.2006.12.059; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Tien T.Y., 1961, J AM CERAM SOC, V44, P391; Wang Y, 2014, CRYSTENGCOMM, V16, P6848, DOI 10.1039/c4ce00917g; Wang Y, 2012, CHEM-EUR J, V18, P12046, DOI 10.1002/chem.201201356; Xiong DB, 2007, J SOLID STATE CHEM, V180, P233, DOI 10.1016/j.jssc.2006.09.034; Zintl E., 1931, ANORG ALLG CHEM, V198, P88	30	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596	1095-726X		J SOLID STATE CHEM	J. Solid State Chem.	MAY	2015	225						65	71		10.1016/j.jssc.2014.11.024		7	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	CF8QW	WOS:000352828000011		
J	Ono, S; Kikegawa, T				Ono, Shigeaki; Kikegawa, Takumi			Determination of the phase boundary of the omega to beta transition in Zr using in situ high-pressure and high-temperature X-ray diffraction	JOURNAL OF SOLID STATE CHEMISTRY			English	Article						Zirconium; High pressure; X-ray diffraction; Phase transition	ZIRCONIUM METAL; ALPHA-ZIRCONIUM; TRANSFORMATIONS; EQUATIONS; DIAGRAM; STATE	The high-pressure behavior of zirconium has been examined using the synchrotron X-ray diffraction technique to a pressure of 38 GPa and a temperature of 800 K employing a hydrothermal diamond anvil cell technique. The structural transition from the omega to the beta phase was observed. This transition has a negative dP/dT gradient, which is in general agreement with those reported in previous studies. The transition boundary was determined to be, P (GPa)=41.2-0.025 x T (K). The negative slope of the transition, dP/dT, determined in our study using the diamond anvil cell technique was less than half that estimated by the previous study using a large press apparatus. (C) 2014 Elsevier Inc. All rights reserved.	[Ono, Shigeaki] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Ocean Drilling Sci, Yokosuka, Kanagawa 2370061, Japan; [Kikegawa, Takumi] High Energy Accelerat Res Org, Tsukuba, Ibaraki 3050801, Japan	Ono, S (reprint author), Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Ocean Drilling Sci, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan.	sono@jamstec.go.jp			JSPS KAKENHI [22340131]	The synchrotron radiation experiments were performed at the PF-AR, KEK (Proposal nos. 2011G507 and 2013G079). This work was partially supported by JSPS KAKENHI Grant number 22340131.	AKAHAMA Y, 1991, J PHYS SOC JPN, V60, P3211, DOI 10.1143/JPSJ.60.3211; AKAHAMA Y, 1990, J PHYS SOC JPN, V59, P3843, DOI 10.1143/JPSJ.59.3843; Ono S, 2005, J APPL PHYS, V97, DOI 10.1063/1.1871355; Dorogokupets PI, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.024115; Dorogokupets PI, 2007, HIGH PRESSURE RES, V27, P431, DOI 10.1080/08957950701659700; Zhang J, 1996, PHYS CHEM MINER, V23, P1, DOI 10.1007/BF00202987; Hao YJ, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/23/235230; JAYARAMAN A, 1963, PHYS REV, V131, P644, DOI 10.1103/PhysRev.131.644; Kutepov AL, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.132102; Zhang JZ, 2005, J PHYS CHEM SOLIDS, V66, P1213, DOI 10.1016/j.jpcs.2005.03.004; ACKLAND GJ, 1995, PHILOS MAG A, V71, P553; WILLAIME F, 1989, PHYS REV LETT, V63, P2244, DOI 10.1103/PhysRevLett.63.2244; BASSETT WA, 1993, REV SCI INSTRUM, V64, P2340, DOI 10.1063/1.1143931; Mendelev MI, 2007, PHIL MAG LETT, V87, P349, DOI 10.1080/09500830701191393; XIA H, 1990, PHYS REV LETT, V64, P204, DOI 10.1103/PhysRevLett.64.204; Bridgman PW, 1952, P AM ACAD ARTS SCI, V81, P165, DOI 10.2307/ 20023677; FISHER ES, 1961, J NUCL MATER, V4, P311, DOI 10.1016/0022-3115(61)90081-2; GYANCHANDANI JS, 1990, J PHYS-CONDENS MAT, V2, P6457, DOI 10.1088/0953-8984/2/30/011; Kusaba K, 1999, P JPN ACAD B-PHYS, V75, P1, DOI 10.2183/pjab.75.1; McQueen R. G., 1970, HIGH VELOCITY IMPACT, P537; Olijnyk H, 1997, PHYS REV B, V56, P10751, DOI 10.1103/PhysRevB.56.10751; Olinger B., 1973, High Temperatures - High Pressures, V5; Ono S, 2010, J PHYS CONF SER, V215, DOI 10.1088/1742-6596/215/1/012196; Ostanin SA, 1998, PHYS REV B, V57, P13485, DOI 10.1103/PhysRevB.57.13485; Pinsook U., 1999, PHYS REV B, V59, P13342; Wenk H.R., 2013, PHYS REV LETT, V111; XIA H, 1991, PHYS REV B, V44, P10374, DOI 10.1103/PhysRevB.44.10374; Xiao B, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.184103; Zhang JZ, 2007, J PHYS CHEM SOLIDS, V68, P2297, DOI 10.1016/j.jpcs.2007.06.016	29	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596	1095-726X		J SOLID STATE CHEM	J. Solid State Chem.	MAY	2015	225						110	113		10.1016/j.jssc.2014.12.006		4	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	CF8QW	WOS:000352828000018		
J	Phraewphiphat, T; Iqbal, M; Suzuki, K; Matsuda, Y; Yonemura, M; Hirayama, M; Kanno, R				Phraewphiphat, Thanya; Iqbal, Muhammad; Suzuki, Kota; Matsuda, Yasuaki; Yonemura, Masao; Hirayama, Masaaki; Kanno, Ryoji			Syntheses, structures, and ionic conductivities of perovskite-structured lithium-strontium-aluminum/gallium-tantalum-oxides	JOURNAL OF SOLID STATE CHEMISTRY			English	Article						Lithium solid electrolyte; Perovskite; Lithium ionic conductor; Neutron diffraction analysis	TITANATE	The ionic conductivities of new perovskite-structured lithium-strontium-aluminum/gallium-tantalum oxides were investigated. Solid solutions of the new perovskite oxides, (LixSr1-x)(Al(1-x)/2Ta(1+x)/2)O-3 and (LixSr1-x)(Ga(1-x)/2Ta(1+x)/2)O-3, were synthesized using a ball-milled-assisted solid-state method. The partial substitution of the smaller Ga+3 for Ta+5 resulted in new compositions, the structures of which were determined by neutron diffraction measurements using a cubic perovskite structural model with the Pm-3m space group. Vacancies were introduced into the Sr(Li) sites by the formation of solid solutions with compositions (LixSr1-x)(Al(1-x)/2Ta(1+x)/2)O-3, where the composition range of 0 <= y <= 0.20 was examined for x=0.2 and 0.25. The highest conductivity, 1.85 x 10(-3) S cm(-1) at 250 degrees C, was obtained for (Li0.25Sr0.625 square(0.125))(Ga0.25Ta0.75)O-3 (x=0.25, y=0.125). Enhanced ionic conductivities were achieved by the introduction of vacancies at the A-sites. (C) 2015 Elsevier Inc. All rights reserved.	[Phraewphiphat, Thanya; Iqbal, Muhammad; Suzuki, Kota; Hirayama, Masaaki; Kanno, Ryoji] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Matsuda, Yasuaki] Mie Univ, Dept Chem, Tsu, Mie 5148507, Japan; [Yonemura, Masao] High Energy Accelerator Res Org, Tokai, Ibaraki 3191106, Japan	Kanno, R (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	thanya@echem.titech.ac.jp; iqbal@echem.titech.ac.jp; ksuzuki@echem.titech.ac.jp; matsuda@chem.mie-u.ac.jp; masao.yonemura@kek.jp; hirayama@echem.titech.ac.jp; kanno@echem.titech.ac.jp	Hirayama, Masaaki/B-5781-2011	Hirayama, Masaaki/0000-0003-4804-4208	Japan Society for the Promotion of Science	This study was partly supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Exploration of nanostructure-property relationships for materials innovation" from the Japan Society for the Promotion of Science. The neutron scattering experiment was performed at the BL-11A POWGEN of ORNL's SNS (IPTS Proposal No. 10030).	KAWAI H, 1994, J ELECTROCHEM SOC, V141, pL78, DOI 10.1149/1.2055043; Birke P, 1997, J ELECTROCHEM SOC, V144, pL167, DOI 10.1149/1.1837713; Inaguma Y, 2004, SOLID STATE IONICS, V174, P19, DOI 10.1016/j.ssi.2004.06.013; Inaguma Y, 2006, SOLID STATE IONICS, V177, P3037, DOI 10.1016/j.ssi.2006.08.012; Thangadurai V, 1999, CHEM MATER, V11, P835, DOI 10.1021/cm9810382; INAGUMA Y, 1994, SOLID STATE IONICS, V70, P196, DOI 10.1016/0167-2738(94)90309-3; Bhuvanesh NSP, 1997, J MATER CHEM, V7, P2297, DOI 10.1039/a703996d; INAGUMA Y, 1993, SOLID STATE COMMUN, V86, P689, DOI 10.1016/0038-1098(93)90841-A; Toby BH, 2001, J APPL CRYSTALLOGR, V34, P210, DOI 10.1107/S0021889801002242; WOODWARD P, 1994, J MATER RES, V9, P2118, DOI 10.1557/JMR.1994.2118; BROUS J, 1953, ACTA CRYSTALLOGR, V6, P67, DOI 10.1107/S0365110X53000156; Barnes P.W., 2006, ACTA CRYSTALLOGR B, V62, P384; Bhuvanesh NSP, 1999, J MATER CHEM, V9, P3093, DOI 10.1039/a903720i; Inaguma Y, 1997, J CERAM SOC JPN, V105, P548, DOI 10.2109/jcersj.105.548; Inaguma Y, 2000, ELECTROCHEMISTRY, V68, P534; ITOH M, 1994, SOLID STATE IONICS, V70, P203, DOI 10.1016/0167-2738(94)90310-7; Larson A.C., 1994, 86748 LAUR LOS AL NA, V86, P86; lzumi F., 2007, SOLID STATE PHENOM, V130, P15; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Stauffer D., 1985, INTRO PERCOLATION TH; Stauffer D., 1992, INTRO PERCOLATION TH; Thangadurai V, 2000, IONICS, V6, P70, DOI 10.1007/BF02375549; Varez A, 2001, J MATER CHEM, V11, P125, DOI 10.1039/b003305g; Wang GX, 2000, J MATER SCI, V35, P4289, DOI 10.1023/A:1004876100938; Watanabe H, 1997, J POWER SOURCES, V68, P421, DOI 10.1016/S0378-7753(97)02645-1; West A.R., 2002, BASIC SOLID STATE CH, Vsecond	26	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596	1095-726X		J SOLID STATE CHEM	J. Solid State Chem.	MAY	2015	225						431	437		10.1016/j.jssc.2015.01.007		7	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	CF8QW	WOS:000352828000061		
J	Nagai, D; Kinemuchi, Y; Suzuki, K; Towata, A; Yasuoka, M				Nagai, Daisuke; Kinemuchi, Yoshiaki; Suzuki, Kazuyuki; Towata, Atsuya; Yasuoka, Masaki			Highly dispersive alpha ''-Fe16N2 particle synthesis using hydroxyapatite coating	JOURNAL OF SOLID STATE CHEMISTRY			English	Article						alpha ''-Fe16N2; Nanoparticle; Sintering; Hydroxyapatite	GIANT MAGNETIC-MOMENT; FE16N2 FILMS; NITRIDATION; DENSITY; PLASMA	Alpha ''-Fe16N2 nanoparticles (NPs) with high magnetic crystalline anisotropy are useful for practical applications such as recording media. However, due to their strongly aggregated and/or sintered form, which occurs during synthesis, the utilization of the NPs has been limited thus far. Here, we report a method for synthesizing highly dispersive alpha ''-Fe16N2 NPs using hydroxyapatite (HAp). The chemically and thermally stable structure of the HAp coating results in the isolation of individual NPs, such that sintering is prevented during synthesis. Additionally, the acicular shape of the HAp crystal did not hinder gas diffusion during the gas reaction. Finally, HAp can be removed by a chelating agent without deteriorating the magnetic properties, resulting in highly dispersive alpha ''-Fe16N2 NPs. (C) 2015 Elsevier Inc. All rights reserved.	[Nagai, Daisuke; Kinemuchi, Yoshiaki; Suzuki, Kazuyuki; Towata, Atsuya; Yasuoka, Masaki] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Kinemuchi, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Moriyama Ku, 2266-98 Anagahora, Nagoya, Aichi 4638560, Japan.	y.kinemuchi@aist.go.jp			project entitled Future Pioneering Projects/Development of magnetic material technology for high-efficiency motors in Japan	This work was supported by the project entitled Future Pioneering Projects/Development of magnetic material technology for high-efficiency motors in Japan.	Takagi K, 2014, J APPL PHYS, V115, DOI 10.1063/1.4868295; Lian JB, 2009, ACS NANO, V3, P3749, DOI 10.1021/nn900941e; KIM TK, 1972, APPL PHYS LETT, V20, P492, DOI 10.1063/1.1654030; Ogawa T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.073007; Gaudisson T, 2014, J MAGN MAGN MATER, V370, P87, DOI 10.1016/j.jmmm.2014.06.014; STONER EC, 1948, PHILOS TR R SOC S-A, V240, P599, DOI 10.1098/rsta.1948.0007; COEY JMD, 1994, J PHYS-CONDENS MAT, V6, pL23, DOI 10.1088/0953-8984/6/4/001; Hattori T., 2001, Journal of the Magnetics Society of Japan, V25, DOI 10.3379/jmsjmag.25.927; JACK KH, 1951, PROC R SOC LON SER-A, V208, P216, DOI 10.1098/rspa.1951.0155; Ke LQ, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.024404; KOMURO M, 1990, J APPL PHYS, V67, P5126, DOI 10.1063/1.344689; Lee DW, 2010, J MATER SCI TECHNOL, V26, P367; Nagatomi A., 1999, J JPN SOC POW POW ME, V49, P151; NAKAJIMA K, 1990, APPL PHYS LETT, V56, P92, DOI 10.1063/1.102614; SAKUMA A, 1991, J MAGN MAGN MATER, V102, P127, DOI 10.1016/0304-8853(91)90277-H; Sasaki Y, 2005, IEEE T MAGN, V41, P3241, DOI 10.1109/TMAG.2005.855247; Shibata K., 2006, Journal of the Magnetics Society of Japan, V30, DOI 10.3379/jmsjmag.30.501; Shoji H, 1996, J MAGN MAGN MATER, V162, P202, DOI 10.1016/S0304-8853(96)00276-4; Takahashi H, 1999, IEEE T MAGN, V35, P2982, DOI 10.1109/20.801054; TAKAHASHI H, 1993, J APPL PHYS, V73, P6060, DOI 10.1063/1.353469; TAKAHASHI M, 1993, IEEE T MAGN, V29, P3040, DOI 10.1109/20.281111; Takahashi M, 2000, J MAGN MAGN MATER, V208, P145, DOI 10.1016/S0304-8853(99)00536-3; Takahashi M, 2002, J MAGN MAGN MATER, V239, P479, DOI 10.1016/S0304-8853(01)00661-8; Wang JP, 2012, IEEE T MAGN, V48, P1710, DOI 10.1109/TMAG.2011.2170156; Yamanaka K, 2010, J SOLID STATE CHEM, V183, P2236, DOI 10.1016/j.jssc.2010.07.045; Yamashita S, 2012, J SOLID STATE CHEM, V194, P76, DOI 10.1016/j.jssc.2012.07.025	26	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596	1095-726X		J SOLID STATE CHEM	J. Solid State Chem.	MAY	2015	225						455	458		10.1016/j.jssc.2015.01.024		4	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	CF8QW	WOS:000352828000064		
J	Awad, MI; Saleh, MM; Ohsaka, T				Awad, M. I.; Saleh, M. M.; Ohsaka, T.			Electroactivity regeneration of sulfur-poisoned platinum nanoparticle-modified glassy carbon electrode at low anodic potentials	JOURNAL OF SOLID STATE ELECTROCHEMISTRY			English	Article						SO2 tolerance; Platinum nanoparticles; Oxygen reduction; Adsorption; RRDE	SINGLE-CRYSTAL PLATINUM; FORMIC-ACID OXIDATION; ROTATING-RING-DISK; OXYGEN REDUCTION; POLYCRYSTALLINE PLATINUM; HYDROGEN ADSORPTION; PREADSORBED SULFUR; PT(111) ELECTRODE; PARTICLE-SIZE; DIOXIDE	This paper focuses on the oxidative regeneration of the electroactivity of sulfur-poisoned polycrystalline Pt (poly-Pt) electrode and Pt nanoparticles-modified glassy carbon (nano-Pt/GC) electrode in O-2-saturated 0.1 M HClO4. Recovery of the electroactivity is examined using oxygen reduction reaction (ORR) as a probing reaction. Recovery of the poisoned electrodes is attempted by applying several potential cycles in the range of 0.06 similar to 1.06 V (reversible hydrogen electrode, RHE) for avoiding the dissolution of platinum when the potential is excursed to higher positive values. The recovery of the poisoned electrodes is significantly affected by the dissolved oxygen, i.e., the recovery is more effective under O-2 atmosphere than under N-2 atmosphere. Moreover, the recovery performance of the nano-Pt/GC electrode is more considerable than that of the poly-Pt electrode. The easier recovery of the former electrode is attributed to the relative small ratio of Pt(100) facet as revealed from the facet-dependent voltammetric behavior for the oxidation of formic acid at the Pt electrode in HClO4 solution and from the X-ray diffraction spectrum of the nano-Pt/GC electrode. Interestingly, controlling the potential range for recovery and the number of potential cycles was found to lead to a remarkable electrocatalytic activity of the electrodes for the ORR. A plausible explanation for the obtained results is given in view of the voltammetric measurements.	[Awad, M. I.; Saleh, M. M.; Ohsaka, T.] Tokyo Inst Technol, Dept Elect Chem, Interdisciplinary Grad Sch Sci & Engn, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Awad, M. I.; Saleh, M. M.] Cairo Univ, Fac Sci, Dept Chem, Cairo, Egypt; [Awad, M. I.] Umm Al Qura Univ, Fac Sci Appl, Dept Chem, Makkah Al Mukarramah 13401, Saudi Arabia	Ohsaka, T (reprint author), Tokyo Inst Technol, Dept Elect Chem, Interdisciplinary Grad Sch Sci & Engn, Midori Ku, 4259-G1-5 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	ohsaka@echem.titech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [19206079]; New Energy and Industrial Technology Development Organization (NEDO), Japan	This work was financially supported by the Grant-in-Aid for Scientific Research (A) (no. 19206079) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan and the New Energy and Industrial Technology Development Organization (NEDO), Japan.	Nagahara Y, 2008, J POWER SOURCES, V182, P422, DOI 10.1016/j.jpowsour.2007.12.091; Mohtadi R, 2003, ELECTROCHEM SOLID ST, V6, pA272, DOI 10.1149/1.1621831; Fernandez PS, 2013, ELECTROCHIM ACTA, V98, P25, DOI 10.1016/j.electacta.2013.02.129; Zhao MC, 2004, J ELECTROCHEM SOC, V151, pA131, DOI 10.1149/1.1630806; TAKASU Y, 1984, CHEM PHYS LETT, V108, P384, DOI 10.1016/0009-2614(84)85211-2; Dekanski A, 2001, CARBON, V39, P1195, DOI 10.1016/S0008-6223(00)00228-1; Genies L, 1998, ELECTROCHIM ACTA, V44, P1317, DOI 10.1016/S0013-4686(98)00254-0; Adzic RR, 1998, J PHYS CHEM B, V102, P8988, DOI 10.1021/jp981057z; Ahmed MS, 2013, ELECTROCHIM ACTA, V92, P168, DOI 10.1016/j.electacta.2012.10.160; Samjeske G, 2006, J PHYS CHEM B, V110, P16559, DOI 10.1021/jp0618911; WANG T, 1982, J CATAL, V78, P306, DOI 10.1016/0021-9517(82)90315-3; LOUCKA T, 1972, J ELECTROANAL CHEM, V36, P355, DOI 10.1016/0368-1874(72)80098-4; CLAVILIER J, 1981, J ELECTROANAL CHEM, V124, P321, DOI 10.1016/S0022-0728(81)80311-7; Takasu Y, 1996, ELECTROCHIM ACTA, V41, P2595, DOI 10.1016/0013-4686(96)00081-3; Bonakdarpour A, 2007, ELECTROCHIM ACTA, V53, P688, DOI 10.1016/j.electacta.2007.07.038; Mayrhofer KJJ, 2005, J PHYS CHEM B, V109, P14433, DOI 10.1021/jp051735z; Macia MD, 2004, J ELECTROANAL CHEM, V564, P141, DOI 10.1016/j.jelechem.2003.09.035; Awad MI, 2001, J POWER SOURCES, V196, P3722; BERGERET G, 1984, J CATAL, V87, P86, DOI 10.1016/0021-9517(84)90170-2; BILLY J, 1984, SURF SCI, V146, pL525; BITTINSCATTANEO B, 1986, ELECTROCHIM ACTA, V31, P1495, DOI 10.1016/0013-4686(86)87067-0; El-Deab MS, 2005, J ELECTROCHEM SOC, V152, pC1, DOI 10.1149/1.1824041; Erikson H, 2013, J ELECTROANAL CHEM, V691, P35, DOI 10.1016/j.jelechem.2012.12.018; FISCHER TE, 1978, J CATAL, V53, P24, DOI 10.1016/0021-9517(78)90004-0; FORAL MJ, 1988, J ELECTROANAL CHEM, V246, P193, DOI 10.1016/0022-0728(88)85060-5; FORAL MJ, 1988, ELECTROCHIM ACTA, V33, P257, DOI 10.1016/0013-4686(88)80012-4; FRELINK T, 1995, ELECTROCHIM ACTA, V40, P545, DOI 10.1016/0013-4686(95)00005-Y; Garsany Y, 2009, J ELECTROCHEM SOC, V156, pB844; Han SJ, 2001, J ELECTROANAL CHEM, V655, P39; HUBBARD AT, 1978, J ELECTROANAL CHEM, V86, P271, DOI 10.1016/S0022-0728(78)80003-5; JAYARAM R, 1978, J ELECTROANAL CHEM, V87, P225, DOI 10.1016/S0022-0728(78)80304-0; Jovanovic VM, 2005, ELECTROCHEM COMMUN, V7, P1039, DOI 10.1016/j.elecom.2005.07.009; LAMYPITARA E, 1985, ELECTROCHIM ACTA, V30, P971, DOI 10.1016/0013-4686(85)80158-4; LANGER SH, 1987, J MOL CATAL, V42, P331, DOI 10.1016/0304-5102(87)85007-1; LOUCKA T, 1971, J ELECTROANAL CHEM, V31, P319, DOI 10.1016/S0022-0728(71)80162-6; LYKE SE, 1991, J ELECTROCHEM SOC, V138, P1682, DOI 10.1149/1.2085853; MARCUS P, 1985, SURF SCI, V161, P533, DOI 10.1016/0039-6028(85)90826-X; Maruyama J, 1998, J ELECTROANAL CHEM, V458, P175, DOI 10.1016/S0022-0728(98)00362-3; McClune W. F., 2003, POWDER DIFFRACTION F; Mo YB, 2003, J ELECTROCHEM SOC, V150, pE39, DOI 10.1149/1.1525270; Mohtadi R, 2005, APPL CATAL B-ENVIRON, V56, P37, DOI 10.1016/j.apcatb.2004.08.012; Narayanamoorthy B, 2012, J COLLOID INTERF SCI, V387, P213, DOI 10.1016/j.jcis.2012.08.002; QUIJADA C, 1994, J ELECTROANAL CHEM, V372, P243, DOI 10.1016/0022-0728(93)03261-M; QUIJADA C, 1995, J ELECTROANAL CHEM, V394, P217, DOI 10.1016/0022-0728(95)03988-S; Rodriguez JA, 1996, CHEM PHYS LETT, V251, P13, DOI 10.1016/0009-2614(96)00066-8; Ross NP, 1977, J ELECTROANAL CHEM, V76, P139; Seo E. T., 1965, ELECTROCHIM ACTA, V10, P239, DOI 10.1016/0013-4686(65)87022-0; Seo ET, 1996, J ELECTROANAL CHEM, V7, P184; SPOTNITZ RM, 1983, ELECTROCHIM ACTA, V28, P1053, DOI 10.1016/0013-4686(83)80008-5; SUMINO MP, 1992, ELECTROCHIM ACTA, V37, P2629, DOI 10.1016/0013-4686(92)87062-5; SZKLARCZYK M, 1982, J ELECTROANAL CHEM, V132, P263, DOI 10.1016/0022-0728(82)85023-7; Tsou Y, 2008, ECS T, V13, P67; VETTER KJ, 1972, J ELECTROANAL CHEM, V34, P131, DOI 10.1016/0022-0728(72)80015-9; YAMAMOTO K, 1979, J ELECTROANAL CHEM, V96, P233, DOI 10.1016/S0022-0728(79)80380-0; YANG QM, 1994, J ELECTROCHEM SOC, V141, P2108, DOI 10.1149/1.2055069; YEAGER E, 1978, J ELECTROCHEM SOC, V125, P348, DOI 10.1149/1.2131445; Zewde BW, 2012, J POWER SOURCES, V216, P502, DOI 10.1016/j.jpowsour.2012.06.058	57	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-8488	1433-0768		J SOLID STATE ELECTR	J. Solid State Electrochem.	MAY	2015	19	5					1331	1340		10.1007/s10008-014-2470-7		10	Electrochemistry	Electrochemistry	CG4DV	WOS:000353234200009		
J	Sato, K; Yamada, M; Okutomi, T; Kato, R; Unno, N; Fujii, K; Kumabe, T				Sato, Kimitoshi; Yamada, Masaru; Okutomi, Toshiyuki; Kato, Rie; Unno, Nobuya; Fujii, Kiyotaka; Kumabe, Toshihiro			Vaginal Delivery under Epidural Analgesia in Pregnant Women with a Diagnosis of Moyamoya Disease	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Analgesia; cesarean section; delivery; moyamoya; stroke; vaginal delivery	CESAREAN-SECTION; ANESTHETIC MANAGEMENT; HEMORRHAGE; PATIENT; TRAUMA; JAPAN; BRAIN; BIRTH; RISK	Background: Moyamoya disease more commonly occurs in young people and women, so patients with this disease may experience pregnancy and delivery. Cesarean section (CS) is often chosen as the mode of delivery for these patients in Japan. No appropriate mode of delivery has yet been established for pregnant women with moyamoya disease in terms of stroke prevention. We have used vaginal delivery under epidural analgesia (EA) in such patients unless CS has been indicated for the maternal or fetal reasons. This study retrospectively analyzed our patients with moyamoya disease who gave birth to confirm the safety of vaginal delivery under EA. Methods: Twelve consecutive patients diagnosed with moyamoya disease had 14 deliveries at our hospital between September 2004 and January 2013. The incidences of intrapartum stroke were compared between cases of vaginal delivery under EA and CS cases. Results: Ten vaginal deliveries under EA and 4 elective CSs were performed. No intrapartum stroke was observed during either vaginal delivery under EA or CS. Among the patients who underwent vaginal delivery under EA, 1 parturient who experienced 2 deliveries suffered transient ischemic attack during both postpartum periods. All 14 infants were healthy without sequelae. Conclusions: Vaginal delivery under EA is an option for patients with moyamoya disease, provided that close cooperation with neurosurgeons, obstetricians, and anesthesiologists is assured.	[Sato, Kimitoshi; Yamada, Masaru; Fujii, Kiyotaka; Kumabe, Toshihiro] Kitasato Univ, Sch Med, Dept Neurosurg, Sagamihara, Kanagawa 2520374, Japan; [Okutomi, Toshiyuki] Kitasato Univ, Sch Med, Dept Anesthesiol, Sagamihara, Kanagawa 2520374, Japan; [Kato, Rie] Kitasato Univ, Sch Med, Div Anesthesiol & Reanimatol Paturients Fetuses I, Res & Dev Ctr New Med Frontiers, Sagamihara, Kanagawa 2520374, Japan; [Unno, Nobuya] Kitasato Univ, Dept Obstet, Sch Med, Sagamihara, Kanagawa 2520374, Japan	Sato, K (reprint author), Kitasato Univ, Sch Med, Dept Neurosurg, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	kimitoshi@k8.dion.ne.jp					AMIAS A G, 1970, Journal of Obstetrics and Gynaecology of the British Commonwealth, V77, P100; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; Noguchi T, 2013, EUR J RADIOL, V82, pE840, DOI 10.1016/j.ejrad.2013.08.040; Meyer S, 1998, OBSTET GYNECOL, V92, P613, DOI 10.1016/S0029-7844(98)00248-8; Liu SL, 2005, OBSTET GYNECOL, V105, P836, DOI 10.1097/01.AOG.0000154153.31193.2c; Doumouchtsis SK, 2008, CLIN PERINATOL, V35, P69, DOI 10.1016/j.clp.2007.11.006; [Anonymous], 2012, NEUROL MED CHIR TOKY, V52, P245; Miyamoto S, 2014, STROKE, V45, P1415, DOI 10.1161/STROKEAHA.113.004386; DIAS MS, 1990, NEUROSURGERY, V27, P855; Edozien LC, 2007, BEST PRACT RES CL OB, V21, P639, DOI 10.1016/j.bpobgyn.2007.03.006; Hashimoto K, 1988, Neurol Med Chir (Tokyo), V28, P588, DOI 10.2176/nmc.28.588; Kato R, 2006, INT J OBSTET ANESTH, V15, P152, DOI 10.1016/j.ijoa.2005.06.012; Komiyama M, 1998, NEUROSURGERY, V43, P360, DOI 10.1097/00006123-199808000-00114; Kume N, 1997, J NUCL MED, V38, P1894; Meyer S, 2000, BRIT J OBSTET GYNAEC, V107, P1360, DOI 10.1111/j.1471-0528.2000.tb11648.x; Miller ES, 2013, OBSTET GYNECOL, V121, P789, DOI 10.1097/AOG.0b013e3182878b43; MIYAKAWA I, 1986, ARCH GYNECOL OBSTET, V237, P175, DOI 10.1007/BF02133862; Nakago S, 1990, SANFUJINKA NO SHINPO, V42, P142; D'Alton ME, 2006, OBSTET GYNECOL, V107, P1386; Saruki N, 1990, RINSHO MASUI, V14, P51; Sasaki J, 1984, SANKA TO FUJINKA, V1, P109; SHARMA SK, 1994, ANESTH ANALG, V79, P183; Shimamoto Yoshinori, 1994, Neurological Surgery, V22, P867; Sun JCL, 2000, CAN J NEUROL SCI, V27, P73; Takahashi JC, 2012, NEUROL MED-CHIR, V52, P304; Takaoka S, 1994, NIHON RINSHO MASUI G, V14, P802; Williams DL, 2000, CAN J ANAESTH, V47, P996; Yih PSW, 1999, ANAESTH INTENS CARE, V27, P66; Yoshitani K, 2013, NEUROL MED-CHIR, V53, P537	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAY	2015	24	5					921	924		10.1016/j.jstrokecerebrovasdis.2014.11.030		4	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CG3MZ	WOS:000353185600010		
J	Takahashi, S; Tanizaki, Y; Kimura, H; Akaji, K; Kano, T; Suzuki, K; Takayama, Y; Kanzawa, T; Shidoh, S; Nakazawa, M; Yoshida, K; Mihara, B				Takahashi, Satoshi; Tanizaki, Yoshio; Kimura, Hiroaki; Akaji, Kazunori; Kano, Tadashige; Suzuki, Kentaro; Takayama, Youhei; Kanzawa, Takao; Shidoh, Satoka; Nakazawa, Masaki; Yoshida, Kazunari; Mihara, Ban			Prediction of Cerebrovascular Reserve Capacity by Computed Tomography Perfusion Using 320-Row Computed Tomography	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						320-row CT; CT perfusion; xenon CT; CVRC; TTP; automated ROI	MOYAMOYA-DISEASE; PULMONARY-EDEMA; ACETAZOLAMIDE; CT; BYPASS; PET	Background: Acetazolamide loading has been the "gold standard'' for evaluating cerebrovascular reserve capacity (CVRC). However, life-threatening side effects of acetazolamide have recently been reported. The aim of the study was to identify alternative methods for evaluating CVRC. Methods: We reviewed 6 patients who underwent both computed tomography perfusion (CTP) imaging and xenon CT (XeCT) imaging with and without acetazolamide loading during the same periods. The data were obtained as volume data using 320-row CT and applied to the automated region of interest-determining software and converted to standardized images. Correlations between CVRC and CTP parameters were analyzed by Pearson correlation coefficient analysis, and simple regression was used to assess the relationship between the data. When statistically significant, correlation between CVRC and any CTP data is identified, and cutoff points for CVRC 30% and 10% were calculated with receiver operating characteristic curves. Results: Of 4 CTP parameters evaluated, statistically significant correlations were observed between time to peak (TTP) by CTP and CVRC (P < .0001, r = -.7228) calculated from XeCT. The regression line using CVRC as outcome variable (y) and using TTP as predictor variable (x) was y = -9.062x + 140.1. The cutoff value for the TTP for CVRC less than 10% was 12.56 seconds (sensitivity of 86% and specificity of 85%) and that for CVRC less than 30% was 9.34 seconds (sensitivity of 77% and specificity of 96%). Conclusions: TTP calculated from CTP data correlated well with the CVRC calculated from XeCT data. These results suggest that TTP calculated from CTP could be used to estimate CVRC in patients with occlusive cardiovascular disease.	[Takahashi, Satoshi; Tanizaki, Yoshio; Akaji, Kazunori; Kano, Tadashige; Shidoh, Satoka] Mihara Mem Hosp, Inst Brain & Blood Vessels, Dept Neurosurg, Gunma, Japan; [Takahashi, Satoshi; Yoshida, Kazunari; Mihara, Ban] Keio Univ, Sch Med, Dept Neurosurg, Shinjuku Ku, Tokyo 1068582, Japan; [Kimura, Hiroaki] Mihara Mem Hosp, Inst Brain & Blood Vessels, Dept Neurol, Gunma, Japan; [Suzuki, Kentaro; Takayama, Youhei] Nippon Med Sch, Dept Neurol, Bunkyo Ku, Tokyo 113, Japan; [Suzuki, Kentaro; Takayama, Youhei; Kanzawa, Takao] Mihara Mem Hosp, Inst Brain & Blood Vessels, Dept Stroke Med, Gunma, Japan; [Nakazawa, Masaki] Mihara Mem Hosp, Inst Brain & Blood Vessels, Dept Image Diag, Gunma, Japan	Takahashi, S (reprint author), Keio Univ, Sch Med, Dept Neurosurg, Shinjuku Ku, Shinanomachi 35, Tokyo 1068582, Japan.	satoshi710@mac.com					Smith MR, 2004, MAGNET RESON MED, V51, P631, DOI 10.1002/mrm.20006; Marushima A, 2011, WORLD NEUROSURG, V76, P304, DOI 10.1016/j.wneu.2011.02.004; Donahue MJ, 2014, STROKE, V45, P2335, DOI 10.1161/STROKEAHA.114.005975; Huang APH, 2014, J NEUROSURG, V120, P473, DOI 10.3171/2013.10.JNS13103; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Honda M, 2012, NEUROL MED-CHIR, V52, P488; Heiss WD, 2014, NEUROSCI BULL, V30, P713, DOI 10.1007/s12264-014-1463-y; Vogiatzis I, 2013, HIPPOKRATIA, V17, P177; BARON JC, 1981, STROKE, V12, P454; D'Onofrio M, 2014, J COMPUT ASSIST TOMO, V38, P733, DOI 10.1097/RCT.0000000000000102; Eicker S, 2011, EUR J MED RES, V16, P484; Imaizumi M, 2004, ANN NUCL MED, V18, P369, DOI 10.1007/BF02984479; KURODA S, 1990, Neurological Surgery, V18, P259; Mesiwala AH, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/2/E15; Nakamura T, 2013, ACTA NEUROCHIR SUPPL, V115, P81, DOI 10.1007/978-3-7091-1192-5_18; Ogasawara Kuniaki, 2006, Nihon Rinsho, V64 Suppl 7, P524; Schubert GA, 2009, NEUROSURG REV, V32, P35; Schubert GA, 2009, NEUROSURG REV, V32, P29, DOI 10.1007/s10143-008-0159-z; Takahashi S, J STROKE CE IN PRESS; Takeuchi Ryo, 2006, Radiat Med, V24, P538, DOI 10.1007/s11604-006-0054-x; Urbanova B, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00004; Zimmermann S, 2014, HEART LUNG, V43, P124, DOI [10.1016/j.hrtlng.2013.11.008, 10.1016/j.hrtIng.2013.11.008]	22	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAY	2015	24	5					939	945		10.1016/j.jstrokecerebrovasdis.2014.12.010		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CG3MZ	WOS:000353185600013		
J	Gon, Y; Sakaguchi, M; Okazaki, S; Mochizuki, H; Kitagawa, K				Gon, Yasufumi; Sakaguchi, Manabu; Okazaki, Shuhei; Mochizuki, Hideki; Kitagawa, Kazuo			Prevalence of Positive Diffusion-Weighted Imaging Findings and Ischemic Stroke Recurrence in Transient Ischemic Attack	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Transient ischemic attack; etiology; diffusion-weighted imaging; D-dimer; ischemic stroke recurrence	MINOR STROKE; D-DIMER; RISK; DIAGNOSIS; SUBTYPES; LESIONS; SCORE	Background: The relationship between transient ischemic attack (TIA) clinical etiology, positive diffusion-weighted imaging (DWI) findings, and stroke recurrence is controversial. This study aimed to clarify the prevalence of positive DWI findings and TIA recurrence in relation to TIA patient characteristics. Methods: The subjects were patients admitted to our stroke unit within 7 days after symptom onset between January 2006 and July 2013. We examined DWI findings and TIA recurrence according to etiologic subtypes. Results: We enrolled 139 patients with lacunar TIA (n = 17), atherothrombotic TIA (n = 35), cardioembolic TIA (n = 25), TIA due to other causes (n = 32), or TIA with undetermined etiology (n = 30). The prevalence of positive DWI findings was highest among the cardioembolic TIA patients (56.0%). No association was found between the prevalence of positive DWI findings and symptom duration, motor presence, or ABCD 2 score. Plasma D-dimer level was significantly higher in the DWI-positive group than that in the DWI-negative group (P = .01). The prevalence of TIA recurrence was highest (5 of 35, 14.3%) among the atherothrombotic TIA patients, regardless of positive DWI findings. None of the patients treated with the anticoagulant and antiplatelet combination therapy experienced a recurrence. In contrast, almost all patients with cardioembolic TIA received anticoagulant treatment and none experienced recurrence. Conclusions: The prevalence of positive DWI findings was high among the cardiogenic TIA patients. TIA recurrence was often observed among the atherothrombotic TIA patients treated with antiplatelets. Management of patients with atherothrombotic TIA requires further aggressive antithrombotic strategy.	[Gon, Yasufumi; Sakaguchi, Manabu; Okazaki, Shuhei; Mochizuki, Hideki] Osaka Univ, Grad Sch Med, Dept Neurol & Stroke Ctr, Suita, Osaka 5650871, Japan; [Kitagawa, Kazuo] Tokyo Womens Med Univ, Dept Neurol, Tokyo, Japan	Gon, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Neurol & Stroke Ctr, 2-2 Yamada, Suita, Osaka 5650871, Japan.	gon@neurol.med.osaka-u.ac.jp					Ageno W, 2002, ARCH INTERN MED, V162, P2589, DOI 10.1001/archinte.162.22.2589; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; LaMonte MP, 2004, STROKE, V35, P1677, DOI 10.1161/01.STR.0000131549.20581.ba; Calvet D, 2009, STROKE, V40, P187, DOI 10.1161/STROKEAHA.108.515817; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; Mlynash M, 2009, NEUROLOGY, V72, P1127, DOI 10.1212/01.wnl.0000340983.00152.69; Purroy F, 2004, STROKE, V35, P2313, DOI 10.1161/01.STR.0000141703.21173.91; Crisostomo RA, 2003, STROKE, V34, P932, DOI 10.1161/01.STR.0000061496.00669.5E; [Anonymous], 1990, STROKE, V21, P637; Coutts SB, 2005, ANN NEUROL, V57, P848, DOI 10.1002/ana.20497; Montaner J, 2008, STROKE, V39, P2280, DOI 10.1161/STROKEAHA.107.505354; Chatzikonstantinou A, 2013, CEREBROVASC DIS, V36, P106, DOI 10.1159/000352060; Cucchiara BL, 2009, J STROKE CEREBROVASC, V18, P367, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.006; FON EA, 1994, STROKE, V25, P282; Kobayashi W, 1997, SEMIN THROMB HEMOST, p[23, 531]; Purroy F, 2013, EUR J NEUROL, V20, P1088, DOI 10.1111/ene.12141; Redgrave JNE, 2007, STROKE, V38, P1482, DOI 10.1161/STROKEAHA.106.477380; Rovia A, 2003, AM J NEURORADIOL, V23, P77	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAY	2015	24	5					1000	1007		10.1016/j.jstrokecerebrovasdis.2014.12.023		8	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CG3MZ	WOS:000353185600022		
J	Uozumi, Y; Okamoto, S; Araki, Y; Izumi, T; Matsubara, N; Yokoyama, K; Sumitomo, M; Miyachi, S; Wakabayashi, T				Uozumi, Yoichi; Okamoto, Sho; Araki, Yoshio; Izumi, Takashi; Matsubara, Noriaki; Yokoyama, Kinya; Sumitomo, Masaki; Miyachi, Shigeru; Wakabayashi, Toshihiko			Treatment of Symptomatic Bilateral Cavernous Carotid Aneurysms: Long-term Results of 6 Cases	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Bilateral cavernous carotid aneurysms; treatment; bypass surgery; parent artery occlusion	SINUS ANEURYSMS; ENDOVASCULAR TREATMENT; MANAGEMENT STRATEGIES; ARTERY ANEURYSMS; OCCLUSION; REVASCULARIZATION; OUTCOMES; DISEASE; CHILD	Background: Bilateral cavernous carotid aneurysms (CCAs) are very rare. A treatment strategy for symptomatic bilateral CCAs has not been established because of their complex pathogenesis. Here we report our treatment strategy and long-term results for 6 cases of symptomatic bilateral CCAs. Methods: From January 2007 to December 2013, we treated 6 patients (2 men and 4 women; mean age at first treatment, 56.0 years) with symptomatic bilateral CCAs. Results: All patients began to experience unilateral symptoms. Five of the 6 underwent high-flow bypass (HFB) with parent artery occlusion (PAO), and 1 received PAO only. Mean follow-up period after the first treatment was 61.3 months. All symptoms improved after the treatment. Five contralateral CCAs became enlarged during the follow-up period. Of these, 4 became symptomatic. One patient received superficial temporal-middle cerebral artery bypass with PAO, 2 received HFB with PAO, and 1 refused treatment. Final modified Rankin Scale scores were 0 in 4 patients, 1 in 1 patient, and 2 in 1 patient. There was no mortality in this series. Conclusions: HFB with PAO is feasible as the first treatment for symptomatic bilateral CCAs. This treatment strategy steadies and simplifies future treatment of contralateral CCAs should they become symptomatic.	[Uozumi, Yoichi; Sumitomo, Masaki] Kami Iida Dai Ichi Gen Hosp, Dept Neurosurg, Nagoya, Aichi, Japan; [Uozumi, Yoichi; Okamoto, Sho; Araki, Yoshio; Izumi, Takashi; Matsubara, Noriaki; Yokoyama, Kinya; Sumitomo, Masaki; Wakabayashi, Toshihiko] Nagoya Univ, Dept Neurosurg, Grad Sch Med, Nagoya, Aichi 4468550, Japan; [Miyachi, Shigeru] Osaka Med Coll, Dept Neurosurg, Takatsuki, Osaka 569, Japan	Okamoto, S (reprint author), Nagoya Univ, Dept Neurosurg, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4468550, Japan.	soknouge@med.nagoya-u.ac.jp					Ahmed M, 2009, J COMPUT ASSIST TOMO, V33, P82, DOI 10.1097/RCT.0b013e31816fee76; Allen CA, 2008, AM J NEURORADIOL, V29, P7, DOI 10.3174/ajnr.A0755; Ambekar S, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.03.042; Field M, 2003, AM J NEURORADIOL, V24, P1200; Ramanathan D, 2012, NEUROSURGERY, V70, P1442, DOI 10.1227/NEU.0b013e31824c046f; Arambepola PK, 2010, SKULL BASE-INTERD AP, V20, P405, DOI 10.1055/s-0030-1253578; Goldenberg-Cohen N, 2004, J NEUROL NEUROSUR PS, V75, P863, DOI 10.1136/jnnp.2003.020917; Brinjikji W, 2013, STROKE, V44, P442, DOI 10.1161/STROKEAHA.112.678151; Kalani MYS, 2014, NEUROSURGERY, V74, P482, DOI 10.1227/NEU.0000000000000312; Shimizu H, 2010, CLIN NEUROL NEUROSUR, V112, P32, DOI 10.1016/j.clineuro.2009.10.002; STANDARD SC, 1995, AM J NEURORADIOL, V16, P1453; Puffer RC, 2014, AM J NEURORADIOL, V35, P948, DOI 10.3174/ajnr.A3826; Stiebel-Kalish H, 2005, NEUROSURGERY, V57, P850, DOI 10.1227/01.NEU.0000179922.48165.42; Caroli M, 2009, J NEUROSURG SCI, V53, P169; de Gast AN, 2007, AM J NEURORADIOL, V28, P508; Houkin K, 1999, J NEUROSURG, V90, P786, DOI 10.3171/jns.1999.90.4.0786; Ishishita Y, 2013, WORLD NEUROSURG, V82, P130; Kagawa K, 2007, NEUROL MED-CHIR, V47, P559, DOI 10.2176/nmc.47.559; Kai Y, 2007, SURG NEUROL, V67, P148, DOI 10.1016/j.surneu.2006.03.037; Kopsachilis N, 2013, CASE REP MED, V2013; Kupersmith Mark J, 2002, J Stroke Cerebrovasc Dis, V11, P9, DOI 10.1053/jscd.2002.123969; Rehman T, 2010, WORLD NEUROSURG, V73, P691, DOI 10.1016/j.wneu.2010.01.022; Schaller Bernhard, 2008, J Stroke Cerebrovasc Dis, V17, P287, DOI 10.1016/j.jstrokecerebrovasdis.2008.03.010; Starke RM, 2014, J CLIN NEUROSCI, V21, P40, DOI 10.1016/j.jocn.2013.03.003; Turfe ZA, 2014, J NEUROINTERV SURG; van Rooij WJ, 2012, AM J NEURORADIOL, V33, P323, DOI 10.3174/ajnr.A2759	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAY	2015	24	5					1013	1018		10.1016/j.jstrokecerebrovasdis.2014.12.027		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CG3MZ	WOS:000353185600024		
J	Kinoshita, S; Kakuda, W; Momosaki, R; Yamada, N; Sugawara, H; Watanabe, S; Abo, M				Kinoshita, Shoji; Kakuda, Wataru; Momosaki, Ryo; Yamada, Naoki; Sugawara, Hidekazu; Watanabe, Shu; Abo, Masahiro			Clinical Management Provided by Board-Certificated Physiatrists in Early Rehabilitation Is a Significant Determinant of Functional Improvement in Acute Stroke Patients: A Retrospective Analysis of Japan Rehabilitation Database	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Board-certificated physiatrist; acute stroke; early rehabilitation; Functional Independence Measure; home discharge	OUTCOMES; MEDICINE; PERSPECTIVE; TRIAL; SCALE	Background: Early rehabilitation for acute stroke patients is widely recommended. We tested the hypothesis that clinical outcome of stroke patients who receive early rehabilitation managed by board-certificated physiatrists (BCP) is generally better than that provided by other medical specialties. Methods: Data of stroke patients who underwent early rehabilitation in 19 acute hospitals between January 2005 and December 2013 were collected from the Japan Rehabilitation Database and analyzed retrospectively. Multivariate linear regression analysis using generalized estimating equations method was performed to assess the association between Functional Independence Measure (FIM) effectiveness and management provided by BCP in early rehabilitation. In addition, multivariate logistic regression analysis was also performed to assess the impact of management provided by BCP in acute phase on discharge destination. Results: After setting the inclusion criteria, data of 3838 stroke patients were eligible for analysis. BCP provided early rehabilitation in 814 patients (21.2%). Both the duration of daily exercise time and the frequency of regular conferencing were significantly higher for patients managed by BCP than by other specialties. Although the mortality rate was not different, multivariate regression analysis showed that FIM effectiveness correlated significantly and positively with the management provided by BCP (coefficient, .35; 95% confidence interval [CI], .012-.059; P<.005). In addition, multivariate logistic analysis identified clinical management by BCP as a significant determinant of home discharge (odds ratio, 1.24; 95% CI, 1.08-1.44; P<.005). Conclusions: Our retrospective cohort study demonstrated that clinical management provided by BCP in early rehabilitation can lead to functional recovery of acute stroke.	[Kinoshita, Shoji; Kakuda, Wataru; Momosaki, Ryo; Yamada, Naoki; Sugawara, Hidekazu; Watanabe, Shu; Abo, Masahiro] Jikei Univ, Sch Med, Dept Rehabil Med, Tokyo 1058461, Japan	Abo, M (reprint author), Jikei Univ, Sch Med, Dept Rehabil Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	abo@jikei.ac.jp					Inouye M, 2000, AM J PHYS MED REHAB, V79, P513, DOI 10.1097/00002060-200011000-00007; Ween JE, 1996, NEUROLOGY, V47, P388; Sulter G, 1999, STROKE, V30, P1538; Lohse KR, 2014, STROKE, V45, P2053, DOI 10.1161/STROKEAHA.114.004695; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Adams HP, 1999, NEUROLOGY, V53, P126; Iyegha UP, 2013, J AM COLL SURGEONS, V216, P363, DOI 10.1016/j.jamcollsurg.2012.11.008; Prystowsky JB, 2002, SURGERY, V132, P663, DOI 10.1067/msy.2002.127550; Bernhardt J, 2008, STROKE, V39, P390, DOI 10.1161/STROKEAHA.107.492363; Sharp LK, 2002, ACAD MED, V77, P534, DOI 10.1097/00001888-200206000-00011; Silber JH, 2002, ANESTHESIOLOGY, V96, P1044, DOI 10.1097/00000542-200205000-00004; Denti L, 2008, EUR J PHYS REHAB MED, V44, P3; Chumney D, 2010, J REHABIL RES DEV, V47, P17, DOI 10.1682/JRRD.2009.08.0140; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Bernhardt J, 2009, COCHRANE DATABASE SY, V21; Brandstater ME, 2000, ARCH PHYS MED REHAB, V81, P1234, DOI 10.1053/apmr.2000.17844; Chino N, 2000, ARCH PHYS MED REHAB, V81, P1248, DOI 10.1053/apmr.2000.17848; Franceschini M, 2009, AM J PHYS MED REHAB, V88, P596, DOI 10.1097/PHM.0b013e3181aea225; Han TR, 2007, AM J PHYS MED REHAB, V86, P335, DOI 10.1097/PHM.0b013e31804b1b3e; Izumi S, 2005, JPN J REHABIL MED, V42, P199; Jeong S, 2010, CLIN AUDIT, V2, P59; SHAH S, 1990, STROKE, V21, P241; Tanwir S, 2014, EUR J PHYS REHAB MED, V50, P355; Ward AB, 2005, AM J PHYS MED REHAB, V84, P233, DOI 10.1097/01.PHM.0000157105.59241.12; Westerkam WR, 1997, TOPICS STROKE REHABI, V4, P29	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAY	2015	24	5					1019	1024		10.1016/j.jstrokecerebrovasdis.2014.12.026		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CG3MZ	WOS:000353185600025		
J	Nakajima, M; Pearce, LA; Ohara, N; Field, TS; Bazan, C; Anderson, DC; Hart, RG; Benavente, OR				Nakajima, Makoto; Pearce, Lesly A.; Ohara, Nobuyuki; Field, Thalia S.; Bazan, Carlos; Anderson, David C.; Hart, Robert G.; Benavente, Oscar R.		SPS3 Investigators	Vertebrobasilar Ectasia in Patients with Lacunar Stroke: The Secondary Prevention of Small Subcortical Strokes Trial	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Lacunar stroke; prognosis; recurrent stroke; death; arterial diameter; vertebrobasilar ectasia	INTRACRANIAL ARTERIAL DOLICHOECTASIA; RESOLUTION COMPUTED-TOMOGRAPHY; SMALL-VESSEL DISEASE; BASILAR ARTERY; DILATATIVE ARTERIOPATHY; CARDIOVASCULAR EVENTS; NORTHERN MANHATTAN; NATURAL-HISTORY; ISCHEMIC-STROKE; RISK	Background: The clinical implications of vertebrobasilar ectasia (VBE) in patients with cerebral small-artery disease are not well defined. We investigated whether VBE is associated with recurrent stroke, major hemorrhage, and death in a large cohort of patients with recent lacunar stroke. Methods: Maximum diameters of the vertebral and basilar arteries were measured by magnetic resonance angiography and computed tomographic angiography in 2621 participants in the Secondary Prevention of Small Subcortical Strokes trial. VBE was defined a priori as basilar artery greater than 4.5 mm and/or vertebral artery greater than 4.0 mm. Patient characteristics and risks of stroke recurrence and mortality during follow-up (median, 3.5 years) were compared between patients with and without VBE. Results: VBE affecting 1 or more arteries was present in 200 (7.6%) patients. Patient features independently associated with VBE were increasing age, male sex, white race ethnicity, hypertension, and higher baseline diastolic blood pressure. Baseline systolic blood pressure was inversely associated with VBE. After adjustment for other risk factors, VBE was not predictive of recurrent stroke (hazard ratio [HR], 1.3; 95% confidence interval [CI],.85-1.9) or major hemorrhage (HR, 1.5; CI,.94-2.6), but was of death (HR, 1.7; CI, 1.1-2.7). Conclusions: In this large well-characterized cohort of patients with recent lacunar stroke, VBE was predictive of death but not of recurrent stroke or major hemorrhage. In these exploratory analyses, the frequency of VBE was directly related to diastolic blood pressure but inversely related to systolic blood pressure.	[Nakajima, Makoto; Field, Thalia S.; Benavente, Oscar R.] Univ British Columbia, Brain Res Ctr, Fac Med, Div Neurol, Vancouver, BC V6T 2B5, Canada; [Nakajima, Makoto; Field, Thalia S.; Benavente, Oscar R.] Kumamoto Univ, Grad Sch Med, Div Neurol, Kumamoto, Japan; [Pearce, Lesly A.] Biostat Consultant, Minot, ND USA; [Ohara, Nobuyuki] David Geffen Sch Med UCLA, UCLA Stroke Ctr, Dept Neurol, Los Angeles, CA USA; [Bazan, Carlos] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol, San Antonio, TX 78229 USA; [Anderson, David C.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Hart, Robert G.] McMaster Univ, Populat Hlth Res Inst, Div Neurol, Hamilton, ON, Canada	Nakajima, M (reprint author), Univ British Columbia, Brain Res Ctr, Fac Med, Div Neurol, S169-2211,Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	nakazima04@gmail.com		Field, Thalia/0000-0002-1176-0633	US National Institutes of Health [U01NS038529]; National Institute of Neurological Disorders and Stroke; Mochida Memorial Foundation for medical and pharmaceutical research by the Japan Society for the Promotion of Science for Young Researcher Overseas Visits Program for Vitalizing Brain Circulation; Start-up Program for International Collaborative Research in Young Researchers at Graduate School of Medical Sciences, Kumamoto University	SPS3 was supported by a Cooperative Agreement (U01NS038529) from the US National Institutes of Health and National Institute of Neurological Disorders and Stroke. M.N. is supported by the Mochida Memorial Foundation for medical and pharmaceutical research by the Japan Society for the Promotion of Science for Young Researcher Overseas Visits Program for Vitalizing Brain Circulation and by the Start-up Program for International Collaborative Research in Young Researchers at Graduate School of Medical Sciences, Kumamoto University.	Pico F, 2007, STROKE, V38, P1197, DOI 10.1161/01.STR.0000259708.05806.76; YU YL, 1982, J NEUROL NEUROSUR PS, V45, P29, DOI 10.1136/jnnp.45.1.29; Ince B, 1998, NEUROLOGY, V50, P1694; Tanaka M, 2013, ARTERIOSCL THROM VAS, V33, P2240, DOI 10.1161/ATVBAHA.113.301467; Passero SG, 2008, NEUROLOGY, V70, P66, DOI 10.1212/01.wnl.0000286947.89193.f3; Flemming KD, 2005, CEREBROVASC DIS, V20, P270, DOI 10.1159/000087710; Benavente OR, 2011, INT J STROKE, V6, P164, DOI 10.1111/j.1747-4949.2010.00573.x; Swartz RH, 2013, ARTERIOSCL THROM VAS, V33, P2051, DOI 10.1161/ATVBAHA.113.301837; Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Pico F, 2003, NEUROLOGY, V61, P1736; Anson JA, 1996, J NEUROSURG, V84, P185, DOI 10.3171/jns.1996.84.2.0185; ECHIVERRI HC, 1989, STROKE, V20, P1741; SMOKER WRK, 1986, AM J NEURORADIOL, V7, P61; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Pico F, 2005, NEUROLOGY, V65, P1503, DOI 10.1212/01.wnl.0000183285.80271.60; Ubogu EE, 2004, J NEUROL NEUROSUR PS, V75, P22; Passero SG, 2005, STROKE, V36, P1421, DOI 10.1161/01.STR.0000172311.64662.9c; Gutierrez J, 2011, NAT REV NEUROL, V7, P41, DOI 10.1038/nrneurol.2010.181; Caplan LR, 2005, ANN NEUROL, V57, P469, DOI 10.1002/ana.20447; Cheung RTF, 1998, STROKE, V29, P2213; DEEB ZL, 1979, J COMPUT ASSIST TOMO, V3, P774; Forster A, 2014, CLIN NEURORADIOL, V24, P347, DOI 10.1007/s00062-013-0261-7; Gutierrez J, 2014, J NEUROIMAGING, V24, P226, DOI 10.1111/j.1552-6569.2012.00781.x; Gutierrez J, 2011, STROKE, V42, pE188; Ikeda K, 2010, CEREBROVASC DIS, V30, P23, DOI 10.1159/000313440; Ionita CC, 2004, NEUROLOGY, V63, P596; Kumral E, 2005, EUR J NEUROL, V12, P437, DOI 10.1111/j.1468-1331.2005.00993.x; Kwon Hyung-Min, 2011, Curr Treat Options Cardiovasc Med, V13, P261, DOI 10.1007/s11936-011-0123-z; Matsukawa H, 2012, CEREBROVASC DIS, V34, P393, DOI 10.1159/000345079; MILANDRE L, 1991, REV NEUROL, V147, P714; Nakamura Y, 2012, J STROKE CEREBROVASC, V21, P5, DOI 10.1016/j.jstrokecerebrovasdis.2010.04.003; NISHIZAKI T, 1986, STROKE, V17, P1277; Park JM, 2013, EUR J NEUROL, V20, P824, DOI 10.1111/ene.12075; Passero S, 1998, STROKE, V29, P653; Pico F, 2006, STROKE, V37, P2342, DOI 10.1161/01.STR.0000236058.57880.03; Pico F, 2005, ANN NEUROL, V57, P472, DOI 10.1002/ana.20423; RESTA M, 1984, NEURORADIOLOGY, V26, P213; SMOKER WRK, 1986, AM J NEURORADIOL, V7, P55; Ubogu EE, 2005, NEUROLOGY, V65, P1681; White CL, 2012, J STROKE CEREBROVASC, V22, P764; Wolfe Thomas, 2008, J Stroke Cerebrovasc Dis, V17, P388, DOI 10.1016/j.jstrokecerebrovasdis.2008.06.006	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAY	2015	24	5					1052	1058		10.1016/j.jstrokecerebrovasdis.2014.12.039		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CG3MZ	WOS:000353185600030		
J	Uno, H; Nagatsuka, K; Kokubo, Y; Higashi, M; Yamada, N; Umesaki, A; Toyoda, K; Naritomi, H				Uno, Hisakazu; Nagatsuka, Kazuyuki; Kokubo, Yoshihiro; Higashi, Masahiro; Yamada, Naoaki; Umesaki, Arisa; Toyoda, Kazunori; Naritomi, Hiroaki			Detectability of Ischemic Lesions on Diffusion-Weighted Imaging Is Biphasic after Transient Ischemic Attack	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Diffusion-weighted imaging; transient ischemic attack; refractory phase; detectability	DELAYED NEURONAL DEATH; CLINICAL CHARACTERISTICS; MRI ABNORMALITIES; CEREBRAL-ISCHEMIA; T2-WEIGHTED MRI; FOCAL ISCHEMIA; TIA PATIENTS; RAT-BRAIN; PERFUSION; INJURY	Background: Experimental studies of transient focal ischemia indicate biphasic detectability of lesions by diffusion-weighted imaging (DWI); poorly detectable phase exists at 1-12 hours after reperfusion. The present study aimed to clarify whether poorly detectable phase also exists in DWI of transient ischemic attack (TIA) patients. Methods: A retrospective study was conducted in 144 consecutive TIA patients who underwent magnetic resonance imaging (MRI) within 2 weeks after carotid TIA. Patients were classified into 9 groups according to time from disappearance of TIA symptoms to DWI: intraischemic period, 0-1 hour, 1-12 hours, 12-24 hours, 1-2 days, 2-3 days, 3-7 days, 7-10 days, and 10-14 days after the end of TIA. Results: Lesions were detected in 33 of 144 patients (22.9%). The frequency of positive lesions was 20% in the intraischemic period and 30.8% at 0-1 hour after the end of TIA; it markedly decreased to 8.7% at 1-12 hours after end of TIA. Thereafter, it increased to 21.7%, 30.8%, 36.4%, 37.0%, 38.5%, and 30% at 12-24 hours, 1-2 days, 2-3 days, 3-7 days, 7-10 days, and 10-14 days after the end of TIA, respectively. In 7 patients, MRI was repeated twice, at 1-12 hours and then at 5-13 days after the end of TIA. Lesions were never detected on the first MRI but were clearly demonstrated in 4 of 7 patients on the second MRI. Conclusions: The detectability of ischemic lesions may be biphasic after TIA as indicated by experimental studies.	[Uno, Hisakazu; Nagatsuka, Kazuyuki; Umesaki, Arisa; Naritomi, Hiroaki] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka, Japan; [Uno, Hisakazu] Takarazuka Sanda Hosp, Dept Internal Med, Sanda, Hyogo 6691537, Japan; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Suita, Osaka, Japan; [Higashi, Masahiro; Yamada, Naoaki] Natl Cerebral & Cardiovasc Ctr, Dept Radiol, Suita, Osaka, Japan; [Toyoda, Kazunori] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan	Uno, H (reprint author), Takarazuka Sanda Hosp, Dept Internal Med, 2-22-10 Nishiyama, Sanda, Hyogo 6691537, Japan.	hisaunotsh@leto.eonet.ne.jp	Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845			Albers GW, 2002, NEW ENGL J MED, V347, P1713, DOI 10.1056/NEJMsb020987; MINTOROVITCH J, 1991, MAGNET RESON MED, V18, P39, DOI 10.1002/mrm.1910180106; Li FH, 2000, STROKE, V31, P946; Inatomi Y, 2004, NEUROLOGY, V62, P376; ABE K, 1995, STROKE, V26, P1478; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; NITATORI T, 1995, J NEUROSCI, V15, P1001; Crisostomo RA, 2003, STROKE, V34, P932, DOI 10.1161/01.STR.0000061496.00669.5E; Kidwell CS, 1999, STROKE, V30, P1174; Dijkhuizen RM, 1998, STROKE, V29, P695; BUSZA AL, 1992, STROKE, V23, P1602; Carpentier N, 2012, J NEURORADIOLOGY, V39, P137, DOI 10.1016/j.neurad.2012.02.002; Haku T, 2006, BRAIN RES, V1100, P136, DOI 10.1016/j.brainres.2006.05.018; Inatomi Y, 2005, CEREBROVASC DIS, V19, P362, DOI 10.1159/000085203; Lecouvet FE, 1999, NEUROLOGY, V52, P1085; LEVY DE, 1979, NEUROLOGY, V29, P1245; Li FH, 2000, NEUROLOGY, V54, P689; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; MINEMATSU K, 1992, STROKE, V23, P1304; Miyasaka N, 2000, AM J NEURORADIOL, V21, P60; Rovira A, 2002, AM J NEURORADIOL, V23, P77; van Dorsten FA, 2002, MAGNET RESON MED, V47, P97, DOI 10.1002/mrm.10021	22	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAY	2015	24	5					1059	1064		10.1016/j.jstrokecerebrovasdis.2014.12.037		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CG3MZ	WOS:000353185600031		
J	Ogawa, K; Suzuki, Y; Oishi, M; Kamei, S				Ogawa, Katsuhiko; Suzuki, Yutaka; Oishi, Minoru; Kamei, Satoshi			Clinical Study of 46 Patients with Lateral Medullary Infarction	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Lateral medullary infarction; severe truncal ataxia; sensory disturbance; dysphagia; soft palate paralysis	IPSILATERAL AXIAL LATEROPULSION; DORSAL SPINOCEREBELLAR TRACT; LOWER BRAIN-STEM; WALLENBERGS-SYNDROME; LESIONS; DYSPHAGIA; NEURONS	Background: Lateral medullary infarction (LMI) exhibits a variety of clinical features. Various bulbar symptoms can occur in LMI. Methods: Neuroradiologic findings of 46 LMI patients were examined. Their infarcts were categorized into the rostral, middle, and caudal groups and were further subdivided into the anteromedial, anterolateral, lateral (L), and posterior regions. Results: The middle medulla was the most common site (27 patients). Most lesions affected the L region alone (25 patients). Dysarthria and facial palsy occurred significantly more frequently in the rostral group than those in the caudal group. Severe truncal ataxia was significantly more common in the caudal group than that in the rostral group. Twenty-five of the 28 patients with severe truncal ataxia displayed vestibular symptoms; otherwise, the other 3 patients showed absence of vestibular symptoms. Soft palate paralysis occurred at a significantly high frequency in the patients with dysphagia and hoarseness compared with the patients without these 2 symptoms. Segmental sensory disturbance occurred in 5 patients, 4 of whom exhibited atypical patterns. Conclusions: The results of our comparisons between the rostral and caudal groups were consistent with those of previous studies. The presence of severe truncal ataxia without vestibular symptoms in LMI was atypical. An analysis of the bulbar symptoms indicated that the extent to which soft palate paralysis contributed to dysphagia was associated with the severity of ischemia in the nucleus ambiguus. The present study showed variability in clinical features of LMI, which was related to differences in the severity and the extent of ischemia in the lateral medulla.	[Ogawa, Katsuhiko; Suzuki, Yutaka; Oishi, Minoru; Kamei, Satoshi] Nihon Univ, Sch Med, Dept Med, Div Neurol, Tokyo 1738610, Japan	Ogawa, K (reprint author), Nihon Univ, Sch Med, Dept Med, Div Neurol,Itabashi Ku, 30-1 Oyaguchi Kamimachi, Tokyo 1738610, Japan.	ogawa.katsuhiko@nihon-u.ac.jp					Aydogdu I, 2001, STROKE, V32, P2081, DOI 10.1161/hs0901.094278; EZURE K, 1988, BRAIN RES, V455, P262, DOI 10.1016/0006-8993(88)90085-6; Thomke F, 2005, NEUROLOGY, V64, P716; Kim JS, 1997, NEUROLOGY, V49, P1557; Fitzek S, 2001, ANN NEUROL, V49, P493; MATSUMOTO S, 1988, NEUROLOGY, V38, P1515; Kwon M, 2005, NEUROLOGY, V65, P714, DOI 10.1212/01.wnl.0000174441.39903.d8; VUILLEUMIER P, 1995, BRAIN, V118, P1013, DOI 10.1093/brain/118.4.1013; Zhang SQ, 2008, EUR NEUROL, V59, P211, DOI 10.1159/000114050; KIM JS, 1994, STROKE, V25, P1405; Kim JS, 2000, CEREBROVASC DIS, V10, P471, DOI 10.1159/000016110; Kim JS, 2003, BRAIN, V126, P1864, DOI 10.1093/brain/awg169; CURRIER RD, 1961, NEUROLOGY, V11, P778; Goto N, 1986, MED TRIBUNE, P109; Kim HJ, 2007, J CLIN NEUROL, V3, P197, DOI 10.3988/jcn.2007.3.4.197; Kim K, 2012, J CLIN NEUROL, V8, P116, DOI 10.3988/jcn.2012.8.2.116; Kim SH, 2004, CEREBROVASC DIS, V18, P344, DOI 10.1159/000080978; Maeda K, 2005, INTERNAL MED, V44, P1295, DOI 10.2169/internalmedicine.44.1295; Norrving Bo, 1991, NEUROLOGY, V41, P244; Nowak DA, 2006, J NEUROL, V253, P507, DOI 10.1007/s00415-005-0982-x; Ordas CM, 2011, J HEADACHE PAIN, V12, P377, DOI 10.1007/s10194-011-0305-9; Parent A, 1996, CARPENTERS HUMAN NEU, P421; Park MH, 2005, J NEUROL NEUROSUR PS, V76, P95, DOI 10.1136/jnnp.2004.039362; SACCO RL, 1993, ARCH NEUROL-CHICAGO, V50, P609; Terao S, 2000, J NEUROL NEUROSUR PS, V69, P262, DOI 10.1136/jnnp.69.2.262; Venketasubramanian N, 1999, CEREBROVASC DIS, V9, P157, DOI 10.1159/000015947	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAY	2015	24	5					1065	1074		10.1016/j.jstrokecerebrovasdis.2015.01.006		10	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CG3MZ	WOS:000353185600032		
J	Miyawaki, S; Imai, H; Shimizu, M; Yagi, S; Ono, H; Nakatomi, H; Shimizu, T; Saito, N				Miyawaki, Satoru; Imai, Hideaki; Shimizu, Masahiro; Yagi, Shinichi; Ono, Hideaki; Nakatomi, Hirofumi; Shimizu, Tsuneo; Saito, Nobuhito			Genetic Analysis of RNF213 c.14576G > A Variant in Nonatherosclerotic Quasi-Moyamoya Disease	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Quasi-moyamoya disease; RNF213; genetics; moyamoya disease	MAJOR ARTERY STENOSIS/OCCLUSION; R4810K RS112735431; VASCULOPATHY; PATHOGENESIS; JAPAN	Background: Quasi-moyamoya disease (MMD) and MMD (definite MMD) have similar cerebral angiographic features, but whether these related diseases have similar etiology or genetic background remains unclear. Recently, we have reported that the recently identified MMD susceptibility gene variant RNF213 c.14576G > A (rs112735431) was associated with atherosclerotic intracranial major artery stenosis/occlusion. The present study investigated the occurrence of RNF213 c.14576G > A in patients with nonatherosclerotic quasi-MMD. Methods: This study was a 2-hospital-based case-control study conducted at the Department of Neurosurgery, The University of Tokyo Hospital and Kanto Neurosurgical Hospital. A total of 87 Japanese patients who agreed to participate in this study were enrolled among both new and revisiting outpatients from October 2011 to December 2013 as follows: 78 patients with definite MMD and 9 patients with nonatherosclerotic quasi-MMD. Results: The 9 patients with nonatherosclerotic quasi-MMD included 3 patients with previous irradiation, 2 with hyperthyroidism, 1 with Turner syndrome, 1 with meningitis, 1 with Behc, et disease, and 1 with idiopathic pachymeningitis. The 78 patients with definite MMD included 66 patients (84.6%) with the c.14576G > Avariant (64 heterozygotes and 2 homozygous). In contrast, no patients with nonatherosclerotic quasi-MMD had the variant. Conclusions: Nonatherosclerotic quasi-MMD did not have RNF213 c.14576G > A variant. Moyamoya disease and related diseases might be classified by genetic analysis of the RNF213 c.14576G > A genotype. Further larger studies are required to confirm the present findings.	[Miyawaki, Satoru; Imai, Hideaki; Ono, Hideaki; Nakatomi, Hirofumi; Saito, Nobuhito] Univ Tokyo, Fac Med, Dept Neurosurg, Tokyo 1138655, Japan; [Shimizu, Masahiro; Yagi, Shinichi; Shimizu, Tsuneo] Kanto Neurosurg Hosp, Kumagaya, Saitama, Japan	Miyawaki, S (reprint author), Univ Tokyo, Fac Med, Dept Neurosurg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	miyawaki-tky@umin.ac.jp			Japan Society for the Promotion of Science [25293304, 25462206, 26893056]; SENSHIN Medical Research Foundation	This work was supported by a Grant-in-Aid for Scientific Research (B) (no. 25293304) to N.S., a Grant-in-Aid for Scientific Research (C) (no. 25462206) to H.I. and a Grant-in-Aid for Research Activity start-up (no. 26893056) to S.M. from the Japan Society for the Promotion of Science, and by grants from SENSHIN Medical Research Foundation to S.M. The other authors report no conflict.	SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Koss M, 2013, J NEUROSURG-PEDIATR, V11, P417, DOI 10.3171/2012.12.PEDS12281; Seol HJ, 2010, J NEUROS-PEDIATR, V5, P297, DOI 10.3171/2009.10.PEDS09452; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Hayashi K, 2013, CLIN NEUROL NEUROSUR, V115, P930, DOI 10.1016/j.clineuro.2012.09.020; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Miyawaki S, 2012, STROKE, V43, P3371, DOI 10.1161/STROKEAHA.112.663864; [Anonymous], 2012, NEUROL MED CHIR TOKY, V52, P245; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Hitomi T, 2013, BIOCHEM BIOPH RES CO, V438, P13, DOI 10.1016/j.bbrc.2013.07.004; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Ogawa A, 2000, NEUROSURGERY, V47, P578, DOI 10.1097/00006123-200009000-00008; Hamilton SJ, 2000, CLIN GENET, V58, P341, DOI 10.1034/j.1399-0004.2000.580501.x; Hayashi K, 2014, ACTA NEUROCHIR, V156, P935, DOI 10.1007/s00701-014-2013-0; Hitomi T, 2013, BIOCHEM BIOPH RES CO, V439, P419, DOI 10.1016/j.bbrc.2013.08.067; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Miyawaki S, 2013, STROKE, V44, P2894, DOI 10.1161/STROKEAHA.113.002477; Suzuki J, 1986, MOYAMOYA DIS, P145; Wei YC, 2014, J STROKE CEREBROVASC, V23, P1344, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.008	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAY	2015	24	5					1075	1079		10.1016/j.jstrokecerebrovasdis.2015.01.005		5	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CG3MZ	WOS:000353185600033		
J	Hayashi, K; Morofuji, Y; Horie, N; Izumo, T				Hayashi, Kentaro; Morofuji, Yoichi; Horie, Nobutaka; Izumo, Tsuyoshi			A Case of Neurofibromatosis Type 1 Complicated with Repeated Intracerebral Hemorrhage due to Quasi-Moyamoya Disease	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Moyamoya disease; quasi-moyamoya disease; neurofibromatosis type 1; cerebral infarction; intracerebral hemorrhage	SURGICAL REVASCULARIZATION; CHILDREN; JAPAN; FEATURES	Moyamoya disease (MMD) is a unique occlusive disease of the bilateral internal carotid arteries with moyamoya vessels. Inherited or acquired disorders and conditions may present in conjunction with MMD. This condition is known as quasi-MMD. We report a case of quasi-MMD complicated with repeated intracerebral hemorrhage during long-term follow-up for cerebral ischemia. A 35-year-old woman who had a diagnosis of neurofibromatosis type 1 visited our hospital because of incidentally found cerebral infarction. Angiography showed occlusive changes in the distal portion of the bilateral internal carotid artery and multiple massive collateral arteries from occluded internal carotid artery. Because revascularization from external carotid artery systems developed, she was treated conservatively and followed annually with radiologic study. During follow-up, she suffered from minor intracerebral hemorrhages. At the age of 55 years, she died of massive intracerebral hemorrhages. Although the intracerebral hemorrhage is not common in quasi-MMD, it has a potential to be fatal. Long-term follow-up with radiologic study and proper surgical treatment is required.	[Hayashi, Kentaro; Morofuji, Yoichi; Horie, Nobutaka; Izumo, Tsuyoshi] Nagasaki Univ, Sch Med, Dept Neurosurg, Nagasaki, Nagasaki 8528501, Japan	Hayashi, K (reprint author), Nagasaki Univ, Sch Med, Dept Neurosurg, Sakamoto 1-7-1, Nagasaki, Nagasaki 8528501, Japan.	kenkuni@nagasaki-u.ac.jp					SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; Koss M, 2013, J NEUROSURG-PEDIATR, V11, P417, DOI 10.3171/2012.12.PEDS12281; Darrigo LG, 2011, SAO PAULO MED J, V129, P110, DOI 10.1590/S1516-31802011000200010; Scott RM, 2004, J NEUROSURG, V100, P142; Rosser TL, 2005, NEUROLOGY, V64, P553; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Hayashi K, 2013, CLIN NEUROL NEUROSUR, V115, P930, DOI 10.1016/j.clineuro.2012.09.020; Fukui M, 1997, SURG NEUROL, V47, P138, DOI 10.1016/S0090-3019(96)00358-8; Baba T, 2008, J NEUROL NEUROSUR PS, V79, P900, DOI 10.1136/jnnp.2007.130666; Miyamoto S, 2014, STROKE, V45, P1415, DOI 10.1161/STROKEAHA.113.004386; Duat-Rodriguez A, 2014, PEDIATR NEUROL, V50, P96, DOI 10.1016/j.pediatrneurol.2013.04.007; Fukui M, 1997, CLIN NEUROL NEUROSUR, V99, pS238; Hayashi K, 2011, PEDIATR NEUROSURG, V47, P15, DOI 10.1159/000324912; Hayashi K, 2014, ACTA NEUROCHIR, V156, P935, DOI 10.1007/s00701-014-2013-0; Horn P, 2004, CHILD NERV SYST, V20, P382, DOI 10.1007/s00381-004-0960-0; Jea A, 2005, PEDIATRICS, V116, pE694, DOI 10.1542/peds.2005-0568; KESTLE JRW, 1993, J NEUROSURG, V79, P32, DOI 10.3171/jns.1993.79.1.0032; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Scott RM, 2006, NEW ENGL J MED, V360, P1226; Suzuki J, 1986, MOYAMOYA DIS, P145; Tan RMR, 2008, SINGAP MED J, V49, pE107	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAY	2015	24	5					E109	E113		10.1016/j.jstrokecerebrovasdis.2014.12.029		5	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CG3MZ	WOS:000353185600002		
J	Kohyama, S; Yamane, F; Ishihara, H; Uemiya, N; Ishihara, S				Kohyama, Shinya; Yamane, Fumitaka; Ishihara, Hideaki; Uemiya, Nahoko; Ishihara, Shoichiro			Rupture of an Aneurysm of the Superior Cerebellar Artery Feeding a Dural Arteriovenous Fistula	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Dural arteriovenous fistula; aneurysm; aneurysmal bleeding; superior cerebellar artery		We experienced a very rare case of bleeding from an aneurysm of a branch of the superior cerebellar artery, which feeds a dural arteriovenous fistula (DAVF) of the posterior fossa. The aneurysm was not detected on initial angiography and 2 episodes of rebleeding resulted in deterioration of the patient's condition. Although rare, aneurysms of the pial feeding arteries should be considered as a cause of bleeding in cases of DAVF.	[Kohyama, Shinya; Yamane, Fumitaka; Ishihara, Hideaki; Uemiya, Nahoko; Ishihara, Shoichiro] Saitama Med Univ, Int Med Ctr, Div Endovasc Neurosurg, Hidaka, Saitama 3501298, Japan	Kohyama, S (reprint author), Saitama Med Univ, Int Med Ctr, Div Endovasc Neurosurg, Doctors Off 309,1397-1 Yamane, Hidaka, Saitama 3501298, Japan.	skohyama@saitama-med.ac.jp					GACS G, 1983, J NEUROSURG, V58, P63, DOI 10.3171/jns.1983.58.1.0063; Kan P, 2007, SKULL BASE-INTERD AP, V17, P205, DOI 10.1055/s-2007-970559; Lawton Michael T, 2008, Neurosurgery, V62, P110, DOI 10.1227/01.neu.0000317381.68561.b0; Lawton MT, 2008, NEUROSURGERY, V62, P24; Muro K, 2010, NEUROSURGERY, V67, pE876, DOI 10.1227/01.NEU.0000383246.54694.9A; Suzuki S, 2000, J CLIN NEUROSCI, V7, P36, DOI 10.1054/jocn.2000.0708; Weil Alexander G, 2011, Surg Neurol Int, V2, P71, DOI 10.4103/2152-7806.81733	7	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAY	2015	24	5					E105	E107		10.1016/j.jstrokecerebrovasdis.2014.12.005		3	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CG3MZ	WOS:000353185600001		
J	Sugawara, E; Nakamura, H; Endo, M; Tanaka, F; Takahashi, T				Sugawara, Eriko; Nakamura, Haruko; Endo, Masanao; Tanaka, Fumiaki; Takahashi, Tatsuya			Isolated Unilateral Ptosis due to Paramedian Midbrain Infarction	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Midbrain infarction; isolated unilateral ptosis; oculomotor fascicles; levator palpebrae superioris muscles		A 59-year-old man who had hypertension, dyslipidemia, diabetes mellitus, and left eye glaucoma developed sudden vertigo and left ptosis; he did not notice diplopia. He visited our hospital on day 3 after onset and neurologic examination showed left ptosis. His left visual acuity was counting fingers, and the light reflex was sluggish owing to glaucoma. Pupil sizes were equal, and eye movements and the lower lid were unremarkable. Magnetic resonance images revealed an acute infarction of the left paramedian midbrain. We considered that selective damage to the oculomotor fascicles innervating the left levator palpebrae superioris caused ipsilateral ptosis. As the fascicles for this ocular muscle run in the small area adjacent to those for the medial rectus, inferior rectus and superior rectus muscles, this is an extremely rare case of midbrain infarction presenting with isolated unilateral ptosis.	[Sugawara, Eriko; Nakamura, Haruko; Endo, Masanao; Takahashi, Tatsuya] Natl Hosp Org, Yokohama Med Ctr, Dept Neurol, Totsuka Ku, Yokohama, Kanagawa 2458575, Japan; [Tanaka, Fumiaki] Yokohama City Univ, Grad Sch Med, Dept Neurol & Stroke Med, Yokohama, Kanagawa 232, Japan	Sugawara, E (reprint author), Natl Hosp Org, Yokohama Med Ctr, Dept Neurol, Totsuka Ku, 30-60-2 Harajuku, Yokohama, Kanagawa 2458575, Japan.	ui.star11@gmail.com					Tsuda H, 2012, INTERNAL MED, V51, P2031, DOI 10.2169/internalmedicine.51.7914; BOGOUSSLAVSKY J, 1994, NEUROLOGY, V44, P2032; Ogawa K, 2012, EUR NEUROL, V67, P81, DOI 10.1159/000334105; Kim JS, 2005, NEUROLOGY, V64, P1227; Chen L, 2009, J NEUROL, V256, P1164, DOI 10.1007/s00415-009-5054-1; KSIAZEK SM, 1994, AM J OPHTHALMOL, V118, P97; Miura K, 2012, INTERNAL MED, V51, P921, DOI 10.2169/internalmedicine.51.6867; Nieuwenhuys R, 2007, HUMAN CENTRAL NERVOU, P927; SCHWARTZ TH, 1995, J NEUROL NEUROSUR PS, V59, P338, DOI 10.1136/jnnp.59.3.338; WARWICK R, 1953, J COMP NEUROL, V98, P449, DOI 10.1002/cne.900980305	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAY	2015	24	5					E121	E123		10.1016/j.jstrokecerebrovasdis.2015.01.027		3	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CG3MZ	WOS:000353185600005		
J	Sugimura, K; Miyata, H; Tanaka, K; Takahashi, T; Kurokawa, Y; Yamasaki, M; Nakajima, K; Takiguchi, S; Mori, M; Doki, Y				Sugimura, Keijiro; Miyata, Hiroshi; Tanaka, Koji; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Yamasaki, Makoto; Nakajima, Kiyokazu; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro			High Infiltration of Tumor-Associated Macrophages is Associated With a Poor Response to Chemotherapy and Poor Prognosis of Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Cancer	JOURNAL OF SURGICAL ONCOLOGY			English	Article						macrophage; esophageal cancer; chemotherapy	SQUAMOUS-CELL CARCINOMA; LUNG-CANCER; EXPRESSION; SURVIVAL; M2; POLARIZATION; AGGRESSIVENESS; METASTASIS; INHIBITION; RECURRENCE	Background and objectiveTumor-associated macrophages (TAMs) are well known to have distinct roles in tumor progression and metastasis. However, the role of TAMs in chemoresistance has not been fully investigated. The aim of this study is to examine whether TAMs, especially M2 macrophages, are associated with the tumor response to chemotherapy with esophageal cancers. MethodsUsing 210 tissues from patients with esophageal cancer who underwent surgery, we calculated the number of intratumoral CD68(+) macrophages, CD163(+) macrophages, and CD8(+) lymphocytes using immunohistochemistry. CD68 and CD163 were used as markers for whole macrophages and M2 macrophages, respectively. ResultsInfiltration of CD68(+) macrophages and CD163(+) macrophages was significantly associated with tumor depth, lymphatic invasion, and venous invasion. High infiltration of CD68(+) macrophages and CD163(+) macrophages was significantly associated with poor prognosis for patients undergoing neoadjuvant chemotherapy. Regarding the response to chemotherapy, high infiltration of CD68(+) and CD163(+) macrophages had a significant association with poor response to chemotherapy, both clinically and pathologically (P<0.001, P<0.001). Multivariate analysis showed that infiltration of CD163(+) macrophages was an independent prognostic factor in patients undergoing neoadjuvant chemotherapy. ConclusionsInfiltration of TAMs, especially M2 macrophages, is associated with a poor response to chemotherapy and poor prognosis of patients with esophageal cancer. J. Surg. Oncol. 2015 111:752-759. (c) 2015 Wiley Periodicals, Inc.	[Sugimura, Keijiro; Miyata, Hiroshi; Tanaka, Koji; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Yamasaki, Makoto; Nakajima, Kiyokazu; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan	Miyata, H (reprint author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hmiyata@gesurg.med.osaka-u.ac.jp					Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363; Ando N, 2011, ANN SURG ONCOL, V19, P68; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; Dijkgraaf EM, 2013, CANCER RES, V73, P2480, DOI 10.1158/0008-5472.CAN-12-3542; Tsutsui S, 2005, ONCOL REP, V14, P425; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Benoit M, 2008, J IMMUNOL, V181, P3733; Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010; Hamano R, 2012, BRIT J CANCER, V106, P1415, DOI 10.1038/bjc.2012.90; Nonomura N, 2011, BJU INT, V107, P1918, DOI 10.1111/j.1464-410X.2010.09804.x; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904; Linde N, 2012, J PATHOL, V227, P17, DOI 10.1002/path.3989; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Nakanishi Y, 2011, CARCINOGENESIS, V32, P1333, DOI 10.1093/carcin/bgr128; Werno C, 2010, CARCINOGENESIS, V31, P1863, DOI 10.1093/carcin/bgq088; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Ando N, 2003, J CLIN ONCOL, V21, P4592, DOI 10.1200/JCO.2003.12.095; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Komohara Y, 2011, CANCER SCI, V102, P1424, DOI 10.1111/j.1349-7006.2011.01945.x; Shigeoka M, 2013, CANCER SCI, V104, P1112, DOI 10.1111/cas.12188; Eslick GD, 2009, GASTROENTEROL CLIN N, P38; Guo SJ, 2007, DIS ESOPHAGUS, V20, P107, DOI 10.1111/j.1442-2050.2007.00655.x; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; HUANG YH, 2011, CANCER CELL, V19, P1; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P112425; Kollarova Helena, 2007, Biomedical Papers (Olomouc), V151, P17; Koukourakis MI, 1998, BRIT J CANCER, V77, P1696, DOI 10.1038/bjc.1998.280; Ma JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-112; Migita T, 1999, INT J CANCER, V84, P74, DOI 10.1002/(SICI)1097-0215(19990219)84:1<74::AID-IJC14>3.0.CO;2-I; Miyata H, 2009, CANCER, V115, P3324, DOI 10.1002/cncr.24390; Miyata Hiroshi, 2011, Gen Thorac Cardiovasc Surg, V59, P461, DOI 10.1007/s11748-011-0780-6; Society JE, 2008, JAPANESE CLASSIFICAT, V10th; Wang XB, 2012, J NEURO-ONCOL, V106, P43, DOI 10.1007/s11060-011-0640-3	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4790	1096-9098		J SURG ONCOL	J. Surg. Oncol.	MAY 1	2015	111	6					752	759		10.1002/jso.23881		8	Oncology; Surgery	Oncology; Surgery	CG6ND	WOS:000353417700015		
J	Kawabata, Y; Hayashi, H; Takai, K; Kidani, A; Tajima, Y				Kawabata, Yasunari; Hayashi, Hikota; Takai, Kiyoe; Kidani, Akihiko; Tajima, Yoshitsugu			Superior Mesenteric Artery-First Approach in Radical Antegrade Modular Pancreatosplenectomy for Borderline Resectable Pancreatic Cancer: A Technique to Obtain Negative Tangential Margins	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							INTERNATIONAL STUDY-GROUP; ADENOCARCINOMA; PANCREATICODUODENECTOMY; RESECTION; BODY		[Kawabata, Yasunari; Hayashi, Hikota; Takai, Kiyoe; Kidani, Akihiko; Tajima, Yoshitsugu] Shimane Univ, Fac Med, Dept Digest & Gen Surg, Izumo, Shimane 6938501, Japan	Kawabata, Y (reprint author), Shimane Univ, Fac Med, Dept Digest & Gen Surg, 89-1 Enyacho, Izumo, Shimane 6938501, Japan.	batayan5@med.shimane-u.ac.jp					[Anonymous], 2012, CLIN PRACT GUID ONC; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Chang DK, 2009, J CLIN ONCOL, V27, P2855, DOI 10.1200/JCO.2008.20.5104; Hirano S, 2007, ANN SURG, V246, P46, DOI 10.1097/01.sla.0000258608.52615.5a; Wagner M, 2004, BRIT J SURG, V91, P586, DOI 10.1002/bjs.4484; Mitchem JB, 2012, J AM COLL SURGEONS, V214, P46, DOI 10.1016/j.jamcollsurg.2011.10.008; Mathur A, 2014, AM SURGEON, V80, P353; Kawabata Y, 2012, EJSO-EUR J SURG ONC, V38, P574, DOI 10.1016/j.ejso.2012.04.007; Li H, 2005, J COMPUT ASSIST TOMO, V29, P170, DOI 10.1097/01.rct.0000155060.73107.83; Nakayama Y, 2001, J COMPUT ASSIST TOMO, V25, P337, DOI 10.1097/00004728-200105000-00002; Bockhorn M, 2014, SURGERY, V155, P977, DOI 10.1016/j.surg.2014.02.001; Strasberg SM, 2003, SURGERY, V133, P521, DOI 10.1067/msy.2003.146; Pessaux P, 2006, J GASTROINTEST SURG, V10, P607, DOI 10.1016/j.gassur.2005.05.001; Strasberg SM, 2007, J AM COLL SURGEONS, V204, P244, DOI 10.1016/j.jamcollsurg.2006.11.002; Apple BL, 2012, CANCER J, V18, P539; Sobin LH, 2010, TNM CLASSIFICATION M; Weitz Jürgen, 2010, J Am Coll Surg, V210, pe1, DOI 10.1016/j.jamcollsurg.2009.10.019	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	MAY	2015	220	5					E49	E54		10.1016/j.jamcollsurg.2014.12.054		6	Surgery	Surgery	CG5OP	WOS:000353342200002		
J	Ito, T; Wada, M; Nagae, K; Nakano-Nakamura, M; Nakahara, T; Hagihara, A; Furue, M; Uchi, H				Ito, T.; Wada, M.; Nagae, K.; Nakano-Nakamura, M.; Nakahara, T.; Hagihara, A.; Furue, M.; Uchi, H.			Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Article							MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; UNITED-STATES; BIOPSY; SURVIVAL; RECURRENCE	BackgroundMetastasis of sentinel lymph node (SLN) is generally evaluated on histopathological examination and controversy still exists over the usefulness of PCR assay of SLN. ObjectiveTo investigate the prognostic value of triple-marker PCR assay of SLN. MethodsA total of 165 patients with primary cutaneous melanoma who underwent SLN biopsy were included. Clinical and histopathological data were retrieved from each patient's file and triple-marker PCR assay (tyrosinase, GP-100 and MART-1) was performed on the SLN as well as routine histopathological evaluation. PCR positivity was defined as the expression of all three PCR markers. To evaluate melanoma-specific survival (MSS) and disease-free survival (DFS), we used the Kaplan-Meier method and the log-rank test. Multivariate analyses using the Cox proportional hazards regression model were also performed. ResultsSentinel lymph nodes were identified in all 165 patients: 61 patients (37.0%) were male and 104 (63.0%) were female, with a mean age of 60.2years. Of the 165 melanomas, 81 (49.1%) were acral lentiginous melanomas. Compared with the patients with PCR positivity (1-2 markers) or PCR negativity, patients with PCR positivity (3 markers) had significantly poor MSS (5-year survival rate, 58.7% vs. 84.4%; P<0.0001) and DFS (5-year survival rate, 25.0% vs. 83.9%; P<0.0001), with median follow-up of 42months for MSS and 38months for DFS. These survival rates of patients with PCR positivity (3 markers) were lower than those of patients with histopathologically positive SLN. In multivariate analysis, PCR positivity (3 markers) was an independent prognostic factor for both MSS (hazard ratio [HR], 2.81; 95% confidence interval [CI], 1.07-7.33; P=0.035) and DFS (HR, 2.48; 95% CI, 1.08-5.69; P=0.032). ConclusionsThe expression of three PCR markers was a significant prognostic factor for both MSS and DFS and might be closely correlated to a dismal prognosis.	[Ito, T.; Wada, M.; Nagae, K.; Nakano-Nakamura, M.; Nakahara, T.; Furue, M.; Uchi, H.] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka, Japan; [Hagihara, A.] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Serv Management & Policy, Fukuoka, Japan	Ito, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka, Japan.	takamiti@dermatol.med.kyushu-u.ac.jp			National Cancer Center, Japan; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare, Japan	This work was partly supported by grants from the National Cancer Center, Japan, and the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labor and Welfare, Japan.	Takeuchi H, 2004, J CLIN ONCOL, V22, P2671, DOI 10.1200/JCO.2004.12.009; Scoggins CR, 2010, ANN SURG ONCOL, V17, P709, DOI 10.1245/s10434-009-0858-x; Hilari JM, 2009, ANN SURG ONCOL, V16, P177, DOI 10.1245/s10434-008-0183-9; Manca G, 2014, CLIN NUCL MED, V39, pE346, DOI 10.1097/RLU.0000000000000366; Ito T, 2012, MELANOMA RES, V22, P38, DOI 10.1097/CMR.0b013e32834dcfdf; Jones EL, 2013, JAMA SURG, V148, P456, DOI 10.1001/jamasurg.2013.1335; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Pollack LA, 2011, J AM ACAD DERMATOL, V65, pS78, DOI 10.1016/j.jaad.2011.05.030; Cochran Alistair J, 2003, Int J Clin Oncol, V8, P139; Gershenwald JE, 1998, J CLIN ONCOL, V16, P2253; Moroi Y, 2009, INT J CLIN ONCOL, V14, P485, DOI 10.1007/s10147-009-0942-z; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Scoggins CR, 2006, J CLIN ONCOL, V24, P2849, DOI 10.1200/JCO.2005.03.2342; Shivers SC, 1998, JAMA-J AM MED ASSOC, V280, P1410, DOI 10.1001/jama.280.16.1410; Wu XC, 2011, J AM ACAD DERMATOL, V65, pS26, DOI 10.1016/j.jaad.2011.05.034	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	MAY	2015	29	5					912	918		10.1111/jdv.12722		7	Dermatology	Dermatology	CG7BM	WOS:000353457100012		
J	Hata, H; Aoyagi, S; Homma, E; Shimizu, H				Hata, H.; Aoyagi, S.; Homma, E.; Shimizu, H.			Lessons from 28 cases of reconstruction by lenticular island pedicle flap at a single institution	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Article								BackgroundLenticular island pedicle flap (LIPF) has been reported to be one of the most useful techniques for reconstructing middle cheek skin defects. LIPF may have been used all over the world on a daily basis; however, no reports have examined a large number of LIPF cases at a single institution. Materials and methodsA total of 28 cases of reconstruction by LIPF at the Hokkaido University Hospital from 2005 to 2013 were analysed. We examined the tumour type, location, area of defect and presence/absence of antithrombotic treatment and complications, including transient circulatory impairment, damage to facial nerves and eyelid ectropion. ResultsWe found that nine patients had transiently impaired circulation. This complication was statistically more frequent in the patients without antithrombotic treatment than in the patients with antithrombotic treatment (0/8 vs. 10/20, P=0.0292; Fisher's exact test). ConclusionWe revelled that LIPF have been safely performed even under antithrombotic treatment, so, when patients are taking antithrombotic agents, we should choose LIPF rather than conventional flap including cheek flap, island pedicle flap and so on.	[Hata, H.; Aoyagi, S.; Homma, E.; Shimizu, H.] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan	Hata, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan.	hata07jp@yahoo.co.jp					Rapstine ED, 2012, PLAST RECONSTR SURG, V129, P1291, DOI 10.1097/PRS.0b013e31824ecac7; Braun M, 2005, DERMATOL SURG, V31, P995; BENNETT RG, 1991, J DERMATOL SURG ONC, V17, P161; Cvancara JL, 2005, DERMATOL SURG, V31, P195; Jowett N1, 2010, CURR OPIN OTOLARYNGO, V18, P44; Kuehnemund M, 2011, FACIAL PLAST SURG, V27, P284, DOI 10.1055/s-0031-1275778; Richmond-Sinclair NM, 2009, J INVEST DERMATOL, V129, P323, DOI 10.1038/jid.2008.234; Zhi-guo Wang, 2012, Aesthetic Plast Surg, V36, P163, DOI 10.1007/s00266-011-9759-z	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	MAY	2015	29	5					1015	1018		10.1111/jdv.12575		4	Dermatology	Dermatology	CG7BM	WOS:000353457100028		
J	Kitamura, S; Hata, H; Homma, E; Aoyagi, S; Shimizu, H				Kitamura, S.; Hata, H.; Homma, E.; Aoyagi, S.; Shimizu, H.			Pigmented skin metastasis of breast cancer showing dermoscopic features of malignant melanoma	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Letter							HYPOHIDROTIC ECTODERMAL DYSPLASIA; MESSENGER-RNA; MUTATION; EDAR; PROTEIN		[Kitamura, S.; Hata, H.; Homma, E.; Aoyagi, S.; Shimizu, H.] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan	Hata, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan.	hata07jp@yahoo.co.jp					Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Monreal AW, 1999, NAT GENET, V22, P366; Callea M, 2013, INT J PEDIATR OTORHI, V77, P1801, DOI 10.1016/j.ijporl.2013.09.004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haghighi A, 2013, BRIT J DERMATOL, V168, P1353, DOI 10.1111/bjd.12151; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Lind LK, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-80; Plaisancie J, 2013, AM J MED GENET A, V161A, P671, DOI 10.1002/ajmg.a.35747; van der Hout AH, 2008, EUR J HUM GENET, V16, P673, DOI 10.1038/sj.ejhg.5202012	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	MAY	2015	29	5					1034	1036		10.1111/jdv.12459		3	Dermatology	Dermatology	CG7BM	WOS:000353457100038		
J	Nakajima, R; Kobayashi, T; Kikuchi, T; Kitano, Y; Watanabe, H; Mizutani, M; Nozaki, T; Senda, N; Saitoh, K; Takagi, R; Yamato, M; Okano, T; Takeda, S				Nakajima, Ryota; Kobayashi, Toyoshige; Kikuchi, Tetsutaro; Kitano, Yuriko; Watanabe, Hiroya; Mizutani, Manabu; Nozaki, Takayuki; Senda, Naoko; Saitoh, Kazuo; Takagi, Ryo; Yamato, Masayuki; Okano, Teruo; Takeda, Shizu			Fabrication of transplantable corneal epithelial and oral mucosal epithelial cell sheets using a novel temperature-responsive closed culture device	Journal of Tissue Engineering and Regenerative Medicine			English	Article						closed cell culture; culture device; automated culture system; epithelial cell; cell sheet; temperature-responsive culture surface	STEM-CELLS; RECONSTRUCTION; REGENERATION; EXPRESSION	Temperature-responsive culture surfaces make it possible to harvest transplantable carrier-free cell sheets. Here, we applied temperature-responsive polymer for polycarbonate surfaces with previously developed closed culture devices for an automated culture system in order to fabricate transplantable stratified epithelial cell sheets. Histological and immunohistochemical analyses and colony-forming assays revealed that corneal epithelial and oral mucosal epithelial cell sheets could be harvested with the temperature-responsive closed culture devices. The results were similar to those obtained using temperature-responsive culture inserts. These results indicate that the novel temperature-responsive closed culture device is useful for fabricating transplantable stratified epithelial cell sheets. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Nakajima, Ryota; Kobayashi, Toyoshige; Nozaki, Takayuki; Senda, Naoko; Saitoh, Kazuo; Takeda, Shizu] Hitachi Ltd, Cent Res Lab, Saitama 3500395, Japan; [Kikuchi, Tetsutaro; Kitano, Yuriko; Watanabe, Hiroya; Mizutani, Manabu] CellSeed Inc, Tokyo, Japan; [Takagi, Ryo; Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan	Takeda, S (reprint author), Hitachi Ltd, Cent Res Lab, 2520 Hatoyama, Saitama 3500395, Japan.	shizu.takeda.me@hitachi.com			Formation of Innovation Centre for Fusion of Advanced Technologies 'Cell Sheet Tissue Engineering Centre (CSTEC)' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	The authors thank Ms Y. Kondo and Ms J. Horie (Hitachi Ltd) for their technical assistance. We are grateful for the helpful suggestions given by Dr Y. Akiyama and Professor M. Egami (Tokyo Women's Medical University). We also express our gratitude to Dr H. Koizumi and Dr H. Takeda (Hitachi Ltd) for their valuable comments. This work was supported in part by the Formation of Innovation Centre for Fusion of Advanced Technologies 'Cell Sheet Tissue Engineering Centre (CSTEC)', from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517; Kino-Oka M, 2009, J BIOSCI BIOENG, V108, P267, DOI 10.1016/j.jbiosc.2009.04.007; Priya SG, 2008, TISSUE ENG PT B-REV, V14, P105, DOI 10.1089/teb.2007.0318; Watanabe R, 2011, TISSUE ENG PT A, V17, P2213, DOI [10.1089/ten.TEA.2010.0568, 10.1089/ten.tea.2010.0568]; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Kwon OH, 2000, J BIOMED MATER RES, V50, P82, DOI 10.1002/(SICI)1097-4636(200004)50:1<82::AID-JBM12>3.0.CO;2-7; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Bans Y, 2003, EXP EYE RES, V76, P663; Fukumoris K, 2008, ACTA BIOMATER, V5, P470; Nakajima R, 2015, J TISSUE ENG REGEN M, V9, P1259, DOI 10.1002/term.1639	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	MAY	2015	9	5					637	640		10.1002/term.1728		4	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	CG6HI	WOS:000353399400015		
J	Hidaka, A; Kitayama, K				Hidaka, Amane; Kitayama, Kanehiro			Physiological linkage in co-variation of foliar nitrogen and phosphorus in tropical tree species along a gradient of soil phosphorus availability	JOURNAL OF TROPICAL ECOLOGY			English	Article						leaf traits; litter; nitrogen; nutrient limitation; phosphorus; resorption; stoichiometry; tropical montane rain forest	DIFFERENT GEOLOGICAL CONDITIONS; LOWER MONTANE FORESTS; NUTRIENT RESORPTION; MOUNT-KINABALU; USE EFFICIENCY; RAIN-FOREST; METROSIDEROS-POLYMORPHA; RESOURCE AVAILABILITY; LEAF NITROGEN; PLANT-GROWTH	In order to understand the stoichiometric balance between foliar nitrogen (N) and phosphorus (P) on P-poor soils, we investigated how foliar N and P attributes (i.e. N and P concentrations in green and senesced leaves, N and P resorption efficiencies) of 30 tropical tree species co-vary along a gradient of soil P availability across three forests on Mount Kinabalu, Borneo. We found strong and positive correlations between foliar N and P in the concentrations and resorption efficiencies within each forest and across the three forests. Slopes of standardized major axis between foliar N and P concentrations for both green and senesced leaves were not different among the three forests, although the values of the scaling exponent in the relationships of foliar N to P across the three forests were significantly lower than 1. We suggest that down-regulation of N concentrations in green leaves on P-poor soils is one of several possible mechanisms explaining why N concentrations decrease with decreasing P concentrations in both green and senesced leaves toward a lower P availability in soils. On the other hand, the physiological and ecological reasons why N and P resorption efficiencies are positively correlated with each other across tree species remain unclear.	[Hidaka, Amane; Kitayama, Kanehiro] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan	Hidaka, A (reprint author), Hokkaido Univ, Field Sci Ctr Northern Biosphere, Japan Wildlife Res Ctr,Tomakomai Res Stn, Network Ctr Forest & Grassland Survey Monitoring, Tomakomai, Hokkaido 0530035, Japan.	amanehidaka.ecology@gmail.com			Japanese MESSC [18255003, 22255002]; JSPS [08J03021]; Japan Science Society [23-510]	This research was supported by a grant-in-aid from the Japanese MESSC(18255003&22255002) to K.K. andby a grant-in-aid from JSPS for Young Scientists (08J03021) and the Sasakawa Scientific Research Grant from The Japan Science Society (23-510) to A.H.	Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Yuan ZY, 2009, GLOBAL ECOL BIOGEOGR, V18, P11, DOI 10.1111/j.1466-8238.2008.00425.x; Lal CB, 2001, CAN J BOT, V79, P1066, DOI 10.1139/cjb-79-9-1066; Aerts R, 2000, ADV ECOL RES, V30, P1; [Anonymous], 2011, FUNCT ECOL, DOI DOI 10.1111/J.1365-2435.2010.01803.X; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Kobe RK, 2005, ECOLOGY, V86, P2780, DOI 10.1890/04-1830; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Mayor JR, 2014, J ECOL, V102, P36, DOI 10.1111/1365-2745.12190; Ostertag R, 2010, PLANT SOIL, V334, P85, DOI 10.1007/s11104-010-0281-x; Takyu M, 2002, PLANT ECOL, V159, P35, DOI 10.1023/A:1015512400074; Quesada CA, 2010, BIOGEOSCIENCES, V7, P1515, DOI 10.5194/bg-7-1515-2010; Hattenschwiler S, 2008, NEW PHYTOL, V179, P165, DOI 10.1111/j.1469-8137.2008.02438.x; Killingbeck KT, 1996, ECOLOGY, V77, P1716, DOI 10.2307/2265777; Veneklaas EJ, 2012, NEW PHYTOL, V195, P306, DOI 10.1111/j.1469-8137.2012.04190.x; Gusewell S, 2005, FUNCT ECOL, V19, P344, DOI 10.1111/j.1365-2435.2005.00967.x; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; Cernusak LA, 2010, NEW PHYTOL, V185, P770, DOI 10.1111/j.1469-8137.2009.03106.x; KITAYAMA K, 1992, VEGETATIO, V102, P149, DOI 10.1007/BF00044731; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; Treseder KK, 2001, OECOLOGIA, V126, P266, DOI 10.1007/s004420000523; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Niklas KJ, 2005, ECOL LETT, V8, P636, DOI 10.1111/j.1461-0248.2005.00759.x; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; Cordell S, 2001, OECOLOGIA, V127, P198, DOI 10.1007/s004420000588; Vergutz L, 2012, ECOL MONOGR, V82, P205, DOI 10.1890/11-0416.1; Reich PB, 2009, OECOLOGIA, V160, P207, DOI 10.1007/s00442-009-1291-3; Tully KL, 2013, ECOLOGY, V94, P930, DOI 10.1890/12-0781.1; Wright IJ, 2003, FUNCT ECOL, V17, P10, DOI 10.1046/j.1365-2435.2003.00694.x; Reed SC, 2012, NEW PHYTOL, V196, P173, DOI 10.1111/j.1469-8137.2012.04249.x; Kitayama K, 2002, J ECOL, V90, P37, DOI 10.1046/j.0022-0477.2001.00634.x; Cai ZQ, 2007, J TROP ECOL, V23, P115, DOI 10.1017/S0266467406003750; Chapin III F. S., 2011, PRINCIPLES TERRESTRI; Hall SJ, 2004, BIOGEOCHEMISTRY, V70, P27, DOI 10.1023/B:BIOG.0000049335.68897.87; Hidaka A, 2009, J ECOL, V97, P984, DOI 10.1111/j.1365-2745.2009.01540.x; Hidaka A, 2011, J ECOL, V99, P849, DOI 10.1111/j.1365-2745.2011.01805.x; Kitayama K, 2004, ECOSYSTEMS, V7, P259, DOI 10.1007/s10021-003-0229-6; Kitayama K, 1998, ECOL RES, V13, P301, DOI 10.1046/j.1440-1703.1998.00264.x; MARSCHNER H., 1995, MINERAL NUTR HIGHER; Matzek V, 2009, ECOL LETT, V12, P765, DOI 10.1111/j.1461-0248.2009.01310.x; Reich PB, 2010, P ROY SOC B-BIOL SCI, V277, P877, DOI 10.1098/rspb.2009.1818; Takyu M, 2003, OECOLOGIA, V134, P397, DOI 10.1007/s00442-002-1115-1	46	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0266-4674	1469-7831		J TROP ECOL	J. Trop. Ecol.	MAY	2015	31		3				221	229		10.1017/S0266467415000103		9	Ecology	Environmental Sciences & Ecology	CG3YA	WOS:000353214500003		
J	Aoyagi, R; Kitayama, K				Aoyagi, Ryota; Kitayama, Kanehiro			Traits associated with nutrient impoverishment and shade-tolerance in tree juveniles of three Bornean rain forests with contrasting nutrient availability	JOURNAL OF TROPICAL ECOLOGY			English	Article						biomass allocation; functional trait; leaf chemistry; leaf dynamics; mixed dipterocarp forest; trait convergence; tropical heath forest	PERFORMANCE TRADE-OFFS; HABITAT SPECIALIZATION; LOW-LIGHT; INTERSPECIFIC VARIATION; AMAZONIAN FORESTS; PLANT SUCCESSION; TROPICAL TREES; LEAF-AREA; GROWTH; PHOSPHORUS	In this study, we tested the hypothesis that functional traits associated with nutrient impoverishment contribute to enhancing shade-tolerance (survival at low light) for the juveniles of canopy tree species in Bornean rain forests. To test the hypothesis, survival and functional traits (biomass allocation, leaf dynamics and foliar nutrient concentration) were investigated as a function of light conditions for saplings of 13 species in three forests with different levels of nutrient availability. As predicted by the hypothesis, the species in the severely nutrient-poor site (a tropical heath forest on nutrient-poor soils) showed greater shade-tolerance (>91% survival for 8 mo at 5% global site factor) than in the other two sites (mixed dipterocarp forests) (54-87% survival). Across the species, greater shade-tolerance was associated with a higher biomass allocation to roots, a slower leaf production and a higher foliar C concentration, which are considered as C-conservation traits under nutrient impoverishment. These results suggest that the juveniles of the canopy species occurring on nutrient-poor soils can enhance shade-tolerance by the same mechanisms as the adaptation to nutrient impoverishments. Tree species in nutrient-poor environments may be selected for surviving also in shaded conditions.	[Aoyagi, Ryota; Kitayama, Kanehiro] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan	Aoyagi, R (reprint author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan.	aoyagi.ryota@gmail.com			Japanese MESSC [22255002]; Global Environment Research Fund of the Ministry of the Environment, Japan [D-1006, I-1403]	We thank Erik, L. Ajon, P. Lagan, N. Imai, T. Seino and K. Miyamoto for assisting our fieldwork and providing valuable suggestions. Permission to conduct our research was granted by the Sabah Parks and Sabah Forestry Department. This study was supported by the grant-in-aid from the Japanese MESSC (22255002) to K.K. and by the Global Environment Research Fund D-1006&I-1403 of the Ministry of the Environment, Japan, to K.K.	Aiba M, 2007, J VEG SCI, V18, P379, DOI 10.1658/1100-9233(2007)18[379:VIJSAR]2.0.CO;2; Canham CD, 1999, OECOLOGIA, V121, P1, DOI 10.1007/s004420050900; Palmiotto PA, 2004, J ECOL, V92, P609, DOI 10.1111/j.0022-0477.2004.00894.x; Walters MB, 1999, NEW PHYTOL, V143, P143, DOI 10.1046/j.1469-8137.1999.00425.x; Imai N, 2010, J TROP ECOL, V26, P627, DOI 10.1017/S0266467410000350; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Russo SE, 2008, J ECOL, V96, P192, DOI 10.1111/j.1365-2745.2007.01330.x; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Agyeman VK, 1999, J ECOL, V87, P815, DOI 10.1046/j.1365-2745.1999.00400.x; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; Lusk CH, 2004, FUNCT ECOL, V18, P820, DOI 10.1111/j.0269-8463.2004.00897.x; Montgomery RA, 2002, OECOLOGIA, V131, P165, DOI 10.1007/s00442-002-0872-1; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; Fine PVA, 2006, ECOLOGY, V87, pS150; Baltzer JL, 2007, J ECOL, V95, P1208, DOI 10.1111/j.1365-2745.2007.01286.x; BAZZAZ FA, 1979, ANNU REV ECOL SYST, V10, P351, DOI 10.1146/annurev.es.10.110179.002031; Lusk CH, 2002, OECOLOGIA, V132, P188, DOI 10.1007/s00442-002-0974-9; Kobe RK, 1997, OIKOS, V80, P226, DOI 10.2307/3546590; CANHAM CD, 1994, CAN J FOREST RES, V24, P337, DOI 10.1139/x94-046; Baraloto C, 2005, ECOLOGY, V86, P2461, DOI 10.1890/04-1956; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Poorter L, 2007, ECOLOGY, V88, P1000, DOI 10.1890/06-0984; REICH PB, 1994, OECOLOGIA, V97, P62, DOI 10.1007/BF00317909; TILMAN D, 1985, AM NAT, V125, P827, DOI 10.1086/284382; Bloor JMG, 2003, J ECOL, V91, P77, DOI 10.1046/j.1365-2745.2003.00743.x; Chua G. L. S., 1995, Journal of Tropical Forest Science, V8, P240; Craine J, 2009, ROUTL STUD HUM GEOGR, V28, P149; Dent DH, 2009, BIOTROPICA, V41, P424, DOI 10.1111/j.1744-7429.2009.00505.x; Kitayama K, 2000, OECOLOGIA, V123, P342, DOI 10.1007/s004420051020; Paoli GD, 2007, ECOSYSTEMS, V10, P503, DOI 10.1007/s10021-007-9042-y; SEINO T., 2007, SABAH PARKS NATURE J, V8, P63; Sterner R. W., 2002, ECOLOGICAL STOICHIOM; Turner IM, 2000, BIOTROPICA, V32, P53, DOI 10.1111/j.1744-7429.2000.tb00447.x	37	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0266-4674	1469-7831		J TROP ECOL	J. Trop. Ecol.	MAY	2015	31		3				231	242		10.1017/S0266467415000097		12	Ecology	Environmental Sciences & Ecology	CG3YA	WOS:000353214500004		
J	Sato, K; Iida, O; Takahara, M; Soga, Y; Suzuki, K; Tanigawa, T; Ito, M; Uematsu, M				Sato, Kei; Iida, Osamu; Takahara, Mitsuyoshi; Soga, Yoshimitsu; Suzuki, Kenji; Tanigawa, Takashi; Ito, Masaaki; Uematsu, Masaaki			Effect of perioperative complications after endovascular therapy in patients with peripheral artery disease due to femoropopliteal lesions	JOURNAL OF VASCULAR SURGERY			English	Article							SUPERFICIAL FEMORAL-ARTERY; INTER-SOCIETY CONSENSUS; OBESITY PARADOX; NITINOL STENTS; TASK-FORCE; FOLLOW-UP; GUIDELINES; BYPASS; IMPLANTATION; CLAUDICATION	Objective: Despite wide use, high initial success, and acceptable durability of endovascular therapy (EVT) for femo-ropopliteal (FP) lesions, the frequency of 30-day perioperative complications (POCs) and their effect on clinical outcomes have not been systematically evaluated, which is the subject of this study. Methods: We used a multicenter database of 2145 consecutive patients (70% male; overall mean age, 73 +/- 9 years) who successfully underwent EVT for FP lesions to investigate independent predictors of POCs (logistic regression analysis) and effect of POCs on prognostic outcomes (Cox proportional regression). Results: POCs were observed in 209 patients (10%). In multivariate logistic regression analysis, body mass index <18.5 kg/ m(2), critical limb ischemia, and TransAtlanic Inter-Society Consensus for the Management of Peripheral Arterial Disease class D lesions were independently associated with POCs (adjusted odds ratios [95% confidence intervals], 2.0 [1.3-2.9], 2.5 [1.9-3.3], and 1.6 [1.2-2.1], respectively). After risk stratification of POCs according to the number of these risk factors, the incidence of POCs was higher in the groups with higher scores. Follow-up for >30 days (mean, 2.3 +/- 1.8 years) was available for 2079 of 2145 patients. A Cox hazard regression model adjusted for baseline clinical characteristics showed POCs were negatively and independently associated with future occurrence of major adverse limb events (defined as major amputation and major reintervention) or death (hazard ratio [95% confidence interval], 1.6 [1.2-2.1]; P < .05). Conclusions: Body mass index <18.5 kg/ m(2), critical limb ischemia, and TransAtlantic Inter-Society Consensus for the Management of Peripheral Arterial Disease class D lesion were positively associated with POCs after EVT for FP lesions. The occurrence of POCs may adversely affect clinical outcomes in the chronic phase.	[Sato, Kei] Sakakibara Heart Inst, Dept Cardiol, Fuchu, Tokyo 1830003, Japan; [Sato, Kei; Ito, Masaaki] Mie Univ, Grad Sch Med, Dept Cardiol, Tsu, Mie 514, Japan; [Iida, Osamu; Uematsu, Masaaki] Kansai Rosai Hosp, Ctr Cardiovasc, Amagasaki, Hyogo, Japan; [Takahara, Mitsuyoshi] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan; [Soga, Yoshimitsu] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka, Japan; [Suzuki, Kenji] Sendai Kosei Hosp, Dept Cardiol, Sendai, Miyagi, Japan; [Tanigawa, Takashi] Matsusaka Gen Cent Hosp, Dept Cardiol, Matsusaka, Japan	Sato, K (reprint author), Sakakibara Heart Inst, 3-16-1 Asahi Chou, Fuchu, Tokyo 1830003, Japan.	satokei715@gmail.com					Rabellino M, 2009, CATHETER CARDIO INTE, V73, P701, DOI 10.1002/ccd.21971; Lammer J, 2013, J AM COLL CARDIOL, V62, P1320, DOI 10.1016/j.jacc.2013.05.079; Rocha-Singh KJ, 2007, CATHETER CARDIO INTE, V69, P910, DOI 10.1002/ccd.21104; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Rogers JH, 2007, CIRCULATION, V116, P2072, DOI 10.1161/CIRCULATIONAHA.107.715433; Antoniou GA, 2013, J VASC SURG, V57, P242, DOI 10.1016/j.jvs.2012.07.038; Galal W, 2008, CHEST, V134, P925, DOI 10.1378/chest.08-0418; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Siracuse JJ, 2012, J VASC SURG, V55, P1001, DOI 10.1016/j.jvs.2011.10.128; Anderson JL, 2013, CIRCULATION, V127, P1425, DOI 10.1161/CIR.0b013e31828b82aa; Laird JR, 2012, J ENDOVASC THER, V19, P1, DOI 10.1583/11-3627.1; Zeller T, 2007, VASC MED, V12, P223, DOI 10.1177/1358863x07079823; Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211; Abbruzzese TA, 2004, J VASC SURG, V39, P1178, DOI 10.1016/j.jvs.2003.12.027; Balzer JO, 2010, EUR J RADIOL, V75, P48, DOI 10.1016/j.ejrad.2010.04.016; Iida O, 2014, JACC-CARDIOVASC INTE, V7, P792, DOI 10.1016/j.jcin.2014.01.168; Lavie CJ, 2009, CHEST, V134, P896; Morris-Stiff G, 2011, ANN ROY COLL SURG, V93, P306, DOI 10.1308/003588411X571999; Ratnam L, 2012, CLIN RADIOL, V67, P949, DOI 10.1016/j.crad.2011.12.011; Schillinger M, 2006, NEW ENGL J MED, V354, P1879, DOI 10.1056/NEJMoa051303; Simons JP, 2012, J VASC SURG, V55, P1629, DOI 10.1016/j.jvs.2011.12.043; Steinberg BA, 2007, AM J CARDIOL, V100, P1331, DOI 10.1016/j.amjcard.2007.06.019	22	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	MAY	2015	61	5					1272	1277		10.1016/j.jvs.2014.12.051		6	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CG7ZI	WOS:000353526000022		
J	Itagaki, R; Tanaka, M; Katayama, I; Itoh, S				Itagaki, Ryo; Tanaka, Masashi; Katayama, Ikuo; Itoh, Satoshi			Aortic arch repair for complex coarctation of the aorta with aberrant bilateral subclavian artery	JOURNAL OF VASCULAR SURGERY			English	Editorial Material									[Itagaki, Ryo; Tanaka, Masashi; Katayama, Ikuo; Itoh, Satoshi] Shonankamakura Gen Hospital, Aort Ctr, Kanagawa, Japan	Itagaki, R (reprint author), Shonankamakura Gen Hospital, Aort Ctr, Kanagawa, Japan.	ryoitagaki11@gmail.com					Bauer M, 2001, ANN THORAC SURG, V72, P2060, DOI 10.1016/S0003-4975(01)03094-6; CAMPBELL M, 1970, BRIT HEART J, V32, P633; Wang R, 2010, J VASC SURG, V51, P1203, DOI 10.1016/j.jvs.2009.12.027	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	MAY	2015	61	5					1330	1330		10.1016/j.jvs.2014.01.052		1	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CG7ZI	WOS:000353526000032		
J	Kano, M; Uchiyama, H; Ohta, M; Ohtani, N				Kano, Masaaki; Uchiyama, Hidehiko; Ohta, Mitsuaki; Ohtani, Nobuyo			Oral tyrosine changed the responses to commands in German shepherds and Labrador retrievers but not in toy poodles	Journal of Veterinary Behavior-Clinical Applications and Research			English	Article						training abilities; tyrosine; German shepherd; Labrador retriever; toy poodle	DEFICIT HYPERACTIVITY DISORDER; ATTENTION; BRAIN; NOREPINEPHRINE; URINARY; STRESS; DOGS; MECHANISMS; CHILDREN; PLASMA	Dog behaviors, particularly being easily distracted and having difficulty sustaining attention, may resemble those of children with the attention deficit hyperactivity disorder, which may be correlated with catecholamine levels in central and peripheral neurons. Thus, in this study, we examined the relationship between dog behavior that involved focusing or concentrating on a human and the sympathetic nervous systems activity. The catecholamines, noradrenaline and adrenaline, which are released into the blood, remain unmetabolized in the urine. The urinary concentrations of noradrenaline and adrenaline seem to strongly reflect the activity level of the sympathetic nervous system. We used 3 dog breeds with different training abilities, German shepherd, Labrador retriever, and toy poodle. Tyrosine is the amino acid known to induce increased levels of catecholamine in the brain. The aim of this study was to examine the effect of oral tyrosine on training levels in the 3 breeds of dogs. The oral tyrosine appeared to induce a dramatic improvement in the training qualities of German shepherds and Labrador retrievers but not in some toy poodle dogs possibly because of much excitement or distractions. These results suggest that catecholamine, probably in the brain, is important for the appropriate attention level. (C) 2015 Elsevier Inc. All rights reserved.	[Kano, Masaaki] Anim Life Solut Co Ltd, Midori Ku, Yokohama, Kanagawa, Japan; [Uchiyama, Hidehiko] Tokyo Univ Agr, Dept Human & Anim Plant Relationships, Atsugi, Kanagawa, Japan; [Ohta, Mitsuaki; Ohtani, Nobuyo] Azabu Univ, Sch Vet Sci, Dept Anim Sci & Biotechnol, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan	Ohtani, N (reprint author), Azabu Univ, Sch Vet Sci, Dept Anim Sci & Biotechnol, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	ohtani@azabu-u.ac.jp					AKERSTEDT T, 1983, ACTA PHYSIOL SCAND, V117, P19, DOI 10.1111/j.1748-1716.1983.tb07174.x; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Journel M, 2012, ADV NUTR, V3, P322, DOI 10.3945/an.112.002071; GROWDON JH, 1982, LIFE SCI, V30, P827, DOI 10.1016/0024-3205(82)90596-3; Konrad K, 2007, J AM ACAD CHILD PSY, V46, P1633, DOI 10.1097/chi.0b013e318157cb3b; Brennan AR, 2008, ANN NY ACAD SCI, V1129, P236, DOI 10.1196/annals.1417.007; Okamoto Y, 2009, J VET MED SCI, V71, P1617; Nieuwenhuis S, 2005, NAT NEUROSCI, V8, P1631, DOI 10.1038/nn1205-1631; Wigal SB, 2003, PEDIATR RES, V53, P756, DOI 10.1203/01.PDR.0000061750.71168.23; Mitsui S, 2011, HORM BEHAV, V60, P239, DOI 10.1016/j.yhbeh.2011.05.012; Skosnik PD, 2000, INT J PSYCHOPHYSIOL, V36, P59, DOI 10.1016/S0167-8760(99)00100-2; Fernstrom F. D., 2007, J NUTR, V137, p1539S; FONBERG E, 1980, ACTA NEUROBIOL EXP, V40, P117; GIBSON CJ, 1978, LIFE SCI, V22, P1399, DOI 10.1016/0024-3205(78)90633-1; Hart B., 1998, PERFECT PUPPY CHOOSE; Hay M, 2000, J ANIM SCI, V78, P420; Kato M, 2012, J VET BEHAV, V7, P21, DOI 10.1016/j.jveb.2011.05.025; MAAS JW, 1984, ADV BIOCHEM PSYCHOPH, V39, P45; Ohtani N, 1999, BRAIN RES, V842, P6, DOI 10.1016/S0006-8993(99)01796-5; OISHI T, 1982, J NEURAL TRANSM, V53, P101, DOI 10.1007/BF01243401; REINSTEIN DK, 1984, LIFE SCI, V34, P2225, DOI 10.1016/0024-3205(84)90209-1; Schmidt L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001266; Serpell JA, 2014, DOMESTIC DOG COGNITI, P31; WURTMAN RJ, 1980, PHARMACOL REV, V32, P315; YOKOGOSHI H, 1986, J NUTR, V116, P356	25	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1558-7878	1878-7517		J VET BEHAV	J. Vet. Behav.-Clin. Appl. Res.	MAY-JUN	2015	10	3					194	198		10.1016/j.jveb.2014.12.009		5	Behavioral Sciences; Veterinary Sciences	Behavioral Sciences; Veterinary Sciences	CG6JY	WOS:000353407800002		
J	Koyamada, K; Yuan, XR				Koyamada, Koji; Yuan, Xiaoru			The 1st China Visualization Conference (ChinaVis)	JOURNAL OF VISUALIZATION			English	Editorial Material									[Koyamada, Koji] Kyoto Univ, Kyoto, Japan; [Yuan, Xiaoru] Peking Univ, Beijing 100871, Peoples R China	Yuan, XR (reprint author), Peking Univ, Beijing 100871, Peoples R China.	xiaoru.yuan@pku.edu.cn						0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	MAY	2015	18	2			SI		131	132		10.1007/s12650-015-0287-9		2	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	CG6KN	WOS:000353409400001		
J	Zhao, K; Sakamoto, N; Koyamada, K				Zhao, Kun; Sakamoto, Naohisa; Koyamada, Koji			Adaptive fused visualization for large-scale blood flow dataset with particle-based rendering	JOURNAL OF VISUALIZATION			English	Article						Adaptive visualization; Fused visualization; Large-scale data visualization; Blood flow; Particle-based rendering; Scientific application	CELL-PROJECTION; VOLUME	The visualization for the large-scale volume dataset obtained from blood flow simulations needs to be performed to help researchers to confirm the detailed positional information of the red blood cells, platelets and vascular walls. However, such a large-scale dataset is difficult to be visualized with an interactive frame rate on a normal computer. Nevertheless, the fusion of different objects, such as red blood cell volumes, platelet volumes and vascular wall surfaces, is also needed in the visualization, which makes it even more challenging. To solve this problem, we propose a system for visualizing such data by applying the particle-based rendering (PBR) (Sakamoto et al. Comput Graph 34(1):34-42, 2010); (Sakamoto and Koyamada Ultra Vis 176-185, 2012) method. This rendering method does not require any visibility sorting; thus, it can handle large-scale volume dataset, and the fusion of different objects is also easy to be implemented. To achieve an interactive frame rate analysis while maintaining good image quality, we combine two types of PBR in the system: object-space PBR (O-PBR) (Sakamoto et al. Comput Graph 34(1):34-42, 2010) and image-space PBR (I-PBR) (Sakamoto and Koyamada Ultra Vis 176-185, 2012). O-PBR method can handle large-scale data at high rendering speed but the image quality is not adequate when the view is enlarged. I-PBR method can provide high-quality rendering but have a limitation for the renderable data size. To obtain a best performance for blood flow visualization, our system adaptively switches O-PBR and I-PBR based on the data size within the view frustum and the computer resources. With this proposed adaptive visualization approach, the large-scale blood flow dataset can be efficiently visualized with the fusion of different objects while maintaining an interactive frame rate and good image quality.	[Zhao, Kun] Kyoto Univ, Grad Sch Engn, Kyoto, Japan; [Sakamoto, Naohisa; Koyamada, Koji] Kyoto Univ, Inst Liberal Arts & Sci, Kyoto, Japan	Zhao, K (reprint author), Kyoto Univ, Grad Sch Engn, Kyoto, Japan.	zhao.kun@viz.media.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [26 837]; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency (JST) [AS2415031H]	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants-in-Aid for JSPS Fellows (Grant Number 26 837), and was partially supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant-in-Aid for Data Integration and Analysis System (DIAS), Grant-in-Aid for Research Programs on Climate Change Adaptation (RECCA) and by the Japan Science and Technology Agency (JST), A-STEP project ("The research and development of fusion visualization technology'', AS2415031H).	Kocer N, 2013, J NEUROSURG, V118, P1000, DOI 10.3171/2012.11.JNS111355; Koyamada K, 2008, 2008 UKSIM TENTH INTERNATIONAL CONFERENCE ON COMPUTER MODELING AND SIMULATION, P372, DOI 10.1109/UKSIM.2008.63; Rottger S, 2000, IEEE VISUAL, P109, DOI 10.1109/VISUAL.2000.885683; Marroquim R, 2008, COMPUT GRAPH FORUM, V27, P24, DOI 10.1111/J.1467-8659.2007.01038.x; Sakamoto N, 2010, COMPUT GRAPH-UK, V34, P34, DOI 10.1016/j.cag.2009.12.001; Knoll A, 2009, IEEE T VIS COMPUT GR, V15, P1571, DOI 10.1109/TVCG.2009.204; Sugiyama K, 2011, J COMPUT PHYS, V230, P596, DOI 10.1016/j.jcp.2010.09.032; Baum K.G., 2008, J DIGIT IMAGING, V21, P59, DOI 10.1007/s10278-007-9082-z; Hasegawa K, 2013, INT J MODELING SIMUL, V4; Kipfer P., 2005, P VIS MOD VIS 2005, P241; Prckovska V, 2011, IEEE T VIS COMPUT GR, V17, P1407, DOI 10.1109/TVCG.2010.244; Sakamoto N, 2012, 2012 SC COMPANION: HIGH PERFORMANCE COMPUTING, NETWORKING, STORAGE AND ANALYSIS (SCC), P176, DOI 10.1109/SC.Companion.2012.33; Sakamoto N., 2009, P 2009 WORKSH ULTR V, P11, DOI 10.1145/1838544.1838546; Sakamoto N., 2008, IEEE VGTC PAC VIS S; Sakamoto N, 2014, P IEEE PAC VIS NOT, P272; Sugiyama K, 2013, P HIGH PERF COMP S T; Tanaka S, 2012, P EUROVIS 2012 VIENN, P5; Tanaka S, 2000, COMPUT GRAPH-UK, V24, P419, DOI 10.1016/S0097-8493(00)00037-6; Yonezawa A, 2011, P SC 11 STAT PRACT R; Zhao K, 2013, INT J MODEL SIMUL S1, V4	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	MAY	2015	18	2			SI		133	145		10.1007/s12650-014-0260-z		13	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	CG6KN	WOS:000353409400002		
J	Anyoji, M; Numata, D; Nagai, H; Asai, K				Anyoji, M.; Numata, D.; Nagai, H.; Asai, K.			Pressure-sensitive paint technique for surface pressure measurements in a low-density wind tunnel	JOURNAL OF VISUALIZATION			English	Article						Pressure-sensitive paint (PSP); Mars wind tunnel; Low-pressure condition; Temperature calibration	SEPARATION BUBBLE; REYNOLDS-NUMBERS; GAS-PERMEABILITY; MODEL; FLOW	A low-density wind tunnel called the Mars wind tunnel, has been developed at Tohoku University that can produce a high subsonic flow at low pressures for aerodynamic measurements of low-Reynolds-number aircraft wings aimed at developing aircraft applicable to the atmosphere on the planet Mars. Accurate surface pressure measurements on the wing are essential for analysis of not only aerodynamic performance, including lift and drag, but also the flow fields around the wing. This paper presents a surface pressure measurement technique using pressure-sensitive paint (PSP) applicable for Mars wind tunnel tests under low-pressure conditions. The results show that a PSP composed of palladium tetra(pentafluorophenyl) porphyrin (PdTFPP) and poly[1-(trimethylsilyl)-propyne] [poly(TMSP)] exhibits a high-pressure sensitivity at pressures as low as 1 kPa, and the absolute values of the static pressures measured by the PSP accorded well with the values derived from static pressure sensors used as a reference. A calibration methodology for the non-uniform pressure sensitivity on the test model, including a temperature calibration, is also established. The PSP technique clearly demonstrated pressure sensitivity over a distinctive low-pressure region inside a leading edge separation bubble on a flat plate at low Reynolds numbers.	[Anyoji, M.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Numata, D.; Nagai, H.; Asai, K.] Tohoku Univ, Dept Aerosp Engn, Aoba Ku, Sendai, Miyagi 980, Japan	Anyoji, M (reprint author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, 6-1-1 Yoshinodai, Sagamihara, Kanagawa 2525210, Japan.	anyoji@flab.isas.jaxa.jp			KAKENHI [2056081]	This work was partially supported by KAKENHI (2056081). We would like to express our sincere thanks to Tadashi Ono, who graduated from Tohoku University, and Daisuke Sasaki, who is a current student at Tohoku University, for this research.	Yamashita T, 2007, J VISUAL-JAPAN, V10, P289; OMEARA MM, 1987, AIAA J, V25, P1033, DOI 10.2514/3.9739; Mori H, 2006, MEAS SCI TECHNOL, V17, P1242, DOI 10.1088/0957-0233/17/6/S02; MASUDA T, 1983, J AM CHEM SOC, V105, P7473, DOI 10.1021/ja00363a061; MASUDA T, 1988, POLYMER, V29, P2041, DOI 10.1016/0032-3861(88)90178-4; Gouterman M, 2004, MEAS SCI TECHNOL, V15, P1986, DOI 10.1088/0957-0233/15/10/007; Nagai K, 2001, PROG POLYM SCI, V26, P721, DOI 10.1016/S0079-6700(01)00008-9; OTA T, 1976, J FLUID ENG-T ASME, V98, P79; Okamoto M, 1996, J EXP BIOL, V199, P281; Anyoji M, 2010, 49 AIAA AER SCI M OR; Anyoji M., 2011, T JAPAN SOC AEROSPAC, V9, P21; Bell J H, 2004, 42 AIAA AER SCI M EX; Brown O, 2000, THESIS STANFORD U; Gerakopulos R, 2010, 40 FLUID DYN C EXH C; Guynn M D, 2003, 2 AIAA UNM UNL SYST; Liu T., 2004, PRESSURE TEMPERATURE; Liu T., 1997, APPL MECH REV, V50-4, P227, DOI DOI 10.1115/1.3101703; Masuda T, 2013, MEMOIRS FUKUI I TECH, V43, P293; Mitsuo K, 2005, P INT C INSTR AER SI, P207; Mori H, 2004, T JPN SOC MECH ENG, V70, P2721; Niimi T, 2005, J THERMOPHYS HEAT TR, V19, P9, DOI 10.2514/1.5047; Ono T, 2010, P 14 ISFV; Oyama A, 2006, 44 AIAA AER SCI M EX; SASAKI K, 1991, J FLUID ENG-T ASME, V113, P405, DOI 10.1115/1.2909510; TAKADA K, 1985, J APPL POLYM SCI, V30, P1605, DOI 10.1002/app.1985.070300426; Tanaka Y, 2005, J JPN SOC AERONAUT S, V54, P24; Tani I., 1961, 364 U TOK AER RES I; Tani I., 1964, PROGRESS AERONAUTICA, V5, P70, DOI DOI 10.1016/0376-0421(64)90004-1	28	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	MAY	2015	18	2			SI		297	309		10.1007/s12650-014-0239-9		13	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	CG6KN	WOS:000353409400015		
J	Sakai, H; Watanabe, Y; Sera, T; Yokota, H; Tanaka, G				Sakai, H.; Watanabe, Y.; Sera, T.; Yokota, H.; Tanaka, G.			Visualization of particle deposition in human nasal cavities	JOURNAL OF VISUALIZATION			English	Article						Nasal airflow; Filtration; Particle deposition; Laser-induced fluorescence	AIR-FLOW	The location and concentration of particle deposition of pollen by filtration in the human nasal cavity were visualized in a transparent silicone nasal airway model using laser-induced fluorescence (LIF) to clarify the relationship between flow and particle deposition. The model was created from a water-soluble plaster mold fabricated by a 3D printer based on X-ray computed tomography images. The working fluid was air and the tracer particles as a substitute for cedar pollen were lycopodium powder doped with fluorescent dye (Rhodamine 6G). After particle deposition, the nasal airway model was filled with an aqueous solution of glycerin that had the same refractive index as silicone. Then, LIF was applied to illuminate the deposited particles with a YAG laser sheet. Results revealed that particle deposition in the right and left cavities was highly heterogeneous and was related to the complex flow structure in the nasal cavities. .	[Sakai, H.; Watanabe, Y.; Tanaka, G.] Chiba Univ, Grad Sch Engn, Dept Mech Engn, Inage Ku, Chiba 2638522, Japan; [Sera, T.] Kyushu Univ, Grad Sch Engn, Dept Mech Engn, Nishi Ku, Fukuoka 8190395, Japan; [Yokota, H.] RIKEN, Biomech Simulat Res Team, Wako, Saitama 3510198, Japan	Tanaka, G (reprint author), Chiba Univ, Grad Sch Engn, Dept Mech Engn, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	gtanaka@faculty.chiba-u.jp			Japan Society for the Promotion of Science [22560187]	We thank Prof. T. Matsuzawa at Japan Advanced Institute of Science and Technology and Dr. S. Ishikawa at Kanazawa Municipal Hospital for their advice in the nasal cavity model preparation. We also thank Prof. R. C. Schroter, Prof. D. J. Doorly and Dr. D. J. Taylor at Imperial College London for helpful discussions in carrying out the present study. The present study was supported by a Grant-in-Aid for Scientific Research (22560187) from Japan Society for the Promotion of Science.	Elad D, 2008, RESP PHYSIOL NEUROBI, V163, P121, DOI 10.1016/j.resp.2008.05.002; Kim SK, 2009, J VISUAL-JAPAN, V12, P259; Wang Z, 2008, J AEROSOL SCI, V39, P1040, DOI 10.1016/j.jaerosci.2008.07.008; Kundoor V, 2010, PHARM RES-DORD, V27, P30, DOI 10.1007/s11095-009-0002-4; Hopkins LM, 2000, EXP FLUIDS, V29, P91, DOI 10.1007/s003480050430; Kelly JT, 2004, AEROSOL SCI TECH, V38, P1063, DOI 10.1080/027868290883360; Bishoff JS, 2008, J AEROSOL SCI, V39, P1055; Doorly D, 2008, P I MECH ENG H, V222, P439, DOI 10.1243/09544119JEIM330; Eccles R, 1996, EUR RESPIR J, V9, P371, DOI 10.1183/09031936.96.09020371; Liu Y, 2007, J AEROSOL SCI, V38, P683, DOI 10.1016/j.jaerosci.2007.05.003; Nakane I, 2012, T JPN SOC MECH ENG S, V78, P1220; Nishizawa T, 2011, P 11 AS S VIS; Okuda M, 2005, RHINOLOGY, V43, P29; Saito Y, 2006, KAHUNSYO KAGAKU; Su WC, 2005, AEROSOL SCI TECH, V39, P888, DOI 10.1080/02786820500295685	15	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	MAY	2015	18	2			SI		349	357		10.1007/s12650-014-0238-x		9	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	CG6KN	WOS:000353409400020		
J	Erkan, N; Kawakami, T; Madokoro, H; Chai, PH; Ishiwatari, Y; Okamoto, K				Erkan, Nejdet; Kawakami, Toshihiro; Madokoro, Hiroshi; Chai, Penghui; Ishiwatari, Yuki; Okamoto, Koji			Numerical simulation of droplet deposition onto a liquid film by VOF-MPS hybrid method	JOURNAL OF VISUALIZATION			English	Article						Particle method; VOF; Droplet deposition	ANNULAR 2-PHASE FLOW; SURFACE-TENSION; ENTRAINMENT; IMPACT; FLUID; RATES	Droplet entrainment and deposition are a couple of significant mechanisms for the heat transfer in annular two-phase flows existing in some heat exchange systems. The basic physics include the peeling of droplets from the liquid film due to high friction with the gas phase and the collision of droplets with the liquid film or deposition into the liquid film. Droplet deposition particularly plays a crucial role in the course of film dryout events which might have a vital importance for particular systems. In this study, a new numerical method (named as VOF-MPS hybrid method) based on the moving particle semi-implicit (MPS) method was developed to analyze the droplet deposition onto a stagnant thin liquid film. That proposed method combines the volume of fluid (VOF) solver of the open-source CFD code OpenFOAM with the MPS method. VOF-MPS technique introduces the surface tension force calculation of VOF model into the MPS method. MPS method formerly employed the continuum surface force (CSF) approach based on the particles. Three-dimensional (3D) VOF-MPS simulation with the novel surface tension modeling addition to the MPS-based modeling provides a smoother liquid-gas interface on the crown formed after the impact. Droplet deposition experiments were also carried out for the validation and comparison of two models. VOF-MPS method could predict the crown parameters such as crown thickness relatively better than the MPS method employing the CSF. However, the instabilities formed at the tip of the crown, observed in the experiments, could not be resolved with both methods.	[Erkan, Nejdet; Okamoto, Koji] Univ Tokyo, Nucl Profess Sch, Tokai, Ibaraki 3191188, Japan; [Kawakami, Toshihiro; Madokoro, Hiroshi; Chai, Penghui; Ishiwatari, Yuki] Univ Tokyo, Dept Nucl Engn & Management, Bunkyo Ku, Tokyo 1138656, Japan; [Ishiwatari, Yuki] Hitachi GE Nucl Energy Ltd, Hitachi, Ibaraki 3170073, Japan	Erkan, N (reprint author), Univ Tokyo, Nucl Profess Sch, 2-22 Shirakata, Tokai, Ibaraki 3191188, Japan.	erkan@vis.t.u-tokyo.ac.jp					Weller HG, 1998, COMPUT PHYS, V12, P620, DOI 10.1063/1.168744; Liu J, 2005, J COMPUT PHYS, V202, P65, DOI 10.1016/j.jcp.2004.07.002; Azzopardi BJ, 1997, INT J MULTIPHAS FLOW, V23, P1; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; Xie H, 2004, J NUCL SCI TECHNOL, V41, P569, DOI 10.3327/jnst.41.569; Weiss DA, 1999, J FLUID MECH, V385, P229, DOI 10.1017/S002211209800411X; Eastoe J, 2000, ADV COLLOID INTERFAC, V85, P103, DOI 10.1016/S0001-8686(99)00017-2; BRACKBILL JU, 1992, J COMPUT PHYS, V100, P335, DOI 10.1016/0021-9991(92)90240-Y; Koshizuka S, 1996, NUCL SCI ENG, V123, P421; Rieber M, 1999, INT J HEAT FLUID FL, V20, P455, DOI 10.1016/S0142-727X(99)00033-8; YARIN AL, 1995, J FLUID MECH, V283, P141, DOI 10.1017/S0022112095002266; ISHII M, 1975, AICHE J, V21, P308, DOI 10.1002/aic.690210212; HARLOW FH, 1967, J APPL PHYS, V38, P3855, DOI 10.1063/1.1709031; Kataoka I, 2000, INT J HEAT MASS TRAN, V43, P1573, DOI 10.1016/S0017-9310(99)00236-7; ISHII M, 1989, INT J HEAT MASS TRAN, V32, P1835, DOI 10.1016/0017-9310(89)90155-5; Nigmatulin RI, 1996, INT J MULTIPHAS FLOW, V22, P19, DOI 10.1016/0301-9322(95)00044-5; PARAS SV, 1991, INT J MULTIPHAS FLOW, V17, P455, DOI 10.1016/0301-9322(91)90042-2; Yoon SS, 2004, INT J MULTIPHAS FLOW, V30, P1369, DOI 10.1016/j.ijmultiphaseflow.2004.07.006	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	MAY	2015	18	2			SI		381	391		10.1007/s12650-014-0241-2		11	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	CG6KN	WOS:000353409400023		
J	Ohguchi, R; Kato, H; Furuhashi, T; Nakamura, M; Nishida, E; Watanabe, S; Shintani, Y; Morita, A				Ohguchi, Ryoko; Kato, Hiroshi; Furuhashi, Takuya; Nakamura, Motoki; Nishida, Emi; Watanabe, Shoichi; Shintani, Yoichi; Morita, Akimichi			Risk factors and treatment responses in patients with vitiligo in Japand-A retrospective large-scale study	KAOHSIUNG JOURNAL OF MEDICAL SCIENCES			English	Article						1-mm minigraft; Treatment response; Type of vitiligo; Vitiligo vulgaris	GENERALIZED VITILIGO; UVB; DISEASES	Vitiligo is a refractory skin disease. To investigate the risk factors and treatment responses of patients with vitiligo in Japan, we recorded and analyzed the details of 713 vitiligo patients (comorbidity, treatment responses, family history, age, and sex) who visited the dermatology clinic of the Nagoya City University Hospital, Nagoya, Japan between January 2004 and August 2010 (mean age, 35.2 years; 302 men, 411 women) using logistic regression analysis. The results are expressed as odds ratios (OR) with 95% confidence interval (CI). Patients were diagnosed with vitiligo [n = 644; 338 generalized type (47.4%), 170 segmental type (23.8%), and 136 localized type (19.1%)], nevus depigmentosus (n = 53, 7.4%), halo nevus (n = 14, 2.0%), and hypomelanosis of Ito (n = 2, 0.3%). For generalized and localized types, none of the analyzed factors were statistically significant. For the segmental type, antinuclear antibody (OR = 1.005; 95% CI, 1.00-1.01; p < 0.05) and onset age < 14 years were the significant factors in patients between 15 years and 29 years (OR = 0.246; 95% CI, 0.113-0.538; p < 0.001), 30-54 years (OR = 0.0419; 95% CI, 0.0133-0.132; p < 0.001), and > 55 years (OR = 0.0171; 95% CI, 0.00333-0.0879; p < 0.001). The treatment response rates for narrow-band UV-B, topical vitamin D-3, and punch graft (1 mm minigraft) were, respectively, as follows: (1) generalized type: 46.3%, 21.1%, and 38.9%; (2) segmental type: 20.3%, 29.0%, and 77.3%; and (3) localized type: 29.2%, 54.8%, and 73.3%. We report the comorbidities and efficacy rates of these treatments. The response data for these treatments, in particular, would be of assistance to the previous explanations, because there were only a few reports on the response data for these treatments. The appropriate treatment should be selected depending on the type of vitiligo. Copyright (C) 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.	[Ohguchi, Ryoko; Kato, Hiroshi; Furuhashi, Takuya; Nakamura, Motoki; Nishida, Emi; Watanabe, Shoichi; Shintani, Yoichi; Morita, Akimichi] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi 4678601, Japan	Kato, H (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Mizuho Ku, Nagoya, Aichi 4678601, Japan.	h-kato@med.nagoya-cu.ac.jp					Taieb A, 2013, BRIT J DERMATOL, V168, P5, DOI 10.1111/j.1365-2133.2012.11197.x; Narita Tomohiko, 2011, Allergology International, V60, P505, DOI 10.2332/allergolint.11-OA-0303; Goktas EO, 2006, J EUR ACAD DERMATOL, V20, P553, DOI 10.1111/j.1468-3083.2006.01546.x; Gorman S, 2010, J STEROID BIOCHEM, V121, P247, DOI 10.1016/j.jsbmb.2010.02.034; Passi S, 1998, PIGM CELL RES, V11, P81, DOI 10.1111/j.1600-0749.1998.tb00714.x; Njoo MD, 2000, J AM ACAD DERMATOL, V42, P245, DOI 10.1016/S0190-9622(00)90133-6; Dong D, 2012, J DERMATOL SCI, V66, P20, DOI 10.1016/j.jdermsci.2012.01.012; de Castro CCS, 2012, J DERMATOL SCI, V65, P63, DOI 10.1016/j.jdermsci.2011.09.011; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Koca R, 2004, CLIN EXP DERMATOL, V29, P406, DOI 10.1111/j.1365-2230.2004.01524.x; Scherschun L, 2001, J AM ACAD DERMATOL, V44, P999, DOI 10.1067/mjd.2001.114752; Tan EM, 1997, ARTHRITIS RHEUM, V40, P1601, DOI 10.1002/art.1780400909; Kato H, 2011, J DERMATOL, V38, P1140, DOI 10.1111/j.1346-8138.2010.01184.x; Kotobuki Y, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2011.00945.x; LILI Y, 2012, PLOS ONE, V0007; Malleson PN, 1997, ARCH DIS CHILD, V77, P299; Mchepange UO, 2010, ACTA DERM-VENEREOL, V90, P136, DOI 10.2340/00015555-0799; Park YK, 1996, J DERMATOL SCI, V11, P111, DOI 10.1016/0923-1811(95)00427-0; Steitz J, 2004, EUR J CELL BIOL, V83, P797, DOI 10.1078/0171-9335-00423; Tanioka Miki, 2009, Dermatoendocrinol, V1, P43; Zaima H, 2002, J DERMATOL, V29, P15	21	0	0	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	1607-551X			KAOHSIUNG J MED SCI	Kaohsiung J. Med. Sci.	MAY	2015	31	5					260	264		10.1016/j.kjms.2015.02.003		5	Medicine, Research & Experimental	Research & Experimental Medicine	CG5QS	WOS:000353349000006		
J	Matsui, Y; Amano, H; Ito, Y; Eshima, K; Tamaki, H; Ogawa, F; Iyoda, A; Shibuya, M; Kumagai, Y; Satoh, Y; Majima, M				Matsui, Yoshio; Amano, Hideki; Ito, Yoshiya; Eshima, Koji; Tamaki, Hideaki; Ogawa, Fumihiro; Iyoda, Akira; Shibuya, Masafumi; Kumagai, Yuji; Satoh, Yukitoshi; Majima, Masataka			The role of vascular endothelial growth factor receptor-1 signaling in compensatory contralateral lung growth following unilateral pneumonectomy	LABORATORY INVESTIGATION			English	Article							DEVELOPING RAT LUNG; TUMOR-GROWTH; EPITHELIAL-CELLS; TYROSINE KINASE; FETAL LUNG; STEM-CELLS; VEGF GENE; II CELLS; ANGIOGENESIS; EXPRESSION	Compensatory lung growth models have been widely used to investigate alveolization because the remaining lung can be kept intact and volume loss can be controlled. Vascular endothelial growth factor (VEGF) plays an important role in blood formation during lung growth and repair, but the precise mechanisms involved are poorly understood; therefore, the aim of this study was to investigate the role of VEGF signaling in compensatory lung growth. After left pneumonectomy, the right lung weight was higher in VEGF transgenic mice than wild-type (WT) mice. Compensatory lung growth was suppressed significantly in mice injected with a VEGF neutralizing antibody and in VEGF receptor-1 tyrosine kinase-deficient mice (TK-/- mice). The mobilization of progenitor cells expressing VEGFR1(+) cells from bone marrow and the recruitment of these cells to lung tissue were also suppressed in the TK-/- mice. WT mice transplanted with bone marrow from TK-/- transgenic GFP(+) mice had significantly lower numbers of GFP(+)/aquaporin 5GFP(+), GFP(+/)surfactant protein A(+), and GFP(+)/VEGFR1(+) cells than WT mice transplanted with bone marrow from WTGFP(+) mice. The GFP(+)/VEGFR1(+) cells also co-stained for aquaporin 5 and surfactant protein A. Overall, these results suggest that VEGF signaling contributes to compensatory lung growth by mobilizing VEGFR1(+) cells.	[Matsui, Yoshio; Amano, Hideki; Ogawa, Fumihiro; Majima, Masataka] Kitasato Univ, Sch Med, Dept Pharmacol, Sagamihara, Kanagawa 2520374, Japan; [Amano, Hideki; Kumagai, Yuji] Kitasato Univ, Sch Med, Dept Clin Res Ctr, Sagamihara, Kanagawa 2520374, Japan; [Ito, Yoshiya] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 2520374, Japan; [Eshima, Koji] Kitasato Univ, Sch Med, Dept Immunol, Sagamihara, Kanagawa 2520374, Japan; [Tamaki, Hideaki] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 2520374, Japan; [Iyoda, Akira; Satoh, Yukitoshi] Kitasato Univ, Sch Med, Dept Thorac Surg, Sagamihara, Kanagawa 2520374, Japan; [Shibuya, Masafumi] Tokyo Med & Dent Univ, Dept Mol Oncol, Tokyo, Japan	Majima, M (reprint author), Kitasato Univ, Sch Med, Dept Pharmacol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	mmajima@med.kitasato-u.ac.jp					Gerber HP, 1999, DEVELOPMENT, V126, P1149; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; Nolen-Walston RD, 2008, AM J PHYSIOL-LUNG C, V294, pL1158, DOI 10.1152/ajplung.00298.2007; Voswinckel R, 2004, EUR RESPIR J, V24, P524, DOI 10.1183/09031936.04.10004904; Wedge SR, 2002, CANCER RES, V62, P4645; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Shibuya Masaubmi, 2006, Angiogenesis, V9, P225, DOI 10.1007/s10456-006-9055-8; Boussat S, 2000, AM J PHYSIOL-LUNG C, V279, pL371; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Chamoto K, 2012, J CELL PHYSIOL, V227, P3208, DOI 10.1002/jcp.24009; Healy AM, 2000, DEV DYNAM, V219, P341, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1061>3.0.CO;2-M; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Kotton DN, 2001, DEVELOPMENT, V128, P5181; Amano H, 2003, J EXP MED, V197, P221, DOI 10.1084/jem.20021408; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Hoffman AM, 2012, CURR MED CHEM, V19, P6003; Amano H, 2013, AM J PATHOL, V182, P553, DOI 10.1016/j.ajpath.2012.10.026; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Pham I, 2002, AM J PHYSIOL-LUNG C, V283, pL1133, DOI 10.1152/ajplung.00464.2001; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Risau W, 1997, NATURE, V386, P671; ADAMSON IYR, 1975, LAB INVEST, V32, P736; Eshima K, 2006, J IMMUNOL, V176, P1628; Lassus P, 2001, AM J RESP CRIT CARE, V164, P1981; Hsia CCW, 2004, J APPL PHYSIOL, V97, P1992, DOI 10.1152/japplphysiol.00530.2004; HSIA CCW, 1994, J CLIN INVEST, V94, P405, DOI 10.1172/JCI117337; DETMAR M, 1994, J EXP MED, V180, P1141, DOI 10.1084/jem.180.3.1141; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Been JV, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-116; Brekken RA, 2000, CANCER RES, V60, P5117; CAGLE PT, 1990, AM J RESP CELL MOL, V3, P153; COWAN MJ, 1975, AM REV RESPIR DIS, V111, P267; DUNNILL M. S., 1964, THORAX, V19, P443, DOI 10.1136/thx.19.5.443; Hara A, 2005, PEDIATR RES, V58, P30, DOI 10.1203/01.PDR.0000163614.20031.C5; Kamoshita E, 2006, AM J PATHOL, V169, P1458, DOI 10.2353/ajpath.2006.051358; Klekamp JG, 1999, AM J PATHOL, V154, P823, DOI 10.1016/S0002-9440(10)65329-1; LESLIE CC, 1985, AM REV RESPIR DIS, V132, P1246; Mae M, 2005, AM J RESP CELL MOL, V33, P629, DOI 10.1165/rcmb.2005-0092OC; Matsui Y, 2012, CANCER SCI, V103, P1795; Muratore CS, 2000, J PEDIATR SURG, V35, P906, DOI 10.1053/jpsu.2000.6916; NIJJAR MS, 1980, EUR J BIOCHEM, V105, P403, DOI 10.1111/j.1432-1033.1980.tb04514.x; RANNELS DE, 1988, EXP LUNG RES, V14, P157, DOI 10.3109/01902148809115122; Raoul W, 2004, AM J PHYSIOL-LUNG C, V286, pL1293, DOI 10.1152/ajplung.00157.2003; Sakurai MK, 2007, AM J PHYSIOL-LUNG C, V292, pL742, DOI 10.1152/ajplung.00064.2006; SCHERLE W, 1970, Mikroskopie, V26, P57; SEKHON HS, 1993, EXP LUNG RES, V19, P519, DOI 10.3109/01902149309031725; STAUB NC, 1974, PHYSIOL REV, V54, P678; Suga A, 2012, J SURG RES; Teisanu RM, 2011, AM J RESP CELL MOL, V44, P794, DOI 10.1165/rcmb.2010-0098OC; Varet J, 2010, AM J PHYSIOL-LUNG C, V298, pL768, DOI 10.1152/ajplung.00353.2009; Zhang QY, 2007, AM J PHYSIOL-LUNG C, V293, pL497, DOI 10.1152/ajplung.00393.2006	56	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	MAY	2015	95	5					456	468		10.1038/labinvest.2014.159		13	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CG8SR	WOS:000353583300001		
J	Urakawa, N; Utsunomiya, S; Nishio, M; Shigeoka, M; Takase, N; Arai, N; Kakeji, Y; Koma, I; Yokozaki, H				Urakawa, Naoki; Utsunomiya, Soken; Nishio, Mari; Shigeoka, Manabu; Takase, Nobuhisa; Arai, Noriaki; Kakeji, Yoshihiro; Koma, Ichiro; Yokozaki, Hiroshi			GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways	LABORATORY INVESTIGATION			English	Article							DIFFERENTIATION FACTOR 15; TGF-BETA SUPERFAMILY; INHIBITORY CYTOKINE-1; CANCER-CELLS; MORPHOGENETIC PROTEIN; MULTIPLE-MYELOMA; GROWTH; PROLIFERATION; INVASION; MICROENVIRONMENT	Tumor-associated macrophages (TAMs) are known to be involved in the progression, angiogenesis, and motility of various cancers. We previously reported the association between an increased number of infiltrating TAMs with tumor progression and poor prognosis in esophageal squamous cell carcinomas (ESCCs). To study the roles of TAMs in ESCC, we first exposed peripheral blood monocyte (PBMo)-derived macrophages from healthy volunteers to conditioned media of TE series human ESCC cell line (TECM) and confirmed the induction of the expression of the M2 macrophage marker CD204 and the protumorigenic factors interleukin (IL)-10, VEGFA, and MMPs. Next, we compared gene expression profiles between PBMo-derived macrophages stimulated with or without TECM by cDNA microarray and focused on growth differentiation factor 15 (GDF15) among the highly expressed genes including IL-6, IL-8, and CXCL1. Our immunohistochemical study of 70 surgically resected ESCCs revealed that GDF15 was present not only in cancer cells but also in macrophages. The high expression of GDF15 in the ESCCs was significantly correlated with several more malignant phenotypes including vessel invasion, lymph node metastasis, and clinical stages. Patients with high GDF15 expression showed significantly poorer disease-free survival (P = 0.011) and overall survival (P = 0.041). We also found that recombinant human GDF15 promotes cell proliferation and the phosphorylation of both Akt and Erk1/2 in ESCC cell lines in vitro. These results indicate that GDF15 is secreted by both TAMs and cancer cells in the tumor microenvironment and is associated with aberrant growth and a poor prognosis in human ESCC.	[Urakawa, Naoki; Utsunomiya, Soken; Nishio, Mari; Shigeoka, Manabu; Takase, Nobuhisa; Arai, Noriaki; Koma, Ichiro; Yokozaki, Hiroshi] Kobe Univ, Grad Sch Med, Dept Pathol, Div Pathol, Kobe, Hyogo 6500017, Japan; [Urakawa, Naoki; Takase, Nobuhisa; Kakeji, Yoshihiro] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo 6500017, Japan; [Shigeoka, Manabu] Kobe Univ, Grad Sch Med, Dept Surg Related, Div Oral & Maxillofacial Surg, Kobe, Hyogo 6500017, Japan	Yokozaki, H (reprint author), Kobe Univ, Grad Sch Med, Dept Pathol, Div Pathol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hyoko@med.kobe-u.ac.jp			Japan Society for the Promotion of Science [23590397, 26460418]	This work was supported by Grants-in-Aid for Scientific Research (C)-23590397 and (C)-26460418 from the Japan Society for the Promotion of Science. We thank Dr Shuho Semba, Dr Hiroki Sasaki, and Dr Kazuhiko Aoyagi for valuable discussions and technical suggestions about this work. We are also grateful for the excellent technical assistance of Atsuko Kawashima, Yumi Hashimoto, Nobuo Kubo, Miki Yamazaki, and Shuichi Matsumoto.	Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Wallin U, 2011, BRIT J CANCER, V104, P1619, DOI 10.1038/bjc.2011.112; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Hasita H, 2010, CANCER SCI, V101, P1913, DOI 10.1111/j.1349-7006.2010.01614.x; Zhang L, 2009, ORAL ONCOL, V45, P627, DOI 10.1016/j.oraloncology.2008.07.017; Zhang CY, 2009, CLIN CANCER RES, V15, P4017, DOI 10.1158/1078-0432.CCR-08-2824; Roth P, 2010, CLIN CANCER RES, V16, P3851, DOI 10.1158/1078-0432.CCR-10-0705; Hiyama T, 2007, INT J CANCER, V121, P1643, DOI 10.1002/ijc.23044; Hromas R, 1997, BBA-GENE STRUCT EXPR, V1354, P40, DOI 10.1016/S0167-4781(97)00122-X; Wang XY, 2013, BIOCHEM PHARMACOL, V85, P597, DOI 10.1016/j.bcp.2012.11.025; Koopmann J, 2006, CLIN CANCER RES, V12, P442, DOI 10.1158/1078-0432.CCR-05-0564; Zhu HD, 2014, LANCET ONCOL, V15, P612, DOI 10.1016/S1470-2045(14)70131-7; Grugan KD, 2012, J IMMUNOL, V189, P5457, DOI 10.4049/jimmunol.1201889; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Helm O, 2014, INT J CANCER, V135, P843, DOI 10.1002/ijc.28736; Tanno T, 2014, BLOOD, V123, P725, DOI 10.1182/blood-2013-08-524025; Corre J, 2012, CANCER RES, V72, P1395, DOI 10.1158/0008-5472.CAN-11-0188; Paralkar VM, 1998, J BIOL CHEM, V273, P13760, DOI 10.1074/jbc.273.22.13760; Jemal A, 2005, CA-CANCER J CLIN, V55, P10; Griner SE, 2013, BIOCHEM PHARMACOL, V85, P46, DOI 10.1016/j.bcp.2012.10.007; Strelau J, 2000, J NEUROSCI, V20, P8597; Hagemann T, 2006, J IMMUNOL, V176, P5023; Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196; Bruzzese F, 2014, CANCER RES, V74, P3408, DOI 10.1158/0008-5472.CAN-13-2259; Li PX, 2000, J BIOL CHEM, V275, P20127, DOI 10.1074/jbc.M909580199; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Baek SJ, 2001, J BIOL CHEM, V276, P33384, DOI 10.1074/jbc.M101814200; Li B, 2009, INT J CANCER, V125, P2576, DOI 10.1002/ijc.24675; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Karan D, 2003, BIOCHEM BIOPH RES CO, V305, P598, DOI 10.1016/S0006-291X(03)00823-4; Komohara Y, 2011, CANCER SCI, V102, P1424, DOI 10.1111/j.1349-7006.2011.01945.x; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Skipworth RJE, 2010, BRIT J CANCER, V102, P665, DOI 10.1038/sj.bjc.6605532; Ago T, 2006, CIRC RES, V98, P294, DOI 10.1161/01.RES.0000207919.83894.9d; Lee DH, 2003, CANCER RES, V63, P4648; Shigeoka M, 2013, CANCER SCI, V104, P1112, DOI 10.1111/cas.12188; Lowe JM, 2014, CANCER RES, V74, P2182, DOI 10.1158/0008-5472.CAN-13-1070; Liu FX, 2013, MOL CELL BIOCHEM, V381, P115, DOI 10.1007/s11010-013-1693-8; Montgomery EA, 2014, WORLD CANC REPORT 20, P374; Si YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019967; Sobin LH, 2011, TNM CLASSIFICATION M; The Japan Esophageal Society, 2008, JAP CLASS ES CANC; Wang XB, 2014, CANCER SCI, V105, P176, DOI 10.1111/cas.12331; Xu W, 2007, EUR J IMMUNOL, V37, P1594, DOI 10.1002/eji.200737042; YokoyamaKobayashi M, 1997, J BIOCHEM-TOKYO, V122, P622	50	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	MAY	2015	95	5					491	503		10.1038/labinvest.2015.36		13	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CG8SR	WOS:000353583300004		
J	Teranishi, Y; Matsubara, T; Krausz, KW; Le, TTT; Gonzalez, FJ; Yoshizato, K; Ikeda, K; Kawada, N				Teranishi, Yuga; Matsubara, Tsutomu; Krausz, Kristopher W.; Le, Thi T. T.; Gonzalez, Frank J.; Yoshizato, Katsutoshi; Ikeda, Kazuo; Kawada, Norifumi			Involvement of hepatic stellate cell cytoglobin in acute hepatocyte damage through the regulation of CYP2E1-mediated xenobiotic metabolism	LABORATORY INVESTIGATION			English	Article							LIVER-INJURY; ACETAMINOPHEN; HYPOXIA; MICE; ACTIVATION; RAT; MICROCIRCULATION; REGENERATION; NEUROGLOBIN; PROTEIN	Oxygen (O-2) is required for cytochrome P450 (CYP)-dependent drug metabolism. Cytoglobin (CYGB) is a unique globin expressed exclusively in hepatic stellate cells (HSCs). However, its role in O-2-dependent metabolism in neighboring hepatocytes remains unknown. This study provides evidence that CYGB in HSCs is involved in acetaminophen (N-acetyl-p-aminophenol; APAP)-induced hepatotoxicity. Serum alanine aminotransferase levels were higher in wild-type mice than in Cygb-null mice. Wild-type mice exhibited more severe hepatocyte necrosis around the central vein area compared with Cygb-null mice, thus indicating that CYGB deficiency protects against APAP-induced liver damage. Although no difference in the hepatic expression of CYP2E1, a key enzyme involved in APAP toxicity, was observed between wild-type and Cygb-null mice, the serum levels of the APAP metabolites cysteinyl-APAP and N-acetyl-cysteinyl-APAP were decreased in Cygb-null mice, suggesting reduced APAP metabolism in the livers of Cygb-null mice. In primary cultures, APAP-induced hepatocyte damage was increased by co-culturing with wild-type HSCs but not with Cygb-null HSCs. In addition, cell damage was markedly alleviated under low O-2 condition (5% O2), suggesting the requirement of O-2 for APAP toxicity. Carbon tetrachloride-induced liver injury (CYP2E1-dependent), but not lipopolysaccharide/ D-galactosamine-induced injury (CYP2E1-independent), was similarly alleviated in Cygb-null mice. Considering the function of CYGB as O-2 carrier, these results strongly support the hypothesis that HSCs are involved in the CYP2E1-mediated xenobiotic activation by augmenting O-2 supply to hepatocytes. In conclusion, CYGB in HSCs contributes to the CYP-mediated metabolism of xenobiotics in hepatocytes by supplying O-2 for enzymatic oxidation.	[Teranishi, Yuga; Le, Thi T. T.; Yoshizato, Katsutoshi; Kawada, Norifumi] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 5458585, Japan; [Matsubara, Tsutomu; Ikeda, Kazuo] Osaka City Univ, Grad Sch Med, Dept Anat & Regenerat Biol, Osaka 5458585, Japan; [Krausz, Kristopher W.; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Yoshizato, Katsutoshi] Phoenixbio Co Ltd, Hiroshima, Japan	Kawada, N (reprint author), Osaka City Univ, Grad Sch Med, Dept Hepatol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	kawadanori@med.osaka-cu.ac.jp			Japan Society for the Promotion of Science (JSPS) [25293177, 20132016]; Mochida Memorial Foundation; National Cancer Institute Intramural Research Program	We thank Ms Chiho Kadono for animal care, and Dr Wenhao Cui, Dr Keiko Iwaisako, and Dr Kazuki Nakatani (Osaka City University) for their valuable discussion and comments on this study. This investigation was supported in part by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS) through grant 25293177 (to NK) (20132016), the Mochida Memorial Foundation (to TM), and the National Cancer Institute Intramural Research Program (to FJG).	Yan HM, 2010, TOXICOL SCI, V117, P515, DOI 10.1093/toxsci/kfq208; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Gonzalez FJ, 2003, ARCH BIOCHEM BIOPHYS, V409, P153, DOI 10.1016/S0003-9861(02)00364-8; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Chen C, 2008, J BIOL CHEM, V283, P4543, DOI 10.1074/jbc.M706299200; Lieber CS, 1997, PHYSIOL REV, V77, P517; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; Cui WH, 2012, BIOCHEM BIOPH RES CO, V425, P642, DOI 10.1016/j.bbrc.2012.07.126; Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Reynaert H, 2002, GUT, V50, P571, DOI 10.1136/gut.50.4.571; Nakatani K, 2004, LAB INVEST, V84, P91, DOI 10.1038/labinvest.3700013; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Gonzalez FJ, 2007, DRUG METAB DISPOS, V35, P1, DOI 10.1124/dmd.106.012492; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; da Rosa EJF, 2012, TOXICOL PATHOL, V40, P605, DOI 10.1177/0192623311436179; Harada H, 2013, NAT COMMUN, V4, P2314; Hinson JA, HDB EXP PHARM; Ishibe T, 2009, LAB INVEST, V89, P68, DOI 10.1038/labinvest.2008.110; Iwaisako K, 2008, J HEPATOL, V49, P768, DOI 10.1016/j.jhep.2008.05.026; Jiang JX, 2013, CURR PATHOBIOL REP, V1, P215, DOI [10.1007/s40139-013-0019-6, DOI 10.1007/S40139-013-0019-6]; Mabuchi A, 2004, J HEPATOL, V40, P910, DOI 10.1016/j.jhep.2004.02.005; Oleksiewicz U, 2011, CELL MOL LIFE SCI, V68, P3869, DOI 10.1007/s00018-011-0764-9; Samoszuk MK, 2004, J HISTOCHEM CYTOCHEM, V52, P837, DOI 10.1369/jha.4B6248.2004.; Tanaka H, 2006, CANCER RES, V66, P11263, DOI 10.1158/0008-5472.CAN-06-1699; Thuy le T.T., 2011, AM J PATHOL, V179, P1050, DOI DOI 10.1016/J.AJPATH.2011.05.006; Tosqui Priscilla, 2011, Rev Bras Hematol Hemoter, V33, P307, DOI 10.5581/1516-8484.20110082	27	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	MAY	2015	95	5					515	524		10.1038/labinvest.2015.29		10	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CG8SR	WOS:000353583300006		
J	Matsui, T; Nakashima, S; Nishino, Y; Ojima, A; Nakamura, N; Arima, K; Fukami, K; Okuda, S; Yamagishi, S				Matsui, Takanori; Nakashima, Sae; Nishino, Yuri; Ojima, Ayako; Nakamura, Nobutaka; Arima, Kazunari; Fukami, Kei; Okuda, Seiya; Yamagishi, Sho-ichi			Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis	LABORATORY INVESTIGATION			English	Article							ENDOTHELIAL-CELLS; VASCULAR COMPLICATIONS; PROGRESSION; INHIBITION; KIDNEY; AGES; MICE; ALBUMINURIA; GENERATION; PREVENTION	Advanced glycation end products (AGEs) and their receptor (RAGE) have a role in diabetic nephropathy. We have recently found that linagliptin, an inhibitor of dipeptidyl peptidase-4 (DPP-4), could inhibit renal damage in type 1 diabetic rats by suppressing the AGE-RAGE axis. However, it remains unclear whether DPP-4 deficiency could also have beneficial effects on experimental diabetic nephropathy. To address the issue, we rendered wild-type F344/NSlc and DPP-4-deficient F344/DuCrl/Crlj rats diabetic by injection of streptozotocin, and then investigated whether DPP-4 deficiency could block the activation of AGE-RAGE axis in the diabetic kidneys and resultantly ameliorate renal injury in streptozotocin-induced diabetic rats. Compared with control rats at 9 and 11 weeks old, body weight and heart rates were significantly lower, while fasting blood glucose was higher in wild-type and DPP-4-deficient diabetic rats at the same age. There was no significant difference of body weight, fasting blood glucose and lipid parameters between the two diabetic rat strains. AGEs, 8-hydroxy-2'-deoxyguanosine (8-OHdG) and nitrotyrosine levels in the kidney, renal gene expression of RAGE and intercellular adhesion molecule-1, glomerular area, urinary excretion of 8-OHdG and albumin, and the ratio of renal to body weight were increased in wild-type diabetic rats at 9 and/or 11 weeks old compared with age-matched control rats, all of which except for urinary 8-OHdG levels at 11 weeks old were significantly suppressed in DPP-4-deficient diabetic rats. Our present study suggests that DPP-4 deficiency could exert beneficial actions on type 1 diabetic nephropathy partly by blocking the AGE-RAGE axis. DPP-4 might be a novel therapeutic target for preventing diabetic nephropathy.	[Matsui, Takanori; Nakashima, Sae; Nishino, Yuri; Ojima, Ayako; Nakamura, Nobutaka; Yamagishi, Sho-ichi] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 8300011, Japan; [Arima, Kazunari] Kagoshima Univ, Fac Sci, Grad Sch Sci & Engn, Dept Chem & Biosci, Kagoshima 890, Japan; [Fukami, Kei; Okuda, Seiya] Kurume Univ, Sch Med, Dept Med, Kurume, Fukuoka 8300011, Japan	Yamagishi, S (reprint author), Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	shoichi@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22390111]	This work was supported in part by Grants-in-Aid for Scientific Research (B) 22390111 (SY) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Matsui T, 2011, PHARMACOL RES, V63, P383, DOI 10.1016/j.phrs.2011.02.003; Yamagishi S, 2005, CURR PHARM DESIGN, V11, P2279, DOI 10.2174/1381612054367300; Kanasaki K, 2014, DIABETES, V63, P2120, DOI 10.2337/db13-1029; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; Rahbar S, 2005, ANN NY ACAD SCI, V1043, P9, DOI 10.1196/annals.1333.002; Busch M, 2010, EUR J CLIN INVEST, V40, P742, DOI 10.1111/j.1365-2362.2010.02317.x; Yamamoto Y, 2001, J CLIN INVEST, V108, P261, DOI 10.1172/JCI11771; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; Yamagishi S, 1998, DIABETOLOGIA, V41, P1435, DOI 10.1007/s001250051089; Yazbeck R, 2009, TRENDS PHARMACOL SCI, V30, P600, DOI 10.1016/j.tips.2009.08.003; Wendt TM, 2003, AM J PATHOL, V162, P1123, DOI 10.1016/S0002-9440(10)63909-0; Groop PH, 2013, DIABETES CARE, V36, P3460, DOI 10.2337/dc13-0323; Stitt AW, 1997, ANN NY ACAD SCI, V811, P115, DOI 10.1111/j.1749-6632.1997.tb51994.x; Nakashima S, 2014, HORM METAB RES, V46, P717, DOI 10.1055/s-0034-1371892; Ojima A, 2012, HORM METAB RES, V44, P501, DOI 10.1055/s-0032-1312595; Ye SD, 2009, EUR J CLIN INVEST, V39, P980, DOI 10.1111/j.1365-2362.2009.02203.x; Ishibashi Y, 2011, METABOLISM, V60, P1271, DOI 10.1016/j.metabol.2011.01.010; Kaida Y, 2013, DIABETES, V62, P3241, DOI 10.2337/db12-1608; Yamagishi S, 2011, CURR PHARM DESIGN, V17, P4379; Chow FY, 2005, J AM SOC NEPHROL, V16, P1711, DOI 10.1681/ASN.2004070612; Yamagishi S, 2006, MICROVASC RES, V72, P86, DOI 10.1016/j.mvr.2006.04.002; Sourris KC, 2009, CURR DRUG TARGETS, V10, P42; DAgati V, 2010, TRENDS ENDOCRIN MET, V21, P50, DOI 10.1016/j.tem.2009.07.003; Sakata K, 2013, DIABETES-METAB RES, V29, P624, DOI 10.1002/dmrr.2437; Tahara N, 2013, CLIN BIOCHEM, V46, P300, DOI 10.1016/j.clinbiochem.2012.11.023; Yamagishi SI, 2008, OPHTHAL RES, V40, P10, DOI 10.1159/000111152; Avogaro A, 2014, DIABETES CARE, V37, P2884, DOI 10.2337/dc14-0865; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Ide Y, 2010, MICROVASC RES, V80, P227, DOI 10.1016/j.mvr.2010.03.015; Ishibashi Y, 2010, BIOCHEM BIOPH RES CO, V391, P1405, DOI 10.1016/j.bbrc.2009.12.075; Ishibashi Y, 2011, HORM METAB RES, V43, P731, DOI 10.1055/s-0031-1284383; Ishibashi Y, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-125; Ojima A, 2013, AM J PATHOL, V182, P132, DOI 10.1016/j.ajpath.2012.09.016; Ojima A, 2015, HORM METAB RES, V47, P253, DOI 10.1055/s-0034-1385904; Sharkovska Y, 2014, J HYPERTENS, V32, P2211, DOI 10.1097/HJH.0000000000000328; Sugimoto H, 1997, DIABETES, V46, P2075, DOI 10.2337/diabetes.46.12.2075; Tan Adeline L Y, 2007, Semin Nephrol, V27, P130, DOI 10.1016/j.semnephrol.2007.01.006; TSUJI E, 1992, BIOCHEMISTRY-US, V31, P11921, DOI 10.1021/bi00162a035; Yamagishi S, 2002, MOL MED, V8, P546	40	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	MAY	2015	95	5					525	533		10.1038/labinvest.2015.35		9	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CG8SR	WOS:000353583300007		
J	Fukusumi, Y; Wakamatsu, A; Takashima, N; Hasegawa, E; Miyauchi, N; Tomita, M; Kawachi, H				Fukusumi, Yoshiyasu; Wakamatsu, Ayako; Takashima, Natsumi; Hasegawa, Eriko; Miyauchi, Naoko; Tomita, Masayuki; Kawachi, Hiroshi			SV2B is essential for the integrity of the glomerular filtration barrier	LABORATORY INVESTIGATION			English	Article							MONOCLONAL-ANTIBODY; PROTEINURIC STATES; SLIT DIAPHRAGM; RAT MODEL; PODOCYTES; NEPHRIN; EXPRESSION; SYNAPTOTAGMIN; TERMINUS; MOLECULE	The glomerular visceral epithelial cell (podocyte) is characterized as a specialized structure of the interdigitating foot processes, covering the outer side of the glomerular basement membrane (GBM). The neighboring foot processes are connected by a slit diaphragm, which is a key structure regulating the barrier function of the glomerular capillary wall to prevent proteinuria. We have previously reported that synaptic vesicle protein 2 B (SV2B) is expressed in the podocyte and that the expression is clearly decreased in nephrotic models. However, the precise function of SV2B in the podocyte is unclear. To investigate the role of SV2B in maintaining the podocyte function and to better understand the function of the neuron-like vesicle expressing SV2B in the podocyte, we analyzed them with SV2B knockout (KO) mice. An increase in the amount of proteinuria, effacement of the foot process of the podocyte, and alterations of the GBM were detected in SV2B KO mice. It was also found that the expression of CD2AP, nephrin, and NEPH1, the functional molecules of the slit diaphragm, and laminin, a critical component of the GBM, is clearly altered in SV2B KO mice. Synaptotagmin and neurexin, which have a role in the synaptic vesicle docking in neurons, are downregulated in the kidney cortex of SV2B KO mice. We have previously reported that neurexin interacts with CD2AP, and the present study shows that SV2B interacts with CD2AP. These findings suggest that the SV2B-neurexin complex is involved in the formation and maintenance of the slit diaphragm. In addition, SV2B is densely expressed close to the cell surface in the presumptive podocyte in the early stage of glomerulogenesis. These results suggest that SV2B has an essential role in the formation and maintenance of the glomerular capillary wall.	[Fukusumi, Yoshiyasu; Wakamatsu, Ayako; Takashima, Natsumi; Hasegawa, Eriko; Miyauchi, Naoko; Tomita, Masayuki; Kawachi, Hiroshi] Niigata Univ, Grad Sch Med & Dent Sci, Inst Nephrol, Dept Cell Biol, Niigata 9518510, Japan	Kawachi, H (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Inst Nephrol, Dept Cell Biol,Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	kawachi@med.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23390224, 23591186]	This work was supported by Grant-Aids for Scientific Research (B: 23390224 to HK), (C: 23591186 to MT) and Grant-Aid for Young Sciences (B: 24790839 to YF) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. We thank Mutsumi Kayaba and Yukina Kitazawa for excellent technical assistance, and Masaaki Nameta for taking EM images.	Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Nakatsue T, 2005, KIDNEY INT, V67, P2239, DOI 10.1111/j.1523-1755.2005.00328.x; Giardino L, 2009, J AM SOC NEPHROL, V20, P1929, DOI 10.1681/ASN.2008121286; Kriz W, 2013, AM J PHYSIOL-RENAL, V304, pF333, DOI 10.1152/ajprenal.00478.2012; Kobayashi N, 2002, MICROSC RES TECHNIQ, V57, P217, DOI 10.1002/jemt.10077; Burford JL, 2014, J CLIN INVEST, V124, P2050, DOI 10.1172/JCI71702; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Miyauchi N, 2006, J AM SOC NEPHROL, V17, P2748, DOI 10.1681/ASN.2005121293; ORIKASA M, 1988, J IMMUNOL, V141, P807; Miner JH, 2012, EXP CELL RES, V318, P973, DOI 10.1016/j.yexcr.2012.02.031; Li C, 2000, AM J PHYSIOL-RENAL, V279, pF785; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; SCHNABEL E, 1990, J CELL BIOL, V111, P1255, DOI 10.1083/jcb.111.3.1255; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010; Kawachi H, 2003, J AM SOC NEPHROL, V14, P46, DOI 10.1097/01.ASN.0000037401.02391.76; Macconi D, 2006, AM J PATHOL, V168, P42, DOI 10.2353/ajpath.2006.050398; Schaldecker T, 2013, J CLIN INVEST, V123, P5298, DOI 10.1172/JCI71165; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Armelloni S, 2012, NEPHRON EXP NEPHROL, V120, pE69, DOI 10.1159/000336166; Bechtel W, 2013, J AM SOC NEPHROL, V24, P727, DOI 10.1681/ASN.2012070700; Fukuda M, 2000, P NATL ACAD SCI USA, V97, P14715, DOI 10.1073/pnas.260491197; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1076/jbc.C200678200; Kawachi H, 1997, AM J PHYSIOL-RENAL, V273, pF984; Kawachi H, 2000, KIDNEY INT, V57, P1949, DOI 10.1046/j.1523-1755.2000.00044.x; KAWACHI H, 1992, CLIN EXP IMMUNOL, V87, P215; Kobayashi Naoto, 2004, Anatomical Science International, V79, P1, DOI 10.1111/j.1447-073x.2004.00066.x; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Morgans CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005230; Otaki Y, 2008, AM J PHYSIOL-RENAL, V295, pF1376, DOI 10.1152/ajprenal.00075.2008; PERIN MS, 1994, J BIOL CHEM, V269, P8576; Plaisier E, 2005, J AM SOC NEPHROL, V16, P3350, DOI 10.1681/ASN.2005050509; Rastaldi MP, 2003, AM J PATHOL, V163, P889, DOI 10.1016/S0002-9440(10)63449-9; Saito A, 2011, AM J PHYSIOL-REG I, V300, pR340, DOI 10.1152/ajpregu.00640.2009; Tian DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001200; Wang H, 2014, J AM SOC NEPHROL, V26, P314; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	38	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	MAY	2015	95	5					534	545		10.1038/labinvest.2015.39		12	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CG8SR	WOS:000353583300008		
J	Hajifathalian, K; Ueda, P; Lu, Y; Woodward, M; Ahmadvand, A; Aguilar-Salinas, CA; Azizi, F; Cifkova, R; Di Cesare, M; Eriksen, L; Farzadfar, F; Ikeda, N; Khalili, D; Khang, YH; Lanska, V; Leon-Munoz, L; Magliano, D; Msyamboza, KP; Oh, K; Rodriguez-Artalejo, F; Rojas-Martinez, R; Shaw, JE; Stevens, GA; Tolstrup, J; Zhou, B; Salomon, JA; Ezzati, M; Danaei, G				Hajifathalian, Kaveh; Ueda, Peter; Lu, Yuan; Woodward, Mark; Ahmadvand, Alireza; Aguilar-Salinas, Carlos A.; Azizi, Fereidoun; Cifkova, Renata; Di Cesare, Mariachiara; Eriksen, Louise; Farzadfar, Farshad; Ikeda, Nayu; Khalili, Davood; Khang, Young-Ho; Lanska, Vera; Leon-Munoz, Luz; Magliano, Dianna; Msyamboza, Kelias P.; Oh, Kyungwon; Rodriguez-Artalejo, Fernando; Rojas-Martinez, Rosalba; Shaw, Jonathan E.; Stevens, Gretchen A.; Tolstrup, Janne; Zhou, Bin; Salomon, Joshua A.; Ezzati, Majid; Danaei, Goodarz			A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys	LANCET DIABETES & ENDOCRINOLOGY			English	Article							CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; MIDDLE-INCOME COUNTRIES; BLOOD-PRESSURE; CASE-FATALITY; JAPANESE MEN; 10-YEAR RISK; FRAMINGHAM; PREVENTION; METAANALYSIS	Background Treatment of cardiovascular risk factors based on disease risk depends on valid risk prediction equations. We aimed to develop, and apply in example countries, a risk prediction equation for cardiovascular disease (consisting here of coronary heart disease and stroke) that can be recalibrated and updated for application in different countries with routinely available information. Methods We used data from eight prospective cohort studies to estimate coefficients of the risk equation with proportional hazard regressions. The risk prediction equation included smoking, blood pressure, diabetes, and total cholesterol, and allowed the effects of sex and age on cardiovascular disease to vary between cohorts or countries. We developed risk equations for fatal cardiovascular disease and for fatal plus non-fatal cardiovascular disease. We validated the risk equations internally and also using data from three cohorts that were not used to create the equations. We then used the risk prediction equation and data from recent (2006 or later) national health surveys to estimate the proportion of the population at different levels of cardiovascular disease risk in 11 countries from different world regions (China, Czech Republic, Denmark, England, Iran, Japan, Malawi, Mexico, South Korea, Spain, and USA). Findings The risk score discriminated well in internal and external validations, with C statistics generally 70% or more. At any age and risk factor level, the estimated 10 year fatal cardiovascular disease risk varied substantially between countries. The prevalence of people at high risk of fatal cardiovascular disease was lowest in South Korea, Spain, and Denmark, where only 5-10% of men and women had more than a 10% risk, and 62-77% of men and 79-82% of women had less than a 3% risk. Conversely, the proportion of people at high risk of fatal cardiovascular disease was largest in China and Mexico. In China, 33% of men and 28% of women had a 10-year risk of fatal cardiovascular disease of 10% or more, whereas in Mexico, the prevalence of this high risk was 16% for men and 11% for women. The prevalence of less than a 3% risk was 37% for men and 42% for women in China, and 55% for men and 69% for women in Mexico. Interpretation We developed a cardiovascular disease risk equation that can be recalibrated for application in different countries with routinely available information. The estimated percentage of people at high risk of fatal cardiovascular disease was higher in low-income and middle-income countries than in high-income countries.	[Hajifathalian, Kaveh; Ueda, Peter; Salomon, Joshua A.; Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Hajifathalian, Kaveh] Cleveland Clin, Dept Internal Med, Cleveland, OH 44106 USA; [Woodward, Mark] Univ Oxford, George Inst Global Hlth, Nuffield Dept Populat Hlth, Oxford, England; [Woodward, Mark] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Woodward, Mark] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Ahmadvand, Alireza; Di Cesare, Mariachiara; Zhou, Bin; Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Ctr Environm & Hlth, London, England; [Ahmadvand, Alireza; Di Cesare, Mariachiara; Zhou, Bin; Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Ahmadvand, Alireza; Farzadfar, Farshad] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran; [Aguilar-Salinas, Carlos A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Endocrinol & Metab, Mexico City, DF, Mexico; [Azizi, Fereidoun; Khalili, Davood] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Tehran, Iran; [Cifkova, Renata; Tolstrup, Janne] Thomayer Teaching Hosp, Dept Prevent Cardiol, Prague, Czech Republic; [Eriksen, Louise] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Ikeda, Nayu] Natl Inst Hlth & Nutr, Ctr Int Collaborat & Partnership, Tokyo 162, Japan; [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Inst Hlth Policy & Management, Seoul, South Korea; [Lanska, Vera] Inst Clin & Expt Med, Stat Unit, Prague, Czech Republic; [Leon-Munoz, Luz; Rodriguez-Artalejo, Fernando] Univ Autonoma Madrid, Idipaz, Dept Prevent Med & Publ Hlth, Sch Med, Madrid, Spain; [Leon-Munoz, Luz; Rodriguez-Artalejo, Fernando] CIBER Epidemiol & Publ Hlth, Madrid, Spain; [Magliano, Dianna; Shaw, Jonathan E.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Msyamboza, Kelias P.] WHO, Malawi Country Off, Lilongwe, Malawi; [Oh, Kyungwon] Korea Ctr Dis Control & Prevent, Div Hlth & Nutr Survey, Cheongwon Gun, South Korea; [Rojas-Martinez, Rosalba] Inst Nacl Salud Publ, Ctr Invest Salud Poblac, Mexico City, DF, Mexico; [Stevens, Gretchen A.] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland; [Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Danaei, G (reprint author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	gdanaei@hsph.harvard.edu	Ahmadvand, Alireza/J-8932-2015; 	Ahmadvand, Alireza/0000-0001-5568-8787; Khang, Young-Ho/0000-0002-9585-8266; Tolstrup, Janne/0000-0002-9796-3967	US National Institutes of Health (NIH) [NIDDK: 1R01-DK090435]; UK Medical Research Council; Wellcome Trust; National Institution of Nutrition and Food Safety, China Center for Disease Control and Prevention, Carolina Population Center [5 R24 HD050924]; University of North Carolina at Chapel Hill; NIH [R01-IID30880, DK056350, R24 IID050924, R01-IId38700]; Fogarty International Center of the NIH; Ministry of Health of China; Japan Society for the Promotion of Science [24590785]	This study was funded by the US National Institutes of Health (NIH; NIDDK: 1R01-DK090435), UK Medical Research Council, and Welcome Trust. Data for prospective cohorts were obtained from the National Heart Lung and Blood Institute (NHLBI) Biologic Specimen and Data Repository Information Coordinating Center. GAS and KPM are staff members of WHO. This study does not necessarily reflect the opinions or views of the cohorts used in the analysis, WHO, or the NHLBI. This research also uses data from China Health and Nutrition Survey (CHNS). We thank the National Institution of Nutrition and Food Safety, China Center for Disease Control and Prevention, Carolina Population Center (5 R24 HD050924), the University of North Carolina at Chapel Hill, the NIH (R01-IID30880, DK056350, R24 IID050924, and R01-IId38700), and the Fogarty International Center of the NIH for financial support for the CHNS data collection and analysis files from 1989 to 2011. We thank the China-Japan Friendship Hospital, Ministry of Health of China for support for CHNS 2009. Access to individual records of the National Health and Nutrition Survey was obtained under the Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant number: 24590785). We thank Pablo Perel and Rod Jackson for their comments on an earlier version of the manuscript.	Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Bhopal R, 2005, J PUBLIC HEALTH, V27, P93, DOI 10.1093/pubmed/fdh202; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Simmonds MC, 2012, J MED SCREEN, V19, P201, DOI 10.1258/jms.2012.012076; Jackson R, 2005, LANCET, V365, P434; Suka M, 2001, HYPERTENS RES, V24, P685, DOI 10.1291/hypres.24.685; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Sans S, 2007, REV ESP CARDIOL, V60, P476, DOI 10.1016/S0300-8932(07)75064-9; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Hammar N, 2001, INT J EPIDEMIOL, V30, pS30; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499; Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4; Degano IR, 2013, REV ESP CARDIOL, V66, P472, DOI [10.1016/j.rec.2013.01.018, 10.1016/j.recesp.2013.01.019]; Khalili D, 2012, AM J EPIDEMIOL, V176, P177, DOI 10.1093/aje/kws204; Cook NR, 2012, CIRCULATION, V125, P1748, DOI 10.1161/CIRCULATIONAHA.111.075929; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180; Ezzati M, 2004, COMP QUANTIFICATION, V2; Danesh J, 2009, STAT MED, V28, P389, DOI 10.1002/sim.3378; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Krumholz HM, 2014, CIRCULATION, V130, P966, DOI 10.1161/CIRCULATIONAHA.113.007787; Lawes CMM, 2003, HYPERTENSION, V42, P69, DOI 10.1161/01.HYP.0000075083.04415.4B; Lewington S, 2007, LANCET, V370, P1829; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Matheny M, 2011, SYSTEMATIC REV CARDI; Mathers C, 2004, GLOBAL BURDEN ISCHAE; Mendis S, 2007, J HYPERTENS, V25, P1578, DOI 10.1097/HJH.0b013e3282861fd3; Neuhauser HK, 2005, EUR J CARDIOV PREV R, V12, P442, DOI 10.1097/01.hjr.0000183909.52118.9f; NICE, 2014, LIP MOD CARD RISK AS; Singh GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065174; Smolina K, 2012, EUR J PUBLIC HEALTH, V22, P848, DOI 10.1093/eurpub/ckr196; Stone NJ, 2013, J AM COLL CARDIOL, V63, P2889, DOI DOI 10.1016/J.JACC.2013.11.002; WHO, 2013, WHO METH DAT SOURC G; Woodward M, 2005, EUR J CARDIOV PREV R, V12, P484; World Health Organisation, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2007, PREV CARD DIS GUID A; YANO K, 1982, AM J MED, V72, P71, DOI 10.1016/0002-9343(82)90580-0; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890	48	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2213-8587			LANCET DIABETES ENDO	Lancet Diabetes Endocrinol.	MAY	2015	3	5					339	355		10.1016/S2213-8587(15)00081-9		17	Endocrinology & Metabolism	Endocrinology & Metabolism	CG6LX	WOS:000353413700018		
J	Vogel, JP; Betran, AP; Vindevoghel, N; Souza, JP; Torloni, MR; Zhang, J; Tuncalp, O; Mori, R; Morisaki, N; Ortiz-Panozo, E; Hernandez, B; Perez-Cuevas, R; Qureshi, Z; Gulmezoglu, AM; Temmerman, M				Vogel, Joshua P.; Betran, Ana Pilar; Vindevoghel, Nadia; Souza, Joao Paulo; Torloni, Maria Regina; Zhang, Jun; Tuncalp, Oezge; Mori, Rintaro; Morisaki, Naho; Ortiz-Panozo, Eduardo; Hernandez, Bernardo; Perez-Cuevas, Ricardo; Qureshi, Zahida; Guelmezoglu, A. Metin; Temmerman, Marleen		WHO Multi-Country Survey Maternal	Use of the Robson classification to assess caesarean section trends in 21 countries: a secondary analysis of two WHO multicountry surveys	LANCET GLOBAL HEALTH			English	Article							PERINATAL HEALTH; GLOBAL SURVEY; PREGNANCY OUTCOMES; UTERINE RUPTURE; DELIVERY-RATES; LATIN-AMERICA; VAGINAL BIRTH; EPIDEMIOLOGY; TRIAL	Background Rates of caesarean section surgery are rising worldwide, but the determinants of this increase, especially in low-income and middle-income countries, are controversial. In this study, we aimed to analyse the contribution of specific obstetric populations to changes in caesarean section rates, by using the Robson classification in two WHO multicountry surveys of deliveries in health-care facilities. The Robson system classifies all deliveries into one of ten groups on the basis of five parameters: obstetric history, onset of labour, fetal lie, number of neonates, and gestational age. Methods We studied deliveries in 287 facilities in 21 countries that were included in both the WHO Global Survey of Maternal and Perinatal Health (WHOGS; 2004-08) and the WHO Multi-Country Survey of Maternal and Newborn Health (WHOMCS; 2010-11). We used the data from these surveys to establish the average annual percentage change (AAPC) in caesarean section rates per country. Countries were stratified according to Human Development Index (HDI) group (very high/high, medium, or low) and the Robson criteria were applied to both datasets. We report the relative size of each Robson group, the caesarean section rate in each Robson group, and the absolute and relative contributions made by each to the overall caesarean section rate. Findings The caesarean section rate increased overall between the two surveys (from 26.4% in the WHOGS to 31.2% in the WHOMCS, p=0.003) and in all countries except Japan. Use of obstetric interventions (induction, prelabour caesarean section, and overall caesarean section) increased over time. Caesarean section rates increased across most Robson groups in all HDI categories. Use of induction and prelabour caesarean section increased in very high/high and low HDI countries, and the caesarean section rate after induction in multiparous women increased significantly across all HDI groups. The proportion of women who had previously had a caesarean section increased in moderate and low HDI countries, as did the caesarean section rate in these women. Interpretation Use of the Robson criteria allows standardised comparisons of data across countries and timepoints and identifies the subpopulations driving changes in caesarean section rates. Women who have previously had a caesarean section are an increasingly important determinant of overall caesarean section rates in countries with a moderate or low HDI. Strategies to reduce the frequency of the procedure should include avoidance of medically unnecessary primary caesarean section. Improved case selection for induction and prelabour caesarean section could also reduce caesarean section rates.	[Vogel, Joshua P.] Univ Western Australia, Fac Med Dent & Hlth Sci, Sch Populat Hlth, Crawley, WA, Australia; [Vogel, Joshua P.; Betran, Ana Pilar; Tuncalp, Oezge; Guelmezoglu, A. Metin; Temmerman, Marleen] World Hlth Org, Dept Reprod Hlth & Res, UNDP UNFPA UNICEF WHO World Bank Special Programm, CH-1211 Geneva, Switzerland; [Vindevoghel, Nadia] Alberta Hlth, Calgary Foothills Primary Care Network, Calgary, AB, Canada; [Souza, Joao Paulo] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Social Med, Sao Paulo, Brazil; [Souza, Joao Paulo] GLIDE Tech Cooperat & Res, Sao Paulo, Brazil; [Torloni, Maria Regina] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil; [Torloni, Maria Regina] Brazilian Cochrane Ctr, Sao Paulo, Brazil; [Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China; [Mori, Rintaro; Morisaki, Naho] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Morisaki, Naho] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan; [Ortiz-Panozo, Eduardo] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Hernandez, Bernardo] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Perez-Cuevas, Ricardo] Interamer Dev Bank, Social Protect & Hlth Div, Mexico City, DF, Mexico; [Qureshi, Zahida] Univ Nairobi, Coll Hlth Sci, Dept Obstet & Gynaecol, Sch Med, Nairobi, Kenya	Vogel, JP (reprint author), World Hlth Org, Dept Reprod Hlth & Res, 20 Ave Appia, CH-1211 Geneva, Switzerland.	vogeljo@who.int	Souza, Joao Paulo/G-1982-2010; 	Souza, Joao Paulo/0000-0002-2288-4244; Ortiz-Panozo, Eduardo/0000-0002-3141-210X	Australian Postgraduate Award; A & A Saw Scholarship; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction; WHO; Government of China; Government of India; Government of Japan; United States Agency for International Development (USAID); USAID; Ministry of Health, Labour and Welfare of Japan; Gynuity Health Projects	This article represents the views of the named authors only, and does not represent the views of the World Health Organization. JPV is supported by an Australian Postgraduate Award and the A & A Saw Scholarship. The WHO Global Survey on Maternal and Perinatal Health was financially supported by the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction; WHO; the Governments of China, India, and Japan; and the United States Agency for International Development (USAID). The WHO Multi-Country Survey on Maternal and Newborn Health was financially supported by the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction; WHO; USAID; the Ministry of Health, Labour and Welfare of Japan; and Gynuity Health Projects. We thank all members of the WHO Global Survey on Maternal and Perinatal Health Research Network and the WHO Multi-Country Survey on Maternal and Newborn Health Research Network, including regional and country coordinators, data collection coordinators, facility coordinators, data collectors, and all staff of the participating facilities who made the surveys possible. We thank Armando Seuc who provided valuable assistance for this analysis.	Abdel-Aleem H, 2013, INT J GYNECOL OBSTET, V123, P119, DOI 10.1016/j.ijgo.2013.05.011; Algert CS, 2008, OBSTET GYNECOL, V112, P1061, DOI 10.1097/AOG.0b013e31818b42e3; Amatya A, 2013, J Nepal Health Res Counc, V11, P255; Robson MS, 2001, BEST PRACT RES CL OB, V15, P179, DOI 10.1053/beog.2000.0156; Stanton CK, 2005, B WORLD HEALTH ORGAN, V83, P449; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Shah A, 2009, INT J GYNECOL OBSTET, V107, P191, DOI 10.1016/j.ijgo.2009.08.013; Kieser KE, 2002, OBSTET GYNECOL, V100, P749, DOI 10.1016/S0029-7844(02)02161-0; Brennan DJ, 2011, OBSTET GYNECOL, V117, P273, DOI 10.1097/AOG.0b013e318204521a; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Ye JF, 2014, BIRTH-ISS PERINAT C, V41, P237, DOI 10.1111/birt.12104; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.1016/j.jclinepi.2007.11.008; Robson M, 2013, BEST PRACT RES CL OB, V27, P297, DOI 10.1016/j.bpobgyn.2012.09.004; Belizan JM, 1999, BRIT MED J, V319, P1397; Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Betran AP, 2013, PLOS ONE, V9; Betrán Ana P, 2009, Reprod Health, V6, P18, DOI 10.1186/1742-4755-6-18; Boyle A, 2012, SEMIN PERINATOL, V36, P308, DOI 10.1053/j.semperi.2012.04.012; Brennan D, 2009, AM J OBSTET GYNECOL, V201; Delbaere I, 2011, BMC PREGNANCY CHILDB, V12, P3; Fuglenes D, 2008, AM J OBSTET GYNECOL, V200, pe1; Fuglenes DD, 2011, AM J OBSTET GYNECOL, V205, P45; Gibbons L, 2012, AM J OBSTET GYNECOL, V206, P331, DOI DOI 10.1016/J.AJ0G.2012.02.026; Kelly Sherrie, 2013, J Obstet Gynaecol Can, V35, P206; Khunpradit S, 2010, COCHRANE DB SYST REV, V6; Perinatal Services British Columbia, 2011, EX CES DEL RAT BRI 1; Robson MS, 2001, FETAL MATERN MED REV, V12, P23; Slavin V, 2012, INT J CHIDBIRTH, V2, P85; Souza J, 2010, BMC MED, V8, P71; Souza JP, 2010, BMC HEALTH SERV RES, V11, P286; Stavrou EP, 2010, BMC PREGNANCY CHILDB, V11, P8; Tan JKH, 2015, J OBSTET GYNAECOL RE, V41, P534, DOI 10.1111/jog.12608; Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566; Torloni MR, 2014, BJOG-INT J OBSTET GY, V121, P548, DOI 10.1111/1471-0528.12513; UNICEF, 2013, STAT WORLDS CHILDR 2; United Nations Development Programme, 2013, HUM DEV REP 2013; Vogel JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065612; WHO, 1985, LANCET, V326, P436, DOI [10.1016/S0140-6736(85)92750-3, DOI 10.1016/S0140-6736(85)92750-3]; WHO UNICEF UNFPA the World Bank the United Nations Population Division, 2013, TRENDS MAT MORT 1990; World Health Organization, 2011, WHO REC IND LAB	43	5	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2214-109X			LANCET GLOB HEALTH	Lancet Glob. Health	MAY	2015	3	5					E260	E270		10.1016/S2214-109X(15)70094-X		11	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CG3BF	WOS:000353150900012		
J	Mitani, Y; Lindhjem, H				Mitani, Yohei; Lindhjem, Henrik			Forest Owners' Participation in Voluntary Biodiversity Conservation: What Does It Take to Forgo Forestry for Eternity?	LAND ECONOMICS			English	Article							CONTINGENT VALUATION APPROACH; LANDOWNER PARTICIPATION; WILLINGNESS; PROGRAM; FARMERS; COMPENSATION; PRESERVATION; INCENTIVES; SERVICES; PAY	We analyze what motivates Norwegian nonindustrial private forest owners to participate in a national voluntary conservation program. Our empirical study provides new insights, since the program requires participants to relinquish all rights to forestry for eternity, including future generations. To achieve an efficient conservation strategy, it is important to understand what drives motivations sufficiently strong to participate on such terms. Our econometric analyses suggest that forest owners' expectation of sustainable nontimber income enhanced by the program, positive attitude toward stricter conservation regulations, and lower share of mature forest have strong positive effects on the likelihood of participation. (JEL Q23, Q24)	[Mitani, Yohei] Kyoto Univ, Grad Sch Agr, Div Nat Resource Econ, Kyoto, Japan; [Mitani, Yohei] Norwegian Univ Life Sci, UMB Sch Econ & Business, As, Norway; [Lindhjem, Henrik] Norwegian Inst Nat Res NINA, Oslo, Norway; [Lindhjem, Henrik] Vista Anal, Oslo, Norway	Mitani, Y (reprint author), Kyoto Univ, Grad Sch Agr, Div Nat Resource Econ, Kyoto, Japan.				European Union [244065]; Japan Society for the Promotion of Science; Norwegian Research Council [160022/F40, 173230/I10]	We would like to acknowledge valuable inputs from Stale Navrud, Eirik Romstad, Anders Lunnan, Even Bergseng, Er lend Nybakk, Birger Vennesland, Stefan Blumentrath, Patty Champ, Travis Warziniack, and Nicholas Flores, and participants at the Annual Conference of the European Association of Environmental and Resource Economists in Toulouse 2013. Financial support for the POLICYMIX project (http://policymix.nina.no) from the European Union's Seventh Programme for research, technological development and demonstration under grant agreement No. 244065, the Japan Society for the Promotion of Science, and the Norwegian Research Council core funding to NINA under the project 160022/F40 for ecosystem services in forests and the AREAL program Grant 173230/I10 is greatly appreciated.	Amacher G.S., 2003, FOR EC, V9, P137, DOI DOI 10.1078/1104-6899-00028; Angrist Joshua, 2001, NBER WORKING PAPER N; Layton DF, 2009, ENVIRON RESOUR ECON, V44, P415, DOI 10.1007/s10640-009-9293-5; Bergseng E, 2009, J FOREST ECON, V15, P147, DOI 10.1016/j.jfe.2008.04.002; Langpap C, 2004, LAND ECON, V80, P375, DOI 10.2307/3654727; Kauneckis D, 2009, ENVIRON MANAGE, V44, P468, DOI 10.1007/s00267-009-9327-3; Bhattacharya J, 2006, STAT MED, V25, P389, DOI 10.1002/sim.2226; Beach RH, 2005, FOREST POLICY ECON, V7, P261, DOI 10.1016/S1389-9341(04)00065-0; Broch SW, 2013, ECOL ECON, V92, P78, DOI 10.1016/j.ecolecon.2011.12.017; Lynch L, 2003, LAND ECON, V79, P259, DOI 10.2307/3146870; Amigues JP, 2002, ECOL ECON, V43, P17, DOI 10.1016/S0921-8009(02)00172-6; Kilgore MA, 2008, FOREST POLICY ECON, V10, P507, DOI 10.1016/j.forpol.2008.05.003; Lindhjem H, 2012, J FOREST ECON, V18, P290, DOI 10.1016/j.jfe.2012.06.004; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; GASSON R, 1973, J AGR ECON, V24, P521, DOI 10.1111/j.1477-9552.1973.tb00952.x; Dickinson BJ, 2012, J FOREST ECON, V18, P36, DOI 10.1016/j.jfe.2011.06.002; Frondel M, 2012, LAND USE POLICY, V29, P388, DOI 10.1016/j.landusepol.2011.08.003; Nybakk E, 2009, FOREST ECOL MANAG, V257, P608, DOI 10.1016/j.foreco.2008.09.040; Convention on Biological Diversity, 2010, COP DECISION X2 STRA; Dillman D, 2000, MAIL AND INTERNET SU; Framstad Erik, 2002, NINA FAGRAPPORT 54; Framstad Erik, 2010, NINA REPORT 535; Hanley N, 2012, OXFORD REV ECON POL, V28, P93, DOI 10.1093/oxrep/grs002; Langpap Christian, 2010, ECO NOMIC MODELING O; Maddala G. S., 1983, LIMITED DEPENDENT AN; Mantymaa E, 2009, FOREST POLICY ECON, V11, P498, DOI 10.1016/j.forpol.2009.05.007; Markowski-Lindsay M, 2011, ECOL ECON, V71, P180, DOI 10.1016/j.ecolecon.2011.08.027; Norwegian Ministry of Environment (NMOE), 2004, REPORT FROM A PUBLIC, V28, P2004; Organisation for Economic Cooperation and Development, 2011, OECD ENVIRONMENTAL P; Raunikar R, 2006, ECOL ECON, V56, P132, DOI 10.1016/j.ecolecon.2005.01.013; Shogren Jason F., 2001, PROTECTING ENDANGERE; Skjeggedal T., 2010, FRIVILLIG VERN AV SK; Soderqvist T, 2003, ECOL ECON, V47, P105, DOI 10.1016/j.ecoleon.2002.09.004; Suter JF, 2008, LAND ECON, V84, P17	34	0	0	UNIV WISCONSIN PRESS	MADISON	JOURNAL DIVISION, 1930 MONROE ST, 3RD FL, MADISON, WI 53711 USA	0023-7639	1543-8325		LAND ECON	Land Econ.	MAY	2015	91	2					235	251				17	Economics; Environmental Studies	Business & Economics; Environmental Sciences & Ecology	CG0YT	WOS:000353000900003		
J	Mandurah, MM; Sadr, A; Bakhsh, TA; Shimada, Y; Sumi, Y; Tagami, J				Mandurah, Mona M.; Sadr, Alireza; Bakhsh, Turki A.; Shimada, Yasushi; Sumi, Yasunori; Tagami, Junji			Characterization of transparent dentin in attrited teeth using optical coherence tomography	LASERS IN MEDICAL SCIENCE			English	Article						Attrition; Transparent dentin; SS-OCT; Attenuation coefficient	COMPOSITE RESTORATIONS; SCLEROTIC DENTIN; LIGHT-SCATTERING; SWEPT-SOURCE; ROOT DENTIN; ENAMEL; ADHESIVE; ATTENUATION; MICROSCOPY	Attrition and wear of tooth surface occur with aging and result in loss of enamel, with exposure and histological changes in dentin. Dealing with attrited teeth and restoration of the lost tissue are clinically challenging. The main objective of this study is to characterize the exposed transparent dentin in the occlusal surface of attrited teeth by optical coherence tomography (OCT). Naturally attrited, extracted human teeth with occlusal-transparent dentin were investigated in comparison to sound and carious teeth. The teeth were subjected to OCT imaging and then cross-sectioned and polished. OCT B-scans were compared to light microscopy images of the same cross section. In OCT images, some changes were evident at the transparent dentin in attrited teeth. An OCT attenuation coefficient parameter (mu (t)) was derived based on the Beer-Lambert law as a function of backscatter signal slope. The mean values of mu (t) were 1.05 +/- 0.3, 2.23 +/- 0.4, and 0.61 +/- 0.27 mm(-1) for sound, carious, and transparent dentins, respectively. One-way ANOVA with Tukey's post-hoc showed a significant difference between groups (p < 0.05). Physiological changes in transparent dentin that involve deposition of mineral casts in the dentinal tubules lead to lower attenuation of OCT signal. OCT has a potential role to detect transparent dentin on the surface of attrited teeth and can be used in the future as a clinical adjunct tool.	[Mandurah, Mona M.] Tokyo Med & Dent Univ, Dept Oral Hlth Sci, Bunkyo Ku, Tokyo 1138549, Japan; [Mandurah, Mona M.] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE Program, Cariol & Operat Dent, Bunkyo Ku, Tokyo 1138549, Japan; [Sadr, Alireza] Tokyo Med & Dent Univ, Dept Cariol & Operat Dent, Global Ctr Excellence GCOE Program, Int Res Ctr Mol Sci Tooth & Bone Dis,Bunkyo Ku, Tokyo 1138549, Japan; [Bakhsh, Turki A.] King Abdulaziz Univ, Conservat Dent Sci, Jeddah 21381, Saudi Arabia; [Bakhsh, Turki A.; Shimada, Yasushi] Tokyo Med & Dent Univ, Dept Oral Hlth Sci Cariol & Operat Dent, Bunkyo Ku, Tokyo 1138549, Japan; [Sumi, Yasunori] Natl Ctr Geriatr & Gerontol, Dept Adv Dent Res, Ctr Adv Med Dent & Oral Dis, Obu, Aichi 4748511, Japan; [Tagami, Junji] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE Program, Dept Cariol & Operat Dent, Bunkyo Ku, Tokyo 1138549, Japan	Sadr, A (reprint author), Tokyo Med & Dent Univ, Dept Cariol & Operat Dent, Global Ctr Excellence GCOE Program, Int Res Ctr Mol Sci Tooth & Bone Dis,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	alireza.ope@tmd.ac.jp			Ministry of Health, Labor, and Welfare [21A-8]; Japan Society for the Promotion of Science (JSPS) [23659886, 24792019]; Japanese Ministry of Education, Global Center of Excellence Program (GCOE), International Research Center for Molecular Science in Tooth and Bone Diseases	This work was supported by a grant from the Japanese Ministry of Education, Global Center of Excellence Program (GCOE), International Research Center for Molecular Science in Tooth and Bone Diseases; the research grant for Longevity Sciences (21A-8) from Ministry of Health, Labor, and Welfare; and grant-in-aid for scientific research (nos. 23659886 and 24792019) from the Japan Society for the Promotion of Science (JSPS).	SCHMITT JM, 1994, PHYS MED BIOL, V39, P1705, DOI 10.1088/0031-9155/39/10/013; Kinney JH, 2005, BIOMATERIALS, V26, P3363, DOI 10.1016/j.biomaterials.2004.09.004; Makishi P, 2011, J DENT, V39, P316, DOI 10.1016/j.jdent.2011.01.011; Ritter AV, 2008, OPER DENT, V33, P370, DOI 10.2341/07-128; Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6; Shimada Y, 2010, J DENT, V38, P655, DOI 10.1016/j.jdent.2010.05.004; Hariri I, 2012, J DENT, V40, P387, DOI 10.1016/j.jdent.2012.01.017; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Choma MA, 2003, OPT EXPRESS, V11, P2183, DOI 10.1364/OE.11.002183; Nazari A, 2013, J BIOPHOTONICS, V6, P171, DOI 10.1002/jbio.201200012; Kusunoki M, 2002, J DENT, V30, P91, DOI 10.1016/S0300-5712(02)00003-9; Bakhsh TA, 2011, DENT MATER, V27, P915, DOI 10.1016/j.dental.2011.05.003; Hemmings KW, 2000, J PROSTHET DENT, V83, P287, DOI 10.1016/S0022-3913(00)70130-2; HEE MR, 1995, ARCH OPHTHALMOL-CHIC, V113, P325; ZIJP JR, 1993, APPL OPTICS, V32, P411, DOI 10.1364/AO.32.000411; FRIED D, 1995, APPL OPTICS, V34, P1278, DOI 10.1364/AO.34.001278; Wang XJ, 1999, APPL OPTICS, V38, P2092, DOI 10.1364/AO.38.002092; Tay FR, 2004, J DENT, V32, P173, DOI 10.1016/j.jdent.2003.10.009; Imai K, 2012, J ENDODONT, V38, P1269, DOI 10.1016/j.joen.2012.05.008; Porter AE, 2005, BIOMATERIALS, V26, P7650, DOI 10.1016/j.biomaterials.2005.05.059; Natsume Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600448; BRANNSTROM M, 1980, SWED DENT J, V4, P87; Darling CL, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2204603; Hariri I, 2012, CARIES RES, V47, P18; IZATT JA, 1994, ARCH OPHTHALMOL-CHIC, V112, P1584; Mandurah MM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046006; Micheletti Cremasco M, 1998, B SOC ITAL BIOL SPER, V74, P19; Mizrahi Basil, 2008, Eur J Esthet Dent, V3, P270; OGAWA K, 1983, J DENT RES, V62, P7, DOI 10.1177/00220345830620011701; Sadr A, 2013, PROC SPIE, V8566, DOI 10.1117/12.2001629; Senawongse P, 2008, ARCH ORAL BIOL, V53, P14, DOI 10.1016/j.archoralbio.2007.07.010; Shimada Y, 2013, J BIOPHOTON IN PRESS; Shinkai K, 2009, DENT MATER J, V28, P197; TRONSTAD L, 1971, Scandinavian Journal of Dental Research, V79, P151; VASILIADIS L, 1983, ARCH ORAL BIOL, V28, P693, DOI 10.1016/0003-9969(83)90103-6	35	2	2	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-8921	1435-604X		LASER MED SCI	Lasers Med. Sci.	MAY	2015	30	4					1189	1196		10.1007/s10103-014-1541-4		8	Engineering, Biomedical; Surgery	Engineering; Surgery	CF9QC	WOS:000352899400003		
J	Fukutomi, D; Ishii, K; Awazu, K				Fukutomi, D.; Ishii, K.; Awazu, K.			Highly accurate scattering spectra of strongly absorbing samples obtained using an integrating sphere system by considering the angular distribution of diffusely reflected light	LASERS IN MEDICAL SCIENCE			English	Article						Integrating sphere; Inverse Monte Carlo simulation; Optical property; Scattering coefficient; Diffuse reflectance; Entrance port diameter	TISSUE OPTICAL-PROPERTIES; WAVELENGTH RANGE; HUMAN SKIN; HUMAN BLOOD; NM	An integrating sphere system has been used to investigate the estimation error in the scattering coefficient for biological tissues. Since the angular distribution of diffusely reflected light from a sample may depend on the sample absorbance, leakage at the entrance port may affect estimates of the scattering coefficient based on measurement of diffuse reflectance. In the present study, the dependence of the angular distribution of the diffusely reflected light on the hemoglobin (Hb) concentration in a sample was investigated. Subsequently, the effect of the entrance port diameter on the error in the scattering coefficient estimated based on diffuse reflectance measurements was evaluated. For a biological tissue phantom, the angular reflectance distribution at a wavelength of 405 nm, at which strong absorption occurred, showed an increasing bias toward specular reflection as the Hb concentration was increased. No such concentration dependence was found at a wavelength of 664 nm, where the absorbance was low. In addition, it was found that the estimation error in the scattering coefficient was reduced for smaller entrance port diameters. Therefore, when attempting to determine the scattering coefficient for strongly absorbing samples, it is necessary to consider both the angular distribution of the diffusely reflected light and the optimal entrance port diameter.	[Fukutomi, D.; Ishii, K.; Awazu, K.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Awazu, K.] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Awazu, K.] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan	Awazu, K (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	awazu@see.eng.osaka-u.ac.jp					SAIDI IS, 1995, APPL OPTICS, V34, P7410, DOI 10.1364/AO.34.007410; Roggan A, 1999, J BIOMED OPT, V4, P36, DOI 10.1117/1.429919; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Ding HF, 2006, PHYS MED BIOL, V51, P1479, DOI 10.1088/0031-9155/51/6/008; Bashkatov AN, 2005, J PHYS D APPL PHYS, V38, P2543, DOI 10.1088/0022-3727/38/15/004; Ritz JP, 2001, LASER SURG MED, V29, P205, DOI 10.1002/lsm.1134; Salomatina E, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2398928; Doornbos RMP, 1999, PHYS MED BIOL, V44, P967, DOI 10.1088/0031-9155/44/4/012; Friebel M, 2006, APPL OPTICS, V45, P2838, DOI 10.1364/AO.45.002838; Sydoruk O, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.115002; Friebel Moritz, 2006, J Biomed Opt, V11, P34021, DOI 10.1117/1.2203659; Troy TL, 2001, J BIOMED OPT, V6, P167, DOI 10.1117/1.1344191; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Horibe T, 2013, P CLSM, V2013, P2; HOURDAKIS CJ, 1995, PHYS MED BIOL, V40, P351, DOI 10.1088/0031-9155/40/3/002; Meinke M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2435177; Terada T, 2011, P SPIE, V7897; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Yust BG, 2012, LASER MED SCI, V27, P413, DOI 10.1007/s10103-011-0927-9	19	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-8921	1435-604X		LASER MED SCI	Lasers Med. Sci.	MAY	2015	30	4					1335	1340		10.1007/s10103-015-1734-5		6	Engineering, Biomedical; Surgery	Engineering; Surgery	CF9QC	WOS:000352899400022		
J	Tashiro, T; Kawanobe, S; Kimura-Minoda, T; Kohko, S; Ishikawa, T; Ayama, M				Tashiro, T.; Kawanobe, S.; Kimura-Minoda, T.; Kohko, S.; Ishikawa, T.; Ayama, M.			Discomfort glare for white LED light sources with different spatial arrangements	Lighting Research & Technology			English	Article							VISIBILITY	Quantitative relations between discomfort glare evaluation and photometric quantities such as illuminance at the observer's eye, average luminance of the source area, average luminance of the effective area and effective glare luminance for white LED sources having a variety of spatial luminance distributions have been investigated. Effective glare luminance, which is the sum of luminances in the luminaire area divided by the effective area, explains the scaling results of all sources in the same way. In addition, a new equation modified from the Commission Internationale de l'Eclairage Unified Glare Rating formula using the effective glare luminance showed a strong correlation with the scaling results. It is thus suggested that effective glare luminance is a useful index of discomfort glare for light sources having different spatial luminance distributions.	[Tashiro, T.; Ishikawa, T.; Ayama, M.] Utsunomiya Univ, Grad Sch Engn, Utsunomiya, Tochigi 3218585, Japan; [Kawanobe, S.; Kimura-Minoda, T.] Stanley Elect Co Ltd, Meguro Ku, Tokyo, Japan; [Kohko, S.] Iwasaki Elect Co Ltd, Chuo Ku, Tokyo, Japan	Tashiro, T (reprint author), Utsunomiya Univ, Ayama Lab, Room 9-410,7-1-2 Yoto, Utsunomiya, Tochigi 3218585, Japan.	dt117117@cc.utsunamiya-u.ac.jp			Iwasaki Electric Co., Ltd.; Stanley Electric Co., Ltd.	This study was supported by the research fund endowed by the Iwasaki Electric Co., Ltd. and Stanley Electric Co., Ltd.	Akashi Y, 1996, LIGHTING RES TECHNOL, V28, P199; Osterhaus WKE, 2005, SOL ENERGY, V79, P140, DOI 10.1016/j.solener.2004.11.011; Holladay LL, 1926, J OPT SOC AM REV SCI, V12, P271, DOI 10.1364/JOSA.12.000271; Bullough J., 2012, SAE INT J PASSENG CA, V5, P199, DOI 10.4271/2012-01-0269; Bullough JD, 2011, 2011010111 SAE; Commission Internationale de l'Eclairage, 1976, GLAR UN ROAD LIGHT I; Commission Internationale de l'Eclairage, 1994, GLAR EV US OUTD SPOR; Commission Internationale de l'Eclairage, 1983, DISC GLAR INT WORK E; Commission Internationale de l'Eclairage, 2002, CIE COLL GLAR; Commission Internationale de l'Eclairage, 1995, DISC GLAR INT LIGHT; de Boer J. B., 1967, PUBLIC LIGHTING; Eble-Hankins ML, 2009, LEUKOS, V6, P51, DOI 10.1582/LEUKOS.2009.06.01003; Harrison W, 1945, ILLUMINATING ENG, P525; Hirning M, 2010, J LIGHT VIS ENV, V34, P101; Holladay LL, 1927, J OPT SOC AM REV SCI, V14, P1, DOI 10.1364/JOSA.14.000001; Iwata T., 1998, LIGHTING RES TECHNOL, V30, P81, DOI DOI 10.1177/096032719803000205; Kasahara T., 2006, J LIGHT VIS ENV, V30, P95, DOI 10.2150/jlve.30.95; Kimura-Minoda T, 2010, COLOR RES APPL, V36, P286; Main A, 2000, HEADACHE, V40, P194, DOI 10.1046/j.1526-4610.2000.00028.x; Matsuda S, 1969, J ILLUMINATING ENG I, V53, P51; Nutting P.G., 1916, Transactions of the American Illuminating Engineering Society, V11; Rea MS, 2000, IESNA LIGHTING HDB R; Schreuder D, 2008, OUTDOOR LIGHTING PHY, P273; Tatsumoto M, 2013, P INT S AUT LIGHT DA, P116; Vos JJ, 1999, P CIE 24 SESS, P38; Vos JJ, 2003, LIGHTING RES TECHNOL, V35, P163, DOI 10.1191/1477153503li083oa	26	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1477-1535	1477-0938		LIGHTING RES TECHNOL	Lighting Res. Technol.	MAY	2015	47	3					316	337		10.1177/1477153514532122		22	Construction & Building Technology; Optics	Construction & Building Technology; Optics	CG7ID	WOS:000353475500006		
J	Wang, T; Lee, SB; Hwang, JH; Lim, JN; Jung, US; Kim, MJ; Kang, HS; Choi, SH; Lee, JS; Roh, SG; Lee, HG				Wang, T.; Lee, S. B.; Hwang, J. H.; Lim, J. N.; Jung, U. S.; Kim, M. J.; Kang, H. S.; Choi, S. H.; Lee, J. S.; Roh, S. G.; Lee, H. G.			Proteomic Analysis Reveals PGAM1 Altering cis-9, trans-11 Conjugated Linoleic Acid Synthesis in Bovine Mammary Gland	LIPIDS			English	Article						cis-9,trans-11 CLA; Isolated bovine milk epithelial cells; MAC-T cells; Stearoyl-CoA desaturase 1	DAIRY-COWS; NEGATIVE REGULATOR; EPITHELIAL-CELLS; VACCENIC ACID; PROTEIN; HSP27; MILK; METHYLTRANSFERASE; IDENTIFICATION; METHYLATION	cis-9, trans-11 Conjugated linoleic acid (CLA) is one of the most extensively studied CLA isomers due to its multiple isomer-specific effects. However, the molecular mechanisms of cis-9,trans-11 CLA synthesis in ruminant mammary gland are still not clearly understood. This process may be mediated, to a certain extent, by trans-11 C18:1 regulated by stearoyl-CoA desaturase-1 (SCD1) and/or its syntrophic proteins. This study aimed to investigate the effects of TVA on SCD1-mediated cis-9,trans-11 CLA synthesis in MAC-T cells and its potential molecular mechanism. Results showed that trans-11 C18:1 was continually taken up and converted into cis-9,trans-11 CLA in MAC-T cells during the 4-h incubation of 50 mu M trans-11 C18:1. SCD1 protein expression increased more than twofold at 2 h (P < 0.01) and 2.5 h (P < 0.05) before decreasing to less than half of the normal level at 4 h (P < 0.05). One up-regulated (RAS guanyl releasing protein 4 isoform 1 [RASGRP4]) and six down-regulated proteins (glucosamine-6-phosphate deaminase 1 [GNPDA1], triosephosphate isomerase [TPI1], phosphoglycerate mutase 1 [PGAM1], heat shock protein beta-1 [HSPB1], annexin A3 [ANXA3], thiopurine S-methyltransferase [TPMT]) were found in MAC-T cells treated with trans-11 C18:1. Of these seven identified proteins, the presence of GNPDA1 and PGAM1 was verified in several models. More trans-11 C18:1 was taken up after PGAM1 knockdown by small interfering RNA (siRNA). In conclusion, our data suggested that PGAM1 may have a negative relationship with SCD1 and seemed to be involved in cis-9, trans-11 CLA synthesis by facilitating the absorption of trans-11 C18:1 in the bovine mammary gland.	[Wang, T.] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun 130118, Jilin Province, Peoples R China; [Wang, T.] Jilin Agr Univ, Key Lab Anim Nutr & Feed Sci Jilin Prov, Changchun 130118, Jilin Province, Peoples R China; [Lee, S. B.; Hwang, J. H.; Lim, J. N.; Jung, U. S.; Kim, M. J.; Lee, J. S.; Lee, H. G.] Konkuk Univ, Dept Anim Sci & Technol, Coll Anim Biosci & Technol, Seoul 143701, South Korea; [Kang, H. S.] Pusan Natl Univ, Coll Nat Resources & Life Sci, Miryang 627706, Gyeongnam Do, South Korea; [Choi, S. H.] Chungbuk Natl Univ, Dept Anim Sci, Cheongju 361763, Chungcheongbuk, South Korea; [Roh, S. G.] Tohoku Univ, Physiol Anim Lab, Grad Sch Agr Sci, Sendai, Miyagi 9888555, Japan	Lee, HG (reprint author), Konkuk Univ, Dept Anim Sci & Technol, Coll Anim Biosci & Technol, Seoul 143701, South Korea.	hglee66@konkuk.ac.kr			iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [112027-01-1-SB010, 313002-03-2-WT011]; China Postdoctoral Science Foundation [2014M550177]	This research was supported by iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea (Project No. 112027-01-1-SB010 and 313002-03-2-WT011) and project funding by the China Postdoctoral Science Foundation (Project No. 2014M550177).	Garrido C, 2002, CELL DEATH DIFFER, V9, P483, DOI 10.1038/sj/cdd/44001005; Mosley EE, 2006, J NUTR, V136, P570; Jogl G, 2003, P NATL ACAD SCI USA, V100, P50, DOI 10.1073/pnas.0233793100; Wang T, 2014, J SCI FOOD AGR, V94, P1835, DOI 10.1002/jsfa.6502; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Bolduc C, 2004, J MOL ENDOCRINOL, V33, P429, DOI 10.1677/jme.1.01503; Kay JK, 2004, J DAIRY SCI, V87, P369; Liu G, 2007, J MED CHEM, V50, P3086, DOI 10.1021/jm070219p; Wang T, 2013, ASIAN AUSTRAL J ANIM, V26, P189, DOI 10.5713/ajas.2012.12466; Tai HL, 1996, AM J HUM GENET, V58, P694; Paul C, 2002, MOL CELL BIOL, V22, P816; CIOCCA DR, 1993, J NATL CANCER I, V85, P1558, DOI 10.1093/jnci/85.19.1558; Hallows WC, 2012, J BIOL CHEM, V287, P3850, DOI 10.1074/jbc.M111.317404; Pandey P, 2000, ONCOGENE, V19, P1975, DOI 10.1038/sj.onc.1203531; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Boutinaud M, 2008, J DAIRY SCI, V91, P988, DOI 10.3168/jds.2007-0587; Lin XB, 2004, J NUTR, V134, P1362; Bauman D. E., 2000, J ANIM SCI, V77, P1, DOI DOI 10.2134/JAS2000.77E-SUPPL1F; Benjamin S, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-36; Champe P. C., 2008, BIOCHEMISTRY; COMB DG, 1958, J BIOL CHEM, V232, P807; Dhiman TR, 2005, CRIT REV FOOD SCI, V45, P463, DOI 10.1080/10408390591034463; FOTHERGILLGILMORE LA, 1989, ADV ENZYMOL RAMB, V62, P227; Jacobs AAA, 2011, THESIS U WAGENINGEN; Jin YC, 2012, J DAIRY SCI, V95, P4286, DOI 10.3168/jds.2011-4281; Jin YC, 2010, BBA-PROTEINS PROTEOM, V1804, P745, DOI 10.1016/j.bbapap.2009.11.016; Kim SW, 2001, FEBS LETT, V489, P243, DOI 10.1016/S0014-5793(00)02326-7; Lengi AJ, 2007, LIPIDS, V42, P499, DOI 10.1007/s11745-007-3056-2; Nathanson NM, 1990, G PROTEINS SIGNAL TR; Park JE, 2005, BIOCHEM BIOPH RES CO, V337, P1283, DOI 10.1016/j.bbrc.2005.10.004; ROSS TS, 1990, SCIENCE, V248, P605, DOI 10.1126/science.2159184; Rothhut B, 1997, CELL MOL LIFE SCI, V53, P522, DOI 10.1007/s000180050066; Seigle JL, 2008, GENETICS, V179, P855, DOI 10.1534/genetics.108.087551; SZUMLANSKI CL, 1995, BRIT J CLIN PHARMACO, V39, P456; Wang T, 2015, CRIT REV FOOD SCI, V55, P720, DOI 10.1080/10408398.2012.674071; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200	37	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0024-4201	1558-9307		LIPIDS	Lipids	MAY	2015	50	5					469	481		10.1007/s11745-015-4009-9		13	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CG8NY	WOS:000353566200004		
J	Nakazawa, M; Andoh, H; Koyama, K; Watanabe, Y; Nakai, T; Ueda, M; Sakamoto, T; Inui, H; Nakano, Y; Miyatake, K				Nakazawa, Masami; Andoh, Hiroko; Koyama, Keiichiro; Watanabe, Yomi; Nakai, Takeo; Ueda, Mitsuhiro; Sakamoto, Tatsuji; Inui, Hiroshi; Nakano, Yoshihisa; Miyatake, Kazutaka			Alteration of Wax Ester Content and Composition in Euglena gracilis with Gene Silencing of 3-ketoacyl-CoA Thiolase Isozymes	LIPIDS			English	Article						Euglena gracilis; Wax ester fermentation; 3-Ketoacyl-CoA thiolase; Mitochondrial fatty acid synthesis; Acyl chain length modification; Algal lipids	FATTY-ACID SYNTHESIS; MOLECULAR CHARACTERIZATION; FERMENTATION; ACCUMULATION; BIOSYNTHESIS; OXIDATION; PROTEINS; FUELS; CYCLE	Euglena gracilis produces wax ester under hypoxic and anaerobic culture conditions with a net synthesis of ATP. In wax ester fermentation, fatty acids are synthesized by reversing beta-oxidation in mitochondria. A major species of wax ester produced by E. gracilis is myristyl myristate (14:0-14:0Alc). Because of its shorter carbon chain length with saturated compounds, biodiesel produced from E. gracilis wax ester may have good cold flow properties with high oxidative stability. We reasoned that a slight metabolic modification would enable E. gracilis to produce a biofuel of ideal composition. In order to produce wax ester with shorter acyl chain length, we focused on isozymes of the enzyme 3-ketoacyl-CoA thiolase (KAT), a condensing enzyme of the mitochondrial fatty acid synthesis pathway in E. gracilis. We performed a gene silencing study of KAT isozymes in E. gracilis. Six KAT isozymes were identified in the E. gracilis EST database, and silencing any three of them (EgKAT1-3) altered the wax ester amount and composition. In particular, silencing EgKAT1 induced a significant compositional shift to shorter carbon chain lengths in wax ester. A model fuel mixture inferred from the composition of wax ester in EgKAT1-silenced cells showed a significant decrease in melting point compared to that of the control cells.	[Nakazawa, Masami; Andoh, Hiroko; Koyama, Keiichiro; Ueda, Mitsuhiro; Sakamoto, Tatsuji; Inui, Hiroshi; Nakano, Yoshihisa; Miyatake, Kazutaka] Osaka Prefecture Univ, Dept Appl Biol Chem, Osaka 5998531, Japan; [Nakazawa, Masami] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Watanabe, Yomi; Nakai, Takeo] Osaka Municipal Tech Res Inst, Osaka 5368553, Japan	Nakazawa, M (reprint author), Osaka Prefecture Univ, Dept Appl Biol Chem, Osaka 5998531, Japan.	mami@biochem.osakafu-u.ac.jp			Japan Science and Technology Agency (JST), PRESTO program	This work was supported by the Japan Science and Technology Agency (JST), PRESTO program. The authors thank Dr. Joseph Rodrigue for critical reading of the manuscript.	Teerawanichpan P, 2010, LIPIDS, V45, P263, DOI 10.1007/s11745-010-3395-2; Fan JL, 2012, PLANT CELL PHYSIOL, V53, P1380, DOI 10.1093/pcp/pcs082; Eccleston VS, 1998, PLANT CELL, V10, P613, DOI 10.1105/tpc.10.4.613; Stansell GR, 2012, J APPL PHYCOL, V24, P791, DOI 10.1007/s10811-011-9696-x; TESSIER LH, 1991, EMBO J, V10, P2621; INUI H, 1982, FEBS LETT, V150, P89, DOI 10.1016/0014-5793(82)81310-0; Thelen JJ, 2002, METAB ENG, V4, P12, DOI 10.1006/mben.2001.0204; Knothe G, 2009, ENERG ENVIRON SCI, V2, P759, DOI 10.1039/b903941d; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; INUI H, 1984, EUR J BIOCHEM, V142, P121, DOI 10.1111/j.1432-1033.1984.tb08258.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; SAUCH JF, 1991, APPL ENVIRON MICROB, V57, P3243; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Ishikawa T, 2010, BIOCHEM J, V426, P125, DOI 10.1042/BJ20091406; Fan JL, 2011, FEBS LETT, V585, P1985, DOI 10.1016/j.febslet.2011.05.018; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fox AR, 2014, GENE, V533, P5, DOI 10.1016/j.gene.2013.09.096; Christie W.W., 1993, ADV LIPID METHODOLOG, P69; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Dunn RO, 1999, J AM OIL CHEM SOC, V76, P109, DOI 10.1007/s11746-999-0056-9; Hodge J. E., 1962, METHODS CARBOHYDRATE, V1, P380; INUI H, 1983, AGR BIOL CHEM TOKYO, V47, P2669; INUI H, 1988, AGR BIOL CHEM TOKYO, V52, P49; KOREN LE, 1967, J PROTOZOOL, VS 14, P17; Merilainen G, 2009, BIOCHEMISTRY-US, V48, P11011, DOI 10.1021/bi901069h; Nakazawa M, 2005, COMP BIOCHEM PHYS B, V141, P445, DOI 10.1016/j.cbpc.2005.05.006; O'Brien EA, 2007, NUCLEIC ACIDS RES, V35, pD445, DOI 10.1093/nar/gkl770; ODA Y, 1982, J GEN MICROBIOL, V128, P853; Radakovits R, 2010, METAB ENG, V13, P89; SIREVAG R, 1972, J BIOL CHEM, V247, P2586; Takenaka S, 1997, J EUKARYOT MICROBIOL, V44, P609	32	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0024-4201	1558-9307		LIPIDS	Lipids	MAY	2015	50	5					483	492		10.1007/s11745-015-4010-3		10	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CG8NY	WOS:000353566200005		
J	Takeda, H; Nishikawa, H; Osaki, Y; Tsuchiya, K; Joko, K; Ogawa, C; Taniguchi, H; Orito, E; Uchida, Y; Izumi, N				Takeda, Haruhiko; Nishikawa, Hiroki; Osaki, Yukio; Tsuchiya, Kaoru; Joko, Kouji; Ogawa, Chikara; Taniguchi, Hiroyoshi; Orito, Etsuro; Uchida, Yasushi; Izumi, Namiki		Japanese Red Cross Liver Study Grp	Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan	LIVER INTERNATIONAL			English	Article						hepatocellular carcinoma; predictive factors; response; sorafenib; survival	ALPHA-FETOPROTEIN RESPONSE; MULTIPLE LUNG METASTASES; THERAPIES; SUBANALYSES; TOXICITY; SURVIVAL; CANCER; TRIAL	Background & AimsThere have been no established predictive factors of responders to sorafenib in patients with unresectable hepatocellular carcinoma (HCC). This study aimed to investigate the factors predicting a good response to sorafenib in Japanese patients with HCC. MethodsA total of 465 patients with unresectable HCC in the Japanese Red Cross Liver Study Group were treated with sorafenib between January 2008 and August 2013, and 316 patients with sufficient clinical data were analysed. To determine the factors predicting a good response, the relationships between radiological response and the following clinicopathological factors were analysed: age, gender, performance status, liver function, tumour status and decrease in serum alpha-foetoprotein (AFP) level after 1month. ResultsThis study included 259 males and 57 females with a median age of 70years (range, 37-90years), of which 191 (60.4%) were classified as Barcelona Clinic Liver Cancer stage C, and 271 (85.8%) had Child-Pugh class A liver function. The median overall survival time was 307days and progression-free survival time was 109days. According to the modified Response Evaluation Criteria In Solid Tumours, four patients achieved a complete response, 51 achieved a partial response, 136 had stable disease and 125 had progressive disease. Multivariate analysis identified female gender (P=0.003) and decreased serum AFP level after 1month (P=0.042) as independent predictors of a complete or partial response. ConclusionOur results suggest female gender and a decrease in serum AFP level are independent predictors of good response to sorafenib.	[Takeda, Haruhiko; Nishikawa, Hiroki; Osaki, Yukio] Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Osaka 5438555, Japan; [Tsuchiya, Kaoru; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Musashino, Tokyo, Japan; [Joko, Kouji] Matsuyama Red Cross Hosp, Ctr Liver Biliary Pancreat Dis, Matsuyama, Ehime, Japan; [Ogawa, Chikara] Takamatsu Red Cross Hosp, Dept Gastroenterol & Hepatol, Takamatsu, Kagawa, Japan; [Taniguchi, Hiroyoshi] Japanese Red Cross Med Ctr, Dept Gastroenterol, Tokyo, Japan; [Orito, Etsuro] Nagoya Daini Red Cross Hosp, Dept Gastroenterol & Hepatol, Nagoya, Aichi, Japan; [Uchida, Yasushi] Matsue Red Cross Hosp, Dept Gastroenterol, Matsue, Shimane, Japan	Takeda, H (reprint author), Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Tennoji Ku, 5-30 Fudegasaki Cho, Osaka 5438555, Japan.	htakeda@kuhp.kyoto-u.ac.jp					Camma C, 2013, HEPATOLOGY, V57, P1046, DOI 10.1002/hep.26221; Shiwaku K, 2004, LANCET, V363, P1077, DOI 10.1016/S0140-6736(04)15856-X; Miyahara K, 2011, J GASTROEN HEPATOL, V26, P1604, DOI 10.1111/j.1440-1746.2011.06887.x; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Vincenzi B, 2010, ONCOLOGIST, V15, P85, DOI 10.1634/theoncologist.2009-0143; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Kudo M, 2012, CURR CANCER DRUG TAR, V12, P1062; Raoul JL, 2012, J HEPATOL, V56, P1080, DOI 10.1016/j.jhep.2011.12.009; Arao T, 2013, HEPATOLOGY, V57, P1407, DOI 10.1002/hep.25956; EDMONDSON HA, 1954, CANCER, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Nishikawa H, 2013, J CANCER, V4, P635, DOI 10.7150/jca.7279; Shingina A, 2013, CAN J GASTROENTEROL, V27, P393; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Personeni N, 2012, J HEPATOL, V57, P101, DOI 10.1016/j.jhep.2012.02.016; Miller AA, 2009, J CLIN ONCOL, V27, P1800, DOI 10.1200/JCO.2008.20.0931; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Carr BI, 2010, J GASTROEN HEPATOL, V25, P1739, DOI 10.1111/j.1440-1746.2010.06404.x; Johnson PJ, 2013, J CLIN ONCOL, V31, P3517, DOI 10.1200/JCO.2012.48.4410; Llovet JM, 2012, CLIN CANCER RES, V18, P2290, DOI 10.1158/1078-0432.CCR-11-2175; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Pazo-Cid RA, 2012, CLIN TRANSL ONCOL, V14, P564, DOI 10.1007/s12094-012-0842-y; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Cho JY, 2013, LIVER INT, V33, P950, DOI 10.1111/liv.12168; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Inuzuka T, 2011, ONCOLOGY-BASEL, V81, P152, DOI 10.1159/000333279; Memon K, 2012, J HEPATOL, V56, P1112, DOI 10.1016/j.jhep.2011.11.020; Park K, 2006, CURR MED RES OPIN, V22, P561, DOI 10.1185/030079906X89847; Shao Yu-Yun, 2013, Liver Cancer, V2, P93, DOI 10.1159/000343845; Yang CH., 2008, LUNG CANCER S4, V60, P23	31	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-3223	1478-3231		LIVER INT	Liver Int.	MAY	2015	35	5					1581	1589		10.1111/liv.12591		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CG9OM	WOS:000353645900013		
J	Sakuma, C; Kurita, J; Furihata, K; Tashiro, M				Sakuma, Chiseko; Kurita, Jun-ichi; Furihata, Kazuo; Tashiro, Mitsuru			Achievement of H-1-F-19 heteronuclear experiments using the conventional spectrometer with a shared single high band amplifier	MAGNETIC RESONANCE IN CHEMISTRY			English	Article						F-19 NMR; H-1-F-19 heteronuclear experiments; conventional spectrometer; F-19{H-1} and H-1{F-19} STD	PROTEIN-RECEPTOR; NMR; FLUORINE; BINDING; METABOLISM; LIGAND	The H-1-F-19 heteronuclear NMR experiments were achieved using the conventional spectrometer equipped with a single high band amplifier and a H-1/F-19/C-13 double-tuned probe. Although double high band amplifiers are generally required to perform such experiments, a simple modification of pathway in the conventional spectrometer was capable of acquiring various H-1-F-19 heteronuclear spectra. The efficiency of the present technique was demonstrated in an application for F-19{H-1} and H-1{F-19} saturation transfer difference experiments. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Sakuma, Chiseko] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan; [Kurita, Jun-ichi] Agilent Technol Japan Ltd, Minato Ku, Tokyo 1080023, Japan; [Furihata, Kazuo] Univ Tokyo, Div Agr & Agr Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Tashiro, Mitsuru] Meisei Univ, Coll Sci & Technol, Dept Chem, Tokyo 1918506, Japan	Tashiro, M (reprint author), Meisei Univ, Coll Sci & Technol, Dept Chem, Tokyo 1918506, Japan.	tashiro@chem.meisei-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [20580108, 21550092]	This study was supported by two Grant-in-Aids for Scientific Research (No. 20580108 for K. F. and 21550092 for M. T.) from the Ministry of Education, Culture, Sports, Science and Technology.	Park BK, 2001, ANNU REV PHARMACOL, V41, P443, DOI 10.1146/annurev.pharmtox.41.1.443; Dalvit C, 2000, J BIOMOL NMR, V18, P65, DOI 10.1023/A:1008354229396; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; Vulpetti A, 2009, J AM CHEM SOC, V131, P12949, DOI 10.1021/ja905207t; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; O'Hagan D, 1999, J FLUORINE CHEM, V100, P127, DOI 10.1016/S0022-1139(99)00201-8; Corcoran O, 2001, ANALYST, V126, P2103, DOI 10.1039/b108648k; Dalvit C., 2003, J AM CHEM SOC, V125, P6108; Elliott A. J., 1995, ACS MONOGR SER, P1119; Furihata K, 2010, ANAL SCI, V26, P1107; Masson M, 2003, DRUG DEV IND PHARM, V29, P107, DOI 10.1081/DDC-120016689; Shikii K, 2004, ANAL SCI, V20, P1475, DOI 10.2116/analsci.20.1475	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-1581	1097-458X		MAGN RESON CHEM	Magn. Reson. Chem.	MAY	2015	53	5					327	329		10.1002/mrc.4210		3	Chemistry, Multidisciplinary; Chemistry, Physical; Spectroscopy	Chemistry; Spectroscopy	CG6IG	WOS:000353402600001		
J	Endo, T; Imanari, M; Hidaka, Y; Seki, H; Nishikawa, K; Sen, S				Endo, Takatsugu; Imanari, Mamoru; Hidaka, Yuki; Seki, Hiroko; Nishikawa, Keiko; Sen, Sabyasachi			Structure and dynamics of room temperature ionic liquids with bromide anion: results from Br-81 NMR spectroscopy	MAGNETIC RESONANCE IN CHEMISTRY			English	Article						NMR; Br-81; ionic liquids; quantum chemical calculations; structure; dynamics	SOLID-STATE NMR; NUCLEAR-MAGNETIC-RESONANCE; AB-INITIO CALCULATIONS; PHYSICOCHEMICAL PROPERTIES; QUADRUPOLAR RELAXATION; LOCAL-STRUCTURE; CATION RING; IMIDAZOLIUM; THERMOMETER; DENSITY	We report the results of a comprehensive Br-81 NMR spectroscopic study of the structure and dynamics of two room temperature ionic liquids (RTILs), 1-butyl-3-methylimidazolium bromide ([C(4)mim]Br) and 1-butyl-2,3-dimethylimidazolium bromide ([C(4)C(1)mim]Br), in both liquid and crystalline states. NMR parameters in the gas phase are also simulated for stable ion pairs using quantum chemical calculations. The combination of Br-81 spin-lattice and spin-spin relaxation measurements in the motionally narrowed region of the stable liquid state provides information on the correlation time of the translational motion of the cation. Br-81 quadrupolar coupling constants (C-Q) of the two RTILs were estimated to be 6.22 and 6.52MHz in the crystalline state which were reduced by nearly 50% in the liquid state, although in the gas phase, the values are higher and span the range of 7-53MHz depending on ion pair structure. The C-Q can be correlated with the distance between the cation-anion pairs in all the three states. The Br-81 C-Q values of the bromide anion in the liquid state indicate the presence of some structural order in these RTILs, the degree of which decreases with increasing temperature. On the other hand, the ionicity of these RTILs is estimated from the combined knowledge of the isotropic chemical shift and the appropriate mean energy of the excited state. [C(4)C(1)mim]Br has higher ionicity than [C(4)mim]Br in the gas phase, while the situation is reverse for the liquid and the crystalline states. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Endo, Takatsugu] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Imanari, Mamoru; Seki, Hiroko] Chiba Univ, Ctr Analyt Instrumentat, Inage Ku, Chiba, Chiba 2638522, Japan; [Hidaka, Yuki; Nishikawa, Keiko] Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba, Chiba 2638522, Japan; [Sen, Sabyasachi] Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA	Endo, T (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	tkendo@staff.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21245003]; Global Center-of-Excellence Program 'Advanced School for Organic Electronics'; JSPS	The present study was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan No. 21245003 Grant-in-Aid for Scientific Research (A) and the Global Center-of-Excellence Program 'Advanced School for Organic Electronics' as well as the JSPS Postdoctoral Fellowships for Research Abroad to T. Endo.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Tokuda H, 2004, J PHYS CHEM B, V108, P16593, DOI 10.1021/jp047480r; Noack K, 2010, PHYS CHEM CHEM PHYS, V12, P14153, DOI 10.1039/c0cp00486c; Kohagen M, 2011, J PHYS CHEM B, V115, P15280, DOI 10.1021/jp206974h; KEITH TA, 1993, CHEM PHYS LETT, V210, P223, DOI 10.1016/0009-2614(93)89127-4; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Iwata K, 2007, ACCOUNTS CHEM RES, V40, P1174, DOI 10.1021/ar700074c; Takahashi T, 1999, SOLID STATE NUCL MAG, V15, P119, DOI 10.1016/S0926-2040(99)00039-9; Ueno K, 2010, PHYS CHEM CHEM PHYS, V12, P1649, DOI 10.1039/b921462n; Yang JZ, 2004, GREEN CHEM, V6, P541, DOI 10.1039/b412286k; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Cheeseman JR, 1996, J CHEM PHYS, V104, P5497, DOI 10.1063/1.471789; Earle MJ, 2006, NATURE, V439, P831, DOI 10.1038/nature04451; Leal JP, 2007, J PHYS CHEM A, V111, P6176, DOI 10.1021/jp073006k; Armstrong JP, 2007, PHYS CHEM CHEM PHYS, V9, P982, DOI 10.1039/b615137j; Fumino K, 2008, ANGEW CHEM INT EDIT, V47, P8731, DOI 10.1002/anie.200803446; Endo T, 2010, J PHYS CHEM B, V114, P9201, DOI 10.1021/jp104123v; VANGEET AL, 1970, ANAL CHEM, V42, P679, DOI 10.1021/ac60288a022; Izgorodina EI, 2011, J PHYS CHEM B, V115, P14688, DOI 10.1021/jp208573y; MacFarlane DR, 2009, PHYS CHEM CHEM PHYS, V11, P4962, DOI 10.1039/b900201d; VANGEET AL, 1968, ANAL CHEM, V40, P2227, DOI 10.1021/ac50158a064; Klimavicius V, 2014, SPECTROCHIM ACTA A, V132, P879, DOI 10.1016/j.saa.2014.04.140; RAIFORD DS, 1979, ANAL CHEM, V51, P2050, DOI 10.1021/ac50048a040; KEITH TA, 1992, CHEM PHYS LETT, V194, P1, DOI 10.1016/0009-2614(92)85733-Q; AMMANN C, 1982, J MAGN RESON, V46, P319, DOI 10.1016/0022-2364(82)90147-0; Tokuda H, 2006, J PHYS CHEM B, V110, P2833, DOI 10.1021/jp053396f; SAIKA A, 1954, J CHEM PHYS, V22, P26; Turner EA, 2003, J PHYS CHEM A, V107, P2277, DOI 10.1021/jp021694w; Strasser D, 2007, J PHYS CHEM A, V111, P3191, DOI [10.1021/jp071323l, 10.1021/jp0713231]; Fujii K, 2009, CHEM LETT, V38, P340, DOI 10.1246/cl.2009.340; Endo T, 2011, J PHYS CHEM A, V115, P2999, DOI 10.1021/jp200635h; Dupont J, 2006, PHYS CHEM CHEM PHYS, V8, P2441, DOI 10.1039/b602046a; Tsuzuki S, 2008, J PHYS CHEM B, V112, P7739, DOI 10.1021/jp802107m; Bryce DL, 2006, MAGN RESON CHEM, V44, P409, DOI 10.1002/mrc.1741; Alonso B, 2009, J PHYS CHEM B, V113, P11906, DOI 10.1021/jp9027904; Chiappe C, 2007, MONATSH CHEM, V138, P1035, DOI 10.1007/s00706-007-0726-y; Gordon PG, 2010, CHEMPHYSCHEM, V11, P260, DOI 10.1002/cphc.200900624; Tokuda H, 2005, J PHYS CHEM B, V109, P6103, DOI 10.1021/jp044626d; Moller C, 1934, PHYS REV, V46, P0618, DOI 10.1103/PhysRev.46.618; Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984; Kutuniva J, 2007, Z NATURFORSCH B, V62, P868; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Hunt PA, 2007, J PHYS CHEM B, V111, P4844, DOI 10.1021/jp067182p; Balevicius V, 2010, J PHYS CHEM A, V114, P5365, DOI 10.1021/jp909293b; BARNES RG, 1954, PHYS REV, V93, P95, DOI 10.1103/PhysRev.93.95; BIELECKI A, 1995, J MAGN RESON SER A, V116, P215; Burgess KMN, 2012, CHEM-EUR J, V18, P5748, DOI 10.1002/chem.201103478; Chaban VV, 2012, J PHYS CHEM LETT, V3, P1657, DOI 10.1021/jz300405q; Chapman RP, 2009, PROG NUCL MAG RES SP, V55, P215, DOI 10.1016/j.pnmrs.2009.05.001; Frisch M. J., 2010, GAUSSIAN 09; George AM, 1996, PHYS CHEM MINER, V23, P526, DOI 10.1007/BF00242002; Gordon PG, 2008, J PHYS CHEM A, V112, P12527, DOI 10.1021/jp808524h; HALLE B, 1981, J MAGN RESON, V44, P89, DOI 10.1016/0022-2364(81)90192-X; Holbrey JD, 2003, CHEM COMMUN, P1636, DOI 10.1039/b304543a; Ingman P, 2012, PHYS CHEM CHEM PHYS, V14, P13053, DOI 10.1039/c2cp41754e; Kendall RA, 1992, J CHEM PHYS, P96; Kirchner B, 2009, TOP CURR CHEM, V290, P213, DOI 10.1007/128_2008_36; Kokorin A., 2011, IONIC LIQUIDS APPL P; KONDO J, 1959, J PHYS CHEM SOLIDS, V10, P245, DOI 10.1016/0022-3697(59)90001-0; Machida H, 2009, FLUID PHASE EQUILIBR, V281, P127, DOI 10.1016/j.fluid.2009.03.025; Ohno H, 2005, ELECTROCHEMICAL ASPECTS OF IONIC LIQUIDS, P1, DOI 10.1002/0471762512; Trill H, 2003, J PHYS CHEM B, V107, P8779, DOI 10.1021/jp0224618; Tsuzuki S, 2008, MOL PHYS, V106, P1621, DOI 10.1080/00268970802258575; Wasserscheid P., 2003, IONIC LIQUIDS SYNTHE; YOSIDA K, 1956, J PHYS SOC JPN, V11, P33, DOI 10.1143/JPSJ.11.33	65	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-1581	1097-458X		MAGN RESON CHEM	Magn. Reson. Chem.	MAY	2015	53	5					369	378		10.1002/mrc.4208		10	Chemistry, Multidisciplinary; Chemistry, Physical; Spectroscopy	Chemistry; Spectroscopy	CG6IG	WOS:000353402600007		
J	Sinha, U; Malis, V; Csapo, R; Moghadasi, A; Kinugasa, R; Sinha, S				Sinha, Usha; Malis, Vadim; Csapo, Robert; Moghadasi, Ali; Kinugasa, Ryuta; Sinha, Shantanu			Age-Related Differences in Strain Rate Tensor of the Medial Gastrocnemius Muscle During Passive Plantarflexion and Active Isometric Contraction Using Velocity Encoded MR Imaging: Potential Index of Lateral Force Transmission	MAGNETIC RESONANCE IN MEDICINE			English	Article						muscle strain rate tensor; velocity encoded MRI; strain rate and fiber direction	SKELETAL-MUSCLE; IN-VIVO; DEFORMATION; ARCHITECTURE; DYNAMICS; MOTION; PHASE; FOOT	PurposeThe strain rate (SR) tensor measures the principal directions and magnitude of the instantaneous deformation; this study aims to track age-related changes in the 2D SR tensor in the medial gastrocnemius during passive joint rotation and active isometric contraction. MethodsSR tensors were derived from velocity encoded magnetic resonance phase-contrast images in nine young (28 years) and eight senior (78 years) women. Strain rates along and in the cross-section of the fiber were calculated from the SR tensor and used to derive the out-plane SR. Age-related and regional differences in the SR eigenvalues, orientation, and the angle between the SR and muscle fiber (SR-fiber angle) were statistically analyzed. ResultsSR along the fiber was significantly different between the cohorts during isometric contraction with higher values in the young (P<0.05). The SR-fiber angle was larger in the young for both motion types but this difference was not statistically significant. Significant regional differences in the SR indices was seen in passive joint rotation (P<0.05) for both cohorts. ConclusionSR mapping reflects age-related and regional differences during active and passive motion respectively; this may arise from differences in contractility (active motion) and elastic properties (active and passive motion). Magn Reson Med, 2014. (c) 2014 Wiley Periodicals, Inc. Magn Reson Med 73:1852-1863, 2015. (c) 2014 Wiley Periodicals, Inc.	[Sinha, Usha; Malis, Vadim] San Diego State Univ, Dept Phys, San Diego, CA 92182 USA; [Csapo, Robert; Moghadasi, Ali; Sinha, Shantanu] Univ Calif San Diego, Dept Radiol, Muscle Imaging & Modeling Lab, San Diego, CA 92103 USA; [Kinugasa, Ryuta] Kanagawa Univ, Dept Human Sci, Yokohama, Kanagawa, Japan; [Kinugasa, Ryuta] RIKEN, Ctr Adv Photon, Imaging Proc Res Team, Saitama, Japan; [Kinugasa, Ryuta] RIKEN TRI Collaborat Ctr Human Interact Robot Res, Robot Sensor Syst Res Team, Nagoya, Aichi, Japan	Sinha, S (reprint author), Univ Calif San Diego, Dept Radiol, RIL, 3510 Dunhill St, San Diego, CA 92121 USA.	shsinha@ucsd.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases [5RO1-AR-053343-07]	Grant sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases; Grant numbers: 5RO1-AR-053343-07.	Stenroth L, 2012, J APPL PHYSIOL, V113, P1537, DOI 10.1152/japplphysiol.00782.2012; Morse CI, 2005, ACTA PHYSIOL SCAND, V183, P291, DOI 10.1111/j.1365-201X.2004.01404.x; Andersen JL, 2003, SCAND J MED SCI SPOR, V13, P40, DOI 10.1034/j.1600-0838.2003.00299.x; Felton SM, 2008, J BIOMECH, V41, P1782, DOI 10.1016/j.jbiomech.2008.01.030; Selskog P, 2002, IEEE T MED IMAGING, V21, P1105, DOI 10.1109/TMI.2002.804431; Hasson CJ, 2012, ANN BIOMED ENG, V40, P1088, DOI 10.1007/s10439-011-0481-4; Narici MV, 2003, J APPL PHYSIOL, V95, P2229, DOI 10.1152/japplphysiol.00433.2003; Gillies AR, 2011, MUSCLE NERVE, V44, P318, DOI 10.1002/mus.22094; Lopata RGP, 2010, J APPL PHYSIOL, V109, P906, DOI 10.1152/japplphysiol.00092.2010; Chleboun GS, 2001, CELLS TISSUES ORGANS, V169, P401, DOI 10.1159/000047908; Csapo R, 2014, J APPL PHYSIOL, V116, P961, DOI 10.1152/japplphysiol.01337.2013; Englund EK, 2011, AM J PHYSIOL-REG I, V300, pR1079, DOI 10.1152/ajpregu.00474.2010; Felton SM, 2007, J APPL PHYSIOL, V103, P255, DOI 10.1152/japplphysiol.01070.2006; Gindre J, 2013, J MECH BEHAV BIOMED, V22, P84, DOI 10.1016/j.jmbbm.2013.02.007; Hodgson JA, 2012, J MECH BEHAV BIOMED, V9, P163, DOI 10.1016/j.jmbbm.2012.01.010; Kim H, 2013, BIOMED RES INT, V2013; Kinugasa R, 2012, J APPL PHYSIOL, V112, P463, DOI 10.1152/japplphysiol.00666.2011; Korosoglou G, 2009, CIRC-CARDIOVASC IMAG, V2, P132, DOI 10.1161/CIRCIMAGING.108.790105; Masood T, 2014, J ELECTROMYOGR KINES; Namburete AIL, 2012, J BIOMECH, V45, P2835, DOI 10.1016/j.jbiomech.2012.08.033; Shin DD, 2009, J APPL PHYSIOL, V107, P1276, DOI 10.1152/japplphysiol.91598.2008; Sinha S, 2012, J MAGN RESON IMAGING, V36, P498, DOI 10.1002/jmri.23617; Sinha U, 2013, J MAGN RESON IMAGING, V38, P946; vansDonkelaar CC, 1999, J BIOMECH, V32, P755; Zhang C, 2014, J BIOMECH, V47, P944, DOI 10.1016/j.jbiomech.2014.01.026; Zhong XD, 2008, J BIOMECH, V41, P532, DOI 10.1016/j.jbiomech.2007.10.026	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0740-3194	1522-2594		MAGN RESON MED	Magn. Reson. Med.	MAY	2015	73	5					1852	1863		10.1002/mrm.25312		12	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CG4FR	WOS:000353240600017		
J	Nishino, A; Ogushi, K; Ueda, K; Roske, D; Mauersberger, D				Nishino, Atsuhiro; Ogushi, Koji; Ueda, Kazunaga; Roeske, Dirk; Mauersberger, Dietmar			Bilateral comparisons of measurement capabilities for the calibration of low nominal capacity torque measuring devices between NMIJ and PTB in the range from 0.1 N m to 10 N m using different procedures	MEASUREMENT			English	Article						Torque standard; Low nominal capacity torque; Comparison; Torque measuring device	STANDARD MACHINE	Bilateral comparisons of the calibration of low nominal capacity torque measuring devices (TMDs) were conducted between NMIJ and PTB for the first time. A 10 N m deadweight torque standard machine (TSM) newly developed at NMIJ was compared with PTB's two TSMs with nominal capacities of 1 N m and 1 kN m, in the range from 0.1 N m to 10 N m. The transfer measurement devices used had nominal capacities of 1 N m and 10 N m. The comparisons were made using two calibration procedures: one based on the CCM. T-K2 Key Comparison procedure and the other according to the daily calibration procedure adopted at each institute. As a result, the torque realized by the TSM at NMIJ was shown to be equivalent to that realized by the two TSMs at PTB. In addition, it was confirmed that the daily calibration procedures of both institutes yielded consistent results in the calibration of low nominal capacity TMDs. (C) 2015 Elsevier Ltd. All rights reserved.	[Nishino, Atsuhiro; Ogushi, Koji; Ueda, Kazunaga] AIST, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan; [Roeske, Dirk; Mauersberger, Dietmar] Phys Tech Bundesanstalt, Braunschweig, Germany	Nishino, A (reprint author), AIST, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan.	a.nishino@aist.go.jp					Adolf K., 1995, P 14 IMEKO TC3 C WAS, P174; [Anonymous], 2005, 51309 DIN; [Anonymous], 2004, JMIF015; [Anonymous], 2012, JCG209S1105; Bruge A., 2012, P 20 IMEKO WORLD C 9; Nishino A, 2014, MEASUREMENT, V49, P77, DOI 10.1016/j.measurement.2013.11.033; Ogushi K, 2012, MEASUREMENT, V45, P1200, DOI 10.1016/j.measurement.2012.01.016; Roske D, 2014, METROLOGIA, V51, P87, DOI 10.1088/0026-1394/51/1/87; Roske D., 2009, FINAL REPORT TORQUE	9	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0263-2241	1873-412X		MEASUREMENT	Measurement	MAY	2015	68						32	41		10.1016/j.measurement.2015.02.030		10	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CG2XX	WOS:000353140300004		
J	Shuai, XM; Tao, KX; Mori, M; Kanda, T				Shuai, Xiaoming; Tao, Kaixiong; Mori, Masayuki; Kanda, Tsugiyasu			Bariatric Surgery for Metabolic Syndrome in Obesity	Metabolic Syndrome and Related Disorders			English	Review							Y GASTRIC BYPASS; LAPAROSCOPIC SLEEVE GASTRECTOMY; OUTCOMES LONGITUDINAL DATABASE; NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; VITAMIN-D DEPLETION; WEIGHT-LOSS; CARDIOVASCULAR RISK; FOLLOW-UP; PROVISIONAL REPORT	Metabolic syndrome is closely associated with morbid obesity and leads to increased risk of cardiovascular diseases and related mortality. Bariatric surgery is considered an effective option for the management of this condition. We searched MEDLINE, Current Contents, and the Cochrane Library for papers published on bariatric surgery outcomes in English from January 1, 1990, to April 20, 2014. Bariatric surgery can significantly reduce body weight, resolve or cure many of the symptoms of metabolic syndrome, including type 2 diabetes, hypertension, hyperlipidemia, and improve long-term survival. Surgery, in addition to existing therapy, could therefore be considered as an optimal treatment for patients with metabolic syndrome and morbid obesity.	[Shuai, Xiaoming; Tao, Kaixiong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gastrointestinal Surg, Wuhan 430074, Hubei Province, Peoples R China; [Shuai, Xiaoming; Mori, Masayuki; Kanda, Tsugiyasu] Kanazawa Med Univ, Dept Community Med, Uchinada, Ishikawa 9200293, Japan	Kanda, T (reprint author), Kanazawa Med Univ, Dept Community Med, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	kandat@kanazawa-med.ac.jp					Baptista V, 2013, CURR OPIN GASTROEN, V29, P684, DOI 10.1097/MOG.0b013e3283651af2; Noria SF, 2013, CAN J SURG, V56, P47, DOI 10.1503/cjs.036111; Dixon JB, 2011, DIABETIC MED, V28, P628, DOI 10.1111/j.1464-5491.2011.03306.x; O'Brien PE, 2006, OBES SURG, V16, P1032, DOI 10.1381/096089206778026316; Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Inabnet WB, 2012, J AM COLL SURGEONS, V214, P550, DOI 10.1016/j.jamcollsurg.2011.12.019; Buchwald H, 2007, SURGERY, V142, P621, DOI 10.1016/j.surg.2007.07.018; Freire RH, 2012, NUTRITION, V28, P53, DOI 10.1016/j.nut.2011.01.011; Kaul A, 2011, SURG CLIN N AM, V91, P1295, DOI 10.1016/j.suc.2011.08.003; Buchwald H, 2009, OBES SURG, V19, P1605, DOI 10.1007/s11695-009-0014-5; Mechanick JI, 2013, OBESITY, V21, pS1, DOI 10.1002/oby.20461; Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; Batchelder AJ, 2013, J SURG RES, V183, P559, DOI 10.1016/j.jss.2013.02.036; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Kolovou GD, 2007, AM J MED SCI, V333, P362, DOI 10.1097/MAJ.0b013e318065c3a1; Rubino F, 2010, ANN SURG, V251, P399, DOI 10.1097/SLA.0b013e3181be34e7; Ricci C, 2014, OBES SURG, V24, P522, DOI 10.1007/s11695-013-1121-x; Kehagias I, 2011, OBES SURG, V21, P1650, DOI 10.1007/s11695-011-0479-x; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Ikramuddin S, 2013, JAMA-J AM MED ASSOC, V309, P2240, DOI 10.1001/jama.2013.5835; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Batsis JA, 2008, MAYO CLIN PROC, V83, P897, DOI 10.4065/83.8.897; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082; Lakdawala M, 2013, SURG OBES RELAT DIS, V9, P370, DOI 10.1016/j.soard.2012.07.017; Handelsman Y, 2009, TOXICOL PATHOL, V37, P18, DOI 10.1177/0192623308329288; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Ionut V, 2013, OBESITY, V21, P1093, DOI 10.1002/oby.20364; Smith BR, 2011, MED CLIN N AM, V95, P1009, DOI 10.1016/j.mcna.2011.06.010; Ikramuddin S, 2011, BRIT J SURG, V98, P1339, DOI 10.1002/bjs.7652; Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005; Hinojosa MW, 2009, J GASTROINTEST SURG, V13, P793, DOI 10.1007/s11605-008-0759-5; Lee WJ, 2012, J GASTROINTEST SURG, V16, P45, DOI 10.1007/s11605-011-1740-2; Knowler WC, 2002, NEW ENGL J MED, V346, P393; Chakravarty PD, 2012, SURG-J R COLL SURG E, V10, P172, DOI 10.1016/j.surge.2012.02.001; Tice JA, 2008, AM J MED, V121, P885, DOI 10.1016/j.amjmed.2008.05.036; [Anonymous], 2013, DIABETES CARE S1, V36, pS11; Hollenbeak CS, 2008, SURGERY, V144, P736, DOI 10.1016/j.surg.2008.05.013; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Buchwald H, 2013, OBES SURG, V23, P427, DOI 10.1007/s11695-012-0864-0; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Maggard-Gibbons M, 2013, JAMA-J AM MED ASSOC, V309, P2250, DOI 10.1001/jama.2013.4851; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; Segal JB, 2009, OBES SURG, V19, P1646, DOI 10.1007/s11695-009-9960-1; Aydin S, 2014, NUTRITION, V30, P1, DOI [10.1016/j.nut.2013.05.013, 10.1016/j.nut2013.05.013]; Balkau B, 1999, DIABETIC MED, V16, P442; Benaiges D, 2011, SURG OBES RELAT DIS, V7, P575, DOI 10.1016/j.soard.2011.03.002; Boza C, 2011, OBES SURG, V21, P1330, DOI 10.1007/s11695-011-0463-5; Schauer PR, 2007, SURGERY, V142, P632; Camerini G, 2004, OBES SURG, V14, P1343, DOI 10.1381/0960892042584049; Carlin AM, 2008, AM J SURG, V195, P349, DOI 10.1016/j.amjsurg.2007.12.016; Carlin AM, 2009, SURG OBES RELAT DIS, V5, P444, DOI 10.1016/j.soard.2008.08.004; Cerezo C, 2013, CURR HYPERTENS REP, V15, P196, DOI 10.1007/s11906-013-0337-4; Chan Dick C, 2004, Am J Cardiovasc Drugs, V4, P227, DOI 10.2165/00129784-200404040-00004; Chaudhary K, 2011, CURR DIABETES REP, V11, P41, DOI 10.1007/s11892-010-0155-x; Cirocchi R, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-53; Coleman KJ, 2014, ANN SURG, V259, P279, DOI 10.1097/SLA.0000000000000258; Dixon JB, 2002, OBES RES, V10, P903, DOI 10.1038/oby.2002.124; Dunkle-Blatter SE, 2007, SURG OBES RELAT DIS, V3, P163, DOI 10.1016/j.soard.2006.12.004; Dunkle-Blatter SE, 2007, SURG OBES RELAT DIS, V3, P169; Einhorn Daniel, 2003, Endocr Pract, V9, P237; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Faria G, 2014, ANN SURG, V260, P279, DOI 10.1097/SLA.0000000000000686; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gade Wayne, 2010, Clin Lab Sci, V23, P51; Gade W, 2010, CLIN LAB SCI, V23, P62; Gracia-Solanas JA, 2011, OBES SURG, V21, P179, DOI 10.1007/s11695-010-0309-6; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Heneghan HM, 2011, AM J CARDIOL, V108, P1499, DOI 10.1016/j.amjcard.2011.06.076; Huang CK, 2011, J MINIM ACCESS SURG, V7, P99, DOI 10.4103/0972-9941.72397; Schirmer B, 2012, J AM COLL SURGEONS, V214, P556; International Diabetes Federation, IDF CONS WORLDW DEF; Kaur J., 2014, CARDIOL RES PRACT, DOI [10.1155/2014/943162, DOI 10.1155/2014/943162]; Knop FK, 2013, DIABETES CARE, V36, pS287, DOI 10.2337/dcS13-2032; Laferrere B, 2008, J CLIN ENDOCR METAB, V93, P2479, DOI 10.1210/jc.2007-2851; Laurenius A, 2010, SURG OBES RELAT DIS, V6, P408, DOI 10.1016/j.soard.2010.03.293; Lee SM, 2011, SURG CLIN N AM, V91, P1373, DOI 10.1016/j.suc.2011.08.016; Forgione PM, 2012, J GASTROINTEST SURG, V16, P51; Majumder S, 2013, SURG ENDOSC, V27, P2305, DOI 10.1007/s00464-012-2765-7; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Neff KJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-8; Nguyen Ninh T, 2006, J Am Coll Surg, V203, P24, DOI 10.1016/j.jamcollsurg.2006.03.019; NIH Conference, 1991, ANN INTERN MED, V115, P956; Nugent C, 2008, OBES SURG, V18, P1278, DOI 10.1007/s11695-008-9511-1; Polymeris A, 2013, HELL J CARDIOL, V54, P212; Pontiroli AE, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-37; Scopinaro N, 2005, DIABETES CARE, V28, P2406, DOI 10.2337/diacare.28.10.2406; Sirbu A, 2012, CHIRURGIA-BUCHAREST, V107, P469; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Topart P, 2013, SURG OBES RELAT DIS, V9, P526, DOI 10.1016/j.soard.2012.02.006; Vest AR, 2013, CIRCULATION, V127, P945, DOI 10.1161/CIRCULATIONAHA.112.103275; Via MA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0366-0; Vu L, 2013, BEST PRACT RES CL EN, V27, P239, DOI 10.1016/j.beem.2012.12.001; Wilson EB, 2013, WORLD J SURG, V37, P2756, DOI 10.1007/s00268-013-2125-3	99	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-4196	1557-8518		METAB SYNDR RELAT D	Metab. Syndr. Relat. Disord.	MAY 1	2015	13	4					149	160		10.1089/met.2014.0115		12	Medicine, Research & Experimental	Research & Experimental Medicine	CG6DU	WOS:000353386800001		
J	Enkh-Oyun, T; Kotani, K; Davaalkham, D; Davaa, G; Ganchimeg, U; Angarmurun, D; Khuderchuluun, N; Batzorig, B; Tsuboi, S; Ae, R; Aoyama, Y; Nakamura, Y				Enkh-Oyun, Tsogzolbaatar; Kotani, Kazuhiko; Davaalkham, Dambadarjaa; Davaa, Gombojav; Ganchimeg, Ulziibayar; Angarmurun, Dayan; Khuderchuluun, Nanjid; Batzorig, Bayartsogt; Tsuboi, Satoshi; Ae, Ryusuke; Aoyama, Yasuko; Nakamura, Yosikazu			Epidemiologic Features of Metabolic Syndrome in a General Mongolian Population	METABOLIC SYNDROME AND RELATED DISORDERS			English	Article							NUTRITION EXAMINATION SURVEY; KOREAN NATIONAL-HEALTH; SOCIOECONOMIC-STATUS; ALCOHOL-CONSUMPTION; HEART-DISEASE; PREVALENCE; ADULTS; EDUCATION; ASSOCIATION; STATEMENT	Background: Although cardiovascular health is a crucial problem for Mongolian people, little information about metabolic syndrome, which is well known to be associated with the development of cardiovascular disease, is available in Mongolia. The aim of this study was to observe the epidemiological features of metabolic syndrome in a general Mongolian population. Methods: This cross-sectional study was performed in 1911 general Mongolian subjects (717 men, 1194 women), who were >= 40 years old and free of ischemic heart disease, by using a dataset from a nationwide population-based cohort study in Mongolia. The prevalence of metabolic syndrome, as defined by International Diabetes Federation criteria, was determined. Alcohol consumption, smoking habits, and physical activity were evaluated. Education, marital status, income, and occupation were also examined as factors of socioeconomic status (SES). Their association with metabolic syndrome was determined by logistic regression models. Results: The prevalence of metabolic syndrome was significantly higher in women (n=488, 40.6%) than in men (n=138, 19.4%). The prevalence of metabolic syndrome was high, especially in the Khangai region, in women. Moderate-to-high alcohol consumption was a significantly positively associated factor of metabolic syndrome in men [odds ratio (OR)=2.01; 95% confidence interval (CI) 1.15-3.51; adjusted odds ratio (AOR)=2.41; 95% CI 1.31-4.44] and widowed status was a significantly positively associated factor of metabolic syndrome in women (OR=1.61, 95% CI 1.18-2.18; AOR=1.49, 95% CI 1.07-2.08). Conclusions: Metabolic syndrome was prevalent in women compared with men among Mongolian adults. Preventive strategies aimed at men with a higher alcohol consumption and women with widowed status may help reduce metabolic syndrome, thereby improving cardiovascular health conditions in Mongolia.	[Enkh-Oyun, Tsogzolbaatar; Kotani, Kazuhiko; Davaalkham, Dambadarjaa; Davaa, Gombojav; Angarmurun, Dayan; Khuderchuluun, Nanjid; Batzorig, Bayartsogt] Mongolian Natl Univ Med Sci, Dept Epidemiol & Biostat, Ulaanbaatar 14210, Mongol Peo Rep; [Ganchimeg, Ulziibayar] Publ Hlth Inst Mongolia, Ulaanbaatar, Mongol Peo Rep; [Tsuboi, Satoshi; Ae, Ryusuke; Aoyama, Yasuko; Nakamura, Yosikazu] Jichi Med Univ, Dept Publ Hlth, Shimotsuke, Japan	Enkh-Oyun, T (reprint author), Mongolian Natl Univ Med Sci, Zorig St 3, Ulaanbaatar 14210, Mongol Peo Rep.	enkhoyun_t@yahoo.com			Department of Public Health, Jichi Medical University, Japan; Department of Epidemiology and Biostatistics, School of Public Health, Mongolia	The authors thank the Department of Public Health, Jichi Medical University, Japan, and the Department of Epidemiology and Biostatistics, School of Public Health, Mongolia for their advice and support; Dr. Eric Swanson, MD, MPH, Brian Allgood Army Community Hospital, for his expertise and advice; and the people who kindly and faithfully participated.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Loucks EB, 2007, ANN EPIDEMIOL, V17, P19, DOI 10.1016/j.annepidem.2006.07.002; Al Rashdan I, 2010, ANGIOLOGY, V61, P42, DOI 10.1177/0003319709333226; Santos AC, 2007, PREV MED, V44, P328, DOI 10.1016/j.ypmed.2006.11.016; Shuumarjav U, 2011, ETHNIC DIS, V21, P74; Freiberg MS, 2004, DIABETES CARE, V27, P2954, DOI 10.2337/diacare.27.12.2954; Shiwaku K, 2005, J OCCUP HEALTH, V47, P126, DOI 10.1539/joh.47.126; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Park SJ, 2012, DIABETES RES CLIN PR, V96, P400, DOI 10.1016/j.diabres.2011.12.025; Yoon YS, 2004, AM J CLIN NUTR, V80, P217; He Y, 2006, J AM COLL CARDIOL, V47, P1588, DOI 10.1016/j.jacc.2005.11.074; Park HS, 2004, INT J EPIDEMIOL, V33, P328, DOI 10.1093/ije/dyh032; Rimm EB, 1999, BRIT MED J, V319, P1523; Delavari A, 2009, DIABETES CARE, V32, P1092, DOI 10.2337/dc08-1800; Iyer Abishek, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P182; Demiral Y, 2012, WOMEN HEALTH, V52, P755, DOI 10.1080/03630242.2012.725240; Department of Health, 2010, HLTH IND 2009; Enkh-Oyun T, 2013, J COMMUN HEALTH, V38, P919, DOI 10.1007/s10900-013-9702-0; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Ferguson TS, 2010, W INDIAN MED J, V59, P265; Ferguson TS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-307; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Magliano DJ, 2006, ANN MED, V38, P34, DOI 10.1080/07853890500300311; Ministry of Health Mongolia Public Health Institute Mongolia World Health Organization, 2010, MONG STEPS SURV PREV; National Statistics Office Mongolia, 2010, MONG STAT YB 2009; Ramsay SE, 2008, DIABETES CARE, V31, P2380, DOI 10.2337/dc08-1158; The World Bank web page, 2012, POV LEV EST 29 8 PER; Troxel WM, 2005, ARCH INTERN MED, V165, P1022, DOI 10.1001/archinte.165.9.1022; Wang JW, 2009, ASIA PAC J CLIN NUTR, V18, P105; WHO Ministry of Health Mongolia Public Health Institute of Mongolia, 2007, MONG STEPS SURV NONC; World Health Organisation, 2002, WORLD HLTH REP 2002; World Health Organization, 2005, WHO STEPS SURV MAN; World Health Organization, 2003, WORLD HLTH REP 2003; Zhan YQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-921	34	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-4196	1557-8518		METAB SYNDR RELAT D	Metab. Syndr. Relat. Disord.	MAY 1	2015	13	4					179	186		10.1089/met.2014.0067		8	Medicine, Research & Experimental	Research & Experimental Medicine	CG6DU	WOS:000353386800005		
J	Chiba, A; Sugimoto, S; Sato, F; Hori, S; Mizunoe, Y				Chiba, Akio; Sugimoto, Shinya; Sato, Fumiya; Hori, Seiji; Mizunoe, Yoshimitsu			A refined technique for extraction of extracellular matrices from bacterial biofilms and its applicability	Microbial Biotechnology			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; SURFACE-PROTEINS; BINDING; EPIDERMIDIS; ADHESION; CURLI; DEGRADATION; ADHERENCE; FIBERS	Biofilm-forming bacteria embedded in polymeric extracellular matrices (ECMs) that consist of polysaccharides, proteins and/or extracellular DNAs (eDNAs) acquire high resistance to antimicrobial agents and host immune systems. To understand molecular mechanisms of biofilm formation and maintenance and to develop therapeutic countermeasures against chronic biofilm-associated infections, reliable methods to isolate ECMs are inevitable. In this study, we refined the ECM extraction method recently reported and evaluated its applicability. Using three Staphylococcus aureus biofilms in which proteins, polysaccharides or eDNAs are major contributors to their integrity, ECMs were extracted using salts and detergents. We found that extraction with 1.5M sodium chloride (NaCl) could be optimum for not only ECM proteins but also polysaccharides and eDNAs. In addition, long-time incubation was not necessary for efficient ECM isolation. Lithium chloride (LiCl) was comparative to NaCl but is more expensive. In contrast to SDS, NaCl hardly caused leakage of intracellular proteins and did not affect viability of bacterial cells within biofilms. Furthermore, this method is applicable to other bacteria such as Gram-positive Staphylococcus epidermidis and Gram-negative Escherichia coli and Pseudomonas aeruginosa. Thus, this refined method is very simple, rapid, low cost and non-invasive and could be used for a broad range of applications.	[Chiba, Akio; Sugimoto, Shinya; Mizunoe, Yoshimitsu] Jikei Univ, Sch Med, Dept Bacteriol, Minato Ku, Tokyo 1058461, Japan; [Sato, Fumiya; Hori, Seiji] Jikei Univ, Sch Med, Dept Infect Dis & Control, Minato Ku, Tokyo 1058461, Japan	Sugimoto, S (reprint author), Jikei Univ, Sch Med, Dept Bacteriol, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	ssugimoto@jikei.ac.jp			JSPS; MEXT	This work was supported by a Grant-in-Aid for Young Scientists (B) to S.S. from JSPS, by a Grant-in-Aid for Scientific Research (B) to Y.M. from JSPS and by a grant to Y.M. from MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016.	FORSGREN A, 1966, J IMMUNOL, V97, P822; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Jucker BA, 1996, J BACTERIOL, V178, P5472; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Wu JF, 2009, APPL ENVIRON MICROB, V75, P5390, DOI 10.1128/AEM.00400-09; Frolund B, 1996, WATER RES, V30, P1749, DOI 10.1016/0043-1354(95)00323-1; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Hussain M, 2008, J CLIN MICROBIOL, V46, P470, DOI 10.1128/JCM.01425-07; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Loferer H, 1997, MOL MICROBIOL, V26, P11, DOI 10.1046/j.1365-2958.1997.5231883.x; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875; Sugimoto S, 2013, J BACTERIOL, V195, P1645, DOI 10.1128/JB.01672-12; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Dalton HM, 1998, CURR OPIN BIOTECH, V9, P252, DOI 10.1016/S0958-1669(98)80055-4; DUNNE WM, 1992, MICROBIOL IMMUNOL, V36, P1019; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; LIANG OD, 1992, INFECT IMMUN, V60, P899; Maeyama R, 2004, J BIOMED MATER RES A, V70A, P274, DOI 10.1002/jbm.a.30077; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Palma M, 1999, J BACTERIOL, V181, P2840; TABOURET M, 1992, J GEN MICROBIOL, V138, P743; Tapia JM, 2009, WATER SCI TECHNOL, V59, P1959, DOI 10.2166/wst.2009.192	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-7907	1751-7915		MICROB BIOTECHNOL	Microb. Biotechnol.	MAY	2015	8	3					392	403		10.1111/1751-7915.12155		12	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CG4EP	WOS:000353236500004		
J	Huang, J; Nara, K; Zong, K; Lian, CL				Huang, Jian; Nara, Kazuhide; Zong, Kun; Lian, Chunlan			Soil Propagule Banks of Ectomycorrhizal Fungi Along Forest Development Stages After Mining	MICROBIAL ECOLOGY			English	Article							RESISTANT PROPAGULES; PRIMARY SUCCESSION; PINUS-MURICATA; SEEDLING ESTABLISHMENT; COMMUNITY STRUCTURE; IDENTIFICATION; DIVERSITY; WILDFIRE; SPORES	Ectomycorrhizal fungal (EMF) propagules play an important role in seedling establishment following disturbance. However, little is known about how the EMF propagule community changes with forest development. In this study, EMF propagules were examined using seedling bioassays in rhizosphere soils collected from a recently closed Pb-Zn tailing (Taolin Pb-Zn tailing (TLT)), a Cu tailing (Dexing Cu No. 2 tailing (DXT)) that had undergone 21 years of restoration, and a mature Masson pine (Pinus massoniana) forest (DXC) outside the Cu mining areas. The corresponding EMF communities colonizing Masson pine at each site were also investigated for comparison. After 8 months of running bioassays, ectomycorrhizal colonization was poor for seedlings grown in TLT (9.0 % +/- 14.9 %) and DXT soils (22.4 % +/- 17.7 %), while DXC seedlings were well colonized (47.5 % +/- 24.9 %). Internal transcribed spacer sequencing revealed that EMF species richness increased with forest development in both the propagule bank (TLT, 6; DXT, 7; DXC, 12) and in the field (TLT, 8; DXT, 14; DXC, 26), though richness was lower in propagule banks. Several lineages, such as Cenococcum, Rhizopogon, Inocybe, Suillus, and Atheliaceae, were frequently encountered in propagule communities, but species assemblages were different among the three sites. Canonical correspondence analysis revealed that several soil parameters, i.e., N, EC, Cu, Pb, Zn, etc., were responsible for the distribution of EMF in the field and bioassay seedlings. The highest overlap in EMF species composition between the propagule bank and the field community was observed at the recently closed tailing (Morisita-Horn similarity = 0.71 for TLT), whereas the lowest overlap occurred at the mature forest (0.26 for DXC). These results indicate that EMF propagules in soil are less frequent and diverse in early primary succession and become more frequent and diverse along forest development, due mainly to the accumulation of dormant spores of Rhizopogon spp. and sclerotia of Cenococcum spp. Thus, EMF propagule communities in soil may diverge from those root-colonizing EMF communities along a gradient of forest development.	[Huang, Jian] Northwest A&F Univ, Coll Forestry, Yangling 712100, Peoples R China; [Huang, Jian; Zong, Kun; Lian, Chunlan] Univ Tokyo, Asian Nat Environm Sci Ctr, Nishitokyo, Tokyo 1880002, Japan; [Nara, Kazuhide] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778563, Japan	Lian, CL (reprint author), Univ Tokyo, Asian Nat Environm Sci Ctr, 1-1-8 Midoricho, Nishitokyo, Tokyo 1880002, Japan.	huangj@nwsuaf.edu.cn; nara@k.u-tokyo.ac.jp; zong@anesc.u-tokyo.ac.jp; lian@anesc.u-tokyo.ac.jp			Japan Society of the Promotion of Sciences [20380087]	This research was supported by grants-in-aid from the Japan Society of the Promotion of Sciences (20380087). We thank Dr. Xinhua He for his critical review on our manuscript. We also thank Dr. Haifeng Wang (Jiangxi Agricultural University), Mr. Kaishui Wu (Bureau of Forestry, Dexing City, Jiangxi Province), and Ms. Le Liu (Asian Natural Environmental Science Center, The University of Tokyo) for their field assistance.	Nara K, 2004, ECOLOGY, V85, P1700, DOI 10.1890/03-0373; Ashkannejhad S, 2006, NEW PHYTOL, V169, P345, DOI 10.1111/j.1469-8137.2005.01593.x; Peay KG, 2009, J ECOL, V97, P537, DOI 10.1111/j.1365-2745.2009.01489.x; Ishida TA, 2008, NEW PHYTOL, V180, P491, DOI 10.1111/j.1469-8137.2008.02572.x; Nara K, 2006, NEW PHYTOL, V169, P169, DOI 10.1111/j.1469-8137.2005.01545.x; Taylor DL, 1999, MOL ECOL, V8, P1837, DOI 10.1046/j.1365-294x.1999.00773.x; Buscardo E, 2010, FUNGAL BIOL-UK, V114, P628, DOI 10.1016/j.funbio.2010.05.004; Huang J, 2012, MYCORRHIZA, V22, P589, DOI 10.1007/s00572-012-0436-0; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Mendez Monica O., 2008, Reviews in Environmental Science and Bio/Technology, V7, P47, DOI 10.1007/s11157-007-9125-4; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Guo GY, 2011, ENVIRON GEOCHEM HLTH, V33, P217, DOI 10.1007/s10653-010-9334-6; Nguyen NH, 2012, FUNGAL ECOL, V5, P741, DOI 10.1016/j.funeco.2012.05.006; Jones MD, 2003, NEW PHYTOL, V157, P399, DOI 10.1046/j.1469-8137.2003.00698.x; Izzo A, 2006, MYCOL RES, V110, P196, DOI 10.1016/j.mycres.2005.08.010; Lian CL, 2006, NEW PHYTOL, V171, P825, DOI 10.1111/j.1469-8137.2006.01801.x; Bruns TD, 2009, NEW PHYTOL, V181, P463, DOI 10.1111/j.1469-8137.2008.02652.x; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Baar J, 1999, NEW PHYTOL, V143, P409, DOI 10.1046/j.1469-8137.1999.00452.x; Gao C, 2013, MOL ECOL, V22, P3403, DOI 10.1111/mec.12297; Peay KG, 2011, FUNGAL ECOL, V4, P233, DOI 10.1016/j.funeco.2010.09.010; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Colpaert JV, 2011, ANN FOREST SCI, V68, P17, DOI 10.1007/s13595-010-0003-9; Colwell R K, 2006, ESTIMATES STAT ESTIM; Hui N, 2011, FEMS MICROBIOL ECOL, V76, P121, DOI 10.1111/j.1574-6941.2010.01038.x; R Development Core Team R, 2006, R LANG ENV STAT COMP; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Wang Q, 2010, BOTANY, V88, P590, DOI 10.1139/B10-023; White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071	29	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0095-3628	1432-184X		MICROB ECOL	Microb. Ecol.	MAY	2015	69	4			SI		768	777		10.1007/s00248-014-0484-4		10	Ecology; Marine & Freshwater Biology; Microbiology	Environmental Sciences & Ecology; Marine & Freshwater Biology; Microbiology	CG4YP	WOS:000353295800005		
J	Moriguchi, T; Yu, L; Takai, J; Hayashi, M; Satoh, H; Suzuki, M; Ohneda, K; Yamamoto, M				Moriguchi, Takashi; Yu, Lei; Takai, Jun; Hayashi, Makiko; Satoh, Hironori; Suzuki, Mikiko; Ohneda, Kinuko; Yamamoto, Masayuki			The Human GATA1 Gene Retains a 5 ' Insulator That Maintains Chromosomal Architecture and GATA1 Expression Levels in Splenic Erythroblasts	MOLECULAR AND CELLULAR BIOLOGY			English	Article							TRANSCRIPTION FACTOR GATA-1; ERYTHROID-CELLS; IN-VIVO; DEFINITIVE ERYTHROPOIESIS; MOUSE; ENHANCER; ELEMENTS; MICE; PROMOTER; DIFFERENTIATION	GATA1 is a key transcription factor for erythropoiesis. GATA1 gene expression is strictly regulated at the transcriptional level. While the regulatory mechanisms governing mouse Gata1 (mGata1) gene expression have been studied extensively, how expression of the human GATA1 (hGATA1) gene is regulated remains to be elucidated. To address this issue, we generated hGATA1 bacterial artificial chromosome (BAC) transgenic mouse lines harboring a 183-kb hGATA1 locus covering the hGATA1 exons and distal flanking sequences. Transgenic hGATA1 expression coincides with endogenous mGata1 expression and fully rescues hematopoietic deficiency in mGata1 knockdown mice. The transgene exhibited copy number-dependent and integration position-independent expression of hGATA1, indicating the presence of chromatin insulator activity within the transgene. We found a novel insulator element at 29 kb 5' to the hGATA1 gene and refer to this element as the 5' CCCTC-binding factor (CTCF) site. Substitution mutation of the 5' CTCF site in the hGATA1 BAC disrupted the chromatin architecture and led to a reduction of hGATA1 expression in splenic erythroblasts under conditions of stress erythropoiesis. Our results demonstrate that expression of the hGATA1 gene is regulated through the chromatin architecture organized by 5' CTCF site-mediated intrachromosomal interactions in the hGATA1 locus.	[Moriguchi, Takashi; Yu, Lei; Takai, Jun; Hayashi, Makiko; Satoh, Hironori; Suzuki, Mikiko; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi, Japan; [Ohneda, Kinuko] Takasaki Univ Hlth & Welf, Dept Pharm, Takasaki, Gumma, Japan	Moriguchi, T (reprint author), Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi, Japan.	moriguch@med.tohoku.ac.jp; masiyamamoto@med.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS) (KAKENHI) [22118001, 24249015, 24590371]; Core Research for Evolutionary Science and Technology (CREST) research program of Japan Science and Technology Agency; Naito Foundation; Mitsubishi Foundation; Takeda Science Foundation	This study was supported in part by the Japan Society for the Promotion of Science (JSPS) (KAKENHI 22118001 and 24249015 to M.Y. and 24590371 to T.M.), the Core Research for Evolutionary Science and Technology (CREST) research program of the Japan Science and Technology Agency (to M.Y.), and the Naito Foundation, Mitsubishi Foundation, and Takeda Science Foundation (to M.Y.).	Ainoya K, 2012, MOL CELL BIOL, V32, P2312, DOI 10.1128/MCB.06699-11; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Kaneko H, 2010, CURR OPIN HEMATOL, V17, P163, DOI 10.1097/MOH.0b013e32833800b8; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; Pishesha N, 2014, P NATL ACAD SCI USA, V111, P4103, DOI 10.1073/pnas.1401598111; Minegishi N, 2005, GENES CELLS, V10, P693, DOI 10.1111/j.1365-2443.2005.00864.x; Migliaccio AR, 2009, BLOOD, V114, P2107, DOI 10.1182/blood-2009-03-211680; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Ziebarth JD, 2013, NUCLEIC ACIDS RES, V41, pD188, DOI 10.1093/nar/gks1165; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; Onodera K, 1997, J BIOCHEM-TOKYO, V121, P251; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Suzuki M, 2009, MOL CELL BIOL, V29, P1163, DOI 10.1128/MCB.01572-08; Shimizu R, 2008, NAT REV CANCER, V8, P279, DOI 10.1038/nrc2348; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Takai J, 2013, BLOOD, V122, P3450, DOI 10.1182/blood-2013-01-476911; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Gutierrez L, 2008, BLOOD, V111, P4375, DOI 10.1182/blood-2007-09-115121; Moriguchi T, 2002, J BIOL CHEM, V277, P16985, DOI 10.1074/jbc.M107962200; Moriguchi T, 2014, INT J HEMATOL, V100, P417, DOI 10.1007/s12185-014-1568-0; Moriguchi T, 2015, MOL CELL BIOL, V35, P805, DOI 10.1128/MCB.01011-14; Nishimura S, 2000, MOL CELL BIOL, V20, P713, DOI 10.1128/MCB.20.2.713-723.2000; Ohneda K, 2002, GENES CELLS, V7, P1243, DOI 10.1046/j.1365-2443.2002.00595.x; Onodera K, 1997, P NATL ACAD SCI USA, V94, P4487, DOI 10.1073/pnas.94.9.4487; Shimizu R, 2013, GENES CELLS, V18, P1032, DOI 10.1111/gtc.12096; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Slayton WB, 2002, BLOOD, V100, P3975, DOI 10.1182/blood-2002-02-0490; Suzuki M, 2013, GENES CELLS, V18, P921, DOI 10.1111/gtc.12086; Suzuki N, 2003, BLOOD, V102, P3575, DOI 10.1182/blood-2003-04-1154; Valverde-Garduno V, 2004, BLOOD, V104, P3106, DOI 10.1182/blood-2004-04-1333; Vyas P, 1999, DEVELOPMENT, V126, P2799; Whyatt D, 2000, NATURE, V406, P519; Yamamoto M, 1997, GENES CELLS, V2, P107, DOI 10.1046/j.1365-2443.1997.1080305.x	43	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	MAY	2015	35	10					1825	1837		10.1128/MCB.00011-15		13	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CG5DB	WOS:000353310200013		
J	Akamatsu, Y; Kobayashi, T				Akamatsu, Yufuko; Kobayashi, Takehiko			The Human RNA Polymerase I Transcription Terminator Complex Acts as a Replication Fork Barrier That Coordinates the Progress of Replication with rRNA Transcription Activity	MOLECULAR AND CELLULAR BIOLOGY			English	Article							MAMMALIAN RDNA REPLICATION; FACTOR TTF-I; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; MOUSE RDNA; FOB1 PROTEIN; S-PHASE; GENES; YEAST; SPACER	In S phase, the replication and transcription of genomic DNA need to accommodate each other, otherwise their machineries collide, with chromosomal instability as a possible consequence. Here, we characterized the human replication fork barrier (RFB) that is present downstream from the 47S pre-rRNA gene (ribosomal DNA [rDNA]). We found that the most proximal transcription terminator, Sal box T1, acts as a polar RFB, while the other, Sal box T4/T5, arrests replication forks bidirectionally. The fork-arresting activity at these sites depends on polymerase I (Pol I) transcription termination factor 1 (TTF-1) and a replisome component, TIMELESS (TIM). We also found that the RFB activity was linked to rDNA copies with hypomethylated CpG and coincided with the time that actively transcribed rRNA genes are replicated. Failed fork arrest at RFB sites led to a slowdown of fork progression moving in the opposite direction to rRNA transcription. Chemical inhibition of transcription counteracted this deceleration of forks, indicating that rRNA transcription impedes replication in the absence of RFB activity. Thus, our results reveal a role of RFB for coordinating the progression of replication and transcription activity in highly transcribed rRNA genes.	[Akamatsu, Yufuko] Natl Inst Genet, Cytogenet Div, Mishima, Shizuoka 411, Japan; Dept Genet, Mishima, Shizuoka, Japan	Akamatsu, Y (reprint author), Natl Inst Genet, Cytogenet Div, Mishima, Shizuoka 411, Japan.	yakamatsu@iam.u-tokyo.ac.jp; tako2015@iam.u-tokyo.ac.jp			JSPS [23114001, 20114002, 23770009, 26840114]	This work is supported by Grant-in-Aid for Scientific Research on Innovative Areas from JSPS grants 23114001 and 20114002 for T.K. and Grant-in-Aid for Young Scientists (B) from JSPS grants 23770009 and 26840114 for Y.A.	Akamatsu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001160; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; An P, 2012, ANNU REV MICROBIOL, V66, P213, DOI 10.1146/annurev-micro-092611-150154; Kobayashi T, 2003, MOL CELL BIOL, V23, P9178, DOI 10.1128/MCB.23.24.9178-9188.2033; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Kobayashi T, 2011, CELL MOL LIFE SCI, V68, P1395, DOI 10.1007/s00018-010-0613-2; LITTLE RD, 1993, MOL CELL BIOL, V13, P6600; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Cho WH, 2013, P NATL ACAD SCI USA, V110, P2523, DOI 10.1073/pnas.1222494110; GRUMMT I, 1985, CELL, V43, P801, DOI 10.1016/0092-8674(85)90253-3; NAWOTKA KA, 1988, MOL CELL BIOL, V8, P1408; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Klein J, 1999, P NATL ACAD SCI USA, V96, P6096, DOI 10.1073/pnas.96.11.6096; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Zhang Y, 2011, NAT STRUCT MOL BIOL, V18, P80, DOI 10.1038/nsmb.1940; Frappier L, 2012, CURR OPIN VIROL, V2, P733, DOI 10.1016/j.coviro.2012.09.005; Mohanty BK, 2006, P NATL ACAD SCI USA, V103, P897, DOI 10.1073/pnas.0506540103; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Stults DM, 2009, CANCER RES, V69, P9096, DOI 10.1158/0008-5472.CAN-09-2680; BARTSCH I, 1988, MOL CELL BIOL, V8, P3891; BARTSCH I, 1987, MOL CELL BIOL, V7, P2521; Burkhalter MD, 2004, MOL CELL, V15, P409, DOI 10.1016/j.molcel.2004.06.024; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Dalgaard JZ, 2011, DNA RELICATION CURRE, P13; Diermeier SD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003786; ERICKSON JM, 1985, AM J HUM GENET, V37, P311; EVERS R, 1995, EMBO J, V14, P1248; Foss EJ, 2001, GENETICS, V157, P567; Gerber JK, 1997, CELL, V90, P559, DOI 10.1016/S0092-8674(00)80515-2; GRUMMT I, 1986, CELL, V45, P837, DOI 10.1016/0092-8674(86)90558-1; Ide S, 2010, CURR PROTOC CELL BIO, V22; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; LAVOLPE A, 1985, J MOL BIOL, V183, P213, DOI 10.1016/0022-2836(85)90214-1; Lebofsky R, 2005, MOL CELL BIOL, V25, P6789, DOI 10.1128/MCB.25.15.6789-6797.2005; Li JW, 2005, EMBO J, V24, P120, DOI 10.1038/sj.emboj.7600492; Lopez-Estrano C, 1998, J MOL BIOL, V277, P249, DOI 10.1006/jmbi.1997.1607; Moriyama K, 2012, J BIOL CHEM, V287, P23977, DOI 10.1074/jbc.M112.368456; NELSON PS, 1993, NUCLEIC ACIDS RES, V21, P681, DOI 10.1093/nar/21.3.681; Nemeth A, 2008, EMBO J, V27, P1255, DOI 10.1038/emboj.2008.57; PFLEIDERER C, 1990, NUCLEIC ACIDS RES, V18, P4727, DOI 10.1093/nar/18.16.4727; Stults DM, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-23; Takeuchi Y, 2003, GENE DEV, V17, P1497, DOI 10.1101/gad.1085403; Wallisch M, 2002, BIOL CHEM, V383, P765, DOI 10.1515/BC.2002.080; Weitao T, 2003, J BIOL CHEM, V278, P22513, DOI 10.1074/jbc.M301610200	49	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	MAY	2015	35	10					1871	1881		10.1128/MCB.01521-14		11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CG5DB	WOS:000353310200017		
J	Taguchi, F; Inoue, Y; Suzuki, T; Inagaki, Y; Yamamoto, M; Toyoda, K; Noutoshi, Y; Shiraishi, T; Ichinose, Y				Taguchi, Fumiko; Inoue, Yuko; Suzuki, Tomoko; Inagaki, Yoshishige; Yamamoto, Mikihiro; Toyoda, Kazuhiro; Noutoshi, Yoshiteru; Shiraishi, Tomonori; Ichinose, Yuki			Characterization of quorum sensing-controlled transcriptional regulator MarR and Rieske (2Fe-2S) cluster-containing protein (Orf5), which are involved in resistance to environmental stresses in Pseudomonas syringae pv. tabaci 6605	MOLECULAR PLANT PATHOLOGY			English	Article						extracellular DNA; nitrite; Rieske 2Fe-2S cluster; superoxide; surface motility	DICKEYA-DADANTII 3937; HYPERSENSITIVE REACTION; VIRULENCE; FAMILY; GLYCOSYLATION; FLAGELLIN; BACTERIA; MEMBERS; SYSTEM; GENES	Pseudomonas syringae pv. tabaci 6605 (Pta6605) produces acyl homoserine lactones (AHLs), quorum sensing (QS) molecules that are indispensable for virulence in host tobacco infection. Genome-wide transcriptional profiling of several QS-defective mutants revealed that the expression of the genes encoding the MarR family transcriptional regulator (MarR) and a Rieske 2Fe-2S cluster-containing protein (Orf5) located adjacent to psyI, a gene encoding AHL synthetase, are significantly repressed. Exogenous application of AHL recovered the expression of both marR and orf5 genes in the psyI mutant, indicating that AHL positively regulates the expression of these genes. To investigate the role of these genes in the virulence of Pta6605, marR and orf5 mutants were generated. Both mutants showed decreased swimming and swarming motilities, decreased survival ability under oxidative and nitrosative stresses and, consequently, reduced virulence on host tobacco plants. Transmission electron micrographs showed that the structure of the cell membranes of marR and orf5 mutants was severely damaged. Furthermore, not only the ratio of dead cells, but also the amount of flagella, extracellular DNA and protein released into the culture supernatant, was significantly increased in both mutants, indicating that the disruption of marR and orf5 genes might induce structural changes in the membrane and cell lysis. Because both mutants showed partly similar expression profiles, both gene products might be involved in the same regulatory cascades that are required for QS-dependent survival under environmentally stressed conditions.	[Taguchi, Fumiko; Inagaki, Yoshishige; Yamamoto, Mikihiro; Toyoda, Kazuhiro; Noutoshi, Yoshiteru; Shiraishi, Tomonori; Ichinose, Yuki] Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, Okayama 7008530, Japan; [Inoue, Yuko] Okayama Univ, Fac Agr, Kita Ku, Okayama 7008530, Japan; [Suzuki, Tomoko] Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Okayama 7008530, Japan	Ichinose, Y (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, Tsushima Naka 1-1-1, Okayama 7008530, Japan.	yuki@cc.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24380028]	We thank the Leaf Tobacco Research Laboratory, Japan Tobacco Inc., Oyama, Japan and Dr D. Studholme, University of Exeter, Exeter, UK for providing Pta 6605 and genome sequence information of Pta 6605, respectively. This work was supported in part by Grants-in-Aid for Scientific Research (B) (No. 24380028) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ALEXEYEV MF, 1995, CAN J MICROBIOL, V41, P1053; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Kawakita Y, 2012, MOL GENET GENOMICS, V287, P473, DOI 10.1007/s00438-012-0693-9; Shen S, 2012, INT J FOOD MICROBIOL, V152, P75, DOI 10.1016/j.ijfoodmicro.2011.04.017; Shimizu R, 2003, MOL GENET GENOMICS, V269, P21, DOI 10.1007/s00438-003-0817-3; Sjoblom S, 2008, MOL PLANT MICROBE IN, V21, P967, DOI 10.1094/MPMI-21-7-0967; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Romeo A, 2012, MICROBIOL-SGM, V158, P1543, DOI 10.1099/mic.0.053850-0; Taguchi F, 2010, MICROBIOL-SGM, V156, P72, DOI 10.1099/mic.0.030700-0; Taguchi F, 2011, MOL PLANT MICROBE IN, V24, P1001, DOI 10.1094/MPMI-02-11-0026; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; McClean KH, 1997, MICROBIOL-UK, V143, P3703; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Taguchi F, 2006, J BACTERIOL, V188, P8376, DOI 10.1128/JB.00763-06; Marutani M, 2008, MOL GENET GENOMICS, V279, P313, DOI 10.1007/s00438-007-0309-y; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; Haque MM, 2009, J BACTERIOL, V191, P5409, DOI 10.1128/JB.00240-09; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Ichinose Yuki, 2003, Journal of General Plant Pathology, V69, P244, DOI 10.1007/s10327-003-0045-z; Kanda E, 2011, MOL GENET GENOMICS, V285, P163, DOI 10.1007/s00438-010-0594-8; Marutani Mizuri, 2005, Journal of General Plant Pathology, V71, P289, DOI 10.1007/s10327-005-0200-9; Schmidt CL, 2001, J BIOENERG BIOMEMBR, V33, P9, DOI 10.1023/A:1005616505962; Schneider D, 2005, BBA-BIOENERGETICS, V1710, P1, DOI 10.1016/j.bbabio.2005.09.003; Suzuki T, 2012, APPL ENVIRON MICROB, V78, P236, DOI 10.1128/AEM.05913-11; Taguchi F, 2013, MOL PLANT PATHOL, V14, P279, DOI 10.1111/mpp.12003; Taguchi F, 2008, J BACTERIOL, V190, P764, DOI 10.1128/JB.01282-07; Taguchi F, 2006, CELL MICROBIOL, V8, P923, DOI 10.1111/j.1462-5822.2005.0674.x; Wei K, 2007, J BACTERIOL, V189, P2055, DOI 10.1128/JB.01331-06; Zou LF, 2012, APPL ENVIRON MICROB, V78, P2888, DOI 10.1128/AEM.07021-11	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-6722	1364-3703		MOL PLANT PATHOL	Mol. Plant Pathol.	MAY	2015	16	4					376	387		10.1111/mpp.12187		12	Plant Sciences	Plant Sciences	CG5PD	WOS:000353344000005		
J	Matsumoto, T; Onishi, T; Tokuda, K; Inutsuka, S				Matsumoto, Tomoaki; Onishi, Toshikazu; Tokuda, Kazuki; Inutsuka, Shu-ichiro			An origin of arc structures deeply embedded in dense molecular cloud cores	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						hydrodynamics; turbulence; stars: formation; ISM: clouds; ISM: kinematics and dynamics	STAR-FORMATION; PROTOSTELLAR COLLAPSE; ALMA OBSERVATIONS; T-TAURI; TRIPLE SYSTEM; TURBULENCE; DISKS; FRAGMENTATION; CONDENSATION; SIMULATIONS	We investigated the formation of arc-like structures in the infalling envelope around protostars, motivated by the recent Atacama Large Millimeter/Submillimeter Array (ALMA) observations of the high-density molecular cloud core, MC27/L1521F. We performed self-gravitational hydrodynamical numerical simulations with an adaptive mesh refinement code. A filamentary cloud with a 0.1 pc width fragments into cloud cores because of perturbations due to weak turbulence. The cloud core undergoes gravitational collapse to form multiple protostars, and gravitational torque from the orbiting protostars produces arc structures extending up to a 1000 au scale. As well as on a spatial extent, the velocity ranges of the arc structures, similar to 0.5 km s(-1), are in agreement with the ALMA observations. We also found that circumstellar discs are often misaligned in triple system. The misalignment is caused by the tidal interaction between the protostars when they undergo close encounters because of a highly eccentric orbit of the tight binary pair.	[Matsumoto, Tomoaki] Hosei Univ, Fac Humanity & Environm, Chiyoda Ku, Tokyo 1028160, Japan; [Onishi, Toshikazu; Tokuda, Kazuki] Osaka Prefecture Univ, Grad Sch Sci, Dept Phys Sci, Naka Ku, Sakai, Osaka 5998531, Japan; [Inutsuka, Shu-ichiro] Nagoya Univ, Dept Phys, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Matsumoto, T (reprint author), Hosei Univ, Fac Humanity & Environm, Chiyoda Ku, Tokyo 1028160, Japan.	matsu@hosei.ac.jp			JSPS KAKENHI [26400233, 26287030, 24244017, 23540270, 23403001, 23244027, 23103005, 22244014]	Numerical computations were carried out on Cray XC30 at the Center for Computational Astrophysics, National Astronomical Observatory of Japan. This research was supported by JSPS KAKENHI Grant Numbers 26400233, 26287030, 24244017, 23540270, 23403001, 23244027, 23103005, 22244014.	Andre P, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014666; DUBINSKI J, 1995, ASTROPHYS J, V448, P226, DOI 10.1086/175954; Truelove JK, 1997, ASTROPHYS J, V489, pL179, DOI 10.1086/310975; Jensen ELN, 2014, NATURE, V511, P567, DOI 10.1038/nature13521; Onishi T, 1998, ASTROPHYS J, V502, P296, DOI 10.1086/305867; NAGASAWA M, 1987, PROG THEOR PHYS, V77, P635, DOI 10.1143/PTP.77.635; Bourke TL, 2006, ASTROPHYS J, V649, pL37, DOI 10.1086/508161; Machida MN, 2005, MON NOT R ASTRON SOC, V362, P382, DOI 10.1111/j.1365-2966.2005.09327.x; Masunaga H, 1998, ASTROPHYS J, V495, P346, DOI 10.1086/305281; Ratzka T, 2009, ASTRON ASTROPHYS, V502, P623, DOI 10.1051/0004-6361/200811390; Arzoumanian D, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201116596; Bate MR, 2002, MON NOT R ASTRON SOC, V332, pL65, DOI 10.1046/j.1365-8711.2002.05539.x; Bonnell IA, 2004, MON NOT R ASTRON SOC, V349, P735, DOI 10.1111/j.1365-2966.2004.07543.x; Codella C, 1997, ASTRON ASTROPHYS, V324, P203; Goodwin SP, 2004, ASTRON ASTROPHYS, V414, P633, DOI 10.1051/0004-6361:20031594; Hacar A, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201220090; HELLER CH, 1993, ASTROPHYS J, V408, P337, DOI 10.1086/172591; LARSON RB, 1969, MON NOT R ASTRON SOC, V145, P271; LARSON RB, 1981, MON NOT R ASTRON SOC, V194, P809; Li ZY, 1996, ASTROPHYS J, V464, P373, DOI 10.1086/177329; Matsumoto T, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/1/47; Matsumoto T, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/2/77; Matsumoto T, 2007, PUBL ASTRON SOC JPN, V59, P905; MIZUNO A, 1994, NATURE, V368, P719, DOI 10.1038/368719a0; Onishi T, 1999, PUBL ASTRON SOC JPN, V51, P257; Onishi T, 2002, ASTROPHYS J, V575, P950, DOI 10.1086/341347; OSTRIKER J, 1964, ASTROPHYS J, V140, P1056, DOI 10.1086/148005; Salyk C, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/68; Skemer AJ, 2008, ASTROPHYS J, V676, P1082, DOI 10.1086/527555; Stodolkiewicz J. S., 1963, ACTA ASTRON, V13, P30; Tassis K, 2005, ASTROPHYS J, V618, P783, DOI 10.1086/424480; Tokuda K, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/1/L4; Tomida K, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/6; TOOMRE A, 1964, ASTROPHYS J, V139, P1217, DOI 10.1086/147861; Williams JP, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/120; Zhao B, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/1/10	36	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	MAY 1	2015	449	1					L123	L127		10.1093/mnrasl/slv031		5	Astronomy & Astrophysics	Astronomy & Astrophysics	CG8KA	WOS:000353555000027		
J	Oguri, M				Oguri, Masamune			Predicted properties of multiple images of the strongly lensed supernova SN Refsdal	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						gravitational lensing: strong; supernovae: individual: SN Refsdal; dark matter	HUBBLE-FRONTIER-FIELDS; MAGNIFICATION MAPS; DISTANT SUPERNOVAE; GALAXY CLUSTERS; FAINT GALAXIES; IA SUPERNOVAE; HIGH-REDSHIFT; MASS; PS1-10AFX; DISCOVERY	We construct a mass model of the cluster MACS J1149.6+2223 to study the expected properties of multiple images of SN Refsdal, the first example of a gravitationally lensed supernova with resolved multiple images recently reported by Kelly et al. We find that the best-fitting model predicts six supernova images in total, i.e. two extra images in addition to the observed four Einstein cross supernova images S1-S4. One extra image is predicted to have appeared about 17 years ago, whereas the other extra image is predicted to appear in about one year from the appearance of S1-S4, which is a testable prediction with near-future observations. The predicted magnification factors of individual supernova images range from similar to 18 for the brightest image to similar to 4 for the faint extra images. Confronting these predictions with future observations should provide an unprecedented opportunity to improve our understanding of cluster mass distributions.	[Oguri, Masamune] Univ Tokyo, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan; [Oguri, Masamune] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Oguri, Masamune] Univ Tokyo, Kavli Inst Phys & Math Universe, Kavli IPMU, WPI, Chiba 2778583, Japan	Oguri, M (reprint author), Univ Tokyo, Res Ctr Early Universe, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	masamune.oguri@ipmu.jp	Oguri, Masamune/C-6230-2011		World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; JSPS [26800093]	I thank R. Quimby, S. More, A. More, M. Werner and K. Nomoto for useful discussions. This Letter was supported in part by World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan and Grant-in-Aid for Scientific Research from the JSPS (26800093).	Amanullah R, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/1/L7; Richard J, 2014, MON NOT R ASTRON SOC, V444, P268, DOI 10.1093/mnras/stu1395; Bolton AS, 2003, ASTROPHYS J, V592, P17, DOI 10.1086/375698; Nordin J, 2014, MON NOT R ASTRON SOC, V440, P2742, DOI 10.1093/mnras/stu376; Oguri M, 2003, ASTROPHYS J, V583, P584, DOI 10.1086/345431; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Zitrin A, 2009, ASTROPHYS J LETT, V703, pL132, DOI 10.1088/0004-637X/703/2/L132; Kolatt TS, 1998, MON NOT R ASTRON SOC, V296, P763, DOI 10.1046/j.1365-8711.1998.01466.x; Oguri M, 2003, MON NOT R ASTRON SOC, V338, pL25, DOI 10.1046/j.1365-8711.2003.06290.x; Jauzac M, 2014, MON NOT R ASTRON SOC, V443, P1549, DOI 10.1093/mnras/stu1355; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; REFSDAL S, 1964, MON NOT R ASTRON SOC, V128, P307; Quimby RM, 2014, SCIENCE, V344, P396, DOI 10.1126/science.1250903; Chornock R, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/162; Goobar A, 2002, ASTRON ASTROPHYS, V393, P25, DOI 10.1051/0004-6361:20020987; Holz DE, 2001, ASTROPHYS J, V556, pL71, DOI 10.1086/322947; Ishigaki M, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/12; Johnson TL, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/48; Kelly P. L., 2015, ARXIV14116009; Oguri M, 2010, PUBL ASTRON SOC JPN, V62, P1017; Oguri M, 2010, MON NOT R ASTRON SOC, V405, P2579, DOI 10.1111/j.1365-2966.2010.16639.x; Patel B, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/9; Postman M, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/25; Quimby RM, 2013, ASTROPHYS J LETT, V768, DOI 10.1088/2041-8205/768/1/L20; Rau S, 2014, MON NOT R ASTRON SOC, V443, P957, DOI 10.1093/mnras/stu1189; Schmidt KB, 2014, ASTROPHYS J LETT, V782, DOI 10.1088/2041-8205/782/2/L36; Sharon K., 2015, ARXIV14116933; Smith GP, 2009, ASTROPHYS J LETT, V707, pL163, DOI 10.1088/0004-637X/707/2/L163	28	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	MAY 1	2015	449	1					L86	L89		10.1093/mnrasl/slv025		4	Astronomy & Astrophysics	Astronomy & Astrophysics	CG8KA	WOS:000353555000019		
J	Hachisuka, A; Komori, T; Abe, T; Hachisuka, K				Hachisuka, Akiko; Komori, Tetsuo; Abe, Tatsuya; Hachisuka, Kenji			REPEATER F-WAVES ARE SIGNS OF MOTOR UNIT PATHOLOGY IN POLIO SURVIVORS	MUSCLE & NERVE			English	Article						F-wave; MUNE; polio; post-polio syndrome; repeater F-waves	AMYOTROPHIC-LATERAL-SCLEROSIS; NEURON INVOLVEMENT; POSTPOLIO SYNDROME	IntroductionThe purpose of this study was to determine whether F-waves reveal electrophysiological features of anterior horn cells in polio survivors. MethodsForty-three polio survivors and 20 healthy controls underwent motor nerve conduction studies of the median and tibial nerves bilaterally, including sampling of F-waves elicited by 100 stimuli and the determination of motor unit number estimation (MUNE). ResultsA significant increase in abnormally stereotyped (repeater) F-waves and a reduction of F-wave persistence were observed in both nerves in the polio group as compared with the control group. Repeater F-waves had a negative correlation with MUNE. ConclusionsThese trends in F-wave persistence and repeater F-waves after motor unit loss are characteristic findings in polio survivors. Repeater F-waves are a sign of motor unit pathology. Muscle Nerve51:680-685, 2015	[Hachisuka, Akiko; Hachisuka, Kenji] Univ Occupat & Environm Hlth, Dept Rehabil Med, Kitakyushu, Fukuoka 8078555, Japan; [Komori, Tetsuo; Abe, Tatsuya] Natl Hakone Hosp, Odawara, Japan; [Hachisuka, Akiko; Hachisuka, Kenji] Univ Occupat & Environm Hlth, Dept Rehabil Med, Kitakyushu, Fukuoka 8078555, Japan; [Komori, Tetsuo; Abe, Tatsuya] Natl Hakone Hosp, Odawara, Kanagawa, Japan	Hachisuka, A (reprint author), Univ Occupat & Environm Hlth, Dept Rehabil Med, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	akih815@med.uoeh-u.ac.jp			Department of Rehabilitation Medicine; JSPS KAKENHI [26750211]	This study was supported by a research grant from the Department of Rehabilitation Medicine (chair: Kenji Hachisuka) and JSPS KAKENHI Grant Number 26750211.	AGRE JC, 1991, ARCH PHYS MED REHAB, V72, P923, DOI 10.1016/0003-9993(91)90013-9; DALAKAS MC, 1986, NEW ENGL J MED, V314, P959, DOI 10.1056/NEJM198604103141505; DOHERTY TJ, 1993, MUSCLE NERVE, V16, P355, DOI 10.1002/mus.880160404; Gonzalez H, 2006, LANCET NEUROL, V5, P493, DOI 10.1016/S1474-4422(06)70447-1; PETAJAN JH, 1985, MUSCLE NERVE, V8, P690, DOI 10.1002/mus.880080811; Gonzalez H, 2010, LANCET NEUROL, V9, P634, DOI 10.1016/S1474-4422(10)70095-8; Grimby G, 1998, MUSCLE NERVE, V21, P1428, DOI 10.1002/(SICI)1097-4598(199811)21:11<1428::AID-MUS10>3.0.CO;2-X; McComas AJ, 1997, BRAIN, V120, P1415, DOI 10.1093/brain/120.8.1415; Argyriou AA, 2006, CLIN NEUROPHYSIOL, V117, P1260, DOI 10.1016/j.clinph.2006.03.002; Chroni E, 2012, MUSCLE NERVE, V45, P477, DOI 10.1002/mus.22333; Drory VE, 2001, AMYOTROPH LATERAL SC, V2, P147, DOI 10.1080/146608201753275616; Fukuda R, 2013, J ADV COMPUT INTEL I, V17, P535; Gawne AC, 1994, POST POLIO SYNDROME, P141; Geijo-Barrientos E, 2012, J PERIPHER NERV SYST, V17, P128, DOI 10.1111/j.1529-8027.2012.00383.x; Honda A, 2012, P 9 INT C MOD DEC AR, P34; Jubelt B, 1995, MERRITTS TXB NEUROLO, P142; Macleod WN, 1987, MUSCLE NERVE, V37, P773; Pastore-Olmedo C, 2009, EUR J NEUROL, V16, P1233, DOI 10.1111/j.1468-1331.2009.02764.x; PEIOGLOUHARMOUSSI S, 1987, J NEUROL NEUROSUR PS, V50, P593, DOI 10.1136/jnnp.50.5.593; Sorenson EJ, 2006, J PERIPHER NERV SYST, V11, P241, DOI 10.1111/j.1529-8027.2006.00094.x; Suzuki K, 2009, J CLIN NEUROPHYSIOL, V37, P441; Wohalfart G, 1957, NEUROLOGY, V7, P124	22	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	MAY	2015	51	5					680	685		10.1002/mus.24428		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CG5AB	WOS:000353299600007		
J	Imai, T; Suzuki, S; Tsuda, E; Nagane, Y; Murai, H; Masuda, M; Konno, S; Suzuki, Y; Nakane, S; Fujihara, K; Suzuki, N; Utsugisawa, K				Imai, Tomihiro; Suzuki, Shigeaki; Tsuda, Emiko; Nagane, Yuriko; Murai, Hiroyuki; Masuda, Masayuki; Konno, Shingo; Suzuki, Yasushi; Nakane, Shunya; Fujihara, Kazuo; Suzuki, Norihiro; Utsugisawa, Kimiaki			ORAL CORTICOSTEROID THERAPY AND PRESENT DISEASE STATUS IN MYASTHENIA GRAVIS	MUSCLE & NERVE			English	Article						cross-sectional study; immunomodulation therapy; myasthenia gravis; postintervention status; prednisolone	PLASMA-EXCHANGE; CONTROLLED-TRIAL; CLINICAL-TRIAL; DOUBLE-BLIND; CYCLOSPORINE; IMMUNOGLOBULIN; PREDNISONE; FK506; MICROEMULSION; AZATHIOPRINE	Introduction: The aim of this study was to elucidate the effectiveness of oral prednisolone (PSL) according to dosing regimen in 472 patients with myasthenia gravis (MG). Methods: We compared the clinical characteristics and PSL treatment between 226 patients who achieved minimal manifestations (MM) or better and 246 patients who remained improved (I) or worsened, according to the MG Foundation of America postintervention status. Results: Achievement of MM or better at peak PSL dose (odds ratio 12.25, P<0.0001) and combined use of plasma exchange/plasmapheresis (PE/PP) and/or intravenous immunoglobulin (IVIg) (odds ratio 1.92, P=0.04) were associated positively, and total PSL dose during the past year (odds ratio 0.17, P=0.03) was associated negatively with present MM or better status. Conclusions: Higher PSL dose and longer PSL treatment do not ensure better outcome. In the absence of a good response, the PSL dose should be decreased by combining with modalities such as PE/PP or IVIg. Muscle Nerve51:692-696, 2015	[Imai, Tomihiro] Sapporo Med Univ, Dept Occupat Therapy, Sch Hlth Sci, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Suzuki, Shigeaki; Suzuki, Norihiro] Keio Univ, Sch Med, Dept Neurol, Tokyo, Japan; [Tsuda, Emiko] Sapporo Med Univ, Dept Neurol, Sch Med, Sapporo, Hokkaido 0608556, Japan; [Nagane, Yuriko; Utsugisawa, Kimiaki] Hanamaki Gen Hosp, Dept Neurol, Hanamaki, Japan; [Murai, Hiroyuki] Kyushu Univ, Grad Sch Med Sci, Dept Neurol, Fukuoka 812, Japan; [Masuda, Masayuki] Tokyo Med Univ, Dept Neurol, Tokyo 1608402, Japan; [Konno, Shingo] Toho Univ, Dept Neurol, Med Ctr, Oh Hashi Hosp, Tokyo, Japan; [Suzuki, Yasushi] Sendai Med Ctr, Natl Hosp Org, Dept Neurol, Sendai, Miyagi, Japan; [Nakane, Shunya] Nagasaki Kawatana Med Ctr, Dept Neurol, Kawatana, Japan; [Fujihara, Kazuo] Tohoku Univ, Dept Neurol, Grad Sch Med, Sendai, Miyagi 980, Japan	Imai, T (reprint author), Sapporo Med Univ, Dept Occupat Therapy, Sch Hlth Sci, Chuo Ku, S1W17, Sapporo, Hokkaido 0608556, Japan.	toimai@sapmed.ac.jp	Suzuki, Shigeaki/N-9555-2013; Suzuki, Norihiro/J-5125-2013		Neuroimmunological Disease Research Committee grant from the Japanese Ministry of Health, Labour, and Welfare	This study was supported by a Neuroimmunological Disease Research Committee grant from the Japanese Ministry of Health, Labour, and Welfare.	Grob D, 2008, MUSCLE NERVE, V37, P141, DOI 10.1002/mus.20950; Gajdos P, 1997, ANN NEUROL, V41, P789, DOI 10.1002/ana.410410615; Dunn CJ, 2001, DRUGS, V61, P1957, DOI 10.2165/00003495-200161130-00006; PASCUZZI RM, 1984, ANN NEUROL, V15, P291, DOI 10.1002/ana.410150316; KINO T, 1987, J ANTIBIOT, V40, P1256; Jaretzki A, 2000, NEUROLOGY, V55, P16; Sanders DB, 2008, NEUROLOGY, V71, P394; TINDALL RSA, 1993, ANN NY ACAD SCI, V681, P539, DOI 10.1111/j.1749-6632.1993.tb22937.x; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; Barth D, 2011, NEUROLOGY, V76, P2017, DOI 10.1212/WNL.0b013e31821e5505; Nagane Y, 2005, EUR NEUROL, V53, P146, DOI 10.1159/000085833; Zinman L, 2007, NEUROLOGY, V68, P837, DOI 10.1212/01.wnl.0000256698.69121.45; TINDALL RSA, 1987, NEW ENGL J MED, V316, P719, DOI 10.1056/NEJM198703193161205; Bromberg MB, 1997, J NEUROL SCI, V150, P59, DOI 10.1016/S0022-510X(97)05370-7; Ciafaloni E, 2000, NEUROLOGY, V55, P448; Sanders DB, 2010, AUTOIMMUNITY, V43, P428, DOI 10.3109/08916930903518107; Bonifati DM, 1997, J NEUROL, V244, P542, DOI 10.1007/s004150050141; Brown ES, 1998, HARVARD REV PSYCHIAT, V5, P239, DOI 10.3109/10673229809000307; Evoli A, 2002, MUSCLE NERVE, V25, P111, DOI 10.1002/mus.10018; Gilhus NE, 2009, EXPERT REV NEUROTHER, V9, P351, DOI 10.1586/14737175.9.3.351; GOTI P, 1995, THORAX, V50, P1080, DOI 10.1136/thx.50.10.1080; Kawaguchi N, 2004, J NEUROL SCI, V224, P43, DOI 10.1016/j.jns.2003.09.016; Kokubun N, 2012, CLIN NEUROPHYSIOL, V123, P613, DOI 10.1016/j.clinph.2011.07.044; Konishi T, 2005, J NEUROL NEUROSUR PS, V76, P448, DOI 10.1136/jnnp.2004.042176; Kulaksizoglu IB, 2007, CNS DRUGS, V21, P473, DOI 10.2165/00023210-200721060-00004; Lavrnic D, 2005, ACTA NEUROL SCAND, V111, P247, DOI 10.1111/j.1600-0404.2005.00378.x; Lindberg C, 1998, ACTA NEUROL SCAND, V97, P370; Masuda M, 2012, MUSCLE NERVE, V46, P166, DOI 10.1002/mus.23398; GAJDOS P, 1993, J NEUROL NEUROSUR PS, V56, P1157; Nagane Y, 2010, MUSCLE NERVE, V41, P212, DOI 10.1002/mus.21462; Nagane Y, 2011, EUR NEUROL, V65, P16, DOI 10.1159/000322497; Nagayasu Takeshi, 2005, Jpn J Thorac Cardiovasc Surg, V53, P2, DOI 10.1007/s11748-005-1001-y; Ronager J, 2001, ARTIF ORGANS, V25, P967, DOI 10.1046/j.1525-1594.2001.06717.x; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; TRUHAN AP, 1989, ANN ALLERGY, V62, P375; Utsugisawa K, 2008, EUR J NEUROL, V15, P598, DOI 10.1111/j.1468-1331.2008.02130.x	36	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	MAY	2015	51	5					692	696		10.1002/mus.24438		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CG5AB	WOS:000353299600009		
J	Maeda, MH; Ohta, H; Izutsu, K; Shimizu, J; Uesaka, Y				Maeda, Meiko Hashimoto; Ohta, Hikari; Izutsu, Koji; Shimizu, Jun; Uesaka, Yoshikazu			SPORADIC LATE-ONSET NEMALINE MYOPATHY AS A RARE CAUSE OF SLOWLY PROGRESSIVE MUSCLE WEAKNESS WITH YOUNG ADULT ONSET	MUSCLE & NERVE			English	Article						auto-PBSCT; HIV-negative patients; monoclonal gammopathy; sporadic late-onset nemaline myopathy; young adult onset	IMMUNODEFICIENCY-VIRUS-INFECTION; HIV-INFECTION; ROD MYOPATHY; GAMMOPATHY	Introduction: Sporadic late-onset nemaline myopathy (SLONM) is a rare intractable acquired myopathy characterized by progressive muscle weakness and atrophy, usually with middle to late adult onset. Autologous peripheral blood stem cell transplantation (auto-PBSCT) has been reported to be a promising treatment for SLONM. Methods: In this study we performed clinical characterization, muscle histopathological analysis, and muscle power monitoring after auto-PBSCT in a 27-year-old HIV-negative man with monoclonal gammopathy. Results: He showed improved muscle strength after treatment with high-dose melphalan and auto-PBSCT. Conclusions: Considering the recent reports of successful treatment of SLONM, early and correct diagnosis of this condition in association with monoclonal gammopathy is important. SLONM should be added to the list of diseases to consider in the differential diagnosis of progressive muscle weakness with young adult onset. Muscle Nerve51:772-774, 2015	[Maeda, Meiko Hashimoto; Uesaka, Yoshikazu] Toranomon Gen Hosp, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Dept Neurol, Tokyo, Japan; [Maeda, Meiko Hashimoto; Shimizu, Jun] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Maeda, Meiko Hashimoto; Uesaka, Yoshikazu] Okinaka Mem Inst Med Res, Minato Ku, Tokyo 1058470, Japan; [Ohta, Hikari; Izutsu, Koji] Toranomon Gen Hosp, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Dept Haematol, Tokyo, Japan	Maeda, MH (reprint author), Toranomon Gen Hosp, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Dept Neurol, Tokyo, Japan.	meiko-h@umin.net			Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science, Sports and Culture; National Center of Neurology and Psychiatry [26-8];  [24591289]	This work was supported in part by a Health and Labour Sciences Research Grant for Intractable Diseases (Neuroimmunological Diseases), Ministry of Health, Labour and Welfare of Japan; the Ministry of Education, Science, Sports and Culture; a Grant-in-Aid for Scientific Research (C), 2012-2014 (24591289 to J.S.); and an Intramural Research Grant (26-8) for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry.	Chahin N, 2005, NEUROLOGY, V65, P1158, DOI 10.1212/01.wnl.0000180362.90078.dc; DALAKAS MC, 1987, NEW ENGL J MED, V317, P1602; DWYER BA, 1992, ARCH NEUROL-CHICAGO, V49, P440; BROOKE MH, 1981, MUSCLE NERVE, V4, P186, DOI 10.1002/mus.880040304; Benveniste O, 2008, NEUROLOGY, V71, P531, DOI 10.1212/01.wnl.0000310813.79325.32; CABELLO A, 1990, J NEUROL, V237, P64, DOI 10.1007/BF00319674; Dispenzieri A, 2014, AM J HEMATOL, V89, P213; Doppler K, 2013, MUSCLE NERVE, V48, P983, DOI 10.1002/mus.23954; GONZALES MF, 1988, ARCH NEUROL-CHICAGO, V45, P585; Novy J, 2010, MUSCLE NERVE, V41, P286, DOI 10.1002/mus.21560; Voermans NC, 2008, NEUROLOGY, V71, P532, DOI 10.1212/01.wnl.0000310814.54623.6f	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	MAY	2015	51	5					772	774		10.1002/mus.24509		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CG5AB	WOS:000353299600022		
J	Steinhauer, S; Singh, V; Cassidy, C; Gspan, C; Grogger, W; Sowwan, M; Kock, A				Steinhauer, Stephan; Singh, Vidyadhar; Cassidy, Cathal; Gspan, Christian; Grogger, Werner; Sowwan, Mukhles; Koeck, Anton			Single CuO nanowires decorated with size-selected Pd nanoparticles for CO sensing in humid atmosphere	NANOTECHNOLOGY			English	Article						gas sensor; CuO nanowire; Pd nanoparticle	OXIDE NANOWIRES; GAS; METAL; FABRICATION; NANORODS; SENSORS	We report on conductometric gas sensors based on single CuO nanowires and compare the carbon monoxide (CO) sensing properties of pristine as well as Pd nanoparticle decorated devices in humid atmosphere. Magnetron sputter inert gas aggregation combined with a quadrupole mass filter for cluster size selection was used for single-step Pd nanoparticle deposition in the soft landing regime. Uniformly dispersed, crystalline Pd nanoparticles with size-selected diameters around 5 nm were deposited on single CuO nanowire devices in a four point configuration. During gas sensing experiments in humid synthetic air, significantly enhanced CO response for CuO nanowires decorated with Pd nanoparticles was observed, which validates that magnetron sputter gas aggregation is very well suited for the realization of nanoparticle-functionalized sensors with improved performance.	[Steinhauer, Stephan; Koeck, Anton] Mat Ctr Leoben Forsch GmbH, A-8700 Leoben, Austria; [Steinhauer, Stephan; Singh, Vidyadhar; Cassidy, Cathal; Sowwan, Mukhles] Okinawa Inst Sci & Technol OIST Grad Univ, Nanoparticles Design Unit, Onna, Okinawa 9040495, Japan; [Gspan, Christian] Graz Ctr Electron Microscopy, A-8010 Graz, Austria; [Grogger, Werner] Graz Univ Technol, Inst Electron Microscopy & Nanoanal, A-8010 Graz, Austria	Steinhauer, S (reprint author), Mat Ctr Leoben Forsch GmbH, A-8700 Leoben, Austria.	anton.koeck@mcl.at	Steinhauer, Stephan/G-2900-2015; Singh, Vidyadhar/E-5966-2010	Singh, Vidyadhar/0000-0001-8164-4534	Japan Society for the Promotion of Science	SS acknowledges support as an International Research Fellow of the Japan Society for the Promotion of Science.	Hansen BJ, 2011, CHEM PHYS LETT, V504, P41, DOI 10.1016/j.cplett.2011.01.040; Steinhauer S, 2013, SENSOR ACTUAT B-CHEM, V186, P550, DOI 10.1016/j.snb.2013.06.044; Chang CM, 2012, RSC ADV, V2, P2469, DOI 10.1039/c2ra01016j; LEAPMAN RD, 1982, PHYS REV B, V26, P614, DOI 10.1103/PhysRevB.26.614; Ramgir NS, 2010, SMALL, V6, P1705, DOI 10.1002/smll.201000972; Ramgir N, 2013, COLLOID SURFACE A, V439, P101, DOI 10.1016/j.colsurfa.2013.02.029; Shao F, 2014, APPL SURF SCI, V311, P177, DOI 10.1016/j.apsusc.2014.05.038; Vallejos S, 2011, CHEM COMMUN, V47, P565, DOI 10.1039/c0cc02398a; Hansen BJ, 2010, J PHYS CHEM C, V114, P2440, DOI 10.1021/jp908850j; Joshi RK, 2009, J PHYS CHEM C, V113, P16199, DOI 10.1021/jp906458b; Steinhauer S, 2013, SENSOR ACTUAT B-CHEM, V187, P50, DOI 10.1016/j.snb.2012.09.034; Hubner M, 2011, SENSOR ACTUAT B-CHEM, V153, P347, DOI 10.1016/j.snb.2010.10.046; Gurlo A, 2011, NANOSCALE, V3, P154, DOI 10.1039/c0nr00560f; Lin YH, 2011, J MATER CHEM, V21, P10552, DOI 10.1039/c1jm10785b; Kim H, 2012, SENSOR ACTUAT B-CHEM, V161, P594, DOI 10.1016/j.snb.2011.11.006; Liao L, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085203; Kim ID, 2013, ACTA MATER, V61, P974, DOI 10.1016/j.actamat.2012.10.041; Gou XL, 2008, J MATER CHEM, V18, P965, DOI 10.1039/b716745h; Choi SW, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/22/225501; Omaye ST, 2002, TOXICOLOGY, V180, P139, DOI 10.1016/S0300-483X(02)00387-6; Franke ME, 2006, SMALL, V2, P36, DOI 10.1002/smll.200500261; Benelmekki M, 2014, NANOSCALE, V6, P3532, DOI 10.1039/c3nr06114k; Hwang IS, 2011, ACS APPL MATER INTER, V3, P3140, DOI 10.1021/am200647f; Kolmakov A, 2005, NANO LETT, V5, P667, DOI 10.1021/nl050082v; Barsan N, 2003, J PHYS-CONDENS MAT, V15, pR813, DOI 10.1088/0953-8984/15/20/201; Cassidy C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03083; Cassidy C., 2013, MRS P, V1546, P106; Comini E, 2010, Materials Today, V13, DOI 10.1016/S1369-7021(10)70126-7; GRUNES LA, 1982, PHYS REV B, V25, P7157, DOI 10.1103/PhysRevB.25.7157; Hernandez-Ramirez F, 2006, NANOTECHNOLOGY, V17, P5577, DOI 10.1088/0957-4484/17/22/009; Kim SS, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/41/415502; Liu XH, 2011, SENSOR ACTUAT B-CHEM, V156, P918, DOI 10.1016/j.snb.2011.03.006; Singh V, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2373-7; Singh V, 2014, J PHYS CHEM C, V118, P13869, DOI 10.1021/jp500684y; Steinhauer S, 2011, PROCEDIA ENGINEER, V25, DOI 10.1016/j.proeng.2011.12.365	35	3	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0957-4484	1361-6528		NANOTECHNOLOGY	Nanotechnology	MAY 1	2015	26	17							175502	10.1088/0957-4484/26/17/175502		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CG2NA	WOS:000353110200009		
J	Takahashi, N; Watanabe, K; Taniguchi, T; Nagashio, K				Takahashi, N.; Watanabe, K.; Taniguchi, T.; Nagashio, K.			Atomic layer deposition of Y2O3 on h-BN for a stack in graphene FETs	NANOTECHNOLOGY			English	Article						dielectric constant; capacitance; molecular electronegativity	THIN-FILMS; EPITAXIAL GRAPHENE; DIELECTRICS; WATER; TRANSISTORS; PRECURSORS; OXIDES; MOS2	The combination of h-BN and high-k dielectrics is required for a top gate insulator in miniaturized graphene field-effect transistors because of the low dielectric constant of h-BN. We investigated the deposition of Y2O3 on h-BN using atomic layer deposition. The deposition of Y2O3 on h-BN was confirmed without any buffer layer. An increase in the deposition temperature reduced the surface coverage. The deposition mechanism could be explained by the competition between the desorption and adsorption of the Y precursor on h-BN due to the polarization. Although a full surface coverage was difficult to achieve, the use of an oxidized metal seeding layer on h-BN resulted in a full surface coverage.	[Takahashi, N.; Nagashio, K.] Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Nagashio, K.] Japan Sci & Technol Agcy, PRESTO, Bunkyo Ku, Tokyo 1138656, Japan	Takahashi, N (reprint author), Univ Tokyo, Dept Mat Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	nagashio@material.t.u-tokyo.ac.jp	WATANABE, Kenji/H-2825-2011	WATANABE, Kenji/0000-0003-3701-8119	Ministry of Education, Culture, Sports, Science and Technology in Japan	The authors acknowledge Professor Toriumi and Dr Nabatame for their helpful suggestions. This research was partly supported by a Grant-in-Aid for Scientific Research on Innovative Areas, for Young scientists, and for Challenging Exploratory Research by the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Addou R, 2012, NAT NANOTECHNOL, V8, P41; de Rouffignac P, 2005, CHEM MATER, V17, P4808, DOI 10.1021/cm050624+; Cheng LX, 2014, ACS APPL MATER INTER, V6, P11834, DOI 10.1021/am5032105; Alaboson JMP, 2011, ACS NANO, V5, P5223, DOI 10.1021/nn201414d; Watanabe K, 2004, NAT MATER, V3, P404, DOI 10.1038/nmat1134; Wang XR, 2008, J AM CHEM SOC, V130, P8152, DOI 10.1021/ja8023059; Farmer DB, 2009, NANO LETT, V9, P4474, DOI 10.1021/nl902788u; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; McDonnell S, 2012, J APPL PHYS, V112, DOI 10.1063/1.4766408; Kanayama K, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4867202; Azcatl A, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869149; Nagashio K, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4804430; Robertson J, 2006, REP PROG PHYS, V69, P327, DOI 10.1088/0034-4885/69/2/R02; Hollander MJ, 2011, NANO LETT, V11, P3601, DOI 10.1021/nl201358y; Fallahazad B, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3689785; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/nnano.2010.89, 10.1038/NNANO.2010.89]; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; McDonnell S, 2013, ACS NANO, V7, P10354, DOI 10.1021/nn404775u; Wang WH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3013820; Liu H, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3703595; ALLRED AL, 1961, J INORG NUCL CHEM, V17, P215, DOI 10.1016/0022-1902(61)80142-5; Iwamoto K, 2007, IEEE S VLSI TECHN JU, P70; Majumder P, 2008, J ELECTROCHEM SOC, V155, pG152, DOI 10.1149/1.2929825; Masubuchi S, 2012, PHYS REV LETT, V109; Niinisto J, 2004, CHEM MATER, V16, P2953, DOI 10.1021/cm040145v; Park IS, 2014, J MATER CHEM C, V2, P9240, DOI 10.1039/c4tc01405g; Putkonen M, 2001, CHEM VAPOR DEPOS, V7, P44, DOI 10.1002/1521-3862(200101)7:1<44::AID-CVDE44>3.0.CO;2-Q; Ritala M., 2009, CHEM VAPOUR DEPOSITI, P158; Sanderson R T, 1976, CHEM BONDS BOND ENER, P77; Zhou P, 2014, SCI REP-UK, V4, DOI 10.1038/srep06448	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0957-4484	1361-6528		NANOTECHNOLOGY	Nanotechnology	MAY 1	2015	26	17							175708	10.1088/0957-4484/26/17/175708		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CG2NA	WOS:000353110200018		
J	Radford, A; Iwasaki, E				Radford, Andrew; Iwasaki, Eiichi			On Swiping in English	NATURAL LANGUAGE & LINGUISTIC THEORY			English	Article						Cartography; Ellipsis; Periphery; Repair; Sluicing; Swiping	LEFT PERIPHERY; EXTRACTION; JAPANESE; ELLIPSIS; REPAIR; INTERVENTION; DELETION; ISLANDS; PF	This paper examines the syntax of clauses in which prepositions undergo Swiping/Sluice-Stranding in elliptical questions like Who with? (e.g. in response to 'She's having an affair'). We begin by outlining characteristic properties of Swiping, noting that this involves an interrogative wh-constituent positioned in front of a focused preposition, and that the clause remnant following the preposition obligatorily undergoes a type of ellipsis traditionally termed Sluicing. We outline the recent CP shell analysis of Swiping developed by van Craenenbroeck (2010), under which a PP containing a wh-word is moved into the specifier position of an inner CP, the wh-word is moved into the specifier position of an outer CP (stranding the preposition on the edge of the inner CP), and the residual TP is deleted at PF. We discuss a range of problems with his analysis, and argue that it can be substantially improved if we adopt a more richly articulated cartographic structure for the clause periphery under which Swiped clauses contain ForceP, FocP, and FinP projections. More specifically, we argue that the wh-PP moves to the edge of FinP (with the auxiliary moving to Fin(o) in structures involving auxiliary inversion), the preposition moves into Foc(o) to mark it as focused, and the wh-constituent moves into Spec-ForceP to type the clause as interrogative. We claim that the obligatory Sluicing component of Swiping involves ellipsis of FinP in the PF component, and that this is required in order to repair violations of PF constraints which would otherwise arise. We show how our analysis accounts for a range of phenomena not captured under van Craenenbroeck's original analysis.	[Radford, Andrew] Univ Essex, Dept Language & Linguist, Colchester CO4 3SQ, Essex, England; [Iwasaki, Eiichi] Waseda Univ, Sch Commerce, Tokyo, Japan	Radford, A (reprint author), Univ Essex, Dept Language & Linguist, Colchester CO4 3SQ, Essex, England.	radford@essex.ac.uk; e.iwasaki@aoni.waseda.jp					Abels K, 2012, LINGUIST INQ, V43, P229; Abels Klaus, 2007, INTERFACES INTERFACE, P115; Abels Klaus, 2003, THESIS; Aelbrecht Lobke, 2009, THESIS; Aelbrecht Lobke, 2010, THE SYNTACTIC LICENS; Muller G, 2010, LINGUIST INQ, V41, P35, DOI 10.1162/ling.2010.41.1.35; Haegeman L, 2006, LINGUA, V116, P1651, DOI 10.1016/j.lingua.2005.03.014; Friedmann N, 2009, LINGUA, V119, P67, DOI 10.1016/j.lingua.2008.09.002; Truswell R, 2007, LINGUA, V117, P1355, DOI 10.1016/j.lingua.2006.06.003; Chaves RP, 2012, NAT LANG LINGUIST TH, V30, P465, DOI 10.1007/s11049-011-9164-y; Baltin M, 2010, LINGUIST INQ, V41, P331, DOI 10.1162/ling.2010.41.2.331; CHOMSKY N, 1977, LINGUIST INQ, V8, P425; Haegeman L, 2003, LINGUIST INQ, V34, P640, DOI 10.1162/ling.2003.34.4.640; Fox D, 2005, THEOR LINGUIST, V31, P1, DOI 10.1515/thli.2005.31.1-2.1; Rackowski A, 2005, LINGUIST INQ, V36, P565, DOI 10.1162/002438905774464368; Boeckx C, 2006, LINGUIST INQ, V37, P150, DOI 10.1162/ling.2006.37.1.150; den Dikken M, 2002, LINGUIST INQ, V33, P31; Kennedy C, 2000, NAT LANG LINGUIST TH, V18, P89, DOI 10.1023/A:1006362716348; Boskovic Z, 2011, LINGUIST INQ, V42, P1, DOI 10.1162/LING_a_00027; Merchant J, 2004, LINGUIST PHILOS, V27, P661; Fox D, 2003, LINGUIST INQ, V34, P143, DOI 10.1162/002438903763255959; Chomsky N, 2005, LINGUIST INQ, V36, P1, DOI 10.1162/0024389052993655; Drummond A, 2010, LINGUIST INQ, V41, P689, DOI 10.1162/LING_a_00018; Chomsky N, 2013, LINGUA, V130, P33, DOI 10.1016/j.lingua.2012.12.003; Merchant J, 2008, TOPICS IN ELLIPSIS, P132; Haegeman L, 2014, LINGUIST REV, V31, P73, DOI 10.1515/tlr-2013-0022; Boeckx C, 2001, LINGUIST INQ, V32, P345, DOI 10.1162/00243890152001799; Beecher Henry, 2007, CAMLING, V2007, P9; Boeckx Cedric, 2007, UNDERSTANDING MINIMA; Boeckx Cedric, 2012, SYNTACTIC ISLANDS; Borsley Robert, 2011, EMPIRICAL ISSUES SYN, V8, P7; Branigan Phil, 2005, THESIS; Cable Seth, 2010, LINGUIST INQ, V41, P367; Cheng Lisa Lai-Shen, 1991, THESIS; Chomsky N, 2008, CURR STUD LINGUIST, P133; Chomsky N., 2001, K HALE LIFE LANGUAGE, P1; Chomsky N., 1995, THE MINIMALIST PROGR; Chomsky Noam, 1964, CURRENT ISSUES IN LI; Chomsky Noam, 1972, GOALS LINGUISTIC THE, P63; CHOMSKY NOAM, 1986, BARRIERS; Chung Sandra, 1995, NAT LANG SEMANT, V3, P239, DOI 10.1007/BF01248819; Chung Sandra, 2011, REPRESENTING LANGUAG, P31; Collins C, 2012, IMPOSTERS: A STUDY OF PRONOMINAL AGREEMENT, P1; COLLINS C, 2007, NYU WORKING PAPERS L, V1, P1; Collins Chris, 2013, GAPS GHOSTS AND GAPL; Costa J, 2004, LINGUA, V114, P711, DOI 10.1016/S0024-3841(03)00049-4; Culicover P. W., 2005, SIMPLER SYNTAX; Culicover Peter, 1999, SYNTACTIC NUTS HARD; den Dikken Marcel, 1995, PARTICLES ON THE SYN; Endo Yoshio, 2007, LOCALITY AND INFORMA; Fabregas Antonio, 2012, THESIS; Fox Danny, 2003, THESIS; Gallego Angel, 2007, THESIS; Gengel Kirsten, 2006, LINGO UNIVERSITY OF; Grohmann K., 2003, PROLIFIC DOMAINS; Gueron J., 1999, ENGLISH GRAMMAR; Aelbrecht L, 2012, LING AKT, V190, P1; Haegeman Liliane, 1996, GENGENP, V2, P133; Hartman Jeremy, 2007, THESIS; Hartman Jeremy, 2009, SELECTED PAPERS FROM, P92; HASEGAWA H, 2006, ENGLISH LINGUISTICS, V23, P433; Henry Alison, 1995, BELFAST ENGLISH AND; Hiraiwa K, 2012, SYNTAX-UK, V15, P142, DOI 10.1111/j.1467-9612.2011.00164.x; Hofmeister Philip, 2012, THESIS; HORNSTEIN N, 2003, LINGUISTIC ANAL, V33, P149; Huang C.-T. J., 1982, THESIS; HUDDLESTON R, 1994, J LINGUIST, V30, P411; Huddleston Rodney, 2002, THE CAMBRIDGE GRAMMA; Hudson R, 2003, LINGUA, V113, P607, DOI 10.1016/S0024-3841(02)00086-4; Ince A, 2012, SYNTAX-UK, V15, P181, DOI 10.1111/j.1467-9612.2011.00162.x; Johnson Kyle, 2001, THE HANDBOOK OF CONT, P439; Jurka Johannes, 2011, P 28 W COAST C FORM, P124; Kim J. -S., 1997, THESIS; Koopman Hilda, 2000, VERBAL COMPLEXES; Koopman Hilda, 2000, THE SYNTAX OF SPECIF; Kroch Anthony, 2000, THE PENN HELSINKI PA; Larson Bradley, 2013, GENERALIZED SWIPING; LASNIK H, 1995, MIT WORKING PAPERS L, V27, P143; Lasnik H., 1999, FRAGMENTS STUDIES EL, P141; Lasnik Howard, 1992, MOVE A CONDITIONS ON; Lasnik Howard, 2001, P 31 ANN M N E LING, P301; Lasnik Howard, 2002, LECTURE HANDOUT; Lasnik Howard, 2013, SYNTAX, V17, P1; Lobeck A., 1995, ELLIPSIS FUNCTIONAL; Merchant J, 2002, STUDIES COMP GERMANI, P295; Merchant J., 2006, THE SYNTAX COMPANION, P269; Merchant Jason, 1999, THESIS; Merchant Jason, 2001, THE SYNTAX OF SILENC; Merchant Jason, 2003, THE INTERFACES DERIV, P55; Nakao Chizuru, 2009, THESIS; Ono Hajime, 2006, WEST COAST CONFERENC, V25, P297; Park Bum-Sik, 2005, THESIS; Pesetsky David, 1987, LINGUISTIC REPRESENT, P98; Radford Andrew, 1993, HEADS GRAMMATICAL TH, P73, DOI 10.1017/CBO9780511659454.005; Rawlins Kyle, 2008, THESIS; Richards N., 1997, THESIS; Richards Norvin, 2001, MOVEMENT IN LANGUAGE; Rizzi Luigi, 2010, THE COMPLEMENTIZER P, P17; Rizzi Luigi, 1997, ELEMENTS GRAMMAR, P281; Rizzi Luigi, 1996, PARAMETERS FUNCTIONA, P63; Rizzi Luigi, 2001, CURRENT STUDIES ITAL, P286; Rizzi L, 2007, STUD GENERAT GRAMM, V89, P115; Rizzi Luigi, 2004, STRUCTURES, P223; ROBERTS I, 1991, LINGUIST INQ, V22, P209; Roberts Ian, 2010, AGREEMENT AND HEAD M; Rosen Carol, 1976, P NELS U MASS, V6, P205; Ross John R., 1969, P CLS, V5, P252; Ross J.R., 1986, INFINITE SYNTAX; Sabel J, 2002, LINGUIST REV, V19, P271, DOI 10.1515/tlir.2002.002; Sheehan Michelle, 2010, NELS 40; Sheehan ML, 2013, SYNTAX-UK, V16, P362, DOI 10.1111/synt.12010; Sobin Nicolas, 2003, SYNTAX, V6, P183, DOI 10.1111/1467-9612.00060; Starke M., 2001, THESIS; Stepanov Arthur, 2007, SYNTAX, V10, P80, DOI DOI 10.1111/J.1467-9612.2007.00094.X; TAKAHASHI D, 1994, J EAST ASIAN LINGUIS, V3, P265, DOI 10.1007/BF01733066; Taylor Ann, 2006, THE PARSED CORPUS OF; Taylor Ann, 2003, THE YORK TORONTO HEL; Travis L., 1984, THESIS; Truswell Robert, 2009, LINGUISTIC VARIATION, V8, P131; Truswell Robert, 2011, EVENTS PHRASES AND Q; Uriagereka J., 2000, SYNTAX, V3, P20, DOI [10.1111/1467-9612.00023, DOI 10.1111/1467-9612.00023]; Uriagereka Juan, 1999, WORKING MINIMALISM, P251; van Craenenbroeck J., 2006, SYNTAX, V9, P248, DOI 10.1111/j.1467-9612.2006.00091.x; van Craenenbroeck J, 2006, LINGUIST INQ, V37, P653, DOI 10.1162/ling.2006.37.4.653; van Craenenbroeck Jeroen, 2004, THESIS; van Craenenbroeck Jeroen, 2010, THE SYNTAX OF ELLIPS; van Riemsdijk Henk, 1982, CASE STUDY SYNTACTIC; Wexler Ken, 1980, FORMAL PRINCIPLES OF; Yoshida Masaya, 2007, WESTERN CONFERENCE O, P322; Yoshimoto K, 2012, ACTA LINGUIST HUNGAR, V59, P339, DOI 10.1556/ALing.59.2012.3.3	130	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-806X	1573-0859		NAT LANG LINGUIST TH	Nat. Lang. Linguist. Theory	MAY	2015	33	2					703	744		10.1007/s11049-014-9265-5		42	Linguistics; Language & Linguistics	Linguistics	CG6IB	WOS:000353402000009		
J	Sung, YM; Yoon, MC; Lim, JM; Rath, H; Naoda, K; Osuka, A; Kim, D				Sung, Young Mo; Yoon, Min-Chul; Lim, Jong Min; Rath, Harapriya; Naoda, Koji; Osuka, Atsuhiro; Kim, Dongho			Reversal of Huckel (anti)aromaticity in the lowest triplet states of hexaphyrins and spectroscopic evidence for Baird's rule	Nature Chemistry			English	Article							ISOMERIZATION STABILIZATION ENERGY; EXCITED-STATE; ELECTRON DELOCALIZATION; ORGANIC-PHOTOCHEMISTRY; CHEMICAL-SHIFTS; SINGLET-STATES; AROMATICITY; ANTIAROMATICITY; CYCLOBUTADIENE; PORPHYRINOIDS	The reversal of (anti) aromaticity in a molecule's triplet excited state compared with its closed-shell singlet ground state is known as Baird's rule and has attracted the interest of synthetic, physical organic chemists and theorists because of the potential to modulate the fundamental properties of highly conjugated molecules. Here we show that two closely related bis-rhodium hexaphyrins (R26H and R28H) containing [26] and [28] pi-electron peripheries, respectively, exhibit properties consistent with Baird's rule. In the ground state, R26H exhibits a sharp Soret-like band and distinct Q-like bands characteristic of an aromatic porphyrinoid, whereas R28H exhibits a broad absorption spectrum without Q-like bands, which is typical of an antiaromatic porphyrinoid. In contrast, the T-T absorption of R26H is broad, weak and featureless, whereas that of R28H displays an intense and sharp Soret-like band. These spectral signatures, in combination with quantum chemical calculations, are in line with qualitative expectations based on Baird's rule.	[Sung, Young Mo; Yoon, Min-Chul; Lim, Jong Min; Kim, Dongho] Yonsei Univ, Spect Lab Funct Elect Syst, Seoul 120749, South Korea; [Sung, Young Mo; Yoon, Min-Chul; Lim, Jong Min; Kim, Dongho] Yonsei Univ, Dept Chem, Seoul 120749, South Korea; [Rath, Harapriya; Naoda, Koji; Osuka, Atsuhiro] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan	Osuka, A (reprint author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan.	osuka@kuchem.kyoto-u.ac.jp; dongho@yonsei.ac.kr			Samsung Science and Technology Foundation [SSTF-BA1402-10]; Global Research Laboratory (GRL) Program - Ministry of Education, Science and Technology (MEST) of Korea [2013K1A1A2A0205183]	This work at Yonsei University was supported by the Samsung Science and Technology Foundation (Project No. SSTF-BA1402-10). The quantum calculations were performed using the supercomputing resources of the Korea Institute of Science and Technology Information (KISTI). The work at Kyoto University was supported financially by the Global Research Laboratory (GRL, 2013K1A1A2A0205183) Program funded by the Ministry of Education, Science and Technology (MEST) of Korea. The authors express their appreciation to R. Herges and J.L. Sessler for valuable discussions.	Herges R, 2006, CHEM REV, V106, P4820, DOI 10.1021/cr0505425; Rosenberg M, 2014, CHEM REV, V114, P5379, DOI 10.1021/cr300471v; GOUTERMAN M, 1963, J MOL SPECTROSC, V11, P108, DOI 10.1016/0022-2852(63)90011-0; Yoon MC, 2009, J AM CHEM SOC, V131, P7360, DOI 10.1021/ja9000536; Geuenich D, 2005, CHEM REV, V105, P3758, DOI 10.1021/cr0300901; Cho S, 2010, J PHYS CHEM LETT, V1, P895, DOI 10.1021/jz100039n; An K, 2014, EUR J ORG CHEM, V2014, P2764, DOI 10.1002/ejoc.201301810; Fowler PW, 2003, CHEM PHYS LETT, V371, P719, DOI 10.1016/S0009-2614(03)00349-X; BAIRD NC, 1972, J AM CHEM SOC, V94, P4941, DOI 10.1021/ja00769a025; Krygowski TM, 1999, TETRAHEDRON, V55, P11143, DOI 10.1016/S0040-4020(99)00629-8; Saito S, 2011, ANGEW CHEM INT EDIT, V50, P4342, DOI 10.1002/anie.201003909; Worner HJ, 2006, ANGEW CHEM INT EDIT, V45, P293, DOI 10.1002/anie.200503032; Cyranski MK, 2005, CHEM REV, V105, P3773, DOI 10.1021/cr0300845; Mollerstedt H, 2004, J AM CHEM SOC, V126, P13938, DOI 10.1021/ja045729c; Gogonea V, 1998, ANGEW CHEM INT EDIT, V37, P1945, DOI 10.1002/(SICI)1521-3773(19980803)37:13/14<1945::AID-ANIE1945>3.0.CO;2-E; Shin JY, 2010, CHEM SOC REV, V39, P2751, DOI 10.1039/b925417j; Rzepa HS, 2005, CHEM REV, V105, P3697, DOI 10.1021/cr030092l; AIHARA J, 1978, B CHEM SOC JPN, V51, P1788, DOI 10.1246/bcsj.51.1788; Huckel E, 1931, Z PHYS, V70, P204, DOI 10.1007/BF01339530; Krygowski TM, 2001, CHEM REV, V101, P1385, DOI 10.1021/cr990326u; Jorner K, 2014, CHEM-EUR J, V20, P9295, DOI 10.1002/chem.201402577; Ahn TK, 2005, J AM CHEM SOC, V127, P12856, DOI 10.1021/ja0508951; Ottosson H, 2012, NAT CHEM, V4, P969, DOI 10.1038/nchem.1518; Feixas F, 2011, PHYS CHEM CHEM PHYS, V13, P20690, DOI 10.1039/c1cp22239b; Karadakov PB, 2008, J PHYS CHEM A, V112, P7303, DOI 10.1021/jp8037335; Karadakov PB, 2008, J PHYS CHEM A, V112, P12707, DOI 10.1021/jp8067365; Stepien M, 2011, ANGEW CHEM INT EDIT, V50, P4288, DOI 10.1002/anie.201003353; Zhu J, 2013, ORG LETT, V15, P2442, DOI 10.1021/ol400908z; Schleyer PV, 1996, J AM CHEM SOC, V118, P6317, DOI 10.1021/ja960582d; Rosenberg M, 2011, PHYS CHEM CHEM PHYS, V13, P12912, DOI 10.1039/c0cp02821e; Ottosson H, 2007, CHEM-EUR J, V13, P6998, DOI 10.1002/chem.200700362; BUHL M, 1994, J AM CHEM SOC, V116, P6005; FRATEV F, 1982, TETRAHEDRON, V38, P2929, DOI 10.1016/0040-4020(82)85021-7; ILIC P, 1980, ISRAEL J CHEM, V20, P258; Kadish K. M., 2010, HDB PORPHYRIN SCI, V1-20; MCAULEY I, 1988, J AM CHEM SOC, V110, P600, DOI 10.1021/ja00210a049; Minkin V. I., 1994, AROMATICITY ANTIAROM; Rath H, 2009, CHEM COMMUN, P3762, DOI 10.1039/b905859a; SHUKLA D, 1993, J AM CHEM SOC, V115, P2990, DOI 10.1021/ja00060a063; Villaume S, 2008, CHEMPHYSCHEM, V9, P257, DOI 10.1002/cphc.200700540; WAN P, 1985, J CHEM SOC CHEM COMM, P1207, DOI 10.1039/c39850001207; Zilberg S, 1998, J PHYS CHEM A, V102, P10843, DOI 10.1021/jp9831029	42	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1755-4330	1755-4349		NAT CHEM	Nat. Chem.	MAY	2015	7	5					418	422		10.1038/NCHEM.2233		5	Chemistry, Multidisciplinary	Chemistry	CG5QI	WOS:000353347900015		
J	Man, SM; Karki, R; Malireddi, RKS; Neale, G; Vogel, P; Yamamoto, M; Lamkanfi, M; Kanneganti, TD				Man, Si Ming; Karki, Rajendra; Malireddi, R. K. Subbarao; Neale, Geoffrey; Vogel, Peter; Yamamoto, Masahiro; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi			The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection	NATURE IMMUNOLOGY			English	Article							GENE REGULATORY ELEMENTS; INNATE IMMUNITY; HOST-DEFENSE; INTRACELLULAR LPS; CYTOPLASMIC DNA; TULARENSIS; CASPASE-11; RECEPTOR; INDUCTION; RESPONSES	Inflammasomes are critical for mounting host defense against pathogens. The molecular mechanisms that control activation of the AIM2 inflammasome in response to different cytosolic pathogens remain unclear. Here we found that the transcription factor IRF1 was required for activation of the AIM2 inflammasome during infection with the Francisella tularensis subspecies novicida (F. novicida), whereas engagement of the AIM2 inflammasome by mouse cytomegalovirus (MCMV) or transfected double-stranded DNA did not require IRF1. Infection of F. novicida detected by the DNA sensor cGAS and its adaptor STING induced type I interferon-dependent expression of IRF1, which drove the expression of guanylate-binding proteins (GBPs); this led to intracellular killing of bacteria and DNA release. Our results reveal a specific requirement for IRF1 and GBPs in the liberation of DNA for sensing by AIM2 depending on the pathogen encountered by the cell.	[Man, Si Ming; Karki, Rajendra; Malireddi, R. K. Subbarao; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Man, Si Ming] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA; [Yamamoto, Masahiro] Osaka Univ, Dept Microbiol & Immunol, Osaka, Japan; [Lamkanfi, Mohamed] Vlaams Inst Biotechnol, Dept Med Prot Res, Ghent, Belgium; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	Kanneganti, TD (reprint author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Man, Si Ming/O-6223-2015	Man, Si Ming/0000-0002-5079-2857	US National Institutes of Health [AR056296, CA163507, AI101935]; American Lebanese Syrian Associated Charities; European Research Council [281600]; Fund for Scientific Research-Flanders [G030212N]; St. Jude Children's Research Hospital; National Health and Medical Research Council	We thank V.M. Dixit (Genentech) and N. Kayagaki (Genentech) for Aim2-deficient mice and Gbp5-deficient mice; K.A. Fitzgerald (University of Massachusetts Medical School) for femurs from cGAS-deficient mice; P. Broz (University of Basel) for femurs from Gbp<SUP>chr3</SUP>-deficient mice; K. Pfeffer (Heinrich-Heine-University Duesseldorf) for femurs from GBP2-deficient mice; P.G. Thomas (St. Jude Children's Research Hospital) for the MCMV Smith MSGV strain; and X. Qi and M. Barr for technical assistance. Supported by the US National Institutes of Health (AR056296, CA163507 and AI101935), the American Lebanese Syrian Associated Charities (T.-D.K.), European Research Council (281600), the Fund for Scientific Research-Flanders (C030212N to M.L.), St. Jude Children's Research Hospital and the National Health and Medical Research Council (Neoma Boadway Endowed Fellowship and R.G. Menzies Early Career Fellowship to S.M.M.).	Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; FUJITA T, 1988, EMBO J, V7, P3397; Khare S, 2014, NAT IMMUNOL, V15, P343, DOI 10.1038/ni.2829; Elkins KL, 2002, INFECT IMMUN, V70, P1936, DOI 10.1128/IAI.70.4.1936-1948.2002; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Hemmi H, 2000, NATURE, V408, P740; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Britzen-Laurent N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014246; Connolly DJ, 2014, BIOCHEM PHARMACOL, V92, P405, DOI 10.1016/j.bcp.2014.08.031; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; STAEHELI P, 1984, VIROLOGY, V137, P135, DOI 10.1016/0042-6822(84)90016-3	50	7	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					467	U174		10.1038/ni.3118		11	Immunology	Immunology	CG5BN	WOS:000353305200009		
J	Meunier, E; Wallet, P; Dreier, RF; Costanzo, S; Anton, L; Ruhl, S; Dussurgey, S; Dick, MS; Kistner, A; Rigard, M; Degrandi, D; Pfeffer, K; Yamamoto, M; Henry, T; Broz, P				Meunier, Etienne; Wallet, Pierre; Dreier, Roland F.; Costanzo, Stephanie; Anton, Leonie; Ruehl, Sebastian; Dussurgey, Sebastien; Dick, Mathias S.; Kistner, Anne; Rigard, Melanie; Degrandi, Daniel; Pfeffer, Klaus; Yamamoto, Masahiro; Henry, Thomas; Broz, Petr			Guanylate-binding proteins promote activation of the AIM2 inflammasome during infection with Francisella novicida	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNE RECOGNITION; IFN-INDUCED GTPASES; TOXOPLASMA-GONDII; HOST-DEFENSE; MYCOBACTERIUM-TUBERCULOSIS; LISTERIA-MONOCYTOGENES; RESISTANCE MECHANISM; CYTOPLASMIC LPS; MGBP2 CONTROLS; MELANOMA 2	The AIM2 inflammasome detects double-stranded DNA in the cytosol and induces caspase-1-dependent pyroptosis as well as release of the inflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18. AIM2 is critical for host defense against DNA viruses and bacteria that replicate in the cytosol, such as Francisella tularensis subspecies novicida (F. novicida). The activation of AIM2 by F. novicida requires bacteriolysis, yet whether this process is accidental or is a host-driven immunological mechanism has remained unclear. By screening nearly 500 interferon-stimulated genes (ISGs) through the use of small interfering RNA (siRNA), we identified guanylate-binding proteins GBP2 and GBP5 as key activators of AIM2 during infection with F. novicida. We confirmed their prominent role in vitro and in a mouse model of tularemia. Mechanistically, these two GBPs targeted cytosolic F. novicida and promoted bacteriolysis. Thus, in addition to their role in host defense against vacuolar pathogens, GBPs also facilitate the presentation of ligands by directly attacking cytosolic bacteria.	[Meunier, Etienne; Dreier, Roland F.; Anton, Leonie; Ruehl, Sebastian; Dick, Mathias S.; Kistner, Anne; Broz, Petr] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland; [Wallet, Pierre; Costanzo, Stephanie; Rigard, Melanie; Henry, Thomas] Univ Lyon 1, Ctr Int Rech Infectiol, Inserm U1111, CNRS UMR 5308,Ecole Normale Super, F-69365 Lyon, France; [Dussurgey, Sebastien] Univ Lyon 1, Struct Federat Rech Biosci, UMS344 US8, INSERM,CNRS,Ecole Normale Super, F-69365 Lyon, France; [Degrandi, Daniel; Pfeffer, Klaus] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany; [Yamamoto, Masahiro] Osaka Univ, Dept Microbiol & Immunol, Osaka, Japan	Henry, T (reprint author), Univ Lyon 1, Ctr Int Rech Infectiol, Inserm U1111, CNRS UMR 5308,Ecole Normale Super, F-69365 Lyon, France.	thomas.henry@inserm.fr; petr.broz@unibas.ch		Pfeffer, Klaus/0000-0002-5652-6330	Swiss National Science Foundation [PP00P3_139120/1]; University of Basel [ID2153162]; European Research Council [311542]; Deleguation Generale de l'Armement	We thank N. Gekara (Umea University) for Sting<SUP>Gt/Gt</SUP> mice; M. Roth and S. Hofer for support with mouse experiments; D. Monack (Stanford University) for chicken antibody to F. novicida; N. Kayagaki (Genentech) and V. Dixit (Genentech) for Gbp5<SUP>-/-</SUP> and Aim<SUP>2-/-</SUP> mice, rat antibody to ASC and rat antibody to caspase-1; L. Gallagher and C. Manoil (University of Washington) for plasmid pFFlp; O. Allatif for statistical analysis; the Imaging and FACS Core Facilities of the Biozentrum, University of Basel, for technical assistance; and the Plateau de Biologie Experimentale de la Souris and the flow cytometry platform of SFR Biosciences Gerland-Lyon Sud. Supported by Swiss National Science Foundation (PP00P3_139120/1 to P.B.), the University of Basel (ID2153162 to P.B.), the European Research Council (311542 to T.H.) and the Deleguation Generale de l'Armement (M.R.).	Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Degrandi D, 2007, J IMMUNOL, V179, P7729; Ge JN, 2012, P NATL ACAD SCI USA, V109, P6193, DOI 10.1073/pnas.1117490109; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Nothelfer K, 2011, VIRULENCE, V2, P54, DOI 10.4161/viru.2.1.14666; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Chong A, 2012, AUTOPHAGY, V8, P1342, DOI 10.4161/auto.20808; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Edwards JA, 2010, MICROBIOL-SGM, V156, P327, DOI 10.1099/mic.0.031716-0; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Briken V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00062; Cole LE, 2008, J IMMUNOL, V180, P6885; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Haldar AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003414; Jones JW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00016; Juruj C, 2013, FRONT CELL INFECT MI, V3, P1; Kravets E, 2012, J BIOL CHEM, V287, P27452, DOI 10.1074/jbc.M112.379636; Kresse Alexandra, 2008, BMC Genomics, V9, P158, DOI 10.1186/1471-2164-9-158; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Zhou HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031752	48	7	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					476	U185		10.1038/ni.3119		11	Immunology	Immunology	CG5BN	WOS:000353305200010		
J	Gunawan, M; Venkatesan, N; Loh, JT; Wong, JF; Berger, H; Neo, WH; Li, LYJ; La Win, MK; Yau, YH; Guo, T; See, PCE; Yamazaki, S; Chin, KC; Gingras, AR; Shochat, SG; Ng, LG; Sze, SK; Ginhoux, F; Su, IH				Gunawan, Merry; Venkatesan, Nandini; Loh, Jia Tong; Wong, Jong Fu; Berger, Heidi; Neo, Wen Hao; Li, Liang Yao Jackson; La Win, Myint Khun; Yau, Yin Hoe; Guo, Tiannan; See, Peter Chi Ee; Yamazaki, Sayuri; Chin, Keh Chuang; Gingras, Alexandre R.; Shochat, Susana Geifman; Ng, Lai Guan; Sze, Siu Kwan; Ginhoux, Florent; Su, I-Hsin			The methyltransferase Ezh2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin	NATURE IMMUNOLOGY			English	Article							BLOOD-BRAIN-BARRIER; LYSINE-METHYLATION; DENDRITIC CELLS; FOCAL ADHESION; NONHISTONE PROTEINS; GENE-EXPRESSION; ACTIVATION; DYNAMICS; BINDING; PHOSPHORYLATION	A cytosolic role for the histone methyltransferase Ezh2 in regulating lymphocyte activation has been suggested, but the molecular mechanisms underpinning this extranuclear function have remained unclear. Here we found that Ezh2 regulated the integrin signaling and adhesion dynamics of neutrophils and dendritic cells (DCs). Ezh2 deficiency impaired the integrin-dependent transendothelial migration of innate leukocytes and restricted disease progression in an animal model of multiple sclerosis. Direct methylation of talin, a key regulatory molecule in cell migration, by Ezh2 disrupted the binding of talin to F-actin and thereby promoted the turnover of adhesion structures. This regulatory effect was abolished by targeted disruption of the interactions of Ezh2 with the cytoskeletal-reorganization effector Vav1. Our studies reveal an unforeseen extranuclear function for Ezh2 in regulating adhesion dynamics, with implications for leukocyte migration, immune responses and potentially pathogenic processes.	[Gunawan, Merry; Venkatesan, Nandini; Loh, Jia Tong; Wong, Jong Fu; Berger, Heidi; Neo, Wen Hao; La Win, Myint Khun; Yau, Yin Hoe; Guo, Tiannan; Shochat, Susana Geifman; Sze, Siu Kwan; Su, I-Hsin] Nanyang Technol Univ, Coll Sci, Sch Biol Sci, Singapore 639798, Singapore; [Li, Liang Yao Jackson; See, Peter Chi Ee; Ng, Lai Guan; Ginhoux, Florent] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Yamazaki, Sayuri] Nagoya City Univ, Dept Immunol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Chin, Keh Chuang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Chin, Keh Chuang] Agcy Sci & Technol Res, Inst Mol & Cell Biol, Singapore, Singapore; [Gingras, Alexandre R.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Su, IH (reprint author), Nanyang Technol Univ, Coll Sci, Sch Biol Sci, Singapore 639798, Singapore.	ihsu@ntu.edu.sg	Su, I-hsin/A-2207-2011; Yau, Yin Hoe/A-2817-2011	Su, I-hsin/0000-0002-5894-9580; Yau, Yin Hoe/0000-0001-8136-2393	Agency for Science, Technology and Research [BMRC 07/1/21/19/545]; Ministry of Education [MOE2009-T2-1-034, MOE2013-T2-2-038]; National Medical Research Council of Singapore [NMRC/CBRG/0057/2014]	We thank K. Saijo, C. Schmedt, K. Sadler, P. Droge, N.E. McCarthy and A. Tarakhovsky for critical reading, discussions and comments on the manuscript; C. Ruedl and K.E. Karjalainen for discussions and suggestions; Y. Zhang (Harvard University) for the EZH2, SUZ12 and EED baculovirus expression vectors; L. Nordenskiold (Nanyang Technological University) for the recombinant octamers; L. Mori and A. Urbano for the EAE-induction protocol; M. Poidinger for processing the microarray data; R. Kraut and A. Matsyik for support for imaging by total internal refraction microscopy; G. White (The University of Manchester) for the eGFP-C1-paxillin plasmid; C.L. Chu (National Taiwan University) for the DC2.4 cell line; and A. Sullivan for editing the manuscript. Supported by the Agency for Science, Technology and Research (BMRC 07/1/21/19/545), the Ministry of Education (MOE2009-T2-1-034 and MOE2013-T2-2-038) and the National Medical Research Council of Singapore (NMRC/CBRG/0057/2014).	Garcia-Bernal D, 2009, IMMUNITY, V31, P953, DOI 10.1016/j.immuni.2009.09.021; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Egorova KS, 2010, BIOCHEMISTRY-MOSCOW+, V75, P535, DOI 10.1134/S0006297910050019; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Zhang FL, 2012, J CELL BIOL, V197, P819, DOI 10.1083/jcb.201112129; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Lee JM, 2012, MOL CELL, V48, P572, DOI 10.1016/j.molcel.2012.09.004; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; He AB, 2012, GENE DEV, V26, P37, DOI 10.1101/gad.173930.111; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Jain P, 2010, J IMMUNOL, V184, P7196, DOI 10.4049/jimmunol.0901404; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Ren XD, 2000, J CELL SCI, V113, P3673; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Howes SC, 2014, MOL BIOL CELL, V25, P257, DOI 10.1091/mbc.E13-07-0387; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Coisne C, 2009, J IMMUNOL, V182, P5909, DOI 10.4049/jimmunol.0803418; Hobert O, 1996, MOL CELL BIOL, V16, P3066; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; McBride AE, 2006, ENZYMES, V24, P51, DOI 10.1016/S1874-6047(06)80005-3; Pang CNI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-92; Pendl GG, 2002, BLOOD, V99, P946, DOI 10.1182/blood.V99.3.946; Price AA, 1997, J EXP MED, V186, P1725, DOI 10.1084/jem.186.10.1725; Ross TD, 2013, CURR OPIN CELL BIOL, V25, P613, DOI 10.1016/j.ceb.2013.05.006; van der Vlag J, 1999, NAT GENET, V23, P474	50	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					505	U225		10.1038/ni.3125		14	Immunology	Immunology	CG5BN	WOS:000353305200013		
J	Ubelhart, R; Hug, E; Bach, MP; Wossning, T; Duhren-von Minden, M; Horn, AHC; Tsiantoulas, D; Kometani, K; Kurosaki, T; Binder, CJ; Sticht, H; Nitschke, L; Reth, M; Jumaa, H				Uebelhart, Rudolf; Hug, Eva; Bach, Martina P.; Wossning, Thomas; Duehren-von Minden, Marcus; Horn, Anselm H. C.; Tsiantoulas, Dimitrios; Kometani, Kohei; Kurosaki, Tomohiro; Binder, Christoph J.; Sticht, Heinrich; Nitschke, Lars; Reth, Michael; Jumaa, Hassan			Responsiveness of B cells is regulated by the hinge region of IgD	NATURE IMMUNOLOGY			English	Article							IMMUNOGLOBULIN-D; POSITIVE SELECTION; DEFICIENT MICE; ANTIGEN; RECEPTOR; SURFACE; LYMPHOCYTES; ANTIBODIES; ACTIVATION; EXPRESSION	Mature B cells express immunoglobulin M (IgM)- and IgD-isotype B cell antigen receptors, but the importance of IgD for B cell function has been unclear. By using a cellular in vitro system and corresponding mouse models, we found that antigens with low valence activated IgM receptors but failed to trigger IgD signaling, whereas polyvalent antigens activated both receptor types. Investigations of the molecular mechanism showed that deletion of the IgD-specific hinge region rendered IgD responsive to monovalent antigen, whereas transferring the hinge to IgM resulted in responsiveness only to polyvalent antigen. Our data suggest that the increased IgD/IgM ratio on conventional B-2 cells is important for preferential immune responses to antigens in immune complexes, and that the increased IgM expression on B-1 cells is essential for B-1 cell homeostasis and function.	[Uebelhart, Rudolf; Hug, Eva; Bach, Martina P.; Duehren-von Minden, Marcus; Jumaa, Hassan] Univ Hosp Ulm, Inst Immunol, Ulm, Germany; [Wossning, Thomas; Reth, Michael; Jumaa, Hassan] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79106 Freiburg, Germany; [Duehren-von Minden, Marcus; Reth, Michael; Jumaa, Hassan] Univ Freiburg, Dept Mol Immunol, Biol 3, Fac Biol, D-79106 Freiburg, Germany; [Horn, Anselm H. C.; Sticht, Heinrich] Univ Erlangen Nurnberg, Dept Bioinformat, Inst Biochem, D-91054 Erlangen, Germany; [Tsiantoulas, Dimitrios; Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Tsiantoulas, Dimitrios; Binder, Christoph J.] Austrian Acad Sci, Ctr Mol Med CeMM, A-1010 Vienna, Austria; [Kometani, Kohei; Reth, Michael] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Kurosaki, Tomohiro] RIKEN Ctr Integrat Med Sci IMS, Lab Lymphocyte Differentiat, Turumi Ku, Yokohama, Kanagawa, Japan; [Kurosaki, Tomohiro] Osaka Univ, Lab Lymphocyte Differentiat, WPI Immunol Frontier Res Ctr, Osaka, Japan; [Nitschke, Lars] Univ Erlangen Nurnberg, Chair Genet, Dept Biol, D-91054 Erlangen, Germany	Jumaa, H (reprint author), Univ Hosp Ulm, Inst Immunol, Ulm, Germany.	hassan.jumaa@uni-ulm.de			Deutsche Forschungsgemeinschaft [JU 463/2-1, TRR130]; Deutsche Krebshilfe [108935]	We thank P. Nielsen for scientific discussion and critical reading of the manuscript; U. Stauffer, N. Joswig and C. Johner for mouse work; A. Wurch and M. Knoblauch for help with flow cytometry experiments; H.-P. Pircher (University of Freiburg) and A. Weiss (University of California, San Francisco) for providing MD4 and ML5 mice, respectively; and F.D. Batista (London Research Institute) for providing cDNA encoding for immunoglobulin HC and LC genes of the HH10 BCR. This work was supported by the Deutsche Forschungsgemeinschaft (JU 463/2-1 and TRR130) and the Deutsche Krebshilfe (Project 108935).	GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; PENNELL CA, 1989, EUR J IMMUNOL, V19, P1289, DOI 10.1002/eji.1830190721; Meixlsperger S, 2007, IMMUNITY, V26, P323, DOI 10.1016/j.immuni.2007.01.012; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Lutz C, 1998, NATURE, V393, P797; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Pillai S, 2004, IMMUNOL REV, V197, P206, DOI 10.1111/j.0105-2896.2003.097.x; Kim YM, 2006, P NATL ACAD SCI USA, V103, P3327, DOI 10.1073/pnas.0511315103; HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; KOSCOVILBOIS MH, 1993, J EXP MED, V178, P2055, DOI 10.1084/jem.178.6.2055; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; NITSCHKE L, 1993, P NATL ACAD SCI USA, V90, P1887, DOI 10.1073/pnas.90.5.1887; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; GU H, 1990, EMBO J, V9, P2133; Shinall SM, 2000, J IMMUNOL, V164, P5729; ALLEN D, 1988, EMBO J, V7, P1995; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414; BRINK R, 1992, J EXP MED, V176, P991, DOI 10.1084/jem.176.4.991; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; RETH M, 1978, EUR J IMMUNOL, V8, P393, DOI 10.1002/eji.1830080605; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.immunol.10.1.359; AVRAMEAS S, 1979, J IMMUNOL, V122, P648; CARSETTI R, 1993, EUR J IMMUNOL, V23, P168, DOI 10.1002/eji.1830230127; Huang F, 2003, ANGEW CHEM INT EDIT, V42, P2269, DOI 10.1002/anie.200250684; Kim KM, 1995, ANN NY ACAD SCI, V766, P81, DOI 10.1111/j.1749-6632.1995.tb26651.x; Klasener K, 2014, ELIFE, V3, DOI 10.7554/eLife.02069; Köhler Fabian, 2008, Immunity, V29, P912, DOI 10.1016/j.immuni.2008.10.013; LAVOIE TB, 1992, J IMMUNOL, V148, P503; MAYUMI M, 1994, J ALLERGY CLIN IMMUN, V94, P612, DOI 10.1016/0091-6749(94)90137-6; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Nezlin R, 1990, Adv Immunol, V48, P1, DOI 10.1016/S0065-2776(08)60750-6; TISCH R, 1988, P NATL ACAD SCI USA, V85, P6914, DOI 10.1073/pnas.85.18.6914; Tsiantoulas Dimitrios, 2012, Front Immunol, V3, P415, DOI 10.3389/fimmu.2012.00415	50	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					534	U257		10.1038/ni.3141		12	Immunology	Immunology	CG5BN	WOS:000353305200016		
J	Soltesz, I; Alger, BE; Kano, M; Lee, SH; Lovinger, DM; Ohno-Shosaku, T; Watanabe, M				Soltesz, Ivan; Alger, Bradley E.; Kano, Masanobu; Lee, Sang-Hun; Lovinger, David M.; Ohno-Shosaku, Takako; Watanabe, Masahiko			Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy	NATURE REVIEWS NEUROSCIENCE			English	Review							LONG-TERM DEPRESSION; TEMPORAL-LOBE EPILEPSY; FRAGILE-X-SYNDROME; DIACYLGLYCEROL LIPASE-ALPHA; HIPPOCAMPAL PYRAMIDAL CELLS; PHOSPHOLIPASE-C-BETA; SPIKING BASKET CELLS; IN-VIVO EXPOSURE; ENDOCANNABINOID SYSTEM; ENDOGENOUS CANNABINOIDS	Endocannabinoids are lipid-derived messengers, and both their synthesis and breakdown are under tight spatiotemporal regulation. As retrograde signalling molecules, endocannabinoids are synthesized postsynaptically but activate presynaptic cannabinoid receptor 1 (CB1) receptors to inhibit neurotransmitter release. In turn, CB1-expressing inhibitory and excitatory synapses act as strategically placed control points for activity-dependent regulation of dynamically changing normal and pathological oscillatory network activity. Here, we highlight emerging principles of cannabinoid circuit control and plasticity, and discuss their relevance for epilepsy and related comorbidities. New insights into cannabinoid signalling may facilitate the translation of the recent interest in cannabis-related substances as antiseizure medications to evidence-based treatment strategies.	[Soltesz, Ivan; Lee, Sang-Hun] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Alger, Bradley E.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo 1130033, Japan; [Lovinger, David M.] NIAAA, Sect Synapt Pharmacol, Lab Integrat Neurosci, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Ohno-Shosaku, Takako] Kanazawa Univ, Grad Sch Med Sci, Dept Impairment Study, Kanazawa, Ishikawa 9200942, Japan; [Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan	Soltesz, I (reprint author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	isoltesz@uci.edu	WATANABE, Masahiko/A-4055-2012; Ohno-Shosaku, Takako/C-3250-2015		US National Institutes of Health grant [NS74432]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23500466, 25000015]	The authors thank J. G. Malpeli for comments on the manuscript and M. Uchigashima for Figure 1c. This work was supported by a US National Institutes of Health grant (NS74432 to I.S.) and Grants-in-Aid for Scientific Research (23500466 to T.O.-S. and 25000015 to M.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alger BE, 2014, EPILEPSY CURR, V14, P272, DOI 10.5698/1535-7597-14.5.272; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Nazzaro C, 2012, NAT NEUROSCI, V15, P284, DOI 10.1038/nn.3022; Gordon E, 2001, EPILEPSIA, V42, P1266, DOI 10.1046/j.1528-1157.2001.19301.x; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Dvorzhak A, 2013, J PHYSIOL-LONDON, V591, P1145, DOI 10.1113/jphysiol.2012.241018; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Maa E, 2014, EPILEPSIA, V55, P783, DOI 10.1111/epi.12610; Chen K, 2007, J NEUROSCI, V27, P46, DOI 10.1523/JNEUROSCI.3966-06.2007; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Uchigashima M, 2011, J NEUROSCI, V31, P7700, DOI 10.1523/JNEUROSCI.5665-10.2011; Depoy L, 2013, P NATL ACAD SCI USA, V110, P14783, DOI 10.1073/pnas.1308198110; Kim J, 2002, J NEUROSCI, V22, P10182; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Stella N, 1997, NATURE, V388, P773; Berkovic SF, 2006, TRENDS NEUROSCI, V29, P391, DOI 10.1016/j.tins.2006.05.009; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Romigi A, 2010, EPILEPSIA, V51, P768, DOI 10.1111/j.1528-1167.2009.02334.x; Goldberg EM, 2013, NAT REV NEUROSCI, V14, P337, DOI 10.1038/nrn3482; Iremonger KJ, 2013, TRENDS NEUROSCI, V36, P471, DOI 10.1016/j.tins.2013.04.007; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Cepeda-Prado E, 2012, J NEUROSCI, V32, P6456, DOI 10.1523/JNEUROSCI.0388-12.2012; MARTIN P, 1976, SCIENCE, V194, P965, DOI 10.1126/science.982057; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Incorpora G, 2002, BRAIN DEV-JPN, V24, P766, DOI 10.1016/S0387-7604(02)00102-X; Gulyas AI, 2010, J NEUROSCI, V30, P15134, DOI 10.1523/JNEUROSCI.4104-10.2010; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Adermark L, 2011, NEUROPHARMACOLOGY, V61, P1160, DOI 10.1016/j.neuropharm.2011.01.014; Falenski KW, 2007, NEUROSCIENCE, V146, P1232, DOI 10.1016/j.neuroscience.2007.01.065; ABE T, 1992, J BIOL CHEM, V267, P13361; Castillo PE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005728; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wallace MJ, 2002, EUR J PHARMACOL, V452, P295, DOI 10.1016/S0014-2999(02)02331-2; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Armstrong C, 2012, J PHYSIOL-LONDON, V590, P683, DOI 10.1113/jphysiol.2011.223669; Varga C, 2012, P NATL ACAD SCI USA, V109, pE2726, DOI 10.1073/pnas.1210929109; Katona I, 2012, ANNU REV NEUROSCI, V35, P529, DOI 10.1146/annurev-neuro-062111-150420; Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Lee SH, 2010, J NEUROSCI, V30, P7993, DOI 10.1523/JNEUROSCI.6238-09.2010; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Adermark L, 2009, J NEUROSCI, V29, P1375, DOI 10.1523/JNEUROSCI.3842-08.2009; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Cilio MR, 2014, EPILEPSIA, V55, P787, DOI 10.1111/epi.12635; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Tanimura A, 2012, P NATL ACAD SCI USA, V109, P12195, DOI 10.1073/pnas.1204404109; Foldy C, 2006, J NEUROSCI, V26, P1465, DOI 10.1523/JNEUROSCI.4587-05.2006; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Edwards CR, 2009, BEHAV NEUROSCI, V123, P894, DOI 10.1037/a0016328; Echegoyen J, 2009, EPILEPSY RES, V85, P123, DOI 10.1016/j.eplepsyres.2009.02.019; Sales-Carbonell C, 2013, P NATL ACAD SCI USA, V110, P719, DOI 10.1073/pnas.1217144110; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Zhang LH, 2010, J NEUROSCI, V30, P5724, DOI 10.1523/JNEUROSCI.0795-10.2010; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; Ventura R, 1999, J NEUROSCI, V19, P6897; Peterfi Z, 2012, J NEUROSCI, V32, P14448, DOI 10.1523/JNEUROSCI.1676-12.2012; Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Hoffman AF, 2000, J NEUROSCI, V20, P2470; YLINEN A, 1995, J NEUROSCI, V15, P30; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Varma N, 2001, J NEUROSCI, V21, part. no.; Falenski KW, 2009, BRAIN RES, V1262, P64, DOI 10.1016/j.brainres.2009.01.036; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Younts TJ, 2013, J NEUROSCI, V33, P13743, DOI 10.1523/JNEUROSCI.0817-13.2013; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Carta M, 2014, EUR J NEUROSCI, V39, P1835, DOI 10.1111/ejn.12590; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Kozan R, 2009, EPILEPSIA, V50, P1760, DOI 10.1111/j.1528-1167.2009.02098.x; Devinsky O, 2014, EPILEPSIA, V55, P791, DOI 10.1111/epi.12631; Ohno-Shosaku T, 2003, EUR J NEUROSCI, V18, P109, DOI 10.1046/j.1460-9568.2003.02732.x; OVIEDO A, 1993, BRAIN RES, V616, P293, DOI 10.1016/0006-8993(93)90220-H; Katona I, 2000, NEUROSCIENCE, V100, P797, DOI 10.1016/S0306-4522(00)00286-4; Hashimotodani Y, 2007, J NEUROSCI, V27, P1211, DOI 10.1523/JNEUROSCI.4159-06.2007; Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Gillies MJ, 2002, J PHYSIOL-LONDON, V543, P779, DOI 10.1113/jphysiol.2002.024588; Suarez J, 2011, NEUROSCIENCE, V192, P112, DOI 10.1016/j.neuroscience.2011.06.062; Atwood BK, 2014, NAT NEUROSCI, V17, P540, DOI 10.1038/nn.3652; Bragin A, 2004, EPILEPSIA, V45, P1017, DOI 10.1111/j.0013-9580.2004.17004.x; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Magloczky Z, 2010, EPILEPSIA, V51, P115, DOI 10.1111/j.1528-1167.2010.02624.x; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Holderith N, 2011, J PHYSIOL-LONDON, V589, P4921, DOI 10.1113/jphysiol.2011.216259; Perucca P, 2012, LANCET NEUROL, V11, P792, DOI 10.1016/S1474-4422(12)70153-9; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Watanabe M, 1998, EUR J NEUROSCI, V10, P2016, DOI 10.1046/j.1460-9568.1998.00213.x; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; Naydenov AV, 2014, NEURON, V83, P361, DOI 10.1016/j.neuron.2014.06.030; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Lawrence JJ, 2008, TRENDS NEUROSCI, V31, P317, DOI 10.1016/j.tins.2008.03.008; Wallace MJ, 2001, EUR J PHARMACOL, V428, P51, DOI 10.1016/S0014-2999(01)01243-2; Maccarrone M, 2010, NEUROPSYCHOPHARMACOL, V35, P1500, DOI 10.1038/npp.2010.19; Fukaya M, 2008, EUR J NEUROSCI, V28, P1744, DOI 10.1111/j.1460-9568.2008.06495.x; PITLER TA, 1994, NEURON, V13, P1447; Xia JX, 2006, ALCOHOL CLIN EXP RES, V30, P819, DOI 10.1111/j.1530-0277.2006.00095.x; Pan B, 2009, J PHARMACOL EXP THER, V331, P591, DOI 10.1124/jpet.109.158162; Goffin K, 2011, BRAIN, V134, P1033, DOI 10.1093/brain/awq385; Deshpande LS, 2007, NEUROSCI LETT, V411, P11, DOI 10.1016/j.neulet.2006.09.046; Armstrong C, 2009, EPILEPSIA, V50, P1657, DOI 10.1111/j.1528-1167.2009.02173.x; Pitkanen A, 2013, EPILEPSIA, V54, P35, DOI 10.1111/epi.12297; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Dudek FE, 2010, EPILEPSIA, V51, P126, DOI 10.1111/j.1528-1167.2010.02626.x; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Fourgeaud L, 2004, J NEUROSCI, V24, P6939, DOI 10.1523/JNEUROSCI.0671-04.2004; Bocker KBE, 2010, J COGNITIVE NEUROSCI, V22, P1906, DOI 10.1162/jocn.2009.21355; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.020; Albayram O, 2011, P NATL ACAD SCI USA, V108, P11256, DOI 10.1073/pnas.1016442108; Katona I, 1999, J NEUROSCI, V19, P4544; Raver SM, 2013, NEUROPSYCHOPHARMACOL, V38, P2338, DOI 10.1038/npp.2013.164; Hoffman AF, 2003, J NEUROSCI, V23, P4815; Hansen HH, 2001, J NEUROCHEM, V78, P1415, DOI 10.1046/j.1471-4159.2001.00542.x; Shafaroodi H, 2004, NEUROPHARMACOLOGY, V47, P390, DOI 10.1016/j.neuropharm.2004.04.011; Kucewicz MT, 2011, J NEUROSCI, V31, P15560, DOI 10.1523/JNEUROSCI.2970-11.2011; Bhaskaran MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010683; Blair RE, 2006, J PHARMACOL EXP THER, V317, P1072, DOI 10.1124/jpet.105.100354; Burns HD, 2007, P NATL ACAD SCI USA, V104, P9800, DOI 10.1073/pnas.0703472104; Daw MI, 2010, J NEUROSCI, V30, P11202, DOI 10.1523/JNEUROSCI.6334-09.2010; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Edwards C. R., 2009, BEHAV NEUROSCI, V123, P1065; Eggan SM, 2010, NEUROSCIENCE, V169, P1651, DOI 10.1016/j.neuroscience.2010.06.011; Guggenhuber S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015707; Hashimotodani Y, 2013, J PHYSIOL-LONDON, V591, P4765, DOI 10.1113/jphysiol.2013.254474; Hofmann ME, 2013, EXP NEUROL, V244, P43, DOI 10.1016/j.expneurol.2011.11.047; Jung KM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2045; Kovacs FE, 2012, NEUROPSYCHOPHARMACOL, V37, P1104, DOI 10.1038/npp.2011.262; Krook-Magnuson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2376; Kullmann DM, 2014, NAT REV NEUROL, V10, P300, DOI 10.1038/nrneurol.2014.43; Le Beau FEN, 1998, J NEUROPHYSIOL, V79, P659; Lourenco J, 2010, NAT NEUROSCI, V13, P197, DOI 10.1038/nn.2481; Lovinger David M, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS132, DOI 10.1016/S1353-8020(11)70041-4; Mason Rob, 2009, Front Integr Neurosci, V3, P13, DOI 10.3389/neuro.07.013.2009; Mathur BN, 2013, NAT NEUROSCI, V16, P1275, DOI 10.1038/nn.3478; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; Nagode DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027691; Neu Axel, 2007, J Physiol, V578, P233, DOI 10.1113/jphysiol.2006.115691; Ohno-Shosaku T, 2014, CURR OPIN NEUROBIOL, V29, P1, DOI 10.1016/j.conb.2014.03.017; Soltesz I, 2006, NAT NEUROSCI, V9, P1461, DOI 10.1038/nn1206-1461; STADNICK.SW, 1974, LIFE SCI, V14, P463, DOI 10.1016/0024-3205(74)90361-0; Szabó Gergely G, 2014, J Neurosci, V34, P7958, DOI 10.1523/JNEUROSCI.0247-14.2014	153	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-003X	1471-0048		NAT REV NEUROSCI	Nat. Rev. Neurosci.	MAY	2015	16	5					264	277		10.1038/nrn3937		14	Neurosciences	Neurosciences & Neurology	CG4CO	WOS:000353229800006		
J	Tobino, K; Muso, E; Iwasaki, Y; Yonemoto, S; Kasuno, K; Tsukamoto, T; Nakamura, H; Tomino, Y				Tobino, Kyoko; Muso, Eri; Iwasaki, Yukako; Yonemoto, Satomi; Kasuno, Kenji; Tsukamoto, Tatsuo; Nakamura, Hajime; Tomino, Yasuhiko			Gender- and disease-specific urinary thioredoxin in chronic kidney disease patients with or without type 2 diabetic nephropathy	NEPHROLOGY			English	Article						chronic kidney disease; diabetic nephropathy; gender; oxidative stress; thioredoxin	OXIDATIVE STRESS; EXPRESSION; PROTEIN; 8-HYDROXYDEOXYGUANOSINE; ACTIVATION; ELEVATION; ROLES; CELLS	Aim: The role of urinary (U-) thioredoxin (Trx), a class of small redox proteins, in physiological and pathological conditions, in addition to its gender specificity, has been insufficiently determined in chronic kidney disease (CKD) patients, especially in diabetes mellitus (DM) nephropathy. Methods: U-Trx was measured cross-sectionally in 110 CKD outpatients with estimated glomerular filtration rate (eGFR) of >15 mL/min per 1.73 m(2), namely, in 57 type 2 DM patients (male: n = 41, female: n = 16) and 53 non-DM patients (M: n = 33, F: n = 20), as well as 30 healthy controls (M: n = 11, F: n = 19). Comparisons were made among controls, DM and non-DM, and between M and F, with clinical parameters compared in each group. In addition, a comparison between average U-Trx level and the changes of renal function during a one-year period was performed. Results: U-Trx was significantly higher in females than in males in controls (P < 0.05) and in non-DM patients (P < 0.05). Multiple regression analysis revealed that urinary protein (UP)/creatinine (Cr) ratio, female sex and HbA1c were independent factors affecting U-Trx among all subjects (adjusted R-2 = 0.468). In DM patients, U-Trx was negatively correlated with eGFR, especially in males, and positively correlated with UP/Cr and NAG in both sexes (all P < 0.01), as well as with systolic blood pressure in all (P < 0.05). Average U-Trx was positively correlated with the rate of annual eGFR decline of male (P < 0.01) but not female DM patients. Conclusion: U-Trx might have a gender-specific physiological and pathological role and be a potent marker of renal damage in DM nephropathy.	[Tobino, Kyoko; Muso, Eri; Iwasaki, Yukako; Yonemoto, Satomi; Tsukamoto, Tatsuo] Kitano Hosp, Tazuke Kofukai Med Res Inst, Div Nephrol & Dialysis, Ctr Nephrol & Urol, Osaka 5308480, Japan; [Yonemoto, Satomi; Nakamura, Hajime] Kitano Hosp, Tazuke Kofukai Med Res Inst, Div Prevent Med, Osaka 5308480, Japan; [Tobino, Kyoko; Tomino, Yasuhiko] Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo, Japan; [Kasuno, Kenji] Univ Fukui Hosp, Div Nephrol, Fukui, Japan; [Kasuno, Kenji] Univ Fukui Hosp, Clin Labs, Fukui, Japan	Muso, E (reprint author), Kitano Hosp, Tazuke Kofukai Med Res Inst, Div Nephrol & Dialysis, Ctr Nephrol & Urol,Kita Ku, 2-4-20 Ohgimachi, Osaka 5308480, Japan.	muso@kitano-hp.or.jp			Osaka Kidney Bank Foundation	We express our sincere thanks to Dr Toshiyuki Komiya for introducing us to outpatients and Dr Yoshio Shimizu for acting as a special adviser. This study was partly supported by a research award from the Osaka Kidney Bank Foundation, 2008. The authors are also grateful to Daniel Mrozek for editing the paper.	Kasuno K, 2003, KIDNEY INT, V64, P1273, DOI 10.1046/j.1523-1755.2003.00224.x; BROWNLEE M, 1995, ANNU REV MED, V46, P223; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Andoh T, 2002, J BIOL CHEM, V277, P9655, DOI 10.1074/jbc.M110701200; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Kakisaka Y, 2002, HORM METAB RES, V34, P160; Advani A, 2009, J AM SOC NEPHROL, V20, P730, DOI 10.1681/ASN.2008020142; Xu GW, 2004, J PHARMACEUT BIOMED, V36, P101, DOI 10.1016/j.jpba.2004.04.016; Dincer Y, 2008, RENAL FAILURE, V30, P1006, DOI 10.1080/08860220802422044; Hamada Yasuhiro, 2007, Kobe J Med Sci, V53, P53; Kasuno K, 2014, AM J PHYSIOL-RENAL, V307, pF1342, DOI 10.1152/ajprenal.00381.2013; Kato A, 2003, KIDNEY INT, V63, P2262, DOI 10.1046/j.1523-1755.2003.t01-3-00002.x; Lee SY, 2003, FASEB J, V17, P947, DOI 10.1096/fj.02-0807fje; Li QY, 2012, AM J MED SCI, V343, P458, DOI 10.1097/MAJ.0b013e318235b03e; Nakamura A, 2013, J DIABETES INVEST, V4, P195, DOI 10.1111/jdi.12004; Saito S, 2000, RES COMMUN MOL PATH, V107, P39; Yoshihara E, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00514	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5358	1440-1797		NEPHROLOGY	Nephrology	MAY	2015	20	5					368	374		10.1111/nep.12403		7	Urology & Nephrology	Urology & Nephrology	CG5OR	WOS:000353342400010		
J	Soma, K; Mori, R; Sato, R; Furumai, N; Nara, S				Soma, Ken-ichiro; Mori, Ryota; Sato, Ryuichi; Furumai, Noriyuki; Nara, Shigetoshi			Simultaneous Multichannel Signal Transfers via Chaos in a Recurrent Neural Network	NEURAL COMPUTATION			English	Article							MEMORY DYNAMICS; MODEL; SEARCH	We propose neural network model that demonstrates the phenomenon of signal transfer between separated neuron groups via other chaotic neurons that show no apparent correlations with the input signal. The model is a recurrent neural network in which it is supposed that synchronous behavior between small groups of input and output neurons has been learned as fragments of high-dimensional memory patterns, and depletion of neural connections results in chaotic wandering dynamics. Computer experiments show that when a strong oscillatory signal is applied to an input group in the chaotic regime, the signal is successfully transferred to the corresponding output group, although no correlation is observed between the input signal and the intermediary neurons. Signal transfer is also observed when multiple signals are applied simultaneously to separate input groups belonging to different memory attractors. In this sense simultaneous multichannel communications are realized, and the chaotic neural dynamics acts as a signal transfer medium in which the signal appears to be hidden.	[Soma, Ken-ichiro; Mori, Ryota; Sato, Ryuichi; Furumai, Noriyuki; Nara, Shigetoshi] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Elect & Elect Engn, Okayama 7008530, Japan	Soma, K (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Dept Elect & Elect Engn, Okayama 7008530, Japan.	nara@ec.okayama-u.ac.jp					Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; AIHARA K, 1990, PHYS LETT A, V144, P333, DOI 10.1016/0375-9601(90)90136-C; Mikami S, 2003, NEURAL COMPUT APPL, V11, P129, DOI 10.1007/s00521-003-0348-1; Nara S, 1997, PHYS REV E, V55, P826, DOI 10.1103/PhysRevE.55.826; Nara S, 2003, CHAOS, V13, P1110, DOI 10.1063/1.1604251; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; NARA S, 1995, INT J BIFURCAT CHAOS, V5, P1205, DOI 10.1142/S0218127495000867; Suemitsu Y, 2004, NEURAL COMPUT, V16, P1943, DOI 10.1162/0899766041336440; NARA S, 1993, NEURAL NETWORKS, V6, P963; HAYASHI H, 1982, PHYS LETT A, V88, P435, DOI 10.1016/0375-9601(82)90674-0; Kuroiwa J., 1999, P IEEE INT C SMC, V1, P290; NARA S, 1992, PROG THEOR PHYS, V88, P845, DOI 10.1143/PTP.88.845; SKARDA CA, 1987, BEHAV BRAIN SCI, V10, P161; Tsuda I., 1991, WORLD FUTURES, V32, P167; Fujii H, 1996, NEURAL NETWORKS, V9, P1303, DOI 10.1016/S0893-6080(96)00054-8; Yamaguchi Y., 1997, COMPLEXITY DIVERSITY, P147	16	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	MAY	2015	27	5					1083	1101		10.1162/NECO_a_00715		19	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CG4FC	WOS:000353238200005		
J	Nitta, T				Nitta, Tohru			Learning Dynamics of a Single Polar Variable Complex-Valued Neuron	NEURAL COMPUTATION			English	Article							NETWORK; SINGULARITIES	This letter investigates the characteristics of the complex-valued neuron model with parameters represented by polar coordinates (called polar variable complex-valued neuron). The parameters of the polar variable complex-valued neuron are unidentifiable. The plateau phenomenon can occur during learning of the polar variable complex-valued neuron. Furthermore, computer simulations suggest that a single polar variable complex-valued neuron has the following characteristics in the case of using the steepest gradient-descent method with square error: (1) unidentifiable parameters (singular points) degrade the learning speed and (2) a plateau can occur during learning. When the weight is attracted to the singular point, the learning tends to become stuck. However, computer simulations also show that the steepest gradient-descent method with amplitude-phase error and the complex-valued natural gradient method could reduce the effects of the singular points. The learning dynamics near singular points depends on the error functions and the training algorithms used.	Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Nitta, T (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan.	tohru-nitta@aist.go.jp					Amari S., 1996, ADV NEURAL PROCESSIN, V9; Kawata S, 2003, OPT LETT, V28, P2524, DOI 10.1364/OL.28.002524; Nitta T, 2008, ADV IMAG ELECT PHYS, V152, P153, DOI 10.1016/S1076-5670(08)00604-6; Amari S, 1998, NEURAL COMPUT, V10, P251, DOI 10.1162/089976698300017746; Tanaka G, 2009, IEEE T NEURAL NETWOR, V20, P1463, DOI 10.1109/TNN.2009.2025500; Amari S, 2006, NEURAL COMPUT, V18, P1007, DOI 10.1162/neco.2006.18.5.1007; Hirose A, 2004, LECT NOTES COMPUT SC, V3316, P116; Satoh S, 2013, NEURAL PROCESS LETT, V38, P99, DOI 10.1007/s11063-013-9283-z; Savitha R, 2013, IEEE T NEUR NET LEAR, V24, P529, DOI 10.1109/TNNLS.2012.2235460; Nitta T, 2013, NEURAL NETWORKS, V43, P1, DOI 10.1016/j.neunet.2013.02.002; Hirose A, 2001, FR ART INT, V69, P576; Arena P., 1998, NEURAL NETWORKS MULT; Cousseau F, 2008, IEEE T NEURAL NETWOR, V19, P1313, DOI 10.1109/TNN.2008.2000391; Fukumizu K., 1999, P 1999 WORKSH INF BA, P221; Hirose A., 2013, COMPLEX VALUED NEURA; Hirose A., 2006, COMPLEX VALUED NEURA; Nitta T., 2006, NEURAL INFORM PROCES, V10, P237; Nitta T., 2013, COMPLEX VALUED NEURA, P59; Nitta T., 2009, COMPLEX VALUED NEURA; Nitta T., 2010, IEICE T INF SYST, VJ93-D, P1614; Nitta T., 2007, P IJCAI WORKSH COMPL, P2; Nitta T., 1992, P INT JOINT C NEUR N, V2, P511; Nitta T., 1994, P IEEE INT C NEUR NE, V5, P2895, DOI 10.1109/ICNN.1994.374691; Nitta T., 2014, INT J ADV COMPUTER S, V5, P193; Tanaka G., 2011, RIMS KOKYUROKU RES C, V1762, P1; Wei HK, 2008, NEURAL COMPUT, V20, P813, DOI 10.1162/neco.2007.12-06-414	26	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	MAY	2015	27	5					1120	1141		10.1162/NECO_a_00729		22	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CG4FC	WOS:000353238200007		
J	Morita, T; Morimoto, M; Yamada, K; Hasegawa, T; Morioka, S; Kidowaki, S; Moroto, M; Yamashita, S; Maeda, H; Chiyonobu, T; Tokuda, S; Hosoi, H				Morita, Takashi; Morimoto, Masafumi; Yamada, Kei; Hasegawa, Tatsuji; Morioka, Shigemi; Kidowaki, Satoshi; Moroto, Masaharu; Yamashita, Satoshi; Maeda, Hiroshi; Chiyonobu, Tomohiro; Tokuda, Sachiko; Hosoi, Hajime			Low-grade intraventricular hemorrhage disrupts cerebellar white matter in preterm infants: evidence from diffusion tensor imaging	NEURORADIOLOGY			English	Article						Intraventricular hemorrhage (IVH); Hemosiderin; Superior cerebellar peduncle (SCP); Fractional anisotropy (FA); Apparent diffusion coefficient (ADC)	BIRTH-WEIGHT INFANTS; TERM-EQUIVALENT AGE; FIBER-TRACKING; CEREBRAL-PALSY; BRAIN-INJURY; PREMATURITY; NEURODEVELOPMENT; SURVIVORS; PREDICT	Recent diffusion tensor imaging (DTI) studies have demonstrated that leakage of hemosiderin into cerebrospinal fluid (CSF), which is caused by high-grade intraventricular hemorrhage (IVH), can affect cerebellar development in preterm born infants. However, a direct effect of low-grade IVH on cerebellar development is unknown. Thus, we evaluated the cerebellar and cerebral white matter (WM) of preterm infants with low-grade IVH. Using DTI tractography performed at term-equivalent age, we analyzed 42 infants who were born less than 30 weeks gestational age (GA) at birth (22 with low-grade IVH, 20 without). These infants were divided into two birth groups depending on GA, and we then compared the presence and absence of IVH which was diagnosed by cerebral ultrasound (CUS) within 10 days after birth or conventional magnetic resonance imaging (MRI) at term-equivalent age in each group. Fractional anisotropy (FA) and apparent diffusion coefficient (ADC) at the superior cerebellar peduncle (SCP), middle cerebellar peduncle (MCP), motor tract, and sensory tract were measured. In the SCP, preterm born infants with IVH had lower FA values compared with infants without IVH. In particular, younger preterm birth with IVH had lower FA values in the SCP and motor tract and higher ADC values in the MCP. Low-grade IVH impaired cerebellar and cerebral WM, especially in the SCP. Moreover, younger preterm infants exhibited greater disruptions to cerebellar WM and the motor tract than infants of older preterm birth.	[Morita, Takashi; Morimoto, Masafumi; Hasegawa, Tatsuji; Morioka, Shigemi; Kidowaki, Satoshi; Moroto, Masaharu; Yamashita, Satoshi; Maeda, Hiroshi; Chiyonobu, Tomohiro; Tokuda, Sachiko; Hosoi, Hajime] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kamigyo Ku, Kyoto 6028566, Japan; [Yamada, Kei] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Radiol, Kyoto 6028566, Japan	Morimoto, M (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kamigyo Ku, Kajii Cho, Kyoto 6028566, Japan.	morimoto@koto.kpu-m.ac.jp			JSPS KAKENHI [24591605]	We thank Ikumitsu Nagasaki, Department of Mathematics, Kyoto Prefectural University of Medicine, for advice on statistical analyses. This work was supported by the JSPS KAKENHI Grant Number 24591605.	Neubauer AP, 2008, EUR J PEDIATR, V167, P87, DOI 10.1007/s00431-007-0435-x; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Srinivasan L, 2006, AM J NEURORADIOL, V27, P573; Miller SP, 2002, J MAGN RESON IMAGING, V16, P621, DOI 10.1002/jmri.10205; Tam EWY, 2009, PEDIATR RES, V66, P102, DOI 10.1203/PDR.0b013e3181a1fb3d; Messerschmidt A, 2008, EUR J PEDIATR, V167, P1141, DOI 10.1007/s00431-007-0647-0; Murakami A, 2008, PEDIATRICS, V122, P500, DOI 10.1542/peds.2007-2816; Hasegawa T, 2011, PEDIATR RES, V69, P249, DOI 10.1203/PDR.0b013e3182084e54; Liu XB, 2013, NEUROSCI BULL, V29, P229, DOI 10.1007/s12264-013-1311-5; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; Ancel PY, 2006, PEDIATRICS, V117, P828, DOI 10.1542/peds.2005-0091; Parker J, 2008, BRAIN, V131, P1344, DOI 10.1093/brain/awn062; Koeppen AH, 2008, ACTA NEUROPATHOL, V116, P371, DOI 10.1007/s00401-008-0421-z; Messerschmidt A, 2005, AM J NEURORADIOL, V26, P1659; Merhar SL, 2012, ACTA PAEDIATR, V101, P414, DOI 10.1111/j.1651-2227.2011.02584.x; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Yeo SS, 2011, EUR NEUROL, V66, P235, DOI 10.1159/000330942; Brouwer A, 2008, J PEDIATR, V152, P648, DOI 10.1016/j.jpeds.2007.10.005; Thompson KJ, 2001, BRAIN RES BULL, V55, P155, DOI 10.1016/S0361-9230(01)00510-X; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Limperopoulos C, 2005, PEDIATRICS, V116, P844, DOI 10.1542/peds.2004-2282; Tam EWY, 2013, NEURORADIOLOGY, V55, P41, DOI 10.1007/s00234-013-1230-1; Tam EWY, 2011, J PEDIATR-US, V158, P366, DOI 10.1016/j.jpeds.2010.09.005; Volpe JJ, 2009, J CHILD NEUROL, V24, P1085, DOI 10.1177/0883073809338067; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Bassan H, 2007, PEDIATRICS, V120, P785, DOI 10.1542/peds.2007-0211; Biran V, 2012, NEUROL RES INT, V2012, DOI DOI 10.1155/2012/858929; FUKUMIZU M, 1995, PEDIATR NEUROL, V13, P230, DOI 10.1016/0887-8994(95)00183-G; Klebermass-Schrehof K, 2012, CHILD NERV SYST, V28, P2085, DOI 10.1007/s00381-012-1897-3; Marret S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062683; Morioka S, 2013, NEURORADIOLOGY, V55, P1251, DOI 10.1007/s00234-013-1245-7; Patra K, 2006, J PEDIATR-US, V149, P169, DOI 10.1016/j.jpeds.2006.04.002; Platt MJ, 2007, LANCET, V369, P43, DOI 10.1016/S0140-6736(07)60030-0; Pogribna U, 2013, AM J NEURORADIOL, DOI [10.3174/ajnr.A3725, DOI 10.3174/AJNR.A3725]; Provenzale JM, 2010, AM J ROENTGENOL, V195, pW456, DOI 10.2214/AJR.10.4886; Volpe J.J., 2008, NEUROLOGY NEWBORN	38	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	MAY	2015	57	5					507	514		10.1007/s00234-015-1487-7		8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CG3YQ	WOS:000353216400007		
J	Kubota, H; Sanada, Y; Tasaki, T; Miyauchi, M; Tanikawa, R; Ohtsuki, T; Kato, A				Kubota, Hisashi; Sanada, Yasuhiro; Tasaki, Takayuki; Miyauchi, Masaharu; Tanikawa, Rokuya; Ohtsuki, Toshiho; Kato, Amami			Surgical Accessibility of the Distal Internal Carotid Artery on Carotid Endarterectomy Evaluated Using Magnetic Resonance Angiography	NEUROSURGERY			English	Article						C1 transvers process; Carotid endarterectomy; Hyoid bone; Internal carotid artery; Magnetic resonance angiography; Surgical accessibility	TECHNICAL NOTE; EXPERIENCE	BACKGROUND:Magnetic resonance angiography (MRA) is helpful for preoperatively evaluating the degree of carotid stenosis, although it is not always useful for assessing surgical accessibility to the distal internal carotid artery (ICA) due to the lack of osteological information.OBJECTIVE:To demonstrate a method for evaluating the accessible distal portion of the ICA for carotid endarterectomy (CEA) using MRA.METHODS:As an indicator of the upper limit of the operating field, a line drawn from the C1 transverse process to the hyoid bone (C1-H line) was defined. The cross-point between the C1-H line and distal ICA was delineated on 3-dimensional (3-D) MRA and 3-D tomography angiography (CTA). The distance between the carotid bifurcation and C1-H line was measured in 11 patients. The exposed distal ICA was compared with the extent of intraoperative ICA exposure.RESULTS:The mean vertical distance (27.5 mm) from the carotid bifurcation to the C1-H line measured using 3-D MRA was almost the same as the distance (28 mm) evaluated on 3-D CTA. The discrepancy in distance between the 2 modalities was 1.9 1.7 mm. Furthermore, the point of the ICA across the C1-H line created on 3-D MRA was in accordance with the intraoperative measurement (28.7 mm) of the exposed ICA.CONCLUSION:The C1-H line measured on 3-D MRA is a simple and useful indicator of the distal point of the accessible ICA during CEA, especially in patients with renal dysfunction and allergies to contrast medium.	[Kubota, Hisashi; Sanada, Yasuhiro; Tasaki, Takayuki; Miyauchi, Masaharu; Kato, Amami] Kinki Univ, Fac Med, Dept Neurosurg, Osaka 5678505, Japan; [Ohtsuki, Toshiho] Kinki Univ, Fac Med, Stroke Ctr, Osaka 5678505, Japan; [Tanikawa, Rokuya] Teishinkai Hosp, Dept Neurosurg, Stroke Ctr, Sapporo, Hokkaido, Japan	Kubota, H (reprint author), Kinki Univ, Fac Med, Dept Neurosurg, 377-2 Onohigashi, Osaka 5678505, Japan.	kubopo@gmail.com					Bartlett ES, 2006, AM J NEURORADIOL, V27, P13; Barth A, 2006, CEREBROVASC DIS, V21, P393, DOI 10.1159/000091964; Beretta Federica, 2006, Neurosurgery, V59, pONS25; BLAISDEL.WF, 1969, J AMER MED ASSOC, V209, P1889, DOI 10.1001/jama.209.12.1889; Katano H, 2004, BRIT J NEUROSURG, V18, P138, DOI 10.1080/02688690410001680993; Kubota H, 2015, ACTA NEUROCHIR, V157, P43, DOI 10.1007/s00701-014-2253-z; MOCK CN, 1991, J VASC SURG, V13, P846; Weaver KD, 2004, NEUROSURGERY, V55, P1227, DOI 10.1227/01.NEU.0000142355.86116.A8	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAY	2015	76	5					633	637		10.1227/NEU.0000000000000664		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG3VY	WOS:000353208900016		
J	Yoneyama, K; Arakawa, R; Ishimoto, K; Kim, HI; Kisugi, T; Xie, XN; Nomura, T; Kanampiu, F; Yokota, T; Ezawa, T; Yoneyama, K				Yoneyama, Kaori; Arakawa, Ryota; Ishimoto, Keiko; Kim, Hyun Il; Kisugi, Takaya; Xie, Xiaonan; Nomura, Takahito; Kanampiu, Fred; Yokota, Takao; Ezawa, Tatsuhiro; Yoneyama, Koichi			Difference in Striga-susceptibility is reflected in strigolactone secretion profile, but not in compatibility and host preference in arbuscular mycorrhizal symbiosis in two maize cultivars	NEW PHYTOLOGIST			English	Article						arbuscular mycorrhizal (AM) fungi; community composition; compatibility; Striga spp; strigolactone; susceptibility; Zea mays (maize)	ROOT PARASITIC PLANTS; SEED-GERMINATION; BROOMRAPE OROBANCHE; PHOSPHORUS DEFICIENCY; LUTEA LOUR; NITROGEN; SORGHUM; FUNGI; STIMULANT; RECOGNITION	Strigolactones released from plant roots trigger both seed germination of parasitic weeds such as Striga spp. and hyphal branching of the symbionts arbuscular mycorrhizal (AM) fungi. Generally, strigolactone composition in exudates is quantitatively and qualitatively different among plants, which may be involved in susceptibility and host specificity in the parasite-plant interactions. We hypothesized that difference in strigolactone composition would have a significant impact on compatibility and host specificity/preference in AM symbiosis. Strigolactones in root exudates of Striga-susceptible (Pioneer 3253) and -resistant (KST 94) maize (Zea mays) cultivars were characterized by LC-MS/MS combined with germination assay using Striga hermonthica seeds. Levels of colonization and community compositions of AM fungi in the two cultivars were investigated in field and glasshouse experiments. 5-Deoxystrigol was exuded exclusively by the susceptible cultivar, while the resistant cultivar mainly exuded sorgomol. Despite the distinctive difference in strigolactone composition, the levels of AM colonization and the community compositions were not different between the cultivars. The present study demonstrated that the difference in strigolactone composition has no appreciable impact on AM symbiosis, at least in the two maize cultivars, and further suggests that the traits involved in Striga-resistance are not necessarily accompanied by reduction in compatibility to AM fungi.	[Yoneyama, Kaori; Kim, Hyun Il; Kisugi, Takaya; Xie, Xiaonan; Nomura, Takahito; Yoneyama, Koichi] Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi 3218505, Japan; [Arakawa, Ryota; Ishimoto, Keiko; Ezawa, Tatsuhiro] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan; [Kanampiu, Fred] Int Inst Trop Agr, Nairobi, Kenya; [Yokota, Takao] Teikyo Univ, Fac Sci & Technol, Dept Biosci, Utsunomiya, Tochigi 3208851, Japan	Yoneyama, K (reprint author), Utsunomiya Univ, Ctr Biosci Res & Educ, 350 Mine Machi, Utsunomiya, Tochigi 3218505, Japan.	yoneyama@cc.utsunomiya-u.ac.jp	Ezawa, Tatsuhiro/B-7735-2012; 	Ezawa, Tatsuhiro/0000-0001-6188-7635; YONEYAMA, KOICHI/0000-0002-4930-035X	KAKENHI [22-9996]; Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry; JSPS Research Fellowship for Young Scientists	The authors thank Professor Kohki Akiyama (Osaka Prefecture University) and Professor Tadao Asami (The University of Tokyo) for generous gifts of synthetic (+/-)-5-deoxystrigol and deuterium-labeled 5-deoxystrigol, respectively. The authors also thank Dr Masashi Asahina (Teikyo University) for technical assistance. This work was supported by KAKENHI (22-9996) and the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry. Kaori Yoneyama was supported by a JSPS Research Fellowship for Young Scientists.	Jamil M, 2011, WEED RES, V51, P373, DOI 10.1111/j.1365-3180.2011.00847.x; Yoneyama K, 2012, PLANTA, V235, P1197, DOI 10.1007/s00425-011-1568-8; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Yoneyama K, 2007, PLANTA, V225, P1031, DOI 10.1007/s00425-006-0410-1; CECHIN I, 1993, NEW PHYTOL, V124, P681, DOI 10.1111/j.1469-8137.1993.tb03858.x; Yoneyama K, 2008, NEW PHYTOL, V179, P484, DOI 10.1111/j.1469-8137.2008.02462.x; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Akiyama K, 2010, PLANT CELL PHYSIOL, V51, P1104, DOI 10.1093/pcp/pcq058; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Xie XN, 2008, TETRAHEDRON LETT, V49, P2066, DOI 10.1016/j.tetlet.2008.01.131; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; COOK CE, 1972, J AM CHEM SOC, V94, P6198, DOI 10.1021/ja00772a048; Sanders IR, 2003, TRENDS PLANT SCI, V8, P143, DOI 10.1016/S1360-1385(03)00012-8; ABUIRMAILEH BE, 1994, WEED SCI, V42, P57; Ueno K, 2010, J LABELLED COMPD RAD, V53, P763, DOI 10.1002/jlcr.1789; Jamil M, 2011, NEW PHYTOL, V192, P964, DOI 10.1111/j.1469-8137.2011.03850.x; Yoneyama K, 2007, PLANTA, V227, P125, DOI 10.1007/s00425-007-0600-5; JAIN R, 1992, WEED TECHNOL, V6, P269; Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; Yoneyama K, 2011, PLANT GROWTH REGUL, V65, P495, DOI 10.1007/s10725-011-9620-z; Yoneyama K, 2010, PLANT CELL PHYSIOL, V51, P1095, DOI 10.1093/pcp/pcq055; MUMERA LM, 1993, CROP SCI, V33, P758; Parker C, 2012, WEED SCI, V60, P269, DOI 10.1614/WS-D-11-00068.1; Xie XN, 2013, MOL PLANT, V6, P153, DOI 10.1093/mp/sss139; Awad AA, 2006, PLANT GROWTH REGUL, V48, P221, DOI 10.1007/s10725-006-0009-3; Fernandez-Aparicio M, 2009, ANN BOT-LONDON, V103, P423, DOI 10.1093/aob/mcn236; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Jamil M, 2012, FIELD CROP RES, V134, P1, DOI 10.1016/j.fcr.2012.03.015; Kawahara A, 2013, OECOLOGIA, V173, P533, DOI 10.1007/s00442-013-2622-y; Kim HI, 2010, J PESTIC SCI, V35, P344, DOI 10.1584/jpestics.G10-17; Kisugi T, 2013, PHYTOCHEMISTRY, V87, P60, DOI 10.1016/j.phytochem.2012.11.013; Koltai H, 2010, J EXP BOT, V61, P1739, DOI 10.1093/jxb/erq041; Phipps CJ, 1996, MYCOLOGIA, V88, P707, DOI 10.2307/3760964; R Development Core Team, 2014, R LANG ENV STAT COMP; RAJU PS, 1990, WEED RES, V30, P139, DOI 10.1111/j.1365-3180.1990.tb01697.x; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Tadano T., 1980, J SCI SOIL MANURE, V51, P399	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0028-646X	1469-8137		NEW PHYTOL	New Phytol.	MAY	2015	206	3					983	989		10.1111/nph.13375		7	Plant Sciences	Plant Sciences	CF8JC	WOS:000352802800012		
J	Maruta, T; Miyazaki, N; Nosaka, R; Tanaka, H; Padilla-Chacon, D; Otori, K; Kimura, A; Tanabe, N; Yoshimura, K; Tamoi, M; Shigeoka, S				Maruta, Takanori; Miyazaki, Nozomi; Nosaka, Ryota; Tanaka, Hiroyuki; Padilla-Chacon, Daniel; Otori, Kumi; Kimura, Ayako; Tanabe, Noriaki; Yoshimura, Kazuya; Tamoi, Masahiro; Shigeoka, Shigeru			A gain-of-function mutation of plastidic invertase alters nuclear gene expression with sucrose treatment partially via GENOMES UNCOUPLED1-mediated signaling	NEW PHYTOLOGIST			English	Article						Arabidopsis; genomes uncoupled 1; plastid gene expression; plastidic invertase; retrograde signaling	CHLOROPLAST DEVELOPMENT; ARABIDOPSIS-THALIANA; RNA-POLYMERASES; STRESS; TRANSCRIPTION; GROWTH; PLANT; METABOLISM; PATHWAY; CARBON	Plastid gene expression (PGE) is one of the signals that regulate the expression of photosynthesis-associated nuclear genes (PhANGs) via GENOMES UNCOUPLED1 (GUN1)-dependent retrograde signaling. We recently isolated Arabidopsis sugar-inducible cotyledon yellow-192 (sicy-192), a gain-of-function mutant of plastidic invertase, and showed that following the treatment of this mutant with sucrose, the expression of PhANGs as well as PGE decreased, suggesting that the sicy-192 mutation activates a PGE-evoked and GUN1-mediated retrograde pathway. To clarify the relationship between the sicy-192 mutation, PGE, and GUN1-mediated pathway, plastid and nuclear gene expression in a double mutant of sicy-192 and gun1-101, a null mutant of GUN1 was studied. Plastid-encoded RNA polymerase (PEP)-dependent PGE was markedly suppressed in the sicy-192 mutant by the sucrose treatment, but the suppression as well as cotyledon yellow phenotype was not mitigated by GUN1 disruption. Microarray analysis revealed that the altered expression of nuclear genes such as PhANG in the sucrose-treated sicy-192 mutant was largely dependent on GUN1. The present findings demonstrated that the sicy-192 mutation alters nuclear gene expression with sucrose treatment via GUN1, which is possibly followed by inhibiting PEP-dependent PGE, providing a new insight into the role of plastid sugar metabolism in nuclear gene expression.	[Maruta, Takanori; Miyazaki, Nozomi; Nosaka, Ryota; Tanaka, Hiroyuki; Padilla-Chacon, Daniel; Otori, Kumi; Kimura, Ayako; Tanabe, Noriaki; Tamoi, Masahiro; Shigeoka, Shigeru] Kinki Univ, Fac Agr, Dept Adv Biosci, Nara 6318505, Japan; [Maruta, Takanori] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane 6908504, Japan; [Padilla-Chacon, Daniel; Otori, Kumi; Tanabe, Noriaki; Yoshimura, Kazuya; Tamoi, Masahiro; Shigeoka, Shigeru] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Yoshimura, Kazuya] Chubu Univ, Dept Food & Nutr Sci, Coll Biosci & Biotechnol, Kasugai, Aichi 4878501, Japan	Shigeoka, S (reprint author), Kinki Univ, Fac Agr, Dept Adv Biosci, Nakamachi, Nara 6318505, Japan.	shigeoka@nara.kindai.ac.jp			Japan Science and Technology Agency; Japan Society for the Promotion of Science (JSPS) [23780108]	We thank Ms Momoko Isoda and Yumiko Hashimoto for their technical assistance. We are grateful to Dr Takehito Inaba (Miyazaki University) for donating the gun1-101 seeds. This work was supported by a Core Research for Evolutional Science and Technology Project of the Japan Science and Technology Agency (2012-2018 to S.S.) and by a Grant-in-Aid for Young Scientists (B) (M.T.: 23780108) from the Japan Society for the Promotion of Science (JSPS).	Albrecht V, 2006, PLANT MOL BIOL, V60, P507, DOI 10.1007/s11103-005-4921-0; Hanaoka M, 2005, EMBO REP, V6, P545, DOI 10.1038/sj.embor.7400411; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.128.2.472; Xiao YM, 2012, CELL, V149, P1525, DOI 10.1016/j.cell.2012.04.038; Stitt M, 1999, CURR OPIN PLANT BIOL, V2, P178, DOI 10.1016/S1369-5266(99)80033-8; Maruta T, 2012, J BIOL CHEM, V287, P11717, DOI 10.1074/jbc.M111.292847; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Hajdukiewicz PTJ, 1997, EMBO J, V16, P4041, DOI 10.1093/emboj/16.13.4041; Queval G, 2012, PHILOS T R SOC B, V367, P3475, DOI 10.1098/rstb.2012.0068; Sato T, 2009, PLANT J, V60, P852, DOI 10.1111/j.1365-313X.2009.04006.x; Woodson JD, 2013, PLANT J, V73, P1, DOI 10.1111/tpj.12011; Nomura H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1926; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Kim C, 2012, PLANT CELL, V24, P3026, DOI 10.1105/tpc.112.100479; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004; Oliveira IC, 1999, PLANT PHYSIOL, V121, P301, DOI 10.1104/pp.121.1.301; Zoschke R, 2007, PLANT J, V50, P710, DOI 10.1111/j.1365-313X.2007.03084.x; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; Kakizaki T, 2009, PLANT PHYSIOL, V151, P1339, DOI 10.1104/pp.109.145987; Chi W, 2013, ANNU REV PLANT BIOL, V64, P559, DOI 10.1146/annurev-arplant-050312-120147; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Zhang ZW, 2010, FEBS LETT, V584, P3573, DOI 10.1016/j.febslet.2010.07.024; Arsova B, 2010, PLANT CELL, V22, P1498, DOI 10.1105/tpc.109.071001; Ishizaki Y, 2005, PLANT J, V42, P133, DOI 10.1111/j.1365-313X.2005.02362.x; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; Maruta Takanori, 2010, Plant Signal Behav, V5, P1131, DOI 10.4161/psb.5.9.12568; Maruta T, 2010, PLANT CELL PHYSIOL, V51, P190, DOI 10.1093/pcp/pcp177; Mochizuki N, 1996, PLANT PHYSIOL, V112, P1465, DOI 10.1104/pp.112.4.1465; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Paparelli E, 2012, PLANT PHYSIOL, V160, P1237, DOI 10.1104/pp.112.204016; Shiina T, 2005, INT REV CYTOL, V244, P1, DOI 10.1016/S0074-7696(05)44001-2; Tamoi M, 2010, J BIOL CHEM, V285, P15399, DOI 10.1074/jbc.M109.055111; Hikosaka K, 1996, FUNCT ECOL, V10, P335, DOI 10.2307/2390281; Vargas WA, 2008, PLANTA, V227, P795, DOI 10.1007/s00425-007-0657-1	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0028-646X	1469-8137		NEW PHYTOL	New Phytol.	MAY	2015	206	3					1013	1023		10.1111/nph.13309		11	Plant Sciences	Plant Sciences	CF8JC	WOS:000352802800015		
J	Kimura, H				Kimura, Hideo			Hydrogen sulfide and polysulfides as signaling molecules	NITRIC OXIDE-BIOLOGY AND CHEMISTRY			English	Meeting Abstract	3rd European Conference on the Biology of Hydrogen Sulfide (H2S)	MAY 03-06, 2015	Athens, GREECE						[Kimura, Hideo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Pharmacol, Tokyo, Japan								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1089-8603	1089-8611		NITRIC OXIDE-BIOL CH	Nitric Oxide-Biol. Chem.	MAY 1	2015	47					OP6	S6	S6		10.1016/j.niox.2015.02.012		1	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CG5EM	WOS:000353313900007		
J	Moustafa, A; Habara, Y				Moustafa, Amira; Habara, Yoshiaki			Interaction between three gaseous molecules in rat pancreatic acinar cells; with special reference to the participation in intracellular Ca2+ dynamics	NITRIC OXIDE-BIOLOGY AND CHEMISTRY			English	Meeting Abstract	3rd European Conference on the Biology of Hydrogen Sulfide (H2S)	MAY 03-06, 2015	Athens, GREECE						[Moustafa, Amira; Habara, Yoshiaki] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Physiol Lab, Sapporo, Hokkaido 0600818, Japan								0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1089-8603	1089-8611		NITRIC OXIDE-BIOL CH	Nitric Oxide-Biol. Chem.	MAY 1	2015	47					PP21	S21	S22		10.1016/j.niox.2015.02.051		2	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CG5EM	WOS:000353313900046		
J	Francoise, JP; Tarama, D				Francoise, Jean-Pierre; Tarama, Daisuke			Analytic extension of the Birkhoff normal forms for the free rigid body dynamics on SO(3)	NONLINEARITY			English	Article						Birkhoff normal form; analytic extension; free rigid body; elliptic fibration; monodromy	SEMIGLOBAL SYMPLECTIC INVARIANTS; FOCUS-FOCUS SINGULARITIES; HAMILTONIAN-SYSTEMS; ELLIPTIC FIBRATIONS; FUNDAMENTAL GROUP; SURFACES; CONVERGENCE; INTEGRALS	Birkhoff normal form is a power series expansion associated with the local behaviour of the Hamiltonian systems near a critical point. It is known that around the critical point one can take a convergent canonical transformation which puts the Hamiltonian into Birkhoff normal form for integrable systems under some non-degeneracy conditions. By means of an expression of the derivative for the inverse of Birkhoff normal form by a period integral, analytic continuation of the Birkhoff normal forms is considered for the free rigid body dynamics on SO(3). It is shown that the monodromy of the analytic continuation for the derivative of the inverse for the Birkhoff normal forms coincides with that of an elliptic fibration which naturally arises from the dynamics.	[Francoise, Jean-Pierre] Univ Paris 06, Lab Jacques Louis Lions, F-75252 Paris, France; [Tarama, Daisuke] Kyoto Univ, Dept Math, Sakyo Ku, Kyoto 6068502, Japan	Francoise, JP (reprint author), Univ Paris 06, Lab Jacques Louis Lions, 4 Pl Jussieu, F-75252 Paris, France.	jean-pierre.francoise@upmc.fr; tarama@math.kyoto-u.ac.jp			Research in Paris, programme of Mairie de Paris; JSPS KAKENHI Grant [25.1543]	This work was done during the stay of the second author at Laboratoire Jacques-Louis Lions, Universite Pierre-Marie Curie, with the support by Research in Paris 2012, programme of Mairie de Paris. He expresses his gratitude to their hospitality and support. The authors thank the referees for many valuable comments. DT was partially supported by Grant-in-Aid for JSPS Fellows, JSPS KAKENHI Grant Number 25.1543.	Abraham R, 1978, FDN MECH; VEY J, 1978, AM J MATH, V100, P591, DOI 10.2307/2373841; KODAIRA K, 1963, ANN MATH, V78, P1, DOI 10.2307/1970500; ELIASSON LH, 1990, COMMENT MATH HELV, V65, P4, DOI 10.1007/BF02566590; KODAIRA K, 1960, ANN MATH, V71, P111, DOI 10.2307/1969881; KODAIRA K, 1963, ANN MATH, V77, P563, DOI 10.2307/1970131; ARTIN E, 1947, ANN MATH, V48, P101, DOI 10.2307/1969218; Arnold V.I., 2012, SINGULARITIES DIFFER, VII; Barth W., 2004, COMPACT COMPLEX SURF; Birkhoff G.D., 1927, DYNAMICAL SYSTEMS; Birkhoff GD, 1927, AM J MATH, V49, P1, DOI 10.2307/2370769; BRIESKOR.E, 1971, INVENT MATH, V12, P57, DOI 10.1007/BF01389827; Brieskorn E., 1973, LECT NOTES MATH, V317, P21; Caratheodory C, 1961, FUNKTIONENTHEORIE, VII; de Rham G., 1954, COMMENT MAT HELV, V28, P346; Dullin HR, 2013, J DIFFER EQUATIONS, V254, P2942, DOI 10.1016/j.jde.2013.01.018; Esole M, 2011, ARXIV11106177; Fontich E, 1997, NONLINEARITY, V10, P467, DOI 10.1088/0951-7715/10/2/010; Francoise JP, 2013, J MATH PHYS, V54, DOI 10.1063/1.4794089; Francoise JP, 2010, J MATH PHYS, V51, DOI 10.1063/1.3316076; Francoise JP, 2006, J DYN CONTROL SYST, V12, P357, DOI 10.1007/s10450-006-0004-z; Gradshteyn I S, 2007, TABLE INTEGRALS SERI; Greuel K-M, 2007, INTRO SINGULARITIES; HOLM DD, 1991, PROG MATH, V99, P189; ITO H, 1989, COMMENT MATH HELV, V64, P412, DOI 10.1007/BF02564686; Iwai T, 2010, DIFFER GEOM APPL, V28, P501, DOI 10.1016/j.difgeo.2010.05.002; Leimanis E, 1965, GEN PROBLEM MOTION C; Marsden J E, 2010, INTRO MECH SYMMETRY, V2nd; Marsden J.E., 1974, REP MATH PHYS, V5, P121, DOI 10.1016/0034-4877(74)90021-4; Matveev VS, 1996, SB MATH+, V187, P495, DOI 10.1070/SM1996v187n04ABEH000122; Naruki I, 2012, HOKKAIDO MATH J, V41, P365; NARUKI I, 1987, PUBL RES I MATH SCI, V23, P409, DOI 10.2977/prims/1195176546; Orlik P., 1992, ARRANGEMENTS HYPERPL; Papadopoulos G, 2013, J GEOM MECH, V5, P215, DOI 10.3934/jgm.2013.5.215; RANDELL R, 1982, INVENT MATH, V69, P103, DOI 10.1007/BF01389187; San VN, 2003, TOPOLOGY, V42, P365; Siegel C L, 1995, CLASSICS MATH; Steenrod N E, 1951, TOPOLOGY FIBRE BUNDL; Tarama D, 2015, RIMS KOKYUR IN PRESS; Whittaker ET, 1927, TREATISE ANAL DYNAMI; Zoladek H, 2006, MONOGRAFIE MATEMATYC, V67; Zung NT, 1997, DIFFER GEOM APPL, V7, P123, DOI 10.1016/S0926-2245(96)00042-3; Zung NT, 2005, ANN MATH, V161, P141	43	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0951-7715	1361-6544		NONLINEARITY	Nonlinearity	MAY	2015	28	5					1193	1216		10.1088/0951-7715/28/5/1193		24	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CG8MO	WOS:000353562300002		
J	Plotnik, DA; Wu, S; Linn, GR; Yip, FCT; Comandante, NL; Krohn, KA; Toyohara, J; Schwartz, JL				Plotnik, David A.; Wu, Stephen; Linn, Geoffrey R.; Yip, Franco Chi Tat; Comandante, Natacha Lou; Krohn, Kenneth A.; Toyohara, Jun; Schwartz, Jeffrey L.			In vitro analysis of transport and metabolism of 4 '-thiothymidine in human tumor cells	NUCLEAR MEDICINE AND BIOLOGY			English	Article						PET imaging; 4 '-[methyl-C-11]thiothymidine; FLT; Nucleoside metabolism	POSITRON-EMISSION-TOMOGRAPHY; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER-1; THYMIDINE ANALOGS; PROLIFERATION; CANCER; TISSUE; VIVO	Introduction: The use of thymidine (TdR) and thymidine analogs such as 3'-fluoro-3'-deoxythymidine (FLT) as positron emission tomography (PET)-based proliferation markers can provide information on tumor response to treatment. Studies on another TdR analog, 4'-thiothymidine (4DST), suggest that it might be a better PET-based proliferation tracer than either TdR or FLT. 4DST is resistant to the catabolism that complicates analysis of TdR in PET studies, but unlike FLT, 4DST is incorporated into DNA. Methods: To further evaluate 4DST, the kinetics of 4DST transport and metabolism were determined and compared to FLT and TdR. Transport and metabolism of FLT, TdR and 4DST were examined in the human adenocarcinoma cell line A549 under exponential-growth conditions. Single cell suspensions were incubated in buffer supplemented with radiolabeled tracer in the presence or absence of nitrobenzylmercaptopurine ribonucleoside (NBMPR), an inhibitor of equilibrative nucleoside transporters (ENT). Kinetics of tracer uptake was determined in whole cells and tracer metabolism measured by high performance liquid chromatography of cell lysates. Results: TdR and 4DST were qualitatively similar in terms of ENT-dependent transport, shapes of uptake curves, and relative levels of DNA incorporation. FLT did not incorporate into DNA, showed a significant temperature effect for uptake, and its transport had a significant NBMPR-resistant component. Overall 4DST metabolism was significantly slower than either TdR or FLT. Conclusions: 4DST provides a good alternative for TdR in PET and has advantages over FLT in proliferation measurement. However, slow 4DST metabolism and the short half-life of the C-11 label might limit widespread use in PET. (C) 2014 Elsevier Inc. All rights reserved.	[Plotnik, David A.; Wu, Stephen; Linn, Geoffrey R.; Yip, Franco Chi Tat; Comandante, Natacha Lou; Krohn, Kenneth A.; Schwartz, Jeffrey L.] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA; [Krohn, Kenneth A.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Toyohara, Jun] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Tokyo, Japan	Schwartz, JL (reprint author), Univ Washington, Dept Radiat Oncol, Box 356069, Seattle, WA 98195 USA.	jschwart@uw.edu			National Institutes of Health [CA118130]; Japan Society for the Promotion of Science [22390241]	This work was supported by grant CA118130 from the National Institutes of Health and grant-in aid for scientific research B 22390241 from the Japan Society for the Promotion of Science.	Toyohara J, 2011, J NUCL MED, V52, P1322, DOI 10.2967/jnumed.111.088435; Hubeek I, 2005, BRIT J CANCER, V93, P1388, DOI 10.1038/sj.bjc.6602881; Toyohara J, 2008, NUCL MED BIOL, V35, P67, DOI 10.1016/j.nucmedbio.2007.10.001; Schwartz JL, 2003, J NUCL MED, V44, P2027; Santini D, 2010, J CELL PHYSIOL, V223, P384, DOI 10.1002/jcp.22045; Rasey JS, 2002, J NUCL MED, V43, P1210; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; Grierson JR, 2004, NUCL MED BIOL, V31, P829, DOI 10.1016/j.nucmedbio.2004.06.004; Kenny LM, 2009, CLIN CANCER RES, V15, P6649, DOI 10.1158/1078-0432.CCR-09-1213; Krohn KA, 2001, Q J NUCL MED, V45, P174; Krohn KA, 2001, J CLIN PHARMACOL, p96S; Minamimoto R, 2014, EJNMMI RES, V4, DOI 10.1186/2191-219X-4-10; Minamimoto R, 2012, J NUCL MED, V53, P199, DOI 10.2967/jnumed.111.095539; Paproski RJ, 2009, BIOCHEM PHARMACOL, V79, P587; Paproski RJ, 2008, MOL PHARMACOL, V74, P1372, DOI 10.1124/mol.108.048900; Perumal M, 2006, CANCER RES, V66, P8558, DOI 10.1158/0008-5472.CAN-06-0898; Plotnik DA, 2010, J NUCL MED, V51, P1464, DOI 10.2967/jnumed.110.076794; Plotnik DA, 2011, NUCL MED BIOL, V38, P979, DOI 10.1016/j.nucmedbio.2011.03.009; Plotnik DA, 2012, NUCL MED BIOL, V39, P1161, DOI 10.1016/j.nucmedbio.2012.07.007; Shields AF, 2003, J NUCL MED, V44, P1432; Spence A M, 2002, J Cell Biochem Suppl, V39, P25; Szkotak AJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1991; Toyohara J, 2006, J NUCL MED, V47, P1717; Toyohara J, 2013, NUCL MED BIOL, V40, P240, DOI 10.1016/j.nucmedbio.2012.10.008; Tsujie M, 2007, ANTICANCER RES, V27, P2241	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0969-8051	1872-9614		NUCL MED BIOL	Nucl. Med. Biol.	MAY	2015	42	5					470	474		10.1016/j.nucmedbio.2014.12.005		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CG5XK	WOS:000353369000008		
J	Ogura, M; Shikano, N; Nakajima, S; Sagara, J; Yamaguchi, N; Kusanagi, K; Okui, Y; Mizutani, A; Kobayashi, M; Kawai, K				Ogura, Masato; Shikano, Naoto; Nakajima, Syuichi; Sagara, Junichi; Yamaguchi, Naoto; Kusanagi, Kentaro; Okui, Yuya; Mizutani, Asuka; Kobayashi, Masato; Kawai, Keiichi			A strategy for improving FDG accumulation for early detection of metastasis from primary pancreatic cancer: Stimulation of the Warburg effect in AsPC-1 cells	NUCLEAR MEDICINE AND BIOLOGY			English	Article						FDG; Ascites tumor cells; Glycolysis; 6-Phosphofructo-1-kinase; Hexose	TUMOR-CELLS; FRUCTOSE 2,6-BISPHOSPHATE; GLUCOSE TRANSPORTERS; HUMAN-BREAST; CARCINOMA; PHOSPHOFRUCTOKINASE; METABOLISM; PET; PFKFB3; TISSUE	Introduction: Early detection and/or prediction of metastasis provide more prognostic relevance than local recurrence. Direct spread into the peritoneum is frequently found in pancreatic cancer patients, but positron emission tomography (PET) with 2-deoxy-2-fluoro-D-glucose (FDG) is not useful for identifying such metastasis. We investigated a method to enhance FDG accumulation using AsPC-1 human ascites tumor cells. Methods: C-14-FDG accumulation was assessed under the following conditions: 1) characteristics of C-14-FDG transport were examined using phloridzin, a Na+-free buffer, and various hexoses, and 2) accumulation of C-14-FDG was measured in cells that were pretreated with hexose for various time periods, and activity of 6-phosphofructo-1-kinase (PFK-1) was assayed. Results: C-14-FDG transport into AsPC-1 cells was mediated primarily by a Na+-independent transport mechanism. Aldohexoses such as D-glucose, D-mannose, and D-galactose inhibited C-14-FDG transport. Cells pretreated with D-glucose, D-mannose, or D-fructose exhibited augmented C-14-FDG accumulation. Pretreatment with higher concentrations of D-glucose or D-fructose tended to increase PFK-1 activity. Conclusions: Very little information has been published about the association between PFK-1 and FDG accumulation, and we confirmed the impacts of various hexoses on the activity of PFK-1 and FOG accumulation in AsPC-1 cells. Clarifying the relevance of PFK-1 in FDG accumulation will contribute to developing new features of FDG-PET, because PFK-1 is the main regulator of glycolysis. (C) 2015 Elsevier Inc. All rights reserved.	[Ogura, Masato; Okui, Yuya; Mizutani, Asuka; Kobayashi, Masato; Kawai, Keiichi] Kanazawa Univ, Grad Sch Hlth Sci, Div Hlth Sci, Kanazawa, Ishikawa 9200942, Japan; [Ogura, Masato; Shikano, Naoto; Nakajima, Syuichi; Kusanagi, Kentaro] Ibaraki Prefectural Univ Hlth Sci, Dept Radiol Sci, Inashiki, Ibaraki 3000394, Japan; [Sagara, Junichi; Yamaguchi, Naoto] Ibaraki Prefectural Univ Hlth Sci, Ctr Med Sci, Inashiki, Ibaraki 3000394, Japan; [Kobayashi, Masato; Kawai, Keiichi] Univ Fukui, Biomed Imaging Res Ctr, Fukui 9101193, Japan	Shikano, N (reprint author), Kanazawa Univ, Grad Sch Hlth Sci, Div Hlth Sci, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 9200942, Japan.	sikano@ipu.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [10770451, 14770498, 13557075, 15659283, 16659322, 17390336, 22591372, 26461801]; Japan Society for the Promotion of Science; Ibaraki Prefectural University; Japan Atherosclerosis Research Foundation	We wish to thank Akihiro Imura, Takahiro Nadamura, Tomohiro Kurosawa, Misa Kozaka, Tomoki Miyazaki, and Kazuaki Arai of Ibaraki Prefectural University for their valuable technical assistance. This work was supported by Grants-in-Aid for Scientific Research (#10770451, #14770498, #13557075, #15659283, #16659322, #17390336, #22591372, and #26461801) from the Ministry of Education, Science, Sports and Culture of Japan and the Japan Society for the Promotion of Science. Financial support was also provided by Ibaraki Prefectural University Grants-in-Aid for the Encouragement of Young Scientists in 2001, 2002, 2004, 2005, 2006, 2008, 2009, 2010, 2012 and 2014 and by a Japan Atherosclerosis Research Foundation Grant in 2014.	Agarwal B, 2008, PANCREAS, V36, pE15, DOI 10.1097/mpa.0b013e31814de421; Diederichs CG, 1998, J NUCL MED, V39, P1030; SZUTOWICZ A, 1979, BRIT J CANCER, V39, P681, DOI 10.1038/bjc.1979.120; Marin-Hernandez A, 2006, FEBS J, V273, P1975, DOI 10.1111/j.1742-4658.2006.05214.x; Wang Z, 2013, WORLD J GASTROENTERO, V19, P4808, DOI 10.3748/wjg.v19.i29.4808; NAKASHIMA RA, 1988, CANCER RES, V48, P913; Atsumi T, 2002, CANCER RES, V62, P5881; Shimada H, 2011, GASTRIC CANCER, V14, P13, DOI 10.1007/s10120-011-0017-5; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Lim JS, 2006, KOREAN J RADIOL, V7, P249; Xie P, 2003, CLIN EXP PHARMACOL P, V30, P643, DOI 10.1046/j.1440-1681.2003.03899.x; Mochizuki TA, 2001, J NUCL MED, V42, P1551; Hara T, 2009, ANN NUCL MED, V23, P657, DOI 10.1007/s12149-009-0288-7; SOM P, 1980, J NUCL MED, V21, P670; Smith TAD, 2001, NUCL MED BIOL, V28, P1, DOI 10.1016/S0969-8051(00)00177-3; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10; Bosetti C, 2012, MOL CARCINOGEN, V51, P3, DOI 10.1002/mc.20785; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Brooke DG, 2014, BIOORGAN MED CHEM, V22, P1029, DOI 10.1016/j.bmc.2013.12.041; COLOMER D, 1987, CANCER RES, V47, P1859; COLVILLE CA, 1993, BIOCHEM J, V294, P753; Dickens F, 1932, BIOCHEM J, V26, P1251; Di Luccio E, 2006, BIOCHEM J, V400, P105, DOI 10.1042/BJ20060660; Gorenberg M, 2002, EUR J NUCL MED MOL I, V29, P1324, DOI 10.1007/s00259-002-0887-1; Hasawi N. A., 2014, CR REV ONCOL HEM, V92, P312, DOI DOI 10.1016/J.CRITREVONC.2014.05.007; Hui HX, 2009, PANCREAS, V38, P706, DOI 10.1097/MPA.0b013e3181a7c6e5; Kang MJ, 2013, J KOREAN SURG SOC, V84, P209, DOI 10.4174/jkss.2013.84.4.209; KOLE HK, 1991, ARCH BIOCHEM BIOPHYS, V286, P586, DOI 10.1016/0003-9861(91)90084-V; Lahoutte T, 2002, J NUCL MED, V43, P1201; Lindholm H, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-50; MALAISSE WJ, 1982, DIABETOLOGIA, V23, P1; MILLER DM, 1968, BIOPHYS J, V8, P1329; NARABAYASHI H, 1985, J BIOL CHEM, V260, P9750; PEDERSEN SN, 1975, CANCER, V35, P469, DOI 10.1002/1097-0142(197502)35:2<469::AID-CNCR2820350226>3.0.CO;2-R; Reske SN, 1997, J NUCL MED, V38, P1344; SanchezMartinez C, 1997, FEBS LETT, V409, P86, DOI 10.1016/S0014-5793(97)00496-1; Shikano N, 2010, NUCL MED BIOL, V37, P189, DOI 10.1016/j.nucmedbio.2009.10.003; Smyth EC, 2011, WORLD J GASTROENTERO, V17, P5056; Torizuka T, 1997, J NUCL MED, V38, P382; Tummala Pavan, 2011, J Gastrointest Oncol, V2, P168, DOI 10.3978/j.issn.2078-6891.2011.036; Vander Heiden MG, 2009, SCIENCE, V324, P1029, DOI DOI 10.1126/SCIENCE.1160809; VORA S, 1985, CANCER RES, V45, P2993; WAHL RL, 1992, RADIOLOGY, V183, P643; Wang GN, 2013, ONCOL LETT, V6, P1701, DOI 10.3892/ol.2013.1599	46	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0969-8051	1872-9614		NUCL MED BIOL	Nucl. Med. Biol.	MAY	2015	42	5					475	481		10.1016/j.nucmedbio.2014.12.017		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CG5XK	WOS:000353369000009		
J	Sakai, T; Saito, Y; Takashima, M; Ogawa, M; Magata, Y				Sakai, Toshihiro; Saito, Yuriko; Takashima, Misato; Ogawa, Mikako; Magata, Yasuhiro			Development of radioiodinated lipophilic cationic compounds for myocardial imaging	NUCLEAR MEDICINE AND BIOLOGY			English	Article						Cationic compound; Phosphonium ion; Myocardial blood flow; SPECT; Radioiodine	F-18-FLUOROBENZYL TRIPHENYL PHOSPHONIUM; VOLTAGE SENSOR; PET TRACER; TL-201; TECHNETIUM-99M-TETROFOSMIN; MODEL	Introduction: Tc-99m compounds are mainly used in myocardial blood flow studies. These compounds, however, are produced by a generator and alternate single photon emission computed tomography (SPECT) radiopharmaceuticals are therefore required to avoid the risks posed by generator failure. Three radiolabeled compounds, including [I-125]p-iodobenzyl triphenylphosphonium ([I-125]ITPP), [I-125]p-lodobenzyl dipropylphenylphosphonium ([I-125]IDPP) and [I-125]p-iodobenzyl methyldiphenylphosphonium ([I-125]IMPP), have been synthesized in the current study. All three of these compounds contain a lipophilic cation, which enhances their cell permeability properties and allows them to accumulate in the myocardium as SPECT probes. Methods: 4-(2-Tributylstannyl) benzyl alcohol was mixed with [I-125]NaI in the presence of aqueous hydrogen peroxide and hydrochloric acid to allow for the synthesis of 4-[I-125]iodobenzyl alcohol. Bromination of the alcohol under standard conditions gave 4-[I-125]iodo benzyl bromide, which was treated with triphenylphosphine, dipropylphenylphosphine or methyldiphenylphosphine to give [I-125]ITPP, [I-125]IDPP and [I-125]IMPP, respectively. These compounds were evaluated in biodistribution and SPECT studies in normal ddY mice. Results: All three of the radiolabeled compounds were synthesized in approximately 60% yield with radiochemical purities greater than 99%. The specific activity of each compound was 74 GBq/mu mol. The results of the biodistribution and SPECT studies showed that all compounds accumulated preferentially in the heart in vivo, especially [I-125]IDPP. Conclusion: [I-123] IDPP could be used in clinical practice as a novel myocardial imaging agent. (C) 2015 Elsevier Inc. All rights reserved.	[Sakai, Toshihiro; Saito, Yuriko; Takashima, Misato; Ogawa, Mikako; Magata, Yasuhiro] Hamamatsu Univ Sch Med, Med Photon Res Ctr, Dept Mol Imaging, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Magata, Y (reprint author), Hamamatsu Univ Sch Med, Med Photon Res Ctr, Dept Mol Imaging, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	magata@hama-med.ac.jp			JSPS KAKENHI [22390232, 23791406, 25293262]	We would like to thank Dr Masahiko Hirata at Osaka University of Pharmaceutical Sciences for helpful discussions and valuable suggestions. Part of this work was supported by JSPS KAKENHI (Grant Nos. 22390232, 23791406 and 25293262).	Murphy MP, 2000, ADV DRUG DELIVER REV, V41, P235, DOI 10.1016/S0169-409X(99)00069-1; Higuchi T, 2011, J NUCL MED, V52, P965, DOI 10.2967/jnumed.110.085993; Madar I, 2006, J NUCL MED, V47, P1359; Kim DY, 2012, J NUCL MED, V53, P1779, DOI 10.2967/jnumed.111.102657; Ravert HT, 2004, J LABELLED COMPD RAD, V47, P469, DOI 10.1002/jlcr.835; Madar I, 2009, J NUCL MED, V50, P774, DOI 10.2967/jnumed.108.061283; Madar I, 2007, EUR J NUCL MED MOL I, V34, P2057, DOI 10.1007/s00259-007-0500-8; Arbab AS, 1998, J NUCL MED, V39, P266; Green Christopher H, 2012, J Med Phys, V37, P66, DOI 10.4103/0971-6203.94740; Gurm GS, 2012, JACC-CARDIOVASC IMAG, V5, P285, DOI 10.1016/j.jcmg.2011.11.017; Koplan BA, 1996, J NUCL MED, V37, P1398; Liu ZL, 2008, EUR J NUCL MED MOL I, V35, P570, DOI 10.1007/s00259-007-0549-4; Madar I, 2002, J NUCL MED, V43, P234; SAJI H, 1992, CHEM PHARM BULL, V40, P165; Small GR, 2013, CIRC-CARDIOVASC IMAG, V6, P683, DOI 10.1161/CIRCIMAGING.113.000585; Zhu Hui-Jun, 2014, Am J Nucl Med Mol Imaging, V4, P293	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0969-8051	1872-9614		NUCL MED BIOL	Nucl. Med. Biol.	MAY	2015	42	5					482	487		10.1016/j.nucmedbio.2014.12.016		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CG5XK	WOS:000353369000010		
J	Okudaira, H; Nakanishi, T; Oka, S; Kobayashi, M; Tamagami, H; Schuster, DM; Goodman, MM; Shirakami, Y; Tamai, I; Kawai, K				Okudaira, Hiroyuki; Nakanishi, Takeo; Oka, Shuntaro; Kobayashi, Masato; Tamagami, Hiroshi; Schuster, David M.; Goodman, Mark M.; Shirakami, Yoshifumi; Tamai, Ikumi; Kawai, Keiichi			Kinetic analyses of trans-1-amino-3-[F-18]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2 (vol 40, pg 670, 2013)	NUCLEAR MEDICINE AND BIOLOGY			English	Correction									[Okudaira, Hiroyuki; Kobayashi, Masato; Kawai, Keiichi] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9200942, Japan; [Okudaira, Hiroyuki; Nakanishi, Takeo; Tamai, Ikumi] Kanazawa Univ, Fac Pharmaceut Sci, Dept Membrane Transport & Biopharmaceut, Kanazawa, Ishikawa 9201192, Japan; [Okudaira, Hiroyuki; Oka, Shuntaro; Tamagami, Hiroshi; Shirakami, Yoshifumi] Nihon Medi Phys Co Ltd, Res Ctr, Chiba 2990266, Japan; [Schuster, David M.; Goodman, Mark M.] Emory Univ, Dept Radiol & Imaging Sci, Div Nucl Med & Mol Imaging, Atlanta, GA 30322 USA; [Kawai, Keiichi] Univ Fukui, Biomed Imaging Res Ctr, Fukui 9101193, Japan	Okudaira, H (reprint author), Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9200942, Japan.	hiroyuki_okudaira@nmp.ca.jp	TAMAI, Ikumi/D-8412-2015				Okudaira H, 2013, NUCL MED BIOL, V40, P670, DOI 10.1016/j.nucmedbio.2013.03.009	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0969-8051	1872-9614		NUCL MED BIOL	Nucl. Med. Biol.	MAY	2015	42	5					513	514		10.1016/j.nucmedbio.2014.12.013		2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CG5XK	WOS:000353369000015		
J	Tsukihara, H; Nakagawa, F; Sakamoto, K; Ishida, K; Tanaka, N; Okabe, H; Uchida, J; Matsuo, K; Takechi, T				Tsukihara, Hiroshi; Nakagawa, Fumio; Sakamoto, Kazuki; Ishida, Keiji; Tanaka, Nozomu; Okabe, Hiroyuki; Uchida, Junji; Matsuo, Kenichi; Takechi, Teiji			Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts	ONCOLOGY REPORTS			English	Article						colorectal cancer; tipiracil hydrochloride bevacizumab; TAS-102; trifluridine; cetuximab; panitumumab	PHASE-III TRIAL; ANTITUMOR-ACTIVITY; IN-VIVO; THYMIDINE PHOSPHORYLASE; 1ST-LINE TREATMENT; MUTATION STATUS; OXALIPLATIN; CELLS; ANTIMETABOLITE; THERAPY	TAS-102 is a novel oral nucleoside antitumor agent that consists of trifluridine (FTD) and tipiracil hydrochloride (TPI) at a molecular ratio of 1:0.5, and was approved in Japan in March 2014 for the treatment of patients with unresectable advanced or recurrent colorectal cancer that is refractory to standard therapies. In the present study, we used colorectal cancer xenografts to assess whether the efficacy of TAS-102 could be improved by combining it with bevacizumab, cetuximab or panitumumab. TAS-102 was orally administered twice a day from day 1 to 14, and bevacizumab, cetuximab and panitumumab were administered intraperitoneally twice a week for 2 weeks. Growth inhibitory activity was evaluated based on the relative tumor volume (RTV) after 2 weeks of drug administration and time taken for the relative tumor volume to increase five-fold (RTV5). Tumor growth inhibition and RTV5 with TAS-102 and bevacizumab combination treatment were significantly better than those with TAS-102 or bevacizumab alone in the SW48 and HCT116 tumor models, and the concentration of phosphorylated FTD in tumors determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis was higher in the TAS-102 and bevacizumab combination group than in the TAS-102 monotherapy group. The combination of TAS-102 and cetuximab or panitumumab was also significantly more effective than either monotherapy in the SW48 tumor model. There was no significant difference in the body weight between the mice treated with TAS-102 monotherapy and any of the combination therapies on day 29. Our preclinical findings indicate that the combination therapy of TAS-102, bevacizumab and cetuximab or panitumumab is a promising treatment option for colorectal cancer.	[Tsukihara, Hiroshi; Takechi, Teiji] Taiho Pharmaceut Co Ltd, Translat Res Lab, Tokushima Res Ctr, Tokushima, Tokushima 7710194, Japan; [Nakagawa, Fumio; Uchida, Junji] Taiho Pharmaceut Co Ltd, Appl Pharmacol Lab, Tokushima Res Ctr, Tokushima, Tokushima 7710194, Japan; [Sakamoto, Kazuki; Ishida, Keiji; Tanaka, Nozomu; Okabe, Hiroyuki; Matsuo, Kenichi] Taiho Pharmaceut Co Ltd, Tsukuba Res Ctr, Tsukuba, Ibaraki 3002611, Japan	Tsukihara, H (reprint author), Taiho Pharmaceut Co Ltd, Translat Res Lab, 224-2 Ebisuno Hiraishi, Tokushima, Tokushima 7710194, Japan.	h-tukihara@taiho.co.jp					DEXTER DL, 1972, CANCER RES, V32, P247; Welch S, 2010, ANN ONCOL, V21, P1152, DOI 10.1093/annonc/mdp533; Emura T, 2005, INT J ONCOL, V27, P449; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Emura T, 2004, INT J ONCOL, V25, P571; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Dunn EF, 2011, ONCOGENE, V30, P561, DOI 10.1038/onc.2010.430; Utsugi T, 2013, JPN J CLIN ONCOL, V43, P945, DOI 10.1093/jjco/hyt131; ARMAND JP, 1995, EUR J CANCER, V31A, P1283, DOI 10.1016/0959-8049(95)00212-2; Bauer P, 1998, STAT MED, V17, P2133, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2133::AID-SIM901>3.0.CO;2-2; Murakami Y, 2000, INT J ONCOL, V17, P277; Price TJ, 2011, J CLIN ONCOL, V29, P2675, DOI 10.1200/JCO.2010.34.5520; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Shelton JW, 2013, INT J RADIAT ONCOL, V86, P469, DOI 10.1016/j.ijrobp.2013.02.015; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Balin-Gauthier D, 2006, CANCER CHEMOTH PHARM, V57, P709, DOI 10.1007/s00280-005-0123-3; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Yoshino T, 2012, LANCET ONCOL, V13, P993, DOI 10.1016/S1470-2045(12)70345-5; Emura T, 2004, INT J MOL MED, V13, P249; Sobrero AF, 2008, J CLIN ONCOL, V26, P2311, DOI 10.1200/JCO.2007.13.1193; Emura T, 2004, INT J MOL MED, V13, P545; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fukushima M, 2000, BIOCHEM PHARMACOL, V59, P1227, DOI 10.1016/S0006-2952(00)00253-7; Kim ST, 2014, CANCER RES TREAT, V46, P48, DOI 10.4143/crt.2014.46.1.48; Nukatsuka M, 2012, EXP THER MED, V3, P755, DOI 10.3892/etm.2012.484; Tanaka N, 2014, ONCOL REP, V32, P2319, DOI 10.3892/or.2014.3487; Yoshino T, 2014, ANN ONCOL, V25, P1	29	3	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	MAY	2015	33	5					2135	2142		10.3892/or.2015.3876		8	Oncology	Oncology	CG3LE	WOS:000353180900006		
J	Sawano, T; Shimizu, T; Yamada, T; Nanashima, N; Miura, T; Morohashi, S; Kudo, D; Hui, FM; Kijima, H; Hakamada, K; Tsuchida, S				Sawano, Takeyuki; Shimizu, Takeshi; Yamada, Toshiyuki; Nanashima, Naoki; Miura, Takuya; Morohashi, Satoko; Kudo, Daisuke; Hui, Feng Mao; Kijima, Hiroshi; Hakamada, Kenichi; Tsuchida, Shigeki			Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan	ONCOLOGY REPORTS			English	Article						fatty acid synthase; liver progenitor cell; Kupffer cell; chemotherapy-associated steatohepatitis; irinotecan	HEPATIC COLORECTAL METASTASES; MESSENGER-RNA; KUPFFER CELLS; CANCER; STEATOHEPATITIS; CHEMOTHERAPY; EXPRESSION; DISEASE; CHOLESTEROL; OXALIPLATIN	Using a rat model, we investigated factors contributing to the pathogenesis of irinotecan-associated fatty liver disease. Male Sprague-Dawley rats were administered 200 mg/kg irinotecan by intraperitoneal injection on days 1-4, but not on days 5-7. This schedule was repeated 3 times. Rats were sacrificed 4, 18 and 25 days after the last injection, and liver steatosis was evaluated by hematoxylin and eosin (H&E) staining, microarray analysis and immunohistochemistry. Panacinar intrahepatocyte vacuoles were absent on days 4 and 25, but present on day 18, and this alteration was more prominent around the bile ducts than the central veins. Microarray analysis showed that the expression of genes involved in the synthesis of cholesterol and fatty acids was upregulated on day 4. Immunohistochemistry detected fatty acid synthase (Fasn)-strongly positive hepatocytes as well as the activation of liver progenitor cells on day 4, whereas intracellular vacuoles were evident in carbonic anhydrase 3 (CA3)-positive hepatocytes on day 18. Thus, irinotecan-induced liver steatosis was preceded by Fasn-strongly-positive hepatocytes and liver progenitor cell activation. The magnitude of the decrease in the number of Fasn-strongly positive hepatocytes between days 4 and 18 was similar to that of the increase in the number of CA3-positive hepatocytes accompanying vacuoles.	[Sawano, Takeyuki; Miura, Takuya; Kudo, Daisuke; Hui, Feng Mao; Hakamada, Kenichi] Hirosaki Univ, Grad Sch Med, Dept Gastroenterol Surg, Hirosaki, Aomori 0368562, Japan; [Shimizu, Takeshi; Yamada, Toshiyuki; Tsuchida, Shigeki] Hirosaki Univ, Grad Sch Med, Dept Biochem & Genome Biol, Hirosaki, Aomori 0368562, Japan; [Nanashima, Naoki] Hirosaki Univ, Grad Sch Hlth Sci, Dept Med Technol, Hirosaki, Aomori 0368562, Japan; [Morohashi, Satoko; Kijima, Hiroshi] Hirosaki Univ, Grad Sch Med, Dept Pathol & Biosci, Hirosaki, Aomori 0368562, Japan	Tsuchida, S (reprint author), Hirosaki Univ, Grad Sch Med, Dept Biochem & Genome Biol, Hirosaki, Aomori 0368562, Japan.	tsuchida@cc.hirosaki-u.ac.jp	Tsuchida, Shigeki/L-3382-2013	Tsuchida, Shigeki/0000-0002-4404-5599	Ministry of Education, Culture, Sports, Science and Technology of Japan	The authors would like to thank Dr Takahito Toba and Ms. Yukie Fujita, Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, for their technical assistance in immunostaining, and Daiichi-Sankyo Co., Ltd., Tokyo, Japan, for donating irinotecan. The present study was supported in part by a Grant-in-Aid for the Training of Cancer Professionals from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557; Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026; Welsh FKS, 2007, BRIT J CANCER, V96, P1037, DOI 10.1038/sj.bjc.6603670; Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047; Paku S, 2001, AM J PATHOL, V158, P1313, DOI 10.1016/S0002-9440(10)64082-5; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Khatri VP, 2005, J CLIN ONCOL, V23, P8490, DOI 10.1200/JCO.2004.00.6155; Pandey PR, 2012, RECENT PAT ANTI-CANC, V7, P185; Gokey NG, 2011, J BIOL CHEM, V286, P29501, DOI 10.1074/jbc.M111.263509; Innocenti F, 2004, J CLIN ONCOL, V22, P1382, DOI 10.1200/JCO.2004.07.173; Vauthey JN, 2006, J CLIN ONCOL, V24, P2065, DOI 10.1200/JCO.2005.05.3074; Bismuth H, 1996, ANN SURG, V224, P509, DOI 10.1097/00000658-199610000-00009; Mathijssen RHJ, 2001, CLIN CANCER RES, V7, P2182; Fernandez FG, 2005, J AM COLL SURGEONS, V200, P845, DOI 10.1016/j.jamcollsurg.2005.01.024; Dorn C, 2010, INT J CLIN EXP PATHO, V3, P505; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Yeh MM, 2007, AM J CLIN PATHOL, V128, P837, DOI 10.1309/RTPM1PY6YGBL2G2R; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Nobili V, 2012, HEPATOLOGY, V56, P2142, DOI 10.1002/hep.25742; Wada T, 2009, TRENDS ENDOCRIN MET, V20, P273, DOI 10.1016/j.tem.2009.03.003; Carrato A, 2002, CRIT REV ONCOL HEMAT, V44, P29, DOI 10.1016/S1040-8428(01)00192-5; Dang Do An N, 2009, Physiol Genomics, V38, P328, DOI 10.1152/physiolgenomics.90396.2008; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; Fong Y, 1996, SEMIN SURG ONCOL, V12, P219, DOI 10.1002/(SICI)1098-2388(199607/08)12:4<219::AID-SSU3>3.0.CO;2-8; HOUGHTON PJ, 1993, CANCER RES, V53, P2823; LYNCH CJ, 1995, BIOCHEM J, V310, P197; Ohlsson B, 2003, ACTA ONCOL, V42, P816, DOI 10.1080/02841860310019016; Sakai I, 1998, MOL CELL, V2, P505; Takahata T, 2004, BIOCHEM PHARMACOL, V67, P1667, DOI 10.1016/j.bcp.2003.12.039; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Yue HB, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.8.e41	35	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	MAY	2015	33	5					2151	2160		10.3892/or.2015.3814		10	Oncology	Oncology	CG3LE	WOS:000353180900008		
J	Jinno, T; Kawano, S; Maruse, Y; Matsubara, R; Goto, Y; Sakamoto, T; Hashiguchi, Y; Kaneko, N; Tanaka, H; Kitamura, R; Toyoshima, T; Jinno, A; Moriyama, M; Oobu, K; Kiyoshima, T; Nakamura, S				Jinno, Teppei; Kawano, Shintaro; Maruse, Yasuyuki; Matsubara, Ryota; Goto, Yuichi; Sakamoto, Taiki; Hashiguchi, Yuma; Kaneko, Naoki; Tanaka, Hideaki; Kitamura, Ryoji; Toyoshima, Takeshi; Jinno, Akiko; Moriyama, Masafumi; Oobu, Kazunari; Kiyoshima, Tamotsu; Nakamura, Seiji			Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma	ONCOLOGY REPORTS			English	Article						interleukin-6; oral squamous cell carcinoma; p-STAT3; chemoradiotherapy; chemoresistance; prognosis; tumor response; inflammation	PREOPERATIVE CONCURRENT CHEMORADIOTHERAPY; RETROSPECTIVE ANALYSIS; SIGNALING PATHWAY; RADICAL SURGERY; NECK-CANCER; CAVITY; HEAD; METASTASIS; INVASION; RADIOCHEMOTHERAPY	Recent studies have revealed that cancer cells are exacerbated by chronic inflammation. The present study examined the immunohistochemical expression for interleukin-6 (IL-6), a pleiotropic inflammatory cytokine, in oral squamous cell carcinoma (OSCC) to elucidate the association of IL-6 expression with tumor progression, chemoresistance and prognosis. Seventy-eight patients with primary OSCC were analyzed by immunohistochemical staining for IL-6. These labeling indexes (LIs) were calculated and evaluated in association with the clinicopathologic characteristics and prognosis in the OSCC patients. The patients were divided into three groups as follows: negative group = LI <5%; low IL-6 group = 5% <= LI <30%; high IL-6 group = LI >= 30%. The patient numbers of the negative, low and high expression groups were 24, 22 and 32, respectively. In the high IL-6 expression group, IL-6 receptor (IL-6R), phospho-signal tranducer and activator of transcription 3 (p-STAT3) were also detected in almost all the cancer cells. The prevalence of the cervical lymph node or the distant metastasis in the high expression group was significantly higher than those in the negative and low expression groups. Furthermore, the high expression group had a significantly poorer tumor response to the preoperative chemoradiotherapy and a more unfavourable prognosis than the negative and the low expression groups. Interestingly, IL-6, IL-6R and p-STAT3 were expressed in the residual cancer cells of all the patients in the high expression group with poor response to chemoradiotherapy. These results suggested that IL-6 signaling possibly is involved in the progression and treatment-resistance of OSCC and IL-6 expression in cancer cells could be a useful predictive factor of poor response to chemoradiotherapy and unfavorable prognosis.	[Jinno, Teppei; Kawano, Shintaro; Maruse, Yasuyuki; Matsubara, Ryota; Goto, Yuichi; Sakamoto, Taiki; Hashiguchi, Yuma; Kaneko, Naoki; Tanaka, Hideaki; Kitamura, Ryoji; Toyoshima, Takeshi; Jinno, Akiko; Moriyama, Masafumi; Oobu, Kazunari; Nakamura, Seiji] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Oncol,Higashi Ku, Fukuoka 8128582, Japan; [Jinno, Akiko; Kiyoshima, Tamotsu] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Lab Oral Pathol,Higashi Ku, Fukuoka 8128582, Japan	Kawano, S (reprint author), Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Oncol,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	skawano@dent.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24249091, 26463014]	The present study was found in part by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, no. 24249091 (to S.N.) and no. 26463014 (to S.K.).	Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Hsu CP, 2006, ANTICANCER RES, V26, P4607; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Lin MT, 2007, INT J CANCER, V120, P2600, DOI 10.1002/ijc.22599; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Freier K, 2008, ORAL ONCOL, V44, P116, DOI 10.1016/j.oraloncology.2007.01.006; Meyer F, 2010, CLIN CANCER RES, V16, P1008, DOI 10.1158/1078-0432.CCR-09-2014; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Duffy SA, 2008, CANCER, V113, P750, DOI 10.1002/cncr.23615; Kiyosue T, 2013, INT J CLIN ONCOL, V18, P154, DOI 10.1007/s10147-011-0358-4; Han ZQ, 2013, BIOCHEM BIOPH RES CO, V435, P188, DOI 10.1016/j.bbrc.2013.04.087; Matsubara R, 2011, INT J ONCOL, V39, P1391, DOI 10.3892/ijo.2011.1151; Sugimura K, 2012, CLIN CANCER RES, V18, P5144, DOI 10.1158/1078-0432.CCR-12-0701; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019; Riedel F, 2005, ANTICANCER RES, V25, P2761; Shinriki S, 2011, J PATHOL, V225, P142, DOI 10.1002/path.2935; Funk GF, 2002, HEAD NECK-J SCI SPEC, V24, P165, DOI 10.1002/hed.10004; Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Sato J, 2013, HEAD NECK-J SCI SPEC, V35, P889, DOI 10.1002/hed.23056; Mojtahedi Z, 2011, PATHOL ONCOL RES, V17, P7, DOI 10.1007/s12253-010-9261-y; KURZROCK R, 1993, CANCER RES, V53, P2118; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Cale V, 2003, J CELL PHYSL, V197, P157; Chakravarti N, 2006, INT J CANCER, V119, P1268, DOI 10.1002/ijc.21967; Chen CC, 2010, INT J RADIAT ONCOL, V76, P1214, DOI 10.1016/j.ijrobp.2009.09.059; Chen CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050104; Chen MF, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-26; Goto Y, 2014, CLIN EXP METASTAS, V31, P293, DOI 10.1007/s10585-013-9628-z; Hirano Toshio, 1997, Cytokine and Growth Factor Reviews, V8, P241, DOI 10.1016/S1359-6101(98)80005-1; Jimi E, 2011, ORAL DIS, V17, P462, DOI 10.1111/j.1601-0825.2010.01781.x; Kawano S, ONCOL LETT IN PRESS; Kirita T, 1999, ORAL ONCOL, V35, P597, DOI 10.1016/S1368-8375(99)00044-5; Kirita T, 2012, INT J ORAL MAX SURG, V41, P421, DOI 10.1016/j.ijom.2011.12.003; Klug C, 2008, J CRANIO MAXILL SURG, V36, P75, DOI 10.1016/j.jcms.2007.06.007; Lane D, 2011, BMC CANCER, V11, P210; MOHR C, 1994, INT J ORAL MAX SURG, V23, P140; Shimosato Y, 1971, JPN J CLIN ONCOL, V1, P19; Sobin LH, 2002, TNM CLASSIFICATION M; Wahi PN, 1977, HISTOLOGICAL TYPING, P15; Wang YF, 2002, HEAD NECK-J SCI SPEC, V24, P850, DOI 10.1002/hed.10145; YAMAMOTO E, 1984, HEAD NECK SURG, V6, P938, DOI 10.1002/hed.2890060508; Yan HQ, 2014, CANCER SCI, V105, P1220, DOI 10.1111/cas.12478	44	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	MAY	2015	33	5					2161	2168		10.3892/or.2015.3838		8	Oncology	Oncology	CG3LE	WOS:000353180900009		
J	Shibayama, Y; Kondo, T; Ohya, H; Fujisawa, SI; Teshima, T; Iseki, K				Shibayama, Yoshihiko; Kondo, Takeshi; Ohya, Hiroki; Fujisawa, Shin-Ichi; Teshima, Takanori; Iseki, Ken			Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients	ONCOLOGY REPORTS			English	Article						acute promyelocytic leukemia; Akt; cytarabine; Klotho; miR-126	ACUTE MYELOID-LEUKEMIA; GIANT-CELL TUMOR; GROUP-B; CANCER; EXPRESSION; KLOTHO; INHIBITION; SUPPRESSOR; TARGETS; PROLIFERATION	MicroRNAs (miRs) have been shown to negatively regulate gene expression by binding to mRNAs, and they play an important role in various physiological processes and malignancies. A previous study identified mature miR-126-3p as an onco-microRNA that is generated from the pre-microRNA, miR-126. Although miR-126 also generates mature miR-126-5p, its function is less clear. In the present study, the relationship between miR-126-5p/3p expression levels and overall survival in 109 patients with acute myeloid leukemia (AML) who received intensive therapy were evaluated. Higher expression levels above the median value of miR-126-5p/3p were correlated with a poorer overall survival. The hazard ratio and 95% confidence intervals (95% CI) for the higher expression group relative to the lower expression group of miR-126-5p/3p were 2.098 (95% CI: 1.075-4.228) and 1.958 (95% CI: 1.001-3.927), respectively. An interaction was not observed between the hazard ratios of miR-126-5p and miR-126-3p (p=0.73). Transfection of the mimic miR-126-5p into the AML cell line, KG-1, resulted in a decrease in the sensitivity to cytarabin and the expression level of Klotho mRNA as well as the elevation in the phosphorylation of Akt. The results of the present study demonstrated that higher expression levels of miR-126-5p/3p in patients with AML resulted in a poorer prognosis. Furthermore, miR-126-5p elevated the phosphorylation of Akt.	[Shibayama, Yoshihiko] Hokkaido Univ, Grad Sch Pharmaceut Sci, Educ Res Ctr Clin Pharm, Sapporo, Hokkaido 0600812, Japan; [Kondo, Takeshi; Teshima, Takanori] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido 0600812, Japan; [Ohya, Hiroki; Iseki, Ken] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Clin Pharmaceut & Therapeut, Sapporo, Hokkaido 0600812, Japan; [Fujisawa, Shin-Ichi] Hokkaido Univ, Hokkaido Univ Hosp, Dept Clin Lab, Sapporo, Hokkaido 0600812, Japan	Shibayama, Y (reprint author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Educ Res Ctr Clin Pharm, Kita Ku, Nishi 6,Kita 12, Sapporo, Hokkaido 0600812, Japan.	sibayama@pharm.hokudai.ac.jp			Shimabara Science Promotion Foundation; Training Program for Oncology Professionals in Hokkaido by the Ministry of Education, Culture, Sports Science and Technology, Japan	The authors would like to thank all the patients who provided bone marrow samples, as well as patient information, medical and nursing staff working at the North Japan Hematology Study Group: The principal investigators of the study, in alphabetical order by city: Asahikawa - Y. Kakinoki (Asahikawa City Hospital); Hakodate - Y. Tsutsumi (Hakodate Municipal Hospital), T. Kawamura (Nanae New Hospital); Kushiro - T. Miyagishima (Kushiro Rosai Hospital); Obihiro - H. Kobayashi (Obihiro-Kosei Hospital); Sapporo A. Shigematsu, M. Nishio (Hokkaido University Hospital), H. Iwasaki (Sapporo-Kosei General Hospital), K. Imai (Sapporo Hokuyu Hospital), M. Kurosawa (National Hospital Organization, Hokkaido Cancer Center), M. Morioka, A. Mori (Aiiku Hospital), S. Yamamoto (Sapporo City General Hospital), Y. Haseyama (KKR Sapporo Medical Center Tonan Hospital); Toyama - A. Wada (Toyama University Hospital). The authors would like to thank Drs. Kumiko Kasashi and Takehiro Yamada at the Department of Pharmacy, Hokkaido University Hospital, for their helpful contributions. The present study was supported by the Shimabara Science Promotion Foundation and the Training Program for Oncology Professionals in Hokkaido by the Ministry of Education, Culture, Sports Science and Technology, Japan.	Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Hayakawa J, 2000, CANCER RES, V60, P5988; Cammarata G, 2010, AM J HEMATOL, V85, P331, DOI 10.1002/ajh.21667; Schober A, 2014, NAT MED, V20, P368, DOI 10.1038/nm.3487; Abramovitz L, 2011, CLIN CANCER RES, V17, P4254, DOI 10.1158/1078-0432.CCR-10-2749; Walker A, 2012, EXPERT REV HEMATOL, V5, P547, DOI [10.1586/ehm.12.45, 10.1586/EHM.12.45]; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Wu ZP, 2014, BIOCHEM BIOPH RES CO, V443, P944, DOI 10.1016/j.bbrc.2013.12.075; Baldus CD, 2003, BLOOD, V102, P1613, DOI 10.1182/blood-2003-02-0359; Shen WF, 2008, MOL CELL BIOL, V28, P4609, DOI 10.1128/MCB.01652-07; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Shibata T, 2009, CANCER LETT, V283, P203, DOI 10.1016/j.canlet.2009.03.038; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Zhou W, 2014, BONE, V66, P267, DOI 10.1016/j.bone.2014.06.021; Liu F, 2011, NAT CELL BIOL, V13, P254, DOI 10.1038/ncb2167; Poh TW, 2005, CANCER RES, V65, P6264, DOI 10.1158/0008-5472.CAN-05-0152; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Chen B, 2010, J EXP CLIN CANC RES, V29, P99; Ebrahimi F, 2004, EXP MOL PATHOL, V96, P98; Felli N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056824; Shibayam Y, 2011, BIOL PHARM BULL, V34, P1418; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057391; Zhou X, 2014, J CANC RES CLIN ONCO	30	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	MAY	2015	33	5					2176	2182		10.3892/or.2015.3839		7	Oncology	Oncology	CG3LE	WOS:000353180900011		
J	Hara, K; Fukui, H; Sun, C; Kitayama, Y; Eda, H; Yamasaki, T; Kondo, T; Tomita, T; Oshima, T; Watari, J; Fujimori, T; Miwa, H				Hara, Ken; Fukui, Hirokazu; Sun, Chao; Kitayama, Yoshitaka; Eda, Hirotsugu; Yamasaki, Takahisa; Kondo, Takashi; Tomita, Toshihiko; Oshima, Tadayuki; Watari, Jiro; Fujimori, Takahiro; Miwa, Hiroto			Effect of REG I alpha protein on angiogenesis in gastric cancer tissues	ONCOLOGY REPORTS			English	Article						REG protein; gastric cancer; angiogenesis; EXTL3; microvessel	GENE-EXPRESSION; COLORECTAL CANCERS; GROWTH; FAMILY; CELLS	Regenerating gene (REG) I alpha is not only over-expressed in a subset of gastric cancers, but also involved in tumor progression. However, the mechanism by which (REG) I alpha promotes tumor growth is not fully understood. In the present study, we investigated whether REG I alpha plays a role in angiogenesis during the progression of gastric cancers. Expression of REG I alpha and its receptor (EXTL3; exostoses like-3) was examined using immunohistochemistry in specimens of human gastric cancer. Microvessel density (MVD) in gastric cancer tissues was evaluated using an image analysis system after CD34 immunostaining. Relationships among clinicopathological features, REG I alpha expression and MVD in gastric cancer tissues were analyzed. Effects of REG I alpha protein on HUVEC cells in terms of proliferation and anti-apoptosis were assessed by WST-1 assay and FACS, respectively. Furthermore, the intracellular signaling by which REG I alpha exerts its biological roles was examined in vitro. REG I alpha expression was significantly related to lymph node metastasis and its receptor EXTL3 was ubiquitously expressed in not only the tumor cells, but also the tumor vessel cells in the gastric cancer tissues. MVD was significantly higher in gastric cancers that were REG I alpha-positive than in those that were negative. Treatment with REG I alpha protein promoted growth and anti-apoptosis through activation of the ERK and Akt signaling pathways in HUVEC cells, whereas these effects were attenuated by treatment with anti-REG I alpha antibody. REG I alpha protein may play a role in angiogenesis during progression of gastric cancer.	[Hara, Ken; Fukui, Hirokazu; Sun, Chao; Kitayama, Yoshitaka; Eda, Hirotsugu; Yamasaki, Takahisa; Kondo, Takashi; Tomita, Toshihiko; Oshima, Tadayuki; Watari, Jiro; Miwa, Hiroto] Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, Nishinomiya, Hyogo 6638501, Japan; [Fujimori, Takahiro] Dokkyo Univ, Sch Med, Dept Surg & Mol Pathol, Mibu, Tochigi, Japan	Fukui, H (reprint author), Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, 1-1 Mukogawa, Nishinomiya, Hyogo 6638501, Japan.	hfukui@hyo-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26460953]	We would like to thank Noriko Kamiya (Hyogo College of Medicine), Chiaki Matsuyama and Ayako Shimizu (Dokkyo University School of Medicine) for technical assistance. The present study was supported in part by Grants-in-aid for Scientific Research 26460953 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Abe A, 2007, J GASTROEN HEPATOL, V22, P1071, DOI 10.1111/j.1440-1746.2006.04778.x; Sekikawa A, 2005, GASTROENTEROLOGY, V128, P642, DOI 10.1053/j.gastro.2004.12.045; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Sekikawa A, 2005, GUT, V54, P1437, DOI 10.1136/gut.2004.053587; Karibe T, 2008, J PATHOL, V216, P32, DOI 10.1002/path.2377; Takaishi S, 2007, CANCER SCI, V98, P284, DOI 10.1111/j.1349-7006.2007.00392.x; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Kobayashi S, 2000, J BIOL CHEM, V275, P10723, DOI 10.1074/jbc.275.15.10723; Sekikawa A, 2008, CARCINOGENESIS, V29, P76, DOI 10.1093/carcin/bgm250; Dhar DK, 2004, CANCER, V100, P1130, DOI 10.1002/cncr.20097; Fukui H, 2004, DIGESTION, V69, P177, DOI 10.1159/000078762; Fukui H, 2003, LAB INVEST, V83, P1777, DOI 10.1097/01.LAB.0000106501.56339.CE; Harada K, 2001, HEPATOLOGY, V33, P1036, DOI 10.1053/jhep.2001.24168; Kadowaki Y, 2002, FEBS LETT, V530, P59, DOI 10.1016/S0014-5793(02)03398-7; Macadam RCA, 2000, BRIT J CANCER, V83, P188; Ozerdem U, 2013, PATHOL INT, V63, P277, DOI 10.1111/pin.12056; Sekikawa A, 2013, BRIT J CANCER, V108, P395, DOI 10.1038/bjc.2012.572; Yamagishi H, 2009, MODERN PATHOL, V22, P906, DOI 10.1038/modpathol.2009.41; Yonemura Y, 2003, CANCER, V98, P1394, DOI 10.1002/cncr.11658; Zhou L, 2010, INT J CANCER, V127, P1795, DOI 10.1002/ijc.25188	20	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	MAY	2015	33	5					2183	2189		10.3892/or.2015.3878		7	Oncology	Oncology	CG3LE	WOS:000353180900012		
J	Tsuji, AB; Sugyo, A; Sudo, H; Suzuki, C; Wakizaka, H; Zhang, MR; Kato, K; Saga, T				Tsuji, Atsushi B.; Sugyo, Aya; Sudo, Hitomi; Suzuki, Chie; Wakizaka, Hedekatsu; Zhang, Ming-Rong; Kato, Koichi; Saga, Tsuneo			Preclinical assessment of early tumor response after irradiation by positron emission tomography with 2-amino[3-C-11]isobutyric acid	ONCOLOGY REPORTS			English	Article						aminoisobutyric acid; imaging; X-rays; radiotherapy; metabolic response; tumor mouse model; amino acid transporter	FDG PET; RADIOTHERAPY; METABOLISM; TRANSPORTERS; INFLAMMATION	The positron emission tomography (PET) probe, 2-amino- [3-C-11]isobutyric acid ([3-C-11]AIB), is reported to accumulate less in inflammatory lesions than 2-deoxy-2-[F-18]fluoro-D-glucose ([F-18]FDG) and has the potential for evaluation of the efficacy of radiotherapy. To determine whether [3-C-11]AIB is useful to monitor early metabolic change in tumors after radiotherapy, we evaluated the temporal change in [3-C-11]AIB tumor uptake, tumor volume, histological features and expression of amino acid transporters early after radiotherapy in a mouse tumor model. PET with [3-C-11]AIB was conducted in mice bearing a subcutaneous tumor (SY, derived from small cell lung cancer) in two schedules: schedule 1, before (day -1) and after (days 1 and 3) 15 Gy of radiation and schedule 2, days -1, 1 and 5. [3-C-11]AIB tumor uptake tended to increase on day 1 after irradiation and decreased thereafter. Tumor uptake was not correlated with tumor volume in schedule 1. Although tumor uptake was correlated with tumor volume in schedule 2, this correlation was lost when the day 5 data of greatly reduced tumor volumes were excluded. In a separate group of tumor-bearing mice, excised tumor sections were stained with terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) or anti-Ki-67 antibody. There was no correlation between tumor uptake and percentages of TUNEL- or Ki-67-positive cells. Expression of amino acid transporters, SLC38A1, SLC38A2 and SLC38A4, was determined by real-time RT-PCR. SLC38A1 and SLC38A2 were expressed in SY tumors, and a significant correlation was observed between [3-C-11]AIB tumor uptake and SLC38A1 expression. In conclusion, early change in [3-C-11]AIB tumor uptake after irradiation reflected the temporal change in amino acid transporter expression, while it was independent of change in tumor volume, apoptosis and cell proliferation. PET with [3-C-11]AIB has the potential for use in non-invasive evaluation of early metabolic change after irradiation before morphological change of tumors.	[Tsuji, Atsushi B.; Sugyo, Aya; Sudo, Hitomi; Suzuki, Chie; Saga, Tsuneo] Natl Inst Radiol Sci, Mol Imaging Ctr, Diagnost Imaging Program, Inage Ku, Chiba 2638555, Japan; [Wakizaka, Hedekatsu] Natl Inst Radiol Sci, Mol Imaging Ctr, Bophys Program, Inage Ku, Chiba 2638555, Japan; [Zhang, Ming-Rong; Kato, Koichi] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Probe Program, Inage Ku, Chiba 2638555, Japan; [Kato, Koichi] Natl Ctr Neurol & Psychiat, Dept Integrat Brain Imaging, Kodaira, Tokyo 1875551, Japan	Tsuji, AB (reprint author), Natl Inst Radiol Sci, Mol Imaging Ctr, Diagnost Imaging Program, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	a_tsuji@nirs.go.jp		Tsuji, Atsushi/0000-0003-2726-288X	Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKENHI 23510289, 24591803]	We thank Takamitsu Morioka for the expertise in assessing the histological findings; Yuriko Ogawa for technical assistance; Yuichiro Yoshida, Masanao Ogawa, and Nobuki Nengaki in the Radiochemistry section for technical support of [3-<SUP>11</SUP>C]AIB production; staff in the Cyclotron Operation section for cyclotron operation; and staff in the Laboratory Animal Sciences section for animal management. The present study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI 23510289 and 24591803).	HABERKORN U, 1991, J NUCL MED, V32, P1485; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; Tsuji AB, 2012, NUCL MED COMMUN, V33, P1058, DOI 10.1097/MNM.0b013e328356efb0; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; McConathy J, 2008, CANCER METAST REV, V27, P555, DOI 10.1007/s10555-008-9154-7; Kato K, 2011, BIOORG MED CHEM LETT, V21, P2437, DOI 10.1016/j.bmcl.2011.02.065; Love C, 2005, RADIOGRAPHICS, V25, P1357, DOI 10.1148/rg.255045122; Shreve PD, 1999, RADIOGRAPHICS, V19, P61; Bading JR, 2008, J NUCL MED, V49, p64S, DOI 10.2967/jnumed.107.046391; Furuta M, 1997, EUR J NUCL MED, V24, P435, DOI 10.1007/BF00881817; Halperin E. C., 2008, PEREZ BRADYS PRINCIP; Hautzel H, 1997, J NUCL MED, V38, P1384; Maruyama I, 1999, J NUCL MED, V40, P1085; Nakanishi T, 2011, J PHARM SCI-US, V100, P3731, DOI 10.1002/jps.22576; ROZENTAL JM, 1991, INT J RADIAT ONCOL, V20, P1053; Van de Wiele C, 2003, INT J RADIAT ONCOL, V55, P5, DOI 10.1016/S0360-3016(02)04122-6; Yoshida C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059248	17	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	MAY	2015	33	5					2361	2367		10.3892/or.2015.3868		7	Oncology	Oncology	CG3LE	WOS:000353180900033		
J	Ishikawa, T; Adachi, S; Okayama, T; Kokura, S; Mizushima, K; Doi, T; Matsuyama, T; Sakamoto, N; Katada, K; Kamada, K; Uchiyama, K; Handa, O; Takagi, T; Naito, Y; Itoh, Y; Yoshikawa, T				Ishikawa, Takeshi; Adachi, Satoko; Okayama, Tetsuya; Kokura, Satoshi; Mizushima, Katsura; Doi, Toshifumi; Matsuyama, Tatsuzo; Sakamoto, Naoyuki; Katada, Kazuhiro; Kamada, Kazuhiro; Uchiyama, Kazuhiko; Handa, Osamu; Takagi, Tomohisa; Naito, Yuji; Itoh, Yoshito; Yoshikawa, Toshikazu			Cytotoxic T lymphocyte-associated antigen 4 inhibition increases the antitumor activity of adoptive T-cell therapy when carried out with naive rather than differentiated T cells	ONCOLOGY REPORTS			English	Article						CTLA-4 antibody; adoptive T-cell therapy; naive T-cell; T helper 1	COLONY-STIMULATING FACTOR; CTLA-4 BLOCKADE; REGULATORY T; CANCER-PATIENTS; ANTI-CTLA-4 THERAPY; CYCLE PROGRESSION; BREAST-CANCER; TUMOR; MELANOMA; COMBINATION	Although treatment with an antibody against cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) combined with multiple therapeutic interventions has been explored, the effect of combination therapy with CTLA-4 inhibition and adoptive T-cell therapy has not been determined. In the present study, our aim was to determine whether CTLA-4 inhibition, combined with adoptive transfer of T cells at different stages of differentiation, exhibits synergistic antitumor effects in a murine colon cancer model. Mice bearing subcutaneous tumors were administered adoptive T-cell transfer of CD62L(high) or CD62L(low) cells combined with an anti-CTLA-4 antibody (alpha-CTLA-4) or control immunoglobulin G. Subcutaneous tumors were harvested, and the antitumor effects and helper T-cell polarization were analyzed. CTLA-4 inhibition combined with CD62L(high) cell administration showed the strongest antitumor effect. Combination therapy increased the number of CD3(+) cells within the tumor.-Moreover, CTLA-4 inhibition induced polarization of T cells infiltrating the tumor toward the T helper 1 lineage, and suppressed the frequency of regulatory T cells within the tumor, particularly in combination with CD62L(high) T-cell transfer. This is the first report demonstrating that the efficacy of alpha-CTLA-4 and adoptive T-cell transfer combination therapy depends on the state of differentiation of the transferred T cells. Our data support the notion that a combination of alpha-CTLA-4 and adoptive T-cell transfer containing an abundance of naive phenotype cells could potentially exert antitumor effects in a clinical setting.	[Ishikawa, Takeshi; Okayama, Tetsuya; Kokura, Satoshi; Mizushima, Katsura; Doi, Toshifumi; Matsuyama, Tatsuzo; Sakamoto, Naoyuki; Katada, Kazuhiro; Kamada, Kazuhiro; Uchiyama, Kazuhiko; Handa, Osamu; Takagi, Tomohisa; Naito, Yuji; Itoh, Yoshito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol, Kyoto, Japan; [Ishikawa, Takeshi; Okayama, Tetsuya; Kokura, Satoshi; Mizushima, Katsura; Doi, Toshifumi; Matsuyama, Tatsuzo; Sakamoto, Naoyuki; Katada, Kazuhiro; Kamada, Kazuhiro; Uchiyama, Kazuhiko; Handa, Osamu; Takagi, Tomohisa; Naito, Yuji; Itoh, Yoshito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Hepatol, Kyoto, Japan; [Ishikawa, Takeshi; Adachi, Satoko; Okayama, Tetsuya; Yoshikawa, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Cancer ImmunoCell Regulat, Kyoto, Japan; [Kokura, Satoshi] Kyoto Gakuen Univ, Kyoto 6218555, Japan	Kokura, S (reprint author), Kyoto Gakuen Univ, Kyoto 6218555, Japan.	s-kokura@koto.kpu-m.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [23590891, 26460914]	The present study was partially supported by Grant-in-Aid for Scientific Research (no. 23590891 and 26460914) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Akbar AN, 2003, IMMUNOLOGY, V109, P319, DOI 10.1046/j.1365-2567.2003.01678.x; Watanabe A, 2010, IMMUNOPHARM IMMUNOT, V32, P238, DOI 10.3109/08923970903222355; Liakou CI, 2008, P NATL ACAD SCI USA, V105, P14987, DOI 10.1073/pnas.0806075105; Perrin PJ, 1996, J IMMUNOL, V157, P1333; Demaria S, 2005, CLIN CANCER RES, V11, P728; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Mokyr MB, 1998, CANCER RES, V58, P5301; Kwon ED, 1999, P NATL ACAD SCI USA, V96, P15074, DOI 10.1073/pnas.96.26.15074; Davila E, 2003, CANCER RES, V63, P3281; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Huang JP, 2005, J IMMUNOTHER, V28, P258, DOI 10.1097/01.cji.0000158855.92792.7a; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Ribas A, 2013, J CLIN ONCOL, V31, P616, DOI 10.1200/JCO.2012.44.6112; Ouchi N, 1999, CIRCULATION, V100, P2473; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Pilones KA, 2009, CLIN CANCER RES, V15, P597, DOI 10.1158/1078-0432.CCR-08-1277; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; Greenwald RJ, 2002, EUR J IMMUNOL, V32, P366, DOI 10.1002/1521-4141(200202)32:2<366::AID-IMMU366>3.0.CO;2-5; Waitz R, 2012, CANCER RES, V72, P430, DOI 10.1158/0008-5472.CAN-11-1782; Ikemoto T, 2006, PANCREAS, V33, P386, DOI 10.1097/01.mpa.0000240275.68279.13; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Hurwitz AA, 1998, P NATL ACAD SCI USA, V95, P10067, DOI 10.1073/pnas.95.17.10067; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Kocak E, 2006, CANCER RES, V66, P7276, DOI 10.1158/0008-5472.CAN-05-2128; Met O, 2006, CANCER LETT, V231, P247, DOI 10.1016/j.canlet.2005.02.005; Hodi FS, 2008, P NATL ACAD SCI USA, V105, P3005, DOI 10.1073/pnas.0712237105; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Curran MA, 2009, CANCER RES, V69, P7747, DOI 10.1158/0008-5472.CAN-08-3289; Daftarian P, 2004, CANCER RES, V64, P5407, DOI 10.1158/0008-5472.CAN-04-0169; Grosso JF, 2013, CANC IMMUN, V13, P5; Ishikawa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083786; Pedersen AE, 2006, CANCER LETT, V235, P229, DOI 10.1016/j.canlet.2005.04.012; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303	39	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	MAY	2015	33	5					2545	2552		10.3892/or.2015.3815		8	Oncology	Oncology	CG3LE	WOS:000353180900055		
J	Habata, S; Iwasaki, M; Sugio, A; Suzuki, M; Tamate, M; Satohisa, S; Tanaka, R; Saito, T				Habata, Shutaro; Iwasaki, Masahiro; Sugio, Asuka; Suzuki, Miwa; Tamate, Masato; Satohisa, Seiro; Tanaka, Ryoichi; Saito, Tsuyoshi			BAG3 increases the invasiveness of uterine corpus carcinoma cells by suppressing miR-29b and enhancing MMP2 expression	ONCOLOGY REPORTS			English	Article						BAG3; MMP2; uterine corpus carcinoma; miR-29b; cell invasion	HEPATOCELLULAR-CARCINOMA; SEROUS ADENOCARCINOMAS; ENDOMETRIAL CANCER; REGULATES MCL-1; WW DOMAIN; MICRORNAS; METASTASIS; MATRIX; INVASION; FAMILY	Approximately 30% of uterine corpus carcinomas are diagnosed at an advanced stage and have a poor prognosis. Our previous study indicated that BCL2-associated athanogene 3 (BAG3) enhances matrix metalloproteinase-2 (MMP2) expression and binds to MMP2 to positively regulate the process of cell invasion in ovarian cancer cells. Recently, altered miRNA expression patterns were observed in several groups of patients with endometrial cancers. One of the altered miRNAs, miR-29b, reportedly reduces tumor invasiveness by suppressing MMP2 expression. Our aim in the present study was to examine the relationships among BAG3, miR-29b and MMP2 in endometrioid adenocarcinoma cells. We found that BAG3 suppresses miR-29b expression and enhances MMP2 expression, which in turn increases. cell motility and invasiveness. Moreover, restoration of miR-29b through BAG3 knockdown reduced MMP2 expression, as well as cell motility and invasiveness. Collectively, our findings indicate that BAG3 enhances MMP2 expression by suppressing miR-29b, thereby increasing the metastatic potential of endometrioid adenocarcinomas.	[Habata, Shutaro; Iwasaki, Masahiro; Sugio, Asuka; Suzuki, Miwa; Tamate, Masato; Satohisa, Seiro; Tanaka, Ryoichi; Saito, Tsuyoshi] Sapporo Med Univ, Dept Obstet & Gynecol, Sapporo, Hokkaido 0608543, Japan	Iwasaki, M (reprint author), Sapporo Med Univ, Dept Obstet & Gynecol, Chuo Ku, South 1 West 16, Sapporo, Hokkaido 0608543, Japan.	miwasaki@sapmed.ac.jp					Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Suzuki M, 2011, CANCER LETT, V303, P65, DOI 10.1016/j.canlet.2011.01.019; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Doong H, 2000, ONCOGENE, V19, P4385, DOI 10.1038/sj.onc.1203797; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; Devor EJ, 2011, ONCOL REP, V26, P995, DOI 10.3892/or.2011.1372; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Wang Y, 2013, EUR J CELL BIOL, V92, P123, DOI 10.1016/j.ejcb.2012.11.004; Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.1253/ajpath.2006.060250; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Hiroki E, 2010, CANCER SCI, V101, P241, DOI 10.1111/j.1349-7006.2009.01385.x; Giannelli G, 2002, INT J CANCER, V97, P425, DOI 10.1002/ijc.1635; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Banno K, 2013, INT J CLIN ONCOL, V18, P186, DOI 10.1007/s10147-013-0526-9; Einbond A, 1996, FEBS LETT, V384, P1, DOI 10.1016/0014-5793(96)00263-3; Iwasaki M, 2007, CANCER RES, V67, P10252, DOI 10.1158/0008-5472.CAN-07-0618; Medel NIB, 2009, EXPERT OPIN PHARMACO, V10, P1939, DOI 10.1517/14656560903061291; Ogasawara S, 2005, ONCOL REP, V13, P1043; Steele R, 2010, GENES CANC, V1, P381, DOI DOI 10.1177/1947601910371978; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Sugio A, 2014, GYNECOL ONCOL, V134, P615, DOI 10.1016/j.ygyno.2014.06.024	27	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	MAY	2015	33	5					2613	2621		10.3892/or.2015.3831		9	Oncology	Oncology	CG3LE	WOS:000353180900064		
J	Yoshida, N; Ikeda, Y; Murakami, Y; Nakatake, S; Fujiwara, K; Notomi, S; Hisatomi, T; Ishibashi, T				Yoshida, Noriko; Ikeda, Yasuhiro; Murakami, Yusuke; Nakatake, Shunji; Fujiwara, Kota; Notomi, Shoji; Hisatomi, Toshio; Ishibashi, Tatsuro			Factors Affecting Visual Acuity after Cataract Surgery in Patients with Retinitis Pigmentosa	OPHTHALMOLOGY			English	Article							OPTICAL COHERENCE TOMOGRAPHY; CYSTOID MACULAR EDEMA; POSTERIOR CAPSULE OPACIFICATION; TOPICAL DORZOLAMIDE; PREVALENCE; OUTCOMES; EYES	Purpose: To investigate the factors affecting visual acuity after cataract surgery in patients with retinitis pigmentosa (RP). Design: Retrospective, observational study. Participants: We retrospectively reviewed the charts of a consecutive series of 40 patients with RP who underwent cataract surgery. Methods: The changes in preoperative and postoperative best-corrected visual acuity (BCVA) were measured. We investigated the relation between preoperative mean deviation (MD) value on the Humphrey Field Analyzer (HFA: the central 10-2 program; Humphrey Instruments, Inc, San Leandro, CA) and final BCVA. We also investigated the relationship between preoperative ellipsoid zone (EZ; also called the inner/outer segment junction) conditions and final BCVA. In addition, we showed the prevalence of macular complications and capsule complications. Main Outcome Measures: The BCVA, slit-lamp biomicroscopic analysis, visual field, and optical coherence tomography (OCT) were obtained. Results: The mean of the BCVA significantly improved after cataract surgery from 0.76 (range, -0.08 to 2.30) to 0.45 (range, -0.18 to 2.00) (P < 0.005). However, final BCVA did not improve in 30 eyes (53.6%). The preoperative MD value and the final BCVA were significantly correlated, and the final BCVA significantly improved in the less advanced RP group (MD was >=-15 decibels [dB]). The final BCVA was significantly better in the group in which preoperative OCT showed a normal EZ than in the groups in which the EZ was abnormal or not visible. Posterior capsular opacification was observed in 47 eyes (83.9%), and 23 eyes (41.1%) underwent YAG laser capsulotomy within a mean follow-up time of 3 years. Conclusions: Final BCVA in approximately half of the eyes improved after cataract surgery in patients with RP. The preoperative ophthalmic examinations that may reflect macular (or foveal) function, such as HFA 10-2 program and OCT, are important parameters to assess postoperative visual outcome. (C) 2015 by the American Academy of Ophthalmology.	[Yoshida, Noriko; Ikeda, Yasuhiro; Murakami, Yusuke; Nakatake, Shunji; Notomi, Shoji; Hisatomi, Toshio; Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 8128582, Japan; [Fujiwara, Kota] Akita Univ, Grad Sch Med, Dept Ophthalmol, Akita 010, Japan	Ikeda, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ymocl@pathol1.med.kyushu-u.ac.jp		Hisatomi, Toshio/0000-0003-2552-9595	Japanese Ministry of Education, Culture, Sports, Science, and Technology [24659763]	Supported in part by a Grant-in-Aid (to Y.I.) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (grant no. 24659763).	Abe K, 2002, JPN J OPHTHALMOL, V46, P581, DOI 10.1016/S0021-5155(02)00548-8; Aizawa S, 2009, EYE, V23, P304, DOI 10.1038/sj.eye.6703076; Huang WY, 2011, INVEST OPHTH VIS SCI, V52, P16, DOI 10.1167/iovs.10-5382; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Hirakawa H, 1999, AM J OPHTHALMOL, V128, P185, DOI 10.1016/S0002-9394(99)00100-2; WONG P, 1994, BIOCHEM CELL BIOL, V72, P489; Trivedi RH, 2002, EYE, V16, P217, DOI 10.1038/sj/eye/6700066; Elgohary MA, 2008, EYE, V22, P613, DOI 10.1038/sj.eye.6702661; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Apushkin MA, 2004, OPHTHALMOLOGY, V111, P1899, DOI 10.1016/j.ophtha.2004.04.019; Findl O, 2003, J CATARACT REFR SURG, V29, P106, DOI 10.1016/S0886-3350(02)01509-2; Lavanya R, 2009, BRIT J OPHTHALMOL, V93, P299, DOI 10.1136/bjo.2008.148650; Inoue M, 2010, AM J OPHTHALMOL, V150, P834, DOI 10.1016/j.ajo.2010.06.006; Hajali M, 2008, BRIT J OPHTHALMOL, V92, P1065, DOI 10.1136/bjo.2008.138560; Auffarth GU, 1997, OPHTHALMOLOGE, V94, P791, DOI 10.1007/s003470050205; Ikeda Y, 2013, BRIT J OPHTHALMOL, V97, P1187, DOI 10.1136/bjophthalmol-2012-303005; Ko TH, 2004, OPHTHALMOLOGY, V111, P2033, DOI 10.1016/j.ophtha.2004.05.021; Oishi A, 2009, EYE, V23, P1411, DOI 10.1038/eye.2008.266; BASTEK JV, 1982, OPHTHALMOLOGY, V89, P880; Bayyoud T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002616; Bender L, 2004, J CATARACT REFR SURG, V30, P2058, DOI 10.1016/j.jcrs.2004.05.010; Dikopf MS, 2013, AM J OPHTHALMOL, V156, P82, DOI 10.1016/j.ajo.2013.02.002; FISHMAN GA, 1985, BRIT J OPHTHALMOL, V69, P263, DOI 10.1136/bjo.69.4.263; Grigoropoulos VG, 2010, OPHTHAL SURG LAS IM, V41, P35, DOI 10.3928/15428877-20091230-07; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075584; Hagiwara A, 2011, ACTA OPHTHALMOL, V89, pE122, DOI 10.1111/j.1755-3768.2010.01866.x; Hayashi K, 1998, OPHTHALMOLOGY, V105, P1239, DOI 10.1016/S0161-6420(98)97028-2; HECKENLIVELY J, 1982, AM J OPHTHALMOL, V93, P733; Hollick EJ, 1998, BRIT J OPHTHALMOL, V82, P1182, DOI 10.1136/bjo.82.10.1182; Iijima H, 2012, JPN J OPHTHALMOL, V56, P224, DOI 10.1007/s10384-012-0135-6; Ikeda Y, 2012, GRAEF ARCH CLIN EXP, V250, P809, DOI 10.1007/s00417-011-1904-5; Itoh Y, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.023; Jackson H, 2001, BRIT J OPHTHALMOL, V85, P936, DOI 10.1136/bjo.85.8.936; Nishi O, 1996, BRIT J OPHTHALMOL, V80, P63, DOI 10.1136/bjo.80.1.63; Pruett R C, 1983, Trans Am Ophthalmol Soc, V81, P693; Yoshida N, 2013, OPHTHALMOLOGY, V120, P100, DOI 10.1016/j.ophtha.2012.07.006	36	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	MAY	2015	122	5					903	908		10.1016/j.ophtha.2014.12.003		6	Ophthalmology	Ophthalmology	CG5NB	WOS:000353337600015		
J	Arita, R; Morishige, N; Koh, S; Shirakawa, R; Kawashima, M; Sakimoto, T; Suzuki, T; Tsubota, K				Arita, Reiko; Morishige, Naoyuki; Koh, Shizuka; Shirakawa, Rika; Kawashima, Motoko; Sakimoto, Tohru; Suzuki, Takashi; Tsubota, Kazuo			Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss A Multicenter Cross-sectional Study	OPHTHALMOLOGY			English	Article							FILM LIPID LAYER; OCULAR SURFACE CHANGES; DRY EYE DISEASE; BREAK-UP; DYSFUNCTION; THICKNESS; INNERVATION; BLINKING; FLUORESCENCE; EVAPORATION	Purpose: To compare tear film parameters as well as meibomian gland morphologic features and function among patients with meibomian gland dysfunction (MGD), those with non-Sjogren syndrome aqueous-deficient dry eye (non-SS ADDE), those with non-SS ADDE and MGD, and normal subjects. Design: Multicenter, cross-sectional, observational case series. Participants: Forty-one eyes of 41 patients (all women; mean age +/- standard deviation, 62.1 +/- 9.9 years) with non-SS ADDE, 70 eyes of 70 patients (all women; 66.0 +/- 8.7 years) with MGD, 17 eyes of 17 patients (all women; 72.4 +/- 7.8 years) with non-SS ADDE and MGD, and 70 eyes of 70 normal control subjects (all women; 65.0 +/- 7.1 years). Methods: Ocular symptoms were scored from 0 to 14 and lid margin abnormalities from 0 to 4 according to their respective number. Meibomian gland changes were scored from 0 to 6 (meiboscore) on the basis of noncontact meibography findings, and meibum was graded from 0 to 3 depending on its volume and quality. Conjunctival and corneal epithelial damage were scored from 0 to 9 (fluorescein score). Tear film break-up time (TBUT) was measured as an index of tear film stability, and tear fluid production was evaluated with Schirmer's test. Main Outcome Measures: Ocular symptom score, lid margin abnormality score, meiboscore, meibum grade, fluorescein score, TBUT, and Schirmer's test value. Results: The ocular symptom score did not differ significantly between the MGD and non-SS ADDE groups (P = 0.762). The lid margin abnormality score, meiboscore, and meibum grade were significantly higher in the MGD group than in the non-SS ADDE group (P = 0.0012, P < 0.0001, and P < 0.0001, respectively). The fluorescein score, TBUT, and Schirmer's test value were significantly worse in the non-SS ADDE group than in the MGD group (P < 0.0001, P = 0.0061, and P < 0.0001, respectively). The meiboscore correlated significantly with Schirmer's test value only in the MGD group (rho = 0.508, P = 8.3x10(-6)). Conclusions: An increase in tear fluid production likely compensates for loss of meibomian glands in individuals with MGD. (C) 2015 by the American Academy of Ophthalmology.	[Arita, Reiko; Morishige, Naoyuki; Koh, Shizuka; Shirakawa, Rika; Kawashima, Motoko; Sakimoto, Tohru; Suzuki, Takashi] Lid & Meibomian Gland Working Grp, Saitama, Japan; [Arita, Reiko] Itoh Clin, Dept Ophthalmol, Saitama, Saitama 3370042, Japan; [Arita, Reiko; Shirakawa, Rika] Univ Tokyo, Dept Ophthalmol, Tokyo 113, Japan; [Arita, Reiko; Kawashima, Motoko; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Morishige, Naoyuki] Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, Yamaguchi, Japan; [Koh, Shizuka] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Osaka, Japan; [Sakimoto, Tohru] Nihon Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Suzuki, Takashi] Ehime Univ, Grad Sch Med, Dept Ophthalmol, Matsuyama, Ehime 790, Japan	Arita, R (reprint author), Itoh Clin, Dept Ophthalmol, 626-11 Minami Nakano, Saitama, Saitama 3370042, Japan.	ritoh@za2.so-net.ne.jp					Aisa J, 2001, HISTOL HISTOPATHOL, V16, P487; Arita R, 2009, OPHTHALMOLOGY, V116, P2058, DOI 10.1016/j.ophtha.2009.04.037; King-Smith PE, 2013, INVEST OPHTH VIS SCI, V54, P4900, DOI 10.1167/iovs.13-11878; Khandelwal P, 2012, MOL VIS, V18, P1055; Bron AJ, 2004, EXP EYE RES, V78, P347, DOI 10.1016/j.exer.2003.09.019; Eom Y, 2013, AM J OPHTHALMOL, V155, P1104, DOI 10.1016/j.ajo.2013.01.008; Dartt DA, 2013, EXP EYE RES, V117, P1, DOI 10.1016/j.exer.2013.10.008; Yokoi N, 1999, ARCH OPHTHALMOL-CHIC, V117, P723; Nichols JJ, 2012, INVEST OPHTH VIS SCI, V53, P5426, DOI 10.1167/iovs.12-10033; Lemp MA, 2012, CORNEA, V31, P472, DOI 10.1097/ICO.0b013e318225415a; MATHERS WD, 1991, CORNEA, V10, P277, DOI 10.1097/00003226-199107000-00001; Schaumberg DA, 2001, JAMA-J AM MED ASSOC, V286, P2114, DOI 10.1001/jama.286.17.2114; Parra A, 2010, NAT MED, V16, P1396, DOI 10.1038/nm.2264; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI [10.1016/j.ophtha.2007.06.031, 10.1016/j.ophtha.2007.06.03]; Lemp MA, 2007, OCUL SURF, V5, P75; Tsubota K, 1996, ARCH OPHTHALMOL-CHIC, V114, P715; Arita R, 2010, JPN J OPHTHALMOL, V54, P387, DOI 10.1007/s10384-010-0858-1; Baudouin C, 2013, OCUL SURF, V11, P246, DOI 10.1016/j.jtos.2013.07.003; Chung CW, 1996, INVEST OPHTH VIS SCI, V37, P238; de Roetth A, 1941, AM J OPHTHALMOL, V24, P20; FAN Q, 1993, REGUL PEPTIDES, V48, P337, DOI 10.1016/0167-0115(93)90162-2; Foulks Gary N, 2003, Ocul Surf, V1, P107; GILBARD JP, 1989, OPHTHALMOLOGY, V96, P1180; Goto E, 2006, AM J OPHTHALMOL, V142, P264, DOI 10.1016/j.ajo.2006.03.022; Guyton AC, 2006, TXB MED PHYSL; Isreb MA, 2003, EYE, V17, P79, DOI 10.1038/sj.eye.6700224; Kawashima M, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-34; King-Smith PE, 2004, CURR EYE RES, V29, P357, DOI 10.1080/02713680490516099; King-Smith PE, 2008, OPTOMETRY VISION SCI, V85, P623, DOI 10.1097/OPX.0b013e318181ae60; King-Smith PE, 2013, INVEST OPHTH VIS SCI, V54, P6003, DOI 10.1167/iovs.13-12628; KORB DR, 1994, CORNEA, V13, P354, DOI 10.1097/00003226-199407000-00012; Kurose M, 2013, J NEUROPHYSIOL, V110, P495, DOI 10.1152/jn.00222.2013; Lemp Michael A., 1995, CLAO Journal, V21, P221; Lemp MA, 2011, CORNEA, V1; LUHTALA J, 1991, EXP EYE RES, V53, P641, DOI 10.1016/0014-4835(91)90224-3; Mathers WD, 1996, CORNEA, V15, P110, DOI 10.1097/00003226-199603000-00002; SHARMA A, 1985, AM J OPTOM PHYS OPT, V62, P246; Shimazaki J, 2006, ATARASHII GANKA, V24, P181; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266; Shirmer O, 1903, VON GRAEFES ARCH OPT, V56, P197; Tung CI, 2014, AM J OPHTHALMOL, V157, P301; VANBIJST.OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10; Windhorst U, 1996, COMPREHENSIVE HUMAN, V1	43	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	MAY	2015	122	5					925	933		10.1016/j.ophtha.2014.12.018		9	Ophthalmology	Ophthalmology	CG5NB	WOS:000353337600018		
J	Kanno, A; Masamune, A; Okazaki, K; Kamisawa, T; Kawa, S; Nishimori, I; Tsuji, I; Shimosegawa, T				Kanno, Atsushi; Masamune, Atsushi; Okazaki, Kazuichi; Kamisawa, Terumi; Kawa, Shigeyuki; Nishimori, Isao; Tsuji, Ichiro; Shimosegawa, Tooru		Res Comm Intractable Dis Pancreas	Nationwide Epidemiological Survey of Autoimmune Pancreatitis in Japan in 2011	PANCREAS			English	Article						pancreatitis; IgG4; steroid; sclerosing cholangitis; epidemiology	IMMUNOGLOBULIN G4-ASSOCIATED CHOLANGITIS; CONSENSUS DIAGNOSTIC-CRITERIA; INTERNATIONAL CONSENSUS; PROPOSAL; PREVALENCE; THERAPY; CANCER; RISK	Objectives: To clarify the clinicoepidemiological features of autoimmune pancreatitis (AIP) in Japan, a nationwide epidemiological survey was conducted. Methods: Patients with AIP who had visited selected hospitals in 2011 were surveyed. Autoimmune pancreatitis was diagnosed according to the revised clinical diagnostic criteria for AIP (Japan Pancreas Society 2011). The study consisted of 2 stage surveys; the number of patients with AIP was estimated by the first questionnaire, and their clinical features were assessed by the second questionnaire. Results: The estimated total number of AIP patients in 2011 was 5745 (95% confidence interval, 5325-6164), with an overall prevalence rate of 4.6 per 100,000 population. The number of patients who were newly diagnosed as AIP was estimated to be 1808 (95% confidence interval, 1597-2018), with an annual incidence rate of 1.4 per 100,000 population. The sex ratio (male to female) was 3.2, and the mean age was 66.3 (11.5). Among the 936 patients whose detailed clinical information was obtained, 86.4% of the patients presented high serum immunoglobulin G4 levels (>= 135 mg/dL), and 82.3% received steroid therapy. Conclusions: The data represent the current clinical features of AIP in Japan.	[Kanno, Atsushi; Masamune, Atsushi; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 9808574, Japan; [Okazaki, Kazuichi] Kansai Med Univ, Dept Internal Med 3, Div Gastroenterol & Hepatol, Osaka, Japan; [Kamisawa, Terumi] Tokyo Metropolitan Komagome Hosp, Dept Internal Med, Tokyo, Japan; [Kawa, Shigeyuki] Shinshu Univ, Ctr Hlth Safety & Environm Management, Matsumoto, Nagano 390, Japan; [Nishimori, Isao] Nishimori Clin, Kochi, Japan; [Tsuji, Ichiro] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 980, Japan	Shimosegawa, T (reprint author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	tshimosegawa@int3.med.tohoku.ac.jp			Research Committee of Intractable Diseases of the Pancreas; Ministry of Health, Labor, and Welfare of Japan	This work was supported in part by the Research Committee of Intractable Diseases of the Pancreas, and by the Ministry of Health, Labor, and Welfare of Japan.	Kamisawa T, 2009, GUT, V58, P1504, DOI 10.1136/gut.2008.172908; Okazaki K, 2006, J GASTROENTEROL, V41, P626, DOI 10.1007/s00535-006-1868-0; Kanno A, 2012, GASTROINTEST ENDOSC, V76, P594, DOI 10.1016/j.gie.2012.05.014; Nishimori I, 2007, J GASTROENTEROL, V42, P6, DOI 10.1007/s00535-007-2043-y; Topazian M, 2008, CLIN GASTROENTEROL H, V6, P364, DOI 10.1016/j.cgh.2007.12.020; Shiokawa M, 2013, AM J GASTROENTEROL, V108, P610, DOI 10.1038/ajg.2012.465; Kuriyama S, 2008, STROKE, V39, P42, DOI 10.1161/STROKEAHA.107.490714; Hart PA, 2014, PANCREAS, V43, P417, DOI 10.1097/MPA.0000000000000053; Ghazale A, 2008, GASTROENTEROLOGY, V134, P706, DOI 10.1053/j.gastro.2007.12.009; Hart PA, 2013, GUT, V62, P1607, DOI 10.1136/gutjnl-2012-302886; Kanno A, 2012, PANCREAS, V41, P835, DOI 10.1097/MPA.0b013e3182480c99; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Hamada S, 2014, PANCREAS, V43, P1244, DOI 10.1097/MPA.0000000000000200; Hashimoto S, 1991, Nihon Koshu Eisei Zasshi, V38, P880; Ishikawa T, 2012, WORLD J GASTROENTERO, V18, P3883, DOI 10.3748/wjg.v18.i29.3883; Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society, 2002, J JPN PAN SOC, V17, P585; Okazaki K, 2012, PANCREAS, V41, P1341; The Japan Pancreas Society the Ministry of Health and Welfare Investigation Research Team for Intractable Pancreatic Disease, 2012, J JPN PANCREAS SOC, V27, P17; Wakai K, 1997, J Epidemiol, V7, P221; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	MAY	2015	44	4					535	539				5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CG3DF	WOS:000353157000004		
J	Miyahara, K; Nouso, K; Morimoto, Y; Kinugasa, H; Kato, H; Yamamoto, N; Tsutsumi, K; Kuwaki, K; Onishi, H; Ikeda, F; Nakamura, S; Shiraha, H; Takaki, A; Nakahara, T; Miura, Y; Asada, H; Amano, M; Nishimura, SI; Yamamoto, K				Miyahara, Koji; Nouso, Kazuhiro; Morimoto, Yuki; Kinugasa, Hideaki; Kato, Hironari; Yamamoto, Naoki; Tsutsumi, Koichiro; Kuwaki, Kenji; Onishi, Hideki; Ikeda, Fusao; Nakamura, Shinichiro; Shiraha, Hidenori; Takaki, Akinobu; Nakahara, Taku; Miura, Yoshiaki; Asada, Hidehisa; Amano, Maho; Nishimura, Shin-Ichiro; Yamamoto, Kazuhide			Prognostic Value of Altered N-Glycosylation of Circulating Glycoproteins in Patients With Unresectable Pancreatic Cancer Treated With Gemcitabine	PANCREAS			English	Article						biomarker; chemotherapy; gemcitabine; N-glycan; pancreatic cancer	PHASE-III TRIAL; PLUS GEMCITABINE; CELL-ADHESION; GLYCANS; MULTICENTER; STATISTICS; CISPLATIN; SURVIVAL; THERAPY	Objectives: The objectives of this study were to examine the whole serum N-glycan profile of patients with unresectable pancreatic cancer and to evaluate the ability of glycans to predict gemcitabine treatment efficacy and patient survival. Methods: We collected serum from 52 patients with advanced pancreatic cancer before they began gemcitabine monotherapy. The serum glycan profile was measured through comprehensive quantitative high-throughput glycome analysis and compared with the treatment efficacy and patient survival. Results: Of the 61 glycans detected, the serum levels of glycan 4310 (molecular weight [m/z] 1549.566), 6301 (m/z 2032.724), and 9200 (m/z 2010.692) were high in patients with a short time to tumor progression (TTP). Multivariate analysis revealed that a high glycan 9200 concentration was an independent risk factor for shorter TTP (hazard ratio, 2.11; 95% confidence interval, 1.07-4.17) and poor overall survival (hazard ratio, 2.56; 95% confidence interval, 1.08-6.19). The median TTP of patients with up-regulation of 9200 after gemcitabine treatment was shorter than for the remaining patients (91 vs 301 days; P = 0.0005). A similar relationship was observed for overall survival (median, 181 vs 561 days; P = 0.001). Conclusions: Glycan 9200 is a possible biomarker predicting gemcitabine efficacy survival in patients with unresectable pancreatic cancer.	[Miyahara, Koji; Nouso, Kazuhiro; Morimoto, Yuki; Kinugasa, Hideaki; Kato, Hironari; Yamamoto, Naoki; Tsutsumi, Koichiro; Kuwaki, Kenji; Onishi, Hideki; Ikeda, Fusao; Nakamura, Shinichiro; Shiraha, Hidenori; Takaki, Akinobu; Yamamoto, Kazuhide] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama, Okayama 7008558, Japan; [Nouso, Kazuhiro; Onishi, Hideki; Ikeda, Fusao] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Hepatol, Okayama, Okayama 7008558, Japan; [Nakahara, Taku; Miura, Yoshiaki; Asada, Hidehisa] Ezose Sci Inc, Pine Brook, NJ USA; [Amano, Maho; Nishimura, Shin-Ichiro] Hokkaido Univ, Grad Sch Life Sci, Fac Adv Life Sci, Field Drug Discovery Res, Sapporo, Hokkaido, Japan; [Amano, Maho; Nishimura, Shin-Ichiro] Med Chem Pharmaceut Co Ltd, Sapporo, Hokkaido, Japan	Nouso, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Hepatol, Kita Ku, 2-5-1 Shikata Cho, Okayama, Okayama 7008558, Japan.	nouso@cc.okayama-u.ac.jp			MSD; Bayer Yakuhin Ltd.; Japan Society for the Promotion of Science [KAKENHI 25220206]	Authors Kazuhiro Nouso, Hideki Onishi, and Fusao Ikeda belong to a donation-funded department (Department of Molecular Hepatology, funded by MSD). Authors Taku Nakahara, Yoshiaki Miura, and Hidehisa Asada worked for Ezose Sciences Inc, a glycomics company in the United States. Authors Maho Amano and Shin-Ichiro Nishimura serve as a consultant to Medicinal Chemistry Pharmaceuticals, Co, Ltd. Author Kazuhide Yamamoto received a financial support from Bayer Yakuhin Ltd. This work was supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (KAKENHI 25220206).	Arshad A, 2014, JPEN-PARENTER ENTER, V38, P214, DOI 10.1177/0148607113476304; Jaffee EM, 2002, CANCER CELL, V2, P25, DOI 10.1016/S1535-6108(02)00093-4; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Sant M, 2009, EUR J CANCER, V45, P931, DOI 10.1016/j.ejca.2008.11.018; Nouso K, 2013, J GASTROENTEROL, V48, P1171, DOI 10.1007/s00535-012-0732-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Nishimura SI, 2011, ADV CARBOHYD CHEM BI, V65, P219, DOI 10.1016/B978-0-12-385520-6.00005-4; Cunningham D, 2009, J CLIN ONCOL, V27, P5513, DOI 10.1200/JCO.2009.24.2446; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Ciliberto D, 2013, EUR J CANCER, V49, P593, DOI 10.1016/j.ejca.2012.08.019; Vickers MF, 1999, BIOCHEM J, V339, P21, DOI 10.1042/0264-6021:3390021; Reni M, 2005, LANCET ONCOL, V6, P369, DOI 10.1016/S1470-2045(05)70175-3; Wang Zhiwei, 2011, Nat Rev Gastroenterol Hepatol, V8, P27, DOI 10.1038/nrgastro.2010.188; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Hung SW, 2012, CANCER LETT, V320, P138, DOI 10.1016/j.canlet.2012.03.007; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Herrmann R, 2007, J CLIN ONCOL, V25, P2212, DOI 10.1200/JCO.2006.09.0886; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Bhat K, 2012, CURR PHARM DESIGN, V18, P2439; Burris HA, 1997, J CLIN ONCOL, V15, P2403; Hirao K, 2011, INT J CLIN ONCOL, V16, P637, DOI 10.1007/s10147-011-0237-z; KAWA S, 1994, PANCREAS, V9, P692, DOI 10.1097/00006676-199411000-00003; Miura Y, 2012, GENET ENG BIOTECHN N, V32, P20; Miyahara K, 2014, HEPATOLOGY, V59, P355, DOI 10.1002/hep.26531; Nakagawa H, 2008, CANCER LETT, V270, P295, DOI 10.1016/j.canlet.2008.05.019; Peracaula R, 2005, GLYCOCONJUGATE J, V22, P135, DOI 10.1007/s10719-005-0734-2	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	MAY	2015	44	4					551	556				6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CG3DF	WOS:000353157000007		
J	Yabusaki, N; Yamada, S; Shimoyama, Y; Fujii, T; Kanda, M; Nakayama, G; Sugimoto, H; Koike, M; Nomoto, S; Fujiwara, M; Nakao, A; Kodera, Y				Yabusaki, Norimitsu; Yamada, Suguru; Shimoyama, Yoshie; Fujii, Tsutomu; Kanda, Mitsuro; Nakayama, Goro; Sugimoto, Hiroyuki; Koike, Masahiko; Nomoto, Shuji; Fujiwara, Michitaka; Nakao, Akimasa; Kodera, Yasuhiro			A Vascular Endothelial Growth Factor Gene Polymorphism Predicts Malignant Potential in Intraductal Papillary Mucinous Neoplasm	PANCREAS			English	Article						IPMN; PDAC; VEGF SNP	INTERNATIONAL CONSENSUS GUIDELINES; SINGLE NUCLEOTIDE POLYMORPHISMS; EPITHELIAL OVARIAN-CANCER; FACTOR VEGF GENE; PANCREATIC ADENOCARCINOMA; HEPATOCELLULAR-CARCINOMA; INVASIVE-CARCINOMA; TUMOR ANGIOGENESIS; COLORECTAL-CANCER; SURVIVAL	Objectives: The aim of this study was to evaluate the clinical relevance of vascular endothelial growth factor (VEGF) single nucleotide polymorphisms (SNPs) in intraductal papillary mucinous neoplasms (IPMNs). Methods: A total of 169 IPMN and 108 pancreatic ductal adenocarcinoma patients who underwent curative resection were enrolled, and VEGF +405G/C and -460C/T SNPs were investigated. Results: Vascular endothelial growth factor +405C/C was found more frequently in malignant IPMNs compared with +405G/G (odds ratio [ OR], 2.7; P = 0.04), and +405C allele was associated with malignant IPMNs compared with +405G (P = 0.055). In branch duct IPMNs, VEGF +405C/C was significantly associated with malignant transformation (CC vs GG: OR, 4.0; P = 0.03; CC vs CG + GG: OR, 3.3; P = 0.04), and there was a trend of VEGF +405C/C associated with malignant transformation of gastric-type IPMNs (CC vs GG: OR, 3.0; P = 0.07). When the survival outcomes were analyzed based on VEGF +405G/C SNPs, however, there was no relationship between VEGF SNPs and overall survival in patients with both IPMNs and pancreatic ductal adenocarcinomas. Conclusions: Vascular endothelial growth factor +405G/C SNP was significantly associated with malignant transformation in IPMNs, especially branch duct and gastric-type IPMNs. Vascular endothelial growth factor +405G/C SNP might be helpful in predicting clinical course in pancreatic disease with potential for malignant transformation.	[Yabusaki, Norimitsu; Yamada, Suguru; Fujii, Tsutomu; Kanda, Mitsuro; Nakayama, Goro; Sugimoto, Hiroyuki; Koike, Masahiko; Nomoto, Shuji; Fujiwara, Michitaka; Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi 4668550, Japan; [Shimoyama, Yoshie] Nagoya Univ Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Nakao, Akimasa] Nagoya Cent Hosp, Dept Surg, Nagoya, Aichi, Japan	Yamada, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	suguru@med.nagoya-u.ac.jp					Adsay NV, 2010, WHO CLASSIFICATION T; Suenaga M, 2013, ONCOTARGETS THER, V6, P1805, DOI 10.2147/OTT.S53625; Furukawa T, 2011, GUT, V60, P509, DOI 10.1136/gut.2010.210567; Sadakari Y, 2010, SURGERY, V147, P812, DOI 10.1016/j.surg.2009.11.011; Karayiannakis AJ, 2003, CANCER LETT, V194, P119, DOI 10.1016/S0304-3835(03)00047-8; Yamada S, 2014, ANN SURG ONCOL, V21, P2444, DOI 10.1245/s10434-014-3565-1; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Yopp AC, 2011, ANN SURG, V253, P968, DOI 10.1097/SLA.0b013e318214bcb4; Jain L, 2009, MOL CANCER THER, V8, P2496, DOI 10.1158/1535-7163.MCT-09-0302; Distler M, 2013, ANN SURG, V258, P324, DOI 10.1097/SLA.0b013e318287ab73; Kim JG, 2008, CLIN CANCER RES, V14, P62, DOI 10.1158/1078-0432.CCR-07-1537; Kammerer PW, 2010, J ORAL PATHOL MED, V39, P786, DOI 10.1111/j.1600-0714.2010.00904.x; Vincenti V, 1996, CIRCULATION, V93, P1493; Wasif N, 2010, CANCER-AM CANCER SOC, V116, P3369, DOI 10.1002/cncr.25070; FURUKAWA T, 1992, CANCER, V70, P1505, DOI 10.1002/1097-0142(19920915)70:6<1505::AID-CNCR2820700611>3.0.CO;2-D; Hansen TF, 2010, J CANCER RES CLIN, V136, P751, DOI 10.1007/s00432-009-0714-1; Schultheis AM, 2008, CLIN CANCER RES, V14, P7554, DOI 10.1158/1078-0432.CCR-08-0351; Tanabe KK, 2008, JAMA-J AM MED ASSOC, V299, P53, DOI 10.1001/jama.2007.65; Ishida M, 2007, PANCREAS, V35, P348; Stevens A, 2003, CANCER RES, V63, P812; Steffensen KD, 2010, GYNECOL ONCOL, V117, P109, DOI 10.1016/j.ygyno.2009.11.011; Maltese P, 2009, INT J COLORECTAL DIS, V24, P165, DOI 10.1007/s00384-008-0586-x; Kang MJ, 2013, PANCREAS, V42, P959, DOI 10.1097/MPA.0b013e31827cddbc; Ku KT, 2005, ORAL ONCOL, V41, P497, DOI 10.1016/j.oraloncology.2004.12.009; Furukawa T, 2005, VIRCHOWS ARCH, V447, P794, DOI 10.1007/s00428-005-0039-7; Schneider BP, 2009, CLIN CANCER RES, V15, P5297, DOI 10.1158/1078-0432.CCR-08-2576; Tzanakis N, 2006, J SURG ONCOL, V94, P624, DOI 10.1002/jso.20619; Lu H, 2005, CANCER RES, V65, P5015, DOI 10.1158/0008-5472.CAN-04-2786; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692; Abbas E, 2012, EUR J GASTROEN HEPAT, V24, P458, DOI 10.1097/MEG.0b013e3283508d45; Smerdel MP, 2009, INT J GYNECOL CANCER, V19, P578, DOI 10.1111/IGC.0b013e3181a13168; Maeda A, 2013, ONCOL REP, V29, P39, DOI 10.3892/or.2012.2075; Chappuis PO, 2001, CANCER INVEST, V19, P65, DOI 10.1081/CNV-100000076; Gold E B, 1998, Surg Oncol Clin N Am, V7, P67; Hefler LA, 2007, CLIN CANCER RES, V13, P898, DOI 10.1158/1078-0432.CCR-06-1008; Iwasaki J, 2009, JPN J CLIN ONCOL, V39, P543, DOI 10.1093/jjco/hyp062; Kobayashi A, 2005, PANCREAS, V31, P74, DOI 10.1097/01.mpa.0000166999.11889.2f; Lin CC, 2003, UROLOGY, V62, P374, DOI 10.1016/S0090-4295(03)00268-1; Longnecker DS, 2005, PANCREAS, V31, P344, DOI 10.1097/01.mpa.0000186245.35716.18; Lose F, 2010, GYNECOL ONCOL, V119, P479, DOI 10.1016/j.ygyno.2010.08.014; Sivaprasad S, 2013, PANCREATOLOGY, V13, P267, DOI 10.1016/j.pan.2013.02.006; Talar-Wojnarowska R, 2010, J PHYSIOL PHARMACOL, V61, P711; Toomey DP, 2009, SURG-J R COLL SURG E, V7, P174	44	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	MAY	2015	44	4					608	614				7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CG3DF	WOS:000353157000016		
J	Kawada, N; Uehara, H; Hosoki, T; Takami, M; Shiroeda, H; Arisawa, T; Tomita, Y				Kawada, Natsuko; Uehara, Hiroyuki; Hosoki, Takuya; Takami, Motohisa; Shiroeda, Hisakazu; Arisawa, Tomiyasu; Tomita, Yasuhiko			Usefulness of Dual-Phase F-18-FDG PET/CT for Diagnosing Small Pancreatic Tumors	PANCREAS			English	Article						FDG PET/CT; dual phase; dual time point; small pancreatic tumor; diagnostic accuracy	POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; TIME-POINT; CANCER; CT	Objectives: The usefulness of dual-phase F-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography/computed tomography (PET/CT) for pancreatic tumors was investigated including numerous small tumors. Methods: Consecutive 116 patients with solid pancreatic tumors were subjected. Maximum standard uptake values (SUVmax) at 1 and 2 hours after FDG injection were defined as early and delayed SUVmax, respectively. Receiver operating characteristic curve was used to determine the optimal cutoff value of early SUVmax. Diagnostic accuracy of dual-phase FDG PET/CT was compared with that of single phase. Results: The mean +/- SD tumor size was 25 +/- 12 mm in diameter. The level of early SUVmax and proportion of elevated SUVmax in delayed phase were significantly higher in malignancy than those in benignancy for less than 25 mm tumors (4.1 +/- 2.6 vs 1.9 +/- 0.5, P < 0.001; 89% vs 17%, P < 0.0001) although they did not reach statistical significance for greater than or equal to 25 mm tumors. When diagnostic criteria of dual-phase FDG PET/CT for less than 25 mm tumors were determined as (1) early SUVmax greater than or equal to 2.1 and/or (2) delayed SUVmax greater than early SUVmax, sensitivity, specificity, and over all accuracy of dual-phase FDG PET/CT were better than that of single phase for less than 25 mm tumor (93%, 83%, and 91% vs 79%, 83%, and 80%, respectively). Conclusions: Dual-phase FDG PET/CT might be useful for diagnosing small pancreatic tumors.	[Kawada, Natsuko; Tomita, Yasuhiko] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka 5378511, Japan; [Kawada, Natsuko; Shiroeda, Hisakazu; Arisawa, Tomiyasu] Kanazawa Med Univ, Dept Gastroenterol, Uchinada, Ishikawa, Japan; [Uehara, Hiroyuki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastroenterol, Osaka 5378511, Japan; [Hosoki, Takuya; Takami, Motohisa] Morinomiya Clin PET Ctr, Osaka, Japan	Kawada, N (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	natz.kawada@gmail.com					Nakamoto Y, 2000, CANCER-AM CANCER SOC, V89, P2547, DOI 10.1002/1097-0142(20001215)89:12<2547::AID-CNCR5>3.0.CO;2-V; YAMADA S, 1995, J NUCL MED, V36, P1301; Asagi A, 2013, PANCREAS, V42, P11, DOI 10.1097/MPA.0b013e3182550d77; Zhuang HM, 2001, J NUCL MED, V42, P1412; Weber WA, 1999, J NUCL MED, V40, P1771; Cheng G, 2013, EUR J NUCL MED MOL I, V40, P779, DOI 10.1007/s00259-013-2343-9; Schillaci O, 2012, SEMIN NUCL MED, V42, P267, DOI 10.1053/j.semnuclmed.2012.02.003; Kim MJ, 2012, PANCREAS, V41, P897, DOI 10.1097/MPA.0b013e318252f4f5; Baiocchi GL, 2012, ANN SURG ONCOL, V19, P3574, DOI 10.1245/s10434-012-2234-5; Dietrichs CG, 1998, J NUCL MED, V39, P1030; Dong AS, 2013, CLIN NUCL MED, V38, pE118, DOI 10.1097/RLU.0b013e318270868a; Epelbaum R, 2013, J NUCL MED, V54, P12, DOI 10.2967/jnumed.112.107466; Kittaka H, 2013, WORLD J SURG, V37, P169, DOI 10.1007/s00268-012-1775-x; Lyshchik A, 2005, EUR J NUCL MED MOL I, V32, P389, DOI 10.1007/s00259-004-1656-0; Nishiyama Yoshihiro, 2005, Nucl Med Commun, V26, P895, DOI 10.1097/00006231-200510000-00008; Okano K, 2011, WORLD J GASTROENTERO, V17, P231, DOI 10.3748/wjg.v17.i2.231; Parlak C, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-37; Sahani DV, 2012, RADIOGRAPHICS, V32, P1133, DOI 10.1148/rg.324115143; Saito M, 2013, CLIN GASTROENTEROL H, V11, P181, DOI 10.1016/j.cgh.2012.10.037; Santhosh S, 2013, J GASTROEN HEPATOL, V28, P255, DOI 10.1111/jgh.12068; Seo S, 2008, J HEPATO-BILIARY-PAN, V15, P634, DOI 10.1007/s00534-007-1339-x; Takanami K, 2011, ANN NUCL MED, V25, P501, DOI 10.1007/s12149-011-0494-y; The American College of Radiology, 2007, ACR PRACT GUID PERF, P767; Treglia G, 2013, CLIN NUCL MED, V38, pE35, DOI 10.1097/RLU.0b013e31824c5e92; Yamamoto T, 2012, TAN TO SUI, V33, P407; Zhang J, 2013, ABDOM IMAGING, V38, P543, DOI 10.1007/s00261-012-9966-3	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	MAY	2015	44	4					655	659				5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CG3DF	WOS:000353157000022		
J	Yamada, S; Fujii, T; Shimoyama, Y; Kanda, M; Nakayama, G; Sugimoto, H; Koike, M; Nomoto, S; Fujiwara, M; Nakao, A; Kodera, Y				Yamada, Suguru; Fujii, Tsutomu; Shimoyama, Yoshie; Kanda, Mitsuro; Nakayama, Goro; Sugimoto, Hiroyuki; Koike, Masahiko; Nomoto, Shuji; Fujiwara, Michitaka; Nakao, Akimasa; Kodera, Yasuhiro			SMAD4 Expression Predicts Local Spread and Treatment Failure in Resected Pancreatic Cancer	PANCREAS			English	Article						pancreatic cancer; SMAD4; prognosis	MESENCHYMAL TRANSITION; TGF-BETA; DUCTAL ADENOCARCINOMA; DPC4 INACTIVATION; PROGRESSION; PROGNOSIS; CELLS; GENE; PATTERNS; SURGERY	Objective: The purpose of this study was to evaluate the prognostic relevance of SMAD4 expression in pancreatic cancer. Methods: We analyzed the correlations between SMAD4 expression and clinicopathological parameters and outcome in 174 patients with pancreatic cancer. Specimens were also classified into subtypes reflecting epithelial-to-mesenchymal transition, based on E-cadherin and vimentin. Results: We found that 59.8% (104/174) of patients were SMAD4(-) and 40.2% (70/174) were SMAD4(+). Disease-specific survival in patients with SMAD4(+) was significantly better than that in SMAD4(-). SMAD4(-) status was significantly correlated with portal vein invasion, lymph vessel invasion, and perineural invasion and was an independent prognostic factor. SMAD4(-) was significantly associated with mesenchymal phenotype. The loss of SMAD4 expression was found in 49.4% of patients with no vascular invasion, 61.9% with portal vein invasion, 76.5% with common hepatic artery invasion, and 80.8% with superior mesenteric artery invasion. In addition, the specimens from 59.0% of patients with local recurrence, 66.7% of those with both local and distant recurrence, and 73.7% of those with distant recurrence were SMAD4(-). Conclusions: The loss of SMAD4 expression is an independent prognostic factor and seems to be associated with tumor progression, pattern of failure, and epithelial-to-mesenchymal transition status. Preoperative stratification based on SMAD4 could lead to appropriate treatment strategy.	[Yamada, Suguru; Fujii, Tsutomu; Kanda, Mitsuro; Nakayama, Goro; Sugimoto, Hiroyuki; Koike, Masahiko; Nomoto, Shuji; Fujiwara, Michitaka; Kodera, Yasuhiro] Nagoya Univ, Nagoya Univ Hosp, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi 4668550, Japan; [Shimoyama, Yoshie] Nagoya Univ, Nagoya Univ Hosp, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4668550, Japan; [Nakao, Akimasa] Nagoya Cent Hosp, Dept Surg, Nagoya, Aichi, Japan	Yamada, S (reprint author), Nagoya Univ, Nagoya Univ Hosp, Grad Sch Med, Dept Gastroenterol Surg Surg 2,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	suguru@med.nagoya-u.ac.jp					Yamada S, 2013, PANCREAS, V42, P1004, DOI 10.1097/MPA.0b013e31827b2d7c; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Wilentz RE, 2000, AM J PATHOL, V156, P37, DOI 10.1016/S0002-9440(10)64703-7; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Oshima M, 2013, ANN SURG, V258, P336, DOI 10.1097/SLA.0b013e3182827a65; Blackford A, 2009, CLIN CANCER RES, V15, P4674, DOI 10.1158/1078-0432.CCR-09-0227; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Vogelmann R, 2005, J CELL SCI, V118, P4901, DOI 10.1242/jcs.02594; Crane CH, 2011, J CLIN ONCOL, V29, P3037, DOI 10.1200/JCO.2010.33.8038; Wray CJ, 2005, GASTROENTEROLOGY, V128, P1626, DOI 10.1053/j.gastro.2005.03.035; Wilentz RE, 2000, CANCER RES, V60, P2002; Tascilar M, 2001, CLIN CANCER RES, V7, P4115; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Yamada S, 2013, SURGERY, V154, P946, DOI 10.1016/j.surg.2013.05.004; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Cameron JL, 2006, ANN SURG, V244, P10, DOI 10.1097/01.sla.0000217673.04165.ea; Biankin AV, 2002, J CLIN ONCOL, V20, P4531, DOI 10.1200/JCO.2002.12.063; Iacobuzio-Donahue CA, 2012, GUT, V61, P1085, DOI 10.1136/gut.2010.236026; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Wan M, 2005, AM J PATHOL, V166, P1379, DOI 10.1016/S0002-9440(10)62356-5; Winter JM, 2013, ANN SURG, V258, P331, DOI 10.1097/SLA.0b013e31827fe9ce; Yamao K, 2009, J GASTROEN HEPATOL, V24, P509, DOI 10.1111/j.1440-1746.2009.05783.x	25	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	MAY	2015	44	4					660	664				5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CG3DF	WOS:000353157000023		
J	Maeda, H; Kurisu, K; Miyata, T; Kusakisako, K; Galay, RL; Rio, TM; Mochizuki, M; Fujisaki, K; Tanaka, T				Maeda, Hiroki; Kurisu, Koshi; Miyata, Takeshi; Kusakisako, Kodai; Galay, Remil Linggatong; Rio, Talactac Melbourne; Mochizuki, Masami; Fujisaki, Kozo; Tanaka, Tetsuya			Identification of the Babesia-responsive leucine-rich repeat domain-containing protein from the hard tick Haemaphysalis longicornis	PARASITOLOGY RESEARCH			English	Article						Leucine-rich repeat; Tick; Babesia; Recombinant; Parasite	GENOME PROJECT; PLASMODIUM; COMPLEMENT; RECOGNITION; PREDICTION; RECEPTORS; IMMUNITY; SYSTEM; GROWTH; SERVER	Haemaphysalis longicornis is a tick known for transmitting Babesia parasites, including Babesia gibsoni, in East Asian countries. The vector tick must have strategies to control Babesia parasites, while Babesia parasites are also considered to establish an evasive mechanism from the tick's innate immunity. Due to this mutual tolerance, H. longicornis is considered to be a vector of Babesia parasites. Recent studies have shown the important roles of leucine-rich repeat (LRR) domain-containing proteins in innate immunity in many living organisms. Some LRR domain-containing proteins were identified in ticks; however, their functions are still unknown. In this study, a novel LRR domain-containing protein was identified from H. longicornis (HlLRR). HlLRR contains two LRR domains, and the expression levels of mRNA and proteins were upregulated during blood feeding, particularly in the salivary glands and midgut. In addition, recombinant HlLRR (rHlLRR) demonstrated growth inhibition activity against B. gibsoni in vitro without a hemolytic effect at any concentration used. Moreover, the diameters of Babesia merozoites treated with rHlLRR were significantly larger than those of the control group. These results strongly indicate the key roles of HlLRR in the tick's innate immunity against Babesia parasites. Furthermore, HlLRR might be a potential alternative drug to treat babesiosis.	[Maeda, Hiroki; Kurisu, Koshi; Kusakisako, Kodai; Galay, Remil Linggatong; Rio, Talactac Melbourne; Mochizuki, Masami; Tanaka, Tetsuya] Kagoshima Univ, Infect Dis Lab, Joint Fac Vet Med, Kagoshima 8900065, Japan; [Maeda, Hiroki; Kusakisako, Kodai; Galay, Remil Linggatong; Rio, Talactac Melbourne; Mochizuki, Masami; Tanaka, Tetsuya] Yamaguchi Univ, United Grad Sch Vet Sci, Dept Pathol & Prevent Vet Sci, Yamaguchi 7538515, Japan; [Miyata, Takeshi] Kagoshima Univ, Dept Biochem & Biotechnol, Div Mol Funct Food, Kagoshima 8900065, Japan; [Fujisaki, Kozo] Natl Agr & Food Res Org, Tsukuba, Ibaraki 3050856, Japan	Tanaka, T (reprint author), Kagoshima Univ, Infect Dis Lab, Joint Fac Vet Med, Kagoshima 8900065, Japan.	tetsuya@ms.kagoshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25292173, 26660229, 26+5872]	We are grateful to Dr. A. Iguchi of the National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, and Dr. A. Matsuu of the Transboundary Animal Diseases Research Center, Joint Faculty of Veterinary Medicine, Kagoshima University, for providing B. gibsoni (Aomori strain). We thank to Dr. H. Izumi of the Shin Nippon Biomedical Laboratories, Ltd. for providing a dog for supplying dog blood. We also thank Dr. T. Masatani of the Transboundary Animal Diseases Research Center, Joint Faculty of Veterinary Medicine, Kagoshima University, for his helpful comments on this work. This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 25292173, 26660229, and 26+5872. H. Maeda is supported by a Grant-in-Aid for JSPS fellows.	Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Van Zee JP, 2007, INT J PARASITOL, V37, P1297, DOI 10.1016/j.ijpara.2007.05.011; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Stark M, 2002, ANTIMICROB AGENTS CH, V46, P3585, DOI 10.1128/AAC.46.11.3585.3590.2002; Baxter RHG, 2010, P NATL ACAD SCI USA, V107, P16817, DOI 10.1073/pnas.1010575107; FUJISAKI K, 1978, NATL I ANIM HEALTH Q, V18, P27; Homer MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Schnittger L, 2012, INFECT GENET EVOL, V12, P1788, DOI 10.1016/j.meegid.2012.07.004; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Vial HJ, 2006, VET PARASITOL, V138, P147, DOI 10.1016/j.vetpar.2006.01.048; Schmidt M, 2014, TRANSFUS MED HEMOTH, V41, P10, DOI 10.1159/000358017; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Hill CA, 2005, TRENDS PARASITOL, V21, P151, DOI 10.1016/j.pt.2005.02.004; Hunfeld KP, 2008, INT J PARASITOL, V38, P1219, DOI 10.1016/j.ijpara.2008.03.001; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Uilenberg G, 2006, VET PARASITOL, V138, P3, DOI 10.1016/j.vetpar.2006.01.035; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bej A, 2014, COMPUT BIOL MED, V53, P164, DOI 10.1016/j.compbiomed.2014.07.016; Chauvin A, 2009, VET RES, V40, DOI 10.1051/vetres/2009020; Florin-Christensen M, 2009, FRONT BIOSCI, V14, P3064, DOI 10.2741/4035; Hajdusek O, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00026; Kagermeier-Schenk B, 2011, DEV CELL, V21, P1129, DOI 10.1016/j.devcel.2011.10.015; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; Matsuu A, 2008, VET PARASITOL, V157, P1, DOI 10.1016/j.vetpar.2008.07.023; Miyata T, 2011, INFECT IMMUN, V79, P4260, DOI 10.1128/IAI.05214-11; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Ramisch S, 2014, P NATL ACAD IN PRESS; Smith AA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00116; Umemiya-Shirafuji R, 2012, INSECT BIOCHEM MOLEC, V42, P164, DOI 10.1016/j.ibmb.2011.12.001; Waterhouse RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-531; Yabsley Michael J, 2013, Int J Parasitol Parasites Wildl, V2, P18, DOI 10.1016/j.ijppaw.2012.11.003	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-0113	1432-1955		PARASITOL RES	Parasitol. Res.	MAY	2015	114	5					1793	1802		10.1007/s00436-015-4365-7		10	Parasitology	Parasitology	CF7GB	WOS:000352723200016		
J	Hirai, K; Tabata, H; Hirayama, M; Kobayashi, T; Oh, Y; Mochizuki, H				Hirai, Kota; Tabata, Hideyuki; Hirayama, Mariko; Kobayashi, Tohru; Oh, Yasumasa; Mochizuki, Hiroyuki			A New Method for Objectively Evaluating Childhood Nocturnal Cough	PEDIATRIC PULMONOLOGY			English	Article						cough; children; cough monitoring system; overnight	FREQUENCY; MONITOR; ASTHMA; QUESTIONNAIRE; SYSTEM	ObjectiveCough is so common that the best method for evaluating nocturnal cough in children is required. MethodsWe developed a cough monitoring system by evaluating 50 child volunteers, and validated the cough monitor in 20 samples from 10 children with cough overnight. Coughs were recorded using a video camera and digital sound recording. At the same time, our system with microphone and accelerometer was used. The number of coughs in each eight hour video-audio recording was counted manually by three trained observers, and all cough data were printed out and the defined cough events, using both these printed-out data and video-audio recordings, were then calculated by three observers. ResultsThe cough monitoring system demonstrated excellent agreement between the number of coughs counted by volunteers, and those counted by cough monitoring system (sensitivity 98.8%, specificity 97.8%). Also, there was significant agreement in the counts of coughs between the video-audio method and our system (P<0.0001), and between the defined cough events and our system (P<0.0001). ConclusionsOur method demonstrated well agreement with the video-audio recording method in children, and is considered to be highly useful for the objective monitoring of overnight cough in children with respiratory diseases. Pediatr Pulmonol. 2015; 50:460-468. (c) 2015 Wiley Periodicals, Inc.	[Hirai, Kota; Tabata, Hideyuki; Hirayama, Mariko; Mochizuki, Hiroyuki] Tokai Univ, Sch Med, Dept Pediat, Isehara, Kanagawa 2591193, Japan; [Oh, Yasumasa] Tokai Univ, Hatioji Hosp, Div Pediat, Hachioji, Tokyo, Japan; [Kobayashi, Tohru] Gunma Univ, Grad Sch Med, Dept Pediat, Maebashi, Gumma 371, Japan	Hirai, K (reprint author), Tokai Univ, Sch Med, Dept Pediat, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	hirai@is.icc.u-tokai.ac.jp			Environmental Restoration and Conservation Agency of Japan	Funding source: Environmental Restoration and Conservation Agency of Japan.	Bacharier LB, 2008, ALLERGY, V63, P5, DOI 10.1111/j.1398-9995.2007.01586.x; Matos S, 2006, IEEE T BIO-MED ENG, V53, P1078, DOI 10.1109/TBME.2006.873548; Morice AH, 2007, EUR RESPIR J, V29, P1256, DOI 10.1183/09031936.00101006; HSU JY, 1994, EUR RESPIR J, V7, P1246, DOI 10.1183/09031936.94.07071246; Kauffmann F, 2011, PULM PHARMACOL THER, V24, P289, DOI 10.1016/j.pupt.2010.10.012; Matos S, 2007, IEEE T BIO-MED ENG, V54, P1472, DOI 10.1109/TBME.2007.900811; MUNYARD P, 1994, PEDIATR PULM, V18, P178, DOI 10.1002/ppul.1950180310; Chang AB, 1997, EUR RESPIR J, V10, P1637, DOI 10.1183/09031936.97.10071637; Smith J, 2008, LUNG, V186, pS48, DOI 10.1007/s00408-007-9059-1; Smith J, 2007, PULM PHARMACOL THER, V20, P313, DOI 10.1016/j.pupt.2006.10.016; Birring SS, 2008, EUR RESPIR J, V31, P1013, DOI 10.1183/09031936.00057407; Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; [Anonymous], 2009, GLOB STRAT DIAGN MAN; Barry Samantha J, 2006, Cough, V2, P8, DOI 10.1186/1745-9974-2-8; Brodlie M, 2012, BMJ-BRIT MED J, V1177, pe1177; Chang AB, 2012, CHEST; Corrigan DL, 2003, PEDIATR PULM, V35, P350, DOI 10.1002/ppul.10267; Coyle Michael A, 2005, Cough, V1, P3, DOI 10.1186/1745-9974-1-3; French CT, 2002, CHEST, V121, P1123, DOI 10.1378/chest.121.4.1123; Gross V, 2007, BIOMED TECH, V52, P73, DOI 10.1515/BMT.2007.014; Japanese Society of Pediatric Allergy and Clinical Immunology, 2011, GUID TREATM MAN PEDI; Krajnik M, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-17; Li AM, 2006, THORAX, V61, P747, DOI 10.1136/thx.2005.050815; Matsumoto I, 1999, Arerugi, V48, P435; Mochizuki Hiroyuki, 2008, Arerugi, V57, P1166; Mochizuki H, 2012, ALLERGOL INT, V61, P373, DOI 10.2332/allergolint.12-RAI-0440; Paul Ian M, 2006, Cough, V2, P7, DOI 10.1186/1745-9974-2-7; Smith Jaclyn A, 2006, Cough, V2, P6, DOI 10.1186/1745-9974-2-6	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-6863	1099-0496		PEDIATR PULM	Pediatr. Pulmonol.	MAY	2015	50	5					460	468		10.1002/ppul.23125		9	Pediatrics; Respiratory System	Pediatrics; Respiratory System	CG1XE	WOS:000353068000009		
J	Awazu, M; Hida, M				Awazu, Midori; Hida, Mariko			Maternal nutrient restriction inhibits ureteric bud branching but does not affect the duration of nephrogenesis in rats	PEDIATRIC RESEARCH			English	Article							DEXAMETHASONE EXPOSURE; CELLULAR-DEVELOPMENT; RENAL MORPHOGENESIS; NEPHRON NUMBER; NEONATAL-RAT; MAP KINASE; KIDNEY; FETAL; PROTEIN; GROWTH	BACKGROUND: Maternal nutrient restriction produces offspring with fewer nephrons. We studied whether the reduced nephron number is due to the inhibition of ureteric branching Or early cessation of nephrogenesis in rats. Signaling pathways involved in kidney development were also examined. METHODS:The offspring of dams given food ad libitum (control (CON)) and those subjected to 50% food restriction (nutrient restriceted (NR)) were examined. RESULTS: At embryonic day 13 (E13), there was no difference between NR and CON in body weight or kidney size. Ureteric buds branched once in both NR and CON. At E14 and E15, body and kidney size were significantly reduced in NR. Ureteric bud tip numbers were also reduced to 50% of CON. On the other hand, the disappearance of nephrogenic zone and a nephron progenitor marker Cited1 was not different between CON and NR. The final glomerular number of NR was 80% of CON. Activated extracellular signal-regulated kinase (ERK), p38, PI3K, Akt, and mammallian target of rapamycin (mTOR), and protein expression of beta-catenin were downregulated at E15. CONCLUSION: Ureteric branching is inhibited and developmentally regulated signaling pathways are downregulated at an early stage by Maternal nutrient restriction. These changes, not early cessation of nephrogenesis, may be a mechanism for the inhibited kidney growth and nephrogenesis.	[Awazu, Midori; Hida, Mariko] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Hida, Mariko] Yokohama Rosai Hosp, Perinatal Ctr, Kanagawa, Japan; [Hida, Mariko] Yokohama Rosai Hosp, Dept Neonatol, Kanagawa, Japan	Awazu, M (reprint author), Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan.	awazu@z3.keio.jp			Ministry of Education, Science, and Culture, Japan [18591225, 20591286, 21591420, 23591584, 24591610]; Keio Gijuku Academic Development Funds; Nateglinide Memorial Toyoshima Research and Education Fund	This study was supported by grants from the Ministry of Education, Science, and Culture, Japan (18591225, 20591286, 21591420, 23591584, 24591610), Keio Gijuku Academic Development Funds, and Nateglinide Memorial Toyoshima Research and Education Fund.	Abdel-Hakeem AK, 2008, AM J OBSTET GYNECOL, V199; Rumballe BA, 2011, DEV BIOL, V360, P110, DOI 10.1016/j.ydbio.2011.09.011; Douglas-Denton R, 2002, J AM SOC NEPHROL, V13, P406; Rodriguez MM, 2004, PEDIATR DEVEL PATHOL, V7, P17, DOI 10.1007/s10024-003-3029-2; Tang MJ, 2002, DEV BIOL, V243, P128, DOI 10.1006/dbio.2001.0557; Pham TD, 2003, AM J PHYSIOL-REG I, V285, pR962, DOI 10.1152/ajpregu.00201.2003; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; Kuure S, 2007, J AM SOC NEPHROL, V18, P1130, DOI 10.1681/ASN.2006111206; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; Jain S, 2006, GENE DEV, V20, P321, DOI 10.1101/gad.1387206; Teodoro GFR, 2012, J NUTR, V142, P924, DOI 10.3945/jn.111.146266; Cebrian C, 2014, CELL REP, V7, P127, DOI 10.1016/j.celrep.2014.02.033; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Araki T, 1999, EXP CELL RES, V248, P423, DOI 10.1006/excr.1999.4424; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Brown AC, 2011, DEVELOPMENT, V138, P5099, DOI 10.1242/dev.065995; Degl'Innocenti D, 2004, ONCOGENE, V23, P7297, DOI 10.1038/sj.onc.1207862; Fisher CE, 2001, DEVELOPMENT, V128, P4329; GALLO PV, 1986, ALCOHOL, V3, P261; Gilbert T, 1996, KIDNEY INT, V50, P783, DOI 10.1038/ki.1996.377; Gopalakrishnan GS, 2005, BRIT J NUTR, V94, P938, DOI 10.1079/BJN20051559; Gray SP, 2010, J AM SOC NEPHROL, V21, P1891, DOI 10.1681/ASN.2010040368; Gupta IR, 2003, KIDNEY INT, V63, P365, DOI 10.1046/j.1523-1755.2003.00715.x; Henry TQ, 2010, J DEV ORIG HLTH DIS, V1, P67, DOI 10.1017/S2040174409990134; Hida M, 2002, KIDNEY INT, V61, P1252, DOI 10.1046/j.1523-1755.2002.00273.x; Hokke SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058243; Iglesias DM, 2014, PEDIATR NEPHROL, V29, P705, DOI 10.1007/s00467-013-2685-3; Jonsson N, 2006, J PHYSL 3, V576, P935; Marshall Stephen, 2006, Sci STKE, V2006, pre7, DOI 10.1126/stke.3462006re7; Nijland MJ, 2007, J PHYSIOL-LONDON, V579, P643, DOI 10.1113/jphysiol.2006.122101; Pozzi A, 2006, MOL BIOL CELL, V17, P2046, DOI 10.1091/mbc.E05-08-0800; Singh RR, 2007, AM J PHYSIOL-RENAL, V293, pF548, DOI 10.1152/ajprenal.00156.2007; SLOTKIN TA, 1991, TERATOLOGY, V43, P301, DOI 10.1002/tera.1420430404; Swali A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023189; Tran S, 2008, J AM SOC NEPHROL, V19, P943, DOI 10.1681/ASN.2007080864; Welham SJM, 2002, KIDNEY INT, V61, P1231, DOI 10.1046/j.1523-1755.2002.00264.x	37	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	MAY	2015	77	5					633	639		10.1038/pr.2015.24		7	Pediatrics	Pediatrics	CG2DM	WOS:000353085100005		
J	Ikeda, K; Castel, AD; Murayama, K				Ikeda, Kenji; Castel, Alan D.; Murayama, Kou			Mastery-Approach Goals Eliminate Retrieval-Induced Forgetting: The Role of Achievement Goals in Memory Inhibition	PERSONALITY AND SOCIAL PSYCHOLOGY BULLETIN			English	Article						motivation; achievement goals; retrieval-induced forgetting; integration effect	REGULATORY FOCUS; MEDIATIONAL ANALYSIS; INTRINSIC MOTIVATION; PERFORMANCE; STRATEGIES; ORIENTATION; CONSEQUENCE; ATTAINMENT; ACCOUNT	The present study examined how achievement goals affect retrieval-induced forgetting. Researchers have suggested that mastery-approach goals (i.e., developing one's own competence) promote a relational encoding, whereas performance-approach goals (i.e., demonstrating one's ability in comparison with others) promote item-specific encoding. These different encoding processes may affect the degree to which participants integrate the exemplars within a category and, as a result, we expected that retrieval-induced forgetting may be reduced or eliminated under mastery-approach goals. Three experiments were conducted using a retrieval-practice paradigm with different stimuli, where participants' achievement goals were manipulated through brief written instructions. A meta-analysis that synthesized the results of the three experiments showed that retrieval-induced forgetting was not statistically significant in the mastery-approach goal condition, whereas it was statistically significant in the performance-approach goal condition. These results suggest that mastery-approach goals eliminate retrieval-induced forgetting, but performance-approach goals do not, demonstrating that motivation factors can influence inhibition and forgetting.	[Ikeda, Kenji] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Castel, Alan D.] Univ Calif Los Angeles, Los Angeles, CA USA; [Murayama, Kou] Univ Reading, Reading RG6 2AH, Berks, England	Ikeda, K (reprint author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	ikeda.kenji00@gmail.com			National Institutes of Health (National Institute on Aging) [R01AG 044335]	This research was supported in part by the National Institutes of Health (National Institute on Aging), Award Number R01AG 044335, awarded to A.D.C.	Anderson MC, 2010, SUCCESSFUL REMEMBERI, P107; Bauml KH, 2007, PSYCHOL SCI, V18, P111, DOI 10.1111/j.1467-9280.2007.01857.x; Barnier A, 2004, COGNITION EMOTION, V18, P457, DOI 10.1080/0269993034000392; Murayama K, 2014, PSYCHOL BULL, V140, P1383, DOI 10.1037/a0037505; Forster J, 2005, PSYCHOL SCI, V16, P631, DOI 10.1111/j.1467-9280.2005.01586.x; Barron KE, 2001, J PERS SOC PSYCHOL, V80, P706, DOI 10.1037//0022-3514.80.5.706; Little JL, 2011, MEMORY, V19, P346, DOI 10.1080/09658211.2011.569725; Anderson MC, 2003, J MEM LANG, V49, P415, DOI 10.1016/j.jml.2003.08.006; Roediger HL, 2006, PSYCHOL SCI, V17, P249, DOI 10.1111/j.1467-9280.2006.01693.x; Cury F, 2002, J EXP SOC PSYCHOL, V38, P473, DOI 10.1016/S0022-1031(02)00017-3; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; HIGGINS ET, 1992, PERS SOC PSYCHOL B, V18, P527; Higgins ET, 1997, J PERS SOC PSYCHOL, V72, P515, DOI 10.1037/0022-3514.72.3.515; Higgins ET, 1998, ADV EXP SOC PSYCHOL, V30, P1; Senko C, 2005, PERS SOC PSYCHOL B, V31, P1739, DOI 10.1177/0146167205281128; Ciranni MA, 1999, J EXP PSYCHOL LEARN, V25, P1403, DOI 10.1037/0278-7393.25.6.1403; Crouzevialle M, 2013, J EXP PSYCHOL GEN, V142, P666, DOI 10.1037/a0029632; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Anderson MC, 2001, J EXP PSYCHOL GEN, V130, P544, DOI 10.1037//0096-3445.130.3.544; Macrae CN, 1999, J PERS SOC PSYCHOL, V77, P463, DOI 10.1037//0022-3514.77.3.463; Hulleman CS, 2010, PSYCHOL BULL, V136, P422, DOI 10.1037/a0018947; Storm BC, 2012, MEM COGNITION, V40, P827, DOI 10.3758/s13421-012-0211-7; Howell AJ, 2007, PERS INDIV DIFFER, V43, P167, DOI 10.1016/j.paid.2006.11.017; ANDERSON MC, 1994, J EXP PSYCHOL LEARN, V20, P1063, DOI 10.1037/0278-7393.20.5.1063; Kaplan A, 2007, EDUC PSYCHOL REV, V19, P141, DOI 10.1007/s10648-006-9012-5; Anderson MC, 2005, DYNAMIC COGNITIVE PROCESSES, P159, DOI 10.1007/4-431-27431-6_8; Elliot AJ, 1999, EDUC PSYCHOL, V34, P169, DOI 10.1207/s15326985ep3403_3; Raaijmakers JGW, 2013, J MEM LANG, V68, P98, DOI 10.1016/j.jml.2012.10.002; Anderson MC, 1999, J EXP PSYCHOL LEARN, V25, P608, DOI 10.1037//0278-7393.25.3.608; Zhu R, 2007, J CONSUM RES, V34, P89, DOI 10.1086/513049; Roediger HL, 2006, PERSPECT PSYCHOL SCI, V1, P181, DOI 10.1111/j.1745-6916.2006.00012.x; Macleod M, 2002, APPL COGNITIVE PSYCH, V16, P135, DOI 10.1002/acp.782; Elliot AJ, 1996, J PERS SOC PSYCHOL, V70, P461, DOI 10.1037//0022-3514.70.3.461; Elliot AJ, 1999, J EDUC PSYCHOL, V91, P549, DOI 10.1037//0022-0663.91.3.549; Mc Culloch KC, 2008, J EXP SOC PSYCHOL, V44, P857, DOI 10.1016/j.jesp.2007.08.004; Butler KM, 2001, J EXP PSYCHOL LEARN, V27, P1314, DOI 10.1037//0278-7393.27.5.1314; Dweck C. S., 1986, AM PSYCHOL, V41, P1010, DOI [10.1037/0003-066X.41.10.1040, DOI 10.1037/0003-066X.41.10.1040]; Elliot A. J., 2005, HDB COMPETENCE MOTIV, V16, P52; Elliot AJ, 2001, J PERS SOC PSYCHOL, V80, P501, DOI 10.1037//0022-3514.80.3.501; Elliot AJ, 2005, J EDUC PSYCHOL, V97, P630, DOI 10.1037/0022-0663.97.4.630; HUNT RR, 1984, J EXP PSYCHOL LEARN, V10, P454, DOI 10.1037//0278-7393.10.3.454; Murayama K, 2011, PERS SOC PSYCHOL B, V37, P1339, DOI 10.1177/0146167211410575; Murayama K., 2012, OXFORD HDB HUMAN MOT, P191; Nicholls JG, 1984, RES MOTIVATION ED ST, V1, P39; NOLEN SB, 1988, COGNITION INSTRUCT, V5, P269, DOI 10.1207/s1532690xci0504_2; Sassenberg K, 2014, J EXP SOC PSYCHOL, V54, P153, DOI 10.1016/j.jesp.2014.05.009; Scholer AA, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P489; Steinhart Y, 2013, SOC COGNITION, V31, P315	49	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0146-1672	1552-7433		PERS SOC PSYCHOL B	Pers. Soc. Psychol. Bull.	MAY	2015	41	5					687	695		10.1177/0146167215575730		9	Psychology, Social	Psychology	CG2ZK	WOS:000353145100006		
J	Hashimoto, O; Miyazaki, T; Hosokawa, J; Shimura, Y; Okuyama, H; Endo, M				Hashimoto, Osamu; Miyazaki, Takuya; Hosokawa, Joji; Shimura, Yumi; Okuyama, Hiroshi; Endo, Masahiro			A case of high-output heart failure caused by a femoral arteriovenous fistula after endovenous laser ablation treatment of the saphenous vein	PHLEBOLOGY			English	Article						Arteriovenous fistula; heart failure; endovenous laser treatment; iatrogenic		Endovenous laser ablation treatment has become the less invasive therapeutic choice for the treatment of superficial venous insufficiency and varicose veins. A 64-year-old woman presented at our hospital with varicose veins and prior endovenous laser ablation treatment. The patient had high-output heart failure caused by a right femoral arteriovenous fistula. She was treated medically and underwent an open repair of the right superficial femoral artery and the right femoral vein with complete resolution of the arteriovenous fistula and heart failure. Here, we have reviewed the literature and discussed possible causes of the complication of arteriovenous fistula after endovenous laser ablation treatment.	[Hashimoto, Osamu; Hosokawa, Joji; Shimura, Yumi] Tokyo Heart Ctr, Dept Cardiol, Tokyo 1400001, Japan; [Miyazaki, Takuya; Okuyama, Hiroshi; Endo, Masahiro] Tokyo Heart Ctr, Dept Cardiovasc Surg, Tokyo 1400001, Japan	Hashimoto, O (reprint author), Tokyo Heart Ctr, Dept Cardiol, Shinagawa Ku, 5-4-12 Kitashinagawa, Tokyo 1400001, Japan.	mhashimoto@tokyoheart.or.jp					Pan Y, 2014, PHLEBOLOGY, V29, P109, DOI 10.1177/0268355512473911; CALLAM MJ, 1994, BRIT J SURG, V81, P167, DOI 10.1002/bjs.1800810204; Dexter D, 2012, Phlebology, V27 Suppl 1, P40, DOI 10.1258/phleb.2012.012S18; Ziporin SJ, 2010, J VASC SURG, V51, P715, DOI 10.1016/j.jvs.2009.10.043	4	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0268-3555	1758-1125		PHLEBOLOGY	Phlebology	MAY	2015	30	4					290	292		10.1177/0268355514525149		3	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CG6NL	WOS:000353418700009		
J	Hiramoto, K; Yamate, Y; Kawanishi, S				Hiramoto, Keiichi; Yamate, Yurika; Kawanishi, Shosuke			Detection of dopa-positive cells in mouse ovaries in response to ocular exposure to ultraviolet B rays	PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE			English	Article						beta-endorphin; dopamine; dopa-positive melanocyte; ultraviolet B	OPIOID-PEPTIDES; ESTROUS-CYCLE; STRESS; PROLIFERATION; PIGMENTATION; MELANOCYTES; NEUTROPHILS; HORMONE; PAIN	BackgroundIt is known that the levels of hormones secreted from the pituitary gland are increased by ultraviolet B (UVB) eye irradiation. The ovaries are affected by the hormones secreted from the pituitary gland. Therefore, we observed the influence of UVB eye irradiation on the ovaries. MethodsIn this study, a 2.5kJ/m(2) dose of UVB irradiation was delivered by a sunlamp to the eye or the ear of C57BL/6j female mice. Five days after UVB irradiation, we removed the ovaries. ResultsThe plasma levels of -melanocyte-stimulating hormone (-MSH), adrenocorticotropic hormone (ACTH), and -endorphin were increased 24h after UVB irradiation of either the eye or the ear. The amounts of ACTH and -MSH were decreased 5 days after UVB irradiation. However, the -endorphin level 5 days after UVB eye irradiation did not decrease. In addition, UVB eye irradiation increased the expression of dopa-positive cells, tyrosinase, and dopa decarboxylase, and also increased the immunoreactivity of melanocortin-1 receptor in the ovaries. The dopamine content in the plasma was also increased. ConclusionsThese results suggest that the melanin and dopamine systems of the ovary are affected by UVB eye irradiation, and the synthesized dopamine is maintained at high levels as -endorphin.	[Hiramoto, Keiichi; Kawanishi, Shosuke] Suzuka Univ Med Sci, Dept Pharmaceut Sci, Suzuka, Mie 5138670, Japan; [Hiramoto, Keiichi; Yamate, Yurika] Osaka City Univ, Dept Dermatol, Grad Sch Med, Osaka 558, Japan	Hiramoto, K (reprint author), Suzuka Univ Med Sci, Dept Pharmaceut Sci, 3500-3 Minamitamagakicho, Suzuka, Mie 5138670, Japan.	hiramoto@suzuka-u.ac.jp					Slominski A, 2000, PHYSIOL REV, V80, P979; Hiramoto K, 2003, J INVEST DERMATOL, V120, P123, DOI 10.1046/j.1523-1747.2003.12004.x; Mizoguchi K, 2008, PHARMACOL BIOCHEM BE, V91, P170, DOI 10.1016/j.pbb.2008.07.002; Mousa SA, 2004, ENDOCRINOLOGY, V145, P1331, DOI 10.1210/en.2003-1287; Sasaki S, 2011, J IMMUNOL, V187, P774, DOI 10.4049/jimmunol.1002489; Cario-Andre M, 1999, CELL MOL BIOL, V45, P931; Hiramoto K, 2014, RES J ENDOCRINOL MET, V2, P1; Hiramoto K, 2010, CLIN EXP DERMATOL, V36, P52; JIMBOW K, 1982, J INVEST DERMATOL, V78, P108, DOI 10.1111/1523-1747.ep12505758; Jutkiewicz EM, 2012, NEUROPSYCHOPHARMACOL, V37, P303, DOI 10.1038/npp.2011.244; Kobayashi Y, 2013, ARCH IMMUNOL THER EX, V61, P187, DOI 10.1007/s00005-013-0218-1; Liang B, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110619; Pan TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045183; RORSMAN H, 1988, PHOTODERMATOLOGY, V5, P30; Salvetti NR, 2010, ANIM REPROD SCI, V122, P98, DOI 10.1016/j.anireprosci.2010.08.003; Yamate Y, 2011, PHOTOCHEM PHOTOBIOL, V87, P191, DOI 10.1111/j.1751-1097.2010.00822.x	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-4383	1600-0781		PHOTODERMATOL PHOTO	Photodermatol. Photoimmunol. Photomed.	MAY	2015	31	3					124	128		10.1111/phpp.12143		5	Dermatology	Dermatology	CG5RZ	WOS:000353353000004		
J	Yamate, Y; Hiramoto, K; Kasahara, E; Sato, EF				Yamate, Yurika; Hiramoto, Keiichi; Kasahara, Emiko; Sato, Eisuke F.			UVA irradiation of the eye modulates the contact hypersensitivity of the skin and intestines by affecting mast cells in mice	PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE			English	Article						4-ethoxymethylene-2-phenyl-2-oxazolin-5-one; contact hypersensitivity; fluorescein isothiocyanate; ultraviolet A	HYPOTHALAMOPITUITARY PROOPIOMELANOCORTIN PATHWAY; ULTRAVIOLET-B IRRADIATION; TUMOR-NECROSIS-FACTOR; RADIATION; HUMANS; PHOTOPROTECTION; CARCINOGENESIS; EXPOSURES; HORMONE; LIGHT	BackgroundUltraviolet A (UVA) irradiation before allergic sensitization induces immunosuppression, but the precise mechanism remained unclear. In this study, we examined the influence of UVA irradiation of the eye on contact hypersensitivity (CHS) and the role of mast cells in CHS. MethodsWe used two types of haptens, fluorescein isothiocyanate (FITC: a Th2 type hapten) and 4-ethoxymethylene-2-phenyl-2-oxazolin-5-one (oxazolone: a Th1 type hapten). A 300kJ/m(2) dose of UVA irradiation was delivered to the eyes. After UVA irradiation, we sensitized abdominal shaved skin and challenged the ear epidermis and colons of these mice with each hapten. ResultsAfter UVA irradiation, the CHS of the skin and colon were not inhibited in the FITC-sensitized mice. However, in the oxazolone-sensitized mice, only the CHS of the skin was inhibited by UVA irradiation. The inflammation of the colon became more severe after UVA irradiation. In mast cell-deficient (W/Wv) mice sensitized to FITC, the CHS was weaker than that in WT mice. Moreover, the reduction of immunosuppression in ear swelling was seen for one of the two models they used. ConclusionsThese results suggest that the mast cells induced by UVA irradiation of the eye have different roles in the epidermis and colon and have different responses to different haptens.	[Yamate, Yurika; Hiramoto, Keiichi; Kasahara, Emiko] Osaka City Univ, Dept Physiol, Grad Sch Med, Osaka 558, Japan; [Yamate, Yurika; Hiramoto, Keiichi; Sato, Eisuke F.] Suzuka Univ Med Sci, Dept Pharmaceut Sci, Suzuka, Mie 5138670, Japan	Hiramoto, K (reprint author), Suzuka Univ Med Sci, Dept Pharmaceut Sci, 3500-3 Minamitamagakicho, Suzuka, Mie 5138670, Japan.	hiramoto@suzuka-u.ac.jp					Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Slominski A, 1998, CLIN DERMATOL, V16, P503, DOI 10.1016/S0738-081X(98)00023-6; Ullrich SE, 2007, PHOTOCHEM PHOTOBIOL, V83, P1095, DOI 10.1111/j.1751-1097.2007.00184.x; [Anonymous], 2012, ADV ANAT EMBRYOL CEL; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011., 10.1152/ajpendo.00217.2011]; Hiramoto K, 2009, J DERMATOL, V36, P335, DOI 10.1111/j.1346-8138.2009.00649.x; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Slominski A, 2000, PHYSIOL REV, V80, P979; Hiramoto K, 2003, J INVEST DERMATOL, V120, P123, DOI 10.1046/j.1523-1747.2003.12004.x; Slominski A, 2013, J STEROID BIOCHEM, V137, P107, DOI 10.1016/j.jsbmb.2013.02.006; Moan J, 1999, PHOTOCHEM PHOTOBIOL, V70, P243, DOI 10.1111/j.1751-1097.1999.tb07995.x; Wang BH, 2000, J IMMUNOL, V165, P6783; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Weichenthal M, 2005, PHOTODERMATOL PHOTO, V21, P260, DOI 10.1111/j.1600-0781.2005.00173.x; KRIPKE ML, 1974, J NATL CANCER I, V53, P1333; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.immunol.10.1.411; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; PIGUET PF, 1991, J EXP MED, V173, P673, DOI 10.1084/jem.173.3.673; TOEWS GB, 1980, J IMMUNOL, V124, P445; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; BIENENSTOCK J, 1982, J ALLERGY CLIN IMMUN, V70, P407, DOI 10.1016/0091-6749(82)90001-X; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P289; Gali SJ, 2008, J DERMATOL SCI, V49, P7; Hiramoto K, 2008, J SCI FOOD AGR, V88, P1151, DOI 10.1002/jsfa.3190; Hiramoto K, 2012, ARCH DERMATOL RES, V304, P39, DOI 10.1007/s00403-011-1183-3; Hiramoto K, 2004, ARCH DERMATOL RES, V295, P307, DOI 10.1007/s00403-003-0437-0; KRIPKE ML, 1976, J NATL CANCER I, V57, P211; Kripke ML, 1977, JNCI-J NATL CANCER I, V59, P227; MORISON WL, 1989, PHOTOCHEM PHOTOBIOL, V50, P515, DOI 10.1111/j.1751-1097.1989.tb05557.x; Narbutt J, 2007, BRIT J DERMATOL, V156, P539, DOI 10.1111/j.1365-2133.2006.07670.x; Narbutt J, 2007, J DERMATOL SCI, V45, P210, DOI 10.1016/j.jdermsci.2006.11.001; Ogawa A, 2010, J INVEST DERMATOL, V130, P1558, DOI 10.1038/jid.2010.25; Takeuchi H, 2013, J INVEST DERMATOL, V133, P1857, DOI 10.1038/jid.2013.71; WOODBURY RG, 1978, P NATL ACAD SCI USA, V75, P5311, DOI 10.1073/pnas.75.11.5311; Yamate Y, 2011, PHOTOCHEM PHOTOBIOL, V87, P191, DOI 10.1111/j.1751-1097.2010.00822.x	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-4383	1600-0781		PHOTODERMATOL PHOTO	Photodermatol. Photoimmunol. Photomed.	MAY	2015	31	3					129	140		10.1111/phpp.12157		12	Dermatology	Dermatology	CG5RZ	WOS:000353353000005		
J	Hanpattanakit, P; Leclerc, MY; Mcmillan, AMS; Limtong, P; Maeght, JL; Panuthai, S; Inubushi, K; Chidthaisong, A				Hanpattanakit, Phongthep; Leclerc, Monique Y.; Mcmillan, Andrew M. S.; Limtong, Pitayakorn; Maeght, Jean-Luc; Panuthai, Samreong; Inubushi, Kazuyuki; Chidthaisong, Amnat			Multiple timescale variations and controls of soil respiration in a tropical dry dipterocarp forest, western Thailand	PLANT AND SOIL			English	Article						Soil respiration; Heterotrophic and autotrophic respiration; Root biomass; Microbial biomass; Temporal variations; Dry dipterocarp forest	RAIN-FOREST; ROOT RESPIRATION; WATER CONTENT; VARIABILITY; ECOSYSTEMS; TEMPERATE; PATTERNS; COMPONENTS; EXCHANGE; TRENDS	This study aims to improve our understanding of temporal variations and controlling factors of soil respiration (R-s) and its components (microbial respiration or R-m and root respiration or R-b) in an Asian tropical seasonal forest at diurnal, seasonal and annual timescales in relation to biotic and abiotic controls. R-s was studied by the trenching method in a seasonal dry diptercarp forest, western Thailand. An automated soil chamber system was used to produce hourly data of R-s during 2008-2011. Analysis of R-s in relation to both biotic and abiotic factors was carried out to understand its temporal variations at different timescales. R-m was the main contributor to overall magnitude and variability of R-s. Soil temperature alone was the main driver of diurnal variation, while the combination of soil moisture and soil temperature determined the seasonal variations. The amount of R-s was also related to the fine root (< 2 mm) and microbial biomass at seasonal timescales. Due to the small inter-annual variations in soil temperature and moisture, total soil respiration among the 4 years was not significantly different (p < 0.05). The annual totals for R-s during 2008-2011 were 3.20, 3.89, 3.52, 4.14 kgCO(2) m(-2) years(-1), respectively. The 4-year average ratio of R-m (trenched) to R-s (untrenched) was 66 +/- 4 %. R-m plays a crucial role in determining the magnitude (large ratio between R-m and R-s) and temporal variations of R-s. In this forest ecosystem, high seasonal variations in R-s were observed and were mainly attributed to the response of R-m to moisture.	[Hanpattanakit, Phongthep; Chidthaisong, Amnat] King Mongkuts Univ Technol Thonburi, JGSEE, Bangkok, Thailand; [Hanpattanakit, Phongthep; Chidthaisong, Amnat] King Mongkuts Univ Technol Thonburi, Ctr Excellence Energy Technol & Environm, Bangkok, Thailand; [Leclerc, Monique Y.] Univ Georgia, Lab Environm Phys, Ctr Atmospher Biogeosci, Griffin, GA USA; [Mcmillan, Andrew M. S.] Landcare Res, Palmerston North, New Zealand; [Limtong, Pitayakorn] Land Dev Dept, Bangkok, Thailand; [Maeght, Jean-Luc] IRD, UMR Bioemco, UMR AMAP, CIRAD TA A51 PS2, Montpellier 5, France; [Panuthai, Samreong] Dept Natl Pk Wildlife & Plant Conservat, Bangkok, Thailand; [Inubushi, Kazuyuki] Chiba Univ, Grad Sch Hort, Natl Univ Corp, Chiba, Japan	Chidthaisong, A (reprint author), King Mongkuts Univ Technol Thonburi, JGSEE, Bangkok, Thailand.	amnat_c@jgsee.kmutt.ac.th			Royal Golden Jubilee (RGJ) - Ph.D. Program of Thailand Research Fund; Mid-career research grant of TRF; PERDO; National Research University Project of Thailand's Office of the Higher Education Commission (CHE)	The authors would like to thank King Mongkut's University of Technology Thonburi, Ratchaburi campus in Ban Ranbua, tambonRanbua, Chombung district, Ratchaburi province for providing access to the study plots. This research was supported by funding from The Royal Golden Jubilee (RGJ) - Ph.D. Program of Thailand Research Fund, Mid-career research grant of TRF to AC, PERDO, and the National Research University Project of Thailand's Office of the Higher Education Commission (CHE). We thank David Durden for editing the English usage.	Adachi A, 2006, APPL SOIL ECOL, V34, P258, DOI [10.1016/j.apsoil.2006.01.006, DOI 10.1016/J.APSOIL.2006.01.006]; Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; Vogt KA, 1996, PLANT SOIL, V187, P159; Martin JG, 2009, SOIL BIOL BIOCHEM, V41, P530, DOI 10.1016/j.soilbio.2008.12.012; Kelting DL, 1998, SOIL BIOL BIOCHEM, V30, P961, DOI 10.1016/S0038-0717(97)00186-7; INUBUSHI K, 1991, SOIL BIOL BIOCHEM, V23, P737, DOI 10.1016/0038-0717(91)90143-8; Savage K, 2013, GLOBAL CHANGE BIOL, V19, P1151, DOI 10.1111/gcb.12108; Adachi M, 2009, J TROP ECOL, V25, P531, DOI 10.1017/S026646740999006X; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; Shi WY, 2011, AGR FOREST METEOROL, V151, P854, DOI 10.1016/j.agrformet.2011.02.003; Savage KE, 2001, GLOBAL BIOGEOCHEM CY, V15, P337, DOI 10.1029/1999GB001248; Butler A, 2012, PLANT SOIL, V352, P129, DOI 10.1007/s11104-011-0984-7; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Ohashi M, 2008, BIOGEOCHEMISTRY, V90, P275, DOI 10.1007/s10533-008-9253-0; Davidson EA, 1998, GLOB CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Grayston SJ, 2001, SOIL BIOL BIOCHEM, V33, P533, DOI 10.1016/S0038-0717(00)00194-2; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Schuur EAG, 2006, GLOBAL CHANGE BIOL, V12, P165, DOI 10.1111/j.1365-2486.2005.01066.x; Hashimoto S, 2007, J FOREST RES-JPN, V12, P209, DOI 10.1007/s10310-007-0009-9; Subke JA, 2006, GLOBAL CHANGE BIOL, V12, P921, DOI 10.1111/j.1365-2486.2006.01117.x; Kosugi Y, 2008, AGR FOREST METEOROL, V148, P439, DOI 10.1016/j.agrformet.2007.10.007; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Bonal D, 2008, GLOBAL CHANGE BIOL, V14, P1917, DOI 10.1111/j.1365-2486.2008.01610.x; Bond-Lamberty B, 2004, TREE PHYSIOL, V24, P1387; Appanah S., 1998, REV DIPTEROCARPS TAX; Gu LH, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003164; Hanpattanakit P, 2012, GMSARN INT J, V6, P169; Hanpattanakit P, 2013, THESIS KING MONGKUTS; Hanpattanakit P., 2009, Kasetsart Journal, Natural Sciences, V43, P650; Hashimoto S, 2004, J FOREST RES-JPN, V9, P75, DOI 10.1007/s10310-003-0046-y; Katayama A, 2009, AGR FOREST METEOROL, V149, P1666, DOI 10.1016/j.agrformet.2009.05.007; Kume T, 2013, ECOHYDROLOGY, V6, P134, DOI 10.1002/eco.1253; Luo Y., 2006, SOIL RESP ENV; Ohashi M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029587; Phiancharoen M, 2008, INSTRUCTION PLANT DR; RAICH JW, 1989, ECOLOGY, V70, P1346, DOI 10.2307/1938194; Sanwangsri M, 2011, 4 INT C SUST ENV SEE; Shibistova O, 2002, TELLUS B, V54, P552, DOI 10.1034/j.1600-0889.2002.01348.x; Takahashi M, 2009, JARQ-JPN AGR RES Q, V43, P337; Thai Meteorological Department, 2008, WEATH CLIM CHANG THA; Vargas R, 2013, GLOBAL CHANGE BIOL, V16, P1589, DOI [10.1111/j.1365-2486.2005.00978.x, DOI 10.1111/J.1365-2486.2005.00978.X]	41	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0032-079X	1573-5036		PLANT SOIL	Plant Soil	MAY	2015	390	1-2					167	181		10.1007/s11104-015-2386-8		15	Agronomy; Plant Sciences; Soil Science	Agriculture; Plant Sciences	CG7IJ	WOS:000353476200012		
J	Dissanayaka, DMSB; Maruyama, H; Masuda, G; Wasaki, J				Dissanayaka, Dissanayaka Mudiyanselage Samantha Bandara; Maruyama, Hayato; Masuda, Genki; Wasaki, Jun			Interspecific facilitation of P acquisition in intercropping of maize with white lupin in two contrasting soils as influenced by different rates and forms of P supply	PLANT AND SOIL			English	Article						Intercropping; Rhizosphere-sharing; P facilitation; P availability; Soil P pools; Soil type	PHOSPHORUS-DEFICIENT CONDITIONS; CLUSTER-ROOT-FORMATION; TRITICUM-AESTIVUM L.; ACID-PHOSPHATASE; ORGANIC PHOSPHORUS; ALBUS L.; CARBOXYLATE EXUDATION; CITRATE EXUDATION; PROTEOID ROOTS; GRAIN LEGUMES	This study of a maize-white lupin model cropping system was conducted to investigate the effects of rhizosphere-sharing of white lupin, a P-efficient plant, on growth and P accumulation of maize under different P rates and forms in two contrasting soils. With Regosol and Andosol, a 42-day pot experiment was conducted for 0P (no P addition), 50Pi, 100Pi (50 and 100 mg P kg(-1) soil by NaHPO(4)a <...2H(2)O respectively), and 100Po (100 mg P kg(-1) soil by phytate). Plant growth, P uptake, rhizosphere pH, and different P fractions were investigated. Complementary effects of intercropping for maize were observed in Regosol, but not in Andosol. Total P uptake by intercropped maize in 0P, 50Pi, and 100Po was elevated by 46, 37, and 65 %, respectively, compared to when it was grown as a monoculture. White lupin mobilized P from sparingly soluble forms. Thereby, maize plant enhanced its P accumulation as a result of access to these two fractions in mixed culture in Regosol, where strong root intermingling occurred among intercropped plants. Results suggest that the P mobilization strategy of white lupin from sparingly soluble P pools in soil can enhance the P acquisition efficiency of coexisting maize with P facilitation in this intercropping occurring in the direction of white lupin to maize. Achieving enhanced growth and P uptake by P-inefficient species in intercropping with white lupin is dependent on the type of soil in which those plants are grown.	[Dissanayaka, Dissanayaka Mudiyanselage Samantha Bandara; Maruyama, Hayato; Masuda, Genki; Wasaki, Jun] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398521, Japan; [Dissanayaka, Dissanayaka Mudiyanselage Samantha Bandara] Univ Peradeniya, Dept Crop Sci, Fac Agr, Peradeniya 20400, Sri Lanka	Wasaki, J (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Kagamiyama 1-7-1, Higashihiroshima 7398521, Japan.	junw@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Agriculture, Forestry and Fisheries (MAFF), Japan [23688010]	This research was partly supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Ministry of Agriculture, Forestry and Fisheries (MAFF), Japan through a Grant-in-Aid for Young Scientists (23688010) and a research project entitled: "Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries."	Cu STT, 2005, PLANT SOIL, V272, P143, DOI 10.1007/s11104-004-4336-8; DINKELAKER B, 1989, PLANT CELL ENVIRON, V12, P285, DOI 10.1111/j.1365-3040.1989.tb01942.x; BOWMAN RA, 1978, SOIL SCI, V125, P49, DOI 10.1097/00010694-197801000-00008; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Hassan HM, 2012, BIOL FERT SOILS, V48, P151, DOI 10.1007/s00374-011-0612-y; Vance CP, 2001, PLANT PHYSIOL, V127, P390, DOI 10.1104/pp.127.2.390; Hinsinger P, 2011, PLANT PHYSIOL, V156, P1078, DOI 10.1104/pp.111.175331; Pearse SJ, 2006, PLANT SOIL, V288, P127, DOI 10.1007/s11104-006-9099-y; Neumann G, 1999, PLANTA, V208, P373, DOI 10.1007/s004250050572; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; Lambers H, 2013, AM J BOT, V100, P263, DOI 10.3732/ajb.1200474; Nuruzzaman M, 2006, PLANT SOIL, V281, P109, DOI 10.1007/s11104-005-3936-2; George TS, 2002, SOIL BIOL BIOCHEM, V34, P1487, DOI 10.1016/S0038-0717(02)00093-7; Wang Y, 2012, PLANT SOIL, V354, P283, DOI 10.1007/s11104-011-1065-7; Li L, 2003, PLANT SOIL, V248, P297, DOI 10.1023/A:1022389707051; Kamh M, 1999, PLANT SOIL, V211, P19, DOI 10.1023/A:1004543716488; AE N, 1990, SCIENCE, V248, P477, DOI 10.1126/science.248.4954.477; Shen J, 2005, PLANT SCI, V168, P837, DOI 10.1016/j.plantsci.2004.10.017; Veneklaas EJ, 2003, PLANT SOIL, V248, P187, DOI 10.1023/A:1022367312851; Gunes A, 2007, J PLANT NUTR, V30, P1455, DOI 10.1080/01904160701555648; Shane MW, 2003, PLANT CELL ENVIRON, V26, P265, DOI 10.1046/j.1365-3040.2003.00957.x; Neumann G, 1999, PLANT SOIL, V211, P121, DOI 10.1023/A:1004380832118; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; TIESSEN H, 1992, AGR ECOSYST ENVIRON, V38, P139, DOI 10.1016/0167-8809(92)90139-3; GARDNER WK, 1983, PLANT SOIL, V70, P107, DOI 10.1007/BF02374754; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; STEWART JWB, 1987, BIOGEOCHEMISTRY, V4, P41, DOI 10.1007/BF02187361; Mollier A, 1999, J EXP BOT, V50, P487, DOI 10.1093/jexbot/50.333.487; Simpson RJ, 2011, PLANT SOIL, V349, P89, DOI 10.1007/s11104-011-0880-1; Richardson AE, 2001, PLANT J, V25, P641, DOI 10.1046/j.1365-313x.2001.00998.x; Li H, 2008, PLANT SOIL, V312, P139, DOI 10.1007/s11104-007-9512-1; Richardson AE, 2009, PLANT SOIL, V321, P305, DOI 10.1007/s11104-009-9895-2; Hinsinger P, 2003, PLANT SOIL, V248, P43, DOI 10.1023/A:1022371130939; Richardson AE, 2011, PLANT SOIL, V349, P121, DOI 10.1007/s11104-011-0950-4; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Wasaki J, 2003, PLANT SOIL, V248, P129, DOI 10.1023/A:1022332320384; Li SM, 2004, ANN BOT-LONDON, V94, P297, DOI 10.1093/aob/mch140; HEDLEY MJ, 1982, SOIL SCI SOC AM J, V46, P970; Song YN, 2007, BIOL FERT SOILS, V43, P565, DOI 10.1007/s00374-006-0139-9; Lambers H, 2006, ANN BOT-LONDON, V98, P693, DOI 10.1093/aob/mcl114; TADANO T, 1991, SOIL SCI PLANT NUTR, V37, P129; ADAMS MA, 1992, PLANT SOIL, V145, P107, DOI 10.1007/BF00009546; Dawson C.J., 2011, FOOD POLICY, V36, P14; GARDNER WK, 1983, PLANT SOIL, V70, P391, DOI 10.1007/BF02374894; GARDNER WK, 1981, PLANT SOIL, V60, P143, DOI 10.1007/BF02377120; George TS, 2002, PLANT SOIL, V246, P65, DOI 10.1023/A:1021523515707; George TS, 2006, EUR J SOIL SCI, V57, P47, DOI 10.1111/j.1365-2389.2005.00767.x; GERKE J, 1992, Z PFLANZ BODENKUNDE, V155, P339, DOI 10.1002/jpln.19921550417; GERKE J, 1994, Z PFLANZ BODENKUNDE, V157, P289, DOI 10.1002/jpln.19941570408; HAJABBASI MA, 1994, PLANT SOIL, V158, P39, DOI 10.1007/BF00007915; Hirata H, 1999, SOIL SCI PLANT NUTR, V45, P577; Hocking PJ, 2001, DEV PLANT SOIL SCI, V92, P548; Keerthisinghe G, 1998, PLANT CELL ENVIRON, V21, P467, DOI 10.1046/j.1365-3040.1998.00300.x; Lambers H., 1998, PLANT PHYSL ECOLOGY; Li CJ, 2005, J INTEGR PLANT BIOL, V47, P172, DOI 10.1111/j.1744-7909.2005.00012.x; Li MG, 1997, SOIL SCI PLANT NUTR, V43, P237; Lukito HP, 1998, SOIL BIOL BIOCHEM, V30, P865, DOI 10.1016/S0038-0717(98)00011-X; Murphy J., 1962, ANAL CHIM ACTA, V27, P31, DOI DOI 10.1016/S0003-2670(00)88444-5; Neumann G, 2000, ANN BOT-LONDON, V85, P909, DOI 10.1006/anbo.2000.1135; OZAWA K, 1995, SOIL SCI PLANT NUTR, V41, P461; Sekiya K, 1970, ANAL METHODS MEASURI, P251; Tang C, 1998, AUST J AGR RES, V49, P53; Tiessen H, 1993, SOIL SAMPLING METHOD, P104; Wang Z, 2006, PLANT SOIL, V287, P247, DOI 10.1007/s11104-006-9071-x	64	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0032-079X	1573-5036		PLANT SOIL	Plant Soil	MAY	2015	390	1-2					223	236		10.1007/s11104-015-2392-x		14	Agronomy; Plant Sciences; Soil Science	Agriculture; Plant Sciences	CG7IJ	WOS:000353476200016		
J	Takahashi, S; Seki, Y; Uchida, A; Nakayama, K; Satoh, H				Takahashi, S.; Seki, Y.; Uchida, A.; Nakayama, K.; Satoh, H.			Are tyrosine residues involved in the photoconversion of the water-soluble chlorophyll-binding protein of Chenopodium album?	PLANT BIOLOGY			English	Article						Chenopodium album; chlorophyll; Class I WSCP; DUF538; photoconversion; water-soluble chlorophyll-binding protein	MOLECULAR-CLONING; LEPIDIUM-VIRGINICUM; INTRACELLULAR-LOCALIZATION; FUNCTIONAL EXPRESSION; BRUSSELS-SPROUTS; OILSEED RAPE; BRASSICA; LEAVES; CRYSTALLIZATION; PURIFICATION	Non-photosynthetic and hydrophilic chlorophyll (Chl) proteins, called water-soluble Chl-binding proteins (WSCPs), are distributed in various species of Chenopodiaceae, Amaranthaceae, Polygonaceae and Brassicaceae. Based on their photoconvertibility, WSCPs are categorised into two classes: Class I (photoconvertible) and Class II (non-photoconvertible). Chenopodium album WSCP (CaWSCP; Class I) is able to convert the chlorin skeleton of Chl a into a bacteriochlorin-like skeleton under light in the presence of molecular oxygen. Potassium iodide (KI) is a strong inhibitor of the photoconversion. Because KI attacks tyrosine residues in proteins, tyrosine residues in CaWSCP are considered to be important amino acid residues for the photoconversion. Recently, we identified the gene encoding CaWSCP and found that the mature region of CaWSCP contained four tyrosine residues: Tyr13, Tyr14, Tyr87 and Tyr134. To gain insight into the effect of the tyrosine residues on the photoconversion, we constructed 15 mutant proteins (Y13A, Y14A, Y87A, Y134A, Y13-14A, Y13-87A, Y13-134A, Y14-87A, Y14-134A, Y87-134A, Y13-14-87A, Y13-14-134A, Y13-87-134A, Y14-87-134A and Y13-14-87-134A) using site-directed mutagenesis. Amazingly, all the mutant proteins retained not only chlorophyll-binding activity, but also photoconvertibility. Furthermore, we found that KI strongly inhibited the photoconversion of Y13-14-87-134A. These findings indicated that the four tyrosine residues are not essential for the photoconversion.	[Takahashi, S.; Seki, Y.; Uchida, A.; Nakayama, K.; Satoh, H.] Toho Univ, Dept Biomol Sci, Chiba 2748510, Japan	Satoh, H (reprint author), Toho Univ, Fac Sci, Dept Biomol Sci, 2-2-1 Miyama, Chiba 2748510, Japan.	hsatoh@biomol.sci.toho-u.ac.jp			Hamaguchi Foundation [H25]	This study was supported by a grant from the Hamaguchi Foundation for the Advancement of Biochemistry (grant number H25) to S.T.	Takahashi S, 2012, PLANT CELL PHYSIOL, V53, P879, DOI 10.1093/pcp/pcs031; Avice JC, 2014, J EXP BOT, V65, P3813, DOI 10.1093/jxb/eru177; Horigome D, 2003, ACTA CRYSTALLOGR D, V59, P2283, DOI 10.1107/S0907444903019127; D'Hooghe P, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-23; DOWNING WL, 1992, PLANT J, V2, P685; Renger G, 2011, J PLANT PHYSIOL, V168, P1462, DOI 10.1016/j.jplph.2010.12.005; Desclos M, 2008, PLANT PHYSIOL, V147, P1830, DOI 10.1104/pp.108.116905; Takahashi S, 2013, J PLANT PHYSIOL, V170, P406, DOI 10.1016/j.jplph.2012.10.007; Satoh H, 2001, PLANT CELL PHYSIOL, V42, P906, DOI 10.1093/pcp/pce117; Bektas I, 2012, PLANTA, V236, P251, DOI 10.1007/s00425-012-1609-y; COVELLI I, 1966, BIOCHEMISTRY-US, V5, P860, DOI 10.1021/bi00867a008; Hagar W. G., 1974, CARNEGIE I WASH YB, V73, P706; HAGAR WG, 1979, PLANT PHYSIOL, V63, P1182, DOI 10.1104/pp.63.6.1182; Hirabayashi H, 2006, J PHOTOCH PHOTOBIO A, V183, P121, DOI 10.1016/j.jphotochem.2006.03.003; ITOH R, 1982, PLANT CELL PHYSIOL, V23, P557; Kamimura Y, 1997, PLANT CELL PHYSIOL, V38, P133; Murata T., 1971, CARNEGIE I WASH YB, V70, P504; Murata T., 1968, COMP BIOCH BIOPHYSIC, P222; MURATA T, 1971, BIOCHIM BIOPHYS ACTA, V245, P208, DOI 10.1016/0005-2728(71)90023-5; MURATA T, 1981, BIOCHIM BIOPHYS ACTA, V635, P341, DOI 10.1016/0005-2728(81)90032-3; Noguchi T, 1999, PLANT CELL PHYSIOL, V40, P305; Ohtsuki T, 2007, ACTA CRYSTALLOGR F, V63, P740, DOI 10.1107/S1744309107035658; OKU T, 1972, PLANT CELL PHYSIOL, V13, P773; OKU T, 1975, PLANT CELL PHYSIOL, V16, P1009; OKU T, 1972, PLANT CELL PHYSIOL, V13, P183; Satoh H, 1998, J BIOL CHEM, V273, P30568, DOI 10.1074/jbc.273.46.30568; Shinashi K, 2000, J PLANT PHYSIOL, V157, P255; SPRINGELL PH, 1962, BIOCHIM BIOPHYS ACTA, V63, P136, DOI 10.1016/0006-3002(62)90346-3; Takahashi S, 2013, PLANTA, V238, P1065, DOI 10.1007/s00425-013-1952-7; Takahashi S, 2014, PROTEIN J, V33, P75, DOI 10.1007/s10930-013-9539-5; Takahashi S., 2014, BIOSCIENCE BIOTECHNO, V25, P1; Takahashi S, 2015, BIOSCI BIOTECH BIOCH, V79, P205, DOI 10.1080/09168451.2014.972326; Takahashi S, 2013, J PLANT PHYSIOL, V170, P1549, DOI 10.1016/j.jplph.2013.06.001; Takahashi S, 2014, PROTEIN J, V33, P337, DOI 10.1007/s10930-014-9565-y; Takamiya A., 1973, CARNEGIE I WASH YB, V72, P330; Takamiya A., 1968, COMP BIOCH BIOPHYSIC, P229; YAKUSHIJI E, 1963, BIOCHIM BIOPHYS ACTA, V75, P293, DOI 10.1016/0006-3002(63)90615-2	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1435-8603	1438-8677		PLANT BIOLOGY	Plant Biol.	MAY	2015	17	3					632	638		10.1111/plb.12274		7	Plant Sciences	Plant Sciences	CG1TN	WOS:000353057300006		
J	Minagawa, J; Tokutsu, R				Minagawa, Jun; Tokutsu, Ryutaro			Dynamic regulation of photosynthesis in Chlamydomonas reinhardtii	PLANT JOURNAL			English	Review						acclimation; light-harvesting complex; non-photochemical quenching; state transitions; cyclic electron flow; green algae; electron transfer; Chlamydomonas reinhardtii	CYCLIC ELECTRON FLOW; LIGHT-HARVESTING-COMPLEX; PHOTOSYSTEM-II COMPLEXES; PHOTOPROTECTIVE ENERGY-DISSIPATION; HIGHER-PLANT CHLOROPLASTS; OXYGEN-EVOLVING COMPLEX; PIGMENT-BINDING PROTEIN; STATE TRANSITIONS; CHLOROPHYLL FLUORESCENCE; GRANA MEMBRANES	Plants and algae have acquired the ability to acclimatize to ever-changing environments to survive. During photosynthesis, light energy is converted by several membrane protein supercomplexes into electrochemical energy, which is eventually used to assimilate CO2. The efficiency of photosynthesis is modulated by many environmental factors, including temperature, drought, CO2 concentration, and the quality and quantity of light. Recently, our understanding of such regulators of photosynthesis and the underlying molecular mechanisms has increased considerably. The photosynthetic supercomplexes undergo supramolecular reorganizations within a short time after receiving environmental cues. These reorganizations include state transitions that balance the excitation of the two photosystems: qE quenching, which thermally dissipates excess energy at the level of the light-harvesting antenna, and cyclic electron flow, which supplies the increased ATP demanded by CO2 assimilation and the pH gradient to activate qE quenching. This review focuses on the recent findings regarding the environmental regulation of photosynthesis in model organisms, paying particular attention to the unicellular green alga Chlamydomonas reinhardtii, which offer a glimpse into the dynamic behavior of photosynthetic machinery in nature. Significance Statement Photosynthesis is dynamically regulated by environmental cues. This review provides an overview of recent findings on representative mechanisms involved in regulating photosynthesis, including state transitions, qE quenching, and cyclic electron flow in Chlamydomonas reinhardtii.	[Minagawa, Jun; Tokutsu, Ryutaro] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 4448585, Japan; [Minagawa, Jun; Tokutsu, Ryutaro] Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Minagawa, Jun; Tokutsu, Ryutaro] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Minagawa, J (reprint author), Natl Inst Nat Sci, Natl Inst Basic Biol, Div Environm Photobiol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	minagawa@nibb.ac.jp			New Energy and Industrial Technology Development Organization; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology	The work performed in our laboratory was partially supported by the New Energy and Industrial Technology Development Organization, the Japan Society for the Promotion of Science, and the Ministry of Education, Culture, Sports, Science and Technology.	Seelert H, 2000, NATURE, V405, P418; Petroutsos D, 2011, PLANT CELL, V23, P2950, DOI 10.1105/tpc.111.087973; Tolleter D, 2011, PLANT CELL, V23, P2619, DOI 10.1105/tpc.111.086876; Finazzi G, 2006, BIOCHEMISTRY-US, V45, P1490, DOI 10.1021/bi0521588; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Terashima M, 2012, P NATL ACAD SCI USA, V109, P17717, DOI 10.1073/pnas.1207118109; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Nagy G, 2014, P NATL ACAD SCI USA, V111, P5042, DOI 10.1073/pnas.1322494111; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; Tokutsu R, 2012, J BIOL CHEM, V287, P31574, DOI 10.1074/jbc.M111.331991; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.2307/3870716; YAMAMOTO HY, 1962, ARCH BIOCHEM BIOPHYS, V97, P168, DOI 10.1016/0003-9861(62)90060-7; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Mustardy L, 2003, TRENDS PLANT SCI, V8, P117, DOI 10.1016/S1360-1385(03)00015-3; Nield J, 2000, PHILOS T ROY SOC B, V355, P1337; BOEKEMA EJ, 1987, FEBS LETT, V217, P283, DOI 10.1016/0014-5793(87)80679-8; Unlu C, 2014, P NATL ACAD SCI USA, V111, P3460, DOI 10.1073/pnas.1319164111; Hertle AP, 2013, MOL CELL, V49, P511, DOI 10.1016/j.molcel.2012.11.030; Iwai M, 2010, P NATL ACAD SCI USA, V107, P2337, DOI 10.1073/pnas.0908808107; Avenson TJ, 2005, P NATL ACAD SCI USA, V102, P9709, DOI 10.1073/pnas.0503952102; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Demmig-Adams B, 2006, PHYSIOL PLANTARUM, V127, P670, DOI 10.1111/j.1399-3054.2006.00698.x; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Breyton C, 2006, BIOCHEMISTRY-US, V45, P13465, DOI 10.1021/bi061439s; Jensen PE, 2004, J BIOL CHEM, V279, P24212, DOI 10.1074/jbc.M403147200; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Drop B, 2011, J BIOL CHEM, V286, P44878, DOI 10.1074/jbc.M111.301101; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Livingston AK, 2010, PLANT CELL, V22, P221, DOI 10.1105/tpc.109.071084; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Kukuczka B, 2014, PLANT PHYSIOL, V165, P1604, DOI 10.1104/pp.114.240648; Joliot P, 2002, P NATL ACAD SCI USA, V99, P10209, DOI 10.1073/pnas.102306999; Lucker B, 2013, PHOTOSYNTH RES, V117, P449, DOI 10.1007/s11120-013-9932-0; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; OGAWA T, 1991, P NATL ACAD SCI USA, V88, P4275, DOI 10.1073/pnas.88.10.4275; Boekema EJ, 1998, EUR J BIOCHEM, V252, P268, DOI 10.1046/j.1432-1327.1998.2520268.x; Houille-Vernes L, 2011, P NATL ACAD SCI USA, V108, P20820, DOI 10.1073/pnas.1110518109; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Minagawa J, 2004, PHOTOSYNTH RES, V82, P241, DOI 10.1007/s11120-004-2079-2; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; Suorsa M, 2012, PLANT CELL, V24, P2934, DOI 10.1105/tpc.112.097162; Sonoike K, 2011, PHYSIOL PLANTARUM, V142, P56, DOI 10.1111/j.1399-3054.2010.01437.x; Nield J, 2000, NAT STRUCT BIOL, V7, P44; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V189, P182, DOI 10.1016/0005-2728(69)90046-2; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; Wilk L, 2013, P NATL ACAD SCI USA, V110, P5452, DOI 10.1073/pnas.1205561110; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; FUNK C, 1994, FEBS LETT, V342, P261, DOI 10.1016/0014-5793(94)80513-X; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kereiche S, 2010, FEBS LETT, V584, P759, DOI 10.1016/j.febslet.2009.12.031; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; WOLLMAN FA, 1988, BIOCHIM BIOPHYS ACTA, V933, P85, DOI 10.1016/0005-2728(88)90058-8; Shimoni E, 2005, PLANT CELL, V17, P2580, DOI 10.1105/tpc.105.035030; Horton P, 2008, FEBS J, V275, P1069, DOI 10.1111/j.1742-4658.2008.06263.x; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Johnson GN, 2011, BBA-BIOENERGETICS, V1807, P384, DOI 10.1016/j.bbabio.2010.11.009; Tokutsu R, 2009, J BIOL CHEM, V284, P7777, DOI 10.1074/jbc.M809360200; Cardol P, 2009, P NATL ACAD SCI USA, V106, P15979, DOI 10.1073/pnas.0908111106; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1005/tpc.002154; Yakushevska AE, 2001, EUR J BIOCHEM, V268, P6020, DOI 10.1046/j.0014-2956.2001.02505.x; Haldrup A, 2001, TRENDS PLANT SCI, V6, P301, DOI 10.1016/S1360-1385(01)01953-7; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Stauber EJ, 2009, PROTEOMICS, V9, P398, DOI 10.1002/pmic.200700620; BULTE L, 1990, BIOCHIM BIOPHYS ACTA, V1020, P72, DOI 10.1016/0005-2728(90)90095-L; Drop B, 2014, PLANT J, V78, P181, DOI 10.1111/tpj.12459; Teramoto H, 2001, PLANT CELL PHYSIOL, V42, P849, DOI 10.1093/pcp/pce115; Tokutsu R, 2013, P NATL ACAD SCI USA, V110, P10016, DOI 10.1073/pnas.1222606110; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Mullineaux CW, 2005, TRENDS PLANT SCI, V10, P521, DOI 10.1016/j.tplants.2005.09.001; WRAIGHT CA, 1971, EUR J BIOCHEM, V19, P386, DOI 10.1111/j.1432-1033.1971.tb01328.x; Dominici P, 2002, J BIOL CHEM, V277, P22750, DOI 10.1074/jbc.M200604200; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; Joliot P, 2011, P NATL ACAD SCI USA, V108, P13317, DOI 10.1073/pnas.1110189108; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Goral TK, 2012, PLANT J, V69, P289, DOI 10.1111/j.1365-313X.2011.04790.x; Kiss AZ, 2008, J BIOL CHEM, V283, P3972, DOI 10.1074/jbc.M707410200; Amarie S, 2007, J PHYS CHEM B, V111, P3481, DOI 10.1021/jp066458q; Allorent G, 2013, PLANT CELL, V25, P545, DOI 10.1105/tpc.112.108274; Petroutsos D, 2009, J BIOL CHEM, V284, P32770, DOI 10.1074/jbc.M109.050468; Minagawa J, 2011, BBA-BIOENERGETICS, V1807, P897, DOI 10.1016/j.bbabio.2010.11.005; Ferrante P, 2012, J BIOL CHEM, V287, P16276, DOI 10.1074/jbc.M111.316729; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; GAGNE G, 1992, PLANT MOL BIOL, V18, P429, DOI 10.1007/BF00040659; Boekema EJ, 1999, EUR J BIOCHEM, V266, P444, DOI 10.1046/j.1432-1327.1999.00876.x; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Richard C, 2000, PLANT MOL BIOL, V42, P303, DOI 10.1023/A:1006340308077; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Nield J, 2000, J BIOL CHEM, V275, P27940; TAGAWA K, 1963, P NATL ACAD SCI USA, V49, P567, DOI 10.1073/pnas.49.4.567; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275; Dall'Osto L, 2012, J BIOL CHEM, V287, P41820, DOI 10.1074/jbc.M112.405498; Niyogi KK, 1997, PLANT CELL, V9, P1369; Johnson X, 2014, PLANT PHYSIOL, V165, P438, DOI 10.1104/pp.113.233593; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Watanabe M, 2011, PLANT CELL PHYSIOL, V52, P162, DOI 10.1093/pcp/pcq183; Ruban AV, 2003, NATURE, V421, P648, DOI 10.1038/nature01344; Galka P, 2012, PLANT CELL, V24, P2963, DOI 10.1105/tpc.112.100339; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; Sacksteder CA, 2000, P NATL ACAD SCI USA, V97, P14283, DOI 10.1073/pnas.97.26.14283; Anwaruzzaman M, 2004, PHOTOSYNTH RES, V82, P265, DOI 10.1007/s11120-004-2439-y; Bertos NR, 1998, J PHYCOL, V34, P1009, DOI 10.1046/j.1529-8817.1998.341009.x; BONAVENT.C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; DEMMIG B, 1987, PLANT PHYSIOL, V84, P218, DOI 10.1104/pp.84.2.218; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; desBianchi S., 2008, PLANT CELL, V20, P1012; desBianchi S., 2010, BIOCHEM SOC T, V38, P651; Fisher N, 2014, BBA-BIOENERGETICS, V1837, P1944, DOI 10.1016/j.bbabio.2014.09.005; FUNK C, 1995, BIOCHEMISTRY-US, V34, P11133, DOI 10.1021/bi00035a019; Govindjee, 1967, FLUORESCENCE THEORY, P511; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; Kirchhoff H, 2004, BBA-BIOENERGETICS, V1659, P63, DOI 10.1016/j.bbabio.2004.08.004; Kouil R., 2011, BIOCHIM BIOPHYS ACTA, V1807, P368; LAISK A, 1993, P ROY SOC B-BIOL SCI, V251, P243, DOI 10.1098/rspb.1993.0036; Leister D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00161; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Maruyama S, 2014, PLANT CELL PHYSIOL, V55, P1304, DOI 10.1093/pcp/pcu068; Minagawa J, 2009, CHLAMYDOMONAS SOURCE, V2, P503, DOI DOI 10.1016/B978-0-12-370873-1.00022-8; Miura K, 2004, PLANT PHYSIOL, V135, P1595, DOI 10.1104/pp.104.041400; MOSS DA, 1984, BIOCHIM BIOPHYS ACTA, V767, P389, DOI 10.1016/0005-2728(84)90036-7; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; Nandha B, 2007, BBA-BIOENERGETICS, V1767, P1252, DOI 10.1016/j.bbabio.2007.07.007; Nevo R, 2009, ADV PHOTOSYNTH RESP, V30, P295; Nield J, 2004, EUKARYOT CELL, V3, P1370, DOI 10.1128/EC.3.6.1370-1380.2004; Sugimoto K, 2013, PLANT CELL PHYSIOL, V54, P1525, DOI 10.1093/pcp/pct098; Sylak-Glassman EJ, 2014, P NATL ACAD SCI USA, V111, P17498, DOI 10.1073/pnas.1418317111; Takahashi H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2954; Takahashi H, 2014, PLANT CELL PHYSIOL, V55, P1437, DOI 10.1093/pcp/pcu071; Tokutsu R, 2004, PLANT CELL PHYSIOL, V45, P138, DOI 10.1093/pcp/pch013; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	156	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	MAY	2015	82	3					413	428		10.1111/tpj.12805		16	Plant Sciences	Plant Sciences	CG7QR	WOS:000353500000005		
J	Tamiru, M; Undan, JR; Takagi, H; Abe, A; Yoshida, K; Undan, JQ; Natsume, S; Uemura, A; Saitoh, H; Matsumura, H; Urasaki, N; Yokota, T; Terauchi, R				Tamiru, Muluneh; Undan, Jerwin R.; Takagi, Hiroki; Abe, Akira; Yoshida, Kakoto; Undan, Jesusa Q.; Natsume, Satoshi; Uemura, Aiko; Saitoh, Hiromasa; Matsumura, Hideo; Urasaki, Naoya; Yokota, Takao; Terauchi, Ryohei			A cytochrome P450, OsDSS1, is involved in growth and drought stress responses in rice (Oryza sativa L.)	PLANT MOLECULAR BIOLOGY			English	Article						ABA; Drought tolerance; DSS1/CYP96B4; Dwarf; GA; Lipid metabolism	TANDEM MASS-SPECTROMETRY; ABSCISIC-ACID; EXPRESSION ANALYSIS; SEED DORMANCY; GIBBERELLIN METABOLISM; INTERNODE ELONGATION; TRANSCRIPTION FACTOR; PLANT EVOLUTION; GENE CLUSTERS; ARABIDOPSIS	Cytochrome P450s are among the largest protein coding gene families in plant genomes. However, majority of the genes remain uncharacterized. Here, we report the characterization of dss1, a rice mutant showing dwarfism and reduced grain size. The dss1 phenotype is caused by a non-synonymous point mutation we identified in DSS1, which is member of a P450 gene cluster located on rice chromosome 3 and corresponds to the previously reported CYP96B4/SD37 gene. Phenotypes of several dwarf mutants characterized in rice are associated with defects in the biosynthesis or perception of the phytohormones gibberellins (GAs) and brassinosteroids (BRs). However, both GA and BR failed to rescue the dss1 phenotype. Hormone profiling revealed the accumulation of abscisic acid (ABA) and ABA metabolites, as well as significant reductions in GA(19) and GA(53) levels, precursors of the bioactive GA(1), in the mutant. The dss1 contents of cytokinin and auxins were not significantly different from wild-type plants. Consistent with the accumulation of ABA and metabolites, germination and early growth was delayed in dss1, which also exhibited an enhanced tolerance to drought. Additionally, expressions of members of the DSS1/CYP96B gene cluster were regulated by drought stress and exogenous ABA. RNA-seq-based transcriptome profiling revealed, among others, that cell wall-related genes and genes involved in lipid metabolism were up- and down-regulated in dss1, respectively. Taken together, these findings suggest that DSS1 mediates growth and stress responses in rice by fine-tuning GA-to-ABA balance, and might as well play a role in lipid metabolism.	[Tamiru, Muluneh; Undan, Jerwin R.; Takagi, Hiroki; Abe, Akira; Yoshida, Kakoto; Undan, Jesusa Q.; Natsume, Satoshi; Uemura, Aiko; Saitoh, Hiromasa; Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Kitakami, Iwate 0240003, Japan; [Matsumura, Hideo] Shinshu Univ, Ctr Gene Res, Ueda, Nagano 3868567, Japan; [Urasaki, Naoya] Okinawa Prefectural Agr Res Ctr, Itoman, Okinawa 9010336, Japan; [Yokota, Takao] Teikyo Univ, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan	Tamiru, M (reprint author), Iwate Biotechnol Res Ctr, 22-174-4 Narita, Kitakami, Iwate 0240003, Japan.	olimt@ibrc.or.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan [PMI-0010]; Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) Japan; Ministry of Education, Cultures, Sports and Technology, Japan [23113009]; Japan Society for the Promotion of Science (JSPS) [24248004]; Japanese Government	This work was partly supported by the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics for Agricultural Innovation PMI-0010), by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) Japan, by Grant-in-aid for Scientific Research from the Ministry of Education, Cultures, Sports and Technology, Japan (Grant-in-Aid for Scientific Research on Innovative Areas 23113009), and by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) (Grant No. 24248004) to RT. JRU was supported by the Japanese Government Scholarship Grant for Foreign Students (Monbukagusho) for his Ph.D. study.	Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Li WQ, 2010, PLANTA, V232, P1383, DOI 10.1007/s00425-010-1263-1; Wellesen K, 2001, P NATL ACAD SCI USA, V98, P9694, DOI 10.1073/pnas.171285998; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Asano K, 2009, MOL GENET GENOMICS, V281, P223, DOI 10.1007/s00438-008-0406-6; Ross ARS, 2004, ANAL BIOCHEM, V329, P324, DOI 10.1016/j.ab.2004.02.026; Gao ZY, 2009, PLANT MOL BIOL, V71, P265, DOI 10.1007/s11103-009-9522-x; Richter R, 2010, GENE DEV, V24, P2093, DOI 10.1101/gad.594910; Li GW, 2008, J PLANT PHYSIOL, V165, P1879, DOI 10.1016/j.jplph.2008.05.002; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Reiter WD, 2002, CURR OPIN PLANT BIOL, V5, P536, DOI 10.1016/S1369-5266(02)00306-0; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Liu CT, 2014, PLANT MOL BIOL, V84, P19, DOI 10.1007/s11103-013-0115-3; Hirano K, 2008, TRENDS PLANT SCI, V13, P192, DOI 10.1016/j.tplants.2008.02.005; Asano K, 2007, BREEDING SCI, V57, P53, DOI 10.1270/jsbbs.57.53; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Nutzmann HW, 2014, CURR OPIN BIOTECH, V26, P91, DOI 10.1016/j.copbio.2013.10.009; Garg R, 2010, DNA RES, V17, P353, DOI 10.1093/dnares/dsq023; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Chu HY, 2011, PLANT J, V66, P66, DOI 10.1111/j.1365-313X.2011.04503.x; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088068; Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Chiwocha SDS, 2005, PLANT J, V42, P35, DOI 10.1111/j.1365-313X.2005.02359.x; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Seo M, 2006, PLANT J, V48, P354, DOI 10.1111/j.1365-313X.2006.02881.x; Mori M, 2002, PLANT PHYSIOL, V130, P1152, DOI 10.1104/pp.007179; Xie XD, 2006, CURR BIOL, V16, P882, DOI 10.1016/j.cub.2006.03.028; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Kanwar P, 2014, CELL CALCIUM, V56, P81, DOI 10.1016/j.ceca.2014.05.003; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Wu YS, 2011, FEBS LETT, V585, P3446, DOI 10.1016/j.febslet.2011.09.038; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Chiwocha SDS, 2003, PLANT J, V35, P405, DOI 10.1046/j.1365-313X.2003.01800.x; Oh E, 2006, PLANT J, V47, P124, DOI 10.1111/j.1365-313X.2006.02773.x; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; McCourt P, 2008, CURR OPIN PLANT BIOL, V11, P474, DOI 10.1016/j.pbi.2008.06.014; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Yang XC, 2008, HEREDITY, V101, P396, DOI 10.1038/hdy.2008.90; Asano K, 2010, P JPN ACAD B-PHYS, V86, P265, DOI 10.2183/pjab.86.265; Bishop G.J., 2002, PLANT CELL, V14, P97; de Saint Germain A, 2013, PLANT PHYSIOL, V163, P1012, DOI 10.1104/pp.113.220541; Feurtado JA, 2011, PLANT CELL, V23, P1772, DOI 10.1105/tpc.111.085134; Hong Z, 2004, J PESTIC SCI, V29, P184, DOI 10.1584/jpestics.29.184; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Kim GT, 2002, J PLANT RES, V115, P169, DOI 10.1007/s102650200022; Kojima Mikiko, 2012, Methods Mol Biol, V918, P151, DOI 10.1007/978-1-61779-995-2_11; Komorisono M, 2005, PLANT PHYSIOL, V138, P1982, DOI 10.1104/pp.105.062968; Nakagawa T, 2009, PLANT BIOTECHNOL, V26, P275, DOI 10.5511/plantbiotechnology.26.275; Sujay Rakshit, 2010, The handbook of plant mutation screening: mining of natural and induced alleles, P187; Ramamoorthy R, 2011, PLOS ONE, V6, P1; Razem FA, 2006, CURR OPIN PLANT BIOL, V9, P454, DOI 10.1016/j.pbi.2006.07.007; Sazuka T, 2005, PLANT CELL PHYSIOL, V46, P1934, DOI 10.1093/pcp/pci206; Takagi H, 2015, NAT BIOTECH IN PRESS; Werck-Reichhart D, 2002, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0028; Xu MR, 2013, PLANT MOL BIOL REP, V31, P877, DOI 10.1007/s11105-013-0559-2; You J, 2014, PLANT PHYSIOL, V166, P2100, DOI 10.1104/pp.114.251116; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x; Zhou HL, 2006, PLANT MOL BIOL, V60, P137, DOI 10.1007/s11103-005-2972-x	69	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4412	1573-5028		PLANT MOL BIOL	Plant Mol.Biol.	MAY	2015	88	1-2					85	99		10.1007/s11103-015-0310-5		15	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CG6IQ	WOS:000353403600007		
J	Bashir, K; Ishimaru, Y; Itai, RN; Senoura, T; Takahashi, M; An, G; Oikawa, T; Ueda, M; Sato, A; Uozumi, N; Nakanishi, H; Nishizawa, NK				Bashir, Khurram; Ishimaru, Yasuhiro; Itai, Reiko Nakanishi; Senoura, Takeshi; Takahashi, Michiko; An, Gynheung; Oikawa, Takaya; Ueda, Minoru; Sato, Aiko; Uozumi, Nobuyuki; Nakanishi, Hiromi; Nishizawa, Naoko K.			Iron deficiency regulated OsOPT7 is essential for iron homeostasis in rice	PLANT MOLECULAR BIOLOGY			English	Article						Oryza sativa; Iron; Iron deficiency; Ferritin; Oligopeptide transporter	METAL-NICOTIANAMINE TRANSPORTER; BHLH TRANSCRIPTION FACTOR; LONG-DISTANCE TRANSPORT; GRAMINEOUS PLANTS; OLIGOPEPTIDE TRANSPORTERS; APOPLASMIC IRON; SYNTHASE GENES; FERRITIN GENE; ARABIDOPSIS; EXPRESSION	The molecular mechanism of iron (Fe) uptake and transport in plants are well-characterized; however, many components of Fe homeostasis remain unclear. We cloned iron-deficiency-regulated oligopeptide transporter 7 (OsOPT7) from rice. OsOPT7 localized to the plasma membrane and did not transport Fe(III)-DMA or Fe(II)-NA and GSH in Xenopus laevis oocytes. Furthermore OsOPT7 did not complement the growth of yeast fet3fet4 mutant. OsOPT7 was specifically upregulated in response to Fe-deficiency. Promoter GUS analysis revealed that OsOPT7 expresses in root tips, root vascular tissue and shoots as well as during seed development. Microarray analysis of OsOPT7 knockout 1 (opt7-1) revealed the upregulation of Fe-deficiency-responsive genes in plants grown under Fe-sufficient conditions, despite the high Fe and ferritin concentrations in shoot tissue indicating that Fe may not be available for physiological functions. Plants overexpressing OsOPT7 do not exhibit any phenotype and do not accumulate more Fe compared to wild type plants. These results indicate that OsOPT7 may be involved in Fe transport in rice.	[Bashir, Khurram; Ishimaru, Yasuhiro; Itai, Reiko Nakanishi; Takahashi, Michiko; Nakanishi, Hiromi; Nishizawa, Naoko K.] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Bashir, Khurram] RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Ishimaru, Yasuhiro; Oikawa, Takaya; Ueda, Minoru] Tohoku Univ, Grad Sch Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Senoura, Takeshi; Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [An, Gynheung] Kyung Hee Univ, Dept Plant Mol Syst, Biotech & Crop Biotech Inst, Yongin 446701, South Korea; [Sato, Aiko; Uozumi, Nobuyuki] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808578, Japan	Nishizawa, NK (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	annaoko@mail.ecc.u-tokyo.ac.jp	Bashir, Khurram/C-6870-2011; Nakanishi, Hiromi/C-6461-2015	Bashir, Khurram/0000-0001-7123-8380; Nakanishi, Hiromi/0000-0001-5556-5058	Ministry of Agriculture, Forestry, and Fisheries of Japan [IP-5003]; Japanese Agency for the promotion of Science	This work was supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Green Technology Project IP-5003). K.B. was supported by Japanese Agency for the promotion of Science. We also express our thanks to Dr. Takanori Kobayashi for critically reading this manuscript. We are also obliged to Houdo Tanaka (The University of Tokyo) for assisting our experiments.	Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Lee S, 2009, PLANT PHYSIOL, V150, P786, DOI 10.1104/pp.109.135418; Mendoza-Cozatl DG, 2014, MOL PLANT, V7, P1455, DOI 10.1093/mp/ssu067; Nozoye T, 2014, PLANT J, V77, P246, DOI 10.1111/tpj.12383; Nozoye Tomoko, 2011, J Biol Chem, V286, P5446, DOI 10.1074/jbc.M110.180026; Mori S, 1999, CURR OPIN PLANT BIOL, V2, P250, DOI 10.1016/S1369-5266(99)80043-0; Ogo Y, 2006, J EXP BOT, V57, P2867, DOI 10.1093/jxb/erl054; Zhang MY, 2004, PLANT PHYSIOL, V134, P482, DOI 10.1104/pp.103.030940; Lingam S, 2011, PLANT CELL, V23, P1815, DOI 10.1105/tpc.111.084715; Bashir K, 2010, RICE, V3, P122, DOI 10.1007/s12284-010-9042-y; Kato Y, 2001, P NATL ACAD SCI USA, V98, P6488, DOI 10.1073/pnas.101556598; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Zhai ZY, 2014, PLANT CELL, V26, P2249, DOI 10.1105/tpc.114.123737; GUERINOT ML, 1994, PLANT PHYSIOL, V104, P815; Yokosho K, 2009, PLANT PHYSIOL, V149, P297, DOI 10.1104/pp.108.128132; Bashir K, 2011, SOIL SCI PLANT NUTR, V57, P803, DOI 10.1080/00380768.2011.637305; Ishimaru Y, 2010, PLANT J, V62, P379, DOI 10.1111/j.1365-313X.2010.04158.x; Inoue H, 2003, PLANT J, V36, P366, DOI 10.1046/j.1365-313X.2003.01878.x; Ryu CH, 2009, PLANT CELL ENVIRON, V32, P1412, DOI 10.1111/j.1365-3040.2009.02008.x; Bashir K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00015; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Ishimaru Y, 2007, P NATL ACAD SCI USA, V104, P7373, DOI 10.1073/pnas.0610555104; Bashir K, 2007, PLANT MOL BIOL, V65, P277, DOI 10.1007/s11103-007-9216-1; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; TAKAGI S, 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; Inoue H, 2009, J BIOL CHEM, V284, P3470, DOI 10.1074/jbc.M806042200; Ishimaru Y, 2011, J BIOL CHEM, V286, P24649, DOI 10.1074/jbc.M111.221168; MARSCHNER H, 1986, J PLANT NUTR, V9, P695, DOI 10.1080/01904168609363475; Kakei Y, 2012, PLANT MOL BIOL, V79, P583, DOI 10.1007/s11103-012-9930-1; TAKAGI SI, 1976, SOIL SCI PLANT NUTR, V22, P423; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; Nishiyama R, 2012, PLANT CELL PHYSIOL, V53, P381, DOI 10.1093/pcp/pcr188; Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Stacey MG, 2008, PLANT PHYSIOL, V146, P589, DOI 10.1104/pp.107.108183; Bashir K, 2006, PLANT SIGNAL BEHAV, V1, P292, DOI [10.4161/psb.1.6.3590, DOI 10.4161/PSB.1.6.3590]; Bashir K, 2014, RICE, V7, DOI 10.1186/s12284-014-0018-1; Bashir K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1326; Bashir K, 2013, RICE, V6, P1; Bashir Khurram, 2011, Plant Signal Behav, V6, P1591, DOI 10.4161/psb.6.10.17132; Bashir K, 2013, BIOTECHNOL ADV, V31, P1624, DOI 10.1016/j.biotechadv.2013.08.012; Bogs J, 2003, PLANT CELL ENVIRON, V26, P1703, DOI 10.1046/j.1365-3040.2003.01088.x; Briat JF, 2010, ANN BOT-LONDON, V105, P811, DOI 10.1093/aob/mcp128; ENGLERBLUM G, 1993, ANAL BIOCHEM, V210, P235, DOI 10.1006/abio.1993.1189; Goto F, 1998, TRANSGENIC RES, V7, P173, DOI 10.1023/A:1008836812714; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Ishimaru Y, 2009, MOL PLANT, V2, P1059, DOI 10.1093/mp/ssp051; Ishimaru Yasuhiro, 2011, Plant Signal Behav, V6, P1624, DOI 10.4161/psb.6.10.17694; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; LESCURE AM, 1991, P NATL ACAD SCI USA, V88, P8222, DOI 10.1073/pnas.88.18.8222; Liu T, 2012, RICE, V5, DOI 10.1186/1939-8433-5-12; MARSCHNER H., 1995, MINERAL NUTR HIGHER; Nozoye T, 2014, PLANT SIG BEH, V9, DOI [10. 4161/ psb. 28660, DOI 10.4161/PSB.28660]; Pang S, 2010, PROG BIOCHEM BIOPHYS, V37, P1120, DOI 10.3724/SP.J.1206.2010.00188; Stacey MG, 2006, PLANTA, V223, P291, DOI 10.1007/s00425-005-0087-x; Van Wuytswinkel O, 1999, PLANT J, V17, P93, DOI 10.1046/j.1365-313X.1999.00349.x; Vasconcelos MW, 2008, PLANT GENOME-US, V1, P77, DOI 10.3835/plantgenome2007.10.0540; Wiles AM, 2006, RES MICROBIOL, V157, P395, DOI 10.1016/j.resmic.2005.10.004; World Health Organisation, 2002, WORLD HLTH REP 2002; Yamaji N, 2014, TRENDS PLANT SCI, V19, P556, DOI 10.1016/j.tplants.2014.05.007; Yoshihara T, 2003, PLANT BIOTECHNOL-NAR, V20, P33, DOI 10.5511/plantbiotechnology.20.33; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x	63	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4412	1573-5028		PLANT MOL BIOL	Plant Mol.Biol.	MAY	2015	88	1-2					165	176		10.1007/s11103-015-0315-0		12	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CG6IQ	WOS:000353403600012		
J	Campbell, R; Morris, WL; Mortimer, CL; Misawa, N; Ducreux, LJM; Morris, JA; Hedley, PE; Fraser, PD; Taylor, MA				Campbell, Raymond; Morris, Wayne L.; Mortimer, Cara L.; Misawa, Norihiko; Ducreux, Laurence J. M.; Morris, Jenny A.; Hedley, Pete E.; Fraser, Paul D.; Taylor, Mark A.			Optimising ketocarotenoid production in potato tubers: Effect of genetic background, transgene combinations and environment	PLANT SCIENCE			English	Article						Astaxanthin; Carotenoid; Environment; Ketocarotenoid; Microarray; Potato	BETA-CAROTENE KETOLASES; TIME RT-PCR; ESCHERICHIA-COLI; HAEMATOCOCCUS-PLUVIALIS; COMPLEMENTATION ANALYSIS; ASTAXANTHIN PRODUCTION; CARROT PLANTS; BIOSYNTHESIS; ACCUMULATION; EXPRESSION	Astaxanthin is a high value carotenoid produced by some bacteria, a few green algae, several fungi but only a limited number of plants from the genus Adonis. Astaxanthin has been industrially exploited as a feed supplement in poultry farming and aquaculture. Consumption of ketocarotenoids, most notably astaxanthin, is also increasingly associated with a wide range of health benefits, as demonstrated in numerous clinical studies. Currently astaxanthin is produced commercially by chemical synthesis or from algal production systems. Several studies have used a metabolic engineering approach to produce astaxanthin in transgenic plants. Previous attempts to produce transgenic potato tubers biofortified with astaxanthin have met with limited success. In this study we have investigated approaches to optimising tuber astaxanthin content. It is demonstrated that the selection of appropriate parental genotype for transgenic approaches and stacking carotenoid biosynthetic pathway genes with the cauliflower Or gene result in enhanced astaxanthin content, to give six-fold higher tuber astaxanthin content than has been achieved previously. Additionally we demonstrate the effects of growth environment on tuber carotenoid content in both wild type and astaxanthin-producing transgenic lines and describe the associated transcriptome and metabolome restructuring. Crown Copyright (C) 2015 Published by Elsevier Ireland Ltd. All rights reserved.	[Campbell, Raymond; Morris, Wayne L.; Ducreux, Laurence J. M.; Morris, Jenny A.; Hedley, Pete E.; Taylor, Mark A.] James Hutton Inst, Cellular & Mol Sci, Dundee DD2 5DA, Scotland; [Mortimer, Cara L.; Fraser, Paul D.] Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [Misawa, Norihiko] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Iskhikawa 9218836, Japan	Taylor, MA (reprint author), James Hutton Inst, Cellular & Mol Sci, Dundee DD2 5DA, Scotland.	Mark.Taylor@hutton.ac.uk		Mortimer, Cara/0000-0003-2170-9556	EU-FP7 METAPRO [244348]; Scottish Government Rural and Environment Science and Analytical Services Division (; European Community's Seventh Framework Programme (FP7) [613513]; New Energy and Industrial Technology Development Organisation (NEDO), Japan	This work was funded by the EU-FP7 METAPRO 244348 (PDF and MT), the Scottish Government Rural and Environment Science and Analytical Services Division (MT). Additionally research from the DISCO-project leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement 613513. N.M is grateful to Central laboratories for Frontier technology, Kirin Holdings Company, Limited, Japan supported by the New Energy and Industrial Technology Development Organisation (NEDO), Japan. We thank Dr. Li Li, USDA-ARS, Cornell for proving the pBI-GBSS-OR construct.	Ahn MJ, 2012, PLANT BIOTECHNOL REP, V6, P133, DOI 10.1007/s11816-011-0206-z; Cunningham FX, 2011, PLANT CELL, V23, P3055, DOI 10.1105/tpc.111.086827; Mann V, 2000, NAT BIOTECHNOL, V18, P888, DOI 10.1038/78515; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Lopez AB, 2008, J EXP BOT, V59, P213, DOI 10.1093/jxb/erm299; JYONOUCHI H, 1995, NUTR CANCER, V23, P171; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; RENSTROM B, 1981, PHYTOCHEMISTRY, V20, P2561, DOI 10.1016/0031-9422(81)83094-4; van den Berg H, 2000, J SCI FOOD AGR, V80, P880, DOI 10.1002/(SICI)1097-0010(20000515)80:7<880::AID-JSFA646>3.3.CO;2-T; Huang JC, 2013, METAB ENG, V17, P59, DOI 10.1016/j.ymben.2013.02.005; Hasunuma T, 2008, PLANT J, V55, P857, DOI 10.1111/j.1365-313X.2008.03559.x; MISAWA N, 1995, J BACTERIOL, V177, P6575; Lindgren LO, 2003, PLANT PHYSIOL, V132, P779, DOI 10.1104/pp.102.017053; Lorenz RT, 2000, TRENDS BIOTECHNOL, V18, P160, DOI 10.1016/S0167-7799(00)01433-5; Lu S, 2006, PLANT CELL, V18, P3594, DOI 10.1105/tpc.106.046417; Jayaraj J, 2008, TRANSGENIC RES, V17, P489, DOI 10.1007/s11248-007-9120-0; TANAKA T, 1994, CARCINOGENESIS, V15, P15, DOI 10.1093/carcin/15.1.15; Gerjets T, 2006, J EXP BOT, V57, P3639, DOI 10.1093/jxb/erl103; Campbell R, 2014, THEOR APPL GENET, V127, P1917, DOI 10.1007/s00122-014-2349-0; Bhosale P, 2005, APPL MICROBIOL BIOT, V68, P445, DOI 10.1007/s00253-005-0032-8; Yuan JP, 2011, MOL NUTR FOOD RES, V55, P150, DOI 10.1002/mnfr.201000414; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Morris WL, 2006, METAB ENG, V8, P253, DOI 10.1016/j.ymben.2006.01.001; Krinsky NI, 2003, ANNU REV NUTR, V23, P171, DOI 10.1146/annurev.nutr.23.011702.073307; Ralley L, 2004, PLANT J, V39, P477, DOI 10.1111/j.1365-313X.2004.02151.x; Li L, 2012, MOL PLANT, V5, P339, DOI 10.1093/mp/ssr099; Mayne ST, 1996, FASEB J, V10, P690; Pasare S, 2013, PROTOPLASMA, V250, P1381, DOI 10.1007/s00709-013-0521-z; Higuera-Ciapara I, 2006, CRIT REV FOOD SCI, V46, P185, DOI 10.1080/10408690590957188; Misawa N, 2009, PLANT BIOTECHNOL, V26, P93, DOI 10.5511/plantbiotechnology.26.93; LOTAN T, 1995, FEBS LETT, V364, P125, DOI 10.1016/0014-5793(95)00368-J; Nishida Y, 2005, APPL ENVIRON MICROB, V71, P4286, DOI 10.1128/AEM.71.8.4286-4296.2005; Beatty S, 2004, ARCH BIOCHEM BIOPHYS, V430, P70, DOI 10.1016/j.abb.2004.03.015; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Britton G., 2004, CAROTENOIDS HDB; Choi SK, 2007, APPL MICROBIOL BIOT, V75, P1335, DOI 10.1007/s00253-007-0967-z; Choi SK, 2005, MAR BIOTECHNOL, V7, P515, DOI 10.1007/s10126-004-5100-z; Ducreux LJM, 2008, J EXP BOT, V59, P4219, DOI 10.1093/jxb/ern264; FernandezGonzalez B, 1997, J BIOL CHEM, V272, P9728; Gann PH, 2003, J NATL CANCER I, V95, P1563, DOI 10.1093/jnci/djg112; Gerjets Tanja, 2007, Biotechnology Journal, V2, P1263, DOI 10.1002/biot.200700040; Goodwin T. W., 1980, BIOCH CAROTENOIDS, V1, P261; Hancock RD, 2014, PLANT CELL ENVIRON, V37, P439, DOI 10.1111/pce.12168; Huang JC, 2012, PLANTA, V236, P691, DOI 10.1007/s00425-012-1654-6; Iwamoto T, 2000, J Atheroscler Thromb, V7, P216; Payyavula RS, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-39; Spiller Gene A., 2003, Journal of Medicinal Food, V6, P51, DOI 10.1089/109662003765184741; Tatsuzawa H, 2000, FEBS LETT, V484, P280, DOI 10.1016/S0014-5793(00)02149-9; The Potato Genome Sequencing Consortium, 2011, NATURE, V475, P189; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; Yuan JP, 2000, FOOD CHEM, V68, P443, DOI 10.1016/S0308-8146(99)00219-8; Zhong YJ, 2011, J EXP BOT, V62, P3659, DOI 10.1093/jxb/err070	52	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-9452			PLANT SCI	Plant Sci.	MAY	2015	234						27	37		10.1016/j.plantsci.2015.01.014		11	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CG2HZ	WOS:000353096800004		
J	Umali, DV; Ito, H; Shirota, K; Ito, T; Katoh, H				Umali, Dennis V.; Ito, Hiroshi; Shirota, Kazutoshi; Ito, Toshihiro; Katoh, Hiromitsu			Atypical velogenic Newcastle disease in a commercial layer flock in Japan	POULTRY SCIENCE			English	Article						commercial layer flock; avian infectious bronchitis; silent infection; velogenic Newcastle disease	VIRUS; ANTIBODY; CLEAVAGE	In 2002, a commercial layer flock in Japan was initially diagnosed as being infected with infectious bronchitis (IB) based on clinical signs, virus isolation, and serological analysis but was later found to be atypically infected with velogenic Newcastle disease virus (NDV) following molecular diagnosis. The flock had slightly decreased egg production and an increased occurrence of soft-shelled eggs without significant mortality. IB-like viruses were isolated, which caused dwarfing and curling in 12-day-old chicken embryos. Ten years after this case, retrospective genetic analyses showed that apart from IB virus (IBV), the flock was also infected with NDV. Mean death time (MDT), intracerebral pathogenicity index (ICPI), and deduced amino acid sequence of the cleavage site of the fusion (F)-protein gene revealed that the NDV isolate was velogenic ((112)RRQKR(116)). These results indicate that poultry clinicians should look out for atypical velogenic ND, especially in vaccinated commercial chicken flocks, which may harbor hidden NDV infection.	[Umali, Dennis V.; Katoh, Hiromitsu] Univ Philippines Los Banos, Coll Vet Med, Dept Vet Clin Sci, College Los Banos 4031, Laguna, Philippines; [Ito, Hiroshi; Ito, Toshihiro] Tottori Univ, Fac Agr, Avian Zoonoses Res Ctr, Tottori 6808553, Japan; [Umali, Dennis V.; Ito, Hiroshi; Ito, Toshihiro] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi 7538515, Japan; [Umali, Dennis V.; Shirota, Kazutoshi; Katoh, Hiromitsu] Poultry Prod Qual Control PPQC Co Ltd, Fukushima 9640062, Japan	Katoh, H (reprint author), Univ Philippines Los Banos, Coll Vet Med, Dept Vet Clin Sci, College Los Banos 4031, Laguna, Philippines.	h_katoh@ppqc.co.jp					Alexander Dennis J., 2009, P19, DOI 10.1007/978-88-470-0826-7_2; Alexander DJ, 2003, DIS POULTRY, P63; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Salk JE, 1944, J IMMUNOL, V49, P87; Yu L, 2001, J CLIN MICROBIOL, V39, P3512, DOI 10.1128/JCM.39.10.3512-3519.2001; Chu DKW, 2011, J VIROL, V85, P12815, DOI 10.1128/JVI.05838-11; GOTOH B, 1992, J VIROL, V66, P6391; NAGAI Y, 1976, VIROLOGY, V72, P494, DOI 10.1016/0042-6822(76)90178-1; BEARD CW, 1970, B WORLD HEALTH ORGAN, V42, P779; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Cavanagh D, 2003, DIS POULTRY, V11th, P101; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Islam M., 1995, JPN J VET RES, V42, P147; Mase M, 2002, J CLIN MICROBIOL, V40, P3826, DOI 10.1128/JCM.40.10.3826-3830.2002; Office International des Epizooties (OIE), 2012, MANUAL DIAGNOSTIC TE, P555; OGASAWARA T, 1992, EMBO J, V11, P467; Takakuwa H, 1998, JPN J VET RES, V45, P207; Truszczynski M., 1996, MAN STAND DIAGN TEST, V3rd, P539; Tsunekuni R, 2010, J VET MED SCI, V72, P453; Umali DV, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-330	21	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-5791	1525-3171		POULTRY SCI	Poult. Sci.	MAY	2015	94	5					890	897		10.3382/ps/pev011		8	Agriculture, Dairy & Animal Science	Agriculture	CG5QC	WOS:000353347200009		
J	Kimura, H; Takahashi, S; Tsuchida, A				Kimura, Hiroshi; Takahashi, Shinya; Tsuchida, Akira			Experimental study for rheological property of exhaustively deionized aqueous suspension of very small colloidal spheres (diameter < ca. 60 nm)	POWDER TECHNOLOGY			English	Article						Small colloidal sphere; Rheology; Deionizadon; Electrical double layer; Glassy state; DLVO theory	ELECTRICAL DOUBLE-LAYERS; STRONG ELECTROLYTES; VISCOSITY; DISPERSIONS; PARTICLES; LIQUIDS	The rheological properties of aqueous suspensions of small silica spheres (18-56 nm in diameter), in an exhaustively deionized state and the presence of a salt, have been investigated. In a deionized state, the suspensions of larger spheres, 29 nm and 56 nm in diameter, were Newtonian fluids at sphere volume fraction phi = 0.10, although the suspension of the smallest spheres, 18 nm, showed shear thinning at phi = 0.087. Debye screening lengths were calculated based on electrical conductivity. The effective volume fractions, including the electrical double layers, of suspensions in the above condition were 0.37, 0.23, and 0.21 for spheres of 18 nm, 29 nm, and 56 nm in diameter, respectively. Experiments provide strong evidence that all of the small spheres form steady electrical double layers in water and that the suspension of 18-nm spheres was in a glassy state. (C) 2015 Elsevier B.V. All rights reserved.	[Kimura, Hiroshi] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu 5011193, Japan; Gifu Univ, Grad Sch Engn, Gifu 5011193, Japan	Kimura, H (reprint author), Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, 1-1 Yanagido, Gifu 5011193, Japan.	kimurah@gifu-u.ac.jp			Japan Society for the Promotion of Science [25550055]	The authors are appreciative of Catalyst & Chemicals Ind. Co. for providing the fine monodisperse colloidal silica spheres. H. K. acknowledges Prof. T. Okubo for providing the deionized aqueous suspensions, and Mr. A. Katsuno for his experimental supports. This work was partly supported by a Grant-in-Aid for Challenging Exploratory Research (No. 25550055) from the Japan Society for the Promotion of Science.	Adamczyk Z, 2004, J COLLOID INTERF SCI, V273, P668, DOI 10.1016/j.jcis.2004.01.008; HACHISU S, 1976, J COLLOID INTERF SCI, V55, P499, DOI 10.1016/0021-9797(76)90060-6; LINDSAY HM, 1982, J CHEM PHYS, V76, P3774, DOI 10.1063/1.443417; Jones G, 1929, J AM CHEM SOC, V51, P2950, DOI 10.1021/ja01385a012; Onsager L, 1932, J PHYS CHEM-US, V36, P2689, DOI 10.1021/j150341a001; JEFFREY GC, 1988, COLLOID POLYM SCI, V266, P173, DOI 10.1007/BF01452815; KOSE A, 1973, J COLLOID INTERF SCI, V44, P330, DOI 10.1016/0021-9797(73)90224-5; OBRIEN RW, 1983, J COLLOID INTERF SCI, V92, P204, DOI 10.1016/0021-9797(83)90129-7; BOOTH F, 1950, PROC R SOC LON SER-A, V203, P533, DOI 10.1098/rspa.1950.0155; Derjaguin B., 1941, ACTA PHYSICOCHIM URS, V14, P633, DOI DOI 10.1016/0079-6816(93)90013-L; Dukhin S. S., 1974, ELECTROKINETIC PHENO; Falkenhagen H., 1932, Philosophical Magazine, V14; HACHISU S, 1973, J COLLOID INTERF SCI, V42, P342, DOI 10.1016/0021-9797(73)90298-1; Hunter R. J., 2001, FDN COLLOID SCI; Kimura H, 2011, RHEOL ACTA, V50, P159, DOI 10.1007/s00397-011-0532-7; Kimura H, 2005, COLLOID POLYM SCI, V283, P1079, DOI 10.1007/s00396-004-1247-4; MENJIVAR JA, 1983, J CHEM PHYS, V79, P953, DOI 10.1063/1.445873; Okubo T, 2002, COLLOID POLYM SCI, V280, P438, DOI 10.1007/s00396-001-0630-7; Okubo T, 1996, COLLOID SURFACE A, V109, P77, DOI 10.1016/0927-7757(96)03475-9; ONSAGER L, 1957, J PHYS CHEM-US, V61, P215, DOI 10.1021/j150548a016; OTTEWILL RH, 1985, BER BUNSEN PHYS CHEM, V89, P517; OTTEWILL RH, 1966, DISCUSS FARADAY SOC, P154; Skvarla J, 2013, LANGMUIR, V29, P8809, DOI 10.1021/la401502f; Verwey E. J. W., 1948, THEORY STABILITY LYO; Zaman AA, 1999, J COLLOID INTERF SCI, V212, P167, DOI 10.1006/jcis.1998.6049	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0032-5910	1873-328X		POWDER TECHNOL	Powder Technol.	MAY	2015	276						118	122		10.1016/j.powtec.2015.02.028		5	Engineering, Chemical	Engineering	CG0ZS	WOS:000353003400013		
J	Yoshino, H; Hosoya, T; Yabuno, H; Lin, SP; Suda, Y				Yoshino, Hayato; Hosoya, Takumi; Yabuno, Hiroshi; Lin, Shihpin; Suda, Yoshihiro			Theoretical and experimental analyses on stabilization of hunting motion by utilizing the traction motor as a passive gyroscopic damper	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART F-JOURNAL OF RAIL AND RAPID TRANSIT			English	Article						Hunting motion; passive gyroscopic damper; traction motor; stabilization control; railway vehicle; experiment	RAILWAY VEHICLE WHEELSET; SIMULATION	The wheelset on a railway vehicle experiences the problem of hunting motion, the onset of which occurs when travelling above the associated critical speed. This is known as a flutter-type self-excited oscillation resulting from non-conservative contact forces acting between the wheels and rails. Traditional methods for preventing hunting motion while running on a straight rail include using bolsters, yaw dampers, or stiffer supports. However, these methods decrease the running performance on a curved rail. To enhance the running performance on both straight and curved rails, we propose using a gyroscopic damper. Until now, a gyroscopic damper has been theoretically and experimentally shown to increase the critical speed for hunting motion. This control method does not need state feedback control, but is not a passive control method, because the gyroscope is rotated by an additional actuator provided separately from the traction motor. In practice, the weight increase from the additional actuator has been a problem in applying this control method. In this study, using the traction motor itself as a passive gyroscopic damper, a new stabilization control mechanism is proposed that eliminates the need for an additional actuator to rotate the gyroscope. An analytical model of a single railway vehicle wheelset was introduced at a scale corresponding to the experimental equipment. From the eigenvalue analysis, it was found that the critical speed increased with an increase in the rotor speed of the gyroscopic damper. Experiments were conducted using a simple apparatus consisting of a roller rig and a two-degree-of-freedom wheelset with a gyroscopic damper that has a mechanism equivalent to what is proposed. The results experimentally validate the proposed passive gyroscopic damper for the stabilization of hunting motion.	[Yoshino, Hayato; Hosoya, Takumi] Keio Univ, Fac Sci & Technol, Yokohama, Kanagawa, Japan; [Yabuno, Hiroshi] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan; [Lin, Shihpin; Suda, Yoshihiro] Univ Tokyo, Inst Ind Sci, Tokyo, Japan	Yabuno, H (reprint author), Univ Tsukuba, Grad Sch Syst & Informat Engn, 1-1-1 Ten No Dai, Tsukuba, Ibaraki 3058573, Japan.	yabuno@esys.tsukuba.ac.jp					Bozzone M, 2011, MULTIBODY SYST DYN, V25, P429, DOI 10.1007/s11044-010-9233-8; Cheng YC, 2012, P I MECH ENG F-J RAI, V226, P187, DOI 10.1177/0954409711407658; Chung WJ, 2003, JSME INT J C-MECH SY, V46, P278, DOI 10.1299/jsmec.46.278; Fujimoto H, 2000, P I MECH ENG F-J RAI, V214, P223, DOI 10.1243/0954409001531324; HIROTSU T, 1991, JSME INT J III-VIB C, V34, P396; Knudsen C., 1991, NONLINEAR DYNAM, V2, P389, DOI 10.1007/BF00045671; Lin SP, 2012, 1 INT C RAILW TECHN; Mohan A, 2004, ASME RAIL TRANSP DIV, V27, P53; Nishimura K, 2009, INT S SPEED SAF SERV, P360; Okamoto H, 2008, T JAP SOC MECH ENG, V74, P235; Simon I, 2006, HDB RAILWAY VEHICLE, P5; Sireteanu T, 2010, P ROMANIAN ACAD A, V11, P355; True H., 1993, APPL MECH REV, V46, P438; Wickens A.H., 1965, INT J SOLIDS STRUCT, V1, P319, DOI 10.1016/0020-7683(65)90037-5; Yabuno H, 2008, J VIB CONTROL, V14, P209, DOI 10.1177/1077546307080020; Yabuno H, 2002, MECCANICA, V37, P555, DOI 10.1023/A:1020957126438; Yongjun Shen, 2006, International Journal of Innovative Computing, Information & Control, V2	17	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4097	2041-3017		P I MECH ENG F-J RAI	Proc. Inst. Mech. Eng. Part F-J. Rail Rapid Transit	MAY	2015	229	4					395	401		10.1177/0954409715569860		7	Engineering, Civil; Engineering, Mechanical; Transportation Science & Technology	Engineering; Transportation	CG8WU	WOS:000353597200005		
J	Tomic, S; Sogabe, T; Okada, Y				Tomic, Stanko; Sogabe, Tomah; Okada, Yoshitaka			In-plane coupling effect on absorption coefficients of InAs/GaAs quantum dots arrays for intermediate band solar cell	PROGRESS IN PHOTOVOLTAICS			English	Article						IBSC; quantum dots; semiconductors; solar cells; high efficiency	EFFICIENCY; TRANSITIONS	Coupled semiconductor quantum dot (QD) arrays emerged recently as promising structures for the next generation of high efficiency intermediate band solar cell (IBSC), because of their ability to facilitate the formation of minibands. The quantum coupling effect that exists between states in QDs in an array influences the electronic and optical properties of such structures. So far, great experimental and theoretical efforts have been devoted to study the vertically coupled QD arrays. We present here a method based on multi-band kp Hamiltonian combined with periodic boundary conditions, applied to predict the electronic and optical properties of InAs/GaAs QDs-based lateral QD arrays. Formation of the intermediate band (IB) in all cases was achieved via delocalisation of the electron ground state (e0). We show that the IB in a laterally coupled QD-IBSC is more robust against external electric field from the solar cell's pn junction than that in a vertically coupled arrangement. Because of symmetry of the QD array lattice and QD states itself, which are C-2v for the zinc blend QDs, the electronic and absorption structures were obtained via sampling throughout the reciprocal space in the first Brillouin zone of QD arrays. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Tomic, Stanko] Univ Salford, Sch Comp Sci & Engn, Joule Phys Lab, Salford M5 4WT, Lancs, England; [Sogabe, Tomah; Okada, Yoshitaka] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	Tomic, S (reprint author), Univ Salford, Sch Comp Sci & Engn, Joule Phys Lab, Salford M5 4WT, Lancs, England.	s.tomic@salford.ac.uk; sogabe@mbe.rcast.u-tokyo.ac.jp	Tomic, Stanko/G-6149-2012		New Energy and Industrial Technology Development Organisation, Japan,; 'Research and Development on Innovative Solar Cells: Post-silicon Solar Cells for Ultra-high Efficiencies'; Royal Society, London; 'High Performance Computing in Modelling of Innovative Photo-voltaic Devices'; STFC's SCARF facility, UK	The authors are grateful to the New Energy and Industrial Technology Development Organisation, Japan, for financial support under grant 'Research and Development on Innovative Solar Cells: Post-silicon Solar Cells for Ultra-high Efficiencies'. S.T. also wishes to thank the Royal Society, London, grant 'High Performance Computing in Modelling of Innovative Photo-voltaic Devices'; the STFC's SCARF facility, UK, for providing the computational resources; and N. Vukmirovic for useful discussions.	Akahane K, 1998, APPL PHYS LETT, V73, P3411, DOI 10.1063/1.122781; Andreev AD, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2130378; Andreev AD, 1998, P SOC PHOTO-OPT INS, V3284, P151, DOI 10.1117/12.304460; Bailey CG, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3580765; Stier O, 1999, PHYS REV B, V59, P5688, DOI 10.1103/PhysRevB.59.5688; WOLF M, 1960, P IRE, V48, P1246, DOI 10.1109/JRPROC.1960.287647; Lazarenkova OL, 2001, J APPL PHYS, V89, P5509, DOI 10.1063/1.1366662; Tomic S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.195321; Andreev AD, 1999, J APPL PHYS, V86, P297, DOI 10.1063/1.370728; Guimard D, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3427392; PIDGEON CR, 1966, PHYS REV, V146, P575, DOI 10.1103/PhysRev.146.575; Sauvage S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.177402; Pryor C, 1998, PHYS REV B, V57, P7190, DOI 10.1103/PhysRevB.57.7190; Blokhin SA, 2009, SEMICONDUCTORS+, V43, P514, DOI 10.1134/S1063782609040204; Tomic S, 2006, J MATER CHEM, V16, P1963, DOI 10.1039/b600701p; Vukmirovic N, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.075356; Hubbard SM, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2903699; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Strandberg R, 2011, PROG PHOTOVOLTAICS, V19, P21, DOI 10.1002/pip.983; Sablon KA, 2011, NANO LETT, V11, P2311, DOI 10.1021/nl200543v; Tomic S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3058716; Birs GL, 1974, SYMMETRY STRAIN INDU; Bragar I, 2012, J APPL PHYS, V112, DOI 10.1063/1.4770383; Hartmann A, 1997, APPL PHYS LETT, V71, P1314, DOI 10.1063/1.119882; Klos JW, 2009, J APPL PHYS, V106, DOI 10.1063/1.3253584; Kotani T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813861; Lis S-S, 1996, PHYS REV B, V54, P11575; Loehrs JP, 1998, PHYS STRAINED QUANTU; Luque A, 1997, PHYS REV LETT, V78, P5014, DOI 10.1103/PhysRevLett.78.5014; Marti A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247701; Okada Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3533423; Oshima R, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2973398; Saputra E, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.125502; Shao Q, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2799172; Sogabes T, 2013, UNPUB; Strandberg R, 2009, J APPL PHYS, V105, DOI 10.1063/1.3153141; TADIC M, 1995, PHYS REV B, V52, P8266, DOI 10.1103/PhysRevB.52.8266; Todorovic G, 1999, SOLID STATE COMMUN, V110, P103, DOI 10.1016/S0038-1098(99)00005-8; Tomic S, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3621876; Tomic S, 2006, J APPL PHYS, V99, DOI 10.1063/1.2190028; Vukmirovc N, 2008, J APPL PHYS, V103, DOI 10.1063/1.2936318; Yoshida K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3488815; Zibik EA, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.161305	43	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1062-7995	1099-159X		PROG PHOTOVOLTAICS	Prog. Photovoltaics	MAY	2015	23	5					546	558		10.1002/pip.2455		13	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CF8FZ	WOS:000352792900002		
J	Espinet-Gonzalez, P; Algora, C; Nunez, N; Orlando, V; Vazquez, M; Bautista, J; Araki, K				Espinet-Gonzalez, P.; Algora, C.; Nunez, N.; Orlando, V.; Vazquez, M.; Bautista, J.; Araki, K.			Temperature accelerated life test on commercial concentrator III-V triple-junction solar cells and reliability analysis as a function of the operating temperature	PROGRESS IN PHOTOVOLTAICS			English	Article						accelerated life test; ALT; reliability; concentration; multijunction; solar cells; III-V; CPV; photovoltaics	MODEL	A temperature accelerated life test on commercial concentrator lattice-matched GaInP/GaInAs/Ge triple-junction solar cells has been carried out. The acceleration of the aging has been accomplished by subjecting the solar cells at temperatures markedly higher than the nominal working temperature inside a concentrator, and the nominal photo-current condition (820 X) has been emulated by injecting current in darkness. Three tests at different temperatures have been carried out. The failure distributions across the three test temperatures have been fitted to an Arrhenius-Weibull model. An Arrhenius activation energy of 1.59eV was determined from the fit. The reliability functions and parameters of these solar cells at two nominal working conditions (80and100 degrees C) have been obtained. In both cases, the instantaneous failure rate function monotonically increases, that is, the failures are of the wear-out kind. We have also observed that the reliability data are very sensitive to the nominal temperature condition. In fact, at a nominal working condition of 820 X and 80 degrees C, assuming that the concentration module works 5h per day, the warranty time obtained for a failure population of 5% has been 113years. However, for a nominal working condition of 820 X and 100 degrees C, the warranty time obtained for a failure population of 5% has been 7years. Therefore, in order to offer a long-term warranty, the working temperature could be a key factor in the design of the concentration photovoltaic systems. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Espinet-Gonzalez, P.; Algora, C.; Nunez, N.; Orlando, V.; Vazquez, M.; Bautista, J.] Univ Politecn Madrid, ETSI Telecomunicac, Inst Energia Solar, E-28040 Madrid, Spain; [Nunez, N.; Vazquez, M.] Univ Politecn Madrid, EUIT Telecomunicac, Madrid 28031, Spain; [Araki, K.] Daido Steel Co, Minami Ku, Nagoya, Aichi, Japan	Espinet-Gonzalez, P (reprint author), Univ Politecn Madrid, ETSI Telecomunicac, Inst Energia Solar, Avda Complutense 30, E-28040 Madrid, Spain.	pespinet@ies-def.upm.es	Vazquez, Manuel/G-2878-2010; nunez, neftali/G-2756-2010	Vazquez, Manuel/0000-0003-1070-1751; nunez, neftali/0000-0003-2339-2441	European Commission under the project NGCPV ' [283798]; Spanish Ministerio de Economia y Competitividad [TEC2011-28639-C02-01, IPT-2011-1441-920000]; Comunidad de Madrid under the NUMANCIA II program [S2009/ENE1477]	This work was supported by the European Commission under the project NGCPV 'A new generation of concentrator photovoltaic solar cells, modules and systems' with grant agreement no. 283798. The Spanish Ministerio de Economia y Competitividad has also contributed with the projects TEC2011-28639-C02-01, IPT-2011-1441-920000, as well as the Comunidad de Madrid under the NUMANCIA II program (S2009/ENE1477).	[Anonymous], 62108 IEC; Garcia I, 2011, IEEE J PHOTOVOLT, V1, P219, DOI 10.1109/JPHOTOV.2011.2171671; Luque A, 2006, PROG PHOTOVOLTAICS, V14, P413, DOI 10.1002/pip.705; Dominguez C, 2010, PROG PHOTOVOLTAICS, V18, P272, DOI 10.1002/pip.965; Swanson RM, 2000, PROG PHOTOVOLTAICS, V8, P93, DOI 10.1002/(SICI)1099-159X(200001/02)8:1<93::AID-PIP303>3.0.CO;2-S; Vazquez M, 2008, PROG PHOTOVOLTAICS, V16, P419, DOI 10.1002/pip.825; Christou A, 1989, SEMICONDUCTOR DEVICE; Davies J, 2012, TECHNICAL REPORT; Escobar L. A., 1998, STAT METHODS RELIABI; Espinet-Gonzalez P, P IEEE 38 PHOT SPEC; Galiana B, 2008, PROG PHOTOVOLTAICS, V16, P331, DOI 10.1002/pip.805; Gonzalez JR, 2009, MICROELECTRON RELIAB, V49, P673, DOI 10.1016/j.microrel.2009.04.001; Kececioglu D., 2002, RELIABILITY ENG HDB, V1; Kurtz S, 2012, TECHNICAL REPORT; Muller M, 2013, PHOT MOD REL WORKSH; Nelson W, 2004, WILEY SERIES PROBABI; Nunez N, 2012, PROGR PHOTOVOLTAICS, V21, P1104; Prior B., 2011, TECHNICAL REPORT; Trevisanello L, 2008, IEEE T DEVICE MAT RE, V8, P304, DOI 10.1109/TDMR.2008.919596; Ueda O., 1996, RELIABILITY DEGRADAT	20	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1062-7995	1099-159X		PROG PHOTOVOLTAICS	Prog. Photovoltaics	MAY	2015	23	5					559	569		10.1002/pip.2461		11	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CF8FZ	WOS:000352792900003		
J	Nishiyama, K; Ichihashi, N; Kazuta, Y; Yomo, T				Nishiyama, Kotaro; Ichihashi, Norikazu; Kazuta, Yasuaki; Yomo, Tetsuya			Development of a reporter peptide that catalytically produces a fluorescent signal through alpha-complementation	PROTEIN SCIENCE			English	Article						alpha-complementation; beta-galactosidase; reporter gene; cell-free translation system; reporter peptide	GALACTOSIDASE ESCHERICHIA-COLI; BETA-GALACTOSIDASE; IN-VITRO; ENZYME; PLASMIDS; SYSTEM; PURIFICATION; REPLICATION; LIPOSOMES; RNA	In -complementation, inactive N-terminal (-domain) and C-terminal (-domain) fragments of -galactosidase associate to reconstitute the active protein. To date, the effect of -domain size on -complementation activity has not been systematically investigated. In this study, we compared the complementation activities of -domains of various sizes using an in vitro system. We found that the complementation activities are similar for -domains comprising between 45 and 229 N-terminal residues but are significantly decreased for those containing less than 37 residues. However, these smaller -domains (15 and 25 residues) exhibited sufficient -complementation activity for application as reporters.	[Nishiyama, Kotaro; Ichihashi, Norikazu; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka 5650871, Japan; [Ichihashi, Norikazu; Kazuta, Yasuaki; Yomo, Tetsuya] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Suita, Osaka 5650871, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Yomo, Tetsuya] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528550, Japan	Yomo, T (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	yomo@ist.osaka-u.ac.jp					LANGLEY KE, 1975, P NATL ACAD SCI USA, V72, P1254, DOI 10.1073/pnas.72.4.1254; Zhang BL, 1997, NATURE, V390, P96; Bartesaghi A, 2014, P NATL ACAD SCI USA, V111, P11709, DOI 10.1073/pnas.1402809111; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; LIS JT, 1983, CELL, V35, P403, DOI 10.1016/0092-8674(83)90173-3; Terasaka N, 2014, NAT CHEM BIOL, V10, P555, DOI [10.1038/nchembio.1549, 10.1038/NCHEMBIO.1549]; Hipolito CJ, 2012, CURR OPIN CHEM BIOL, V16, P196, DOI 10.1016/j.cbpa.2012.02.014; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Kita H, 2008, CHEMBIOCHEM, V9, P2403, DOI 10.1002/cbic.200800360; Nishiyama K, 2012, CHEMBIOCHEM, V13, P2701, DOI 10.1002/cbic.201200586; BRONSTEIN I, 1989, J CLIN LAB ANAL, V3, P316, DOI 10.1002/jcla.1860030511; Burkard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101762; Gallagher CN, 1998, J PROTEIN CHEM, V17, P131, DOI 10.1023/A:1022579416300; Gallagher CN, 1999, BIOCHEM CELL BIOL, V77, P109, DOI 10.1139/bcb-77-2-109; GALLAGHER CN, 1994, PREP BIOCHEM, V24, P297, DOI 10.1080/10826069408010101; Juers DH, 2000, PROTEIN SCI, V9, P1685; Kazuta Y, 2014, J BIOSCI BIOENG, V118, P554, DOI 10.1016/j.jbiosc.2014.04.019; LANGLEY KE, 1975, J BIOL CHEM, V250, P2587; LANGLEY KE, 1976, BIOCHEMISTRY-US, V15, P4866, DOI 10.1021/bi00667a018; LIN S, 1970, BIOCHEM BIOPH RES CO, V40, P249, DOI 10.1016/0006-291X(70)91002-8; Matthews BW, 2005, CR BIOL, V328, P549, DOI 10.1016/j.crvi.2005.03.006; Ohta A, 2008, CURR OPIN CHEM BIOL, V12, P159, DOI 10.1016/j.cbpa.2007.12.009; RUTHER U, 1980, MOL GEN GENET, V178, P475, DOI 10.1007/BF00270503; RYAN W, 1989, BIOTECHNOL BIOENG, V34, P309, DOI 10.1002/bit.260340306; SCHULZ VP, 1990, J MOL BIOL, V211, P427, DOI 10.1016/0022-2836(90)90363-Q; Seeber F, 1996, GENE, V169, P39, DOI 10.1016/0378-1119(95)00786-5; Tung CH, 2004, CANCER RES, V64, P1579, DOI 10.1158/0008-5472.CAN-03-3226; ULLMANN A, 1965, J MOL BIOL, V12, P918; Verkaar F, 2010, FASEB J, V24, P1205, DOI 10.1096/fj.09-141671; WARNES A, 1986, PLASMID, V16, P116, DOI 10.1016/0147-619X(86)90070-3	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	MAY	2015	24	5					599	603		10.1002/pro.2667		5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG7YV	WOS:000353524700004		
J	Biancalana, M; Makabe, K; Yan, SD; Koide, S				Biancalana, Matthew; Makabe, Koki; Yan, Shude; Koide, Shohei			Aromatic cluster mutations produce focal modulations of beta-sheet structure	PROTEIN SCIENCE			English	Article						protein design; conformational stability; beta-sheet formation; secondary structure	HYDROPHOBIC SURFACE BURIAL; SIDE-CHAIN INTERACTIONS; SELF-ASSEMBLY MIMICS; HAIRPIN PEPTIDE; PROTEINS; STABILITY; STABILIZATION; CONFORMATION; DETERMINANT; SEQUENCE	Site-directed mutagenesis is a powerful tool for altering the structure and function of proteins in a focused manner. Here, we examined how a model beta-sheet protein could be tuned by mutation of numerous surface-exposed residues to aromatic amino acids. We designed these aromatic side chain "clusters" at highly solvent-exposed positions in the flat, single-layer beta-sheet of Borrelia outer surface protein A (OspA). This unusual b-sheet scaffold allows us to interrogate the effects of these mutations in the context of well-defined structure but in the absence of the strong scaffolding effects of globular protein architecture. We anticipated that the introduction of a cluster of aromatic amino acid residues on the b-sheet surface would result in large conformational changes and/or stabilization and thereby provide new means of controlling the properties of beta-sheets. Surprisingly, Xray crystal structures revealed that the introduction of aromatic clusters produced only subtle conformational changes in the OspA beta-sheet. Additionally, despite burying a large degree of hydrophobic surface area, the aromatic cluster mutants were slightly less stable than the wild-type scaffold. These results thereby demonstrate that the introduction of aromatic cluster mutations can serve as a means for subtly modulating b-sheet conformation in protein design.	[Biancalana, Matthew; Makabe, Koki; Yan, Shude; Koide, Shohei] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Makabe, Koki] Inst Mol Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	Koide, S (reprint author), Univ Chicago, Dept Biochem & Mol Biol, 929 East 57th St, Chicago, IL 60637 USA.	skoide@uchicago.edu			NIH [R01-GM72688, T90-DK070076]; NSF [CMMI-0709079]; University of Chicago Cancer Research Center [20870043, 20508072]; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357, W-31-109-ENG-38]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; JSPS KAKENHI	Grant sponsor: NIH; Grant number: R01-GM72688; NSF; Grant CMMI-0709079; Grant sponsor: University of Chicago Cancer Research Center; Grant numbers: 20870043, 20508072; Grant sponsor: NIH; Grant number: T90-DK070076; Grant sponsor: U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences; Grant numbers: DE-AC02-06CH11357, W-31-109-ENG-38; Grant sponsor: National Cancer Institute; Grant number: Y1-CO-1020; Grant sponsor: National Institute of General Medical Science; Grant number: Y1-GM-1104; Grant sponsor: JSPS KAKENHI, Paul K. Richter and Evalyn E. Cobb Richter Memorial Fund.	Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898; Gilbreth RN, 2012, CURR OPIN STRUC BIOL, V22, P413, DOI 10.1016/j.sbi.2012.06.001; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Biancalana M, 2008, J MOL BIOL, V383, P205, DOI 10.1016/j.jmb.2008.08.031; MINOR DL, 1994, NATURE, V371, P264, DOI 10.1038/371264a0; Makabe K, 2006, P NATL ACAD SCI USA, V103, P17753, DOI 10.1073/pnas.0606690103; Thomas A, 2002, PROTEINS, V48, P628, DOI 10.1002/prot.10190; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Budyak IL, 2013, J MOL BIOL, V425, P3522, DOI 10.1016/j.jmb.2013.06.030; Derewenda ZS, 2006, ACTA CRYSTALLOGR D, V62, P116, DOI 10.1107/S0907444905035237; Wu L, 2010, BIOCHEMISTRY-US, V49, P4705, DOI 10.1021/bi100491s; Aravinda S, 2002, ANGEW CHEM INT EDIT, V41, P3863, DOI 10.1002/1521-3773(20021018)41:20<3863::AID-ANIE3863>3.0.CO;2-A; Butterfoss GL, 2003, PROTEIN SCI, V12, P2719, DOI 10.1110/ps.03273303; Collaborative-Computational-ProjectG, 1994, ACTA CRYSTALLOGRAP D, V50, P760; Hughes RM, 2006, CURR OPIN STRUC BIOL, V16, P514, DOI 10.1016/j.sbi.2006.06.008; Makabe K, 2008, J MOL BIOL, V378, P459, DOI 10.1016/j.jmb.2008.02.051; Makabe K, 2006, PROTEIN SCI, V15, P1907, DOI 10.1110/ps.062246706; Merkel JS, 1998, FOLD DES, V3, P449, DOI 10.1016/S1359-0278(98)00062-5; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Nesloney CL, 1996, BIOORGAN MED CHEM, V4, P739, DOI 10.1016/0968-0896(96)00051-X; Roy RS, 2005, BIOPOLYMERS, V80, P787, DOI 10.1002/bip.20294; Santiveri CM, 2003, J PEPT RES, V61, P177, DOI 10.1034/j.1399-3011.2003.00045.x; Santiveri CM, 2004, PROTEIN SCI, V13, P1134, DOI 10.1110/ps.03520704; Sengupta A, 2005, J PEPT RES, V65, P113, DOI 10.1111/j.1399-3011.2004.00191.x; Simeonov P, 2011, PROTEIN ENG DES SEL, V24, P261, DOI 10.1093/protein/gzq104; SMITH CK, 1995, SCIENCE, V270, P980, DOI 10.1126/science.270.5238.980; Tatko CD, 2002, J AM CHEM SOC, V124, P9372, DOI 10.1021/ja0262481; Tsai HH, 2006, STRUCTURE, V14, P1059, DOI 10.1016/j.str.2006.03.015; Tuffery P, 1997, PROTEIN ENG, V10, P361, DOI 10.1093/protein/10.4.361; Yan SD, 2007, J MOL BIOL, V368, P230, DOI 10.1016/j.jmb.2007.02.003; Yan SD, 2004, J MOL BIOL, V338, P811, DOI 10.1016/j.jmb.2004.02.063	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	MAY	2015	24	5					841	+		10.1002/pro.2657		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG7YV	WOS:000353524700001		
J	Takei, T; Tsumoto, K; Okonogi, A; Kimura, A; Kojima, S; Yazaki, K; Takei, T; Ueda, T; Miura, K				Takei, Toshiaki; Tsumoto, Kouhei; Okonogi, Atsuhito; Kimura, Akiko; Kojima, Shuichi; Yazaki, Kazumori; Takei, Tsunetomo; Ueda, Takuya; Miura, Kin-ichiro			pH responsiveness of fibrous assemblies of repeat-sequence amphipathic alpha-helix polypeptides	PROTEIN SCIENCE			English	Article						aggregation; amphipathic -helix; fibrous assembly; pH responsiveness; self-assembly	COILED-COIL PEPTIDES; DESIGNED PROTEIN FIBER; DE-NOVO DESIGN; CHAIN-LENGTH; FORMING POLYPEPTIDE; ELECTRON-MICROSCOPY; FIBRIL FORMATION; RATIONAL DESIGN; AMINO-ACIDS; ION-PAIRS	We reported previously that our designed polypeptide 3 (21 residues), which has three repeats of a seven-amino-acid sequence (LETLAKA)(3), forms not only an amphipathic -helix structure but also long fibrous assemblies in aqueous solution. To address the relationship between the electrical states of the polypeptide and its -helix and fibrous assembly formation, we characterized mutated polypeptides in which charged amino acid residues of 3 were replaced with Ser. We prepared the following polypeptides: 2S3 (LSTLAKA)(3), in which all Glu residues were replaced with Ser residues; 6S3 (LETLASA)(3), in which all Lys residues were replaced with Ser; and 2S6S3 (LSTLASA)(3); in which all Glu and Lys residues were replaced with Ser. In 0.1M KCl, 2S3 formed an -helix under basic conditions and 6S3 formed an -helix under acid conditions. In 1M KCl, they both formed -helices under a wide pH range. In addition, 2S3 and 6S3 formed fibrous assemblies under the same buffer conditions in which they formed -helices. -Helix and fibrous assembly formation by these polypeptides was reversible in a pH-dependent manner. In contrast, 2S6S3 formed an -helix under basic conditions in 1M KCl. Taken together, these findings reveal that the charge states of the charged amino acid residues and the charge state of the Leu residue located at the terminus play an important role in -helix formation.	[Takei, Toshiaki; Tsumoto, Kouhei; Ueda, Takuya; Miura, Kin-ichiro] Univ Tokyo, Grad Sch Frontier, Dept Med Genome Sci, Kashiwa, Chiba, Japan; [Takei, Toshiaki; Okonogi, Atsuhito; Kimura, Akiko; Kojima, Shuichi; Miura, Kin-ichiro] Gakushuin Univ, Inst Biomol Sci, Toshima Ku, Tokyo 171, Japan; [Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan; [Tsumoto, Kouhei] Univ Tokyo, Sch Engn, Minato Ku, Tokyo, Japan; [Yazaki, Kazumori] Tokyo Metropolitan Inst Med Sci Rinshoken, Dept Ultrastruct Res, Bunkyo Ku, Tokyo, Japan; [Takei, Tsunetomo] Iwate Med Univ, Pediat Sch Med, Morioka, Iwate 020, Japan	Tsumoto, K (reprint author), Univ Tokyo, Grad Sch Frontier, Dept Med Genome Sci, Kashiwa, Chiba, Japan.	takei104@k.u-tokyo.ac.jp; tsumoto@ims.u-tokyo.ac.jp	Ueda, Takuya/K-5217-2014	Ueda, Takuya/0000-0002-7760-8271	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Science Research Promotion Fund of the Japan Private School Promotion Foundation	Grant sponsor: Grant-in-Aid for General Research from the Japan Society for the Promotion of Science (to K.T. and K.M.); Grant sponsor: Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grant sponsor: Science Research Promotion Fund of the Japan Private School Promotion Foundation.	Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Papapostolou D, 2007, P NATL ACAD SCI USA, V104, P10853, DOI 10.1073/pnas.0700801104; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; Collier JH, 2001, J AM CHEM SOC, V123, P9463, DOI 10.1021/ja011535a; Matsuura K, 2005, J AM CHEM SOC, V127, P10148, DOI 10.1021/ja052644i; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Bromley EHC, 2010, BIOPHYS J, V98, P1668, DOI 10.1016/j.bpj.2009.12.4309; Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005; Sharp TH, 2012, P NATL ACAD SCI USA, V109, P13266, DOI 10.1073/pnas.1118622109; Zaccai NR, 2011, NAT CHEM BIOL, V7, P935, DOI [10.1038/nchembio.692, 10.1038/NCHEMBIO.692]; Dublin SN, 2008, J AM CHEM SOC, V130, P49, DOI 10.1021/ja0775016; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g; Mahmoud ZN, 2010, BIOMATERIALS, V31, P7468, DOI 10.1016/j.biomaterials.2010.06.041; Schreck JS, 2013, J PHYS CHEM B, V117, P6574, DOI 10.1021/jp401586p; Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h; Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102; Hadley EB, 2008, P NATL ACAD SCI USA, V105, P530, DOI 10.1073/pnas.0709068105; Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103; Toledano S, 2006, J AM CHEM SOC, V128, P1070, DOI 10.1021/ja056549l; Woolfson DN, 2006, CURR OPIN CHEM BIOL, V10, P559, DOI 10.1016/j.cbpa.2006.09.019; Dong H, 2008, J AM CHEM SOC, V130, P13691, DOI 10.1021/ja8037323; Malisauskas M, 2008, BIOTECHNOL PROGR, V24, P1166, DOI [10.1002/btpr.49, 10.1021/bp.49]; Kohn WD, 1997, J MOL BIOL, V267, P1039, DOI 10.1006/jmbi.1997.0930; Acharya A, 2006, BIOCHEMISTRY-US, V45, P11324, DOI 10.1021/bi060822u; Potekhin SA, 2001, CHEM BIOL, V8, P1025, DOI 10.1016/S1074-5521(01)00073-4; Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; FAIRMAN R, 1989, PROTEINS, V5, P1, DOI 10.1002/prot.340050102; Papapostolou D, 2008, J AM CHEM SOC, V130, P5124, DOI 10.1021/ja0778444; Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044; Yang ZM, 2006, J AM CHEM SOC, V128, P3038, DOI 10.1021/ja057412y; Mahmoud ZN, 2011, BIOMATERIALS, V32, P3712, DOI 10.1016/j.biomaterials.2010.12.002; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Skaat H, 2012, BIOMACROMOLECULES, V13, P2662, DOI 10.1021/bm3011177; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Anzini P, 2013, J AM CHEM SOC, V135, P10278, DOI 10.1021/ja404677c; Boon CL, 2004, BIOPOLYMERS, V76, P244, DOI 10.1002/bip.20074; Dublin S, 2009, BIOCHEM SOC T, V37, P653, DOI 10.1042/BST0370653; Frost DWH, 2005, BIOPOLYMERS, V80, P26, DOI 10.1002/bip.20188; Gribbon C, 2008, BIOCHEMISTRY-US, V47, P10365, DOI 10.1021/bi801072s; HIBINO T, 1994, J BIOTECHNOL, V32, P139, DOI 10.1016/0168-1656(94)90176-7; Hume J, 2014, BIOMACROMOLECULES, V15, P3503, DOI 10.1021/bm5004948; Janek K, 1999, BIOCHEMISTRY-US, V38, P8246, DOI 10.1021/bi990510+; Kajava AV, 2004, J PEPT SCI, V10, P291, DOI 10.1002/psc.520; Kasotakis E, 2009, BIOPOLYMERS, V92, P164, DOI 10.1002/bip.21163; Kojima S, 1997, P JPN ACAD B-PHYS, V73, P7, DOI 10.2183/pjab.73.7; Kwok SC, 2004, BIOPOLYMERS, V76, P378, DOI 10.1002/bip.20141; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; Melnik TN, 2003, PROTEIN ENG, V16, P1125, DOI 10.1093/protein/gzg138; Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404; Pandya MJ, 2000, BIOCHEMISTRY-US, V39, P8728, DOI 10.1021/bi000246g; Ryan SJ, 2007, J AM CHEM SOC, V129, P10255, DOI 10.1021/ja073717w; Takei T, 2014, BIOPOLYMERS, V102, P260, DOI 10.1002/bip.22479; Takei T, 2006, J BIOCHEM, V139, P271, DOI 10.1093/jb/mvj031; Takei T, 2013, BIOCHEMISTRY-US, V52, P2810, DOI 10.1021/bi400001c; Testa OD, 2009, NUCLEIC ACIDS RES, V37, pD315, DOI 10.1093/nar/gkn675; vonsMaltzahn G, 2003, LANGMUIR, V19, P4332; Vu C, 2001, PROTEIN SCI, V10, P631, DOI 10.1110/ps.41101; Woolfson DN, 2010, BIOPOLYMERS, V94, P118, DOI 10.1002/bip.21345; Yu Y, 1996, J MOL BIOL, V255, P367, DOI 10.1006/jmbi.1996.0030; ZHOU NE, 1994, PROTEIN ENG, V7, P1365, DOI 10.1093/protein/7.11.1365; Zhou Z, 2011, BIOPHYS J, V101, P1483, DOI 10.1016/j.bpj.2011.08.018; ZHU BY, 1993, PROTEIN SCI, V2, P383; Zimenkov Y, 2006, J AM CHEM SOC, V128, P6770, DOI 10.1021/ja0605974; Zimenkov Y, 2004, TETRAHEDRON, V60, P7237, DOI 10.1016/j.tet.2004.06.068	68	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	MAY	2015	24	5					883	894		10.1002/pro.2665		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG7YV	WOS:000353524700028		
J	Kanada, R; Takagi, F; Kikuchi, M				Kanada, Ryo; Takagi, Fumiko; Kikuchi, Macoto			Nucleotide-dependent structural fluctuations and regulation of microtubule-binding affinity of KIF1A	PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS			English	Article						molecular motor; kinesin; allosteric enzyme; molecular dynamics; G-like model	FLY-CASTING MECHANISM; ENERGY LANDSCAPE; KINESIN MOTOR; GLOBULAR-PROTEINS; MODEL; DYNAMICS; TUBULIN; PROCESSIVITY; SITE; RAS	Molecular motors such as kinesin regulate affinity to a rail protein during the ATP hydrolysis cycle. The regulation mechanism, however, is yet to be determined. To understand this mechanism, we investigated the structural fluctuations of the motor head of the single-headed kinesin called KIF1A in different nucleotide states using molecular dynamics simulations of a G-like model. We found that the helix 4 at the microtubule (MT) binding site intermittently exhibits a large structural fluctuation when MT is absent. Frequency of this fluctuation changes systematically according to the nucleotide states and correlates strongly with the experimentally observed binding affinity to MT. We also showed that thermal fluctuation enhances the correlation and the interaction with the nucleotide suppresses the fluctuation of the helix 4. These results suggest that KIF1A regulates affinity to MT by changing the flexibility of the helix 4 during the ATP hydrolysis process: the binding site becomes more flexible in the strong binding state than in the weak binding state. Proteins 2015; 83:809-819. (c) 2015 Wiley Periodicals, Inc.	[Kanada, Ryo; Kikuchi, Macoto] Osaka Univ, Cybermedia Ctr, Toyonaka, Osaka 5600043, Japan; [Kanada, Ryo] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; [Takagi, Fumiko] Univ Tokyo, Grad Sch Engn, Dept Appl Phys, Tokyo 1138656, Japan; [Kikuchi, Macoto] Osaka Univ, Dept Phys, Toyonaka, Osaka 5600043, Japan; [Kikuchi, Macoto] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Kanada, R (reprint author), Osaka Univ, Cybermedia Ctr, Toyonaka, Osaka 5600043, Japan.	kikuchi@cmc.osaka-u.ac.jp			Scientific Research on Innovative Areas (MEXT Japan) [21113006]	Grant sponsor: Scientific Research on Innovative Areas (MEXT Japan); Grant number: 21113006.	Alberts B, 2007, MOL BIOL CELL, V5th, P1014; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Grant BJ, 2007, J MOL BIOL, V368, P1231, DOI 10.1016/j.jmb.2007.02.049; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Hyeon C, 2007, P NATL ACAD SCI USA, V104, P2175, DOI 10.1073/pnas.0610939104; Takagi F, 2007, BIOPHYS J, V93, P3820, DOI 10.1529/biophysj.106.103796; Koga N, 2001, J MOL BIOL, V313, P171, DOI 10.1006/jmbi.2001.5037; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Schief WR, 2001, CURR OPIN CELL BIOL, V13, P19, DOI 10.1016/S0955-0674(00)00169-1; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; HONEYCUTT JD, 1992, BIOPOLYMERS, V32, P695, DOI 10.1002/bip.360320610; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Koga N, 2006, P NATL ACAD SCI USA, V103, P5367, DOI 10.1073/pnas.0509642103; Cross RA, 2004, TRENDS BIOCHEM SCI, V29, P301, DOI 10.1016/j.tibs.2004.04.010; GO N, 1983, ANNU REV BIOPHYS BIO, V12, P183, DOI 10.1146/annurev.bb.12.060183.001151; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P877, DOI 10.1038/nrm2807; Li WF, 2014, P NATL ACAD SCI USA, V111, P10550, DOI 10.1073/pnas.1402768111; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Zheng WJ, 2003, P NATL ACAD SCI USA, V100, P13253, DOI 10.1073/pnas.2235686100; Trizac E, 2010, P NATL ACAD SCI USA, V107, P2746, DOI 10.1073/pnas.0914727107; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Hyeon C, 2007, P NATL ACAD SCI USA, V104, P17382, DOI 10.1073/pnas.0708828104; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Hyeon C, 2006, P NATL ACAD SCI USA, V103, P18939, DOI 10.1073/pnas.0608759103; Aprodu I, 2008, J BIOMECH, V41, P3196, DOI 10.1016/j.jbiomech.2008.08.014; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Howard J., 2001, MECH MOTOR PROTEINS; Kenzaki H, 2008, PROTEINS, V71, P389, DOI 10.1002/prot.21707; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Li WF, 2015, CURR OPIN STRUC BIOL, V30, P25, DOI 10.1016/j.sbi.2014.11.006; Lu Q, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.128105; Nie QM, 2014, PHYS CHEM CHEM PHYS, V16, P6441, DOI 10.1039/c3cp54464h; Nie QM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003552; Nishinari K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.118101; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Okada Y, 2003, NATURE, V424, P574, DOI 10.1038/nature01804; Rashid DJ, 2005, J PEPT RES, V65, P538, DOI 10.1111/j.1399-3011.2005.00255.x; Sack S, 1999, EUR J BIOCHEM, V262, P1, DOI 10.1046/j.1432-1327.1999.00341.x; Tehver R, 2010, STRUCTURE, V18, P471, DOI 10.1016/j.str.2010.01.019; Wriggers W, 1998, BIOPHYS J, V75, P921; Xie P, 2010, INT J BIOL SCI, V6, P665; Xie P, 2007, BBA-BIOENERGETICS, V1767, P1418, DOI 10.1016/j.bbabio.2007.09.006	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-3585	1097-0134		PROTEINS	Proteins	MAY	2015	83	5					809	819		10.1002/prot.24780		11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CG1US	WOS:000353060900004		
J	Kamita, M; Mori, T; Sakai, Y; Ito, S; Gomi, M; Miyamoto, Y; Harada, A; Niida, S; Yamada, T; Watanabe, K; Ono, M				Kamita, Masahiro; Mori, Taiki; Sakai, Yoshihito; Ito, Sadayuki; Gomi, Masahiro; Miyamoto, Yuko; Harada, Atsushi; Niida, Shumpei; Yamada, Tesshi; Watanabe, Ken; Ono, Masaya			Proteomic analysis of ligamentum flavum from patients with lumbar spinal stenosis	PROTEOMICS			English	Article						2D image converted analysis of LC; MS; Biomedicine; Ligamentum flavum; Lumbar spinal stenosis	HTRA1 SERINE-PROTEASE; EXTRACELLULAR-MATRIX; MASS-SPECTROMETRY; CARTILAGE; DISEASE; CELLS; MINERALIZATION; POLYMORPHISM; POPULATION; PEPTIDES	Lumbar spinal stenosis (LSS) is a syndromic degenerative spinal disease and is characterized by spinal canal narrowing with subsequent neural compression causing gait disturbances. Although LSS is a major age-related musculoskeletal disease that causes large decreases in the daily living activities of the elderly, its molecular pathology has not been investigated using proteomics. Thus, we used several proteomic technologies to analyze the ligamentum flavum (LF) of individuals with LSS. Using comprehensive proteomics with strong cation exchange fractionation, we detected 1288 proteins in these LF samples. A GO analysis of the comprehensive proteome revealed that more than 30% of the identified proteins were extracellular. Next, we used 2D image converted analysis of LC/MS to compare LF obtained from individuals with LSS to that obtained from individuals with disc herniation (nondegenerative control). We detected 64781 MS peaks and identified 1675 differentially expressed peptides derived from 286 proteins. We verified four differentially expressed proteins (fibronectin, serine protease HTRA1, tenascin, and asporin) by quantitative proteomics using SRM/MRM. The present proteomic study is the first to identify proteins from degenerated and hypertrophied LF in LSS, which will help in studying LSS.	[Kamita, Masahiro; Miyamoto, Yuko; Yamada, Tesshi; Ono, Masaya] Natl Canc Ctr, Div Chemotherapy & Clin Res, Res Inst, Chuo Ku, Tokyo 1040045, Japan; [Mori, Taiki; Niida, Shumpei] Natl Ctr Geriatr & Gerontol NCGG, BioBank Omics Unit, Obu, Aichi, Japan; [Sakai, Yoshihito; Ito, Sadayuki; Harada, Atsushi] NCGG, Dept Orthoped Surg, Obu, Aichi, Japan; [Gomi, Masahiro] Mitsui Knowledge Ind, BioBusiness Grp, Tokyo, Japan; [Watanabe, Ken] NCGG, Dept Bone & Joint Dis, Obu, Aichi, Japan	Ono, M (reprint author), Natl Canc Ctr, Div Chemotherapy & Clin Res, Res Inst, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	masono@ncc.go.jp			Program for Promotion of Fundamental Studies in Health Sciences [10-44, 10-45]	This work was supported by the Program for Promotion of Fundamental Studies in Health Sciences conducted by the National Institute of Biomedical Innovation of Japan (10-44 and 10-45).	Yamada S, 2007, J BIOL CHEM, V282, P23070, DOI 10.1074/jbc.M611181200; Yabuki S, 2013, J ORTHOP SCI, V18, P893, DOI 10.1007/s00776-013-0455-5; Lurie JD, 2003, SPINE, V28, P616, DOI 10.1097/00007632-200303150-00018; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Benjamin M, 2000, INT REV CYTOL, V196, P85; Katz JN, 2008, NEW ENGL J MED, V358, P818, DOI 10.1056/NEJMcp0708097; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Deten A, 2001, J MOL CELL CARDIOL, V33, P1191, DOI 10.1006/jmcc.2001.1383; Zhang YY, 2013, CHEM REV, V113, P2343, DOI 10.1021/cr3003533; Fusaro VA, 2009, NAT BIOTECHNOL, V27, P190, DOI 10.1038/nbt.1524; Ishimoto Y, 2013, OSTEOARTHR CARTILAGE, V21, P783, DOI 10.1016/j.joca.2013.02.656; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; [Anonymous], 2011, NASS EV BAS CLIN GUI; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Chamberland A, 2009, J BIOL CHEM, V284, P27352, DOI 10.1074/jbc.M109.037051; Specchia N, 2001, J ORTHOPAED RES, V19, P294, DOI 10.1016/S0736-0266(00)00026-7; Nakajima M, 2007, J BIOL CHEM, V282, P32185, DOI 10.1074/jbc.M700522200; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Tiaden AN, 2013, AM J PATHOL, V182, P1482, DOI 10.1016/j.ajpath.2013.02.003; Siebert E, 2009, NAT REV NEUROL, V5, P392, DOI 10.1038/nrneurol.2009.90; Schrader PK, 1999, EUR SPINE J, V8, P323, DOI 10.1007/s005860050181; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Honda K, 2013, JPN J CLIN ONCOL, V43, P103, DOI 10.1093/jjco/hys200; POSTACCHINI F, 1994, SPINE, V19, P917, DOI 10.1097/00007632-199404150-00009; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Brown J. P., 2012, PLOS ONE, V7, P7; CRUZCONDE R, 1995, SPINE, V20, P1506, DOI 10.1097/00007632-199507000-00012; Juneja SC, 2013, ARTHRITIS, V2013, DOI 10.1155/2013/154812; Kosaka H., 1976, SPINE, V32, P2805; Matsumoto Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-190; MISAWA H, 1994, J SPINAL DISORD, V7, P495; NACHEMSON A L, 1968, Journal of Biomechanics, V1, P211, DOI 10.1016/0021-9290(68)90006-7; Nakamura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085542; Nakatani T, 2002, J ORTHOPAED RES, V20, P1380, DOI 10.1016/S0736-0266(02)00046-3; Nguyen AD, 2004, CIRC RES, V95, P1067, DOI 10.1161/01.RES.0000149568.85071.FB; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Sairyo K, 2005, SPINE, V30, P2649, DOI 10.1097/01.brs.0000188117.77657.ee	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	MAY	2015	15	9					1622	1630		10.1002/pmic.201400442		9	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG6KX	WOS:000353410500016		
J	Suzuki, M				Suzuki, Michio			Targets in schizophrenia	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Editorial Material									Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Neuropsychiat, Toyama 930, Japan	Suzuki, M (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Neuropsychiat, Toyama 930, Japan.						Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P220, DOI 10.1001/archgenpsychiatry.2011.1472; Amminger GP, 2010, ARCH GEN PSYCHIAT, V67, P146, DOI 10.1001/archgenpsychiatry.2009.192; Sado M, 2013, NEUROPSYCH DIS TREAT, V9, P787, DOI 10.2147/NDT.S41632	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	MAY	2015	69	5			SI		241	242		10.1111/pcn.12292		2	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CG8FY	WOS:000353543900001		
J	Kusumi, I; Boku, S; Takahashi, Y				Kusumi, Ichiro; Boku, Shuken; Takahashi, Yoshito			Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Review						atypicality; brain-derived neurotrophic factor; dopamine; glycogen synthase kinase-3; serotonin	DOPAMINE D-3 RECEPTOR; GLYCOGEN-SYNTHASE KINASE-3; NEURAL PRECURSOR CELLS; MEDIAL PREFRONTAL CORTEX; ADULT-RAT HIPPOCAMPUS; IN-VIVO OCCUPATION; GRAY-MATTER VOLUME; NEUROTROPHIC FACTOR; 5-HT6 RECEPTOR; DENTATE GYRUS	The original definition of atypical antipsychotic drugs (APD) was drugs that are effective against positive symptoms in schizophrenia with no or little extrapyramidal symptoms (EPS). However, atypical APD have been reported to be more effective for cognitive dysfunction and negative symptoms in schizophrenia than typical APD, which expands the definition of atypicality'. This article provides a critical review of the pharmacology of atypical APD, especially from the viewpoint of receptor binding profiles and neurotransmitter regulations as well as neuroprotection and neurogenesis. A variety of serotonin (5-HT) receptors, such as 5-HT2A/2C, 5-HT1A, 5-HT6 and 5-HT7 receptors, may contribute to the mechanisms of action of atypicality'. The dopaminergic modulations, including a low affinity for dopamine D-2 receptors and a partial D-2 receptor agonistic action, and glutamatergic regulations may also be involved in the pharmacological backgrounds of atypicality'. Atypical APD, but not typical APD, may facilitate cortical neuroprotection and hippocampal neurogenesis, which might be a part of the action mechanisms of atypical APD. The facilitation of cortical neuroprotection and hippocampal neurogenesis induced by atypical APD might be mediated by an increase in the Ser9 phosphorylation of glycogen synthase kinase-3 (GSK-3). The stimulation of 5-HT1A receptors and/or the blockade of 5-HT2 receptors, which is characteristic of atypical APD, might increase Ser9 phosphorylation of GSK-3. Moreover, atypical APD increase brain-derived neurotrophic factor (BDNF) levels. BDNF increases Ser9 phosphorylation of GSK-3 and has neuroprotective and neurogenic effects, as in the case of atypical APD. These findings suggest that GSK-3 might play a role in the action mechanisms of atypical APD, in both the 5-HT-dependent and BDNF-dependent mechanisms.	[Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido 0608638, Japan; [Takahashi, Yoshito] Sapporo City Gen Hosp, Dept Psychiat, Sapporo, Hokkaido, Japan; [Boku, Shuken] Kobe Univ, Grad Sch Med, Dept Psychiat, Kobe, Hyogo 657, Japan	Kusumi, I (reprint author), Hokkaido Univ, Grad Sch Med, Dept Psychiat, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	ikusumi@med.hokudai.ac.jp			AbbVie GK; Asahi Kasei Pharma; Astellas; Boehringer Ingelhaim; Chugai Pharmaceutical; Daiichi Sankyo; Dainippon Sumitomo Pharma; Eisai; Eli Lilly; GlaxoSmithKline; Kyowa Hakko Kirin; Meiji Seika Pharma; MSD; Novartis Pharma; Ono Pharmaceutical; Otsuka Pharmaceutical; Pfeizer; Takeda Pharmaceutical; Tanabe Mitsubishi Pharma; Shionogi; Yoshitomi Pharmaceutical	The authors have no direct financial support relevant to this study. Dr Kusumi has received honoraria from Astellas, Dainippon Sumitomo Pharma, Eisai, Eli Lilly, Janssen Pharmaceutical, Kyowa Hakko Kirin, Meiji Seika Pharma, MSD, Nippon Chemiphar, Novartis Pharma, Otsuka Pharmaceutical, Pfeizer, Tanabe Mitsubishi Pharma, Shionogi and Yoshitomi Pharmaceutical and has received research/grant support from AbbVie GK, Asahi Kasei Pharma, Astellas, Boehringer Ingelhaim, Chugai Pharmaceutical, Daiichi Sankyo, Dainippon Sumitomo Pharma, Eisai, Eli Lilly, GlaxoSmithKline, Kyowa Hakko Kirin, Meiji Seika Pharma, MSD, Novartis Pharma, Ono Pharmaceutical, Otsuka Pharmaceutical, Pfeizer, Takeda Pharmaceutical, Tanabe Mitsubishi Pharma, Shionogi and Yoshitomi Pharmaceutical. He is a member of the advisory board of Dainippon Sumitomo Pharma and Tanabe Mitsubishi Pharma. Dr Takahashi has received honoraria from Daiichi Sankyo, Dainippon Sumitomo Pharma, Eli Lilly, Novartis Pharma, Otsuka Pharmaceutical, Pfeizer, Takeda Pharmaceutical, Shionogi and Tanabe Mitsubishi Pharma. Dr Boku has no conflict of interest.	Abekawa T, 2011, SCHIZOPHR RES, V125, P77, DOI 10.1016/j.schres.2010.08.011; ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248; Jeanneteau F, 2006, P NATL ACAD SCI USA, V103, P10753, DOI 10.1073/pnas.0508189103; Abekawa T, 2008, SCHIZOPHR RES, V101, P84, DOI 10.1016/j.schres.2007.12.488; Schotte A, 1996, PSYCHOPHARMACOLOGY, V124, P57, DOI 10.1007/BF02245606; Luo C, 2005, BRAIN RES, V1063, P32, DOI 10.1016/j.brainres.2005.09.043; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; MELTZER HY, 1976, SCHIZOPHRENIA BULL, V2, P19; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Tripathi PP, 2010, NEUROREPORT, V21, P846, DOI 10.1097/WNR.0b013e32833d5891; Hetts SW, 1998, JAMA-J AM MED ASSOC, V279, P300, DOI 10.1001/jama.279.4.300; Millan MJ, 2005, PSYCHOPHARMACOLOGY, V179, P30, DOI 10.1007/s00213-005-2199-1; Li XH, 2007, INT J NEUROPSYCHOPH, V10, P7, DOI 10.1017/S1461145706006547; Llado-Pelfort L, 2012, CEREB CORTEX, V22, P1487, DOI 10.1093/cercor/bhr220; Benes FM, 1998, BIOL PSYCHIAT, V44, P88, DOI 10.1016/S0006-3223(98)00138-3; BREIER A, 1992, ARCH GEN PSYCHIAT, V49, P921; Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Xu HY, 2002, NEUROSCI LETT, V321, P65, DOI 10.1016/S0304-3940(02)00034-4; MELTZER HY, 1989, J PHARMACOL EXP THER, V251, P238; Maeda K, 2007, J PHARMACOL SCI, V103, P299, DOI 10.1254/jphs.FP0061424; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Meltzer HY, 2012, CURR PHARM BIOTECHNO, V13, P1572; Gil-Ad I, 2001, CELL MOL NEUROBIOL, V21, P705, DOI 10.1023/A:1015152021192; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Boku S, 2009, NEUROPSYCHOPHARMACOL, V34, P805, DOI 10.1038/npp.2008.198; Li XH, 2004, NEUROPSYCHOPHARMACOL, V29, P1426, DOI 10.1038/sj.npp.1300439; Leucht S, 2009, LANCET, V373, P31, DOI [10.1016/S0140-6736(08)61764-X, 10.1016/S01406736(08)61764-X]; Gross G, 2013, N-S ARCH PHARMACOL, V386, P155, DOI 10.1007/s00210-012-0806-3; Sumiyoshi T, 2001, AM J PSYCHIAT, V158, P1722, DOI 10.1176/appi.ajp.158.10.1722; MARGOLIS RL, 1994, BIOL PSYCHIAT, V35, P946, DOI 10.1016/0006-3223(94)91241-6; Bostwick JR, 2009, PHARMACOTHERAPY, V29, P64, DOI 10.1592/phco.29.1.64; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Hetman M, 2000, J NEUROSCI, V20, P2567; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Bai O, 2003, J NEUROSCI RES, V71, P127, DOI 10.1002/jnr.10440; Ohno Y, 2011, NEUROPHARMACOLOGY, V60, P201, DOI 10.1016/j.neuropharm.2010.08.019; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Bombin I, 2008, AM J MED GENET B, V147B, P873, DOI 10.1002/ajmg.b.30710; Newman-Tancredi A, 2010, CURR OPIN INVEST DR, V11, P802; Woodward ND, 2005, INT J NEUROPSYCHOPH, V8, P457, DOI 10.1017/S146114570500516X; Abbas AI, 2009, PSYCHOPHARMACOLOGY, V205, P119, DOI 10.1007/s00213-009-1521-8; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629; Qing H, 2003, EUR J NEUROSCI, V17, P1563, DOI 10.1046/j.1460-9568.2003.02590.x; Shimizu S, 2013, CNS NEUROL DISORD-DR, V12, P861; Winters BD, 2010, NEUROPSYCHOLOGIA, V48, P2251, DOI 10.1016/j.neuropsychologia.2010.01.023; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Benes FM, 2006, MOL PSYCHIATR, V11, P241, DOI 10.1038/sj.mp.4001758; Schotte A, 1995, JPN J PHARMACOL, V69, P399, DOI 10.1254/jjp.69.399; Gyertyan I, 2007, EUR J PHARMACOL, V572, P171, DOI 10.1016/j.ejphar.2007.06.035; Arnt J, 2010, INT J NEUROPSYCHOPH, V13, P1021, DOI 10.1017/S1461145710000659; Wakade CG, 2002, J NEUROSCI RES, V69, P72, DOI 10.1002/jnr.10281; Riemer C, 2003, J MED CHEM, V46, P1273, DOI 10.1021/jm021085c; Thotala DK, 2012, CELL DEATH DIFFER, V19, P387, DOI 10.1038/cdd.2011.94; Meltzer HY, 2011, PSYCHOPHARMACOLOGY, V213, P289, DOI 10.1007/s00213-010-2137-8; Piontkewitz Y, 2012, BRAIN BEHAV IMMUN, V26, P353, DOI 10.1016/j.bbi.2011.11.004; Diaz-Mataix L, 2005, J NEUROSCI, V25, P10831, DOI 10.1523/JNEUROSCI.2999-05.2005; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Noh JS, 2000, J NEUROCHEM, V75, P2327, DOI 10.1046/j.1471-4159.2000.0752327.x; Gur RE, 1998, ARCH GEN PSYCHIAT, V55, P145, DOI 10.1001/archpsyc.55.2.145; Halim ND, 2004, NEUROPSYCHOPHARMACOL, V29, P1063, DOI 10.1038/sj.npp.1300422; Shapiro DA, 2003, NEUROPSYCHOPHARMACOL, V28, P1400, DOI 10.1038/sj.npp.1300203; Miyamoto S, 2012, MOL PSYCHIATR, V17, P1206, DOI 10.1038/mp.2012.47; Horacek J, 2006, CNS DRUGS, V20, P389, DOI 10.2165/00023210-200620050-00004; Schmidt AW, 2001, EUR J PHARMACOL, V425, P197, DOI 10.1016/S0014-2999(01)01188-8; ROTH BL, 1994, J PHARMACOL EXP THER, V268, P1403; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Hedlund PB, 2004, TRENDS PHARMACOL SCI, V25, P481, DOI 10.1016/j.tips.2004.07.002; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199; Cardon M, 2010, MOL PSYCHIATR, V15, P415, DOI 10.1038/mp.2009.66; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Lieberman JA, 2004, CNS DRUGS, V18, P251, DOI 10.2165/00023210-200418040-00005; NODA Y, 1995, BRIT J PHARMACOL, V116, P2531; Sumiyoshi T, 2007, SCHIZOPHR RES, V95, P158, DOI 10.1016/j.schres.2007.06.008; Meltzer HY, 2012, HANDB EXP PHARMACOL, V212, P87, DOI 10.1007/978-3-642-25761-2_4; Parikh V, 2004, NEUROSCI LETT, V356, P135, DOI 10.1016/j.neulet.2003.10.079; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kapur S, 2000, ARCH GEN PSYCHIAT, V57, P553, DOI 10.1001/archpsyc.57.6.553; Benraiss A, 2001, J NEUROSCI, V21, P6718; AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258; Wexler EM, 2008, MOL PSYCHIATR, V13, P285, DOI 10.1038/sj.mp.4002093; Seeman P, 1998, MOL PSYCHIATR, V3, P123, DOI 10.1038/sj.mp.4000336; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Masuda T, 2012, PROG NEURO-PSYCHOPH, V36, P44, DOI 10.1016/j.pnpbp.2011.08.019; de Bartolomeis A, 2013, PSYCHOPHARMACOLOGY, V225, P1, DOI 10.1007/s00213-012-2921-8; BOGERTS B, 1993, BIOL PSYCHIAT, V33, P236, DOI 10.1016/0006-3223(93)90289-P; Boku S, 2014, EUR J PHARMACOL, V723, P425, DOI 10.1016/j.ejphar.2013.10.060; Bharti S, 2012, FEBS LETT, V586, P180, DOI 10.1016/j.febslet.2011.12.015; DENBOER JA, 1995, PSYCHOPHARMACOLOGY, V121, P317; Duncan GE, 1999, MOL PSYCHIATR, V4, P418, DOI 10.1038/sj.mp.4000581; Galili-Mosberg R, 2000, J NEURAL TRANSM, V107, P479, DOI 10.1007/s007020070089; Giakoumaki SG, 2007, PSYCHOPHARMACOLOGY, V194, P289, DOI 10.1007/s00213-007-0843-7; Gravius A, 2011, BEHAV PHARMACOL, V22, P122, DOI 10.1097/FBP.0b013e328343d804; Gross G, 2012, HDB EXP PHARM, V213, P167, DOI DOI 10.1007/978-3-642-25758-2_7; He J, 2004, BRAIN RES, V1018, P186, DOI 10.1016/j.brainres.2004.05.060; HIPPIUS H, 1989, PSYCHOPHARMACOLOGY, V99, pS3, DOI 10.1007/BF00442551; Ishikane T, 1997, EUR J PHARMACOL, V321, P163, DOI 10.1016/S0014-2999(96)00948-X; Jarkskog LF, 2004, AM J PSYCHIAT, V161, P109; Jarkskog LF, 2000, BIOL PSYCHIAT, V48, P641; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Jha S, 2008, NEUROSCI LETT, V441, P210, DOI 10.1016/j.neulet.2008.06.028; Kim NR, 2008, BIOL PSYCHIAT, V32, P633; KLAWANS HL, 1980, AM J PSYCHIAT, V137, P900; Kodamo M, 2004, BIOL PSYCHIAT, V56, P570, DOI 10.1016/j.biopsych.2004.07.008; Kozlovsky N, 2006, INT J NEUROPSYCHOPH, V9, P337, DOI 10.1017/S1461145705006097; Kramer MS, 1997, ARCH GEN PSYCHIAT, V54, P567; Kulikov R, 2005, MOL CELL BIOL, V25, P7170, DOI 10.1128/MCB.25.16.7170-7180.2005; Kuroki T, 2008, PROG BRAIN RES, V172, P199, DOI 10.1016/S0079-6123(08)00910-2; Kusumi I, 2008, PROG NEURO-PSYCHOPH, V32, P520, DOI 10.1016/j.pnpbp.2007.10.008; Lawrence MS, 1996, J NEUROSCI, V16, P486; Leng A, 2003, PHARMACOL BIOCHEM BE, V75, P281, DOI 10.1016/S0091-3057(03)00082-0; Li Z, 2007, BRAIN RES, V1134, P70, DOI 10.1016/j.brainres.2006.11.060; Liu Juan, 2006, Synapse, V60, P56, DOI 10.1002/syn.20275; LYNCH MR, 1992, PROG NEURO-PSYCHOPH, V16, P797, DOI 10.1016/0278-5846(92)90102-K; MACHIYAMA Y, 1992, SCHIZOPHRENIA BULL, V18, P107; Marberg JE, 2000, J NEUROSCI, V20, P9104; Masui T, 2006, PROG NEURO-PSYCHOPH, V30, P1330, DOI 10.1016/j.pnpbp.2006.02.012; MATSUBARA S, 1993, J PHARMACOL EXP THER, V265, P498; McCreary AC, 2010, CURR PHARM DESIGN, V16, P516; McIntyre R, 2003, BIPOLAR DISORD, V5, P20, DOI 10.1111/j.1399-2406.2003.00061.x; MELTZER HY, 1985, ADV BIOCHEM PSYCHOPH, V40, P59; Millan MJ, 1997, EUR J PHARMACOL, V321, pR7; Nair VD, 2008, J BIOL CHEM, V283, P15469, DOI 10.1074/jbc.M707238200; PAKKENBERG B, 1993, BIOL PSYCHIAT, V34, P768, DOI 10.1016/0006-3223(93)90065-L; Pitsikas N, 2008, BEHAV BRAIN RES, V188, P304, DOI 10.1016/j.bbr.2007.11.010; Polter AM, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00031; Polter AM, 2012, CELL SIGNAL, V24, P265, DOI 10.1016/j.cellsig.2011.09.009; ROTH BL, 1992, J PHARMACOL EXP THER, V260, P1361; Roussos P, 2008, BIOL PSYCHIAT, V64, P235, DOI 10.1016/j.biopsych.2008.01.020; Schabitz WR, 2000, STROKE, V31, P2212; SCHLAEPFER TE, 1994, AM J PSYCHIAT, V151, P842; Schotte A, 1996, HISTOCHEM J, V28, P791, DOI 10.1007/BF02272152; SEEMAN P, 1992, NEUROPSYCHOPHARMACOL, V7, P261; Sumiyoshi T, 2013, FRONT BEHAV NEUROSCI, V7, P1; Takahashi Y, 1998, J PSYCHIATR NEUROSCI, V23, P157; Takahashi Y, 1998, J NEURAL TRANSM, V105, P181, DOI 10.1007/s007020050047; Tan QR, 2007, EUR NEUROPSYCHOPHARM, V17, P768, DOI 10.1016/j.euroneuro.2007.03.003; Teuchert-Noodt G, 2000, J NEURAL TRANSM, V107, P133, DOI 10.1007/s007020050012; Ukai W, 2004, J NEURAL TRANSM, V111, P667, DOI 10.1007/s00702-004-0109-z; Une T, 2007, JPN J CLIN PSYCHOPHA, V10, P1263; WADENBERG ML, 1992, J NEURAL TRANSM-GEN, V89, P49, DOI 10.1007/BF01245351; Wang C, 2001, NEUROSCIENCE, V107, P535, DOI 10.1016/S0306-4522(01)00384-0; ZHONG LT, 1993, MOL BRAIN RES, V19, P353, DOI 10.1016/0169-328X(93)90139-G; ZIPURSKY RB, 1992, ARCH GEN PSYCHIAT, V49, P195	148	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	MAY	2015	69	5			SI		243	258		10.1111/pcn.12242		16	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CG8FY	WOS:000353543900002		
J	Fujiwara, H; Yassin, W; Murai, T				Fujiwara, Hironobu; Yassin, Walid; Murai, Toshiya			Neuroimaging studies of social cognition in schizophrenia	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Review						magnetic resonance imaging; multimodal imaging; quality of life; schizophrenia; social cognition	EMOTIONAL FACIAL EXPRESSIONS; VOXEL-BASED MORPHOMETRY; WHITE-MATTER INTEGRITY; FRONTAL-LOBE PATHOLOGY; HUMAN AMYGDALA; GRAY-MATTER; NORMAL ADULTS; MIND; RECOGNITION; AUTISM	Impaired social cognition is considered a core contributor to unfavorable psychosocial functioning in schizophrenia. Rather than being a unitary process, social cognition is a collection of multifaceted processes that recruit multiple brain structures, thus structural and functional neuroimaging techniques are ideal methodologies for revealing the underlying pathophysiology of impaired social cognition. Many neuroimaging studies have suggested that in addition to white-matter deficits, schizophrenia is associated with decreased gray-matter volume in multiple brain areas, especially fronto-temporal and limbic regions. However, few schizophrenia studies have examined associations between brain abnormalities and social cognitive disabilities. During the last decade, we have investigated structural brain abnormalities in schizophrenia using high-resolution magnetic resonance imaging, and our findings have been confirmed by us and others. By assessing different types of social cognitive abilities, structural abnormalities in multiple brain regions have been found to be associated with disabilities in social cognition, such as recognition of facial emotion, theory of mind, and empathy. These structural deficits have also been associated with alexithymia and quality of life in ways that are closely related to the social cognitive disabilities found in schizophrenia. Here, we overview a series of neuroimaging studies from our laboratory that exemplify current research into this topic, and discuss how it can be further tackled using recent advances in neuroimaging technology.	[Fujiwara, Hironobu; Yassin, Walid; Murai, Toshiya] Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto 6068507, Japan; [Fujiwara, Hironobu] Kyoto Univ Hosp, Integrated Clin Educ Ctr, Kyoto 606, Japan	Murai, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Psychiat, Sakyo Ku, Shogoinkawahara Cho 54, Kyoto 6068507, Japan.	murai@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science [22220003, 23390290, 23118004]; Ministry of Education, Culture, Sports, Science and Technology, Japan	The authors declare no conflict of interest. This study was funded by a Grant-in-Aid for Scientific Research (S) (22220003), a Grant-in-Aid for Scientific Research (B) (23390290), and a Grant-in-Aid for Scientific Research on Innovative Areas (23118004), from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology, Japan. H.F. wrote the first draft of the manuscript, critically reviewed it, and approved the final manuscript as submitted. W.Y. managed the literature search, contributed to the writing of the manuscript, critically reviewed it, and approved the final manuscript as submitted. T.M. supervised, reviewed, and edited the manuscript, and approved it as submitted.	Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Fujino J, 2014, PROG NEURO-PSYCHOPH, V48, P117, DOI 10.1016/j.pnpbp.2013.09.018; Ubukata S, 2013, J PSYCHIATR RES, V47, P548, DOI 10.1016/j.jpsychires.2013.01.002; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Hooker CI, 2012, SCHIZOPHR RES, V139, P53, DOI 10.1016/j.schres.2012.05.009; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Guttman H, 2002, COMPR PSYCHIAT, V43, P448, DOI 10.1053/comp.2002.35905; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037//0022-3514.44.1.113; Hoe M, 2012, PSYCHOL MED, V42, P2287, DOI 10.1017/S0033291712000578; Whalen PJ, 1998, J NEUROSCI, V18, P411; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Namiki C, 2007, PSYCHIAT RES-NEUROIM, V156, P23, DOI 10.1016/j.pscychresns.2007.03.004; Lee KH, 2006, AM J PSYCHIAT, V163, P1926, DOI 10.1176/appi.ajp.163.11.1926; BARONCOHEN S, 1994, BRIT J PSYCHIAT, V165, P640, DOI 10.1192/bjp.165.5.640; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Fujiwara H, 2007, NEUROIMAGE, V36, P1236, DOI 10.1016/j.neuroimage.2007.03.068; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Mehta UM, 2013, SCHIZOPHR RES, V148, P3, DOI 10.1016/j.schres.2013.05.009; Kubota M, 2011, NEUROSCI RES, V70, P206, DOI 10.1016/j.neures.2011.01.019; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; CACIOPPO JT, 1992, AM PSYCHOL, V47, P1019, DOI 10.1037/0003-066X.47.8.1019; Straube B, 2014, SCHIZOPHRENIA BULL, V40, P936, DOI 10.1093/schbul/sbt110; Herbener ES, 2005, AM J PSYCHIAT, V162, P1746, DOI 10.1176/appi.ajp.162.9.1746; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Mende-Siedlecki P, 2013, J COGNITIVE NEUROSCI, V25, P2086, DOI 10.1162/jocn_a_00469; Kalkstein S, 2010, CURR TOP BEHAV NEURO, V4, P373, DOI 10.1007/7854_2010_42; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Kubota M, 2012, SCHIZOPHR RES, V141, P137, DOI 10.1016/j.schres.2012.08.026; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Yamada M, 2007, NEUROIMAGE, V35, P292, DOI 10.1016/j.neuroimage.2006.10.046; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Bellack AS, 2004, AM J PSYCHIAT, V161, P364, DOI 10.1176/appi.ajp.161.2.364; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Ekman P., 1976, PICTURES FACIAL AFFE; Fujiwara H, 2008, PROG NEURO-PSYCHOPH, V32, P1728, DOI 10.1016/j.pnpbp.2008.07.013; GOLDBERG TE, 1988, SCHIZOPHRENIA BULL, V14, P179; Hirao K, 2008, SCHIZOPHR RES, V105, P165, DOI 10.1016/j.schres.2008.07.021; Keshavan MS, 2011, SCHIZOPHR RES, V130, P123, DOI 10.1016/j.schres.2011.05.001; Pohl A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069886; Rau JC, 1993, DISS ABSTR INT B, VB54, p506B; Sasamoto A, 2011, SOC NEUROSCI-UK, V6, P548, DOI 10.1080/17470919.2011.575693; STANGHELLINI G, 1995, PSYCHOPATHOLOGY, V28, P263; vanst Wout M, 2007, COMPR PSYCHIAT, V48, P27	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	MAY	2015	69	5			SI		259	267		10.1111/pcn.12258		9	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CG8FY	WOS:000353543900003		
J	Yamamoto, N; Inada, T				Yamamoto, Nobutomo; Inada, Toshiya			Case of elderly patient who developed hallucinations upon administration of oseltamivir	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Letter									[Yamamoto, Nobutomo] Sakakibara Hosp, Natl Hosp Org, Dept Psychiat, Tsu, Mie, Japan; [Inada, Toshiya] Seiwa Hosp, Inst Neuropsychiat, Tokyo, Japan	Yamamoto, N (reprint author), Sakakibara Hosp, Natl Hosp Org, Dept Psychiat, Tsu, Mie, Japan.	ravonal@hotmail.com					Kruker Anna Tina, 2010, Ther Umsch, V67, P613, DOI 10.1024/0040-5930/a000106	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	MAY	2015	69	5			SI		305	306		10.1111/pcn.12228		2	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CG8FY	WOS:000353543900009		
J	Kyo, M; Mii, H; Takekita, Y; Tokuhara, D; Yazaki, M; Nakamori, Y; Kono, S; Kinoshita, T				Kyo, Masatoshi; Mii, Hiroshi; Takekita, Yoshiteru; Tokuhara, Daisuke; Yazaki, Masahide; Nakamori, Yasushi; Kono, Satoshi; Kinoshita, Toshihiko			Case of adult-onset type II citrullinemia treated as schizophrenia for a long time	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Letter									[Kyo, Masatoshi; Mii, Hiroshi; Takekita, Yoshiteru; Kono, Satoshi; Kinoshita, Toshihiko] Kansai Med Univ, Dept Neuropsychiat, Osaka, Japan; [Nakamori, Yasushi] Kansai Med Univ, Dept Emergency & Crit Care Med, Osaka, Japan; [Tokuhara, Daisuke] Osaka City Univ, Dept Pediat, Osaka 558, Japan; [Yazaki, Masahide] Shinshu Univ, Inst Biomed Sci, Matsumoto, Nagano 390, Japan; [Takekita, Yoshiteru] Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy	Kyo, M (reprint author), Kansai Med Univ, Dept Neuropsychiat, Osaka, Japan.	kyomasa@takii.kmu.ac.jp					Kobayashi K, GENE REV; Nakamura M, 2011, J NUTR SCI VITAMINOL, V57, P239, DOI 10.3177/jnsv.57.239; Yazaki M, 2013, CLIN NEUROL NEUROSUR, V115, P1542, DOI 10.1016/j.clineuro.2012.12.027	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	MAY	2015	69	5			SI		306	307		10.1111/pcn.12253		2	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CG8FY	WOS:000353543900010		
J	Pontifex, MB; Parks, AC; Henning, DA; Kamijo, K				Pontifex, Matthew B.; Parks, Andrew C.; Henning, David A.; Kamijo, Keita			Single bouts of exercise selectively sustain attentional processes	PSYCHOPHYSIOLOGY			English	Article						Acute exercise; Stimulus discrimination; Attentional orienting; P300; P3a; P3b	AEROBIC EXERCISE; PREADOLESCENT CHILDREN; EXECUTIVE FUNCTIONS; COGNITIVE CONTROL; PHYSICAL-ACTIVITY; RESPONSE-TIME; P300; P3A; STIMULI; TASK	This study examined how single bouts of exercise may differentially modulate neuroelectric correlates of attentional orienting and processing. Using a within-participants design, ERPs and task performance were assessed in response to a perceptually challenging three-stimulus oddball task prior to and following a bout of exercise or seated rest during two separate, counterbalanced sessions. Findings revealed that, following a single bout of exercise, attentional processing was sustained relative to pretest whereas prolonged sitting resulted in attentional decrements. Focal attention resulting from attentional orienting, in contrast, does not appear to be sensitive to the influences of single bouts of physical activity. These findings suggest that acute exercise-induced changes in cognition do not originate from an overall modulation of attention but instead are specific to aspects of attentional processing.	[Pontifex, Matthew B.; Parks, Andrew C.; Henning, David A.] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Kamijo, Keita] Waseda Univ, Sch Sport Sci, Tokyo, Japan	Pontifex, MB (reprint author), Michigan State Univ, Dept Kinesiol, 27P IM Sports Circle, E Lansing, MI 48824 USA.	pontifex@msu.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R21 HD078566]; College of Education; Graduate School at Michigan State University	Support for the preparation of this manuscript was provided by a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to MBP (R21 HD078566) and a Summer Research Development Fellowship awarded to ACP through the College of Education and the Graduate School at Michigan State University.	Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Pontifex MB, 2013, J PEDIATR-US, V162, P543, DOI 10.1016/j.jpeds.2012.08.036; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; MAGLIERO A, 1984, PSYCHOPHYSIOLOGY, V21, P171, DOI 10.1111/j.1469-8986.1984.tb00201.x; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Kamijo K, 2009, J GERONTOL B-PSYCHOL, V64, P356, DOI 10.1093/geronb/gbp030; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Bunce DM, 2010, J CHEM EDUC, V87, P1438, DOI 10.1021/ed100409p; [Anonymous], 1843, OFFLINE ANAL ACQUIRE, V3, P2; Pontifex MB, 2009, PSYCHOPHYSIOLOGY, V46, P379, DOI 10.1111/j.1469-8986.2008.00782.x; Ilan AB, 1999, CLIN NEUROPHYSIOL, V110, P367; Magnie MN, 2000, PSYCHOPHYSIOLOGY, V37, P369, DOI 10.1017/S0048577200981435; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Kamijo K, 2004, EUR J APPL PHYSIOL, V92, P305, DOI 10.1007/s00421-004-1097-2; Hillman CH, 2009, NEUROSCIENCE, V159, P1044, DOI 10.1016/j.neuroscience.2009.01.057; Yagi Y, 1999, EUR J APPL PHYSIOL O, V80, P402, DOI 10.1007/s004210050611; Walhovd KB, 2008, PSYCHOPHYSIOLOGY, V45, P545, DOI 10.1111/j.1469-8986.2008.00661.x; Hagen GF, 2006, INT J PSYCHOPHYSIOL, V59, P8, DOI 10.1016/j.ijpsycho.2005.08.003; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Dishman RK, 2000, BRAIN RES BULL, V52, P337, DOI 10.1016/S0361-9230(00)00271-9; Verburgh L, 2014, BRIT J SPORT MED, V48, P973, DOI 10.1136/bjsports-2012-091441; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Buckworth J., 2002, EXERCISE PSYCHOL, P191; Chatrian G. E., 1985, American Journal of EEG Technology, V25; Conroy MA, 2007, J PSYCHOPHYSIOL, V21, P22, DOI 10.1027/0269-8803.21.1.22; Cooter S., 2011, WONDERS UNIVERSE; DIMSDALE JE, 1984, JAMA-J AM MED ASSOC, V251, P630, DOI 10.1001/jama.251.5.630; Hillman C. H., 2012, FUNCTIONAL NEUROIMAG, P419, DOI DOI 10.1007/978-1-4614-3293-7_18; Hillman CH, 2014, PEDIATRICS, V134, P1063, DOI DOI 10.1542/PEDS.2013-3219; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; Kumar Naresh, 2012, Int J Appl Basic Med Res, V2, P67, DOI 10.4103/2229-516X.96813; Nakamura Y, 1999, Electromyogr Clin Neurophysiol, V39, P71; Olmsted JA, 1999, J CHEM EDUC, V76, P525; Peirce J. W., 2009, FRONT NEUROINFORM, V2, P10, DOI [10.3389/neuro.11.010, DOI 10.3389/NEURO.11.010.2008]; Rushby JA, 2005, CLIN NEUROPHYSIOL, V116, P2363, DOI 10.1016/j.clinph.2005.06.008; Scudder MR, 2012, BIOL PSYCHOL, V89, P528, DOI 10.1016/j.biopsycho.2011.12.009; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; YAMAGUCHI S, 1991, ELECTROEN CLIN NEURO, V78, P297, DOI 10.1016/0013-4694(91)90184-6	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	MAY	2015	52	5					618	625		10.1111/psyp.12395		8	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CG1MB	WOS:000353035600002		
J	Miyadera, T				Miyadera, Takayuki			An examination of regionality in a configuration of smallest space analysis using Loevinger's homogeneity coefficient	QUALITY & QUANTITY			English	Article						Facet theory; Smallest space analysis; Guttman scale; Homogeneity coefficient; Radex		When applying smallest space analysis to behavioural science data, we may observe a radex structure in the two-dimensional output. This study proposes a method to support the investigation of the radex. A radex structure includes both polar and modular facets as defined in facet theory, where the modular facet of the concentric circles represents the frequency of variables. The polar facet of the pie shape, intersected by lines emanating from the centre, represents the semantic theme, grouped by variable clusters. When a dataset of dichotomous variables is analysed in this type of structure, variables with a higher proportion of positive answers often fall near the centre, whereas variables with a lower proportion of positive answers tend to fall near the outer area. When a few variable points fall along the line emanating from the centre to the outer rim, that series of variables may form a Guttman scale. The proposed method first determines the centre of the concentric circles, based on variable frequencies, using the quasi-Newton method of optimisation. Next, weighted Loevinger's homogeneity coefficients () are used to measure the degree of Guttman scalability. The author examined possible borders among the regions of the polar facet by investigating the peaks and troughs of values, using different ways of weighting homogeneity coefficients. Applications of the method to artificial and survey data showed that the proposed method was adequately effective for detecting the centre of concentric circles and radial lines to suggest regionality for the polar facet in a radex.	[Miyadera, Takayuki] Natl Res Inst Police Sci, Kashiwa, Chiba 2770882, Japan; [Miyadera, Takayuki] Grad Univ Adv Studies, Hayama, Kanagawa 2400193, Japan	Miyadera, T (reprint author), Natl Res Inst Police Sci, 6-3-1 Kashiwanoha, Kashiwa, Chiba 2770882, Japan.	miyadera@nrips.go.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [20730466]	This study was carried out under the supervision of Associate Professor Takahiro Tsuchiya of the Institute of Statistical Mathematics. The collection of the survey data used in this study was supported by KAKENHI, the Grant-in Aid for Young Scientists (B) (No. 20730466), from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Alison L. J., 2001, QUALITATIVE RES, V1, P241, DOI 10.1177/146879410100100208; Guttman L, 1944, AM SOCIOL REV, V9, P139, DOI 10.2307/2086306; Guttman R, 1998, EUR PSYCHOL, V3, P13, DOI 10.1027/1016-9040.3.1.13; GUTTMAN L, 1968, PSYCHOMETRIKA, V33, P469, DOI 10.1007/BF02290164; LOEVINGER J, 1948, PSYCHOL BULL, V45, P507, DOI 10.1037/h0055827; Borg I., 1995, FACET THEORY FORM CO; Canter D., 2000, LEGAL CRIMINOL PSYCH, V5, P23, DOI DOI 10.1348/135532500167958; Canter D., 1985, FACET THEORY APPROAC; Canter DV, 2003, BEHAV SCI LAW, V21, P157, DOI 10.1002/bsl.526; CLOGG CC, 1981, SOCIOLOGICAL METHODO, V0012; Coxon A. P. M., 1982, MULTIDIMENSIONAL SCA; Guttman L., 1954, MATH THINKING SOCIAL, P258; Jaccard P., 1908, B SOCIETE VAUDOISE S, V44, P223, DOI DOI 10.5169/SEALS-268384; Kimura M., 2002, FASETTO RIRON TO KAI; Shye S., 1994, INTRO FACET THEORY C; Van Schuur W. H., 2011, ORDINAL ITEM RESPONS; Yokota K., 2004, BEHAVIORMETRIKA, V31, P153, DOI 10.2333/bhmk.31.153	17	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0033-5177	1573-7845		QUAL QUANT	Qual. Quant.	MAY	2015	49	3					1203	1218		10.1007/s11135-014-0043-6		16	Social Sciences, Interdisciplinary; Statistics & Probability	Social Sciences - Other Topics; Mathematics	CG3VX	WOS:000353208800024		
J	Okamoto, T; Onozuka, T				Okamoto, Takuya; Onozuka, Tomokazu			Mean value theorems for the Mordell-Tornheim double zeta-function	RAMANUJAN JOURNAL			English	Article						Mordell-Tornheim double zeta-function; Mean value; Mellin-Barnes integral; Euler-Maclaurin formula	ANALYTIC CONTINUATION	Matsumoto and Tsumura proved mean value theorems for the Euler-Zagier double zeta-function. In this paper, we consider mean value theorems for the Mordell-Tornheim double zeta-function.	[Okamoto, Takuya] Nippon Inst Technol, Fac Engn, Miyashiro, Saitama 3458501, Japan; [Onozuka, Tomokazu] Nagoya Univ, Grad Sch Math, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Okamoto, T (reprint author), Nippon Inst Technol, Fac Engn, 4-1 Gakuendai, Miyashiro, Saitama 3458501, Japan.	takuyaoka@leo.nit.ac.jp; m11022v@math.nagoya-u.ac.jp					Zhao JQ, 2000, P AM MATH SOC, V128, P1275, DOI 10.1090/S0002-9939-99-05398-8; TORNHEIM L, 1950, AM J MATH, V72, P303, DOI 10.2307/2372034; Matsumoto K, 2003, J NUMBER THEORY, V101, P223, DOI 10.1016/S0022-314X(03)00041-6; Akiyama S, 2001, ACTA ARITH, V98, P107, DOI 10.4064/aa98-2-1; Ivic A., 1985, RIEMANN ZETA FUNCTIO; Matsumoto K., 2002, NUMBER THEORY MILLEN, P417; Matsumoto K., ARXIV12032242V2; Mordell L.J., 1958, J LOND MATH SOC, V33, P368; Titchmarsh B. C., 1986, THEORY RIEMANN ZETA; Whittaker E.T., 1927, COURSE MODERN ANAL	10	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1382-4090	1572-9303		RAMANUJAN J	Ramanujan J.	MAY	2015	37	1					131	163		10.1007/s11139-014-9593-4		33	Mathematics	Mathematics	CG4WW	WOS:000353289800009		
J	Inoue, Y; Morita, Y; Takikawa, M; Takao, K; Kanamoto, I; Sugibayashi, K				Inoue, Yutaka; Morita, Yuki; Takikawa, Mayu; Takao, Koichi; Kanamoto, Ikuo; Sugibayashi, Kenji			Future expectations for Japanese pharmacists as compared to the rest of the world	Research in Social & Administrative Pharmacy			English	Editorial Material						Role of the pharmacist; Dispensing system; Pharmacy assistant; Team medical care; Health promotion	SELF-MEDICATION; COMMUNITY; PRESCRIPTION; INFECTIONS; MANAGEMENT; SEPARATION; GERMANY; NEEDS	It is important to share information about other countries' pharmacists to optimize cross-border medical cooperation. This paper examines the dispensing systems and the work done by pharmacists in the United Kingdom, Germany, France, Thailand, and Malaysia so as to compare these countries' medical practices and develop a cohesive vision for the future of Japanese pharmacists. All five of the countries have dispensing assistants. Pharmacists in Japan have duties of inventory control, drug dispensing, and providing medication advice. In contrast, assistants working in other countries are responsible for some aspects of dispensing and inventory control, allowing the pharmacists to spend their time and competency in instructing patients on how to take their medication. Because of this, pharmacists were actively involved with health promotion intervention in the United Kingdom, Germany, and France. It is hoped that work done by Japanese pharmacists would transition from primarily dispensing drugs to patient care, advice, and counseling to enrich overall health promotion and health/nutrition counseling. (C) 2015 Elsevier Inc. All rights reserved.	[Inoue, Yutaka; Morita, Yuki; Takikawa, Mayu; Takao, Koichi; Kanamoto, Ikuo; Sugibayashi, Kenji] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan	Inoue, Y (reprint author), Josai Univ, Fac Pharmaceut Sci, 1-1 Keyakidai, Sakado, Saitama 3500295, Japan.	yinoue@josai.ac.jp					Maddux MS, 2000, PHARMACOTHERAPY, V20, P991; Chisholm-Burns MA, 2010, MED CARE, V48, P923, DOI 10.1097/MLR.0b013e3181e57962; Shafie AA, 2012, RES SOC ADMIN PHARM, V8, P258, DOI 10.1016/j.sapharm.2011.06.002; George PP, 2010, ANN ACAD MED SINGAP, V39, P861; Sihavong A, 2006, SEX TRANSM INFECT, V82, P182, DOI 10.1136/sti.2005.016352; Hammond RW, 2003, PHARMACOTHERAPY, V23, P1210; [Anonymous], 2003, IMPL COMM PHARM MIN; Alkhateeb Fadi M, 2011, Int J Pharm Pract, V19, P219, DOI 10.1111/j.2042-7174.2011.00095.x; Bell HM, 2000, J SOC ADMIN PHARM, V17, P119; Blenkinsopp A, 2002, MINOR ILLNESS MANAGE; Colin-Thome D, 2003, BETTER MANAGEMENT MI; Department of Health, 2000, NHS PLAN PLAN INV PL; Department of Health, 2005, SELF CAR REAL CHOIC; General Pharmaceutical Council, PHARM IND PRESCR; Hayase Y, 2003, YAKUGAKU ZASSHI, V123, P121; McKee MD, 1999, J FAM PRACTICE, V48, P993; Michael JR, 2003, AM J HEALTH-SYST PH, V60, P37; Pumtong S, 2011, INT J CLIN PHARM-NET, V33, P573, DOI 10.1007/s11096-011-9513-2; PUMTONG S, 2008, INT J PHARM PRACT, V16, P73, DOI DOI 10.1211/ijpp.16.2.0004; Reeves DS, 1999, J ANTIMICROB CHEMOTH, V44, P163, DOI 10.1093/jac/44.2.163; Saramunee K, 2011, IJPS, V7, P1; Schmiedel K, 2013, INT J CLIN PHARM-NET, V35, P138, DOI 10.1007/s11096-012-9722-3; Steyer TE, 2004, VACCINE, V22, P1001, DOI 10.1016/j.vaccine.2003.08.045; Widayati A, 2011, BMC RES NOTES, V11, P491; Wilson Debbie L., 2003, Journal of Pharmacy Technology, V19, P159; World Health Organization, 2011, NCD COUNTR PROF GERM; Wustmann AF, 2013, INT J CLIN PHARM-NET, V35, P584, DOI 10.1007/s11096-013-9772-1	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1551-7411	1934-8150		RES SOC ADMIN PHARM	Res. Soc. Adm. Pharm.	MAY-JUN	2015	11	3					448	458		10.1016/j.sapharm.2014.08.007		11	Public, Environmental & Occupational Health; Pharmacology & Pharmacy	Public, Environmental & Occupational Health; Pharmacology & Pharmacy	CG5KN	WOS:000353330500018		
J	Murayama, K; Nirei, M; Shimizu, H				Murayama, Kota; Nirei, Makoto; Shimizu, Hiroshi			Management of science, serendipity, and research performance: Evidence from a survey of scientists in Japan and the US	RESEARCH POLICY			English	Article						Science; Serendipity; Productivity; Research management	KNOWLEDGE; INNOVATION; TECHNOLOGY; COMMUNICATION; ORGANIZATIONS; COLLABORATION; CREATIVITY; DIVISION; PATTERNS; COSTS	In science, research teams are increasing in size, which suggests that science is becoming more organisational. This paper aims to empirically investigate the effects of the division of labour in management and science on serendipity, which has been considered one of the great factors in science. Specifically, in examining the survey of scientists conducted in Japan and the U.S., this paper treats the following questions: Does pursuing serendipity really bring about better scientific outcomes? How does the division of labour in science influence serendipity and publication productivity? The empirical results suggest that serendipity actually brings about better research quality on average. It also finds that if the managerial role is played by a leading scientist in the team, this is positively associated with the quality of the paper through allowing researchers to pursue serendipitous findings. In contrast, if the managerial role and leading research role are played by different members, this has a positive association with the number of papers published, as the project size becomes larger. These results indicate there is a trade-off between serendipity and publication productivity in science via who plays the leading role in research and management. (C) 2015 Elsevier B.V. All rights reserved.	[Murayama, Kota] Northwestern Univ, Dept Econ, Evanston, IL 60208 USA; [Nirei, Makoto; Shimizu, Hiroshi] Hitotsubashi Univ, Inst Innovat Res, Kunitachi, Tokyo 1868603, Japan	Murayama, K (reprint author), Northwestern Univ, Dept Econ, 2001 Sheridan Rd, Evanston, IL 60208 USA.	KotaMurayama2013@u.northwestern.edu			Japan Society for the Promotion of Science [21243020]	This paper is a part of a joint research project of Hitotsubashi University, the National Institute of Science and Technology Policy of the Ministry of Education, Culture, Sports, Science, and Technology, and Georgia Institute of Technology. The research project was funded by the Japan Society for the Promotion of Science, Grants (A), 21243020. We are grateful to Reiko Aoki, Masatsura Igami, Sadao Nagaoka, Paula Stephan, John P. Walsh, seminar participants at the Asia-Pacific Innovation Conference, two anonymous reviewers, and editor Keun Lee for helpful comments.	Allen T.J., 1977, MANAGING FLOW TECHNO; Andrews F. M., 1979, SCI PRODUCTIVITY EFF; Fleming L, 2007, ADMIN SCI QUART, V52, P443; POLANYI M, 1962, MINERVA, V1, P54, DOI 10.1007/BF01101453; Ellison G, 2002, J POLIT ECON, V110, P994, DOI 10.1086/341871; KOGUT B, 1992, ORGAN SCI, V3, P383, DOI 10.1287/orsc.3.3.383; Hagedoorn J, 2002, RES POLICY, V31, P477, DOI 10.1016/S0048-7333(01)00120-2; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Singh J, 2010, MANAGE SCI, V56, P41, DOI 10.1287/mnsc.1090.1072; DASGUPTA P, 1994, RES POLICY, V23, P487; Brown JS, 1991, ORGAN SCI, V2, P40, DOI 10.1287/orsc.2.1.40; March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71; PERROW C, 1967, AM SOCIOL REV, V32, P194, DOI 10.2307/2091811; Birkinshaw J, 2002, ORGAN SCI, V13, P274, DOI 10.1287/orsc.13.3.274.2778; Heinze T, 2009, RES POLICY, V38, P610, DOI 10.1016/j.respol.2009.01.014; Collins H, 2007, STUD HIST PHILOS SCI, V38, P657, DOI 10.1016/j.shpsa.2007.09.003; Agrawal A, 2008, AM ECON REV, V98, P1578, DOI 10.1257/aer.98.4.1578; Jacobs BA, 2010, BRIT J CRIMINOL, V50, P514, DOI 10.1093/bjc/azq002; Ding WW, 2010, MANAGE SCI, V56, P1439, DOI 10.1287/mnsc.1100.1195; Pelled LH, 1999, ADMIN SCI QUART, V44, P1, DOI 10.2307/2667029; Adams JD, 2005, RES POLICY, V34, P259, DOI 10.1016/j.respol.2005.01.014; ARORA A, 1994, RES POLICY, V23, P523, DOI 10.1016/0048-7333(94)01003-X; BARBER B, 1958, AM J SOCIOL, V64, P128, DOI 10.1086/222420; Barnard C. I., 1938, FUNCTIONS EXECUTIVE; BECKER GS, 1992, Q J ECON, V107, P1137, DOI 10.2307/2118383; Biagioli M., 1999, SCI STUDIES READER, P137; Burns T, 1961, MANAGEMENT INNOVATIO; Cameron C., 2005, MICROECONOMETRICS ME; Chesbrough HW, 2003, OPEN INNOVATION NEW; COLLINS HM, 1975, SOC STUD SCI, V5, P441, DOI 10.1177/030631277500500404; Galison P., 1997, IMAGE LOGIC MAT CULT; Garvey W. D., 1979, COMMUNICATION ESSENC; Gouldner A. W., 1954, PATTERNS IND BUREAUC; Hollingsworth R. J., 2006, TRANSFORMATIONEN KAP, P361; KAPLAN N, 1959, ADMIN SCI QUART, V4, P20, DOI 10.2307/2390647; Kasperson C. J., 1978, HUMAN COMMUNICATION, V4, P113, DOI 10.1111/j.1468-2958.1978.tb00601.x; Kuhn Thomas S., 1970, STRUCTURE SCI REVOLU; Kulakowski E. C., 2006, RES ADM MANAGEMENT; Lave J., 1991, SITUATED LEARNING LE; Lawrence P.R., 1967, ORG ENV MANAGING DIF; Merton Robert K., 1957, SOCIAL THEORY SOCIAL; Merton RK, 2004, TRAVELS AND ADVENTURES OF SERENDIPITY: A STUDY IN SOCIOLOGICAL SEMANTICS AND THE SOCIOLOGY OF SCIENCE, P1; Nagaoka S., 2010, 1008 IIR; Nagaoka S., 2011, 1109 IIR; Nonaka I., 1995, KNOWLEDGE CREATING C; Pelz D. C., 1966, SCI ORG PRODUCTIVE C; Polanyi M., 1967, TACIT DIMENSION; Powell WW, 1996, ADMIN SCI QUART, V41, P116, DOI 10.2307/2393988; Presser S., 1980, SOC STUD SCI, V10, P96; Roberts Royston M., 1989, SERENDIPITY ACCIDENT; Sauer A. D., 1988, J POLIT ECON, V96, P855; Scott W. R., 1981, ORG RATIONAL NATURAL; Selznick P., 1949, TVA GRASS ROOTS STUD; Shapiro G., 1986, SKELETON DARKROOM ST; Simon H.A., 1976, ADM BEHAV STUDY DECI; Stephan P., 2010, HDB EC INNOVATION, V1, P217; Stephan P.E., 1992, STRIKING MOTHER LODE; Svensson G., 2005, Management Decision, V43, DOI 10.1108/00251740510609992; Thompson JD, 2003, ORG ACTION SOCIAL SC; UDWADIA FE, 1990, TECHNOL FORECAST SOC, V38, P65, DOI 10.1016/0040-1625(90)90018-Q; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; VanAndel P., 1992, CREATIVITY INNOVATIO, V1, P20; Woodward Joan, 1965, IND ORG THEORY PRACT; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Wooldridge JM, 2001, ECONOMET THEOR, V17, P451, DOI 10.1017/S0266466601172075; Zuckerman H., 1977, SCI ELITE NOBEL LAUR	66	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0048-7333	1873-7625		RES POLICY	Res. Policy	MAY	2015	44	4					862	873		10.1016/j.respol.2015.01.018		12	Management; Planning & Development	Business & Economics; Public Administration	CG1AZ	WOS:000353006700004		
J	Shibayama, S; Baba, Y				Shibayama, Sotaro; Baba, Yasunori			Impact-oriented science policies and scientific publication practices: The case of life sciences in Japan	RESEARCH POLICY			English	Article						Scientific production; Publication; Impact factor; Science policy; Evaluation	COERCIVE CITATION; JOURNALS; PERFORMANCE; UNIVERSITY; INNOVATION; CONSEQUENCES; PRODUCTIVITY; RESEARCHERS; COMPETITION; PATTERNS	The modern science system relies on intense evaluation of scientific publication, in which scientific impact is highly emphasized, but its contribution to the progress of science has been controversial. Focusing on two aspects of the science system, resource allocation and academic career design, this study explores whether these policies, presumably aiming at high-impact research, actually achieve the goal. Drawing on in-depth interviews and econometric analyses of Japanese biology professors, this study first shows that merit-based resource allocation can result in biased resource allocation, and that excessive resource concentration can facilitate low-impact publications. Second, results show that a lack of mobility, in particular inbreeding, increases low-impact publications, while international mobility decreases it. The latter effect is found to be mediated by fewer publications in low-impact journals, and thus, internationally mobile academics seem to decide the publication destination more strategically. (C) 2015 Elsevier B.V. All rights reserved.	[Shibayama, Sotaro; Baba, Yasunori] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Shibayama, Sotaro] Univ Tokyo, Dept Technol Management Innovat, Bunkyo Ku, Tokyo 1138656, Japan	Shibayama, S (reprint author), Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	shibayama@00.alumni.u-tokyo.ac.jp			Konosuke Matsushita Memorial Foundation; Inamori Foundation; Japan Society for the Promotion of Science [24710160]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23330121]	We acknowledge Paul David, Miho Funamori, David N. Laband, John P. Walsh, and three anonymous referees for constructive comments. We also acknowledge Noriyuki Morichika and Naohiro Shichijo for technical support. Funding for this research was provided by the Konosuke Matsushita Memorial Foundation, Inamori Foundation, Grant-in-Aid for Young Scientists (B) of the Japan Society for the Promotion of Science (#24710160), and Grant-in-Aid for Scientific Research (B) Program (#23330121) form the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Adams J., 2010, GLOBAL RES REPORT JA; Franzoni C, 2014, ECON LETT, V122, P89, DOI 10.1016/j.econlet.2013.10.040; Hicks D, 2012, RES POLICY, V41, P251, DOI 10.1016/j.respol.2011.09.007; COLE JR, 1972, SCIENCE, V178, P368, DOI 10.1126/science.178.4059.368; Weingart P, 2005, SCIENTOMETRICS, V62, P117, DOI 10.1007/s11192-005-0007-7; GARFIELD E, 1972, SCIENCE, V178, P471, DOI 10.1126/science.178.4060.471; Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837; Van Raan AFJ, 2005, SCIENTOMETRICS, V62, P133, DOI 10.1007/s11192-005-0008-6; van Leeuwen TN, 2001, SCIENTOMETRICS, V51, P335, DOI 10.1023/A:1010549719484; Saha S, 2003, J MED LIBR ASSOC, V91, P42; Hargadon A, 1997, ADMIN SCI QUART, V42, P716, DOI 10.2307/2393655; Butler L, 2003, RES POLICY, V32, P143, DOI 10.1016/S0048-7333(02)00007-0; Reich ES, 2013, NATURE, V502, P291, DOI 10.1038/502291a; Crespi GA, 2008, RES POLICY, V37, P565, DOI 10.1016/j.respol.2007.12.007; Calcagno V, 2012, SCIENCE, V338, P1065, DOI 10.1126/science.1227833; Anderson MS, 2007, SCI ENG ETHICS, V13, P437, DOI 10.1007/s11948-007-9042-5; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Cyranoski D, 2011, NATURE, V472, P276, DOI 10.1038/472276a; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; DASGUPTA P, 1994, RES POLICY, V23, P487; Etzkowitz H, 2000, RES POLICY, V29, P109, DOI 10.1016/S0048-7333(99)00055-4; MacRoberts MH, 1996, SCIENTOMETRICS, V36, P435, DOI 10.1007/BF02129604; Baruffaldi SH, 2012, RES POLICY, V41, P1655, DOI 10.1016/j.respol.2012.04.005; Bohannon J, 2013, SCIENCE, V342, P60, DOI 10.1126/science.342.6154.60; Narin F, 1996, SCIENTOMETRICS, V36, P293, DOI 10.1007/BF02129596; Agrawal A, 2011, J URBAN ECON, V69, P43, DOI 10.1016/j.jue.2010.06.003; Mervis J, 2014, SCIENCE, V344, P1328, DOI 10.1126/science.344.6190.1328; HAGSTROM WO, 1974, AM SOCIOL REV, V39, P1, DOI 10.2307/2094272; Clawson D, 2009, SCIENCE, V324, P1147, DOI 10.1126/science.1172995; Bornmann L, 2008, J DOC, V64, P45, DOI 10.1108/00220410810844150; Wilhite AW, 2012, SCIENCE, V335, P542, DOI 10.1126/science.1212540; Franzoni C, 2012, NAT BIOTECHNOL, V30, P1250, DOI 10.1038/nbt.2449; Tijssen RJW, 2010, J AM SOC INF SCI TEC, V61, P1842, DOI 10.1002/asi.21366; MCALLISTER PR, 1980, J AM SOC INFORM SCI, V31, P147, DOI 10.1002/asi.4630310304; NARIN F, 1991, SCIENTOMETRICS, V21, P313, DOI 10.1007/BF02093973; CARD D, 1994, AM ECON REV, V84, P772; Horta H, 2010, MANAGE SCI, V56, P414, DOI 10.1287/mnsc.1090.1109; Bhattacharjee Y, 2011, SCIENCE, V334, P1344, DOI 10.1126/science.334.6061.1344; BROAD WJ, 1981, SCIENCE, V211, P1137, DOI 10.1126/science.7008199; CNUFM (Center for National University Finance and Management), 2009, RES TUIT EXP BAS ED; Cruz-Castro L, 2010, RES POLICY, V39, P27, DOI 10.1016/j.respol.2009.11.008; David PA, 2004, IND CORP CHANGE, V13, P571, DOI 10.1093/icc/dth023; EC, 2010, EUR 2020 EUR STRAT S; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Fortin JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065263; FRANK E, 1994, JAMA-J AM MED ASSOC, V272, P163, DOI 10.1001/jama.272.2.163; Geuna A., 2014, GLOBAL MOBILITY RES; GORDON MD, 1984, SOC STUD SCI, V14, P27, DOI 10.1177/030631284014001003; Geuna A, 2003, MINERVA, V41, P277, DOI 10.1023/B:MINE.0000005155.70870.bd; Hamermesh DS, 2012, ECON INQ, V50, P1, DOI 10.1111/j.1465-7295.2011.00381.x; Hand E, 2008, NATURE, V452, P258, DOI 10.1038/452258a; HOLUB HW, 1991, SOUTH ECON J, V58, P317, DOI 10.2307/1060176; Horta H, 2011, ASIA PAC EDUC REV, V12, P35, DOI 10.1007/s12564-010-9126-9; Inanc O, 2011, SCIENTOMETRICS, V88, P885, DOI 10.1007/s11192-011-0415-9; Jacob BA, 2011, RES POLICY, V40, P864, DOI 10.1016/j.respol.2011.04.003; Kneller R., 2007, CHANGING GOVERNANCE; Laband DN, 2003, KYKLOS, V56, P161, DOI 10.1111/1467-6435.00215; Martin BR, 2013, RES POLICY, V42, P1005, DOI 10.1016/j.respol.2013.03.011; Merton R. K., 1973, SOCIOLOGY SCI; Merton RK, 2004, TRAVELS AND ADVENTURES OF SERENDIPITY: A STUDY IN SOCIOLOGICAL SEMANTICS AND THE SOCIOLOGY OF SCIENCE, P1; MEXT, 2009, DEV HUM RES DRIV FOR; Organization for Economic Cooperation and Development (OECD), 2008, GLOB COMP TAL MOB HI; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Rockwell S., 2009, RES MANAGE REV, V61, P29; Salonius A., 2008, WORKING LAB SOCIAL O; SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; Shibayama S, 2011, SCIENTOMETRICS, V88, P43, DOI 10.1007/s11192-011-0392-z; Shibayama S., 2015, IMPACT INBR IN PRESS; Shibayama S., 2015, INT RES VISITS CAREE; Sousa R, 2008, SCIENCE, V322, P1324, DOI 10.1126/science.322.5906.1324b; Stephan Paula, 2012, EC SHAPES SCI; Yamanoi A., 2007, ACAD MARKETPLACE JAP; Grieneisen ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044118; Zhao DZ, 2010, SCIENTOMETRICS, V84, P293, DOI 10.1007/s11192-010-0191-y	74	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0048-7333	1873-7625		RES POLICY	Res. Policy	MAY	2015	44	4					936	950		10.1016/j.respol.2015.01.012		15	Management; Planning & Development	Business & Economics; Public Administration	CG1AZ	WOS:000353006700009		
J	Brown, RC; Lemmon, BE; Shimamura, M; Villarreal, JC; Renzaglia, KS				Brown, R. C.; Lemmon, B. E.; Shimamura, M.; Villarreal, J. C.; Renzaglia, K. S.			Spores of relictual bryophytes: Diverse adaptations to life on land	REVIEW OF PALAEOBOTANY AND PALYNOLOGY			English	Article						Bryophyte; Gyptospore; Early land plant; Spore; Tripartite lamella; Trilete spore	CAMBRIAN PALYNOMORPHS; WELSH BORDERLAND; WALL DEVELOPMENT; PLANTS; ULTRASTRUCTURE; PHYLOGENY; LIVERWORTS; EVOLUTION; MARCHANTIOPHYTA; DIVERSIFICATION	Sporogenesis and the evolution of thick-walled meiospores were of paramount importance in the establishment of the first life on land nearly half a billion years ago. Indeed, the first evidence of plant life on land is the sudden appearance of spores (palynomorphs or cryptospores) about 470 million years ago, predating the first megafossils by some forty million years. Affinities of these fossil spores with living embryophytes are often difficult to assess due to significant gaps in knowledge of spore diversity in critical extant taxa. The bryophytes (liverworts, mosses and hornworts) are the most ancient living plant lineages. To fill in data and provide a framework in which to evaluate spore evolution, we conducted ultrastructural and developmental studies of eight early-divergent or relictual bryophytes, as identified by cladistic/molecular and morphological studies. Spore wall data are presented for the liverworts Apotreubia, Haplomitrium, and Blasia; the mosses Takakia, Sphagnum, Andreaea, and Oedipodium; and the hornwort Leiosporoceros. Wall ontogeny is based on tripartite lamellae (TPL) in all taxa except Andreaea, which has a unique spongy exine. While a single foundation TPL is typical of biyopsid mosses, Takakia has a multilamellate layer (MLL) composed of numerous appressed segments of TPL. Spores of Sphagnum, liverworts, and the hornwort Leiosporoceros have a MLL layer composed of continuous, not segmented, TPL. We conclude that TPL and multilamellate layers are plesiomorphic in sporoderm development in land plants. Proximal wall modifications evolved into distinct apertures in mosses and hornworts but not in liverworts. Analysis of relictual bryophyte species indicates that the ancestral spore types would be tetrahedral with trifacial proximal surfaces having less ornamentation than the distal surfaces. Identification of features specific to relictual liverwort, moss and hornwort spores provides a foundation for determining fossil spore affinities and interpreting spore evolution and diversification in the earliest land plants. (C) 2015 Elsevier B.V. All rights reserved.	[Brown, R. C.; Lemmon, B. E.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Shimamura, M.] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Higashihiroshima, Hiroshima 7398526, Japan; [Villarreal, J. C.] Univ Munich LMU, Systemat Bot & Mycol, Munich, Germany; [Renzaglia, K. S.] So Illinois Univ, Dept Plant Biol, Carbondale, IL 62901 USA	Renzaglia, KS (reprint author), So Illinois Univ, Dept Plant Biol, Carbondale, IL 62901 USA.				NSF [0638722]	We thank Joel Andy Long for contribution of data on Takakia sporogenesis and Paul Strother for valuable input on the evolution of cryptospores. This research was supported by NSF Grant 0638722.	Cox CJ, 2014, SYST BIOL, V63, P272, DOI 10.1093/sysbio/syt109; Shaw J, 2004, AM J BOT, V91, P1557, DOI 10.3732/ajb.91.10.1557; Villarreal JC, 2010, PHYTOTAXA, V9, P150; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Shimamura M, 2004, PLANT CELL, V16, P45, DOI 10.1105/tpc.016501; Forrest LL, 2006, BRYOLOGIST, V109, P303, DOI 10.1639/0007-2745(2006)109[303:UTEHOT]2.0.CO;2; Chang Y, 2011, AM J BOT, V98, P839, DOI 10.3732/ajb.0900384; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884; Cox CJ, 2010, PHYTOTAXA, V9, P175; Wellman CH, 1998, BOT J LINN SOC, V127, P117, DOI 10.1111/j.1095-8339.1998.tb02092.x; Brown RC, 2011, NEW PHYTOL, V190, P875, DOI 10.1111/j.1469-8137.2011.03709.x; Crandall-Stotler B., 2009, Edinburgh Journal of Botany, V66, P155, DOI 10.1017/S0960428609005393; Edwards D, 2014, NEW PHYTOL, V202, P50, DOI 10.1111/nph.12645; Taylor WA, 2009, REV PALAEOBOT PALYNO, V153, P296, DOI 10.1016/j.revpalbo.2008.09.001; Taylor WA, 2008, REV PALAEOBOT PALYNO, V151, P41, DOI 10.1016/j.revpalbo.2008.01.012; Shaw AJ, 2011, AM J BOT, V98, P352, DOI 10.3732/ajb.1000316; BLACKMORE S, 1987, Cladistics, V3, P185, DOI 10.1111/j.1096-0031.1987.tb00506.x; BROWN RC, 1982, REV PALAEOBOT PALYNO, V38, P99, DOI 10.1016/0034-6667(82)90051-3; Brown R.C., 1990, MICROSPORES EVOLUTIO, P55; Brown R.C., 1988, ADV BRYOL, V3, P159; Brown R.C., 2013, BOT REV; BROWN RC, 1986, AM J BOT, V73, P593, DOI 10.2307/2444265; BROWN RC, 1984, AM J BOT, V71, P412, DOI 10.2307/2443498; BROWN RC, 1990, AM J BOT, V77, P559, DOI 10.2307/2444391; Brown R.C., 1993, DUM J HATT BOT LAB, V74, P83; BROWN RC, 1980, AM J BOT, V67, P918, DOI 10.2307/2442433; BROWN RC, 1986, CAN J BOT, V64, P1174; Carafa A, 2003, ANN BOT-LONDON, V92, P299, DOI 10.1093/aob/mcg140; CRANDALL-STOTLER B., 2009, BRYOPHYTE BIOL, P1; DEMENENDEZ GGH, 1986, J BRYOL, V14, P255; Goffinet B., 2009, BRYOPHYTE BIOL, P55; Johnson TR, 2005, REV PALAEOBOT PALYNO, V137, P163, DOI 10.1016/j.revpalbo.2005.08.003; Lugardon B., 1990, MICROSPORES EVOLUTIO, P95; MISHLER BD, 1984, BRITTONIA, V36, P406, DOI 10.2307/2806602; Quilichini T. D., 2014, PHYTOCHEMISTRY; Renzaglia K. S., 2009, BRYOPHYTE BIOL, P139; Renzaglia K. S., 1978, J HATTORI BOT LAB, V44, P31; Renzaglia KS, 2007, BRYOLOGIST, V110, P179, DOI 10.1639/0007-2745(2007)110[179:BPATMA]2.0.CO;2; Renzaglia K.S., 2015, PLANTA IN PRESS; RENZAGLIA KS, 1994, CAN J BOT, V72, P65; Renzaglia KS, 1997, AM J BOT, V84, P1337, DOI 10.2307/2446132; SHIMAMURA M, 2003, J HATTORI BOT LAB, V94, P179; Shimamura M., 2008, BRYOLOGY NEW MILLENI, P319; Shimamura M, 2005, BRYOLOGIST, V108, P420, DOI 10.1639/0007-2745(2005)108[0420:SAOCDB]2.0.CO;2; Shimamura Masaki, 2001, Hikobia, V13, P551; Strother P.K., 2015, REV PALAEOBOT PALYNO, P97; Taylor W.A., 2010, REV PALAEOBOT PALYNO, V163, P264; Taylor W.A., 2000, POLLEN SPORES MORPHO, P425; Wallace S., 2011, AOB PLANTS; Wellman CH, 2000, PHILOS T ROY SOC B, V355, P717; Wellman C.H., 2004, EVOLUTION PLANT PHYS, P43, DOI 10.1016/B978-012339552-8/50004-4	52	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0034-6667	1879-0615		REV PALAEOBOT PALYNO	Rev. Palaeobot. Palynology	MAY	2015	216						1	17		10.1016/j.revpalbo.2015.01.004		17	Plant Sciences; Paleontology	Plant Sciences; Paleontology	CG6QK	WOS:000353426800001		
J	Ishise, H; Matsuo, M				Ishise, Hirokazu; Matsuo, Miwa			US-Canada border effect between 1993 and 2007: smaller, less asymmetrical, and declining	REVIEW OF WORLD ECONOMICS			English	Article						Gravity equation; Border effect; Trade barrier asymmetry; US trade after September 11	INTRANATIONAL HOME BIAS; STRUCTURAL ESTIMATION; INTERNATIONAL-TRADE; GRAVITY EQUATION; GEOGRAPHY; PUZZLE	We revisit the US-Canadian border effect on trade from 1993 through 2007. For 1993 data, we find that traditional log-transformed gravity models make the border effect larger, while data construction processes make the border effect smaller . Overall, we find that the border effect in 1993 is 4.1, which is 15-20 % lower than the previous estimates of approximately 5 by Anderson and van Wincoop (Am Econ Rev 93(1):170-192, 2003) and Feenstra (Scott J Polit Econ 49(5):491-506, 2002). Using the same data construction and specification methodologies, we find that the effect has shrunk to 3.2 by 2007; namely, the border effect in 2007 reduces state-province trade by two-thirds. Thus, between 1993 and 2007, the border effect declined by 22 %. Based on the structural estimator, we also find that the border effect is stronger for Canadian provinces as shown by Anderson and van Wincoop (2003), but the asymmetry in the border effect between the US and Canada shrank between 1993 and 2007.	[Ishise, Hirokazu] Osaka Univ, Inst Social & Econ Res, Osaka 5670047, Japan; [Matsuo, Miwa] Waseda Unviers, Waseda Inst Adv Study, Sinjuku Ku, Tokyo 1698050, Japan	Matsuo, M (reprint author), Waseda Unviers, Waseda Inst Adv Study, Sinjuku Ku, 1-6-1 Nishi Waseda, Tokyo 1698050, Japan.	mmatsuo@aoni.waseda.jp			Mid-American Transportation Center	We would like to thank the editor Harmen Lehment, the anonymous referee, Robert Dekle, Giovanni Facchini, Yasusada Murata, Ray Riezman, seminar participants at the University of Tokyo. All errors are our own. Matsuo acknowledges the financial support from Mid-American Transportation Center. The "Online Appendix" is available upon request.	Wolf HC, 2000, REV ECON STAT, V82, P555, DOI 10.1162/003465300559046; Hillberry R, 2008, EUR ECON REV, V52, P527, DOI 10.1016/j.euroecorev.2007.03.003; Eaton J, 2002, ECONOMETRICA, V70, P1741, DOI 10.1111/1468-0262.00352; GOURIEROUX C, 1984, ECONOMETRICA, V52, P681, DOI 10.2307/1913471; Feenstra RC, 2002, SCOT J POLIT ECON, V49, P491, DOI 10.1111/1467-9485.00244; Helliwell JF, 2001, CAN J ECON, V34, P1024, DOI 10.1111/0008-4085.00111; Disdier AC, 2008, REV ECON STAT, V90, P37, DOI 10.1162/rest.90.1.37; Balistreri EJ, 2007, J INT ECON, V72, P451, DOI 10.1016/j.jinteco.2007.01.001; Baier SL, 2009, J INT ECON, V77, P77, DOI 10.1016/j.jinteco.2008.10.004; Anderson JE, 2003, AM ECON REV, V93, P170, DOI 10.1257/000282803321455214; ANDERSON JE, 1979, AM ECON REV, V69, P106; Yi KM, 2010, AM ECON REV, V100, P364, DOI 10.1257/aer.100.1.364; Hillberry R, 2003, REV ECON STAT, V85, P1089, DOI 10.1162/003465303772815970; Anderson JE, 2010, AM ECON REV, V100, P2157, DOI 10.1257/aer.100.5.2157; ARMINGTON PS, 1969, INT MONET FUND S PAP, V16, P159; Balistreri EJ, 2008, ECON INQ, V46, P511, DOI 10.1111/j.1465-7295.2007.00093.x; Behrens K., 2009, 7369 CEPR; Border Policy Research Institute, 2009, TRAD TRAV PATT CAN U, V4; Bradbury SL, 2010, TRANSPORT POLICY, V17, P367, DOI 10.1016/j.tranpol.2010.04.003; Brown WM, 2002, PAP REG SCI, V81, P99; Cafiso G, 2011, REV WORLD ECON, V147, P543, DOI 10.1007/s10290-011-0091-0; Dias D. A., 2011, BORDER EFFECT REARVI; Fally T., 2012, STRUCTURAL GRAVITY F; Feenstra RC, 2004, ADVANCED INTERNATIONAL TRADE: THEORY AND EVIDENCE, P1; Helble M, 2007, REV WORLD ECON, V143, P433, DOI 10.1007/s10290-007-0116-x; Helliwell J. F., 1998, MUCH DO NATL BORDERS; Ishise H, 2015, ECON INQ, V53, P1647, DOI 10.1111/ecin.12177; MCCALLUM J, 1995, AM ECON REV, V85, P615; Santos Silva J. M. C., 2006, REV ECON STAT, V88, P641; Taylor JC, 2004, TRANSPORT J, V43, P5; Tenreyro S., 2011, ECON LETT, V112, P220; Wolf N, 2009, J ECON HIST, V69, P846; Wooldridge J., 2010, ECONOMETRICS CROSS S; WOOLDRIDGE JM, 1991, J ECONOMETRICS, V48, P29, DOI 10.1016/0304-4076(91)90031-8; Woudsma C., 1999, J TRANSP GEOGR, V7, P105, DOI 10.1016/S0966-6923(98)00045-3	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1610-2878	1610-2886		REV WORLD ECON	Rev. World Econ.	MAY	2015	151	2					291	308		10.1007/s10290-015-0212-2		18	Economics; International Relations	Business & Economics; International Relations	CG4AA	WOS:000353220800005		
J	Kumari, P; Narayanan, S; Kumar, H				Kumari, Puja; Narayanan, Sathish; Kumar, Himanshu			Herpesviruses: interfering innate immunity by targeting viral sensing and interferon pathways	REVIEWS IN MEDICAL VIROLOGY			English	Review							SARCOMA-ASSOCIATED HERPESVIRUS; SIMPLEX-VIRUS TYPE-1; ACTIVATED PROTEIN-KINASE; CYTOMEGALOVIRUS IE1 PROTEIN; IFN REGULATORY FACTOR-3; NUCLEAR-BODY FORMATION; PML ONCOGENIC DOMAINS; TOLL-LIKE RECEPTORS; I INTERFERON; ANTIVIRAL RESPONSE	Type I-interferon (IFN-I) induction pathway is one of the most commonly stimulated signaling pathways in response to viral infection. During viral infection this pathway is stimulated by various pattern-recognition receptors, which recognize different pathogen-associated molecular patterns. The pathways stimulated by different pattern-recognition receptors merge into common transcription factors IRF3 and IRF7, lead to the production of IFN-I. The secreted IFN-I stimulates JAK-STAT pathway leading to induction of interferon-stimulated genes (ISGs). The ISGs along with IFN-I create antiviral state to eliminate the virus from host. HHV infection enhances IFN-I-mediated innate antiviral response during both de novo infection and lytic reactivation from latency. However, HHV developed various molecular strategies to evade the sudden upsurge of the IFN-I and IFN-I-mediated antiviral response to establish a successful infection. Here, we focus on IFN-I induction and signaling pathways induced by three representative HHVs from each sub-family of HHV and strategies acquired by these HHVs to subvert the induction of IFN-I and ISGs to evade the host innate immunity. These fundamental understanding provides the clue for viral targets for pharmacological manipulation to develop potential therapeutics for broad subtypes of HHVs. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Kumari, Puja; Kumar, Himanshu] IISER, Dept Biol Sci, Immunol Lab, Bhopal, India; [Kumar, Himanshu] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Host Def, Osaka, Japan; [Narayanan, Sathish] IISER, Dept Biol Sci, Virol Lab, Bhopal, India	Kumar, H (reprint author), IISER, Dept Biol Sci, Immunol Lab, Bhopal, India.	hkumar@iiserb.ac.in			Council of Scientific & Industrial Research (CSIR); Department of Science and Technology (DST) [SR/S2/RJN-55/2009, BT/PR6009/GBD/27/382/2012]; Department of Biotechnology (DBT), Government of India; Department of Atomic Energy (DAE), Government of India [2012/37B/31/BRNS]; Intramural Research Grants of Indian Institute of Science Education and Research (IISER) Bhopal, Bhopal, India	P. K. is supported by the Council of Scientific & Industrial Research (CSIR). H. K. is supported by research grant numbers SR/S2/RJN-55/2009 and BT/PR6009/GBD/27/382/2012 from the Department of Science and Technology (DST) and Department of Biotechnology (DBT), Government of India. S. N. was supported by research grant number 2012/37B/31/BRNS from the Department of Atomic Energy (DAE), Government of India. Authors are also supported by Intramural Research Grants of Indian Institute of Science Education and Research (IISER) Bhopal, Bhopal, India.	Abate DA, 2004, J VIROL, V78, P10995, DOI 10.1128/JVI.78.20.10995-11006.2004; Ahns JH, 1997, J VIROL, V71, P4599; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Abend JR, 2012, J VIROL, V86, P11663, DOI 10.1128/JVI.01147-12; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028; Johnson KE, 2008, VIROLOGY, V374, P487, DOI 10.1016/j.virol.2008.01.001; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Bisson SA, 2009, J VIROL, V83, P5056, DOI 10.1128/JVI.02516-08; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Gu HD, 2003, P NATL ACAD SCI USA, V100, P8963, DOI 10.1073/pnas.1533420100; Marcos-Villar L, 2011, J GEN VIROL, V92, P188, DOI 10.1099/vir.0.024984-0; Burysek L, 2001, J VIROL, V75, P2345, DOI 10.1128/JVI.75.5.2345-2352.2001; Kew C, 2013, J VIROL, V87, P13141, DOI 10.1128/JVI.02564-13; Lee HR, 2009, J INTERF CYTOK RES, V29, P621, DOI 10.1089/jir.2009.0067; Daubeuf S, 2009, BLOOD, V113, P3264, DOI 10.1182/blood-2008-07-168203; Esteban M, 2003, J GEN VIROL, V84, P1463, DOI 10.1099/vir.0.19014-0; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; Cloutier N, 2010, J BIOL CHEM, V285, P7208, DOI 10.1074/jbc.M109.018838; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sathish N, 2011, J VIROL, V85, P10934, DOI 10.1128/JVI.00687-11; Rossetto CC, 2011, J VIROL, V85, P13290, DOI 10.1128/JVI.05886-11; Zenner HL, 2013, J VIROL, V87, P13115, DOI 10.1128/JVI.02167-13; Cassady KA, 2002, J VIROL, V76, P2029, DOI 10.1128/JVI.76.5.2029; Pham TH, 2013, J VIROL, V87, P3076, DOI 10.1128/JVI.02860-12; Sanchez R, 2007, J VIROL, V81, P3455, DOI 10.1128/JVI.02520-06; Cullen BR, 2013, NAT IMMUNOL, V14, P205, DOI 10.1038/ni.2537; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; Areste C, 2009, J BIOL CHEM, V284, P23272, DOI 10.1074/jbc.M109.033290; Marcos-Villar L, 2009, J VIROL, V83, P8849, DOI 10.1128/JVI.00339-09; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Miller DM, 1999, J IMMUNOL, V162, P6107; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Wang S, 2013, J VIROL, V87, P11851, DOI 10.1128/JVI.01211-13; Justesen J, 2000, CELL MOL LIFE SCI, V57, P1593, DOI 10.1007/PL00000644; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Kim YE, 2011, J VIROL, V85, P11928, DOI 10.1128/JVI.00758-11; Korioth F, 1996, EXP CELL RES, V229, P155, DOI 10.1006/excr.1996.0353; Fuld S, 2006, J VIROL, V80, P3092, DOI 10.1128/JVI.80.6.3092-3097.2006; Wies E, 2009, J BIOL CHEM, V284, P8525, DOI 10.1074/jbc.M809252200; Yokota S, 2001, VIROLOGY, V286, P119, DOI 10.1006/viro.2001.0941; Li YP, 2011, J BIOL CHEM, V286, P24785, DOI 10.1074/jbc.M111.232439; Gilden DH, 2007, NAT CLIN PRACT NEURO, V3, P82, DOI 10.1038/ncpneuro0401; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Inn KS, 2011, J VIROL, V85, P10899, DOI 10.1128/JVI.00690-11; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Boutell C, 2003, J VIROL, V77, P8686, DOI 10.1128/JVI.77.16.8686-8694.2003; Tan JCG, 2011, J VIROL, V85, P5696, DOI 10.1128/JVI.02463-10; Lin RT, 2001, ONCOGENE, V20, P800, DOI 10.1038/sj.onc.1204163; Boehmer PE, 2003, IUBMB LIFE, V55, P13, DOI 10.1080/1521654031000070645; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Chee AV, 2004, J VIROL, V78, P4185, DOI 10.1128/JVI.78.8.4185-4196.2004; Hakki M, 2006, J VIROL, V80, P11817, DOI 10.1128/JVI.00957-06; Burysek L, 1999, J VIROL, V73, P7334; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; Johnson KE, 2010, VIROLOGY, V396, P21, DOI 10.1016/j.virol.2009.09.021; Ahmad H, 2011, J BIOL CHEM, V286, P7865, DOI 10.1074/jbc.M110.191452; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; West JA, 2014, J VIROL, V88, P5778, DOI 10.1128/JVI.03226-13; Rasmussen SB, 2009, J GEN VIROL, V90, P74, DOI 10.1099/vir.0.005389-0; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Lefort S, 2007, J VIROL, V81, P10950, DOI 10.1128/JVI.00183-07; Liang DG, 2011, CELL RES, V21, P793, DOI 10.1038/cr.2011.5; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; Poppers J, 2000, J VIROL, V74, P11215, DOI 10.1128/JVI.74.23.11215-11221.2000; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Juckem LK, 2008, J IMMUNOL, V180, P4965; Tavalai N, 2008, BBA-MOL CELL RES, V1783, P2207, DOI 10.1016/j.bbamcr.2008.08.004; Muller S, 1999, J VIROL, V73, P5137; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Cristea IM, 2010, J VIROL, V84, P7803, DOI 10.1128/JVI.00139-10; Pasieka TJ, 2006, J VIROL, V80, P7600, DOI 10.1128/JVI.00333-06; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Yokota S, 2004, J VIROL, V78, P6282, DOI 10.1128/JVI.78.12.6282-6286.2004; Liang QM, 2012, J VIROL, V86, P10162, DOI 10.1128/JVI.05224-11; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Hwang SM, 2009, CELL HOST MICROBE, V5, P166, DOI 10.1016/j.chom.2008.12.013; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Child SJ, 2004, J VIROL, V78, P197, DOI 10.1128/JVI.78.1.197-205.2004; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Xing JJ, 2013, J VIROL, V87, P9788, DOI 10.1128/JVI.01440-13; Zhong S, 2000, BLOOD, V95, P2748; Bi XH, 2011, J INTERF CYTOK RES, V31, P373, DOI 10.1089/jir.2010.0084; Boehme KW, 2004, J VIROL, V78, P1202, DOI 10.1128/JVI.78.3.1202-1211.2004; Boyle KA, 1999, MOL CELL BIOL, V19, P3607; Cassady Kevin A., 1998, Journal of Virology, V72, P8620; Cassady KA, 1998, J VIROL, V72, P7005; Cassady KA, 2012, J VIROL, V86, P610, DOI 10.1128/JVI.05099-11; Chang WLW, 2009, VIROLOGY, V390, P330, DOI 10.1016/j.virol.2009.05.013; Edelman DC, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-78; Editorial board, 2014, ANTIMICROBIAL AGENTS, V58, pA3, DOI [10.1128/AAC.masthead.58-12, DOI 10.1128/AAC.MASTHEAD.58-12]; Everett RD, 1998, EMBO J, V17, P7161, DOI 10.1093/emboj/17.24.7161; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Hagglund R, 2002, P NATL ACAD SCI USA, V99, P631, DOI 10.1073/pnas.022531599; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; Huh YH, 2008, J VIROL, V82, P10444, DOI 10.1128/JVI.00833-08; Kang H, 2006, J GEN VIROL, V87, P2181, DOI 10.1099/vir.0.81787-0; Le VTK, 2008, J GEN VIROL, V89, P2416, DOI 10.1099/vir.0.2008/001669-0; Lee HR, 2004, J VIROL, V78, P6527, DOI 10.1128/JVI.78.12.6527-6542.2004; Ma YJ, 2012, J VIROL, V86, P2188, DOI 10.1128/JVI.05376-11; Moore PS, 2003, ANNU REV MICROBIOL, V57, P609, DOI 10.1146/annurev.micro.57.030502.090824; Neils SJ, 2013, CURR TOP MICROBIOL, V371, P67, DOI [10.1007/978-3-642-37765-5_3, DOI :10.1007/978-3-642-37765-5_3]; Nicholl MJ, 2000, J GEN VIROL, V81, P2215; Paladino P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010428; Paulus C, 2006, P NATL ACAD SCI USA, V103, P3840, DOI 10.1073/pnas.0600007103; Peri P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-140; Preston CM, 2001, J VIROL, V75, P8909, DOI 10.1128/JVI.75.19.8909-8916.2001; Rivera-Molina Yisel A, 2013, World J Virol, V2, P110, DOI 10.5501/wjv.v2.i3.110; Scott I, 2009, MICROBES INFECT, V11, P973, DOI 10.1016/j.micinf.2009.07.001; Sen J, 2013, VIROLOGY, V439, P65, DOI [10.1016/j.virol.2013.01.026, 10.1016/j.viro1.2013.01.026]; Shen GH, 2014, J VIROL, V88, P12163, DOI 10.1128/JVI.01380-14; Smith PD, 2014, J IMMUNOL, V193, P5604, DOI 10.4049/jimmunol.1302608; Unterholzner L, 2008, BIOCHEM PHARMACOL, V75, P589, DOI 10.1016/j.bcp.2007.07.043; vans Lints AL, 2010, J VIROL, V84, P10802, DOI [10.1128/JVI.00063-10, DOI 10.1128/JVI.00063-10]; Viswanathan K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002332; Xing JJ, 2012, J VIROL, V86, P3528, DOI 10.1128/JVI.06713-11; Zhao QL, 2015, J VIROL, V89, P415, DOI 10.1128/JVI.02591-14; Zhu FX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010573	125	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1052-9276	1099-1654		REV MED VIROL	Rev. Med. Virol.	MAY	2015	25	3					187	201		10.1002/rmv.1836		15	Virology	Virology	CG6MV	WOS:000353416400005		
J	Kaneda, I; Iwasaki, S				Kaneda, Isamu; Iwasaki, Sayuri			Solvent transportation behavior of mechanically constrained agarose gels	RHEOLOGICA ACTA			English	Article						Agarose gel; Compression; Solvent transportation; Quenching temperature	DIFFUSION; KINETICS; GELATION; TEXTURE	The mode of transport of solvent from compressed agarose gels that were quenched at various temperatures was investigated. The compression load and the volume of the agarose gels decreased with time during compressive restraint. The decrease in volume was induced by squeezing of the solvent from the gel by compressive restraint. Relaxation of the compression load and the decrease in volume of the gels could be analyzed using a stretched exponential function; moreover, interestingly, both time constants were coupled. It is proposed that relaxation of the compression load was induced by solvent transportation (squeezing out). The hydrogel prepared at just below the sol-gel coexisting temperature (T (gel)) exhibited distinguishing behavior, characterized by an increase in the rate of the solvent transportation. It is postulated that micro-phase separation occurred in the sample quenched close to T (gel) due to spinodal decomposition, with consequent formation of relatively large solvent paths in the gel. Turbidity measurements and small angle light scattering data supported this postulate.	[Kaneda, Isamu; Iwasaki, Sayuri] Rakuno Gakuen Univ, Dept Food Sci & Wellness, Ebetsu, Hokkaido 0698501, Japan	Kaneda, I (reprint author), Rakuno Gakuen Univ, Dept Food Sci & Wellness, Bunkyodai Midori Machi, Ebetsu, Hokkaido 0698501, Japan.	kaneda-i@rakuno.ac.jp			JSPS KAKENHI [25410231]	This work was supported by JSPS KAKENHI Grant Number 25410231.	Wang Z, 2014, FOOD HYDROCOLLOID, V36, P196, DOI 10.1016/j.foodhyd.2013.09.016; Nordqvist D, 2011, FOOD BIOPHYS, V6, P450, DOI 10.1007/s11483-011-9225-0; Fatin-Rouge N, 2003, J PHYS CHEM B, V107, P12126, DOI 10.1021/jp0303164; Amici E, 2002, BIOMACROMOLECULES, V3, P466, DOI 10.1021/bm010157z; Yamaue T, 2005, J CHEM PHYS, V122, DOI [10.1063/1.1884597, 10.1063/1.1849153]; Russ N, 2013, BIOMACROMOLECULES, V14, P4116, DOI 10.1021/bm4012776; Boral S, 2009, POLYMER, V50, P5585, DOI 10.1016/j.polymer.2009.09.033; Mohammed ZH, 1998, CARBOHYD POLYM, V36, P15, DOI 10.1016/S0144-8617(98)00011-3; TANAKA T, 1979, J CHEM PHYS, V70, P1214, DOI 10.1063/1.437602; Stieger M, 2013, CURR OPIN COLLOID IN, V18, P334, DOI 10.1016/j.cocis.2013.04.007; Suzuki A, 2001, J CHEM PHYS, V114, P5012, DOI 10.1063/1.1350576; TOKITA M, 1991, J CHEM PHYS, V95, P4613, DOI 10.1063/1.461729; Arnott S, 1974, J MOL BIOL, V90, P273; de Gennes P. G., 1979, SCALING CONCEPTS POL; DOI M, 1990, SPRINGER PROC PHYS, V52, P100; Hanazaki Yohei, 2013, Journal of Biorheology, V26, DOI 10.1007/s12573-011-0043-2; Kneabel A, 1998, POLYM GELS NETW, V5, P577; Morita T, 2013, AIP ADV, V3, DOI 10.1063/1.4802968; Morris VJ, 1998, FUNCTIONAL PROPERTIE, P148; Nakamura K, 2001, FOOD HYDROCOLLOID, V15, P247, DOI 10.1016/S0268-005X(01)00021-2; Takahashi S, 2014, NIHON REOROJI GAKK, V42, P103; WATASE M, 1983, RHEOL ACTA, V22, P580, DOI 10.1007/BF01351404	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0035-4511	1435-1528		RHEOL ACTA	Rheol. Acta	MAY	2015	54	5					437	443		10.1007/s00397-015-0842-2		7	Mechanics	Mechanics	CF8YO	WOS:000352848300009		
J	Nara, Y				Nara, Yoshitaka			Effect of Anisotropy on the Long-Term Strength of Granite	ROCK MECHANICS AND ROCK ENGINEERING			English	Article						Anisotropy; Granite; Subcritical crack growth; Fracture toughness; Long-term strength	SUBCRITICAL CRACK-GROWTH; INADA GRANITE; POLYCRYSTALLINE ALUMINA; CHELMSFORD GRANITE; FRACTURE-TOUGHNESS; OSHIMA GRANITE; ROCK; MICROCRACKS; PARAMETERS; VELOCITY	Granite rock mass is used for various rock engineering purposes. To ensure long-term stability, information about the subcritical crack growth (SCG) and an estimate of the long-term strength (LTS) of the rock are necessary. The influence of the anisotropy of granite on its LTS has not yet been clarified. In this study, the anisotropy of the long-term rock strength was investigated for two types of granite rocks, Oshima granite and Inada granite. Specifically, the effect of the anisotropy in crack propagation on the LTS was examined. The results showed that the LTS of granite is anisotropic, as are the fracture toughness and Brazilian tensile strength measured in this study. The LTS was lowest when crack propagation occurred parallel to the rift plane, where most of the microcracks occur. For Inada granite, which has an anisotropic SCG index, the degree of anisotropy of the LTS increased as the time-to-failure increased. This suggests that the LTS of granite is anisotropic.	[Nara, Yoshitaka] Kyoto Univ, Grad Sch Engn, Dept Civil & Earth Resources Engn, Nishikyo Ku, Kyoto 6158540, Japan	Nara, Y (reprint author), Tottori Univ, Grad Sch Engn, Dept Management Social Syst & Civil Engn, 4-101 Koyama Minami, Tottori 6808552, Japan.	nara@cv.tottori-u.ac.jp					ALI SA, 1968, J SEDIMENT PETROL, V38, P681; EVANS AG, 1972, J MATER SCI, V7, P1137, DOI 10.1007/BF00550196; CHARLES RJ, 1958, J APPL PHYS, V29, P1554, DOI 10.1063/1.1722992; Nara Y, 2010, INT J FRACTURE, V164, P57, DOI [10.1007/s10704-010-9455-Z, 10.1007/s10704-010-9455-z]; PENG S, 1972, INT J ROCK MECH MIN, V9, P37, DOI 10.1016/0148-9062(72)90050-2; WILLIAMS DP, 1973, J TEST EVAL, V1, P264; EVANS AG, 1974, MATER SCI ENG, V15, P253, DOI 10.1016/0025-5416(74)90059-7; Nara Y, 2013, GEOPHYS J INT, V193, P47, DOI 10.1093/gji/ggs116; Lin WR, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000648; ATKINSON BK, 1984, J GEOPHYS RES, V89, P4077, DOI 10.1029/JB089iB06p04077; Shyam A, 2006, J MATER SCI, V41, P4093, DOI 10.1007/s10853-005-5553-0; Atkinson BK, 1979, INT J ROCK MECH MIN, V16, P46; Atkinson BK, 1987, FRACT MECH ROCK, V2, P111; Chen Y, 1999, INT J ROCK MECH MIN, V36, P535, DOI 10.1016/S0148-9062(99)00014-5; Dale TN, 1923, US GEOL SURV B, V738, P22; DOUGLASS PM, 1969, GEOTECHNIQUE, V19, P376; Fairbairn EMR, 2002, MATER STRUCT, V35, P195, DOI 10.1007/BF02533589; Fujii Y, 2007, INT J ROCK MECH MIN, V44, P98, DOI 10.1016/j.ijrmms.2006.05.001; GARDNER RD, 1968, INT J ROCK MECH MIN, V5, P155, DOI 10.1016/0148-9062(68)90031-4; KANAORI Y, 1991, J STRUCT GEOL, V13, P777, DOI 10.1016/0191-8141(91)90003-2; Ko TY, 2013, INT J ROCK MECH MIN, V59, P166, DOI 10.1016/j.ijrmms.2012.11.006; Murakami Y, 1986, STRESS INTENSITY FAC; Nara Y, 2012, INT J SOLIDS STRUCT, V49, P2471, DOI 10.1016/j.ijsolstr.2012.05.009; Nara Y, 2011, INT J ROCK MECH MIN, V48, P316, DOI 10.1016/j.ijrmms.2010.08.009; Nara Y, 2006, INT J ROCK MECH MIN, V43, P1256, DOI 10.1016/j.ijrmms.2006.03.016; Nara Y, 2006, INT J ROCK MECH MIN, V43, P437, DOI 10.1016/j.ijrmms.2005.07.008; NISHIYAMA T, 1994, INT J ROCK MECH MIN, V31, P369, DOI 10.1016/0148-9062(94)90904-0; Pletka BJ, 1979, ASTM STP; SANO O, 1992, J GEOPHYS RES-SOL EA, V97, P3367, DOI 10.1029/91JB02934; SANO O, 1981, J GEOPHYS RES, V86, P9299, DOI 10.1029/JB086iB10p09299; SANO O, 1992, PURE APPL GEOPHYS, V138, P657, DOI 10.1007/BF00876343; Selcuk A, 2000, J AM CERAM SOC, V83, P2029; SIMMONS G, 1975, AM J SCI, V275, P318; Takemura T, 2003, INT J ROCK MECH MIN, V40, P443, DOI 10.1016/S1365-1609(03)00014-5; Takemura T, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003395; THILL RE, 1973, INT J ROCK MECH MIN, V10, P535, DOI 10.1016/0148-9062(73)90004-1	36	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0723-2632	1434-453X		ROCK MECH ROCK ENG	Rock Mech. Rock Eng.	MAY	2015	48	3					959	969		10.1007/s00603-014-0634-5		11	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CF9RY	WOS:000352905100005		
J	Demircan, O; Ashibe, S; Kosui, T; Nakai, A				Demircan, Ozgur; Ashibe, Shinsuke; Kosui, Tatsuya; Nakai, Asami			Modeling of tensile and bending properties of biaxial weft knitted composites	SCIENCE AND ENGINEERING OF COMPOSITE MATERIALS			English	Article						biaxial weft knitting; mechanical properties; modeling; textile composites	FABRIC-REINFORCED COMPOSITES; TEXTILE COMPOSITES; MECHANICAL-PROPERTIES; WOVEN; BEHAVIOR	Within the scope of experiments, the effect of aramid and glass yarns as stitch and biaxial (warp and weft) yarns in the biaxial weft knitted (BWK) composite was compared. After production of four types of composite panel using the hand lay-up method, the tensile and bending properties of the BWK composites were investigated both experimentally and numerically. The composite with the glass stitch and biaxial yarns exhibited higher tensile and bending properties than did the composite with the aramid stitch and biaxial yarns. The good agreement between the experimental results and the numerical results validated the applicability of the finite-element method for the BWK composites. The laminate beam theory was utilized as another modeling method for calculation of the bending modulus.	[Demircan, Ozgur] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Adv Fibro Sci, Sakyo Ku, Kyoto 6068585, Japan; [Demircan, Ozgur] Sabanci Univ, Fac Engn & Nat Sci, Mat Sci & Engn Program, TR-34956 Istanbul, Turkey; [Demircan, Ozgur] Ondokuz Mayis Univ, Fac Engn, Dept Mat Sci & Engn, TR-55139 Samsun, Turkey; [Ashibe, Shinsuke; Kosui, Tatsuya] Shima Seiki Mfg Ltd, R&D New Technol Applicat, Wakayama 6418511, Japan; [Nakai, Asami] Gifu Univ, Fac Engn, Dept Mech & Syst Engn, Gifu 5011193, Japan	Demircan, O (reprint author), Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Adv Fibro Sci, Sakyo Ku, Kyoto 6068585, Japan.	ozgurd@sabanciuniv.edu					Andrews MC, 1996, J MATER SCI, V31, P3893, DOI 10.1007/BF00352650; Lomov SV, 2001, COMPOS PART A-APPL S, V32, P1379, DOI 10.1016/S1359-835X(01)00038-0; Lomov SV, 2007, COMPOS SCI TECHNOL, V67, P1870, DOI 10.1016/j.compscitech.2006.10.017; Tanimoto Y, 2004, J BIOMED MATER RES B, V71B, P188, DOI 10.1002/jbm.b.30079; Tan P, 1997, COMPOS PART A-APPL S, V28, P903, DOI 10.1016/S1359-835X(97)00069-9; Haller P, 2006, COMPOS PART B-ENG, V37, P278, DOI 10.1016/j.compositesb.2006.01.003; Sheng SZ, 2003, J THERMOPLAST COMPOS, V16, P45, DOI 10.1106/089270503023206; KALANTAR J, 1990, J MATER SCI, V25, P4186, DOI 10.1007/BF00581071; Lomov SV, 2008, COMPOS PART A-APPL S, V39, P1218, DOI 10.1016/j.compositesa.2007.09.011; Lomov SV, 2011, TEXT RES J, V81, P28, DOI 10.1177/0040517510385169; Liu L, 2008, APPL SURF SCI, V254, P2594, DOI 10.1016/j.apsusc.2007.09.091; Leong KH, 2000, COMPOS PART A-APPL S, V31, P197, DOI 10.1016/S1359-835X(99)00067-6; Huang ZM, 2000, COMPOS SCI TECHNOL, V60, P479, DOI 10.1016/S0266-3538(99)00148-7; Verpoest I, 2005, COMPOS SCI TECHNOL, V65, P2563, DOI 10.1016/j.compscitech.2005.05.031; Sheng SZ, 2001, J COMPOS MATER, V35, P1701, DOI 10.1177/002199801772661506; Araujo M, 2004, AUTEX RES J, V4, P72; Baba F, 2009, 17 INT C COMP MAT ED; Demircan O, 2011, 12 JAP INT SAMP S EX; Demircan O, 2013, SCI ENG COMPOS MATER, V20, P255, DOI 10.1515/secm-2012-0046; Fujita A., 1996, NUMERICAL MODELING T; Huang ZM, 2002, J REINF PLAST COMP, V21, P1123, DOI 10.1106/073168402025788; Huang ZM, 2000, COMPOS PART A-APPL S, V31, P479, DOI 10.1016/S1359-835X(99)00083-4; Huang ZM, 2000, COMPOS SCI TECHNOL, V60, P671, DOI 10.1016/S0266-3538(99)00164-5; Ju Wu, 2006, Journal of Applied Polymer Science, V102, DOI 10.1002/app.24460; Ju Wu, 2004, Journal of Materials Science, V39, DOI 10.1023/B:JMSC.0000007756.65458.2b; Khondker OA, 2004, COMPOS PART A-APPL S, V35, P1185, DOI 10.1016/j.compositesa.2004.03.003; Khondker OA, 2001, COMPOS PART A-APPL S, V32, P1513, DOI 10.1016/S1359-835X(01)00051-3; Kyosev Y, 2010, P 10 INT C TEXT COMP, P397; LI JJ, 2010, J TEXT I, V101, P33; Miravete A., 1999, 3D TEXTILE REINFORCE; Nishiwaki T, 1996, P JOINT CAN JAP WORK; Nishiwaki T, 1998, 2 JOINT CAN JAP WORK; NISHIWAKI T, 1995, COMPOS STRUCT, V32, P641, DOI 10.1016/0263-8223(95)00030-5; Pandita SD, 2002, COMPOS SCI TECHNOL, V62, P1113, DOI 10.1016/S0266-3538(02)00057-X; Ramakrishna S, 1997, COMPOS SCI TECHNOL, V57, P1, DOI 10.1016/S0266-3538(96)00098-X; Ramakrishna S, 1997, COMPOS PART A-APPL S, V28, P25, DOI 10.1016/S1359-835X(96)00091-7; Tanimoto Y, 2004, J BIOMED MATER RES A, V68A, P107, DOI 10.1002/jbm.a.20062; Wikipedia, YOUNGS MOD	38	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0792-1233	2191-0359		SCI ENG COMPOS MATER	Sci. Eng. Compos. Mater.	MAY	2015	22	3					303	313		10.1515/secm-2013-0274		11	Materials Science, Composites	Materials Science	CG9MK	WOS:000353639500012		
J	Saigusa, K; Morita, T				Saigusa, Katsuhiro; Morita, Takeshi			Self-sensing control of piezoelectric positioning stage by detecting permittivity	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						Piezoelectric actuator; Hysteresis; Permittivity detection; Self-sensing control	ACTUATOR CONTROL; HYSTERESIS	Piezoelectric displacement contains hysteresis and creep properties. Therefore, a displacement sensor is indispensable in precise positioning devices; however, the additional space and cost are problems. On the other hand, self-sensing methods that utilize the piezoelectric actuator itself as the displacement sensor have been proposed. With these self-sensing methods, precise positioning becomes possible without an additional displacement sensor. We developed a self-sensing method utilizing the non-hysteresis relationship between the permittivity change and the piezoelectric displacement. Furthermore, a differential current measurement method using two piezoelectric elements with a bimorph actuator could improve the positioning accuracy. In this study, we examine the control of a positioning stage using two multilayered piezoelectric actuators by applying the differential current measurement method for self-sensing control. The results indicate that the differential current measurement method is effective for precise positioning control. The positioning errors due to hysteresis decreased from 0.8 mu m to 0.1 mu m for a 10 mu m displacement range. In addition, permittivity feedback control could compensate for the creep property. (C) 2015 Elsevier B.V. All rights reserved.	[Saigusa, Katsuhiro; Morita, Takeshi] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778563, Japan	Saigusa, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778563, Japan.	saigusa@ems.k.u-tokyo.ac.jp	MORITA, Takeshi/E-8484-2010				NEWCOMB CV, 1982, ELECTRON LETT, V18, P442, DOI 10.1049/el:19820301; Devasia S, 2007, IEEE T CONTR SYST T, V15, P802, DOI 10.1109/TCST.2007.903345; Xu F, 2001, J APPL PHYS, V89, P1336, DOI 10.1063/1.1325005; EALEY MA, 1990, OPT ENG, V29, P1191, DOI 10.1117/12.55715; Furutani K, 1998, NANOTECHNOLOGY, V9, P93, DOI 10.1088/0957-4484/9/2/009; Ikeda H, 2011, SENSOR ACTUAT A-PHYS, V170, P147, DOI 10.1016/j.sna.2011.06.009; Ishikiriyama Y, 2010, J ADV MECH DES SYST, V4, P143, DOI 10.1299/jamdsm.4.143; Ivan IA, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3142486; Jang MJ, 2009, J FRANKLIN I, V346, P17, DOI 10.1016/j.jfranklin.2008.06.005; Kawamata A, 2008, FERROELECTRICS, V368, P432, DOI 10.1080/00150190802368495; Low TS, 1995, J MICROELECTROMECH S, V4, P230, DOI 10.1109/84.475550; Rakotondrabe M., 2007, IEEE ASME INT C ADV, P1; Uzgur E, 2011, J ELECTROCERAM, V27, P38, DOI 10.1007/s10832-011-9647-6	13	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	MAY 1	2015	226						76	80		10.1016/j.sna.2015.02.022		5	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CG3KT	WOS:000353179800009		
J	Matsumoto, H; Yamakawa, K; Ogura, H; Koh, T; Matsumoto, N; Shimazu, T				Matsumoto, Hisatake; Yamakawa, Kazuma; Ogura, Hiroshi; Koh, Taichin; Matsumoto, Naoya; Shimazu, Takeshi			ENHANCED EXPRESSION OF CELL-SPECIFIC SURFACE ANTIGENS ON ENDOTHELIAL MICROPARTICLES IN SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION	SHOCK			English	Article						CD146 antigen; endothelial cell protein C receptor; flow cytometry; tissue factor; thrombomodulin	INFLAMMATORY RESPONSE SYNDROME; ACTIVATED PROTEIN-C; TISSUE FACTOR; HUMAN ENDOTOXEMIA; SEPTIC SHOCK; THROMBOMODULIN; CRITERIA; ANTICOAGULANT; THROMBOSIS; INDUCTION	Sepsis-induced disseminated intravascular coagulation (DIC) is a major cause of death in patients admitted to intensive care units. Endothelial injury with microparticle production is reported in the pathogenesis of sepsis. Endothelial microparticles (EMPs) present several cell-specific surface antigens with different bioactivities, for example, tissue factor (TF), thrombomodulin (TM), and endothelial protein C receptor (EPCR). We investigated associations between these three different surface antigen-positive EMPs and sepsis-induced DIC. This cross-sectional study composed of 24 patients with sepsis and 23 healthy controls was conducted from November 2012 to September 2013. Blood samples were collected from patients within 24 h of diagnosis of severe sepsis and from healthy controls. Numbers of TF-positive EMPs (TF+ EMPs), TM-positive EMPs (TM+ EMPs), and EPCR-positive EMPs (EPCR+ EMPs) were measured by flow cytometry immediately thereafter. Acute Physiology and Chronic Health Evaluation II and Sequential Organ Failure Assessment scores were assessed in the severe sepsis patients at enrollment. We assessed DIC with the International Society of Thrombosis and Haemostasis (ISTH) overt DIC diagnostic criteria algorithm. Numbers of antigen-positive EMPs were increased significantly in both severe sepsis patients and controls and with the increase in ISTH DIC score. Numbers of TF+ EMPs and EPCR+ EMPs correlated significantly with Sequential Organ Failure Assessment score, and numbers of EPCR+ EMPs correlated significantly with Acute Physiology and Chronic Health Evaluation II score. Numbers of the three antigen-positive EMPs were increased significantly in severe sepsis patients versus those in healthy controls and with the increase of ISTH DIC score, suggesting that the specific bioactivity of each antigen-positive EMP may play a role in the progression of sepsis-induced DIC.	[Matsumoto, Hisatake; Yamakawa, Kazuma; Ogura, Hiroshi; Matsumoto, Naoya; Shimazu, Takeshi] Osaka Univ, Dept Traumatol & Acute Crit Med, Grad Sch Med, Suita, Osaka 5650871, Japan; [Koh, Taichin] Osaka Univ Hosp, Lab Clin Invest, Osaka 553, Japan	Matsumoto, H (reprint author), Osaka Univ, Dept Traumatol & Acute Crit Med, Grad Sch Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.	h-matsumoto@hp-emerg.med.osaka-u.ac.jp			Marumo Critical Care Medicine Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan	For all authors, no competing interests or sources of funding are declared. This study was supported by a grant-in-aid for scientific research from Marumo Critical Care Medicine Foundation and by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Delabranche X, 2013, INTENS CARE MED, V39, P1695, DOI 10.1007/s00134-013-2993-x; Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Takemitsu T, 2011, THROMB HAEMOSTASIS, V105, P40, DOI 10.1160/TH10-05-0293; Ogura H, 2004, J TRAUMA, V56, P823, DOI 10.1097/01.TA.0000084517.39244.46; De Willige SU, 2004, J THROMB HAEMOST, V2, P1305; Perez-Casal M, 2009, HAEMATOL-HEMATOL J, V94, P387, DOI 10.3324/haematol.13547; Ohlin AK, 2005, J THROMB HAEMOST, V3, P976, DOI 10.1111/j.1538-7836.2005.01267.x; Bulut D, 2008, J CARD FAIL, V14, P336, DOI 10.1016/j.cardfail.2007.11.002; Key NS, 2010, THROMB RES, V125, pS42, DOI 10.1016/j.thromres.2010.01.035; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Aras O, 2004, BLOOD, V103, P4545, DOI 10.1182/blood-2003-03-0713; Amabile N, 2012, NEPHROL DIAL TRANSPL, V27, P1873, DOI 10.1093/ndt/gfr573; Reid VL, 2012, BRIT J ANAESTH, V109, P503, DOI 10.1093/bja/aes321; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI 10.1007/s00134-012-2769-8; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Nieuwland R, 2000, BLOOD, V95, P930; Gando S, 2009, THROMB RES, V123, P715, DOI 10.1016/j.thromres.2008.07.006; Gando S, 1996, THROMB HAEMOSTASIS, V75, P224; Ishikura H, 2014, CRIT CARE, V18, DOI 10.1186/cc13700; Janssens U, 2001, CRIT CARE, V5, pP225; Letsky EA, 2001, BEST PRACT RES CL OB, V15, P623, DOI 10.1053/beog.2001.0204; Levi M, 2013, MINERVA ANESTESIOL, V79, P294; Levi M, 2013, INTENS CARE MED, V39, P1839, DOI 10.1007/s00134-013-3054-1; MARUYAMA I, 1985, J BIOL CHEM, V260, P5432; Meziani F, 2010, CRIT CARE, V14, DOI 10.1186/cc9231; Perez-Casal M, 2011, CRIT CARE, V15, DOI 10.1186/cc10356; Puddu Paolo, 2010, Can J Cardiol, V26, P140; Satta N, 1997, BRIT J HAEMATOL, V96, P534, DOI 10.1046/j.1365-2141.1997.d01-2059.x; Woei-A-Jin FJSH, 2012, J THROMB HAEMOST, V10, P1185, DOI 10.1111/j.1538-7836.2012.04733.x; Zeerleder S, 2005, CHEST, V128, P2864, DOI 10.1378/chest.128.4.2864; Hack CE, 2001, CRIT CARE MED, V29, pS21, DOI 10.1097/00003246-200107001-00011	35	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	MAY	2015	43	5					443	449		10.1097/SHK.0000000000000331		7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CG2ZT	WOS:000353146200004		
J	Takeuchi, S; Kitamura, T; Ohbuchi, T; Koizumi, H; Takahashi, R; Hohchi, N; Suzuki, H				Takeuchi, Shoko; Kitamura, Takuro; Ohbuchi, Toyoaki; Koizumi, Hiroki; Takahashi, Risa; Hohchi, Nobusuke; Suzuki, Hideaki			Relationship between sleep apnea and thyroid function (vol 19, pg 85, 2015)	SLEEP AND BREATHING			English	Correction									[Takeuchi, Shoko; Kitamura, Takuro; Ohbuchi, Toyoaki; Koizumi, Hiroki; Takahashi, Risa; Hohchi, Nobusuke; Suzuki, Hideaki] Univ Occupat & Environm Hlth, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan	Suzuki, H (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	suzuhyde@med.uoeh-u.ac.jp					Takeuchi S, 2015, SLEEP BREATH, V19, P85, DOI 10.1007/s11325-014-0966-0	1	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1520-9512	1522-1709		SLEEP BREATH	Sleep Breath.	MAY	2015	19	2					751	751		10.1007/s11325-014-1054-1		1	Clinical Neurology; Respiratory System	Neurosciences & Neurology; Respiratory System	CF9TM	WOS:000352909700048		
J	Guo, DP; He, C; Xu, C; Hamada, M				Guo, Deping; He, Chuan; Xu, Chong; Hamada, Masanori			Analysis of the relations between slope failure distribution and seismic ground motion during the 2008 Wenchuan earthquake	SOIL DYNAMICS AND EARTHQUAKE ENGINEERING			English	Article						Wenchuan earthquake; Slope failure distribution; Seismic ground motion; Attenuation relation	W 7.9 WENCHUAN; INDUCED LANDSLIDES; RUPTURE PROCESS; CHINA; ATTENUATION; SICHUAN; MODELS	The 2008 Wenchuan earthquake with M(w)7.9 occurred at Yingxiu County in Longmenshan thrust fault belt, southwest China, having triggered a huge amount of slope failures. This paper applied a detailed inventory with more than 190,000 slope failures and strong ground motion records of 187 seismic stations to analyze the qualitative and quantitative relations between slope failure distribution and seismic parameters. The results revealed that slope failure distribution was exponentially decreased with the increment of epicentral distance and distance from surface fault rupture; peak ground acceleration (PGA) on the hanging wall side was apparently larger than that on footwall side. Linear correlation between concentration of slope failures (LNC) and the percentage of the area affected by slope failure (LAP) and PGA was demonstrated by statistical analysis, which revealed that 0.18 similar to 0.21 g horizontal PGA was the threshold value of the occurrence of slope failure. Furthermore, this paper presented an empirical model for the attenuation relation of slope failure distribution. (C) 2015 Elsevier Ltd. All rights reserved.	[Guo, Deping; He, Chuan] Southwest Jiaotong Univ, Sch Civil Engn, Minist Educ, Key Lab Transportat Tunnel Engn, Chengdu 610031, Peoples R China; [Guo, Deping; Hamada, Masanori] Waseda Univ, Dept Civil & Environm Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Guo, Deping] Sichuan Railway Investment Grp Co Ltd, Chengdu 610041, Peoples R China; [Xu, Chong] Chinese Earthquake Adm, Inst Geol, Key Lab Act Tecton & Volcano, Beijing 100029, Peoples R China	Guo, DP (reprint author), Sichuan Railway Investment Grp Co Ltd, Chengdu 610041, Peoples R China.	guodeping99@gmail.com	Xu, Chong/B-6460-2012	Xu, Chong/0000-0002-3956-4925	China Scholarship Council (CSC); National Natural Science Foundation of China [U1134208]; High-Speed Railway [U1134208]; National Science and Technology Support Program [2012BAG05B03]	This study is financially supported by the China Scholarship Council (CSC), the Joint Fund of National Natural Science Foundation of China and High-Speed Railway (No. U1134208), National Science and Technology Support Program (No. 2012BAG05B03). The authors are grateful to all who contributed to the success in recording, collecting and processing the seismic ground motion data. Prof. David K. Keefer, U.S. Geological Survey, is greatly appreciated for sharing landslide distribution data of 1989 Loma Prieta, California earthquake.	Hubbard J, 2010, B SEISMOL SOC AM, V100, P2713, DOI 10.1785/0120090341; Wang WM, 2008, CHINESE J GEOPHYS-CH, V51, P1403; Harp EL, 2011, ENG GEOL, V122, P9, DOI 10.1016/j.enggeo.2010.06.013; Gorum T, 2011, GEOMORPHOLOGY, V133, P152, DOI 10.1016/j.geomorph.2010.12.030; Rodriguez CE, 1999, SOIL DYN EARTHQ ENG, V18, P325, DOI 10.1016/S0267-7261(99)00012-3; Zhang Y, 2009, SCI CHINA SER D, V52, P145, DOI 10.1007/s11430-008-0148-7; Kurahashi S, 2010, B SEISMOL SOC AM, V100, P2450, DOI 10.1785/0120090308; Xu XW, 2009, GEOLOGY, V37, P515, DOI 10.1130/G25462A.1; Qi SW, 2010, ENG GEOL, V116, P95, DOI 10.1016/j.enggeo.2010.07.011; Aydan O, 2009, J SEISMOL, V13, P399, DOI 10.1007/s10950-008-9146-7; Chigira M, 2010, GEOMORPHOLOGY, V118, P225, DOI 10.1016/j.geomorph.2010.01.003; Keefer DK, 2002, SURV GEOPHYS, V23, P473, DOI 10.1023/A:1021274710840; Delgado J, 2011, ENG GEOL, V123, P204, DOI 10.1016/j.enggeo.2011.08.002; Zhao CP, 2010, CHINESE SCI BULL, V55, P284, DOI 10.1007/s11434-009-0425-7; Xu C, 2012, ENG GEOL, V133, P40, DOI 10.1016/j.enggeo.2012.02.017; Keefer DK, 2000, ENG GEOL, V58, P231, DOI 10.1016/S0013-7952(00)00037-5; Yin YP, 2009, LANDSLIDES, V6, P139, DOI 10.1007/s10346-009-0148-5; Huang RQ, 2009, B ENG GEOL ENVIRON, V68, P363, DOI 10.1007/s10064-009-0207-0; Papadopoulos GA, 2000, ENG GEOL, V58, P377, DOI 10.1016/S0013-7952(00)00043-0; Li XJ, 2008, EARTHQ ENG ENG VIB, V7, P235, DOI 10.1007/s11803-008-0892-x; AYDAN O, 2009, J SCH MAR SCI TECHNO, V7, P1; Aydan O, 2009, P 12 INT C SOIL MECH; Aydan O, 2006, P S REC ISS REC GREA, P114; Aydan O, 2007, P 6 NAT EARTHQ ENG C, P563; Bjerrum LW, 2010, B SEISMOL SOC AM, V100, P2396, DOI 10.1785/0120090239; Chasemi H, 2010, B SEISMOL SOC AM, V100, P2476; Chavez M, 2010, B SEISMOL SOC AM, V100, P2561, DOI 10.1785/0120090240; Chen Y, 2009, EPISODES, V31, P374; Chen YT, 2008, ANAL SOURCE CHARACTE; Dai FC, 2011, J ASIAN EARTH SCI, V40, P833; Furuya M, 2010, B SEISMOL SOC AM, V100, P2750, DOI 10.1785/0120090242; Guo DP, 2013, ENG GEOL, V152, P202, DOI 10.1016/j.enggeo.2012.10.012; Hancox G. T., 2002, B NZ SOC EARTHQUAKE, V35, P59; Hancox G. T., 1997, 43601B GNS; [黄润秋 HUANG Runqiu], 2008, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V27, P2585; Ji C, 2008, FINITE FAULT MODEL P; KEEFER DK, 1984, GEOL SOC AM BULL, V95, P406; Khazai B., 2003, ENG GEOL, V71, P79, DOI DOI 10.1016/50013-7952(03)00127-3; Li XJ, 2010, B SEISMOL SOC AM, V100, P2440, DOI 10.1785/0120090245; Meunier P, 2007, GEOPHYS RES LETT, V34, P5; TAYLOR SR, 1986, J GEOPHYS RES-SOLID, V91, P7309, DOI 10.1029/JB091iB07p07309; TRIFUNAC MD, 1994, SOIL DYN EARTHQ ENG, V13, P149, DOI 10.1016/0267-7261(94)90014-0; Wang D, 2010, B SEISMOL SOC AM, V100, P2381, DOI 10.1785/0120090009; Wang WJ, 2008, J ASIAN ARCHIT BUILD, V7, P1, DOI 10.3130/jaabe.7.1; [王秀英 WANG Xiuying], 2010, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V29, P82; Wang XY, 2010, EARTHQUAKE SCI, V23, P233; Wen ZP, 2010, B SEISMOL SOC AM, V100, P2425, DOI 10.1785/0120090266; Xu C, 2013, LANDSLIDES; Xu C, 2013, J ENG GEOL, V21, P25; Xu C, 2010, CHIN J ROCK MECH S1, V29, pS2972; Xu C, 2009, CHIN J ROCK MECH S2, V28, pS1; [许强 XU Qiang], 2008, [工程地质学报, Journal of Engineering Geology], V16, P721; Xu Q., 2009, LARGE SCALE LANDSLID; [徐锡伟 XU Xiwei], 2008, [地震地质, Seismology and Geology], V30, P597; Xu Y, 2010, B SEISMOL SOC AM, V100, P2508, DOI 10.1785/0120090196; Yu HY, 2008, TECHNOLOGY EARTHQUAK, V3, P321; Yuan RM, 2010, B SEISMOL SOC AM, V100, P2689, DOI 10.1785/0120090256	57	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0267-7261	1879-341X		SOIL DYN EARTHQ ENG	Soil Dyn. Earthq. Eng.	MAY	2015	72						99	107		10.1016/j.soildyn.2015.02.001		9	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG6QF	WOS:000353426300009		
J	Rasouli, R; Towhata, I; Hayashida, T				Rasouli, Rouzbeh; Towhata, Ikuo; Hayashida, Toshihiko			Mitigation of seismic settlement of light surface structures by installation of sheet-pile walls around the foundation	SOIL DYNAMICS AND EARTHQUAKE ENGINEERING			English	Article						Mitigation; Model tests; Liquefaction; Settlement; Soil/structure interaction	SAND	Settlement of surface structures, which is particularly a private house, due to subsoil liquefaction is not a, new issue in geotechnical engineering. It has been happening during earthquakes in liquefaction-prone areas since many years ago. However, to date no reliable measure against this problem with reasonable cost has been proposed to people. In this paper, results of a series of 1-g shaking table tests which have been conducted to evaluate performance of a possible mitigation against this problem are presented. The proposed mitigation herein is installation of sheet-pile walls around the foundation. In order to reduce the cost of mitigation, sheet-piling with gap and half-length sheet-piling were examined. The experiments were conducted in different ground water levels. It is found out that installing sheet-pile walls in relatively low ground water level can stop settlement of structures completely. Sheet-piling with gaps delays initiation of settlement but it may increase the ultimate settlement of structure. In addition, it is found that formation of a water film under the building's foundation is the governing mechanism of post-shaking settlement of structures. (C) 2015 Elsevier Ltd. All rights reserved.	[Rasouli, Rouzbeh; Towhata, Ikuo] Univ Tokyo, Dept Civil Engn, Tokyo 113, Japan; [Hayashida, Toshihiko] Fudo Tetra Corp, Geotech Div, Tokyo, Japan	Rasouli, R (reprint author), Univ Tokyo, Dept Civil Engn, 7-3-1 Hongo, Tokyo 113, Japan.	rouzbehrasouli@geot.t.u-tokyo.ac.jp					Adalier K, 1998, J GEOTECH GEOENVIRON, V124, P500, DOI 10.1061/(ASCE)1090-0241(1998)124:6(500); Dashti S, 2010, J GEOTECH GEOENVIRON, V136, P918, DOI 10.1061/(ASCE)GT.1943-5606.0000306; Dashti S, 2010, J GEOTECH GEOENVIRON, V136, P151, DOI 10.1061/(ASCE)GT.1943-5606.0000179; Liu L, 1997, J GEOTECH GEOENVIRON, V123, P557, DOI 10.1061/(ASCE)1090-0241(1997)123:6(557); Asada A, 1998, MEMORIAL PUBLICATION; Iai S., 1989, SOILS FOUND, V29, P105; Ishihara K, 1985, P 11 INT C SOIL MECH, V1, P321; Koga Y, 1988, P 23 JGS ANN M MIY J, P1019; Kokusho T, 2002, J GEOTECH GEOENVIRON, V128, P129, DOI 10.1061/(ASCE)1090-0241(2002)128:2(129); Kuriki A, 2012, P 47 C JAP GEOT SOC, P1497; Mizutani T, 2001, P 4 INT C REC ADV GE; Rasouli R, 2012, P 1 INT S EARTHQ ENG, P199; Rasouli R, 2014, P 8 INT C PHYS MOD G, V2, P1001; Towhata I., 2008, SPRINGER SERIES GEOM, P522; Towhata I, 2013, P 4 INT SEM FOR GEOT; Tsukamoto Y, 2012, INT J GEOMECH, V12, P462, DOI 10.1061/(ASCE)GM.1943-5622.0000153; Yasuda S, 2013, P 48 C JAP GEOT SOC, P1759; Yoshimi Y, 1977, J SOILS FDN, V17, P23; Youd TL, 1978, 993 US GEOL SURV US	19	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0267-7261	1879-341X		SOIL DYN EARTHQ ENG	Soil Dyn. Earthq. Eng.	MAY	2015	72						108	118		10.1016/j.soildyn.2015.02.010		11	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG6QF	WOS:000353426300010		
J	Lee, SH; Lee, KB; Lee, JH; Kang, S; Kim, HG; Asahara, T; Kwon, SM				Lee, Sang Hun; Lee, Kyeung Bin; Lee, Jun Hee; Kang, Songhwa; Kim, Hwi Gon; Asahara, Takayuki; Kwon, Sang Mo			Selective Interference Targeting of Lnk in Umbilical Cord-Derived Late Endothelial Progenitor Cells Improves Vascular Repair, Following Hind Limb Ischemic Injury, via Regulation of JAK2/STAT3 Signaling	STEM CELLS			English	Article						Lnk; Endothelial progenitor cells; JAK2/STAT3; Repopulation ability; Neovascularization	ADAPTER PROTEIN LNK; HEMATOPOIETIC STEM-CELLS; SELF-RENEWAL; BONE-MARROW; C-KIT; DEFICIENT MICE; SPINAL-CORD; NEOVASCULARIZATION; TRANSPLANTATION; PROLIFERATION	The Lnk adaptor protein is a strong negative regulator that affects self-renewal of hematopoietic stem cells and vascular repair in injured tissues. However, the signaling mechanisms through which these proteins influence the vascular regeneration function of endothelial progenitor cells (EPCs) remain unknown. In this study, we investigated the effect of Lnk-targeted small interfering RNA (si-lnk) on the clonogenic proliferative potential and vascular regenerative function of EPCs and the activation of the JAK/STAT3 signaling pathway. Treatment with stem cell factor (SCF) increased the clonogenic proliferation of si-lnk EPCs. Importantly, activation of the JAK2/STAT3 pathway was enhanced in SCF-sensitized si-lnk EPCs. In a hind limb model of ischemia, transplantation of si-lnk EPCs increased the blood flow ratio, capillary density, proliferation, and survival of transplanted cells, and the secretion of pivotal angiogenic cytokines at ischemic sites. These results provide strong evidence that si-lnk regulates the clonogenic proliferative potential of EPCs through the activation of the JAK2/STAT3 signaling pathway, thereby accelerating angiogenesis and promoting repair in injured hind limb ischemia.	[Lee, Sang Hun] Soonchunhyang Univ, Seoul Hosp, Med Sci Res Inst, Seoul, South Korea; [Lee, Sang Hun] Soonchunhyang Univ, Sch Med, Dept Biochem, Cheonan, South Korea; [Lee, Sang Hun; Lee, Kyeung Bin; Lee, Jun Hee; Kang, Songhwa; Kwon, Sang Mo] Pusan Natl Univ Yangsan, Sch Med, Dept Physiol, Lab Vasc Med & Stem Cell Biol, Gyeongnam, South Korea; [Lee, Jun Hee; Kang, Songhwa; Kwon, Sang Mo] Pusan Natl Univ Yangsan, Brain Busan Project 21, Immunoregulatory Therapeut Grp, Convergence Stem Cell Res Ctr, Gyeongnam, South Korea; [Kim, Hwi Gon] Pusan Natl Univ, Sch Med, Dept Obstet & Gynecol, Busan, South Korea; [Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa 25911, Japan	Kwon, SM (reprint author), Pusan Natl Univ, Sch Med, Dept Physiol, Lab Vasc Med & Stem Cell Biol, Yangsan, Gyeongnam, South Korea.	smkwon323@pusan.ac.kr			Soonchunhyang University; National Research Foundation - Korean government [NRF-2011-0009610, NRF-2010-0020260, NRF-2012R1A2A2A01045085, NRF-2012M3A9C6049720]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI12C0199]	This study was supported by the Soonchunhyang University Research Fund and a National Research Foundation grant funded by the Korean government (NRF-2011-0009610, NRF-2010-0020260, NRF-2012R1A2A2A01045085, and NRF-2012M3A9C6049720) and a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI12C0199). The funders had no role in the study design, data collection or analysis, the decision to publish, or preparation of the manuscript.	Fitau J, 2006, J BIOL CHEM, V281, P20148, DOI 10.1074/jbc.M510997200; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Lin DC, 2012, BLOOD, V120, P3310, DOI 10.1182/blood-2011-10-388611; Rafii S, 2002, GENE THER, V9, P631, DOI 10.1038/sj/gt/3301723; Asahara T, 1999, CIRC RES, V85, P221; Takaki S, 2002, J EXP MED, V195, P151, DOI 10.1084/jem.20011170; Takami T, 2002, J NEUROSCI, V22, P6670; Lee JH, 2013, ARTERIOSCL THROM VAS, V33, P1622, DOI 10.1161/ATVBAHA.112.301052; Yoo SY, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/127170; Zhao ZM, 2004, CELL TRANSPLANT, V13, P113; Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541; Lutz M, 2008, CARDIOVASC RES, V77, P143, DOI 10.1093/cvr/cvm027; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Kamei KI, 2010, LAB CHIP, V10, P1113, DOI 10.1039/b922884e; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Tu B, 2012, CANCER LETT, V325, P80, DOI 10.1016/j.canlet.2012.06.006; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Asahara T, 1998, CIRC RES, V83, P233; Bersenev A, 2008, J CLIN INVEST, V118, P2832, DOI 10.1172/JCI35808; Dentelli P, 2007, BLOOD, V109, P4264, DOI 10.1182/blood-2006-06-029603; Takaki S, 2000, IMMUNITY, V13, P599, DOI 10.1016/S1074-7613(00)00060-1; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Baran-Marszak F, 2010, BLOOD, V116, P5961, DOI 10.1182/blood-2009-12-256768; Barbosa HSC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038963; Carcamo-Orive I, 2008, EXP CELL RES, V314, P1777, DOI 10.1016/j.yexcr.2008.01.020; Fitau Juliette, 2005, Nephrol Ther, V1, P228, DOI 10.1016/j.nephro.2005.06.010; Gery S, 2009, J LEUKOCYTE BIOL, V85, P957, DOI 10.1189/jlb.0908575; Gery S, 2007, BLOOD, V110, P3360, DOI 10.1182/blood-2007-05-089326; Gueller S, 2008, BIOCHEM J, V415, P241, DOI 10.1042/BJ20080102; Gueller S, 2010, J LEUKOCYTE BIOL, V88, P699, DOI 10.1189/jlb.0309185; Gueller S, 2011, EXP HEMATOL, V39, P591, DOI 10.1016/j.exphem.2011.02.001; Kwon SM, 2009, CIRC RES, V104, P969, DOI 10.1161/CIRCRESAHA.108.192856; LEE S, 2013, ARTERIOSCLER THROMB, V155, P33; Matsumoto M, 2011, SURG RADIOL ANAT, V33, P223, DOI 10.1007/s00276-010-0746-x; Nobuhisa I, 2003, MOL CELL BIOL, V23, P8486, DOI 10.1128/MCB.23.23.8486-8494.2003; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203; Simon Clotilde, 2008, Blood, V112, P4039, DOI 10.1182/blood-2008-05-154849; Takaki S, 1997, J BIOL CHEM, V272, P14562, DOI 10.1074/jbc.272.23.14562; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883	46	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	MAY	2015	33	5					1490	1500		10.1002/stem.1938		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CG4XM	WOS:000353292600011		
J	Sun, JN; Mandai, M; Kamao, H; Hashiguchi, T; Shikamura, M; Kawamata, S; Sugita, S; Takahashi, M				Sun, Jianan; Mandai, Michiko; Kamao, Hiroyuki; Hashiguchi, Tomoyo; Shikamura, Masayuki; Kawamata, Shin; Sugita, Sunao; Takahashi, Masayo			Protective Effects of Human iPS-Derived Retinal Pigmented Epithelial Cells in Comparison with Human Mesenchymal Stromal Cells and Human Neural Stem Cells on the Degenerating Retina in rd1 Mice	STEM CELLS			English	Article						Transplantation; Cell-based therapy; Induced pluripotent stem cells; Retinal pigment epithelium cells; Retinal degeneration; Pigment epithelium-derived factor	NERVE GROWTH-FACTOR; PHOTORECEPTOR DEGENERATION; MOUSE RETINA; NEUROTROPHIC FACTOR; PROGENITOR CELLS; FACTOR-BETA; CHOROIDAL NEOVASCULARIZATION; INTRAVITREAL BEVACIZUMAB; VISUAL FUNCTIONS; GENE-EXPRESSION	Retinitis pigmentosa (RP) is a group of visual impairments characterized by progressive rod photoreceptor cell loss due to a genetic background. Pigment epithelium-derived factor (PEDF) predominantly secreted by the retinal pigmented epithelium (RPE) has been reported to protect photoreceptors in retinal degeneration models, including rd1. In addition, clinical trials are currently underway outside Japan using human mesenchymal stromal cells and human neural stem cells to protect photoreceptors in RP and dry age-related macular degeneration, respectively. Thus, this study aimed to investigate the rescue effects of induced pluripotent stem (iPS)-RPE cells in comparison with those types of cells used in clinical trials on photoreceptor degeneration in rd1 mice. Cells were injected into the subretinal space of immune-suppressed 2-week-old rd1 mice. The results demonstrated that human iPS-RPE cells significantly attenuated photoreceptor degeneration on postoperative days (PODs) 14 and 21 and survived longer up to at least 12 weeks after operation than the other two types of graft cells with less immune responses and apoptosis. The mean PEDF concentration in the intraocular fluid in RPE-transplanted eyes was more than 1 mu g/ml at PODs 14 and 21, and this may have contributed to the protective effect of RPE transplantation. Our findings suggest that iPS-RPE cells serve as a competent source to delay photoreceptor degeneration through stable survival in degenerating ocular environment and by releasing neuroprotective factors such as PEDF.	[Sun, Jianan; Mandai, Michiko; Kamao, Hiroyuki; Hashiguchi, Tomoyo; Sugita, Sunao; Takahashi, Masayo] RIKEN Ctr Dev Biol CDB, Lab Retinal Regenerat, Kobe, Hyogo, Japan; [Sun, Jianan] Kyoto Univ, Grad Sch Med, Applicat Biol & Regenerat Med, Kyoto, Japan; [Kamao, Hiroyuki] Kawasaki Med Univ, Dept Ophthalmol, Kurashiki, Okayama, Japan; [Shikamura, Masayuki; Kawamata, Shin] Fdn Biomed Res & Innovat, Res & Dev Ctr Cell Therapy, Kobe, Hyogo, Japan	Mandai, M (reprint author), RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	mmandai@cdb.riken.jp			Japanese Government (Monbukagakusho: MEXT) Scholarship Program; MEXT	We thank Tadao Maeda, Kyoko Iseki, Noriko Sakai, and Satoshi Okamoto for technical assistance and advice and all members of the Takahashi Laboratory for valuable discussion and comments. J.S. also thanks the Japanese Government (Monbukagakusho: MEXT) Scholarship Program. This study was supported by a grant from the Project for Realization of Regenerative Medicine, MEXT.	Acharya NR, 2011, RETINA-J RET VIT DIS, V31, P1871, DOI 10.1097/IAE.0b013e318213da43; Ahuja-Jensen P, 2007, NEUROREPORT, V18, P797, DOI 10.1097/WNR.0b013e3280c1e344; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Bai YJ, 2012, J PHARMACOL EXP THER, V342, P131, DOI 10.1124/jpet.112.192575; Cao W, 1999, J NEUROSCI RES, V57, P789, DOI 10.1002/(SICI)1097-4547(19990915)57:6<789::AID-JNR4>3.3.CO;2-D; Nomoto H, 2009, INVEST OPHTH VIS SCI, V50, P4807, DOI 10.1167/iovs.08-3148; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Cao W, 2001, INVEST OPHTH VIS SCI, V42, P1646; McGill TJ, 2012, EUR J NEUROSCI, V35, P468, DOI 10.1111/j.1460-9568.2011.07970.x; Amaral J, 2010, INVEST OPHTH VIS SCI, V51, P1318, DOI 10.1167/iovs.09-4455; Maeda T, 2013, J BIOL CHEM, V288, P34484, DOI 10.1074/jbc.M113.518571; Houenou LJ, 1999, J COMP NEUROL, V412, P506; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; Zou LH, 2011, THERANOSTICS, V1, P395, DOI 10.7150/thno/v01p0395; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Bilak MM, 1999, J NEUROPATH EXP NEUR, V58, P719, DOI 10.1097/00005072-199907000-00006; Mori K, 2001, J CELL PHYSIOL, V188, P253, DOI 10.1002/jcp.1114; Sugita S, 2008, J IMMUNOL, V181, P7525; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Akerud P, 2001, J NEUROSCI, V21, P8108; Murakami Y, 2008, AM J PATHOL, V173, P1326, DOI 10.2353/ajpath.2008.080466; Bowne SJ, 2011, EUR J HUM GENET, V19, P1074, DOI 10.1038/ejhg.2011.86; Arnhold S, 2007, GRAEF ARCH CLIN EXP, V245, P414, DOI 10.1007/s00417-006-0382-7; Frasson M, 1999, NAT MED, V5, P1183; Gal A, 2000, NAT GENET, V26, P270; Li Y, 2012, MOL MED, V18, P1312, DOI 10.2119/molmed.2012.00242; Cayouette M, 1999, NEUROBIOL DIS, V6, P523, DOI 10.1006/nbdi.1999.0263; Lund RD, 2007, STEM CELLS, V25, P602, DOI 10.1634/stemcells.2006-0308; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; Delyfer MN, 2005, MOL VIS, V11, P688; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Wang J, 2011, EXPERT OPIN BIOL TH, V11, P893, DOI 10.1517/14712598.2011.574119; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Xiong N, 2011, GENE THER, V18, P394, DOI 10.1038/gt.2010.152; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Rosenfeld PJ, 2011, OPHTHALMOLOGY, V118, P523, DOI 10.1016/j.ophtha.2010.07.011; Li PY, 2005, ARCH NEUROL-CHICAGO, V62, P223, DOI 10.1001/archneur.62.2.223; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Kicic A, 2003, J NEUROSCI, V23, P7742; Vega JL, 2010, OCUL IMMUNOL INFLAMM, V18, P459, DOI 10.3109/09273948.2010.509532; Fischer AJ, 2010, MOL NEUROBIOL, V42, P199, DOI 10.1007/s12035-010-8152-2; Taniwaki T, 1997, J NEUROCHEM, V68, P26; Bhutto IA, 2006, EXP EYE RES, V82, P99, DOI 10.1016/j.exer.2005.05.007; Horwitz EM, 2008, CYTOTHERAPY, V10, P771, DOI 10.1080/14653240802618085; Berglin L, 1997, GRAEF ARCH CLIN EXP, V235, P103, DOI 10.1007/BF00941738; Carnicero E, 2002, NEUROSCI LETT, V321, P149; Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152; Gamm DM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000338; Gamm DM, 2008, INVEST OPHTH VIS SCI, V49, P788, DOI 10.1167/iovs.07-0777; Hanhart J, 2014, EYE, V28, P646, DOI 10.1038/eye.2014.94; Hashimoto Yuki, 2012, Open Ophthalmol J, V6, P125, DOI 10.2174/1874364101206010125; HE S, 1993, GRAEF ARCH CLIN EXP, V231, P737, DOI 10.1007/BF00919290; Ishida K, 1997, CURR EYE RES, V16, P96, DOI 10.1076/ceyr.16.2.96.5093; Jones LL, 1998, BRAIN RES, V795, P301, DOI 10.1016/S0006-8993(98)00325-4; Jung GL, 2013, STEM CELL TRANSL MED, V2, P1001, DOI 10.5966/sctm.2013-0013; Kanemura H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02334; Klassen HJ, 2003, CYTOKINE, V22, P101, DOI 10.1016/S1043-4666(03)00120-0; Lambiase A, 1996, GRAEF ARCH CLIN EXP, V234, pS96, DOI 10.1007/BF02343055; LI LX, 1988, EXP EYE RES, V47, P911, DOI 10.1016/0014-4835(88)90073-5; Mandai M, 2012, CELL MED, V4, P45; MARTINEZSERRANO A, 1995, J NEUROSCI, V15, P5668; Mitamura Yoshinori, 2012, J Med Invest, V59, P1; Paglinawan R, 2003, GLIA, V44, P219, DOI 10.1002/glia.10286; Pressmar S, 2001, INVEST OPHTH VIS SCI, V42, P3311; Semkova I, 1999, NEUROCHEM INT, V35, P1, DOI 10.1016/S0197-0186(99)00021-2; Shen WY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-137; Shii D, 2009, CURR EYE RES, V34, P426, DOI 10.1080/02713680902866980; Sugita S, 2006, EXP EYE RES, V83, P1459, DOI 10.1016/j.exer.2006.08.005; SUZUMURA A, 1993, J IMMUNOL, V151, P2150; Takita H, 2003, INVEST OPHTH VIS SCI, V44, P4497, DOI 10.1167/iovs.03-0052; TOMBRANTINK J, 1995, J NEUROSCI, V15, P4992; Tovar YRLB, 2010, J NEUROCHEM, V115, P1090, DOI DOI 10.1111/J.1471-4159.2010.06766.X; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Warfvinge K, 2011, J TRANSPLANT, V2011; Wu ZQ, 2008, ANN ACAD MED SINGAP, V37, P591; Zhang Y, 2010, INVEST OPHTH VIS SCI, V51, P3742, DOI 10.1167/iovs.08-3314; Zhu L, 2008, NEUROCHEM RES, V33, P784, DOI 10.1007/s11064-007-9495-6	83	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	MAY	2015	33	5					1543	1553		10.1002/stem.1960		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CG4XM	WOS:000353292600016		
J	Matsuoka, Y; Nakatsuka, R; Sumide, K; Kawamura, H; Takahashi, M; Fujioka, T; Uemura, Y; Asano, H; Sasaki, Y; Inoue, M; Ogawa, H; Takahashi, T; Hino, M; Sonoda, Y				Matsuoka, Yoshikazu; Nakatsuka, Ryusuke; Sumide, Keisuke; Kawamura, Hiroshi; Takahashi, Masaya; Fujioka, Tatsuya; Uemura, Yasushi; Asano, Hiroaki; Sasaki, Yutaka; Inoue, Masami; Ogawa, Hiroyasu; Takahashi, Takayuki; Hino, Masayuki; Sonoda, Yoshiaki			Prospectively Isolated Human Bone Marrow Cell-Derived MSCs Support Primitive Human CD34-Negative Hematopoietic Stem Cells	STEM CELLS			English	Article						Mesenchymal stem/stromal cells; CD271; SSEA-4; CD34-negative; Hematopoietic stem cell; Niche	SCID-REPOPULATING CELLS; MESENCHYMAL PROGENITORS; TRANSCRIPTION FACTOR; GROWTH-FACTOR; LONG-TERM; BLOOD; NICHE; INJECTION; IDENTIFICATION; MICROENVIRONMENT	Hematopoietic stem cells (HSCs) are maintained in a specialized bone marrow (BM) niche, which consists of osteoblasts, endothelial cells, and a variety of mesenchymal stem/stromal cells (MSCs). However, precisely what types of MSCs support human HSCs in the BM remain to be elucidated because of their heterogeneity. In this study, we succeeded in prospectively isolating/establishing three types of MSCs from human BM-derived lineage- and CD45-negative cells, according to their cell surface expression of CD271 and stage-specific embryonic antigen (SSEA)-4. Among them, the MSCs established from the Lineage(-)CD45(-)CD271(+)SSEA-4(+) fraction (DP MSC) could differentiate into osteoblasts and chondrocytes, but they lacked adipogenic differentiation potential. The DP MSCs expressed significantly higher levels of well-characterized HSC-supportive genes, including IGF-2, Wnt3a, Jagged1, TGF beta 3, nestin, CXCL12, and Foxc1, compared with other MSCs. Interestingly, these osteo-chondrogenic DP MSCs possessed the ability to support cord blood-derived primitive human CD34-negative severe combined immunodeficiency-repopulating cells. The HSC-supportive actions of DP MSCs were partially carried out by soluble factors, including IGF-2, Wnt3a, and Jagged1. Moreover, contact between DP MSCs and CD34-positive (CD34(+)) as well as CD34-negative (CD34(-)) HSCs was important for the support/maintenance of the CD34(+/-) HSCs in vitro. These data suggest that DP MSCs might play an important role in the maintenance of human primitive HSCs in the BM niche. Therefore, the establishment of DP MSCs provides a new tool for the elucidation of the human HSC/niche interaction in vitro as well as in vivo.	[Matsuoka, Yoshikazu; Nakatsuka, Ryusuke; Sumide, Keisuke; Kawamura, Hiroshi; Fujioka, Tatsuya; Sasaki, Yutaka; Sonoda, Yoshiaki] Kansai Med Univ, Dept Stem Cell Biol & Regenerat Med, Grad Sch Med Sci, Hirakata, Osaka 5731010, Japan; [Kawamura, Hiroshi] Kansai Med Univ, Dept Orthoped Surg, Hirakata, Osaka 5731010, Japan; [Takahashi, Masaya] Kansai Med Univ, Dept Pediat, Hirakata, Osaka 5731010, Japan; [Uemura, Yasushi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Canc Immunotherapy, Kashiwa, Chiba, Japan; [Asano, Hiroaki] Kyoto Prefectural Univ Med, Sch Nursing, Kyoto, Japan; [Inoue, Masami] Osaka Med Ctr, Dept Hematol Oncol, Izumi, Osaka, Japan; [Inoue, Masami] Res Inst Maternal & Child Hlth, Izumi, Osaka, Japan; [Ogawa, Hiroyasu] Hyogo Coll Med, Dept Internal Med, Div Hematol, Nishinomiya, Hyogo 6638501, Japan; [Takahashi, Takayuki] Shinko Hosp, Dept Hematol, Kobe, Hyogo, Japan; [Hino, Masayuki] Osaka City Univ, Grad Sch Med, Dept Haematol, Osaka, Osaka, Japan	Sonoda, Y (reprint author), Kansai Med Univ, Dept Stem Cell Biol & Regenerat Med, Grad Sch Med Sci, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan.	sonoda@hirakata.kmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21591251, 24591432]; MEXT; A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R&D) Feasibility Study (FS) Stage (Exploratory Research type) from the Japan Science and Technology Agency (JST) [AS231Z03109G]; Strategic Research Base Development Program for Private Universities from the MEXT; Promotion and Mutual Aid Corporation for Private Schools of Japan; Japan Leukemia Research Foundation; Mitsubishi Pharma Research Foundation; Takeda Science Foundation; Terumo Life Science Foundation; SENSHIN Medical Research Foundation; Japan Society for the Promotion of Science [24790984, 26860741]; Kansai Medical University [D1]; Science Research Promotion Fund	This work was supported by Grants-in-Aid for Scientific Research C (Grant Nos. 21591251 and 24591432) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; a grant from the Science Frontier Program of the MEXT; a grant of A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R&D) Feasibility Study (FS) Stage (Exploratory Research type) from the Japan Science and Technology Agency (JST) (Grant No.AS231Z03109G); a grant from the Strategic Research Base Development Program for Private Universities from the MEXT; the MEXT-Supported Program for the Strategic Research Foundation at Private Universities; a grant from the Promotion and Mutual Aid Corporation for Private Schools of Japan; a grant from the Japan Leukemia Research Foundation; a grant from the Mitsubishi Pharma Research Foundation; a grant from the Takeda Science Foundation; a grant from the Terumo Life Science Foundation; and a grant from SENSHIN Medical Research Foundation. All these grants were given to Yo.So. This work was also supported by Grants-in-Aid for Young Scientists (B) (Grant Nos. 24790984 and 26860741) from the Japan Society for the Promotion of Science; a grant from Kansai Medical University (Research grant D1); a grant from the Science Research Promotion Fund; and a grant from the Takeda Science Foundation given to Y.M. The authors are grateful to the Japanese Red Cross Kinki Cord Blood Bank for providing the samples used in this study.	Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Takahashi M, 2014, LEUKEMIA, V28, P1308, DOI 10.1038/leu.2013.326; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/jmoldx.2006.050079; Jones EA, 2002, ARTHRITIS RHEUM, V46, P3349, DOI 10.1002/art.10696; Quirici N, 2002, EXP HEMATOL, V30, P783, DOI 10.1016/S0301-472X(02)00812-3; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Schajnovitz A, 2011, NAT IMMUNOL, V12, P391, DOI 10.1038/ni.2017; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Muraglia A, 2000, J CELL SCI, V113, P1161; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Mabuchi Y, 2013, STEM CELL REP, V1, P152, DOI 10.1016/j.stemcr.2013.06.001; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Omatsu Y, 2014, NATURE, V508, P536, DOI 10.1038/nature13071; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; OGAWA M, 1993, BLOOD, V81, P2844; Hogan CJ, 2002, P NATL ACAD SCI USA, V99, P413, DOI 10.1073/pnas.012336799; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; SIMMONS PJ, 1991, BLOOD, V78, P55; Tormin A, 2011, BLOOD, V117, P5067, DOI 10.1182/blood-2010-08-304287; Wang JCY, 1997, BLOOD, V89, P3919; Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740; Batard P, 2000, J CELL SCI, V113, P383; Dick J E, 1996, Semin Immunol, V8, P197, DOI 10.1006/smim.1996.0025; Ishii M, 2011, EXP HEMATOL, V39, P203, DOI 10.1016/j.exphem.2010.11.008; Kimura T, 2010, LEUKEMIA, V24, P162, DOI 10.1038/leu.2009.206; Kimura T, 2007, STEM CELLS, V25, P1348, DOI 10.1634/stemcells.2006-0727; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P209; Sonoda Y, 2008, J AUTOIMMUN, V30, P136, DOI 10.1016/j.jaut.2007.12.004; Wang JF, 2003, BLOOD, V101, P2924, DOI 10.1182/blood-2002-09-2782; Zhang J, 2003, NATURE	48	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	MAY	2015	33	5					1554	1565		10.1002/stem.1941		12	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CG4XM	WOS:000353292600017		
J	Kitajima, S; Kohno, S; Kondoh, A; Sasaki, N; Nishimoto, Y; Li, F; Mohammed, MSA; Muranaka, H; Nagatani, N; Suzuki, M; Kido, Y; Takahashi, C				Kitajima, Shunsuke; Kohno, Susumu; Kondoh, Atsushi; Sasaki, Nobunari; Nishimoto, Yuuki; Li, Fengkai; Mohammed, Mohammed Salah Abdallah; Muranaka, Hayato; Nagatani, Naoko; Suzuki, Misa; Kido, Yukiharu; Takahashi, Chiaki			Undifferentiated State Induced by Rb-p53 Double Inactivation in Mouse Thyroid Neuroendocrine Cells and Embryonic Fibroblasts	STEM CELLS			English	Article						Rb; p53; Undifferentiated state; Stem cell; Cancer	CANCER STEM-CELLS; LUNG-CANCER; TUMOR SUPPRESSION; BREAST-TUMORS; RB; P53; MICE; DIFFERENTIATION; IDENTIFICATION; MUTATION	Retinoblastoma tumor suppressor protein (RB) is inactivated more frequently during tumor progression than during tumor initiation. However, its exact role in controlling the malignant features associated with tumor progression is poorly understood. We established in vivo and in vitro models to investigate the undifferentiated state induced by Rb inactivation. Rb heterozygous mice develop well-differentiated thyroid medullary carcinoma. We found that additional deletion of Trp53, without change in lineage, converted these Rb-deficient tumors to a poorly differentiated type associated with higher self-renewal activity. Freshly prepared mouse embryonic fibroblasts (MEFs) of Rb-/-; Trp53(-/-) background formed stem cell-like spheres that expressed significant levels of embryonic genes despite of lacking the ability to form colonies on soft agar or tumors in immune-deficient mice. This suggested that Rb-p53 double inactivation resulted in an undifferentiated status but without carcinogenic conversion. We next established Rb-/-; N-ras(-/-) MEFs that harbored a spontaneous carcinogenic mutation in Trp53. These cells (RN6), in an Rb-dependent manner, efficiently generated spheres that expressed very high levels of embryonic genes, and appeared to be carcinogenic. We then screened an FDA-approved drug library to search for agents that suppressed the spherogenic activity of RN6 cells. Data revealed that RN6 cells were sensitive to specific agents including ones those are effective against cancer stem cells. Taken together, all these findings suggest that the genetic interaction between Rb and p53 is a critical determinant of the undifferentiated state in normal and tumor cells.	[Kitajima, Shunsuke; Kohno, Susumu; Kondoh, Atsushi; Sasaki, Nobunari; Nishimoto, Yuuki; Li, Fengkai; Mohammed, Mohammed Salah Abdallah; Muranaka, Hayato; Nagatani, Naoko; Suzuki, Misa; Kido, Yukiharu; Takahashi, Chiaki] Kanazawa Univ, Canc Res Inst, Div Oncol & Mol Biol, Stem Cell Res Program, Kanazawa, Ishikawa 9201192, Japan; [Mohammed, Mohammed Salah Abdallah] South Valley Univ, Dept Biochem, Fac Vet Med, Qena, Egypt; [Kido, Yukiharu] Jichi Med Univ, Dept Anat, Shimotsuke, Tochigi, Japan	Takahashi, C (reprint author), Kanazawa Univ, Canc Res Inst, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	kaha@staff.kanazawa-u.ac.jp			Funding Program for Next Generation World-Leading Researchers (NEXT); MEXT; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation; Naito Foundation; Daiichi-Sankyo Foundation for Life Science; NOVARTIS Foundation (Japan) for Promotion of Science; Hokkoku Foundation for Cancer Research; Hokuriku Bank Research Grant for Young Scientists	We thank Drs. T. Jacks, T. Kamijo, P. Leder, and T. Tanaka for providing materials, Drs. Asano and Kamimura for assistance in animal experiments, Dr. A. Yoshida for assistance in drawing survival curve, and all the colleagues in Takahashi laboratory for valuable discussion. This work was supported by Funding Program for Next Generation World-Leading Researchers (NEXT) to C.T., Grant-in-Aid for Scientific Research (MEXT) to C.T., S. Kitajima, and N.S., Astellas Foundation for Research on Metabolic Disorders, Takeda Science Foundation, Naito Foundation, Daiichi-Sankyo Foundation for Life Science, NOVARTIS Foundation (Japan) for Promotion of Science, and Hokkoku Foundation for Cancer Research to C.T., and Hokuriku Bank Research Grant for Young Scientists to S. Kitajima. S. Kitajima thanks Strategic Young Researcher Overseas Visit Program for Accelerating Brain Circulation for fellowship.	Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Shamma A, 2009, CANCER CELL, V15, P255, DOI 10.1016/j.ccr.2009.03.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009; Miura T, 2004, STEM CELLS DEV, V13, P694, DOI 10.1089/scd.2004.13.694; Conklin JF, 2009, J CELL BIOCHEM, V108, P1023, DOI 10.1002/jcb.22342; Macleod KF, 1996, EMBO J, V15, P6178; Shamma A, 2013, MOL CELL BIOL, V33, P3113, DOI 10.1128/MCB.01597-12; Choi J, 2010, AM J PATHOL, V177, P2645, DOI 10.2353/ajpath.2010.100306; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Li F, 2010, CELL STEM CELL, V7, P508, DOI 10.1016/j.stem.2010.09.003; Chinnam M, 2011, CURR TOP DEV BIOL, V94, P129, DOI 10.1016/B978-0-12-380916-2.00005-X; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Liu YQ, 2009, CELL STEM CELL, V4, P336, DOI 10.1016/j.stem.2009.02.015; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; TSUKADA T, 1993, ONCOGENE, V8, P3313; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Bhat-Nakshatri P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02530; Chavez L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-314; Conklin JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2254; Gauthier ML, 2007, CANCER CELL, V12, P479, DOI 10.1016/j.ccr.2007.10.017; HARVEY M, 1995, CANCER RES, V55, P1146; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; Kareta MS, 2015, CELL STEM CELL, V16, P39, DOI 10.1016/j.stem.2014.10.019; Kitajima S, 2011, ONCOGENE, V30, P737, DOI 10.1038/onc.2010.448; Sage J, 2012, GENE DEV, V26, P1409, DOI 10.1101/gad.193730.112; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Takahashi C, 2012, CANCER SCI, V103, P1182, DOI 10.1111/j.1349-7006.2012.02284.x; Takahashi C, 2004, MOL CELL BIOL, V24, P10406, DOI 10.1128/MCB.24.23.10406-10415.2004; Takahashi C, 2006, NAT GENET, V38, P118, DOI 10.1038/ng1703; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; TODARO GJ, 1965, SCIENCE, V147, P513, DOI 10.1126/science.147.3657.513; Tsai KY, 2002, P NATL ACAD SCI USA, V99, P16865, DOI 10.1073/pnas.262499599; Wikenheiser-Brokamp KA, 2006, CURR MOL MED, V6, P783; Wikenheiser-Brokamp KA, 2006, CELL MOL LIFE SCI, V63, P767, DOI 10.1007/s00018-005-5487-3; WILLIAMS BO, 1994, NAT GENET, V7, P480, DOI 10.1038/ng0894-480	48	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	MAY	2015	33	5					1657	1669		10.1002/stem.1971		13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CG4XM	WOS:000353292600025		
J	Dai, JG; Miyazawa, M; Wu, J				Dai, J. G.; Miyazawa, Masakiyo; Wu, Jian			Decomposable stationary distribution of a multidimensional SRBM	STOCHASTIC PROCESSES AND THEIR APPLICATIONS			English	Article						Semimartingale reflecting Brownian motion; Queueing network; Stationary distribution; Decomposability; Marginal distribution; Product form approximation; Completely-S matrix	REFLECTING BROWNIAN MOTIONS; GEOMETRIC VIEWS	We focus on the stationary distribution of a multidimensional semimartingale reflecting Brownian motion (SRBM) on a nonnegative orthant. Assuming that the stationary distribution exists and is decomposable-equal to the product of two marginal distributions, we prove that these marginal distributions are the stationary distributions of some lower dimensional SRBMs, whose data can be explicitly computed through that of the original SRBM. Thus, under the decomposability condition, the stationary distribution of a high dimensional SRBM can be computed through those of lower dimensional SRBMs. Next, we derive necessary and sufficient conditions for some classes of SRBMs to satisfy the decomposability condition. (C) 2014 Elsevier B.V. All rights reserved.	[Dai, J. G.; Wu, Jian] Cornell Univ, Sch Operat Res & Informat Engn, Ithaca, NY 14853 USA; [Miyazawa, Masakiyo] Tokyo Univ Sci, Dept Informat Sci, Noda, Chiba 2788510, Japan	Miyazawa, M (reprint author), Tokyo Univ Sci, Dept Informat Sci, Noda, Chiba 2788510, Japan.	jim.dai@cornell.edu; miyazawa@rs.tus.ac.jp; jw926@cornell.edu			National Science Foundation [CMMI-1030589, CNS-1248117, CMMI-1335724]; Japanese Society for the Promotion of Science [24310115]	We are grateful to the anonymous referees for their stimulating questions and helpful comments. This paper was initiated when MM (the second author) visited JD (the first author) at Cornell University in July, 2013. MM is grateful for the hospitality of School of ORIE of Cornell University. JD is supported in part by National Science Foundation Grants CMMI-1030589, CNS-1248117, and CMMI-1335724. MM is supported in part by Japanese Society for the Promotion of Science Grant 24310115.	Avram F, 2001, QUEUEING SYST, V37, P259, DOI 10.1023/A:1011004620420; Berman A., 1979, NONNEGATIVE MATRICES; Bramson M, 2010, ANN APPL PROBAB, V20, P753, DOI 10.1214/09-AAP631; Chen H., 2001, FUNDAMENTALS QUEUEIN; Cottle R., 1992, LINEAR COMPLEMENTARI; DAI J. G., 2011, STOCH SYST, V1, P146, DOI DOI 10.1214/10-SSY022; Dai J.G., 1994, PREPRINT; Dai JG, 2006, THEOR PROBAB APPL+, V50, P346, DOI 10.1137/S0040585X97981779; Dai J.G., 1992, ANN APPL PROBAB, V2, P65, DOI 10.1214/aoap/1177005771; Dai JG, 2013, QUEUEING SYST, V74, P181, DOI 10.1007/s11134-012-9339-1; Dai JG, 2014, QUEUEING SYST, V78, P313, DOI 10.1007/s11134-014-9411-0; Dieker AB, 2009, ELECTRON COMMUN PROB, V14, P1; FOSCHINI GJ, 1982, IEEE T INFORM THEORY, V28, P273, DOI 10.1109/TIT.1982.1056473; Harrison J. M., 1985, BROWNIAN MOTION STOC; Harrison J. M., 1990, Queueing Systems Theory and Applications, V6, DOI 10.1007/BF02411463; Harrison J. M., 1987, Stochastics, V22, DOI 10.1080/17442508708833469; HARRISON JM, 1987, ANN PROBAB, V15, P115, DOI 10.1214/aop/1176992259; Kang W., ANN APPL PROBAB, V24, P1329; Kang WN, 2009, ANN APPL PROBAB, V19, P1719, DOI 10.1214/08-AAP591; Latouche G, 2014, QUEUEING SYST, V77, P373, DOI 10.1007/s11134-013-9381-7; Markushevich A.I., 1977, THEORY FUNCTIONS COM, VIII; Markushevich A.I., 1977, THEORY FUNCTIONS COM, VII; Markushevich A.I., 1977, THEORY FUNCTIONS COM, VI-III; REIMAN MI, 1988, PROBAB THEORY REL, V77, P87, DOI 10.1007/BF01848132; Shkolnikov M., 2013, TIME REVERSAL UNPUB; Strichartz R.S., 2003, GUIDE DISTRIBUTION T; TAYLOR LM, 1993, PROBAB THEORY REL, V96, P283, DOI 10.1007/BF01292674; Williams R. J., 1996, STOCHASTIC NETWORKS; WILLIAMS R. J., 1995, STOCHASTIC NETWORKS, V71, P125	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4149	1879-209X		STOCH PROC APPL	Stoch. Process. Their Appl.	MAY	2015	125	5					1799	1820		10.1016/j.spa.2014.11.014		22	Statistics & Probability	Mathematics	CF9YP	WOS:000352924100003		
J	Wu, Q; Yu, FM; Okabe, Y; Saito, K; Kobayashi, S				Wu, Qi; Yu, Fengming; Okabe, Yoji; Saito, Kazuya; Kobayashi, Satoshi			Acoustic emission detection and position identification of transverse cracks in carbon fiber-reinforced plastic laminates by using a novel optical fiber ultrasonic sensing system	STRUCTURAL HEALTH MONITORING-AN INTERNATIONAL JOURNAL			English	Article						Acoustic emission; optical fiber sensor; composites; fiber Bragg grating; transverse cracks	COMPOSITE-MATERIALS; DAMAGE DETECTION; MATRIX CRACKING; DELAMINATION; SENSOR	Utilizing optical fiber technique to structural health monitoring of composite materials is attracting attention recently due to the inherent advantages in optical fiber sensor. However, acoustic emission signals with low energy and high frequency from transverse cracks in carbon fiber-reinforced plastic laminates are difficult to be detected by normal optical techniques. In this work, we present a phase-shifted fiber Bragg grating balanced sensing system to detect acoustic emission signals generated in a carbon fiber-reinforced plastic laminate in a three-point bending test. We demonstrated that the phase-shifted fiber Bragg grating balanced sensing system with a broad bandwidth and high sensitivity can detect high-frequency, low-energy acoustic emission signals caused by transverse cracks. In our experiments, the transverse cracks were identified very well through the detected acoustic emission signals. The relationship between the strain and the acoustic emission signals, and the typical waveforms of the acoustic emission signals were investigated. Furthermore, accurate position identification using acoustic emission detection by the phase-shifted fiber Bragg grating sensor was demonstrated. All the results obtained from the phase-shifted fiber Bragg grating sensor were compared to the results obtained from commercial lead-zirconate-titanate acoustic emission sensors. We found that the phase-shifted fiber Bragg grating balanced sensing system performance was comparable to the commercial lead-zirconate-titanate acoustic emission sensors.	[Wu, Qi; Yu, Fengming; Okabe, Yoji; Saito, Kazuya] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Kobayashi, Satoshi] Tokyo Metropolitan Univ, Dept Mech Engn, Tokyo 158, Japan	Wu, Q (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	wuqi@iis.u-tokyo.ac.jp					Feldman M, 2011, MECH SYST SIGNAL PR, V25, P735, DOI 10.1016/j.ymssp.2010.07.018; OGIHARA S, 1995, COMPOS SCI TECHNOL, V54, P395, DOI 10.1016/0266-3538(95)00084-4; Aggelis DG, 2012, COMPOS SCI TECHNOL, V72, P1127, DOI 10.1016/j.compscitech.2011.10.011; ZIOLA SM, 1991, J ACOUST SOC AM, V90, P2551, DOI 10.1121/1.402348; LIM JS, 1979, P IEEE, V67, P1586, DOI 10.1109/PROC.1979.11540; PROSSER WH, 1995, MATER EVAL, V53, P1052; Liu TQ, 2012, IEEE SENS J, V12, P2368, DOI 10.1109/JSEN.2012.2189383; Wu Q, 2012, OPT EXPRESS, V20, P28353, DOI 10.1364/OE.20.028353; Wild G, 2008, IEEE SENS J, V8, P1184, DOI 10.1109/JSEN.2008.926894; Buderath M., 2002, P 1 EUR WORKSH STRUC, P76; Fu T, 2009, OPT LASER ENG, V47, P1056, DOI 10.1016/j.optlaseng.2009.03.011; GORMAN MR, 1991, J ACOUST SOC AM, V90, P358, DOI 10.1121/1.401258; GORMAN MR, 1991, ULTRASONICS, V29, P245, DOI 10.1016/0041-624X(91)90063-E; HAMSTAD MA, 1986, EXP MECH, V26, P7, DOI 10.1007/BF02319949; Hu N, 2008, COMPOS SCI TECHNOL, V68, P1548, DOI 10.1016/j.compscitech.2007.10.015; Johnson M, 2000, COMPOS SCI TECHNOL, V60, P2803, DOI 10.1016/S0266-3538(00)00148-2; Raju Azmi AI, 2012, J REINF PLAST COMP, V31, P495; Read I, 2002, MEAS SCI TECHNOL, V13, pN5, DOI 10.1088/0957-0233/13/1/402; Rippert L, 2000, COMPOS SCI TECHNOL, V60, P2713, DOI 10.1016/S0266-3538(00)00135-4; Scruby C. B., 1987, Journal of Physics E (Scientific Instruments), V20, DOI 10.1088/0022-3735/20/8/001; Surgeon M, 1999, NDT&E INT, V32, P311, DOI 10.1016/S0963-8695(98)00077-2; Tsuda H, 2009, OPT LETT, V34, P2942, DOI 10.1364/OL.34.002942	22	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1475-9217	1741-3168		STRUCT HEALTH MONIT	Struct. Health Monit.	MAY	2015	14	3					205	213		10.1177/1475921714560074		9	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CG3WM	WOS:000353210300002		
J	Ainslie, MD; Fujishiro, H				Ainslie, M. D.; Fujishiro, H.			Modelling of bulk superconductor magnetization	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Review						numerical modelling; bulk superconductors; (RE)BCO; MgB2; bulk superconductor magnetization; pulsed field magnetization; trapped field magnets	PULSED-FIELD MAGNETIZATION; HIGH-TEMPERATURE SUPERCONDUCTORS; TRANSPORT AC LOSSES; CURRENT-VOLTAGE CHARACTERISTICS; MELT-TEXTURED YBA2CU3O7-DELTA; DISK-SHAPED SUPERCONDUCTORS; CRITICAL-CURRENT-DENSITY; FINITE-ELEMENT-ANALYSIS; CRITICAL-STATE MODEL; CU-O SUPERCONDUCTOR	This paper presents a topical review of the current state of the art in modelling the magnetization of bulk superconductors, including both (RE)BCO (where RE = rare earth or Y) and MgB2 materials. Such modelling is a powerful tool to understand the physical mechanisms of their magnetization, to assist in interpretation of experimental results, and to predict the performance of practical bulk superconductor-based devices, which is particularly important as many superconducting applications head towards the commercialization stage of their development in the coming years. In addition to the analytical and numerical techniques currently used by researchers for modelling such materials, the commonly used practical techniques to magnetize bulk superconductors are summarized with a particular focus on pulsed field magnetization (PFM), which is promising as a compact, mobile and relatively inexpensive magnetizing technique. A number of numerical models developed to analyse the issues related to PFM and optimise the technique are described in detail, including understanding the dynamics of the magnetic flux penetration and the influence of material inhomogeneities, thermal properties, pulse duration, magnitude and shape, and the shape of the magnetization coil(s). The effect of externally applied magnetic fields in different configurations on the attenuation of the trapped field is also discussed. A number of novel and hybrid bulk superconductor structures are described, including improved thermal conductivity structures and ferromagnet-superconductor structures, which have been designed to overcome some of the issues related to bulk superconductors and their magnetization and enhance the intrinsic properties of bulk superconductors acting as trapped field magnets. Finally, the use of hollow bulk cylinders/tubes for shielding is analysed.	[Ainslie, M. D.] Univ Cambridge, Dept Engn, Bulk Superconduct Grp, Cambridge CB2 1PZ, England; [Fujishiro, H.] Iwate Univ, Fac Engn, Dept Mat Sci & Engn, Morioka, Iwate 0208551, Japan	Ainslie, MD (reprint author), Univ Cambridge, Dept Engn, Bulk Superconduct Grp, Trumpington St, Cambridge CB2 1PZ, England.	mda36@cam.ac.uk	Ainslie, Mark/I-9027-2014	Ainslie, Mark/0000-0003-0466-3680	Royal Academy of Engineering Research Fellowship; Ministry of Education, Culture, Sports, Science and Technology, Japan; Royal Society International Exchanges Scheme grant [IE131084]	Dr Mark Ainslie would like to acknowledge the support of a Royal Academy of Engineering Research Fellowship. Professor Hiroyuki Fujishiro would also like to acknowledge support in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This research was also supported in part by a Royal Society International Exchanges Scheme grant, IE131084.	Ainslie MD, 2015, IEEE T APPL SUPERCON, V25; Ainslie MD, 2010, PHYSICA C, V470, P1752, DOI 10.1016/j.physc.2010.05.200; Amemiya N, 1997, IEEE T APPL SUPERCON, V7, P2110, DOI 10.1109/77.621008; Amemiya N, 1998, PHYSICA C, V310, P30, DOI 10.1016/S0921-4534(98)00428-6; Hong Z, 2006, SUPERCOND SCI TECH, V19, P1246, DOI 10.1088/0953-2048/19/12/004; Ainslie MD, 2011, COMPEL, V30, P762, DOI 10.1108/03321641111101195; Sawh RP, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/10/105014; Wang YX, 2001, PHYSICA C, V355, P179, DOI 10.1016/S0921-4534(01)00617-7; Patel A, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/12/125015; Yamamoto A, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4890724; KIM YB, 1962, PHYS REV LETT, V9, P306, DOI 10.1103/PhysRevLett.9.306; Brandt EH, 1996, PHYS REV B, V54, P4246, DOI 10.1103/PhysRevB.54.4246; Ainslie MD, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2227639; MIKHEENKO PN, 1993, PHYSICA C, V204, P229, DOI 10.1016/0921-4534(93)91004-F; Brambilla R, 2007, SUPERCOND SCI TECH, V20, P16, DOI 10.1088/0953-2048/20/1/004; BEAN CP, 1962, PHYS REV LETT, V8, P250, DOI 10.1103/PhysRevLett.8.250; Larbalestier DC, 2001, NATURE, V410, P186, DOI 10.1038/35065559; Durrell JH, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/8/082001; Shi YH, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/4/045006; PLUMMER CJG, 1987, IEEE T MAGN, V23, P1179, DOI 10.1109/TMAG.1987.1064997; Grilli F, 2005, IEEE T APPL SUPERCON, V15, P17, DOI 10.1109/TASC.2004.839774; Sologubenko AV, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.014504; Fujishiro H, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/6/065019; BRANDT EH, 1994, PHYS REV B, V50, P4034, DOI 10.1103/PhysRevB.50.4034; Yamaguchi K, 2008, J PHYS CONF SER, V97, DOI 10.1088/1742-6596/97/1/012278; Kruger P, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807136; Zhang M, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/1/015009; Gomory F, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/3/034012; Grilli F, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2259827; RHYNER J, 1993, PHYSICA C, V212, P292, DOI 10.1016/0921-4534(93)90592-E; Tomita M, 2003, NATURE, V421, P517, DOI 10.1038/nature01350; Ainslie MD, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/6/065008; Ainslie MD, 2012, PHYSICA C, V472, P50, DOI 10.1016/j.physc.2011.10.008; Grilli F, 2013, CRYOGENICS, V53, P142, DOI 10.1016/j.cryogenics.2012.03.007; Kimura Y, 2006, SUPERCOND SCI TECH, V19, pS466, DOI 10.1088/0953-2048/19/7/S09; Sanchez A, 2001, PHYS REV B, V64, DOI [10.1103/PhysRevB.64.214506, 10.1103/PhysRevLett.87.214506]; BEAN CP, 1964, REV MOD PHYS, V36, P31, DOI 10.1103/RevModPhys.36.31; Ainslie MD, 2011, SUPERCOND SCI TECH, V24, DOI 10.1088/0953-2048/24/4/045005; Lousberg GP, 2011, SUPERCOND SCI TECH, V24, DOI 10.1088/0953-2048/24/3/035008; Kambara M, 2001, SUPERCOND SCI TECH, V14, pL5, DOI 10.1088/0953-2048/14/4/101; Baskys A, 2014, J PHYS CONF SER, V507, DOI 10.1088/1742-6596/507/1/012003; Xiang FX, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4799360; Durrell JH, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/11/112002; BRANDT EH, 1994, PHYS REV B, V49, P9024, DOI 10.1103/PhysRevB.49.9024; Zhou DF, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/10/103001; Prigozhin L, 1996, J COMPUT PHYS, V129, P190, DOI 10.1006/jcph.1996.0243; Patel A, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/3/032001; Dew-Hughes D, 2001, LOW TEMP PHYS+, V27, P713, DOI 10.1063/1.1401180; Fujishiro H, 2009, IEEE T APPL SUPERCON, V19, P3545, DOI 10.1109/TASC.2009.2018081; ANDERSON PW, 1962, PHYS REV LETT, V9, P309, DOI 10.1103/PhysRevLett.9.309; Campbell AM, 2007, SUPERCOND SCI TECH, V20, P292, DOI 10.1088/0953-2048/20/3/031; Prigozhin L, 1997, IEEE T APPL SUPERCON, V7, P3866, DOI 10.1109/77.659440; Ma GT, 2008, SUPERCOND SCI TECH, V21, DOI 10.1088/0953-2048/21/6/065020; Ohsaki H, 2002, SUPERCOND SCI TECH, V15, P754, DOI 10.1088/0953-2048/15/5/322; Masson PJ, 2007, SUPERCOND SCI TECH, V20, P748, DOI 10.1088/0953-2048/20/8/005; Xu ZH, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/2/025016; Perini E, 2011, IEEE T APPL SUPERCON, V21, P2690, DOI 10.1109/TASC.2010.2086043; Baghdadi M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4879263; Fujishiro H, 2006, PHYSICA C, V445, P334, DOI 10.1016/j.physc.2006.04.077; Murakami M, 2007, INT J APPL CERAM TEC, V4, P225, DOI 10.1111/j.1744-7402.2007.02136.x; Nariki S, 2005, SUPERCOND SCI TECH, V18, pS126, DOI 10.1088/0953-2048/18/2/026; Hull JR, 2004, P IEEE, V92, P1705, DOI 10.1109/JPROC.2004.833796; Yokoyama K, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2237934; Wongsatanawarid A, 2010, J PHYS CONF SER, V234, DOI 10.1088/1742-6596/234/1/012047; Fuchs G, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/12/122002; Pardo E, 2008, SUPERCOND SCI TECH, V21, DOI 10.1088/0953-2048/21/6/065014; Nguyen DN, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/2/025001; Zou J, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2379692; Sander M, 2000, SUPERCOND SCI TECH, V13, P841, DOI 10.1088/0953-2048/13/6/344; Prigozhin L, 2011, SUPERCOND SCI TECH, V24, DOI 10.1088/0953-2048/24/7/075012; Zermeno VMR, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/5/052001; Gomory F, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/3/034017; Brandt EH, 1998, PHYS REV B, V58, P6506, DOI 10.1103/PhysRevB.58.6506; Aydiner A, 2010, J SUPERCOND NOV MAGN, V23, P457, DOI 10.1007/s10948-009-0598-y; Aydiner A, 2005, SUPERCOND SCI TECH, V18, P1010, DOI 10.1088/0953-2048/18/7/014; Babu NH, 2007, IEEE T APPL SUPERCON, V17, P2949, DOI 10.1109/TASC.2007.899063; Banno N, 1999, IEEE T APPL SUPERCON, V9, P2561, DOI 10.1109/77.785009; Barnes GJ, 2000, SUPERCOND SCI TECH, V13, P875, DOI 10.1088/0953-2048/13/6/352; Berger K, 2007, IEEE T APPL SUPERCON, V17, P3028, DOI 10.1109/TASC.2007.902095; BOSSAVIT A, 1994, IEEE T MAGN, V30, P3363, DOI 10.1109/20.312659; Campbell AM, 1997, CRYOGENICS, V37, P567, DOI 10.1016/S0011-2275(97)00068-4; Campbell AM, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/12/124006; Campbell AM, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/3/034005; Campbell AM, 2011, J SUPERCOND NOV MAGN, V24, P27, DOI 10.1007/s10948-010-0895-5; CAPLIN AD, 1994, SUPERCOND SCI TECH, V7, P412, DOI 10.1088/0953-2048/7/6/014; Cardwell DA, 2005, SUPERCOND SCI TECH, V18, pS173, DOI 10.1088/0953-2048/18/2/035; Cavallin T, 2007, IEEE T APPL SUPERCON, V17, P2770, DOI 10.1109/TASC.2007.897923; Chaud X, 2005, J EUR CERAM SOC, V25, P2955, DOI 10.1016/j.jeurceramsoc.2005.03.204; Chechurin V L, 1976, IEEE T MAGN, V6, P1048; CHEN IG, 1992, J APPL PHYS, V72, P1013, DOI 10.1063/1.351826; Cheng L, 2013, J CRYST GROWTH, V366, P1, DOI 10.1016/j.jcrysgro.2012.11.069; CONNER LW, 1991, PHYS REV B, V43, P402, DOI 10.1103/PhysRevB.43.402; Daeumling D, 1989, PHYS REV B, V40, P9350; Deng Z, 2012, PHYSCS PROC, V36, P958, DOI 10.1016/j.phpro.2012.06.088; Denis S, 2007, SUPERCOND SCI TECH, V20, P192, DOI 10.1088/0953-2048/20/3/014; Denis S, 2007, SUPERCOND SCI TECH, V20, P418, DOI 10.1088/0953-2048/20/5/002; Dewhurst CD, 1997, IEEE T APPL SUPERCON, V7, P1925, DOI 10.1109/77.620962; Eisterer M, 2003, SUPERCOND SCI TECH, V16, P1282, DOI 10.1088/0953-2048/16/11/005; Fagnard JF, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/10/105002; FRANKEL DJ, 1979, J APPL PHYS, V50, P5402, DOI 10.1063/1.326642; Fuchs G, 2003, J LOW TEMP PHYS, V133, P159, DOI 10.1023/A:1025641302208; Fujishiro H, 2011, SUPERCOND SCI TECH, V24, DOI 10.1088/0953-2048/24/7/075015; Fujishiro H, 2011, PHYSICA C, V471, P889, DOI 10.1016/j.physc.2011.05.081; Fujishiro H, 2015, IEEE T APPL SUPERCON, V25; Fujishiro H, 2006, IEEE T APPL SUPERCON, V16, P1080, DOI 10.1109/TASC.2006.871278; Fujishiro H, 2005, PHYSICA C, V426, P699, DOI 10.1016/j.physc.2005.01.045; Fujishiro H, 2005, SUPERCOND SCI TECH, V18, P158, DOI 10.1088/0953-2048/18/1/025; Fujishiro H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.093005; Fujishiro H, 2004, PHYSICA C, V412, P646, DOI 10.1016/j.physc.2004.01.083; Fujishiro H, 2006, J PHYS CONF SER, V43, P405, DOI 10.1088/1742-6596/43/1/101; Fujishiro H, 2005, JPN J APPL PHYS 2, V44, pL1221, DOI 10.1143/JJAP.44.L1221; Fujishiro H, 2011, SUPERCOND SCI TECH, V24, DOI 10.1088/0953-2048/24/10/105003; Fujishiro H, 2003, SUPERCOND SCI TECH, V16, P809, DOI 10.1088/0953-2048/16/7/312; Fujishiro H, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/10/105021; Fujiyama K, 2005, PHYSICA C, V426, P681, DOI 10.1016/j.physc.2005.01.044; Fukai H, 2002, SUPERCOND SCI TECH, V15, P1054, DOI 10.1088/0953-2048/15/7/311; Fukai H, 2001, PHYSICA C, V357, P774, DOI 10.1016/S0921-4534(01)00386-0; Fukui S, 2006, IEEE T APPL SUPERCON, V16, P143, DOI 10.1109/TASC.2006.870818; Granados X, 2008, Superconductor Science & Technology, V21, DOI 10.1088/0953-2048/21/3/034010; Granados X, 2007, IEEE T APPL SUPERCON, V17, P1629, DOI 10.1109/TASC.2007.898133; Grilli F, 2007, IEEE T APPL SUPERCON, V17, P3155, DOI 10.1109/TASC.2007.902144; Gyoda M, 1998, ADV SUPERCOND, P1353; Hull JR, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/12/124005; Ida T, 2008, J PHYS CONF SER, V97, DOI 10.1088/1742-6596/97/1/012292; Ida T, 2004, PHYSICA C, V412, P638, DOI 10.1016/j.physc.2003.12.082; Ikuta H, 2002, SUPERCOND SCI TECH, V15, P606, DOI 10.1088/0953-2048/15/4/321; Itoh M, 1996, IEEE T MAGN, V32, P2605, DOI 10.1109/20.511407; Itoh M., 1993, IEEE Transactions on Applied Superconductivity, V3, DOI 10.1109/77.233700; Itoh Y, 1996, JPN J APPL PHYS 1, V35, P2114, DOI 10.1143/JJAP.35.2114; Itoh Y, 1997, J APPL PHYS, V82, P5600, DOI 10.1063/1.366421; Jiang Y, 2008, SUPERCOND SCI TECH, V21; Jirsa M, 1997, PHYS REV B, V55, P3276, DOI 10.1103/PhysRevB.55.3276; Johansen TH, 1997, PHYS REV B, V56, P11273, DOI 10.1103/PhysRevB.56.11273; Kajikawa K, 2003, IEEE T APPL SUPERCON, V13, P3630, DOI 10.1109/TASC.2003.812415; Kajikawa K, 2008, PHYSICA C, V468, P1494, DOI 10.1016/j.physc.2008.05.062; Kamijo H, 2001, IEEE T APPL SUPERCON, V11, P1816, DOI 10.1109/77.920200; Kimura Y, 2008, J PHYS CONF SER, V97, DOI 10.1088/1742-6596/97/1/012295; Komi Y, 2009, PHYSICA C, V469, P1262, DOI 10.1016/j.physc.2009.05.121; Kovac P, 2003, SUPERCOND SCI TECH, V16, P1195, DOI 10.1088/0953-2048/16/10/312; Kovalev LK, 2002, SUPERCOND SCI TECH, V15, P817, DOI 10.1088/0953-2048/15/5/335; Krabbes G, 2006, HIGH TEMPERATURE SUP, P106; Laurent P, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/12/124004; Li BZ, 2012, PHYSICA C, V482, P50, DOI 10.1016/j.physc.2012.04.026; Lousberg GP, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/5/055005; Lousberg GP, 2010, IEEE T APPL SUPERCON, V20, P33, DOI 10.1109/TASC.2009.2036855; Majoros M, 2009, IEEE T APPL SUPERCON, V19, P3352, DOI 10.1109/TASC.2009.2019583; Majoros M, 2001, IEEE T APPL SUPERCON, V11, P2780, DOI 10.1109/77.919640; Majoros M, 2000, PHYSICA C, V338, P251, DOI 10.1016/S0921-4534(00)00300-2; Matsushita T., 1993, IEEE Transactions on Applied Superconductivity, V3, DOI 10.1109/77.233879; Matsuzaki H, 2005, IEEE T APPL SUPERCON, V15, P2222, DOI 10.1109/TASC.2005.849617; Meslin S, 2006, SUPERCOND SCI TECH, V19, pS585, DOI 10.1088/0953-2048/19/7/S32; Miki M, 2006, SUPERCOND SCI TECH, V19, pS494, DOI 10.1088/0953-2048/19/7/S14; Mikitik GP, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2245504; Mizutani U, 1998, APPL SUPERCOND, V6, P235, DOI 10.1016/S0964-1807(98)00106-9; Mori K, 1997, IEEE T APPL SUPERCON, V7, P378, DOI 10.1109/77.614508; Murata K, 2004, PHYSICA C, V412, P704, DOI 10.1016/j.physc.2004.01.093; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Nishijima N, 2003, IEEE T APPL SUPERCON, V13, P1580, DOI 10.1109/TASC.2003.812794; Noudem JG, 2004, SUPERCOND SCI TECH, V17, P931, DOI 10.1088/0953-2048/17/7/018; Ogawa J, 2003, PHYSICA C, V386, P26, DOI 10.1016/S0921-4534(02)02114-7; Ogawa J, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2282174; Ohsaki H, 2008, AIP CONF PROC, V985, P999; Oka T, 2014, J PHYS CONF SER, V507, DOI 10.1088/1742-6596/507/1/012039; Pardo E, 2007, SUPERCOND SCI TECH, V20, P351, DOI 10.1088/0953-2048/20/4/009; Patel A, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4795016; Patel A, 2014, J PHYS CONF SER, V507, DOI 10.1088/1742-6596/507/2/022024; Pecher R, 2003, P 6 EUCAS, P1; Philippe MP, 2014, PHYSICA C, V502, P20, DOI 10.1016/j.physc.2014.04.025; Prigozhin L, 1998, J COMPUT PHYS, V144, P180, DOI 10.1006/jcph.1998.5978; Qiu M., 2004, IEEE T APPL SUPERCON, V14, P1989; Qiu M, 2005, IEEE T APPL SUPERCON, V15, P3172, DOI 10.1109/TASC.2005.848773; Sano T, 2008, J PHYS CONF SER, V97, DOI 10.1088/1742-6596/97/1/012194; Selva K, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/11/115006; Selva K, 2015, IEEE T APPL SUPERCON, V25; Shen ZJ, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2366972; Shiraishi R, 2006, IEEE T APPL SUPERCON, V16, P1794, DOI 10.1109/TASC.2005.864280; Sirois F, 2015, SUPERCOND SCI TECH, V28, DOI 10.1088/0953-2048/28/4/043002; Sirois F, 2008, J PHYS CONF SER, V97, DOI 10.1088/1742-6596/97/1/012030; Stavrev S, 2002, IEEE T MAGN, V38, P849, DOI 10.1109/20.996219; Sykulski JK, 1997, IEEE T MAGN, V33, P1568, DOI 10.1109/20.582565; Sykulski JK, 2000, IEEE T MAGN, V36, P1178, DOI 10.1109/20.877650; Sykulski JK, 1999, COMPEL, V18, P215, DOI 10.1108/03321649910264217; THEUSS H, 1992, PHYSICA C, V190, P345, DOI 10.1016/0921-4534(92)90617-L; Tinkham M, 1996, INTRO SUPERCONDUCTIV, P179; Tsukamoto O, 2005, J MATER PROCESS TECH, V161, P52, DOI 10.1016/j.jmatprotec.2004.07.009; Vanderbemden P, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.174515; Vanderbemden P, 2007, SUPERCOND SCI TECH, V20, pS174, DOI 10.1088/0953-2048/20/9/S10; Vanderbemden P, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/7/075006; Vinot E, 2000, IEEE T MAGN, V36, P1226, DOI 10.1109/20.877661; Vojenciak M, 2011, SUPERCOND SCI TECH, V24, DOI 10.1088/0953-2048/24/7/075001; Weinstein R., 2015, IEEE T APPL SUPERCON, V25; Weinstein R, 1998, MAT SCI ENG B-SOLID, V53, P38, DOI 10.1016/S0921-5107(97)00299-7; Wen HM, 2009, IEEE T APPL SUPERCON, V19, P1652, DOI 10.1109/TASC.2009.2017832; Xian W, 2011, IEEE T APPL SUPERCON, V21, P1171, DOI 10.1109/TASC.2010.2092745; Xu M, 2001, APPL PHYS LETT, V79, P2779, DOI 10.1063/1.1413729; Xu Z, 2012, THESIS U CAMBRIDGE; Yamagishi K, 2014, J PHYS CONF SER, V507, DOI 10.1088/1742-6596/507/3/032060; Yamagishi K, 2003, PHYSICA C, V392, P659, DOI 10.1016/S0921-4534(03)00988-2; Yamagishi K, 2015, IEEE T APPL SUPERCON, V25; Yamagishi K, 2011, IEEE T APPL SUPERCON, V21, P3320, DOI 10.1109/TASC.2010.2093111; Yamasaki H, 2000, SUPERCOND SCI TECH, V13, P202, DOI 10.1088/0953-2048/13/2/315; Yanagi Y., 2000, ADV SUPERCONDUCTIVIT, V12, P470; Yanagi Y, 2005, SUPERCOND SCI TECH, V18, P839, DOI 10.1088/0953-2048/18/6/009; Yoshida T, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2381558; Zhang M, 2012, J APPL PHYS, V112, DOI 10.1063/1.4747925; ZHU J, 1993, PHYSICA C, V212, P216, DOI 10.1016/0921-4534(93)90506-L; Zushi Y, 2004, PHYSICA C, V412, P708, DOI 10.1016/j.physc.2004.01.094; Zushi Y, 2005, CRYOGENICS, V45, P17, DOI 10.1016/j.cryogenics.2004.06.007	208	6	6	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	MAY	2015	28	5							053002	10.1088/0953-2048/28/5/053002		20	Physics, Applied; Physics, Condensed Matter	Physics	CG1EK	WOS:000353015700004		
J	Gross, B; Rudau, F; Kinev, N; Tsujimoto, M; Yuan, J; Huang, Y; Ji, M; Zhou, XJ; An, DY; Ishii, A; Wu, PH; Hatano, T; Koelle, D; Wang, HB; Koshelets, VP; Kleiner, R				Gross, B.; Rudau, F.; Kinev, N.; Tsujimoto, M.; Yuan, J.; Huang, Y.; Ji, M.; Zhou, X. J.; An, D. Y.; Ishii, A.; Wu, P. H.; Hatano, T.; Koelle, D.; Wang, H. B.; Koshelets, V. P.; Kleiner, R.			Electrothermal behavior and terahertz emission properties of a planar array of two Bi2Sr2CaCu2O8+delta intrinsic Josephson junction stacks	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						intrinsic Josephson junction; terahertz; high temperature superconductor	THZ RADIATION; SUPERCONDUCTORS; SYNCHRONIZATION; EMITTERS	We report on the investigation of the electrothermal behavior and the terahertz (THz) emission properties of two nearby Bi2Sr2CaCu2O8+delta (BSCCO) intrinsic Josephson junction stacks, using a combination of electric transport and THz emission measurements plus low temperature scanning laser microscopy. We start with a compact BSCCO stack (placed in a z-shaped structure between two BSCCO electrodes) with lateral dimensions of 330 x 60 mu m(2) and 0.7 mu m height, consisting of about 480 junctions. After characterization, a 200 nm wide slit was introduced by focused ion beam milling, splitting the stack into two halves connected by continuous superconducting electrodes. In a third step, the upper electrode was also split, leading to a structure where the two stacks can be biased separately. In all configurations hot-spot formation was observed. Despite the separation into two stacks only a single hot spot formed, which, depending on the bias condition, could either be located in one of the stacks or extend into both stacks with its center in the slit. In none of the structures it was possible to achieve mutual synchronization of the two stacks, indicating that additional synchronizing elements or the presence of a base crystal as for mesa structures may be necessary for the operation of parallel array structures.	[Gross, B.; Rudau, F.; Tsujimoto, M.; Koelle, D.; Kleiner, R.] Univ Tubingen, Phys Inst Expt Phys 2, D-72076 Tubingen, Germany; [Gross, B.; Rudau, F.; Tsujimoto, M.; Koelle, D.; Kleiner, R.] Univ Tubingen, Ctr Collect Quantum Phenomena LISA, D-72076 Tubingen, Germany; [Kinev, N.; Koshelets, V. P.] Kotelnikov Inst Radio Engn & Elect, Moscow, Russia; [Tsujimoto, M.] Kyoto Univ, Kyoto, Japan; [Yuan, J.; Huang, Y.; Ji, M.; Zhou, X. J.; Ishii, A.; Hatano, T.; Wang, H. B.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Huang, Y.; Ji, M.; Zhou, X. J.; An, D. Y.; Wu, P. H.; Wang, H. B.] Nanjing Univ, Res Inst Superconductor Elect, Nanjing 210093, Jiangsu, Peoples R China	Gross, B (reprint author), Univ Tubingen, Phys Inst Expt Phys 2, Morgenstelle 14, D-72076 Tubingen, Germany.	borisgross@arcor.de	Koelle, Dieter/E-5111-2011; Koshelets, Valery/A-6959-2012	Koshelets, Valery/0000-0002-1563-1257	National Natural Science Foundation of China [11234006]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Deutsche Forschungsgemeinschaft [KL930/12-1]; JSPS; RFBR [13-02-00493-a, 14-02-91335, 14-02-31374]; Ministry of Education and Science of the Russian Federation [14.607.21.0100]	We gratefully acknowledge financial support by the National Natural Science Foundation of China (Grant No. 11234006), the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Deutsche Forschungsgemeinschaft (Project KL930/12-1), the Grants-in-Aid for scientific research from JSPS, RFBR grants 13-02-00493-a, 14-02-91335 and 14-02-31374, and grant No. 14.607.21.0100 by the Ministry of Education and Science of the Russian Federation.	GUREVICH AV, 1987, REV MOD PHYS, V59, P941, DOI 10.1103/RevModPhys.59.941; Kashiwagi T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.010113; Koshelev AE, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.014530; An DY, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4794072; Koyama T, 2011, SUPERCOND SCI TECH, V24, DOI 10.1088/0953-2048/24/8/085007; Guenon S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214506; Averkov YO, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.027005; Koshelev AE, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174512; Sekimoto S, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4827094; Asai H, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.064521; Yurgens A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.184501; Tsujimoto M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.037005; Tachiki M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.127002; Tsujimoto M, 2012, J APPL PHYS, V111, DOI 10.1063/1.4729799; Wang HB, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.057002; Ji M, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4896684; Krasnov VM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.174517; Kashiwagi T, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866898; Krasnov VM, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.134524; Asai H, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868219; Kakeya I, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4727899; Grib A, 2014, PHYS STATUS SOLIDI B, V251, P1040, DOI 10.1002/pssb.201350256; Barbara P, 1999, PHYS REV LETT, V82, P1963, DOI 10.1103/PhysRevLett.82.1963; KLEINER R, 1992, PHYS REV LETT, V68, P2394, DOI 10.1103/PhysRevLett.68.2394; Gross B, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.014524; Tsujimoto M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.107006; Benseman TM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.064523; Lin SZ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.247006; Lin SZ, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.020504; Ozyuzer L, 2007, SCIENCE, V318, P1291, DOI 10.1126/science.1149802; Welp U, 2013, NAT PHOTONICS, V7, P702, DOI [10.1038/nphoton.2013.216, 10.1038/NPHOTON.2013.216]; Koshelev AE, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.174509; Lin SZ, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.054506; Krasnov VM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.227002; Kawayama I, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/9/093002; Benseman TM, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/8/085016; Benseman TM, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813536; Benseman TM, 2013, J APPL PHYS, V113, DOI 10.1063/1.4795591; Darula M, 1999, SUPERCOND SCI TECH, V12, pR1, DOI 10.1088/0953-2048/12/1/001; Gross B, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.094524; Koshelets VP, 2010, P SOC PHOTO-OPT INS, V7854, DOI 10.1117/12.868916; Kurter C, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.224518; Li MY, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.060505; Lin SZ, 2014, J APPL PHYS, V115, DOI 10.1063/1.4874677; Lin SZ, 2013, PHYSICA C, V491, P24, DOI 10.1016/j.physc.2012.11.008; Minami H, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.054503; Orita N, 2010, PHYSICA C, V470, pS786, DOI 10.1016/j.physc.2010.01.051; Pedersen NF, 2009, IEEE T APPL SUPERCON, V19, P726, DOI 10.1109/TASC.2009.2018770; Shukrinov YM, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/12/124007; Song F, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3253417; Spenke E, 1935, ELECTRON ENG, V30, P728; Spenke E, 1936, WISSENSCHAFTLICHE VE, V15, P92; Turkoglu F, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/12/125004; Wang HB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.017006; Wang HB, 2002, APPL PHYS LETT, V80, P1604, DOI 10.1063/1.1456555; Wang HB, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.224507; Watanabe C, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/17/172201; Yuan J, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/7/075015; Yurgens A, 2011, SUPERCOND SCI TECH, V24, DOI 10.1088/0953-2048/24/1/015003	59	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	MAY	2015	28	5							055004	10.1088/0953-2048/28/5/055004		10	Physics, Applied; Physics, Condensed Matter	Physics	CG1EK	WOS:000353015700010		
J	Sugino, S; Yamamoto, A; Shimoyama, J; Kishio, K				Sugino, Sho; Yamamoto, Akiyasu; Shimoyama, Jun-ichi; Kishio, Kohji			Enhanced trapped field in MgB2 bulk magnets by tuning grain boundary pinning through milling	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						MgB2; superconducting bulk magnet; trapped field; grain boundaries; flux pinning; milling; permanent magnet	CRITICAL-CURRENT DENSITY; DOPED MGB2; SUPERCONDUCTING MGB2; POWDER; CARBON; J(C)	The effects of the grain size, lattice strain, and microstructure on the trapped field properties of ball-milled MgB2 bulks were studied. A decrease in the in-plane lattice parameters and transition temperature and an increase in the in-plane x-ray diffraction peak widths occurred with milling as a result of grain refinement and carbon substitution. Microstructural analysis revealed that sub-micron-size fine MgB2 grains were well connected, resulting in increased grain boundary density. The trapped field of the magnetized bulk samples exhibited a large improvement with milling and reached 3.72 T at 5 K, which is the highest among MgB2 bulks prepared using pressureless synthesis. Excess milling resulted in degradation of the trapped field because of T-c reduction. The increased grain boundary density and electron scattering are considered to contribute to the high trapped field through quantitatively and qualitatively enhancing the grain boundary flux pinning.	[Sugino, Sho; Yamamoto, Akiyasu; Shimoyama, Jun-ichi; Kishio, Kohji] Univ Tokyo, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; [Yamamoto, Akiyasu] JST PRESTO, Kawaguchi, Saitama 3320012, Japan	Sugino, S (reprint author), Univ Tokyo, Dept Appl Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	yamamoto@appchem.t.u-tokyo.ac.jp	Yamamoto, Akiyasu/A-5119-2012		Japan Society for the Promotion of Science [22860019, 23246110, 24656368]; Japan Science and Technology Agency, PRESTO	The authors gratefully acknowledge A Ishihara, T Akasaka and M Tomita (Railway Technical Research Institute) for helpful discussions and S Ohtsuka and T Moroyama (The University of Tokyo) for their assistance with the SEM analysis. This work was supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Grant Nos. 22860019, 23246110 and 24656368) and by the Japan Science and Technology Agency, PRESTO. The microstructural analysis was conducted at the Center for Nano Lithography & Analysis, The University of Tokyo, which is supported by the Ministry of Education, Sports, Culture, Science, and Technology, Japan.	Aldica G, 2014, PHYSICA C, V505, P18, DOI 10.1016/j.physc.2014.07.001; Yamamoto A, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4890724; Zehetmayer M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.052505; Kim JH, 2012, NPG ASIA MATER, V4, DOI 10.1038/am.2012.3; Larbalestier DC, 2001, NATURE, V410, P186, DOI 10.1038/35065559; Durrell JH, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/8/082001; Yamamoto A, 2007, SUPERCOND SCI TECH, V20, P658, DOI 10.1088/0953-2048/20/7/012; Fujishiro H, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/6/065019; [Anonymous], 2005, PHYS REV B, DOI DOI 10.1103/PHYSREVB.71.012504; Noudem JG, 2014, J APPL PHYS, V116, DOI 10.1063/1.4900725; Eskildsen MR, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.187003; Hassler W, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/2/025005; Bhadauria PPS, 2014, J APPL PHYS, V115, DOI 10.1063/1.4875664; Tomita M, 2003, NATURE, V421, P517, DOI 10.1038/nature01350; Durrell JH, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/11/112002; Susner MA, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4871578; Perini E, 2011, IEEE T APPL SUPERCON, V21, P2690, DOI 10.1109/TASC.2010.2086043; Eisterer M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.247002; Putti M, 2011, MRS BULL, V36, P608, DOI 10.1557/mrs.2011.176; Fuchs G, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/12/122002; Badica P, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/9/095013; Bhagurkar AG, 2015, SUPERCOND SCI TECH, V28, DOI 10.1088/0953-2048/28/1/015012; Cai Q, 2014, APPL PHYS A-MATER, V114, P919, DOI 10.1007/s00339-013-7764-6; Campbell AM, 1997, CRYOGENICS, V37, P567, DOI 10.1016/S0011-2275(97)00068-4; Chen SK, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/12/125018; Hari Babu N, 2003, APPL PHYS LETT, V83, P4806, DOI 10.1063/1.1631738; Hossain MSA, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/9/095016; Kim CJ, 2014, PHYSICA C, V502, P4, DOI 10.1016/j.physc.2014.04.006; Eisterer M, 2007, SUPERCOND SCI TECH, V20, pR47, DOI 10.1088/0953-2048/20/12/R01; Kodama M, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/5/055003; Lee S, 2003, PHYSICA C, V397; Lezza P, 2006, SUPERCOND SCI TECH, V19, P1030, DOI 10.1088/0953-2048/19/10/007; Maeda M, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.013101; Matsushita T, 2008, SUPERCOND SCI TECH, V21, DOI 10.1088/0953-2048/21/01/015008; Meerovich V, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/3/035015; Mizutani S, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/4/044012; Muralidhar M, 2001, APPL PHYS LETT, V79, P3107, DOI 10.1063/1.1414303; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Polyanskii AA, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.214509; Rowell JM, 2003, SUPERCOND SCI TECH, V16, pR17, DOI 10.1088/0953-2048/16/6/201; Senkowicz BJ, 2007, SUPERCOND SCI TECH, V20, P650, DOI 10.1088/0953-2048/20/7/011; Su XC, 2014, J LOW TEMP PHYS, V177, P8, DOI 10.1007/s10909-014-1178-5; Sudesh Kumar N, 2014, SUPERCOND SCI TECH, V26; Tang SP, 2014, J SUPERCOND NOV MAGN, V27, P2699, DOI 10.1007/s10948-014-2804-9; Yamamoto A, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1937991; Yamamoto A, 2004, SUPERCOND SCI TECH, V17, P921, DOI 10.1088/0953-2048/17/7/016; Ye SJ, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/8/085012	47	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	MAY	2015	28	5							055016	10.1088/0953-2048/28/5/055016		7	Physics, Applied; Physics, Condensed Matter	Physics	CG1EK	WOS:000353015700022		
J	Venkateshwarlu, D; Ganesan, V; Ohashi, Y; Kikkawa, S; Yakhmi, JV				Venkateshwarlu, D.; Ganesan, V.; Ohashi, Y.; Kikkawa, S.; Yakhmi, J. V.			TAFF and vortex glass state in a niobium oxy-nitride Nb(N0.98O0.02)	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						superconductors; niobium oxynitrides; TAFF; AL theory; LLL scaling; vortex phases	HIGH-TEMPERATURE SUPERCONDUCTORS; MAGNETIC-FIELD; FLUCTUATIONS; OXYNITRIDES; DEPENDENCE; TRANSPORT; CRYSTAL; MGB2; SI	Resistivity broadening of niobium oxy-nitride [Nb(N0.98O0.02)] is analyzed in terms of fluctuation conductivity, thermally activated flux flow (TAFF) and vortex glass study in magnetic fields up to 14 T. Zero field fluctuation analysis of excess conductivity using the Aslamzov-Larkin theory shows an indication of a 3D character that is further supported by the lowest Landau level (LLL) scaling. We could obtain a clear vortex glass region from an extended analysis of the resistivity data. Different regions of interest are estimated that include vortex glass and vortex liquids of the phase diagram. The TAFF has been analyzed using conventional Arrhenius relation, as well as its modified version that includes a temperature-and field-dependent pre-factor. While the conventional TAFF scaling is well suited for the present system, the modified version yields deeper insight into the material parameters of interest. Ginzburg number, coherence length, critical exponents related to the vortex glass transition, etc, are estimated and discussed.	[Venkateshwarlu, D.; Ganesan, V.] UGC DAE Consortium Sci Res, Indore 452001, Madhya Pradesh, India; [Ohashi, Y.; Kikkawa, S.] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Yakhmi, J. V.] Homi Bhabha Natl Inst, Bombay 400094, Maharashtra, India	Venkateshwarlu, D (reprint author), UGC DAE Consortium Sci Res, Khandwa Rd, Indore 452001, Madhya Pradesh, India.	vganesan@csr.res.in	Yakhmi, Jatinder/H-2369-2011	Yakhmi, Jatinder/0000-0003-2175-9967	Japan Society for the Promotion of Science (JSPS) [21245047]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [19053001, 22015001]	Authors at Indore thank the director and staff of LTL, UGC-DAE CSR for support, Mr P Saravanan and his cryogenic team for their technical support, and DST, India for their initial support in setting up a14T PPMS at CSR Indore. This research was supported in part by a Grant-in-Aid for Scientific Research (Kakenhi (A)#21245047) from the Japan Society for the Promotion of Science (JSPS) and a Grant-in-Aid for Scientific Research on Priority Areas (#19053001and 22015001) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Kaushik SD, 2008, PRAMANA-J PHYS, V71, P1335; FISHER MPA, 1989, PHYS REV LETT, V62, P1415, DOI 10.1103/PhysRevLett.62.1415; Ohashi Y, 2012, J SOLID STATE CHEM, V188, P66, DOI 10.1016/j.jssc.2012.01.024; Pandya S, 2011, SUPERCOND SCI TECH, V24, DOI 10.1088/0953-2048/24/4/045011; Pandya S, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/7/075015; Hillier AD, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.014508; Lei HC, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.134525; Zhang YZ, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/6/065012; Thompson JR, 2005, SUPERCOND SCI TECH, V18, P970, DOI 10.1088/0953-2048/18/7/008; Kamlapure A, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3314308; HELFAND E, 1966, PHYS REV, V147, P288, DOI 10.1103/PhysRev.147.288; PALSTRA TTM, 1988, PHYS REV LETT, V61, P1662, DOI 10.1103/PhysRevLett.61.1662; SKELTON EF, 1981, J APPL CRYSTALLOGR, V14, P51, DOI 10.1107/S0021889881008650; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; Zhang YZ, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.144521; Berger R, 1997, J ALLOY COMPD, V259, P9; Bhoi D, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/9/095015; Bourgeois O, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2403934; FABBRICATORE P, 1989, J APPL PHYS, V66, P5944, DOI 10.1063/1.343621; GUARD RW, 1967, T METALL SOC AIME, V239, P643; Lee HS, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.104523; Linde AV, 2009, MATER RES BULL, V44, P1025, DOI 10.1016/j.materresbull.2008.11.008; Ohashi Y, 2010, J SOLID STATE CHEM, V183, P1710, DOI 10.1016/j.jssc.2010.05.023; Ohashi Y, 2011, J SOLID STATE CHEM, V184, P2061, DOI 10.1016/j.jssc.2011.06.003; Ohashi Y, 2014, J SOLID STATE CHEM, V210, P238, DOI 10.1016/j.jssc.2013.11.034; SCHEERER B, 1980, J CRYST GROWTH, V49, P61, DOI 10.1016/0022-0248(80)90060-3; Song YJ, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/47003; TERAO N, 1971, J LESS-COMMON MET, V23, P159, DOI 10.1016/0022-5088(71)90076-2; ULLAH S, 1990, PHYS REV LETT, V65, P2066, DOI 10.1103/PhysRevLett.65.2066; ULLAH S, 1991, PHYS REV B, V44, P262, DOI 10.1103/PhysRevB.44.262; Venkateshwarlu D, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/8/085002; WILLIAMS MW, 1967, J PHYS CHEM SOLIDS, V28, P333, DOI 10.1016/0022-3697(67)90129-1; Yamamoto S, 2009, J ALLOY COMPD, V482, P160, DOI 10.1016/j.jallcom.2009.03.151; Yin DL, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.092503	34	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	MAY	2015	28	5							055009	10.1088/0953-2048/28/5/055009		7	Physics, Applied; Physics, Condensed Matter	Physics	CG1EK	WOS:000353015700015		
J	Sawa, Y				Sawa, Yoshiki			Transcatheter aortic valve implantation	SURGERY TODAY			English	Review						Aortic valve stenosis; Transcatheter aortic valve implantation; Aortic valve replacement	HIGH-RISK PATIENTS; COREVALVE REVALVING SYSTEM; ACUTE KIDNEY INJURY; ELDERLY-PATIENTS; NATURAL-HISTORY; STENOSIS; REPLACEMENT; PROSTHESIS; SURVIVAL; ARTERY	With the improvement in the overall life expectancy, the incidence of aortic stenosis has been increasing. Although aortic valve replacement is a standard therapy, many patients do not undergo surgery for various reasons, including advanced age or the presence of multiple comorbidities. Transcatheter aortic valve implantation (TAVI) has been proposed as a less invasive and equally effective treatment for inoperable or high-risk symptomatic aortic stenosis. Numerous rigorous global clinical trials, as well as a pivotal clinical trial in Japan, have been conducted. In this review, we provide data on the development of TAVI worldwide and discuss the prospects for TAVI in Japan.	Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan	Sawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	sawa@surg1.med.osaka-u.ac.jp					Alegria-Barrero E, 2012, CARDIOVASC REVASC ME, V13, pe5; Grube E, 2007, J AM COLL CARDIOL, V50, P69, DOI 10.1016/j.jacc.2007.04.047; Elhmidi Y, 2011, AM HEART J, V161, P735, DOI 10.1016/j.ahj.2011.01.009; Webb JG, 2006, CIRCULATION, V113, P842, DOI 10.1161/CIRCULATIONAHA.105.582882; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Bruschi G, 2011, EUR J CARDIO-THORAC, V39, pE151, DOI 10.1016/j.ejcts.2011.01.014; Bartel T, 2011, J AM SOC ECHOCARDIOG, V24, P966, DOI 10.1016/j.echo.2011.04.009; Eide KR, 2009, EUR J VASC ENDOVASC, V37, P23, DOI 10.1016/j.ejvs.2008.09.017; Webb JG, 2007, CIRCULATION, V116, P755, DOI 10.1161/CIRCULATIONAHA.107.698258; Suh WM, 2010, CATHETER CARDIO INTE, V76, P616, DOI 10.1002/ccd.22609; Fraccaro C, 2009, JACC-CARDIOVASC INTE, V2, P828, DOI 10.1016/j.jcin.2009.06.016; Piazza N, 2008, JACC-CARDIOVASC INTE, V1, P310, DOI 10.1016/j.jcin.2008.04.007; Bagur R, 2010, EUR HEART J, V31, P865, DOI 10.1093/eurheartj/ehp552; Himbert D, 2010, EUR HEART J, V31, P2995, DOI 10.1093/eurheartj/ehq301; Khawaja MZ, 2011, CIRCULATION, V123, P951, DOI 10.1161/CIRCULATIONAHA.109.927152; Kvidal P, 2000, J AM COLL CARDIOL, V35, P747, DOI 10.1016/S0735-1097(99)00584-7; Gurvitch R, 2011, CATHETER CARDIO INTE, V77, P439, DOI 10.1002/ccd.22861; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630; LUND O, 1990, CIRCULATION, V82, P124; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; SCHWARZ F, 1982, CIRCULATION, V66, P1105; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; Ye J, 2006, J THORAC CARDIOV SUR, V131, P1194, DOI 10.1016/j.jtcvs.2006.01.026; Grube E, 2006, CIRCULATION, V114, P1616, DOI 10.1161/CIRCULATIONAHA.106.639450; Chevreul K, 2013, ARCH CARDIOVASC DIS, V106, P209, DOI 10.1016/j.acvd.2013.01.006; Ye J, 2007, EUR J CARDIO-THORAC, V31, P16, DOI 10.1016/j.ejcts.2006.10.023; Tay ELW, 2011, JACC-CARDIOVASC INTE, V4, P228, DOI 10.1016/j.jcin.2010.10.010; Murayama Y, 2011, NEUROSURGERY, V68, P1427, DOI 10.1227/NEU.0b013e31820b4f1c; Sinhal A, 2008, JACC-CARDIOVASC INTE, V1, P305, DOI 10.1016/j.jcin.2007.12.009; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Bouma BJ, 1999, HEART, V82, P143; Lester SJ, 1998, CHEST, V113, P1109, DOI 10.1378/chest.113.4.1109; Petronio AS, 2010, CIRC-CARDIOVASC INTE, V3, P359, DOI 10.1161/CIRCINTERVENTIONS.109.930453; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Connolly HM, 1997, CIRCULATION, V95, P2395; Cribier A, 2004, J AM COLL CARDIOL, V43, P698, DOI 10.1016/j.jacc.2003.11.026; Fairbairn TA, 2013, HEART, V99, P914, DOI 10.1136/heartjnl-2013-303722; Lichtenstein SV, 2006, CIRCULATION, V114, P591, DOI 10.1161/CIRCULATIONAHA.106.632927; Varadarajan P, 2006, ANN THORAC SURG, V82, P2111, DOI 10.1016/j.athoracsur.2006.07.048; Abdel-Wahab M, 2011, HEART, V97, P899, DOI 10.1136/hrt.2010.217158; Asgar AW, 2009, J THORAC CARDIOV SUR, V137, P773, DOI 10.1016/j.jtcvs.2007.12.084; Bauernschmitt R, 2009, HEART SURG FORUM, V12, pE63, DOI 10.1532/HSF98.20081112; Biasi L, 2008, EUR J CARDIO-THORAC, V34, P1251, DOI 10.1016/j.ejcts.2008.09.013; Bojara W, 2009, CLIN RES CARDIOL, V98, P201, DOI 10.1007/s00392-009-0750-5; Bruschi G, 2010, J THORAC CARDIOV SUR, V140, P715, DOI 10.1016/j.jtcvs.2010.02.030; D'Ancona G, 2012, INTERACT CARDIOV TH, V14, P426, DOI 10.1093/icvts/ivr095; Hanzel GS, 2005, CATHETER CARDIO INTE, V64, P322, DOI 10.1002/ccd.20299; Hayashida K, 2012, CATHETER CARDIOVASC, V82, pE742; Himbert D, 2011, EUROINTERVENTION, V6, P784, DOI 10.4244/EIJV6I6A133; Holzhey David M, 2012, Ann Cardiothorac Surg, V1, P240, DOI 10.3978/j.issn.2225-319X.2012.07.03; Jilaihawi H, 2010, JACC-CARDIOVASC INTE, V3, P859, DOI 10.1016/j.jcin.2010.05.015; Kempfert J, 2009, ANN THORAC SURG, V88, P2041, DOI 10.1016/j.athoracsur.2009.01.029; MURPHY ES, 1981, CIRCULATION, V64, P184; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Ross Jr J, 1968, CIRCULATION S5, V38, P61; Ruge H, 2008, HEART SURG FORUM, V11, pE323, DOI 10.1532/HSF98.20081021; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; U. S. Census Bureau, 2004, US INT PROJ AG SEX R; Unbehaun A, 2011, J THORAC CARDIOVASC, V143, P1356; Ussia GP, 2010, CATHETER CARDIO INTE, V76, P757, DOI 10.1002/ccd.22602	63	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					527	536		10.1007/s00595-014-0902-8		10	Surgery	Surgery	CF7GS	WOS:000352724900001		
J	Yamazaki, M; Yasuda, H; Koda, K				Yamazaki, Masato; Yasuda, Hideki; Koda, Keiji			Single-incision laparoscopic cholecystectomy: a systematic review of methodology and outcomes	SURGERY TODAY			English	Review						SILC; Methodology; Complication; Operative procedure; Minimally invasive surgery	PORT-ACCESS CHOLECYSTECTOMY; NEEDLESCOPIC CHOLECYSTECTOMY; MULTIPORT CHOLECYSTECTOMY; EARLY EXPERIENCE; SURGERY; METAANALYSIS; GALLBLADDER; INSTRUMENTS; TRIALS; SILC	Purpose (1) To survey the dissemination of SILC; (2) to determine which SILC method has become mainstream; (3) to determine whether the characteristic complications vary according to the type of procedure. Methods An electronic search of PubMed, Databases@Ovid, and SciVerse Scopus between 2003/01/01 and 2012/12/31 was performed. Results The peak number of annually published articles was 70 in 2011. The most common procedures were single skin incision, the use of a SILS Port(A (R)), suture suspension and a 5-mm oblique scope. The intraoperative complications rate was 1.69 %. Postoperative complications occurred in 213/5283 cases. According to the surgical procedure, five factors (approach; P = 0.0017, gallbladder anchorage; P < 0.001, size; P = 0.049 and type; P < 0.001 of the scope, and size of the clip applier; P = 0.074) significantly affected the incidence of wound infection. The incidence of wound seroma/bleeding was significantly influenced by gallbladder anchorage (P = 0.009), the use of curved/articulated instruments (P = 0.048), and the diameter of the clip applier (P < 0.001). Conclusion To determine the best operative procedure for SILC, an analysis of uniform operative procedures is needed.	[Yamazaki, Masato; Koda, Keiji] Teikyo Univ, Chiba Med Ctr, Dept Surg, Ichihara, Chiba 2990111, Japan; [Yasuda, Hideki] Teikyo Heisei Univ, Fac Reg Hlth Therapy, Ichihara, Chiba 2990111, Japan	Yamazaki, M (reprint author), Teikyo Univ, Chiba Med Ctr, Dept Surg, 3426-3 Anesaki, Ichihara, Chiba 2990111, Japan.	greatyamazaki@hotmail.com					Allemann P, 2010, BRIT J SURG, V97, P1476, DOI 10.1002/bjs.7189; Leung D, 2012, J AM COLL SURGEONS, V215, P702, DOI 10.1016/j.jamcollsurg.2012.05.038; Sasaki K, 2012, WORLD J GASTROENTERO, V18, P944, DOI 10.3748/wjg.v18.i9.944; Jacob D, 2011, HEPATOB PANCREAT DIS, V10, P521, DOI 10.1016/S1499-3872(11)60088-X; Erbella J, 2010, SURG ENDOSC, V24, P1958, DOI 10.1007/s00464-010-0886-4; Joseph M, 2012, ANN SURG, V256, P1, DOI 10.1097/SLA.0b013e3182583fde; Bignell M, 2011, SURG ENDOSC, V25, P2574, DOI 10.1007/s00464-011-1589-1; Gill IS, 2010, SURG ENDOSC, V24, P762, DOI 10.1007/s00464-009-0688-8; Catarci M, 2001, SURG ENDOSC-ULTRAS, V15, P566, DOI 10.1007/s004640000381; Sajid MS, 2012, WORLD J SURG, V36, P2644, DOI 10.1007/s00268-012-1719-5; Podolsky ER, 2010, SURG ENDOSC, V24, P3038, DOI 10.1007/s00464-010-1081-3; Pisanu A, 2012, J GASTROINTEST SURG, V16, P1790, DOI 10.1007/s11605-012-1956-9; Pfluke JM, 2011, J AM COLL SURGEONS, V212, P113, DOI 10.1016/j.jamcollsurg.2010.09.008; Markar SR, 2012, SURG ENDOSC, V26, P1205, DOI 10.1007/s00464-011-2051-0; Gangl O, 2011, LANGENBECK ARCH SURG, V396, P819, DOI 10.1007/s00423-011-0817-4; Hall TC, 2012, ARCH SURG-CHICAGO, V147, P657, DOI 10.1001/archsurg.2012.814; Trastulli S, 2013, BRIT J SURG, V100, P191, DOI 10.1002/bjs.8937; Lee PC, 2004, SURG ENDOSC, V18, P1480, DOI 10.1007/s00464-003-8247-1; Khambaty F, 2011, WORLD J SURG, V35, P967, DOI 10.1007/s00268-011-0998-6; Cantore Fabrizio, 2011, Updates Surg, V63, P31, DOI 10.1007/s13304-011-0046-y; Chang SKY, 2012, SINGAP MED J, V53, P377; Dapri Giovanni, 2010, Surg Technol Int, V20, P21; Dominguez G, 2009, SURG ENDOSC, V23, P1660, DOI 10.1007/s00464-009-0504-5; Garcia-Henriquez N, 2011, J LAPAROENDOSC ADV S, V21, P555, DOI 10.1089/lap.2010.0512; Grau-Talens EJ, 2010, ENDOSCOPY, V42, P395, DOI 10.1055/s-0029-1243860; Han HJ, 2011, ARCH SURG-CHICAGO, V146, P68, DOI 10.1001/archsurg.2010.287; Hawasli A, 2010, AM J SURG, V199, P289, DOI 10.1016/j.amjsurg.2009.08.037; Keus F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-80; Leggett PL, 2001, SURG ENDOSC-ULTRAS, V15, P293, DOI 10.1007/s004640000302; Muhe E, 1986, LANGENBECKS ARCH CHI, V369, P804, DOI 10.1007/BF01274615; Navarra G, 1997, BRIT J SURG, V84, P695, DOI 10.1002/bjs.1800840536; Noguera JF, 2013, SURG INNOV, V20, P256, DOI 10.1177/1553350612451355; Ramachandran CS, 1998, J LAPAROENDOSC ADV A, V8, P303, DOI 10.1089/lap.1998.8.303; Rosemurgy AS, 2010, DIAGN THER ENDOSC, DOI [10.1155/2010/943091, DOI 10.1155/2010/943091]; Rupp CC, 2011, AM SURGEON, V77, P916; Sinan H, 2012, SURG LAPARO ENDO PER, V22, P12, DOI 10.1097/SLE.0b013e3182402448; Sinha R, 2011, J LAPAROENDOSC ADV S, V21, P497, DOI 10.1089/lap.2010.0435; Sodergren M, 2013, J GASTROINTEST SURG, V17, P567; Tagaya N, 2011, J HEPATO-BIL-PAN SCI, V18, P516, DOI 10.1007/s00534-011-0398-1; Tanaka J, 1998, SURG TODAY, V28, P111; Wong Jeff S. W., 2011, Hong Kong Medical Journal, V17, P465; Yin HL, 2011, SURG INNOV, V18, P289, DOI 10.1177/1553350611401428	42	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					537	548		10.1007/s00595-014-0908-2		12	Surgery	Surgery	CF7GS	WOS:000352724900002		
J	Okabe, H; Tsunoda, S; Tanaka, E; Hisamori, S; Kawada, H; Sakai, Y				Okabe, Hiroshi; Tsunoda, Shigeru; Tanaka, Eiji; Hisamori, Shigeo; Kawada, Hironori; Sakai, Yoshiharu			Is laparoscopic total gastrectomy a safe operation? A review of various anastomotic techniques and their outcomes	SURGERY TODAY			English	Review						Laparoscopic surgery; Total gastrectomy; Esophagojejunostomy	ASSISTED TOTAL GASTRECTOMY; ADVANCED GASTRIC-CANCER; PURSE-STRING SUTURE; OPEN DISTAL GASTRECTOMY; INTRACORPOREAL ESOPHAGOJEJUNOSTOMY; STAPLING TECHNIQUE; SURGICAL OUTCOMES; NODAL DISSECTION; CIRCULAR STAPLER; HAND-SEWN	Laparoscopic distal gastrectomy is an accepted option for gastric cancer surgery; however, laparoscopic total gastrectomy (LTG) is not widely performed. There is concern about the safety of the operation due to the difficulty of extracorporeal reconstruction through a mini-laparotomy. Efforts have been made to establish an intracorporeal anastomotic technique for esophagojejunostomy. This article reviews the current techniques available for laparoscopic esophagojejunostomy and their surgical outcomes. Several different techniques using either circular or linear staplers have been reported; however, the apparent superiority of any particular method has not been confirmed. The incidence of anastomosis-related complications varied among studies, but different techniques all successfully achieved excellent outcomes. The overall complication rate of LTG was similar to that of open total gastrectomy, suggesting that LTG is a safe and feasible option. However, the feasibility of LTG with D2 lymph node dissection for advanced upper gastric cancer needs to be confirmed in further studies, because most of the patients included in the LTG studies were diagnosed with early stages of disease.	[Okabe, Hiroshi; Tsunoda, Shigeru; Tanaka, Eiji; Hisamori, Shigeo; Kawada, Hironori; Sakai, Yoshiharu] Kyoto Univ Grad Sch Med, Dept Surg, Sakyo Ku, Kyoto 6068507, Japan; [Okabe, Hiroshi; Tsunoda, Shigeru; Tanaka, Eiji; Hisamori, Shigeo; Kawada, Hironori; Sakai, Yoshiharu] Kyoto Univ, Grad Sch Med, Dept Surg, Sakyo Ku, Kyoto 6068507, Japan	Okabe, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	hokabe@kuhp.kyoto-u.ac.jp					Wada N, 2014, GASTRIC CANCER, V17, P137, DOI 10.1007/s10120-013-0235-0; Zuiki T, 2013, SURG ENDOSC, V27, P3683, DOI 10.1007/s00464-013-2945-0; Nunobe S, 2011, J GASTROINTEST SURG, V15, P1520, DOI 10.1007/s11605-011-1489-7; Nakamura K, 2013, JPN J CLIN ONCOL, V43, P324, DOI 10.1093/jjco/hys220; Lee MS, 2013, SURG ENDOSC, V27, P2598, DOI 10.1007/s00464-013-2796-8; Sierzega M, 2010, BRIT J SURG, V97, P1035, DOI 10.1002/bjs.7038; Katai H, 1998, JPN J CLIN ONCOL, V28, P112, DOI 10.1093/jjco/28.2.112; Okabe H, 2014, ANN SURG, V259, P109, DOI 10.1097/SLA.0b013e31828dfa5d; Jeong GA, 2009, SURGERY, V146, P469, DOI 10.1016/j.surg.2009.03.023; Sakuramoto S, 2009, SURG ENDOSC, V23, P2416, DOI 10.1007/s00464-009-0371-0; Kunisaki C, 2011, SURG ENDOSC, V25, P1300, DOI 10.1007/s00464-010-1367-5; Bo T, 2013, J GASTROINTEST SURG, V17, P1202, DOI 10.1007/s11605-013-2218-1; Eom BW, 2012, EJSO-EUR J SURG ONC, V38, P57, DOI 10.1016/j.ejso.2011.09.006; Lee SE, 2009, J SURG ONCOL, V100, P392, DOI 10.1002/jso.21345; STEICHEN FM, 1968, SURGERY, V64, P948; Katai H, 2010, GASTRIC CANCER, V13, P238, DOI 10.1007/s10120-010-0565-0; Shinohara T, 2009, ARCH SURG-CHICAGO, V144, P1138, DOI 10.1001/archsurg.2009.223; Haverkamp L, 2013, SURG ENDOSC, V27, P1509, DOI 10.1007/s00464-012-2661-1; Kinoshita T, 2010, SURG ENDOSC, V24, P2908, DOI 10.1007/s00464-010-1041-y; Lee JH, 2012, WORLD J SURG, V36, P2394, DOI 10.1007/s00268-012-1669-y; Cai J, 2011, DIGEST SURG, V28, P331, DOI 10.1159/000330782; Sakuramoto S, 2010, SURGERY, V147, P742, DOI 10.1016/j.surg.2009.06.016; Usui S, 2008, GASTRIC CANCER, V11, P233, DOI 10.1007/s10120-008-0481-8; Kim MG, 2011, J KOREAN SURG SOC, V80, P245, DOI 10.4174/jkss.2011.80.4.245; Kim KM, 2012, BRIT J SURG, V99, P1681, DOI 10.1002/bjs.8924; Vinuela EF, 2012, ANN SURG, V255, P446, DOI 10.1097/SLA.0b013e31824682f4; Nagai E, 2013, SURGERY, V153, P732, DOI 10.1016/j.surg.2012.10.012; Bracale U, 2010, SURG ENDOSC, V24, P2475, DOI 10.1007/s00464-010-0988-z; Lang H, 2000, EUR J SURG ONCOL, V26, P168, DOI 10.1053/ejso.1999.0764; Okabe H, 2009, SURG ENDOSC, V23, P2167, DOI 10.1007/s00464-008-9987-8; Jeong O, 2009, SURG ENDOSC, V23, P2624, DOI 10.1007/s00464-009-0461-z; Kim HH, 2010, ANN SURG, V251, P417, DOI 10.1097/SLA.0b013e3181cc8f6b; Azagra JS, 1999, SURG ENDOSC-ULTRAS, V13, P351, DOI 10.1007/s004649900988; Campos GM, 2010, EUR J CARDIO-THORAC, V37, P1421, DOI 10.1016/j.ejcts.2010.01.010; Deguchi Y, 2012, WORLD J SURG, V36, P1617, DOI 10.1007/s00268-012-1559-3; Ebihara Y, 2013, LANGENBECK ARCH SURG, V398, P475, DOI 10.1007/s00423-013-1051-z; Facy O, 2012, J VISC SURG, V149, pE179, DOI 10.1016/j.jviscsurg.2012.04.009; Fukagawa T, 2010, WORLD J SURG, V34, P1859, DOI 10.1007/s00268-010-0609-y; Goh PMY, 1997, SURG ENDOSC-ULTRAS, V11, P650, DOI 10.1007/s004649900413; Inaba K, 2010, J AM COLL SURGEONS, V211, pE25, DOI 10.1016/j.jamcollsurg.2010.09.005; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jeong O, 2012, SURG ENDOSC, V26, P3418, DOI 10.1007/s00464-012-2356-7; Kasakura Y, 2000, AM J SURG, V179, P237, DOI 10.1016/S0002-9610(00)00293-2; Kim HI, 2013, J AM COLL SURGEONS, V216, pE11, DOI 10.1016/j.jamcollsurg.2012.10.008; Kim HS, 2012, J LAPAROENDOSC ADV S, V22, P889, DOI 10.1089/lap.2012.0238; KITANO S, 1994, SURG LAPAROSC ENDOSC, V4, P146; Omori Takeshi, 2009, Am J Surg, V197, pe13, DOI 10.1016/j.amjsurg.2008.04.019; Otsuji E, 1999, BRIT J CANCER, V79, P1789, DOI 10.1038/sj.bjc.6690285; Sano T, 2010, J CLIN ONCOL, V28, P4020; So Kwang Oh, 2011, J Gastric Cancer, V11, P206, DOI 10.5230/jgc.2011.11.4.206; Takeyoshi I, 2000, HEPATO-GASTROENTEROL, V47, P1026; Tsunoda S, 2014, SURG TODAY, V44, P271, DOI 10.1007/s00595-013-0533-5; Uyama I, 1999, GASTRIC CANCER, V2, P230, DOI DOI 10.1007/S101209900041	53	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					549	558		10.1007/s00595-014-0901-9		10	Surgery	Surgery	CF7GS	WOS:000352724900003		
J	Tani, M; Kawai, M; Okada, K; Hirono, S; Hotta, T; Takifuji, K; Yamaue, H				Tani, Masaji; Kawai, Manabu; Okada, Ken-ichi; Hirono, Seiko; Hotta, Tsukasa; Takifuji, Katsunari; Yamaue, Hiroki			Evaluation of the health-related quality of life for patients following laparoscopic cholecystectomy	SURGERY TODAY			English	Article						Laparoscopic cholecystectomy; SF-8; HRQOL; VAS	RANDOMIZED CONTROLLED-TRIAL; DAY-SURGERY; MINILAPAROTOMY	Purpose Laparoscopic cholecystectomy (LC) has become the standard procedure, and contributes to a shorter hospital stay. However, there have been no reports regarding when the patients can be discharged in terms of their health-related quality of life (HRQOL). Methods The HRQOL was evaluated by using the SF-8 health survey (SF-8) 24-hour version in 127 consecutive patients treated from May 2007 to December 2008. The HRQOL and a visual analogue scale (VAS) score were assessed on the day before surgery and on postoperative day (POD) 1, POD2 and POD7. Results All scores of the eight domains on POD1 were significantly decreased compared to the preoperative score (P < 0.05), and seven scores were still decreased on POD2, with the mental health (MH) domain showing an improvement. On POD7, the general health score improved to the preoperative level. The physical component summary 8 (PCS-8) was suppressed for all 7 days after LC. The mental health component summary 8 (MCS-8) was improved to the preoperative level on POD2, despite the significant suppression observed on POD1 (P < 0.05). The VAS score was higher in the low PCS-8 (PCS-8 < 42.4) and low MCS-8 (MCS-8 < 40.6) patients than in the high PCS-8 and high MCS-8 patients. Conclusion The HRQOL score demonstrated the improvement of the MCS-8 on POD2, which might suggest that a discharge of LC patients is appropriate on POD2 in terms of the patients' point of view.	[Tani, Masaji; Kawai, Manabu; Okada, Ken-ichi; Hirono, Seiko; Hotta, Tsukasa; Takifuji, Katsunari; Yamaue, Hiroki] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama 6418510, Japan	Yamaue, H (reprint author), Wakayama Med Univ, Sch Med, Dept Surg 2, 811-1 Kimiidera, Wakayama 6418510, Japan.	yamaue-h@wakayama-med.ac.jp					Abd Ellatif ME, 2013, SURG ENDOSC, V27, P1896, DOI 10.1007/s00464-012-2625-5; Wills VL, 2000, BRIT J SURG, V87, P273, DOI 10.1046/j.1365-2168.2000.01374.x; Psaila J, 2008, WORLD J SURG, V32, P76, DOI 10.1007/s00268-007-9225-x; Uchiyama K, 2007, J HEPATO-BILIARY-PAN, V14, P551, DOI 10.1007/s00534-007-1221-x; Turner-Bowker DM, 2003, QUAL LIFE RES, V12, P1003; Harju J, 2010, SCAND J SURG, V99, P132; Petersen MA, 2006, EUR J CANCER, V42, P1159, DOI 10.1016/j.ejca.2006.01.032; MCMAHON AJ, 1994, LANCET, V343, P135, DOI 10.1016/S0140-6736(94)90932-6; Uchiyama K, 2002, SURG ENDOSC, V16, P1594, DOI 10.1007/s00464-002-9018-0; Ros A, 2001, ANN SURG, V234, P741, DOI 10.1097/00000658-200112000-00005; Liu SS, 2007, ANESTH ANALG, V105, P789, DOI 10.1213/01.ane.0000278089.16848.1e; BARKUN JS, 1992, LANCET, V340, P1116, DOI 10.1016/0140-6736(92)93148-G; Fukuhara S, 2004, MANUAL SF 8 JAP VERS; Marinis Athanasios, 2010, BMC Res Notes, V3, P207, DOI 10.1186/1756-0500-3-207; Uchiyama K, 2004, HEPATO-GASTROENTEROL, V51, P346; Shimozuma K, 2009, SUPPORT CARE CANCER, V20, P3355; Suzukamo Yoshimi, 2005, Health Qual Life Outcomes, V3, P65, DOI 10.1186/1477-7525-3-65; Uchiyama K, 2003, DIGEST DIS SCI, V48, P1955, DOI 10.1023/A:1026114203622; Uchiyama K, 2006, SURG ENDOSC, V20, P1119, DOI 10.1007/s00464-005-0689-1	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					564	568		10.1007/s00595-014-0938-9		5	Surgery	Surgery	CF7GS	WOS:000352724900005		
J	Hirosawa, T; Itabashi, M; Ohnuki, T; Yamaguchi, N; Sugihara, K; Kameoka, S				Hirosawa, Tomoichiro; Itabashi, Michio; Ohnuki, Takamasa; Yamaguchi, Naoto; Sugihara, Kenichi; Kameoka, Shingo			Proposal of a new prognostic staging system for pulmonary metastases from colorectal cancer	SURGERY TODAY			English	Article						Colorectal cancer; Lung metastases; Prognostic staging system	COMPLETE RESECTION; LUNG METASTASES; FOLLOW-UP; CARCINOMA; SURVIVAL; OUTCOMES	Purpose The aim of this retrospective study was to establish a new prognostic staging system for pulmonary metastases from colorectal carcinoma (CRC). Methods The baseline characteristics and outcomes on 352 CRC patients who underwent complete pulmonary resection were collected from 19 institutions by the Japanese Society for Cancer of the Colon and Rectum (JSCCR) Study Group (group A). The clinical and pathological factors were entered into a multivariate analysis to identify independent variables that were helpful for accurately predicting the long-term prognosis after pulmonary resection. Using the selected variables in group A, we developed a new prognostic staging system (PSS). The new PSS was examined in a validation study in a series of 841 patients from 110 institutions of the JSCCR by the 78th society of the JSCCR (group B). Results We evaluated four variables selected in the multivariate analysis: the number of pulmonary metastases, the distribution, the disease-free interval and the lymph node metastases of primary cancer in group A. Using these four variables, we developed a new PSS. This PSS was found to significantly predict the prognosis in group B. Conclusions Our new PSS was useful for the selection of patients suitable for pulmonary resection.	[Hirosawa, Tomoichiro; Itabashi, Michio; Kameoka, Shingo] Tokyo Womens Med Univ, Dept Surg 2, Shinjuku Ku, Tokyo 1628666, Japan; [Ohnuki, Takamasa] Tokyo Womens Med Univ, Dept Thorac Surg, Tokyo 1628666, Japan; [Yamaguchi, Naoto] Tokyo Womens Med Univ, Dept Hyg & Publ Hlth 2, Div Publ Hlth, Tokyo 1628666, Japan; [Sugihara, Kenichi] Tokyo Med & Dent Univ, Grad Sch, Dept Surg Oncol, Tokyo, Japan	Hirosawa, T (reprint author), Tokyo Womens Med Univ, Dept Surg 2, Shinjuku Ku, 8-1 Kawadacho, Tokyo 1628666, Japan.	hirosawa@surg2.twmu.ac.jp; itabashi@surg2.twmu.ac.jp					Adam R, 2011, ANN SURG, V253, P349, DOI 10.1097/SLA.0b013e318207bf2c; Melloni G, 2006, ANN THORAC SURG, V81, P2008, DOI 10.1016/j.athoracsur.2006.01.007; Lin BR, 2009, ANN SURG ONCOL, V16, P1026, DOI 10.1245/s10434-008-0286-3; Fiorentino F, 2010, J ROY SOC MED, V103, P60, DOI 10.1258/jrsm.2009.090299; Miller G, 2007, J AM COLL SURGEONS, V205, P231, DOI 10.1016/j.jamcollsurg.2007.04.039; Shiono S, 2005, ANN THORAC SURG, V79, P278, DOI 10.1016/j.athoracsur.2004.06.096; Watanabe K, 2009, BRIT J SURG, V96, P1058, DOI 10.1002/bjs.6682; Pfannschmidt J, 2007, ANN THORAC SURG, V84, P324, DOI 10.1016/j.athoracsur.2007.02.093; Saito Y, 2002, J THORAC CARDIOV SUR, V124, P1007, DOI 10.1067/mtc.2002.125165; Onaitis MW, 2009, ANN THORAC SURG, V87, P1684, DOI 10.1016/j.athoracsur.2009.03.034; Welter S, 2007, ANN THORAC SURG, V84, P203, DOI 10.1016/j.athoracsur.2007.03.028; Takahashi S, 2007, JPN J CLIN ONCOL, V37, P186, DOI 10.1093/jjco/hym006; Chen FS, 2009, WORLD J SURG, V33, P505, DOI 10.1007/s00268-008-9875-3; Hirosawa T, 2013, SURG TODAY, V43, P494, DOI 10.1007/s00595-012-0373-8; Ike H, 2002, DIS COLON RECTUM, V45, P468, DOI 10.1007/s10350-004-6222-0; Japanese Society for Cancer of the Colon and Rectum, 2009, JAP CLASS COL CARC; Lee WS, 2008, J GASTROEN HEPATOL, V23, pE367, DOI 10.1111/j.1440-1746.2007.05178.x; Pfannschmidt J, 2010, J THORAC ONCOL S2, V5, P172; The Japanese Society for Cancer of the Colon and Rectum, 2005, TREATM GUID COL CANC; The Japanese Society for Cancer of the Colon and Rectum, 2013, JAP CLASS COL CARC	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					576	584		10.1007/s00595-014-0986-1		9	Surgery	Surgery	CF7GS	WOS:000352724900007		
J	Tsuboshima, K; Wakahara, T; Matoba, Y; Miyauchi, H; Hayashi, C; Kobayashi, I; Oue, H; Watanabe, Y; Ono, T; Maniwa, Y				Tsuboshima, Kenji; Wakahara, Teppei; Matoba, Yasumi; Miyauchi, Harunori; Hayashi, Chikako; Kobayashi, Iwao; Oue, Hiroaki; Watanabe, Yoshihisa; Ono, Toru; Maniwa, Yoshimasa			Single-incision thoracoscopic surgery using a chest wall pulley for lung excision in patients with primary spontaneous pneumothorax	SURGERY TODAY			English	Article						Single-incision thoracoscopic surgery; SITS; Chest wall pulley; PulLE; Primary spontaneous pneumothorax; PSP		Purpose The aim of the study was to evaluate the feasibility and compare the outcomes of single-incision thoracoscopic surgery using a chest wall pulley for lung excision (PulLE) vs. those of conventional video-assisted thoracic surgery (cVATS) in patients with primary spontaneous pneumothorax (PSP). Methods Sixty-nine patients who underwent PulLE (n = 34) or cVATS (n = 35) between January 2009 and December 2013 were enrolled in this study. PulLE was performed as follows. After making a 17- to 25-mm single incision in the 6th intercostal space (6ICS) at the median axillary line, the visceral pleura near the bulla was sutured for traction. The parietal pleura at 3ICS was then sutured from the thoracic cavity to serve as the chest wall pulley and a traction thread was passed through the pulley. By manipulating the traction thread, it was possible to move the lesion to an arbitrary site for excision. The postoperative scar was nearly invisible. Results The operative time, duration of postoperative drainage, and postoperative hospital stay were equivalent for PulLE vs. cVATS. There was no significant difference in postoperative recurrence rates. Conclusions PulLE has cosmetic benefits over cVATS and is easy to perform. We believe our novel procedure has the potential to become the standard operative treatment for PSP.	[Tsuboshima, Kenji; Wakahara, Teppei; Matoba, Yasumi] Takasago Municipal Hosp, Dept Thorac Surg, Takasago, Hyogo 6768585, Japan; [Miyauchi, Harunori; Hayashi, Chikako; Kobayashi, Iwao; Oue, Hiroaki; Watanabe, Yoshihisa; Ono, Toru] Takasago Municipal Hosp, Dept Gen Surg, Takasago, Hyogo 6768585, Japan; [Maniwa, Yoshimasa] Kobe Univ, Grad Sch Med, Div Thorac Surg, Kobe, Hyogo 657, Japan	Tsuboshima, K (reprint author), Takasago Municipal Hosp, Dept Thorac Surg, 33-1 Kamimachi, Takasago, Hyogo 6768585, Japan.	drniwatori@smn.enjoy.ne.jp					Rocco G, 2004, ANN THORAC SURG, V77, P726, DOI 10.1016/S0003-4975(03)01219-0; Berlanga LA, 2010, SURG ENDOSC, V25, P2044; Chen PR, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-58; Ichinose J, 2010, Kyobu Geka, V63, P371; Salati Michele, 2008, Interact Cardiovasc Thorac Surg, V7, P63, DOI 10.1510/icvts.2007.165712; Tsuboshima Kenji, 2013, Kyobu Geka, V66, P210; Yamamoto H, 1998, ARCH SURG-CHICAGO, V133, P145, DOI 10.1001/archsurg.133.2.145	7	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					595	599		10.1007/s00595-014-0992-3		5	Surgery	Surgery	CF7GS	WOS:000352724900009		
J	Beppu, N; Matsubara, N; Noda, M; Kimura, F; Yamanaka, N; Yanagi, H; Tomita, N				Beppu, Naohito; Matsubara, Nagahide; Noda, Masashi; Kimura, Fumihiko; Yamanaka, Naoki; Yanagi, Hidenori; Tomita, Naohiro			A'high tie'confers an increased risk of anastomotic leakage for lower rectal cancer surgery in patients treated with preoperative radiotherapy	SURGERY TODAY			English	Article						Rectal cancer; High tie; Preoperative radiotherapy	INFERIOR MESENTERIC-ARTERY; SIGMOID COLON; INTERSPHINCTERIC RESECTION; ANTERIOR RESECTION; HIGH LIGATION; BLOOD-FLOW; RADIATION; BENEFIT; SKIN	Purpose This study aimed at analyzing retrospectively the risk factors for anastomotic leakage for lower rectal cancer treated with preoperative radiotherapy. Methods The subjects were 108 patients with T3 lower rectal cancer, who underwent curative resection following preoperative radiotherapy. All patients had a diverting stoma made. Univariate and multivariate analyses were conducted for the independent clinical variables. Results Anastomotic leakage developed in 19 (17.6 %) patients. Univariate analysis of the risk factors for anastomotic leakage revealed that arterial ligation with a high tie (p = 0.001), undifferentiated tumor type (p = 0.002), a shorter distance from the anal verge (p = 0.086), and a longer hospital stay (p = 0.0002) were significant predictors of leakage. Multivariate analysis revealed that a high tie [hazard ratio 12.22 (95 % confidence interval 2.83-87.94); p = 0.0003], undifferentiated tumor type [91.15 (5.98-3128.03); p = 0.0008], and a long hospital stay [13.03 (2.86-104.93); p = 0.0004] were independently associated with anastomotic leakage. Conclusion Our data suggest that preoperative radiotherapy and a high tie for lower rectal cancer are independent risk factors for anastomotic leakage.	[Beppu, Naohito; Matsubara, Nagahide; Noda, Masashi; Tomita, Naohiro] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; [Kimura, Fumihiko; Yamanaka, Naoki; Yanagi, Hidenori] Meiwa Hosp, Dept Surg, Nishinomiya, Hyogo 6638186, Japan	Beppu, N (reprint author), Hyogo Coll Med, Dept Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	beppu-n@hyo-med.ac.jp					Rutegard M, 2012, BRIT J SURG, V99, P127, DOI 10.1002/bjs.7712; Seike K, 2007, INT J COLORECTAL DIS, V22, P689, DOI 10.1007/s00384-006-0221-7; Chamlou R, 2007, ANN SURG, V246, P916, DOI 10.1097/SLA.0b013e31815c29ff; Akasu T, 2007, J AM COLL SURGEONS, V205, P642, DOI 10.1016/j.jamcollsurg.2007.05.036; Buie WD, 2005, DIS COLON RECTUM, V48, P1868, DOI 10.1007/s10350-005-0154-1; Gerard JP, 2010, J CLIN ONCOL, V28, P1638, DOI 10.1200/JCO.2009.25.8376; Warschkow R, 2011, ANN SURG ONCOL, V18, P2772, DOI 10.1245/s10434-011-1696-1; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Doi H, 2013, J RADIAT RES, V54, P1118, DOI 10.1093/jrr/rrt058; Chin CC, 2008, INT J COLORECTAL DIS, V23, P783, DOI 10.1007/s00384-008-0465-5; Cirocchi R, 2012, SURG ONCOL, V21, P111; Dworkin MJ, 1996, J AM COLL SURGEONS, V183, P357; Gupta I, 2013, INT J ANAT VAR, V6, P13; HOPEWELL JW, 1990, INT J RADIAT BIOL, V57, P751, DOI 10.1080/09553009014550911; Japanese Society for Cancer of the Colon and Rectum, 2006, GEN RUL CLIN PATH ST; Kanemitsu Y, 2006, BRIT J SURG, V93, P609, DOI 10.1002/bjs.5327; Lyall A, 2007, COLORECTAL DIS, V9, P801, DOI 10.1111/j.1463-1318.2006.01197.x; MOORE MJ, 1984, OTOLARYNG CLIN N AM, V17, P389; RUDOLPH R, 1982, ANN PLAS SURG, V9, P282, DOI 10.1097/00000637-198210000-00003; Sekimoto M, 2011, SURG ENDOSC, V25, P861, DOI 10.1007/s00464-010-1284-7; Walker TG, 2009, INTERVENT RADIOL, V26, P167; Wang L, 2010, WORLD J SURG, V34, P1080, DOI 10.1007/s00268-010-0449-9	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					600	605		10.1007/s00595-014-1022-1		6	Surgery	Surgery	CF7GS	WOS:000352724900010		
J	Wakasugi, M; Masuzawa, T; Tei, M; Omori, T; Ueshima, S; Tori, M; Akamatsu, H				Wakasugi, Masaki; Masuzawa, Toru; Tei, Mitsuyoshi; Omori, Takeshi; Ueshima, Shigeyuki; Tori, Masayuki; Akamatsu, Hiroki			Single-incision totally extraperitoneal inguinal hernia repair: our initial 100 cases and comparison with conventional three-port laparoscopic totally extraperitoneal inguinal hernia repair	SURGERY TODAY			English	Article						Single-incision laparoscopic surgery (SILS); Totally extraperitoneal repair (TEP); Inguinal hernia	TRIAL; PREPERITONEAL; HERNIOPLASTY; OUTCOMES	Purpose To compare the outcomes of single-incision laparoscopic surgery for totally extraperitoneal inguinal hernia repair (SILS-TEP) and conventional three-port totally extraperitoneal (TEP) repair. Methods We performed a retrospective analysis of 137 patients (SILS-TEP, 100; conventional TEP, 37) scheduled to undergo elective inguinal hernia from January 2011 to July 2013 at Osaka Police Hospital. Results There were no significant differences in the patient demographics. There were no significant differences in the length of the operation between the two groups (SILS-TEP group, 93 min vs. conventional TEP group, 92 min for unilateral hernias, p = 0.8; SILS-TEP group, 142 min vs. conventional TEP, 128 min for bilateral hernias, p = 0.4). The postoperative hospital stay, total medical charge for the hospital stay and the numerical rating scale before and 3 months after surgery were comparable in both groups. Two cases treated by SILS-TEP repair were converted to conventional three-port TEP repair (one case) and mesh-plug method (one case). The postoperative complications were comparable in both groups, and these were managed conservatively. One recurrence (2 %, 1/37) developed in the conventional TEP group, compared with 0 recurrences (0/100) in the SILS-TEP group. Conclusions SILS-TEP repair seems to be safe and feasible, with no significant differences in the total medical charges for the hospital stay or the postoperative pain score 3 months after surgery compared with conventional three-port TEP repair.	[Wakasugi, Masaki; Masuzawa, Toru; Tei, Mitsuyoshi; Omori, Takeshi; Ueshima, Shigeyuki; Tori, Masayuki; Akamatsu, Hiroki] Osaka Police Hosp, Dept Surg, Ten Nouji Ku, Osaka 5430035, Japan	Wakasugi, M (reprint author), Osaka Police Hosp, Dept Surg, Ten Nouji Ku, 10-31 Kitayama Cho, Osaka 5430035, Japan.	wakasugi@oph.gr.jp					Tai HC, 2011, SURG ENDOSC, V25, P2879, DOI 10.1007/s00464-011-1636-y; Bittner R, 2011, SURG ENDOSC, V25, P2773, DOI 10.1007/s00464-011-1799-6; Choi YY, 2012, J KOREAN SURG SOC, V82, P40, DOI 10.4174/jkss.2012.82.1.40; Kugel RD, 1999, AM J SURG, V178, P298, DOI 10.1016/S0002-9610(99)00181-6; LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6; Gong K, 2011, SURG ENDOSC, V25, P234, DOI 10.1007/s00464-010-1165-0; Filipovic-Cugura J, 2009, SURG ENDOSC, V23, P920, DOI 10.1007/s00464-008-0318-x; Garg P, 2010, SURG ENDOSC, V24, P450, DOI 10.1007/s00464-009-0602-4; Hayashi Y, 2014, SURG TODAY; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim JH, 2013, WORLD J SURG, V37, P746, DOI 10.1007/s00268-013-1925-9; Nakagawa M, 2013, SURG TODAY, V43, P1109, DOI 10.1007/s00595-012-0384-5; Tsai YC, 2013, SURG ENDOSC, V27, P4684, DOI 10.1007/s00464-013-3116-z; Wakasugi M, 2013, SURG TODAY, V43, P942, DOI 10.1007/s00595-013-0567-8; Wakasugi Masaki, 2013, Asian J Endosc Surg, V6, P143, DOI 10.1111/ases.12011	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					606	610		10.1007/s00595-014-0967-4		5	Surgery	Surgery	CF7GS	WOS:000352724900011		
J	Aizawa, M; Nashimoto, A; Yabusaki, H; Nakagawa, S; Matsuki, A; Homma, K; Kawasaki, T				Aizawa, Masaki; Nashimoto, Atsushi; Yabusaki, Hiroshi; Nakagawa, Satoru; Matsuki, Atsushi; Homma, Keiichi; Kawasaki, Takashi			The clinical significance of potentially curative resection for gastric cancer following the clearance of free cancer cells in the peritoneal cavity by induction chemotherapy	SURGERY TODAY			English	Article						Gastric cancer; Positive peritoneal cytology; Induction chemotherapy; Multimodal therapy	PROGNOSTIC-SIGNIFICANCE; STAGING LAPAROSCOPY; WASHING CYTOLOGY; LAVAGE CYTOLOGY; CARCINOMA	Purpose The aim of this study was to evaluate the significance of the conversion of the peritoneal cytology from positive to negative following induction chemotherapy in relation to the prognosis after subsequent resection for gastric cancer. Methods This retrospective study was conducted using a prospectively maintained database. A total of 47 patients with free cancer cells in the peritoneal cavity, as evaluated by staging laparoscopy, but no other evidence of distant metastasis, who underwent induction chemotherapy followed by surgery were enrolled in the study. Then, the clinicopathological factors and survival in the study subjects were assessed. Results The median survival time and 5-year overall survival rate of the 47 study participants were 20.4 months and 25.0 %, respectively. In 23 of the patients, the peritoneal cytology converted from positive to negative after the induction chemotherapy, and a microscopically margin-negative gastrectomy was performed. The median survival time of 30.4 months and the 5-year survival rate of 34.6 % of these patients was significantly more favorable than the corresponding values of 15.0 months and 17.6 % in the patients who had persistently positive cytology (P = 0.03). Conclusion Based on our findings, the clearance of free cancer cells in the peritoneal cavity by induction chemotherapy improves the prognosis of patients following subsequent gastrectomy.	[Aizawa, Masaki; Nashimoto, Atsushi; Yabusaki, Hiroshi; Nakagawa, Satoru; Matsuki, Atsushi] Niigata Canc Ctr Hosp, Dept Digest Surg, Niigata 9518566, Japan; [Homma, Keiichi; Kawasaki, Takashi] Niigata Canc Ctr Hosp, Dept Pathol, Niigata 9518566, Japan	Aizawa, M (reprint author), Niigata Canc Ctr Hosp, Dept Digest Surg, 2-15-3 Kawagishicho, Niigata 9518566, Japan.	maizawa@niigata-cc.jp					La Torre M, 2010, EJSO-EUR J SURG ONC, V36, P982, DOI 10.1016/j.ejso.2010.06.007; Kodera Y, 2012, GASTRIC CANCER, V15, P335, DOI 10.1007/s10120-012-0156-3; Bonenkamp JJ, 1996, BRIT J SURG, V83, P672, DOI 10.1002/bjs.1800830526; Shimizu H, 2010, SURG TODAY, V40, P119, DOI 10.1007/s00595-009-4017-6; Nakagawa S, 2007, GASTRIC CANCER, V10, P29, DOI 10.1007/s10120-006-0406-3; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Bando E, 1999, AM J SURG, V178, P256, DOI 10.1016/S0002-9610(99)00162-2; Mezhir JJ, 2010, ANN SURG ONCOL, V17, P3173, DOI 10.1245/s10434-010-1183-0; Lee SD, 2012, BRIT J SURG, V99, P397, DOI 10.1002/bjs.7812; Bentrem D, 2005, ANN SURG ONCOL, V12, P347, DOI 10.1245/ASO.2005.03.065; Lowy AM, 1996, SURGERY, V119, P611, DOI 10.1016/S0039-6060(96)80184-X; Okabe H, 2009, ANN SURG ONCOL, V16, P3227, DOI 10.1245/s10434-009-0706-z; Lorenzen S, 2010, ANN SURG ONCOL, V17, P2733, DOI 10.1245/s10434-010-1090-4; Kuramoto M, 2009, ANN SURG, V250, P242, DOI 10.1097/SLA.0b013e3181b0c80e; Isobe Y, 2011, GASTRIC CANCER, V14, P301, DOI 10.1007/s10120-011-0085-6; Fujiwara Y, 2012, J SURG ONCOL, V105, P38, DOI 10.1002/jso.22057; Gold JS, 2007, ANN SURG ONCOL, V14, P365, DOI 10.1245/s10434-006-9059-z; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kodera Y, 1999, J SURG ONCOL, V72, P60, DOI 10.1002/(SICI)1096-9098(199910)72:2<60::AID-JSO3>3.0.CO;2-1; Leslie H, 2010, TMN CLASSIFICATION M; Oh CA, 2012, J SURG ONCOL, V105, P393, DOI 10.1002/jso.22091; Stephen B, 2010, AJCC CANC STAGING MA	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					611	617		10.1007/s00595-014-0979-0		7	Surgery	Surgery	CF7GS	WOS:000352724900012		
J	Takiguchi, S; Fujiwara, Y; Yamasaki, M; Miyata, H; Nakajima, K; Nishida, T; Sekimoto, M; Hori, M; Nakamura, H; Mori, M; Doki, Y				Takiguchi, Shuji; Fujiwara, Y.; Yamasaki, M.; Miyata, H.; Nakajima, K.; Nishida, T.; Sekimoto, M.; Hori, M.; Nakamura, H.; Mori, M.; Doki, Y.			Laparoscopic intraoperative navigation surgery for gastric cancer using real-time rendered 3D CT images	SURGERY TODAY			English	Article						Laparoscopic surgery; Real-time navigation; 3D CT; Motion sensor; Virtual laparoscopy	BILLROTH-I GASTRECTOMY	Purpose Recent advances in laparoscopic surgical technology have made it possible to perform advanced high-level surgery, such as lymph node dissection for malignancy. Grasping the anatomy during such procedures is important for a safe operation. We have developed a new image information system that provides three-dimensional (3D) reconstructed CT images synchronized with the motion of the laparoscope. This study assesses this new navigation system. Methods Enhanced CT using a custom-made software program can provide 3D angiography images reconstructed as a laparoscopic view. A motion sensor mounted on the laparoscope can detect the direction angle of the laparoscope. The real-time rendered 3D CT images are synchronized with the laparoscopic video images according to the motion of the scope. These 3D CT images are projected on another monitor close to the laparoscopic video monitor. Lymph node dissection can be performed with the help of the real-time navigation system that provides a detailed 3D view of the vasculature. Results Ten laparoscopic gastrectomies were performed using this navigation system. Real-time intraoperative navigation of the vasculature was available, allowing for an excellent surgical outcome. No complications occurred in this series. Conclusion Our intraoperative navigation system allows for safe laparoscopic gastric lymph node dissection.	[Takiguchi, Shuji; Fujiwara, Y.; Yamasaki, M.; Miyata, H.; Nakajima, K.; Nishida, T.; Sekimoto, M.; Mori, M.; Doki, Y.] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Fac Med, Suita, Osaka 5650876, Japan; [Hori, M.; Nakamura, H.] Osaka Univ, Dept Radiol, Fac Med, Suita, Osaka 5650876, Japan	Takiguchi, S (reprint author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Fac Med, 2-2 Yamadaoka, Suita, Osaka 5650876, Japan.	stakiguchi@gesurg.med.osaka-u.ac.jp					Lee SW, 2003, J AM COLL SURGEONS, V197, P927, DOI 10.1016/j.jamcollsurg.2003.07.021; Allaf ME, 1998, SURG ENDOSC-ULTRAS, V12, P1415, DOI 10.1007/s004649900871; Azagra JS, 1999, SURG ENDOSC-ULTRAS, V13, P351, DOI 10.1007/s004649900988; Busse H, 2006, J MAGN RESON IMAGING, V24, P140, DOI 10.1002/jmri.20597; Caversaccio M, 1998, AM J RHINOL, V3, P283; Ecke U, 1997, COMPUT AIDED SURG, V39, P45; Gumprecht H, 2000, BRIT J NEUROSURG, V14, P129, DOI 10.1080/02688690050004552; KITANO S, 1994, SURG LAPAROSC ENDOSC, V4, P146; Morrin MM, 2003, NEW ENGL J MED, V349, P2261, DOI 10.1056/NEJMe038181; NAGAI Y, 1995, SURG LAPAROSC ENDOSC, V5, P281; Reiner BI, 2002, AM J ROENTGENOL, V179, P1407; Scholz M, 2000, J NEUROSURG, V93, P342, DOI 10.3171/jns.2000.93.2.0342; Takiguchi S, 2004, SURG ENDOSC, V18, P106, DOI 10.1007/s00464-003-8116-y; Tanimura Shinya, 2003, Gastric Cancer, V6, P64, DOI 10.1007/s101200300009; Uyama I, 2000, GASTRIC CANCER, V3, P50, DOI 10.1007/PL00011690; WATSON DI, 1995, BRIT J SURG, V82, P661, DOI 10.1002/bjs.1800820530	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					618	624		10.1007/s00595-014-0983-4		7	Surgery	Surgery	CF7GS	WOS:000352724900013		
J	Oishi, H; Okada, Y; Saiki, Y; Sado, T; Noda, M; Hoshikawa, Y; Endo, C; Sakurada, A; Maeda, S; Akiba, M; Hoshi, K; Kondo, T				Oishi, Hisashi; Okada, Yoshinori; Saiki, Yoshikatsu; Sado, Tetsu; Noda, Masafumi; Hoshikawa, Yasushi; Endo, Chiaki; Sakurada, Akira; Maeda, Sumiko; Akiba, Miki; Hoshi, Kunihiko; Kondo, Takashi			Successful bilateral lung transplantation after 16 h of lung preservation with EP-TU solution: report of a case	SURGERY TODAY			English	Article						Lung transplantation; Ischemic time; Lung preservation solution		We report a case of bilateral lung transplantation (BLT) after preservation of the donor graft for 16 h 5 min with EP-TU, an extracellular phosphate-buffered lung preservation solution. The recipient was a 26-year-old woman with idiopathic pulmonary arterial hypertension and the graft ischemic time was prolonged significantly because of the time required to induce peripheral veno-arterial extracorporeal membrane oxygenation (V-A ECMO) under local anesthesia, and address the severe intrathoracic and pericardial adhesions from past surgery for partial anomalous pulmonary venous return, with concurrent annular plication of the tricuspid valve. After the operation, ECMO and continuous hemodiafiltration were started preemptively to protect the grafts against excessive edema. Postoperative chest X-ray showed diffuse bilateral infiltrates, which improved within a few days and she was weaned off ECMO on day 9. Successful BLT after a graft ischemic time of over 16 h has rarely been described in clinical lung transplantation.	[Oishi, Hisashi; Okada, Yoshinori; Sado, Tetsu; Noda, Masafumi; Hoshikawa, Yasushi; Endo, Chiaki; Sakurada, Akira; Maeda, Sumiko; Kondo, Takashi] Tohoku Univ, Inst Dev Aging & Canc, Dept Thorac Surg, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Saiki, Yoshikatsu] Tohoku Univ, Grad Sch Med, Div Cardiovasc Surg, Sendai, Miyagi 9808575, Japan; [Akiba, Miki] Tohoku Univ Hosp, Div Organ Transplantat, Sendai, Miyagi, Japan; [Hoshi, Kunihiko] Tohoku Univ Hosp, Dept Anesthesiol & Intens Care Med, Sendai, Miyagi, Japan	Okada, Y (reprint author), Tohoku Univ, Inst Dev Aging & Canc, Dept Thorac Surg, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	yokada@idac.tohoku.ac.jp					Kuntz CL, 2009, CLIN TRANSPLANT, V23, P819, DOI 10.1111/j.1399-0012.2008.00951.x; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Thabut G, 2005, AM J RESP CRIT CARE, V171, P786, DOI 10.1164/rccm.200409-1248OC; HANDA M, 1989, TOHOKU J EXP MED, V159, P205, DOI 10.1620/tjem.159.205; Noda M, 2013, ANN THORAC SURG, V96, pE17, DOI 10.1016/j.athoracsur.2013.01.029; Okada Yoshinori, 2009, Gen Thorac Cardiovasc Surg, V57, P635, DOI 10.1007/s11748-009-0492-3; Okada Y, 1997, TRANSPLANTATION, V64, P801, DOI 10.1097/00007890-199709270-00002; Okada Y, 2012, SURG TODAY, V42, P152, DOI 10.1007/s00595-011-0052-1; Yoshida O, 2013, SURG TODAY, V43, P1	9	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					630	633		10.1007/s00595-014-0931-3		4	Surgery	Surgery	CF7GS	WOS:000352724900015		
J	Aoi, S; Kimura, K; Tsuda, T				Aoi, Shigeyoshi; Kimura, Kouseki; Tsuda, Tomoki			Double and synchronous trichobezoars causing small-bowel obstruction and detected by multidetector computed tomography: report of two cases	SURGERY TODAY			English	Article						Trichobezoar; Diagnosis; Small-bowel obstruction	RAPUNZEL-SYNDROME; GASTRIC TRICHOBEZOAR; DIAGNOSIS; ENDOSCOPY; BEZOAR	A trichobezoar is a rare mass formed by the ingestion and accumulation of hair within the gastrointestinal tract, especially the stomach. Cases of an isolated gastric trichobezoar with extension into the duodenum or the jejunum have been reported; however, synchronous gastric and intestinal trichobezoars causing a small-bowel obstruction is very unusual. We report our experience of two such cases to demonstrate the efficiency of preoperative multidetector computed tomography in locating the double bezoars and assisting us in surgical decision making. Open surgery is inevitable for symptomatic bezoars, because the masses are too hard and large to break up with endoscopic devices.	[Aoi, Shigeyoshi; Kimura, Kouseki; Tsuda, Tomoki] Omihachiman Community Med Ctr, Dept Pediat Surg, Omihachiman, Shiga 5230082, Japan	Aoi, S (reprint author), Omihachiman Community Med Ctr, Dept Pediat Surg, 1379 Tsuchida Cho, Omihachiman, Shiga 5230082, Japan.	aoishige@koto.kpu-m.ac.jp					Alsafwah S, 2000, GASTROINTEST ENDOSC, V52, P784, DOI 10.1067/mge.2000.108927; Jensen AR, 2005, J PEDIATR SURG, V40, P1364, DOI 10.1016/j.jpedsurg.2005.05.021; VAUGHAN ED, 1968, SURGERY, V63, P339; Nirasawa Y, 1998, J PEDIATR SURG, V33, P663, DOI 10.1016/S0022-3468(98)90342-6; Frey AS, 2005, AM J PSYCHIAT, V162, P242, DOI 10.1176/appi.ajp.162.2.242; O'Sullivan MJ, 2001, J ROY SOC MED, V94, P68; Coufal NG, 2011, CASE REP MED, DOI [10.1155/2011/217570, DOI 10.1155/2011/217570]; De Backer A, 1999, J PEDIATR GASTR NUTR, V28, P513, DOI 10.1097/00005176-199905000-00015; DeBakey M, 1939, SURGERY, V5, P132; Hoover K, 2006, J PEDIATR SURG, V41, P1495, DOI 10.1016/j.jpedsurg.2006.04.003; Hussain AA, 2007, SAMJ S AFR MED J, V97, P343; Klipfel AA, 2003, SURGERY, V133, P120, DOI 10.1067/mys.2003.41; Krol CM, 2001, AM J ROENTGENOL, V177, P255; NEWMAN B, 1990, PEDIATR RADIOL, V20, P526, DOI 10.1007/BF02011382; West WM, 1998, PEDIATR RADIOL, V28, P315, DOI 10.1007/s002470050362	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					634	637		10.1007/s00595-014-0922-4		4	Surgery	Surgery	CF7GS	WOS:000352724900016		
J	Obuchi, T; Sasaki, A; Baba, S; Nitta, H; Otsuka, K; Wakabayashi, G				Obuchi, Toru; Sasaki, Akira; Baba, Shigeaki; Nitta, Hiroyuki; Otsuka, Koki; Wakabayashi, Go			Single-port laparoscopic and endoscopic cooperative surgery for a gastric gastrointestinal stromal tumor: report of a case	SURGERY TODAY			English	Article						Laparoscopic and endoscopic cooperative surgery (LECS); Gastrointestinal stromal tumor; Laparoscopic gastric resection; Single-port surgery; Single-incision surgery	SUBMUCOSAL TUMORS; RESECTION; CHOLECYSTECTOMY; TRIAL	We herein report a case of single-port laparoscopic and endoscopic cooperative surgery (LECS) for a gastric gastrointestinal stromal tumor (GIST). A 75-year-old female with an endoluminal GIST located near the esophagogastric junction underwent LECS. Both the mucosal and submucosal layers around the tumor were circumferentially dissected using endoscopic submucosal dissection via intraluminal endoscopy. The endoluminal GIST was exteriorized to the abdominal cavity. The tumor and the edge of the incision line were closed using an endoscopic linear stapler. The LECS was successfully accomplished without the need for any skin incisions or additional ports. The length of the operation was 120 min and blood loss was 5 ml. Oral intake was resumed on the second day and the length of hospital stay was 5 days. No complications were noted and the patient had an excellent cosmetic result. In our experience, single-port LECS is feasible and safe for gastric GIST when performed by a surgeon experienced in laparoscopic and gastric surgery.	[Obuchi, Toru; Sasaki, Akira; Baba, Shigeaki; Nitta, Hiroyuki; Otsuka, Koki; Wakabayashi, Go] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 0208505, Japan	Obuchi, T (reprint author), Iwate Med Univ, Sch Med, Dept Surg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	tobuchi@iwate-med.ac.jp					Tsujimoto H, 2012, WORLD J SURG, V36, P327, DOI 10.1007/s00268-011-1387-x; Lee PC, 2010, BRIT J SURG, V97, P1007, DOI 10.1002/bjs.7087; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; Aogi K, 1999, SURG TODAY, V29, P102; Novitsky YW, 2006, ANN SURG, V243, P738, DOI 10.1097/01.sla.0000219739.11758.27; Kawahira H, 2012, HEPATO-GASTROENTEROL, V59, P415, DOI 10.5754/hge11456; Kang WM, 2013, WORLD J GASTROENTERO, V19, P5720, DOI 10.3748/wjg.v19.i34.5720; Ma J, 2011, ANN SURG, V254, P22, DOI 10.1097/SLA.0b013e3182192f89; PELOSI MA, 1992, J REPROD MED, V37, P588; Qiu WQ, 2013, J DIGEST DIS, V14, P469, DOI 10.1111/1751-2980.12076; Nishida T, 2008, INT J CLIN ONCOL, V13, P416, DOI 10.1007/s10147-008-0798-7; Hiki N, 2008, SURG ENDOSC, V22, P1729, DOI 10.1007/s00464-007-9696-8; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Yoshikawa K, 2013, SURG TODAY, V43, P1162, DOI 10.1007/s00595-012-0411-6; Hiki N, 2008, JPN J GASTROENTEROL, V41, P1661; Hirano Y, 2010, SURG LAPARO ENDO PER, V20, P262, DOI 10.1097/SLE.0b013e3181e36a5b; Hwang SH, 2009, SURG ENDOSC, V23, P1980, DOI 10.1007/s00464-008-9955-3; Navarra G, 1997, BRIT J SURG, V84, P695, DOI 10.1002/bjs.1800840536; Park Ji Yeon, 2012, J Gastric Cancer, V12, P173, DOI 10.5230/jgc.2012.12.3.173; Sasaki A, 2011, SURG TODAY, V41, P133, DOI 10.1007/s00595-009-4204-5; Sasaki A, 2012, SURG LAPARO ENDO PER, V22, P396, DOI 10.1097/SLE.0b013e3182631a9a; Sasaki A, 2009, SURGERY, V147, P516	22	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					641	646		10.1007/s00595-014-0870-z		6	Surgery	Surgery	CF7GS	WOS:000352724900018		
J	Sumiyoshi, T; Shima, Y; Okabayashi, T; Kozuki, A; Nakamura, T; Iwata, J; Noda, Y; Hata, Y; Murata, Y; Uka, K; Morita, S				Sumiyoshi, Tatsuaki; Shima, Yasuo; Okabayashi, Takehiro; Kozuki, Akihito; Nakamura, Toshio; Iwata, Jun; Noda, Yoshihiro; Hata, Yasuhiro; Murata, Yoriko; Uka, Kiminori; Morita, Sojiro			Rapid shrinkage of a pancreatic serous cystadenoma with cystic degeneration: report of a case	SURGERY TODAY			English	Article						Pancreatic serous cystadenoma; Cystic degeneration; Tumor shrinkage	NEOPLASMS; FEATURES	We report a rare case of pancreatic serous cystadenoma, which shrank remarkably from 6 to 1.5 cm in diameter, with cystic degeneration, over a period of only 3 weeks. A 29-year-old woman who presented with epigastric pain and jaundice underwent computed tomography, which showed a 6-cm monolocular cystic tumor in the pancreatic head. Endoscopic retrograde cholangiopancreatography showed stenosis and deviation of the inferior part of the extrahepatic bile duct. We performed surgery 3 weeks later for suspected mucinous cystadenoma or macroscopic serous cystadenoma of the pancreas. At laparotomy, the tumor in the pancreatic head was found to have shrunk remarkably. We excised the tumor completely by performing the Whipple procedure. Macroscopically, the mass was a 1.5-cm monolocular cyst. Microscopically, the cystic tumor was composed of a thick fibrous wall with granulation tissue and hemorrhage. Although epithelial cells were not found inside the cystic wall, numerous grossly invisible microcysts with glycogen-containing epithelial cells were seen at its periphery. Based on these findings, the tumor was diagnosed as a serous cystadenoma with cystic degeneration.	[Sumiyoshi, Tatsuaki; Shima, Yasuo; Okabayashi, Takehiro; Kozuki, Akihito; Nakamura, Toshio] Kochi Hlth Sci Ctr, Dept Surg Gastroenterol, Kochi, Kochi 7818555, Japan; [Iwata, Jun] Kochi Hlth Sci Ctr, Dept Diagnost Pathol, Kochi, Japan; [Noda, Yoshihiro; Hata, Yasuhiro; Murata, Yoriko; Morita, Sojiro] Kochi Hlth Sci Ctr, Dept Radiol, Kochi, Japan; [Uka, Kiminori] Kochi Hlth Sci Ctr, Dept Gastroenterol, Kochi, Japan	Sumiyoshi, T (reprint author), Kochi Hlth Sci Ctr, Dept Surg Gastroenterol, 2125 Ike, Kochi, Kochi 7818555, Japan.	tasu050520@yahoo.co.jp			Kochi Organization for Medical Reformation and Renewal	This work was supported by the Kochi Organization for Medical Reformation and Renewal.	Khashab MA, 2013, PANCREAS, V42, P717, DOI 10.1097/MPA.0b013e3182883a91; Galanis C, 2007, J GASTROINTEST SURG, V11, P820, DOI 10.1007/s11605-007-0157-4; Lee SE, 2008, ANN SURG ONCOL, V15, P2089, DOI 10.1245/s10434-008-9959-1; Panarelli NC, 2012, AM J SURG PATHOL, V36, P726, DOI 10.1097/PAS.0b013e31824cf879; Kimura W, 2012, PANCREAS, V41, P380, DOI 10.1097/MPA.0b013e31822a27db; PerezOrdonez B, 1996, AM J SURG PATHOL, V20, P1401, DOI 10.1097/00000478-199611000-00012; Boujaoude J, 2007, WORLD J GASTROENTERO, V13, P3662; Capella C, 2000, SEROUS CYSTIC NEOPLA, P231; De Angelis Claudio, 2007, JOP, V8, P85; Kloppel G, 2001, PANCREATOLOGY, V1, P648, DOI 10.1159/000055876; Kosmahl M, 2005, MODERN PATHOL, V18, P1157, DOI 10.1038/modpathol.3800446; Singhi AD, 2012, AM J SURG PATHOL, V36, P1666, DOI 10.1097/PAS.0b013e31826a0048	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					647	651		10.1007/s00595-014-0972-7		5	Surgery	Surgery	CF7GS	WOS:000352724900019		
J	Sonoda, H; Shimizu, T; Takebayashi, K; Ohta, H; Murakami, K; Shiomi, H; Naka, S; Hanaoka, J; Tani, T				Sonoda, Hiromichi; Shimizu, Tomoharu; Takebayashi, Katsushi; Ohta, Hiroyuki; Murakami, Koichiro; Shiomi, Hisanori; Naka, Shigeyuki; Hanaoka, Jun; Tani, Tohru			Minimally invasive surgery using the open magnetic resonance imaging system combined with video-assisted thoracoscopic surgery for synchronous hepatic and pulmonary metastases from colorectal cancer: report of four cases	SURGERY TODAY			English	Article						MCT; VATS; Microwave coagulation therapy; RFA	GUIDED MICROWAVE THERMOCOAGULATION; RADIOFREQUENCY ABLATION; SURGICAL RESECTION; PROGNOSTIC-FACTORS; LIVER METASTASES; FOLLOW-UP; HEPATOCELLULAR-CARCINOMA; COAGULATION THERAPY; RECURRENCE; EXPERIENCE	Simultaneous resection of hepatic and pulmonary metastases (HPM) from colorectal cancer (CRC) has been reported to be effective, but it is also considered invasive. We report the preliminary results of performing minimally invasive surgery using the open magnetic resonance (MR) imaging system to resect synchronous HPM from CRC in four patients. All four patients were referred for thoracoscopy-assisted interventional MR-guided microwave coagulation therapy (T-IVMR-MCT) combined with video-assisted thoracoscopic surgery (VATS). The median diameters of the HPM were 18.2 and 23.2 mm, respectively. The median duration of VATS and T-IVMR-MCT was 82.5 and 139 min, respectively. All patients were discharged without any major postoperative complications. One patient was still free of disease at 24 months and the others died of disease progression 13, 36, and 47 months without evidence of recurrence in the treated area. Thus, simultaneous VATS + T-IVMR-MCT appears to be an effective option as a minimally invasive treatment for synchronous HPM from CRC.	[Sonoda, Hiromichi; Shimizu, Tomoharu; Takebayashi, Katsushi; Ohta, Hiroyuki; Murakami, Koichiro; Shiomi, Hisanori; Naka, Shigeyuki; Hanaoka, Jun; Tani, Tohru] Shiga Univ Med Sci, Dept Surg, Otsu, Shiga 5202192, Japan	Shimizu, T (reprint author), Shiga Univ Med Sci, Dept Surg, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	tomoharu@belle.shiga-med.ac.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ike H, 2002, BRIT J SURG, V89, P1164, DOI 10.1046/j.1365-2168.2002.02174.x; Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71; Okumura S, 1996, J THORAC CARDIOV SUR, V112, P867, DOI 10.1016/S0022-5223(96)70085-5; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Miller G, 2007, J AM COLL SURGEONS, V205, P231, DOI 10.1016/j.jamcollsurg.2007.04.039; Nguyen KT, 2009, ANN SURG, V250, P842, DOI 10.1097/SLA.0b013e3181bc789c; Minami Y, 2013, GUT LIVER, V7, P1, DOI 10.5009/gnl.2013.7.1.1; GOYA T, 1989, CANCER, V64, P1418, DOI 10.1002/1097-0142(19891001)64:7<1418::AID-CNCR2820640709>3.0.CO;2-N; Uehara T, 2007, J GASTROENTEROL, V42, P306, DOI 10.1007/s00535-006-1949-0; Shiomi H, 2008, AM J SURG, V195, P854, DOI 10.1016/j.amjsurg.2007.08.056; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Nordlinger B, 1996, CANCER, V77, P1254, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.3.CO;2-R; Inoue M, 2004, ANN THORAC SURG, V78, P238, DOI 10.1016/j.athoracsur.2004.02.017; Shah SA, 2006, J AM COLL SURGEONS, V202, P468, DOI 10.1016/j.jamcollsurg.2005.11.008; Sardi A, 1999, AM SURGEON, V65, P566; Bradley AL, 1999, AM SURGEON, V65, P560; Delis SG, 2007, J SURG ONCOL, V96, P178, DOI 10.1002/jso.20723; Dionigi G, 2006, SURG LAPARO ENDO PER, V16, P423, DOI 10.1097/01.sle.0000213727.80332.2c; Fusai G, 2003, Colorectal Dis, V5, P2, DOI 10.1046/j.1463-1318.2003.00410.x; Goldberg SN, 2003, RADIOLOGY, V228, P335, DOI 10.1148/radiol.2282021787; Hirosawa T, 2013, SURG TODAY, V43, P494, DOI 10.1007/s00595-012-0373-8; Kobayashi K, 1999, J THORAC CARDIOV SUR, V118, P1090, DOI 10.1016/S0022-5223(99)70106-6; Kurumi Y, 2007, INT J CLIN ONCOL, V12, P85, DOI 10.1007/s10147-006-0653-7; Lehnert T, 1999, BRIT J SURG, V86, P241; Machi J, 2002, SURG LAPARO ENDO PER, V12, P160, DOI 10.1097/SLE.0000017669.43677.D6; MANSEL JK, 1986, CHEST, V89, P109, DOI 10.1378/chest.89.1.109; McCormack P M, 1998, Chest Surg Clin N Am, V8, P119; Mineo TC, 2003, J AM COLL SURGEONS, V197, P386, DOI 10.1016/S0172-7515(03)00387-9; Morikawa S, 2002, J MAGN RESON IMAGING, V16, P576, DOI 10.1002/jmri.10198; Morikawa S, 2003, ACAD RADIOL, V10, P180, DOI 10.1016/S1076-6332(03)80043-0; Nagakura S, 2001, J AM COLL SURGEONS, V193, P153, DOI 10.1016/S1072-7515(01)00970-X; Neeff H, 2009, J GASTROINTEST SURG, V13, P1813, DOI 10.1007/s11605-009-0960-1; Reddy RHV, 2004, EUR J CARDIO-THORAC, V25, P151, DOI 10.1016/j.ejcts.2003.11.020; Shimizu T, 2010, DIS COLON RECTUM, V53, P1555, DOI 10.1007/DCR.0b013e3181e8f4b6; Stattner S, 2015, SURG TODAY, V45, P407, DOI 10.1007/s00595-014-0879-3; Taylor M, 1997, AM J SURG, V173, P467, DOI 10.1016/S0002-9610(97)00020-2; Waki K, 2010, J GASTROEN HEPATOL, V25, P597, DOI 10.1111/j.1440-1746.2009.06125.x	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					652	658		10.1007/s00595-014-1002-5		7	Surgery	Surgery	CF7GS	WOS:000352724900020		
J	Beppu, N; Matsubara, N; Noda, M; Kimura, F; Yamanaka, N; Yanagi, H; Tomita, N				Beppu, Naohito; Matsubara, Nagahide; Noda, Masashi; Kimura, Fumihiko; Yamanaka, Naoki; Yanagi, Hidenori; Tomita, Naohiro			Laparoscopic intersphincteric resection and J-pouch reconstruction without laparotomy	SURGERY TODAY			English	Article						Laparoscopic intersphincteric resection; J-pouch reconstruction; Transanal approach	COLONIC-J-POUCH; STRAIGHT COLOANAL ANASTOMOSIS; LOW COLORECTAL ANASTOMOSIS; ANAL ANASTOMOSIS; RECTAL-CARCINOMA	In some cases, a J-pouch is not created after laparoscopic intersphincteric resection (Lap-ISR), because this procedure usually does not involve laparotomy. This study aimed to develop a new technique for Lap-ISR and J-pouch reconstruction without laparotomy and to assess the short- and long-term outcomes of this technique. After a rectal specimen is excised using the transanal approach, the reconstructed intestine is reinserted into the intra-abdominal space. To create the J-shape, the reconstructed intestine is looped back using Allis forceps, and the septum of the J-shape is divided using a surgical stapler. We performed 20 surgeries using the new technique. Although three patients developed pelvic infections, no J-pouch-related complications were noted. Intestinal continuity could be maintained in all patients who received a diverting stoma.	[Beppu, Naohito; Matsubara, Nagahide; Noda, Masashi; Tomita, Naohiro] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; [Kimura, Fumihiko; Yamanaka, Naoki; Yanagi, Hidenori] Meiwa Hosp, Dept Surg, Nishinomiya, Hyogo 6638186, Japan	Beppu, N (reprint author), Hyogo Coll Med, Dept Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	beppu-n@hyo-med.ac.jp					Lazorthes F, 1997, BRIT J SURG, V84, P1449; KUSUNOKI M, 1991, BRIT J SURG, V78, P1434, DOI 10.1002/bjs.1800781208; Barrier A, 1999, BRIT J SURG, V86, P1176, DOI 10.1046/j.1365-2168.1999.01224.x; Benoist S, 1997, J AM COLL SURGEONS, V185, P114, DOI 10.1016/S1072-7515(97)00016-1; Dehni N, 1998, DIS COLON RECTUM, V41, P817, DOI 10.1007/BF02235358; Hida J, 2010, SURG TODAY, V40, P307, DOI 10.1007/s00595-009-4046-1; Joo JS, 1998, DIS COLON RECTUM, V41, P740, DOI 10.1007/BF02236262; Yamamoto S, 2013, ANN SURG, V258, P283, DOI 10.1097/SLA.0b013e318283669c	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	MAY	2015	45	5					659	662		10.1007/s00595-014-1023-0		4	Surgery	Surgery	CF7GS	WOS:000352724900021		
J	Kurata, K; Inoue, K; Nishimura, K; Hoshiya, N; Kawai, N; Uenishi, J				Kurata, Kaoruko; Inoue, Kumiko; Nishimura, Kazuhiko; Hoshiya, Naoyuki; Kawai, Nobuyuki; Uenishi, Jun'ichi			Synthesis of Optically Pure (R)- and (S)-Tetrahydroisoquinoline-1-and-3-Carboxylic Acids	SYNTHESIS-STUTTGART			English	Article						quinolines; amino acids; peptides; asymmetric synthesis; Lewis acids	1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXYLIC ACID; STEREOSELECTIVE-SYNTHESIS; ASYMMETRIC-SYNTHESIS; DERIVATIVES; DESIGN	The synthesis of (R)- and (S)-tetrahydroisoquinoline-1-carboxylic acids was achieved from N-Boc-protected (R)- and (S)-1-propenyltetrahydroisoquinoline, respectively, in a three-step sequence of ozonolysis, NaBH4 reduction, oxidation, and deprotection of the N-Boc group. Similarly, (S)-tetrahydroisoquinoline-3-carboxylic acids were obtained from N-Boc-protected (S)-3-(4-phenylbutenyl) tetrahydroisoquinolines. This synthetic route provides tetrahydroisoquinoline ring-based cyclic amino acids in enantiomerically pure form in a practical and efficient manner.	[Kurata, Kaoruko; Inoue, Kumiko; Nishimura, Kazuhiko; Hoshiya, Naoyuki; Uenishi, Jun'ichi] Kyoto Pharmaceut Univ, Dept Pharmaceut Chem, Yamashina Ku, Kyoto 6078412, Japan; [Kawai, Nobuyuki] Mukogawa Womens Univ, Sch Pharmaceut Sci, Nishinomiya, Hyogo 6638179, Japan	Hoshiya, N (reprint author), Kyoto Pharmaceut Univ, Dept Pharmaceut Chem, Yamashina Ku, Kyoto 6078412, Japan.	hoshiya@mb.kyoto-phu.ac.jp					Kawai N, 2011, J ORG CHEM, V76, P2102, DOI 10.1021/jo102452d; Paal TA, 2007, TETRAHEDRON-ASYMMETR, V18, P1428, DOI 10.1016/j.tetasy.2007.05.016; Hanessian S, 1997, TETRAHEDRON, V53, P12789; Kawai N, 2011, TETRAHEDRON, V67, P8648, DOI 10.1016/j.tet.2011.09.033; Lukaszuk A, 2009, J MED CHEM, V52, P5612, DOI 10.1021/jm900651p; Truax VM, 2013, ACS MED CHEM LETT, V4, P1025, DOI 10.1021/ml400183q; Cheng RP, 2001, CHEM REV, V101, P3219, DOI 10.1021/cr000045i; Maillard MC, 2011, BIOORGAN MED CHEM, V19, P5833, DOI 10.1016/j.bmc.2011.08.020; Siengalewicz P, 2008, CHEM SOC REV, V37, P2676, DOI 10.1039/b804167a; Contu VR, 2014, J NEUROCHEM, V130, P826, DOI 10.1111/jnc.12762; Lin S, 2008, J AM CHEM SOC, V130, P12901, DOI 10.1021/ja803452p; Kiss L, 2014, CHEM REV, V114, P1116, DOI 10.1021/cr300454h; Martinek TA, 2012, CHEM SOC REV, V41, P687, DOI 10.1039/c1cs15097a; Avendano C, 2010, CHEM-EUR J, V16, P9722, DOI 10.1002/chem.201000532; Bajusz S., 1993, CHEM BIOCH AMINO ACI, Patent No. WO 199312091; Barrett G. C., 1985, Chemistry and Biochemistry of the Amino Acids, Patent No. 199312091; Cheng SL, 2009, EUR J MED CHEM, V44, P4904, DOI 10.1016/j.ejmech.2009.08.002; Fulop F, 2001, CHEM REV, V101, P2181, DOI 10.1021/cr000456z; Jannapu R., 2012, J ORG CHEM, V77, P11101; Kanemitsu T, 2006, SYNLETT, P1595, DOI 10.1055/s-2006-941586; Kawai N, 2009, TETRAHEDRON LETT, V50, P6580, DOI 10.1016/j.tetlet.2009.09.053; KUHL A, 2005, J AMINO ACIDS, V29, P89; Paal TA, 2008, EUR J ORG CHEM, P5269, DOI 10.1002/ejoc.200800789; Page D, 2001, J MED CHEM, V44, P2387, DOI 10.1021/jm015532k; Park KH, 2002, TETRAHEDRON, V58, P8629, DOI 10.1016/S0040-4020(02)00989-4; Rodriguez-Vazquez N, 2013, EUR J ORG CHEM, P3477, DOI 10.1002/ejoc.201201565; Schuster I, 2007, LETT ORG CHEM, V4, P102, DOI 10.2174/157017807780414226; Sieck O, 2003, SYNLETT, P337; Toselli N, 2010, TETRAHEDRON-ASYMMETR, V21, P1238, DOI 10.1016/j.tetasy.2010.03.013; Uenishi J, 2011, ORG LETT, V13, P2350, DOI 10.1021/ol2005984	30	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	MAY	2015	47	9					1238	1244		10.1055/s-0034-1380289		7	Chemistry, Organic	Chemistry	CG4BP	WOS:000353226100004		
J	Shimojo, H; Moriyama, K; Togo, H				Shimojo, Hiroyuki; Moriyama, Katsuhiko; Togo, Hideo			A One-Pot, Transition-Metal-Free Procedure for C-O, C-S, and C-N Bond Formation at the Benzylic Position of Methylarenes	SYNTHESIS-STUTTGART			English	Article						methylarenes; C(sp(3))-H bond activation; Wohl-Ziegler reaction; 1,3-dibromo-5,5-dimethylhydantoin; N-bromosuccinimide	H BONDS; ACTIVATION; FUNCTIONALIZATION; CONVERSION; AMINATION; PALLADIUM; ETHERS; ESTER	Various methylarenes are treated with 1,3-dibromo-5,5-dimethylhydantoin or N-bromosuccinimide and a catalytic amount of 2,2'-azobis(isobutyronitrile) in acetonitrile, carbon tetrachloride, or methyl tert-butyl ether, and then reacted with benzoic acid, p-toluenethiol, sodium p-toluenesulfinate, aqueous dimethylamine, and succinimide (formed from N-bromosuccinimide) to provide the corresponding arylmethyl benzoates, arylmethyl p-tolyl thioethers, arylmethyl p-tolyl sulfones, N-arylmethyl-N, N-dimethylamines, and N-(arylmethyl) succinimides in good yields, respectively. The reactions involve one-pot, transition-metal-free functionalizations to form C-O, C-S or C-N bonds at the benzylic positions of the methylarenes.	[Shimojo, Hiroyuki; Moriyama, Katsuhiko; Togo, Hideo] Chiba Univ, Grad Sch Sci, Inage Ku, Chiba 2638522, Japan	Togo, H (reprint author), Chiba Univ, Grad Sch Sci, Inage Ku, Yayoi Cho 1-33, Chiba 2638522, Japan.	togo@faculty.chiba-u.jp			Ministry of Education, Culture, Sports, Science, and Technology in Japan [25105710]; Chiba University	Financial support in the form of a Grant-in-Aid for Scientific Research (No. 25105710) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan, and Iodine Research Project in Chiba University is gratefully acknowledged.	Whited MT, 2009, ACCOUNTS CHEM RES, V42, P1607, DOI 10.1021/ar900103e; Badsara SS, 2014, CHEM COMMUN, V50, P11374, DOI 10.1039/c4cc04503c; Bellina F, 2010, CHEM REV, V110, P1082, DOI 10.1021/cr9000836; Pappas CS, 2004, CARBOHYD POLYM, V56, P465, DOI 10.1016/j.carbpol.2004.03.014; Chen C, 2014, ORG LETT, V16, P3372, DOI 10.1021/ol501400u; Guntreddi T, 2014, TETRAHEDRON, V70, P3887, DOI 10.1016/j.tet.2014.04.041; Aliboni A, 2011, J AGR FOOD CHEM, V59, P282, DOI 10.1021/jf1034866; Xue QC, 2013, CHEM COMMUN, V49, P3700, DOI 10.1039/c3cc41558a; Tsuchiya D, 2013, ORG LETT, V15, P4194, DOI 10.1021/ol401906q; Balcells D, 2010, CHEM REV, V110, P749, DOI 10.1021/cr900315k; Gao X, 2014, ORG LETT, V16, P3664, DOI 10.1021/ol501422k; Daugulis O, 2010, TOP CURR CHEM, V292, P57, DOI 10.1007/128_2009_10; He C, 2014, TETRAHEDRON LETT, V55, P4458, DOI 10.1016/j.tetlet.2014.06.047; Wang NC, 2014, J ORG CHEM, V79, P5379, DOI 10.1021/jo5008515; Vindigni V, 2009, INT J MOL SCI, V10, P2972, DOI 10.3390/ijms10072972; Liu HQ, 2013, ORG LETT, V15, P4098, DOI 10.1021/ol401687f; Conejero S, 2010, ACCOUNTS CHEM RES, V43, P572, DOI 10.1021/ar9002625; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Li CJ, 2009, ACCOUNTS CHEM RES, V42, P335, DOI 10.1021/ar800164n; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Lewis JC, 2008, ACCOUNTS CHEM RES, V41, P1013, DOI 10.1021/ar800042p; Kawagoe Y, 2014, EUR J ORG CHEM, P4115, DOI 10.1002/ejoc.201402270; Koten I. A., 1973, ORG SYNTH, V5, P145; Parkin G., 2009, ACCOUNTS CHEM RES, V42, P10830; Suarez JR, 2013, CHEM COMMUN, V49, P9194, DOI 10.1039/c3cc44594a; Wohl A, 1919, BER DTSCH CHEM GES, V52, P51, DOI 10.1002/cber.19190520109; Yuan JW, 2014, CHEM COMMUN, V50, P14386, DOI 10.1039/c4cc05661b; Ziegler K., 1942, LIEBIGS ANN CHEM, V551, P30	28	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	MAY	2015	47	9					1280	1290		10.1055/s-0034-1380069		11	Chemistry, Organic	Chemistry	CG4BP	WOS:000353226100008		
J	Yoneyama, H; Magata, T; Uemura, K; Usami, Y; Tanaka, S; Takaoka, M; Harusawa, S				Yoneyama, Hiroki; Magata, Takuji; Uemura, Kenji; Usami, Yoshihide; Tanaka, Satoshi; Takaoka, Masanori; Harusawa, Shinya			Efficient Synthesis of N-[4-(4-Chlorophenyl)butyl]-S-(3-piperidinopropyl)isothiourea (OUP-186) and Its Analogues Using 2-Nitrophenylacetyl Isothiocyanate: Application to Novel Histamine H3R Antagonists	SYNTHESIS-STUTTGART			English	Article						S-alkyl-N-alkylisothiourea; histamine H-3 receptor; non-imidazole; H-3 antagonist; cancer growth inhibition	H-3 RECEPTOR ANTAGONISTS; THERAPEUTIC TARGETS; MOLECULAR-CLONING; ISOTHIOUREAS; DERIVATIVES; LIGANDS; BRAIN; CATALYSTS; THIOUREA; AGONISTS	A potent histamine H-3 receptor antagonist OUP-186 with an S-alkyl-N-alkylisothiourea structure was synthesized using 3-phenylpropanoyl isothiocyanate (PPI) as an SCN source. The synthetic route was significantly improved by replacing 3-phenylpropanoyl isothiocyanate with 2-nitrophenylacetyl isothiocyanate (NPAI), giving a 74% overall yield in three steps from 4-(4-chlorophenyl) butylamine. In addition, the 2-nitrophenylacetyl isothiocyanate method successfully yielded two fluorine-containing analogues, and a shorter, C-2 homologue of OUP-186.	[Yoneyama, Hiroki; Magata, Takuji; Uemura, Kenji; Usami, Yoshihide; Tanaka, Satoshi; Takaoka, Masanori; Harusawa, Shinya] Osaka Univ Pharmaceut Sci, Takatsuki, Osaka 5691094, Japan	Harusawa, S (reprint author), Osaka Univ Pharmaceut Sci, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan.	yoneyama@gly.oups.ac.jp			JSPS [26460160]	This research was supported in part by a Grant-in-Aid for Scientific Research [Grant No. 26460160 (to S.H.)] from JSPS, 2014-2017.	Oda T, 2000, J BIOL CHEM, V275, P36781, DOI 10.1074/jbc.M006480200; Berlin M, 2011, J MED CHEM, V54, P26, DOI 10.1021/jm100064d; Stephanos JJ, 1996, J INORG BIOCHEM, V62, P155, DOI 10.1016/0162-0134(95)00144-1; [Anonymous], 2012, CHEM SOC REV, DOI DOI 10.1039/C2CS15288F; Powell DA, 2002, ORG LETT, V4, P2913, DOI 10.1021/ol026293d; Cowart MD, 2008, J MED CHEM, V51, P6547, DOI 10.1021/jm800670r; ARRANG JM, 1983, NATURE, V302, P832, DOI 10.1038/302832a0; Hill SJ, 1997, PHARMACOL REV, V49, P253; Hough LB, 2001, MOL PHARMACOL, V59, P415; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35001102; Welch JT, 2007, BIOORGAN MED CHEM, V15, P6659, DOI 10.1016/j.bmc.2007.08.012; Schwartz JC, 2011, BRIT J PHARMACOL, V163, P713, DOI 10.1111/j.1476-5381.2011.01286.x; Mignot E, 2002, NAT NEUROSCI, V5, P1071, DOI 10.1038/nn944; Pillot C, 2002, J NEUROSCI, V22, P7272; Nakamura T, 2000, BIOCHEM BIOPH RES CO, V279, P615, DOI 10.1006/bbrc.2000.4008; Sander K, 2008, BIOL PHARM BULL, V31, P2163, DOI 10.1248/bpb.31.2163; SCHLICKER E, 1993, J NEURAL TRANSM-GEN, V93, P1, DOI 10.1007/BF01244933; Morisset S, 2000, NATURE, V408, P860; ARRANG JM, 1987, NATURE, V327, P117, DOI 10.1038/327117a0; CHADHA HS, 1994, BIOORG MED CHEM LETT, V4, P2511, DOI 10.1016/S0960-894X(01)80274-2; Denk MK, 2005, TETRAHEDRON LETT, V46, P7597, DOI 10.1016/j.tetlet.2005.08.150; Drouin C, 2004, TETRAHEDRON LETT, V45, P7197, DOI 10.1016/j.tetlet.2004.08.038; Harusawa S, 2013, BIOORG MED CHEM LETT, V23, P6415, DOI 10.1016/j.bmcl.2013.09.052; HASEGAWA K, 1975, B CHEM SOC JPN, V48, P2611, DOI 10.1246/bcsj.48.2611; IWAKAWA T, 1988, CHEM PHARM BULL, V36, P4755; Katrizky A. R., 1996, COMPREHENSIVE HETERO; Lazewska D, 2010, EXPERT OPIN THER PAT, V20, P1147, DOI 10.1517/13543776.2010.509346; Leurs R, 1998, TRENDS PHARMACOL SCI, V19, P177, DOI 10.1016/S0165-6147(98)01201-2; Mampuys P, 2014, ANGEW CHEM INT EDIT, V53, P12849, DOI 10.1002/anie.201406717; Manimala JC, 2002, EUR J ORG CHEM, P3909; Medina V, 2008, CANCER BIOL THER, V7, P28; Sandler R. S., 1986, ORGANIC FUNCTIONAL G, V2nd, P206; Sclicker E., 1988, ARCH PHARM, V337, P588; Smith M. B., 2001, MARCHS ADV ORGANIC C, V5th, P495; Smith P. A. S., 1973, ORG SYNTH COLL, VV; Smits RA, 2009, DRUG DISCOV TODAY, V14, P745, DOI 10.1016/j.drudis.2009.05.007; Srinivas K, 2012, CATAL SCI TECHNOL, V2, P1180, DOI 10.1039/c2cy00542e; Stark H., 2013, HISTAMINE H4 RECEPTO; TAKAGI K, 1985, CHEM LETT, P1307, DOI 10.1246/cl.1985.1307; VOWINKEL E, 1974, CHEM BER-RECL, V107, P898, DOI 10.1002/cber.19741070317; Wolin R, 1998, BIOORG MED CHEM LETT, V8, P2157, DOI 10.1016/S0960-894X(98)00379-5; Yasunaga T, 1998, J MED CHEM, V41, P2765, DOI 10.1021/jm9707840; Yoneyama H, 2008, J ORG CHEM, V73, P2096, DOI 10.1021/jo702181x	43	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	MAY	2015	47	9					1291	1302		10.1055/s-0034-1380345		12	Chemistry, Organic	Chemistry	CG4BP	WOS:000353226100009		
J	Ito, F; Ohbatake, Y; Aoyama, S; Ikeda, T; Arima, S; Yamada, Y; Ikeda, H; Nagamitsu, T				Ito, Fumihiro; Ohbatake, Yuki; Aoyama, Satoshi; Ikeda, Tatsuya; Arima, Shiho; Yamada, Yuuki; Ikeda, Haruo; Nagamitsu, Tohru			Total Synthesis of (+)-Clavulatriene A	SYNTHESIS-STUTTGART			English	Article						protecting-group-free; total synthesis; clavulatriene A; absolute configuration	TERPENE SYNTHASES; (+)-ALPHA-CYPERONE; ACID; CONVERSION; EFFICIENT; SQUALENE	The protecting-group-free total synthesis of (+)-clavulatriene A has been achieved. Key features of the synthetic strategy include the development of a novel strategy for the practical synthesis of alpha-cyperone, and a one-pot palladium-catalyzed reductive desulfonylation and deacetoxylation reaction. Furthermore, the total synthesis described in this study allowed for the determination of the absolute configuration of (+)-clavulatriene A.	[Ito, Fumihiro; Ohbatake, Yuki; Aoyama, Satoshi; Ikeda, Tatsuya; Arima, Shiho; Nagamitsu, Tohru] Kitasato Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan; [Yamada, Yuuki; Ikeda, Haruo] Kitasato Univ, Kitasato Inst Life Sci, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Yamada, Yuuki; Ikeda, Haruo] Kitasato Univ, Grad Sch Infect Control Sci, Minami Ku, Sagamihara, Kanagawa 2520373, Japan	Nagamitsu, T (reprint author), Kitasato Univ, Grad Sch Pharmaceut Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	nagamitsut@pharm.kitasato-u.ac.jp			Grant for All Kitasato Project Study	This work was supported in part by a Grant for All Kitasato Project Study. We would like to thank Ms. N. Sato and Dr. K. Nagai (Kitasato University) for kindly measuring the NMR and mass spectra.	AGAMI C, 1993, TETRAHEDRON-ASYMMETR, V4, P641, DOI 10.1016/S0957-4166(00)80168-8; Yamada Y, 2012, METHOD ENZYMOL, V515, P123, DOI 10.1016/B978-0-12-394290-6.00007-0; Komatsu M, 2008, P NATL ACAD SCI USA, V105, P7422, DOI 10.1073/pnas.0802312105; Cane DE, 2012, ACCOUNTS CHEM RES, V45, P463, DOI 10.1021/ar200198d; Nakano S, 2004, ORG BIOMOL CHEM, V2, P2012, DOI 10.1039/b404287e; PFAU M, 1985, J AM CHEM SOC, V107, P273, DOI 10.1021/ja00287a061; Yamada Y, 2015, P NATL ACAD SCI USA, V112, P857, DOI 10.1073/pnas.1422108112; Trost BM, 2010, CHEM-EUR J, V16, P6265, DOI 10.1002/chem.200903356; CAINE D, 1974, J ORG CHEM, V39, P2654, DOI 10.1021/jo00931a056; DUHAMEL P, 1986, TETRAHEDRON, V42, P4777, DOI 10.1016/S0040-4020(01)82058-5; GREENE AE, 1971, TETRAHEDRON LETT, P4147; HAAKSMA AA, 1992, TETRAHEDRON, V48, P3121, DOI 10.1016/S0040-4020(01)92253-7; HEGDE SG, 1980, TETRAHEDRON LETT, V21, P441, DOI 10.1016/S0040-4039(00)71427-4; Ito F, 2005, TETRAHEDRON LETT, V46, P7765, DOI 10.1016/j.tetlet.2005.09.028; Komatsua M, 2010, P NATL ACAD SCI USA, V107, P2646, DOI 10.1073/pnas.0914833107; KUO F, 1986, SYNTHETIC COMMUN, V16, P1745, DOI 10.1080/00397918608057197; Li L, 2011, J NAT PROD, V74, P2089, DOI 10.1021/np2003325; MOHRI M, 1985, CHEM LETT, P451, DOI 10.1246/cl.1985.451; PIERS E, 1968, CAN J CHEMISTRY, V46, P377, DOI 10.1139/v68-060; Tang ZY, 2009, CHINESE CHEM LETT, V20, P1017, DOI 10.1016/j.cclet.2009.03.010; Tenius BSM, 1996, SYNTHETIC COMMUN, V26, P197, DOI 10.1080/00397919608003880; Weinges K., 1993, LIEBIGS ANN CHEM, V1993, P811, DOI 10.1002/jlac.1993199301128; Xiong ZM, 1996, TETRAHEDRON-ASYMMETR, V7, P2607; Yamada Y, 2015, J ANTIBIOT, DOI [10.1038/ja.2014.171, DOI 10.1038/JA.2014.171]; Zhabinskii VN, 1996, J ORG CHEM, V61, P4022, DOI 10.1021/jo9602534	25	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	MAY	2015	47	9					1348	1355		10.1055/s-0034-1379898		8	Chemistry, Organic	Chemistry	CG4BP	WOS:000353226100016		
J	Tanaka, H; Kajii, H; Ohmori, Y				Tanaka, Hitoshi; Kajii, Hirotake; Ohmori, Yutaka			Effects of molecular packing on the field-effect mobility and external quantum efficiency of ambipolar polymer light-emitting transistors incorporating a donor-acceptor polymer	SYNTHETIC METALS			English	Article						Ambipolar polymer light-emitting transistor; Donor-acceptor polymer; Light-emitting device; Field-effect mobility; External quantum efficiency	CONJUGATED POLYMERS; ORGANIC TRANSISTOR; TRIPLET EXCITONS; TOP-GATE; TRANSPORT; POLYFLUORENE; POLY(9,9-DI-N-OCTYLFLUORENE-ALT-BENZOTHIADIAZOLE); DYNAMICS; DEVICES	The effects of molecular packing on the field-effect mobility and external quantum efficiency of polymer light-emitting transistors based on films composed of a donor-acceptor polymer, poly(9,9-dioctylfluorene-alt-benzothiadiazole) (F8BT), are investigated. The molecular packing structures of F8BT films are modified by annealing at different temperatures, such that large grains in a mesophase are formed. In the case of F8BT films in the mesophase, highly crystalline three-dimensional configurations with adjacent chains result in effective electron transport. The electron mobility, mu(e), in a device in which the F8BT film is in the mesophase is approximately ten times greater than that for F8BT films annealed at other temperatures, and is estimated to be approximately 3.4 x 10(-3) cm(2) V-1 s(-1). This same device exhibits the highest hole and electron mobilities along with the highest maximum external quantum efficiency (approximately 1.4%) due to improved electron transport and carrier balance. (C) 2015 Elsevier B.V. All rights reserved.	[Tanaka, Hitoshi; Kajii, Hirotake; Ohmori, Yutaka] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Kajii, H (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	kajii@oled.eei.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26289087]; Special Coordination Funds for Promoting Science and Technology	Part of this work was supported by the Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 26289087). This research was also financially supported in part by a grant from the Grant-in-Aid of Special Coordination Funds for Promoting Science and Technology. The authors thank Sumitomo Chemical Co., Ltd., for providing F8BT.	Petrozza A, 2012, J PHYS CHEM C, V116, P11298, DOI 10.1021/jp2104215; Watts B, 2011, ADV FUNCT MATER, V21, P1122, DOI 10.1002/adfm.201001918; Dhoot AS, 2002, ADV MATER, V14, P1834, DOI 10.1002/adma.200290013; Wohlgenannt M, 2001, NATURE, V409, P494, DOI 10.1038/35054025; Segal M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.075211; Rivnay J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.121306; Kudo K, 2003, THIN SOLID FILMS, V438, P330, DOI 10.1016/S0040-6090(03)00751-X; Luo C, 2014, NANO LETT, V14, P2764, DOI 10.1021/nl500758w; Schubert M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.024203; Gwinner MC, 2009, CHEM MATER, V21, P4425, DOI 10.1021/cm900982a; Rost C, 2004, APPL PHYS LETT, V85, P1613, DOI 10.1063/1.1785290; Koiwai K, 2011, SYNTHETIC MET, V161, P2107, DOI 10.1016/j.synthmet.2011.08.003; Zaumseil J, 2006, ADV MATER, V18, P2708, DOI 10.1002/adma.200601080; Hepp A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.157406; Zheng ZJ, 2007, NANO LETT, V7, P987, DOI 10.1021/nl070022k; Kajii H, 2010, ORG ELECTRON, V11, P509, DOI 10.1016/j.orgel.2009.12.004; Muccini M, 2006, NAT MATER, V5, P605, DOI 10.1038/nmat1699; Santato C, 2004, SYNTHETIC MET, V146, P329, DOI 10.1016/j.synthmet.2004.08.028; Xu Y, 2011, J APPL PHYS, V110, DOI 10.1063/1.3602997; McCarthy MA, 2011, SCIENCE, V332, P570, DOI 10.1126/science.1203052; Donley CL, 2005, J AM CHEM SOC, V127, P12890, DOI 10.1021/ja051891j; Gwinner MC, 2012, ADV MATER, V24, P2728, DOI 10.1002/adma.201104602; Horowitz G, 2000, ADV MATER, V12, P1046, DOI 10.1002/1521-4095(200007)12:14<1046::AID-ADMA1046>3.0.CO;2-W; Li WW, 2010, POLYMER, V51, P3031, DOI 10.1016/j.polymer.2010.05.015; Necliudov PV, 2000, J APPL PHYS, V88, P6594, DOI 10.1063/1.1323534; Sonar P, 2011, ENERG ENVIRON SCI, V4, P2288, DOI 10.1039/c1ee01213d; Campbell AJ, 2001, APPL PHYS LETT, V79, P2133, DOI 10.1063/1.1406143; Comil J., 2003, J CHEM PHYS, V118, P6615; Faria GC, 2012, IEEE T DIELECT EL IN, V19, P1181, DOI 10.1109/TDEI.2012.6259987; Ikezoe I, 2014, ORG ELECTRON, V15, P105, DOI 10.1016/j.orgel.2013.10.020; Li YP, 2011, COMPUT THEOR CHEM, V977, P157, DOI 10.1016/j.comptc.2011.09.020; Sakanoue T, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2734389; Schmechel R, 2005, J APPL PHYS, V98, DOI 10.1063/1.2106009; Shinar J, 1996, SYNTHETIC MET, V78, P277, DOI 10.1016/0379-6779(96)80150-0; Swensen JS, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2149986; Takenobu T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.066601; Veres J, 2003, P SOC PHOTO-OPT INS, V5217, P147, DOI 10.1117/12.508475; Vooren A. V., 2008, CHEMPHYSCHEM, V9, P989; Yamane K, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2719680; Yoneda K, 2008, JPN J APPL PHYS, V47, P1293, DOI 10.1143/JJAP.47.1293; Zaumseil J, 2006, NAT MATER, V5, P69, DOI 10.1038/nmat1537; Zaumseil J, 2008, J APPL PHYS, V103, DOI 10.1063/1.2894723	42	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0379-6779			SYNTHETIC MET	Synth. Met.	MAY	2015	203						10	15		10.1016/j.synthmet.2015.02.008		6	Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer Science	Materials Science; Physics; Polymer Science	CG2IH	WOS:000353097600002		
J	Liang, Y; Xiao, XW; Meng, LR; Xiao, DB; Zhao, D; Shen, LJ; Fang, JH; Fujiwara, H				Liang, Yue; Xiao, Xunwen; Meng, Liran; Xiao, Debao; Zhao, Dan; Shen, Liangjun; Fang, Jianghua; Fujiwara, Hideki			Synthesis, structure, and properties of coordination complexes based on zinc halides and TTF-pyridyl ligand	SYNTHETIC METALS			English	Article						TTF derivative; Pyridine substitution; Coordination complexes; Microstructures; Self-assembly	INTRAMOLECULAR CHARGE-TRANSFER; TETRATHIAFULVALENE DERIVATIVES; METAL	Two Zn-II coordination complexes of EDT-TTF-4-py, (EDT-TTF-4-py = 4-ethylenedithiotetrathiafulvalenylpyridine) have been synthesized and characterized in micro and bulk crystal forms. These two complexes were synthesized by coordinative self-assemble through a solution process. At room temperature, the complex 2, (EDT-TTF-4-py)2 center dot ZnBr2 center dot CH2Cl2 shows high conductivity without external manipulation, whereas the complex 1, (EDT-TTF-4-py)(2)center dot ZnCl2 is an insulator. These investigations show that the size of the halide and the difference of the molecular packing motif could result different conductive properties in these two complexes. (C) 2015 Elsevier B.V. All rights reserved.	[Liang, Yue; Xiao, Xunwen; Meng, Liran; Zhao, Dan; Shen, Liangjun; Fang, Jianghua] Ningbo Univ Technol, Dept Chem Engn, Ningbo 315016, Zhejiang, Peoples R China; [Meng, Liran; Xiao, Debao] Yanshan Univ, Hebei Key Lab Appl Chem, Coll Environm & Chem Engn, Qinhuangdao 066004, Peoples R China; [Fujiwara, Hideki] Osaka Prefecture Univ, Dept Chem, Grad Sch Sci, Naka Ku, Sakai, Osaka 5998531, Japan	Xiao, XW (reprint author), Ningbo Univ Technol, Dept Chem Engn, Ningbo 315016, Zhejiang, Peoples R China.	xunwenxiao@gmail.com; debao.xiao@ysu.edu.cn; hfuji@c.s.osakafu-u.ac.jp			National Natural Science Foundation of China [21203104, 21372136]; Zhejiang Provincial Natural Science Foundation of China [Y4110538]; Ningbo Science and Technology Innovation Team [2011B82002]; Natural Science Foundation of Ningbo [2014A610104]; Project for College Technology Innovation [2014R422003]	This work was supported by the National Natural Science Foundation of China (21203104,21372136), Zhejiang Provincial Natural Science Foundation of China (Y4110538), Ningbo Science and Technology Innovation Team (2011B82002), Natural Science Foundation of Ningbo (2014A610104), and Project for College Technology Innovation (2014R422003).	Kim HJ, 2007, J AM CHEM SOC, V129, P10994, DOI 10.1021/ja073554b; Zhu QY, 2007, INORG CHEM, V46, P10065, DOI 10.1021/ic700672e; Han YF, 2007, J ORGANOMET CHEM, V692, P4545, DOI 10.1016/j.jorganchem.2007.04.034; Liang HW, 2013, ACCOUNTS CHEM RES, V46, P1450, DOI 10.1021/ar300272m; Wang LB, 2012, ACCOUNTS CHEM RES, V45, P1916, DOI 10.1021/ar200305f; Jeon YM, 2007, J AM CHEM SOC, V129, P7480, DOI 10.1021/ja071046w; Hasegawa M, 2010, CHEM SOC REV, V39, P2420, DOI 10.1039/b909347h; Kobayashi A, 2004, CHEM REV, V104, P5243, DOI 10.1021/cr030656I; Geng Y, 2009, CHEM-EUR J, V15, P5124, DOI 10.1002/chem.200802433; Canevet D, 2009, CHEM COMMUN, P2245, DOI 10.1039/b818607n; Cui GL, 2004, J PHYS CHEM B, V108, P13638, DOI 10.1021/jp048195a; Levi J.Y., 2001, TETRAHEDRON LETT, V42, P1571; Liu B, 2006, CHEM COMMUN, P3175, DOI 10.1039/b606967c; Lorcy D, 2009, COORDIN CHEM REV, V253, P1398, DOI 10.1016/j.ccr.2008.09.012; Naka K, 2007, LANGMUIR, V23, P3450, DOI 10.1021/la063367b; Pauling L., 1939, NATURE CHEM BOND; Sheldrick G M., 1997, SHELX 97 PROGRAM SOL; Sheldrick G. M., 1997, SHELXL 97 PROGRAM CR; Xiao XW, 2013, HETEROATOM CHEM, V24, P72, DOI 10.1002/hc.21066; Xiao XW, 2012, SYNTHETIC MET, V162, P900, DOI 10.1016/j.synthmet.2012.04.018; Xiao XW, 2014, SYNTHETIC MET, V189, P42, DOI 10.1016/j.synthmet.2013.12.023	21	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0379-6779			SYNTHETIC MET	Synth. Met.	MAY	2015	203						255	260		10.1016/j.synthmet.2015.02.022		6	Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer Science	Materials Science; Physics; Polymer Science	CG2IH	WOS:000353097600036		
J	Kohlbacher, F; Herstatt, C; Levsen, N				Kohlbacher, Florian; Herstatt, Cornelius; Levsen, Nils			Golden opportunities for silver innovation: How demographic changes give rise to entrepreneurial opportunities to meet the needs of older people	TECHNOVATION			English	Article						Aging; Demographic change; Innovation management; Older users; Opportunity exploitation; Opportunity identification; Opportunity recognition	TECHNOLOGICAL OPPORTUNITIES; STRATEGIC ENTREPRENEURSHIP; EXPERIENCED ENTREPRENEURS; EXPLOIT OPPORTUNITIES; RECOGNITION; IDENTIFICATION; PERSPECTIVE; DISCOVERY; CREATION; UNCERTAINTY	This paper deals with the recognition and exploitation of opportunities arising from demographic changes in the form of population aging. Moreover, it explores the product development process for solutions to meet the demand of the increasing number of older people due to the demographic shift Using a qualitative approach, we analyze opportunity identification and exploitation in the "silver" market (i.e. the market targeting older people). We employ a multiple case analysis based on six different approaches to opportunity recognition and exploitation in the form of product innovations addressing specific needs of older people. Our cases present how firms in different industrial contexts and user settings tackle these needs. We contribute to the state-of-the-field in entrepreneurship and innovation management by providing insights on (a) opportunity recognition and exploitation in connection with demographic change, (b) innovation management and product development for older users, (c) the wider context of opportunity recognition beyond the individual level of the entrepreneur (i.e. the individual-opportunity nexus), and finally (d) the under-researched exploitation process subsequent to opportunity recognition. (C) 2014 Elsevier Ltd. All rights reserved.	[Kohlbacher, Florian] German Inst Japanese Studies DIJ Tokyo, Tokyo 1020094, Japan; [Herstatt, Cornelius; Levsen, Nils] Hamburg Univ Technol, Hamburg, Germany	Kohlbacher, F (reprint author), German Inst Japanese Studies DIJ Tokyo, Japan Jochi Kioizaka Bldg 2F 7-1 Kioicho Chiyoda, Tokyo 1020094, Japan.	kohlbacher@dijtokyo.org					Dimov D, 2011, ENTREP THEORY PRACT, V35, P57, DOI 10.1111/j.1540-6520.2010.00423.x; Webb JW, 2011, J ACAD MARKET SCI, V39, P537, DOI 10.1007/s11747-010-0237-y; Zahra SA, 2008, STRATEG ENTREP J, V2, P243, DOI 10.1002/sej.47; Ucbasaran D, 2009, J BUS VENTURING, V24, P99, DOI 10.1016/j.jbusvent.2008.01.008; KLEVORICK AK, 1995, RES POLICY, V24, P185, DOI 10.1016/0048-7333(93)00762-I; Ardichvili A, 2003, J BUS VENTURING, V18, P105, DOI 10.1016/S0883-9026(01)00068-4; Busenitz LW, 2003, J MANAGE, V29, P285, DOI 10.1016/S0149-2063(03)00013-8; Mitchell JR, 2010, J BUS VENTURING, V25, P138, DOI 10.1016/j.jbusvent.2008.08.001; Eckhardt JT, 2003, J MANAGE, V29, P333, DOI 10.1177/014920630302900304; Shah SK, 2007, STRATEG ENTREP J, V1, P123, DOI 10.1002/sej.15; Aldrich HE, 2003, J BUS VENTURING, V18, P573, DOI 10.1016/S0883-9026(03)00011-9; Vaghely IP, 2010, J BUS VENTURING, V25, P73, DOI 10.1016/j.jbusvent.2008.06.004; Shepherd DA, 2007, STRATEG ENTREP J, V1, P75, DOI 10.1002/sej.3; Haynie JM, 2009, J MANAGE STUD, V46, P337, DOI 10.1111/j.1467-6486.2009.00824.x; Gregoire DA, 2010, ORGAN RES METHODS, V13, P114, DOI 10.1177/1094428109334369; Dimov D, 2007, ENTREP THEORY PRACT, V31, P713, DOI 10.1111/j.1540-6520.2007.00196.x; Ireland RD, 2003, J MANAGE, V29, P963, DOI 10.1016/S0149-2063(03)00086-2; Wood MS, 2010, STRATEG ENTREP J, V4, P66, DOI 10.1002/sej.83; Ozgen E, 2007, J BUS VENTURING, V22, P174, DOI 10.1016/j.jbusvent.2005.12.001; Shane S, 2000, ACAD MANAGE REV, V25, P217, DOI 10.5465/amr.2000.2791611; Baron RA, 2006, ACAD MANAGE PERSPECT, V20, P104; Chiasson M, 2005, J BUS VENTURING, V20, P747, DOI 10.1016/j.jbusvent.2004.07.004; Baron RA, 2006, MANAGE SCI, V52, P1331, DOI 10.1287/mnsc.1060.0538; Alvarez SA, 2007, STRATEG ENTREP J, V1, P11, DOI 10.1002/sej.4; Ketchen DJ, 2007, STRATEG ENTREP J, V1, P371, DOI 10.1002/sej.20; Ireland RD, 2001, ACAD MANAGE EXEC, V15, P49; Shane S, 2000, ORGAN SCI, V11, P448, DOI 10.1287/orsc.11.4.448.14602; Short JC, 2010, J MANAGE, V36, P40, DOI 10.1177/0149206309342746; Katila R, 2003, RES POLICY, V32, P317, DOI 10.1016/S0048-7333(02)00102-6; McMullen JS, 2006, ACAD MANAGE REV, V31, P132; Sarason Y, 2006, J BUS VENTURING, V21, P286, DOI 10.1016/j.jbusvent.2005.02.007; Choi YR, 2004, J MANAGE, V30, P377, DOI 10.1016/j.jm.2003.04.002; de Jong JPJ, 2013, ENTREP THEORY PRACT, V37, P281, DOI 10.1111/j.1540-6520.2011.00459.x; DOSI G, 1988, J ECON LIT, V26, P1120; Drucker P.F., 1985, INNOVATION ENTREPREN, Vix, P277; Eckhardt JT, 2010, INT HANDB SER ENTREP, P47, DOI 10.1007/978-1-4419-1191-9_3; Hideg A., 2011, MARK MANAG, V20, P38; Hill SA, 2010, ORGAN RES METHODS, V13, P85, DOI 10.1177/1094428109337542; Hmieleski KM, 2008, STRATEG ENTREP J, V2, P285, DOI 10.1002/sej.56; Holcombe R.G., 2003, REV AUSTRIAN EC, V16, P25, DOI DOI 10.1023/A:1022953123111; Kohlbacher F., 2011, AGEING INT, V36, P82, DOI DOI 10.1007/S12126-010-9076-X; Kohlbacher F, 2011, FROM GREY TO SILVER: MANAGING THE DEMOGRAPHIC CHANGE SUCCESSFULLY, P189, DOI 10.1007/978-3-642-15594-9_17; Kohlbacher F, 2011, SILVER MARKET PHENOMENON: MARKETING AND INNOVATION IN THE AGING SOCIETY, SECOND EDITION, P1, DOI 10.1007/978-3-642-14338-0; Lettl C, 2008, IEEE T ENG MANAGE, V55, P219, DOI 10.1109/TEM.2008.919717; Park JS, 2005, TECHNOVATION, V25, P739, DOI 10.1016/j.technovation.2004.01.006; Sambasivan M, 2009, TECHNOVATION, V29, P798, DOI 10.1016/j.technovation.2009.04.002; van Burg E, 2012, J PROD INNOVAT MANAG, V29, P1000, DOI 10.1111/j.1540-5885.2012.00976.x; Yin R., 2003, CASE STUDY RES DESIG	48	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4972	1879-2383		TECHNOVATION	Technovation	MAY-JUN	2015	39-40				SI		73	82		10.1016/j.technovation.2014.05.002		10	Engineering, Industrial; Management; Operations Research & Management Science	Engineering; Business & Economics; Operations Research & Management Science	CG2CP	WOS:000353082800007		
J	Hirai, K; Yamada, Y; Hayashi, H; Tanaka, M; Izumiya, K; Suzuki, M; Yoshizawa, M; Moriwaki, H; Akimoto, T; Tsuji, D; Inoue, K; Itoh, K				Hirai, Keita; Yamada, Yuto; Hayashi, Hideki; Tanaka, Masaki; Izumiya, Kohei; Suzuki, Masayuki; Yoshizawa, Misa; Moriwaki, Hideaki; Akimoto, Takehide; Tsuji, Daiki; Inoue, Kazuyuki; Itoh, Kunihiko			Plasma vitamin K concentrations depend on CYP4F2 polymorphism and influence on anticoagulation in Japanese patients with warfarin therapy	THROMBOSIS RESEARCH			English	Article						Warfarin; Vitamin K1; Menaquinone-4; CYP4F2; VKORC1; CYP2C9	EPOXIDE REDUCTASE COMPLEX; CYTOCHROME P4502C9; COAGULATION-FACTOR; DOSE REQUIREMENTS; CLINICAL FACTORS; VKORC1; CYP2C9; VARIANT; IMPACT; COHORT	Introduction: Warfarin is characterized by a large inter-individual variability in dosage requirement. This study aimed to analyze the contribution of the CYP4F2 genetic polymorphism and plasma vitamin K concentration on the warfarin pharmacodynamics in patients and to clarify the plasma vitamin K concentration affecting warfarin sensitivity index in rats. Materials and Methods: Genetic analyses of selected genes were performed and plasma concentrations of warfarin, vitamin K1 (VK1) and menaquinone-4 (MK-4) were measured in 217 Japanese patients. We also assessed the association of plasma VK1 and MK-4 concentrations with the warfarin sensitivity index (INR/Cp) in rats. Results: Patients with the CYP4F2 (rs2108622) TT genotype had significantly higher plasma VK1 and MK-4 concentrations than those with CC and CT genotypes. The multiple linear regression model including VKORC1, CYP4F2, and CYP2C9 genetic variants, age, and weight could explain 42% of the variability in warfarin dosage. The contribution of CYP4F2 polymorphism was estimated to be 2.2%. In contrast, plasma VK1 and MK-4 concentrations were not significantly associated with warfarin dosage in patients. Nevertheless, we were able to demonstrate that the warfarin sensitivity index was attenuated and negatively correlated with plasma VK1 concentration by the oral administration of VK1 in rats, as it resulted in a higher VK1 concentration than that in patients. Conclusions: The plasma VK1 and MK-4 concentrations are significantly influenced by CYP4F2 genetic polymorphism but not associated with warfarin therapy at the observed concentration in Japanese patients. The CYP4F2 polymorphism is poorly associated with inter-individual variability of warfarin dosage requirement. (C) 2015 Elsevier Ltd. All rights reserved.	[Hirai, Keita; Yamada, Yuto; Hayashi, Hideki; Tanaka, Masaki; Izumiya, Kohei; Suzuki, Masayuki; Yoshizawa, Misa; Tsuji, Daiki; Inoue, Kazuyuki; Itoh, Kunihiko] Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Genet, Suruga Ku, Shizuoka 4228526, Japan; [Hayashi, Hideki] Gifu Pharmaceut Univ, Lab Pharm Practice & Social Sci, Gifu 5011196, Japan; [Moriwaki, Hideaki] Shizuoka Prefectural Gen Hosp, Dept Cardiol, Aoi Ku, Shizuoka 4208527, Japan; [Akimoto, Takehide] Shizuoka Prefectural Gen Hosp, Dept Cardiovasc Surg, Aoi Ku, Shizuoka 4208527, Japan	Itoh, K (reprint author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Genet, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	itohk@u-shizuoka-ken.ac.jp	Hirai, Keita/K-6290-2014	Hirai, Keita/0000-0001-8027-3508			KARLSON B, 1986, ACTA MED SCAND, V220, P347; Cha PC, 2010, HUM MOL GENET, V19, P4735, DOI 10.1093/hmg/ddq389; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Kimura R, 2007, THROMB RES, V120, P181, DOI 10.1016/j.thromres.2006.09.007; Lenzini P, 2010, CLIN PHARMACOL THER, V87, P572, DOI 10.1038/clpt.2010.13; WILLIAMS DA, 1972, BIOMETRICS, V28, P519, DOI 10.2307/2556164; Tham LS, 2006, CLIN PHARMACOL THER, V80, P346, DOI 10.1016/j.clpt.2006.06.009; McDonald MG, 2009, MOL PHARMACOL, V75, P1337, DOI 10.1124/mol.109.054833; Wallin R, 2004, TRENDS MOL MED, V10, P299, DOI 10.1016/j.molmed.2004.05.003; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Harrington DJ, 2005, THROMB HAEMOSTASIS, V93, P23, DOI 10.1160/TH04-08-0540; Danese E, 2012, CLIN PHARMACOL THER, V92, P746, DOI 10.1038/clpt.2012.184; Di Fusco D, 2013, THROMB RES, V132, P123, DOI 10.1016/j.thromres.2013.05.002; Johnson JA, 2013, PHARMACOL REV, V65, P987, DOI 10.1124/pr.112.007252; Aquilante CL, 2006, CLIN PHARMACOL THER, V79, P291, DOI 10.1016/j.clpt.2005.11.011; Yoshizawa M, 2009, THROMB RES, V124, P161, DOI 10.1016/j.thromres.2008.11.011; Schurgers LJ, 2004, BLOOD, V104, P2682, DOI 10.1182/blood-2004-04-1525; Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200; Borgiani P, 2009, PHARMACOGENOMICS, V10, P261, DOI 10.2217/14622416.10.2.261; Wang DX, 2008, BLOOD, V112, P1013, DOI 10.1182/blood-2008-03-144899; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Lane S, 2012, BRIT J CLIN PHARMACO, V73, P66, DOI 10.1111/j.1365-2125.2011.04051.x; Hamberg AK, 2007, CLIN PHARMACOL THER, V81, P529, DOI 10.1038/sj.clpt.6100084; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Wadelius M, 2009, BLOOD, V113, P784, DOI 10.1182/blood-2008-04-149070; Bejarano-Achache I, 2012, CLIN THER, V34, P811, DOI 10.1016/j.clinthera.2012.02.009; Cen HJ, 2010, BRIT J CLIN PHARMACO, V70, P234, DOI 10.1111/j.1365-2125.2010.03698.x; Cushman M, 2001, BRIT J HAEMATOL, V112, P572, DOI 10.1046/j.1365-2141.2001.02635.x; Edson KZ, 2013, BIOCHEMISTRY-US, V52, P8276, DOI 10.1021/bi401208m; Harada T, 2010, THROMB RES, V126, P183, DOI 10.1016/j.thromres.2010.05.016; Hirai K, 2013, DRUG METAB PHARMACOK, V28, P132, DOI 10.2133/dmpk.DMPK-12-RG-078; Klein TE, 2009, NEW ENGL J MED, V360, P753; Kurnik D, 2003, ANN PHARMACOTHER, V37, P1603, DOI 10.1345/aph.1D102; Moridani M, 2006, CLIN BIOCHEM, V39, P606, DOI 10.1016/j.clinbiochem.2006.01.023; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433	38	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	MAY	2015	135	5					861	866		10.1016/j.thromres.2015.02.019		6	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CG7NP	WOS:000353490800015		
J	Kuroiwa, M; Takahira, N; Ujihashi, Y; Miida, K; Arai, Y; Kawatani, H				Kuroiwa, Masayuki; Takahira, Naonobu; Ujihashi, Yosikatsu; Miida, Kazumasa; Arai, Yumi; Kawatani, Hiroko			Reduction in the soles of graduated compression stockings prevents falls without reducing the preventive effect for venous stasis	THROMBOSIS RESEARCH			English	Article						venous thrombosis; graduated compression stocking; fall-prevention; venous stasis	THIGH-LENGTH; BLOOD-FLOW; THROMBOSIS; SOCKS	Introduction: Graduated compression stockings (GCS) are widely used to prevent venous thromboembolism; however, GCS are slippery and a fall hazard owing to the synthetic fibers. Therefore, we investigated whether changing the sole's shape decreased slipping. Materials and Methods: We designed four GCS types with varying sole shapes and normal slipperiness to compare with normal GCS and a barefoot model without GCS (control). A mannequin foot with a GCS type or the control was placed on a ramp at 0 degrees, and the angle was slowly increased. When the mannequin foot had moved >= 100% from the original position, the angle of slide-out (AS) was measured, and the forward and backward AS values were compared. Next, we investigated whether sole modification influenced the effectiveness of the normal GCS for preventing venous stasis. The same GCS type (Torenka)was given to 30 healthy volunteers. Peak systolic velocities (PSV) of the popliteal vein prior to wearing GCS and 20 and 40 min after wearing GCS were measured using Doppler ultrasound, and the changes were compared with those of the normal GCS. Results: Only the AS of the GCS type with the smallest sole area (Torenka) was not significantly different from the control's AS, which was significantly larger than the normal GCS' AS. Normal and Torenka GCS resulted in significantly increased PSV after 20 and 40 min compared with no GCS, with no significant difference between the two groups. Conclusion: Torenka-type GCS were the least slippery but were as effective as normal GCS for venous stasis. (C) 2015 Elsevier Ltd. All rights reserved.	[Kuroiwa, Masayuki] Kitasato Univ, Dept Anesthesiol, Sch Med, Sagamihara, Kanagawa 2520375, Japan; [Takahira, Naonobu] Kitasato Univ, Dept Rehabil, Sch Allied Hlth Sci, Sagamihara, Kanagawa 2520375, Japan; [Ujihashi, Yosikatsu; Miida, Kazumasa; Arai, Yumi; Kawatani, Hiroko] Kitasato Univ Hosp, Sagamihara, Kanagawa, Japan	Kuroiwa, M (reprint author), Kitasato Univ, Dept Anesthesiol, Sch Med, Sagamihara, Kanagawa 2520375, Japan.	mkuroiwa@med.kitasato-u.ac.jp			Kitasato University Hospital's Employee's Public Appeal	This work was solely supported by research funds obtained through the Kitasato University Hospital's 2012 Employee's Public Appeal. The study sponsor did not have any role in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; or in the decision to submit the article for publication.	Tsai YJ, 2013, GAIT POSTURE, V37, P88, DOI 10.1016/j.gaitpost.2012.06.034; Agu O, 1999, BRIT J SURG, V86, P992, DOI 10.1046/j.1365-2168.1999.01195.x; Delis KT, 2004, THROMB HAEMOSTASIS, V91, P941, DOI 10.1160/TH03-12-0754; SIGEL B, 1975, ARCH SURG-CHICAGO, V110, P171; Menant JC, 2008, J REHABIL RES DEV, V45, P1167, DOI 10.1682/JRRD.2007.10.0168; Benko T, 2001, CLIN ORTHOP RELAT R, P197; Chari Satyan, 2009, BMC Geriatr, V9, P39, DOI 10.1186/1471-2318-9-39; Charles T, 2011, ADV THER, V28, P227, DOI 10.1007/s12325-010-0107-5; Dennis M, 2010, ANN INTERN MED, V153, P553, DOI 10.7326/0003-4819-153-9-201011020-00280; Gillon R, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7817; Gronqvist R, 2001, ERGONOMICS, V44, P1167, DOI 10.1080/00140130110085556; Hitos K, 2007, J THROMB HAEMOST, V5, P1890, DOI 10.1111/j.1538-7836.2007.02664.x; Hubscher M, 2011, GAIT POSTURE, V33, P740, DOI 10.1016/j.gaitpost.2011.02.021; Kalodiki E, 2007, EUR J VASC ENDOVASC, V33, P483, DOI 10.1016/j.ejvs.2006.11.033; Sachdeva A, 2014, COCHRANE DB SYST REV, V12; Stein PD, 2010, THROMB HAEMOSTASIS, V103, P138, DOI 10.1160/TH09-06-0365	16	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	MAY	2015	135	5					877	881		10.1016/j.thromres.2015.02.028		5	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CG7NP	WOS:000353490800018		
J	Iba, T; Saitoh, D; Gando, S; Thachil, J				Iba, Toshiaki; Saitoh, Daizoh; Gando, Satoshi; Thachil, Jecko			The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation	THROMBOSIS RESEARCH			English	Article						Antithrombin III; Disseminated intravascular coagulation; Sepsis; Anticoagulant agents; Consumption coagulopathies	CRITICALLY-ILL PATIENTS; ORGAN FAILURE; BLEEDING RISK; SEPTIC SHOCK; MULTICENTER; GUIDELINES; MORTALITY; EFFICACY; MARKERS; TRIAL	Introduction: Recent studies have repeatedly reported the effectiveness of antithrombin (AT) supplementation for sepsis-associated disseminated intravascular coagulation (DIC). In this study, we intended to elucidate the usefulness of monitoring antithrombin activity during antithrombin supplementation. Methods: Data of 926 patients with sepsis-associated DIC who had been undergone AT substitution were retrospectively analyzed. All the patients had received 1500 IU/day of AT concentrate for three consecutive days. The patients' demographic characteristics, including the age, body weight, baseline DIC score and baseline AT activity, and treatment-relatedmarkers such as the change in DIC score and the change in the AT activity with treatment were analyzed in relation to the 28-day mortality. Results: Logistic regression analysis revealed a significant association of the patients' age, baseline AT activity, Delta AT activity, baseline DIC score and. DIC score to the patients' outcomes. The cutoff values of the AT activities for death calculated by the ROC curve analysis were 41.3% for the baseline AT activity, 72.9% for the post-treatment AT activity and 37.0% for Delta AT activity. The area under the ROC curve (AUC) showed discriminative powers for the baseline AT activity, post-treatment AT activity and Delta AT activity of 0.58, 0.69 and 0.66, respectively. Conclusions: Monitoring of the AT activity is useful to predict the patients' outcome. Furthermore, the measurement of baseline AT activity may help in determining the appropriate dose for AT supplementation. (C) 2015 Elsevier Ltd. All rights reserved.	[Iba, Toshiaki] Juntendo Univ, Dept Emergency & Disaster Med, Grad Sch Med, Tokyo 1138421, Japan; [Saitoh, Daizoh] Natl Def Med Coll, Res Inst, Div Traumatol, Tokorozawa, Saitama, Japan; [Gando, Satoshi] Hokkaido Univ, Dept Anesthesiol & Crit Care Med, Grad Sch Med, Div Acute & Crit Care Med, Sapporo, Hokkaido 060, Japan; [Thachil, Jecko] Manchester Royal Infirm, Dept Haematol, Manchester, Lancs, England	Iba, T (reprint author), Juntendo Univ, Emergency & Disaster Med, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	toshiiba@cf6.so-net.ne.jp; ds0711@ndmc.ac.jp; gando@med.hokudai.ac.jp; Jecko.thachil@cmft.nhs.uk					BONE RC, 1992, CRIT CARE MED, V20, P864; Kinasewitz GT, 2004, CRIT CARE, V8, pR82, DOI 10.1186/cc2459; Pettila V, 2002, CRIT CARE MED, V30, P271, DOI 10.1097/00003246-200202000-00001; Iba T, 2012, THROMB RES, V130, pE129, DOI 10.1016/j.thromres.2012.03.021; Kienast J, 2006, J THROMB HAEMOST, V4, P90, DOI 10.1111/j.1538-7836.2005.01697.x; FOURRIER F, 1992, CHEST, V101, P816, DOI 10.1378/chest.101.3.816; Wada H, 2010, THROMB RES, V125, P6, DOI 10.1016/j.thromres.2009.08.017; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Dhainaut JF, 2005, CRIT CARE MED, V33, P341, DOI 10.1097/01.CCM.0000153520.31562.48; Gando S, 2006, CRIT CARE MED, V34, P625, DOI 10.1097/01.CCM.0000202209.42491.38; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI 10.1007/s00134-012-2769-8; Gando S, 1996, THROMB HAEMOSTASIS, V75, P224; Gando S, 2013, CRIT CARE, V17, DOI 10.1186/cc13163; Iba T, 2005, SHOCK, V23, P25, DOI 10.1097/01.shk.0000144422.32647.b6; Iba T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0497-x; Okabayashi K, 2004, AM J HEMATOL, V76, P225, DOI 10.1002/ajh.20089; Sawamura A, 2009, CLIN APPL THROMB-HEM, V15, P561, DOI 10.1177/1076029608323497; Sivula M, 2005, INTENS CARE MED, V31, P1209, DOI 10.1007/s00134-005-2685-2; Tagami T, 2014, J THROMB HAEMOST, V12, P1470, DOI 10.1111/jth.12643; Wiedermann CJ, 2006, BLOOD COAGUL FIBRIN, V17, P521, DOI 10.1097/01.mbc.0000245302.18010.40	20	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	MAY	2015	135	5					897	901		10.1016/j.thromres.2015.03.007		5	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CG7NP	WOS:000353490800021		
J	Ohno, K; Tomizawa, A; Jakubowski, JA; Mizuno, M; Sugidachi, A				Ohno, Kousaku; Tomizawa, Atsuyuki; Jakubowski, Joseph A.; Mizuno, Makoto; Sugidachi, Atsuhiro			Characterization of platelet aggregation responses in microminipigs: Comparison with miniature pigs and the influence of dual antiplatelet administration of aspirin plus prasugrel	THROMBOSIS RESEARCH			English	Article						Antiplatelet; Aspirin; Microminipig; Miniature Pig; Platelet Aggregation; Prasugrel	P2Y(12) RECEPTOR ANTAGONIST; CORONARY-ARTERY-DISEASE; EX-VIVO MODEL; ANIMAL-MODEL; MYOCARDIAL-INFARCTION; ENDOTHELIAL FUNCTION; POTENT ANTIPLATELET; THROMBUS FORMATION; CHOLESTEROL DIET; COMBINED THERAPY	We aimed to characterize platelet aggregation responses and the impact of dual antiplatelet therapy in microminipigs. In this in vitro study, both adenosine-5'-diphosphate (ADP, 5-50 mu M) and collagen (2-20 mu g/ml) induced concentration-related platelet aggregation in the microminipigs; 20 mu M ADP and 5 and 12.5 mu g/ml collagen were selected for further ex vivo studies. Aspirin plus prasugrel were administered orally for 7 days (n = 4/each group). Ex vivo platelet aggregation was analyzed on Day 1 (1 and 4 h after administration), Day 4 (4 h), and Day 7 (4 h) under three different prasugrel dosing regimens: LD0/MD1 (1 mg/kg/day), LD0/MD3 (3 mg/kg/day), and LD10/MD1 (10 mg/kg loading dose and 1 mg/kg/day maintenance dose). Aspirin (10 mg/kg/day) was administered to all groups. In the presence of aspirin, prasugrel at 3 and 10 mg/kg significantly inhibited ADP-induced platelet aggregation on Day 1. On Days 4 and 7, significant inhibition of platelet aggregation (IPA) was also observed in each group. With 5 mu g/ml collagen-induced platelet aggregation, all three groups showed significant IPA at 4 h on Day 1 or later. In 12.5 mu g/ml collagen-induced platelet aggregation, all groups showed significant effects on Days 4 and 7; however, the 30%-35% IPA was considerably lower than that (50%-60%) found with 5 mu g/ml collagen. In Clawn miniature pigs, similar inhibitory patterns were observed for both ADP-and collagen-induced ex vivo platelet aggregation. In conclusion, these results indicated that microminipigs as well as miniature pigs may represent useful experimental animals for thrombosis research. (C) 2015 Elsevier Ltd. All rights reserved.	[Ohno, Kousaku; Tomizawa, Atsuyuki; Mizuno, Makoto; Sugidachi, Atsuhiro] Daiichi Sankyo Co Ltd, Biol Res Labs, Tokyo 1408710, Japan; [Jakubowski, Joseph A.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Sugidachi, A (reprint author), Daiichi Sankyo Co Ltd, Biol Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	sugidachi.atsuhiro.r7@daiichisankyo.co.jp					Niitsu Y, 2005, SEMIN THROMB HEMOST, V31, P184, DOI 10.1055/s-2005-869524; Dobesh PP, 2009, PHARMACOTHERAPY, V29, P1089, DOI 10.1592/phco.29.9.1089; Puccinelli E, 2011, CURR DRUG METAB, V12, P507; Kawaguchi H, 2011, J PHARMACOL SCI, V115, P115, DOI 10.1254/jphs.10R17FM; Akioka K, 2014, IN VIVO, V28, P81; Jneid H, 2012, CIRCULATION, V126, P875, DOI 10.1161/CIR.0b013e318256f1e0; Merrifield CA, 2011, MOL BIOSYST, V7, P2577, DOI 10.1039/c1mb05023k; Li YG, 2009, PLATELETS, V20, P316, DOI 10.1080/09537100903046317; Goodrich JA, 2003, FERTIL STERIL, V79, P779, DOI 10.1016/S0015-0282(02)04826-4; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Jernberg T, 2006, EUR HEART J, V27, P1166, DOI 10.1093/eurheartj/ehi877; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Buergler JM, 2005, J THROMB THROMBOLYS, V19, P115, DOI 10.1007/s11239-005-1381-y; Sugiyama A, 2011, J PHARMACOL SCI, V115, P122, DOI 10.1254/jphs.10R21FM; Herrmann J, 2007, CIRC RES, V101, P865, DOI 10.1161/CIRCRESAHA.107.152959; Yokoi H, 2012, THROMB RES, V129, P623, DOI 10.1016/j.thromres.2011.11.023; Turk JR, 2005, INT J EXP PATHOL, V86, P335, DOI 10.1111/j.0959-9673.2005.00446.x; Niitsu Y, 2008, EUR J PHARMACOL, V579, P276, DOI 10.1016/j.ejphar.2007.10.005; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Miyauchi K, 2008, CIRC J, V72, P832, DOI 10.1253/circj.72.832; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Jakubowski JA, 2007, CARDIOVASC DRUG REV, V25, P357; Murayama N, 2009, DRUG METAB PHARMACOK, V24, P404; Bierbach B, 2006, THROMB HAEMOSTASIS, V95, P354, DOI 10.1160/TH05-05-0377; EVANS G, 1968, J EXP MED, V128, P877, DOI 10.1084/jem.128.5.877; Forster R, 2010, J PHARMACOL TOX MET, V62, P227, DOI 10.1016/j.vascn.2010.05.007; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Jakubowski JA, 2012, CARDIOVASC THER, V30, pe174, DOI 10.1111/j.1755-5922.2011.00263.x; Kawaguchi H, 2014, J ATHEROSCLER THROMB, V21, P186; Makkar RR, 1998, EUR HEART J, V19, P1538, DOI 10.1053/euhj.1998.1042; Miura N, 2013, IN VIVO, V27, P357; Miyoshi N, 2010, IN VIVO, V24, P671; Osende JI, 2004, J THROMB HAEMOST, V2, P492, DOI 10.1111/j.1538-7933.2004.00639.x; Pendyala LK, 2012, JACC-CARDIOVASC INTE, V5, P436, DOI 10.1016/j.jcin.2011.11.013; Sheehy Alexander, 2011, Cardiovasc Revasc Med, V12, P375, DOI 10.1016/j.carrev.2011.05.003; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Sugidachi A, 2000, BRIT J PHARMACOL, V129, P1439, DOI 10.1038/sj.bjp.0703237; Sugidachi A, 2001, BRIT J PHARMACOL, V132, P47, DOI 10.1038/sj.bjp.0703761; Takai H, 2008, J VET MED SCI, V70, P943, DOI 10.1292/jvms.70.943; Vilahur G, 2004, CIRCULATION, V110, P1686, DOI 10.1161/01.CIR.0000142296.19558.99; Winchester DE, 2011, J AM COLL CARDIOL, V57, P1190, DOI 10.1016/j.jacc.2010.10.030; Zhang C, 2006, J LIPID RES, V47, P2055, DOI 10.1194/jlrM600226-JLR200	42	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	MAY	2015	135	5					933	938		10.1016/j.thromres.2015.02.014		6	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CG7NP	WOS:000353490800025		
J	Masuda, Y; Tamura, S; Matsuno, K; Nagasawa, A; Hayasaka, K; Shimizu, C; Moriyama, T				Masuda, Yuya; Tamura, Shogo; Matsuno, Kazuhiko; Nagasawa, Ayumi; Hayasaka, Koji; Shimizu, Chikara; Moriyama, Takanori			Diverse CD36 expression among Japanese population: defective CD36 mutations cause platelet and monocyte CD36 reductions in not only deficient but also normal phenotype subjects	THROMBOSIS RESEARCH			English	Article						CD36 molecule expression; CD36 deficiency; gene polymorphisms; platelets; monocytes	LOW-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR CD36; FATTY-ACID UPTAKE; GLYCOPROTEIN-IV; MOLECULAR-BASIS; OXIDIZED LDL; ATHEROSCLEROSIS; IDENTIFICATION; NAKA; ATHEROGENESIS	Introduction: CD36 is a multifunctional glycoprotein expressed on various human cells, including platelets and monocytes. Five CD36 gene mutations (C268T, 949insA, 329-339del, 1228-1239del and 629-631del/insAAAAC) are mainly responsible for CD36-deficient phenotypes in Japan. It has also been reported that platelet CD36 expression varies widely among normal phenotype individuals. Here, in order to obtain further insight into CD36 expression, we investigated the association between platelet and monocyte CD36 expression levels and defective mutations in the Japanese population. Materials and Methods: Blood samples were collected from 135 healthy Japanese volunteers. CD36 expression levels on platelets and monocytes were quantitatively analyzed by flow cytometry. Real-time PCR, PCR-RFLP and allele-specific PCR were performed to detect mutant genotypes. Results: In this population, we found 2 (1.5%) and 9 (6.7%) CD36-deficient subjects as type I and type II, respectively. Among normal phenotype subjects, CD36 expression levels ranged from 1,259 to 11,002 (4,487 +/- 2,017) molecules/platelet and from 211 to 5,150 (1,628 +/- 986) molecules/monocyte. Genotyping assay showed that heterozygotes with the defective mutations were present in normal (12.9%) and type II-deficient (66.7%) subjects, and that these heterozygous mutations led to decreases in CD36 surface expression on platelets and monocytes. Conclusions: Heterozygous CD36 mutations, previously known to lead to deficiency in this molecule, are one of the factors responsible for the diversity of CD36 surface expression levels on platelets and monocytes in normal phenotype subjects. (C) 2015 Elsevier Ltd. All rights reserved.	[Masuda, Yuya] Hokkaido Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Masuda, Yuya; Matsuno, Kazuhiko; Hayasaka, Koji; Shimizu, Chikara] Hokkaido Univ Hosp, Div Lab & Transfus Med, Sapporo, Hokkaido 060, Japan; [Tamura, Shogo] Univ Yamanashi, Dept Clin Lab Med, Fac Med, Chuo Ku, Kofu, Yamanashi, Japan; [Tamura, Shogo] Japan Soc Promot Sci, Tokyo, Japan; [Nagasawa, Ayumi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Moriyama, Takanori] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan	Moriyama, T (reprint author), Kita 12,Nishi 5,Kita Ku, Sapporo, Hokkaido 0600812, Japan.	moriyama@hs.hokudai.ac.jp			Sapporo Bio Cluster "Bio-S"; Ministry of Education, Sports, Science and Technology (MEXT); Hokkaido University, Sapporo, Japan	This study was partially supported by the Sapporo Bio Cluster "Bio-S", the Program for Fostering Regional Innovation (Global Type) of the Ministry of Education, Sports, Science and Technology (MEXT), and by the internal funds of Hokkaido University, Sapporo, Japan.	Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Ghosh A, 2011, BLOOD, V117, P6355, DOI 10.1182/blood-2011-02-338582; Silverstein RL, 2000, CURR OPIN LIPIDOL, V11, P483, DOI 10.1097/00041433-200010000-00006; Rac ME, 2007, MOL MED, V13, P288, DOI 10.2119/2006-00088.Rac; Tanaka T, 2001, J LIPID RES, V42, P751; ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Yamashita S, 2007, MOL CELL BIOCHEM, V299, P19, DOI 10.1007/s11010-005-9031-4; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Yanai H, 2000, THROMB HAEMOSTASIS, V84, P436; Love-Gregory L, 2011, HUM MOL GENET, V20, P193, DOI 10.1093/hmg/ddq449; Daub K, 2010, SEMIN THROMB HEMOST, V36, P146, DOI 10.1055/s-0030-1251498; GREENWALT DE, 1992, BLOOD, V80, P1105; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2004, ARTERIOSCL THROM VAS, V24, P2333, DOI 10.1161/01.ATV.0000148007.06370.68; YAMAMOTO N, 1990, BLOOD, V76, P1698; Chiba H, 2001, LANCET, V358, P243, DOI 10.1016/S0140-6736(01)05430-7; IKEDA H, 1989, VOX SANG, V57, P213; KASHIWAGI H, 1995, THROMB HAEMOSTASIS, V74, P758; KASHIWAGI H, 1995, J CLIN INVEST, V95, P1040, DOI 10.1172/JCI117749; Kashiwagi H, 1996, ARTERIOSCL THROM VAS, V16, P1026; Kashiwagi H, 2001, HUM GENET, V108, P459, DOI 10.1007/s004390100525; KASHIWAGI H, 1994, BLOOD, V83, P3545; Matsumoto K, 2000, ARTERIOSCL THROM VAS, V20, P1027; Miyaoka K, 2001, LANCET, V357, P686, DOI 10.1016/S0140-6736(00)04138-6; Nergiz-Unal R, 2011, J THROMB HAEMOST, V9, P1835, DOI 10.1111/j.1538-7836.2011.04416.x; Nergiz-Unal R., 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P42, DOI 10.2174/187152511794182855; Nozaki S, 1999, MOL CELL BIOCHEM, V192, P129, DOI 10.1023/A:1006816702425; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Okamoto F, 1998, JPN CIRC J, V62, P499, DOI 10.1253/jcj.62.499; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; Siegel-Axel D, 2008, CARDIOVASC RES, V78, P8, DOI 10.1093/cvr/cvn015; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Silverstein RL, 2009, CLIN LIPIDOL, V4, P767, DOI 10.2217/CLP.09.57; TAKE H, 1993, BRIT J HAEMATOL, V84, P387, DOI 10.1111/j.1365-2141.1993.tb03091.x; TOMIYAMA Y, 1990, BLOOD, V75, P684; Watanabe K, 1998, Ann Nucl Med, V12, P261; Xu X, 2014, BLOOD TRANSFUS, P1; Xu XZ, 2013, THROMB HAEMOSTASIS, V110, P1199, DOI 10.1160/TH13-05-0435; YAMAMOTO N, 1994, BLOOD, V83, P392; Yanai H, 2000, AM J MED GENET, V93, P299, DOI 10.1002/1096-8628(20000814)93:4<299::AID-AJMG9>3.0.CO;2-7	41	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	MAY	2015	135	5					951	957		10.1016/j.thromres.2015.03.002		7	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CG7NP	WOS:000353490800028		
J	Honda, Y; Morishima, Y				Honda, Yuko; Morishima, Yoshiyuki			Thrombin generation induced by tissue factor plus ADP in human platelet rich plasma: A potential new measurement to assess the effect of the concomitant use of an oral factor Xa inhibitor edoxaban and P2Y(12) receptor antagonists	THROMBOSIS RESEARCH			English	Article; Proceedings Paper	24th Congress of the International-Society-on-Thrombosis-and-Haemostasis	JUN 29-JUL 04, 2013	Amsterdam, NETHERLANDS	Int Soc Thrombosis & Haemostasis		Thrombin generation; ADP; Tissue factor; Factor Xa inhibitor; P2Y(12) receptor antagonist; Edoxaban	ACUTE CORONARY SYNDROME; ATRIAL-FIBRILLATION; PERCUTANEOUS CORONARY; ANTIPLATELET THERAPY; WARFARIN; RIVAROXABAN; DABIGATRAN; APIXABAN; TRIAL	Introduction: Patients with atrial fibrillation undergoing percutaneous coronary intervention may require combination therapy with anticoagulants and antiplatelet agents. The objectives of this study were to establish an assay which can evaluate the effects of both anticoagulants and P2Y(12) receptor antagonists and determine the effects of edoxaban, a direct factor Xa inhibitor, and P2Y12 receptor antagonists (clopidogrel and ticagrelor) alone and when combined. Material and methods: Human platelet-rich plasma (PRP) from healthy subjects was stimulated with adenosine diphosphate (ADP) plus tissue factor. Thrombin generation was measured by means of calibrated automated thrombography. Results: Combination of 10 mu M ADP and lowconcentration (0.25 pM) tissue factor induced reproducible thrombin generation in human PRP. Edoxaban (40 and 80 ng/mL), active metabolite of clopidogrel (AM-clopidogrel, 10 and 20 mu g/mL), and ticagrelor (3 mu g/mL) alone inhibited ADP plus tissue factor-induced thrombin generation. Edoxaban suppressed all 5 parameters (lag time, peak, time to peak, endogenous thrombin potential, and maximum rate), whereas AM-clopidogrel and ticagrelor inhibited 4 and 3 parameters, respectively. Concomitant treatment with edoxaban and AM-clopidogrel or ticagrelor produced an additive inhibition of thrombin generation compared to the single treatments. Conclusions: The thrombin generation assay induced by ADP plus tissue factor can detect the activities of both edoxaban and P2Y12 receptor antagonists. Combination of edoxaban and a P2Y12 receptor antagonist shows additive inhibition. These results suggest that ADP plus tissue factor-induced thrombin generation may be a useful measurement to assess the combination effects of anticoagulants and P2Y12 receptor antagonists in a single assay. (C) 2015 Elsevier Ltd. All rights reserved.	[Honda, Yuko; Morishima, Yoshiyuki] Daiichi Sankyo Co Ltd, Biol Res Labs, R&D Div, Tokyo 1408710, Japan	Morishima, Y (reprint author), Daiichi Sankyo Co Ltd, Biol Res Labs, R&D Div, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	morishima.yoshiyuki.t4@daiichisankyo.co.jp					Alexander JH, 2011, NEW ENGL J MED, V365, P699, DOI 10.1056/NEJMoa1105819; Altman Raul, 2006, Thromb J, V4, P5, DOI 10.1186/1477-9560-4-5; Favaloro EJ, 2011, PATHOLOGY, V43, P682, DOI 10.1097/PAT.0b013e32834bf5f4; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Oldgren J, 2011, EUR HEART J, V32, P2781, DOI 10.1093/eurheartj/ehr113; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; [Anonymous], 2014, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.G2116; van der Meijden PEJ, 2005, THROMB HAEMOSTASIS, V93, P1128, DOI 10.1160/TH04-09-0597; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Fitchett D, 2014, CURR OPIN CARDIOL, V29, P1, DOI 10.1097/HCO.0000000000000024; Furugohri T, 2008, J THROMB HAEMOST, V6, P1542, DOI 10.1111/j.1538-7836.2008.03064.x; Kralev S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024964; Lip GYH, 2014, EUR HEART J, V35, P3155, DOI 10.1093/eurheartj/ehu298; Mezzano D, 2009, SEMIN THROMB HEMOST, V35, P242, DOI 10.1055/s-0029-1220785; Morishima Y, 2011, J THROMB HAEMOST SS2, V9, P901	19	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	MAY	2015	135	5					958	962		10.1016/j.thromres.2015.03.001		5	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CG7NP	WOS:000353490800029		
J	Iba, T; Nagakari, K				Iba, Toshiaki; Nagakari, Kunihiko			The effect of plasma-derived activated protein C on leukocyte cell-death and vascular endothelial damage	THROMBOSIS RESEARCH			English	Article						Microcirculation; Necrosis; Neutrophil extracellular traps; Nucleosome; High Mobility Group Box 1; Intravital microscope	NEUTROPHIL EXTRACELLULAR TRAPS; SEPTIC SHOCK; SEVERE SEPSIS; ANTICOAGULANT; INFLAMMATION; ENDOTOXEMIA; HISTONES; PATHWAY; MICROCIRCULATION; MECHANISMS	Introduction: The role of leukocyte and its death in the progression in inflammation attracts attention nowadays. The purpose of this study is to examine the effects of activated protein C (APC) on leucocyte cell death and vascular endothelial damage in sepsis. Methods: Wistar rats were infused with lipopolysaccharide (8.0 mg/kg) concomitantly with either a low dose (0.5 mg/kg), a high dose (5.0 mg/kg) of plasma-derived APC or albumin. One and 3 hours after the injections, the mesenteric microcirculation was observed by intravital microscopy. The serum levels of nucleosome and High Mobility Group Box 1 (HMGB1) were measured in each group. In another series, cultured leukocyte cell-death in the medium supplemented with serum obtained from each group was examined in vitro. Results: Microcirculatory disturbance was significantly suppressed in both the high-dose and low-dose groups compared to the control group (P < 0.01, 0.05, respectively). The bleeding area was significantly increased in the control and high-dose groups (P < 0.05, 0.01, respectively). Serumlevels of cell death markers such as nucleosome and HMGB1 were significantly decreased in the treatment groups (P < 0.01), and the protective effect was more pronounced in high-dose group. Cell death suppression was most prominent in high-dose group and the formation of neutrophil extracellular traps (NETs) was significantly suppressed in the treatment groups. Conclusion: Low-dose plasma-derived APC exerted protective effects on the microcirculation without increasing the risk of bleeding. The protective effect against leukocyte cell death and the suppressive effect on NETs formation of APC might be related to its beneficial effects. (C) 2015 Elsevier Ltd. All rights reserved.	[Iba, Toshiaki; Nagakari, Kunihiko] Juntendo Univ, Grad Sch Med, Dept Emergency & Disaster Med, Tokyo 1138421, Japan	Iba, T (reprint author), Juntendo Univ, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	toshiiba@cf6.so-net.ne.jp; kun@juntendo-urayasu.jp			Kaketsuken and Teijin Pharma	This study was funded by Kaketsuken and Teijin Pharma.	Cao CZ, 2010, J CLIN INVEST, V120, P1971, DOI 10.1172/JCI40380; Sturn DH, 2003, BLOOD, V102, P1499, DOI 10.1182/blood-2002-12-3880; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Steppich BA, 2008, THROMB HAEMOSTASIS, V100, P1068, DOI 10.1160/TH08-05-0293; Bouwens EAM, 2013, J THROMB HAEMOST, V11, P242, DOI 10.1111/jth.12247; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Griffin JH, 2012, INT J HEMATOL, V95, P333, DOI 10.1007/s12185-012-1059-0; Magna M, 2014, MOL MED, V20, P138, DOI 10.2119/molmed.2013.00164; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Elphick GF, 2009, BLOOD, V113, P4078, DOI 10.1182/blood-2008-09-180968; Fuchs TA, 2011, BLOOD, V118, P3708, DOI 10.1182/blood-2011-01-332676; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Nick JA, 2004, BLOOD, V104, P3878, DOI 10.1182/blood-2004-06-2140; Christiaans SC, 2013, AM J PHYSIOL-LUNG C, V305, pL455, DOI 10.1152/ajplung.00093.2013; Aoki N, 2002, INT J HEMATOL, V75, P540, DOI 10.1007/BF02982120; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436; Hoffmann JN, 2004, CRIT CARE MED, V32, P1011, DOI 10.1097/01.CCM.0000120058.88975.42; Macias WL, 2005, CRIT CARE, V9, pS38, DOI 10.1186/cc3747; Bir N, 2011, AM J RESP CELL MOL, V45, P632, DOI 10.1165/rcmb.2010-0397OC; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Gillrie MR, 2012, AM J PATHOL, V180, P1028, DOI 10.1016/j.ajpath.2011.11.037; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Hemmer CJ, 2011, TROP MED INT HEALTH, V16, P906, DOI 10.1111/j.1365-3156.2011.02788.x; Iba T, 2005, J JPN SOC INTENSIVE, V12, P191; Iba T, 2005, CRIT CARE MED, V33, P368, DOI 10.1097/01.CCM.0000153415.04995.88; Iba T, 2014, CRIT CARE, V18, DOI 10.1186/cc13983; Iba T, 2002, SHOCK, V17, P159, DOI 10.1097/00024382-200202000-00013; Kager LM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002306; Kalil AC, 2012, LANCET INFECT DIS, V12, P678, DOI 10.1016/S1473-3099(12)70157-3; Kambas K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045427; Levi M, 2007, CRIT CARE, V11, DOI 10.1186/cc6154; MILETICH JP, 1990, J BIOL CHEM, V265, P11397; Rimmer E, 2012, CRIT CARE MED, V40, P2974, DOI 10.1097/CCM.0b013e31825fd6d9; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Schouten M, 2012, CRIT CARE, V16, DOI 10.1186/cc11910; Simioni P, 1996, BLOOD, V88, P2101; Weiler H, 2010, CRIT CARE MED, V38, pS18, DOI 10.1097/CCM.0b013e3181c9cbb5; Zhou J, 2012, MICROVASC RES, V83, P276, DOI 10.1016/j.mvr.2012.03.003	40	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	MAY	2015	135	5					963	969		10.1016/j.thromres.2015.03.012		7	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CG7NP	WOS:000353490800030		
J	Bilano, VLF; Borja, MP; Cruz, EL; Tan, AG; Mortera, LL; Reganit, PFM				Bilano, Ver Luanni Feliciano; Borja, Maridel P.; Cruz, Eduardo L.; Tan, Alvin G.; Mortera, Lalaine L.; Reganit, Paul Ferdinand M.			Smoking-attributable burden of lung cancer in the Philippines	TOBACCO CONTROL			English	Article							TOBACCO CONTROL; CALIFORNIA; DISEASES	Background In the Philippines, smoking is highly prevalent and tobacco control policies fail to fully implement the WHO Framework Convention on Tobacco Control provisions. To aid in policy change, intervention implementation, monitoring and evaluation, this study aimed to provide the first internally consistent and latest Philippine estimates of the following: disability-adjusted life-years (DALYs) lost due to lung cancer; population-attributable fractions (PAFs) of smoking; and smoking-attributable lung cancer DALYs. Methods This study applied the Global Burden of Disease and Comparative Risk Assessment frameworks to secondary data, supplemented by expert opinion. A comprehensive internally consistent assessment of disease epidemiology was conducted using DISMOD II and disease impact was quantified as DALYs. PAFs were calculated using the smoking impact ratio and Monte Carlo uncertainty analyses were conducted. Results For 2008, lung cancer incidence and mortality estimates were 10 871 cases and 9871 deaths respectively. Lung cancer accounted for an estimated 267 787 DALYs lost, 99% of which were due to years of life lost. Overall, the PAF of smoking was 65% and a total of 173 103 DALYs were smoking-attributable. There were increasing trends in incidence, mortality and DALY rates with age. The majority of incidence (72%), mortality (71%) and disease burden (72%) occurred among men, who also had higher PAF estimates. Conclusions Considerable health gains could be achieved if smoking exposure were reduced in the Philippines. Strong enforcement of measures like increasing taxation to the WHO-endorsed rate, expanding smoke-free environments, and requiring large graphic warnings within a comprehensive tobacco control programme is recommended.	[Bilano, Ver Luanni Feliciano] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo 1130033, Japan; [Borja, Maridel P.] Univ Philippines, Coll Publ Hlth, Dept Epidemiol & Biostat, Manila, Philippines; [Cruz, Eduardo L.] De La Salle Coll St Benilde, Sch Multidisciplinary Studies, Manila, Philippines; [Tan, Alvin G.] Res Inst Trop Med, Manila, Philippines; [Mortera, Lalaine L.] MCU FDTMF Hosp, Dept Med, Clin Trial Unit, Res Dev Off, Caloocan City, Philippines; [Reganit, Paul Ferdinand M.] UP Coll Med, Sect Cardiol, Manila, Philippines; [Reganit, Paul Ferdinand M.] Philippine Gen Hosp, Manila, Philippines	Bilano, VLF (reprint author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ver.bilano@gmail.com		Bilano, Ver/0000-0002-1220-6220	NSO; DOST-PCHRD	The authors acknowledge Miss Arlene Quiambao and Miss Victoria Medina of UP Manila for obtaining data from the NSO and DOST-PCHRD for Miss Bilano's scholarship. The authors also thank Professor Kenji Shibuya and Mr Stuart Gilmour of the Department of Global Health Policy, University of Tokyo for their epidemiological and methodological advice, and their feedback on the manuscript.	Hammond D, 2011, TOB CONTROL, V20, P327, DOI 10.1136/tc.2010.037630; [Anonymous], 2013, LANCET, V382, P659; Barnoya J, 2004, CANCER CAUSE CONTROL, V15, P689, DOI 10.1023/B:CACO.0000036187.13805.30; Murray CJL, 2003, POP STUD-J DEMOG, V57, P165, DOI 10.1080/0032472032000097083; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Barendregt JJ, 2003, POPUL HEALTH METR, V1, P4, DOI DOI 10.1186/1478-7954-1-4.PUBMED:12773212; Cowling DW, 2010, TOB CONTROL, V19, pI62, DOI 10.1136/tc.2009.030791; Dans A, 1999, MONOGRAPH CIGARETTE; Department of Health, 2010, 2009 PHIL GLOB AD TO; Ezzati M., 2004, COMP QUANTIFICATION; Ferlay J, GLOBOCAN 2008 V2 0; Glantz S, 2012, LANCET, V379, P1269, DOI 10.1016/S0140-6736(11)60615-6; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; National Statistics Office, 2004, DEATH STAT 2004; National Statistics Office, DEATH STAT 2007 SPEC; Redaniel MT, 2008, CANC PHILIPPINES; Redaniel MT, 2011, EUR J PUBLIC HEALTH, V21, P221, DOI 10.1093/eurpub/ckq031; The Thai Working Group on Burden of Disease and Injuries, 2002, BURD DIS INJ THAIL; Thun M, 1997, AGE EXPOSURE RESPONS; World Health Organization, MON TOB US PREV POL; World Health Organization, DIS INJ COUNTR EST; World Health Organization, SOFTW TOOLS; World Health Organization, 2009, GLOB HLTH RISKS MORT; World Health Organization, 2009, WHO REP GLOB TOB EP; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization, 2008, TOB POV PHIL IRIS; World Health Organization, TOBACCO CONTROL COUN; World Health Organization, WHO SUPP HIGH TOB TA; World Health Organization, 2013, WHO REP GLOB TOB EP; World Health Organization, WHO FRAM CONV TOB CO	31	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0964-4563	1468-3318		TOB CONTROL	Tob. Control	MAY	2015	24	3					263	268		10.1136/tobaccocontrol-2013-051082		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CG5NA	WOS:000353337500015		
J	Kubota, Y; Inagaki, S				Kubota, Y.; Inagaki, S.			High-Performance Catalysts with MSE-Type Zeolite Framework	TOPICS IN CATALYSIS			English	Article						MSE; MCM-68; Zeolite; OSDA; Dealumination; YNU-2; Titanosilicate	DRY-GEL CONVERSION; FAU-TYPE ZEOLITE; STRUCTURE-DIRECTING AGENT; CHA-TYPE ZEOLITE; HYDROTHERMAL CONVERSION; INTERZEOLITE CONVERSION; MOLECULAR-SIEVES; STRUCTURAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; MCM-68 ZEOLITE	Advances on the preparation routes to MSE-type zeolites, microporous silicates with a 12-10-10-ring micropore system, are reviewed and some examples of the catalytic application are presented. MCM-68 as the most typical aluminosilicate material with the MSE framework synthesized by using a rigid and bulky diquaternary ammonium cation as the organic structure-directing agent exhibited excellent catalytic performance for hexane cracking and dimethyl ether-to-olefin reactions when it was post-synthetically dealuminated with nitric acid. Variation of the synthetic route provided characteristic aluminosilicate MSE-type materials with the improved catalytic performances for hexane cracking. Dealuminated MCM-68 was efficiently converted to titanosilicate [Ti]-MCM-68, which exhibited high catalytic performance in epoxidation and phenol oxidation. In addition, the pure-silica version of MSE framework, YNU-2, was successfully synthesized by dry-gel conversion method using the same organic cation followed by stabilization via steaming. To the remaining site defects in the stabilized framework of YNU-2, Ti atoms were introduced to give the new microporous titanosilicate [Ti]-YNU-2, which showed very high activity and para-selectivity during phenol oxidation using H2O2 as an oxidant.	[Kubota, Y.; Inagaki, S.] Yokohama Natl Univ, Fac Engn, Div Mat Sci & Chem Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Kubota, Y (reprint author), Yokohama Natl Univ, Fac Engn, Div Mat Sci & Chem Engn, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	kubota@ynu.ac.jp			Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency (JST) [AS231Z03507C]; New Energy and Industrial Technology Development Organization (NEDO);  [13199071];  [23760741]	This work was financially supported in part by Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP, AS231Z03507C) from Japan Science and Technology Agency (JST), by the New Energy and Industrial Technology Development Organization (NEDO), and by Grant-in-Aid for Scientific Research (Nos. 13199071 and 23760741).	Ahedi RK, 2001, J MATER CHEM, V11, P2922, DOI 10.1039/b105438b; Ahedi RK, 2003, B CHEM SOC JPN, V76, P883; Kubota Y, 2014, CHEM MATER, V26, P1250, DOI 10.1021/cm403797j; Inoue T, 2009, MICROPOR MESOPOR MAT, V122, P149, DOI 10.1016/j.micromeso.2009.02.027; Itabashi K, 2012, J AM CHEM SOC, V134, P11542, DOI 10.1021/ja3022335; Yashiki A, 2011, J CRYST GROWTH, V325, P96, DOI 10.1016/j.jcrysgro.2011.04.040; Ikeda T, 2010, J PHYS CHEM C, V114, P19641, DOI 10.1021/jp1079586; Iyoki K, 2010, CHEM LETT, V39, P730, DOI 10.1246/cl.2010.730; Inagaki S, 2010, CHEM COMMUN, V46, P2662, DOI 10.1039/b925408k; Ratnasamy P, 2004, ADV CATAL, V48, P1, DOI 10.1016/S0360-0564(04)48001-S; SUBOTIC B, 1982, ZEOLITES, V2, P135, DOI 10.1016/S0144-2449(82)80015-8; Matsukata M, 2001, MICROPOR MESOPOR MAT, V48, P23, DOI 10.1016/S1387-1811(01)00326-2; Gil B, 2010, MICROPOR MESOPOR MAT, V129, P256, DOI 10.1016/j.micromeso.2009.10.003; Zilkova N, 2009, J CATAL, V266, P79, DOI 10.1016/j.jcat.2009.05.017; Zecchina A, 1996, CATAL TODAY, V32, P97, DOI 10.1016/S0920-5861(96)00075-2; Kubota Y, 1996, MICROPOROUS MATER, V6, P213, DOI 10.1016/0927-6513(96)00002-8; Shibata T, 2009, J MOL CATAL A-CHEM, V297, P80, DOI 10.1016/j.molcata.2008.09.016; ZONES SI, 1991, J CHEM SOC FARADAY T, V87, P3709, DOI 10.1039/ft9918703709; Honda K, 2011, MICROPOR MESOPOR MAT, V142, P161, DOI 10.1016/j.micromeso.2010.11.031; Kubota Y, 2014, CATAL TODAY, V226, P109, DOI 10.1016/j.cattod.2013.10.032; Park S, 2014, J CATAL, V319, P265, DOI 10.1016/j.jcat.2014.09.002; Sun JL, 2009, NATURE, V458, P1154, DOI 10.1038/nature07957; Matsukata M, 1999, TOP CATAL, V9, P77, DOI 10.1023/A:1019106421183; Wu P, 2004, J PHYS CHEM B, V108, P19126, DOI 10.1021/jp037459a; Dorset DL, 2006, J PHYS CHEM B, V110, P2045, DOI 10.1021/jp0565352; Wu P, 2014, ACS CATAL, V4, P23, DOI 10.1021/cs4006056; Wu P, 2002, J PHYS CHEM B, V106, P748, DOI 10.1021/jp0120965; Elangovan SP, 2006, MICROPOR MESOPOR MAT, V96, P210, DOI 10.1016/j.micromeso.2006.06.038; Itakura M, 2011, MICROPOR MESOPOR MAT, V144, P91, DOI 10.1016/j.micromeso.2011.03.041; Yamanaka N, 2012, MICROPOR MESOPOR MAT, V158, P141, DOI 10.1016/j.micromeso.2012.03.030; Sasaki M, 2014, ACS CATAL, V4, P2653, DOI 10.1021/cs5007926; Baerlocher Ch., 2007, ATLAS ZEOLITE FRAMEW; Bandyopadhyay R, 1999, MICROPOR MESOPOR MAT, V32, P81, DOI 10.1016/S1387-1811(99)00092-X; BARRER RM, 1961, J CHEM SOC, P971, DOI 10.1039/jr9610000971; Burton A, 2003, NAT MATER, V2, P438, DOI 10.1038/nmat937; Burton AW, 2013, [No title captured], Patent No. [US 2013/0095030, 20130095030]; Calabro DC, 2000, US Patent, Patent No. 6049018; Dhingra SS, 2013, US Patent, Patent No. 6656268; Dorset DL, 2005, J PHYS CHEM B, V109, P13891, DOI 10.1021/jp0580219; Ernst S, 2004, STUD SURF SCI CATAL, V154, P2861; Ernst S, 2004, 14 INT ZEOL C, V982; Goto I, 2012, MICROPOR MESOPOR MAT, V158, P117, DOI 10.1016/j.micromeso.2012.03.032; Rao PRHP, 1998, APPL CATAL A-GEN, V166, P97; Rao PRHP, 1996, CHEM COMMUN, P1441, DOI 10.1039/cc9960001441; Inagaki S, 2013, CHEM-EUR J, V19, P7780, DOI 10.1002/chem.201300125; Itakura M, 2011, J CRYST GROWTH, V314, P274, DOI 10.1016/j.jcrysgro.2010.10.163; Itakura M, 2008, CHEM LETT, V39, P908; Itakura M, 2010, MATER RES BULL, V45, P646, DOI 10.1016/j.materresbull.2010.01.007; Johnson ID, 2013, US Patent, Patent No. 8562941; Jon H, 2008, CHEM MATER, V20, P4135, DOI 10.1021/cm703676y; Jon H, 2006, MICROPOR MESOPOR MAT, V96, P72, DOI 10.1016/j.micromeso.2006.06.024; Jon H, 2008, MICROPOR MESOPOR MAT, V113, P56, DOI 10.1016/j.micromeso.2007.11.003; KIM MH, 1993, MICROPOROUS MATER, V1, P191, DOI 10.1016/0927-6513(93)80077-8; Koyama Y, 2008, ANGEW CHEM INT EDIT, V47, P1042, DOI 10.1002/anie.200704222; Kubota Y, 2015, CATAL TODAY, V243, P85, DOI 10.1016/j.cattod.2014.06.39; Kubota Y, 2007, MICROPOR MESOPOR MAT, V101, P115, DOI 10.1016/j.micromeso.2006.11.037; Kubota Y, 2008, CHEM COMMUN, P6224, DOI 10.1039/b814286f; Li JT, 2013, CATAL COMMUN, V38, P59, DOI 10.1016/j.catcom.2013.04.008; Maekawa H, 2004, CHEM LETT, V33, P1126, DOI 10.1246/cl.2004.1126; MATSUKATA M, 1994, J CHEM SOC CHEM COMM, P339, DOI 10.1039/c39940000339; Moscoso JG, 2011, US Patent, Patent No. 8022262; Nicholas CP, 2010, ZEOLITES IND SEPARAT; Sasaki H, 2009, J POROUS MAT, V16, P465, DOI 10.1007/s10934-008-9220-0; Shibata S, 2011, MICROPOR MESOPOR MAT, V138, P32, DOI 10.1016/j.micromeso.2010.09.034; Shibata T, 2008, MICROPOR MESOPOR MAT, V116, P216, DOI 10.1016/j.micromeso.2008.04.006; Strohmaier KG, 2011, US Patent, Patent No. 8025863; SUBOTIC B, 1980, J CRYST GROWTH, V50, P498, DOI 10.1016/0022-0248(80)90099-8; SUBOTIC B, 1986, J CRYST GROWTH, V75, P561, DOI 10.1016/0022-0248(86)90102-8; Tatsumi T, 1998, J PHYS CHEM B, V102, P7126, DOI 10.1021/jp9816216; Weston SC, 2013, [No title captured], Patent No. [US 2013/0115163, 20130115163]; Xie D, 2009, J PHYS CHEM C, V113, P9845, DOI 10.1021/jp903500q; Xu W, 1990, J CHEM SOC CHEM COMM; Zones SI, 2013, US Patent, Patent No. 8545800; Zones SI, 1994, MICROPOROUS MATER, V2, P557, DOI 10.1016/0927-6513(94)00025-5; Zones SI, 1993, P 9 INT ZEOL C, V1, P163	75	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1022-5528	1572-9028		TOP CATAL	Top. Catal.	MAY	2015	58	7-9					480	493		10.1007/s11244-015-0389-6		14	Chemistry, Applied; Chemistry, Physical	Chemistry	CG8QQ	WOS:000353575500010		
J	Ogino, I; Yokoyama, Y; Mukai, SR				Ogino, Isao; Yokoyama, Yuya; Mukai, Shin R.			Sonication-Free Exfoliation of Graphite Oxide via Rapid Phase Change of Water	TOPICS IN CATALYSIS			English	Article						Graphene oxide; Graphene; Exfoliation; Delamination	REDUCED GRAPHENE OXIDE; LAYERED ZEOLITE PRECURSOR; CHEMICAL-REDUCTION; CARBON SUPPORT; NANOSHEETS; DELAMINATION; SHEETS; NANOPARTICLES; SPECTROSCOPY; DISPERSIONS	Efficacy of a new approach for the synthesis of graphene oxide (GO) nanosheets that has been recently reported (Ogino et al. in Chem Mater 26:3334-3339, 2014) was investigated further using graphite oxides with various degrees of oxidation and average particle sizes. The approach consists of rapid freeze-thaw cycles of water containing graphite oxide, which enables the efficient exfoliation of graphite oxide layers with the minimal fragmentation of GO sheets. The method is effective for the exfoliation of graphite oxides with C/O atomic ratios <= 2.6 as shown by experiments with various degrees of oxidation of graphite oxides. When this method was tested for large particle-size graphite oxide that had been prepared from graphite with the average particle size of 60 mu m, it formed approximately tenfold larger GO sheets than those prepared using sonication. Exfoliation experiments conducted at different freezing rates of water demonstrate that a faster freezing rate of water yielded a higher concentration of a dispersed GO solution. Thus, the results support the hypothesis that rapid phase change enables efficient layer exfoliation.	[Ogino, Isao; Yokoyama, Yuya; Mukai, Shin R.] Hokkaido Univ, Grad Sch Engn, Div Chem Proc Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Ogino, I (reprint author), Hokkaido Univ, Grad Sch Engn, Div Chem Proc Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan.	iogino@eng.hokudai.ac.jp			JSPS [24656478, 60625581]	We acknowledge Mr. Junichi Nishimura and Mr. Kohei Kitano for their help in the measurements of Raman spectra. This research was supported by JSPS KAKENHI Grant Numbers 24656478 and 60625581.	Dimiev AM, 2014, ACS NANO, V8, P3060, DOI 10.1021/nn500606a; Paredes JI, 2008, LANGMUIR, V24, P10560, DOI 10.1021/la801744a; Acik M, 2011, J PHYS CHEM C, V115, P19761, DOI 10.1021/jp2052618; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; Li H, 2013, SCIENCE, V342, P95, DOI 10.1126/science.1236686; Lambert S, 2009, J CATAL, V261, P23, DOI 10.1016/j.jcat.2008.10.014; Ogino I, 2014, CHEM MATER, V26, P3334, DOI 10.1021/cm501305c; Ogino I, 2010, DALTON T, V39, P8423, DOI 10.1039/c001136c; Li L, 2005, CHEM MATER, V17, P4386, DOI 10.1021/cm0510460; Mukai SR, 2004, CHEM COMMUN, P874, DOI 10.1039/b316597c; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; Yang XW, 2013, SCIENCE, V341, P534, DOI 10.1126/science.1239089; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Ramanathan T, 2008, NAT NANOTECHNOL, V3, P327, DOI 10.1038/nnano.2008.96; Karim MR, 2013, J AM CHEM SOC, V135, P8097, DOI 10.1021/ja401060q; Chua CK, 2014, CHEM SOC REV, V43, P291, DOI 10.1039/c3cs60303b; Krishnamoorthy K, 2013, CARBON, V53, P38, DOI 10.1016/j.carbon.2012.10.013; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Talyzin AV, 2011, CARBON, V49, P1894, DOI 10.1016/j.carbon.2011.01.013; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Joshi RK, 2014, SCIENCE, V343, P752, DOI 10.1126/science.1245711; Tsapatsis M, 2014, AICHE J, V60, P2374, DOI 10.1002/aic.14462; Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/nnano.2009.58, 10.1038/NNANO.2009.58]; Diaz U, 2014, DALTON T, V43, P10292, DOI 10.1039/c3dt53181c; Pan SY, 2011, ACS NANO, V5, P4073, DOI 10.1021/nn200666r; Ouyang XY, 2014, J AM CHEM SOC, V136, P1449, DOI 10.1021/ja410141u; Roth WJ, 2014, CHEM REV, V114, P4807, DOI 10.1021/cr400600f; Maheshwari S, 2008, J AM CHEM SOC, V130, P1507, DOI 10.1021/ja077711i; Kamat PV, 2010, J PHYS CHEM LETT, V1, P520, DOI 10.1021/jz900265j; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; Paton KR, 2014, NAT MATER, V13, P624, DOI [10.1038/nmat3944, 10.1038/NMAT3944]; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Cancado LG, 2011, NANO LETT, V11, P3190, DOI 10.1021/nl201432g; Takagaki A, 2003, J AM CHEM SOC, V125, P5479, DOI 10.1021/ja034085q; Wang XL, 2011, J AM CHEM SOC, V133, P6338, DOI 10.1021/ja200218y; Wang Q, 2012, CHEM REV, V112, P4124, DOI 10.1021/cr200434v; Ogino I, 2011, J AM CHEM SOC, V133, P3288, DOI 10.1021/ja111147z; Seger B, 2009, J PHYS CHEM C, V113, P7990, DOI 10.1021/jp900360k; Ogino I, 2014, J PHYS CHEM C, V118, P6866, DOI 10.1021/jp412781d; Li YJ, 2010, CARBON, V48, P1124, DOI 10.1016/j.carbon.2009.11.034; Eilertsen EA, 2011, CHEM MATER, V23, P5404, DOI 10.1021/cm202364q; Feng HB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2555; Galande C, 2014, PART PART SYST CHAR, V31, P619, DOI 10.1002/ppsc.201300232; Guittonneau F, 2010, ULTRASON SONOCHEM, V17, P391, DOI 10.1016/j.ultsonch.2009.08.011; Haag D, 2014, TOP CATAL, V57, P762; Lei ZW, 2014, J PHYS CHEM C, V118, P6624, DOI 10.1021/jp412570s; Mustafa L, 2013, NANOTECHNOLOGY, V24; Ogino I, 2013, CHEM MATER, V25, P1502, DOI 10.1021/cm3032785; Perrozzi F, 2014, CARBON, V77, P473, DOI 10.1016/j.carbon.2014.05.052; Qiu L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2251; Su C., 2012, ACCOUNTS CHEM RES, V46, P2275, DOI DOI 10.1021/AR300118V	53	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1022-5528	1572-9028		TOP CATAL	Top. Catal.	MAY	2015	58	7-9					522	528		10.1007/s11244-015-0391-z		7	Chemistry, Applied; Chemistry, Physical	Chemistry	CG8QQ	WOS:000353575500014		
J	Makiyama, T; Nakamura, H; Nagasaka, N; Yamashita, H; Honda, T; Yamaguchi, N; Nishida, A; Murayama, T				Makiyama, Tomohiko; Nakamura, Hiroyuki; Nagasaka, Nobuo; Yamashita, Hisahiro; Honda, Takuya; Yamaguchi, Naoto; Nishida, Atsushi; Murayama, Toshihiko			Trafficking of Acetyl-C16-Ceramide-NBD with Long-Term Stability and No Cytotoxicity into the Golgi Complex	TRAFFIC			English	Article						acetyl-C16-ceramide-NBD; Golgi complex; cytotoxicity; CERT; CHO cells	CYTOSOLIC PHOSPHOLIPASE A(2)ALPHA; FLUORESCENT CERAMIDE ANALOG; HAMSTER OVARY CELLS; ENDOPLASMIC-RETICULUM; NONVESICULAR TRAFFICKING; SPHINGOLIPID METABOLISM; SPHINGOMYELIN SYNTHESIS; CULTURED FIBROBLASTS; INHIBITOR HPA-12; MEDIATED PATHWAY	The Golgi complex plays a prominent role in the modification and sorting of lipids and proteins, and is a highly dynamic organelle that is dispersed and rearranged before and after mitosis. Several reagents including 4-nitrobenzo-2-oxa-1,3-diazole-labeled C6-ceramide (NBD-C6-ceramide, a ceramide having an NBD-bound C6-N-acyl chain) and Golgi-specific proteins that emit fluorescence are used as Golgi markers. In the present study, we synthesized a new ceramide analog, acetyl-C16-ceramide-NBD (a ceramide having an acetylated C-1 hydroxyl group, C16-N-acyl chain, and NBD-bound C15-sphingosine), and showed that it preferentially accumulated in the Golgi complex without cytotoxicity for over 24 h. Pathways for cellular uptake and interorganelle trafficking of acetyl-C16-ceramide-NBD were investigated. Acetyl-C16-ceramide-NBD was transported to the Golgi complex via ceramide transport proteins. In contrast to NBD-C6-ceramide, acetyl-C16-ceramide-NBD was resistant to ceramide metabolic enzymes such as sphingomyelin synthase and glucosylceramide synthase. Because of its weaker cytotoxicity and resistance to ceramide metabolic enzymes, the localization of the Golgi complex could be observed in acetyl-C16-ceramide-NBD-labeled cells before and after mitosis.	[Makiyama, Tomohiko; Nakamura, Hiroyuki; Yamashita, Hisahiro; Murayama, Toshihiko] Chiba Univ, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Chiba 2608675, Japan; [Nagasaka, Nobuo; Nishida, Atsushi] Chiba Univ, Grad Sch Pharmaceut Sci, Organ Chem Lab, Chiba 2608675, Japan; [Honda, Takuya; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Mol Cell Biol Lab, Chiba 2608675, Japan	Murayama, T (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Chiba 2608675, Japan.	murayama-toshi@faculty.chiba-u.jp	Nakamura, Hiroyuki/B-4089-2015		Ministry of Education, Culture, Sports, Science and Technology, Japan [23590106, 24790066]	This work was supported in part by grants (23590106 to T. M. and 24790066 to H. N.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We thank Dr. Kentaro Hanada for providing LY-A cells, LY-A/hCERT cells and HPA-12, Dr. Tetsuya Hirabayashi for providing CHO-W11A cells and Dr. Tamas Balla for providing vectors for mCherry-Rab5Q79L and dynamin 1K44A. T. H. is a Research Assistant for LGS (Program for Leading Graduate School Chiba University).	Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Gangalum RK, 2004, J BIOL CHEM, V279, P43374, DOI 10.1074/jbc.C400371200; LIPSKY NG, 1983, P NATL ACAD SCI-BIOL, V80, P2608, DOI 10.1073/pnas.80.9.2608; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Thayer DA, 2013, P NATL ACAD SCI USA, V110, P1482, DOI 10.1073/pnas.1220978110; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Bexiga MG, 2013, INT J MOL SCI, V14, P18670, DOI 10.3390/ijms140918670; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Boath A, 2008, J BIOL CHEM, V283, P8517, DOI 10.1074/jbc.M707107200; Duris A, 2011, ORG LETT, V13, P1642, DOI 10.1021/ol2001057; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; PUTZ U, 1995, EUR J CELL BIOL, V68, P113; Kolter T, 2011, CHEM PHYS LIPIDS, V164, P590, DOI 10.1016/j.chemphyslip.2011.04.013; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Nakamura H, 2010, J LIPID RES, V51, P720, DOI 10.1194/jlr.M002428; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Altan-Bonnet N, 2003, P NATL ACAD SCI USA, V100, P13314, DOI 10.1073/pnas.2234055100; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; LIPSKY NG, 1985, SCIENCE, V228, P745, DOI 10.1126/science.2581316; MARTIN OC, 1993, P NATL ACAD SCI USA, V90, P2661, DOI 10.1073/pnas.90.7.2661; Duwel M, 2006, MOL BIOL CELL, V17, P4513, DOI 10.1091/mbc.E06-05-0390; Gaietta GM, 2006, P NATL ACAD SCI USA, V103, P17777, DOI 10.1073/pnas.0608509103; Keithley RB, 2013, ANALYST, V138, P164, DOI 10.1039/c2an36286d; Seksek O, 1996, J BIOL CHEM, V271, P15542; Darroch PI, 2005, J LIPID RES, V46, P2315, DOI 10.1194/jlr.M500136-JLR200; DIBIASE A, 1991, NEUROCHEM RES, V16, P551; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; Graf C, 2008, MOL PHARMACOL, V74, P925, DOI 10.1124/mol.108.048652; Hanada K, 2014, TRAFFIC, V15, P889, DOI 10.1111/tra.12193; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; JIN MJ, 1993, J BIOL CHEM, V268, P18390; Kang YS, 2009, J CELL SCI, V122, P4062, DOI 10.1242/jcs.046292; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Liu XL, 2008, BIOCHEM BIOPH RES CO, V376, P688, DOI 10.1016/j.bbrc.2008.09.065; Makiyama T, 2010, BIOCHEM PHARMACOL, V80, P1396, DOI 10.1016/j.bcp.2010.07.028; Makiyama T, 2012, EUR J PHARMACOL, V697, P144, DOI 10.1016/j.ejphar.2012.09.041; Martys JL, 1996, J BIOL CHEM, V271, P10953; Meisslitzer-Ruppitsch C, 2011, HISTOCHEM CELL BIOL, V135, P159, DOI 10.1007/s00418-010-0773-z; Nakamura H, 2013, J BIOL CHEM, V288, P23264, DOI 10.1074/jbc.M113.491431; Nakamura H, 2014, J PHARMACOL SCI, V124, P307, DOI 10.1254/jphs.13R18CP; Nusshold C, 2013, BBA-MOL CELL BIOL L, V1831, P1665, DOI 10.1016/j.bbalip.2013.08.007; Pagano RE, 2000, TRAFFIC, V1, P807, DOI 10.1034/j.1600-0854.2000.011101.x; Sasaki H, 2014, ARCH BIOCHEM BIOPHYS, V550, P12, DOI 10.1016/j.abb.2014.03.012; Shimizu M, 2009, CELL SIGNAL, V21, P440, DOI 10.1016/j.cellsig.2008.11.014; Sundaramoorthy S, 2010, CELL CYCLE, V9, P3100, DOI 10.4161/cc.9.15.12522; Tada E, 2010, J PHARMACOL SCI, V114, P420, DOI 10.1254/jphs.10181FP; Ueno M, 2013, ORG LETT, V15, P2869, DOI 10.1021/ol401101u; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; WOLF DE, 1992, BIOCHEMISTRY-US, V31, P2865, DOI 10.1021/bi00126a004; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200; Zigdon H, 2014, BBA-MOL CELL BIOL L, V1841, P1189, DOI 10.1016/j.bbalip.2014.02.008	61	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-9219	1600-0854		TRAFFIC	Traffic	MAY	2015	16	5					476	492		10.1111/tra.12265		17	Cell Biology	Cell Biology	CG7DB	WOS:000353461400003		
J	Hoepflinger, MC; Geretschlaeger, A; Sommer, A; Hoeftberger, M; Hametner, C; Ueda, T; Foissner, I				Hoepflinger, Marion C.; Geretschlaeger, Anja; Sommer, Aniela; Hoeftberger, Margit; Hametner, Christina; Ueda, Takashi; Foissner, Ilse			Molecular Analysis and Localization of CaARA7 a Conventional RAB5 GTPase from Characean Algae	TRAFFIC			English	Article						ARA7; Chara australis; endosomal trafficking; multivesicular endosome; RAB5 GTPase; RABF2	PLASMA-MEMBRANE DOMAINS; C-TERMINAL DOMAIN; ARABIDOPSIS-THALIANA; INTERNODAL CELLS; MODEL SYSTEM; MULTIVESICULAR BODIES; TRAFFICKING PATHWAY; MAXIMUM-LIKELIHOOD; ENDOCYTIC PATHWAY; PLANT PREVACUOLAR	RAB5 GTPases are important regulators of endosomal membrane traffic. Among them Arabidopsis thalianaARA7/RABF2b is highly conserved and homologues are present in fungal, animal and plant kingdoms. In land plants ARA7 and its homologues are involved in endocytosis and transport towards the vacuole. Here we report on the isolation of an ARA7 homologue (CaARA7/CaRABF2) in the highly evolved characean green alga Chara australis. It encodes a polypeptide of 202 amino acids with a calculated molecular mass of 22.2 kDa and intrinsic GTPase activity. Immunolabelling of internodal cells with a specific antibody reveals CaARA7 epitopes at multivesicular endosomes (MVEs) and at MVE-containing wortmannin (WM) compartments. When transiently expressed in epidermal cells of Nicotiana benthamiana leaves, fluorescently tagged CaARA7 localizes to small organelles (putative MVEs) and WM compartments, and partially colocalizes with AtARA7 and CaARA6, a plant specific RABF1 GTPase. Mutations in membrane anchoring and GTP binding sites alter localization of CaARA7 and affect GTPase activity, respectively. This first detailed study of a conventional RAB5 GTPase in green algae demonstrates that CaARA7 is similar to RAB5 GTPases from land plants and other organisms and shows conserved structure and localization.	[Hoepflinger, Marion C.; Geretschlaeger, Anja; Sommer, Aniela; Hoeftberger, Margit; Foissner, Ilse] Salzburg Univ, Dept Cell Biol Plant Physiol, A-5020 Salzburg, Austria; [Hametner, Christina] Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria; [Ueda, Takashi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Foissner, I (reprint author), Salzburg Univ, Dept Cell Biol Plant Physiol, Hellbrunnerstr 34, A-5020 Salzburg, Austria.	Marion.Hoepflinger2@sbg.ac.at; Ilse.Foissner@sbg.ac.at	UEDA, TAKASHI/G-4939-2014; Ueda, Takashi/G-6984-2011		Austrian Science Fund (FWF) [P 22957-B20]	We are grateful to Raimund Tenhaken (University of Salzburg) for support and valuable discussion and to Karin Schumacher (University of Heidelberg) for SYP61-mRFP. This research was funded by the Austrian Science Fund (FWF project no. P 22957-B20 to IF). The authors declare that they have no conflict of interest.	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Anand B, 2013, BIOCHEMISTRY-US, V52, P1122, DOI 10.1021/bi3014054; Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Wang JQ, 2009, J EXP BOT, V60, P3075, DOI 10.1093/jxb/erp136; Ceresa BP, 2001, J BIOL CHEM, V276, P9649, DOI 10.1074/jbc.M010387200; Klima A, 2008, PLANT CELL PHYSIOL, V49, P1508, DOI 10.1093/pcp/pcn122; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; SOLDATI T, 1993, MOL BIOL CELL, V4, P425; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Hoepflinger MC, 2013, J EXP BOT, V64, P5553, DOI 10.1093/jxb/ert322; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Dhonukshe P, 2006, DEV CELL, V10, P137, DOI 10.1016/j.devcel.2005.11.015; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Scheuring D, 2011, PLANT CELL, V23, P3463, DOI 10.1105/tpc.111.086918; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828; Derrien B, 2012, P NATL ACAD SCI USA, V109, P15942, DOI 10.1073/pnas.1209487109; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Haas TJ, 2007, PLANT CELL, V19, P1295, DOI 10.1105/tpc.106.049346; Dinneen JL, 2004, EXP CELL RES, V294, P509, DOI 10.1016/j.yexer.2003.12.006; Ueda T, 2004, PLANT J, V40, P783, DOI 10.1111/j.1365-313X.2004.02249.x; BERANGER F, 1994, MOL CELL BIOL, V14, P744; Martiniere A, 2013, PLANT CELL, V25, P4028, DOI 10.1105/tpc.113.116897; Littlejohn GR, 2010, NEW PHYTOL, V186, P1018, DOI 10.1111/j.1469-8137.2010.03244.x; NORRIS SR, 1993, PLANT MOL BIOL, V21, P895, DOI 10.1007/BF00027120; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Fujimoto M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00197; Beck M, 2012, PLANT CELL, V24, P4205, DOI 10.1105/tpc.112.100263; Kotzer AM, 2004, J CELL SCI, V117, P6377, DOI 10.1242/jcs.01564; Foissner I, 2012, J MICROSC-OXFORD, V247, P10, DOI 10.1111/j.1365-2818.2011.03572.x; HOFFENBERG S, 1995, J BIOL CHEM, V270, P5048; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ebine K, 2009, J PLANT RES, V122, P21, DOI 10.1007/s10265-008-0200-x; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; BRENNWALD P, 1993, NATURE, V362, P560, DOI 10.1038/362560a0; Ebine K, 2011, NAT CELL BIOL, V13, P853, DOI 10.1038/ncb2270; Goh T, 2007, PLANT CELL, V19, P3504, DOI 10.1105/tpc.107.053876; FOISSNER I, 1991, PLANT CELL ENVIRON, V14, P907, DOI 10.1111/j.1365-3040.1991.tb00959.x; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; ARAKI S, 1991, MOL CELL BIOL, V11, P1438; Bolte S, 2000, PLANT MOL BIOL, V42, P923, DOI 10.1023/A:1006449715236; Bottanelli F, 2011, PLANT CELL, V23, P3007, DOI 10.1105/tpc.111.085480; Braun Markus, 2007, V68, P193, DOI 10.1007/978-3-540-36832-8_9; Ebine Kazuo, 2012, Small GTPases, V3, P23, DOI 10.4161/sgtp.18299; Foissner I, 2014, INT REV CEL MOL BIO, V311, P307, DOI 10.1016/B978-0-12-800179-0.00006-4; Foissner I, 2014, METHODS MOL BIOL, V1080, P183, DOI 10.1007/978-1-62703-643-6_15; Glez-Pena D, 2010, NUCLEIC ACIDS RES, V38, pW14, DOI 10.1093/nar/gkq321; Hoepflinger M, 2014, PLANT SIGNAL BEHAV, V9; Jia TR, 2013, J EXP BOT, V64, P2817, DOI 10.1093/jxb/ert125; Lam SK, 2007, J INTEGR PLANT BIOL, V49, P1119, DOI 10.1111/j.1672-9072.2007.00517.x; Li F, 2014, P NATL ACAD SCI USA, V111, P2572, DOI 10.1073/pnas.1313655111; LI GP, 1994, J BIOL CHEM, V269, P14631; LI GP, 1993, J BIOL CHEM, V268, P24475; LI GP, 1995, ARCH BIOCHEM BIOPHYS, V316, P529, DOI 10.1006/abbi.1995.1070; MUSHA T, 1992, J BIOL CHEM, V267, P9821; Olkkonen VM, 1997, INT REV CYTOL, V176, P1, DOI 10.1016/S0074-7696(08)61608-3; Rambaut A, 2007, TRACER V1 4, V4; Rambaut A, FIGTREE TREE FIGURE; Saito C, 2009, INT REV CEL MOL BIO, V274, P183, DOI 10.1016/S1937-6448(08)02004-2; Schmolzer PM, 2011, PLANT CELL PHYSIOL, V52, P1274, DOI 10.1093/pcp/pcr074; Tazawa M, 2001, AUST J PLANT PHYSIOL, V28, P523; Ueda T, 2000, PLANT J, V21, P341, DOI 10.1046/j.1365-313x.2000.00681.x; Weigel D, 2002, ARABIDOPSIS LAB MANU; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Wu YW, 2010, NAT CHEM BIOL, V6, P534, DOI [10.1038/nchembio.386, 10.1038/NCHEMBIO.386]	72	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-9219	1600-0854		TRAFFIC	Traffic	MAY	2015	16	5					534	554		10.1111/tra.12267		21	Cell Biology	Cell Biology	CG7DB	WOS:000353461400007		
J	Zhao, BX; Sasaki, S				Zhao, Bingxuan; Sasaki, Shigenobu			Active spectrum sensing for cognitive radio networks	Transactions on Emerging Telecommunications Technologies			English	Article							WIRELESS MESH NETWORKS; SYSTEMS; ACCESS	An energy detection-based active spectrum sensing scheme is proposed to carry out spectrum sensing and secondary transmissions simultaneously. It successfully avoids the widely used quiet periods, which have at least two shortcomings. First, periodical interruptions of secondary transmissions degrade the quality of service of secondary networks (e.g. decreasing the system capacity and increasing end-to-end packet delay). Second, frequent tight synchronisation is necessary but very difficult to implement in the distributed networks. With the assistance of the geolocations, the proposed sensing scheme is able to decompose the received power into the primary signal power, secondary signal power, and the device noise power. The power decomposition is formulated into a problem of solving a homogeneous linear equation set with a coefficient matrix involving only the distances among the primary users, secondary users, and the sensors. Through the decomposition, the primary signal power can be differentiated from the secondary signal power, which is generally treated as interference in spectrum sensing. When constructing the test statistic, such interference can be cancelled from the collected energy. As a result, the noise uncertainty problem, which significantly compromises the performance of the energy detection, can be greatly alleviated by noticing the fact that the interference dominates the noise uncertainty problem. Because the achieved signal-to-interference ratio can be improved by cancelling the interference, the detection errors in terms of the probability of false alarm and missed detection can be significantly reduced. Simulations verify the feasibility and efficiency of the proposed scheme. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Zhao, Bingxuan; Sasaki, Shigenobu] Niigata Univ, Dept Elect & Elect Engn, Niigata 9502181, Japan	Zhao, BX (reprint author), Niigata Univ, Dept Elect & Elect Engn, Nishi Ku, 8050,Ikarashi 2 No Cho, Niigata 9502181, Japan.	bxzhao@ieee.org					Akyildiz I. F., 2011, PHYS COMMUNICATION, V4, P40, DOI DOI 10.1016/J.PHYCOM.2010.12.003; Boyd SW, 2012, IEEE T COMMUN, V60, P547, DOI 10.1109/TCOMM.2011.122111.100603; Hu WD, 2007, IEEE COMMUN MAG, V45, P80, DOI 10.1109/MCOM.2007.358853; Chowdhury KR, 2008, IEEE J SEL AREA COMM, V26, P168, DOI 10.1109/JSAC.2008.080115; Song SH, 2010, IEEE T WIREL COMMUN, V9, P1849, DOI 10.1109/TWC.2010.06.090924; Huang J, 2006, MOBILE NETW APPL, V11, P405, DOI 10.1007/s11036-006-5192-y; Liang YC, 2008, IEEE T WIREL COMMUN, V7, P1326, DOI 10.1109/TWC.2008.060869; Zhang W, 2008, IEEE ICC, P3411, DOI 10.1109/ICC.2008.641; Jeon WS, 2008, IEEE T WIREL COMMUN, V7, P505, DOI 10.1109/TWC.2008.060867; Letaief B, 2009, P IEEE, V97, P878; Lopez-Benitez M, 2010, EUR T TELECOMMUN, V21, P680, DOI 10.1002/ett.1453; Mangold S, 2006, EUROPEAN TRANSACTION, V17, P395; Mishra A., 2006, SIGMETRICS PERFORM E, V34, P63; Press W. H., 2007, NUMERICAL RECIPES; Sahai A., 2004, P ALL C COMM CONTR C, P1662; Shankar N. S., 2005, P 1 IEEE INT S NEW F, P160, DOI DOI 10.1109/TWC.2010.090210.100291; Shellhammer S., 2006, IEEE 802 22 06 0075R; Yu R, 2012, IEEE WIREL COMMUN, V19, P30; Zeng YH, 2010, EURASIP J ADV SIG PR, DOI 10.1155/2010/381465; Zhang SB, 2011, EUR T TELECOMMUN, V22, P211, DOI 10.1002/ett.1470; Zhao B, 2012, THE PROCEEDINGS OF 1, P320; Zhao BX, 2012, IEICE T COMMUN, VE95B, P234, DOI 10.1587/transcom.E95.B.234; Zhao BX, 2011, IEEE T CONSUM ELECTR, V57, P1049; Zhao Y, 2007, THESIS	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2161-3915			T EMERG TELECOMMUN T	Trans. Emerg. Telecommun. Technol.	MAY	2015	26	5					789	799		10.1002/ett.2731		11	Telecommunications	Telecommunications	CG6HK	WOS:000353399700005		
J	Yanagisawa, R; Ishii, E; Motoki, N; Yamazaki, S; Morita, D; Sakashita, K; Shiohara, M; Tanaka, M; Hidaka, Y; Kubota, N; Hidaka, E; Ogiso, Y; Nakamura, T; Yasukochi, S				Yanagisawa, Ryu; Ishii, Eizaburo; Motoki, Noriko; Yamazaki, Shoko; Morita, Daisuke; Sakashita, Kazuo; Shiohara, Masaaki; Tanaka, Miyuki; Hidaka, Yoshihiko; Kubota, Noriko; Hidaka, Eiko; Ogiso, Yoshifumi; Nakamura, Tomohiko; Yasukochi, Satoshi			Pretransplant-corrected QT dispersion as a predictor of pericardial effusion after pediatric hematopoietic stem cell transplantation	TRANSPLANT INTERNATIONAL			English	Article						cardiac tamponade; fenestration; hemolytic uremic syndrome; pericardiocentesis; thrombotic microangiopathy; thrombotic thrombocytopenic purpura	BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMOLYTIC-UREMIC SYNDROME; ACUTE HEART-FAILURE; CARDIAC COMPLICATIONS; THROMBOTIC MICROANGIOPATHY; ANTHRACYCLINE THERAPY; TAMPONADE; CARDIOMYOPATHY	Pericardial effusion is a potentially fatal complication following hematopoietic stem cell transplantation (HSCT). Therefore, the identification of risk factors could improve the outcome. Prolonged QT dispersion (QTD) and corrected QTD (QTcD) are associated with serious arrhythmias and sudden death in many forms of heart disease. However, no study has evaluated the efficacy of QTD and QTcD to predict pericardial effusion post-HSCT. We studied 89 pediatric HSCT patients to identify preoperative risk factors for pericardial effusion with particular focus on QTD and QTcD. Pericardial effusion occurred in 15 patients (cumulative onset rate: 17.4%) within one year post-HSCT, of which 8 (9.2%) were symptomatic. Patients with pericardial effusion following allogeneic HSCT showed significantly lower overall survival; however, pericardial effusion was not the direct cause of death in any patient. Univariate and multivariate analyses revealed that transplantation-associated thrombotic microangiopathy (TA-TMA) was an independent risk factor for post-HSCT pericardial effusion. In addition, pretransplant QTcD was significantly prolonged in the pericardial effusion group. These results suggest that pediatric patients with abnormally prolonged QTcD before the preparative regimen for HSCT should be regularly followed-up by echocardiography to detect pericardial effusion, particularly when accompanied by complications including TA-TMA.	[Yanagisawa, Ryu; Sakashita, Kazuo; Nakamura, Tomohiko] Nagano Childrens Hosp, Div Hematol Oncol, Azumino, Japan; [Yanagisawa, Ryu; Motoki, Noriko; Yamazaki, Shoko; Morita, Daisuke; Sakashita, Kazuo; Tanaka, Miyuki; Hidaka, Yoshihiko] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 390, Japan; [Ishii, Eizaburo] Nagano Prefectural Suzaka Hosp, Dept Pediat, Suzaka, Japan; [Shiohara, Masaaki] Matsumoto Dent Univ, Sch Dent, Dept Pediat, Shiojiri, Japan; [Kubota, Noriko; Hidaka, Eiko] Nagano Childrens Hosp, Dept Lab Med, Azumino, Japan; [Kubota, Noriko; Hidaka, Eiko; Nakamura, Tomohiko] Nagano Childrens Hosp, Life Sci Res Ctr, Azumino, Japan; [Ogiso, Yoshifumi] Nagano Childrens Hosp, Div Clin Pathol, Azumino, Japan; [Yasukochi, Satoshi] Nagano Childrens Hosp, Div Pediat Cardiol, Azumino, Japan	Yanagisawa, R (reprint author), Nagano Childrens Hosp, 3100 Toyoshina, Azumino City, Nagano 3998288, Japan.	ryu@shinshu-u.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [26860790]	This work was supported in part by the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number 26860790 to the author).	Aldoss O, 2013, PEDIATR TRANSPLANT, V17, P294, DOI 10.1111/petr.12062; ANGELUCCI E, 1992, LANCET, V339, P287, DOI 10.1016/0140-6736(92)91343-7; Sallee M, 2010, NEPHROL DIAL TRANSPL, V25, P2028, DOI 10.1093/ndt/gfq160; Willems E, 2010, BONE MARROW TRANSPL, V45, P689, DOI 10.1038/bmt.2009.230; Nousiainen T, 1999, J INTERN MED, V245, P359, DOI 10.1046/j.1365-2796.1999.00480.x; Tichelli A, 2008, BRIT J HAEMATOL, V142, P11, DOI 10.1111/j.1365-2141.2008.07165.x; Swan H, 1998, J AM COLL CARDIOL, V32, P486, DOI 10.1016/S0735-1097(98)00248-4; Laskin BL, 2011, BLOOD, V118, P1452, DOI 10.1182/blood-2011-02-321315; Hawkins BM, 2008, TRANSFUSION, V48, P382, DOI 10.1111/j.1537-2995.2007.01534.x; Ho VT, 2005, BIOL BLOOD MARROW TR, V11, P571, DOI 10.1016/j.bbmt.2005.06.001; Batts ED, 2007, BONE MARROW TRANSPL, V40, P709, DOI 10.1038/sj.bmt.1705758; Ruutu T, 2007, HAEMATOL-HEMATOL J, V92, P95, DOI 10.3324/haematol.10699; Murdych T, 2001, BONE MARROW TRANSPL, V28, P283, DOI 10.1038/sj.bmt.1703133; DRITSAS A, 1992, CLIN CARDIOL, V15, P739; Barr CS, 1997, AM J CARDIOL, V79, P328; Cavet J, 2000, BONE MARROW TRANSPL, V25, P571, DOI 10.1038/sj.bmt.1702186; CAZIN B, 1986, CANCER, V57, P2061, DOI 10.1002/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO;2-H; Dandoy C, 2014, BIOL BLOOD MARROW TR, V21, P113; EINSELE H, 1989, BONE MARROW TRANSPL, V4, P323; Galetta F, 2005, BIOMED PHARMACOTHER, V59, P541, DOI 10.1016/j.biopha.2004.12.003; Grimm W, 1996, PACE, V19, P1886, DOI 10.1111/j.1540-8159.1996.tb03246.x; Gulen H, 2007, Minerva Pediatr, V59, P107; Gupta M, 2002, PEDIATR HEMAT ONCOL, V19, P533, DOI 10.1080/08880010290097387; Holbro A, 2012, BONE MARROW TRANSPL, V47, P294, DOI 10.1038/bmt.2011.44; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kondo M, 1998, BONE MARROW TRANSPL, V21, P281, DOI 10.1038/sj.bmt.1701082; Lev A, 2010, BONE MARROW TRANSPL, V45, P1084, DOI 10.1038/bmt.2009.314; Liu YC, 2012, ANN HEMATOL, V91, P1953, DOI 10.1007/s00277-012-1541-z; Motoki N, 2010, PEDIATR TRANSPLANT, V14, P986, DOI 10.1111/j.1399-3046.2010.01389.x; Nakamae H, 2000, LANCET, V355, P805, DOI 10.1016/S0140-6736(00)02051-1; Nakamae H, 2004, AM J HEMATOL, V76, P1, DOI 10.1002/ajh.20042; Neier M, 2011, BONE MARROW TRANSPL, V46, P529, DOI 10.1038/bmt.2010.149; Norkin M, 2011, BONE MARROW TRANSPL, V46, P1353, DOI 10.1038/bmt.2010.297; Pudil R, 2008, LEUKEMIA RES, V32, P998, DOI 10.1016/j.leukres.2007.09.020; Retortillo JAP, 1998, BONE MARROW TRANSPL, V21, P299, DOI 10.1038/sj.bmt.1701072; Rhodes M, 2005, BONE MARROW TRANSPL, V36, P139, DOI 10.1038/sj.bmt.1705023; Sakata-Yanagimoto M, 2004, BONE MARROW TRANSPL, V33, P1043, DOI 10.1038/sj.bmt.1704487; SCERPELLA EG, 1994, CLIN INFECT DIS, V19, P1168; Seber A, 1996, BONE MARROW TRANSPL, V17, P207; Tobias JD, 2007, PEDIATR ANESTH, V17, P584, DOI 10.1111/j.1460-9592.2006.02175.x; Toren A, 1997, BONE MARROW TRANSPL, V20, P805, DOI 10.1038/sj.bmt.1700960; VEYS PA, 1987, BONE MARROW TRANSPL, V2, P213	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0934-0874	1432-2277		TRANSPL INT	Transpl. Int.	MAY	2015	28	5					565	574		10.1111/tri.12532		10	Surgery; Transplantation	Surgery; Transplantation	CG7GS	WOS:000353471500009		
J	Arakaki, T; Hasegawa, J; Nakamura, M; Hamada, S; Muramoto, M; Takita, H; Ichizuka, K; Sekizawa, A				Arakaki, T.; Hasegawa, J.; Nakamura, M.; Hamada, S.; Muramoto, M.; Takita, H.; Ichizuka, K.; Sekizawa, A.			Prediction of early- and late-onset pregnancy-induced hypertension using placental volume on three-dimensional ultrasound and uterine artery Doppler	ULTRASOUND IN OBSTETRICS & GYNECOLOGY			English	Article						first-trimester screening; placental volume; pre-eclampsia; pregnancy-induced hypertension; uterine artery	FETAL-GROWTH RESTRICTION; 1ST TRIMESTER; TROPHOBLAST INVASION; PREECLAMPSIA; GESTATION; INDEXES	ObjectivesTo determine whether uterine artery (UtA) Doppler findings and three-dimensional (3D) ultrasound measurement of placental volume during the first trimester allowed prediction of early- and late-onset pregnancy-induced hypertension (early PIH and late PIH). MethodsSubjects with singleton pregnancy who underwent an ultrasound scan at 11-13 weeks' gestation and delivered between 2011 and 2013 were enrolled prospectively into the study. The UtA Doppler indices and placental volume on 3D ultrasound at 11-13 weeks' gestation in cases that developed early PIH (<34weeks) or PIH later in pregnancy (34weeks) were compared with values in unaffected pregnancies. ResultsTen cases of early PIH, 67 cases of late PIH and 1285 unaffected pregnancies were analyzed. The UtA pulsatility index (PI) was higher in cases of early PIH than that in unaffected pregnancies (median, 2.35 vs 1.79; P=0.043) but did not differ between cases of late PIH and unaffected pregnancies. Placental volume was smaller in cases of early PIH than that in unaffected pregnancies (median, 43cm(3)vs 62cm(3); P=0.003) but did not differ between cases of late PIH and unaffected pregnancies. The area under the receiver-operating characteristics curve for the prediction of early PIH, by combining UtA-PI and placental volume, was 0.832 (95% CI, 0.742-0.921), with this combination providing a detection rate for early PIH of 67.5% for a 5% false-positive rate. ConclusionsHigh UtA-PI and small placental volume were observed more often in cases of early PIH compared with unaffected pregnancies, but not in cases of late PIH. These results may indicate that there are differences in pathophysiology between early PIH and late PIH. Copyright (c) 2014 ISUOG. Published by John Wiley & Sons Ltd.	[Arakaki, T.; Hasegawa, J.; Nakamura, M.; Hamada, S.; Muramoto, M.; Takita, H.; Ichizuka, K.; Sekizawa, A.] Showa Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1428666, Japan	Hasegawa, J (reprint author), Showa Univ, Sch Med, Dept Obstet & Gynecol, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	hasejun@oak.dti.ne.jp					Aardema MW, 2004, CLIN SCI, V106, P377, DOI 10.1042/CS20030385; Papageorghiou AT, 2001, ULTRASOUND OBST GYN, V18, P441, DOI 10.1046/j.0960-7692.2001.00572.x; Wegrzyn P, 2005, ULTRASOUND OBST GYN, V26, P28, DOI 10.1002/uog.1923; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Metzenbauer M, 2002, ULTRASOUND OBST GYN, V19, P240, DOI 10.1046/j.1469-0705.2002.00655.x; Plasencia W, 2008, ULTRASOUND OBST GYN, V32, P138, DOI 10.1002/uog.5402; Poon LCY, 2009, ULTRASOUND OBST GYN, V33, P23, DOI 10.1002/uog.6280; Hasegawa J, 2011, J OBSTET GYNAECOL RE, V37, P1658, DOI 10.1111/j.1447-0756.2011.01600.x; Jaffe R, 1997, AM J OBSTET GYNECOL, V176, P695, DOI 10.1016/S0002-9378(97)70572-6; Akolekar R, 2013, FETAL DIAGN THER, V33, P8, DOI 10.1159/000341264; Prefumo F, 2004, HUM REPROD, V19, P206, DOI 10.1093/humrep/deh037; HUSTIN J, 1987, AM J OBSTET GYNECOL, V157, P162; LaMarca BD, 2008, HYPERTENSION, V51, P982, DOI 10.1161/HYPERTENSIONAHA.107.108837; Albaiges G, 2000, OBSTET GYNECOL, V96, P559, DOI 10.1016/S0029-7844(00)00946-7; Zhong Y, 2010, PRENATAL DIAG, V30, P293, DOI 10.1002/pd.2475; Melchiorre K, 2008, ULTRASOUND OBST GYN, V32, P133, DOI 10.1002/uog.5400; Odeh M, 2011, PRENATAL DIAG, V31, P367, DOI 10.1002/pd.2697; Egbor M, 2006, BJOG-INT J OBSTET GY, V113, P580, DOI 10.1111/j.1471-0528.2006.00882.x; Itabashi K, 2010, ACTA PEDIAT JPN, V114, P1271; Nakamura M, 2013, PRENATAL DIAG, V33, P759, DOI 10.1002/pd.4120; Rizzo G, 2008, EUR J OBSTET GYN R B, V138, P147, DOI 10.1016/j.ejogrb.2007.08.015; Scazzocchio E, 2013, AM J OBSTET GYNECOL, V208; Tranquilli AL, 2010, MED HYPOTHESES, V75, P38, DOI 10.1016/j.mehy.2010.01.024	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7692	1469-0705		ULTRASOUND OBST GYN	Ultrasound Obstet. Gynecol.	MAY	2015	45	5					539	543		10.1002/uog.14633		5	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	CG7RR	WOS:000353503000009		
J	Tachibana, D; Glosemeyer, P; Diehl, W; Nakagawa, K; Wada, N; Kurihara, Y; Fukui, M; Koyama, M; Hecher, K				Tachibana, D.; Glosemeyer, P.; Diehl, W.; Nakagawa, K.; Wada, N.; Kurihara, Y.; Fukui, M.; Koyama, M.; Hecher, K.			Time-interval analysis of ductus venosus flow velocity waveforms in twin-to-twin transfusion syndrome treated with laser surgery	ULTRASOUND IN OBSTETRICS & GYNECOLOGY			English	Article						ductus venosus; laser surgery; monochorionic twins; time-related analysis; twin-to-twin transfusion syndrome	PLACENTAL ANASTOMOSES; DOPPLER; CIRCULATION; COAGULATION; ABLATION; THERAPY	ObjectivesTo investigate time-interval variables of ductus venosus (DV) flow velocity waveforms (FVWs) in twin-to-twin transfusion syndrome (TTTS), comparing the results with reference ranges from normal singleton fetuses. The impact of laser surgery and the effect of prognostic factors were also evaluated. MethodsIn 107 TTTS cases, DV-FVWs of both recipients and donors were recorded 1day before and 2days after laser therapy. Time intervals for systolic (S) and early diastolic (D) peaks were analyzed retrospectively with regard to acceleration time (acc-S and acc-D for S and D, respectively) and deceleration time (dec-S and dec-D for S and D, respectively). For each variable, Z-scores were calculated with respect to previously reported normal reference ranges. ResultsZ-scores for all variables showed statistically significant differences from those observed previously in normal fetuses, with the exception of dec-S of donors. The most striking differences were observed in longer dec-S of recipients (P<0.001) and longer dec-D of donors (P<0.001). Laser therapy showed significant impact on dec-S and acc-D in recipients and on all variables in donors. Regarding the short-term prognosis, acc-S and dec-S showed significant differences for the prediction of intrauterine fetal demise in donors (P=0.009 and P=0.011, respectively). ConclusionThis study demonstrates that time-interval variables of DV-FVWs may differentiate the characteristic hemodynamic changes caused by unbalanced blood volume between recipients and donors. Copyright (c) 2014 ISUOG. Published by John Wiley & Sons Ltd.	[Tachibana, D.; Nakagawa, K.; Wada, N.; Kurihara, Y.; Koyama, M.] Osaka City Univ, Grad Sch Med, Dept Obstet & Gynecol, Osaka 5458585, Japan; [Tachibana, D.; Glosemeyer, P.; Diehl, W.; Hecher, K.] Univ Med Ctr, Dept Obstet & Fetal Med, Hamburg, Germany; [Fukui, M.] Osaka City Univ, Grad Sch Med, Stat Lab, Osaka 5458585, Japan	Tachibana, D (reprint author), Osaka City Univ, Grad Sch Med, Dept Obstet & Gynecol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	dtachibana@med.osaka-cu.ac.jp					Van Mieghem T, 2013, ULTRASOUND OBST GYN, V42, P64, DOI 10.1002/uog.12454; HECHER K, 1995, CIRCULATION, V91, P129; Huber A, 2006, OBSTET GYNECOL, V108, P333, DOI 10.1097/01.AOG.0000225945.17022.6b; Barrea C, 2006, AM J OBSTET GYNECOL, V195, P1388, DOI 10.1016/j.ajog.2006.03.042; Zikulnig L, 1999, ULTRASOUND OBST GYN, V14, P380, DOI 10.1046/j.1469-0705.1999.14060380.x; Raboisson MJ, 2004, CIRCULATION, V110, P3043, DOI 10.1161/01.CIR.0000146896.20317.59; Nakagawa K, 2012, PRENATAL DIAG, V32, P803, DOI 10.1002/pd.3908; Senat MV, 2004, NEW ENGL J MED, V351, P136, DOI 10.1056/NEJMoa032597; Baschat AA, 2004, AM J OBSTET GYNECOL, V191, P277, DOI 10.1016/j.ajog.2003.11.028; Baschat AA, 2010, AM J OBSTET GYNECOL, V203, p479e1; Becker J, 2006, ULTRASOUND OBST GYN, V28, P674, DOI 10.1002/uog.2734; Bensouda B, 2007, ULTRASOUND OBST GYN, V30, P983, DOI 10.1002/uog.5161; Diehl W, 2010, ULTRASOUND OBST GYN, V36, P67, DOI 10.1002/uog.7974; Diehl W, 2014, BEST PRACT RES CL OB, V28, P227, DOI 10.1016/j.bpobgyn.2013.12.001; Gungor S, 2008, ULTRASOUND OBST GYN, V32, P800, DOI 10.1002/uog.6227; Habli M, 2008, AM J OBSTET GYNECOL, V199, pe1; Huber A, 2008, ULTRASOUND OBST GYN, V31, P412, DOI 10.1002/uog.5283; KISERUD T, 1994, ULTRASOUND OBST GYN, V4, P109, DOI 10.1046/j.1469-0705.1994.04020109.x; Lewi L, 2008, AM J OBSTET GYNECOL, V199, P514; Martinez JM, 2003, ULTRASOUND OBST GYN, V22, P246, DOI 10.1002/uog.215; Moon-Grady AJ, 2011, AM J OBSTET GYNECOL, V205; Quintero R A, 1999, J Perinatol, V19, P550, DOI 10.1038/sj.jp.7200292; Van Mieghem T, 2009, AM J OBSTET GYNECOL, V200, pe1	23	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7692	1469-0705		ULTRASOUND OBST GYN	Ultrasound Obstet. Gynecol.	MAY	2015	45	5					544	550		10.1002/uog.13449		7	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	CG7RR	WOS:000353503000010		
J	Oda, A; Isa, K; Ogasawara, K; Kameyama, K; Okuda, K; Hirashima, M; Ishii, H; Kimura, K; Matsukura, H; Hirayama, F; Kawa, K				Oda, A.; Isa, K.; Ogasawara, K.; Kameyama, K.; Okuda, K.; Hirashima, M.; Ishii, H.; Kimura, K.; Matsukura, H.; Hirayama, F.; Kawa, K.			A novel mutation of the GATA site in the erythroid cell-specific regulatory element of the ABO gene in a blood donor with the A(m)B phenotype	VOX SANGUINIS			English	Article						ABO blood group; A(m)B phenotype; enhancer; GATA factor-binding motif; transcription	BINDING-SITE; TRANSCRIPTION; INDIVIDUALS; ALLELES	The A(m) and B-m phenotypes are characterized by weak expression of the A or B antigens, respectively, by red blood cells with a normal expression by the saliva of secretors. Deletion of the regulatory element in the first intron of the ABO gene and disruption of the GATA motif in the element were found to be responsible. In this study, we identified a novel mutation within the GATA motif (G>C substitution at position c.28+5830) in the regulatory element of the A allele that might diminish transcription activity causing the generation of the A(m)B phenotype.	[Oda, A.; Kameyama, K.; Okuda, K.; Hirashima, M.; Ishii, H.; Kimura, K.; Matsukura, H.; Hirayama, F.; Kawa, K.] Japanese Red Cross, Kinki Block Blood Ctr, Osaka 5670085, Japan; [Isa, K.; Ogasawara, K.] Japanese Red Cross, Cent Blood Inst, Tokyo, Japan	Oda, A (reprint author), Japanese Red Cross, Kinki Block Blood Ctr, 7-5-17 Saito Asagi, Osaka 5670085, Japan.	a-oda@kk.bbc.jrc.or.jp					Kominato Y, 1997, J BIOL CHEM, V272, P25890, DOI 10.1074/jbc.272.41.25890; Seltsam A, 2005, TRANSFUSION, V45, P1663, DOI 10.1111/j.1537-2995.2005.00558.x; Daniels G., 2013, HUMAN BLOOD GROUPS; Nakajima T, 2013, TRANSFUSION, V53, P2917, DOI 10.1111/trf.12181; Ogasawara K, 1998, VOX SANG, V74, P242, DOI 10.1159/000030942; Ogasawara K, 2001, IMMUNOGENETICS, V53, P190, DOI 10.1007/s002510100315; Ogasawara K, 1996, HUM GENET, V97, P777; Sano R, 2012, BLOOD, V119, P5301, DOI 10.1182/blood-2011-10-387167; Takahashi Y, 2014, VOX SANG, V107, P171, DOI 10.1111/vox.12136; Takahashi Y, 2014, VOX SANG, V106, P167, DOI 10.1111/vox.12077; Thuresson B, 2013, VOX SANG, V105, P44; Yamamoto F, 2000, VOX SANG, V78, P91	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0042-9007	1423-0410		VOX SANG	Vox Sang.	MAY	2015	108	4					425	427		10.1111/vox.12229		3	Hematology	Hematology	CG2JY	WOS:000353101900013		
J	Matsuura, H; Akatsuka, Y; Muramatsu, C; Isogai, S; Sugiura, Y; Arakawa, S; Murayama, M; Kurahashi, M; Takasuga, H; Oshige, T; Yuba, T; Mizuta, S; Emi, N				Matsuura, H.; Akatsuka, Y.; Muramatsu, C.; Isogai, S.; Sugiura, Y.; Arakawa, S.; Murayama, M.; Kurahashi, M.; Takasuga, H.; Oshige, T.; Yuba, T.; Mizuta, S.; Emi, N.			Evaluation of the potassium adsorption capacity of a potassium adsorption filter during rapid blood transfusion	VOX SANGUINIS			English	Article						hyperkalemia; massive transfusion; potassium adsorption filter; rapid transfusion; red cell components	MASSIVE TRANSFUSION; HYPERKALEMIA; IRRADIATION; CELLS	The concentration of extracellular potassium in red blood cell concentrates (RCCs) increases during storage, leading to risk of hyperkalemia. A potassium adsorption filter (PAF) can eliminate the potassium at normal blood transfusion. This study aimed to investigate the potassium adsorption capacity of a PAF during rapid blood transfusion. We tested several different potassium concentrations under a rapid transfusion condition using a pressure bag. The adsorption rates of the 70-mEq/l model were 768%. The PAF showed good potassium adsorption capacity, suggesting that this filter may provide a convenient method to prevent hyperkalemia during rapid blood transfusion.	[Matsuura, H.; Muramatsu, C.; Isogai, S.; Sugiura, Y.; Arakawa, S.; Murayama, M.; Kurahashi, M.; Takasuga, H.] Fujita Hlth Univ Hosp, Dept Clin Lab Med, Toyoake, Aichi, Japan; [Matsuura, H.; Akatsuka, Y.; Muramatsu, C.; Isogai, S.; Sugiura, Y.; Arakawa, S.; Murayama, M.; Kurahashi, M.; Takasuga, H.; Mizuta, S.; Emi, N.] Fujita Hlth Univ Hosp, Dept Blood Transfus Med, Toyoake, Aichi, Japan; [Akatsuka, Y.; Mizuta, S.; Emi, N.] Fujita Hlth Univ, Sch Med, Dept Hematol, Toyoake, Aichi 4701192, Japan; [Oshige, T.; Yuba, T.] Kawasumi Labs Inc, Tokyo, Japan	Emi, N (reprint author), Fujita Hlth Univ, Sch Med, Dept Hematol, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	nemi@fujita-hu.ac.jp			Fujita Health University	We wish to thank the staff of the Japanese Red Cross Society Tokai Hokuriku Block Blood Center and Associate Professor Koji Ohashi of Fujita Health University Medical School for their guidance and co-operation. This work was supported in part by a faculty grant from Fujita Health University.	Smith HM, 2008, ANESTH ANALG, V106, P1062, DOI [10.1213/ane.0b013e318164f03d, 10.1213/ane.0b013618164f03d]; Yamada C, 2010, TRANSFUSION, V50, P1926, DOI 10.1111/j.1537-2995.2010.02742.x; Cid J, 2008, TRANSFUSION, V48, P1966, DOI 10.1111/j.1537-2995.2008.01776.x; Asai T, 2000, TRANSFUSION MED, V10, P315, DOI 10.1046/j.1365-3148.2000.00264.x; Vraets A, 2011, TRANSFUS MED REV, V25, P184, DOI 10.1016/j.tmrv.2011.01.006; Lee AC, 2014, TRANSFUSION, V54, P244, DOI 10.1111/trf.12192; JAMESON LC, 1990, ANESTHESIOLOGY, V73, P1050, DOI 10.1097/00000542-199011000-00039; HALL TL, 1993, TRANSFUSION, V33, P606, DOI 10.1046/j.1537-2995.1993.33793325059.x; Inaba S, 2000, TRANSFUSION, V40, P1469, DOI 10.1046/j.1537-2995.2000.40121469.x; Inaba S, 1996, JPN J TRANSFUS MED, V42, P218; Ministry of Health Labour and Welfare Pharmaceutical and Food Safety Bureau Blood and Blood Products Division, 2012, GUID US BLOOD PROD; THORP JA, 1990, AM J OBSTET GYNECOL, V163, P607	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0042-9007	1423-0410		VOX SANG	Vox Sang.	MAY	2015	108	4					428	431		10.1111/vox.12242		4	Hematology	Hematology	CG2JY	WOS:000353101900014		
J	Woo, J				Woo, Jongwon			Inequality in the Workplace: Labor Market Reform in Japan and Korea.	WORK AND OCCUPATIONS			English	Book Review									[Woo, Jongwon] Saitama Univ, Fac Econ, Saitama, Saitama 3388570, Japan	Woo, J (reprint author), Saitama Univ, Fac Econ, Saitama, Saitama 3388570, Japan.						SONG J, 2014, INEQUALITY WORKPLACE	1	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0730-8884	1552-8464		WORK OCCUPATION	Work Occup.	MAY	2015	42	2					259	261		10.1177/0730888415570825		3	Industrial Relations & Labor; Sociology	Business & Economics; Sociology	CG6NV	WOS:000353419800007		
J	Shuto, T				Shuto, Takashi			Authors' reply to "Pathogenesis of radiosurgery-induced cyst formation in patients with arteriovenous malformation"	ACTA NEUROCHIRURGICA			English	Letter									Yokohama Rosai Hosp, Dept Neurosurg, Kouhoku Ku, Yokohama, Kanagawa 2220036, Japan	Shuto, T (reprint author), Yokohama Rosai Hosp, Dept Neurosurg, Kouhoku Ku, 3211 Kozukue Cho, Yokohama, Kanagawa 2220036, Japan.	shuto@yokohamah.rofuku.go.jp					Ding D, 2015, ACTA NEUROCHIR WEIN, DOI [10.1007/s00701-015-2380-1, DOI 10.1007/S00701-015-2380-1]; Shuto T, 2015, ACTA NEUROCHIR, V157, P293, DOI 10.1007/s00701-014-2298-z	2	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAY	2015	157	5					779	780		10.1007/s00701-015-2398-4		2	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF8NG	WOS:000352817800007		
J	Shimizu, K; Matsumoto, M; Wada, A; Mizutani, T				Shimizu, Katsuyoshi; Matsumoto, Masaki; Wada, Akira; Mizutani, Tohoru			Lateral basal approach with a supine, no-retractor method for microvascular decompression for hemifacial spasm	ACTA NEUROCHIRURGICA			English	Article						Hemifacial spasm; Microvascular decompression; Supine position; No retractor		We describe the details of our unique surgical procedures for microvascular decompression for hemifacial spasm. A patient is just laid supine, skipping the complicated preparation for the lateral or park-bench position. The subfloccular approach from a small cranial window situated on the more lateral and basal side of the occipital cranium enables the surgeon to reach all the segments of the facial nerve root without cerebellar retraction by a spatula. We believe this approach is ideal for the safe and precise decompression of any part of the facial nerve root.	[Shimizu, Katsuyoshi; Matsumoto, Masaki; Wada, Akira; Mizutani, Tohoru] Showa Univ, Sch Med, Dept Neurosurg, Shinagawa Ku, Tokyo 1428666, Japan	Shimizu, K (reprint author), Showa Univ, Sch Med, Dept Neurosurg, Shinagawa Ku, 5-8 Hatanodai 1, Tokyo 1428666, Japan.	katsuyoshis@aol.com					JANNETTA PJ, 1977, J NEUROSURG, V47, P321, DOI 10.3171/jns.1977.47.3.0321; Campos-Benitez M, 2008, J NEUROSURG, V109, P416, DOI 10.3171/JNS/2008/109/9/0416; Zhang M, 2002, OTOLARYNG HEAD NECK, V127, P452, DOI 10.1067/mhn.2002.129823; McLaughlin MR, 1999, J NEUROSURG, V90, P1, DOI 10.3171/jns.1999.90.1.0001; De Ridder D, 2002, NEUROSURGERY, V51, P427, DOI 10.1227/01.NEU.0000020080.8116.9D; GARDNER WJ, 1962, J NEUROSURG, V19, P240, DOI 10.3171/jns.1962.19.3.0240	6	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAY	2015	157	5					803	806		10.1007/s00701-015-2393-9		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF8NG	WOS:000352817800011		
J	Ishikawa, M; Ota, Y; Yoshida, N; Iino, Y; Tanaka, Y; Watanabe, E				Ishikawa, Mami; Ota, Yasushi; Yoshida, Naohiro; Iino, Yukiko; Tanaka, Yuichi; Watanabe, Eiju			Endonasal ultrasonography-assisted neuroendoscopic transsphenoidal surgery	ACTA NEUROCHIRURGICA			English	Article						Neuroendoscope; Endonasal; Pituitary; Ultrasonography; Transsphenoidal	INTRAOPERATIVE ULTRASOUND; EBUS-TBNA; RESECTION; DISEASE	We report endonasal ultrasonography (US)-assisted neuroendoscopic transsphenoidal surgery (TSS) in seven patients. With sagittal and coronal US images, internal carotid arteries, anterior cerebral arteries, residual tumor, and lateral ventricles were recognized, and the tumors were removed without leakage of cerebrospinal fluid in patients with pituitary adenoma. US images clearly depicted the carotid arteries, anterior cerebral arteries, middle cerebral arteries, chiasmatic cistern, and residual tumor. Endonasal US images can provide real-time animated information and may help neuroendoscopic TSS, whenever needed during TSS.	[Ishikawa, Mami; Tanaka, Yuichi] JichiMed Univ, Saitama Med Ctr, Dept Neurosurg, Saitamashi, Saitama 3308503, Japan; [Ota, Yasushi] Toho Med Ctr, Sakura Hosp, Dept ENT Surg, Chiba, Japan; [Yoshida, Naohiro; Iino, Yukiko] Jichi Med Univ, Saitama Med Ctr, Dept ENT Surg, Saitamashi, Saitama 3308503, Japan; [Watanabe, Eiju] Jichi Med Univ, Dept Neurosurg, Shimotsukeshi, Tochigi 3290498, Japan	Ishikawa, M (reprint author), JichiMed Univ, Saitama Med Ctr, Dept Neurosurg, 1-847 Amanumacho, Saitamashi, Saitama 3308503, Japan.	m.ishikawa@jichi.ac.jp					Fahlbusch R, 2001, J NEUROSURG, V95, P381, DOI 10.3171/jns.2001.95.3.0381; Xiang Y, 2013, J THORAC DIS, V5, P36, DOI 10.3978/j.issn.2072-1439.2012.12.06; Bohinski RJ, 2001, NEUROSURGERY, V49, P1133; Arita K, 1998, NEUROSURGERY, V42, P81, DOI 10.1097/00006123-199801000-00016; Medford ARL, 2010, RESPIROLOGY, V15, P71, DOI 10.1111/j.1440-1843.2009.01652.x; Ota Y, 2013, ORL J OTO-RHINO-LARY, V75, P27, DOI 10.1159/000346931; Peterno V, 2014, ACTA NEUROCHIR, V156, P463; RAM Z, 1995, J NEUROSURG, V83, P225, DOI 10.3171/jns.1995.83.2.0225; Solheim O, 2010, NEUROSURGERY, V66, P173, DOI 10.1227/01.NEU.0000360571.11582.4F; Watson JC, 1998, J NEUROSURG, V89, P927, DOI 10.3171/jns.1998.89.6.0927; Yamamoto T, 2014, J CLIN MONIT COMPUT, V28, P165, DOI 10.1007/s10877-013-9509-7	11	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAY	2015	157	5					863	868		10.1007/s00701-015-2382-z		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF8NG	WOS:000352817800020		
J	Duyckaerts, C; Braak, H; Brion, JP; Buee, L; Del Tredici, K; Goedert, M; Halliday, G; Neumann, M; Spillantini, MG; Tolnay, M; Uchihara, T				Duyckaerts, Charles; Braak, Heiko; Brion, Jean-Pierre; Buee, Luc; Del Tredici, Kelly; Goedert, Michel; Halliday, Glenda; Neumann, Manuela; Spillantini, Maria Grazia; Tolnay, Markus; Uchihara, Toshiki			PART is part of Alzheimer disease	ACTA NEUROPATHOLOGICA			English	Article						Alzheimer disease; Amyloid; A beta; PART hypothesis; Tau; Tauopathy	NATIONAL INSTITUTE; NEUROPATHOLOGIC ASSESSMENT; NEUROFIBRILLARY CHANGES; ASSOCIATION GUIDELINES; PATHOLOGICAL PROCESS; MOUSE-BRAIN; TAU; TAUOPATHY; TRANSMISSION; INDIVIDUALS	It has been proposed that tau aggregation confined to entorhinal cortex and hippocampus, with no or only minimal A beta deposition, should be considered as a 'primary age-related tauopathy' (PART) that is not integral to the continuum of sporadic Alzheimer disease (AD). Here, we examine the evidence that PART has a pathogenic mechanism and a prognosis which differ from those of AD. We contend that no specific property of the entorhinal-hippocampal tau pathology makes it possible to predict either a limited progression or the development of AD, and that biochemical differences await an evidence base. On the other hand, entorhinal-hippocampal tau pathology is an invariant feature of AD and is always associated with its development. Rather than creating a separate disease entity, we recommend the continued use of an analytical approach based on NFT stages and A beta phases with no inference about hypothetical disease processes.	[Duyckaerts, Charles] Hop La Pitie Salpetriere, AP HP, Lab Neuropathol Escourolle, F-75651 Paris 13, France; [Duyckaerts, Charles] UPMC, Univ Paris 04, Alzheimer Prion Team, INSERM,CNRS,UMR 7225,U1127,UMR S 1127,ICM, F-75651 Paris 13, France; [Braak, Heiko; Del Tredici, Kelly] Univ Ulm, Ctr Biomed Res, Dept Neurol, Clin Neuroanat, D-89081 Ulm, Germany; [Brion, Jean-Pierre] Univ Libre Bruxelles, ULB Neurosci Inst UNI, Lab Histol Neuroanat & Neuropathol, B-1070 Brussels, Belgium; [Buee, Luc] Univ Lille, INSERM, F-59045 Lille, France; [Goedert, Michel] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Halliday, Glenda] Neurosci Res Australia, Sydney, NSW 2031, Australia; [Halliday, Glenda] Univ New S Wales, Sydney, NSW 2031, Australia; [Neumann, Manuela] Univ Tubingen, Dept Neuropathol, D-72072 Tubingen, Germany; [Neumann, Manuela] German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany; [Spillantini, Maria Grazia] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0AH, England; [Tolnay, Markus] Univ Basel Hosp, Inst Pathol, Dept Neuropathol, CH-4031 Basel, Switzerland; [Uchihara, Toshiki] Tokyo Metropolitan Inst Med Sci, Lab Struct Neuropathol, Kamikitazawa, Setagaya, Japan	Duyckaerts, C (reprint author), Hop La Pitie Salpetriere, AP HP, Lab Neuropathol Escourolle, 47 Bd Hop, F-75651 Paris 13, France.	charles.duyckaerts@psl.aphp.fr	BUEE, Luc/B-3126-2010; Neumann, Manuela/F-6558-2011; Halliday, Glenda/E-8555-2011	BUEE, Luc/0000-0002-6261-4230; Halliday, Glenda/0000-0003-0422-8398			Jack CR, 2014, LANCET NEUROL, V13, P997, DOI 10.1016/S1474-4422(14)70194-2; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; DELAERE P, 1993, NEUROBIOL AGING, V14, P191, DOI 10.1016/0197-4580(93)90096-T; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Grinberg LT, 2009, NEUROPATH APPL NEURO, V35, P406, DOI [10.1111/j.1365-2990.2009.00997.x, 10.1111/j.1365-2990.2008.00997.x]; Dugger BN, 2013, J ALZHEIMERS DIS, V34, P529, DOI 10.3233/JAD-121864; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; BRAAK H, 1992, NEUROSCI RES, V15, P6, DOI 10.1016/0168-0102(92)90014-4; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Thal DR, 2002, NEUROLOGY, V58, P1791; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Wider C, 2012, J NEUROL NEUROSUR PS, V83, P424, DOI 10.1136/jnnp-2011-301413; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Delacourte A, 2002, NEUROLOGY, V59, P398; Ghebremedhin E, 1998, EXP NEUROL, V153, P152, DOI 10.1006/exnr.1998.6860; Knopman DS, 2013, ANN NEUROL, V73, P472, DOI 10.1002/ana.23816; Myers AJ, 2005, HUM MOL GENET, V14, P2399, DOI 10.1093/hmg/ddi241; Elbaz A, 2011, ANN NEUROL, V69, P778, DOI 10.1002/ana.22321; Braak H, 2014, ACTA NEUROPATHOL, V128, P767, DOI 10.1007/s00401-014-1356-1; Braak H, 2015, ADV ANAT EMBRYOL CEL, V215, pVII, DOI 10.1007/978-3-319-12679-1; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Dujardin Simon, 2014, Acta Neuropathol Commun, V2, P14, DOI 10.1186/2051-5960-2-14; Goedert M, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0495-z; Jack CR, 2014, ACTA NEUROPATHOL, V128, P773, DOI 10.1007/s00401-014-1362-3	27	6	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	MAY	2015	129	5					749	756		10.1007/s00401-015-1390-7		8	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CF7DN	WOS:000352716500010		
J	Matsubara, S; Ohkuchi, A; Suzuki, H; Kimura, M; Takahashi, H; Fujiwara, H				Matsubara, Shigeki; Ohkuchi, Akihide; Suzuki, Hirotada; Kimura, Madoka; Takahashi, Hironori; Fujiwara, Hiroyuki			Cesarean hysterectomy: amputation-first technique (Matsubara)	ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA			English	Letter							PLACENTA PREVIA ACCRETA		[Matsubara, Shigeki; Ohkuchi, Akihide; Suzuki, Hirotada; Kimura, Madoka; Takahashi, Hironori; Fujiwara, Hiroyuki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan.	matsushi@jichi.ac.jp					Matsubara S, 2012, ARCH GYNECOL OBSTET, V285, P1765, DOI 10.1007/s00404-011-2204-3; Matsubara S, 2013, ACTA OBSTET GYN SCAN, V92, P372, DOI 10.1111/aogs.12074; Matsubara S, 2013, J OBSTET GYNAECOL, V33, P163, DOI 10.3109/01443615.2012.740525; Matsubara S, 2013, ACTA OBSTET GYN SCAN, V92, P1234, DOI 10.1111/aogs.12199; Matsubara S, 2012, ACTA OBSTET GYN SCAN, V91, P155, DOI 10.1111/j.1600-0412.2011.01272.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6349	1600-0412		ACTA OBSTET GYN SCAN	Acta Obstet. Gynecol. Scand.	MAY	2015	94	5					552	553		10.1111/aogs.12602		2	Obstetrics & Gynecology	Obstetrics & Gynecology	CG1LB	WOS:000353033000017		
J	Makino, S; Takeda, J; Hirai, C; Itakura, A; Takeda, S				Makino, Shintaro; Takeda, Jun; Hirai, Chihiro; Itakura, Atsuo; Takeda, Satoru			Uterine balloon tamponade as a test to assess further treatment	ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA			English	Letter									[Makino, Shintaro; Takeda, Jun; Hirai, Chihiro; Itakura, Atsuo; Takeda, Satoru] Juntendo Univ, Fac Med, Dept Obstet & Gynecol, Tokyo, Japan	Makino, S (reprint author), Juntendo Univ, Fac Med, Dept Obstet & Gynecol, Tokyo, Japan.	shintaro@juntendo.ac.jp					Matsubara S, 2014, ACTA OBSTET GYN SCAN, V93, P120, DOI 10.1111/aogs.12241; Takahashi H, 2015, ACTA OBSTET GYN SCAN, V94, P336, DOI 10.1111/aogs.12563; Yorifuji T, 2011, ACTA OBSTET GYN SCAN, V90, P1171, DOI 10.1111/j.1600-0412.2011.01169.x	3	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6349	1600-0412		ACTA OBSTET GYN SCAN	Acta Obstet. Gynecol. Scand.	MAY	2015	94	5					556	556		10.1111/aogs.12599		1	Obstetrics & Gynecology	Obstetrics & Gynecology	CG1LB	WOS:000353033000020		
J	Takahashi, H; Matsubara, S				Takahashi, Hironori; Matsubara, Shigeki			Authors' reply: No vaginal bleeding does not indicate no bleeding: still valid for Bakri balloon and also for "holding the cervix"	ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA			English	Letter							HEMORRHAGE		[Takahashi, Hironori; Matsubara, Shigeki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan.	matsushi@jichi.ac.jp					Makino S, 2015, ACTA OBSTET GYN SCAN, V94, P556, DOI 10.1111/aogs.12599; Matsubara S, 2014, ACTA OBSTET GYN SCAN, V93, P314, DOI 10.1111/aogs.12282; Matsubara S, 2014, AUST NZ J OBSTET GYN, V54, P283, DOI 10.1111/ajo.12184; Ohkuchi A, 2003, J PERINAT MED, V31, P209, DOI 10.1515/JPM.2003.028; Takahashi H, 2015, ACTA OBSTET GYN SCAN, V94, P336, DOI 10.1111/aogs.12563	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6349	1600-0412		ACTA OBSTET GYN SCAN	Acta Obstet. Gynecol. Scand.	MAY	2015	94	5					557	557		10.1111/aogs.12617		1	Obstetrics & Gynecology	Obstetrics & Gynecology	CG1LB	WOS:000353033000021		
J	Tanito, M; Sano, I; Ohira, A				Tanito, Masaki; Sano, Ichiya; Ohira, Akihiro			Possible bidirectional flow of aqueous fluid after Baerveldt glaucoma implant surgery	ACTA OPHTHALMOLOGICA			English	Letter									[Tanito, Masaki; Sano, Ichiya] Matsue Red Cross Hosp, Div Ophthalmol, Matsue, Shimane 6908506, Japan; [Tanito, Masaki; Sano, Ichiya; Ohira, Akihiro] Shimane Univ, Fac Med, Dept Ophthalmol, Izumo, Shimane, Japan	Tanito, M (reprint author), Matsue Red Cross Hosp, Div Ophthalmol, 200 Horo Machi, Matsue, Shimane 6908506, Japan.	tanito-oph@umin.ac.jp					Christakis PG, 2011, OPHTHALMOLOGY, V118, P2180, DOI 10.1016/j.ophtha.2011.05.004; Chihara E, 2012, JPN J OPHTHALMOL, V56, P119, DOI 10.1007/s10384-011-0108-1; Budenz DL, 2011, OPHTHALMOLOGY, V118, P443, DOI 10.1016/j.ophtha.2010.07.016; Minckler D. S., 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004918PUB2	4	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-375X	1755-3768		ACTA OPHTHALMOL	Acta Ophthalmol.	MAY	2015	93	3					e237	e238		10.1111/aos.12561		2	Ophthalmology	Ophthalmology	CG1SA	WOS:000353053000021		
J	Tanito, M; Hara, K; Akahori, M; Harata, A; Itabashi, T; Takai, Y; Kaidzu, S; Ohira, A; Iwata, T				Tanito, Masaki; Hara, Katsunori; Akahori, Masakazu; Harata, Ayano; Itabashi, Takeshi; Takai, Yasuyuki; Kaidzu, Sachiko; Ohira, Akihiro; Iwata, Takeshi			Lack of association of LOXL1 gene variants in Japanese patients with central retinal vein occlusion without clinically detectable pseudoexfoliation material deposits	ACTA OPHTHALMOLOGICA			English	Article						cataract; central retinal vein occlusion; exfoliation syndrome; LOXL1; SNPs	OPEN-ANGLE GLAUCOMA; EXFOLIATION SYNDROME; MACULAR DEGENERATION; ARMS2 LOC387715; RISK-FACTORS; POLYMORPHISMS; DISEASE; BRANCH; EPIDEMIOLOGY; POPULATION	PurposeA possible association has been reported between exfoliation syndrome (EX) and various ocular and systemic vascular disorders; however, it is unclear if there is an association between EX and central retinal vein occlusion (CRVO). Because latent deposits of exfoliation materials might not be recognized during slit-lamp examination, an ocular biopsy is required to establish a precise diagnosis. We evaluated a possible association between EX and CRVO using lysyl oxidase-like 1 (LOXL1) gene variants as alternative markers for EX. MethodsThe allelic and genotypic frequencies of three LOXL1 variants (rs1048661, rs3825942, and rs2165241) were determined in 68 consecutive Japanese patients with CRVO [15 with exfoliation syndrome (EX+) and 53 without exfoliation syndrome (EX-)] and 90 control patients with cataract without EX (CT). ResultsThe frequencies of the rs1048661 and rs3825942 variants showed borderline difference between the CRVO and CT groups (p=0.04085 and p=0.06088, respectively, for allelic frequencies, and p=0.06838 and p=0.03482, respectively, for genotypic frequencies). Compared with the CT group, subgroup analysis showed that the CRVO EX+ group had significant differences in the allelic and genotypic frequencies of rs1048661 (p=0.0006447 and p=0.0001392, respectively) and had borderline differences in the allelic and genotypic frequencies of rs3825942 (p=0.03403 and p=0.07341, respectively), while the CRVO EX- group did not (p=0.1324-0.6306). Subgroup analysis showed that the frequencies of rs2165241 did not differ between the CRVO and CT groups. ConclusionsWhen the LOXL1 variants were used as disease markers for clinically undetectable EX, there was no association between CRVO and EX. The results suggested that the LOXL1 variants, which are well-established markers for EX, are not likely genetic markers for CRVO in Japanese subjects.	[Tanito, Masaki; Hara, Katsunori; Takai, Yasuyuki; Kaidzu, Sachiko; Ohira, Akihiro] Shimane Univ, Fac Med, Izumo, Shimane 6938501, Japan; [Tanito, Masaki] Matsue Red Cross Hosp, Div Ophthalmol, Matsue, Shimane, Japan; [Akahori, Masakazu; Harata, Ayano; Itabashi, Takeshi; Iwata, Takeshi] Natl Hosp Org, Tokyo Med Ctr, Natl Inst Sensory Organs, Tokyo, Japan	Tanito, M (reprint author), Shimane Univ, Fac Med, Dept Ophthalmol, Enya 89-1, Izumo, Shimane 6938501, Japan.	tanito-oph@umin.ac.jp					Abramsson A, 2011, NEUROMOL MED, V13, P160, DOI 10.1007/s12017-011-8144-z; YANNUZZI LA, 1993, AM J OPHTHALMOL, V116, P286; Tanito M, 2008, MOL VIS, V14, P1898; Jonasson F, 2009, ACTA OPHTHALMOL, V87, P478, DOI 10.1111/j.1755-3768.2009.01635.x; Hayashi H, 2008, AM J OPHTHALMOL, V145, P582, DOI 10.1016/j.ajo.2007.10.023; Cahill MT, 2003, AM J OPHTHALMOL, V136, P1136, DOI 10.1016/S0002-9394(03)00571-3; Mabuchi F, 2008, MOL VIS, V14, P1303; Mori K, 2008, MOL VIS, V14, P1037; Fuse N, 2011, AM J OPHTHALMOL, V151, P550, DOI 10.1016/j.ajo.2010.08.048; DAVID R, 1988, OPHTHALMOLOGICA, V197, P69; Ritch R, 2001, SURV OPHTHALMOL, V45, P265, DOI 10.1016/S0039-6257(00)00196-X; Fuse N, 2008, MOL VIS, V14, P1338; KONSTAS AGP, 1993, OPHTHALMOLOGY, V100, P619; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Koizumi H, 2007, AM J OPHTHALMOL, V144, P858, DOI 10.1016/j.ajo.2007.07.036; Ozaki M, 2008, INVEST OPHTH VIS SCI, V49, P3976, DOI 10.1167/iovs.08-1805; Andrikopoulos GK, 2009, EYE, V23, P442, DOI 10.1038/sj.eye.6702992; PRINCE AM, 1987, ARCH OPHTHALMOL-CHIC, V105, P1076; Bojic L, 2005, GRAEF ARCH CLIN EXP, V243, P446, DOI 10.1007/s00417-004-1074-9; Cursiefen C, 1997, KLIN MONATSBL AUGENH, V211, P17, DOI 10.1055/s-2008-1035088; Cursiefen C, 2001, ACTA OPHTHALMOL SCAN, V79, P476, DOI 10.1034/j.1600-0420.2001.790509.x; Hara K, 2011, MOL VIS, V17, P3309; Hollo G, 2011, J GLAUCOMA, V20, P143, DOI 10.1097/IJG.0b013e3181d9d8dd; Irkec M, 2006, BRIT J OPHTHALMOL, V90, P529, DOI 10.1136/bjo.2006.090688; Janciauskiene S, 2001, ACTA OPHTHALMOL SCAN, V79, P328, DOI 10.1034/j.1600-0420.2001.790327.x; KARJALAINEN K, 1987, ACTA OPHTHALMOL, V65, P320; Lepre T, 2011, AM J OPHTHALMOL, V152, P325, DOI 10.1016/j.ajo.2011.04.021; Linner E, 2001, ACTA OPHTHALMOL SCAN, V79, P283, DOI 10.1034/j.1600-0420.2001.790314.x; Ritch R, 2010, ACTA OPHTHALMOL, V88, P91, DOI 10.1111/j.1755-3768.2009.01578.x; Saatci Osman A., 1999, International Ophthalmology, V23, P75, DOI 10.1023/A:1026557029227; Sakurada Y, 2011, AM J OPHTHALMOL, V152, P499, DOI 10.1016/j.ajo.2011.04.022; STREETEN BW, 1992, ARCH OPHTHALMOL-CHIC, V110, P1757; Tanito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049680; Yazdani S, 2008, OPHTHALMOLOGY, V115, P425, DOI 10.1016/j.ophtha.2007.10.038	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-375X	1755-3768		ACTA OPHTHALMOL	Acta Ophthalmol.	MAY	2015	93	3					e214	e217		10.1111/aos.12534		4	Ophthalmology	Ophthalmology	CG1SA	WOS:000353053000010		
J	Yoshida, S; Sugahara, K; Hashimoto, M; Hirose, Y; Shimogori, H; Yamashita, H				Yoshida, Shuhei; Sugahara, Kazuma; Hashimoto, Makoto; Hirose, Yoshinobu; Shimogori, Hiroaki; Yamashita, Hiroshi			The minimum peptides of IGF-1 and substance P protect vestibular hair cells against neomycin ototoxicity	ACTA OTO-LARYNGOLOGICA			English	Article						SSSR; FGLM-NH2; aminoglycoside; hair cell degeneration	GROWTH-FACTOR-I; INNER-EAR; KERATOPATHY; HYDROGELS; DEATH	Conclusions: Our data indicate that SSSR and SSSR + FGLM-NH2 protect sensory hair cells against neomycin-induced death in the vestibular epithelium. In addition, the results show that SSSR and FGLM-NH2 can be used as protective molecules against aminoglycoside ototoxicity. Objectives: This study investigated the role of the peptides SSSR and SSSR + FGLM-NH2 in mammalian vestibular hair cell death induced by aminoglycoside. Methods: Cultured utricles from mature CBA/N mice were used in this study. The cultured utricles were assigned to five groups (control group, neomycin group, neomycin + SSSR group, neomycin + FGLM-NH2 group, and neomycin + SSSR + FGLM-NH2 group). Aat 24 h after exposure to neomycin, the hair cells were labeled immunohistochemically, and the rate of survival of vestibular hair cells was evaluated using a fluorescence microscope. Results: The rate of survival of vestibular hair cells was significantly higher in the neomycin + SSSR and neomycin + SSSR + FGLM-NH2 groups than in the neomycin group. The results suggest that SSSR could protect hair cells against aminoglycoside ototoxicity.	[Yoshida, Shuhei; Sugahara, Kazuma; Hashimoto, Makoto; Hirose, Yoshinobu; Shimogori, Hiroaki; Yamashita, Hiroshi] Yamaguchi Univ, Grad Sch Med, Dept Otolaryngol, Ube, Yamaguchi 7558505, Japan	Yamashita, H (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Otolaryngol, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	hiro-shi@yamaguchi-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology	We would like to thank Dr Teruo Nishida for his valuable suggestions. This work was supported by a grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Camarero G, 2001, J NEUROSCI, V21, P7630; Yamada N, 2008, BRIT J OPHTHALMOL, V92, P896, DOI 10.1136/bjo.2007.130013; Cunningham LL, 2006, BRAIN RES, V1091, P277, DOI 10.1016/j.brainres.2006.01.128; Nishida T, 1996, J CELL PHYSIOL, V169, P159, DOI 10.1002/(SICI)1097-4652(199610)169:1<159::AID-JCP16>3.0.CO;2-8; Chikamoto N, 2009, JPN J OPHTHALMOL, V53, P464, DOI 10.1007/s10384-009-0693-4; Fujiwara T, 2008, NEUROREPORT, V19, P1585, DOI 10.1097/WNR.0b013e328311ca4b; Iwai K, 2006, LARYNGOSCOPE, V116, P529, DOI 10.1097/01.mlg.0000200791.77819.eb; Levresse V, 2000, J NEUROSCI RES, V62, P799; Murillo-Cuesta S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00011; Nakagawa T, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-76; PARK JY, 2007, ACTA OTO-LARYNGOL, V558, P22; Sugahara K, 2006, HEARING RES, V221, P128, DOI 10.1016/j.heares.2006.08.009; Toyota H, 2012, NEUROSCI LETT, V526, P128, DOI 10.1016/j.neulet.2012.08.026; Varela-Nieto I, 2004, HEARING RES, V196, P19, DOI 10.1016/j.heares.2003.12.022	14	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	MAY	2015	135	5					411	415		10.3109/00016489.2014.979438		5	Otorhinolaryngology	Otorhinolaryngology	CG1MM	WOS:000353036800001		
J	Kanzaki, J; Goto, F				Kanzaki, Jin; Goto, Fumiyuki			Psychiatric disorders in patients with dizziness and Meniere's disease	ACTA OTO-LARYNGOLOGICA			English	Article						Vestibular disorder; depression; anxiety disorder; Self-Rating Depression Score; Hospital Anxiety and Depression Scale	RATING DEPRESSION SCALE; HOSPITAL ANXIETY; VALIDATION; OUTPATIENTS	Conclusions: The Self-Rating Depression Score (SDS) is a useful metric for identifying patients with possible psychiatric disorders. Objective: A dilemma commonly encountered by otolaryngologists is how to diagnose and treat depression and anxiety disorders in patients who have dizziness or Meniere's disease. Methods: We administered the SDS and Hospital Anxiety and Depression Scale (HADS) to patients with dizziness (n = 116) or Meniere's disease (n = 22). Overall, 31 and 9 patients, respectively, had SDS >= 41. We investigated the correlation between the two questionnaire scores and the relationship between scores and a diagnosis of depression by a psychiatrist. Results: We referred 12 patients with dizziness and 4 with Meniere's disease to a psychiatrist. The most common psychiatric comorbidities were anxiety disorder and major depression. Overall, 7 of the 12 patients who had dizziness and all 4 patients with Meniere's disease were diagnosed with major depression. Patients with an SDS >= 41 and >= 11 on the D portion of HADS were likely to be diagnosed with major depression (9 of 11). No psychiatric disorders were diagnosed in patients with an SDS < 41. No specific characteristics were identified by HADS in patients with a psychiatric comorbidity.	[Kanzaki, Jin] Int Univ Hlth & Welf, Atami Hosp, Dept Otolaryngol, Shizuoka, Japan; [Goto, Fumiyuki] Tokyo Med Ctr, Dept Otolaryngol, Tokyo, Japan; [Goto, Fumiyuki] Nihon Univ, Sch Med, Dept Psychosomat Med, Tokyo, Japan	Goto, F (reprint author), Tokyo Med Ctr, Tokyo Med Ctr, Dept Otolaryngol, 2-5-1 Higashigaoka Meguro, Tokyo 1520021, Japan.	amifumi@bc5.so-net.ne.jp					Yardley L, 2000, OTOLARYNG CLIN N AM, V33, P603, DOI 10.1016/S0030-6665(05)70229-2; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; [Anonymous], 1995, OTOLARYNGOL HEAD NEC, V113, P181; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508; SNAITH RP, 1986, BRIT MED J, V292, P344; MCKENNA L, 1991, CLIN OTOLARYNGOL, V16, P452, DOI 10.1111/j.1365-2273.1991.tb01038.x; Eckhardt-Henn A, 2008, J NEUROL, V255, P420, DOI 10.1007/s00415-008-0697-x; Yardley L, 1998, J NEUROL NEUROSUR PS, V65, P679, DOI 10.1136/jnnp.65.5.679; Goto F, 2012, GEN HOSP PSYCHIAT, V34, P206, DOI 10.1016/j.genhosppsych.2011.09.014; KROENKE K, 1993, J GEN INTERN MED, V8, P530, DOI 10.1007/BF02599633; Persoons P, 2003, GEN HOSP PSYCHIAT, V25, P316, DOI 10.1016/S0163-8343(03)00072-0; Sheehan DV, 1998, J CLIN PSYCHIAT S20, V59, P4; SULLIVAN M, 1993, ARCH INTERN MED, V153, P1479, DOI 10.1001/archinte.153.12.1479; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	15	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	MAY	2015	135	5					447	450		10.3109/00016489.2014.990581		4	Otorhinolaryngology	Otorhinolaryngology	CG1MM	WOS:000353036800007		
J	Yokobori, Y; Toyoda, M; Sakakura, K; Kaira, K; Tsushima, Y; Chikamatsu, K				Yokobori, Yuki; Toyoda, Minoru; Sakakura, Koichi; Kaira, Kyoichi; Tsushima, Yoshito; Chikamatsu, Kazuaki			F-18-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma	ACTA OTO-LARYNGOLOGICA			English	Article						SUVmax; imaging biomarkers; angiogenesis; cell metabolism	TRANSPORTER 1 EXPRESSION; LUNG-CANCER; PROGNOSTIC-SIGNIFICANCE; BREAST-CANCER; LAT1	Conclusion: The maximum standardized uptake value (SUVmax) of early oral squamous cell carcinoma (OSCC) may have a role as an imaging biomarker for assessment of malignant potential, including cell metabolism and angiogenesis. Objective: The usefulness of F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) has been proven in various cancers, including OSCC. Moreover, in several carcinomas, the SUVmax of the tumor has been shown to correlate with the histological type, tumor stage, differentiation, and prognosis. Here, we investigated whether the SUVmax of early OSCC was associated with the biological features. Methods: Twenty-seven patients with newly diagnosed early OSCC who underwent preoperative FDG-PET and curative surgical resection were included in this study. Tumor sections were stained by immunohistochemistry for glucose transporter 1 (GLUT1), L-type amino acid transporter 1 (LAT1), CD98, microvessels (CD34), cell proliferation marker (Ki-67), and cell cycle regulator (p53). The correlation between SUVmax and clinicopathological findings or the expression level of these molecules was analyzed. Results: SUVmax of primary OSCC was significantly higher in patients with T2 stage. Moreover, patients whose tumors showed vascular invasion had a tendency to show higher SUVmax. A significant correlation was observed between SUVmax and the expression of LAT1 or microvessel density.	[Yokobori, Yuki; Toyoda, Minoru; Sakakura, Koichi; Chikamatsu, Kazuaki] Gunma Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Gunma, Japan; [Kaira, Kyoichi] Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Gunma, Japan; [Tsushima, Yoshito] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Gunma, Japan	Chikamatsu, K (reprint author), Gunma Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	tikamatu@gunma-u.ac.jp			Ministry of Education, Culture, Sport, Science and Technology of Japan [25861525, 24791820, 26670736]	This work was supported in part by grants-in-aid (no. 25861525 to M.T., no. 24791820 to K.S., no. 26670736 to K.C.) from the Ministry of Education, Culture, Sport, Science and Technology of Japan. We thank Dr Goro Takahashi (Department of Otolaryngology/Head & Neck Surgery, Hamamatsu University School of Medicine) for his cooperation in statistical analysis.	Sauter AW, 2012, J NUCL MED, V53, P521, DOI 10.2967/jnumed.111.097865; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Argiris A, 2011, J CLIN ONCOL, V29, P1140, DOI 10.1200/JCO.2010.33.3591; Martens-de Kemp SR, 2013, STEM CELL RES, V10, P477, DOI 10.1016/j.scr.2013.02.004; Nobusawa A, 2013, EUR J NUCL MED MOL I, V40, P1692, DOI 10.1007/s00259-013-2477-9; Marioni G, 2013, J ORAL PATHOL MED, V42, P606, DOI 10.1111/jop.12053; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Groves AM, 2011, EUR J NUCL MED MOL I, V38, P46, DOI 10.1007/s00259-010-1590-2; Tian M, 2004, EUR J NUCL MED MOL I, V31, P5, DOI 10.1007/s00259-003-1316-9; Kaira K, 2010, J CLIN ONCOL, V28, P3746, DOI 10.1200/JCO.2009.27.4662; Troost EGC, 2010, J NUCL MED, V51, P66, DOI 10.2967/jnumed.108.061499; Koolen BB, 2012, EUR J NUCL MED MOL I, V39, P1830, DOI 10.1007/s00259-012-2211-z; Kaira K, 2012, BRIT J CANCER, V107, P632, DOI 10.1038/bjc.2012.310; Toyoda M, 2014, BRIT J CANCER, V110, P2506, DOI 10.1038/bjc.2014.178; Imai H, 2009, HISTOPATHOLOGY, V54, P804, DOI 10.1111/j.1365-2559.2009.03300.x; Kaira K, 2011, AM J TRANSL RES, V3, P383; Kim DK, 2004, ANTICANCER RES, V24, P1671; Miyashita G, 2010, ANN NUCL MED, V24, P579, DOI 10.1007/s12149-010-0398-2; Miyawaki A, 2010, ONCOL REP, V23, P1205, DOI 10.3892/or_00000751; Tian M, 2005, ANN NUCL MED, V19, P335, DOI 10.1007/BF02984629	20	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	MAY	2015	135	5					494	499		10.3109/00016489.2014.969385		6	Otorhinolaryngology	Otorhinolaryngology	CG1MM	WOS:000353036800015		
J	Honda, K; Ishiyama, K; Suzuki, S; Oumi, E; Sato, T; Kawasaki, Y; Saito, H; Ishikawa, K				Honda, Kohei; Ishiyama, Koich; Suzuki, Shinsuke; Oumi, Eigo; Sato, Teruyuki; Kawasaki, Yohei; Saito, Hidekazu; Ishikawa, Kazuo			Sentinel lymph node biopsy using computed tomographic lymphography in patients with early tongue cancer	ACTA OTO-LARYNGOLOGICA			English	Article						Cervical lymph node; metastasis; iopamidol; blue dye method	SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; CT LYMPHOGRAPHY; NECK-CANCER; ORAL CAVITY; METASTASIS; HEAD; DISSECTION; STAGE	Conclusions: Because computed tomography (CT) lymphography provides preoperative images of anatomic relationships between a tumor, its associated lymph vessels, and the sentinel lymph node (SLN), it may aid in directing the SLN biopsy for management of early tongue cancer. Objectives: SLN biopsy using a radioisotope (RI) generally has been performed in head and neck cancer. However, this method can be performed only at institutions that are licenced for its use. In this study, we evaluated the utility of performing SLN biopsy in patients with early tongue cancer using the newly developed technique of CT lymphography. Methods: Enrolled in this study were 31 patients with T1N0 or T2N0 tongue cancer. CT images were obtained before and after injection of iopamidol into the peritumoral region and the SLN was identified as the first enhanced lymph node. SLN biopsy was performed using CT lymphographic guidance combined with blue dye injection. Results: The SLN was detected by CT lymphography in 28 cases (90.3%). By intraoperative frozen section examination, metastases to SLNs were found in 4 (14.3%) (T1N0, 1 patient; T2N0, 3 patients) of the 28 patients. Of these four, SLN micrometastases were found in one patient.	[Honda, Kohei; Suzuki, Shinsuke; Oumi, Eigo; Sato, Teruyuki; Kawasaki, Yohei; Saito, Hidekazu; Ishikawa, Kazuo] Akita Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Akita 0108543, Japan; [Ishiyama, Koich] Akita Univ, Grad Sch Med, Dept Radiol, Akita 0108543, Japan	Honda, K (reprint author), Akita Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Akita 0108543, Japan.	kohei@med.akita-u.ac.jp					Alkureishi LWT, 2007, HEAD NECK-J SCI SPEC, V29, P95, DOI 10.1002/hed.20486; VANDENBREKEL MWM, 1990, RADIOLOGY, V177, P379; Ferlito A, 2003, ORAL ONCOL, V39, P429, DOI 10.1016/S1368-8375(02)00010-1; KLIGERMAN J, 1994, AM J SURG, V168, P391, DOI 10.1016/S0002-9610(05)80082-0; Yuen APW, 1997, HEAD NECK-J SCI SPEC, V19, P583, DOI 10.1002/(SICI)1097-0347(199710)19:7<583::AID-HED4>3.0.CO;2-3; CUNNINGHAM MJ, 1986, AM J SURG, V152, P361, DOI 10.1016/0002-9610(86)90305-3; Thompson CF, 2013, EUR ARCH OTO-RHINO-L, V270, P2115, DOI 10.1007/s00405-012-2320-0; HO CM, 1992, HEAD NECK-J SCI SPEC, V14, P359, DOI 10.1002/hed.2880140504; Cabanas RM, 2000, RECENT RES CANCER, V157, P109; GIULIANO AE, 1994, ANN SURG, V220, P391, DOI 10.1097/00000658-199409000-00015; Hayashi H, 2006, SURGERY, V139, P224, DOI 10.1016/j.surg.2005.07.027; Hoft S, 2004, BRIT J CANCER, V91, P124, DOI 10.1038/sj.bjc.6601877; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Motomura K, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-42; Nason RW, 2005, HEAD NECK-J SCI SPEC, V27, P333, DOI 10.1002/hed.20173; Suga K, 2005, RADIOLOGY, V237, P952, DOI 10.1148/radiol.2373041578; Suga K, 2003, SURGERY, V133, P170, DOI 10.1067/msy.2003.17; Takahashi M, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-57; Tangoku A, 2004, SURGERY, V135, P258, DOI 10.1016/j.surg.2003.07.003; Yamamoto S, 2012, BREAST CANCER-TOKYO, V19, P77, DOI 10.1007/s12282-011-0275-4	20	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	MAY	2015	135	5					507	512		10.3109/00016489.2015.1010126		6	Otorhinolaryngology	Otorhinolaryngology	CG1MM	WOS:000353036800017		
J	Okumura, Y; Nomura, K; Kikuchi, T; Suzuki, T; Hidaka, H; Ogawa, T; Katori, Y				Okumura, Yuri; Nomura, Kazuhiro; Kikuchi, Toshiaki; Suzuki, Takahiro; Hidaka, Hiroshi; Ogawa, Takenori; Katori, Yukio			Clinical factors indicating the presence of malignant lymphoma before lymph node dissection	ACTA OTO-LARYNGOLOGICA			English	Article						Positron-emission tomography; soluble interleukin-2 receptor; lactate dehydrogenase	NON-HODGKINS-LYMPHOMA; NEEDLE-BIOPSY; DIAGNOSIS; DISEASE; DEHYDROGENASE; MANAGEMENT	Conclusion: Lymph node swelling in the neck is one of the initial symptoms of malignant lymphoma (ML). The present study showed that clinical factors including higher age, higher level of maximum standardized uptake value (SUV-max) of positron-emission tomography, elevated serum lactate dehydrogenase (LDH), and elevated serum soluble interleukin-2 receptor (sIL-2R) were all useful indicators to suggest the diagnosis of ML, so may be helpful in the selection of patients for lymph node dissection. Objective: Lymph node dissection is essential for the diagnosis of ML. The factors important for the diagnosis of ML were investigated, to establish surgical indicators. Methods: Preoperative data including age, number and side of lymph nodes, SUV-max, serum LDH, serum sIL-2R, and size of lymph nodes were obtained from medical records. The cut-off level for each factor was calculated using the Youden Index for logistic regression analysis. Results: Multivariate logistic regression analysis showed that the following factors were associated with ML: higher age (>= 53 years), higher level of SUV-max (>= 9.0), elevated serum LDH (>= 203 U/L), elevated serum sIL-2R (>= 2590 U/ml), with odds ratios of 3.7, 4.9, 3.7, and 11.9, respectively.	[Okumura, Yuri; Nomura, Kazuhiro; Kikuchi, Toshiaki; Suzuki, Takahiro; Hidaka, Hiroshi; Ogawa, Takenori; Katori, Yukio] Tohoku Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Sendai, Miyagi 980, Japan	Okumura, Y (reprint author), Tohoku Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Sendai, Miyagi 980, Japan.	yuuri-yuuri@hotmail.co.jp					Gallamini A, 2012, BLOOD, V120, P4913, DOI 10.1182/blood-2012-03-403790; Saif Muhammad Wasif, 2010, Yale Journal of Biology and Medicine, V83, P53; Orita Y, 2013, SURG TODAY, V43, P67, DOI 10.1007/s00595-012-0149-1; Buchmann I, 2001, CANCER, V91, P889; Viviani S, 1998, BRIT J CANCER, V77, P992, DOI 10.1038/bjc.1998.163; CARBONE PP, 1971, CANCER RES, V31, P1860; de Kerviler E, 2007, EUR RADIOL, V17, P843, DOI 10.1007/s00330-006-0393-0; SHIPP MA, 1993, NEW ENGL J MED, V329, P987; COWAN RA, 1989, BRIT J CANCER, V59, P276, DOI 10.1038/bjc.1989.57; FERRARIS AM, 1979, BLOOD, V54, P928; GARCIA R, 1993, BRIT J CANCER, V68, P1227, DOI 10.1038/bjc.1993.509; Morris-Stiff G, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-13; Pfeiffer J, 2009, LARYNGOSCOPE, V119, P689, DOI 10.1002/lary.20110; Tsujioka T., 2011, Kawasaki Medical Journal, V37, P19	14	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	MAY	2015	135	5					513	518		10.3109/00016489.2014.993088		6	Otorhinolaryngology	Otorhinolaryngology	CG1MM	WOS:000353036800018		
J	Nzelu, CO; Caceres, AG; Arrunategui-Jimenez, MJ; Lanas-Rosas, MF; Yanez-Trujillano, HH; Luna-Caipo, DV; Holguin-Mauricci, CE; Katakura, K; Hashiguchi, Y; Kato, H				Nzelu, Chukwunonso O.; Caceres, Abraham G.; Arrunategui-Jimenez, Martin J.; Lanas-Rosas, Maximo F.; Yanez-Trujillano, Henrry H.; Luna-Caipo, Deysi V.; Holguin-Mauricci, Carlos E.; Katakura, Ken; Hashiguchi, Yoshihisa; Kato, Hirotomo			DNA barcoding for identification of sand fly species (Diptera: Psychodidae) from leishmaniasis-endemic areas of Peru	ACTA TROPICA			English	Article						DNA barcode; Sand flies; Leishmaniasis; Vector; Peru	ANDEAN CUTANEOUS LEISHMANIASIS; LUTZOMYIA-PERUENSIS DIPTERA; FLIES DIPTERA; VIANNIA PERUVIANA; PHLEBOTOMUS-PAPATASI; GENETIC-DIVERGENCE; VECTOR; SEQUENCES; AYACUCHENSIS; LONGIPALPIS	Phlebotomine sand flies are the only proven vectors of leishmaniases, a group of human and animal diseases. Accurate knowledge of sand fly species identification is essential in understanding the epidemiology of leishmaniasis and vector control in endemic areas. Classical identification of sand fly species based on morphological characteristics often remains difficult and requires taxonomic expertise. Here, we generated DNA barcodes of the cytochrome c oxidase subunit 1 (COI) gene using 159 adult specimens morphologically identified to be 19 species of sand flies, belonging to 6 subgenera/species groups circulating in Peru, including the vector species. Neighbor-joining (NJ) analysis based on Kimura 2-Parameter genetic distances formed non-overlapping clusters for all species. The levels of intraspecific genetic divergence ranged from 0 to 5.96%, whereas interspecific genetic divergence among different species ranged from 8.39 to 19.08%. The generated COI barcodes could discriminate between all the sand fly taxa. Besides its success in separating known species, we found that DNA barcoding is useful in revealing population differentiation and cryptic diversity, and thus promises to be a valuable tool for epidemiological studies of leishmaniasis. (C) 2015 Elsevier B.V. All rights reserved.	[Nzelu, Chukwunonso O.; Katakura, Ken; Kato, Hirotomo] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Parasitol Lab, Sapporo, Hokkaido 0600818, Japan; [Caceres, Abraham G.] Univ Nacl Mayor San Marcos, Fac Med Humana, Dept Acad Microbiol Med, Lima 14, Peru; [Caceres, Abraham G.] Inst Nacl Salud, Lab Entomol, Lima, Peru; [Arrunategui-Jimenez, Martin J.] Lab Referencial, Gerencia Reg Salud Lambayeque, Direcc Ejecut Salud Ambiental, Peru Area Entomol, Lima, Peru; [Lanas-Rosas, Maximo F.] Lab Referencial, Area Entomol, Lima, Peru; [Yanez-Trujillano, Henrry H.] Direcc Reg Salud Cusco, Direcc Ejecut Salud Ambiental, Lima, Peru; [Luna-Caipo, Deysi V.] Direcc Reg Salud Cajamarca, Direcc Ejecut Salud Ambiental, Direcc Sub Reg Salud Cutervo, Lima, Peru; [Holguin-Mauricci, Carlos E.] Lab Referencial, Direcc Reg Salud Piura, Lima, Peru; [Hashiguchi, Yoshihisa] Kochi Univ, Kochi Med Sch, Dept Parasitol, Kochi 780, Japan; [Hashiguchi, Yoshihisa] Univ Cent Ecuador, Ctr Biomed, Quito, Ecuador; [Hashiguchi, Yoshihisa] Secretaria Nacl Educ Super Ciencia Tecnol & Innov, Quito, Ecuador	Kato, H (reprint author), Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Parasitol Lab,Kita Ku, North 18 West 9, Sapporo, Hokkaido 0600818, Japan.	hkato@vetmed.hokudai.ac.jp	Kato, Hirotomo/A-4820-2012	Kato, Hirotomo/0000-0001-5429-9536	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23256002, 25257501]; Program for Leading Graduate Schools "Fostering Global Leaders in Veterinary Science for Contributing to One Health", MEXT, Japan [FO1]; Japanese Government Ministry of Education, Culture, Science and Technology (MEXT)	This study was financially supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Grant nos. 23256002 and 25257501), the Program for Leading Graduate Schools "Fostering Global Leaders in Veterinary Science for Contributing to One Health" (FO1), MEXT, Japan. CON is a recipient of the Japanese Government Ministry of Education, Culture, Science and Technology (MEXT) PhD fellowship.	ALEXANDER JB, 1987, J MED ENTOMOL, V24, P552; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kato H, 2010, INT J ENV RES PUB HE, V7, P814, DOI 10.3390/ijerph7030814; Kato H, 2008, AM J TROP MED HYG, V79, P719; Depaquit J, 2002, INT J PARASITOL, V32, P1123, DOI 10.1016/S0020-7519(02)00088-7; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Mukhopadhyay J, 2000, ACTA TROP, V76, P277, DOI 10.1016/S0001-706X(00)00130-3; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Pramual P, 2011, GENOME, V54, P1, DOI 10.1139/G10-100; Gomez EA, 2014, ACTA TROP, V137, P118, DOI 10.1016/j.actatropica.2014.05.006; Fujita M, 2012, ACTA TROP, V121, P93, DOI 10.1016/j.actatropica.2011.10.004; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Maroli M, 2013, MED VET ENTOMOL, V27, P123, DOI 10.1111/j.1365-2915.2012.01034.x; Perez JE, 2007, MEM I OSWALDO CRUZ, V102, P655; PEREZ JE, 1994, T ROY SOC TROP MED H, V88, P161, DOI 10.1016/0035-9203(94)90276-3; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651; Beati L, 2004, INT J PARASITOL, V34, P225, DOI 10.1016/j.ijpara.2003.10.012; Kumar NP, 2012, MOL ECOL RESOUR, V12, P414, DOI 10.1111/j.1755-0998.2012.03117.x; Meier R, 2006, SYSTEMATIC BIOL, V55, P715, DOI 10.1080/10635150600969864; MORRISON AC, 1993, J MED ENTOMOL, V30, P427; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257; Khalid N, 2010, MED VET ENTOMOL, V24, P352, DOI 10.1111/j.1365-2915.2010.00893.x; Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Azpurua J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000627; Caceres AG, 2004, AM J TROP MED HYG, V70, P607; Cohnstaedt LW, 2011, AM J TROP MED HYG, V84, P913, DOI 10.4269/ajtmh.2011.11-0040; DAVIES CR, 1993, T ROY SOC TROP MED H, V87, P603, DOI 10.1016/0035-9203(93)90103-W; Gutierrez MAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085496; Hassan MM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-46; Kato H, 2011, VECTOR-BORNE ZOONOT, V11, P515, DOI 10.1089/vbz.2010.0138; Kato H, 2015, ACTA TROP, V141, P79, DOI 10.1016/j.actatropica.2014.10.004; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LANZARO GC, 1993, AM J TROP MED HYG, V48, P839; MUNSTERMANN L.E., 2004, BIOL DIS VECTORS, P141; Nei M, 2000, MOL EVOLUTION PHYLOG, P333; Nzelu CO, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002630; O'Loughlin SM, 2008, J EVOLUTION BIOL, V21, P1555, DOI 10.1111/j.1420-9101.2008.01606.x; PEREZ JE, 1991, T ROY SOC TROP MED H, V85, P60, DOI 10.1016/0035-9203(91)90158-U; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Scarpassa VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037341; Soto SIU, 2001, MOL PHYLOGENET EVOL, V18, P84, DOI 10.1006/mpev.2000.0863; WHO, 2010, WHO TECH REP SER; Yamamoto K, 2013, ACTA TROP, V126, P156, DOI 10.1016/j.actatropica.2013.02.007; Young D.G., 1994, MEMOIRS AM ENTOMOLOG, V54	50	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	MAY	2015	145						45	51		10.1016/j.actatropica.2015.02.003		7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CG1BC	WOS:000353007000008		
J	Dieng, H; Hassan, RB; Abu Hassan, A; Ghani, IA; Abang, FB; Satho, T; Miake, F; Ahmad, H; Fukumitsu, Y; Hashim, NA; Zuharah, WF; Abu Kassim, NF; Ab Majid, AH; Selvarajoo, R; Nolasco-Hipolito, C; Ajibola, OO; Tuen, AA				Dieng, Hamady; Hassan, Rahimah Binti; Abu Hassan, Ahmad; Ghani, Idris Abd; Abang, Fatimah Bt; Satho, Tomomitsu; Miake, Fumio; Ahmad, Hamdan; Fukumitsu, Yuki; Hashim, Nur Aida; Zuharah, Wan Fatma; Abu Kassim, Nur Faeza; Ab Majid, Abdul Hafiz; Selvarajoo, Rekha; Nolasco-Hipolito, Cirilo; Ajibola, Olaide Olawunmi; Tuen, Andrew Alek			Occurrence of a mosquito vector in bird houses: Developmental consequences and potential epidemiological implications	ACTA TROPICA			English	Article						Bird feces; Aedes larvae; Nutrient; Development; Adult life traits; Epidemiological significance	AEDES-ALBOPICTUS DIPTERA; CULEX-QUINQUEFASCIATUS; DENGUE VIRUS; CULICIDAE MOSQUITOS; COMMUNITY DYNAMICS; LARVAL DEVELOPMENT; FEEDING-BEHAVIOR; SPECIES RICHNESS; AEGYPTI LARVAE; WATER-QUALITY	Even with continuous vector control, dengue is still a growing threat to public health in Southeast Asia. Main causes comprise difficulties in identifying productive breeding sites and inappropriate targeted chemical interventions. In this region, rural families keep live birds in backyards and dengue mosquitoes have been reported in containers in the cages. To focus on this particular breeding site, we examined the capacity of bird fecal matter (BFM) from the spotted dove, to support Aedes albopictus larval growth. The impact of BFM larval uptake on some adult fitness traits influencing vectorial capacity was also investigated. In serial bioassays involving a high and low larval density (HD and LD), BFM and larval standard food (LSF) affected differently larval development. At HD, development was longer in the BFM environment. There were no appreciable mortality differences between the two treatments, which resulted in similar pupation and adult emergence successes. BFM treatment produced a better gender balance. There were comparable levels of blood uptake and egg production in BFM and LSF females at LD; that was not the case for the HD one, which resulted in bigger adults. BFM and LSF females displayed equivalent lifespans; in males, this parameter was shorter in those derived from the BFM/LD treatment. Taken together these results suggest that bird defecations successfully support the development of Ae. albopictus. Due to their cryptic aspects, containers used to supply water to encaged birds may not have been targeted by chemical interventions. (C) 2015 Elsevier B.V. All rights reserved.	[Dieng, Hamady; Hassan, Rahimah Binti; Abu Hassan, Ahmad; Ahmad, Hamdan; Zuharah, Wan Fatma; Abu Kassim, Nur Faeza; Ab Majid, Abdul Hafiz] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Dieng, Hamady; Tuen, Andrew Alek] Univ Malaysia Sarawak, IBEC, Kuching, Kota Samarahan, Malaysia; [Ghani, Idris Abd] Univ Kebangsaan Malaysia, Fac Sci & Technol, Bangi 43600, Malaysia; [Abang, Fatimah Bt; Nolasco-Hipolito, Cirilo; Ajibola, Olaide Olawunmi] Univ Malaysia Sarawak, Fac Resource Sci & Technol, Kota Samarahan, Malaysia; [Satho, Tomomitsu; Miake, Fumio; Fukumitsu, Yuki; Hashim, Nur Aida] Fukuoka Univ, Fac Pharmaceut Sci, Fukuoka, Japan; [Satho, Tomomitsu; Miake, Fumio; Fukumitsu, Yuki; Hashim, Nur Aida] Univ Malaysia Terengganu, Sch Food Sci & Technol, Kuala Terengganu, Malaysia; [Selvarajoo, Rekha] Univ Utara Malaysia, Sch Social Sci, Kedah Darul Aman, Malaysia	Dieng, H (reprint author), Univ Malaysia Sarawak, Fac Resource Sci & Technol, IBEC, Kuching, Malaysia.	hamachan1@yahoo.com	Zuharah, Wan Fatma/A-5498-2011	Zuharah, Wan Fatma/0000-0002-5789-2244	Long Term Research Grant (LRGS) for Infectious Diseases; Ministry of Higher Education, Malaysia; USM [304/Pbiology/650575/U112]	This study was supported by a Long Term Research Grant (LRGS) for Infectious Diseases, 2011-2014, Ministry of Higher Education, Malaysia, and USM (304/Pbiology/650575/U112). The authors are grateful to the population of Teluk Tompoyak (Penang).	Ahmad F., 2006, American Journal of Environmental Sciences, V2; AINI I, 1990, WORLD POULTRY SCI J, V46, P51, DOI 10.1079/WPS19900010; Alencar J, 2014, MEM I OSWALDO CRUZ, V109, P114, DOI 10.1590/0074-0276130168; Ali M. Syed, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P570, DOI 10.1016/S2221-1691(12)60099-9; Ali S.R., 1970, THESIS JOHN HOPKINS; Ishida A, 1997, ECOL RES, V12, P249, DOI 10.1007/BF02529454; Ligeza S, 2003, CHEMOSPHERE, V52, P595, DOI 10.1016/S0045-6535(03)00241-8; Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892; Sehgal RNM, 2010, J EXP BIOL, V213, P955, DOI 10.1242/jeb.037663; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; Lam PHY, 2010, SE ASIAN J TROP MED, V41, P1071; Briegel H, 2001, J MED ENTOMOL, V38, P566, DOI 10.1603/0022-2585-38.4.566; Telang A, 2004, J INSECT PHYSIOL, V50, P677, DOI 10.1016/j.jinphys.2004.05.001; NASCI RS, 1989, J AM MOSQUITO CONTR, V5, P416; Ellis JC, 2005, PLANT ECOL, V181, P227, DOI 10.1007/s11258-005-7147-y; Mostl E, 2005, ANN NY ACAD SCI, V1046, P17, DOI 10.1196/annals.1343.004; Juliano SA, 2002, BEHAV ECOL, V13, P301, DOI 10.1093/beheco/13.3.301; Hubalek Z, 2004, J WILDLIFE DIS, V40, P639; Thenmozhi V, 2007, JPN J INFECT DIS, V60, P245; Goodsell JA, 1999, CONSERV BIOL, V13, P921, DOI 10.1046/j.1523-1739.1999.98237.x; Farrar J, 2007, TROP MED INT HEALTH, V12, P695, DOI 10.1111/j.1365-3156.2007.01838; Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031; Sunish IP, 2001, MED VET ENTOMOL, V15, P381, DOI 10.1046/j.0269-283x.2001.00324.x; Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004; Farjana T, 2013, J MED ENTOMOL, V50, P838, DOI 10.1603/ME12146; Aida H. Nur, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P472, DOI 10.1016/S2221-1691(11)60103-2; Das B, 2013, INFECT GENET EVOL, V16, P401, DOI 10.1016/j.meegid.2013.03.016; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349; Klasing KC, 2005, ANN NY ACAD SCI, V1046, P5, DOI 10.1196/annals.1343.003; Cheah SX, 2013, PARASITOL RES, V112, P3275, DOI 10.1007/s00436-013-3506-0; LOUNIBOS LP, 1981, ECOL ENTOMOL, V6, P129, DOI 10.1111/j.1365-2311.1981.tb00601.x; Gubler DJ, 2004, NAT MED, V10, P129, DOI 10.1038/nm0204-129; AOAC, 1990, OFFICIAL METHODS ANA; Arana-Guardia R, 2014, ACTA TROP, V134, P33, DOI 10.1016/j.actatropica.2014.01.011; Barrera R, 2014, AM J TROP MED HYG, V91, P1269, DOI 10.4269/ajtmh.14-0426; BAZELY DR, 1985, J APPL ECOL, V22, P693, DOI 10.2307/2403222; Bedhomme S, 2005, PLOS BIOL, V3, P1403, DOI 10.1371/journal.pbio.0030262; Benoit JB, 2008, POLAR BIOL, V31, P1445, DOI 10.1007/s00300-008-0485-1; Bowen JL, 2004, ESTUARIES, V27, P482, DOI 10.1007/BF02803540; BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y; Centers for Disease Control and Prevention (CDC), 2012, DENG AED AEG MOSQ; Chastain J.P., 2003, POULTRY MANURE PRODU; Clements A., 1992, BIOL MOSQUITOES DEV; Clements A.N, 1999, BIOL MOSQUITOES, V2, p[xvi, 740]; Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468; Darriet F, 2008, CR BIOL, V331, P617, DOI 10.1016/j.crvi.2008.05.003; Dia I, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-238; Dieng H, 2002, J VECTOR ECOL, V27, P31; Dieng Hamady, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P228, DOI 10.1016/S2221-1691(12)60047-1; Dieng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011790; Dieng H, 2013, ACTA TROP, V128, P584, DOI 10.1016/j.actatropica.2013.08.013; Dieng H., 2013, PARASITE VECTOR, V6, P206; Dieng H, 2006, J AM MOSQUITO CONTR, V22, P382, DOI 10.2987/8756-971X(2006)22[382:STAEDO]2.0.CO;2; Eldridge B.F., 2005, BIOL DIS VECTORS; Fleming R., 2001, IMPACT WATERFOWL WAT; Fujita M, 2007, ECOL APPL, V17, P648, DOI 10.1890/06-0118; Gonzalez R, 2007, COLOMBIA REV COLOMB, V33, P148; GOULD DJ, 1978, WATER RES, V12, P665, DOI 10.1016/0043-1354(78)90176-8; Hahn DA, 2005, J INSECT PHYSIOL, V51, P1210, DOI 10.1016/j.jinsphys.2005.06.011; Hansen C, 2013, PEST BIRDS CORROSIVE; Heatley J. J., 2012, Veterinary Medicine: Research and Reports, V3, P19; Huang C.P., 2011, IMPACTS BIRD DROPPIN, V221; KAROWE DN, 1989, J INSECT PHYSIOL, V35, P699, DOI 10.1016/0022-1910(89)90089-9; Kaufman MG, 1999, APPL ENVIRON MICROB, V65, P2661; Kersting D.J, 2014, POOPOLOGY; Khan I, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-90; Kitching R.L., 1983, P205; Klowden M.J., 2005, BIOL DIS VECTORS; Koenraadt CJM, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-92; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Lehmann T, 2006, INFECT GENET EVOL, V6, P410, DOI 10.1016/j.meegid.2006.01.007; Liman N, 2010, J ANAT, V217, P57, DOI 10.1111/j.1469-7580.2010.01243.x; Livdahl T., 1985, ECOLOGY MOSQUITOES; LIVDAHL TP, 1984, ECOL ENTOMOL, V9, P437, DOI 10.1111/j.1365-2311.1984.tb00841.x; Lounibos LP, 2008, J AM MOSQUITO CONTR, V24, P11, DOI 10.2987/5656.1; Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252; Male T, 2003, CONSERV BIOL, V17, P928, DOI 10.1046/j.1523-1739.2003.02424.x; Mamat N.Z., 2014, INT AQUATIC RES, V6, P2; Manorenjitha-Malar S., 2012, INT J LIFE SCI MED R, V2, P63; Marques GRAM, 2013, REV SAUDE PUBL, V47, P579, DOI 10.1590/S0034-8910.2013047004289; Mitchell C. J., 1995, Parassitologia (Rome), V37, P109; Mohan L, 2005, J ENVIRON BIOL, V26, P399; MORI A, 1981, Tropical Medicine, V23, P79; Mun HT, 1997, PLANT SOIL, V197, P55, DOI 10.1023/A:1004292103610; Nash SV, 1993, SOLD SONG TRADE SE A; NOVAK RJ, 1978, MOSQ NEWS, V38, P515; Omotoso O.T., 2006, Journal of Zhejiang University Science B, V7, P51, DOI 10.1631/jzus.2006.B0051; Pica-Ciamarra U., 2010, SMALL SCALE POULTRY; Puggioli A, 2013, J MED ENTOMOL, V50, P819, DOI 10.1603/ME13011; Ramlah A.H., 1999, 1 INFPD FAO EL C FAM; REISEN WK, 1975, MOSQ NEWS, V35, P473; Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Saifur RGM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030919; SCHROEDER LA, 1986, ENTOMOL EXP APPL, V41, P115; Shepherd CR, 2004, OPEN SEASON ANAL PET; Shin D, 2012, J HERED, V103, P303, DOI 10.1093/jhered/esr134; Slansky F.J., 1985, COMPREHENSIVE INSECT, V4; Systat Software Inc, SYST 11 DAT 2004 SYS; Tan R., 2001, SPOTTED DOVE STREPTO; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; Tessari P., 2006, CACHEXIA WASTING MOD; Thiagaletchumi M, 2014, TROP BIOMED, V31, P466; Tizard I, 2004, SEMIN AVIAN EXOT PET, V13, P50, DOI 10.1053/j.saep.2004.01.008; Tsuda Yoshio, 1994, Japanese Journal of Sanitary Zoology, V45, P103; Tsurim I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057875; Turley AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-36; Vasiliu A., 2010, INT J CONSERV SCI, V1, P83; Ventura A, 2013, INT J MORPHOL, V31, P1331, DOI 10.4067/S0717-95022013000400030; Wait DA, 2005, J ARID ENVIRON, V60, P681, DOI 10.1016/j.jaridenv.2004.07.001; Wandah L., 2010, THESIS CENTRAL OSTRO; Watson M.S., 1967, AEDES STEGOMYIA ALBO, V22, P1; Weber W. J., 1979, HLTH HAZARDS PIGEONS; Wildlife Conservation Society, 2004, AV FLU WILDL EXP SAY; World Health Organization, 2014, DENG SEV DENG; World Health Organization (WHO), 2010, DENG SEV DENG; Xue RD, 2010, J MED ENTOMOL, V47, P778, DOI 10.1603/ME09222; Yee DA, 2004, J VECTOR ECOL, V29, P315; Zuharah WF, 2014, TROP BIOMED, V31, P297	120	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	MAY	2015	145						68	78		10.1016/j.actatropica.2015.01.004		11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CG1BC	WOS:000353007000012		
J	Kondoh, H; Yamanaka, T; Saito, S; Shoda-Kagaya, E; Makino, S				Kondoh, Hiroshi; Yamanaka, Takehiko; Saito, Shoichi; Shoda-Kagaya, Etsuko; Makino, Shun'ichi			Development of a hazard map for oak wilt disease in Japan	AGRICULTURAL AND FOREST ENTOMOLOGY			English	Article						Ambrosia beetle; area under curve (AUC) profile analysis; hazard map; oak wilt disease; Platypus quercivorus; Raffaelea quercivora	COLEOPTERA; DISPERSAL; INVASION; SPREAD; CONNECTIVITY; PLATYPODIDAE; PATTERNS; MODELS; TREES; AREA	We constructed a hazard map for oak wilt disease in Yamagata and Fukushima Prefectures, Japan, based on a logistic regression model. Within the framework of a regression model, we incorporated data from previously damaged areas on vegetation type, geography and meteorology, and pest immigration. We evaluated the predictive power of the model using defoliation records within the same prefecture taken from the subsequent year. The results obtained for Yamagata Prefecture were highly predictive and we conclude that practical hazard maps can be constructed based on damage records from the previous year combined with other environmental data. The predictive value of the model was improved dramatically by incorporating an immigration effect. The model used to predict damage in Yamagata Prefecture was correct for only 46.7% of the actual damage in Fukushima Prefecture. Several difficulties were identified regarding the application of the model in other prefectures. Based on our results, we suggest that defoliation data should be collected quickly in the target area when constructing a localized regression model that includes immigration. Collection and organization of defoliation data could help to quickly draw up hazard maps before oak wilt disease begins to occur in a given year.	[Kondoh, Hiroshi] Kyushu Res Ctr, Forestry & Forest Prod Res Inst, Chuo Ku, Kumamoto 8600862, Japan; [Yamanaka, Takehiko] Natl Inst Agroenvironm Sci, Nat Resources Inventory Ctr, Tsukuba, Ibaraki 3058604, Japan; [Saito, Shoichi] Yamagata Prefectural Forest Res & Instruct Ctr, Sagae, Yamagata 9910041, Japan; [Shoda-Kagaya, Etsuko] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Makino, Shun'ichi] Hokkaido Res Ctr, Forestry & Forest Prod Res Inst, Toyohira Ku, Sapporo, Hokkaido 0628516, Japan	Kondoh, H (reprint author), Kyushu Res Ctr, Forestry & Forest Prod Res Inst, Chuo Ku, Kurokami 4-11-16, Kumamoto 8600862, Japan.	kondoh@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries, Japan [24030]	This work was supported in part by a Grant-in-Aid for a Research Project Utilizing Advanced Technologies in Agriculture, Forestry and Fisheries (24030) from the Ministry of Agriculture, Forestry and Fisheries, Japan.	Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Koch FH, 2008, ENVIRON ENTOMOL, V37, P442, DOI 10.1603/0046-225X(2008)37[442:SAOXGC]2.0.CO;2; Johnson DM, 2006, NATURE, V444, P361, DOI 10.1038/nature05242; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Muirhead JR, 2006, DIVERS DISTRIB, V12, P71, DOI 10.1111/j.1366-9516.2006.00218.x; Kamata N, 2002, B ENTOMOL RES, V92, P119, DOI 10.1079/BER2002158; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Wulder MA, 2006, REMOTE SENS ENVIRON, V101, P150, DOI 10.1016/j.rse.2005.12.010; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.2307/3071919; Bourg NA, 2005, ECOLOGY, V86, P2793, DOI 10.1890/04-1666; Burnham K. P., 2002, MODEL SELECTION MULT; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Forest Agency, 2012, ANN REP FOR FOR JAP; Forest Agency, 2011, COUNT MAN OAK WILT D; Havel JE, 2002, ECOLOGY, V83, P3306, DOI 10.2307/3072081; Ichihara Y., 2009, TOHOKU J FOR SCI, V14, P7; Ito S., 1998, Journal of the Japanese Forestry Society, V80, P229; Jorgensen SE, 2001, FUNDAMENTALS ECOLOGI; Kobayashi M, 2004, JPN J APPL ENTOMOL Z, V48, P141, DOI 10.1303/jjaez.2004.141; Kobayashi M., 2005, Journal of the Japanese Forest Society, V87, P435; KOT M, 1984, THEOR POPUL BIOL, V26, P340, DOI 10.1016/0040-5809(84)90038-8; Kubono Takanori, 2002, Mycoscience, V43, P255, DOI 10.1007/s102670200037; Mangel M., 1997, ECOLOGICAL DETECTIVE; McCune B., 2002, ANAL ECOLOGICAL COMM, P300; Ministry of the Environment, 2014, JAP INT BIOD INF SYS; Moilanen A., 2006, CONNECTIVITY CONSERV, P44, DOI 10.1017/CBO9780511754821.004; Nishimura M., 2007, J TOYAMA FOR RES CTR, V20, P1; Osawa T., 2013, JPN J CONSERV ECOL, V18, P157; Prasad AM, 2010, LANDSCAPE ECOL, V25, P353, DOI 10.1007/s10980-009-9434-9; R Development Core Team, 2014, R LANG ENV STAT COMP; Shoda-Kagaya Etsuko, 2010, BMC Ecology, V10, P21, DOI 10.1186/1472-6785-10-21; Takasu F, 2009, POPULATION ECOLOGY, V51, P411; Tobin PC, 2007, ECOL LETT, V10, P36, DOI 10.1111/j.1461-0248.2006.00991.x; Yamanaka T, 2009, OIKOS, V118, P67, DOI 10.1111/j.1600-0706.2008.16722.x; Yamanaka T, 2003, ECOL MODEL, V161, P35, DOI 10.1016/S0304-3800(02)00291-0; Zhang Z., 2005, UW BIOSTATISTICS WOR	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1461-9555	1461-9563		AGR FOREST ENTOMOL	Agric. For. Entomol.	MAY	2015	17	2					205	213		10.1111/afe.12098		9	Entomology	Entomology	CF4SK	WOS:000352541300012		
J	Niikura, R; Nagata, N; Shimbo, T; Aoki, T; Yamada, A; Hirata, Y; Sekine, K; Okubo, H; Watanabe, K; Sakurai, T; Yokoi, C; Mizokami, M; Yanase, M; Akiyama, J; Koike, K; Uemura, N				Niikura, R.; Nagata, N.; Shimbo, T.; Aoki, T.; Yamada, A.; Hirata, Y.; Sekine, K.; Okubo, H.; Watanabe, K.; Sakurai, T.; Yokoi, C.; Mizokami, M.; Yanase, M.; Akiyama, J.; Koike, K.; Uemura, N.			Natural history of bleeding risk in colonic diverticulosis patients: a long-term colonoscopy-based cohort study	ALIMENTARY PHARMACOLOGY & THERAPEUTICS			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HEMORRHAGE; THERAPY; DISEASE; ENEMA	BackgroundThe natural history of bleeding risk from colonic diverticulosis remains unclear. AimTo identify the incidence of bleeding in colonic diverticulosis patients and associated risk factors. MethodsA cohort of 1514 patients with colonoscopy-confirmed asymptomatic diverticulosis was selected between 2001 and 2013. Age, sex and location of colonic diverticulosis (right or left side, or bilateral) were assessed. The endpoint was a bleeding event, and data were censored at the time of last colonoscopy. The cumulative and overall incidences of bleeding were estimated using the Kaplan-Meier and person-years methods. The Cox proportional hazards model was used to estimate age- and sex-adjusted hazard ratios (aHRs). ResultsThe median follow-up period was 46months. Bleeding events occurred in 35 patients, and the median time-to-event interval was 50months. Kaplan-Meier analysis showed that the cumulative incidence of diverticular bleeding was 0.21% at 12months, 2.2% at 60months and 9.5% at 120months. By the person-years method, the overall incidence rate of bleeding was 0.46 per 1000 patient-years. On multivariate analysis, age 70 (aHR. 3.7) and bilateral diverticulosis (aHR, 2.4) were significant risk factors for bleeding. ConclusionsThis long-term follow-up study demonstrated that the cumulative incidence of bleeding from diverticulosis was approximately 2% at 5years and 10% at 10years, and the overall incidence was 0.46 per 1000 patient-years. Bilateral diverticulosis increased the risk of bleeding.	[Niikura, R.; Nagata, N.; Aoki, T.; Sekine, K.; Okubo, H.; Watanabe, K.; Sakurai, T.; Yokoi, C.; Yanase, M.; Akiyama, J.] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Niikura, R.; Yamada, A.; Hirata, Y.; Koike, K.] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Shimbo, T.] Ohta Nishinouchi Hosp, Koriyama, Fukushima, Japan; [Mizokami, M.] Kohnodai Hosp, Res Ctr Hepatitis & Immunol, Natl Ctr Global Hlth & Med, Chiba, Japan; [Uemura, N.] Kohnodai Hosp, Dept Gastroenterol & Hepatol, Natl Ctr Global Hlth & Med, Chiba, Japan	Nagata, N (reprint author), Natl Ctr Global Hlth & Med NCGM, Dept Gastroenterol & Hepatol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nnagata_ncgm@yahoo.co.jp			National Center for Global Health and Medicine [26A-201]	This study was supported in part by Grants-in-Aid for Research from the National Center for Global Health and Medicine (26A-201). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alberti LR, 2012, SURG ENDOSC, V26, P3157, DOI 10.1007/s00464-012-2308-2; Niikura R, 2012, COLORECTAL DIS, V14, P302, DOI 10.1111/j.1463-1318.2011.02611.x; Strate LL, 2010, CLIN GASTROENTEROL H, V8, P333, DOI 10.1016/j.cgh.2009.12.017; Song Jung Hoon, 2010, Korean Journal of Internal Medicine, V25, P140, DOI 10.3904/kjim.2010.25.2.140; Strate LL, 2008, CLIN GASTROENTEROL H, V6, P1004, DOI 10.1016/j.cgh.2008.03.021; Zuckerman GR, 1999, GASTROINTEST ENDOSC, V49, P228, DOI 10.1016/S0016-5107(99)70491-8; Niikura R, 2013, WORLD J GASTROENTERO, V19, P2362, DOI 10.3748/wjg.v19.i15.2362; Aldoori WH, 1998, ARCH FAM MED, V7, P255, DOI 10.1001/archfami.7.3.255; Suzuki K, 2012, DIGESTION, V85, P261, DOI 10.1159/000336351; Okamoto T, 2012, INT J COLORECTAL DIS, V27, P1161, DOI 10.1007/s00384-012-1491-x; Strate LL, 2011, GASTROENTEROLOGY, V140, P1427, DOI 10.1053/j.gastro.2011.02.004; ROBERTS P, 1995, DIS COLON RECTUM, V38, P125; Sharara AI, 2013, J CLIN GASTROENTEROL, V47, P420, DOI 10.1097/MCG.0b013e31826be847; Hu ZP, 2005, DRUGS, V65, P1239, DOI 10.2165/00003495-200565090-00005; Poncet G, 2010, ALIMENT PHARM THER, V32, P466, DOI 10.1111/j.1365-2036.2010.04362.x; Niikura R, 2012, INT J COLORECTAL DIS, V27, P1137, DOI 10.1007/s00384-012-1422-x; Longstreth GF, 1997, AM J GASTROENTEROL, V92, P419; Nagata N, 2014, GASTROINTEST ENDOSC, V80, P1124, DOI 10.1016/j.gie.2014.06.039; Jensen DM, 2000, NEW ENGL J MED, V342, P78, DOI 10.1056/NEJM200001133420202; Arora G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042910; Gan T., 2010, COCHRANE DB SYST REV, V10; MCGUIRE HH, 1972, ANN SURG, V175, P847, DOI 10.1097/00000658-197206010-00004; MCGUIRE HH, 1994, ANN SURG, V220, P653, DOI 10.1097/00000658-199411000-00008; Nagata N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081137; Nagata N, 2014, INT J COLORECTAL DIS, V29, P379, DOI 10.1007/s00384-013-1808-4; Niikura R, 2015, J CLIN GASTROENTEROL, V49, pE24, DOI 10.1097/MCG.0000000000000140; RIGG BM, 1966, ARCH SURG-CHICAGO, V92, P321; Suh Seungchul, 2012, Korean J Gastroenterol, V60, P349; Vergili-Nelsen JM, 2003, J AM DIET ASSOC, V103, P1174, DOI 10.1053/jada.2003.50577; WOLFF WI, 1975, AM J SURG, V129, P181, DOI 10.1016/0002-9610(75)90295-0	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-2813	1365-2036		ALIMENT PHARM THER	Aliment. Pharmacol. Ther.	MAY	2015	41	9					888	894		10.1111/apt.13148		7	Gastroenterology & Hepatology; Pharmacology & Pharmacy	Gastroenterology & Hepatology; Pharmacology & Pharmacy	CF4XM	WOS:000352557300009		
J	Nakao, A; Nakamura, Y; Shibata, S				Nakao, A.; Nakamura, Y.; Shibata, S.			The circadian clock functions as a potent regulator of allergic reaction	ALLERGY			English	Review						allergy; circadian clock; IgE; mast cell	MAST-CELLS; IMMUNE-RESPONSES; HOST RESPONSE; RHINITIS; ASTHMA; SYSTEM; IGE; EOSINOPHILS; ACTIVATION; RECEPTOR	Symptoms and laboratory parameters of allergic diseases exhibit prominent similar to 24-h variations. For instance, in most allergic rhinitis patients, symptoms worsen overnight or early in the morning. Accordingly, there are benefits to nighttime dosing of anti-allergy medications in such patients. Although the circadian pathophysiology of allergic diseases is well documented, the biological basis of this phenomenon remains poorly understood. Recent studies have begun to reveal that the internal timekeeping system termed the circadian clock plays a key role in temporal regulation of allergic reaction, and may therefore underlie the circadian pathophysiology of allergic diseases. Here, we review new knowledge that highlights the emerging role of the circadian clock as a potent regulator of allergic reactions. Given the strong influence of circadian rhythms on allergic diseases, we believe that research on how the time of day impacts allergic reaction which we may call chronoallergology' will provide new insight into previously unknown aspects of the biology of allergies. Such knowledge should facilitate novel strategies for prevention and treatment of these diseases.	[Nakao, A.; Nakamura, Y.] Univ Yamanashi, Fac Med, Dept Immunol, Chuo, Yamanashi 4093898, Japan; [Nakao, A.] Juntendo Univ, Sch Med, Atopy Res Ctr, Bunkyo Ku, Tokyo 113, Japan; [Shibata, S.] Waseda Univ, Dept Physiol & Pharmacol, Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan	Nakao, A (reprint author), Univ Yamanashi, Fac Med, Dept Immunol, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	anakao@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Ando N, 2015, ALLERGY, V70, P319, DOI 10.1111/all.12552; Paladino N, 2014, CHRONOBIOL INT, V31, P668, DOI 10.3109/07420528.2014.886588; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Smolensky MH, 2007, ADV DRUG DELIVER REV, V59, P852, DOI 10.1016/j.addr.2007.08.016; Kraft S, 2004, INT ARCH ALLERGY IMM, V135, P62, DOI 10.1159/000080231; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P9897, DOI 10.1073/pnas.1120636110; REINBERG A, 1988, J ALLERGY CLIN IMMUN, V81, P51, DOI 10.1016/0091-6749(88)90220-5; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Prendergast BJ, 2013, BRAIN BEHAV IMMUN, V32, P94, DOI 10.1016/j.bbi.2013.02.007; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Aoyagi M, 1999, INT ARCH ALLERGY IMM, V120, P95, DOI 10.1159/000053604; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Gibbs JE, 2009, ENDOCRINOLOGY, V150, P268, DOI 10.1210/en.2008-0638; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Arjona A, 2012, TRENDS IMMUNOL, V33, P607, DOI 10.1016/j.it.2012.08.007; Nakamura Y, 2014, J ALLERGY CLIN IMMUN, V133, P568, DOI 10.1016/j.jaci.2013.07.040; Dallmann R, 2014, ANNU REV PHARMACOL, V54, P339, DOI 10.1146/annurev-pharmtox-011613-135923; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Hiraoka S, 1999, INT IMMUNOL, V11, P199, DOI 10.1093/intimm/11.2.199; Fortier EE, 2011, J IMMUNOL, V187, P6291, DOI 10.4049/jimmunol.1004030; Nakamura Y, 2011, J ALLERGY CLIN IMMUN, V127, P1038, DOI 10.1016/j.jaci.2011.02.006; Cermakian N, 2013, CHRONOBIOL INT, V30, P870, DOI 10.3109/07420528.2013.782315; Baumann A, 2015, MOL IMMUNOL, V64, P76, DOI 10.1016/j.molimm.2014.10.026; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Stevens RG, 2005, EPIDEMIOLOGY, V16, P254, DOI 10.1097/01.ede.0000152525.21924.54; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Tanioka M, 2009, J INVEST DERMATOL, V129, P1225, DOI 10.1038/jid.2008.345; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Gelfand EW, 2004, J ALLERGY CLIN IMMUN, V114, pS135, DOI 10.1016/j.jaci.2004.08.043; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Arjona A, 2006, J INTERF CYTOK RES, V26, P645, DOI 10.1089/jir.2006.26.645; Baumann A, 2013, IMMUNOLOGY, V140, P465, DOI 10.1111/imm.12157; Bollinger T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029801; Caelius Aurelianus, 1709, MORBIS ACUITIS CHRON; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Durrington HJ, 2014, THORAX, V69, P90, DOI 10.1136/thoraxjnl-2013-203482; GERVAIS P, 1977, J ALLERGY CLIN IMMUN, V59, P207, DOI 10.1016/0091-6749(77)90151-8; Hawking F., 1975, Advances Parasit, V13, P123, DOI 10.1016/S0065-308X(08)60320-6; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kelly EAB, 2004, CLIN EXP ALLERGY, V34, P227, DOI 10.1111/j.1365-2222.2004.01866.x; LEE RE, 1977, ANN ALLERGY, V38, P231; Logan RW, 2012, MOL CELL ENDOCRINOL, V349, P82, DOI 10.1016/j.mce.2011.06.039; Maurer M, 2009, BRIT J DERMATOL, V160, P633, DOI 10.1111/j.1365-2133.2008.08920.x; MILLER P, 1976, CLIN EXP IMMUNOL, V25, P177; NAKAMURA Y, 2014, J IMMUNOL RES; Pincus DJ, 1997, J ALLERGY CLIN IMMUN, V100, P771, DOI 10.1016/S0091-6749(97)70272-0; Seery JP, 1998, ANN ALLERG ASTHMA IM, V80, P329; SPERBER PA, 1972, ANN ALLERGY, V30, P642; Wang X, 2010, BRAIN BEHAV IMMUN, V25, P127	56	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-4538	1398-9995		ALLERGY	Allergy	MAY	2015	70	5					467	473		10.1111/all.12596		7	Allergy; Immunology	Allergy; Immunology	CF4RJ	WOS:000352538200001		
J	Hasegawa, W; Yamauchi, Y; Yasunaga, H; Sunohara, M; Jo, T; Matsui, H; Fushimi, K; Takami, K; Nagase, T				Hasegawa, W.; Yamauchi, Y.; Yasunaga, H.; Sunohara, M.; Jo, T.; Matsui, H.; Fushimi, K.; Takami, K.; Nagase, T.			Factors that predict in-hospital mortality in eosinophilic granulomatosis with polyangiitis	ALLERGY			English	Article						eosinophilic granulomatosis with polyangiitis; peripheral neuropathy; predictive factors for in-hospital mortality	CHURG-STRAUSS-SYNDROME; TERM-FOLLOW-UP; SYSTEMIC-NECROTIZING-VASCULITIDES; ANTIBODY-ASSOCIATED VASCULITIS; POOR-PROGNOSIS FACTORS; POLYARTERITIS-NODOSA; MICROSCOPIC POLYANGIITIS; PROSPECTIVE TRIALS; INVOLVEMENT; FEATURES	BackgroundEosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic small-vessel vasculitis associated with asthma, eosinophilia, and necrotizing vasculitis. EGPA is potentially life-threatening and often involves peripheral neuropathies, peptic ulcers, cerebral vessel disease, and cardiovascular disease. However, there is limited understanding of the prognostics factors for patients with EGPA. We investigated the clinical features and factors affecting patients' in-hospital mortality, using a national inpatient database in Japan. MethodsWe retrospectively collected data of EGPA patients who required hospitalization between July 2010 and March 2013, using the Diagnosis Procedure Combination database. We evaluated EGPA patients' characteristics and performed multivariate logistic regression analyses to assess the factors associated with in-hospital mortality. ResultsA total of 2195 EGPA patients were identified. The mean age was 61.9years, 42.1% (924/2195) were male, and 41.6% (914/2195) had emergent admission. In-hospital deaths occurred in 97/2195 patients (4.4%). Higher in-hospital mortality was associated with age older than 65years, disturbance of consciousness on admission, unscheduled admission, respiratory disease, cardio-cerebrovascular disease, renal disease, sepsis, and malignant disease on admission. Lower mortality was associated with female gender and peripheral neuropathies. ConclusionsOur study revealed the clinical features of EGPA patients who required hospitalization and the factors associated with their mortality. These results may be useful for physicians when assessing disease severity or treatments for hospitalized EGPA patients.	[Hasegawa, W.; Yamauchi, Y.; Sunohara, M.; Jo, T.; Takami, K.; Nagase, T.] Univ Tokyo, Grad Sch Med, Dept Resp Med, Tokyo 1138655, Japan; [Yamauchi, Y.; Jo, T.] Univ Tokyo, Div Hlth Serv Promot, Tokyo 1138655, Japan; [Yasunaga, H.; Matsui, H.] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Fushimi, K.] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	Yamauchi, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yamauchiy-int@h.u-tokyo.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan	This work was supported by grants from the Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation and a grant to the Respiratory Failure Research Group).	Abril A, 2011, CURR RHEUMATOL REP, V13, P489, DOI 10.1007/s11926-011-0205-7; Samson M, 2013, J AUTOIMMUN, V43, P60, DOI 10.1016/j.jaut.2013.03.003; Ribi C, 2008, ARTHRITIS RHEUM, V58, P586, DOI 10.1002/art.23198; Suppiah R, 2011, RHEUMATOLOGY, V50, P2214, DOI 10.1093/rheumatology/ker266; Danieli MG, 2004, ANN RHEUM DIS, V63, P1649, DOI 10.1136/ard.2003.015453; Keogh KA, 2003, AM J MED, V115, P284, DOI 10.1016/S0002-9343(03)00359-0; Bosch X, 2007, JAMA-J AM MED ASSOC, V298, P655, DOI 10.1001/jama.298.6.655; Zhang W, 2009, CLIN EXP RHEUMATOL, V27, pS65; MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094; Li ZY, 2014, ARTHRITIS RHEUMATOL, V66, P1920, DOI 10.1002/art.38621; Guillevin L, 1999, MEDICINE, V78, P26, DOI 10.1097/00005792-199901000-00003; Cohen P, 2007, ARTHRIT RHEUM-ARTHR, V57, P686, DOI 10.1002/art.22679; Guillevin L, 2011, MEDICINE, V90, P19, DOI 10.1097/MD.0b013e318205a4c6; Moosig F, 2013, ANN RHEUM DIS, V72, P1011, DOI 10.1136/annrheumdis-2012-201531; Noth I, 2003, LANCET, V361, P587, DOI 10.1016/S0140-6736(03)12518-4; Gayraud M, 2001, ARTHRITIS RHEUM, V44, P666, DOI 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A; CHURG J, 1951, AM J PATHOL, V27, P277; Vaglio A, 2013, ALLERGY, V68, P261, DOI 10.1111/all.12088; Bourgarit A, 2005, MEDICINE, V84, P323, DOI 10.1097/01.md.0000180793.80212.17; Pagnoux C, 2005, MEDICINE, V84, P115, DOI 10.1097/01.md.0000158825.87055.0b; Comarmond C, 2013, ARTHRITIS RHEUM-US, V65, P270, DOI 10.1002/art.37721; Pagnoux C, 2007, CURR OPIN RHEUMATOL, V19, P25, DOI 10.1097/BOR.0b013e3280119854; Conron M, 2000, THORAX, V55, P870, DOI 10.1136/thorax.55.10.870; Guillevin L, 1996, MEDICINE, V75, P17, DOI 10.1097/00005792-199601000-00003; Hellmich B, 2004, EXPERT OPIN PHARMACO, V5, P25; Katzenstein ALA, 2000, AM J CLIN PATHOL, V114, P767; Ohta T, 1974, No Shinkei Geka, V2, P623; Sablé-Fourtassou Régis, 2005, Ann Intern Med, V143, P632; Sada KE, 2014, MOD RHEUMATOL, V24, P640, DOI 10.3109/14397595.2013.857582; Szczeklik W, 2013, CLIN REV ALLERG IMMU, V44, P39, DOI 10.1007/s12016-011-8266-y; TODO T, 1991, J NEUROSURG, V74, P81, DOI 10.3171/jns.1991.74.1.0081; United Nations, POP VIT STAT REP 201	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-4538	1398-9995		ALLERGY	Allergy	MAY	2015	70	5					585	590		10.1111/all.12597		6	Allergy; Immunology	Allergy; Immunology	CF4RJ	WOS:000352538200013		
J	Hotta, R; Doi, T; Shimada, H; Makizako, H; Yoshida, D; Anan, Y; Tsutsumimoto, K; Uemura, K; Park, H; Suzuki, T				Hotta, Ryo; Doi, Takehiko; Shimada, Hiroyuki; Makizako, Hyuma; Yoshida, Daisuke; Anan, Yuya; Tsutsumimoto, Kota; Uemura, Kazuki; Park, Hyuntae; Suzuki, Takao			Cigarette Smoking and Cognitive Health in Elderly Japanese	AMERICAN JOURNAL OF HEALTH BEHAVIOR			English	Article						smoking; pack-years; cognitive function; elderly	LUNG-CANCER; OLDER-ADULTS; NEUROCOGNITIVE FUNCTION; ALZHEIMERS-DISEASE; RISK-FACTOR; BRAIN; COHORT; METAANALYSIS; DEMENTIA; DRINKING	Objective: To examine the relationships between smoking status and various domains of cognitive function in community-dwelling elderly subjects. Methods: Participants (N = 4348) were asked about smoking status, demographic variables, and lifestyle factors, and underwent multidimensional neurocognitive tests. Results: All analyses were conducted separately by sex. Women never smokers exhibited significantly better scores than past and/or current smokers in some neurocognitive tests. Among men, never smokers had significantly higher scores, such as in the Symbol Digit Substitution Test. Multiple linear regression analysis showed that pack-years (history of smoking) were significantly associated with the Symbol Digit Substitution Test in men. Conclusions: Smoking status may be associated with a decline in processing speed, and this decline varies by sex.	[Hotta, Ryo; Doi, Takehiko; Shimada, Hiroyuki; Makizako, Hyuma; Yoshida, Daisuke; Anan, Yuya; Tsutsumimoto, Kota] Natl Ctr Geriatr & Gerontol, Dept Functioning Activat, Ctr Gerontol & Social Sci, Obu, Aichi, Japan; [Uemura, Kazuki] Nagoya Univ, Inst Innovat Future Soc, Nagoya, Aichi 4648601, Japan; [Park, Hyuntae; Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Res Inst, Obu, Aichi, Japan	Hotta, R (reprint author), Natl Ctr Geriatr & Gerontol, Dept Functioning Activat, Ctr Gerontol & Social Sci, Obu, Aichi, Japan.	ryo-h@ncgg.go.jp			Japanese Ministry of Health, Labour, and Welfare (Programs Minimizing Long-Term Care B-3)	We extend our appreciation to the Obu Office for assisting with recruiting participants. This study was supported by a grant from the Japanese Ministry of Health, Labour, and Welfare (Programs Minimizing Long-Term Care B-3, to T.S.).	Abreu-Villaca Y, 2003, NEUROPSYCHOPHARMACOL, V28, P1935, DOI 10.1038/sj.npp.1300221; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Simonato L, 2001, INT J CANCER, V91, P876, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1139>3.0.CO;2-7; Gallinat J, 2006, EUR J NEUROSCI, V24, P1744, DOI 10.1111/j.1460-9568.2006.05050.x; Glass JM, 2009, ADDICTION, V104, P38, DOI 10.1111/j.1360-0443.2008.02415.x; Yaffe K, 2009, NEUROLOGY, V72, P2029, DOI 10.1212/WNL.0b013e3181a92c36; Pathan SS, 2011, EUR J NEUROL, V18, P888, DOI 10.1111/j.1468-1331.2010.03340.x; Ott A, 1998, LANCET, V351, P1840, DOI 10.1016/S0140-6736(97)07541-7; Venkatraman VK, 2010, NEUROIMAGE, V49, P3436, DOI 10.1016/j.neuroimage.2009.11.019; Makizako H, 2013, GERIATR GERONTOL INT, V13, P860, DOI 10.1111/ggi.12014; Sabia S, 2012, ARCH GEN PSYCHIAT, V69, P627, DOI 10.1001/archgenpsychiatry.2011.2016; Ott A, 2004, NEUROLOGY, V62, P920; Elwood PC, 1999, J EPIDEMIOL COMMUN H, V53, P9; Glass JM, 2006, DRUG ALCOHOL DEPEN, V82, P119, DOI 10.1016/j.drugalcdep.2005.08.013; Beason-Held LL, 2012, STROKE, V43, P1542, DOI 10.1161/STROKEAHA.111.638437; Mons U, 2013, EUR J EPIDEMIOL, V28, P823, DOI 10.1007/s10654-013-9840-9; Durazzo TC, 2012, ALZHEIMERS DEMENT, V8, P513, DOI 10.1016/j.jalz.2011.10.006; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Launer LJ, 1996, AM J EPIDEMIOL, V143, P219; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Slotkin TA, 2002, NEUROTOXICOL TERATOL, V24, P369, DOI 10.1016/S0892-0362(02)00199-X; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Cadar D, 2012, J AGING RES, V2012, P1; Duron E, 2008, Vasc Health Risk Manag, V4, P363; Edwards R, 2004, BRIT MED J, V328, P217, DOI 10.1136/bmj.328.7433.217; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goriounova NA, 2012, COLD SPRING HARB PER, V2, P1; Health Labour and Welfare Ministry, 2012, NAT HLTH NUTR SURV J; Kalmijn S, 2002, AM J EPIDEMIOL, V156, P936, DOI 10.1093/aje/kwf135; Lee PN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-385; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matteis AD, 2013, AM J EPIDEMIOL, V177, P601; Nakahachi T, 2008, NEUROPSYCHOBIOLOGY, V57, P151, DOI 10.1159/000147467; Oh Hye Young, 2014, Korean J Fam Med, V35, P35, DOI 10.4082/kjfm.2014.35.1.35; Shimada H, 2014, FRONT AGING NEUROSCI, V6, P1; SHIMIZU J, 1994, SURG TODAY, V24, P19; Sobue T, 2002, INT J CANCER, V99, P245, DOI 10.1002/ijc.10308; World Health Organization, TOB FREE IN TFI TOB; World Health Organization (WHO), TOBACCO ATLAS; Young J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5042; Zhou HD, 2003, AGE AGEING, V32, P205, DOI 10.1093/ageing/32.2.205	41	0	0	PNG PUBLICATIONS	OAK RIDGE	2205-K OAK RIDGE RD, #115, OAK RIDGE, NC 27310 USA	1945-7359			AM J HEALTH BEHAV	Am. J. Health Behav.	MAY	2015	39	3					294	300		10.5993/AJHB.39.3.1		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF5UD	WOS:000352621700001		
J	Ito, Y; Ishibashi, K; Masaki, A; Fujii, K; Fujiyoshi, Y; Hattori, H; Kawakita, D; Matsumoto, M; Miyabe, S; Shimozato, K; Nagao, T; Inagaki, H				Ito, Yohei; Ishibashi, Kenichiro; Masaki, Ayako; Fujii, Kana; Fujiyoshi, Yukio; Hattori, Hideo; Kawakita, Daisuke; Matsumoto, Manabu; Miyabe, Satoru; Shimozato, Kazuo; Nagao, Toshitaka; Inagaki, Hiroshi			Mammary Analogue Secretory Carcinoma of Salivary Glands A Clinicopathologic and Molecular Study Including 2 Cases Harboring ETV6-X Fusion	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						mammary analogue secretory carcinoma; ETV6-NTRK3; gene rearrangement; linicopathologic analysis	MUCOEPIDERMOID CARCINOMA; CLINICOPATHOLOGICAL SIGNIFICANCE; FUSION TRANSCRIPT; ETV6-NTRK3; EXPRESSION	Mammary analogue secretory carcinoma (MASC) is a recently described low-grade carcinoma with morphologic and genetic similarity, including ETV6-NTRK3 fusion, to secretory carcinoma of the breast. ETV6 is frequently involved in other epithelial and nonepithelial tumors, and many fusion partners of ETV6 have been reported. In the present study, 14 Japanese MASC cases were clinicopathologically and molecularly analyzed. The median age of the patients was 39 years, and the male: female ratio was 6:8. All cases showed histopathologic findings compatible with those previously described for MASC and harbored an ETV6 split as visualized by fluorescence in situ hybridization. Two cases showed thick fibrous septa and invasive features including vascular or perineural tumor involvement, findings that are rare in MASC. In addition, in these 2 cases, non-NTRK3 genes appeared to fuse with ETV6 (ETV6-X fusion). NTRK1 and NTRK2, both members of the NTRK family, were not involved. Of the 14 MASC cases, the ETV6-NTRK3 fusion transcript was positive in 6 cases, and the relative expression level of the ETV6-NTRK3 fusion transcript was variable, ranging from 1 to 5.8. Results of the present study of MASC suggest that (1) ETV6 occasionally fuses with unknown non-NTRK3 genes, (2) ETV6-X cases might have an invasive histology, (3) for molecular diagnosis of MASC, fluorescence in situ hybridization to detect ETV6 splits is the method of choice, and (4) the expression level of the ETV6-NTRK3 fusion transcript is considerably variable. These findings provide a novel insight into the oncogenesis, histopathology, diagnosis, treatment, and prognosis of this newly recognized carcinoma.	[Ito, Yohei; Ishibashi, Kenichiro; Masaki, Ayako; Fujii, Kana; Fujiyoshi, Yukio; Hattori, Hideo; Miyabe, Satoru; Inagaki, Hiroshi] Nagoya City Univ, Grad Sch Med Sci, Dept Pathol & Mol Diagnost, Nagoya, Aichi 4678601, Japan; [Kawakita, Daisuke] Nagoya City Univ, Grad Sch Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Nagoya, Aichi 4678601, Japan; [Ito, Yohei; Ishibashi, Kenichiro; Miyabe, Satoru; Shimozato, Kazuo] Aichi Gakuin Univ, Sch Dent, Dept Maxillofacial Surg, Nagoya, Aichi 464, Japan; [Matsumoto, Manabu] Kochi Hlth Sci Ctr, Dept Diagnost Pathol, Kochi, Japan; [Nagao, Toshitaka] Tokyo Med Univ, Dept Anat Pathol, Tokyo 1608402, Japan	Inagaki, H (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Pathol & Mol Diagnost, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	hinagaki@med.nagoya-cu.ac.jp					De Braekeleer E, 2012, LEUKEMIA RES, V36, P945, DOI 10.1016/j.leukres.2012.04.010; Chiosea SI, 2012, HISTOPATHOLOGY, V61, P387, DOI 10.1111/j.1365-2559.2012.04232.x; Noda H, 2013, CANCER SCI, V104, P85, DOI 10.1111/cas.12039; Okabe M, 2006, CLIN CANCER RES, V12, P3902, DOI 10.1158/1078-0432.CCR-05-2376; Jung MJ, 2013, KOREAN J PATHOL, V47, P36, DOI 10.4132/KoreanJPathol.2013.47.1.36; Sethi R, 2014, LARYNGOSCOPE, V124, P188, DOI 10.1002/lary.24254; Stenman G, 2014, ORAL ONCOL, V50, P683, DOI 10.1016/j.oraloncology.2014.04.008; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Skalova A, 2014, AM J SURG PATHOL, V38, P23, DOI 10.1097/PAS.0000000000000088; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Xia HJ, 2011, HUM PATHOL, V42, P1297, DOI 10.1016/j.humpath.2010.11.022; Connor A, 2012, AM J SURG PATHOL, V36, P27, DOI 10.1097/PAS.0b013e318231542a; von Bergh ARM, 2006, GENE CHROMOSOME CANC, V45, P731, DOI 10.1002/gcc.20335; Skalova A, 2010, AM J SURG PATHOL, V34, P599, DOI 10.1097/PAS.0b013e3181d9efcc; Bishop JA, 2013, AM J SURG PATHOL, V37, P1053, DOI 10.1097/PAS.0b013e3182841554; Nakayama T, 2009, MODERN PATHOL, V22, P1575, DOI 10.1038/modpathol.2009.126; Bishop Justin A, 2013, Head Neck Pathol, V7, P35, DOI 10.1007/s12105-013-0429-0; Higuchi K, 2014, DIAGN CYTOPATHOL, V42, P846, DOI 10.1002/dc.23139; Mariano FV, 2013, HISTOPATHOLOGY, V63, P558, DOI 10.1111/his.12192; Shah AA, 2015, HEAD NECK PATHOL; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374	21	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	MAY	2015	39	5					602	610		10.1097/PAS.0000000000000392		9	Pathology; Surgery	Pathology; Surgery	CG1VC	WOS:000353062200003		
J	Roma, AA; De Vivar, AD; Park, KJ; Alvarado-Cabrero, I; Rasty, G; Chanona-Vilchis, JG; Mikami, Y; Hong, SR; Teramoto, N; Ali-Fehmi, R; Rutgers, JKL; Barbuto, D; Silva, EG				Roma, Andres A.; De Vivar, Andrea Diaz; Park, Kay J.; Alvarado-Cabrero, Isabel; Rasty, Golnar; Chanona-Vilchis, Jose G.; Mikami, Yoshiki; Hong, Sung R.; Teramoto, Norihiro; Ali-Fehmi, Rouba; Rutgers, Joanne K. L.; Barbuto, Denise; Silva, Elvio G.			Invasive Endocervical Adenocarcinoma A New Pattern-based Classification System With Important Clinical Significance	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						invasive endocervical adenocarcinoma; new pattern-based classification system; lymph node metastasis	UTERINE CERVIX; MICROINVASIVE ADENOCARCINOMA; CARCINOMA; METASTASIS; RECURRENCE	A new 3-tier pattern-based system to classify endocervical adenocarcinoma was recently presented. In short, pattern A tumors were characterized by well-demarcated glands frequently forming clusters or groups with relative lobular architecture. Pattern B tumors demonstrated localized destructive invasion defined as desmoplastic stroma surrounding glands with irregular and/or ill-defined borders or incomplete glands and associated tumor cells (individual or small clusters) within the stroma. Tumors with pattern C showed diffusely infiltrative glands with associated extensive desmoplastic response. In total, 352 cases (all FIGO stages) from 12 institutions were identified. Mean patient age was 45 years (range, 20 to 83 y). Forty-nine (13.9%) cases demonstrated lymph nodes (LNs) with metastatic endocervical carcinoma. Using this new system, 73 patients (20.7%) were identified with pattern A tumors (all stage I); none had LN metastases and/or recurrences. Ninety patients (25.6%) were identified with pattern B tumors (all stage I); only 4 (4.4%) had LN metastases; 1 had vaginal recurrence. The 189 (53.7%) remaining patients had pattern C tumors; 45 (23.8%) of them had LN metastases. This new classification system demonstrated 20.7% of patients (pattern A) with negative LNs, and patients with pattern A tumors can be spared of lymphadenectomy. Patients with pattern B tumors rarely presented with metastatic LNs, and sentinel LN examination could potentially identify these patients. Aggressive treatment is justified in patients with pattern C tumors.	[Roma, Andres A.] Cleveland Clin, Cleveland, OH 44106 USA; [De Vivar, Andrea Diaz] Texas Childrens Hosp Pavil Women, Baylor Coll Med, Houston, TX USA; [Silva, Elvio G.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Park, Kay J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Ali-Fehmi, Rouba] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [Rutgers, Joanne K. L.; Barbuto, Denise; Silva, Elvio G.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Alvarado-Cabrero, Isabel] Mexican Oncol Hosp, Mexico City, DF, Mexico; [Chanona-Vilchis, Jose G.] Inst Nacl Cancerol Mexico, Mexico City, DF, Mexico; [Rasty, Golnar] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Mikami, Yoshiki] Kyoto Univ Hosp, Kyoto 606, Japan; [Teramoto, Norihiro] Shikoku Canc Ctr, Matsuyama, Ehime, Japan; [Hong, Sung R.] Kwandong Univ, Cheil Gen Hosp, Kangnung, South Korea; [Hong, Sung R.] Kwandong Univ, Womens Healthcare Ctr, Kangnung, South Korea	Roma, AA (reprint author), 9500 Euclid Ave,L2, Cleveland, OH 44122 USA.	romaa@ccf.org			International Society of Gynecological Pathologists; Cedars Sinai Medical Center, Los Angeles, CA	Sponsored by the International Society of Gynecological Pathologists and Cedars Sinai Medical Center, Los Angeles, CA. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.	Smith HO, 2000, GYNECOL ONCOL, V78, P97, DOI 10.1006/gyno.2000.5826; Reynolds EA, 2010, OBSTET GYNECOL, V116, P1150, DOI 10.1097/AOG.0b013e3181f74062; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Bean SM, 2011, J LOW GENIT TRACT DI, V15, P146, DOI 10.1097/LGT.0b013e3181fb425d; De Vivar AD, 2013, INT J GYNECOL PATHOL, V32, P592, DOI 10.1097/PGP.0b013e31829952c6; Sakuragi N, 1999, CANCER, V85, P1547, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1547::AID-CNCR16>3.0.CO;2-2; Webb JC, 2001, OBSTET GYNECOL, V97, P701, DOI 10.1016/S0029-7844(01)01330-8; Moschiano EJ, 2014, INT J GYNECOL PATHOL, V33, P268, DOI 10.1097/PGP.0b013e31829c6757; Poynor EA, 2006, GYNECOL ONCOL, V103, P960, DOI 10.1016/j.ygyno.2006.05.041; Elliott P, 2000, INT J GYNECOL CANCER, V10, P42, DOI 10.1046/j.1525-1438.2000.00011.x; Bisseling KCHM, 2007, GYNECOL ONCOL, V107, P424, DOI 10.1016/j.ygyno.2007.07.062; Baalbergen A, 2011, INT J GYNECOL CANCER, V21, P1640, DOI 10.1097/IGC.0b013e3182262059; Hirai Y, 2003, BJOG-INT J OBSTET GY, V110, P241, DOI 10.1016/S1470-0328(02)02992-6; Kaku T, 1997, GYNECOL ONCOL, V65, P281, DOI 10.1006/gyno.1997.4652; Kasamatsu T, 2002, GYNECOL ONCOL, V85, P327, DOI 10.1006/gyno.2002.6624; Ostor G., 2000, INT J GYNECOL PATHOL, V19, P29; Wilbur DC, 2014, WHO CLASSIFICATION T, P184	17	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	MAY	2015	39	5					667	672		10.1097/PAS.0000000000000402		6	Pathology; Surgery	Pathology; Surgery	CG1VC	WOS:000353062200011		
J	Pezzotti, G; Zhu, WL; Boffelli, M; Adachi, T; Ichioka, H; Yamamoto, T; Marunaka, Y; Kanamura, N				Pezzotti, Giuseppe; Zhu, Wenliang; Boffelli, Marco; Adachi, Tetsuya; Ichioka, Hiroaki; Yamamoto, Toshiro; Marunaka, Yoshinori; Kanamura, Narisato			Vibrational algorithms for quantitative crystallographic analyses of hydroxyapatite-based biomaterials: I, theoretical foundations	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Hydroxyapatite; Polarized Raman spectroscopy; Crystallographic analyses; Tooth enamel	TRANSFORM INFRARED-SPECTROSCOPY; EARLY DENTAL-CARIES; LASER RAMAN-SPECTROSCOPY; CARBONATED APATITES; CALCIUM-PHOSPHATE; EARLY DEPOSITS; HUMAN-ENAMEL; SOLID-PHASE; PO4 DOMAIN; ENVIRONMENT	The Raman spectroscopic method has quantitatively been applied to the analysis of local crystallographic orientation in both single-crystal hydroxyapatite and human teeth. Raman selection rules for all the vibrational modes of the hexagonal structure were expanded into explicit functions of Euler angles in space and six Raman tensor elements (RTE). A theoretical treatment has also been put forward according to the orientation distribution function (ODF) formalism, which allows one to resolve the statistical orientation patterns of the nm-sized hydroxyapatite crystallite comprised in the Raman microprobe. Close-form solutions could be obtained for the Euler angles and their statistical distributions resolved with respect to the direction of the average texture axis. Polarized Raman spectra from single-crystalline hydroxyapatite and textured polycrystalline (teeth enamel) samples were compared, and a validation of the proposed Raman method could be obtained through confirming the agreement between RTE values obtained from different samples.	[Pezzotti, Giuseppe; Boffelli, Marco] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068126, Japan; [Pezzotti, Giuseppe; Marunaka, Yoshinori] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Cell Physiol, Kamigyo Ku, Kyoto 6028566, Japan; [Zhu, Wenliang] Osaka Univ, Dept Med Engn Treatment Bone & Joint Disorders, Suita, Osaka 5650854, Japan; [Adachi, Tetsuya; Ichioka, Hiroaki; Yamamoto, Toshiro; Kanamura, Narisato] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dent Med, Kamigyo Ku, Kyoto 6020841, Japan; [Marunaka, Yoshinori] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Bioion, Kamigyo Ku, Kyoto 6028566, Japan	Pezzotti, G (reprint author), Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068126, Japan.	pezzotti@kit.ac.jp					VANGURP M, 1995, COLLOID POLYM SCI, V273, P607, DOI 10.1007/BF00652253; Simmons LM, 2011, EUR J ORAL SCI, V119, P19, DOI 10.1111/j.1600-0722.2011.00909.x; Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561; Ko ACT, 2008, OPT EXPRESS, V16, P6274, DOI 10.1364/OE.16.006274; Kneipp K, 1999, CHEM REV, V99, P2957, DOI 10.1021/cr980133r; LOUDON R, 1964, ADV PHYS, V13, P423, DOI 10.1080/00018736400101051; Wilson RM, 1999, AM MINERAL, V84, P1406; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Bechtle S, 2010, BIOMATERIALS, V31, P375, DOI 10.1016/j.biomaterials.2009.09.050; TSUDA H, 1994, J DENT RES, V73, P1703; REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969; [Anonymous], MATHEMATICA 7 0; REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059; PORTO SPS, 1967, J CHEM PHYS, V47, P1009, DOI 10.1063/1.1711980; Al-Jawad M, 2007, BIOMATERIALS, V28, P2908, DOI 10.1016/j/biomaterials.2007.02.019; Apap M, 1985, J DENT RES, V11, P1293; Choo-Smith LP, 2008, J CAN DENT ASSOC, V74, P913; Choo-Smith L-P, 2010, OPT EXPRESS, V2, pO43; Corno M, 2006, PHYS CHEM CHEM PHYS, V8, P2464, DOI 10.1039/b602419j; DEMUL FFM, 1986, J DENT RES, V65, P437, DOI 10.1177/00220345860650031301; FERNANDES CP, 1991, J PROSTHET DENT, V65, P793, DOI 10.1016/S0022-3913(05)80015-0; GILINSKAYA LG, 1995, J STRUCT CHEM+, V36, P76, DOI 10.1007/BF02577752; Grisafe DA, 1970, J SOLID STATE CHEM, V2, P167, DOI 10.1016/0022-4596(70)90065-4; Hill W, 2000, APPL SPECTROSC, V54, P795, DOI 10.1366/0003702001950409; Ionita I, 2009, ROM REP PHYS, V61, P567; Johansen E, 1965, TOOTH ENAMEL ITS COM; Ko ACT, 2006, OPT EXPRESS, V14, P203, DOI 10.1364/OPEX.14.000203; Ko ACT, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1915488; KRAVITZ LC, 1968, J CHEM PHYS, V49, P4600, DOI 10.1063/1.1669918; LeGeros R Z, 1990, J Dent Res, V69 Spec No, P567; Mahoney P, 2012, AM J PHYS ANTHROPOL, V147, P637, DOI 10.1002/ajpa.22029; NELSON DGA, 1982, AUST J CHEM, V35, P715; NISHINO M, 1981, J DENT RES, V60, P751, DOI 10.1177/00220345810600031601; Perez R, 2008, J APPL PHYS, V103; PETICOLAS WL, 1975, BIOCHIMIE, V57, P417, DOI 10.1016/S0300-9084(75)80328-2; Pezzotti G, 2013, J APPL PHYS, V113; Pezzotti G, 2012, J APPL PHYS, V111; Pezzotti G, 2013, J PHYS D, V46; Prabhakar N.K., 2011, ARCH ORAL SCI RES, V1, P168; REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847; Sanchez-Pastenes E, 2005, REV MEX FIS, V51, P525; SAUER GR, 1994, CALCIFIED TISSUE INT, V54, P414, DOI 10.1007/BF00305529; Schaeberle MD, 1999, ANAL CHEM, V71, p175A, DOI 10.1021/ac990251u; Scott JH, 1982, INTRO DENT ANATOMY; Takahashi Y, 2010, ACTA BIOMATER, V6, P3583, DOI 10.1016/j.actbio.2010.02.051; Ten Cate AR, 2008, ORAL HISTOLOGY DEV S, P3; TROMBE JC, 1973, ANN CHIM FRANCE, V8, P251; Tsuda H, 1997, Adv Dent Res, V11, P539; Tu AT, 2003, J CHIN CHEM SOC-TAIP, V50, P1; Wigner E.P., 1959, GROUP THEORY ITS APP	50	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	MAY	2015	407	12					3325	3342		10.1007/s00216-015-8472-1		18	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CF6BB	WOS:000352640300009		
J	Adachi, T; Pezzotti, G; Yamamoto, T; Ichioka, H; Boffelli, M; Zhu, WL; Kanamura, N				Adachi, Tetsuya; Pezzotti, Giuseppe; Yamamoto, Toshiro; Ichioka, Hiroaki; Boffelli, Marco; Zhu, Wenliang; Kanamura, Narisato			Vibrational algorithms for quantitative crystallographic analyses of hydroxyapatite-based biomaterials: II, application to decayed human teeth	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Polarized Raman spectroscopy; Tooth enamel; Dental caries; Carious lesions	RAMAN-SPECTROSCOPY; DENTAL-CARIES; LAZARET CAVE; AB-INITIO; IN-VITRO; ENAMEL; CRYSTALLINITY; LESIONS; BONE; DEMINERALIZATION	A systematic investigation, based on highly spectrally resolved Raman spectroscopy, was undertaken to research the efficacy of vibrational assessments in locating chemical and crystallographic fingerprints for the characterization of dental caries and the early detection of non-cavitated carious lesions. Raman results published by other authors have indicated possible approaches for this method. However, they conspicuously lacked physical insight at the molecular scale and, thus, the rigor necessary to prove the efficacy of this spectroscopy method. After solving basic physical challenges in a companion paper, we apply them here in the form of newly developed Raman algorithms for practical dental research. Relevant differences in mineral crystallite (average) orientation and texture distribution were revealed for diseased enamel at different stages compared with healthy mineralized enamel. Clear spectroscopy features could be directly translated in terms of a rigorous and quantitative classification of crystallography and chemical characteristics of diseased enamel structures. The Raman procedure enabled us to trace back otherwise invisible characteristics in early caries, in the translucent zone (i.e., the advancing front of the disease) and in the body of lesion of cavitated caries.	[Adachi, Tetsuya; Yamamoto, Toshiro; Ichioka, Hiroaki; Kanamura, Narisato] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dent Med, Kamigyo Ku, Kyoto 6020841, Japan; [Pezzotti, Giuseppe; Boffelli, Marco] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068126, Japan; [Pezzotti, Giuseppe] Kyoto Prefectural Univ Med, Dept Mol Cell Physiol, Grad Sch Med Sci, Kamigyo Ku, Kyoto 6020841, Japan; [Zhu, Wenliang] Osaka Univ, Dept Med Engn Treatment Bone & Joint Disorders, Suita, Osaka 5650854, Japan	Pezzotti, G (reprint author), Kyoto Prefectural Univ Med, Dept Mol Cell Physiol, Grad Sch Med Sci, Kamigyo Ku, 465 Kajii Cho, Kyoto 6020841, Japan.	pezzotti@kit.ac.jp					Bader JD, 2002, J PUBLIC HEALTH DENT, V62, P201, DOI 10.1111/j.1752-7325.2002.tb03446.x; TENCATE JM, 1982, CARIES RES, V16, P201; Lan K, 2001, J CHROMATOGR A, V915, P1, DOI 10.1016/S0021-9673(01)00594-5; Bader JD, 2001, COMMUNITY DENT ORAL, V29, P399, DOI 10.1034/j.1600-0528.2001.290601.x; Calderin L, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.224304; [Anonymous], MATEHMATICA 70; Featherstone JDB, 1999, COMMUNITY DENT ORAL, V27, P31, DOI 10.1111/j.1600-0528.1999.tb01989.x; Puceat E, 2004, CHEM GEOL, V205, P83, DOI 10.1016/j.chemgeo.2003.12.014; Al-Jawad M, 2012, J DENT, V40, P1074, DOI 10.1016/j.jdent.2012.08.020; Murdoch-Kinch CA, 2003, J AM DENT ASSOC, V134, P87; WEINER S, 1990, J ARCHAEOL SCI, V17, P187, DOI 10.1016/0305-4403(90)90058-D; Chai H, 2009, P NATL ACAD SCI USA, V106, P7289, DOI 10.1073/pnas.0902466106; Ekstrand KR, 1997, CARIES RES, V31, P224; Robinson C, 2000, CRIT REV ORAL BIOL M, V11, P481; Schneiderman A, 1997, CARIES RES, V31, P103; TSUDA H, 1994, J DENT RES, V73, P1703; REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; Miro S, 2011, J RAMAN SPECTROSC, V42, P2036, DOI 10.1002/jrs.2955; Liu J, 2008, APPL PHYS A-MATER, V91, P17, DOI 10.1007/s00339-008-4402-9; Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2; Lussi A, 2001, EUR J ORAL SCI, V109, P14, DOI 10.1034/j.1600-0722.2001.109001014.x; Balan E, 2011, PHYS CHEM MINER, V38, P111, DOI 10.1007/s00269-010-0388-x; Corno M, 2006, PHYS CHEM CHEM PHYS, V8, P2464, DOI 10.1039/b602419j; Cury Jaime Aparecido, 2009, Braz Oral Res, V23 Suppl 1, P23, DOI 10.1590/S1806-83242009000500005; Dawes Colin, 2003, J Can Dent Assoc, V69, P722; Edgar W M, 1995, Adv Dent Res, V9, P235; Elliott S. R., 1990, PHYS AMORPHOUS MAT; Featherstone J D B, 2004, J Dent Res, V83 Spec No C, pC39; Gröndahl H G, 1977, Swed Dent J, V1, P45; Kittel C., 1986, INTRO SOLID STATE PH; Ko ACT, 2006, OPT EXPRESS, V14, P203, DOI 10.1364/OPEX.14.000203; Krasse B, 1988, Int Dent J, V38, P219; Michel V, 1996, PALAEOGEOGR PALAEOCL, V126, P109, DOI 10.1016/S0031-0182(96)00074-0; MICHEL V, 1995, APPL GEOCHEM, V10, P145, DOI 10.1016/0883-2927(95)00001-Z; Moller J, 1973, SCAND J DENT RES, V81, P1; Pedone A, 2007, J MATER CHEM, V17, P2061, DOI 10.1039/b617858h; Pezzotti G, 2015, ANAL BIOANAL CHEM, DOI [10.1007/s00216-015-8472-1, DOI 10.1007/S00216-015-8472-1]; Robinson C, 1983, DEMINERALISATION REM, P209; Rulis P, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.155104; Schmuck BD, 2010, J RES NATL INST STAN, V115, P75, DOI 0.6028/jres.115.006; SHEMESH A, 1990, GEOCHIM COSMOCHIM AC, V54, P2433, DOI 10.1016/0016-7037(90)90230-I; Surovell TA, 2001, J ARCHAEOL SCI, V28, P633, DOI 10.1006/jasc.2000.0633; Zero D T, 1995, Adv Dent Res, V9, P214	44	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	MAY	2015	407	12					3343	3356		10.1007/s00216-015-8539-z		14	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CF6BB	WOS:000352640300010		
J	Umemoto, M; Hoshino, T; Miyashita, T; Tani, W; Kuwa, K				Umemoto, Masao; Hoshino, Tadao; Miyashita, Tetsuo; Tani, Wataru; Kuwa, Katsuhiko			Report on HbA(1c) Proficiency Testing in Asia in 2012	ANNALS OF LABORATORY MEDICINE			English	Article						HbA(1c); National Glycohemoglobin Standardization Program; Proficiency testing; Asian Secondary Reference Laboratory		In 2010, the Japan Diabetes Society decided to introduce the National Glycohemoglobin Standardization Program (NGSP) values into clinical practice. Accordingly, NGSP Certification of Japanese manufacturers of HbA(1c)-related diagnostic reagents and instruments was initiated in February, 2012, through an NGSP network laboratory, the Asian Secondary Reference Laboratory (ASRL) #1. Traceability to the NGSP reference system can be endorsed by manufacturer certification, as well as by the College of American Pathologists (CAP) survey. Nevertheless, only a few manufacturers participate in the CAP survey in Japan. Thus, proficiency testing (PT) was proposed and executed by ASRL #1. Single-donor whole-blood samples were used for the PT. The participated measurement systems were NGSP certified. Twenty-two laboratories obtained certification through ASRL #1; 2 through the Secondary Reference Laboratory (SRL) #8; and 9 through the SRL #9. The combination plots of the bias data in this PT and in the NGSP certification performed in March and May in 2012 were consistent with each other: mean NGSP values at each level agreed well with the target value. In conclusion, PT using whole blood is useful in endorsing NGSP certification.	[Umemoto, Masao] Reference Mat Inst Clin Chem Standards, Yokohama, Kanagawa, Japan; [Hoshino, Tadao] Reference Lab Inst Biopathol Med, Fujisawa, Kanagawa, Japan; [Miyashita, Tetsuo] Nihon Univ Itabashi Hosp, Tokyo, Japan; [Tani, Wataru] Reference Mat Inst Clin Chem Standards, Kawasaki, Kanagawa, Japan; [Kuwa, Katsuhiko] Natl Metrol Inst Japan, Ibaraki, Japan	Kuwa, K (reprint author), Natl Metrol Inst Japan, 503 Surpass Tsukuba Kenkyugaku, Tsukuba, Ibaraki 3050817, Japan.	kkuwa@gol.com					Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x	1	0	0	KOREAN SOC LABORATORY MEDICINE	SEOUL	KOREAN MEDICAL ASSOC BLDG, RM 602,302-75 ICHON 1-DONG, YONGSAN-GU, SEOUL, 140-721, SOUTH KOREA	2234-3806	2234-3814		ANN LAB MED	Ann. Lab. Med.	MAY	2015	35	3					352	355		10.3343/alm.2015.35.3.352		4	Medical Laboratory Technology	Medical Laboratory Technology	CF7RS	WOS:000352754600011		
J	Wakisaka, N; Yoshida, S; Kondo, S; Kita, M; Endo, K; Tsuji, A; Murono, S; Muramatsu, M; Yoshizaki, T				Wakisaka, Naohiro; Yoshida, Shinya; Kondo, Satoru; Kita, Makiko; Endo, Kazuhira; Tsuji, Akira; Murono, Shigeyuki; Muramatsu, Masamichi; Yoshizaki, Tomokazu			HPV Status Determines the Efficacy of Adjuvant Chemotherapy With S-1, an Oral Fluorouracil Prodrug, in Oropharyngeal Cancer	ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY			English	Article						oropharyngeal squamous cell carcinoma; human papillomavirus; S-1 adjuvant chemotherapy; 5-fluorouracil; thymidylate synthase	SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; THYMIDYLATE-SYNTHASE; NECK-CANCER; IMPROVED SURVIVAL; HEAD; 5-FLUOROURACIL; INDUCTION; RECEPTOR	Objectives: A subgroup of oropharyngeal squamous cell carcinoma (OPC) is infected with high-risk human papillomavirus (HPV). The object of this study is to evaluate the efficacy of adjuvant chemotherapy with S-1, an oral 5-fluorouracil prodrug, on survival of patients with OPC according to HPV status. Methods: Among OPC patients of stage III or IV who received definitive treatment from 1998 to 2008, 38 who were confirmed tumor-free after primary treatment were analyzed. Before 2003, none of the patients received S-1 adjuvant chemotherapy (S-1(-)-group); however, all patients who were eligible were administered S-1 (S-1(+)-group) after 2003. The expression of thymidylate synthase (TYMS) involved in 5-FU metabolism was also examined in protein and mRNA levels. Results: Although there was a trend to disease-free and overall survival benefit in HPV-negative patients with S-1, it did not achieve statistical significance (P = .082 and P = .065, respectively). For the HPV-positive patients, the survivals were similar with or without S-1 administration. TYMS-expression in HPV-positive OPC tissues was significantly higher than in HPV-negative ones in both protein and mRNA levels (P = .0489 and P = .0446, respectively). Conclusion: The current study provides a rationale to plan a randomized trial to compare the efficacy of S-1 according to the HPV status in OPCs.	[Wakisaka, Naohiro; Yoshida, Shinya; Kondo, Satoru; Kita, Makiko; Endo, Kazuhira; Tsuji, Akira; Murono, Shigeyuki; Yoshizaki, Tomokazu] Kanazawa Univ, Div Otolaryngol Head & Neck Surg, Grad Sch Med Sci, Kanazawa, Ishikawa 9208640, Japan; [Muramatsu, Masamichi] Kanazawa Univ, Div Mol Genet, Grad Sch Med Sci, Kanazawa, Ishikawa 9208640, Japan	Yoshizaki, T (reprint author), Kanazawa Univ, Div Otolaryngol Head & Neck Surg, Grad Sch Med Sci, Takara Machi 13-1, Kanazawa, Ishikawa 9208640, Japan.	tomoy@med.kanazawa-u.ac.jp			Ministry of Education, Science, Sports, Culture and Technology of Japan [C21592189]; Taiho Pharmaceutical Co LTD (Tokyo, Japan)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Financial support was provided by the grant from the Ministry of Education, Science, Sports, Culture and Technology of Japan (C21592189); and Taiho Pharmaceutical Co LTD (Tokyo, Japan). This study was partially supported by Taiho Pharmaceutical Co LTD (Tokyo, Japan).	Tsukuda M, 2005, BRIT J CANCER, V93, P884, DOI 10.1038/sj.bjc.6602804; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Fakhry C, 2008, J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Nishiwaki M, 2008, J CLIN MICROBIOL, V46, P1161, DOI 10.1128/JCM.00793-07; Deng ZY, 2011, EUR ARCH OTO-RHINO-L, V268, P1625, DOI 10.1007/s00405-011-1515-0; LARAMORE GE, 1992, INT J RADIAT ONCOL, V23, P705; Mizumachi T, 2013, INT J CLIN ONCOL, V18, P824, DOI 10.1007/s10147-012-0469-6; Lurje G, 2009, MOL CANCER THER, V8, P1000, DOI 10.1158/1535-7163.MCT-08-0219; Matsubara J, 2008, BRIT J CANCER, V98, P832, DOI 10.1038/sj.bjc.6604211; Gillison ML, 2000, J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Lee Y, 1997, EXP CELL RES, V234, P270, DOI 10.1006/excr.1997.3605; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Genden EM, 2013, EUR ARCH OTO-RHINO-L, V270, P405, DOI 10.1007/s00405-012-2086-4; Malet-Martino M, 2002, ONCOLOGIST, V7, P288, DOI 10.1634/theoncologist.7-4-288; Syrjanen S, 2004, J CLIN PATHOL, V57, P449, DOI 10.1136/jcp.2003.008656; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Peters GJ, 2002, BBA-MOL BASIS DIS, V1587, P194, DOI 10.1016/S0925-4439(02)00082-0; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; ERVIN TJ, 1987, J CLIN ONCOL, V5, P10; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; Johnson JT, 1996, CANCER, V77, P181, DOI 10.1002/(SICI)1097-0142(19960101)77:1<181::AID-CNCR29>3.3.CO;2-4; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Sobin LH, 2009, TNM CLASSIFICATION M; Taguchi T, 2013, J CLIN ONCOL, V31; Tsuji A, 2008, CLIN CANCER RES, V14, P5368, DOI 10.1158/1078-0432.CCR-08-0198; Tsukuda M, 1994, Gan To Kagaku Ryoho, V21, P1169	26	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-4894	1943-572X		ANN OTO RHINOL LARYN	Ann. Otol. Rhinol. Laryngol.	MAY	2015	124	5					400	406		10.1177/0003489414560434		7	Otorhinolaryngology	Otorhinolaryngology	CF6EY	WOS:000352651000011		
J	Piromyou, P; Greetatorn, T; Teamtisong, K; Okubo, T; Shinoda, R; Nuntakij, A; Tittabutr, P; Boonkerd, N; Minamisawa, K; Teaumroong, N				Piromyou, Pongdet; Greetatorn, Teerana; Teamtisong, Kamonluck; Okubo, Takashi; Shinoda, Ryo; Nuntakij, Achara; Tittabutr, Panlada; Boonkerd, Nantakorn; Minamisawa, Kiwamu; Teaumroong, Neung			Preferential Association of Endophytic Bradyrhizobia with Different Rice Cultivars and Its Implications for Rice Endophyte Evolution	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							LEGUMINOSARUM BV TRIFOLII; AESCHYNOMENE-INDICA; MAXIMUM-LIKELIHOOD; GENETIC DIVERSITY; GROWTH; JAPONICUM; RHIZOBIUM; NODULATION; BACTERIA; STRAINS	Plant colonization by bradyrhizobia is found not only in leguminous plants but also in nonleguminous species such as rice. To understand the evolution of the endophytic symbiosis of bradyrhizobia, the effect of the ecosystems of rice plantations on their associations was investigated. Samples were collected from various rice (Oryza sativa) tissues and crop rotational systems. The rice endophytic bradyrhizobia were isolated on the basis of oligotrophic properties, selective medium, and nodulation on siratro (Macroptilium atropurpureum). Six bradyrhizobial strains were obtained exclusively from rice grown in a crop rotational system. The isolates were separated into photosynthetic bradyrhizobia (PB) and nonphotosynthetic bradyrhizobia (non-PB). Thai bradyrhizobial strains promoted rice growth of Thai rice cultivars better than the Japanese bradyrhizobial strains. This implies that the rice cultivars possess characteristics that govern rice-bacterium associations. To examine whether leguminous plants in a rice plantation system support the persistence of rice endophytic bradyrhizobia, isolates were tested for legume nodulation. All PB strains formed symbioses with Aeschynomene indica and Aeschynomene evenia. On the other hand, non-PB strains were able to nodulate Aeschynomene americana, Vigna radiata, and M. atropurpureum but unable to nodulate either A. indica or A. evenia. Interestingly, the nodABC genes of all of these bradyrhizobial strains seem to exhibit low levels of similarity to those of Bradyrhizobium diazoefficiens USDA110 and Bradyrhizobium sp. strain ORS285. From these results, we discuss the evolution of the plant-bradyrhizobium association, including nonlegumes, in terms of photosynthetic lifestyle and nod-independent interactions.	[Piromyou, Pongdet; Greetatorn, Teerana; Tittabutr, Panlada; Boonkerd, Nantakorn; Teaumroong, Neung] Swanaree Univ Technol, Sch Biotechnol, Inst Agr Technol, Nakhon Ratchasilma, Thailand; [Teamtisong, Kamonluck] Swanaree Univ Technol, Ctr Sci & Technol Equipment, Nakhon Ratchasilma, Thailand; [Okubo, Takashi; Shinoda, Ryo; Minamisawa, Kiwamu] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Nuntakij, Achara] Dept Agr, Div Soil Sci, Soil Microbiol Grp, Bangkok, Thailand	Minamisawa, K (reprint author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan.	kiwamu@igetohoku.ac.jp; neung@sut.ac.tn			Suranaree University of Technology; United Nations Educational, Scientific and Cultural Organization (UNESCO); Ministry of Agriculture, Forestry, and Fisheries of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23248052, 26252065]	This work was financially supported by Suranaree University of Technology (Ph.D. research grant SUT-Ph.D.), the United Nations Educational, Scientific and Cultural Organization (UNESCO), a BRAIN grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan, and by Grants-in-Aid for Scientific Research (A) 23248052 and 26252065 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Abbasi MK, 2008, PLANT PROD SCI, V11, P368, DOI 10.1626/pps.11.368; Noisangiam R, 2012, APPL ENVIRON MICROB, V78, P6236, DOI 10.1128/AEM.00897-12; SADOWSKY MJ, 1987, APPL ENVIRON MICROB, V53, P2624; Stephens JHG, 2000, FIELD CROP RES, V65, P249, DOI 10.1016/S0378-4290(99)00090-8; COLE MA, 1973, ANTIMICROB AGENTS CH, V4, P248; Bonaldi K, 2010, MOL PLANT MICROBE IN, V23, P760, DOI 10.1094/MPMI-23-6-0760; Okubo T, 2012, MICROBES ENVIRON, V27, P306, DOI 10.1264/jsme2.ME11321; WEISBURG WG, 1991, J BACTERIOL, V173, P697; Chaintreuil C, 2013, NEW PHYTOL, V200, P1247, DOI 10.1111/nph.12424; Scott HN, 2003, PLASMID, V50, P74, DOI 10.1016/S0147-619X(03)00030-1; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Yanni YG, 2001, AUST J PLANT PHYSIOL, V28, P845, DOI 10.1071/PP01069; Sasaki K, 2013, MICROBES ENVIRON, V28, P391, DOI 10.1264/jsme2.ME12212; ALLARDETSERVENT A, 1993, J BACTERIOL, V175, P7869; Okubo T, 2012, PLANT CELL PHYSIOL, V53, P2000, DOI 10.1093/pcp/pcs150; Elbeltagy A, 2001, APPL ENVIRON MICROB, V67, P5285, DOI 10.1128/AEM.67.11.5285-5293.2001; Prakamhang J, 2009, APPL SOIL ECOL, V42, P141, DOI 10.1016/j.apsoil.2009.02.008; Manassila M, 2007, AFR J BIOTECHNOL, V6, P1393; Webster G, 1997, PLANT SOIL, V194, P115, DOI 10.1023/A:1004283819084; Chaintreuil C, 2000, APPL ENVIRON MICROB, V66, P5437, DOI 10.1128/AEM.66.12.5437-5447.2000; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Yanni YG, 1997, PLANT SOIL, V194, P99, DOI 10.1023/A:1004269902246; MAE T, 1981, PLANT CELL PHYSIOL, V22, P1067; WILSON KJ, 1995, MICROBIOL-UK, V141, P1691; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vinuesa P, 2005, MOL PHYLOGENET EVOL, V34, P29, DOI 10.1016/j.ympev.2004.08.020; Giraud E, 2000, P NATL ACAD SCI USA, V97, P14795, DOI 10.1073/pnas.250484097; Antoun H, 1998, PLANT SOIL, V204, P57, DOI 10.1023/A:1004326910584; Baldwin EA, 1996, POSTHARVEST BIOL TEC, V9, P151, DOI 10.1016/S0925-5214(96)00044-0; Cannon SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011630; CRIST DK, 1984, APPL ENVIRON MICROB, V47, P895; Gourion B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021900; Guong VT, 2012, BIOL FERT SOILS, V48, P217; Ikeda S, 2014, MICROBES ENVIRON, V29, P50, DOI 10.1264/jsme2.ME13110; Lima AS, 2009, PLANT SOIL, V319, P127, DOI 10.1007/s11104-008-9855-2; Lorquin J, 1997, APPL ENVIRON MICROB, V63, P1151; Masuda S, 2010, MICROBES ENVIRON, V25, P220, DOI 10.1264/jsme2.ME10124; Mornico Damien, 2011, Genes (Basel), V3, P35, DOI 10.3390/genes3010035; Nzoue A, 2009, SYST APPL MICROBIOL, V32, P400, DOI 10.1016/j.syapm.2009.06.002; Okubo T, 2013, APPL ENVIRON MICROB, V79, P2542, DOI 10.1128/AEM.00009-13; Piromyou P, 2011, EUR J SOIL BIOL, V47, P44, DOI 10.1016/j.ejsobi.2010.11.004; Prevost D, 2012, APPL SOIL ECOL, V59, P29, DOI 10.1016/j.apsoil.2012.03.018; Saito A, 1998, FEMS MICROBIOL ECOL, V25, P277, DOI 10.1111/j.1574-6941.1998.tb00480.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sambrook J., 1989, MOL CLONING LAB MANU; Somasegaran P., 1994, HDB RHIZOBIA METHODS; Steel R.G., 1980, PRINCIPLES PROCEDURE; TONG ZK, 1994, APPL ENVIRON MICROB, V60, P581; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25	50	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	MAY	2015	81	9					3049	3061		10.1128/AEM.04253-14		13	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CF6FM	WOS:000352652400010		
J	Horiike, T; Yamashita, M				Horiike, Takumi; Yamashita, Mitsuo			A New Fungal Isolate, Penidiella sp. Strain T9, Accumulates the Rare Earth Element Dysprosium	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; HEAVY-METALS; MICROORGANISMS; SORPTION; BIOREMEDIATION; BIOSORPTION; ADSORPTION; PHOSPHATE; BACTERIA; BEHAVIOR	With an aim to develop a highly efficient method for the recovery of rare earth elements (REEs) by using microorganisms, we attempted to isolate dysprosium (Dy)-accumulating microorganisms that grow under acidic conditions from environmental samples containing high concentrations of heavy metals. One acidophilic strain, T9, which was isolated from an abandoned mine, decreased the concentration of Dy in medium that contained 100 mg/liter Dy to 53 mg/liter Dy after 3 days of cultivation at pH 2.5. The Dy content in the cell pellet of the T9 strain was 910 mu g/mg of dry cells. The T9 strain also accumulated other REEs. Based on the results of 28S-D1/D2 rRNA gene sequencing and morphological characterization, we designated this fungal strain Penidiella sp. T9. Bioaccumulation of Dy was observed on the cell surface of the T9 strain by elemental mapping using scanning electron microscopy-energy dispersive X-ray spectroscopy. Our results indicate that Penidiella sp. T9 has the potential to recover REEs such as Dy from mine drainage and industrial liquid waste under acidic conditions.	[Horiike, Takumi; Yamashita, Mitsuo] Shibaura Inst Technol, Res Org Adv Engn, Rare Met Biores Ctr, Saitama, Saitama, Japan	Yamashita, M (reprint author), Shibaura Inst Technol, Res Org Adv Engn, Rare Met Biores Ctr, Saitama, Saitama, Japan.	yamashi@sic.shibaura-it.ac.jp			Ministry of Economy, Trade, and Industry (METI) of Japan	This study was supported by the Ministry of Economy, Trade, and Industry (METI) of Japan.	Protano G, 2002, ENVIRON POLLUT, V117, P499, DOI 10.1016/S0269-7491(01)00173-7; MARMUR J, 1961, J MOL BIOL, V3, P208; Crous PW, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.58.01; Takahashi Y, 2005, CHEM GEOL, V219, P53, DOI 10.1016/j.chemgeo.2005.02.009; Jiang MY, 2010, CHEM GEOL, V277, P61, DOI 10.1016/j.chemgeo.2010.07.010; MULLEN MD, 1989, APPL ENVIRON MICROB, V55, P3143; Gadd GM, 2010, MICROBIOL-SGM, V156, P609, DOI 10.1099/mic.0.037143-0; Tsuruta T, 2007, J RARE EARTH, V25, P526, DOI 10.1016/S1002-0721(07)60556-0; Elbaz-Poulichet F, 1999, APPL GEOCHEM, V14, P1063, DOI 10.1016/S0883-2927(99)00007-4; Malik A, 2004, ENVIRON INT, V30, P261, DOI 10.1016/j.envint.2003.08.001; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216; Texier AC, 1999, ENVIRON SCI TECHNOL, V33, P489, DOI 10.1021/es9807744; Adachi G, 1998, CHEM REV, V98, P1479, DOI 10.1021/cr940055h; Vijayaraghavan K, 2008, BIOTECHNOL ADV, V26, P266, DOI 10.1016/j.biotechadv.2008.02.002; Crous PW, 2009, PERSOONIA, V23, P119, DOI 10.3767/003158509X479531; Bensch K, 2012, STUD MYCOL, P1, DOI 10.3114/sim0003; Ahluwalia SS, 2007, BIORESOURCE TECHNOL, V98, P2243, DOI 10.1016/j.biortech.2005.12.006; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Jiang MY, 2012, GEOCHIM COSMOCHIM AC, V93, P30, DOI 10.1016/j.gca.2012.06.016; Kornerup A., 1978, METHUEN HDB COLOUR; Ozaki T, 2004, RADIOCHIM ACTA, V92, P741, DOI 10.1524/ract.92.9.741.55006; Ruibal C, 2009, STUD MYCOL, P123, DOI 10.3114/sim.2009.64.06; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SEIFERT K. A., 2011, GENERA HYPHOMYCETES; Takahashi Y, 2007, CHEM GEOL, V244, P569, DOI 10.1016/j.chemgeo.2007.07.005; Takahashi Y, 2010, GEOCHIM COSMOCHIM AC, V74, P5443, DOI 10.1016/j.gca.2010.07.001; Tsuruta T, 2006, COLLOID SURFACE B, V52, P117, DOI 10.1016/j.colsurfb.2006.04.014; Yamazaki A, 2010, MYCOSCIENCE, V51, P443, DOI 10.1007/s10267-010-0059-2	29	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	MAY	2015	81	9					3062	3068		10.1128/AEM.00300-15		7	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CF6FM	WOS:000352652400011		
J	Shimada, Y; Watanabe, Y; Wakinaka, T; Funeno, Y; Kubota, M; Chaiwangsri, T; Kurihara, S; Yamamoto, K; Katayama, T; Ashida, H				Shimada, Yoshimi; Watanabe, Yuka; Wakinaka, Takura; Funeno, Yoshihisa; Kubota, Masayuki; Chaiwangsri, Thida; Kurihara, Shin; Yamamoto, Kenji; Katayama, Takane; Ashida, Hisashi			alpha-N-Acetylglucosaminidase from Bifidobacterium bifidum specifically hydrolyzes alpha-linked N-acetylglucosamine at nonreducing terminus of O-glycan on gastric mucin	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						alpha-N-Acetylglucosaminidase; Bifidobacterium bifidum; CBM32; GH89; Mucin; Probiotics	HUMAN-MILK OLIGOSACCHARIDES; GLYCOSIDE HYDROLASE FAMILY; CARBOHYDRATE-BINDING MODULE; ENDO-BETA-GALACTOSIDASE; MOLECULAR-CLONING; BIOSE-I; LONGUM; DISACCHARIDE; DEGRADATION; ACETYLGALACTOSAMINIDASE	alpha-Linked N-acetylglucosamine is one of the major glyco-epitopes in O-glycan of gastroduodenal mucin. Here, we identified glycoside hydrolase (GH) family 89 alpha-N-acetylglucosaminidase, termed AgnB, from Bifidobacterium bifidum JCM 1254, which is essentially specific to GlcNAc alpha 1-4Gal structure. AgnB is a membrane-anchored extracellular enzyme consisting of a GH89 domain and four carbohydrate-binding module (CBM) 32 domains. Among four CBM32 domains, three tandem ones at C-terminus showed to bind porcine gastric mucin, suggesting that these domains enhance the enzyme activity by increasing affinity for multivalent substrates. AgnB might be important for assimilation of gastroduodenal mucin by B. bifidum and also applicable to production of prebiotic oligosaccharides from porcine gastric mucin.	[Shimada, Yoshimi; Funeno, Yoshihisa; Kubota, Masayuki; Ashida, Hisashi] Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama 6496493, Japan; [Watanabe, Yuka; Wakinaka, Takura] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Chaiwangsri, Thida] Univ Phayao, Sch Med Sci, Phayao 56000, Thailand; [Kurihara, Shin; Katayama, Takane] Ishikawa Prefectural Univ, Host Microbe Interact Res Lab, Nonoichi, Ishikawa 9218836, Japan; [Yamamoto, Kenji] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan	Ashida, H (reprint author), Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama 6496493, Japan.	ashida@waka.kindai.ac.jp			JSPS KAKENHI [24580179]; JSPS Core-to-Core Program	This work was supported by JSPS KAKENHI grant number 24580179 (to H.A.) and JSPS Core-to-Core Program (to T.C., K.Y., T.K., and H.A.). We thank Dr. Masaya Fujita (The Noguchi Institute, Tokyo, Japan) for providing pMP-disaccharides. Our thanks are due to the late Dr. Masashi Kiyohara for contribution in the initial stage of this study.	Picard C, 2005, ALIMENT PHARM THERAP, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Kawakubo M, 2004, SCIENCE, V305, P1003, DOI 10.1126/science.1099250; Weber B, 2001, PROTEIN EXPRES PURIF, V21, P251, DOI 10.1006/prep.2000.1361; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Asakuma S, 2011, J BIOL CHEM, V286, P34583, DOI 10.1074/jbc.M111.248138; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.4885-4893.2004; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Kiyohara M, 2011, GLYCOBIOLOGY, V21, P437, DOI 10.1093/glycob/cwq175; Ficko-Blean E, 2008, P NATL ACAD SCI USA, V105, P6560, DOI 10.1073/pnas.0711491105; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Yoshida E, 2012, GLYCOBIOLOGY, V22, P361, DOI 10.1093/glycob/cwr116; Wakinaka T, 2013, GLYCOBIOLOGY, V23, P232, DOI 10.1093/glycob/cws142; Sakurama H, 2013, J BIOL CHEM, V288, P25194, DOI 10.1074/jbc.M113.484733; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Ashida H, 2001, J BIOL CHEM, V276, P28226, DOI 10.1074/jbc.M103589200; Ashida H, 2002, BIOCHEMISTRY-US, V41, P2388, DOI 10.1021/bi011940e; Ficko-Blean E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033524; Ficko-Blean E, 2012, GLYCOBIOLOGY, V22, P590, DOI 10.1093/glycob/cwr165; Fujita M, 2011, J BIOL CHEM, V286, P6479, DOI 10.1074/jbc.M110.206722; Grondin JM, 2014, J MOL BIOL, V426, P869, DOI 10.1016/j.jmb.2013.11.029; Kiyohara M, 2009, BIOSCI BIOTECH BIOCH, V73, P1175, DOI 10.1271/bbb.80697; Kiyohara M, 2012, J BIOL CHEM, V287, P693, DOI 10.1074/jbc.M111.277384; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; Sakurama H, 2012, J BIOL CHEM, V287, P16709, DOI 10.1074/jbc.M111.333781; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	MAY	2015	99	9					3941	3948		10.1007/s00253-014-6201-x		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CF8NM	WOS:000352818800016		
J	Romanenko, LA; Tanaka, N; Svetashev, VI; Kalinovskaya, NI; Mikhailov, VV				Romanenko, L. A.; Tanaka, N.; Svetashev, V. I.; Kalinovskaya, N. I.; Mikhailov, V. V.			Rheinheimera japonica sp nov., a novel bacterium with antimicrobial activity from seashore sediments of the Sea of Japan	ARCHIVES OF MICROBIOLOGY			English	Article						Rheinheimera japonica sp nov.; Marine sediments	WATER CULTURE POND; CENTRAL BALTIC SEA; ET-AL. 2002; EMENDED DESCRIPTION; GEN. NOV.; GAMMAPROTEOBACTERIUM; KOREA; ACID; LAKE	Two gram-negative, aerobic, brown-pigmented, motile rod-shaped bacteria KMM 9512 and KMM 9513(T) were isolated from a sediment sample collected from the Sea of Japan seashore, Russia. On the basis of the 16S rRNA gene sequence analysis, novel strains KMM 9512 and KMM 9513(T) positioned within the genus Rheinheimera (class Gammaproteobacteria) as a separate subline adjacent to Rheinheimera baltica DSM 14885(T) sharing highest gene sequence similarities of 98.6-97.6 % to their closest phylogenetic relatives, Rheinheimera muenzenbergensis LMG 27269(T), R. baltica DSM 14885(T), Rheinheimera aquimaris JCM 14331(T), Rheinheimera nanhaiensis KACC 14030(T), and Rheinheimera pacifica KMM 1406(T). Strains KMM 9512 and KMM 9513(T) belong to the same separate genospecies on the basis of the 16S rRNA gene sequence similarity (99.8 %) and their DNA relatedness to each other (89 %) and to closely related Rheinheimera species (25-53 %). The major isoprenoid quinone was Q-8, polar lipids consisted of phosphatidylserine, phosphatidylglycerol, phosphatidylethanolamine, unknown aminolipids, unknown aminophospholipids, unknown phospholipids, and unknown lipids, and major fatty acid were C-16:0, C-16:1 omega 7c, C-17:1 omega 8c, C-12:0 3-OH followed by C-17:0 and C-18:1 omega 7c in both strains. Strains KMM 9512 and KMM 9513(T) revealed a remarkable antagonistic activity toward a number of gram-positive and gram-negative microorganisms. On the basis of phylogenetic analysis, DNA-DNA hybridization results, and phenotypic differences, strains KMM 9512 and KMM 9513(T) are proposed to be classified as a novel species of the genus Rheinheimera, Rheinheimera japonica sp. nov. The type strain of this species is KMM 9513(T) = NRIC 0918(T).	[Romanenko, L. A.; Kalinovskaya, N. I.; Mikhailov, V. V.] Russian Acad Sci, Far Eastern Branch, GB Elyakov Pacific Inst Bioorgan Chem, Vladivostok 690022, Russia; [Tanaka, N.] Tokyo Univ Agr, NODAI Culture Collect Ctr, Setagaya Ku, Tokyo 1568502, Japan; [Svetashev, V. I.] Russian Acad Sci, Inst Marine Biol, Far Eastern Branch, Vladivostok 690041, Russia; [Mikhailov, V. V.] Far Eastern Fed Univ, Vladivostok 690091, Russia	Romanenko, LA (reprint author), Russian Acad Sci, Far Eastern Branch, GB Elyakov Pacific Inst Bioorgan Chem, Prospect 100 Let Vladivostoku,159, Vladivostok 690022, Russia.	lro@piboc.dvo.ru			RSF "Biodiversity and biotechnological potential of marine bacteria and fungi" [14-14-00030]	We would like to thank Dr. Moriya Ohkuma, Japan Collection of Microorganisms, JCM, Japan, Dr. Claudine Vereecke, BCCM (TM)/LMG Bacteria Collection, Ghent University, Gent, Belgium, Dr. Soon-Wo Kwon, Korean Agricultural Culture Collection, KACC, Microbial genetics Division, National Institute of Agricultural Biotechnology, RDA, Republic of Korea, for providing Rheinheimera type strains for comparative analyses, to thank Dr. Claudine Vereecke, BCCM (TM)/LMG Bacteria Collection, Ghent University, Gent, Belgium, and Dr. Chantal Bizet, the Collection de l'Institut Pasteur, Institut Pasteur, CIP, Paris, France, for providing indicator strains. This study was supported by a grant from the RSF "Biodiversity and biotechnological potential of marine bacteria and fungi" no. 14-14-00030.	Zhong ZP, 2014, INT J SYST EVOL MICR, V64, P1142, DOI 10.1099/ijs.0.056473-0; Zhang XX, 2008, INT J SYST EVOL MICR, V58, P2420, DOI 10.1099/ijs.0.65605-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Bruns A, 2001, INT J SYST EVOL MICR, V51, P1997; Ryu SH, 2008, INT J SYST EVOL MICR, V58, P2271, DOI 10.1099/ijs.0.65489-0; Chen WM, 2010, ENZYME MICROB TECH, V46, P487, DOI 10.1016/j.enzmictec.2010.01.006; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224; Chen WM, 2013, INT J SYST EVOL MICR, V63, P1457, DOI 10.1099/ijs.0.043836-0; Romanenko LA, 2004, INT J SYST EVOL MICR, V54, P669, DOI 10.1099/ijs.0.02846-0; Romanenko LA, 2007, INT J SYST EVOL MICR, V57, P358, DOI 10.1099/ijs.0.64441-0; Shida O, 1997, INT J SYST BACTERIOL, V47, P289; Romanenko LA, 2003, INT J SYST EVOL MICR, V53, P1973, DOI 10.1099/ijs.0.02252-0; Yoon JH, 2007, INT J SYST EVOL MICR, V57, P1386, DOI 10.1099/ijs.0.64898-0; Halpern M, 2007, INT J SYST EVOL MICR, V57, P1872, DOI 10.1099/ijs.0.64927-0; Chen WM, 2010, J MICROBIOL BIOTECHN, V20, P1386, DOI 10.4014/jmb.1004.04048; Park S, 2014, INT J SYST EVOL MICR, V64, P3749, DOI 10.1099/ijs.0.067504-0; Romanenko LA, 2008, MICROBIOL RES, V163, P633, DOI 10.1016/j.micres.2006.10.001; Brettar I, 2002, INT J SYST EVOL MICR, V52, P1851, DOI 10.1099/ijs.0.02151-0; Brettar I, 2006, INT J SYST EVOL MICR, V56, P2177, DOI 10.1099/ijs.0.64172-0; Liu Y, 2012, INT J SYST EVOL MICR, V62, P2927, DOI 10.1099/ijs.0.036020-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; COLLINS MD, 1984, ARCH MICROBIOL, V137, P247, DOI 10.1007/BF00414552; Li HJ, 2011, INT J SYST EVOL MICR, V61, P1016, DOI 10.1099/ijs.0.019281-0; Suarez C, 2014, INT J SYST EVOL MICR, V64, P1202, DOI 10.1099/ijs.0.061200-0; Merchant MM, 2007, INT J SYST EVOL MICR, V57, P2376, DOI 10.1099/ijs.0.65045-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; MITCHELL K, 1990, J GEN MICROBIOL, V136, P2035; Romanenko LA, 2013, INT J SYST EVOL MICR, V63, P1261, DOI 10.1099/ijs.0.043273-0; Romanenko LA, 2013, INT J SYST EVOL MICR, V63, P3079, DOI 10.1099/ijs.0.046607-0; Sasser M., 1990, 101 MIDI; Smibert Robert M., 1994, P607; STACKEBRANDT E, 2006, MICROBIOL TODAY, V33, P153; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P1, DOI DOI 10.1002/0471250953.BI0203S00; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-8933	1432-072X		ARCH MICROBIOL	Arch. Microbiol.	MAY	2015	197	4					613	620		10.1007/s00203-015-1095-2		8	Microbiology	Microbiology	CF9OZ	WOS:000352896000012		
J	Tada, H; Torisu, T; Tanaka, M; Murata, H; De Laat, A; Svensson, P				Tada, Hiroaki; Torisu, Tetsurou; Tanaka, Mihoko; Murata, Hiroshi; De Laat, Antoon; Svensson, Peter			Experimental low-level jaw clenching inhibits temporal summation evoked by electrical stimulation in healthy human volunteers	ARCHIVES OF ORAL BIOLOGY			English	Article						Temporal summation; Pain sensitivity; Temporomandibular disorders; Masticatory muscles; Concentric electrode; Stimulation depth	TEMPOROMANDIBULAR DISORDERS; MASSETER MUSCLE; REFERRED PAIN; TOOTH CONTACT; TMD PAIN; PLASTICITY; FATIGUE; REFLEX; FORCE	Objective: To examine the effect of low-level jaw clenching on temporal summation in healthy volunteers. Design: In 18 healthy volunteers, the pain intensities evoked at the masseter muscle and the hand palm by the first and last stimuli in a train of repeated electrical stimuli (0.3 or 2.0 Hz) were rated using 0-100 mm visual analogue scales (VAS), in order to evaluate temporal summation before and after three types of jaw-muscle tasks: low-level jaw clenching, repetitive gum chewing and mandibular rest position. A set of concentric surface electrodes with different diameters (small and large) was used for the electrical stimulation. Results: The temporal summation evoked by the large diameter electrode with 2.0 Hz stimulation decreased significantly both on the masseter and the hand after low-level clenching (P <= 0.03), but did not show any significant change after the other tasks (P > 0.23). The VAS score of the first stimulation did not show any significant changes after low-level clenching (P > 0.57). Conclusions: Experimental low-level jaw clenching can inhibit pain sensitivity, especially temporal summation. Low-level jaw clenching can modify pain sensitivity, most likely through the central nervous system. The findings suggest that potential harmful low-level jaw clenching or tooth contacting could continue despite painful symptoms, e.g., temporomandibular disorders. (C) 2015 Elsevier Ltd. All rights reserved.	[Tada, Hiroaki; Torisu, Tetsurou; Tanaka, Mihoko; Murata, Hiroshi] Nagasaki Univ, Dept Prosthet Dent, Grad Sch Biomed Sci, Nagasaki 8528588, Japan; [De Laat, Antoon] Katholieke Univ Leuven, Dept Oral Hlth Sci, Leuven, Belgium; [De Laat, Antoon] Univ Hosp Leuven, Dent, B-3000 Leuven, Belgium; [Svensson, Peter] Aarhus Univ, Sch Dent, Sect Clin Oral Physiol, Aarhus, Denmark; [Svensson, Peter] Scandinavian Ctr Orofacial Neurosci SCON, DK-8000 Aarhus C, Denmark; [Svensson, Peter] Karolinska Inst, Dept Dent Med, Huddinge, Sweden	Torisu, T (reprint author), Nagasaki Univ, Dept Prosthet Dent, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	dm09119f@cc.nagasaki-u.ac.jp; torisu@nagasaki-u.ac.jp; mihobonn@nagasaki-u.ac.jp; hmurata@nagasaki-u.ac.jp; antoon.delaat@uzleuven.be; peter.svensson@odont.au.dk			JSPS [25463006]	This study was supported by JSPS Grant-in-Aid for Scientific Research (C), Grant Number 25463006.	Ren K, 1999, J OROFAC PAIN, V13, P155; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709; Torisu T, 2007, CLIN NEUROPHYSIOL, V118, P999, DOI 10.1016/j.clinph.2006.11.311; Sato Fumiaki, 2006, Journal of Medical and Dental Sciences, V53, P103; Glaros AG, 1998, J OROFAC PAIN, V12, P145; Iida T, 2014, EUR J ORAL SCI, V122, P42, DOI 10.1111/eos.12101; Jensen R, 1996, CEPHALALGIA, V16, P175, DOI 10.1046/j.1468-2982.1996.1603175.x; Muller F, 2012, CLIN ORAL IMPLAN RES, V23, P144, DOI 10.1111/j.1600-0501.2011.02213.x; Graven-Nielsen T, 2000, PAIN, V85, P483, DOI 10.1016/S0304-3959(99)00308-5; Kino K, 2005, J ORAL REHABIL, V32, P315, DOI 10.1111/j.1365-2842.2004.01439.x; Svensson P, 2001, ARCH ORAL BIOL, V46, P773, DOI 10.1016/S0003-9969(01)00028-0; ArendtNielsen L, 1997, MUSCLE NERVE, V20, P1311, DOI 10.1002/(SICI)1097-4598(199710)20:10<1311::AID-MUS15>3.0.CO;2-5; Kaube H, 2000, CLIN NEUROPHYSIOL, V111, P413, DOI 10.1016/S1388-2457(99)00295-3; [Anonymous], 2004, CLIN EXP PHARM PHYSL, V31, P485; Roark AL, 2003, J ORAL REHABIL, V30, P573, DOI 10.1046/j.1365-2842.2003.01139.x; Mohri Y, 2005, PAIN, V118, P35, DOI 10.1016/j.pain.2005.07.009; Crisan Diana, 2012, Indian J Dermatol Venereol Leprol, V78, P519, DOI 10.4103/0378-6323.98096; Farella M, 2001, EUR J ORAL SCI, V109, P81, DOI 10.1034/j.1600-0722.2001.00991.x; Farella M, 2010, J DENT RES, V89, P717, DOI 10.1177/0022034510365448; Fenger-Gron LS, 1998, J MUSCULOSKELET PAIN, V6, P33, DOI 10.1300/J094v06n04_04; Glaros AG, 2012, J OROFAC PAIN, V26, P176; Jensen R, 1996, CEPHALALGIA, V16; LAM EWN, 1992, ARCH ORAL BIOL, V37, P49, DOI 10.1016/0003-9969(92)90152-X; LUND JP, 1991, CAN J PHYSIOL PHARM, V69, P683; Nishiyama Akira, 2012, Open Dent J, V6, P240, DOI 10.2174/1874210601206010240; Oono Y, 2014, EXP BRAIN RES, V232, P3111, DOI 10.1007/s00221-014-3997-7; Pfau DB, 2011, PAIN, V152, P1532, DOI 10.1016/j.pain.2011.02.037; PRICE DD, 1994, PAIN, V59, P165, DOI 10.1016/0304-3959(94)90069-8; Raphael KG, 2013, J ORAL REHABIL, V40, P883, DOI 10.1111/joor.12112; Ren K, 1999, J OROFAC PAIN, V13, P164; Torisu T, 2010, EUR J PAIN, V14, P719, DOI 10.1016/j.ejpain.2009.12.001; WALL PD, 1984, J PHYSIOL-LONDON, V356, P443; Woda A., 2001, OROFACIAL PAIN BASIC, P67	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	MAY	2015	60	5					681	689		10.1016/j.archoralbio.2015.02.013		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CF6KA	WOS:000352664400002		
J	Takano, T; Nakano, K; Doki, T; Hohdatsu, T				Takano, Tomomi; Nakano, Kenta; Doki, Tomoyoshi; Hohdatsu, Tsutomu			Differential effects of viroporin inhibitors against feline infectious peritonitis virus serotypes I and II	ARCHIVES OF VIROLOGY			English	Article							CORONAVIRUS ENVELOPE PROTEIN; ESCHERICHIA-COLI-CELLS; MEMBRANE-PERMEABILITY; ION CHANNELS; ASSOCIATION; AMILORIDE; FORMS; CATS	Feline infectious peritonitis virus (FIP virus: FIPV), a feline coronavirus of the family Coronaviridae, causes a fatal disease called FIP in wild and domestic cat species. The genome of coronaviruses encodes a hydrophobic transmembrane protein, the envelope (E) protein. The E protein possesses ion channel activity. Viral proteins with ion channel activity are collectively termed "viroporins". Hexamethylene amiloride (HMA), a viroporin inhibitor, can inhibit the ion channel activity of the E protein and replication of several coronaviruses. However, it is not clear whether HMA and other viroporin inhibitors affect replication of FIPV. We examined the effect of HMA and other viroporin inhibitors (DIDS [4,4'-disothiocyano-2,2'-stilbenedisulphonic acid] and amantadine) on infection by FIPV serotypes I and II. HMA treatment drastically decreased the titers of FIPV serotype I strains Black and KU-2 in a dose-dependent manner, but it only slightly decreased the titer of FIPV serotype II strain 79-1146. In contrast, DIDS treatment decreased the titer of FIPV serotype II strain 79-1146 in dose-dependent manner, but it only slightly decreased the titers of FIPV serotype I strains Black and KU-2. We investigated whether there is a difference in ion channel activity of the E protein between viral serotypes using E. coli cells expressing the E protein of FIPV serotypes I and II. No difference was observed, suggesting that a viroporin other than the E protein influences the differences in the actions of HMA and DIDS on FIPV serotypes I and II.	[Takano, Tomomi; Nakano, Kenta; Doki, Tomoyoshi; Hohdatsu, Tsutomu] Kitasato Univ, Sch Vet Med, Lab Vet Infect Dis, Towada, Aomori 0348628, Japan	Hohdatsu, T (reprint author), Kitasato Univ, Sch Vet Med, Lab Vet Infect Dis, Towada, Aomori 0348628, Japan.	hohdatsu@vmas.kitasato-u.ac.jp			KAKENHI from Ministry of Education, Culture, Sports, Science and Technology [25292183]	This work was in part supported by KAKENHI (Grants-in-Aid for Scientific Research (B), No. 25292183) from the Ministry of Education, Culture, Sports, Science and Technology.	Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Liao Y, 2006, VIROLOGY, V349, P264, DOI 10.1016/j.virol.2006.01.028; Liao Y, 2004, BIOCHEM BIOPH RES CO, V325, P374, DOI 10.1016/j.bbrc.2004.10.050; Melton JV, 2002, J BIOL CHEM, V277, P46923, DOI 10.1074/jbc.M207847200; Bodelon G, 2002, J BIOL CHEM, V277, P17789, DOI 10.1074/jbc.M202018200; Wilson L, 2006, VIROLOGY, V353, P294, DOI 10.1016/j.virol.2006.05.028; Zhang RH, 2014, BBA-BIOMEMBRANES, V1838, P1088, DOI 10.1016/j.bbamem.2013.07.025; OLSEN CW, 1993, VET MICROBIOL, V36, P1, DOI 10.1016/0378-1135(93)90126-R; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Takano T, 2007, VET MICROBIOL, V119, P121, DOI 10.1016/j.vetmic.2006.08.033; Agirre A, 2002, J BIOL CHEM, V277, P40434, DOI 10.1074/jbc.M205393200; Pedersen NC, 2009, J FELINE MED SURG, V11, P225, DOI 10.1016/j.jfms.2008.09.008; Lu W, 2006, P NATL ACAD SCI USA, V103, P12540, DOI 10.1073/pnas.0605402103; GUINEA R, 1994, FEBS LETT, V343, P242, DOI 10.1016/0014-5793(94)80564-4; Motokawa K, 1996, MICROBIOL IMMUNOL, V40, P425; Madan V, 2005, FEBS LETT, V579, P3607, DOI 10.1016/j.febslet.2005.05.046; Balint A, 2012, J VIROL, V86, P6258, DOI 10.1128/JVI.00189-12; HOHDATSU T, 1992, J VET MED SCI, V54, P557; HOHDATSU T, 1991, VET MICROBIOL, V28, P13, DOI 10.1016/0378-1135(91)90096-X; Hyser JM, 2010, MBIO, V1, DOI 10.1128/mBio.00265-10; Ito M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002857; Kummrow M, 2005, CLIN DIAGN LAB IMMUN, V12, P1209, DOI 10.1128/CDLI.12.10.1209-1215.2005; LANE JW, 1992, BRIT J PHARMACOL, V106, P283; Lin CN, 2009, VET MICROBIOL, V136, P233, DOI 10.1016/j.vetmic.2008.11.010; Nelson MT, 1997, J PHYSIOL-LONDON, V502, P259, DOI 10.1111/j.1469-7793.1997.259bk.x; Shiba N, 2007, VET MICROBIOL, V124, P348, DOI 10.1016/j.vetmic.2007.04.031	26	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	MAY	2015	160	5					1163	1170		10.1007/s00705-015-2370-x		8	Virology	Virology	CF8FB	WOS:000352790400003		
J	Nemoto, M; Nagai, M; Tsunemitsu, H; Omatsu, T; Furuya, T; Shirai, J; Kondo, T; Fujii, Y; Todaka, R; Katayama, K; Mizutani, T				Nemoto, Manabu; Nagai, Makoto; Tsunemitsu, Hiroshi; Omatsu, Tsutomu; Furuya, Tetsuya; Shirai, Junsuke; Kondo, Takashi; Fujii, Yoshiki; Todaka, Reiko; Katayama, Kazuhiko; Mizutani, Tetsuya			Whole-genome sequence analysis of G3 and G14 equine group A rotaviruses isolated in the late 1990s and 2009-2010	ARCHIVES OF VIROLOGY			English	Article							HOST-RANGE RESTRICTION; MOLECULAR CHARACTERIZATION; PORCINE ROTAVIRUS; BOVINE; STRAINS; PATHOGENICITY; JAPAN; FOALS; IDENTIFICATION; DIARRHEA	Equine group A rotavirus (RVA) G3P[12] and G14P[12] strains cause gastroenteritis in foals worldwide. Both of these strains have been co-circulating in Japan since G14P[12] strains emerged in the late 1990s. Although it is important to comprehensively understand the evolution of RVA strains, whole-genome sequence data on recent equine RVA strains in Japan are lacking. Therefore, in this study, whole-genome analysis of 23 equine RVA isolates from the late 1990s and 2009-2010 and the vaccine strain RVA/Horse-tc/JPN/HO-5/1982/G3P[12] (HO-5) was performed. The G3 strains, including strain HO-5, shared a G3-P[12]-I6-R2-C2-M3-A10-N2-T3-E2-H7 genotype constellation, and all of their 11 gene segments were highly conserved, regardless of the year of isolation. G14 strains also exhibited an identical genotype constellation (G14-P[12]-I2-R2-C2-M3-A10-N2-T3-E2-H7), but, phylogenetically, segregated into two lineages within the VP7-G14 and NSP4-E2 genotypes. G14 strains were closely related to G3 strains in their VP4, VP1-3, NSP1-3 and NSP5 gene segments. Interestingly, the NSP4 gene of all G3 and G14 strains isolated in the late 1990s branched into a bovine-RVA-like NSP4 gene cluster. These results indicate that, apart from VP7, VP6, and NSP4 genes, the Japanese equine RVA strains share a highly conserved genetic backbone, and that strains possessing a bovine-RVA-like NSP4 gene were predominant in the late 1990s in Japan.	[Nemoto, Manabu; Kondo, Takashi] Japan Racing Assoc, Equine Res Inst, Epizoot Res Ctr, Shimotsuku, Tochigi 3290412, Japan; [Nagai, Makoto; Omatsu, Tsutomu; Furuya, Tetsuya; Shirai, Junsuke; Mizutani, Tetsuya] Tokyo Univ Agr & Technol, Res & Educ Ctr Prevent Global Infect Dis Anim, Fuchu, Tokyo 1838509, Japan; [Tsunemitsu, Hiroshi] Natl Inst Anim Hlth, Dairy Hyg Res Div, Hokkaido Res Stn, Sapporo, Hokkaido 0620045, Japan; [Fujii, Yoshiki; Todaka, Reiko; Katayama, Kazuhiko] Natl Inst Infect Dis, Dept Virol 2, Tokyo 2080011, Japan	Nagai, M (reprint author), Tokyo Univ Agr & Technol, Res & Educ Ctr Prevent Global Infect Dis Anim, Fuchu, Tokyo 1838509, Japan.	m-nagai@cc.tuat.ac.jp; tmizutan@cc.tuat.ac.jp	Shirai, Junsuke/C-8812-2013; Nagai, Makoto/C-2363-2013		Ministry of Health, Labour and Welfare, Japan [H24-shinkou-ippan-005]	This work was supported by the Grants-in-Aid for Research on Emerging and Re-emerging Infectious Diseases by the Ministry of Health, Labour and Welfare, Japan (grant H24-shinkou-ippan-005).	Collins PJ, 2008, J CLIN MICROBIOL, V46, P3346, DOI 10.1128/JCM.00995-08; Ghosh S, 2012, VET MICROBIOL, V158, P410, DOI 10.1016/j.vetmic.2012.02.037; Tsunemitsu H, 2001, ARCH VIROL, V146, P1949, DOI 10.1007/s007050170044; Nemoto M, 2011, VET MICROBIOL, V152, P67, DOI 10.1016/j.vetmic.2011.04.016; Minami-Fukuda F, 2013, J VET MED SCI, V75, P1651, DOI 10.1292/jvms.13-0265; Ntafis V, 2010, VET MICROBIOL, V144, P461, DOI 10.1016/j.vetmic.2010.01.020; Mino S, 2013, VET MICROBIOL, V161, P239, DOI 10.1016/j.vetmic.2012.07.033; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; HOSHINO Y, 1995, VIROLOGY, V209, P274, DOI 10.1006/viro.1995.1255; Monini M, 2011, VET MICROBIOL, V149, P248, DOI 10.1016/j.vetmic.2010.11.007; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Masuda T, 2014, VET MICROBIOL, V171, P66, DOI 10.1016/j.vetmic.2014.03.009; Ghosh S, 2011, FUTURE MICROBIOL, V6, P1049, DOI [10.2217/fmb.11.90, 10.2217/FMB.11.90]; Kojima K, 1996, ARCH VIROL, V141, P1, DOI 10.1007/BF01718584; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Garaicoechea L, 2011, VET MICROBIOL, V148, P150, DOI 10.1016/j.vetmic.2010.08.032; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Matthijnssens J, 2012, J GEN VIROL, V93, P866, DOI 10.1099/vir.0.039255-0; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Burke B, 1996, VIROLOGY, V218, P299, DOI 10.1006/viro.1996.0198; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Frederick J, 2009, J VET INTERN MED, V23, P1254, DOI 10.1111/j.1939-1676.2009.0383.x; Batty EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066129; BROWNING GF, 1991, EQUINE VET J, V23, P405; El-Attar L, 2001, VIROLOGY, V291, P172, DOI 10.1006/viro.2001.1222; Elschner M, 2005, VET MICROBIOL, V105, P123, DOI 10.1016/j.vetmic.2004.10.010; Estes M. K., 2013, FIELDS VIROLOGY, P1347; Estes MK, 2013, FIELDS VIROLOGY, V2, P1347; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Ghosh S, 2013, VET MICROBIOL, V166, P475; Imagawa Hiroshi, 2005, Journal of Equine Science, V16, P35, DOI 10.1294/jes.16.35; IMAGAWA H, 1994, J CLIN MICROBIOL, V32, P2009; Imagawa H, 1981, B EQUINE RES I, V18, P119; IMAGAWA H, 1993, ARCH VIROL, V131, P169, DOI 10.1007/BF01379088; KATAYAMA K, 1995, VIRUS GENES, V10, P185, DOI 10.1007/BF01702600; Kim HJ, 2012, VET MICROBIOL, V159, P11, DOI 10.1016/j.vetmic.2012.03.017; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Mori Y, 2003, VIROLOGY, V316, P126, DOI 10.1016/j.virol.2003.08.006; Nakagomi T, 2003, ARCH VIROL, V148, P925, DOI 10.1007/s00705-002-0967-3; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Nemoto M, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-63; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Slovis NM, 2014, EQUINE VET J, V46, P311, DOI 10.1111/evj.12119	44	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	MAY	2015	160	5					1171	1179		10.1007/s00705-015-2374-6		9	Virology	Virology	CF8FB	WOS:000352790400004		
J	Takeshima, S; Kitamura-Muramatsu, Y; Yuan, Y; Polat, M; Saito, S; Aida, Y				Takeshima, Shin-nosuke; Kitamura-Muramatsu, Yuri; Yuan, Yuan; Polat, Meripet; Saito, Susumu; Aida, Yoko			BLV-CoCoMo-qPCR-2: improvements to the BLV-CoCoMo-qPCR assay for bovine leukemia virus by reducing primer degeneracy and constructing an optimal standard curve	ARCHIVES OF VIROLOGY			English	Article						Bovine leukemia virus; Quantitative PCR; BLV-CoCoMo-qPCR; Cattle; CoCoMo algorithm; Viral load	T-CELL LEUKEMIA; INFECTIOUS MOLECULAR CLONE; PROVIRAL LOAD; CATTLE; DESIGN; TOOL; DNA	Bovine leukemia virus (BLV) is the etiological agent of enzootic bovine leukosis, which is the most common neoplastic disease of cattle. Because BLV infection can remain clinically silent, the proviral load is an important index for estimating disease progression. CoCoMo-qPCR, an assay developed to estimate BLV proviral load, allows the highly sensitive detection of BLV originating in different countries. Here, we developed a modified version of the CoCoMo-qPCR assay, the "BLV-CoCoMo-qPCR-2" assay, which uses optimized degenerate primers. We also constructed a new plasmid standard. Finally, we used both assays to examine DNA samples from BLV-infected cattle and compared the results.	[Takeshima, Shin-nosuke; Polat, Meripet; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama 3510198, Japan; [Takeshima, Shin-nosuke; Polat, Meripet; Aida, Yoko] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Viral Infect Dis, Wako, Saitama 3510198, Japan; [Kitamura-Muramatsu, Yuri; Yuan, Yuan; Saito, Susumu] RIKEN GENESIS CO LTD, Riken Yokohama Inst, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Aida, Y (reprint author), RIKEN, Viral Infect Dis Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	aida@riken.jp			A-STEP (Adaptable and Seamless Technology Transfer Program through Target-Driven RD); Japan Society for the Promotion of Science (JSPS); Program for the Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industry of Japan	This work was supported by A-STEP (Adaptable and Seamless Technology Transfer Program through Target-Driven R&D), Grants-in-Aid for Scientific Research (A, B, and C) from the Japan Society for the Promotion of Science (JSPS), and a grant from the Program for the Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industry of Japan.	Aida Y, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00328; Hugerth LW, 2014, APPL ENVIRON MICROB, V80, P5116, DOI 10.1128/AEM.01403-14; Tang LX, 2014, BIOTECHNIQUES, V56, P301, DOI 10.2144/000114177; Ott SL, 2003, PREV VET MED, V61, P249, DOI 10.1016/j.prevetmed.2003.08.003; Tajima S, 1998, J VIROL, V72, P7569; Buehring GC, 2014, EMERG INFECT DIS, V20, P772, DOI 10.3201/eid2005.131298; ADACHI A, 1986, J VIROL, V59, P284; Miyasaka T, 2013, TISSUE ANTIGENS, V81, P72, DOI 10.1111/tan.12041; Inabe K, 1998, VIROLOGY, V245, P53, DOI 10.1006/viro.1998.9140; Jimba M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-91; Jimba M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-167; KOBAYASHI N, 1984, EMBO J, V3, P1339; Konishi H, 1984, Mol Biol Med, V2, P273; KORBER B, 1991, J VIROL, V65, P5471; Lee J, 2005, J KOREAN MED SCI, V20, P603; OHSHIMA K, 1991, CANCER RES, V51, P4639; Panei CJ, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-95; Tajima S, 2003, J VIROL, V77, P4423, DOI 10.1128/JVI.77.7.4423-4430.2003; ZHAO TM, 1995, J VIROL, V69, P2024	19	3	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	MAY	2015	160	5					1325	1332		10.1007/s00705-015-2377-3		8	Virology	Virology	CF8FB	WOS:000352790400022		
J	Majima, S; Tanaka, M; Okada, H; Senmaru, T; Asano, M; Yamazaki, M; Toda, H; Oda, Y; Hasegawa, G; Nakamura, N; Fukui, M				Majima, Saori; Tanaka, Muhei; Okada, Hiroshi; Senmaru, Takafumi; Asano, Mai; Yamazaki, Masahiro; Toda, Hitoshi; Oda, Yohei; Hasegawa, Goji; Nakamura, Naoto; Fukui, Michiaki			The PR interval and QRS duration could be predictors of renal function decline	ATHEROSCLEROSIS			English	Article						PR interval; QRS duration; Renal function decline; Healthy subjects	CHRONIC KIDNEY-DISEASE; ENDOTHELIAL DYSFUNCTION; ATRIOVENTRICULAR-BLOCK; CARDIOVASCULAR-DISEASE; HYPERTENSIVE PATIENTS; HEART-FAILURE; RISK-FACTOR; MORTALITY; OUTCOMES; HEALTH	Objective: Previous studies have implicated PR interval (iPR) and QRS duration (dQRS) obtained by electrocardiography in independent predictors of cardiovascular disease, which often precedes renal dysfunction. The aim of this study was to examine whether iPR or dQRS could be a predictor of renal function decline in a community-based cohort. Methods: We enrolled 1149 healthy subjects, and retrospectively evaluated the relationships between iPR or dQRS and renal function decline, observation period of which was 3 years, and assessed whether iPR or dQRS could predict renal function decline. Results: The iPR (r = -0.102, p = 0.0006) or dQRS (r = -0.097, p = 0.0010) was negatively associated with a rate of decline in estimated glomerular filtration rate (eGFR). Multiple regression analyses revealed that iPR (beta = -0.095, p = 0.0023) or dQRS (beta = -0.069, p = 0.0351) was an independent determinant of the rate of decline in eGFR after adjustment for covariates. Logistic regression analyses demonstrated that the longest iPR (odds ratios (OR), 2.03; 95% confidence intervals (CI), 1.49 to 2.76; p < 0.0001) or dQRS (OR, 1.62; 95% CI, 1.16 to 2.25; p = 0.0043) tertile showed an increased OR for prevalence of the rate of decline in eGFR <= 1 ml/min/1.73 m(2)/year compared to the shortest iPR or dQRS tertile after adjustment for covariates. Conclusion: The iPR and dQRS could be independent predictors of renal function decline in healthy subjects. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Majima, Saori; Tanaka, Muhei; Senmaru, Takafumi; Asano, Mai; Yamazaki, Masahiro; Oda, Yohei; Nakamura, Naoto; Fukui, Michiaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan; [Okada, Hiroshi; Toda, Hitoshi] Oike Clin, Dept Internal Med, Kyoto, Japan; [Hasegawa, Goji] Japanese Red Cross Kyoto Daini Hosp, Div Metab Nephrol & Rheumatol, Kyoto, Japan	Fukui, M (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kamigyo Ku, 465 Kajii Cho Kawaramachi Hirokoji, Kyoto 6028566, Japan.	sayarinapm@hotmail.com					Iwanaga Y, 2010, CIRC J, V74, P1274, DOI 10.1253/circj.CJ-10-0444; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Kiyosue A, 2010, CIRC J, V74, P786, DOI 10.1253/circj.CJ-09-0715; Badheka AO, 2013, AM J CARDIOL, V112, P671, DOI 10.1016/j.amjcard.2013.04.040; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Sciarretta S, 2009, J HYPERTENS, V27, P410, DOI 10.1097/HJH.0b013e32831bc764; ROWE JW, 1976, J GERONTOL, V31, P155; Iuliano S, 2002, AM HEART J, V143, P1085, DOI 10.1067/mhj.2002.122516; [Anonymous], 2003, DIABETES CARE S1, V26, pS5; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Nakamura K, 2006, CIRC J, V70, P954, DOI 10.1253/circj.70.954; Elsayed EF, 2007, ARCH INTERN MED, V167, P1130, DOI 10.1001/archinte.167.11.1130; Hovind P, 2001, KIDNEY INT, V60, P277, DOI 10.1046/j.1523-1755.2001.00797.x; Nada A, 2013, AM HEART J, V165, P489, DOI 10.1016/j.ahj.2013.01.011; Suzuki M, 2012, CLIN J AM SOC NEPHRO, V7, P1454, DOI 10.2215/CJN.09430911; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Segura J, 2004, J AM SOC NEPHROL, V15, P1616, DOI 10.1097/01.ASN.0000127045.14709.75; Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x; Chan YH, 2013, J INTERV CARD ELECTR, V37, P55, DOI 10.1007/s10840-012-9777-z; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Eberhard R., 1999, NEW ENGL J MED, V341, P1127; Flueckiger P, 2014, ANN TRANSPL, V19, P257, DOI 10.12659/AOT.889927; Kociol R, 2009, BLOOD PURIFICAT, V27, P311, DOI 10.1159/000207198; LAKATTA EG, 1975, CIRC RES, V36, P262; LEV M, 1964, AM J MED, V37, P742, DOI 10.1016/0002-9343(64)90022-1; Schetz M., 2009, F1000PRIME REP, P1; WHO Working Group, 1986, B WORLD HEALTH ORGAN, V64, P929; Yilmaz MI, 2006, AM J KIDNEY DIS, V47, P42, DOI 10.1053/j.ajkd.2005.09.029; YIN FCP, 1979, MECH AGEING DEV, V10, P17, DOI 10.1016/0047-6374(79)90067-8	30	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	MAY	2015	240	1					105	109		10.1016/j.atherosclerosis.2015.03.001		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF6YR	WOS:000352703400016		
J	Papafaklis, MI; Takahashi, S; Antoniadis, AP; Coskun, AU; Tsuda, M; Mizuno, S; Andreou, I; Nakamura, S; Makita, Y; Hirohata, A; Saito, S; Feldman, CL; Stone, PH				Papafaklis, Michail I.; Takahashi, Saeko; Antoniadis, Antonios P.; Coskun, Ahmet U.; Tsuda, Masaya; Mizuno, Shingo; Andreou, Ioannis; Nakamura, Shigeru; Makita, Yasuhiro; Hirohata, Atsushi; Saito, Shigeru; Feldman, Charles L.; Stone, Peter H.			Effect of the local hemodynamic environment on the de novo development and progression of eccentric coronary atherosclerosis in humans: Insights from PREDICTION	ATHEROSCLEROSIS			English	Article						Plaque eccentricity; Endothelial shear stress; Natural history; Atherosclerosis; Coronary artery disease; Vulnerable plaque	ENDOTHELIAL SHEAR-STRESS; 3-DIMENSIONAL INTRAVASCULAR ULTRASOUND; IN-VIVO; PLAQUE DISTRIBUTION; ARTERY-DISEASE; PATTERNS; ANGIOGRAPHY; RUPTURE; REGIONS; LESIONS	Background: Eccentric distribution of atheroma has been associated with plaques likely to rupture and cause an acute coronary syndrome, but the factors responsible for the development of eccentricity remain unknown. Endothelial shear stress (ESS) drives plaque formation. We aimed to investigate the role of the local ESS characteristics in the de novo development and progressive worsening of plaque eccentricity in humans. Methods: Vascular profiling (3-vessel 3D coronary reconstruction by angiography/intravascular ultrasound, and blood flow simulation for ESS computation) was performed in 374 patients at baseline & 6 -10 months follow-up. At baseline, we identified (i) disease-free segments (n = 2157), and (ii) diseased regions of luminal obstructions (n = 408). Results: In disease-free regions, baseline low ESS magnitude (p < 0.001), marked ESS circumferential heterogeneity (p = 0.001), and their interaction (p = 0.026) were associated with an increased probability of de novo eccentric plaque formation at follow-up. In diseased regions, baseline low ESS (odds ratio [OR]: 2.33, p = 0.003) and large plaque burden (OR: 2.46, p = 0.002) were independent predictors of substantially increasing plaque eccentricity index with worsening lumen encroachment. This combined outcome was more frequent in obstructions with both features vs. all others (33 vs. 12%; p < 0.001). The incidence of percutaneous coronary intervention in worsening obstructions with increasing plaque eccentricity was higher (13.3 vs. 4.3%, p = 0.011). Conclusions: The local hemodynamic environment has a critical effect on the development of eccentric coronary plaques at both an early and advanced stage of atherosclerosis. Local ESS assessment could help in predicting sites prone to plaque disruption and acute coronary syndromes in humans. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Papafaklis, Michail I.; Antoniadis, Antonios P.; Tsuda, Masaya; Mizuno, Shingo; Andreou, Ioannis; Feldman, Charles L.; Stone, Peter H.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Takahashi, Saeko; Saito, Shigeru] Shonan Kamakura Gen Hosp, Kamakura, Kanagawa, Japan; [Coskun, Ahmet U.] Northeastern Univ, Mech & Ind Engn, Boston, MA 02115 USA; [Nakamura, Shigeru] Kyoto Katsura Hosp, Kyoto, Japan; [Makita, Yasuhiro] Hakodate Municipal Hosp, Hakodate, Hokkaido, Japan; [Hirohata, Atsushi] Sakakibara Heart Inst Okayama, Okayama, Japan	Stone, PH (reprint author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	pstone@partners.org			Boston Scientific Corp.; George D. Behrakis Fellowship; Hellenic Heart Foundation	This investigator-initiated study was supported by Boston Scientific Corp. We acknowledge the support of the George D. Behrakis Fellowship and the Hellenic Heart Foundation. We thank Michelle Lucier, Gail MacCallum, Nicholas Cefalo and Emily Bomba-Rienzo for technical evaluation of imaging data.	Feldman CL, 2002, AM HEART J, V143, P931, DOI 10.1067/mhj.2002.123118; Yamagishi M, 2000, J AM COLL CARDIOL, V35, P106, DOI 10.1016/S0735-1097(99)00533-1; Wentzel JJ, 2012, CARDIOVASC RES, V96, P234, DOI 10.1093/cvr/cvs217; Buchanan JR, 2003, J BIOMECH, V36, P1185, DOI 10.1016/S0021-9290(03)00088-5; Tardy Y, 1997, ARTERIOSCL THROM VAS, V17, P3102; Knight J, 2010, ATHEROSCLEROSIS, V211, P445, DOI 10.1016/j.atherosclerosis.2010.03.001; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; Stone PH, 2012, CIRCULATION, V126, P172, DOI 10.1161/CIRCULATIONAHA.112.096438; Sano K, 2006, J AM COLL CARDIOL, V47, P734, DOI 10.1016/j.jacc.2005.09.061; Chatzizisis YS, 2011, CIRCULATION, V123, P621, DOI 10.1161/CIRCULATIONAHA.110.970038; Myers JG, 2001, ANN BIOMED ENG, V29, P109, DOI 10.1114/1.1349703; Phinikaridou A, 2013, CIRC-CARDIOVASC IMAG, V6, P302, DOI 10.1161/CIRCIMAGING.112.000176; Caro CG, 2009, ARTERIOSCL THROM VAS, V29, P158, DOI 10.1161/ATVBAHA.108.166736; Chen WQ, 2007, AM J PHYSIOL-HEART C, V293, pH2836, DOI 10.1152/ajpheart.00472.2007; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONHA.105.590018; Bayturan O, 2009, JACC-CARDIOVASC INTE, V2, P672, DOI 10.1016/j.jcin.2009.05.007; Fukumoto Y, 2008, J AM COLL CARDIOL, V51, P645, DOI 10.1016/j.jacc.2007.10.030; Koskinas KC, 2013, ARTERIOSCL THROM VAS, V33, P1494, DOI 10.1161/ATVBAHA.112.300827; Bourantas CV, 2012, INT J CARDIOL, V155, pE24, DOI 10.1016/j.ijcard.2011.07.005; Box LC, 2007, CATHETER CARDIO INTE, V70, P349, DOI 10.1002/ccd.21088; Feldman CL, 2006, AM J CARDIOL, V97, P13, DOI 10.1016/j.amjcard.2005.07.121; Liu YS, 2011, YONSEI MED J, V52, P914, DOI 10.3349/ymj.2011.52.6.914; Mintz GS, 1996, CIRCULATION, V93, P924; Mohler ER, 2008, ARTERIOSCL THROM VAS, V28, P850, DOI 10.1161/ATVBAHA.107.154534; Ohara T, 2008, AM J NEURORADIOL, V29, P1200, DOI 10.3174/ajnr.A0997; Puri R, 2012, EUR HEART J, V33, P495, DOI 10.1093/eurheartj/ehr359; Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46; Virmani Renu, 2003, J Interv Cardiol, V16, P267, DOI 10.1034/j.1600-0854.2003.8042.x; von Birgelen C, 2001, J AM COLL CARDIOL, V37, P1864, DOI 10.1016/S0735-1097(01)01234-7	29	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	MAY	2015	240	1					205	211		10.1016/j.atherosclerosis.2015.03.017		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF6YR	WOS:000352703400032		
J	Inoue, T; Inoguchi, T; Sonoda, N; Hendarto, H; Makimura, H; Sasaki, S; Yokomizo, H; Fujimura, Y; Miura, D; Takayanagi, R				Inoue, Tomoaki; Inoguchi, Toyoshi; Sonoda, Noriyuki; Hendarto, Hari; Makimura, Hiroaki; Sasaki, Shuji; Yokomizo, Hisashi; Fujimura, Yoshinori; Miura, Daisuke; Takayanagi, Ryoichi			GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats	ATHEROSCLEROSIS			English	Article						Diabetic cardiomyopathy; Glucagon-like peptide-1; Cardiac steatosis; Protein kinase C; Oxidative stress	GLUCAGON-LIKE PEPTIDE-1; ADIPOSE TRIGLYCERIDE LIPASE; AORTIC ENDOTHELIAL-CELLS; C-DEPENDENT ACTIVATION; ACETYL-COA CARBOXYLASE; KINASE-C; ENERGY-EXPENDITURE; NAD(P)H OXIDASE; NADPH OXIDASE; RECEPTOR	Objective: Accumulating evidence has implicated that GLP-1 may have a beneficial effect on cardiovascular but the mechanism is not fully understood. Here we show that GLP-1 analog, liraglutide, inhibits cardiac steatosis, oxidative stress and apoptosis in streptozotocin (STZ)-induced type 1 diabetic rats, via activation of AMPK-Sirt1 pathway. Methods: Diabetic rats were treated with subcutaneous injections of liraglutide (0.3 mg/kg/12 h) for 4 weeks. Myocardial steatosis (detected by oil red O staining and myocardial triglyceride and diacylglycerol (DAG) contents assay), expression of protein kinase C (PKC), heart NAD(P) H oxidase activity, oxidative stress markers (8-hydroxy-2'-deoxyguanosine staining), apoptosis (TUNEL analysis) and genes that affect apoptosis and lipid metabolism were evaluated. Results: Administration of liraglutide did not affect plasma glucose and insulin levels or body weights in STZ-induced diabetic rats, but normalized myocardial steatosis, expression of PKC, NAD(P) H oxidase activity, oxidative stress markers and apoptosis, all of which were significantly increased in diabetic hearts. Additionally, expression of genes mediating lipid uptake, synthesis and oxidation were increased in the diabetic hearts, and these increases were all reduced by liraglutide. In addition, liraglutide increased expression of Sirt1 and phosphorylated AMPK in the diabetic hearts. Conclusions: Liraglutide may have a beneficial effect on cardiac steatosis, DAG-PKC-NAD(P) H pathway, oxidative stress and apoptosis via activation of AMPK-Sirt1 pathway, independently of a glucose-lowering effect. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Inoue, Tomoaki; Inoguchi, Toyoshi; Sonoda, Noriyuki; Hendarto, Hari; Makimura, Hiroaki; Sasaki, Shuji; Yokomizo, Hisashi; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Fukuoka 8128582, Japan; [Inoguchi, Toyoshi; Sonoda, Noriyuki; Fujimura, Yoshinori; Miura, Daisuke] Kyushu Univ, Innovat Ctr Med Redox Nav, Higashi Ku, Fukuoka 8128582, Japan	Inoguchi, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	toyoshi@intmed3.med.kyushu-u.ac.jp			Special Coordination Funds for Promoting Science and Technology (SCF funding program "Innovation Center for Medical Redox Navigation")	This work was supported in part by the Special Coordination Funds for Promoting Science and Technology (SCF funding program "Innovation Center for Medical Redox Navigation"). We appreciate the technical support from the Research Support Center, Graduate School of Medical Sciences, Kyushu University. We also thank Novo Nordisk Pharma, Ltd., for kindly supplying liraglutide.	Bullock BP, 1996, ENDOCRINOLOGY, V137, P2968, DOI 10.1210/en.137.7.2968; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Inoue T, 2011, J BIOL CHEM, V286, P32045, DOI 10.1074/jbc.M111.285650; Sturis J, 2003, BRIT J PHARMACOL, V140, P123, DOI 10.1038/sj.bjp.0705397; Kakimoto M, 2002, DIABETES, V51, P1588, DOI 10.2337/diabetes.51.5.1588; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; WOLFF SP, 1991, FREE RADICAL BIO MED, V10, P339, DOI 10.1016/0891-5849(91)90040-A; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Batchuluun B, 2014, ATHEROSCLEROSIS, V232, P156, DOI 10.1016/j.atherosclerosis.2013.10.025; INOGUCHI T, 1992, P NATL ACAD SCI USA, V89, P11059, DOI 10.1073/pnas.89.22.11059; Febbraio M, 2007, INT J BIOCHEM CELL B, V39, P2012, DOI 10.1016/j.biocel.2007.03.012; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Etoh T, 2003, DIABETOLOGIA, V46, P1428, DOI 10.1007/s00125-003-1205-6; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; HA HJ, 1994, FREE RADICAL BIO MED, V16, P271, DOI 10.1016/0891-5849(94)90152-X; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; HA J, 1994, J BIOL CHEM, V269, P22162; Bose AK, 2005, DIABETES, V54, P146, DOI 10.2337/diabetes.54.1.146; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Cai L, 2002, DIABETES, V51, P1938, DOI 10.2337/diabetes.51.6.1938; Dirkx E, 2011, PROSTAG LEUKOTR ESS, V85, P219, DOI 10.1016/j.plefa.2011.04.018; Kim M, 2013, NAT MED, V19, P567, DOI 10.1038/nm.3128; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Johar S, 2006, FASEB J, V20, P1546, DOI 10.1096/fj.05-4652fje; Frustaci A, 2000, CIRC RES, V87, P1123; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Arakawa M, 2010, DIABETES, V59, P1030, DOI 10.2337/db09-1694; Munday MR, 2002, BIOCHEM SOC T, V30, P1059; Nogueiras R, 2009, J NEUROSCI, V29, P5916, DOI 10.1523/JNEUROSCI.5977-08.2009; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Noyan-Ashraf MH, 2013, CIRCULATION, V127, P74, DOI 10.1161/CIRCULATIONAHA.112.091215; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Balteau M, 2014, AM J PHYSIOL-HEART C, V307, pH1120, DOI 10.1152/ajpheart.00210.2014; Carley AN, 2011, J BIOL CHEM, V286, P4589, DOI 10.1074/jbc.M110.182162; Chaudhary N, 2009, CURR OPIN CLIN NUTR, V12, P431, DOI 10.1097/MCO.0b013e32832cdaae; FOLCH J, 1957, J BIOL CHEM, V226, P497; Inoue T, 2013, BIOCHEM BIOPH RES CO, V438, P224, DOI 10.1016/j.bbrc.2013.07.063; Irwin DM, 2001, REGUL PEPTIDES, V98, P1, DOI 10.1016/S0167-0115(00)00232-9; Khan M.A., 2012, HEART FAIL REV, V18, P141; OBERLEY LW, 1988, FREE RADICAL BIO MED, V5, P113, DOI 10.1016/0891-5849(88)90036-6; Rolin B, 2002, AM J PHYSIOL-ENDOC M, V283, pE745, DOI 10.1152/ajpendo.00030.2002; Taha M, 2007, ANN MED, V39, P594, DOI 10.1080/07853890701618305; Watanabe Kenichi, 2010, Curr Cardiol Rev, V6, P280, DOI 10.2174/157340310793566145; Xu Ming, 2007, Sheng Li Xue Bao, V59, P175	50	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	MAY	2015	240	1					250	259		10.1016/j.atherosclerosis.2015.03.026		10	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF6YR	WOS:000352703400039		
J	Azushima, K; Tamura, K; Haku, S; Wakui, H; Kanaoka, T; Ohsawa, M; Uneda, K; Kobayashi, R; Ohki, K; Dejima, T; Maeda, A; Hashimoto, T; Oshikawa, J; Kobayashi, Y; Nomura, K; Azushima, C; Takeshita, Y; Fujino, R; Uchida, K; Shibuya, K; Ando, D; Tokita, Y; Fujikawa, T; Toya, Y; Umemura, S				Azushima, Kengo; Tamura, Kouichi; Haku, Sona; Wakui, Hiromichi; Kanaoka, Tomohiko; Ohsawa, Masato; Uneda, Kazushi; Kobayashi, Ryu; Ohki, Kohji; Dejima, Toru; Maeda, Akinobu; Hashimoto, Tatsuo; Oshikawa, Jin; Kobayashi, Yusuke; Nomura, Koichiro; Azushima, Chieko; Takeshita, Yasuyo; Fujino, Ryota; Uchida, Ken; Shibuya, Ken; Ando, Daisaku; Tokita, Yasuo; Fujikawa, Tetsuya; Toya, Yoshiyuki; Umemura, Satoshi			Effects of the oriental herbal medicine Bofu-tsusho-san in obesity hypertension: A multicenter, randomized, parallel-group controlled trial (ATH-D-14-01021.R2)	ATHEROSCLEROSIS			English	Article						Ambulatory blood pressure monitoring; Blood pressure variability; Glucose metabolism; Hypertension; Integrative medicine; Obesity; Oriental herbal medicine	BLOOD-PRESSURE VARIABILITY; CARDIOVASCULAR RISK-FACTORS; CHRONIC KIDNEY-DISEASE; OXIDATIVE DNA-DAMAGE; PROGNOSTIC VALUE; ORGAN DAMAGE; WEIGHT-LOSS; ARTERIAL STIFFNESS; GENERAL-POPULATION; BOFUTSUSHOSAN	Objective: There is no clinical evidence that supports the benefit of integrative medicine, defined as combination therapy of oriental and western medicine, on obesity-related hypertension. This study evaluates the efficacy of Bofu-tsusho-san (BOF), an oriental herbal medicine, on the ambulatory blood pressure (BP) profile in hypertensive patients with obesity. Methods: The study design was a multicenter, randomized, open-label, parallel-group controlled trial in 107 hypertensive patients with obesity. Participants were randomly assigned to receive either the conventional control therapy or BOF add-on therapy. In both groups antihypertensive therapy was aimed at achieving the target clinic BP. The primary outcome was change in the ambulatory BP profile from baseline to 24 weeks after randomization. Results: Daytime systolic BP variability, an important parameter of ambulatory BP profile, was decreased in the BOF group, and the difference in the changes in daytime systolic BP variability was significant between the BOF and control group (Control vs BOF; the change from baseline in daytime systolic BP variability, 1.0 +/- 3.3 vs -1.0 +/- 3.3%; p = 0.006). Conclusion: The BOF add-on therapy effectively improved the ambulatory BP variability. This is the first report suggesting that an integrative medicine approach may exert favorable effects on obesity-related hypertension compared with conventional pharmaceutical treatment. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.	[Azushima, Kengo; Tamura, Kouichi; Haku, Sona; Wakui, Hiromichi; Kanaoka, Tomohiko; Ohsawa, Masato; Uneda, Kazushi; Kobayashi, Ryu; Ohki, Kohji; Dejima, Toru; Maeda, Akinobu; Hashimoto, Tatsuo; Oshikawa, Jin; Kobayashi, Yusuke; Nomura, Koichiro; Fujikawa, Tetsuya; Toya, Yoshiyuki; Umemura, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2360004, Japan; [Azushima, Chieko] Azushima Med Clin, Tokyo, Japan; [Takeshita, Yasuyo] Yamato Municipal Hosp, Dept Med, Div Renal, Yamato, Japan; [Fujino, Ryota; Uchida, Ken; Shibuya, Ken] Omori Red Cross Hosp, Dept Med, Div Renal, Tokyo, Japan; [Ando, Daisaku; Tokita, Yasuo] Fujisawa Municipal Hosp, Dept Med, Div Renal, Fujisawa, Kanagawa, Japan	Tamura, K (reprint author), Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	tamukou@med.yokohama-cu.ac.jp			Japanese Ministry of Health, Labour and Welfare (Health and Labour Sciences Research grant)	This study was entirely funded by the Japanese Ministry of Health, Labour and Welfare (Health and Labour Sciences Research grant).	Landsberg L, 2013, OBESITY, V21, P8, DOI 10.1002/oby.20181; Tatasciore A, 2007, HYPERTENSION, V50, P325, DOI 10.1161/HYPERTENSIONAHA.107.090084; Mancia G, 2007, HYPERTENSION, V49, P1265, DOI 10.1161/HYPERTENSIONAHA.107.088708; Kanaoka T, 2012, J CLIN HYPERTENS, V14, P522, DOI 10.1111/j.1751-7176.2012.00640.x; Yiannikouris F, 2012, HYPERTENSION, V60, P1524, DOI 10.1161/HYPERTENSIONAHA.112.192690; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Yanagawa Y, 2010, ENDOCR J, V57, P339, DOI 10.1507/endocrj.K09E-359; Dixon JB, 2012, LANCET, V379, P2300, DOI 10.1016/S0140-6736(12)60401-2; Shintani Y, 2007, J HYPERTENS, V25, P1704, DOI 10.1097/HJH.0b013e328172dc2e; Palatini P, 2014, HYPERTENSION, V64, P487, DOI 10.1161/HYPERTENSIONAHA.114.03694; Parati G, 2012, CURR HYPERTENS REP, V14, P421, DOI 10.1007/s11906-012-0290-7; Kikuya M, 2000, HYPERTENSION, V36, P901; Rosello-Lleti E, 2012, AM J HYPERTENS, V25, P236, DOI 10.1038/ajh.2011.202; Kotsis V, 2011, ATHEROSCLEROSIS, V219, P194, DOI 10.1016/j.atherosclerosis.2011.07.111; Sega R, 2002, HYPERTENSION, V39, P710, DOI 10.1161/hy0202.104376; Ono M, 2014, J GASTROENTEROL, V49, P1065, DOI 10.1007/s00535-013-0852-8; Mancia G, 2000, HYPERTENSION, V36, P894; Dietrich MO, 2012, NAT REV DRUG DISCOV, V11, P675, DOI 10.1038/nrd3739; Pringle E, 2003, J HYPERTENS, V21, P2251, DOI 10.1097/01.hjh.0000098144.70956.0f; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P2218, DOI 10.1016/j.jacc.2012.08.979; Sander D, 2000, CIRCULATION, V102, P1536; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Xiong XJ, 2013, HYPERTENS RES, V36, P570, DOI 10.1038/hr.2013.18; Ahmadi N, 2011, AM J MED, V124, P978, DOI 10.1016/j.amjmed.2011.02.032; Imai Y, 1997, AM J HYPERTENS, V10, P1281, DOI 10.1016/S0895-7061(97)00277-X; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; Elloumi M, 2009, ACTA PAEDIATR, V98, P1487, DOI 10.1111/j.1651-2227.2009.01365.x; Pierdomenico SD, 2009, AM J HYPERTENS, V22, P842, DOI 10.1038/ajh.2009.103; Mizoue T, 2007, CANCER SCI, V98, P1254, DOI 10.1111/j.1349-7006.2007.00511.x; Azushima K., 2014, BIOMED RES INT, V2014; Azushima K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075560; Hansen TW, 2010, HYPERTENSION, V55, P1049, DOI 10.1161/HYPERTENSIONAHA.109.140798; Hioki C, 2004, CLIN EXP PHARMACOL P, V31, P614, DOI 10.1111/j.1440-1681.2004.04056.x; Hodgkinson J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3621; Horvath K, 2008, ARCH INTERN MED, V168, P571, DOI 10.1001/archinte.168.6.571; Kanaoka T, 2011, CLIN EXP HYPERTENS, V33, P255, DOI 10.3109/10641963.2011.583971; Kanaoka T, 2013, INT J MOL SCI, V14, P16866, DOI 10.3390/ijms140816866; Koebnick C, 2006, INT J OBESITY, V30, P1097, DOI 10.1038/sj.ijo.0803242; Lee KH, 2006, CARCINOGENESIS, V27, P1398, DOI 10.1093/carcin/bgi337; Lopes-Virella MF, 2012, ATHEROSCLEROSIS, V224, P526, DOI 10.1016/j.atherosclerosis.2012.08.006; Manios E, 2011, J HYPERTENS, V29, P1109, DOI 10.1097/HJH.0b013e3283454ff4; Menzaghi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064729; Ng M, 2013, LANCET, V384, P766, DOI DOI 10.1016/S0140-6736(14)60460-8; Ninomiya T, 2013, BMJ-BRIT MED J, V347, pf5680, DOI DOI 10.1136/BMJ.F5680.A; Ohno K, 2005, BIOL PHARM BULL, V28, P2162, DOI 10.1248/bpb.28.2162; Sakurai Y, 2013, INTERNAL MED, V52, P1499, DOI 10.2169/internalmedicine.52.0045; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; Tatasciore A, 2013, J HYPERTENS, V31, P1653, DOI 10.1097/HJH.0b013e328361e4a6; Yanagi M, 2013, HYPERTENS RES, V36, P262, DOI 10.1038/hr.2012.184; YOSHIDA T, 1995, INT J OBESITY, V19, P717	50	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	MAY	2015	240	1					297	304		10.1016/j.atherosclerosis.2015.01.025		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF6YR	WOS:000352703400044		
J	Ang, RY; Zhao, CY; Doria, MC; Wang, QC; Daniel, BS; Ramirez, M; Boettiger, DC; Law, MG; Ishii, N; Hashimoto, T; Murrell, DF				Ang, R. Y.; Zhao, C. Y.; Doria, M. C.; Wang, Q. C.; Daniel, B. S.; Ramirez, M.; Boettiger, D. C.; Law, M. G.; Ishii, N.; Hashimoto, T.; Murrell, D. F.			The autoimmune bullous disease quality of life and treatment of autoimmune bullous disease quality of life questionnaires - trends and responsiveness	AUSTRALASIAN JOURNAL OF DERMATOLOGY			English	Meeting Abstract									[Ang, R. Y.; Zhao, C. Y.; Doria, M. C.; Wang, Q. C.; Daniel, B. S.; Ramirez, M.; Murrell, D. F.] St George Hosp, Dept Dermatol, Sydney, NSW, Australia; [Boettiger, D. C.; Law, M. G.] Kirby Inst, Sydney, NSW, Australia; [Ishii, N.; Hashimoto, T.] Kurume Univ, Inst Cutaneous Cell Biol, Fukuoka, Japan; [Ang, R. Y.; Zhao, C. Y.; Doria, M. C.; Wang, Q. C.; Daniel, B. S.; Ramirez, M.; Murrell, D. F.] Univ New S Wales, Sydney, NSW, Australia								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0004-8380	1440-0960		AUSTRALAS J DERMATOL	Australas. J. Dermatol.	MAY	2015	56			2	SI		22	22				1	Dermatology	Dermatology	CF4ZC	WOS:000352562300062		
J	Chiang, YZ; Zhao, CY; Melbourne, W; Wijayanti, A; Tran, K; Kim, J; Legaspi, K; Ishii, N; Koga, H; Schmidt, E; Zillikens, D; Hashimoto, T; Murrell, DF				Chiang, Y. Z.; Zhao, C. Y.; Melbourne, W.; Wijayanti, A.; Tran, K.; Kim, J.; Legaspi, K.; Ishii, N.; Koga, H.; Schmidt, E.; Zillikens, D.; Hashimoto, T.; Murrell, D. F.			Biochip immunofluorescence microscopy as a new diagnostic tool for autoimmune blistering skin diseases in Australia	AUSTRALASIAN JOURNAL OF DERMATOLOGY			English	Meeting Abstract									[Chiang, Y. Z.; Zhao, C. Y.; Melbourne, W.; Wijayanti, A.; Kim, J.; Legaspi, K.; Murrell, D. F.] St George Hosp, Dermatol, Sydney, NSW, Australia; [Zhao, C. Y.; Murrell, D. F.] Univ New S Wales, Sydney, NSW, Australia; [Melbourne, W.; Tran, K.] St George Hosp, Anat Pathol, Sydney, NSW, Australia; [Ishii, N.; Koga, H.; Hashimoto, T.] Kurume Univ, Kurume, Fukuoka 830, Japan; [Schmidt, E.; Zillikens, D.] Med Univ Lubeck, D-23538 Lubeck, Germany								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0004-8380	1440-0960		AUSTRALAS J DERMATOL	Australas. J. Dermatol.	MAY	2015	56			2	SI		26	26				1	Dermatology	Dermatology	CF4ZC	WOS:000352562300073		
J	Wijayanti, A; Zhao, CY; Boettiger, D; Chiang, YZ; Ishii, N; Hashimoto, T; Murrell, DF				Wijayanti, A.; Zhao, C. Y.; Boettiger, D.; Chiang, Y. Z.; Ishii, N.; Hashimoto, T.; Murrell, D. F.			Validity, reliability, responsiveness and minimal clinically important difference of the Bullous Pemphigoid Disease Area Index (BPDAI)	AUSTRALASIAN JOURNAL OF DERMATOLOGY			English	Meeting Abstract									[Wijayanti, A.; Zhao, C. Y.; Chiang, Y. Z.; Murrell, D. F.] St George Hosp, Dept Dermatol, Sydney, NSW, Australia; [Boettiger, D.] Kirby Inst, Sydney, NSW, Australia; [Ishii, N.; Hashimoto, T.] Kurume Univ, Kurume, Fukuoka 830, Japan; [Zhao, C. Y.; Boettiger, D.; Murrell, D. F.] Univ New S Wales, Sydney, NSW, Australia								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0004-8380	1440-0960		AUSTRALAS J DERMATOL	Australas. J. Dermatol.	MAY	2015	56			2	SI		82	82				1	Dermatology	Dermatology	CF4ZC	WOS:000352562300217		
J	Ota, Y; Ago, Y; Tanaka, T; Hasebe, S; Toratani, Y; Onaka, Y; Hashimoto, H; Takuma, K; Matsuda, T				Ota, Yuki; Ago, Yukio; Tanaka, Tatsunori; Hasebe, Shigeru; Toratani, Yui; Onaka, Yusuke; Hashimoto, Hitoshi; Takuma, Kazuhiro; Matsuda, Toshio			Anxiolytic-like effects of restraint during the dark cycle in adolescent mice	BEHAVIOURAL BRAIN RESEARCH			English	Article						Restraint; Anxiety behavior; Dark cycle; Light cycle	ANXIETY-LIKE BEHAVIOR; C-FOS EXPRESSION; EXTRACELLULAR LEVELS; IMMOBILIZATION STRESS; ENRICHED ENVIRONMENT; TRANSCRIPTION FACTOR; PREFRONTAL CORTEX; GABA(A) RECEPTORS; SOCIAL-ISOLATION; DEFICIENT MICE	Stress during developmental stage may cause psychological morbidities, and then the studies on stress are important in adolescent rodents. Restraint is used as a common stressor in rodents and the effects of restraint during the light cycle have been studied, but those of restraint during the dark cycle have not. The present study examined the effects of restraint during the light and dark cycles on anxiety behaviors in adolescent mice. Restraint for 3 h during either the light or dark cycle impaired memory function in the fear conditioning test, but did not affect locomotor activity. In the elevated plus-maze test, restraint during the dark cycle reduced anxiety-like behaviors in mice. Repeated exposure to a 3-h period dark cycle restraint for 2 weeks had a similar anxiolytic-like effect. In contrast, restraint for 3 h during the light cycle produced anxiety behavior in adolescent, but not adult, mice. The light cycle stress increased plasma corticosterone levels, and elevated c-Fos expression in the prefrontal cortex, paraventricular hypothalamic nucleus, basolateral amygdala and dentate gyrus, and enhanced serotonin turnover in the hippocampus and striatum, while the dark cycle stress did not. There was no difference in the stress-mediated reduction in pentobarbital-induced sleeping time between dark and light cycle restraint. These findings suggest that the anxiolytic effect of dark cycle restraint is mediated by corticosterone, serotonin or "y-aminobutyric acid-independent mechanisms, although the anxiogenic effect of light cycle restraint is associated with changes in plasma corticosterone levels and serotonin turnover in specific brain regions. (C) 2015 Elsevier B.V. All rights reserved.	[Ota, Yuki; Ago, Yukio; Tanaka, Tatsunori; Hasebe, Shigeru; Toratani, Yui; Onaka, Yusuke; Takuma, Kazuhiro; Matsuda, Toshio] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Med Pharmacol, Suita, Osaka 5650871, Japan; [Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka 5650871, Japan; [Hashimoto, Hitoshi; Matsuda, Toshio] Osaka Univ, United Grad Sch Child Dev, Suita, Osaka 5650871, Japan; [Hashimoto, Hitoshi; Matsuda, Toshio] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan; [Hashimoto, Hitoshi; Matsuda, Toshio] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan; [Hashimoto, Hitoshi; Matsuda, Toshio] Chiba Univ, Chiba, Japan; [Hashimoto, Hitoshi; Matsuda, Toshio] Univ Fukui, Fukui, Japan; [Takuma, Kazuhiro] Osaka Univ, Grad Sch Dent, Dept Pharmacol, Suita, Osaka 5650871, Japan	Matsuda, T (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Med Pharmacol, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan.	matsuda@phs.osaka-u.ac.jp			KAKENHI [25460099, 26293020, 26670122]; Neuropsychiatry Drug Discovery Consortium; Osaka University; Takeda Science Foundation (Japan); Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers	This study was supported in part by KAKENHI (25460099 (YA), 26293020 (HH) and 26670122 (HH)), the Neuropsychiatry Drug Discovery Consortium established by Dainippon Sumitomo Pharma Co., Ltd. (Japan) with Osaka University (TM, HH), Takeda Science Foundation (Japan) (YA) and Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (HH).	Ago Y, 2014, BEHAV BRAIN RES, V270, P37, DOI 10.1016/j.bbr.2014.04.047; Kawasaki T, 2006, EUR J PHARMACOL, V542, P92, DOI 10.1016/j.ejphar.2006.05.012; Harrison NL, 2007, J CLIN PSYCHIAT, V68, P6; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Ago Y, 2013, NEUROPHARMACOLOGY, V65, P29, DOI 10.1016/j.neuropharm.2012.09.008; Bain MJ, 2004, NEUROSCI LETT, V368, P7, DOI 10.1016/j.neulet.2004.04.096; Ago Y, 2011, PSYCHOPHARMACOLOGY, V217, P377, DOI 10.1007/s00213-011-2293-5; Ago Y, 2013, NEUROPSYCHOPHARMACOL, V38, P1535, DOI 10.1038/npp.2013.52; Kataoka S, 2013, INT J NEUROPSYCHOPH, V16, P91, DOI 10.1017/S1461145711001714; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Yun J, 2010, J NEUROCHEM, V114, P1840, DOI 10.1111/j.1471-4159.2010.06893.x; Smith KS, 2012, NEUROPHARMACOLOGY, V62, P54, DOI 10.1016/j.neuropharm.2011.07.026; Weinberg MS, 2007, NEUROSCIENCE, V150, P478, DOI 10.1016/j.neuroscience.2007.09.013; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; Koda K, 2010, J NEUROCHEM, V114, P259, DOI 10.1111/j.1471-4159.2010.06750.x; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Lancel M, 1999, SLEEP, V22, P33; Higashino K, 2014, EUR J PHARMACOL, V729, P86, DOI 10.1016/j.ejphar.2014.02.012; Takuma K, 2011, J PHARMACOL SCI, V117, P71, DOI 10.1254/jphs.11R07CP; Cecchi M, 2002, NEUROPHARMACOLOGY, V43, P1139, DOI 10.1016/S0028-3908(02)00292-7; Mongeau R, 2010, J NEUROCHEM, V115, P438, DOI 10.1111/j.1471-4159.2010.06932.x; Winsky-Sommerer R, 2009, EUR J NEUROSCI, V29, P1779, DOI 10.1111/j.1460-9568.2009.06716.x; Sanchez S, 2008, MOL CELL BIOCHEM, V317, P105, DOI 10.1007/s11010-008-9836-z; Mohler H, 2012, NEUROPHARMACOLOGY, V62, P42, DOI 10.1016/j.neuropharm.2011.08.040; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Dhir A, 2006, EUR J PHARMACOL, V535, P192, DOI 10.1016/j.ejphar.2006.01.064; ENNA SJ, 1984, PSYCHOPATHOLOGY, V17, P15; Gameiro GH, 2006, PHYSIOL BEHAV, V87, P643, DOI 10.1016/j.physbeh.2005.12.007; HOEHNSARIC R, 1982, ARCH GEN PSYCHIAT, V39, P735; Horiguchi N, 2013, PHARMACOL BIOCHEM BE, V113, P46, DOI 10.1016/j.pbb.2013.10.017; Hsu HR, 2007, EUR J PHARMACOL, V566, P124, DOI 10.1016/j.ejphar.2007.03.040; Li K S, 2000, Stress, V3, P285, DOI 10.3109/10253890009001134; Matsuda T, 2013, BIOL PHARM BULL, V36, P1871; Matsumoto K, 1996, BRAIN RES, V708, P1, DOI 10.1016/0006-8993(95)01277-X; MITCHELL SN, 1988, PHARMACOLOGY, V37, P105, DOI 10.1159/000138453; O'Mahony CM, 2010, BEHAV BRAIN RES, V213, P148, DOI 10.1016/j.bbr.2010.04.038; Takuma K, 2014, BEHAV BRAIN RES, V272, P269, DOI 10.1016/j.bbr.2014.07.005; Thorre K, 1997, BRAIN RES, V772, P209, DOI 10.1016/S0006-8993(97)00841-X; Tsukiyama N, 2011, STRESS, V14, P368, DOI 10.3109/10253890.2010.544345; Vollmer LE, 2013, GENES BRAIN BEHAV, V12, P241, DOI 10.1111/j.1601-183X.2012.00867.x	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAY 1	2015	284						103	111		10.1016/j.bbr.2015.02.010		9	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CF6NB	WOS:000352672300013		
J	Hamao, K; Kawaura, K; Soeda, F; Hamasaki, R; Shirasaki, T; Takahama, K				Hamao, Keiko; Kawaura, Kazuaki; Soeda, Fumio; Hamasaki, Ryota; Shirasaki, Tetsuya; Takahama, Kazuo			Tipepidine increases dopamine level in the nucleus accumbens without methamphetamine-like behavioral sensitization	BEHAVIOURAL BRAIN RESEARCH			English	Article						Tipepidine; Nucleus accumbens; G protein-coupled inwardly rectifying potassium channel; Dopamine; Antitussive	RECEPTOR STIMULATION INCREASES; ANTIDEPRESSANT-LIKE ACTION; EXTRACELLULAR DOPAMINE; PLACE PREFERENCE; COCAINE; RATS; BRAIN; MICE; NEURONS; SYSTEM	We previously reported that the novel antidepressant-like effect of tipepidine may be produced at least partly through the activation of mesolimbic dopamine neurons via inhibition of G protein-coupled inwardly rectifying potassium channels. In this study, we investigated whether tipepidine increases dopamine levels in the nucleus accumbens (NAc) in rats using an in vivo microdialysis technique. We further assessed whether tipepidine at antidepressant-like effective doses induces behavioral- and cross-sensitization of locomotor activity in rats using the open field test. We found that acute administration of tipepidine increased dopamine levels in the NAc in freely moving rats without increasing locomotor activity. Tipepidine at antidepressant-like effective doses (20 and 40 mg/kg, i.p.) did not cause behavioral sensitization in rats. Furthermore, cross-sensitization between tipepidine and methamphetamine was not observed in rats. These results further support our working hypothesis that tipepidine may produce a novel antidepressant-like effect through activation of ventral tegmental area-NAc dopaminergic neurons whose mechanisms differ from those contributing to the reinforcing effects of addictive drugs. (C) 2015 Elsevier B.V. All rights reserved.	[Hamao, Keiko; Kawaura, Kazuaki; Soeda, Fumio; Hamasaki, Ryota; Shirasaki, Tetsuya; Takahama, Kazuo] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Environm & Mol Hlth Sci, Kumamoto 8620973, Japan; [Takahama, Kazuo] Kumamoto Hlth Sci Univ, Fac Hlth Sci, Kita Ku, Kumamoto 8615598, Japan	Takahama, K (reprint author), Kumamoto Hlth Sci Univ, Fac Hlth Sci, Kita Ku, 325 Izumimachi, Kumamoto 8615598, Japan.	takahama@kumamoto-hsu.ac.jp			Japan Society for the Promotion of Science [19390066]	This study was supported by Grant-in-Aid for scientific research (B) (JSPS KAKENHI Grant Number 19390066) from the Japan Society for the Promotion of Science.	Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Izawa JI, 2006, EUR J PHARMACOL, V549, P84, DOI 10.1016/j.ejphar.2006.08.031; Kawahara R, 2013, BRAIN RES, V1513, P135, DOI 10.1016/j.brainres.2013.03.034; HENRY DJ, 1989, J PHARMACOL EXP THER, V251, P833; Podda MV, 2010, NEUROSCIENCE, V167, P678, DOI 10.1016/j.neuroscience.2010.02.075; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Suzuki T, 1999, LIFE SCI, V64, pPL151, DOI 10.1016/S0024-3205(99)00036-3; Kitamura Y, 2010, N-S ARCH PHARMACOL, V382, P151, DOI 10.1007/s00210-010-0521-x; Watson CJ, 2006, ANAL CHEM, V78, P1391, DOI 10.1021/ac0693722; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Cassano P, 2004, DEPRESS ANXIETY, V20, P131, DOI 10.1002/da.20038; TANDA G, 1994, PSYCHOPHARMACOLOGY, V115, P285, DOI 10.1007/BF02244785; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Kawaura K, 2009, BEHAV BRAIN RES, V205, P315, DOI 10.1016/j.bbr.2009.07.004; Hamasaki R, 2013, NEUROSCIENCE, V252, P24, DOI 10.1016/j.neuroscience.2013.07.044; Kawaura K, 2012, BEHAV BRAIN RES, V226, P381, DOI 10.1016/j.bbr.2011.09.031; Chao SZ, 2002, J NEUROCHEM, V83, P704, DOI 10.1046/j.1471-4159.2002.01164.x; ICHIKAWA J, 1995, EUR J PHARMACOL, V281, P255, DOI 10.1016/0014-2999(95)00264-L; Kitaichi Y, 2010, EUR J PHARMACOL, V647, P90, DOI 10.1016/j.ejphar.2010.08.026; HENRY DJ, 1991, J PHARMACOL EXP THER, V258, P882; Higuchi H, 2005, CLIN NEUROPHARMACOL, V28, P191, DOI 10.1097/01.wnf.0000171248.89726.2f; Honda S, 2011, BEHAV BRAIN RES, V216, P308, DOI 10.1016/j.bbr.2010.08.010; Honda S, 20 JAP KOR JOINT SEM, V51; Hu XT, 2002, SYNAPSE, V45, P159, DOI 10.1002/syn.10095; Kase Y, 1960, FOLIA PHARM JAPAN, V56, P74; Kawaura K, 2010, YAKUGAKU ZASSHI, V130, P699; Kobayashi T, 2006, NEUROPSYCHOPHARMACOL, V31, P516, DOI 10.1038/sj.npp.1300844; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; MISERENDINO MJD, 1995, BRAIN RES, V674, P299, DOI 10.1016/0006-8993(95)00030-T; Morgan AD, 2003, NEUROPSYCHOPHARMACOL, V28, P932, DOI 10.1038/sj.npp.1300100; Muneoka K, 2009, NEUROCHEM RES, V34, P542, DOI 10.1007/s11064-008-9818-2; NOMIKOS GG, 1991, PSYCHOPHARMACOLOGY, V105, P230, DOI 10.1007/BF02244315; Parsons LH, 1998, J CHROMATOGR B, V709, P35, DOI 10.1016/S0378-4347(98)00024-3; Slattery DA, 2004, FUND CLIN PHARMACOL, V18, P1, DOI 10.1111/j.1472-8206.2004.00195.x; Szumlinski KK, 2000, PSYCHOPHARMACOLOGY, V151, P234, DOI 10.1007/s002130000478; Takamatsu Y, 2011, CURR NEUROPHARMACOL, V9, P68, DOI 10.2174/157015911795017236; WHITE FJ, 1993, J PHARMACOL EXP THER, V266, P1075; WHITE FJ, 1986, J NEUROSCI, V6, P274; Willner P, 1997, INT CLIN PSYCHOPHARM, V12, pS7, DOI 10.1097/00004850-199707003-00002; WOLF ME, 1993, J PHARMACOL EXP THER, V264, P249	42	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAY 1	2015	284						118	124		10.1016/j.bbr.2015.02.012		7	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CF6NB	WOS:000352672300015		
J	Mitsuya, H; Omata, N; Kiyono, Y; Mizuno, T; Murata, T; Mita, K; Okazawa, H; Wada, Y				Mitsuya, Hironori; Omata, Naoto; Kiyono, Yasushi; Mizuno, Tomoyuki; Murata, Tetsuhito; Mita, Kayo; Okazawa, Hidehiko; Wada, Yuji			The co-occurrence of zinc deficiency and social isolation has the opposite effects on mood compared with either condition alone due to changes in the central norepinephrine system	BEHAVIOURAL BRAIN RESEARCH			English	Article						Zinc deficiency; Social isolation; Elevated plus maze test; Forced swim test; Cerebral norepinephrine concentration; Norepinephrine transporter	ANXIETY-LIKE BEHAVIOR; BRAIN NOREPINEPHRINE; ISOLATED RATS; DEPRESSION; ANTIDEPRESSANT; TRANSPORTER; STRESS; 3-METHOXY-4-HYDROXYPHENYLGLYCOL; ENVIRONMENT; EXPERIENCE	Nutritional and social environmental problems during the early stages of life are closely associated with the pathophysiology of mood disorders such as depression. Disruption or dysfunction of the central norepinephrine (NE) system is also considered to play a role in mood disorders. Therefore, we evaluated the effects of zinc deficiency and/or social isolation on mood and changes in the central NE system using rats. Compared with the controls, the rats subjected to zinc deficiency or social isolation alone exhibited increased anxiety-related behavior in the elevated plus maze and greater depression-like behavior in the forced swim test. However, the co-occurrence of zinc deficiency and social isolation resulted in decreased anxiety-related behavior and control levels of depression-like behavior. Social isolation alone decreased the rats' cerebral NE concentrations. The expression of the NE transporter was not affected by social isolation alone, but its expression in the locus coeruleus was markedly decreased by the co-occurrence of social isolation and zinc deficiency, and this change was accompanied by an increase in the blood concentration of 3-methoxy-4-hydroxyphenylglycol, which is a marker of central NE system activity. These findings suggest that zinc deficiency or social isolation alone induce anxious or depressive symptoms, but the presence of both conditions has anxiolytic or antidepressive effects. Furthermore, these opposing effects of mood-related behaviors were found to be associated with changes in the central NE system. (C) 2015 The Authors. Published by Elsevier B.V.	[Mitsuya, Hironori; Omata, Naoto; Mizuno, Tomoyuki; Murata, Tetsuhito; Mita, Kayo; Wada, Yuji] Univ Fukui, Fac Med Sci, Dept Neuropsychiat, Eiheiji, Fukui 9101193, Japan; [Kiyono, Yasushi; Okazawa, Hidehiko] Univ Fukui, Biomed Imaging Res Ctr, Eiheiji, Fukui 9101193, Japan; [Kiyono, Yasushi] Univ Fukui, Res & Educ Program Life Sci, Eiheiji, Fukui 9101193, Japan; [Mizuno, Tomoyuki; Murata, Tetsuhito] Fukui Prefectural Hosp, Psychiat Med Ctr, Fukui, Fukui 9108526, Japan	Omata, N (reprint author), Univ Fukui, Fac Med Sci, Dept Neuropsychiat, 23-3 Matsuokashimoaizuki, Eiheiji, Fukui 9101193, Japan.	omata@u-fukui.ac.jp			JSPS KAKENHI [25461753, 25293261]	This study was supported by JSPS KAKENHI Grant Numbers 25461753 and 25293261.	Lukkes JL, 2009, HORM BEHAV, V55, P248, DOI 10.1016/j.yhbeh.2008.10.014; Siwek M, 2010, J AFFECT DISORDERS, V126, P447, DOI 10.1016/j.jad.2010.04.024; Swardfager W, 2013, BIOL PSYCHIAT, V74, P872, DOI 10.1016/j.biopsych.2013.05.008; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Gutman DA, 2003, PHYSIOL BEHAV, V79, P471, DOI 10.1016/S0031-9384(03)00166-5; Lukkes J, 2009, J NEUROSCI, V29, P9955, DOI 10.1523/JNEUROSCI.0854-09.2009; Neumann CS, 2013, PERSONAL DISORD, V4, P129, DOI 10.1037/a0027886; Gilmer WS, 2003, J AFFECT DISORDERS, V75, P97, DOI 10.1016/S0165-0327(03)00046-6; Takeda A, 2008, LIFE SCI, V82, P909, DOI 10.1016/j.lfs.2008.02.005; Mehler MF, 2009, BRAIN RES REV, V59, P388, DOI 10.1016/j.brainresrev.2008.11.001; BLAKELY RD, 1994, J EXP BIOL, V196, P263; Siwek M, 2009, J AFFECT DISORDERS, V118, P187, DOI 10.1016/j.jad.2009.02.014; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Dremencov E, 2009, CURR DRUG TARGETS, V10, P1061; Sastre E, 2004, J CHROMATOGR B, V801, P205, DOI 10.1016/j.jchrom.2003.11.012; Roohani N, 2013, J RES MED SCI, V18, P144; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883; Brenes JC, 2008, PHARMACOL BIOCHEM BE, V89, P85, DOI 10.1016/j.pbb,2007.11.004; Watanabe M, 2010, NEUROCHEM INT, V56, P410, DOI 10.1016/j.neuint.2009.11.014; Xu F, 2000, NAT NEUROSCI, V3, P465; Morilak DA, 2005, PROG NEURO-PSYCHOPH, V29, P1214, DOI 10.1016/j.pnpbp.2005.08.007; Kim CH, 2006, P NATL ACAD SCI USA, V103, P19164, DOI 10.1073/pnas.0510836103; Brown LH, 2011, J NERV MENT DIS, V199, P403, DOI 10.1097/NMD.0b013e31821cd24b; Choi NG, 2013, CURR TRANSL GERIATRR, V2, P16; Dronjak S, 2006, BRAZ J MED BIOL RES, V39, P785, DOI 10.1590/S0100-879X2006000600011; FARRINGTON DP, 1988, PSYCHIATRY, V51, P116; Fellow S., 1985, NEUROSCI METHODS, V14, P149; Frazer A, 2000, J CLIN PSYCHIAT, V61, P25; Grippo Angela J, 2008, Depress Anxiety, V25, pE17, DOI 10.1002/da.20375; HAAPARANTA M, 1995, NUCL MED BIOL, V22, P483, DOI 10.1016/0969-8051(94)00121-Y; Haenisch B, 2009, J NEUROCHEM, V111, P403, DOI 10.1111/j.1471-4159.2009.06345.x; Heide KM, 2006, INT J LAW PSYCHIAT, V29, P220, DOI 10.1016/j.ijlp.2005.10.001; Jonson-Reid M, 2010, J AM ACAD CHILD PSY, V49, P321, DOI 10.1016/j.jaac.2009.11.015; Kanegawa N, 2006, EUR J NUCL MED MOL I, V33, P639, DOI 10.1007/s00259-005-0017-y; Kiyono Y, 2012, J NUCL MED, V53, P1603; Lukkes JL, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.018.2009; Maeda T, 2000, J CHEM NEUROANAT, V18, P57, DOI 10.1016/S0891-0618(99)00051-4; Mizuno T, 2013, MED HYPOTHESES, V81, P175, DOI 10.1016/j.mehy.2013.05.012; Norgaard-Nielsen K, 2006, HANDB EXP PHARM, V175, P1; Sandstead HH, 2000, J NUTR, V130, P496; SCHOMIG E, 1989, N-S ARCH PHARMACOL, V340, P502; Sepede G, 2012, CLIN TER, V163, pE255; Solomon EP, 1999, INT J OFFENDER THER, V43, P202, DOI 10.1177/0306624X99432007; Spasojevic N, 2012, NEUROENDOCRINOL LETT, V33, P631; Takeda A, 2007, BEHAV BRAIN RES, V177, P1, DOI 10.1016/j.bbr.2006.11.023; Tubbs RS, 2011, CHILD NERV SYST, V27, P1031, DOI 10.1007/s00381-011-1424-y; Yoshimura R, 2004, PROG NEURO-PSYCHOPH, V28, P611, DOI 10.1016/j.pnpbp.2004.01.008; Young LT, 2001, J PSYCHIATR NEUROSCI, V26, pS17	48	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAY 1	2015	284						125	130		10.1016/j.bbr.2015.02.005		6	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CF6NB	WOS:000352672300016		
J	Onaka, Y; Shintani, N; Nakazawa, T; Haba, R; Ago, Y; Wang, H; Kanoh, T; Hayata-Takano, A; Hirai, H; Nagata, K; Nakamura, M; Hashimoto, R; Matsuda, T; Waschek, JA; Kasai, A; Nagayasu, K; Baba, A; Hashimoto, H				Onaka, Yusuke; Shintani, Norihito; Nakazawa, Takanobu; Haba, Ryota; Ago, Yukio; Wang, Hyper; Kanoh, Takuya; Hayata-Takano, Atsuko; Hirai, Hiroyuki; Nagata, Kin-ya; Nakamura, Masataka; Hashimoto, Ryota; Matsuda, Toshio; Waschek, James A.; Kasai, Atsushi; Nagayasu, Kazuki; Baba, Akemichi; Hashimoto, Hitoshi			CRTH2, a prostaglandin D-2 receptor, mediates depression-related behavior in mice	BEHAVIOURAL BRAIN RESEARCH			English	Article						Depression; Prostaglandin D2; CRTH2; Noradrenaline; Depression-related behavior	CYCLASE-ACTIVATING POLYPEPTIDE; GLUCOCORTICOID-RECEPTOR; SICKNESS BEHAVIOR; MAJOR DEPRESSION; STRESS; MODEL; EXPRESSION; ANXIETY; PACAP; BRAIN	Depression is a complex neuropsychiatric disorder with an unclear molecular etiology. Inflammatory cytokines and molecular intermediates (including prostaglandins) are suggested to be involved in depression; however, the roles of prostaglandins and their respective receptors are largely unknown in depression. Using genetic and pharmacological approaches, we show here that chemoattractant receptorhomologous molecule expressed on T helper type 2 cells (CRTH2), a second receptor for prostaglandin D2 (PGD2), mediates depression-related behavior in mice. CRTH2-deficient (CRTH2(-/-)) mice showed antidepressant-like activity in a chronic corticosterone treatment-induced depression. Consistent with this observation, the pharmacological inhibition of CRTH2 via the clinically available drug ramatroban also rescued abnormal social interaction and depression-related behavior in well-established models, including chronic corticosterone-, lipopolysaccharide-, and tumor-induced pathologically relevant depression models. Importantly, chronic stress via corticosterone treatment increased mRNA levels in PGD2-producing enzymes, such as cyclooxygenase-2 and lipocalin-type PGD2 synthase, in the brain. Furthermore, the activity of the hippocampal noradrenergic system but not the dopaminergic or serotonergic systems was increased in CRTH2(-/-) mice. Together with the observation that untreated CRTH2(-/-) mice showed antidepressant-like activity in the forced swim test, these results provide evidence that central CRTH2-mediated signaling is critically involved in depression-related behavior. (C) 2015 Elsevier B.V. All rights reserved.	[Onaka, Yusuke; Shintani, Norihito; Haba, Ryota; Wang, Hyper; Kanoh, Takuya; Hayata-Takano, Atsuko; Kasai, Atsushi; Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka 5650871, Japan; [Onaka, Yusuke; Ago, Yukio; Matsuda, Toshio] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Med Pharmacol, Suita, Osaka 5650871, Japan; [Nakazawa, Takanobu; Nagayasu, Kazuki; Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, iPS Cell Based Res Project Brain Neuropharmacol &, Suita, Osaka 5650871, Japan; [Ago, Yukio; Waschek, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Intellectual Dev & Disabil Res Ctr, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Hayata-Takano, Atsuko; Hashimoto, Ryota; Hashimoto, Hitoshi] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Suita, Osaka 5650871, Japan; [Hayata-Takano, Atsuko; Hashimoto, Ryota; Hashimoto, Hitoshi] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan; [Hayata-Takano, Atsuko; Hashimoto, Ryota; Hashimoto, Hitoshi] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan; [Hayata-Takano, Atsuko; Hashimoto, Ryota; Hashimoto, Hitoshi] Chiba Univ, Chiba, Japan; [Hayata-Takano, Atsuko; Hashimoto, Ryota; Hashimoto, Hitoshi] Univ Fukui, Fukui, Japan; [Hirai, Hiroyuki; Nagata, Kin-ya] Bio Med Labs Inc, Dept Adv Med & Dev, Kawagoe, Saitama 3501101, Japan; [Nakamura, Masataka] Tokyo Med & Dent Univ, Human Gene Sci Ctr, Bunkyo Ku, Tokyo 1138510, Japan; [Hashimoto, Ryota] Osaka Univ, Grad Sch Med, Dept Psychiat, Suita, Osaka 5650871, Japan; [Baba, Akemichi] Hyogo Univ Hlth Sci, Pharmaceut Sci, Chuo Ku, Kobe, Hyogo 6508530, Japan	Hashimoto, H (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	shintani@phs.osaka-u.ac.jp; hasimoto@phs.osaka-u.ac.jp	Kasai, Atsushi/C-8073-2011	Kasai, Atsushi/0000-0002-1612-3078	Japan Society for the Promotion of Science (JSPS); Funding Program for Next Generation World-Leading Researchers [LS081]; Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers [S2603]; Uehara Memorial Foundation, Japan	This work was supported in part by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research, KAKENHI; the Funding Program for Next Generation World-Leading Researchers, Grant No. LS081 (H.H.); Research Fellowships for Young Scientists (Y.O. and R. Hab); the Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers, Grant No. S2603; and grants for research from the Uehara Memorial Foundation, Japan.	Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Guo JY, 2009, EUR J PHARMACOL, V612, P54, DOI 10.1016/j.ejphar.2009.03.076; Kumar A, 2010, NEUROSCI BULL, V26, P17, DOI 10.1007/s12264-010-0713-x; Sugimoto H, 2003, J PHARMACOL EXP THER, V305, P347, DOI 10.1124/jpet.102.046748; Gregus A, 2005, BEHAV BRAIN RES, V156, P105, DOI 10.1016/j.bbr.2004.05.013; Haenisch B, 2011, PHARMACOL THERAPEUT, V129, P352, DOI 10.1016/j.pharmthera.2010.12.002; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Hashimoto H, 2002, BIOCHEM BIOPH RES CO, V297, P427, DOI 10.1016/S0006-291X(02)02144-7; Teeling JL, 2010, BRAIN BEHAV IMMUN, V24, P409, DOI 10.1016/j.bbi.2009.11.006; de Paiva VN, 2010, BEHAV BRAIN RES, V215, P146, DOI 10.1016/j.bbr.2010.07.015; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Kalueff AV, 2007, BEHAV BRAIN RES, V179, P1, DOI 10.1016/j.bbr.2007.01.023; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Muller N, 2006, MOL PSYCHIATR, V11, P680, DOI 10.1038/sj.mp.4001805; Donner NC, 2012, PSYCHONEUROENDOCRINO, V37, P645, DOI 10.1016/j.psyneuen.2011.08.008; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Lanni C, 2009, CELL MOL LIFE SCI, V66, P2985, DOI 10.1007/s00018-009-0055-x; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Marsden WN, 2013, PROG NEURO-PSYCHOPH, V43, P168, DOI 10.1016/j.pnpbp.2012.12.012; Gavornik JP, 2014, NAT NEUROSCI, V17, P732, DOI 10.1038/nn.3683; Muller N, 2013, PSYCHIAT DANUB, V25, P292; Sakaue M, 2000, BRIT J PHARMACOL, V129, P1028, DOI 10.1038/sj.bjp.0703139; Hatanaka M, 2010, J PHARMACOL SCI, V113, P89, DOI 10.1254/jphs.10001SC; Mendlewicz J, 2006, INT CLIN PSYCHOPHARM, V21, P227, DOI 10.1097/00004850-200607000-00005; Ago Y, 2008, NEUROPHARMACOLOGY, V55, P1355, DOI 10.1016/j.neuropharm.2008.08.026; Dantzer R, 2009, IMMUNOL ALLERGY CLIN, V29, P247, DOI 10.1016/j.iac.2009.02.002; Lang UE, 2013, CELL PHYSIOL BIOCHEM, V31, P761, DOI 10.1159/000350094; Ohinata K, 2008, FEBS LETT, V582, P679, DOI 10.1016/j.febslet.2008.01.050; Haba R, 2012, BEHAV BRAIN RES, V228, P423, DOI 10.1016/j.bbr.2011.12.027; Fan Y, 2014, J NEUROCHEM, V128, P445, DOI 10.1111/jnc.12459; Fishkin RJ, 1997, PSYCHOPHARMACOLOGY, V132, P335, DOI 10.1007/s002130050353; Furuyashiki T, 2009, CURR OPIN PHARMACOL, V9, P31, DOI 10.1016/j.coph.2008.12.010; Galecki P, 2012, J AFFECT DISORDERS, V138, P360, DOI 10.1016/j.jad.2012.01.016; Haba R, 2014, J NEUROSCI, V34, P2514, DOI 10.1523/JNEUROSCI.1407-13.2014; Hashimoto H, 2009, J NEUROCHEM, V110, P595, DOI 10.1111/j.1471-4159.2009.06168.x; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; Korte SM, 1996, EUR J PHARMACOL, V301, P19, DOI 10.1016/0014-2999(96)00064-7; Mannangatti P, 2011, J BIOL CHEM, V286, P20239, DOI 10.1074/jbc.M111.226811; Minami T, 1996, J PHARMACOL EXP THER, V278, P1146; Mizoguchi A, 2001, P NATL ACAD SCI USA, V98, P11674, DOI 10.1073/pnas.201398898; Naoi K, 2006, BIOL PHARM BULL, V29, P1319, DOI 10.1248/bpb.29.1319; Satoh T, 2006, J IMMUNOL, V177, P2621; Sonnenberg CM, 2008, J AFFECT DISORDERS, V111, P299, DOI 10.1016/j.jad.2008.03.009; Tanaka K, 2012, J NEUROSCI, V32, P4319, DOI 10.1523/JNEUROSCI.5952-11.2012; TERAO A, 1995, J NEUROCHEM, V65, P2742; Tomimoto S, 2008, J PHARMACOL SCI, V107, P41, DOI 10.1254/jphs.FP0072173; Tully K, 2010, MOL BRAIN, V13, P15; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370	51	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAY 1	2015	284						131	137		10.1016/j.bbr.2015.02.013		7	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CF6NB	WOS:000352672300017		
J	Ishida, A; Misumi, S; Ueda, Y; Shimizu, Y; Cha-Gyun, J; Tamakoshi, K; Ishida, K; Hida, H				Ishida, Akimasa; Misumi, Sachiyo; Ueda, Yoshitomo; Shimizu, Yuko; Cha-Gyun, Jung; Tamakoshi, Keigo; Ishida, Kazuto; Hida, Hideki			Early constraint-induced movement therapy promotes functional recovery and neuronal plasticity in a subcortical hemorrhage model rat	BEHAVIOURAL BRAIN RESEARCH			English	Article						Rehabilitation; Growth factor; Intracerebral hemorrhage; Forelimb function; Plasticity; Rat	EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; USE-DEPENDENT EXAGGERATION; BRAIN-INJURY; NEUROTROPHIC FACTOR; MOTOR RECOVERY; HIPPOCAMPAL-NEURONS; AFFECTED FORELIMB; GENE-EXPRESSION; FOCAL ISCHEMIA; DELTA-FOSB	Constraint-induced movement therapy (CIMT) promotes functional recovery of impaired forelimbs after hemiplegic strokes, including intracerebral hemorrhage (ICH). We used a rat model of subcortical hemorrhage to compare the effects of delivering early or late CIMT after ICH. The rat model was made by injecting collagenase into the globus pallidus near the internal capsule, and then forcing rats to use the affected forelimb for 7 days starting either 1 day (early CIMT) or 17 days (late CIMT) after the lesion. Recovery of forelimb function in the skilled reaching test and the ladder stepping test was found after early-CIMT, while no significant recovery was shown after late CIMT or in the non-CIMT controls. Early CIMT was associated with greater numbers of AFosB-positive cells in the ipsi-lesional sensorimotor cortex layers and V. Additionally, we found expression of the growth-related genes brain-derived neurotrophic factor (BDNF) and growth-related protein 43 (GAP-43), and abundant dendritic arborization of pyramidal neurons in the sensorimotor area. Similar results were not detected in the contra-lesional cortex. In contrast to early CIMT, late CIMT failed to induce any changes in plasticity. We conclude that CIMT induces molecular and morphological plasticity in the ipsi-lesional sensorimotor cortex and facilitates better functional recovery when initiated immediately after hemorrhage. (C) 2015 Elsevier B.V. All rights reserved.	[Ishida, Akimasa; Misumi, Sachiyo; Ueda, Yoshitomo; Shimizu, Yuko; Cha-Gyun, Jung; Hida, Hideki] Nagoya City Univ, Grad Sch Med, Dept Neurophysiol & Brain Sci, Nagoya, Aichi 4678601, Japan; [Ishida, Akimasa; Tamakoshi, Keigo; Ishida, Kazuto] Nagoya Univ, Grad Sch Med, Program Phys & Occupat Therapy, Dept Phys Therapy, Nagoya, Aichi 4618673, Japan	Hida, H (reprint author), 1 Kawasumi,Mizuho Ku, Nagoya, Aichi 4678601, Japan.	hhida@med.nagoya-cu.ac.jp			Japan Society for the Promotion of Science (JSPS) [23500395, 26430020, 22500546, 26860851, 25750213, 23700471]; Japan Brain Foundation	This study was supported by Grants-in-Aid for Scientific Research in priority area (C) (No. 23500395 and No. 26430020 to HH, No. 22500546 to KI), young area (B) (No. 26860851 to SM, No. 25750213 to AI) and start up area (No. 23700471 to AI) from the Japan Society for the Promotion of Science (JSPS), and was also supported by a grant (H.H.) from the Japan Brain Foundation.	Metz GAS, 2000, BEHAV BRAIN RES, V116, P111, DOI 10.1016/S0166-4328(00)00245-X; Houle JD, 2013, ANN NY ACAD SCI, V1279, P154, DOI 10.1111/nyas.12052; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Diederich K, 2012, STROKE, V43, P185, DOI 10.1161/STROKEAHA.111.622159; Zhao SS, 2013, STROKE, V44, P1698, DOI 10.1161/STROKEAHA.111.000361; Dromerick AW, 2009, NEUROLOGY, V73, P195, DOI 10.1212/WNL.0b013e3181ab2b27; Ghosh A, 2010, NAT NEUROSCI, V13, P97, DOI 10.1038/nn.2448; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; JONES TA, 1994, J NEUROSCI, V14, P2140; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Joo HW, 2012, EUR J NEUROSCI, V36, P3691, DOI 10.1111/ejn.12014; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; DeBow SB, 2004, CAN J PHYSIOL PHARM, V82, P231, DOI 10.1139/Y04-013; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Bland ST, 2000, STROKE, V31, P1144; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Humm JL, 1999, EXP NEUROL, V157, P349, DOI 10.1006/exnr.1999.7061; Koganemaru S, 2010, BRAIN, V133, P3373, DOI 10.1093/brain/awq193; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; SINAR EJ, 1987, J NEUROSURG, V66, P568, DOI 10.3171/jns.1987.66.4.0568; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Chen JS, 1997, J NEUROSCI, V17, P4933; Clarkson AN, 2011, J NEUROSCI, V31, P3766, DOI 10.1523/JNEUROSCI.5780-10.2011; Gauthier LV, 2008, STROKE, V39, P1520, DOI 10.1161/STROKEAHA.107.502229; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45; Shen YP, 2002, J NEUROSCI, V22, P239; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6; Ishida A, 2011, J NEUROSCI RES, V89, P457, DOI 10.1002/jnr.22566; Ishida A, 2011, BEHAV BRAIN RES, V225, P126, DOI 10.1016/j.bbr.2011.06.036; Jones TA, 2013, STROKE, V44, pS104, DOI 10.1161/STROKEAHA.111.000037; Lang KC, 2013, NEUROREHAB NEURAL RE, V27, P654, DOI 10.1177/1545968313481281; Liepert J, 2006, NEUROIMAGE, V32, P1216, DOI 10.1016/j.neuroimage.2006.05.028; Livingston-Thomas JM, 2014, BEHAV BRAIN RES, V261, P210, DOI 10.1016/j.bbr.2013.12.032; Martins RAP, 2005, J NEUROCHEM, V95, P244, DOI 10.1111/j.1471-4159.2005.03360.x; Masuda T, 2007, J NEUROSCI RES, V85, P213, DOI 10.1002/jnr.21089; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; O'Bryant AJ, 2014, NEUROREHABIL NEURAL; Rodriguez Guerrero C, 2010, C P IEEE ENG MED BIO, V2010, P4472; Routtenberg A, 2000, P NATL ACAD SCI USA, V97, P7657, DOI 10.1073/pnas.97.13.7657; Sholl DA, 1956, PROG NEUROBIOL, V32, P4	54	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAY 1	2015	284						158	166		10.1016/j.bbr.2015.02.022		9	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CF6NB	WOS:000352672300020		
J	Hori, T; Inoue, N; Suzuki, H; Harakawa, S				Hori, Takuya; Inoue, Noboru; Suzuki, Hiroshi; Harakawa, Shinji			Exposure to 50 Hz Electric Fields Reduces Stress-Induced Glucocorticoid Levels in BALB/c Mice in a kV/m- and Duration-Dependent Manner	BIOELECTROMAGNETICS			English	Article						ELF; stress response; dose-dependent; glucocorticoid	CORTICAL MICROSTIMULATION; PLASMA ACTH; RATS; CORTICOSTERONE	Electric fields (EFs) can reduce elevated levels of stress-related hormones in some organisms. In this study, endocrine effects of exposure to a 50Hz EF were investigated in male BALB/c mice. Specifically, plasma glucocorticoid (GC) levels were examined because GC is known to mediate the stress response in mice, including changes induced by immobilization. Mice were exposed to 50Hz EFs (at 2.5-200kV/m) for 60min. They were immobilized for the latter half (30min). At the end of exposure period, blood samples were collected and GC levels estimated by spectrofluorometry. GC levels were not influenced by EFs in absence of immobilization, but they were significantly higher in immobilized mice than in non-immobilized mice (P<0.01). Elevated GC levels induced by immobilization were significantly reduced by exposure to an EF at 10kV/m (P<0.05), and the effect of EFs at 0-10kV/m on GC levels increased in a kV/m-dependent manner (P<0.05). In contrast, following treatment with EFs at 50 and 200kV/m, GC levels were higher than those observed at 10kV/m. To assess the effect of EF treatment duration, mice were also exposed to 50Hz EFs (10kV/m) for 6, 20, or 60min. Immobilization-induced increase in GC levels was significantly suppressed by EF exposure for 20 and 60min. Therefore, our results demonstrate that extremely low-frequency EFs alter stress response of mice in a kV/m- and duration-dependent manner. Bioelectromagnetics. 36:302-308, 2015. (c) 2015 Wiley Periodicals, Inc.	[Hori, Takuya; Inoue, Noboru; Suzuki, Hiroshi; Harakawa, Shinji] Obihiro Univ Agr & Vet Med, Bioself Regulating Sci Lab, Obihiro, Hokkaido 0808555, Japan; [Hori, Takuya; Harakawa, Shinji] Hakuju Inst Hlth Sci, Tokyo, Japan	Harakawa, S (reprint author), Obihiro Univ Agr & Vet Med, Bioself Regulating Sci Lab, Obihiro, Hokkaido 0808555, Japan.	sharakawa_hakuju@obihiro.ac.jp					Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Cho MR, 1999, FASEB J, V13, P677; Harakawa S, 2005, BIOELECTROMAGNETICS, V26, P589, DOI 10.1002/bem.20137; BASSETT CAL, 1981, J BONE JOINT SURG AM, V63, P511; MCLEOD KJ, 1987, SCIENCE, V236, P1465, DOI 10.1126/science.3589667; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Arakawa H, 1997, J PHARMACOL EXP THER, V280, P1296; DEBRUYN L, 1994, ENVIRON RES, V65, P149, DOI 10.1006/enrs.1994.1028; FDA, 2006, FDA EX SUMM ORTH REH; FREE M J, 1981, Bioelectromagnetics, V2, P105, DOI 10.1002/bem.2250020203; HACKMAN RM, 1981, BEHAV NEURAL BIOL, V32, P201, DOI 10.1016/S0163-1047(81)90483-0; Hara H., 1961, NIIGATA IGAKKAI ZASS, V75, P265; Harakawa S, 2008, J VET MED SCI, V70, P611, DOI 10.1292/jvms.70.611; Harakawa S, 2004, BIOELECTROMAGNETICS, V25, P346, DOI 10.1002/bem.10202; Harakawa S, 2004, BIOELECTROMAGNETICS, V25, P204, DOI 10.1002/bem.10187; Hjeresen D L, 1980, Bioelectromagnetics, V1, P299, DOI 10.1002/bem.2250010306; Hori T, 2005, J REPROD DEVELOP, V51, P393, DOI 10.1262/jrd.16088; Hori T, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-68; Inoue M, 2009, BIOMED RES-TOKYO, V30, P157; JAFFE R A, 1981, Bioelectromagnetics, V2, P227, DOI 10.1002/bem.2250020304; JAFFE R A, 1980, Bioelectromagnetics, V1, P131, DOI 10.1002/bem.2250010204; KATO M, 1989, BIOELECTROMAGNETICS, V10, P319, DOI 10.1002/bem.2250100309; Kim HS, 2014, BIOELECTROMAGNETICS, V35, P100, DOI 10.1002/bem.21819; KVETNANSKY R, 1979, J PHARMACOL EXP THER, V209, P287; MARINO AA, 1977, PHYSIOL CHEM PHYS M, V9, P433; MARINO AA, 1980, AM J PHYSIOL, V239, pR424; Romanenko S, 2014, J NEUROPHYSIOL, V112, P2423, DOI 10.1152/jn.00357.2014; Romo R, 2002, PHILOS T ROY SOC B, V357, P1039, DOI 10.1098/rstb.2002.1100; SUDO A, 1993, IND HEALTH, V31, P101; TAKANOYAMAMOTO T, 1992, J DENT RES, V71, P1920, DOI 10.1177/00220345920710121301; WEIGEL RJ, 1987, BIOELECTROMAGNETICS, V8, P107, DOI 10.1002/bem.2250080112; WEIGEL RJ, 1987, BIOELECTROMAGNETICS, V8, P337, DOI 10.1002/bem.2250080403; Yamada K, 1996, BIOL PHARM BULL, V19, P1244	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0197-8462	1521-186X		BIOELECTROMAGNETICS	Bioelectromagnetics	MAY	2015	36	4					302	308		10.1002/bem.21914		7	Biology; Biophysics	Life Sciences & Biomedicine - Other Topics; Biophysics	CF8OC	WOS:000352820400006		
J	Akiyama, K; Saito, S; Saito, A; Kuratomi, G; Ozeki, Y; Watanabe, T; Fujii, K; Takano, Y; Shimoda, K; Inukai, T; Nakamoto, T; Honda, G; Mori, H; Ohmori, K				Akiyama, Kazufumi; Saito, Satoshi; Saito, Atsushi; Kuratomi, Go; Ozeki, Yuji; Watanabe, Takashi; Fujii, Kumiko; Takano, Yumiko; Shimoda, Kazutaka; Inukai, Toshihiko; Nakamoto, Takaaki; Honda, Gyo; Mori, Harunobu; Ohmori, Kenichi			Effect of Aging and Premorbid IQ on Cognitive Function Assessment with BACS-J in Japanese Schizophrenia Patients and Controls	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		Schizophrenia; BACS; Reading Test; aging; antipsychotic			[Akiyama, Kazufumi; Saito, Satoshi; Saito, Atsushi; Kuratomi, Go] Dokkyo Med Univ, Sch Med, Biol Psychiat & Neurosci, Mibu, Tochigi, Japan; [Ozeki, Yuji; Watanabe, Takashi; Fujii, Kumiko; Takano, Yumiko; Shimoda, Kazutaka] Dokkyo Med Univ, Sch Med, Psychiat, Mibu, Tochigi, Japan; [Inukai, Toshihiko] Dokkyo Med Univ Koshigaya, Internal Med, Koshigaya, Japan; [Nakamoto, Takaaki] Dokkyo Med Univ Nikko, Med Ctr, Internal Med, Nikko, Japan; [Honda, Gyo; Mori, Harunobu] Mori Hosp, Psychiat, Utsunomiya, Tochigi, Japan; [Ohmori, Kenichi] Takizawa Hosp, Psychiat, Utsunomiya, Tochigi, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		568						1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207501162		
J	Citrome, L; Ota, A; Nagamizu, K; Perry, P; Weiller, E; Baker, R				Citrome, Leslie; Ota, Ai; Nagamizu, Kazuhiro; Perry, Pamela; Weiller, Emmanuelle; Baker, Ross			The Effect of Brexpiprazole (OPC-34712) versus Aripiprazole in Adult Patients with Acute Schizophrenia: An Exploratory Study	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		brexpiprazole			[Citrome, Leslie] New York Med Coll, Psychiat & Behav Sci, Suffern, NY USA; [Ota, Ai; Nagamizu, Kazuhiro] Otsuka Pharmaceut Co Ltd, Clin Res & Dev, Tokyo, Japan; [Perry, Pamela] Otsuka Pharmaceut Dev & Commercializat Inc, CNS Global Med Affairs, Princeton, NJ USA; [Weiller, Emmanuelle; Baker, Ross] H Lundbeck & Co AS, Corp Med Affairs, Valby, Denmark								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		560						1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207501154		
J	Iwata, Y; Nakajima, S; Uchida, H; Suzuki, T; Keefe, R; Plitman, E; Chung, JK; Caravaggio, F; Gerretsen, P; Mimura, M; Graff-Guerrero, A				Iwata, Yusuke; Nakajima, Shinichiro; Uchida, Hiroyuki; Suzuki, Takefumi; Keefe, Richard; Plitman, Eric; Chung, Jun Ku; Caravaggio, Fernando; Gerretsen, Philip; Mimura, Masaru; Graff-Guerrero, Ariel			Effects of Glutamate Modulators on Cognitive Impairments In Schizophrenia: A Meta-Analysis of Double-Blind Controlled Trials	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		glutamate; cognition; schizophrenia			[Iwata, Yusuke; Nakajima, Shinichiro; Plitman, Eric; Chung, Jun Ku; Caravaggio, Fernando; Gerretsen, Philip; Graff-Guerrero, Ariel] Ctr Addict & Mental Hlth, Multimodal Imaging Grp, Toronto, ON, Canada; [Uchida, Hiroyuki; Suzuki, Takefumi; Mimura, Masaru] Keio Univ Med, Dept Neuropsychiat, Tokyo, Japan; [Keefe, Richard] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		522						1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207501116		
J	Lerdrup, L; Arnt, J; Maeda, K; Stensbol, TB				Lerdrup, Linda; Arnt, Jorn; Maeda, Kenji; Stensbol, Tine B.			Brexpiprazole Reduces Impulsive Behaviour of Rats in a Delayed Discounting Test and 5-Choice-Serial-Reaction-Time-Test	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		Brexpiprazole			[Lerdrup, Linda; Arnt, Jorn; Stensbol, Tine B.] H Lundbeck & Co AS, Synapt Transmiss Vivo, Valby, Denmark; [Maeda, Kenji] Otsuka Pharmaceut Co Ltd, Qs Res Inst, Tokushima 77101, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		733						2	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207501327		
J	Moriguchi, S; Yamada, M; Nagashima, T; Takano, H; Takahata, K; Yokokawa, K; Ito, T; Kimura, Y; Ishii, T; Kato, M; Mimura, M; Suhara, T				Moriguchi, Sho; Yamada, Makiko; Nagashima, Tomohisa; Takano, Harumasa; Takahata, Keisuke; Yokokawa, Keita; Ito, Takehito; Kimura, Yasuyuki; Ishii, Tatsuya; Kato, Motoichiro; Mimura, Masaru; Suhara, Tetsuya			Evaluation of Norepinephrine Transporter in Major Depressive Disorder Using Positron Emission Tomography	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		major depressive disorder; norepinephrine transporter; PET; [18F]FMeNER-D2; mood disorder			[Moriguchi, Sho; Yamada, Makiko; Nagashima, Tomohisa; Takano, Harumasa; Takahata, Keisuke; Yokokawa, Keita; Ito, Takehito; Kimura, Yasuyuki; Ishii, Tatsuya; Suhara, Tetsuya] Natl Inst Radiol Sci, Clin Neuroimaging Team, Mol Neuroimaging Program, Mol Imaging Ctr, Chiba 260, Japan; [Moriguchi, Sho; Kato, Motoichiro; Mimura, Masaru] Keio Univ, Neuropsychiat, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		654						1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207501248		
J	Takeuchi, H; Fervaha, G; Uchida, H; Bies, RR; Remington, G				Takeuchi, Hiroyoshi; Fervaha, Gagan; Uchida, Hiroyuki; Bies, Robert R.; Remington, Gary			Antipsychotic Drug Plasma Concentrations and Amotivation in Schizophrenia	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		schizophrenia; antipsychotics; amotivation; negative symptoms; plasma concentrations			[Takeuchi, Hiroyoshi; Fervaha, Gagan; Remington, Gary] Ctr Addict & Mental Hlth, Schizophrenia Div, Toronto, ON, Canada; [Uchida, Hiroyuki] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Bies, Robert R.] Indiana Univ Sch Med, Div Clin Pharmacol, Indianapolis, IN 46202 USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		722						1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207501316		
J	Yoshida, K; Imasaka, Y; Kubo, K; Suzuki, T; Mimura, M; Uchida, H				Yoshida, Kazunari; Imasaka, Yasushi; Kubo, Ken-ichiro; Suzuki, Takefumi; Mimura, Masaru; Uchida, Hiroyuki			Resilience in Patients with Schizophrenia: A Comparative Study between a Distant Island and an Urban Area	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		Resilience; Schizophrenia; Duration of illness			[Yoshida, Kazunari; Suzuki, Takefumi; Mimura, Masaru; Uchida, Hiroyuki] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Imasaka, Yasushi; Kubo, Ken-ichiro] Ohizumi Hosp, Dept Neuropsychiat, Tokyo, Japan; [Imasaka, Yasushi; Kubo, Ken-ichiro] Ohshima Med Ctr, Dept Neuropsychiat, Tokyo, Japan; [Kubo, Ken-ichiro] Keio Univ, Sch Med, Dept Anat, Tokyo, Japan; [Suzuki, Takefumi] Inokashira Hosp, Dept Psychiat, Tokyo, Japan; [Uchida, Hiroyuki] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		601						1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207501195		
J	Nakamura, M; Noda, Y; Saeki, T; Hayasaka, S; Izuno, T; Yoshiike, T; Morinaga, S; Hirayasu, Y				Nakamura, Motoaki; Noda, Yoshihiro; Saeki, Takashi; Hayasaka, Shunsuke; Izuno, Takuji; Yoshiike, Takuya; Morinaga, Shuichi; Hirayasu, Yoshio			Functional and Structural Neuroplasticity Possibly Induced by a Series of Prefrontal rTMS for Major Depression	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		repetitive transcranial magnetic stimulation; neuroplasticity; prefrontal; theta gamma coupling; MRI			[Nakamura, Motoaki; Yoshiike, Takuya; Morinaga, Shuichi] Kanagawa Psychiat Ctr, Lab Neuromodulat, Yokohama, Kanagawa, Japan; [Nakamura, Motoaki; Saeki, Takashi; Hayasaka, Shunsuke; Hirayasu, Yoshio] Yokohama City Univ, Sch Med, Dept Psychiat, Yokohama, Kanagawa 232, Japan; [Nakamura, Motoaki; Izuno, Takuji] Showa Univ, Sch Med, Dept Psychiat, Tokyo 142, Japan; [Nakamura, Motoaki; Hayasaka, Shunsuke] Adv Telecommun Res Inst Int ATR, Computat Neurosci Labs, Brain Informat Commun Res Lab Grp, Kyoto, Japan; [Noda, Yoshihiro] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON M5S 1A1, Canada								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		58	22S	23S				2	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207500059		
J	Shumyatsky, G; Uchida, S; Martel, G				Shumyatsky, Gleb; Uchida, Shusaku; Martel, Guillaume			Understanding Fear Memory Encoding Is Critical for Improving Memory Strength	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		learning-dependent; synapse; nucleus; dendritic transport; microtubules			[Shumyatsky, Gleb] Rutgers State Univ, Genet, Piscataway, NJ USA; [Uchida, Shusaku] Yamaguchi Univ, Neurosci, Grad Sch Med, Yamaguchi, Japan; [Martel, Guillaume] INSERM, U894, Equipe Epelbaum, Ctr Psychiat & Neurosci, Paris, France								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		87	33S	34S				2	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207500088		
J	Davis, LL; Ota, A; Perry, P; Tsuneyoshi, K; Weiller, E; Baker, R				Davis, Lori L.; Ota, Ai; Perry, Pamela; Tsuneyoshi, Kana; Weiller, Emmanuelle; Baker, Ross			Adjunctive Brexpiprazole (OPC-34712) in Patients with Major Depressive Disorder and Anxiety Symptoms: An Exploratory Study	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		Major depressive disorder; Anxiety			[Davis, Lori L.] VA Med Ctr, Res & Dev, Tuscaloosa, AL USA; [Ota, Ai; Tsuneyoshi, Kana] Otsuka Pharmaceut Co Ltd, Clin Res & Dev, Tokyo, Japan; [Perry, Pamela; Baker, Ross] Otsuka Pharmaceut Dev & Commercializat Inc, CNS Global Med Affairs, Princeton, NJ USA; [Weiller, Emmanuelle] Corp Med Affairs H Lundbeck AS, Valby, Denmark								0	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		177	66S	66S				1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207500170		
J	Nakajima, S; Caravaggio, F; Mamo, DC; Mulsant, BH; Chung, JK; Plitman, E; Iwata, Y; Gerretsen, P; Uchida, H; Suzuki, T; Mar, W; Wilson, AA; Houle, S; Graff-Guerrero, A				Nakajima, Shinichiro; Caravaggio, Fernando; Mamo, David C.; Mulsant, Benoit H.; Chung, Jun Ku; Plitman, Eric; Iwata, Yusuke; Gerretsen, Philip; Uchida, Hiroyuki; Suzuki, Takefumi; Mar, Wanna; Wilson, Alan A.; Houle, Sylvain; Graff-Guerrero, Ariel			Dopamine D2 and D3 Receptor Availability in Antipsychotic-free patients with Schizophrenia in Later Life: A Cross-sectional [11C]-(+)-PHNO and [11C]-raclopride PET Study	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		schizophrenia; PET; dopamine; geriatric; D3			[Nakajima, Shinichiro; Caravaggio, Fernando; Chung, Jun Ku; Plitman, Eric; Iwata, Yusuke; Gerretsen, Philip; Mar, Wanna; Graff-Guerrero, Ariel] Ctr Addict & Mental Hlth, Multimodal Imaging Grp, Toronto, ON, Canada; [Mamo, David C.] Univ Malta, Dept Psychiat, Valletta, Malta; [Mulsant, Benoit H.] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Div, Toronto, ON, Canada; [Uchida, Hiroyuki; Suzuki, Takefumi] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Wilson, Alan A.; Houle, Sylvain] Ctr Addict & Mental Hlth, Res Imaging Ctr, Toronto, ON, Canada								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		303	118S	118S				1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207500296		
J	Lerdrup, L; Maeda, K; Bundgaard, C; Stensbol, TB				Lerdrup, Linda; Maeda, Kenji; Bundgaard, Christoffer; Stensbol, Tine B.			Brexpiprazole Shows Antidepressant-and Anxiolytic-Like Effects in the Rat Forced Swim and Vogel Conflict Tests	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		Brexpiprazole			[Lerdrup, Linda; Bundgaard, Christoffer; Stensbol, Tine B.] H Lundbeck & Co AS, Synapt Transmiss Res, Valby, Denmark; [Maeda, Kenji] Otsuka Pharmaceut Co Ltd Tokushima, Qs Res Inst, Tokushima, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		861	309S	309S				1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207502062		
J	Ray, B; Boakye-Agyeman, F; Zhu, HJ; Biernacka, J; Liu, D; Biendarra, S; Jenkins, G; Kalari, K; Mushiroda, T; Nakamura, Y; Kubo, M; Matson, W; Wang, LW; Kaddurah-Daouk, R; Weinshilboum, R				Ray, Balmiki; Boakye-Agyeman, Felix; Zhu, Hongjie; Biernacka, Joanna; Liu, Duan; Biendarra, Sherri; Jenkins, Gregory; Kalari, Krishna; Mushiroda, Taisei; Nakamura, Yusuke; Kubo, Michiaki; Matson, Wayne; Wang, Liewei; Kaddurah-Daouk, Rima; Weinshilboum, Richard			Aryl Hydrocarbon Receptor (AHR) Genetic Variation Is Associated with Baseline Plasma Kynurenine (KYN) Concentrations in Major Depressive Disorder (MDD) Mediated by AHR-Repressor (AHRR): A Pharmacometabolomics-Informed Pharmacogenomic Study	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		Major Depressive Disorder; Pharmacogenomics; Pharmacometabolomics; Kynurenine; AHR			[Ray, Balmiki; Boakye-Agyeman, Felix; Biernacka, Joanna; Liu, Duan; Biendarra, Sherri; Jenkins, Gregory; Kalari, Krishna; Wang, Liewei; Weinshilboum, Richard] Mayo Clin, Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Zhu, Hongjie; Kaddurah-Daouk, Rima] Duke Univ, Sch Med, Psychiat & Behav Sci, Pharmacometabol Res Network, Durham, NC USA; [Mushiroda, Taisei; Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Riken Ctr Genom Med, Yokohama, Kanagawa, Japan; [Nakamura, Yusuke] Univ Chicago, Knapp Ctr Biomed Discovery, Chicago, IL 60637 USA; [Matson, Wayne] Bedford VA Med Ctr, Biochem, Bedford, MA USA			Mushiroda, Taisei/E-3022-2010					0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		914	330S	331S				2	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207502115		
J	Harada, K; Matsuo, K; Yamagata, H; Nakashima, M; Nakano, M; Higuchi, N; Higuchi, F; Hobara, T; Otsuki, K; Shibata, T; Watanuki, T; Ueda, K; Furukawa, M; Fukunaga, M; Fujita, Y; Shimoji, K; Matsubara, T; Matsunaga, N; Watanabe, Y				Harada, Kenichiro; Matsuo, Koji; Yamagata, Hirotaka; Nakashima, Mami; Nakano, Masayuki; Higuchi, Naoko; Higuchi, Fumihiro; Hobara, Teruyuki; Otsuki, Koji; Shibata, Tomohiko; Watanuki, Toshio; Ueda, Katsuhiko; Furukawa, Matakazu; Fukunaga, Masaki; Fujita, Yusuke; Shimoji, Keigo; Matsubara, Toshio; Matsunaga, Naofumi; Watanabe, Yoshifumi			Reduced Gray-matter Volume of Fronto-temporal Cortex in Patients with Late-life Depression	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		late-life depression; voxel-based morphometry; diffusion tensor imaging; orbitofrontal cortex			[Harada, Kenichiro; Matsuo, Koji; Yamagata, Hirotaka; Higuchi, Naoko; Higuchi, Fumihiro; Hobara, Teruyuki; Watanuki, Toshio; Matsubara, Toshio; Watanabe, Yoshifumi] Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Ube, Yamaguchi 755, Japan; [Nakashima, Mami] Nagatoichinomiya Hosp, Dept Psychiat, Shimonoseki, Yamaguchi, Japan; [Nakano, Masayuki] Katakura Hosp, Dept Psychiat, Ube, Yamaguchi, Japan; [Otsuki, Koji] Misumi Hosp, Dept Pschiat, Nagato, Japan; [Shibata, Tomohiko] Yamaguchi Grand Med Ctr, Dept Psychiat, Hofu, Japan; [Ueda, Katsuhiko; Furukawa, Matakazu; Matsunaga, Naofumi] Yamaguchi Univ, Grad Sch Med, Dept Radiol, Ube, Yamaguchi 755, Japan; [Fukunaga, Masaki] Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi, Japan; [Fujita, Yusuke] Yamaguchi Univ, Fac Engn, Dept Comp Sci & Syst Engn, Ube, Yamaguchi 755, Japan; [Shimoji, Keigo] Tokyo Metropolitan Geriatr Hosp, Dept Radiol, Tokyo 173, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		983	355S	355S				1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207502176		
J	Matsubara, T; Matsuo, K; Harada, K; Nakashima, M; Nakano, M; Hirotsu, M; Higuchi, N; Watanuki, T; Higuchi, F; Otsuki, K; Shibata, T; Hobara, T; Yamagata, H; Watanabe, Y				Matsubara, Toshio; Matsuo, Koji; Harada, Kenichiro; Nakashima, Mami; Nakano, Masayuki; Hirotsu, Masako; Higuchi, Naoko; Watanuki, Toshio; Higuchi, Fumihiro; Otsuki, Koji; Shibata, Tomohiko; Hobara, Teruyuki; Yamagata, Hirotaka; Watanabe, Yoshifumi			Different Fronto-Temporal Activation During an Emotional Word Task in Patients with Unipolar and Bipolar Depression: A Functional Near-Infrared Spectroscopy Study	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		bipolar disorder; A functional near-infrared spectroscopy; major depressive disorder			[Matsubara, Toshio; Matsuo, Koji; Harada, Kenichiro; Hirotsu, Masako; Higuchi, Naoko; Watanuki, Toshio; Higuchi, Fumihiro; Hobara, Teruyuki; Yamagata, Hirotaka; Watanabe, Yoshifumi] Yamaguchi Univ, Grad Sch Med, Neurosci, Ube, Yamaguchi 755, Japan; [Nakashima, Mami] Nagatoichinomiya Hosp, Psychiat, Shimonoseki, Yamaguchi, Japan; [Nakano, Masayuki] Katakura Hosp, Psychiat, Ube, Yamaguchi, Japan; [Otsuki, Koji] Misumi Hosp, Psychiat, Nagato, Japan; [Shibata, Tomohiko] Yamaguchi Grand Med Ctr, Dept Psychiat, Hofu, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		984	355S	355S				1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207502177		
J	Takahata, K; Shimada, H; Shinotoh, H; Kimura, Y; Kitamura, S; Endo, H; Niwa, F; Moriguchi, S; Ichise, M; Mizushima, J; Tabuchi, H; Mimura, M; Kato, M; Yamada, M; Higuchi, M; Suhara, T				Takahata, Keisuke; Shimada, Hitoshi; Shinotoh, Hitoshi; Kimura, Yasuyuki; Kitamura, Soichiro; Endo, Hironobu; Niwa, Fumitoshi; Moriguchi, Sho; Ichise, Masanori; Mizushima, Jin; Tabuchi, Hajime; Mimura, Masaru; Kato, Motoichiro; Yamada, Makiko; Higuchi, Makoto; Suhara, Tetsuya			Imaging of Tau and Amyloid Pathology in Patients With Traumatic Brain Injury: A PET Study Using [11C]PBB3 and [11C]PIB	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		Traumatic Brain Injury; Tau; Amyloid; PET; Chronic Traumatic Encephalopahty			[Takahata, Keisuke; Shimada, Hitoshi; Shinotoh, Hitoshi; Kimura, Yasuyuki; Kitamura, Soichiro; Endo, Hironobu; Niwa, Fumitoshi; Moriguchi, Sho; Ichise, Masanori; Yamada, Makiko; Higuchi, Makoto; Suhara, Tetsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Takahata, Keisuke; Mizushima, Jin; Tabuchi, Hajime; Kato, Motoichiro] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Mimura, Masaru] Key Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		1007	364S	365S				2	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207502200		
J	Mizuno, Y; Suzuki, T; Hofer, A; Fleischhacker, WW; Mimura, M; Uchida, H				Mizuno, Yuya; Suzuki, Takefumi; Hofer, Alex; Fleischhacker, Wolfgang W.; Mimura, Masaru; Uchida, Hiroyuki			Clinical and Biological Correlates of Resilience in Patients with Schizophrenia, Bipolar I Disorder, and Healthy Individuals: A Cross-sectional Study	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		resilience; schizophrenia; bipolar disorder; recovery; vulnerability			[Mizuno, Yuya; Suzuki, Takefumi; Mimura, Masaru; Uchida, Hiroyuki] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Hofer, Alex; Fleischhacker, Wolfgang W.] Med Univ Innsbruck, Dept Psychiat & Psychotherapy, A-6020 Innsbruck, Austria								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		1022	370S	370S				1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207502215		
J	Oshibuchi, H				Oshibuchi, Hidehiro			Counteraction of Serotonin 5-HT2C Receptors Expressed on the Non-gabaergic Neurons Versus on the Gabaergic Neurons	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		5-HT 2C receptor; non-GABAergic neuron; mCPP; Schizophrenia; Treatment-Refractory Schizophrenia			[Oshibuchi, Hidehiro] Tokyo Womens Med Univ, Psychiat, Tokyo, Japan; [Oshibuchi, Hidehiro] UCSF, Ctr Neurobiol & Psychiat, San Francisco, CA USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		1089	398S	398S				1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207502282		
J	Featherstone, RE; Liang, YL; Nagy, L; Shin, R; Kogan, JH; Matsumoto, M; Siegel, SJ				Featherstone, Robert E.; Liang, Yuling; Nagy, Lauren; Shin, Rick; Kogan, Jeffery H.; Matsumoto, Mitsuyuki; Siegel, Steven J.			Baclofen Restores Excitatory-inhibitory Balance in 15q13.3 Deletion Mice	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		EEG; Gamma oscillation; Autism; Copy number variation; GABA			[Featherstone, Robert E.; Liang, Yuling; Nagy, Lauren; Siegel, Steven J.] Univ Penn, Psychiat Translat Neurosci, Philadelphia, PA 19104 USA; [Shin, Rick; Kogan, Jeffery H.] Astellas Res Inst Amer LLC, CNS, Skokie, IL USA; [Matsumoto, Mitsuyuki] Astellas Res Inst Japan LLC, CNS, Tokyo, Japan			Matsumoto, Mitsuyuki/G-3207-2012	Matsumoto, Mitsuyuki/0000-0002-1172-2354				0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		1092	399S	399S				1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207502285		
J	Ohi, K; Li, M; Shin, JH; Ye, TZ; Bigos, KL; Ursini, G; Chen, Q; Goldman, AL; Mattay, VS; Kleinman, JE; Hyde, TM; Weinberger, DR				Ohi, Kazutaka; Li, Ming; Shin, Joo Heon; Ye, Tianzhang; Bigos, Kristin L.; Ursini, Gianluca; Chen, Qiang; Goldman, Aaron L.; Mattay, Venkata S.; Kleinman, Joel E.; Hyde, Thomas M.; Weinberger, Daniel R.			Schizophrenia-Associated Genetic Variants on Chromosome 22q13 Regulate NAGA and CYP2D6 Genes Expression in Dorsolateral Prefrontal Cortex	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		genome-wide association study; RNA-seq; gene expression; NAGA; CYP2D6			[Ohi, Kazutaka; Li, Ming; Shin, Joo Heon; Ye, Tianzhang; Bigos, Kristin L.; Ursini, Gianluca; Chen, Qiang; Goldman, Aaron L.; Mattay, Venkata S.; Kleinman, Joel E.; Hyde, Thomas M.; Weinberger, Daniel R.] Johns Hopkins Med Campus, Lieber Inst Brain Dev, Baltimore, MD USA; [Ohi, Kazutaka] Osaka Univ, Dept Psychiat, Grad Sch Med, Osaka, Japan; [Hyde, Thomas M.; Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Hyde, Thomas M.; Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Inst Genet Med, Baltimore, MD USA			Li, Ming/K-7455-2013	Li, Ming/0000-0002-8197-6552				0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		1101	403S	403S				1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207502294		
J	Huang, E; Zai, C; Maciukiewicz, M; Felsky, D; Ikeda, M; Santos, PM; Porcelli, S; Samochowiec, J; Gao, SG; Meltzer, H; Lieberman, J; Potkin, S; Mueller, D; Kennedy, JL				Huang, Eric; Zai, Clement; Maciukiewicz, Malgorzata; Felsky, Daniel; Ikeda, Masashi; Molero Santos, Patricio; Porcelli, Stefano; Samochowiec, Jerzy; Gao, Shugui; Meltzer, Herbert; Lieberman, Jeffrey; Potkin, Steven; Mueller, Daniel; Kennedy, James L.			Catechol-o-methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment: A Meta-analysis	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		Antipsychotics; Clinical Response; Catechol-O-methyltransferase; Schizophrenia			[Huang, Eric; Zai, Clement; Maciukiewicz, Malgorzata; Felsky, Daniel; Mueller, Daniel; Kennedy, James L.] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Ikeda, Masashi] Fujita Hlth Univ, Dept Psychiat, Toyoake, Aichi, Japan; [Molero Santos, Patricio] Univ Navarra Clin, Dept Psiquiatria, Pamplona, Spain; [Porcelli, Stefano] Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy; [Samochowiec, Jerzy] Pomeranian Med Univ, Dept Psychiat, Szczecin, Poland; [Gao, Shugui] Ningbo Univ, Dept Psychiat, Sch Med, Ningbo 315211, Zhejiang, Peoples R China; [Meltzer, Herbert] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Lieberman, Jeffrey] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA; [Potkin, Steven] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA USA			Zai, Clement/G-7379-2015; Molero, Patricio/K-8834-2013; Samochowiec, Jerzy/G-8175-2014	Samochowiec, Jerzy/0000-0003-1438-583X				0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		1110	406S	406S				1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207502303		
J	Uemura, T; Green, M; Warsh, JJ				Uemura, Takuji; Green, Marty; Warsh, Jerry J.			Chronic LiCl Treatment Suppresses Thrombin-Induced Intracellular Calcium Mobilization through TRPC3 Channels in U-87MG Cells	BIOLOGICAL PSYCHIATRY			English	Meeting Abstract	70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology	MAY 14-16, 2015	Toronto, CANADA	Soc Biol Psychiat		Lithium; Thrombin; Calcium; TRPC3; S100B			[Uemura, Takuji] Univ Yamanashi, Dept Neuropsychiat, Chuo Ku, Yamanashi, Japan; [Uemura, Takuji; Green, Marty; Warsh, Jerry J.] Ctr Addict & Mental Hlth, Lab Cellular & Mol Pathophysiol, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Uemura, Takuji; Warsh, Jerry J.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Warsh, Jerry J.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Warsh, Jerry J.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Warsh, Jerry J.] Univ Toronto, Program Neurosci, Toronto, ON, Canada								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAY 1	2015	77	9		S		1125	412S	412S				1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0BM	WOS:000352207502318		
J	Takai, T; Koike, T; Honda, E; Kajita, Y; Nakamura, M; Morimoto, S; Hoashi, Y; Kamata, M; Watanabe, T; Igari, T; Terauchi, J				Takai, Takafumi; Koike, Tatsuki; Honda, Eiji; Kajita, Yuichi; Nakamura, Minoru; Morimoto, Sachie; Hoashi, Yasutaka; Kamata, Makoto; Watanabe, Tomomichi; Igari, Tomoko; Terauchi, Jun			Design and synthesis of piperazine derivatives as a novel class of gamma-secretase modulators that selectively lower A beta(42) production	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						gamma-Secretase modulator; Alzheimer's disease; Amyloid beta	ALZHEIMERS-DISEASE; INHIBITOR; DISCOVERY	Novel piperazine derivatives as gamma-secretase modulators (GSMs) were prepared and tested for their ability to selectively lower A beta(42) production. Lead compound 3, with selective A beta(42)-lowering activity, was modified by replacing its imidazolylphenyl moiety with an oxazolylphenyl moiety. Optimization of the urea group significantly improved mouse microsomal stability, while retaining both activity and selectivity. These efforts led to the successful identification of an orally available and brain-penetrant GSM, 6j, which selectively reduced brain A beta(42) in mice. (C) 2015 Elsevier Ltd. All rights reserved.	[Takai, Takafumi; Koike, Tatsuki; Honda, Eiji; Kajita, Yuichi; Nakamura, Minoru; Morimoto, Sachie; Hoashi, Yasutaka; Kamata, Makoto; Watanabe, Tomomichi; Igari, Tomoko; Terauchi, Jun] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan	Takai, T (reprint author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraokahigashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	takafumi.takai@takeda.com					[Anonymous], MOL OP ENV MOE 2011; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; [Anonymous], CLOGP VERS 4 82; Pettersson M, 2011, EXPERT OPIN THER PAT, V21, P205, DOI 10.1517/13543776.2011.547479; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Selkoe DJ, 2001, PHYSIOL REV, V81, P741; Waring MJ, 2010, EXPERT OPIN DRUG DIS, V5, P235, DOI 10.1517/17460441003605098; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; SAKAI K, 1986, B CHEM SOC JPN, V59, P179, DOI 10.1246/bcsj.59.179; Fischer C, 2011, BIOORG MED CHEM LETT, V21, P773, DOI 10.1016/j.bmcl.2010.11.111; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Carlson C, 2011, ALZHEIMERS DEMENT, V7, P396, DOI 10.1016/j.jalz.2011.05.2353; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Pettersson M, 2013, EXPERT OPIN THER PAT, V23, P1349, DOI 10.1517/13543776.2013.821465; Fischer C, 2011, BIOORG MED CHEM LETT, V21, P4083, DOI 10.1016/j.bmcl.2011.04.089; Hall A, 2014, PROGR MED CHEM, V53, P101, DOI 10.1016/B978-0-444-63380-4.00003-2; Koike T., 2011, WO Patent, Patent No. [WO2011016559, 2011016559]; Oehlrich D, 2011, J MED CHEM, V54, P669, DOI 10.1021/jm101168r; SUZUKI N, 1994, AM J PATHOL, V145, P452; Varma RS, 1998, J HETEROCYCLIC CHEM, V35, P1533	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	MAY 1	2015	23	9					1923	1934		10.1016/j.bmc.2015.03.055		12	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CF6WZ	WOS:000352698700002		
J	Hayashi, D; Tsukioka, N; Inoue, Y; Matsubayashi, Y; Iizuka, T; Higuchi, K; Ikegami, Y; Kawasaki, T				Hayashi, Daigo; Tsukioka, Naoki; Inoue, Yutaka; Matsubayashi, Yoshiki; Iizuka, Toshimasa; Higuchi, Kazuhiro; Ikegami, Yoji; Kawasaki, Tomomi			Synthesis and ABCG2 inhibitory evaluation of 5-N-acetylardeemin derivatives	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Ardeemin; Multicomponent reaction; Suzuki-Miyaura coupling; ABCG2 modulator; Multidrug resistance	CANCER RESISTANCE PROTEIN; REVERSES MULTIDRUG-RESISTANCE; MULTIPLE-DRUG RESISTANCE; P-GLYCOPROTEIN; IN-VITRO; HETEROCYCLIC COMPOUND; FUMITREMORGIN-C; MDR REVERSAL; LUNG-CANCER; TUMOR-CELLS	An efficient and versatile synthesis of 5-N-acetylardeemin (1a) and sixteen 2-, 3-and 13-substituted derivatives 1b-q was achieved through Ugi three-component reaction of 3,3a, 8,8a-tetrahydropyrrolo[2,3-b] indole and cyclization/epimerization. Their inhibitory activity on the drug efflux of breast cancer resistance protein (ABCG2) was evaluated by flow cytometric analysis of accumulation of Hoechst 33342 stain in Flp-In-293/ABCG2 cells. Most of the derivatives exhibited a stronger ABCG2 inhibitory effect compared with natural product 1a. The derivative 1m with a 4-tolyl substituent at the C-13 position exhibited the most potent ABCG2 inhibition. This preliminary structure-activity relationship study indicates that an electron-rich aryl moiety as the 13-substituent is key to increasing the inhibitory activity. (C) 2015 Elsevier Ltd. All rights reserved.	[Hayashi, Daigo; Tsukioka, Naoki; Inoue, Yutaka; Matsubayashi, Yoshiki; Iizuka, Toshimasa; Higuchi, Kazuhiro; Ikegami, Yoji; Kawasaki, Tomomi] Meiji Pharmaceut Univ, Tokyo 2048588, Japan	Higuchi, K (reprint author), Meiji Pharmaceut Univ, 2-522-1 Noshio, Tokyo 2048588, Japan.	khiguchi@my-pharm.ac.jp; kawasaki@my-pharm.ac.jp			JSPS KAKENHI [24590032]	This work was supported by JSPS KAKENHI Grant Number 24590032. We are grateful to N. Eguchi, T. Koseki, and S. Yamada at the Analytical Center of MPU for performing microanalysis and mass spectrometry.	MARSDEN SP, 1994, J AM CHEM SOC, V116, P11143, DOI 10.1021/ja00103a034; Matsson P, 2007, J PHARMACOL EXP THER, V323, P19, DOI 10.1124/jpet.107.124768; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; He B, 2009, J ORG CHEM, V74, P298, DOI 10.1021/jo802216z; HOCHLOWSKI JE, 1993, J ANTIBIOT, V46, P380; Kannan P, 2011, ACS CHEM NEUROSCI, V2, P82, DOI 10.1021/cn100078a; Rabindran SK, 2000, CANCER RES, V60, P47; Kuhnle M, 2009, J MED CHEM, V52, P1190, DOI 10.1021/jm8013822; Allen JD, 2002, MOL CANCER THER, V1, P417; Takiguchi S, 2010, J ORG CHEM, V75, P1126, DOI 10.1021/jo9023107; Depew KM, 1999, J AM CHEM SOC, V121, P11953, DOI 10.1021/ja991558d; Smith PJ, 2009, CYTOM PART A, V75A, P924, DOI 10.1002/cyto.a.20800; Hitchcock SA, 2012, J MED CHEM, V55, P4877, DOI 10.1021/jm201136z; Chou TC, 1998, P NATL ACAD SCI USA, V95, P8369, DOI 10.1073/pnas.95.14.8369; KARWOWSKI JP, 1993, J ANTIBIOT, V46, P374; Dai CL, 2008, CANCER RES, V68, P7905, DOI 10.1158/0008-5472.CAN-08-0499; de Bruin M, 1999, CANCER LETT, V146, P117, DOI 10.1016/S0304-3835(99)00182-2; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Borisov RS, 2010, ORG LETT, V12, P3894, DOI 10.1021/ol101590w; Lin JH, 2003, DRUG METAB REV, V35, P417, DOI 10.1081/DMR-120026871; Robey RW, 2007, CANCER METAST REV, V26, P39, DOI 10.1007/s10555-007-9042-6; Robey RW, 2004, CANCER RES, V64, P1242, DOI 10.1158/0008-5472.CAN-03-3298; Robert J, 2003, J MED CHEM, V46, P4805, DOI 10.1021/jm030183a; TSURUO T, 1981, CANCER RES, V41, P1967; Wang Y, 2012, ORG BIOMOL CHEM, V10, P2793, DOI 10.1039/c2ob00014h; Avenano A., 2002, CURR MED CHEM, V9, P159; Avendano C, 2006, LETT DRUG DES DISCOV, V3, P369, DOI 10.2174/157018006777805558; Gu XK, 2014, BIOORG MED CHEM LETT, V24, P3419, DOI 10.1016/j.bmcl.2014.05.081; Iizuka T, 2010, TETRAHEDRON LETT, V51, P6003, DOI 10.1016/j.tetlet.2010.09.026; Ishikawa T, 2005, NATURWISSENSCHAFTEN, V92, P451, DOI 10.1007/s00114-005-0019-4; Kobayashi K, 2001, CHEM LETT, P602; Medez V. C., 1998, CANC LETT, V132, P45; Minami T, 2012, MOL CANCER THER, V11, P830, DOI 10.1158/1535-7163.MCT-11-0884; Nakagawa H., 2009, FEBS J, V276, P1126; Ochoa-Puentes C, 2013, ACS MED CHEM LETT, V4, P393, DOI 10.1021/ml4000832; Valdameri G, 2012, J MED CHEM, V55, P966, DOI 10.1021/jm201404w; Zheng XL, 2014, APOPTOSIS, V19, P1293, DOI 10.1007/s10495-014-0998-8	37	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	MAY 1	2015	23	9					2010	2023		10.1016/j.bmc.2015.03.017		14	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CF6WZ	WOS:000352698700011		
J	Itadani, S; Takahashi, S; Ima, M; Sekiguchi, T; Aratani, Y; Egashira, H; Matsumura, N; Inoue, A; Yonetomi, Y; Fujita, M; Nakayama, Y; Takeuchi, J				Itadani, Satoshi; Takahashi, Shinya; Ima, Masaki; Sekiguchi, Tetsuya; Aratani, Yoshiyuki; Egashira, Hiromu; Matsumura, Naoya; Inoue, Atsuto; Yonetomi, Yasuo; Fujita, Manabu; Nakayama, Yoshisuke; Takeuchi, Jun			Discovery of a potent, orally available dual CysLT(1) and CysLT(2) antagonist with dicarboxylic acid	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						CysLT(1); CysLT(2); Dual antagonist; Dicarboxylic acid; Pharmacokinetics; HBDs	CYSTEINYL-LEUKOTRIENES; ASTHMATIC-PATIENTS; PROPERTY PROFILES; DRUG CANDIDATES; RECEPTOR; EXPRESSION; PREDICTION; CELLS; PHARMACOKINETICS; BIOAVAILABILITY	A potent, orally available dual CysLT(1) and CysLT(2) receptor antagonist with a dicarboxylic acid is described. 4-(3-(Carboxymethyl)-4-{(E)-2-[4-(4-phenoxybutoxy) phenyl] vinyl}-1H-indol-1-yl) butanoic acid (15: ONO-4310321, IC50: CysLT(1) = 13 nM, CysLT(2) = 25 nM) showed excellent pharmacokinetic profiles (%F-rat = 100) compared with our previously reported compound 1 (%F-rat = 1.5). In addition, we describe a new rule for dicarboxylic acid derivatives to show good oral bioavailability (%F-rat >= 40) in rats (HBDs: <= 2, ClogP: >6.5 and TPSA: <100). Especially, reduction of only one hydrogen-bond donor (HBDs) showed dramatically improved oral bioavailability. This small change of HBDs in dicarboxylic acid derivatives is generally a very effective modification. (C) 2015 Elsevier Ltd. All rights reserved.	[Itadani, Satoshi; Takahashi, Shinya; Ima, Masaki; Sekiguchi, Tetsuya; Aratani, Yoshiyuki; Egashira, Hiromu; Nakayama, Yoshisuke; Takeuchi, Jun] Ono Pharmaceut Co Ltd, Med Chem Res Labs, Shimamoto, Osaka 6188585, Japan; [Matsumura, Naoya] Ono Pharmaceut Co Ltd, Pharmaceut Technol Labs, Exploratory Pharmaceut Grp, Shimamoto, Osaka 6188585, Japan; [Inoue, Atsuto; Yonetomi, Yasuo; Fujita, Manabu] Ono Pharmaceut Co Ltd, Dept Biol & Pharmacol, Shimamoto, Osaka 6188585, Japan	Itadani, S (reprint author), Ono Pharmaceut Co Ltd, Med Chem Res Labs, 3-1-1 Sakurai, Shimamoto, Osaka 6188585, Japan.	itadani@ono.co.jp					Accelrys Inc., MDDR MDL DRUG DAT RE; Mellor EA, 2003, P NATL ACAD SCI USA, V100, P11589, DOI 10.1073/pnas.2034927100; Charifson PS, 2014, J MED CHEM, V57, P9701, DOI 10.1021/jm501000a; Mita H, 2001, CLIN EXP ALLERGY, V31, P1714, DOI 10.1046/j.1365-2222.2001.01184.x; Higashi N, 2004, J ALLERGY CLIN IMMUN, V113, P277, DOI 10.1016/j.jaci.2003.10.068; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Egan WJ, 2000, J MED CHEM, V43, P3867, DOI 10.1021/jm000292e; Wenlock MC, 2003, J MED CHEM, V46, P1250, DOI 10.1021/jm021053p; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Capra V, 2007, MED RES REV, V27, P469, DOI 10.1002/med.20071; Egan WJ, 2002, ADV DRUG DELIVER REV, V54, P273, DOI 10.1016/S0169-409X(02)00004-2; Lynch KR, 1999, NATURE, V399, P789; Figueroa DJ, 2003, CLIN EXP ALLERGY, V33, P1380, DOI 10.1046/j.1365-2222.2003.01786.x; Leeson PD, 2004, J MED CHEM, V47, P6338, DOI 10.1021/jm049717d; Hou TJ, 2007, J CHEM INF MODEL, V47, P208, DOI 10.1021/ci600343x; Kohara Y, 1996, J MED CHEM, V39, P5228, DOI 10.1021/jm960547h; Martin YC, 2005, J MED CHEM, V48, P3164, DOI 10.1021/jm0492002; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Sjostrom M, 2003, ARTERIOSCL THROM VAS, V23, pE37, DOI 10.1161/01.ATV.0000082689.46538.DF; Green SA, 2004, THORAX, V59, P100, DOI 10.1136/thx.2004.006825; Back M, 2002, LIFE SCI, V71, P611, DOI 10.1016/S0024-3205(02)01733-2; Berellini G, 2005, J MED CHEM, V48, P4389, DOI 10.1021/jm049024x; Bocker A, 2010, CHEMMEDCHEM, V5, P2102, DOI 10.1002/cmdc.201000355; Dahlen SE, 2006, EUR J PHARMACOL, V533, P40, DOI 10.1016/j.ejphar.2005.12.070; Dong XW, 2013, EUR J MED CHEM, V62, P754, DOI 10.1016/j.ejmech.2013.01.041; Evans JF, 2002, PROSTAG OTH LIPID M, V68-9, P587, DOI 10.1016/S0090-6980(02)00057-6; Gauvreau G. M., 2000, BIOCHEM BIOPH RES CO, V274, P316; Itadani S, 2014, ACS MED CHEM LETT, V5, P1230, DOI 10.1021/ml500298y; Kumlin M, 2000, AM J RESP CRIT CARE, V161, P102; Lazerwith SE, 2011, ACS MED CHEM LETT, V2, P715, DOI 10.1021/ml200163b; Leeson PD, 2011, MEDCHEMCOMM, V2, P91, DOI 10.1039/c0md00157k; Montuschi P., 2010, PHARMACEUTICALS, V3, P1792; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SOMEI M, 1985, CHEM PHARM BULL, V33, P3696; Tanaka H, 1999, ALLERGY, V54, P489, DOI 10.1034/j.1398-9995.1999.00011.x	36	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	MAY 1	2015	23	9					2079	2097		10.1016/j.bmc.2015.03.011		19	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CF6WZ	WOS:000352698700017		
J	Inoue, R; Watanabe, K; Katou, T; Ikezawa, Y; Hamasaki, K				Inoue, Ryo; Watanabe, Kentarou; Katou, Toyofusa; Ikezawa, Yasunori; Hamasaki, Keita			Nucleobase modified neamines with a lysine as a linker, their inhibition specificity for TAR-Tat derived from HIV-1	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Aminoglycoside; Neamine; Nucleobase; Potential inhibitor; TAR RNA; RRE RNA	REV RESPONSIVE ELEMENT; RIBOSOMAL-RNA; AMINOGLYCOSIDE ANTIBIOTICS; SMALL MOLECULES; POTENTIAL INHIBITORS; TARGETING RNA; BINDING; DESIGN; SITE; RECOGNITION	Nucleobase modified neamines with a lysine as the linker (NbK-neamines) were synthesized and their binding toward hairpin RNAs derived from HIV-1 activator region were studied. NbK-neamines were bind those RNAs with micro molar level of binding affinities and compete with corresponding activator peptide for TAR RNA, but not for RRE RNA. GbK-neamine denotes the highest binding affinity with TAR RNA, three to five times higher than other three NbK-neamines. GbK-neamine could be a candidate of potential inhibitor for TAR-Tat. (C) 2015 Elsevier Ltd. All rights reserved.	[Inoue, Ryo; Watanabe, Kentarou; Katou, Toyofusa; Ikezawa, Yasunori; Hamasaki, Keita] Shibaura Inst Technol, Dept Appl Chem, Koto Ku, Tokyo 1388548, Japan	Hamasaki, K (reprint author), Shibaura Inst Technol, Dept Appl Chem, Koto Ku, Toyosu 3-7-5, Tokyo 1388548, Japan.	hamie@shibaura-it.ac.jp					Agnelli Fabio, 2004, Angew Chem Int Ed Engl, V43, P1562, DOI 10.1002/anie.200353225; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Recht MI, 1996, J MOL BIOL, V262, P421, DOI 10.1006/jmbi.1996.0526; Lacourciere KA, 2000, BIOCHEMISTRY-US, V39, P5630, DOI 10.1021/bi992932p; Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546; Hanessian S, 2007, J MED CHEM, V50, P2352, DOI 10.1021/jm061200+; ABOULELA F, 1995, J MOL BIOL, V253, P313, DOI 10.1006/jmbi.1995.0555; PUROHIT P, 1994, NATURE, V370, P659, DOI 10.1038/370659a0; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Kumar S, 2012, BIOCHEMISTRY-US, V51, P2331, DOI 10.1021/bi201657k; AboulEla F, 1996, NUCLEIC ACIDS RES, V24, P3974, DOI 10.1093/nar/24.20.3974; Guan LR, 2012, ACS CHEM BIOL, V7, P73, DOI 10.1021/cb200447r; Kondo J, 2006, BIOCHIMIE, V88, P1027, DOI 10.1016/j.biochi.2006.05.017; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; Disney MD, 2008, J AM CHEM SOC, V130, P11185, DOI 10.1021/ja803234t; DUEHOLM KL, 1994, J ORG CHEM, V59, P5767, DOI 10.1021/jo00098a042; Greenberg WA, 1999, J AM CHEM SOC, V121, P6527, DOI 10.1021/ja9910356; Hendrix M, 1997, J AM CHEM SOC, V119, P3641, DOI 10.1021/ja964290o; Blount K. F., 2003, NUCLEIC ACIDS RES, V31, P4590; Ding YL, 2003, ANGEW CHEM INT EDIT, V42, P3409, DOI 10.1002/anie.200351354; Faber C, 2000, J BIOL CHEM, V275, P20660, DOI 10.1074/jbc.M000920200; Haddad J, 2002, J AM CHEM SOC, V124, P3229, DOI 10.1021/ja011695m; Hamasaki K, 2000, TETRAHEDRON LETT, V41, P8327, DOI 10.1016/S0040-4039(00)01449-0; Hamasaki K, 2001, BIOORG MED CHEM LETT, V11, P591, DOI 10.1016/S0960-894X(01)00005-1; KIM MK, 2002, INFEC DIS T, V28, P125; Lee JK, 2004, J AM CHEM SOC, V126, P1956, DOI 10.1021/ja038937y; Ma CS, 2002, J AM CHEM SOC, V124, P1438, DOI 10.1021/ja016830+; Matsumoto C, 2000, BIOORG MED CHEM LETT, V10, P1857, DOI 10.1016/S0960-894X(00)00359-0; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; Park WKC, 1996, J AM CHEM SOC, V118, P10150, DOI 10.1021/ja9612817; Riguet E, 2005, BIOORG MED CHEM LETT, V15, P4651, DOI 10.1016/j.bmcl.2005.07.082; Riguet E, 2004, TETRAHEDRON, V60, P8053, DOI 10.1016/j.tet.2004.06.122; Sucheck SJ, 2000, J AM CHEM SOC, V122, P5230, DOI 10.1021/ja000575w; Vashinnov N. Y., 1991, ANNU REV BIOCHEM, V60, P577; Wang SH, 1998, BIOCHEMISTRY-US, V37, P5549, DOI 10.1021/bi972808a; Wang Y, 1997, BIOCHEMISTRY-US, V36, P768, DOI 10.1021/bi962095g; Yajima S, 2006, BIOORGAN MED CHEM, V14, P2799, DOI 10.1016/j.bmc.2005.11.056; Yokogawa S., 1998, EMBO J, V17, P6437; ZAPP ML, 1993, CELL, V74, P969, DOI 10.1016/0092-8674(93)90720-B	40	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	MAY 1	2015	23	9					2139	2147		10.1016/j.bmc.2015.03.001		9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CF6WZ	WOS:000352698700023		
J	Misawa, T; Dodo, K; Ishikawa, M; Hashimoto, Y; Sagawa, M; Kizaki, M; Aoyama, H				Misawa, Takashi; Dodo, Kosuke; Ishikawa, Minoru; Hashimoto, Yuichi; Sagawa, Morihiko; Kizaki, Masahiro; Aoyama, Hiroshi			Structure-activity relationships of benzhydrol derivatives based on 1 '-acetoxychavicol acetate (ACA) and their inhibitory activities on multiple myeloma cell growth via inactivation of the NF-kappa B pathway	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						1 '-Acetoxychavicol acetate (ACA); NF-kappa B; Multiple myeloma; Benzhydrol skeleton	1-ACETOXYCHAVICOL ACETATE; ALPINIA-GALANGA; CARCINOMA CELLS; IN-VITRO; CARCINOGENESIS; SUPPRESSION; ANALOGS; CANCER	1'-Acetoxychavicol acetate (ACA), which was isolated from the rhizomes of Zingiberaceae, exhibits various biological actions, including anti-inflammatory, anti-human immunodeficiency virus (HIV), and anti-cancer activities. ACA represents an attractive candidate for the treatment of many cancers. We herein examined the structure-activity relationships of ACA derivatives based on the benzhydrol skeleton in human leukemia cells (HL-60). Our results revealed that the ACA derivatives synthesized (ACA, 1, and 18) had inhibitory effects on the growth of multiple myeloma cells (IM-9 cells) by inactivating the NF-kappa B pathway. (C) 2015 Elsevier Ltd. All rights reserved.	[Misawa, Takashi; Dodo, Kosuke; Ishikawa, Minoru; Hashimoto, Yuichi; Aoyama, Hiroshi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Misawa, Takashi] Natl Inst Hlth Sci, Div Organ Chem, Setagaya Ku, Tokyo 1588501, Japan; [Aoyama, Hiroshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan; [Sagawa, Morihiko; Kizaki, Masahiro] Saitama Med Univ, Saitama Med Ctr, Dept Hematol, Kawagoe, Saitama 3508550, Japan; [Dodo, Kosuke] RIKEN, Synthet Organ Chem Lab, Wako, Saitama 3510198, Japan	Misawa, T (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	misawa@nihs.go.jp	Dodo, Kosuke/G-2264-2012				Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Wietek C, 2007, TRENDS BIOCHEM SCI, V32, P311, DOI 10.1016/j.tibs.2007.05.003; Nakamura Y, 1998, CANCER RES, V58, P4832; Aziz AN, 2013, J ETHNOPHARMACOL, V145, P798, DOI 10.1016/j.jep.2012.12.024; Campbell CT, 2007, TOXICOL LETT, V173, P151, DOI 10.1016/j.toxiet.2007.07.008; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Ito K, 2005, CANCER RES, V65, P4417, DOI 10.1158/0008-5472.CAN-05-0072; Kato R, 2014, CHEM-BIOL INTERACT, V212, P1, DOI 10.1016/j.cbi.2014.01.010; KONDO A, 1993, BIOSCI BIOTECH BIOCH, V57, P1344; Medeiros Marcell Costa de, 2014, J Appl Oral Sci, V22, P185; Misawa T, 2008, CHEM PHARM BULL, V56, P1490, DOI 10.1248/cpb.56.1490; Mori H, 2001, MUTAT RES-FUND MOL M, V480, P201, DOI 10.1016/S0027-5107(01)00200-7; Ohata T, 1998, CARCINOGENESIS, V19, P1007, DOI 10.1093/carcin/19.6.1007; Tamura S, 2010, BIOORG MED CHEM LETT, V20, P2082, DOI 10.1016/j.bmcl.2010.02.070; Tanaka T, 1997, JPN J CANCER RES, V88, P821; Wang JQ, 2014, BREAST CANCER RES TR, V148, P279, DOI 10.1007/s10549-014-3165-6; Ye Y, 2006, J GEN VIROL, V87, P2047, DOI 10.1099/vir.0.81685-0	17	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	MAY 1	2015	23	9					2241	2246		10.1016/j.bmc.2015.02.039		6	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CF6WZ	WOS:000352698700033		
J	Kusakabe, K; Ide, N; Daigo, Y; Itoh, T; Yamamoto, T; Kojima, E; Mitsuoka, Y; Tadano, G; Tagashira, S; Higashino, K; Okano, Y; Sato, Y; Inoue, M; Iguchi, M; Kanazawa, T; Ishioka, Y; Dohi, K; Kido, Y; Sakamoto, S; Ando, S; Maeda, M; Higaki, M; Yoshizawa, H; Murai, H; Nakamura, Y				Kusakabe, Ken-ichi; Ide, Nobuyuki; Daigo, Yataro; Itoh, Takeshi; Yamamoto, Takahiko; Kojima, Eiichi; Mitsuoka, Yasunori; Tadano, Genta; Tagashira, Sachie; Higashino, Kenichi; Okano, Yousuke; Sato, Yuji; Inoue, Makiko; Iguchi, Motofumi; Kanazawa, Takayuki; Ishioka, Yukichi; Dohi, Keiji; Kido, Yasuto; Sakamoto, Shingo; Ando, Shigeru; Maeda, Masahiro; Higaki, Masayo; Yoshizawa, Hidenori; Murai, Hitoshi; Nakamura, Yusuke			A unique hinge binder of extremely selective aminopyridine-based Mps1 (TTK) kinase inhibitors with cellular activity	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Monopolar spindle 1; Mps1; TTK; Kinase; Inhibitor; Peptide flip; Flipped peptide; Cancer	ACTIVATED PROTEIN-KINASE; SMALL-MOLECULE INHIBITOR; BREAST-CANCER CELLS; MITOTIC CHECKPOINT; CENTROSOME DUPLICATION; GENE-EXPRESSION; MAP KINASE; POTENT; DISCOVERY; INSTABILITY	Mps1, also known as TTK, is a dual-specificity kinase that regulates the spindle assembly check point. Increased expression levels of Mps1 are observed in cancer cells, and the expression levels correlate well with tumor grade. Such evidence points to selective inhibition of Mps1 as an attractive strategy for cancer therapeutics. Starting from an aminopyridine-based lead 3a that binds to a flipped-peptide conformation at the hinge region in Mps1, elaboration of the aminopyridine scaffold at the 2-and 6-positions led to the discovery of 19c that exhibited no significant inhibition for 287 kinases as well as improved cellular Mps1 and antiproliferative activities in A549 lung carcinoma cells (cellular Mps1 IC50 = 5.3 nM, A549 IC50 = 26 nM). A clear correlation between cellular Mps1 and antiproliferative IC50 values indicated that the antiproliferative activity observed in A549 cells would be responsible for the cellular inhibition of Mps1. The X-ray structure of 19c in complex with Mps1 revealed that this compound retains the ability to bind to the peptide flip conformation. Finally, comparative analysis of the X-ray structures of 19c, a deamino analogue 33, and a known Mps1 inhibitor bound to Mps1 provided insights into the unique binding mode at the hinge region. (C) 2015 Elsevier Ltd. All rights reserved.	[Kusakabe, Ken-ichi; Ide, Nobuyuki; Itoh, Takeshi; Kojima, Eiichi; Mitsuoka, Yasunori; Tadano, Genta; Tagashira, Sachie; Sato, Yuji; Inoue, Makiko; Iguchi, Motofumi; Kanazawa, Takayuki; Ishioka, Yukichi; Dohi, Keiji; Ando, Shigeru; Yoshizawa, Hidenori; Murai, Hitoshi] Shionogi Pharmaceut Res Ctr, Med Res Labs, Toyonaka, Osaka 5610825, Japan; [Kido, Yasuto; Sakamoto, Shingo] Shionogi Pharmaceut Res Ctr, Drug Dev Res Labs, Toyonaka, Osaka 5610825, Japan; [Yamamoto, Takahiko; Higashino, Kenichi; Okano, Yousuke; Maeda, Masahiro; Higaki, Masayo] Shionogi Pharmaceut Res Ctr, Innovat Drug Discovery Res Labs, Toyonaka, Osaka 5610825, Japan; [Daigo, Yataro; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med,Minato Ku, Tokyo 1088639, Japan; [Daigo, Yataro] Shiga Univ Med Sci, Dept Med Oncol, Otsu, Shiga 5202192, Japan	Kusakabe, K (reprint author), Shionogi Pharmaceut Res Ctr, Med Res Labs, 1-1 Futaba Cho 3 Chome, Toyonaka, Osaka 5610825, Japan.	ken-ichi.kusakabe@shionogi.co.jp					Kusakabe K, 2013, J MED CHEM, V56, P4343, DOI 10.1021/jm4000215; [Anonymous], 2005, MOE VERS 2013 08; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Langdon SR, 2013, J CHEM INF MODEL, V53, P1100, DOI 10.1021/ci400100c; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Chu MLH, 2010, BIOCHEMISTRY-US, V49, P1689, DOI 10.1021/bi901970c; [Anonymous], 2013, CHEMBIODRAW ULTR VER; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Duesberg P, 1998, P NATL ACAD SCI USA, V95, P13692, DOI 10.1073/pnas.95.23.13692; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Kikuchi T, 2003, ONCOGENE, V22, P2192, DOI 10.1038/sj.onc.1206288; Fitzgerald CE, 2003, NAT STRUCT BIOL, V10, P764, DOI 10.1038/nsb949; Tardif KD, 2011, MOL CANCER THER, V10, P2267, DOI 10.1158/1535-7163.MCT-11-0453; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Laufer R, 2014, BIOORGAN MED CHEM, V22, P4968, DOI 10.1016/j.bmc.2014.06.027; Naud S, 2013, J MED CHEM, V56, P10045, DOI 10.1021/jm401395s; Wu B, 2010, J MED CHEM, V53, P6398, DOI 10.1021/jm100567y; [Anonymous], 2010, The kinase profiling was conducted at Cerep, Patent No. 2010007756; Szczepankiewicz BG, 2006, J MED CHEM, V49, P3563, DOI 10.1021/jm060199b; Kusakabe K, 2012, ACS MED CHEM LETT, V3, P560, DOI 10.1021/ml3000879; Chu MLH, 2008, J BIOL CHEM, V283, P21495, DOI 10.1074/jbc.M803026200; MILLS GB, 1992, J BIOL CHEM, V267, P16000; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Saito-Hisaminato A, 2002, DNA RES, V9, P35, DOI 10.1093/dnares/9.2.35; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101; Caldarelli M, 2011, BIOORG MED CHEM LETT, V21, P4507, DOI 10.1016/j.bmcl.2011.05.122; Colombo R., 2012, 24 EORTC NCI AACR S; Herberich B, 2008, J MED CHEM, V51, P6271, DOI 10.1021/jm8005417; Kusakabe K, 2015, J MED CHEM, V58, P1760, DOI 10.1021/jm501599u; Lan WJ, 2010, J CELL BIOL, V190, P21, DOI 10.1083/jcb.201006080; LAUZE E, 1995, EMBO J, V14, P1655; Liu G, 2006, BIOORG MED CHEM LETT, V16, P5723, DOI 10.1016/j.bmcl.2006.08.097; Pettus LH, 2008, J MED CHEM, V51, P6280, DOI 10.1021/jm8005405; Stelmach JE, 2003, BIOORG MED CHEM LETT, V13, P277, DOI 10.1016/S0960-894X(02)00752-7; Vijay K. D., 2012, BIOORG MED CHEM LETT, V22, P4377, DOI DOI 10.1016/J.BMCL.2012.04.131; Yamabuki T, 2006, INT J ONCOL, V28, P1375	42	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	MAY 1	2015	23	9					2247	2260		10.1016/j.bmc.2015.02.042		14	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CF6WZ	WOS:000352698700034		
J	Matsushima, K; Kaneda, H; Harada, K; Matsuura, H; Hirata, K				Matsushima, Kazuki; Kaneda, Hirokazu; Harada, Kazuo; Matsuura, Hideyuki; Hirata, Kazumasa			Immobilization of enzymatic extracts of Portulaca oleracea cv. roots for oxidizing aqueous bisphenol A	BIOTECHNOLOGY LETTERS			English	Article						Bisphenol A; Enzyme immobilization; Phytoremediation; Portulaca oleracea cv.; Wastewater treatment	GLASS-BEADS; REMOVAL; PHYTOREMEDIATION; WATER	Water pollution from the release of industrial wastewater is a serious problem for almost every industry. Enzymes from portulaca, Portulaca oleracea cv., have been investigated for their ability to degrade bisphenol A (BPA), one of the well-known estrogenic pollutants. Enzymatic crude extracts from P. oleracea cv. roots were immobilized on aminopropyl-modified glass beads. They maintained BPA metabolic activity over a broad range of pH values and temperatures. The immobilized enzyme was reusable with more than 50 % of its initial activity retained after 12 batch reactions and no loss of activity after storage for 1 month at -30 A degrees C. Thus, the immobilization of extracts from P. oleracea cv. roots is a useful method for removing BPA from industrial wastewater.	[Matsushima, Kazuki; Kaneda, Hirokazu; Harada, Kazuo; Matsuura, Hideyuki; Hirata, Kazumasa] Osaka Univ, Grad Sch Pharmaceut Sci, Appl Environm Biol, Suita, Osaka 5650871, Japan	Hirata, K (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, Appl Environm Biol, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan.	matsushima-k@phs.osaka-u.ac.jp; savanna.vanna@gmail.com; harada6@phs.osaka-u.ac.jp; hmhide@phs.osaka-u.ac.jp; hirata@phs.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [23659064]; Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI)	This research was supported in part by a Grant-in-Aid for Challenging Exploratory Research (No. 23659064) from Japan Society for the Promotion of Science (JSPS), and a grant from the Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI).	Chapin RE, 2008, BIRTH DEFECTS RES B, V83, P157, DOI 10.1002/bdrb.20147; Lopez-Gallego F, 2005, J BIOTECHNOL, V119, P70, DOI 10.1016/j.jbiotec.2005.05.021; Gomez JL, 2006, ENZYME MICROB TECH, V39, P1016, DOI 10.1016/j.enzmictec.2006.02.008; Kampmann M, 2014, WATER RES, V57, P295, DOI 10.1016/j.watres.2014.03.054; Imai S, 2007, J BIOSCI BIOENG, V103, P420, DOI 10.1263/jbb.103.420; Kramer U, 2005, CURR OPIN BIOTECH, V16, P133, DOI 10.1016/j.copbio.2005.02.006; Kaneda H, 2012, PLANT BIOTECHNOL-NAR, V29, P351, DOI 10.5511/plantbiotechnology.12.0423a; LeDuc DL, 2005, J IND MICROBIOL BIOT, V32, P514, DOI 10.1007/s10295-005-0227-0; Liu ZH, 2009, SCI TOTAL ENVIRON, V407, P731, DOI 10.1016/j.scitotenv.2008.08.039; Bhushan I, 2008, PROCESS BIOCHEM, V43, P321, DOI 10.1016/j.procbio.2007.11.019; Kahraman MV, 2007, FOOD CHEM, V104, P1385, DOI 10.1016/j.foodchem.2007.01.054; Rosa CC, 2002, BIOSENS BIOELECTRON, V17, P45, DOI 10.1016/S0956-5663(01)00263-9; Songulashvili G, 2012, FUNGAL BIOL-UK, V116, P883, DOI 10.1016/j.funbio.2012.05.005; Watanabe I, 2012, BIOSCI BIOTECH BIOCH, V76, P1015, DOI 10.1271/bbb.110967	14	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	MAY	2015	37	5					1037	1042		10.1007/s10529-014-1761-5		6	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CF6BP	WOS:000352641700010		
J	Aburai, N; Abe, K				Aburai, Nobuhiro; Abe, Katsuya			Metabolic switching: synergistic induction of carotenogenesis in the aerial microalga, Vischeria helvetica, under environmental stress conditions by inhibitors of fatty acid biosynthesis	BIOTECHNOLOGY LETTERS			English	Article						Aerial microalga; Bioactive compound; Carotenogenesis; Fatty acid biosynthesis; MAPK; Metabolic switching; Molinate	HAEMATOCOCCUS-LACUSTRIS; DUNALIELLA-BARDAWIL; BETA-CAROTENE; PHOSPHORYLATION; PHOTOSYNTHESIS; PROTEINS; VIRIDIS	To investigate the roles of fatty acid biosynthesis in carotenogenesis in the high-lipid accumulating aerial microalga Vischeria helvetica KGU-Y001, we cultured algal cells with fatty acid biosynthesis inhibitors. Under nitrogen-deficient, high-light (200 A mu mol photons m(-2) s(-1)) conditions, the alga accumulated 6.2 mg carotenoids g(-1) dry weight cells (DWC) after 1 week of culture. The total fatty acid content increased gradually, and reached 290 mg g(-1) DWC after 9 weeks. When algal cells were cultured with a fatty acid biosynthesis inhibitor (molinate) under nitrogen-deficient, high-light conditions for 1 week, carotenoid accumulation was synergistically increased to 2.4 times that in algal cells cultured without the inhibitor in nitrogen-deficient, low-light conditions (40 A mu mol photons m(-2) s(-1)). The synergistic induction of carotenogenesis was suppressed by an inhibitor of c-jun N-terminal kinase, a mitogen-activated protein kinase-like protein. In a commercial context, carotenoid production could be increased by using fatty acid biosynthesis inhibitors to redirect metabolic flux to carotenoid biosynthesis instead of fatty acid synthesis.	[Aburai, Nobuhiro; Abe, Katsuya] Kogakuin Univ, Fac Engn, Dept Appl Chem, Hachioji, Tokyo 1920015, Japan	Abe, K (reprint author), Kogakuin Univ, Fac Engn, Dept Appl Chem, 2665-1 Nakano Machi, Hachioji, Tokyo 1920015, Japan.	bt10335@ns.kogakuin.ac.jp			Research Institute for Science and Technology of Kogakuin University Japan Society for the Promotion of Science; Strategic Research Foundation from Ministry of Education, Culture, Sport, Science, and Technology, Japan [S1411005]	This work was supported by the Research Institute for Science and Technology of Kogakuin University for a special Grant-in-Aid to earn KAKENHI by the Japan Society for the Promotion of Science. This study was supported in part by a grant from the Strategic Research Foundation Grant-aided Project for Private Universities from Ministry of Education, Culture, Sport, Science, and Technology, Japan (S1411005).	Aburai N, 2013, ALGAL RES, V2, P237, DOI 10.1016/j.algal.2013.03.001; Omura S, 2011, TETRAHEDRON, V67, P6420, DOI 10.1016/j.tet.2011.03.117; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; SHAISH A, 1993, PLANTA, V190, P363; Abe K, 2007, FOOD CHEM, V100, P656, DOI 10.1016/j.foodchem.2005.10.026; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Moustafa K, 2014, PLANT CELL REP, V33, P1217, DOI 10.1007/s00299-014-1629-0; Rabbani S, 1998, PLANT PHYSIOL, V116, P1239, DOI 10.1104/pp.116.4.1239; Bhosale P, 2004, APPL MICROBIOL BIOT, V63, P351, DOI 10.1007/s00253-003-1441-1; Casida JE, 2009, CHEM RES TOXICOL, V22, P609, DOI 10.1021/tx8004949; Galhano V, 2010, ENVIRON TOXICOL, V25, P147, DOI 10.1002/tox.20486; Tran NP, 2009, BIOTECHNOL BIOPROC E, V14, P322, DOI 10.1007/s12257-008-0216-z; Mendoza H, 1999, J APPL PHYCOL, V11, P15, DOI 10.1023/A:1008014332067; Garcia-Gomez C, 2012, J EXP BOT, V63, P5259, DOI 10.1093/jxb/ers185; Jimenez C, 2007, J EXP BOT, V58, P1001, DOI 10.1093/jxb/erl260; Jimenez C, 2004, BBA-MOL CELL RES, V1644, P61, DOI 10.1016/j.bbamcr.2003.10.009; Tran NP, 2009, ENZYME MICROB TECH, V45, P241, DOI 10.1016/j.enzmictec.2009.07.006	17	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	MAY	2015	37	5					1073	1080		10.1007/s10529-015-1770-z		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CF6BP	WOS:000352641700015		
J	Sakai, G; Kojima, K; Mori, K; Oonishi, Y; Sode, K				Sakai, Genki; Kojima, Katsuhiro; Mori, Kazushige; Oonishi, Yosuke; Sode, Koji			Stabilization of fungi-derived recombinant FAD-dependent glucose dehydrogenase by introducing a disulfide bond	BIOTECHNOLOGY LETTERS			English	Article						Aspergillus flavus; Disulfide bond; FAD; Glucose dehydrogenase; Site directed mutagenesis; Thermal stability	ASPERGILLUS ORYZAE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PICHIA-PASTORIS; SIGNAL PEPTIDES; PURIFICATION; PREDICTION; OXIDASE; NIGER	To improve the stability of E. coli-produced non-glycosylated fungal FAd-glucose dehydrogenase induced a disulfide bond by site-directed mutagenesis based on structural comparisons with glucose oxidases. The FAD-glucose dehydrogenase (GDH) mutant Val149Cys/Gly190Cys, which was constructed based on a comparison with the three dimensional structure of glucose oxidase, showed a 110 min half-life of thermal inactivation at 45 A degrees C, which is 13-fold greater than that of the wild-type enzyme. The considerable increase in thermal stability was further supported by Eyring plot analysis. The kinetic parameters of Val149Cys/Gly190Cys (k (cat) = 760 s(-1), K-m = 35 mM, and catalytic efficiency (k (cat)/K-m) = 22 s(-1) mM(-1)) were almost identical to those of the wild-type enzyme (k (cat) = 780 s(-1), K-m = 35 mM, k (cat)/K-m = 22 s(-1) mM(-1)). The substrate specificity of Val149Cys/Gly190Cys is indistinguishable from that of the wild type. The constructed mutant, Val149Cys/Gly190Cys, had significantly increased structural stability without changing the catalytic activity and kinetic parameters of FAD-GDH, including its characteristic substrate specificity.	[Sakai, Genki; Oonishi, Yosuke; Sode, Koji] Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan; [Kojima, Katsuhiro; Mori, Kazushige; Sode, Koji] Ultizyme Int Ltd, Minami Ku, Tokyo, Japan	Sode, K (reprint author), Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan.	sode@cc.tuat.ac.jp	Sode, Koji/F-6914-2013				Hallberg BM, 2002, J MOL BIOL, V315, P421, DOI 10.1006/jmbi.2001.5246; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Tsujimura S, 2006, BIOSCI BIOTECH BIOCH, V70, P654, DOI 10.1271/bbb.70.654; CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x; Gouda MD, 2003, J BIOL CHEM, V278, P24324, DOI 10.1074/jbc.M208711200; Macheroux P, 1999, METH MOL B, V131, P1; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Wohlfahrt G, 1999, ACTA CRYSTALLOGR D, V55, P969, DOI 10.1107/S0907444999003431; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Mori K, 2011, BIOTECHNOL LETT, V33, P2255, DOI 10.1007/s10529-011-0694-5; BAK TG, 1967, BIOCHIM BIOPHYS ACTA, V139, P277, DOI 10.1016/0005-2744(67)90032-0; BAK TG, 1967, BIOCHIM BIOPHYS ACTA, V139, P265, DOI 10.1016/0005-2744(67)90031-9; BAK TG, 1967, BIOCHIM BIOPHYS ACTA, V146, P328, DOI 10.1016/0005-2744(67)90219-7; BAK TG, 1967, BIOCHIM BIOPHYS ACTA, V146, P317, DOI 10.1016/0005-2744(67)90218-5; Fernandez IS, 2009, ACTA CRYSTALLOGR D, V65, P1196, DOI 10.1107/S0907444909035860; Ferri Stefano, 2011, J Diabetes Sci Technol, V5, P1068; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Müller H M, 1977, Zentralbl Bakteriol Parasitenkd Infektionskr Hyg, V132, P14; OGURA YASUYUKI, 1951, JOUR BIOCHEM [TOKYO], V38, P75; Ogura Y., 1937, BOT MAG TOKYO, V51, P597; Piumi F, 2014, APPL MICROBIOL BIOT, V98, P10105, DOI 10.1007/s00253-014-5891-4; Sygmund C, 2011, MICROBIOL-SGM, V157, P3203, DOI 10.1099/mic.0.051904-0; Sygmund C, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-106; Yang YF, 2014, J MICROBIOL BIOTECHN, V24, P1516, DOI 10.4014/jmb.1401.01061	26	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	MAY	2015	37	5					1091	1099		10.1007/s10529-015-1774-8		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CF6BP	WOS:000352641700017		
J	Saitoh, M; Shinohara, M; Ishii, A; Ihara, Y; Hirose, S; Shiomi, M; Kawawaki, H; Kubota, M; Yamagata, T; Miyamoto, A; Yamanaka, G; Amemiya, K; Kikuchi, K; Kamei, A; Akasaka, M; Anzai, Y; Mizuguchi, M				Saitoh, Makiko; Shinohara, Mayu; Ishii, Atsushi; Ihara, Yukiko; Hirose, Shinichi; Shiomi, Masashi; Kawawaki, Hisashi; Kubota, Masaya; Yamagata, Takanori; Miyamoto, Akie; Yamanaka, Gaku; Amemiya, Kaoru; Kikuchi, Kenjiro; Kamei, Atsushi; Akasaka, Manami; Anzai, Yuki; Mizuguchi, Masashi			Clinical and genetic features of acute encephalopathy in children taking theophylline	BRAIN & DEVELOPMENT			English	Article						Theophylline; Adenosine receptors; Acute encephalopathy; Status epilepticus	STATUS EPILEPTICUS; SEIZURES; INFLUENZA; POLYMORPHISM; ADORA2A	Background: Theophylline has recently been suspected as a risk factor of acute encephalopathy with biphasic seizures and late reduced diffusion (AESD), although there has been no systematic study on the relationship between acute encephalopathy in children taking theophylline (AET) and AESD. Methods: We recruited 16 Japanese patients (11 male and 5 female, median age of 2 years and 7 months) with AET from 2008 to 2013. We evaluated their clinical features, such as the duration of first seizure, biphasic clinical course and cranial CT/MRI imaging and compared them with those of AESD. We analyzed the polymorphisms or mutations of genes which are associated with AESD. Results: Clinically, 12 patients had neurological and/or radiological features of AESD. Only one patient died, whereas all 15 surviving patients were left with motor and/or intellectual deficits. Genetically, 14 patients had at least one of the following polymorphisms or mutations associated with AESD: thennolabile variation of the carnitine palmitoyltransferase 2 (CPT2) gene, polymorphism causing high expression of the adenosine receptor A2A (ADORA2A) gene, and heterozygous missense mutation of the voltage gated sodium channel 1A (SCN1A) and 2A (SCN2A) gene. Conclusions: Our results demonstrate that AET overlaps with AESD, and that AET is a multifactorial disorder sharing a genetic background with AESD. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Saitoh, Makiko; Shinohara, Mayu; Mizuguchi, Masashi] Univ Tokyo, Grad Sch Med, Dept Dev Med Sci, Tokyo 1130033, Japan; [Shiomi, Masashi] Osaka City Gen Hosp, Child Med Ctr, Dept Pediat, Osaka, Japan; [Kawawaki, Hisashi] Osaka City Gen Hosp, Child Med Ctr, Dept Pediat Neurol, Osaka, Japan; [Shiomi, Masashi] Natl Ctr Child Hlth & Dev, Dept Neurol, Tokyo, Japan; [Yamagata, Takanori] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan; [Miyamoto, Akie] Asahikawa Habilitat Ctr Disabled Children, Dept Pediat, Asahikawa, Hokkaido, Japan; [Yamanaka, Gaku] Tokyo Med Univ, Dept Pediat, Tokyo 1608402, Japan; [Amemiya, Kaoru] Tokyo Metropolitan Hachioji Childrens Hosp, Dept Neurol, Tokyo, Japan; [Kikuchi, Kenjiro] Saitama Childrens Med Ctr, Div Neurol, Saitama, Japan; [Kamei, Atsushi; Akasaka, Manami] Iwate Med Univ, Dept Pediat, Morioka, Iwate, Japan; [Anzai, Yuki] Saiseikai Yokohainashi Tobu Hosp, Dept Pediat, Yokohama, Kanagawa, Japan	Saitoh, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Dev Med Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	makisaito-tky@umin.ac.jp			Japan Society for the Promotion of Science [24390258]; Ministry of Health, Labour and Welfare, Japan [H25-Nanjitou-Ippan-009, H24-Nanji-Ippan-29]; Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [221S0002, 25129708]; MEXT; Ministry of Health, Labor and Welfare, Intramural Research Grant (24-7) for Neurological and Psychiatric Disorders of NCNP [H23-Nanji-Ippan-78]; Medical Research Institute; Tokyo Medical and Dental University; Mitsubishi Foundation; Takeda Scientific Foundation; Fukuoka University Nervous and Mental Disorder Grand 24-7 [117016]; Ministry of Health, Labour and Welfare, Japan;  [23791201];  [24249060];  [25670481]	Dr. Saitoh is funded by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science No. 24390258 and by a Grant-in-Aid for research on Measures for Intractable Diseases H25-Nanjitou-Ippan-009 from the Ministry of Health, Labour and Welfare, Japan. Dr. Ishii is funded by a Grant-in-Aid for Young Scientists (B) (23791201), Grants for Scientific Research on Innovative Areas (221S0002 and 25129708). Dr. Hirose is funded by a Grant-in-Aid for Grant-in-Aid for Scientific Research (A) (24249060), Grant-in-Aid for Challenging Exploratory Research (25670481), Bilateral Joint Research Projects from Japan Society for the Promotion of Science (JSPS), Grants for Scientific Research on Innovative Areas (221S0002 and 25129708) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), MEXT-supported Program for the Strategic Research Foundation at Private Universities 2013-2017, a Grant-in-aid for the Research on Measures for Intractable Diseases (No. H23-Nanji-Ippan-78) from the Ministry of Health, Labor and Welfare, Intramural Research Grant (24-7) for Neurological and Psychiatric Disorders of NCNP, the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University, Grants from The Mitsubishi Foundation and Takeda Scientific Foundation, 2013-2017 "Research grants for Central Research Institute for the Molecular Pathomethanisms of Epilepsy of Fukuoka University", Recommended Projects of Fukuoka University (117016) Nervous and Mental Disorder Grand 24-7 and H24-Nanji-Ippan-29 from the Ministry of Health, Labour and Welfare, Japan. Dr. Mizuguchi is funded by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science No. 24390258 and by a Grant-in-Aid for research on Measures for Intractable Diseases H25-Nanjitou-Ippan-009 from the Ministry of Health, Labour and Welfare, Japan.	Chen Y, 2005, FEBS LETT, V579, P2040, DOI 10.1016/j.febslet.2005.02.050; NAKADA T, 1983, WESTERN J MED, V138, P371; Mizuguchi M, 2013, INFLUENZA OTHER RESP, V7, P67, DOI 10.1111/irv.12177; Nabbout R, 2011, LANCET NEUROL, V10, P99, DOI 10.1016/S1474-4422(10)70214-3; Shinohara M, 2011, BRAIN DEV-JPN, V33, P512, DOI 10.1016/j.braindev.2010.09.002; Shinohara M, 2013, NEUROLOGY, V80, P1571, DOI 10.1212/WNL.0b013e31828f18d8; Saitoh M, 2012, EPILEPSIA, V53, P558, DOI 10.1111/j.1528-1167.2011.03402.x; Shi XY, 2009, BRAIN DEV-JPN, V31, P758, DOI 10.1016/j.braindev.2009.08.009; Hoshino A, 2012, BRAIN DEV-JPN, V34, P337, DOI 10.1016/j.braindev.2011.07.012; Takanashi J, 2006, NEUROLOGY, V66, P1304, DOI 10.1212/01.wnl.0000210487.36667.a5; Mizuguchi M, 2007, ACTA NEUROL SCAND, V115, P45, DOI 10.1111/j.1600-0404.2007.00809.x; Kobayashi K, 2012, EPILEPSY RES, V102, P109, DOI 10.1016/j.eplepsyres.2012.04.016; Dunwiddie T V, 1999, Adv Neurol, V79, P1001; DUNWIDDIE TV, 1980, EPILEPSIA, V21, P541, DOI 10.1111/j.1528-1157.1980.tb04305.x; Fukuda M, 2010, EPILEPSIA, V51, P483, DOI 10.1111/j.1528-1167.2009.02382.x; Korematsu S, 2008, PEDIATR INT, V50, P95, DOI 10.1111/j.1442-200X.2007.02524.x; Miura T, 2000, PEDIATRICS, V105, P920, DOI 10.1542/peds.105.4.920; Rogers PJ, 2010, NEUROPSYCHOPHARMACOL, V35, P1973, DOI 10.1038/npp.2010.71; Shiomi M., 2000, JPN J PEDIAT, V53, P1739; Singh NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000649; Somekawa-Kondo T, 2013, J PHARM PHARMACOL, V65, P102, DOI 10.1111/j.2042-7158.2012.01566.x; TSIU SJ, 1990, ANN ALLERGY, V64, P241; Yoshikawa H, 2007, ACTA NEUROL SCAND, V115, P57, DOI 10.1111/j.1600-0404.2007.00810.x	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	MAY	2015	37	5					463	470		10.1016/j.braindev.2014.07.010		8	Clinical Neurology	Neurosciences & Neurology	CG1ZS	WOS:000353075300001		
J	Ueda, R; Saito, Y; Ohno, K; Maruta, K; Matsunami, K; Saiki, Y; Sokota, T; Sugihara, S; Nishimura, Y; Tamasaki, A; Narita, A; Imamura, A; Maegaki, Y				Ueda, Riyo; Saito, Yoshiaki; Ohno, Koyo; Maruta, Kanako; Matsunami, Kunihiro; Saiki, Yusuke; Sokota, Tatsuyuki; Sugihara, Susumu; Nishimura, Yoko; Tamasaki, Akiko; Narita, Aya; Imamura, Atsushi; Maegaki, Yoshihiro			Effect of levetiracetam in acute encephalitis with refractory, repetitive partial seizures during acute and chronic phase	BRAIN & DEVELOPMENT			English	Article						Status epilepticus; Levetiracetam; Febrile infection-related epilepsy syndrome; Barbiturate coma	EPILEPSY SYNDROME FIRES; ENCEPHALOPATHY; CHILDREN; CHILDHOOD	Aim: To clarify the effect of levetiracetam (LEV) for acute and chronic seizure control in acute encephalitis with refractory, repetitive partial seizures (AERRPS). Methods: We retrospectively reviewed the clinical course of six AERRPS cases treated with LEV, and explored the acute phase termination by withdrawal from barbiturate-induced coma under artificial ventilation, and the reduction in seizure frequency during the chronic phase. LEV was administrated orally or via nasogastric tubes as an add-on agent during acute (n = 3; age 8-10 years) and chronic (n = 3; age 19-30 years) AERRPS. Results: In the acute phase, administration of LEV (50-60 mg/kg/d) in combination with phenobarbital (n = 3; peak 57.9 76.1 mu g/ml) and potassium bromide (n = 2; 30-36 mg/kg/d)) resulted in successful reduction of intravenous barbiturate dosage and withdrawal from artificial ventilation. In the chronic phase, seizure frequency reduced by >75% for 5-18 months with LEV 750-1500 mg/d. Conclusion: LEV may affect seizure control in AERRPS, particularly during the chronic phase, through its unique action of inhibition of excitatory neurotransmitter release. The regimen of oral barbiturate, potassium bromide and LEV would be worth for trial during the acute phase of AERRPS. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Ueda, Riyo; Saito, Yoshiaki; Ohno, Koyo; Saiki, Yusuke; Sokota, Tatsuyuki; Sugihara, Susumu; Nishimura, Yoko; Tamasaki, Akiko; Narita, Aya; Maegaki, Yoshihiro] Tottori Univ, Fac Med, Div Child Neurol, Inst Neurol Sci, Yonago, Tottori 6838504, Japan; [Maruta, Kanako; Matsunami, Kunihiro; Imamura, Atsushi] Gifu Prefectural Gen Med Ctr, Dept Pediat, Gifu, Japan	Maegaki, Y (reprint author), Tottori Univ, Fac Med, Div Child Neurol, Inst Neurol Sci, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan.	maegaki@med.tottori-u.ac.jp			Ministry of Health, Labor, and Welfare, Japan [24-7]	This study was financially supported by the Research Grant for Nervous and Mental Disorders 24-7 from the Ministry of Health, Labor, and Welfare, Japan.	Saito Y, 2007, BRAIN DEV-JPN, V29, P147, DOI 10.1016/j.braindev.2006.08.005; Nabbout R, 2010, EPILEPSIA, V51, P2033, DOI 10.1111/j.1528-1167.2010.02703.x; Kramer U, 2011, EPILEPSIA, V52, P1956, DOI 10.1111/j.1528-1167.2011.03250.x; Caraballo RH, 2013, SEIZURE-EUR J EPILEP, V22, P553, DOI 10.1016/j.seizure.2013.04.005; van Baalen A, 2010, EPILEPSIA, V51, P1323, DOI 10.1111/j.1528-1167.2010.02535.x; Sakuma H, 2010, ACTA NEUROL SCAND, V121, P251, DOI 10.1111/j.1600-0404.2009.01198.x; Lin JJ, 2009, BRAIN DEV-JPN, V31, P605, DOI 10.1016/j.braindev.2008.09.010; AWAYA Y, 1986, JPN J PSYCHIAT NEUR, V40, P385; Deshpande Laxmikant S, 2014, Front Neurol, V5, P11, DOI 10.3389/fneur.2014.00011; Gallentine WB, 2009, EPILEPSY BEHAV, V14, P215, DOI 10.1016/j.yebeh.2008.09.028; Goraya JS, 2008, PEDIATR NEUROL, V38, P177, DOI 10.1016/j.pediatrneurol.2007.11.003; Howell KB, 2012, EPILEPSIA, V53, P101, DOI 10.1111/j.1528-1167.2011.03350.x; Shiomi M, 1988, NO HATTATSU S, V20, pS195	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	MAY	2015	37	5					471	477		10.1016/j.braindev.2014.08.003		7	Clinical Neurology	Neurosciences & Neurology	CG1ZS	WOS:000353075300002		
J	Maegaki, Y; Kurozawa, Y; Tamasaki, A; Togawa, M; Tamura, A; Hirao, M; Nagao, A; Kouda, T; Okada, T; Hayashibara, H; Harada, Y; Urushibara, M; Sugiura, C; Sejima, H; Tanaka, Y; Matsuda-Ohtahara, H; Kasai, T; Kishi, K; Kaji, S; Toyoshima, M; Kanzaki, S; Ohno, K				Maegaki, Yoshihiro; Kurozawa, Youichi; Tamasaki, Akiko; Togawa, Masami; Tamura, Akiko; Hirao, Masato; Nagao, Akihisa; Kouda, Takayuki; Okada, Takayoshi; Hayashibara, Hiroshi; Harada, Yuichiro; Urushibara, Makoto; Sugiura, Chitose; Sejima, Hitoshi; Tanaka, Yuji; Matsuda-Ohtahara, Hiroko; Kasai, Takeshi; Kishi, Kazuko; Kaji, Syunsaku; Toyoshima, Mitsuo; Kanzaki, Susumu; Ohno, Kousaku		Status Epilepticus Study Grp	Early predictors of status epilepticus-associated mortality and morbidity in children	BRAIN & DEVELOPMENT			English	Article						Status epilepticus; Prognosis; Predictors; Acute encephalopathy	CONVULSIVE STATUS EPILEPTICUS; INFLUENZA-ASSOCIATED ENCEPHALOPATHY; BIPHASIC CLINICAL-COURSE; NEUROLOGICAL SEQUELAE; PROGNOSTIC-FACTORS; OBSCURE ORIGIN; ABNORMALITIES; DIFFUSION; ETIOLOGY	Background: Early predictors of status epilepticus (SE)-associated mortality and morbidity have not been systematically studied in children, considerably impeding the identification of patients at risk. Objectives: To determine reliable early predictors of SE-associated mortality and morbidity and identify the etiology of SE-associated sequelae in Japanese children. Methods: We conducted a prospective multicenter study of clinical findings and initial laboratory data acquired at SE onset, and assessed outcomes at the last follow-up examination. In-hospital death during the acute period and neurological sequelae were classified as poor outcomes. Results: Of the 201 children who experienced their first SE episode, 16 exhibited poor outcome that was most commonly associated with acute encephalopathy. Univariate analysis revealed that the following were associated with poor outcomes: young age (<= 24 months); seizure duration >90 mm; seizure intractability (failure of the second anticonvulsive drug); biphasic seizures; abnormal blood glucose levels (<61 or >250 mg/dL); serum aspartate aminotransferase (AST) >= 56 U/L; and C-reactive protein (CRP) levels >2.00 mg/dL. Multivariate analysis revealed that young age, seizure intractability, abnormal blood glucose levels, and elevated AST and CRP levels were statistically significant. Conclusions: Young age and seizure intractability were highly predictive of poor outcomes in pediatric SE. Moreover, abnormal blood glucose levels and elevated AST and CRP levels were predictors that might be closely associated with the etiology, especially acute encephalopathy and severe bacterial infection (sepsis and meningitis) in Japanese children. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Maegaki, Yoshihiro; Tamasaki, Akiko; Ohno, Kousaku] Tottori Univ, Fac Med, Div Child Neurol, Yonago, Tottori 6838504, Japan; [Kurozawa, Youichi] Tottori Univ, Fac Med, Div Hlth Adm & Promot, Yonago, Tottori 6838504, Japan; [Togawa, Masami; Tamura, Akiko] Tottori Prefecture Cent Hosp, Tottori, Japan; [Hirao, Masato] Tottori Red Cross Hosp, Tottori, Japan; [Nagao, Akihisa] Tottori Seikyo Hosp, Tottori, Japan; [Kouda, Takayuki] Tottori Municipal Hosp, Tottori, Japan; [Okada, Takayoshi] Tottori Prefecture Kousei Hosp, Kurayoshi, Japan; [Hayashibara, Hiroshi] Yonago Med Ctr, Yonago, Tottori, Japan; [Harada, Yuichiro] Hakuai Hosp, Yonago, Tottori, Japan; [Urushibara, Makoto] Tottori Prefecture Saiseikai Sakaiminato Gen Hos, Sakaiminato, Japan; [Sugiura, Chitose] Tottori Prefectural Rehabil Ctr Disabled Children, Yonago, Tottori, Japan; [Sejima, Hitoshi] Matsue Red Cross Hosp, Matsue, Shimane, Japan; [Tanaka, Yuji] Matsue City Hosp, Matsue, Shimane, Japan; [Matsuda-Ohtahara, Hiroko] Yasugi Municipal Hosp, Yasugi, Japan; [Kasai, Takeshi] Unnan City Hosp, Unnan, Japan; [Kishi, Kazuko] Shimane Med Univ, Sch Med, Izumo, Shimane 693, Japan; [Kaji, Syunsaku] Tsuyama Chuo Hosp, Tsuyania, Japan; [Toyoshima, Mitsuo] Kagoshima Univ, Kagoshima 890, Japan; [Kanzaki, Susumu] Tottori Univ, Fac Med, Div Pediat & Perinatol, Yonago, Tottori 6838504, Japan	Maegaki, Y (reprint author), Tottori Univ, Fac Med, Div Child Neurol, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan.	maegaki@med.tottori-u.ac.jp			MEXT KAKENHI [23591497]	This study was supported by Grant from MEXT KAKENHI Grant Number 23591497.	Morishima T, 2002, CLIN INFECT DIS, V35, P512, DOI 10.1086/341407; Chen Y, 2005, FEBS LETT, V579, P2040, DOI 10.1016/j.febslet.2005.02.050; Nabbout R, 2011, LANCET NEUROL, V10, P99, DOI 10.1016/S1474-4422(10)70214-3; Raspall-Chaure M, 2006, LANCET NEUROL, V5, P769, DOI 10.1016/S1474-4422(06)70546-4; MAYTAL J, 1989, PEDIATRICS, V83, P323; Kravljanac R, 2011, EPILEPSIA, V52, P358, DOI 10.1111/j.1528-1167.2010.02943.x; Rossetti AO, 2006, J NEUROL NEUROSUR PS, V77, P611, DOI 10.1136/jnnp.2005.080887; Lambrechtsen FACP, 2008, EPILEPSIA, V49, P615, DOI 10.1111/j.1528-1167.2007.01465.x; Shinohara M, 2013, NEUROLOGY, V80, P1571, DOI 10.1212/WNL.0b013e31828f18d8; Nakai Y, 2003, ACTA NEUROPATHOL, V105, P233, DOI 10.1007/s00401-002-0605-x; Chin RFM, 2006, LANCET, V368, P222, DOI 10.1016/S0140-6736(06)69043-0; Hoshino A, 2012, BRAIN DEV-JPN, V34, P337, DOI 10.1016/j.braindev.2011.07.012; Takanashi J, 2006, NEUROLOGY, V66, P1304, DOI 10.1212/01.wnl.0000210487.36667.a5; Mizuguchi M, 2007, ACTA NEUROL SCAND, V115, P45, DOI 10.1111/j.1600-0404.2007.00809.x; DUNN DW, 1988, J CHILD NEUROL, V3, P167, DOI 10.1177/088307388800300303; Gygax MJ, 2011, EUR J PAEDIATR NEURO, V15, P158, DOI 10.1016/j.ejpn.2010.08.001; Hayashi N, 2012, BRAIN DEV-JPN, V34, P632, DOI 10.1016/j.braindev.2011.11.007; Legriel S, 2010, CRIT CARE MED, V38, P2295, DOI 10.1097/CCM.0b013e3181f859a6; Loddenkemper T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047474; LYON G, 1961, BRAIN, V84, P680, DOI 10.1093/brain/84.4.680; Maegaki Y, 2006, NEUROPEDIATRICS, V37, P269, DOI 10.1055/s-2006-955928; Maegaki Y, 2005, NEUROPEDIATRICS, V36, P186, DOI 10.1055/s-2005-865611; Nagao T, 2008, PEDIATR INFECT DIS J, V27, P384, DOI 10.1097/INF.0b013e318162a13b; Okamoto R, 2006, NEUROPEDIATRICS, V37, P32, DOI 10.1055/s-2006-923949; Raha S, 2012, INDIAN J PEDIATR, V79, P1654, DOI 10.1007/s12098-011-0642-3; Rathakrishnan R, 2009, SEIZURE-EUR J EPILEP, V18, P202, DOI 10.1016/j.seizure.2008.09.005; Sadarangani Manish, 2008, Lancet Neurol, V7, P145, DOI 10.1016/S1474-4422(07)70331-9; Sugaya Norio, 2002, Semin Pediatr Infect Dis, V13, P79, DOI 10.1053/spid.2002.122993	28	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	MAY	2015	37	5					478	486		10.1016/j.braindev.2014.08.004		9	Clinical Neurology	Neurosciences & Neurology	CG1ZS	WOS:000353075300003		
J	Kobayashi, K; Yunoki, K; Zensho, K; Akiyama, T; Oka, M; Yoshinaga, H				Kobayashi, Katsuhiro; Yunoki, Kosuke; Zensho, Kazumasa; Akiyama, Tomoyuki; Oka, Makio; Yoshinaga, Harumi			Trend figures assist with untrained emergency electroencephalogram interpretation	BRAIN & DEVELOPMENT			English	Article						aEEG; Frequency; Emergency; Non-expert interpretation	SPECTRAL EDGE FREQUENCY; EEG	Objective: Acute electroencephalogram (EEG) findings are important for diagnosing emergency patients with suspected neurological disorders, but they can be difficult for untrained medical staff to interpret. In this research, we will develop an emergency EEG trend figure that we hypothesize will be more easily understood by untrained staff compared with the raw original traces. Methods: For each of several EEG patterns (wakefulness, sleep, seizure activity, and encephalopathy), trend figures incorporating information on both amplitude and frequency were built. The accuracy of untrained reviewers' interpretation was compared with that of the raw EEG trace interpretation. Results: The rate of correct answers was significantly higher in response to the EEG trend figures than to the raw traces showing wakefulness, sleep, and encephalopathy, but there was no difference when seizure activity patterns were viewed. The rates of misjudging normal or abnormal findings were significantly lower with the trend figures in the wakefulness pattern; in the other patterns, misjudgments were equally low for the trend figures and the raw traces. Conclusion: EEG trend figures improved the accuracy with which untrained medical staff interpreted emergency EEGs. Emergency EEG figures that can be understood intuitively with minimal training might improve the accuracy of emergency EEG interpretation. However, additional studies are required to confirm these results because there may be many types of clinical EEGs that are difficult to interpret. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Kobayashi, Katsuhiro; Akiyama, Tomoyuki; Oka, Makio; Yoshinaga, Harumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Child Neurol, Kita Ku, Okayama 7008558, Japan; [Kobayashi, Katsuhiro; Akiyama, Tomoyuki; Oka, Makio; Yoshinaga, Harumi] Okayama Univ Hosp, Okayama, Japan; [Yunoki, Kosuke; Zensho, Kazumasa] Okayama Univ, Sch Med, Fac Med, Okayama 7008558, Japan	Kobayashi, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Child Neurol, Kita Ku, Shikata Cho 2 Chome 5-1, Okayama 7008558, Japan.	k_koba@md.okayama-u.ac.jp			Ministry of Health, Labour and Welfare, Japan [24-7]; Health and Labour Sciences Research Grant: Research on catastrophic epilepsy in infancy and early childhood epidemiology, diagnosis and treatment guide in Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan [24591513]; Japan Epilepsy Research Foundation	K. Kobayashi was supported by the Research Grant (24-7) for Nervous and Mental Disorders from the Ministry of Health, Labour and Welfare, Japan; by the Health and Labour Sciences Research Grant: Research on catastrophic epilepsy in infancy and early childhood epidemiology, diagnosis and treatment guide in Japan; and by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (No. 24591513). H. Yoshinaga was supported in part by the Japan Epilepsy Research Foundation.	Abdel Baki SG, 2011, INT J EMERG MED, V4, P36; Choi S, 2008, EXPERT SYST APPL, V34, P1056, DOI 10.1016/j.eswa.2006.12.015; Hellstrom-Westas L, 2006, SEMIN FETAL NEONAT M, V11, P503, DOI 10.1016/j.siny.2006.07.011; Komatsu M, 2010, BRAIN DEV-JPN, V32, P472, DOI 10.1016/j.braindev.2009.09.012; Khan SF, 2005, CLIN NEUROPHYSIOL, V116, P2454, DOI 10.1016/j.clinph.2005.06.024; Kikumoto K, 2009, BRAIN DEV-JPN, V31, P148, DOI 10.1016/j.braindev.2008.04.009; Kobayashi K, 2011, EPILEPSY RES, V96, P276, DOI 10.1016/j.eplepsyres.2011.06.012; Leira EC, 2004, INTENS CARE MED, V30, P207, DOI 10.1007/s00134-003-2046-y; Silber Michael H, 2007, J Clin Sleep Med, V3, P121; SZETO HH, 1990, PEDIATR RES, V27, P289; Zehtabchi S, 2011, EPILEPSY BEHAV, V22, P139, DOI 10.1016/j.yebeh.2011.06.012	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	MAY	2015	37	5					487	494		10.1016/j.braindev.2014.08.006		8	Clinical Neurology	Neurosciences & Neurology	CG1ZS	WOS:000353075300004		
J	Shibata, Y; Okada, K; Fukumoto, R; Nomura, K				Shibata, Yuki; Okada, Kaori; Fukumoto, Rie; Nomura, Kenji			Psychometric properties of the parent and teacher forms of the Japanese version of the Strengths and Difficulties Questionnaire	BRAIN & DEVELOPMENT			English	Article						Elementary school; Factor structure; Factor invariance; Sex differences; Teacher-rated; Parent-rated; Reliability	COMMUNITY SAMPLE; SCALE PROPERTIES; SDQ	Objective: This study examined the psychometric properties of the parent and teacher forms of the Japanese version of the Strengths and Difficulties Questionnaire (SDQ). Method: Parents and teachers of 1487 elementary school children (759 boys and 728 girls aged 6-12 years) participated in this study. Results: The results of confirmatory factor analyses of the parent and teacher versions of the SDQ supported the five-factor structure reported in previous studies. However, factor invariance across sex was not observed. The alpha coefficients for the subscales of the SDQs varied between 0.55 and 0.86, the same reliability measures that were also reported in previous studies. Moreover, analyses of variance showed significant differences on all of the subscales according to sex and teacher parent ratings. Conclusion: The factor structure of the SDQ was generally supported, but more gender-segregated investigations of the factor structures are needed. Parents tended to give higher ratings on the difficulties and strengths of children compared to the teachers. Boys were rated higher than girls were on difficulties, while girls were rated higher than boys were on strengths. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Shibata, Yuki] Doshisha Univ, Res Ctr Psychol Sci, Kyotanabe, Kyoto 6100394, Japan; [Okada, Kaori; Fukumoto, Rie; Nomura, Kenji] Nagoya Univ, Ctr Dev Clin Psychol & Psychiat, Nagoya, Aichi 4648601, Japan	Shibata, Y (reprint author), Doshisha Univ, Res Ctr Psychol Sci, 1-3 Tatara Miyakodani, Kyotanabe, Kyoto Fu 6100394, Japan.	yukishibata.mail@gmail.com			Ministry of Education, Culture, Sports, Science, and Technology	The present study was conducted as a part of the Therapeutic Educational Support Project for Developmental Disorders, funded by a special education research grant from the Ministry of Education, Culture, Sports, Science, and Technology.	Mellor D, 2007, EUR J PSYCHOL ASSESS, V23, P105, DOI 10.1027/1015-5759.23.2.105; van Widenfelt BM, 2003, EUR CHILD ADOLES PSY, V12, P281, DOI 10.1007/s00787-003-0341-3; Becker A, 2004, EUR CHILD ADOLES PSY, V13, P11, DOI 10.1007/s00787-004-2003-5; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Woerner W, 2004, EUR CHILD ADOLES PSY, V13, P3, DOI 10.1007/s00787-004-2002-6; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; d'Acremont M, 2008, EUR J PSYCHOL ASSESS, V24, P1, DOI 10.1027/1015-5759.24.1.1; Goodman A, 2010, J ABNORM CHILD PSYCH, V38, P1179, DOI 10.1007/s10802-010-9434-x; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Matsuishi T, 2008, BRAIN DEV-JPN, V30, P410, DOI 10.1016/j.braindev.2007.12.003; Ministry of Education Culture Sports Science and Technology Japan, 2012, RES CHILDR ATT REG C; Ministry of Health Labour and Welfare, 2007, STRENGTHS DIFF QUEST; Nishimura T, 2010, B FUKUOKA U ED 4, V59, P103; Ullebo AK, 2011, EUR CHILD ADOLES PSY, V20, P451, DOI 10.1007/s00787-011-0198-9	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	MAY	2015	37	5					501	507		10.1016/j.braindev.2014.08.001		7	Clinical Neurology	Neurosciences & Neurology	CG1ZS	WOS:000353075300006		
J	Kamide, A; Hashimoto, K; Miyamura, K; Honda, M				Kamide, Anri; Hashimoto, Keiji; Miyamura, Kohei; Honda, Manami			Assessment of feeding and swallowing in children: Validity and reliability of the Ability for Basic Feeding and Swallowing Scale for Children (ABFS-C)	BRAIN & DEVELOPMENT			English	Article						Dysphagia; Children; ABFS-C; Clinical assessment scale	ORAL FUNCTIONS; DYSPHAGIA	Objective: The purpose was to devise a dysphagia scale for disabled children that could be applied by various medical professionals, family members, and personnel in treatment and education institutions and facilities for disabled children and to assess the validity and reliability of that scale, "Ability for Basic Feeding and Swallowing Scale for Children" (ABFS-C). Methods: Subjects were 54 children (aged 2 months to 14 years and 7 months, median 14 months) who visited the National Center for Child Health and Development from January 2012 to December 2013. They were examined using the Fujishima's Grade of Feeding and Swallowing Ability (Fujishima's Grade), the Functional Independence Measure for Children (WeeFIM) and the ABFS-C composed of 5 items (wakefulness, head control, hypersensitivity, oral motor and saliva control). Validity was evaluated according to correlations of the ABFS-C with Fujishima's Grade or WeeFIM. To assess interrater reliability, 17 children were assessed by a doctor and occupational therapist independently. Results: The ABFS-C scores and Fujishima's Grade were correlated using Spearman rank correlation coefficients. Fujishima's Grade was significantly correlated with saliva control (R = 0.470) and the total ABFS-C scores (R = 0.322) but not with wakefulness (R = -0.014), head control (R = 0.122), hypersensitivity (R = -0.009), or oral motor (R = 0.139). In addition, the total ABFS-C scores had a significant correlation with the total score of the WeeFIM (R = 0.562), motor WeeFIM (R = 0.451), cognitive WeeFIM (R = 0,478), and the eating subscore of the WeeFIM (R = 0.460). Interrater reliability was demonstrated for all items except hypersensitivity. Conclusions: There were significant correlations between the total ABFS-C scores and Fujishima's Grade and WeeFIM, which suggested the need for comprehensive assessments rather than assessments of individual feeding and swallowing functions. To improve the reliability for hypersensitivity, the assessment process for hypersensitivity should be reviewed. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Kamide, Anri; Hashimoto, Keiji; Honda, Manami] Natl Ctr Child Hlth & Dev, Div Rehabil Med, Tokyo 1578535, Japan; [Kamide, Anri; Hashimoto, Keiji; Honda, Manami] Natl Ctr Child Hlth & Dev, Dev Evaluat Ctr, Tokyo 1578535, Japan; [Miyamura, Kohei] Tokyo Metropolitan Otsuka Hosp, Tokyo, Japan	Kamide, A (reprint author), Natl Ctr Child Hlth & Dev, Setagaya Ku, 10-1,Okura 2 Chome, Tokyo 1578535, Japan.	kamide-a@ncchd.go.jp					Kunieda K, 2013, J PAIN SYMPTOM MANAG, V46, P201, DOI 10.1016/j.jpainsymman.2012.07.020; OTTENBACHER K, 1985, AM J OCCUP THER, V39, P436; Sheppard JJ, 2008, LANG SPEECH HEAR SER, V39, P227, DOI 10.1044/0161-1461(2008/022); Arvedson J, 2002, PEDIAT SWALLOWING FE; Benfer KA, 2012, DEV MED CHILD NEUROL, V54, P784, DOI 10.1111/j.1469-8749.2012.04302.x; Cintas HL, 2011, PHYS OCCUP THER PEDI, V31, P440, DOI 10.3109/01942638.2011.572148; Fujishima I, 1998, REHABILITATION SWALL; Fujishima I, 2006, JPN J REHABIL MED, V43, pS249; Groher ME, 2009, DYSPHAGIA CLIN MANAG; Ko Moon Ju, 2011, Ann Rehabil Med, V35, P477, DOI 10.5535/arm.2011.35.4.477; Lefton-Greif MA, 2008, PHYS MED REHABIL CLI, V19, P837, DOI 10.1016/j.pmr.2008.05.007; Miyamura K, 2011, BRAIN DEV-JPN, V33, P508, DOI 10.1016/j.braindev.2010.12.001; Mukai Y, 2013, DENT MED RES, V33, P23; Murayama K, 2004, JPM J DYSPHAGIA REHA, V8, P143; Nagai S, 2011, SOGO REHABIL, V39, P231; Nishio M, 2008, JPM J DYSPHAGIA REHA, V12, P11; STRATTON M, 1981, AM J OCCUP THER, V35, P719; Yokoyama M, 2012, SOGO REHABIL, V40, P137	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	MAY	2015	37	5					508	514		10.1016/j.braindev.2014.08.005		7	Clinical Neurology	Neurosciences & Neurology	CG1ZS	WOS:000353075300007		
J	Shimada, S; Shimojima, K; Okamoto, N; Sangu, N; Hirasawa, K; Matsuo, M; Ikeuchi, M; Shimakawa, S; Shimizu, K; Mizuno, S; Kubota, M; Adachi, M; Saito, Y; Tomiwa, K; Haginoya, K; Numabe, H; Kako, Y; Hayashi, A; Sakamoto, H; Hiraki, Y; Minami, K; Takemoto, K; Watanabe, K; Miura, K; Chiyonobu, T; Kumada, T; Imai, K; Maegaki, Y; Nagata, S; Kosaki, K; Izumi, T; Nagai, T; Yamamoto, T				Shimada, Shino; Shimojima, Keiko; Okamoto, Nobuhiko; Sangu, Noriko; Hirasawa, Kyoko; Matsuo, Mari; Ikeuchi, Mayo; Shimakawa, Shuichi; Shimizu, Kenji; Mizuno, Seiji; Kubota, Masaya; Adachi, Masao; Saito, Yoshiaki; Tomiwa, Kiyotaka; Haginoya, Kazuhiro; Numabe, Hironao; Kako, Yuko; Hayashi, Ai; Sakamoto, Haruko; Hiraki, Yoko; Minami, Koichi; Takemoto, Kiyoshi; Watanabe, Kyoko; Miura, Kiyokuni; Chiyonobu, Tomohiro; Kumada, Tomohiro; Imai, Katsumi; Maegaki, Yoshihiro; Nagata, Satoru; Kosaki, Kenjiro; Izumi, Tatsuro; Nagai, Toshiro; Yamamoto, Toshiyuki			Microarray analysis of 50 patients reveals the critical chromosomal regions responsible for 1p36 deletion syndrome-related complications	BRAIN & DEVELOPMENT			English	Article						1p36 deletion syndrome; Chromosomal deletion; Genotype-phenotype correlation; Intellectual disability; Ambulation; Epilepsy; Distinctive features	HYPOPLASTIC LEFT-HEART; PERIVENTRICULAR NODULAR HETEROTOPIA; VENTRICULAR NON-COMPACTION; WILLI-LIKE PHENOTYPE; MONOSOMY 1P36; TERMINAL DELETION; DEVELOPMENTAL DELAY; ARRAY-CGH; POLYMICROGYRIA; TRISOMY	Objective: Monosomy 1p36 syndrome is the most commonly observed subtelomeric deletion syndrome. Patients with this syndrome typically have common clinical features, such as intellectual disability, epilepsy, and characteristic craniofacial features. Method: In cooperation with academic societies, we analyzed the genomic copy number aberrations using chromosomal microarray testing. Finally, the genotype-phenotype correlation among them was examined. Results: We obtained clinical information of 86 patients who had been diagnosed with chromosomal deletions in the 1p36 region. Among them, blood samples were obtained from 50 patients (15 males and 35 females). The precise deletion regions were successfully genotyped. There were variable deletion patterns: pure terminal deletions in 38 patients (76%), including three cases of mosaicism; unbalanced translocations in seven (14%); and interstitial deletions in five (10%). Craniofacial/skeletal features, neurodevelopmental impairments, and cardiac anomalies were commonly observed in patients, with correlation to deletion sizes. Conclusion: The genotype-phenotype correlation analysis narrowed the region responsible for distinctive craniofacial features and intellectual disability into 1.8-2.1 and 1.8-2.2 Mb region, respectively. Patients with deletions larger than 6.2 Mb showed no ambulation, indicating that severe neurodevelopmental prognosis may be modified by haploinsufficiencies of KCNAB2 and CHD5, located at 6.2 Mb away from the telomere. Although the genotype-phenotype correlation for the cardiac abnormalities is unclear, PRDM16, PRKCZ, and RERE may be related to this complication. Our study also revealed that female patients who acquired ambulatory ability were likely to be at risk for obesity. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Shimada, Shino; Shimojima, Keiko; Sangu, Noriko; Yamamoto, Toshiyuki] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo 1628666, Japan; [Shimada, Shino; Hirasawa, Kyoko; Nagata, Satoru] Tokyo Womens Med Univ, Dept Pediat, Tokyo 1628666, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Dept Med Genet, Izumi, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Izumi, Japan; [Sangu, Noriko] Tokyo Womens Med Univ, Sch Med, Dept Oral & Maxillofacial Surg, Tokyo 1628666, Japan; [Matsuo, Mari] Tokyo Womens Med Univ, Inst Med Genet, Tokyo 1628666, Japan; [Ikeuchi, Mayo; Izumi, Tatsuro] Oita Univ, Fac Med, Dept Pediat & Child Neurol, Oita 87011, Japan; [Shimakawa, Shuichi] Osaka Med Coll, Dept Pediat, Takatsuki, Osaka 569, Japan; [Shimizu, Kenji] Saitama Childrens Med Ctr, Div Med Genet, Saitama, Japan; [Mizuno, Seiji] Cent Hosp Kasugai, Aichi Human Serv Ctr, Dept Pediat, Kasugai, Aichi, Japan; [Kubota, Masaya] Natl Ctr Child Hlth & Dev, Div Neurol, Tokyo, Japan; [Adachi, Masao] Kakogawa West City Hosp, Kakogawa Hosp Org, Dept Pediat, Kakogawa, Hyogo, Japan; [Saito, Yoshiaki] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Tokyo, Japan; [Tomiwa, Kiyotaka] Osaka City Gen Hosp, Med Ctr Children, Dept Pediat, Osaka, Japan; [Haginoya, Kazuhiro] Takuto Rehabil Ctr Children, Dept Pediat Neurol, Sendai, Miyagi, Japan; [Numabe, Hironao] Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Genet Counseling, Tokyo 112, Japan; [Kako, Yuko] Showa Univ, Sch Med, Dept Pediat, Tokyo 142, Japan; [Hayashi, Ai] Japanese Red Cross Kyoto Daiichi Hosp, Dept Neonatol, Kyoto, Japan; [Sakamoto, Haruko] Osaka Red Cross Hosp, Dept Pediat, Osaka, Japan; [Hiraki, Yoko] Hiroshima Municipal Ctr Child Hlth & Dev, Hiroshima, Japan; [Minami, Koichi] Wakayama Med Univ, Dept Pediat, Wakayama, Japan; [Takemoto, Kiyoshi] Osaka Dev Rehabil Ctr, Osaka, Japan; [Watanabe, Kyoko] Natl Hosp Org, Kolcura Med Ctr, Dept Pediat, Kitakyushu, Fukuoka, Japan; [Miura, Kiyokuni] Nagoya Univ, Grad Sch Med, Dev Disabil Med, Nagoya, Aichi, Japan; [Chiyonobu, Tomohiro] Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kyoto 602, Japan; [Kumada, Tomohiro] Shiga Med Ctr Children, Dept Pediat, Moriyama, Japan; [Imai, Katsumi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka, Japan; [Maegaki, Yoshihiro] Tottori Univ, Sch Med, Div Child Neurol, Yonago, Tottori 683, Japan; [Kosaki, Kenjiro] Keio Univ, Sch Med, Ctr Med Genet, Tokyo, Japan; [Nagai, Toshiro] Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Saitama, Japan	Yamamoto, T (reprint author), Tokyo Womens Med Univ, Inst Integrated Med Sci, Shinjuku Ward, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yamamoto.toshiyuki@twmu.ac.jp			Japanese Society of Child Neurology; Japan Society of Pediatric Genetics; Health Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare, Japan	We would like to express our gratitude to the patients and their families for their cooperation. We also thank the Japanese Society of Child Neurology and the Japan Society of Pediatric Genetics for their supports. This work was supported by a Grant-in-Aid for Scientific Research from Health Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare, Japan.	Redon R, 2005, J MED GENET, V42, P166, DOI 10.1136/jmg.2004.023861; Battaglia A, 2008, PEDIATRICS, V121, P404, DOI 10.1542/peds.2007-0929; Shimada S, 2013, BRAIN DEV-JPN, V35, P411, DOI 10.1016/j.braindev.2012.07.010; Kang SHL, 2007, CLIN GENET, V72, P329, DOI 10.1111/j.1399-0004.2007.00876.x; Slavotinek A, 1999, J MED GENET, V36, P657; Arndt AK, 2013, AM J HUM GENET, V93, P67, DOI 10.1016/j.ajhg.2013.05.015; Rosenfeld JA, 2010, AM J MED GENET A, V152A, P1951, DOI 10.1002/ajmg.a.33516; Heilstedt HA, 2003, CLIN GENET, V64, P310, DOI 10.1034/j.1399-0004.2003.00126.x; Heilstedt HA, 2003, AM J HUM GENET, V72, P1200, DOI 10.1086/375179; Dobyns WB, 2008, AM J MED GENET A, V146A, P1637, DOI 10.1002/ajmg.a.32293; Barron DJ, 2009, LANCET, V374, P551, DOI 10.1016/S0140-6736(09)60563-8; Gajecka M, 2007, AM J MED GENET C, V145C, P346, DOI 10.1002/ajmg.c.30154; Sinkovec M, 2005, INT J CARDIOL, V102, P297, DOI 10.1016/j.ijcard.2004.05.033; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Gajecka M, 2005, EUR J HUM GENET, V13, P139, DOI 10.1038/sj.ejhg.5201302; Benzing T, 2012, CURR OPIN NEPHROL HY, V21, P272, DOI 10.1097/MNH.0b013e3283520f17; Shao L, 2008, AM J MED GENET A, V146A, P2242, DOI 10.1002/ajmg.a.32399; Battaglia A, 2005, BRAIN DEV-JPN, V27, P358, DOI 10.1016/j.braindev.2004.03.011; Buck A, 2011, AM J MED GENET A, V155A, P3164, DOI 10.1002/ajmg.a.34333; Chen CP, 2005, PRENATAL DIAG, V25, P334, DOI 10.1002/pd.1126; Colmenares C, 2002, NAT GENET, V30, P106, DOI 10.1038/ng770; Cremer K, 2008, EUR J MED GENET, V51, P685, DOI 10.1016/j.ejmg.2008.07.006; D'Angelo CS, 2006, EUR J MED GENET, V49, P451, DOI 10.1016/j.ejmg.2006.02.001; Descartes M, 2011, PEDIATR NEUROL, V45, P274, DOI 10.1016/j.pediatrneurol.2011.06.002; Digilio MC, 2011, AM J MED GENET A, V155A, P2196, DOI 10.1002/ajmg.a.34131; Faivre L, 1999, Prenat Diagn, V19, P49, DOI 10.1002/(SICI)1097-0223(199901)19:1<49::AID-PD450>3.0.CO;2-C; Gajecka M, 2010, AM J MED GENET A, V152A, P3074, DOI 10.1002/ajmg.a.33733; Grossfeld PD, 1999, CARDIOL YOUNG, V9, P627; Heilstedt HA, 2001, EPILEPSIA, V42, P1103, DOI 10.1046/j.1528-1157.2001.08801.x; Hiraki Y, 2006, AM J MED GENET A, V140A, P1773, DOI 10.1002/ajmg.a.31364; Kim BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057460; Kurosawa K, 2005, BRAIN DEV-JPN, V27, P378, DOI 10.1016/j.braindev.2005.02.004; Neal J, 2006, AM J MED GENET A, V140A, P1692, DOI 10.1002/ajmg.a.31334; Okamoto N, 2002, J HUM GENET, V47, P556, DOI 10.1007/s100380200085; Otto EA, 2011, J MED GENET, V48, P105, DOI 10.1136/jmg.2010.082552; Potts RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024515; Riegel M, 1999, AM J MED GENET, V82, P249, DOI 10.1002/(SICI)1096-8628(19990129)82:3<249::AID-AJMG10>3.0.CO;2-8; Saito S, 2008, AM J MED GENET A, V146A, P2891, DOI 10.1002/ajmg.a.32556; Saito Y, 2011, BRAIN DEV-JPN, V33, P437, DOI 10.1016/j.braindev.2010.07.004; Sanchez-Valle A, 2011, AM J MED GENET A, V155A, P363, DOI 10.1002/ajmg.a.33844; Sentex E, 2006, CAN J PHYSIOL PHARM, V84, P227, DOI 10.1139/Y05-120; Shapria SK, 1997, AM J HUM GENET, V61, P642, DOI 10.1086/515520; Shimada S, 2014, AM J MED GENET A, V164, P415, DOI 10.1002/ajmg.a.36304; Shimada S, 2013, AM J MED GENET A, V161A, P1779, DOI 10.1002/ajmg.a.35975; Shimojima K, 2009, BRAIN DEV-JPN, V31, P629, DOI 10.1016/j.braindev.2008.08.013; Thienpont B, 2007, EUR J MED GENET, V50, P233, DOI 10.1016/j.ejmg.2007.01.002; Tsuyusaki Y, 2010, PEDIATR INT, V52, P547, DOI 10.1111/j.1442-200X.2010.03090.x; Wu YQ, 1999, HUM MOL GENET, V8, P313, DOI 10.1093/hmg/8.2.313; Zenker M, 2002, CLIN DYSMORPHOL, V11, P43, DOI 10.1097/00019605-200201000-00009	49	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	MAY	2015	37	5					515	526		10.1016/j.braindev.2014.08.002		12	Clinical Neurology	Neurosciences & Neurology	CG1ZS	WOS:000353075300008		
J	Suehiro, Y; Hasegawa, A; Iino, T; Sasada, A; Watanabe, N; Matsuoka, M; Takamori, A; Tanosaki, R; Utsunomiya, A; Choi, I; Fukuda, T; Miura, O; Takaishi, S; Teshima, T; Akashi, K; Kannagi, M; Uike, N; Okamura, J				Suehiro, Youko; Hasegawa, Atsuhiko; Iino, Tadafumi; Sasada, Amane; Watanabe, Nobukazu; Matsuoka, Masao; Takamori, Ayako; Tanosaki, Ryuji; Utsunomiya, Atae; Choi, Ilseung; Fukuda, Tetsuya; Miura, Osamu; Takaishi, Shigeo; Teshima, Takanori; Akashi, Koichi; Kannagi, Mari; Uike, Naokuni; Okamura, Jun			Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						adult T cell leukaemia; lymphoma; tumour vaccine; dendritic cell; human T cell leukaemia virus type-I; cytotoxic T lymphocyte	VIRUS TYPE-I; PROSTATE-CANCER PATIENTS; LEUKEMIA-LYMPHOMA; INTERFERON-ALPHA; TRANSPLANTATION; LYMPHOCYTES; LEUKEMIA/LYMPHOMA; DISEASE; ANTIGEN; IMMUNOTHERAPY	Adult T cell leukaemia/lymphoma (ATL) is a human T cell leukaemia virus type-I (HTLV-I)-infected T cell malignancy with poor prognosis. We herein developed a novel therapeutic vaccine designed to augment an HTLV-I Tax-specific cytotoxic T lymphocyte (CTL) response that has been implicated in anti-ATL effects, and conducted a pilot study to investigate its safety and efficacy. Three previously treated ATL patients, classified as intermediate- to high-risk, were subcutaneously administered with the vaccine, consisting of autologous dendritic cells (DCs) pulsed with Tax peptides corresponding to the CTL epitopes. In all patients, the performance status improved after vaccination without severe adverse events, and Tax-specific CTL responses were observed with peaks at 16-20weeks. Two patients achieved partial remission in the first 8weeks, one of whom later achieved complete remission, maintaining their remission status without any additional chemotherapy 24 and 19months after vaccination, respectively. The third patient, whose tumour cells lacked the ability to express Tax at biopsy, obtained stable disease in the first 8weeks and later developed slowly progressive disease although additional therapy was not required for 14months. The clinical outcomes of this pilot study indicate that the Tax peptide-pulsed DC vaccine is a safe and promising immunotherapy for ATL.	[Suehiro, Youko; Choi, Ilseung; Uike, Naokuni] Kyushu Natl Canc Ctr, Dept Haematol, Fukuoka, Japan; [Hasegawa, Atsuhiko; Sasada, Amane; Takamori, Ayako; Kannagi, Mari] Tokyo Med & Dent Univ, Dept Immunotherapeut, Tokyo 1138519, Japan; [Iino, Tadafumi; Takaishi, Shigeo] Kyushu Univ, Ctr Adv Med Innovat, Fukuoka 812, Japan; [Watanabe, Nobukazu] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan; [Tanosaki, Ryuji] Natl Canc Ctr, Clin Lab Div, Tokyo, Japan; [Utsunomiya, Atae] Imamura Bun Hosp, Dept Haematol, Kagoshima, Japan; [Fukuda, Tetsuya; Miura, Osamu] Tokyo Med & Dent Univ, Dept Haematol, Tokyo 1138519, Japan; [Teshima, Takanori] Hokkaido Univ, Dept Haematol, Sapporo, Hokkaido 060, Japan; [Akashi, Koichi] Kyushu Univ, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Okamura, Jun] Kyushu Natl Canc Ctr, Inst Clin Res, Fukuoka, Japan	Kannagi, M (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Immunotherapeut, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	kann.impt@tmd.ac.jp			Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Satomi Ando and Yuji Murakami (Tokyo Medical and Dental University), and Eri Watanabe (Tokyo University) for performing the immunological analysis. This work was supported by an anti-cancer grant from the Ministry of Health, Labour and Welfare of Japan, and the scientific support program for cancer research of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ishida T, 2011, CANCER SCI, V102, P44, DOI 10.1111/j.1349-7006.2010.01767.x; Wu L, 2008, CLIN CANCER RES, V14, P4650, DOI 10.1158/1078-0432.CCR-07-4405; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Makino M, 2000, VIROLOGY, V274, P140, DOI 10.1006/viro.2000.0445; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; JACOBSON S, 1990, NATURE, V348, P245, DOI 10.1038/348245a0; UCHIYAMA T, 1977, BLOOD, V50, P481; Katsuya H, 2012, J CLIN ONCOL, V30, P1635, DOI 10.1200/JCO.2011.38.2101; KANNAGI M, 1992, J VIROL, V66, P2928; Wierecky J, 2006, CANCER RES, V66, P5910, DOI 10.1158/0008-5472.CAN-05-3905; HERMINE O, 1995, NEW ENGL J MED, V332, P1749, DOI 10.1056/NEJM199506293322604; Nagayama H, 2003, MELANOMA RES, V13, P521, DOI 10.1097/01.cmr.0000056275.15046.fa; Utsunomiya A, 2001, BONE MARROW TRANSPL, V27, P15, DOI 10.1038/sj.bmt.1702731; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Rende F, 2011, BLOOD, V117, P4855, DOI 10.1182/blood-2010-11-316463; Hishizawa M, 2010, BLOOD, V116, P1369, DOI 10.1182/blood-2009-10-247510; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; Hishizawa M, 2004, BRIT J HAEMATOL, V125, P568, DOI 10.1111/j.1365-2141.2004.04956.x; Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745; GILL PS, 1995, NEW ENGL J MED, V332, P1744, DOI 10.1056/NEJM199506293322603; DesKeersmaecker B., 2012, J VIROL, V86, P9351; Fuessel S, 2006, PROSTATE, V66, P811, DOI 10.1002/pros.20404; Hanabuchi S, 2001, J NATL CANCER I, V93, P1775, DOI 10.1093/jnci/93.23.1775; Harashima N, 2004, CANCER RES, V64, P391, DOI 10.1158/0008-5472.CAN-03-1452; Harashima N, 2005, J VIROL, V79, P10088, DOI 10.1128/JVI.79.15.10088-10092.2005; Ishida T, 2013, BIOL BLOOD MARROW TR, V19, P1731, DOI 10.1016/j.bbmt.2013.09.014; Kurihara K, 2005, INT J CANCER, V114, P257, DOI 10.1002/ijc.20737; LEE B, 1989, TOHOKU J EXP MED, V157, P1, DOI 10.1620/tjem.157.1; Linette GP, 2005, CLIN CANCER RES, V11, P7692, DOI 10.1158/1078-0432.CCR-05-1198; Ohashi T, 2000, J VIROL, V74, P9610, DOI 10.1128/JVI.74.20.9610-9616.2000; Okamura J, 2005, BLOOD, V105, P4143, DOI 10.1182/blood-2004-11-4193; Takamori A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-100; Tanosaki R, 2008, BIOL BLOOD MARROW TR, V14, P702, DOI 10.1016/j.bbmt.2008.03.010; Tsukasaki K, 2012, JPN J CLIN ONCOL, V42, P85, DOI 10.1093/jjco/hyr168; Ueda Y, 2004, INT J ONCOL, V24, P909; Thomas-Kaskell AK, 2006, INT J CANCER, V119, P2428, DOI 10.1002/ijc.22097	37	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	MAY	2015	169	3					356	367		10.1111/bjh.13302		12	Hematology	Hematology	CG1LJ	WOS:000353033800006		
J	Nonaka, M; Morimoto, S; Murayama, T; Kurebayashi, N; Li, L; Wang, YY; Arioka, M; Yoshihara, T; Takahashi-Yanaga, F; Sasaguri, T				Nonaka, Miki; Morimoto, Sachio; Murayama, Takashi; Kurebayashi, Nagomi; Li, Lei; Wang, Yuan-Yuan; Arioka, Masaki; Yoshihara, Tatsuya; Takahashi-Yanaga, Fumi; Sasaguri, Toshiyuki			Stage-dependent benefits and risks of pimobendan in mice with genetic dilated cardiomyopathy and progressive heart failure	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							FAILING HUMAN MYOCARDIUM; CONCISE GUIDE; VENTRICULAR MYOCYTES; CALCIUM SENSITIVITY; NA+-CA2+ EXCHANGER; ARRIVE GUIDELINES; TROPONIN MUTATION; MOUSE MODEL; PHARMACOLOGY; EXPRESSION	Background and PurposeThe Ca2+ sensitizer pimobendan is a unique inotropic agent that improves cardiac contractility with less of an increase in oxygen consumption and potentially fewer adverse effects on myocardial remodelling and arrhythmia, compared with traditional inotropes. However, clinical trials report contradictory effects of pimobendan in patients with heart failure (HF). We provide mechanistic experimental evidence of the efficacy of pimobendan using a novel mouse model of progressive HF. Experimental ApproachA knock-in mouse model of human genetic dilated cardiomyopathy, which shows a clear transition from compensatory to end-stage HF at a fixed time during growth, was used to evaluate the efficacy of pimobendan and explore the underlying molecular and cellular mechanisms. Key ResultsPimobendan prevented myocardial remodelling in compensated HF and significantly extended life span in both compensated and end-stage HF, but dose-dependently increased sudden death in end-stage HF. In cardiomyocytes isolated from end-stage HF mice, pimobendan induced triggered activity probably because of early or delayed afterdepolarizations. The L-type Ca2+ channel blocker verapamil decreased the incidence of triggered activity, suggesting that this was from over-elevated cytoplasmic Ca2+ through increased Ca2+ entry by PDE3 inhibition under diminished sarcoplasmic reticulum Ca2+ reuptake and increased Ca2+ leakage from sarcoplasmic reticulum in end-stage HF. Conclusions and ImplicationsPimobendan was beneficial regardless of HF stage, but increased sudden cardiac death in end-stage HF with extensive remodelling of Ca2+ handling. Reduction of cytoplasmic Ca2+ elevated by PDE3 inhibition might decrease this risk of sudden cardiac death.	[Nonaka, Miki; Morimoto, Sachio; Li, Lei; Wang, Yuan-Yuan; Arioka, Masaki; Yoshihara, Tatsuya; Takahashi-Yanaga, Fumi; Sasaguri, Toshiyuki] Kyushu Univ, Grad Sch Med Sci, Dept Clin Pharmacol, Fukuoka 8128582, Japan; [Takahashi-Yanaga, Fumi] Kyushu Univ, Grad Sch Med Sci, Global Med Sci Educ Unit, Fukuoka 8128582, Japan; [Murayama, Takashi; Kurebayashi, Nagomi] Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Pharmacol, Tokyo, Japan	Morimoto, S (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Pharmacol, Fukuoka 8128582, Japan.	morimoto@med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25670130, 23300145]; Kyushu University	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to S. M. (No. 25670130, 23300145); and Grants-in-Aid for Graduate Students at Kyushu University to M. N. We would like to thank Ms Hayakawa and Ms Takami for their technical assistance at the Research Support Centre, Research Centre for Human Disease Modelling, Kyushu University Graduate School of Medical Sciences.	Ahmed A, 2010, J CARD FAIL, V16, P268, DOI 10.1016/j.cardfail.2009.11.004; Amsallem E, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002230.PUB2; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Hjalmarson A, 1999, LANCET, V353, P2001; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1797, DOI 10.1111/bph.12451; Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066; Sipido KR, 2007, ANN NY ACAD SCI, V1099, P339, DOI 10.1196/annals.1387.066; Terentyev D, 2003, P NATL ACAD SCI USA, V100, P11759, DOI 10.1073/pnas.1932318100; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1706, DOI 10.1111/bph.12450; Flesch M, 1996, CIRCULATION, V94, P992; Murai K, 2013, INT HEART J, V54, P75; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1607, DOI 10.1111/bph.12447; ARAI M, 1994, CIRC RES, V74, P555; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Miyata S, 2000, CIRC RES, V86, P386; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; McAlister FA, 2009, ANN INTERN MED, V150, P784; FUJINO K, 1988, CIRC RES, V63, P911; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; BOHM M, 1991, CIRC RES, V68, P689; Chugun A, 2003, AM J PHYSIOL-REG I, V285, pR601, DOI 10.1152/ajpregu.00419.2002; Dash R, 2001, J MOL CELL CARDIOL, V33, P1345, DOI 10.1006/jmcc.2001.1394; DiPaola NR, 2001, J MOL CELL CARDIOL, V33, P1283, DOI 10.1006/jmcc.2001.1390; Kato K, 2002, CIRC J, V66, P149; Endoh M, 2013, CIRC RES, V113, P358, DOI 10.1161/CIRCRESAHA.113.301689; Fischer TH, 2013, CIRCULATION, V128, P970, DOI 10.1161/CIRCULATIONAHA.113.001746; Houser SR, 2000, J MOL CELL CARDIOL, V32, P1595, DOI 10.1006/jmcc.2000.1206; Kubalova Z, 2004, J PHYSIOL-LONDON, V561, P515, DOI 10.1113/jphysiol.2004.073940; Li L, 2012, J MOL CELL CARDIOL, V53, P760, DOI 10.1016/j.yjmcc.2012.08.006; Heyndrickx G, 1996, HEART, V76, P223; Lechat P, 1999, LANCET, V353, P9; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Nakaura H, 1999, AM J PHYSIOL-CELL PH, V277, pC225; Odagiri F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101838; OVASKA M, 1991, PROTEINS, V11, P79, DOI 10.1002/prot.340110202; Reinecke H, 1996, CARDIOVASC RES, V31, P48, DOI 10.1016/S0008-6363(95)00176-X; SCHELD HH, 1989, J CLIN PHARMACOL, V29, P360; Schwinger RHG, 1999, J MOL CELL CARDIOL, V31, P479, DOI 10.1006/jmcc.1998.0897; SOLARO RJ, 1989, J CARDIOVASC PHARM, V14, pS7; STUDER R, 1994, CIRC RES, V75, P443; Summerfield NJ, 2012, J VET INTERN MED, V26, P1337, DOI 10.1111/j.1939-1676.2012.01026.x; Wang YY, 2010, CARDIOVASC RES, V87, P636, DOI 10.1093/cvr/cvq133; Zhan DY, 2009, CARDIOVASC RES, V84, P64, DOI 10.1093/cvr/cvp168	50	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	MAY	2015	172	9					2369	2382		10.1111/bph.13062		14	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CF8LB	WOS:000352809900015		
J	Ogra, Y; Awaya, Y; Anan, Y				Ogra, Yasumitsu; Awaya, Yumi; Anan, Yasumi			Comparison of Accumulation of Four Metalloids in Allium Sativum	BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY			English	Article						Garlic; Phytoremediation; Selenium; Arsenic; Antimony; Tellurium	MASS-SPECTROMETRY; SELENIUM; IDENTIFICATION; SPECIATION; TELLURIUM; BRASSICA; ANTIMONY; CARCINOGENICITY; THIOARSENICALS; METABOLISM	In this study, we evaluated the accumulation and metabolism of four metalloids: arsenic (As), selenium (Se), antimony (Sb), and tellurium (Te) in garlic to determine whether garlic can be used for the phytoremediation of those metalloids. Garlic was able to efficiently accumulate As and Se, the two-fourth-period metalloids. However, it was not able to accumulate Sb and Te, the two-fifth-period metalloids, because their bioaccumulation factors were below one. Speciation analyses revealed that four metalloids could be metabolized in garlic, although their metabolites could not be identified yet. Results also suggested that garlic was able to distinguish the metalloids in groups 15 and 16 and the fourth and fifth periods, i.e., As, Se, Sb, and Te. Therefore, garlic is one of the potential plants for the phytoremediation of the fourth-period metalloids.	[Ogra, Yasumitsu; Awaya, Yumi; Anan, Yasumi] Showa Pharmaceut Univ, Lab Chem Toxicol & Environm Hlth, Machida, Tokyo 1948543, Japan	Ogra, Y (reprint author), Showa Pharmaceut Univ, Lab Chem Toxicol & Environm Hlth, Machida, Tokyo 1948543, Japan.	ogra@ac.shoyaku.ac.jp		Ogra, Yasumitsu/0000-0002-8268-1828	JSPS KAKENHI [23390032, 24659022, 25870739, 26293030]; MEXT; Takeda Science Foundation, Japan	This study was supported by JSPS KAKENHI Grants (Nos. 23390032, 24659022, 25870739 and 26293030) and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2013-2017). We also thank Takeda Science Foundation, Japan for financial support.	Anan Y, 2013, METALLOMICS, V5, P1215, DOI 10.1039/c3mt00108c; Ogra Y, 2007, J ANAL ATOM SPECTROM, V22, P1390, DOI 10.1039/b707348h; Naranmandura H, 2008, TOXICOL APPL PHARM, V231, P328, DOI 10.1016/j.taap.2008.05.005; Bentley R, 2002, MICROBIOL MOL BIOL R, V66, P250, DOI 10.1128/MMBR.66.2.250-271.2002; Grant TD, 2004, J CHROMATOGR A, V1026, P159, DOI 10.1016/j.chroma.2003.11.039; Khaleghian A, 2014, J CELL BIOCHEM, V115, P1729, DOI 10.1002/jcb.24838; FAN AM, 1990, WESTERN J MED, V153, P160; Arnault I, 2006, J CHROMATOGR A, V1112, P23, DOI 10.1016/j.chroma.2006.01.036; Suzuki N, 2008, CHEM RES TOXICOL, V21, P550, DOI 10.1021/tx700346z; Lampe JW, 2002, J NUTR, V132, P2991; Ogra Y, 2009, J ANAL ATOM SPECTROM, V24, P1477, DOI 10.1039/b910235c; Ogra Y, 2005, J CHROMATOGR A, V1093, P118, DOI 10.1016/j.chroma.2005.07.081; Flora SJS, 2009, CHEM-BIOL INTERACT, V177, P227, DOI 10.1016/j.cbi.2008.08.017; Zhao FJ, 2013, ENVIRON SCI TECHNOL, V47, P3957, DOI 10.1021/es304295n; Banuelos G, 2007, ENVIRON SCI TECHNOL, V41, P599, DOI 10.1021/es061152i; Bustaffa E, 2014, ARCH TOXICOL, V88, P1043, DOI 10.1007/s00204-014-1233-7; Guo JB, 2012, J HAZARD MATER, V199, P309, DOI 10.1016/j.jhazmat.2011.11.008; Hansen HR, 2007, ANAL CHEM, V79, P5304, DOI 10.1021/ac070130r; Kobayashi A, 2009, J TOXICOL SCI, V34, P295; Leonard A, 1996, MUTAT RES-REV GENET, V366, P1, DOI 10.1016/S0165-1110(96)90003-2; LEVANDER OA, 1991, J AM DIET ASSOC, V91, P1572; Ogra Y, 2009, ANAL SCI, V25, P1189; Taylor A, 1996, BIOL TRACE ELEM RES, V55, P231, DOI 10.1007/BF02785282; Yathavakilla SVK, 2005, J CHROMATOGR A, V1100, P153, DOI 10.1016/j.chroma.2005.09.025	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4861	1432-0800		B ENVIRON CONTAM TOX	Bull. Environ. Contam. Toxicol.	MAY	2015	94	5					604	608		10.1007/s00128-015-1508-6		5	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CF5RJ	WOS:000352614400011		
J	Oyarzun, AM; Radovic, LR; Kyotani, T				Oyarzun, Andrea M.; Radovic, Ljubisa R.; Kyotani, Takashi			An update on the mechanism of the graphene-NO reaction	CARBON			English	Article							CARBON-OXYGEN REACTION; NITRIC-OXIDE; ACTIVATED CARBONS; CELLULOSIC CHARS; NITROGEN-OXIDES; SURFACE-AREA; REDUCTION; CHEMISORPTION; GASIFICATION; SOOT	Cognizant of the key experimental facts from studies of carbonaceous solids ranging from soot to graphite, we performed a quantum chemistry study of the interaction of NO monomer or dimer with one or more zigzag sites. Thermodynamic and kinetic results were used to examine two alternative mechanisms proposed in the literature, and to compare them with the graphene-O-2 reaction mechanism. The chemisorption stoichiometry similarities are striking; but the differences, especially regarding the intermediate role of N2O, have important practical implications. Monomer chemisorption on an isolated site is a deadend and temporarily inhibiting process, similar to that of formation of a stable C-O surface complex in the graphene-O-2 reaction. When two sites are available, successive monomer adsorption eventually leads to N2O formation subsequent to parallel reorientation of the first NO molecule. If three contiguous sites are available, N-2 and CO are the principal products. Chemisorption of the dimer provides a straightforward path to N-2 and CO2 when one site is available and to N-2 and CO when two sites are available. The formation of N2O is also feasible in this case, both during adsorption and desorption; in the adsorption phase it is very sensitive to the details of the electron pairing processes. (C) 2015 Elsevier Ltd. All rights reserved.	[Oyarzun, Andrea M.; Radovic, Ljubisa R.] Univ Concepcion, Dept Chem Engn, Concepcion, Chile; [Radovic, Ljubisa R.] Penn State Univ, Dept Energy & Mineral Engn, University Pk, PA 16802 USA; [Kyotani, Takashi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Radovic, LR (reprint author), Penn State Univ, Dept Energy & Mineral Engn, University Pk, PA 16802 USA.	lradovic@udec.cl			CONICYT-Chile [1120609, PFB-27]	This study was supported by CONICYT-Chile, grants 1120609 and PFB-27 (CCTE-UDT), as well as a PhD scholarship to A.O. We are grateful to the reviewers, whose constructive criticism and comments helped us to clarify some of the ambiguities in the initial submission.	Liu YFM, 2013, ACS APPL MATER INTER, V5, P12624, DOI 10.1021/am403983g; Radovic LR, 2009, J AM CHEM SOC, V131, P17166, DOI 10.1021/ja904731q; Chambrion P, 1997, FUEL, V76, P493, DOI 10.1016/S0016-2361(96)00224-4; Radovic LR, 2005, J AM CHEM SOC, V127, P5917, DOI 10.1021/ja050124h; LAINE NR, 1963, J PHYS CHEM-US, V67, P2030, DOI 10.1021/j100804a016; IllanGomez MJ, 1996, ENERG FUEL, V10, P158, DOI 10.1021/ef950066t; LAURENDEAU NM, 1978, PROG ENERG COMBUST, V4, P221, DOI 10.1016/0360-1285(78)90008-4; Silva-Tapia AB, 2012, CARBON, V50, P1152, DOI 10.1016/j.carbon.2011.10.028; Sander M, 2009, CARBON, V47, P866, DOI 10.1016/j.carbon.2008.11.043; Aarna I, 1997, FUEL, V76, P475, DOI 10.1016/S0016-2361(96)00212-8; SMITH IW, 1978, FUEL, V57, P409, DOI 10.1016/0016-2361(78)90055-8; Chambrion P, 1997, ENERG FUEL, V11, P681, DOI 10.1021/ef960109l; Li WW, 2011, ACS NANO, V5, P6955, DOI 10.1021/nn201433r; RADOVIC LR, 1983, FUEL, V62, P849, DOI 10.1016/0016-2361(83)90041-8; WESTERN CM, 1981, MOL PHYS, V44, P145, DOI 10.1080/00268978100102341; Arenillas A, 2010, THEOR CHEM ACC, V127, P95, DOI 10.1007/s00214-009-0708-8; Chambrion P, 1998, ENERG FUEL, V12, P416, DOI 10.1021/ef970182r; DEGROOT WF, 1991, CARBON, V29, P185, DOI 10.1016/0008-6223(91)90069-U; DEGROOT WF, 1991, CARBON, V29, P179, DOI 10.1016/0008-6223(91)90068-T; Essenhigh R.H., 1981, CHEM COAL UTILIZAT S, P1153; Frisch M. J., 2004, GAUSSIAN 03 REVISION; Fuente SA, 2012, SURF SCI, V606, P1948, DOI 10.1016/j.susc.2012.08.003; Garcia-Fernandez C, 2014, J PHYS CHEM A, V118, P1443, DOI 10.1021/jp412217q; ILLANGOMEZ MJ, 1993, ENERG FUEL, V7, P146, DOI 10.1021/ef00037a023; Kane JJ, 2013, CARBON, V59, P49, DOI 10.1016/j.carbon.2013.02.053; KANEKO K, 1987, LANGMUIR, V3, P357, DOI 10.1021/la00075a014; Kyotani T, 1999, J PHYS CHEM B, V103, P3434, DOI 10.1021/jp9845928; Ochterski J.W., 2000, THERMOCHEMISTRY GAUS; Pisarello ML, 2002, CATAL TODAY, V75, P465, DOI 10.1016/S0920-5861(02)00097-4; Radovic LR, 2001, ENCY MAT SCI TECHNOL, P975; Radovic LR, 2011, CARBON, V49, P4218, DOI 10.1016/j.carbon.2011.05.059; TENG HH, 1993, IND ENG CHEM RES, V32, P416, DOI 10.1021/ie00015a004; TENG HS, 1993, J PHYS CHEM-US, V97, P478, DOI 10.1021/j100104a033; VARIAVA MF, 2014, ACS APPL MATER INTER, V6, P2917; Vincent MA, 2000, PHYS CHEM CHEM PHYS, V2, P707, DOI 10.1039/a908420g; WALKER PL, 1959, ADV CATAL, V11, P133, DOI 10.1016/S0360-0564(08)60418-6; WALKER PL, 1991, CARBON, V29, P411, DOI 10.1016/0008-6223(91)90210-A; Wang YY, 2010, J PHYS CHEM C, V114, P2711, DOI 10.1021/jp9103596; Zhang H, 2014, IND ENG CHEM RES, V53, P6307, DOI 10.1021/ie403920j	39	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0008-6223	1873-3891		CARBON	Carbon	MAY	2015	86						58	68		10.1016/j.carbon.2015.01.020		11	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CF9YB	WOS:000352922700008		
J	Zenda, M; Yasui, H; Oishi, S; Masuda, R; Fujii, N; Koide, T				Zenda, Miyu; Yasui, Hiroyuki; Oishi, Shinya; Masuda, Ryo; Fujii, Nobutaka; Koide, Takaki			A Cisplatin Derivative that Inhibits Collagen Fibril-Formation in vitro	CHEMICAL BIOLOGY & DRUG DESIGN			English	Editorial Material						cisplatin; collagen; dimethylsulphoxide; fibril-formation; peptide	PEPTIDES; BINDING; SITES; CARBOPLATIN; COMPLEXES; HISTIDINE; DMSO	Using an in vitro random screening of small-molecule compounds, we discovered cis-diamminedichloroplatinum(II) (cisplatin), an anticancer agent, as a potential inhibitor of collagen fibril-formation. The inhibitory effect was found only when cisplatin was dissolved in dimethylsulphoxide (DMSO), indicating that the active species were cisplatin derivatives formed in the DMSO solution. The cisplatin derivatives inhibited the formation of collagen fibrils in vitro without affecting the triple-helical conformation of the collagen molecules. Incubation with the cisplatin solution in DMSO also inhibited in situ deposition of collagen fibrils in a human umbilical vein endothelial cell (HUVEC) culture. In addition, the derivatization of cisplatin in DMSO abolished the cytotoxicity of the original compound. The platinum complex was further revealed to interact with specific sites on the collagen triple helix, and the binding sites were suggested to contain His and/or Met residues. Mass spectrometry analysis of the cisplatin solution in DMSO and a structure-activity relationship study strongly suggested that the active compound is [Pt(NH3)(2)(Cl)(DMSO)](+). This platinum complex will be useful for investigating molecular mechanisms of collagen self-assembly and for drug development for the treatment of fibrotic diseases.	[Zenda, Miyu; Masuda, Ryo; Koide, Takaki] Waseda Univ, Sch Adv Sci & Engn, Dept Chem & Biochem, Tokyo 1698555, Japan; [Yasui, Hiroyuki] Kyoto Pharmaceut Univ, Div Analyt & Phys Sci, Dept Analyt & Bioinorgan Chem, Kyoto 6078414, Japan; [Oishi, Shinya; Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan	Koide, T (reprint author), Waseda Univ, Sch Adv Sci & Engn, Dept Chem & Biochem, Tokyo 1698555, Japan.	koi@waseda.jp			Japan Society for the Promotion of Science [24659051]; Waseda University [2011A-039]; Cosmetology Research Foundation; Nakatomi Foundation; Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan	The authors thank Mr. Kenya Kubota and Dr. Chisato M. Yamazaki for conducting preliminary experiments for this study. The authors also thank Professor Akira Odani of Kanazawa University and Professor Koji Ishihara of Waseda University for valuable discussion. This work was supported in part by a Grant-in-Aid for Challenging Exploratory Research (No. 24659051) from the Japan Society for the Promotion of Science, a Waseda University Grant for Special Research Projects (2011A-039), Cosmetology Research Foundation, The Nakatomi Foundation and Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan.	Tanley SWM, 2012, ACTA CRYSTALLOGR D, V68, P601, DOI 10.1107/S0907444912006907; Fischer SJ, 2008, NEUROTOXICOLOGY, V29, P444, DOI 10.1016/j.neuro.2008.02.010; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Hall MD, 2014, CANCER RES, V74, P3913, DOI 10.1158/0008-5472.CAN-14-0247; Hanson DA, 1996, J BIOL CHEM, V271, P26508; Orgel JPRO, 2011, CONNECT TISSUE RES, V52, P2, DOI 10.3109/03008207.2010.511353; Chung HJ, 2008, J BIOL CHEM, V283, P25879, DOI 10.1074/jbc.M804272200; Chval Z, 2008, J COMPUT CHEM, V29, P2370, DOI 10.1002/jcc.20980; FIETZEK PP, 1977, P NATL ACAD SCI USA, V74, P84, DOI 10.1073/pnas.74.1.84; Hahn M, 2001, J BIOL INORG CHEM, V6, P556, DOI 10.1007/s007750100232; Kunii S, 2010, J BIOL CHEM, V285, P17465, DOI 10.1074/jbc.M110.110759; Okano-Kosugi H, 2009, ANAL BIOCHEM, V394, P125, DOI 10.1016/j.ab.2009.07.017; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; WU JJ, 1984, BIOCHEMISTRY-US, V23, P1850, DOI 10.1021/bi00303a041	14	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-0277	1747-0285		CHEM BIOL DRUG DES	Chem. Biol. Drug Des.	MAY	2015	85	5					519	526		10.1111/cbdd.12450		8	Biochemistry & Molecular Biology; Chemistry, Medicinal	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CF8MB	WOS:000352813400001		
J	Anderson, RH; Brown, NA; Meno, C; Spicer, DE				Anderson, Robert H.; Brown, Nigel A.; Meno, Chikara; Spicer, Diane E.			The Importance of Being Isomeric	CLINICAL ANATOMY			English	Review						visceral heterotaxy; situs solitus; left isomerism; right isomerism; morphological method	APPENDAGE MORPHOLOGY; VISCERAL HETEROTAXY; ATRIAL APPENDAGES; HEART; POLYSPLENIA; ASPLENIA; ANATOMY	In the normal individual, the parietal components of the body are mirror-imaged and appropriately described as isomeric. The thoraco-abdominal organs, in contrast, are lateralized. However, in visceral heterotaxy, the thoraco-abdominal organs also show some degree of isomerism, best seen in the arrangement of the bronchial tree. Whether isomerism can be found within the heart remains controversial. One of two recent publications in this journal emphasized the crucial features of bronchial isomerism; the other, in contrast, confused the situation of isomerism within the heart. In this review, we show how the topic of cardiac isomerism is clarified by concentrating on the anatomical features of the cardiac components and determining how best they can be described. Appropriate manipulation of developing mice produces unequivocal evidence of isomerism of the atrial appendages, but with no evidence of ventricular isomerism. In hearts from patients with so-called heterotaxy, only the atrial appendages, distinguished on the basis of the pectinate muscles lining their walls, are uniformly isomeric, permitting the syndrome to be differentiated into the subsets of left as opposed to right atrial appendage isomerism. Thus, controversies are defused by simply describing the isomerism of the atrial appendages rather than atrial isomerism, recognizing the frequency of abnormal venoatrial connections in these settings. Any suggestion of ambiguity is removed by the equally simple expedient of describing all the variable cardiac features, describing the arrangements of the thoracic and abdominal organs separately should there be discordances. Clin. Anat. 28:477-486, 2015. (c) 2015 Wiley Periodicals, Inc.	[Anderson, Robert H.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Brown, Nigel A.] St Georges Univ, Div Biomed Sci, London, England; [Meno, Chikara] Kyushu Univ, Grad Sch Med Sci, Fukuoka, Kyushu, Japan; [Spicer, Diane E.] Univ Florida, Dept Pediat Cardiol, Gainesville, FL USA; [Spicer, Diane E.] Congenital Heart Inst Florida, St Petersburg, FL USA	Anderson, RH (reprint author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	sejjran@ucl.ac.uk					MACARTNEY FJ, 1980, BRIT HEART J, V44, P657; Spicer DE, 2013, J CARDIOVASC TRANSL, V6, P145, DOI 10.1007/s12265-012-9432-1; VANPRAAGH R, 1990, AM J CARDIOL, V66, P1504, DOI 10.1016/0002-9149(90)90543-A; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; UEMURA H, 1995, ANN THORAC SURG, V60, P561, DOI 10.1016/0003-4975(95)00538-V; MOLLER JH, 1967, CIRCULATION, V36, P789; SHARMA S, 1988, BRIT HEART J, V60, P227; Moorman AFM, 2007, PHILOS T R SOC B, V362, P1257, DOI 10.1098/rstb.2007.2113; Smith A, 2006, CARDIOL YOUNG, V16, P437, DOI 10.1017/S1047951106000382; Liu CY, 2001, DEVELOPMENT, V128, P2039; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; VANPRAAGH R, 1980, CIRCULATION, V61, P1057; Gutgesell HP, 1998, SCI PRACTICE PEDIAT, V2, P1539; JACOBS JP, 2007, CARDIOL YOUNG S2, V17, P1; KEETON BR, 1979, CIRCULATION, V59, P403; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Spentzouris G, 2014, CLIN ANAT, V27, P1234, DOI 10.1002/ca.22445; UEMURA H, 1995, AM J CARDIOL, V76, P846, DOI 10.1016/S0002-9149(99)80243-4; Van Mierop LHS, 1972, BIRTH DEFECTS OAS, V8, P36; Van Praagh R, 1972, BIRTH DEFECTS OAS, VVIII, P4; VANMIEROP LHS, 1962, LAB INVEST, V11, P1303; Wooten C, 2014, CLIN ANAT, V27, P1223, DOI 10.1002/ca.22351	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0897-3806	1098-2353		CLIN ANAT	Clin. Anat.	MAY	2015	28	4					477	486		10.1002/ca.22517		10	Anatomy & Morphology	Anatomy & Morphology	CG1OB	WOS:000353041400013		
J	Mori, S; Fukuzawa, K; Takaya, T; Takamine, S; Ito, T; Kinugasa, M; Shigeru, M; Fujiwara, S; Nishii, T; Kono, AK; Yoshida, A; Hirata, KI				Mori, Shumpei; Fukuzawa, Koji; Takaya, Tomofumi; Takamine, Sachiko; Ito, Tatsuro; Kinugasa, Mitsuo; Shigeru, Mayumi; Fujiwara, Sei; Nishii, Tatsuya; Kono, Atsushi K.; Yoshida, Akihiro; Hirata, Ken-Ichi			Optimal Angulations for Obtaining an En Face View of Each Coronary Aortic Sinus and the Interventricular Septum: Correlative Anatomy Around the Left Ventricular Outflow Tract	CLINICAL ANATOMY			English	Article						coronary aortic sinus; en face view; fluoroscopic anatomy; image intensifier; interventricular septum; left ventricular outflow tract	RADIOFREQUENCY CATHETER ABLATION; COMPUTED-TOMOGRAPHY; CARDIAC ANATOMY; ELECTROCARDIOGRAPHIC CHARACTERISTICS; ARRHYTHMIAS; TACHYCARDIA; HEART; ROOT; IDENTIFICATION; LOCALIZATION	An optimal image intensifier angulation used for obtaining an en face view of a target structure is important in electrophysiologic procedures performed around each coronary aortic sinus (CAS). However, few studies have revealed the fluoroscopic anatomy of the target area. This study investigated the optimal angulation for each CAS and the interventricular septum (IVS). The study included 102 consecutive patients who underwent computed tomography coronary angiography. The optimal angle for each CAS was determined by rotating the volume-rendered image around the vertical axis. The angle formed between the anteroposterior axis and IVS was measured using the horizontal section. The frontal direction was defined as zero, positive, or negative if the en face view of the target CAS was obtained in the frontal view, left anterior oblique (LAO) direction, or right anterior oblique (RAO) direction, respectively. The optimal angles for the left, right, and non-CASs were 120.3 +/- 10.5 degrees, 4.8 +/- 16.3 degrees, and -110.0 +/- 13.8 degrees, respectively. The IVS angle was 42.6 +/- 8.5 degrees. Accordingly, the optimal image intensifier angulations for the left, right, and non-CASs and the IVS were estimated to be RAO 60 degrees, LAO 5 degrees, LAO 70 degrees, and RAO 50 degrees, respectively. The IVS angle was the most common independent predictor of the optimal angle for each CAS. Differences in the optimal angulations for each CAS and the IVS are demonstrated. The biplane angulation needs to be tailored according to the individual patients and target structures for electrophysiologic procedures. Clin. Anat. 28:494-505, 2015. (c) 2015 Wiley Periodicals, Inc.	[Mori, Shumpei; Fukuzawa, Koji; Takaya, Tomofumi; Takamine, Sachiko; Ito, Tatsuro; Kinugasa, Mitsuo; Shigeru, Mayumi; Fujiwara, Sei; Yoshida, Akihiro; Hirata, Ken-Ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan; [Nishii, Tatsuya; Kono, Atsushi K.] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 6500017, Japan	Mori, S (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	shumpei_8@hotmail.com		Takaya, Tomofumi/0000-0001-5775-8072			Anderson RH, 2000, HEART, V84, P670, DOI 10.1136/heart.84.6.670; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Steven D, 2009, CIRC-ARRHYTHMIA ELEC, V2, P660, DOI 10.1161/CIRCEP.109.853531; Yamada T, 2010, J CARDIOVASC ELECTR, V21, P170, DOI 10.1111/j.1540-8167.2009.01608.x; Lin D, 2008, HEART RHYTHM, V5, P663, DOI 10.1016/j.hrthm.2008.02.009; Kuon E, 2004, J AM COLL CARDIOL, V44, P1420, DOI 10.1016/j.jacc.2004.06.057; Kamakura S, 1998, CIRCULATION, V98, P1525; Yamada T, 2008, J AM COLL CARDIOL, V52, P139, DOI 10.1016/j.jacc.2008.03.040; Yamada T, 2010, CIRC-ARRHYTHMIA ELEC, V3, P616, DOI 10.1161/CIRCEP.110.939744; Yamada T, 2008, CIRC-ARRHYTHMIA ELEC, V1, P396, DOI 10.1161/CIRCEP.108.795948; Zhang FX, 2009, EUROPACE, V11, P1214, DOI 10.1093/europace/eup231; Binder RK, 2012, CIRC-CARDIOVASC INTE, V5, P247, DOI 10.1161/CIRCINTERVENTIONS.111.966531; Lamers WH, 2002, CIRC RES, V91, P93, DOI 10.1161/01.RES.00000275135.63141.89; Osmancik P, 2013, CIRC-ARRHYTHMIA ELEC, V6, P719, DOI 10.1161/CIRCEP.113.000232; Daniels DV, 2006, CIRCULATION, V113, P1659, DOI 10.1161/CIRCULATIONAHA.105.611640; Asirvatham SJ, 2009, J CARDIOVASC ELECTR, V20, P955, DOI 10.1111/j.1540-8167.2009.01472.x; Samim M, 2013, JACC-CARDIOVASC IMAG, V6, P238, DOI 10.1016/j.jcmg.2012.12.004; Mond HG, 2007, PACE, V30, P482, DOI 10.1111/j.1540-8159.2007.00697.x; Chen J, 2012, EUROPACE, V14, P388, DOI 10.1093/europace/eur318; Anderson RH, 2004, J ANAT, V205, P159, DOI 10.1111/j.0021-8782.2004.00330.x; Burri H, 2012, EUROPACE, V14, P847, DOI 10.1093/europace/eur404; De Ponti R, 1998, EUR HEART J, V19, P943, DOI 10.1053/euhj.1998.0979; Farre J, 2002, PACE, V25, P76, DOI 10.1046/j.1460-9592.2002.00076.x; Farre J, 2010, PACE, V33, P497, DOI 10.1111/j.1540-8159.2009.02644.x; Gonzalez MD, 2001, J INTERV CARD ELECTR, V5, P89, DOI 10.1023/A:1009818210563; Kumagai K, 2008, J CARDIOVASC ELECTR, V19, P495, DOI 10.1111/j.1540-8167.2007.01085.x; Letsa KP, 2011, CARDIOL RES PRACT, V2011; Mori S, 2014, CLIN ANAT, V27, P1200, DOI 10.1002/ca.22452; PARRILLO JE, 1984, CIRCULATION, V69, P93; Spicer DE, 2014, CARDIOL YOUNG, V24, P1008, DOI 10.1017/S1047951114001942; TAHARA Y, 1991, J ELECTROCARDIOL, V24, P239, DOI 10.1016/0022-0736(91)90029-L; VOLLEBERGH FEMG, 1977, BRIT HEART J, V39, P1006; Webb S, 2003, J ANAT, V202, P327	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0897-3806	1098-2353		CLIN ANAT	Clin. Anat.	MAY	2015	28	4					494	505		10.1002/ca.22521		12	Anatomy & Morphology	Anatomy & Morphology	CG1OB	WOS:000353041400015		
J	Onuki, T; Kanzaki, M; Kikkawa, T; Isaka, T; Sakamoto, K; Oyama, K; Murasugi, M				Onuki, Takamasa; Kanzaki, Masato; Kikkawa, Takuma; Isaka, Tamami; Sakamoto, Kei; Oyama, Kunihiro; Murasugi, Masahide			New Findings on the Three-Dimensional Anatomical Relations between the Bronchi and Pulmonary Blood Vessels at the Pulmonary Hilum	CLINICAL ANATOMY			English	Article						three-dimensional; anatomy; development; bronchi; pulmonary artery; pulmonary veins	BRONCHOPULMONARY SEGMENTS; LUNG; IDENTIFICATION	During the 1940s, considerable knowledge was acquired about the anatomy of pulmonary segments, and anatomical terms were proposed and have been widely accepted. In recent years, minimally invasive and thoracoscopic segmentectomy has been performed with a versatile sublobar resection approach on patients with early peripheral lung cancer, metastatic lung tumors, and undiagnosed nodules. The three-dimensional (3D) anatomy of the bronchi and the pulmonary vessels has also been studied in individual patients. Three-dimensional models of the bronchi and pulmonary vessels were prepared using homemade software from computed tomograms (CT) of the chests of patients scheduled to undergo surgical procedures. Using these models, the authors examined the 3D positional relationships of the segmental broncho-arterial triangle (SBAT) created by three points defined by the origins and courses of the bronchi and the pulmonary arteries, which are located apart from each other at the pulmonary hilum, and the segmental pulmonary veins (SPV), which run near the SBAT. In the left and right upper lobes, many branches of the pulmonary arteries and parallel bronchi in subsegments were widely separated at the origin of the pulmonary hilum, creating a relatively large SBAT. However, as an exceptional case, an SPV passed through an SBAT in only one of 158 patients. To our knowledge, no similar findings have been documented previously. Our findings could help to determine resection surfaces for thoracoscopic segmentectomy in the future, and provide new insights into the 3D anatomy and development of the lung. Clin. Anat. 28:506-511, 2015. (c) 2014 Wiley Periodicals, Inc.	[Onuki, Takamasa; Kanzaki, Masato; Kikkawa, Takuma; Isaka, Tamami; Sakamoto, Kei; Oyama, Kunihiro; Murasugi, Masahide] Tokyo Womens Med Univ, Dept Surg, Shinjuku Ku, Tokyo 1620054, Japan	Onuki, T (reprint author), 8-1 Kawada Chou,Shinjuku Ku, Tokyo 1620054, Japan.	tonuki@chi.twmu.ac.jp					Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; WEIBEL ER, 1962, SCIENCE, V137, P577, DOI 10.1126/science.137.3530.577; Schuchert MJ, 2012, ANN THORAC SURG, V93, P1780, DOI 10.1016/j.athoracsur.2011.11.074; Okada M, 2007, J THORAC CARDIOV SUR, V133, P753, DOI 10.1016/j.jtcvs.2006.11.005; Asai K, 2005, ANN THORAC SURG, V79, P1866, DOI 10.1016/j.athoracsur.2004.12.014; BOYDEN EA, 1945, SURGERY, V18, P706; Boyden EA., 1954, SEGMENTAL ANATOMY LU, P23; BROCK RC, 1950, THORAX, V5, P5, DOI 10.1136/thx.5.1.5; deMello DE, 1997, AM J RESP CELL MOL B, V16, P561; Hall SM, 2000, AM J RESP CELL MOL, V23, P194; Ikeda N, 2013, ANN THORAC CARDIOVAS, V19, P1, DOI 10.5761/atcs.ra.12.02174; Jackson CL, 1943, CHEST, V9, P319, DOI 10.1378/chest.9.4.319; Kanzaki M, 2011, J THORAC CARDIOV SUR, V142, P243, DOI 10.1016/j.jtcvs.2011.02.044; Kanzaki Masato, 2013, Asian J Endosc Surg, V6, P110, DOI 10.1111/ases.12015; Matsumoto T, 2011, EURO J CARIOTHORAC S, V41, P1098; Oizumi H, 2011, J THORAC CARDIOV SUR, V141, P678, DOI 10.1016/j.jtcvs.2010.08.027; Onuki Takamasa, 2009, Kyobu Geka, V62, P733; OSBORNE D, 1984, AM J ROENTGENOL, V142, P47; Parera MC, 2005, AM J PHYSIOL-LUNG C, V288, pL141, DOI 10.1152/ajplung.00148.2004; RAMSAY BH, 1949, SURGERY, V25, P533; Schwarz MA, 2009, AM J PHYSIOL-LUNG C, V296, pL71, DOI 10.1152/ajplung.90452.2008; SEALY WC, 1993, ANN THORAC SURG, V55, P184; Yamashita H., 1978, ROENTGENOLOGIC ANATO, P10	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0897-3806	1098-2353		CLIN ANAT	Clin. Anat.	MAY	2015	28	4					506	511		10.1002/ca.22486		6	Anatomy & Morphology	Anatomy & Morphology	CG1OB	WOS:000353041400016		
J	Volpe, C; Hamberger, B; Hoog, A; Mukai, K; Calissendorff, J; Wahrenberg, H; Zedenius, J; Thoren, M				Volpe, Cristina; Hamberger, Bertil; Hoog, Anders; Mukai, Kuniaki; Calissendorff, Jan; Wahrenberg, Hans; Zedenius, Jan; Thoren, Marja			Primary aldosteronism: functional histopathology and long-term follow-up after unilateral adrenalectomy	CLINICAL ENDOCRINOLOGY			English	Article							MESSENGER-RNA EXPRESSION; PRIMARY HYPERALDOSTERONISM; LAPAROSCOPIC ADRENALECTOMY; HYPERPLASIA; DIAGNOSIS; CYP11B2; ADENOMA; OUTCOMES; IMMUNOHISTOCHEMISTRY; SCINTIGRAPHY	ObjectivesTo investigate the long-term outcome after unilateral adrenalectomy in patients with primary aldosteronism (PA) and to establish the role of functional pathology for the final diagnosis of aldosterone-producing adenoma (APA) or hyperplasia. DesignA single-centre, retrospective cohort study in a hospital setting. PatientsConsecutive patients with PA, n=120, who underwent unilateral adrenalectomy between 1985 and 2010. Preoperative and postoperative data were analysed. To indicate the site of aldosterone secretion in the resected adrenal, we added functional methods to routine histopathology, using in situ hybridization and immunohistochemistry to detect the presence of enzymes needed for aldosterone (CYP11B2) and cortisol (CYP11B1, CYP17A1) synthesis. ResultsThe median follow-up was 5years and the cure rate of PA 91%. Hypertension was improved in 97% and normalized in 38%. Functional histopathology changed the final diagnosis from APA to hyperplasia in 6 cases (7%). Five of these had no expression of or staining for aldosterone synthase in the adenoma, but only in nodules in the adjacent cortex. All except one APA patient were cured of PA. They had lower preoperative serum potassium and higher 24-h urinary aldosterone than patients with hyperplasia. Among patients with hyperplasia 16 of 26 were cured. ConclusionsMost patients were cured of PA by unilateral adrenalectomy. Almost all noncured benefitted from the operation as the blood pressure improved. Functional histopathology proved helpful in the distinction between APA and hyperplasia, and we recommend that functional histopathology should be added to routine histopathology to improve the diagnostic evaluation and aid in tailoring the follow-up.	[Volpe, Cristina; Hamberger, Bertil; Zedenius, Jan; Thoren, Marja] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Volpe, Cristina; Calissendorff, Jan] Soder Sjukhuset, Dept Internal Med, Div Endocrinol, S-11883 Stockholm, Sweden; [Hamberger, Bertil; Zedenius, Jan] Karolinska Univ Hosp Solna, Dept Breast & Endocrine Surg, Stockholm, Sweden; [Hoog, Anders] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden; [Hoog, Anders] Karolinska Univ Hosp Solna, Dept Clin Pathol & Cytol, Stockholm, Sweden; [Mukai, Kuniaki] Keio Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Calissendorff, Jan] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden; [Wahrenberg, Hans] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden; [Wahrenberg, Hans; Thoren, Marja] Karolinska Univ Hosp, Dept Endocrinol Metab & Diabet, Stockholm, Sweden	Volpe, C (reprint author), Soder Sjukhuset, Dept Internal Med, S-11883 Stockholm, Sweden.	cristina.dahlqvist-volpe@sodersjukhuset.se			Stockholm County; Karolinska Institutet; Cancer Society in Stockholm	This work was supported by grants from the Stockholm County, Karolinska Institutet and The Cancer Society in Stockholm.	Kempers MJE, 2009, ANN INTERN MED, V151, P329; Catena C, 2008, ARCH INTERN MED, V168, P80, DOI 10.1001/archinternmed.2007.33; Nanba K, 2013, J CLIN ENDOCR METAB, V98, P1567, DOI 10.1210/jc.2012-3726; Nishimoto K, 2010, J CLIN ENDOCR METAB, V95, P2296, DOI 10.1210/jc.2009-2010; Zarnegar R, 2008, ANN SURG, V247, P511, DOI 10.1097/SLA.0b013e318165c075; Letavernier E, 2008, J HYPERTENS, V26, P1816, DOI 10.1097/HJH.0b013e3283060f0c; Stowasser M, 2001, J RENIN-ANGIO-ALDO S, V2, P156, DOI 10.3317/jraas.2001.022; Gomez-Sanchez CE, 2014, MOL CELL ENDOCRINOL, V383, P111, DOI 10.1016/j.mce.2013.11.022; Hannemann A, 2012, HORM METAB RES, V44, P157, DOI 10.1055/s-0031-1295438; Steichen O, 2012, HORM METAB RES, V44, P221, DOI 10.1055/s-0031-1299681; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Stowasser M, 2003, BEST PRACT RES CL EN, V17, P591, DOI 10.1016/S1521-690X(03)00050-2; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; Born-Frontsberg E, 2009, J CLIN ENDOCR METAB, V94, P1125, DOI 10.1210/jc.2008-2116; Lim V, 2014, J CLIN ENDOCR METAB, V99, P2712, DOI 10.1210/jc.2013-4146; DeLellis R. A., 2004, PATHOLOGY GENETICS T, P143; Enberg U, 2001, WORLD J SURG, V25, P957; Enberg U, 2004, EUR J ENDOCRINOL, V151, P73, DOI 10.1530/eje.0.1510073; Goh BKP, 2007, WORLD J SURG, V31, P72, DOI 10.1007/s00268-005-0594-8; Hennings J, 2010, LANGENBECK ARCH SURG, V395, P133, DOI 10.1007/s00423-009-0498-4; Jiang SB, 2014, INT UROL NEPHROL, V46, P1283, DOI 10.1007/s11255-013-0614-9; Lack E., 2007, WASHINGTON AM REGI 4, V8, P112; Nocaudie-Calzada M, 1999, EUR J NUCL MED, V26, P1326, DOI 10.1007/PL00006653; Novitsky YW, 2005, SURGERY, V138, P1009, DOI 10.1016/j.surg.2005.09.027; Quillo AR, 2011, J AM COLL SURGEONS, V213, P106, DOI 10.1016/j.jamcollsurg.2011.03.007; Sigurjonsdottir HA, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-17; Tresallet C, 2010, SURGERY, V148, P129, DOI 10.1016/j.surg.2009.11.020; Volpe C, 2013, J CLIN PATHOL, V66, P351, DOI 10.1136/jclinpath-2012-201287; Volpe C, 2008, SCAND J SURG, V97, P248; Weisbrod AB, 2013, ANN SURG ONCOL, V20, P753, DOI 10.1245/s10434-012-2670-2	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	MAY	2015	82	5					639	647		10.1111/cen.12645		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CF7DS	WOS:000352717000004		
J	Motokawa, M; Kaku, M; Matsuda, Y; Kojima, S; Sumi, C; Kimura, A; Tanimoto, K				Motokawa, M.; Kaku, M.; Matsuda, Y.; Kojima, S.; Sumi, C.; Kimura, A.; Tanimoto, K.			Effects of occlusal hypofunction and its recovery on PDL structure and expression of VEGF and bFGF in rats	CLINICAL ORAL INVESTIGATIONS			English	Article						Occlusal stimuli; PDL area; VEGF; bFGF	ENDOTHELIAL GROWTH-FACTOR; BONE; PERIODONTIUM; RESORPTION; STIMULI; ATROPHY; MOLARS	The purpose of this study was to clarify whether occlusal hypofunction and its recovery affect the structure of the periodontal ligament (PDL) and expression of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in rats. Forty-eight Wistar rats aged 5 weeks were used and randomly divided into three groups: the hypofunctional group (HG), recovery group (RG), and control group (CG). In HG and RG, appliances were attached to the maxillary and mandibular incisors. In HG, appliances were set for 11 weeks. In RG, appliances were set for 7 weeks. Appliances were then removed at 0, 1, 3, 7, 14, and 28 days. Untreated rats served as CG. Histological sections were prepared and immunohistochemically stained for VEGF and bFGF. Three groups were evaluated for PDL area and the number of VEGF and bFGF immunopositive cells in PDL. The number of immunopositive cells and PDL area in CG and RG were significantly larger when compared with HG, and PDL area in RG was similar to that in CG. In the recovery process, PDL area and number of VEGF-positive cells in PDL increased from days 0 to 7 and decreased from days 7 to 28. Conversely, the number of bFGF-positive cells in PDL increased significantly after day 1 and peaked at 28 days. This study suggests that occlusal stimuli regulate PDL area through expression of VEGF and bFGF in rat PDL. Occlusal stimuli are able to regulate the expression of VEGF and bFGF in PDL cells, and these growth factors may lead to alveolar bone remodeling in PDL.	[Motokawa, M.; Kaku, M.; Matsuda, Y.; Kojima, S.; Sumi, C.; Kimura, A.; Tanimoto, K.] Hiroshima Univ, Dept Orthodont Appl Life Sci, Inst Biomed & Hlth Sci, Minami Ku, Hiroshima 7348553, Japan	Motokawa, M (reprint author), Hiroshima Univ, Dept Orthodont Appl Life Sci, Inst Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	motumo@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25862015]	This study was funded by a Grant-in-Aid for Young Scientists (B) (no. 25862015) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors are also grateful to Drs. Hiromi Sumi, Hanaka Shikata, Shotoku Kojima, Tahsin Raquib Abonti, and Kazuo Tanne (Department of Orthodontics, Applied Life Sciences, Hiroshima University Institute of Biomedical and Health Sciences) for their helpful advice. Drs. Motokawa, Kaku, Fujita, Matsuda, Kojima, Sumi, and Tanimoto report no conflicts of interest related to this study.	Aldridge SE, 2005, BRIT J CANCER, V92, P1531, DOI 10.1038/sj.bjc.6602417; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Shimizu Y, 2011, ARCH ORAL BIOL, V56, P1404, DOI 10.1016/j.archoralbio.2011.05.004; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; BERNICK S, 1960, ARCH ORAL BIOL, V2, P57, DOI 10.1016/0003-9969(60)90038-8; Boonpratham Supatchai, 2007, Journal of Medical and Dental Sciences, V54, P71; COHN S. A., 1965, ARCH ORAL BIOL, V10, P909, DOI 10.1016/0003-9969(65)90084-1; COHN SA, 1966, ARCH ORAL BIOL, V11, P95, DOI 10.1016/0003-9969(66)90120-8; Faitová J, 2004, Cesk Fysiol, V53, P92; GOSPODAROWICZ D, 1990, CLIN ORTHOP RELAT R, P231; HARRIS EF, 1992, AM J ORTHOD DENTOFAC, V101, P112, DOI 10.1016/0889-5406(92)70002-R; Koike K, 1996, PERIODONTOL, V38, P1; LEVY GG, 1980, J PERIODONTOL, V51, P393; Motokawa M, 2013, EUR J ORTHODONT, V35, P790, DOI 10.1093/ejo/cjs100; Motokawa M, 2013, ANGLE ORTHOD, V83, P597, DOI 10.2319/081812-661.1; Muramoto T, 2000, ARCH HISTOL CYTOL, V63, P369, DOI 10.1679/aohc.63.369; Saeki M, 1959, J STOMATOL SOC JPN, V26, P317; Suhr ES, 2002, ORTHODONTIC WAVES, V61, P165; Tanaka AI, 1998, ORTHOD WAVES, V57, P180; Usumi-Fujita R, 2013, ANGLE ORTHOD, V83, P48, DOI 10.2319/011712-45.1	21	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1432-6981	1436-3771		CLIN ORAL INVEST	Clin. Oral Investig.	MAY	2015	19	4					929	935		10.1007/s00784-014-1310-6		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CF8NW	WOS:000352819800020		
J	Nakashima, Y				Nakashima, Yasuharu			CORR Insights((R)): How are Dysplastic Hips Different? A Three-dimensional CT Study	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Editorial Material							PERIACETABULAR OSTEOTOMY; FEMORAL ANTEVERSION; ANTERIOR		Kyushu Univ, Dept Orthoped Surg, Higashi Ku, Fukuoka 8128582, Japan	Nakashima, Y (reprint author), Kyushu Univ, Dept Orthoped Surg, Higashi Ku, 311 Maidashi, Fukuoka 8128582, Japan.	yasunaka@ortho.med.kyushu-u.ac.jp					ANDA S, 1991, J COMPUT ASSIST TOMO, V15, P115, DOI 10.1097/00004728-199101000-00018; Akiyama M, 2012, SKELETAL RADIOL, V41, P1411, DOI 10.1007/s00256-012-1368-7; Clohisy JC, 2008, J BONE JOINT SURG AM, V90A, P47, DOI 10.2106/JBJS.H.00756; Fujii M, 2011, J BONE JOINT SURG BR, V93B, P1449, DOI 10.1302/0301-620X.93B11.27314; Dandachli W, 2008, J BONE JOINT SURG BR, V90B, P1428, DOI 10.1302/0301-620X.90B11.20073; Fujii M, 2011, CLIN ORTHOP RELAT R, V469, P1735, DOI 10.1007/s11999-010-1746-1; GANZ R, 1988, CLIN ORTHOP RELAT R, P26; Myers SR, 1999, CLIN ORTHOP RELAT R, P93; Trousdale RT, 2004, CLIN ORTHOP RELAT R, P182, DOI 10.1097/01.blo.0000150308.40850.c1	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	MAY	2015	473	5					1724	1725		10.1007/s11999-015-4165-5		2	Orthopedics; Surgery	Orthopedics; Surgery	CF1CB	WOS:000352280100028		
J	Kobayashi, D; Satsuma, S; Kinugasa, M; Kuroda, R; Kurosaka, M				Kobayashi, Daisuke; Satsuma, Shinichi; Kinugasa, Maki; Kuroda, Ryosuke; Kurosaka, Masahiro			Does Salter Innominate Osteotomy Predispose the Patient to Acetabular Retroversion in Adulthood?	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							CONGENITAL DISLOCATION; DEVELOPMENTAL DYSPLASIA; PERIACETABULAR OSTEOTOMY; FOLLOW-UP; HIP; OSTEOARTHRITIS; IMPINGEMENT; SUBLUXATION; PREVALENCE; COVERAGE	Salter innominate osteotomy has been identified as an effective additional surgery for the dysplastic hip. However, because in this procedure, the distal segment of the pelvis is displaced laterally and anteriorly, it may predispose the patient to acetabular retroversion. The degree to which this may be the case, however, remains incompletely characterized. We asked, in a group of pediatric patients with acetabular dysplasia who underwent Salter osteotomy, whether the operated hip developed (1) acetabular retroversion compared with contralateral unaffected hips; (2) radiographic evidence of osteoarthritis; or (3) worse functional scores. (4) In addition, we asked whether femoral head deformity resulting from aseptic necrosis was a risk factor for acetabular retroversion. Between 1971 and 2001, we performed 213 Salter innominate osteotomies for unilateral pediatric dysplasia, of which 99 hips (47%) in 99 patients were available for review at a mean of 16 years after surgery (range, 12-25 years). Average patient age at surgery was 4 years (range, 2-9 years) and the average age at the most recent followup was 21 years (range, 18-29 years). Acetabular retroversion was diagnosed based on the presence of a positive crossover sign and prominence of the ischial spine sign at the final visit. The center-edge angle, acetabular angle of Sharp, and acetabular index were measured at preoperative and final visits. Contralateral unaffected hips were used as controls, and statistical comparison was made in each patient. Clinical findings, including Harris hip score (HHS) and the anterior impingement sign, were recorded at the final visit. Patients were no more likely to have a positive crossover sign in the surgically treated hips (20 of 99 hips [20%]) than in the contralateral control hips (17 of 99 hips [17%]; p = 0584). In addition, the percentage of positive prominence of the ischial spine sign was not different between treated hips (22 of 99 hips [22%]) and contralateral hips (18 of 99 hips [18%]; p = 0.256). Hips that had a positive crossover or prominence of the ischial spine sign in the operated hips were likely also to have a positive crossover sign or prominence of the ischial spine sign in the unaffected hips (16 of 20 hips [80%] crossover sign, 17 of 22 hips [77%] prominence of the ischial spine sign). At the final visit, five hips (5%) showed osteoarthritic change; one of the five hips (20%) showed positive crossover and prominence of the ischial spine signs, and the remaining four hips showed negative crossover and prominence of the ischial spine signs. There was no significant difference in HHS between the crossover-positive and crossover-negative patient groups nor in the prominence of the ischial spine-positive and prominence of the ischial spine-negative patient groups (crossover sign, p = 0.68; prominence of the ischial spine sign, p = 0.54). Hips with femoral head deformity (25 of 99 hips [25%]) were more likely to have acetabular retroversion compared with hips without femoral-head deformity (crossover sign, p = 0.029, prominence of the ischial spine sign, p = 0.013). Our results suggest that Salter innominate osteotomy does not consistently cause acetabular retroversion in adulthood. We propose that retroversion of the acetabulum is a result of intrinsic development of the pelvis in each patient. A longer-term followup study is needed to determine whether retroverted acetabulum after Slater innominate osteotomy is a true risk factor for early osteoarthritis. Femoral head deformity is a risk factor for subsequent acetabular retroversion. Level III, therapeutic study.	[Kobayashi, Daisuke; Satsuma, Shinichi; Kinugasa, Maki] Kobe Childrens Hosp, Dept Orthopaed Surg, Suma Ku, Kobe, Hyogo, Japan; [Kuroda, Ryosuke; Kurosaka, Masahiro] Kobe Univ Hosp, Dept Orthopaeid Surg, Kobe, Hyogo, Japan	Kobayashi, D (reprint author), Kobe Childrens Hosp, Dept Orthopaed Surg, Suma Ku, 1-1-1 Takakuradai, Kobe, Hyogo, Japan.	kobayashi_kch@hp.pref.hyogo.jp					Akiyama M, 2014, J ORTHOP SCI, V19, P90, DOI 10.1007/s00776-013-0473-3; Giori NJ, 2003, CLIN ORTHOP RELAT R, P263, DOI 10.1097/01.blo.0000093014.90435.64; Kalberer F, 2008, CLIN ORTHOP RELAT R, V466, P677, DOI 10.1007/s11999-007-0058-6; SALTER RB, 1966, J BONE JOINT SURG AM, VA 48, P1413; Ziebarth K, 2011, CLIN ORTHOP RELAT R, V469, P447, DOI 10.1007/s11999-010-1544-9; Siebenrock KA, 2003, J BONE JOINT SURG AM, V85A, P278; KALAMCHI A, 1980, J BONE JOINT SURG AM, V62, P876; [Anonymous], 2003, CLIN OTHROP RELAT RE, DOI 10.1097/00003086-200302000-00033; Bohm P, 2002, J BONE JOINT SURG AM, V84A, P178; Li PLS, 2003, CLIN ORTHOP RELAT R, P245, DOI 10.1097/01.blo.0000081934.75404.36; Wassilew GI, 2012, J ORTHOP RES, V30, P1369, DOI 10.1002/jor.22086; Reynolds D, 1999, J BONE JOINT SURG BR, V81B, P281, DOI 10.1302/0301-620X.81B2.8291; Fujii M, 2010, J BONE JOINT SURG AM, V92A, P895, DOI 10.2106/JBJS.I.00046; Tonnis D, 1999, J BONE JOINT SURG AM, V81A, P1747; Ezoe M, 2006, J BONE JOINT SURG AM, V88A, P372, DOI 10.2106/JBJS.D.02385; Barnes JR, 2011, J PEDIATR ORTHOPED, V31, P530, DOI 10.1097/BPO.0b013e31821991ee; BARRETT WP, 1986, J BONE JOINT SURG AM, V68A, P79; Dora C, 2002, J PEDIATR ORTHOP B, V11, P34, DOI 10.1097/00009957-200201000-00006; SALTER RB, 1974, CLIN ORTHOP RELAT R, P72; Jacobsen S, 2006, CLIN ORTHOP RELAT R, P239, DOI 10.1097/01.blo.0000201151.91206.50; Kawahara S, 2012, J ORTHOP SCI, V17, P226, DOI 10.1007/s00776-012-0213-0; Kitoh H, 2009, J PEDIATR ORTHOPED, V29, P879, DOI 10.1097/BPO.0b013e3181c1e314; Kobayashi D, 2010, J BONE JOINT SURG AM, V92A, P1390, DOI 10.2106/JBJS.I.00840; Robb CA, 2009, HIP INT, V19, P8; Sankar WN, 2008, J PEDIATR ORTHOPED, V28, P440, DOI 10.1097/BPO.0b013e318168d97e; Wang CW, 2014, CLIN ORTHOP RELAT R, V472, P1001, DOI 10.1007/s11999-013-3319-6; Wiberg G, 1939, ACTA CHIR SCAND    S, V83, P58	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	MAY	2015	473	5					1755	1762		10.1007/s11999-014-4053-4		8	Orthopedics; Surgery	Orthopedics; Surgery	CF1CB	WOS:000352280100035		
J	Sorensen, H; Rasmussen, P; Siebenmann, C; Zaar, M; Hvidtfeldt, M; Ogoh, S; Sato, K; Kohl-Bareis, M; Secher, NH; Lundby, C				Sorensen, Henrik; Rasmussen, Peter; Siebenmann, Christoph; Zaar, Morten; Hvidtfeldt, Morten; Ogoh, Shigehiko; Sato, Kohei; Kohl-Bareis, Matthias; Secher, Niels H.; Lundby, Carsten			Extra-cerebral oxygenation influence on near-infraredspectroscopy- determined frontal lobe oxygenation in healthy volunteers: a comparison between INVOS-4100 and NIRO-200NX	CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING			English	Article						cerebral oxygenation; cutaneous oxygenation; humans; jugular vein; monitoring	INFRARED SPECTROSCOPY; BLOOD-FLOW; METABOLIC-RESPONSE; SATURATION; PHENYLEPHRINE; NOREPINEPHRINE; PERFORMANCE; EXERCISE; HYPOXIA; HUMANS	IntroductionFrontal lobe oxygenation (ScO2) is assessed by spatially resolved near-infrared spectroscopy (SR-NIRS) although it seems influenced by extra-cerebral oxygenation. We aimed to quantify the impact of extra-cerebral oxygenation on two SR-NIRS derived ScO2. MethodsMultiple regression analysis estimated the influence of extra-cerebral oxygenation as exemplified by skin oxygenation (SskinO2) on ScO2 in 21 healthy subjects exposed to whole-body exercise in hypoxia (FiO2=12%; n=10) and normoxia (n=12), whole-body heating, hyperventilation (n=21), administration of norepinephrine with and without petCO(2)-correction (n=15), phenylephrine and head-up tilt (n=7). ScO2 was assessed simultaneously by NIRO-200NX (SniroO2) and INVOS-4100 (SinvosO2). Arterial (SaO2) and jugular bulb oxygen saturations (SjO2) were obtained. ResultsThe regression analysis indicated that SinvosO2 reflects 46% arterial, 14% jugular, 35% skin and 4% oxygenation of tissues not interrogated. SinvosO2 follows a calculated estimate of cerebral capillary oxygenation (r=067; P<00001). In contrast, the NIRO-200NX-determined ScO2 did not correlate with the estimate of cerebral oxygenation (r=0026; P=071). ConclusionFor all interventions, 35% of the INVOS-4100 signal reflected extra-cerebral oxygenation while, on the other hand, NIRO-200NX did not follow changes in a calculated estimate of cerebral capillary oxygenation. Thus, the NIRO-200NX and INVOS-4100 do not provide for unbiased evaluation of the cerebral signal.	[Sorensen, Henrik; Zaar, Morten; Hvidtfeldt, Morten; Secher, Niels H.] Univ Copenhagen, Rigshosp, Copenhagen Muscle Res Ctr, Dept Anaesthesia, DK-2100 Copenhagen, Denmark; [Sorensen, Henrik; Siebenmann, Christoph; Lundby, Carsten] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Rasmussen, Peter] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Ogoh, Shigehiko] Toyo Univ, Dept Biomed Engn, Saitama, Japan; [Sato, Kohei] Japan Womens Coll Phys Educ, Res Inst Phys Fitness, Tokyo, Japan; [Kohl-Bareis, Matthias] Univ Appl Sci Koblenz, RheinAhrCampus Remagen, Remagen, Germany	Sorensen, H (reprint author), Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	hs770@hotmail.com	Sorensen, Henrik/H-8404-2013	Sorensen, Henrik/0000-0003-0819-106X			Sorensen H, 2012, ANESTHESIOLOGY, V117, P263, DOI 10.1097/ALN.0b013e3182605afe; Rath GP, 2009, BRIT J ANAESTH, V102, P499, DOI 10.1093/bja/aep021; NELSON E, 1970, BRAIN, V93, P475, DOI 10.1093/brain/93.3.475; Gjedde A, 2005, J CEREBR BLOOD F MET, V25, P1183, DOI 10.1038/sj.jcbfm.9600113; Ogoh S, 2011, CLIN PHYSIOL FUNCT I, V31, P445, DOI 10.1111/j.1475-097X.2011.01040.x; Mitchell DA, 2009, J PHYSIOL-LONDON, V587, P2589, DOI 10.1113/jphysiol.2008.167999; Suzuki S, 1999, P SOC PHOTO-OPT INS, V3597, P582, DOI 10.1117/12.356862; Lucas SJE, 2010, HYPERTENSION, V55, P698, DOI 10.1161/HYPERTENSIONAHA.109.146290; Rasmussen P, 2007, J CEREBR BLOOD F MET, V27, P1082, DOI 10.1038/sj.jcbfm.9600416; Sato H, 2004, NEUROIMAGE, V21, P1554, DOI 10.1016/j.neuroimage.2003.12.017; Al-Rawi PG, 2006, STROKE, V37, P2720, DOI 10.1161/01.STR.0000244807.99073.ae; Bickler PE, 2013, ANESTH ANALG, V117, P813, DOI 10.1213/ANE.0b013e318297d763; Meng L, 2011, BRIT J ANAESTH, V107, P209, DOI 10.1093/bja/aer150; Phelps HM, 2009, ANN THORAC SURG, V87, P1490, DOI 10.1016/j.athoracsur.2009.01.071; Kishi K, 2003, J NEUROSURG ANESTH, V15, P302, DOI 10.1097/00008506-200310000-00002; MATCHER SJ, 1995, ANAL BIOCHEM, V227, P54, DOI 10.1006/abio.1995.1252; Nissen P, 2010, NEUROCRIT CARE, V12, P17, DOI 10.1007/s12028-009-9313-x; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE; Yoshitani K, 2007, ANESTHESIOLOGY, V106, P458, DOI 10.1097/00000542-200703000-00009; Ide K, 1999, J APPL PHYSIOL, V87, P1604; Franceschini MA, 1998, APPL OPTICS, V37, P7447, DOI 10.1364/AO.37.007447; Brassard P, 2009, BRIT J ANAESTH, V102, P800, DOI 10.1093/bja/aep065; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; Hove JD, 2006, CLIN PHYSIOL FUNCT I, V26, P323, DOI 10.1111/j.1475-097X.2006.00697.x; Moppett IK, 2009, BRIT J ANAESTH, V103, P769, DOI 10.1093/bja/aep281; Murkin JM, 2009, BR J ANAESTH S1, V103, pi3, DOI DOI 10.1093/BJA/AEP299; Rasmussen P, 2010, INT J IND ERGONOM, V40, P190, DOI 10.1016/j.ergon.2008.06.002; SOrensen H, 2014, BR J ANAEST IN PRESS; SOrensen H, 2014, FRONT PHYSIOL, V4, P403; Strangman GE, 2014, NEUROIMAGE, V85, P136, DOI 10.1016/j.neuroimage.2013.04.090; Young AER, 2000, BRIT J ANAESTH, V84, P38	31	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1475-0961	1475-097X		CLIN PHYSIOL FUNCT I	Clin. Physiol. Funct. Imaging	MAY	2015	35	3					177	184		10.1111/cpf.12142		8	Physiology	Physiology	CF7HG	WOS:000352726400002		
J	Kurobe, K; Huang, Z; Nishiwaki, M; Yamamoto, M; Kanehisa, H; Ogita, F				Kurobe, Kazumichi; Huang, Zhong; Nishiwaki, Masato; Yamamoto, Masayoshi; Kanehisa, Hiroaki; Ogita, Futoshi			Effects of resistance training under hypoxic conditions on muscle hypertrophy and strength	CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING			English	Article						cross-education; growth hormone; hypoxia; muscle thickness; unilateral training; upper arm	HORMONAL RESPONSES; NEUROMUSCULAR ADAPTATIONS; PHYSICAL-EXERCISE; MUSCULAR STRENGTH; OLDER MEN; GROWTH; THICKNESS; ALTITUDE; HUMANS; WOMEN	It has been reported that exercise under hypoxic conditions elevates acute growth hormone secretion after exercise compared with that under normoxic conditions. This study examined the influence of resistance training under moderate hypoxic conditions on muscle thickness, strength and hormonal responses. Thirteen healthy men were assigned into two groups matched for physical fitness level and then randomized into two groups that performed exercise under normoxic (FiO(2)=209%) or hypoxic (FiO(2)=127%) conditions. Three sets of elbow extensions with unilateral arm were performed to exhaustion at a workload of a 10 repetition maximum with 1-minute intervals for 3days per week for 8weeks. The thickness of the biceps and triceps brachii was determined using B-mode ultrasound before and after training. Blood sampling was carried out before and after exercise, as well as during the first and last training sessions. Increase in the thickness of the triceps brachii in trained arm was significantly greater in the hypoxic group than in the normoxic group. The 10 repetition maximum was significantly increased not only in the trained arm but also in the untrained arm in both groups. Serum growth hormone concentrations after exercise were significantly higher in the hypoxic group than in the normoxic group on both the first and last training sessions. These findings suggest that hypoxic resistance training elicits more muscle hypertrophy associated with a higher growth hormone secretion, but that the greater muscle hypertrophy did not necessarily contribute a greater gain of muscle strength.	[Kurobe, Kazumichi] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Kumamoto, Japan; [Huang, Zhong] Japan Inst Sports Sci, Dept Sports Sci, Tokyo, Japan; [Nishiwaki, Masato] Osaka Inst Technol, Fac Engn, Osaka 535, Japan; [Yamamoto, Masayoshi; Kanehisa, Hiroaki; Ogita, Futoshi] Natl Inst Fitness & Sports, Dept Sports & Life Sci, Kanoya 8912393, Japan	Ogita, F (reprint author), Natl Inst Fitness & Sports, Dept Sports & Life Sci, 1 Shiromizu Cho, Kanoya 8912393, Japan.	ogita@nifs-k.ac.jp			National Institute of Fitness and Sports	We are grateful for the subjects and members of the laboratory who helped with the implementation of this study. This study was supported by a grant-in-aid for scientific research from the National Institute of Fitness and Sports (President's Discretionary Budget 2009).	Hakkinen K, 1996, ACTA PHYSIOL SCAND, V158, P77, DOI 10.1046/j.1365-201X.1996.523293000.x; Benso A, 2007, EUR J ENDOCRINOL, V157, P733, DOI 10.1530/EJE-07-0355; Kraemer WJ, 1999, J APPL PHYSIOL, V87, P982; Farthing JP, 2003, EUR J APPL PHYSIOL, V89, P578, DOI 10.1007/s00421-003-0842-2; Madarame H, 2008, MED SCI SPORT EXER, V40, P258, DOI 10.1249/mss.0b013e31815c6d7e; Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364; Katayama K, 2010, METABOLISM, V59, P959, DOI 10.1016/j.metabol.2009.10.017; Borst SE, 2001, MED SCI SPORT EXER, V33, P648; McCall GE, 1999, CAN J APPL PHYSIOL, V24, P96; DEVOL DL, 1990, AM J PHYSIOL, V259, pE89; Nogueira W, 2009, INT J SPORTS MED, V30, P200, DOI 10.1055/s-0028-1104584; Shima N, 2002, EUR J APPL PHYSIOL, V86, P287, DOI 10.1007/s00421-001-0559-z; Enoka RM, 1997, J BIOMECH, V30, P447, DOI 10.1016/S0021-9290(96)00170-4; Abe T, 2000, EUR J APPL PHYSIOL O, V81, P174, DOI 10.1007/s004210050027; ENGFRED K, 1994, EUR J APPL PHYSIOL O, V68, P303, DOI 10.1007/BF00571448; Goto K, 2005, MED SCI SPORT EXER, V37, P955, DOI 10.1249/01.mss.0000170470.98084.39; Gutierrez A, 2003, J SPORT MED PHYS FIT, V43, P554; Kamen G, 2004, RES Q EXERCISE SPORT, V75, P3; KJAER M, 1988, AM J PHYSIOL, V254, pR197; Kon M, 2010, MED SCI SPORT EXER, V42, P1279, DOI 10.1249/MSS.0b013e3181ce61a5; Kurobe K, 2012, J EXERCISE SPORTS PH, V19, P87; MORITANI T, 1993, J BIOMECH, V26, P95, DOI 10.1016/0021-9290(93)90082-P; SUTTON JR, 1977, J APPL PHYSIOL, V42, P587	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1475-0961	1475-097X		CLIN PHYSIOL FUNCT I	Clin. Physiol. Funct. Imaging	MAY	2015	35	3					197	202		10.1111/cpf.12147		6	Physiology	Physiology	CF7HG	WOS:000352726400005		
J	Hirasawa, A; Yanagisawa, S; Tanaka, N; Funane, T; Kiguchi, M; Sorensen, H; Secher, NH; Ogoh, S				Hirasawa, Ai; Yanagisawa, Shintaro; Tanaka, Naoki; Funane, Tsukasa; Kiguchi, Masashi; Sorensen, Henrik; Secher, Niels H.; Ogoh, Shigehiko			Influence of skin blood flow and source-detector distance on near-infrared spectroscopy-determined cerebral oxygenation in humans	CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING			English	Article						deoxyhaemoglobin; extracranial blood flow; head cuff; oxyhaemoglobin; temporal artery	PREDICTS COGNITIVE DECLINE; LONGER HOSPITAL STAY; MAXIMAL EXERCISE; HEALTHY-SUBJECTS; CARDIAC-SURGERY; SATURATION; HYPOXIA; VOLUME; TISSUE; ADULTS	Most near-infrared spectroscopy (NIRS) apparatus fails to isolate cerebral oxygenation from an extracranial contribution although they use different source-detector distances. Nevertheless, the effect of different source-detector distances and change in extracranial blood flow on the NIRS signal has not been identified in humans. This study evaluated the extracranial contribution, as indicated by forehead skin blood flow (SkBF) to changes in the NIRS-determined cerebral oxyhaemoglobin concentration (O(2)Hb) by use of a custom-made multidistance probe. Seven males (age 21 +/- 1year) were in a semi-recumbent position, while extracranial blood flow was restricted by application of four different pressures (+20 to +80mmHg) to the left temporal artery. The O(2)Hb was measured at the forehead via a multidistance probe (source-detector distance; 15, 225 and 30mm), and SkBF was determined by laser Doppler. Heart rate and blood pressure were unaffected by application of pressure to the temporal artery, while SkBF gradually decreased (P<0001), indicating that extracranial blood flow was manipulated without haemodynamic changes. Also, O(2)Hb gradually decreased with increasing applied pressure (P<005), and the decrease was related to that in SkBF (r=0737, P<001) independent of the NIRS source to detector distance. These findings suggest that the NIRS-determined cerebral oxyhaemoglobin is affected by change in extracranial blood flow independent of the source-detector distance from 15 to 30mm. Therefore, new algorithms need to be developed for unbiased NIRS detection of cerebral oxygenation.	[Hirasawa, Ai; Tanaka, Naoki; Ogoh, Shigehiko] Toyo Univ, Grad Sch Engn, Kawagoe, Saitama 3508585, Japan; [Yanagisawa, Shintaro; Tanaka, Naoki; Ogoh, Shigehiko] Toyo Univ, Fac Sci & Engn, Dept Biomed Engn, Kawagoe, Saitama 3508585, Japan; [Funane, Tsukasa; Kiguchi, Masashi] Hitachi Ltd, Cent Res Lab, Hatoyama, Saitama, Japan; [Sorensen, Henrik; Secher, Niels H.] Univ Copenhagen, Rigshosp, Dept Anesthesia, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark	Ogoh, S (reprint author), Toyo Univ, Fac Sci & Engn, Dept Biomed Engn, 2100 Kujirai, Kawagoe, Saitama 3508585, Japan.	ogoh@toyo.jp	Sorensen, Henrik/H-8404-2013	Sorensen, Henrik/0000-0003-0819-106X	 [24300237];  [25560299]	The time and effort expended by all the volunteer subjects are greatly appreciated. This study was supported in part by Grant-in-Aid for Scientific Research (B) 24300237 and Grant-in-Aid for Exploratory Research 25560299 (to S. Ogoh).	Sorensen H, 2012, ANESTHESIOLOGY, V117, P263, DOI 10.1097/ALN.0b013e3182605afe; Bhambhani Y, 2007, RESP PHYSIOL NEUROBI, V156, P196, DOI 10.1016/j.resp.2006.08.009; Germon TJ, 1999, BRIT J ANAESTH, V82, P831; Subudhi AW, 2009, J APPL PHYSIOL, V106, P1153, DOI 10.1152/japplphysiol.91475.2008; GERMON TJ, 1994, BRIT J ANAESTH, V73, P503, DOI 10.1093/bja/73.4.503; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Murkin JM, 2007, ANESTH ANALG, V104, P51, DOI 10.1213/01.ane.0000246814.29362.f4; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Hwang K, 1999, J CRANIOFAC SURG, V10, P395, DOI 10.1097/00001665-199909000-00004; Lucas SJE, 2012, EXP GERONTOL, V47, P541, DOI 10.1016/j.exger.2011.12.002; Ogoh S, 2011, CLIN PHYSIOL FUNCT I, V31, P445, DOI 10.1111/j.1475-097X.2011.01040.x; Kameyama M, 2004, NEUROIMAGE, V22, P1715, DOI 10.1016/j.neuroimage.2004.03.050; Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070; Rasmussen P, 2007, J CEREBR BLOOD F MET, V27, P1082, DOI 10.1038/sj.jcbfm.9600416; Yamada T, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275469; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Hoshi Y, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2142325; Meng L, 2012, BRIT J ANAESTH, V108, P815, DOI 10.1093/bja/aes023; WYATT JS, 1990, J APPL PHYSIOL, V68, P1086; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Herrmann MJ, 2006, NEUROBIOL AGING, V27, P888, DOI 10.1016/j.neurobiolaging.2005.04.013; Ide K, 1999, J APPL PHYSIOL, V87, P1604; Franceschini MA, 1998, APPL OPTICS, V37, P7447, DOI 10.1364/AO.37.007447; Brassard P, 2009, BRIT J ANAESTH, V102, P800, DOI 10.1093/bja/aep065; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; Denault André, 2007, Semin Cardiothorac Vasc Anesth, V11, P274, DOI 10.1177/1089253207311685; Ekkekakis P, 2009, J SPORT EXERCISE PSY, V31, P505; ELWELL CE, 1994, J APPL PHYSIOL, V77, P2753; Ferrari M, 1986, Adv Exp Med Biol, V200, P213; Funane T, 2014, NEUROIMAGE, V85, P150, DOI 10.1016/j.neuroimage.2013.02.026; HAMPSON NB, 1990, J APPL PHYSIOL, V69, P907; HARRIS DNF, 1993, ANAESTHESIA, V48, P694, DOI 10.1111/j.1365-2044.1993.tb07183.x; Maki A, 1995, MED PHYS, V22, P1997, DOI 10.1118/1.597496; Marshall HC, 2008, EUR J APPL PHYSIOL, V104, P383, DOI 10.1007/s00421-007-0616-3; MCCORMICK PW, 1992, J NEUROSURG, V76, P315, DOI 10.3171/jns.1992.76.2.0315; OwenReece H, 1996, PHYSIOL MEAS, V17, P279, DOI 10.1088/0967-3334/17/4/005; Peltonen JE, 2009, RESP PHYSIOL NEUROBI, V169, P24, DOI 10.1016/j.resp.2009.08.013; Kramer RS, 2009, ANN THORAC SURG, V87, P44; Umeyama S, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275466; Yamada T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050271	40	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1475-0961	1475-097X		CLIN PHYSIOL FUNCT I	Clin. Physiol. Funct. Imaging	MAY	2015	35	3					237	244		10.1111/cpf.12156		8	Physiology	Physiology	CF7HG	WOS:000352726400011		
J	Takehara, T; Ochiai, F; Suzuki, N				Takehara, Takuma; Ochiai, Fumio; Suzuki, Naoto			Scaling laws in emotion-associated words and corresponding network topology	COGNITIVE PROCESSING			English	Article						Emotion-associated words; Zipf's law; Complex networks; Small-world; Scale-free	SCIENTIFIC COLLABORATION; SEMANTIC NETWORKS; LEXICON; MEMORY; WORLD; EXPLORATION; RATINGS; SYSTEMS	We investigated whether scaling laws were present in the appearance-frequency distribution of emotion-associated words and determined whether the network constructed from those words had small-world or scale-free properties. Over 1,400 participants were asked to write down the first single noun that came to mind in response to nine emotional cue words, resulting in a total of 12,556 responses. We identified Zipf's law in the distribution of the data, as the slopes of the regression lines reached approximately -1.0 in the appearance frequencies for each emotional cue word. This suggested that the emotion-associated words had a clear regularity, were not randomly generated, were scale-invariant, and were influenced by unification/diversification forces. Thus, we predicted that the emotional intensity of the words might play an important role for a Zipf's law. Moreover, we also found that the 1-mode network of emotion-associated words clearly had small-world properties in terms of the network topologies of clustering, average distance, and small-worldness value, indicating that all nodes (words) were highly interconnected with each other and were only a few short steps apart. Furthermore, the data suggested the possibility of a scale-free property. Interestingly, we were able to identify hub words with neutral emotional content, such as 'dog', 'woman', and 'face', indicating that these neutral words might be an intermediary between words with conflicting emotional valence. Additionally, efficiency and optimal navigation in terms of complex networks were discussed.	[Takehara, Takuma; Suzuki, Naoto] Doshisha Univ, Dept Psychol, Kyoto 6100394, Japan; [Takehara, Takuma] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Ochiai, Fumio] Tezukayama Gakuin Univ, Dept Business Adm, Nara, Japan	Takehara, T (reprint author), Doshisha Univ, Dept Psychol, 1-3 Tatara Miyakodani, Kyoto 6100394, Japan.	takehara@mail.doshisha.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24650140]	This research was supported by the Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Challenging Exploratory Research, 24650140, 2012, awarded to the primary author. We are grateful to Toshio Shibata, Kunio Midzuno, Toru Tazumi, Takanobu Baba, Yosuke Tezuka, Kyoko Yamamoto, and Akemi Takehara for their assistance. We are also grateful to Guston Rankin, Mariko Shirai, and two anonymous reviewers for their extremely valuable comments.	Alonso-Arbiol I, 2006, COGNITION EMOTION, V20, P836, DOI 10.1080/02699930500405469; De Castro R, 1999, MATH INTELL, V21, P51; Batagelj V, 2004, MATH VISUAL, P77; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; McCowan B, 1999, ANIM BEHAV, V57, P409, DOI 10.1006/anbe.1998.1000; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Jeong H, 2000, NATURE, V407, P651; Borgatti SP, 1997, SOC NETWORKS, V19, P243, DOI 10.1016/S0378-8733(96)00301-2; Lundgren R, 2005, ARCT ANTARCT ALP RES, V37, P514, DOI 10.1657/1523-0430(2005)037[0514:TDAHCW]2.0.CO;2; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037//0033-295X.82.6.407; Steyvers M, 2005, COGNITIVE SCI, V29, P41, DOI 10.1207/s15516709cog2901_3; Baronchelli A, 2013, TRENDS COGN SCI, V17, P348, DOI 10.1016/j.tics.2013.04.010; Albert R, 1999, NATURE, V401, P130; Baek SK, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043004; WAGENAAR WA, 1986, COGNITIVE PSYCHOL, V18, P225, DOI 10.1016/0010-0285(86)90013-7; De Deyne S, 2008, BEHAV RES METHODS, V40, P198, DOI 10.3758/BRM.40.1.198; Levenson RW, 1999, COGNITION EMOTION, V13, P481, DOI 10.1080/026999399379159; Latapy M, 2008, SOC NETWORKS, V30, P31, DOI 10.1016/j.socnet.2007.04.006; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Coronges KA, 2007, J APPL SOC PSYCHOL, V37, P2097, DOI 10.1111/j.1559-1816.2007.00253.x; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Adamic L, 2011, NATURE, V474, P164, DOI 10.1038/474164a; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Niedenthal P, 2004, COGNITION EMOTION, V18, P289, DOI 10.1080/02699930341000086; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Sole RV, 2010, COMPLEXITY, V15, P20, DOI 10.1002/cplx.20305; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; Balasubrahmanyan V, 1996, J QUANT LINGUIST, V3, P177, DOI 10.1080/09296179608599629; Bastian M, 2009, ICWSM, V8, P361; Beckage N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019348; Borgatti S. P., 2002, UCINET 6 WINDOWS; Borsboom D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027407; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037//0003-066X.36.2.129; Church T, 1998, COGNITION EMOTION, V12, P63, DOI 10.1080/026999398379781; CLUTTONBROCK TH, 1980, J ZOOL, V190, P309; Edwards AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045174; Ekman P., 1975, UNMASKING FACE; Ferreira AAA, 2006, BRAZ J PHYS, V36, P755, DOI 10.1590/S0103-97332006000500032; Ferrer i Cancho Ramon, 2003, Proceedings of the National Academy of Sciences of the United States of America, V100, P788; Ferrer-i-Cancho R, 2005, PHYSICA A, V345, P275, DOI [10.1016/j.physa.2004.06.158, DOI 10.1016/J.PHYSA.2004.06.158]; Ferrer i Cancho Ramon, 2001, Proceedings of the Royal Society Biological Sciences Series B, V268, P2261; Galati D, 2008, SOC SCI INFORM, V47, P205, DOI 10.1177/0539018408089079; Harremoes P, 2005, ELECT NOTES DISCRETE, V21, P315, DOI 10.1016/j.endm.2005.07.075; Hills TT, 2009, PSYCHOL SCI, V20, P729, DOI 10.1111/j.1467-9280.2009.02365.x; Hills TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060488; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Ke JY, 2008, J QUANT LINGUIST, V15, P70, DOI 10.1080/09296170701794286; Knuth D. E., 1993, STANFORD GRAPHBASE P; Luduena GA, 2014, COGN PROCESS, V15, P195, DOI 10.1007/s10339-013-0590-0; Marino Lori, 1996, Evolutionary Anthropology, V5, P81, DOI 10.1002/(SICI)1520-6505(1996)5:3<81::AID-EVAN3>3.0.CO;2-Z; Mathias N, 2001, PHYS REV E, V63, part. no., DOI 10.1103/PhysRevE.63.021117; Naranan S., 1998, J QUANT LINGUIST, V5, P35, DOI 10.1080/09296179808590110; Nelson DL, 2005, PSYCHON B REV, V12, P711, DOI 10.3758/BF03196762; Nesse R M, 1990, Hum Nat, V1, P261, DOI 10.1007/BF02733986; Neta M, 2011, EMOTION, V11, P1425, DOI 10.1037/a0022993; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Ohman A., 2008, HDB EMOTIONS, P709; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00943; SHAVER P, 1987, J PERS SOC PSYCHOL, V52, P1061, DOI 10.1037/0022-3514.52.6.1061; Raphael B, 1999, CURR OPIN PSYCHIATR, V12, P99, DOI 10.1097/00001504-199901000-00025; Reisenzein R., 2000, MESSAGE ROLE SUBJECT, P262; Shaver PR, 2001, ASIAN J SOC PSYCHOL, V4, P201, DOI 10.1111/1467-839X.00086; Shiota MN, 2005, PSYCHOL INQ, V16, P32; Sole R. V., 2001, J QUANT LINGUIST, V8, P165, DOI 10.1076/jqul.8.3.165.4101; THOMPSON CP, 1985, MOTIV EMOTION, V9, P277, DOI 10.1007/BF00991832; Toivonen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028883; Tsonis AA, 1997, COMPLEXITY, V2, P12, DOI 10.1002/(SICI)1099-0526(199705/06)2:5<12::AID-CPLX3>3.0.CO;2-C; Wang B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00887; Wasserman S., 1994, SOCIAL NETWORKS ANAL; Zammuner VL, 1998, COGNITION EMOTION, V12, P243; Zanette D. H., 2005, J QUANT LINGUIST, V12, P29, DOI DOI 10.1080/09296170500055293; Zipf G., 1949, HUMAN BEHAV PRINCIPL	76	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1612-4782	1612-4790		COGN PROCESS	Cogn. Process.	MAY	2015	16	2					151	163		10.1007/s10339-014-0643-z		13	Psychology, Experimental	Psychology	CF8ZM	WOS:000352851000003		
J	Miura, Y; Kageyama, T; Moriyama, A				Miura, Yoko; Kageyama, Takashi; Moriyama, Akihiko			Pepsinogens and pepsins from largemouth bass, Micropterus salmoides: Purification and characterization with special reference to high proteolytic activities of bass enzymes	COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY			English	Article						Aspartic proteinase; Gastric digestion; Largemouth bass; Pepsinogen; Pepsin	DISC ELECTROPHORESIS; ASPARTIC PROTEINASES; STOMACH; EVOLUTION; EXPRESSION; FISHES	Six pepsinogens were purified from the gastric mucosa of largemouth bass (Micropterus salmoides) by DEAE-Sephacel chromatography, Sephadex G-100 gel filtration, and Mono Q FPLC. The potential specific activities of two major pepsinogens, PG1-1 and PG2-2, against hemoglobin were 51 and 118 units/mg protein, respectively. The activity of pepsin 2-2 was the highest among the pepsins reported to date; this might be linked to the strongly carnivorous diet of the largemouth bass. The molecular masses of PG1-1 and PG2-2 were 39.0 and 41.0 kDa, respectively. The N-terminal amino acid sequences of PG 1-1 and PG2-2 were LVQVPLEVGQTAREYLE- and LVRLPLIVGKTARQALLE-, respectively, showing similarities with those of fish type-A pepsinogens. The optimal pHs for hemoglobin-digestive activity of pepsins 1-1 and 2-2 were around 1.5 and 2.0, respectively, though both pepsins retained considerable activity at pHs over 3.5. They showed maximal activity around 50 and 40 degrees C, respectively. They were inhibited by pepstatin similarly to porcine pepsin A. The cleavage specificities clarified with oxidized insulin B chain were shown to be restricted to a few bonds consisting of hydrophobic/aromatic residues, such as the Leu(15)-Try(16), Phe(24)-Phe(25) and Phe(25)-Tyr(26) bonds. When hemoglobin was used as a substrate, the k(cat)/k(m) value of bass pepsin 2-2 was 4.6- to 36.8-fold larger than those of other fish pepsins. In the case of substance P, an ideal pepsin substrate mimic, the k(cat)/k(m) values were about 200-fold larger than those of porcine pepsin A, supporting the high activity of the bass pepsin. (C) 2015 Elsevier Inc. All rights reserved.	[Miura, Yoko; Moriyama, Akihiko] Nagoya City Univ, Div Biomol Sci, Grad Sch Nat Sci, Nagoya, Aichi 4678501, Japan; [Miura, Yoko; Kageyama, Takashi] Nagoya Bunri Univ, Dept Hlth & Nutr, Inazawa 4928213, Japan	Miura, Y (reprint author), Nagoya City Univ, Div Biomol Sci, Grad Sch Nat Sci, Mizuho Ku, 1 Yamanohata,Mizuho Cho, Nagoya, Aichi 4678501, Japan.	y.miura@nsc.nagoya-cu.ac.jp; kageyama.takashi@nagoya-bunri.ac.jp; moriyama@nsc.nagoya-cu.ac.jp					LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; Brier S, 2007, FEBS J, V274, P6152, DOI 10.1111/j.1742-4658.2007.06136.x; GILDBERG A, 1990, COMP BIOCHEM PHYS B, V96, P323, DOI 10.1016/0305-0491(90)90382-4; Dunn BM, 2000, BBA-PROTEIN STRUCT M, V1477, P231, DOI 10.1016/S0167-4838(99)00275-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lundberg JG, 2000, ANN MO BOT GARD, V87, P26, DOI 10.2307/2666207; Sugiura SH, 2006, J EXP BIOL, V209, P3719, DOI 10.1242/jeb.02436; Klomklao S, 2007, COMP BIOCHEM PHYS B, V147, P682, DOI 10.1016/j.cbpb.2007.04.008; AOYAGI T, 1971, J ANTIBIOT, V24, P687; Briggs J.C., 1986, P1; Chen WQ, 2009, J AGR FOOD CHEM, V57, P10972, DOI 10.1021/jf902548p; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Etnier D.A., 1993, FISHES TENNESSEE; Feng SZ, 2008, COMP BIOCHEM PHYS B, V149, P275, DOI 10.1016/j.cbpb.2007.09.017; Foltmann B., 2004, HDB PROTEOLYTIC ENZY, V1, P28; FOLTMANN B, 1981, ESSAYS BIOCHEM, V17, P52; GARRIDO MVO, 1993, AQUACULTURE, V115, P121; GILDBERG A, 1988, COMP BIOCHEM PHYS B, V91, P425, DOI 10.1016/0305-0491(88)90002-8; Henshall J. A., 1881, BOOK BLACK BASS; Inokuchi T, 2013, COMP BIOCHEM PHYS B, V165, P226, DOI 10.1016/j.cbpb.2013.05.003; Kageyama T, 2002, CELL MOL LIFE SCI, V59, P288, DOI 10.1007/s00018-002-8423-9; Kageyama T, 2004, BIOCHEMISTRY-US, V43, P15122, DOI 10.1021/bi048440g; Nalinanon S, 2010, FOOD CHEM, V121, P49, DOI 10.1016/j.foodchem.2009.11.089; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; Philipp D. P., 2002, SYMPOSIUM, V31; Powers J C, 1977, Adv Exp Med Biol, V95, P141; Suzuki M, 1999, COMP BIOCHEM PHYS B, V122, P453, DOI 10.1016/S0305-0491(99)00029-2; Tang J, 2004, HDB PROTEOLYTIC ENZY, V1, P19; Tanji M, 2009, COMP BIOCHEM PHYS B, V152, P9, DOI 10.1016/j.cbpb.2008.08.006; TANJI M, 1988, EUR J BIOCHEM, V177, P251, DOI 10.1111/j.1432-1033.1988.tb14369.x; Weng WY, 2011, FISH PHYSIOL BIOCHEM, V37, P543, DOI 10.1007/s10695-010-9456-x; Wu T, 2009, FOOD CHEM, V115, P137, DOI 10.1016/j.foodchem.2008.11.077; Zhao LiSha, 2011, Journal of Food Processing and Technology, V2, P126; Zhou Q, 2008, J AGR FOOD CHEM, V56, P5401, DOI 10.1021/jf800458n; Zhou QO, 2007, FOOD CHEM, V103, P795, DOI 10.1016/j.foodchem.2006.09.021	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1096-4959	1879-1107		COMP BIOCHEM PHYS B	Comp. Biochem. Physiol. B-Biochem. Mol. Biol.	MAY	2015	183						42	48		10.1016/j.cbpb.2015.01.001		7	Biochemistry & Molecular Biology; Zoology	Biochemistry & Molecular Biology; Zoology	CG2EI	WOS:000353087300005		
J	Itoh, T; Fusazaki, T; Kimura, T; Oikawa, H; Sasou, S; Ishikawa, Y; Goto, I; Komuro, K; Nakajima, S; Koeda, Y; Kaneko, K; Nishiyama, O; Nakamura, M; Morino, Y				Itoh, Tomonori; Fusazaki, Tetsuya; Kimura, Takumi; Oikawa, Hiroki; Sasou, Shunichi; Ishikawa, Yu; Goto, Iwao; Komuro, Kentaro; Nakajima, Satoshi; Koeda, Yorihiko; Kaneko, Kyosuke; Nishiyama, Osamu; Nakamura, Motoyuki; Morino, Yoshihiro			Clinical and pathological characteristics of homogeneous and nonhomogeneous tissue of in-stent restenosis visualized by optical coherence tomography	CORONARY ARTERY DISEASE			English	Article						fibrin thrombi; inflammation; in-stent restenosis; optical coherence tomography	SIROLIMUS-ELUTING STENT; CORONARY-ARTERY-DISEASE; ATHEROSCLEROTIC LESIONS; BALLOON ANGIOPLASTY; LATE THROMBOSIS; IMPLANTATION; NEOATHEROSCLEROSIS; PLAQUE; REVASCULARIZATION; PATTERNS	Background Although it is known that in-stent restenosis (ISR) patterns appear homogeneous or nonhomogeneous by optical coherence tomography (OCT), interpretations of the ISR inflammatory response, of the OCT image, and its pathological implications are unclear. The aim of this study was to use OCT to characterize ISR and its inflammatory index in patients after coronary stenting. Methods OCT was performed at follow-up in 100 angiographic ISR lesions. ISR lesions were divided into two groups: (a) homogeneous (n = 48) and (b) nonhomogeneous (n= 52) image groups. We assessed the ISR images produced by OCT for tissue heterogeneity and neo-intimal hyperplasia using the normalized standard deviation of OCT signal-intensity (OCT-NSD) observed in neo-intimal hyperplasia tissue. In some patients with a nonhomogeneous OCT image, we collected pathological tissue. Results The prevalence of drug-eluting stents was 48% in the nonhomogeneous group and 29% in the homogeneous group (P = 0.05). The OCT-NSD value in the nonhomogeneous group (0.223 +/- 0.019) was significantly higher than that in the homogeneous group (0.203 +/- 0.025; P < 0.0001). Pathological tissue showed fibrin thrombi with infiltrating macrophage in 12 cases of nonhomogeneous ISR. The area under the receiver operating characteristic curve for the prediction of a nonhomogeneous image was 0.73 for OCT-NSD (95% confidence interval: 0.62-0.83: P < 0.0001). The odds ratio for the prediction of a nonhomogeneous image was 3.47 (95% confidence interval: 1.18-10.2: P= 0.02) for smoking by logistic regression analysis. Conclusion Nonhomogeneous ISR visualized by OCT showed a high OCT-NSD value, which was a useful predictor for nonhomogeneous images. Moreover, the nonhomogeneous ISR image visualized by OCT may show chronic inflammation and fibrin thrombi. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Itoh, Tomonori; Fusazaki, Tetsuya; Kimura, Takumi; Ishikawa, Yu; Komuro, Kentaro; Nakajima, Satoshi; Koeda, Yorihiko; Kaneko, Kyosuke; Morino, Yoshihiro] Iwate Med Univ, Mem Heart Ctr, Div Cardiol, Dept Internal Med, Morioka, Iwate, Japan; [Oikawa, Hiroki] Iwate Med Univ, Div Pathol, Morioka, Iwate, Japan; [Goto, Iwao] Hachinohe Red Cross Hosp, Dept Cardiol, Aomori, Japan; [Sasou, Shunichi] Hachinohe Red Cross Hosp, Dept Pathol, Aomori, Japan; [Nishiyama, Osamu] Iwate Prefectural Ninohe Hosp, Dept Cardiol, Ninohe, Japan; [Nakamura, Motoyuki] Iwate Med Univ, Dept Internal Med, Div Cardiovasc Med Nephrol & Endocrinol, Morioka, Iwate, Japan	Itoh, T (reprint author), 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	tomoitoh@iwate-med.ac.jp					Kang SJ, 2011, CIRCULATION, V123, P2954, DOI 10.1161/CIRCULATIONAHA.110.988436; MacNeill BD, 2004, J AM COLL CARDIOL, V44, P972, DOI 10.1016/j.jacc.2004.05.066; Kim JS, 2014, JACC-CARDIOVASC IMAG, V7, P788, DOI 10.1016/j.jcmg.2014.05.004; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Tearney GJ, 2003, CIRCULATION, V107, P113, DOI 10.1161/01.CIR.0000044384.41037.43; Schampaert E, 2004, J AM COLL CARDIOL, V43, P1110, DOI 10.1016/j.jacc.2004.01.024; Malle C, 2013, ARTERIOSCL THROM VAS, V33, P1376, DOI 10.1161/ATVBAHA.113.301227; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Gonzalo N, 2009, AM HEART J, V158, P284, DOI 10.1016/j.ahj.2009.06.004; Kimura T, 2012, CIRCULATION, V125, P584, DOI 10.1161/CIRCULATIONAHA.111.046599; Teramoto T, 2010, CIRC J, V74, P1257, DOI 10.1253/circj.CJ-10-0189; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262; Park SJ, 2012, J AM COLL CARDIOL, V59, P2051, DOI 10.1016/j.jacc.2011.10.909; Kume T, 2006, AM J CARDIOL, V97, P1713, DOI 10.1016/j.amjcard.2006.01.031; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Nagoshi R, 2013, CIRC J, V77, P652, DOI 10.1253/circj.CJ-12-0610; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; FOLEY JB, 1993, AM HEART J, V125, P686, DOI 10.1016/0002-8703(93)90159-7; Itoh T, 2009, CIRC-CARDIOVASC INTE, V2, P264, DOI 10.1161/CIRCINTERVENTIONS.108.813881; Itoh T, 2011, J CARDIOL CASES, V3, pe2, DOI 10.1016/j.jccase.2010.07.005; Matsui H, 2010, J CARDIOL CASES, V2, pe67; Mishkel GJ, 2008, AM HEART J, V156, P141, DOI 10.1016/j.ahj.2008.02.012; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Oikawa Y, 2010, EUROINTERVENTION, V6, P380, DOI 10.4244/EIJV6I3A63; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Yamamoto M, 2011, INT J CARDIOL, V149, P169, DOI 10.1016/j.ijcard.2009.12.027	32	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0954-6928	1473-5830		CORONARY ARTERY DIS	Coronary Artery Dis.	MAY	2015	26	3					201	211		10.1097/MCA.0000000000000225		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CF6CM	WOS:000352644300004		
J	Sun, YF; Fujii, H; Imai, H; Kondoh, K				Sun, Yufeng; Fujii, Hidetoshi; Imai, Hisashi; Kondoh, Katsuyoshi			Suppression of hydrogen-induced damage in friction stir welded low carbon steel joints	CORROSION SCIENCE			English	Article						Carbon steel; Hydrogen embrittlement; Welding	ASSISTED CRACK-PROPAGATION; LOW-ALLOY STEEL; STAINLESS-STEEL; CRYSTALLOGRAPHIC TEXTURE; FERRITIC STEEL; FUSION WELDS; EMBRITTLEMENT; IRON; MICROSTRUCTURE; FAILURE	Hydrogen-induced damage including blister and cracking in friction stir welded low carbon steel were evaluated by the cathodic hydrogen charging method. After hydrogen charging for 2 h, irreversible dome-shaped blisters and internal cracking began to appear on the surface of the base metal. However, after hydrogen charging for 16 h, cracking formed along the thermo-mechanically affected zone boundary, while the blisters or cracking were hardly observed in the stir zone. In addition, the stir zone showed a plasticity reduction from 38% to 28%, much less than that of the base metal reduced from 48% to 2%. (C) 2015 Elsevier Ltd. All rights reserved.	[Sun, Yufeng; Fujii, Hidetoshi; Imai, Hisashi; Kondoh, Katsuyoshi] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Japan	Sun, YF (reprint author), Osaka Univ, Joining & Welding Res Inst, Ibaraki, Japan.	yfsun@jwri.osaka-u.ac.jp			Collaborative Research Based on Industrial Demand "Heterogeneous Structure Control: Towards Innovative Development of Metallic Structural Materials" by Japan Science and Technology Agency (JST); Global COE Programs from the Ministry of Education, Sports, Culture, Science; Japan Society for Promotion of Science and Technology of Japan, ISIJ Research Promotion Grant	The authors wish to acknowledge the financial support of a Collaborative Research Based on Industrial Demand "Heterogeneous Structure Control: Towards Innovative Development of Metallic Structural Materials" by Japan Science and Technology Agency (JST), the Global COE Programs from the Ministry of Education, Sports, Culture, Science, and a Grant-in-Aid for Science Research from the Japan Society for Promotion of Science and Technology of Japan, ISIJ Research Promotion Grant.	Maroef I, 2002, INT MATER REV, V47, P191, DOI 10.1179/095066002225006548; Jackson HF, 2013, CORROS SCI, V77, P210, DOI 10.1016/j.corsci.2013.08.004; Sato YS, 2009, SCI TECHNOL WELD JOI, V14, P202, DOI 10.1179/136217108X386518; Cui L, 2007, SCRIPTA MATER, V56, P637, DOI 10.1016/j.scriptamat.2006.12.004; Nagao A, 2012, ACTA MATER, V60, P5182, DOI 10.1016/j.actamat.2012.06.040; Fujii H, 2006, MAT SCI ENG A-STRUCT, V429, P50, DOI 10.1016/j.msea.2006.04.118; Wang G, 2013, CORROS SCI, V77, P273, DOI 10.1016/j.corsci.2013.08.013; Jackson HF, 2012, CORROS SCI, V60, P136, DOI 10.1016/j.corsci.2012.03.046; Neeraj T, 2012, ACTA MATER, V60, P5160, DOI 10.1016/j.actamat.2012.06.014; Nandan R, 2008, PROG MATER SCI, V53, P980, DOI 10.1016/j.pmatsci.2008.05.001; Venegas V, 2007, METALL MATER TRANS A, V38A, P1022, DOI 10.1007/s11661-007-9130-9; Dieudonne T, 2014, CORROS SCI, V82, P218, DOI 10.1016/j.corsci.2014.01.022; Morisada Y, 2011, SCRIPTA MATER, V65, P1085, DOI 10.1016/j.scriptamat.2011.09.021; Mishra RS, 2005, MAT SCI ENG R, V50, P1, DOI 10.1016/j.mser.2005.07.001; Arafin MA, 2009, CORROS SCI, V51, P119, DOI 10.1016/j.corsci.2008.10.006; Fujii H, 2010, MAT SCI ENG A-STRUCT, V527, P3386, DOI 10.1016/j.msea.2010.02.023; Wang S, 2014, ACTA MATER, V69, P275, DOI 10.1016/j.actamat.2014.01.060; Koyama M, 2013, ACTA MATER, V61, P4607, DOI 10.1016/j.actamat.2013.04.030; Ramasubramaniam A, 2008, J MATER RES, V23, P2757, DOI 10.1557/JMR.2008.0340; BERNSTEI.IM, 1973, METALL TRANS, V4, P1545; Cwiek J., 2006, J ACHIEV MAT MANUF E, V18, P207; Davidson JL, 1995, MATER FORUM, V19, P35; GARBER R, 1981, METALL TRANS A, V12, P225, DOI 10.1007/BF02655195; GAROFALO F, 1960, ACTA METALL MATER, V8, P504, DOI 10.1016/0001-6160(60)90103-6; Khodir S, 2013, J MATER SCI, V48, P4313, DOI 10.1007/s10853-013-7246-4; KIRCHHEIM R, 1986, ACTA METALL MATER, V34, P37, DOI 10.1016/0001-6160(86)90229-4; Lai J. K. L., 2012, STAINLESS STEELS INT; Olden V., 2012, INT J HYDROGEN ENERG, V37; Opiela M., 2010, J ACHIEVEMENTS MAT M, V38, P41; Schlogl SM, 2002, SCRIPTA MATER, V46, P431, DOI 10.1016/S1359-6462(02)00008-8; Singh SK, 1999, ISIJ INT, V39, P371, DOI 10.2355/isijinternational.39.371; Sun YF, 2010, MAT SCI ENG A-STRUCT, V527, P6879, DOI 10.1016/j.msea.2010.07.030; Thomas W.M., 1991, Int. patent Appl. No, Patent No. [PCT/GB92/02203, 9202203]	33	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	MAY	2015	94						88	98		10.1016/j.corsci.2015.01.046		11	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CF6MG	WOS:000352670200009		
J	Yamanaka, K; Mori, M; Chiba, A				Yamanaka, Kenta; Mori, Manami; Chiba, Akihiko			Surface characterisation of Ni-free Co-Cr-W-based dental alloys exposed to high temperatures and the effects of adding silicon	CORROSION SCIENCE			English	Article						Alloy; Cobalt; SEM; XPS; XRD; Oxidation	OXIDATION BEHAVIOR; W/O CR; HOT DEFORMATION; BOND STRENGTH; RESTORATIONS; MICROSTRUCTURES; PREOXIDATION; ADHERENCE	We characterised the effects of the addition of Si on the surface oxide films formed on Ni-free Co-Cr-W-based dental alloys. The addition of Si prevented the formation of Co-containing oxides and stabilised the uniform oxide films, which primarily consisted of Cr2O3. Si segregation was noticed at the interface between the oxide films and the metal substrate. The Cr2O3 and SiO2 layers formed were observed to protect against oxygen diffusion, reducing the oxidation rate at elevated temperatures. Further, the addition of Si reduced the thickness and surface roughness of the oxide films. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamanaka, Kenta; Mori, Manami; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Mori, Manami] Sendai Natl Coll Technol, Dept Mat & Environm Engn, Natori, Miyagi 9811239, Japan	Yamanaka, K (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	k_yamanaka@imr.tohoku.ac.jp			Inter-University Cooperative Research Program of the Institute for Materials Research, Tohoku University; Supporting Industry Program of the Ministry of Economy, Trade and Industry (METI), Japan; Innovative Research for Biosis-Abiosis Intelligent Interface program of the Graduate School of Dentistry, Tohoku University; Regional Innovation Cluster Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	The authors would like to thank Isamu Yoshii, Koji Kuramoto, Yoshihiro Murakami, Kazuyo Ohmura, and Issei Narita, Institute for Materials Research, Tohoku University, for helping with sample preparation and the XRD, XPS, and EPMA measurements. We also thank Keita Ishimizu, KYOCERA Medical Corporation, for contributing to fruitful discussions. This research was financially supported by a Grant-in-aid for Japan Society for the Promotion of Science (JSPS) Fellows; the Inter-University Cooperative Research Program of the Institute for Materials Research, Tohoku University; the Supporting Industry Program of the Ministry of Economy, Trade and Industry (METI), Japan; the Innovative Research for Biosis-Abiosis Intelligent Interface program of the Graduate School of Dentistry, Tohoku University; and the Regional Innovation Cluster Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Klein L, 2011, CORROS SCI, V53, P2713, DOI 10.1016/j.corsci.2011.04.020; MURAKAMI I, 1990, DENT MATER, V6, P217, DOI 10.1016/S0109-5641(05)80001-6; Ozcan M, 2003, J ORAL REHABIL, V30, P265, DOI 10.1046/j.1365-2842.2003.01038.x; Li YP, 2013, CORROS SCI, V73, P72, DOI 10.1016/j.corsci.2013.03.026; Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1; Henriques B, 2012, MAT SCI ENG C-MATER, V32, P2374, DOI 10.1016/j.msec.2012.07.010; WAGNER WC, 1993, J BIOMED MATER RES, V27, P531, DOI 10.1002/jbm.820270414; Willer J, 1998, J PROSTHET DENT, V80, P346, DOI 10.1016/S0022-3913(98)70136-2; Tang N, 2011, CORROS SCI, V53, P4324, DOI 10.1016/j.corsci.2011.08.015; Johnson T, 2006, DENT MATER, V22, P330, DOI 10.1016/j.dental.2005.05.003; WU Y, 1991, J PROSTHET DENT, V66, P439, DOI 10.1016/0022-3913(91)90502-N; Viennot S, 2006, J PROSTHET DENT, V96, P100, DOI 10.1016/j.prosdent.2006.04.013; Petitto SC, 2008, J MOL CATAL A-CHEM, V281, P49, DOI 10.1016/j.molcata.2007.08.023; Beuer F, 2009, DENT MATER, V25, P121, DOI 10.1016/j.dental.2008.04.019; Li B, 2006, OXID MET, V65, P101, DOI 10.1007/s11085-006-9003-4; Yamanaka K, 2014, MAT SCI ENG A-STRUCT, V592, P173, DOI 10.1016/j.msea.2013.11.002; DOUGLASS DL, 1971, OXID MET, V3, P185, DOI 10.1007/BF00603486; Japan Institute of Metals, 2004, KINZBK DAT; KOFSTAD PK, 1969, J ELECTROCHEM SOC, V116, P224, DOI 10.1149/1.2411802; KOFSTAD PK, 1969, J ELECTROCHEM SOC, V116, P1542, DOI 10.1149/1.2411603; KOFSTAD PK, 1969, J ELECTROCHEM SOC, V116, P229, DOI 10.1149/1.2411803; Mackert J R Jr, 1985, Dent Mater, V1, P111, DOI 10.1016/S0109-5641(85)80039-7; MACKERT JR, 1984, J DENT RES, V63, P1335, DOI 10.1177/00220345840630111701; Moulder J. F., 1995, HDB XRAY PHOTOELECTR; Rekow E.D., 2008, J AM DENT ASSOC, V137, P5; Shibasaki Y., 1970, Materials Research Bulletin, V5, DOI 10.1016/0025-5408(70)90055-3; Yamanaka K, 2014, MATER DESIGN, V57, P421, DOI 10.1016/j.matdes.2013.12.080; YAMANAKA K, 2014, MATER DESIGN, V55, P987; Yamanaka K, 2014, MATER LETT, V116, P82, DOI 10.1016/j.matlet.2013.10.109; Zeng CL, 1999, CORROS SCI, V41, P1731, DOI 10.1016/S0010-938X(99)00011-6	30	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	MAY	2015	94						411	419		10.1016/j.corsci.2015.02.030		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CF6MG	WOS:000352670200043		
J	Suetomi, T; Sakamoto, T; Tokunaga, Y; Kameyama, T; Honda, Y; Kamitsuji, H; Kameshita, I; Izumitsu, K; Suzuki, K; Irie, T				Suetomi, Takashi; Sakamoto, Takaiku; Tokunaga, Yoshitaka; Kameyama, Toru; Honda, Yoichi; Kamitsuji, Hisatoshi; Kameshita, Isamu; Izumitsu, Kousuke; Suzuki, Kazumi; Irie, Toshikazu			Effects of calmodulin on expression of lignin-modifying enzymes in Pleurotus ostreatus	CURRENT GENETICS			English	Article						Lignin; Basidiomycetes; Manganese peroxidase; Calmodulin	FUNGUS PHANEROCHAETE-CHRYSOSPORIUM; ERYNGII-VERSATILE-PEROXIDASE; WHITE-ROT BASIDIOMYCETE; MANGANESE PEROXIDASE; HETEROLOGOUS EXPRESSION; DIRECTED-MUTAGENESIS; MOLECULAR-STRUCTURE; GENOME SEQUENCE; GENE-EXPRESSION; TRANSFORMATION	Previously, we suppressed the expression of genes encoding isozymes of lignin peroxidase (LiP) and manganese peroxidase (MnP) using a calmodulin (CaM) inhibitor, W7, in the white-rot fungus Phanerochaete chrysosporium; this suggested that CaM positively regulates their expression. Here, we studied the role of CaM in another white-rot fungus, Pleurotus ostreatus, which produces MnP and versatile peroxidase (VP), but not LiP. W7 upregulated Mn2+-dependent oxidation of guaiacol, suggesting that CaM negatively regulates the production of the enzymes. Suppression of CaM in P. ostreatus using RNAi also led to upregulation of enzyme activity, whereas overexpression of CaM in P. ostreatus caused downregulation. Real-time RT-PCR showed that MnP1-6 and VP3 levels in the CaM-knockdown strain were higher than those in the wild-type strain, while MnP-5 and -6 and VP1 and 2 levels in the CaM-overexpressing strain were lower than in the wild type. Moreover, we also found that another ligninolytic enzyme, laccase, which is not produced by P. chrysosporium, was negatively regulated by CaM in P. ostreatus similar to MnP and VP. Although overexpression of CaM did not reduce the ability of P. ostreatus to digest beech wood powder, the percentage of lignin remaining in the digest was slightly higher than in the wild-type strain digest.	[Suetomi, Takashi; Sakamoto, Takaiku; Tokunaga, Yoshitaka; Kameyama, Toru; Izumitsu, Kousuke; Suzuki, Kazumi; Irie, Toshikazu] Univ Shiga Prefecture, Sch Environm Sci, Hikone City, Shiga 5228533, Japan; [Honda, Yoichi] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan; [Kamitsuji, Hisatoshi] Gifu Prefectural Res Inst Forests, Gifu 5013714, Japan; [Kameshita, Isamu] Kagawa Univ, Fac Agr, Miki, Kagawa 7610795, Japan	Irie, T (reprint author), Univ Shiga Prefecture, Sch Environm Sci, 2500 Hassaka Cho, Hikone City, Shiga 5228533, Japan.	tirie@ses.usp.ac.jp			Japan Science and Technology Agency	This work was partially supported by the grant of an FS Stage Project for Advanced Low Carbon Technology Research and the Development Program of the Japan Science and Technology Agency.	Ahn IP, 2003, PHYSIOL MOL PLANT P, V63, P281, DOI 10.1016/j.pmpp.2004.01.001; Amore A, 2012, FEMS MICROBIOL LETT, V337, P155, DOI 10.1111/1574-6968.12023; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Salame TM, 2010, MICROB BIOTECHNOL, V3, P93, DOI 10.1111/j.1751-7915.2009.00154.x; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Sakamoto T, 2013, MYCOSCIENCE, V54, P241, DOI 10.1016/j.myc.2012.09.017; Irie T, 2001, APPL MICROBIOL BIOT, V56, P707; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; PALMIERI G, 1993, APPL MICROBIOL BIOT, V39, P632; Sato T, 2004, BIOL PHARM BULL, V27, P1281, DOI 10.1248/bpb.27.1281; Ruiz-Duenas FJ, 2011, CR BIOL, V334, P795, DOI 10.1016/j.crvi.2011.06.004; MACDONALD MJ, 1984, J BACTERIOL, V160, P470; Hatfield R, 2005, CROP SCI, V45, P832, DOI 10.2135/cropsci2004.0238; LI D, 1995, APPL ENVIRON MICROB, V61, P341; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; BOOMINATHAN K, 1992, P NATL ACAD SCI USA, V89, P5586, DOI 10.1073/pnas.89.12.5586; Belinky PA, 2003, APPL ENVIRON MICROB, V69, P6500, DOI 10.1128/AEM.69.11.6500-6506.2003; Salame TM, 2013, APPL ENVIRON MICROB, V79, P2405, DOI 10.1128/AEM.03849-12; Ahn Il-Pyung, 2007, Journal of General Plant Pathology, V73, P113, DOI 10.1007/s10327-006-0326-4; Minami M, 2009, BIOSCI BIOTECH BIOCH, V73, P1722, DOI 10.1271/bbb.80870; Irie T, 2001, APPL MICROBIOL BIOT, V55, P566, DOI 10.1007/s002530000540; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Ruiz-Duenas FJ, 2007, BIOCHEMISTRY-US, V46, P66, DOI 10.1021/bi061542h; Choinowski T, 1999, J MOL BIOL, V286, P809, DOI 10.1006/jmbi.1998.2507; Morales M, 2012, J BIOL CHEM, V287, P41053, DOI 10.1074/jbc.M112.405548; Sakamoto T, 2010, CURR GENET, V56, P401, DOI 10.1007/s00294-010-0309-z; Osawa M, 1998, J MOL BIOL, V276, P165, DOI 10.1006/jmbi.1997.1524; HIDAKA H, 1981, P NATL ACAD SCI-BIOL, V78, P4354, DOI 10.1073/pnas.78.7.4354; Minami M, 2007, APPL MICROBIOL BIOT, V75, P609, DOI 10.1007/s00253-007-0850-y; Honda Y, 2000, CURR GENET, V37, P209, DOI 10.1007/s002940050521; Pezzella C, 2013, APPL MICROBIOL BIOT, V97, P705, DOI 10.1007/s00253-012-3980-9; Singh D, 2011, LETT APPL MICROBIOL, V53, P120, DOI 10.1111/j.1472-765X.2011.03070.x; KEREM Z, 1993, APPL ENVIRON MICROB, V59, P4115; BONNARME P, 1990, APPL ENVIRON MICROB, V56, P210; BROWN JA, 1990, J BACTERIOL, V172, P3125; Cullen D, 2004, MYCOTA, V3, P249; Dashtban M., 2010, INT J BIOCH MOL BIOL, V1, P36; DAVIS TN, 1986, CELL, V47, P423, DOI 10.1016/0092-8674(86)90599-4; Dence C. W., 1992, METHODS LIGNIN CHEM, P33; Fernandez-Fueyo E, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-2; Fernandez-Fueyo E, 2014, FUNGAL GENET BIOL, V2014, P2014, DOI DOI 10.1016/J.FGB.2014.02.003; GOLD MH, 1984, ARCH BIOCHEM BIOPHYS, V234, P353, DOI 10.1016/0003-9861(84)90280-7; Heinzkill M, 1997, FUNGAL BIOTECHNOLOGY, P213; Irie T, 2001, APPL MICROBIOL BIOT, V55, P563, DOI 10.1007/s002530000535; KIRK TK, 1975, P NATL ACAD SCI USA, V72, P2515, DOI 10.1073/pnas.72.7.2515; Kobayashi Issei, 2007, Journal of General Plant Pathology, V73, P399, DOI 10.1007/s10327-007-0040-x; KUWAHARA M, 1984, FEBS LETT, V169, P247, DOI 10.1016/0014-5793(84)80327-0; PASZCZYNSKI A, 1992, APPL ENVIRON MICROB, V58, P3598; Pezzella C, 2009, CURR GENET, V55, P45, DOI 10.1007/s00294-008-0221-y; Sakamoto T, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-7; Salame TM, 2014, ENVIRON MICROBIOL, V16, P225; Salame TM, 2012, APPL ENVIRON MICROB, V78, P5341, DOI 10.1128/AEM.01234-12; Wang G, 2006, PROTOPLASMA, V228, P159, DOI 10.1007/s00709-006-0181-3; Yao Yuki, 2013, Biosci Biotechnol Biochem, V77, P2309	54	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-8083	1432-0983		CURR GENET	Curr. Genet.	MAY	2015	61	2					127	140		10.1007/s00294-014-0460-z		14	Genetics & Heredity	Genetics & Heredity	CF6BS	WOS:000352642100003		
J	Suetomi, T; Sakamoto, T; Tokunaga, Y; Kameyama, T; Honda, Y; Kamitsuji, H; Kameshita, I; Izumitsu, K; Suzuki, K; Irie, T				Suetomi, Takashi; Sakamoto, Takaiku; Tokunaga, Yoshitaka; Kameyama, Toru; Honda, Yoichi; Kamitsuji, Hisatoshi; Kameshita, Isamu; Izumitsu, Kousuke; Suzuki, Kazumi; Irie, Toshikazu			Effects of calmodulin on expression of lignin-modifying enzymes in Pleurotus ostreatus (vol 61, pg 127, 2015)	CURRENT GENETICS			English	Correction									[Suetomi, Takashi; Sakamoto, Takaiku; Tokunaga, Yoshitaka; Kameyama, Toru; Izumitsu, Kousuke; Suzuki, Kazumi; Irie, Toshikazu] Univ Shiga Prefecture, Sch Environm Sci, Shiga 5228533, Japan; [Honda, Yoichi] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan; [Kamitsuji, Hisatoshi] Gifu Prefectural Res Inst Forests, Gifu 5013714, Japan; [Kameshita, Isamu] Kagawa Univ, Fac Agr, Miki, Kagawa 7610795, Japan	Irie, T (reprint author), Univ Shiga Prefecture, Sch Environm Sci, 2500 Hassaka Cho, Hikone, Shiga 5228533, Japan.	tirie@ses.usp.ac.jp					Suetomi T, 2015, CURR GENET, V61, P127, DOI 10.1007/s00294-014-0460-z	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-8083	1432-0983		CURR GENET	Curr. Genet.	MAY	2015	61	2					141	142		10.1007/s00294-014-0468-4		2	Genetics & Heredity	Genetics & Heredity	CF6BS	WOS:000352642100004		
J	Nishida-Aoki, N; Mori, H; Kuroda, K; Ueda, M				Nishida-Aoki, Nao; Mori, Hitoshi; Kuroda, Kouichi; Ueda, Mitsuyoshi			Activation of the mitochondrial signaling pathway in response to organic solvent stress in yeast	CURRENT GENETICS			English	Article						Organic solvent tolerance; Pleiotropic drug resistance (PDR); Pdr3p; Mitochondria; Retrograde signaling; Saccharomyces cerevisiae	PLEIOTROPIC DRUG-RESISTANCE; ZINC CLUSTER PROTEINS; SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; GENE-EXPRESSION; GENOME-WIDE; TRANSCRIPTIONAL REGULATORS; RETROGRADE REGULATION; PDR5 GENE; TRANSPORTER	In Saccharomyces cerevisiae, we have demonstrated that organic solvent stress activated the pleiotropic drug resistance (PDR) pathway, which involves the transcription factors Pdr1p and Pdr3p. Pdr1p and Pdr3p are functionally homologous in multidrug resistance, although Pdr3p has been reported to have some distinct functions. Here, we analyzed the functions of Pdr1p and Pdr3p during the cellular response to isooctane, as a representative of organic solvents, and observed the differential functions of Pdr1p and Pdr3p. In response to organic solvent stress, only Pdr3p contributed to the regulation of downstream genes of the PDR pathway, while Pdr1p had a rather inhibitory role on transcriptional induction through competition with Pdr3p for binding to their recognition sequence, pleiotropic drug response element. Our results demonstrated that organic solvent stress was likely to damage mitochondria, causing generation of reactive oxygen species and mitochondrial fragmentation, and to activate retrograde signaling pathway via Pdr3p to upregulate PDR5 expression. Therefore, the unique function of Pdr3p in organic solvent stress distinguishes this pathway from the multidrug response.	[Nishida-Aoki, Nao; Mori, Hitoshi; Kuroda, Kouichi; Ueda, Mitsuyoshi] Kyoto Univ, Div Appl Life Sci, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan	Ueda, M (reprint author), Kyoto Univ, Div Appl Life Sci, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan.	miueda@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science [25450099, 243819]; commission for Development of Artificial Genes Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan	This work was supported by a Grant-in-Aid for Scientific Research (C) (No. 25450099) and a Grant-in-Aid for JSPS Fellows (No. 243819) from the Japan Society for the Promotion of Science and by the commission for Development of Artificial Genes Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan. We are grateful to our colleague, Mr. Y. Tatsukami for contribution to the experiments.	Akache B, 2002, J BIOL CHEM, V277, P21254, DOI 10.1074/jbc.M202566200; Akache B, 2004, J BIOL CHEM, V279, P27855, DOI 10.1074/jbc.M403487200; Epstein CB, 2001, MOL BIOL CELL, V12, P297; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Nourani A, 1997, MOL GEN GENET, V256, P397; SIKORSKI RS, 1989, GENETICS, V122, P19; Zhang XT, 2001, J BIOL CHEM, V276, P47844, DOI 10.1074/jbc.M106285200; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Zhang XT, 2005, J BIOL CHEM, V280, P2759, DOI 10.1074/jbc.M408333200; Mamnun YM, 2002, MOL MICROBIOL, V46, P1429, DOI 10.1046/j.1365-2958.2002.03262.x; Matsui K, 2008, APPL ENVIRON MICROB, V74, P4222, DOI 10.1128/AEM.02874-07; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; KATZMANN DJ, 1994, MOL CELL BIOL, V14, P4653; Jungwirth H, 2006, FEBS LETT, V580, P1131, DOI 10.1016/j.febslet.2005.12.050; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Carvajal E, 1997, MOL GEN GENET, V256, P406; BALZI E, 1994, J BIOL CHEM, V269, P2206; Borecka-Melkusova S, 2008, FEMS YEAST RES, V8, P414, DOI 10.1111/j.1567-1364.2007.00352.x; DELAHODDE A, 1995, MOL CELL BIOL, V15, P4043; DELAVEAU T, 1994, MOL GEN GENET, V244, P501, DOI 10.1007/BF00583901; Devaux F, 2002, FEBS LETT, V515, P25, DOI 10.1016/S0014-5793(02)02387-6; Gulshan K, 2008, MOL CELL BIOL, V28, P5851, DOI 10.1128/MCB.00405-08; Hallstrom TC, 2000, J BIOL CHEM, V275, P37347, DOI 10.1074/jbc.M007338200; Hellauer K, 2002, J BIOL CHEM, V277, P17671, DOI 10.1074/jbc.M2-1637200; Hikkel I, 2003, J BIOL CHEM, V278, P11427, DOI 10.1074/jbc.M208549200; Jazwinski SM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00139; Katzmann DJ, 1996, J BIOL CHEM, V271, P23049; Kawamoto T, 2001, APPL MICROBIOL BIOT, V55, P476, DOI 10.1007/s002530000536; Larochelle M, 2006, MOL CELL BIOL, V26, P6690, DOI 10.1128/MCB.02450-06; Le Crom S, 2002, MOL CELL BIOL, V22, P2642, DOI 10.1128/MCB.22.8.2642-2649.2002; Moye-Rowley WS, 2003, PROG NUCLEIC ACID RE, V73, P251, DOI 10.1016/S0079-6603(03)01008-0; Moye-Rowley WS, 2005, GENE, V354, P15, DOI 10.1016/j.gene.2005.03.019; Nishida N, 2014, CURR GENET, V60, P149, DOI 10.1007/s00294-013-0419-5; Shahi P, 2010, MOL BIOL CELL, V21, P2469, DOI 10.1091/mbc.E09-10-0899; Shahi P, 2007, J BIOL CHEM, V282, P26822, DOI 10.1074/jbc.M704772200; Zhang XT, 2001, J BIOL CHEM, V276, P8812, DOI 10.1074/jbc.M010686200	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-8083	1432-0983		CURR GENET	Curr. Genet.	MAY	2015	61	2					153	164		10.1007/s00294-014-0463-9		12	Genetics & Heredity	Genetics & Heredity	CF6BS	WOS:000352642100006		
J	Dimke, H; Maezawa, Y; Quaggin, SE				Dimke, Henrik; Maezawa, Yoshiro; Quaggin, Susan E.			Crosstalk in glomerular injury and repair	CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION			English	Review						activated protein C; angiopoietin; C-X-C chemokine ligand 12; endothelin-1; vascular endothelial growth factor	PODOCYTE DIFFERENTIATION; DIABETIC-NEPHROPATHY; ENDOTHELIAL-CELLS; PERICYTE LOSS; TGF-BETA; MICE; GLOMERULOSCLEROSIS; ANGIOPOIETIN-1; VASCULATURE; PROTEINURIA	Purpose of review The glomerulus is a unique structure required for filtration of blood, while retaining plasma proteins based on size and charge selectivity. Distinct cell types form the structural unit that creates the filtration barrier. Structurally, fenestrated endothelial cells line the capillary loops and lie in close contact with mesangial cells. Podocytes are connected by specialized intercellular junctions known as slit diaphragms and separated from the endothelial compartment by the glomerular basement membrane. In order for this highly specialized structure to function, cross-communication between these cells must occur. Recent findings Although classical studies have established key roles for vascular endothelial and platelet-derived growth factors in glomerular cross-communication, novel paracrine signaling pathways within the glomerulus have recently been identified. In addition, unique cellular pathways of established signaling cascades have been identified that are important for maintaining glomerular barrier function in health and disease. Summary Here, we will review our current understanding of the processes of cross-communication between the unique cellular constituents forming the glomerular filtration unit. We will highlight recent findings of cellular crosstalk via signaling pathways that regulate glomerular barrier function in pathophysiological conditions.	[Dimke, Henrik] Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense, Denmark; [Maezawa, Yoshiro] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol & Med, Chiba, Japan; [Maezawa, Yoshiro] Chiba Univ Hosp, Div Diabet Metab & Endocrinol, Chiba, Japan; [Quaggin, Susan E.] Northwestern Univ, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Quaggin, Susan E.] Northwestern Univ, Div Nephrol & Hypertens, Chicago, IL 60611 USA	Quaggin, SE (reprint author), Northwestern Univ, Feinberg Sch Med, 303 E Super St,Lurie 10-105, Chicago, IL 60611 USA.	quaggin@northwestern.edu	Dimke, Henrik/G-7970-2011	Dimke, Henrik/0000-0002-9170-2168	Ministry of Education, Culture, Sports, Science, and Technology in Japan; NIH; NHLBI [HL1241200]; CIHR [MOP62931, MOP77756]; E-Rare Joint Translational Call (JTC) [016002]	The laboratory of H.D. is supported by the Novo Nordisk Foundation, the Carlsberg Foundation, and the A.P. Moller Foundation for the Advancement of Medical Science. Y.M. is supported by Grants-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan. S.E.Q. holds the Charles Mayo Chair of Medicine at the Feinberg School of Medicine and a Finnish Distinguished Professorship at the Oulu Biocenter. The laboratory of S.E.Q. is funded by NIH, NHLBI Grant HL1241200, CIHR Grants MOP62931 and MOP77756, E-Rare Joint Translational Call (JTC 2011) for European Research Projects on Rare Diseases, and TF Grant 016002.	Jin J, 2012, CELL, V151, P384, DOI 10.1016/j.cell.2012.08.037; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Madhusudhan T, 2012, BLOOD, V119, P874, DOI 10.1182/blood-2011-07-365973; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Yuen DA, 2012, J AM SOC NEPHROL, V23, P1810, DOI 10.1681/ASN.2011121170; Lenoir O, 2014, J AM SOC NEPHROL, V25, P1050, DOI 10.1681/ASN.2013020195; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Bock F, 2013, P NATL ACAD SCI USA, V110, P648, DOI 10.1073/pnas.1218667110; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Sivaskandarajah GA, 2012, DIABETES, V61, P2958, DOI 10.2337/db11-1655; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Sayyed SG, 2009, DIABETOLOGIA, V52, P2445, DOI 10.1007/s00125-009-1493-6; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Veron D, 2011, DIABETOLOGIA, V54, P1227, DOI 10.1007/s00125-010-2034-z; Ku CH, 2008, DIABETES, V57, P2824, DOI 10.2337/db08-0647; Davis B, 2007, J AM SOC NEPHROL, V18, P2320, DOI 10.1681/ASN.2006101093; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Lindahl P, 1998, DEVELOPMENT, V125, P3313; Daehn I, 2014, J CLIN INVEST, V124, P1608, DOI 10.1172/JCI71195; Kuravi SJ, 2014, J IMMUNOL, V193, P234, DOI 10.4049/jimmunol.1300229; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Clement LC, 2014, NAT MED, V20, P37, DOI 10.1038/nm.3396; Dessapt-Baradez C, 2014, J AM SOC NEPHROL, V25, P33, DOI 10.1681/ASN.2012121218; Dimke H, 2014, J AM SOC NEPHROL, DOI [10.1681/ASN.2014010060, DOI 10.1681/ASN.2014010060]; Haege S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042814; Hinamoto N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107934; Khan S, 2011, AM J PATHOL, V178, P609, DOI 10.1016/j.ajpath.2010.10.031; Kim SI, 2014, J AM SOC NEPHROL, V25, P1966, DOI 10.1681/ASN.2013030252; Maezawa Y, 2012, SELDIN GIEBISCHS KID, V1, P721; Maezawa Y, 2014, J AM SOC NEPHROL, V25, P2459, DOI 10.1681/ASN.2013121307; Petruzziello-Pellegrini TN, 2012, J CLIN INVEST, V122, P759, DOI 10.1172/JCI57313; Takabatake Y, 2009, J AM SOC NEPHROL, V20, P1714, DOI 10.1681/ASN.2008060640; Thomson BR, 2014, J CLIN INVEST, V124, P4320, DOI 10.1172/JCI77162; Vaughan MR, 2008, J AM SOC NEPHROL, V19, P24, DOI 10.1681/ASN.2007040471; Veron D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040589; Veron D, 2014, J AM SOC NEPHROL, V25, P1814, DOI 10.1681/ASN.2013070752	40	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1062-4821	1473-6543		CURR OPIN NEPHROL HY	Curr. Opin. Nephrol. Hypertens.	MAY	2015	24	3					231	238		10.1097/MNH.0000000000000117		8	Urology & Nephrology; Peripheral Vascular Disease	Urology & Nephrology; Cardiovascular System & Cardiology	CF8FO	WOS:000352791700005		
J	Kimura, M; Muto, S; Horie, S				Kimura, Masaki; Muto, Satoru; Horie, Shigeo			Opportunities for targeted focal treatment in Japan	CURRENT OPINION IN UROLOGY			English	Review						focal therapy; prostate cancer; target biopsy	INTENSITY-FOCUSED ULTRASOUND; LOCALIZED PROSTATE-CANCER; RADICAL PROSTATECTOMY; ACTIVE SURVEILLANCE; PATIENT SELECTION; INCIDENCE RATES; THERAPY; BIOPSY; ASIA; EPIDEMIOLOGY	Purpose of review Widespread prostate-specific antigen screening has led to an increase in prostate cancer diagnoses in Asian populations, reflecting changes in socioeconomic status and epidemiological features in these countries. In this setting, the present review explores opportunities for target focal therapy in Japan. Recent findings Our review examines several topics relating to focal therapy in Asia, and discusses the current status of prostate cancer diagnosis and treatment in that region. First, we summarize the prevalence of prostate cancer in Asian populations. Second, we examine prostate cancer diagnosis and treatment options such as mapping biopsy and MRI fusion biopsy in Japan. Third, we review treatment strategies for localized prostate cancer, especially robotic-assisted surgery, active surveillance, and high-intensity focused ultrasound. Lastly, we discuss the potential for focal therapy in Japan. Summary The number of localized prostate cancer patients is expected to increase in Asia. Accordingly, the need for precise diagnosis in terms of localization of prostate cancer foci will also expand. MRI fusion target biopsies are being performed in Asia, particularly in some Japanese academic institutions, but as pilot studies. In recent years, an increase in robotic-assisted surgery in East Asia has yielded new options in prostate cancer treatment. Although active surveillance is a practical choice for low-risk prostate cancer in some Asian countries, focal therapy is expected to see increasing interest as another alternative in Japan.	[Kimura, Masaki; Muto, Satoru] Teikyo Univ, Dept Urol, Tokyo 173, Japan; [Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Urol, Tokyo 1138421, Japan	Horie, S (reprint author), Juntendo Univ, Grad Sch Med, Dept Urol, 2-1-1 Bunkyo Ku, Tokyo 1138421, Japan.	shorie@juntendo.ac.jp			Department of Urology, Teikyo University Hospital, Tokyo, Japan	The study was supported by the Department of Urology, Teikyo University Hospital, Tokyo, Japan.	Matsuoka Y, 2014, EUR UROL, V65, P186, DOI 10.1016/j.eururo.2012.10.010; Shoji S, 2010, INT J UROL, V17, P715, DOI 10.1111/j.1442-2042.2010.02568.x; Kimura M, 2011, J SEX MED, V8, P2935, DOI 10.1111/j.1743-6109.2011.02387.x; Shoji S, 2013, J UROLOGY, V190, P1224, DOI 10.1016/j.juro.2013.03.116; Ito K, 2006, INT J UROL, V13, P1365, DOI 10.1111/j.1442-2042.2006.01563.x; Bul M, 2013, EUR UROL, V63, P597, DOI 10.1016/j.eururo.2012.11.005; Muto S, 2008, JPN J CLIN ONCOL, V38, P192, DOI 10.1093/jjco/hym173; Numao N, 2007, EUR UROL, V52, P1663, DOI 10.1016/j.eururo.2007.01.025; Moore MA, 2010, ASIAN PAC J CANCER P, V11, P17; Salim EI, 2010, ASIAN PAC J CANCER P, V11, P33; Villers A, 2006, J UROLOGY, V176, P2432, DOI 10.1016/j.juro.2006.08.007; Fujimoto H, 2011, INT J UROL, V18, P876, DOI 10.1111/j.1442-2042.2011.02895.x; Kimura M, 2010, BJU INT, V105, P191, DOI 10.1111/j.1464-410X.2009.08715.x; Lim GH, 2012, SINGAP MED J, V53, P3; Ouzzane A, 2011, UROLOGY, V78, P1356, DOI 10.1016/j.urology.2011.06.022; Uchida T, 2009, INT J UROL, V16, P881, DOI 10.1111/j.1442-2042.2009.02389.x; Ito K, 2014, NAT REV UROL, V11, P197, DOI 10.1038/nrurol.2014.42; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hirama H, 2014, J CANCER RES CLIN, V140, P257, DOI 10.1007/s00432-013-1566-2; Kitamura K, 2014, PROSTATE INT, V2, P1; Matsuda T, 2010, JPN J CLIN ONCOL, V40, P1192, DOI 10.1093/jjco/hyq109; Matsuoka Y, 2014, BJU INT IN PRESS; Numao N, 2008, INT J UROL, V15, P1061, DOI 10.1111/j.1442-2042.2008.02162.x; Shin HR, 2010, ASIAN PAC J CANCER P, V11, P11; Shoji S, 2014, INT J UROL IN PRESS; Sugimoto M, 2010, JPN J CLIN ONCOL, V40, P973, DOI 10.1093/jjco/hyq082; Trpkov K, 2010, BJU INT, V106, P304, DOI 10.1111/j.1464-410X.2010.09499.x	27	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0963-0643	1473-6586		CURR OPIN UROL	Curr. Opin. Urol.	MAY	2015	25	3					225	229		10.1097/MOU.0000000000000163		5	Urology & Nephrology	Urology & Nephrology	CF6ED	WOS:000352648600008		
J	Abdulhaleem, MFA; Song, XH; Kawano, R; Uezono, N; Ito, A; Ahmed, G; Hossain, M; Nakashima, K; Tanaka, H; Ohta, K				Abdulhaleem, Felemban Athary M.; Song, Xiaohong; Kawano, Rie; Uezono, Naohiro; Ito, Ayako; Ahmed, Giasuddin; Hossain, Mahmud; Nakashima, Kinichi; Tanaka, Hideaki; Ohta, Kunimasa			Akhirin Regulates the Proliferation and Differentiation of Neural Stem Cells in Intact and Injured Mouse Spinal Cord	DEVELOPMENTAL NEUROBIOLOGY			English	Article						Akhirin; neural stem cells; spinal cord injury; mouse	CENTRAL-NERVOUS-SYSTEM; EPENDYMAL REGION; ADULT-RAT; EXPRESSION; CNS; TRANSPLANTATION; NEUROGENESIS; PATTERN; ORIGIN	Although the central nervous system is considered a comparatively static tissue with limited cell turnover, cells with stem cell properties have been isolated from most neural tissues. The spinal cord ependymal cells show neural stem cell potential in vitro and in vivo in injured spinal cord. However, very little is known regarding the ependymal niche in the mouse spinal cord. We previously reported that a secreted factor, chick Akhirin, is expressed in the ciliary marginal zone of the eye, where it works as a heterophilic cell-adhesion molecule. Here, we describe a new crucial function for mouse Akhirin (M-AKH) in regulating the proliferation and differentiation of progenitors in the mouse spinal cord. During embryonic spinal cord development, M-AKH is transiently expressed in the central canal ependymal cells, which possess latent neural stem cell properties. Targeted inactivation of the AKH gene in mice causes a reduction in the size of the spinal cord and decreases BrdU incorporation in the spinal cord. Remarkably, the expression patterns of ependymal niche molecules in AKH knockout (AKH-/-) mice are different from those of AKH+/+, both in vitro and in vivo. Furthermore, we provide evidence that AKH expression in the central canal is rapidly upregulated in the injured spinal cord. Taken together, these results indicate that M-AKH plays a crucial role in mouse spinal cord formation by regulating the ependymal niche in the central canal. (c) 2014 Wiley Periodicals, Inc. Develop Neurobiol 75: 494-504, 2015	[Abdulhaleem, Felemban Athary M.; Song, Xiaohong; Kawano, Rie; Ito, Ayako; Ahmed, Giasuddin; Hossain, Mahmud; Tanaka, Hideaki; Ohta, Kunimasa] Kumamoto Univ, Grad Sch Med Sci, Dept Dev Neurobiol, Kumamoto 8608556, Japan; [Abdulhaleem, Felemban Athary M.; Kawano, Rie; Tanaka, Hideaki; Ohta, Kunimasa] Kumamoto Univ, Stem Cell Based Tissue Regenerat Res & Educ Unit, Kumamoto 8608556, Japan; [Abdulhaleem, Felemban Athary M.; Song, Xiaohong] Kumamoto Univ, Globle COE Cell Fate Regulat Res & Educ Unit, Kumamoto 8608556, Japan; [Abdulhaleem, Felemban Athary M.] Minist Higher Educ Saudi Arabia, Riyadh 11153, Saudi Arabia; [Uezono, Naohiro; Nakashima, Kinichi] Kyushu Univ, Grad Sch Med Sci, Dept Stem Cell Biol & Med, Fukuoka 8128581, Japan	Ohta, K (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Dev Neurobiol, Kumamoto 8608556, Japan.	ohta9203@gpo.kumamoto-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan; Kumamoto University Advanced Research Project "Stem Cell-Based Tissue Regeneration Research and Education Unit"; King Abdullah Scholarship Program (Ministry of Higher Education in Saudi Arabia)	Contract grant sponsor: Ministry of Education, Science, Sports, and Culture of Japan (to K.O.).; Contract grant sponsor: Kumamoto University Advanced Research Project "Stem Cell-Based Tissue Regeneration Research and Education Unit" (to A.A.F. and K.O.).; Contract grant sponsor: King Abdullah Scholarship Program (Ministry of Higher Education in Saudi Arabia) (to A.A.F.).	Fu H, 2002, DEVELOPMENT, V129, P681; Liang XQ, 2011, MOL CELL NEUROSCI, V47, P215, DOI 10.1016/j.mcn.2011.04.007; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Ahsan M, 2005, DEV DYNAM, V233, P95, DOI 10.1002/dvdy.20303; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008; Hugnot JP, 2011, FRONT BIOSCI-LANDMRK, V16, P1044, DOI 10.2741/3734; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; Yasuda A, 2011, STEM CELLS, V29, P1983, DOI 10.1002/stem.767; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Hamilton LK, 2009, NEUROSCIENCE, V164, P1044, DOI 10.1016/j.neuroscience.2009.09.006; Yu K, 2013, DEVELOPMENT, V140, P1594, DOI 10.1242/dev.090845; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Sabourin JC, 2009, STEM CELLS, V27, P2722, DOI 10.1002/stem.226; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Horky LL, 2006, J COMP NEUROL, V498, P525, DOI 10.1002/cne.21065; Weiss S, 1996, J NEUROSCI, V16, P7599; Fujimoto Y, 2012, STEM CELLS, V30, P1163, DOI 10.1002/stem.1083; BODEGA G, 1994, HISTOCHEMISTRY, V102, P113, DOI 10.1007/BF00269015; EDWARDS MA, 1990, NEUROSCIENCE, V36, P121, DOI 10.1016/0306-4522(90)90356-9; Hugnot JP., 2010, NEURAL STEM CELLS TH, P71; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Kojima A, 2002, J NEUROTRAUM, V19, P223, DOI 10.1089/08977150252806974; Lukaszewicz AI, 2011, P NATL ACAD SCI USA, V108, P11632, DOI 10.1073/pnas.1106230108; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8451	1932-846X		DEV NEUROBIOL	Dev. Neurobiol.	MAY	2015	75	5					494	504		10.1002/dneu.22238		11	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CG1QO	WOS:000353048600005		
J	Tanaka, S; Kashida, H; Saito, Y; Yahagi, N; Yamano, H; Saito, S; Hisabe, T; Yao, T; Watanabe, M; Yoshida, M; Kudo, S; Tsuruta, O; Sugihara, K; Watanabe, T; Saitoh, Y; Igarashi, M; Toyonaga, T; Ajioka, Y; Ichinose, M; Matsui, T; Sugita, A; Sugano, K; Fujimoto, K; Tajiri, H				Tanaka, Shinji; Kashida, Hiroshi; Saito, Yutaka; Yahagi, Naohisa; Yamano, Hiroo; Saito, Shoichi; Hisabe, Takashi; Yao, Takashi; Watanabe, Masahiko; Yoshida, Masahiro; Kudo, Shin-ei; Tsuruta, Osamu; Sugihara, Ken-ichi; Watanabe, Toshiaki; Saitoh, Yusuke; Igarashi, Masahiro; Toyonaga, Takashi; Ajioka, Yoichi; Ichinose, Masao; Matsui, Toshiyuki; Sugita, Akira; Sugano, Kentaro; Fujimoto, Kazuma; Tajiri, Hisao			JGES guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection	DIGESTIVE ENDOSCOPY			English	Article						colorectal tumor; early colorectal carcinoma; endoscopic mucosal resection (EMR); endoscopic submucosal dissection (ESD); guidelines	SESSILE SERRATED ADENOMAS; MULTICENTER QUESTIONNAIRE SURVEY; CARBON-DIOXIDE INSUFFLATION; LATERALLY SPREADING TUMORS; LASER IMAGING-SYSTEM; INVASION DEPTH; LOCAL RECURRENCE; COLONIC POLYPS; MAGNIFYING CHROMOENDOSCOPY; COLONOSCOPIC POLYPECTOMY	Colorectal endoscopic submucosal dissection (ESD) has become common in recent years. Suitable lesions for endoscopic treatment include not only early colorectal carcinomas but also many types of precarcinomatous adenomas. It is important to establish practical guidelines in which the preoperative diagnosis of colorectal neoplasia and the selection of endoscopic treatment procedures are properly outlined, and to ensure that the actual endoscopic treatment is useful and safe in general hospitals when carried out in accordance with the guidelines. In cooperation with the Japanese Society for Cancer of the Colon and Rectum, the Japanese Society of Coloproctology, and the Japanese Society of Gastroenterology, the Japan Gastroenterological Endoscopy Society has recently compiled a set of colorectal ESD/endoscopic mucosal resection (EMR) guidelines using evidence-based methods. The guidelines focus on the diagnostic and therapeutic strategies and caveat before, during, and after ESD/EMR and, in this regard, exclude the specific procedures, types and proper use of instruments, devices, and drugs. Although eight areas, ranging from indication to pathology, were originally planned for inclusion in these guidelines, evidence was scarce in each area. Therefore, grades of recommendation were determined largely through expert consensus in these areas.	[Tanaka, Shinji; Kashida, Hiroshi; Saito, Yutaka; Yahagi, Naohisa; Yamano, Hiroo; Saito, Shoichi; Hisabe, Takashi; Kudo, Shin-ei; Tsuruta, Osamu; Saitoh, Yusuke; Igarashi, Masahiro; Toyonaga, Takashi; Ichinose, Masao; Matsui, Toshiyuki; Fujimoto, Kazuma; Tajiri, Hisao] Japan Gastroenterol Endoscopy Soc, Tokyo, Japan; [Tanaka, Shinji; Yao, Takashi; Watanabe, Masahiko; Sugihara, Ken-ichi; Watanabe, Toshiaki; Ajioka, Yoichi] Japanese Soc Canc Colon & Rectum, Tokyo, Japan; [Watanabe, Masahiko; Matsui, Toshiyuki; Sugita, Akira] Japanese Soc Coloproctol, Tokyo, Japan; [Yoshida, Masahiro; Sugano, Kentaro] Japanese Soc Gastroenterol, Tokyo, Japan	Tanaka, S (reprint author), Hiroshima Univ, Endoscopy & Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	colon@hiroshima-u.ac.jp					Ahlawat SK, 2011, J CLIN GASTROENTEROL, V45, P347, DOI 10.1097/MCG.0b013e3181f3a2e0; Ajioka Y, 2010, STOMACH INTESTINE, V45, P678; Aldridge AJ, 2001, EUR J SURG, V167, P777; Lash RH, 2010, J CLIN PATHOL, V63, P681, DOI 10.1136/jcp.2010.075507; Saito Y, 2010, SURG ENDOSC, V24, P343, DOI 10.1007/s00464-009-0562-8; Sakamoto T, 2011, DIS COLON RECTUM, V54, P1307, DOI 10.1097/DCR.0b013e3182282ab0; UNO Y, 1994, GASTROINTEST ENDOSC, V40, P485; Repici A, 2009, DIS COLON RECTUM, V52, P1502, DOI 10.1007/DCR.0b013e3181a74d9b; Parikh ND, 2013, CLIN GASTROENTEROL H, V11, P1319, DOI 10.1016/j.cgh.2012.12.044; Liaquat H, 2013, GASTROINTEST ENDOSC, V77, P401, DOI 10.1016/j.gie.2012.10.024; KUDO S, 1994, J CLIN PATHOL, V47, P880, DOI 10.1136/jcp.47.10.880; Salaria SN, 2012, HUM PATHOL, V43, P1808, DOI 10.1016/j.humpath.2012.04.001; Hiraoka S, 2010, GASTROENTEROLOGY, V139, P1503, DOI 10.1053/j.gastro.2010.07.011; Ikematsu H, 2013, GASTROENTEROLOGY, V144, P551, DOI 10.1053/j.gastro.2012.12.003; Terasaki M, 2012, J GASTROEN HEPATOL, V27, P734, DOI 10.1111/j.1440-1746.2011.06977.x; Woodward TA, 2012, AM J GASTROENTEROL, V107, P650, DOI 10.1038/ajg.2011.473; Lazarus R, 2005, AM J CLIN PATHOL, V123, P349, DOI 10.1309/VBAGV3BR96N2EQTR; Kobayashi N, 2007, ENDOSCOPY, V39, P701, DOI 10.1055/s-2007-966587; Tanaka S, 2006, GASTROINTEST ENDOSC, V64, P604, DOI 10.1016/j.gie.2006.06.007; Hotta K, 2009, INT J COLORECTAL DIS, V24, P225, DOI 10.1007/s00384-008-0596-8; Fujishiro M, 2006, GASTROINTEST ENDOSC, V63, P243, DOI 10.1016/j.gie.2005.08.002; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Oka S, 2010, DIGEST ENDOSC, V22, P376, DOI 10.1111/j.1443-1661.2010.01016.x; Tanaka S, 2007, GASTROINTEST ENDOSC, V66, P100, DOI 10.1016/j.gie.2007.02.032; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; dos Santos CEO, 2010, EUR J GASTROEN HEPAT, V22, P1364, DOI 10.1097/MEG.0b013e32833a5d63; Kobayashi N, 2012, J GASTROEN HEPATOL, V27, P728, DOI 10.1111/j.1440-1746.2011.06942.x; Cipolletta L, 2009, DIS COLON RECTUM, V52, P1774, DOI 10.1007/DCR.0b013e3181b5539c; Tanaka S, 2008, J GASTROENTEROL, V43, P641, DOI 10.1007/s00535-008-2223-4; Saito Y, 2007, GASTROINTEST ENDOSC, V65, P537, DOI 10.1016/j.gie.2006.11.002; Saito Y, 2010, GASTROINTEST ENDOSC, V72, P1217, DOI 10.1016/j.gie.2010.08.004; Matsumoto A, 2010, SCAND J GASTROENTERO, V45, P1329, DOI 10.3109/00365521.2010.495416; Watabe H, 2006, GASTROINTEST ENDOSC, V64, P73, DOI 10.1016/j.gie.2006.02.054; Leufkens AM, 2012, ENDOSCOPY, V44, P470, DOI 10.1055/s-0031-1291666; Sakamoto T, 2011, SURG ENDOSC, V25, P255, DOI 10.1007/s00464-010-1169-9; Taku K, 2007, J GASTROEN HEPATOL, V22, P1409, DOI 10.1111/j.1440-1746.2007.05022.x; Matsumoto M, 2012, JPN J CLIN ONCOL, V42, P1028, DOI 10.1093/jjco/hys131; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Sakamoto T, 2011, DIGEST ENDOSC, V23, P118, DOI 10.1111/j.1443-1661.2010.01049.x; Santoro GA, 2009, DIS COLON RECTUM, V52, P1837, DOI 10.1007/DCR.0b013e3181b16ce9; Kikuchi T, 2010, SURG ENDOSC, V24, P2231, DOI 10.1007/s00464-010-0939-8; WALSH RM, 1992, GASTROINTEST ENDOSC, V38, P303; Yoshida N, 2014, DIGEST ENDOSC, V26, P250, DOI 10.1111/den.12127; Kudo SE, 1996, GASTROINTEST ENDOSC, V44, P8, DOI 10.1016/S0016-5107(96)70222-5; Sano Y, 2001, GASTROINTEST ENDOSC, V53, pAB125; Buchner AM, 2012, GASTROINTEST ENDOSC, V76, P255, DOI 10.1016/j.gie.2012.02.060; Tamai N, 2012, INT J COLORECTAL DIS, V27, P1493, DOI 10.1007/s00384-012-1514-7; Hofstad B, 1996, GUT, V39, P449, DOI 10.1136/gut.39.3.449; Nusko G, 2002, GUT, V51, P424, DOI 10.1136/gut.51.3.424; Iacopini F, 2012, GASTROINTEST ENDOSC, V76, P1188, DOI 10.1016/j.gie.2012.08.024; Kiriyama S, 2012, ENDOSCOPY, V44, P1024, DOI 10.1055/s-0032-1310259; Oono Y, 2009, DIGEST DIS SCI, V54, P906, DOI 10.1007/s10620-008-0407-7; Nakajima T, 2013, SURG ENDOSC, V27, P3262, DOI 10.1007/s00464-013-2903-x; Saitoh Y, 2001, GASTROENTEROLOGY, V120, P1657, DOI 10.1053/gast.2001.24886; Shioji K, 2003, GASTROINTEST ENDOSC, V57, P691, DOI 10.1067/mge.2003.193; Fujishiro M, 2007, CLIN GASTROENTEROL H, V5, P678, DOI 10.1016/j.cgh.2007.01.006; Uraoka T, 2006, GUT, V55, P1592, DOI 10.1136/gut.2005.087452; Kudo S, 1997, WORLD J SURG, V21, P694; Uraoka T, 2013, J GASTROEN HEPATOL, V28, P406, DOI 10.1111/jgh.12099; Matsuda T, 2008, AM J GASTROENTEROL, V103, P2700, DOI 10.1111/j.1572-0241.2008.02190.x; Ishiguro A, 1999, GASTROINTEST ENDOSC, V50, P329, DOI 10.1053/ge.1999.v50.98591; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Nakadoi K, 2012, J GASTROEN HEPATOL, V27, P1057, DOI 10.1111/j.1440-1746.2011.07041.x; [Anonymous], 2010, JSCCR GUID 2010 TREA; Puli SR, 2009, ANN SURG ONCOL, V16, P2147, DOI 10.1245/s10434-009-0520-7; Kimura T, 2012, AM J GASTROENTEROL, V107, P460, DOI 10.1038/ajg.2011.457; Uraoka T, 2011, SURG ENDOSC, V25, P3000, DOI 10.1007/s00464-011-1660-y; Isomoto H, 2009, ENDOSCOPY, V41, P679, DOI 10.1055/s-0029-1214979; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Schreiner MA, 2010, GASTROENTEROLOGY, V139, P1497, DOI 10.1053/j.gastro.2010.06.074; Puli SR, 2009, WORLD J GASTROENTERO, V15, P4273, DOI 10.3748/wjg.15.4273; Ikematsu H, 2012, J GASTROENTEROL, V47, P1099, DOI 10.1007/s00535-012-0575-2; Renehan AG, 2002, BRIT MED J, V324, P813, DOI 10.1136/bmj.324.7341.813; Lu FI, 2010, AM J SURG PATHOL, V34, P927, DOI 10.1097/PAS.0b013e3181e4f256; Fujimoto K, 2014, DIGEST ENDOSC, V26, P1, DOI 10.1111/den.12183; Moss A, 2011, GASTROENTEROLOGY, V140, P1909, DOI 10.1053/j.gastro.2011.02.062; Kobayashi H, 2011, J GASTROENTEROL, V46, P203, DOI 10.1007/s00535-010-0341-2; Sakamoto T, 2012, CLIN GASTROENTEROL H, V10, P22, DOI 10.1016/j.cgh.2011.10.007; Aoki T, 2012, WORLD J GASTROENTERO, V18, P3721, DOI 10.3748/wjg.v18.i28.3721; Ballas KD, 2008, J LAPAROENDOSC ADV S, V18, P717, DOI 10.1089/lap.2008.0003; Benjelloun EB, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-13; Benson BC, 2013, CASE REO EMERG MED; Colorectal ESD Standardization Implementation Working Group, 2009, COL ESD GUID; DEYHLE P, 1973, ENDOSCOPY, V5, P38; Dior M, 2013, SURG ENDOSC, V27, P2775, DOI 10.1007/s00464-013-2807-9; Field MJ, 1990, CLIN PRACTICE GUIDEL; Figureueredo A, 2003, BMC CANCER, V6, P26; Fujii T, 2012, ENDOSC DIG, V24, P1199; Fujishiro M, 2013, GASTROENTEROL ENDO S, V55, P1331; Hamamoto Norihiro, 2004, Stomach and Intestine (Tokyo), V39, P1375; Hamatani S, 2007, CLIN GASTROENTEROL, V22, P1319; Hasegawa S, 2009, CANCER, V2, P328; Hirao M, 1986, Gan No Rinsho, V32, P1180; Hirasaki S, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-1; Hirata I, 2006, J JPN SOC COLOPROCTO, V59, P880; Hisabe T, 2009, DIACHO SHIKKAN NOW, P48; Horimatsu T, 2007, EARLY COLORECTAL CAN, V11, P113; Hotta K, 2010, DIGEST ENDOSC, V22, pS63, DOI 10.1111/j.1443-1661.2010.00965.x; Igarashi Masahiro, 1999, Stomach and Intestine (Tokyo), V34, P645; Ikematsu H, 2011, DIGEST ENDOSC, V23, P95, DOI 10.1111/j.1443-1661.2011.01145.x; Inayama Y, 2005, JPN J DIAGN PATHOL, V22, P6; Japanese Society for Cancer of the Colon and Rectum, 2014, JSCCR GUID 2014 TREA; Japanese Society for Cancer of the Colon and Rectum, 2003, MULT REG LARG BOW CA, V17; Kashida H, 2012, ENDOSC DIG, V24, P605; Kashida Hiroshi, 2006, Int J Clin Oncol, V11, P1, DOI 10.1007/s10147-005-0550-5; Kashida H, 2010, INTESTINE, V14, P145; Kato S, 2001, ENDOSC DIG, V13, P384; Kawachi H, 2009, FRON COLORECTAL CANC, V2, P113; Kikuchi Yosuke, 2001, Stomach and Intestine (Tokyo), V36, P392; Kiriyama S, 2011, J GASTROEN HEPATOL, V26, P1028, DOI 10.1111/j.1440-1746.2011.06684.x; Koika T, 2008, PROG DIG ENDOSC, V73, P84; Kudo Shin-Ei, 1996, Stomach and Intestine, V31, P167; Kudo S, 2001, Gastrointest Endosc Clin N Am, V11, P519; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Kudo S, 2005, CLIN GASTROENTEROL H, V3, P33; Liang JJ, 2013, ANZ J SURG, V83, P325, DOI 10.1111/j.1445-2197.2012.06269.x; Maeda S, 2005, INFORMED CONSECT THE, P16; Matsubara A, 2010, STOMACH INTESTINE, V45, P699; Matsuda K, 1999, J GASTROENTEROL, V34, P260, DOI 10.1007/s005350050254; Matsuda T, 2009, JPN J CLIN ONCOL, V39, P435, DOI 10.1093/jjco/hyp047; Mitomi H, 2001, EARLY COLORECTAL CAN, V5, P441; Nakajima Takashi, 1996, Stomach and Intestine (Tokyo), V31, P1607; Nikami T, 2011, STOMACH INTESTINE, V46, P1459; Nishizawa Mamoru, 1995, Stomach and Intestine, V30, P1519; Oka Shiro, 2004, Stomach and Intestine (Tokyo), V39, P1731; Oka Shiro, 2004, Stomach and Intestine (Tokyo), V39, P1363; Oka S, 2011, DIGEST ENDOSC, V23, P190, DOI 10.1111/j.1443-1661.2010.01072.x; Oka S, 2012, J JPN SOC COLOPROCTO, V65, P793; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Saitoh Y, 1996, GASTROINTEST ENDOSC, V44, P34, DOI 10.1016/S0016-5107(96)70226-2; Saitoh Y, 2008, COLORECTAL CANC, V1, P133; Sakamoto T, 2012, J GASTROENTEROL, V47, P635, DOI 10.1007/s00535-011-0524-5; Sano Y, 2008, NEW CHALLENGES IN GASTROINTESTINAL ENDOSCOPY, P306, DOI 10.1007/978-4-431-78889-8_30; Shimizu M, 2010, STOMACH INTESTINE, V45, P981; Snover DC, 2010, WHO CLASSIFICATION T, P160; Tajiri H, 2004, DIGEST ENDOSC, V16, P134; Tanaka S, 2004, GASTROENTEROL ENDOSC, V46, P243; Tanaka S, 2001, GASTROINTEST ENDOSC, V54, P62, DOI 10.1067/mge.2001.115729; Tanaka S, 2012, DIGEST ENDOSC, V25, P107; Tanaka S, 2015, J GASTROENT IN PRESS; Tanaka S, 2010, DIGEST ENDOSC, V22, pS2, DOI 10.1111/j.1443-1661.2010.00952.x; The Japanese Society for Cancer of the Colon and Rectum, 2013, JAP CLASS COL CARC; Tobaru T, 2007, STOMACH INTESTINE, V42, P809; Togashi K, 2009, GASTROINTEST ENDOSC, V69, P734, DOI 10.1016/j.gie.2008.10.063; Togashi K, 2007, GASTROINTEST ENDOSC, V65, pAB335, DOI 10.1016/j.gie.2007.03.840; Toyonaga T, 2009, DIGEST ENDOSC, V21, P31; Tsuda S, 2006, J JPN SOC COLOPROCTO, V59, P874; Tsuda Sumio, 2001, Stomach and Intestine (Tokyo), V36, P769; Tsuruta Osamu, 2001, Stomach and Intestine (Tokyo), V36, P791; Tsuruta Osamu, 1999, Stomach and Intestine (Tokyo), V34, P1613; Uragami N, 2007, STOMACH INTESTINE EN, V42, P1470; Uraoka T, 2007, STOMACH INTESTINE, V42, P817; Wada Y, 2013, STOMACH INTESTINE, V48, P134; Winawer Sidney J, 2002, Gastrointest Endosc Clin N Am, V12, P1, DOI 10.1016/S1052-5157(03)00053-9; Yamamoto H, 2005, CLIN GASTROENTEROL H, V3, P74; Yamano H, 2008, NEW CHALLENGES IN GASTROINTESTINAL ENDOSCOPY, P295, DOI 10.1007/978-4-431-78889-8_29; Yoshida N, 2014, J GASTROENTEROL, V49, P73, DOI 10.1007/s00535-013-0772-7; Yoshii S, 2012, GASTROENTEROL ENDOSC, V54, P244; Yoshino J, 2010, GASTROENTEROL ENDOSC, V52, P95	159	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	MAY	2015	27	4					417	434		10.1111/den.12456		18	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG1KL	WOS:000353031400001		
J	Obara, K; Haruma, K; Irisawa, A; Kaise, M; Gotoda, T; Sugiyama, M; Tanabe, S; Horiuchi, A; Fujita, N; Ozaki, M; Yoshida, M; Matsui, T; Ichinose, M; Kaminishi, M				Obara, Katsutoshi; Haruma, Ken; Irisawa, Atsushi; Kaise, Mitsuru; Gotoda, Takuji; Sugiyama, Masanori; Tanabe, Satoshi; Horiuchi, Akira; Fujita, Naotaka; Ozaki, Makoto; Yoshida, Masahiro; Matsui, Toshiyuki; Ichinose, Masao; Kaminishi, Michio			Guidelines for sedation in gastroenterological endoscopy	DIGESTIVE ENDOSCOPY			English	Article						anesthetic; antagonist; gastroenterological endoscopy; sedation; sedative	UPPER GASTROINTESTINAL ENDOSCOPY; UPPER GI ENDOSCOPY; CONSCIOUS SEDATION; PULSE OXIMETRY; RETROGRADE CHOLANGIOPANCREATOGRAPHY; PROPOFOL SEDATION; MIDAZOLAM PREMEDICATION; RESPIRATORY DEPRESSION; OUTPATIENT COLONOSCOPY; ADMINISTERED PROPOFOL	Recently, the need for sedation in gastrointestinal endoscopy has been increasing. However, the National Health Insurance Drug Price list in Japan does not include any drug specifically used for the sedation. Although benzodiazepines are the main medication, their use in cases of gastrointestinal endoscopy has not been approved. This has led the Japan Gastrointestinal Endoscopy Society to develop the first set of guidelines for sedation in gastrointestinal endoscopy on the basis of evidence-based medicine in collaboration with the Japanese Society for Anesthesiologists. The present guidelines comprise 14 statements, five of which were judged to be valid on the highest evidence level and three on the second highest level. The guidelines are not intended to strongly recommend the use of sedation for gastrointestinal endoscopy, but rather to indicate the policy as to the choice of appropriate procedures when such sedation is deemed necessary. In clinical practice, the final decision as to the use of sedation should be made by physicians considering patient willingness and physical condition.	[Obara, Katsutoshi; Haruma, Ken; Irisawa, Atsushi; Kaise, Mitsuru; Gotoda, Takuji; Sugiyama, Masanori; Tanabe, Satoshi; Horiuchi, Akira; Fujita, Naotaka; Yoshida, Masahiro; Matsui, Toshiyuki; Ichinose, Masao; Kaminishi, Michio] Japan Gastroenterol Endoscopy Soc, Tokyo 1010062, Japan; [Ozaki, Makoto] Japanese Soc Anesthesiologists, Tokyo, Japan	Obara, K (reprint author), Japan Gastroenterol Endoscopy Soc, Chiyodak Ku, 3-2-1 Kandasurugadai, Tokyo 1010062, Japan.	k-obara@fmu.ac.jp		Ozaki, Makoto/0000-0001-7841-6661	Astellas Pharma Inc.; AstraZeneca PLC.; Daiichi Sankyo Co., Ltd; Eisai Co., Ltd; Takeda Pharmaceutical Co. Ltd; Mitsubishi Tanabe Pharma Co.; Ajinomoto Pharmaceuticals Co., Ltd; Kyorin Pharmaceutical Co., Ltd; JIMRO Co., Ltd; AbbVie Inc.; Zeria Pharmaceutical Co., Ltd; Fukuoka Prefecture	AUTHOR M.K. RECEIVED a royalty from Nihon Pharmaceutical Co. Ltd for patent no. 2002-250780, a suppressant for enterokinesis; author K.H. received lecture fees from Astellas Pharma Inc., AstraZeneca PLC., Daiichi Sankyo Co., Ltd, Eisai Co., Ltd, and Takeda Pharmaceutical Co. Ltd, and scholarship contributions from Astellas Pharma Inc., AstraZeneca PLC., Daiichi Sankyo Co., Ltd, Eisai Co., Ltd, and Takeda Pharmaceutical Co. Ltd; author T.M. received lecture fees from Eisai Co., Ltd, scholarship contributions from Astellas Pharma Inc., Eisai Co., Ltd, Mitsubishi Tanabe Pharma Co., and study group sponsorship from AbbVie Inc., Ajinomoto Pharmaceuticals Co., Ltd, Eisai Co., Ltd, Kyorin Pharmaceutical Co., Ltd, JIMRO Co., Ltd, Zeria Pharmaceutical Co., Ltd, Mitsubishi Tanabe Pharma Co. and Fukuoka Prefecture; and author T.G. received scholarship contributions from Takeda Pharmaceutical Co. Ltd. None of the other authors have any relevant conflict of interest to disclose. The funding source had no role in the design, practice or analysis of this study.	American Society for Gastrointestinal Endoscopy, 1995, GASTROINTEST ENDOSC, V42, P626; Gross JB, 2002, ANESTHESIOLOGY, V96, P1004; Nelson DB, 2000, GASTROINTEST ENDOSC, V51, P288, DOI 10.1016/S0016-5107(00)70357-9; ANDREWS PJD, 1990, ANAESTHESIA, V45, P445, DOI 10.1111/j.1365-2044.1990.tb14330.x; Abraham N, 2002, GASTROINTEST ENDOSC, V56, P180, DOI 10.1067/mge.2002.125825; Ristikankare M, 1999, GASTROINTEST ENDOSC, V49, P566, DOI 10.1016/S0016-5107(99)70383-4; Schilling D, 2009, ENDOSCOPY, V41, P295, DOI 10.1055/s-0028-1119671; SALETIN M, 1991, ENDOSCOPY, V23, P331, DOI 10.1055/s-2007-1010709; IBER FL, 1993, GASTROINTEST ENDOSC, V39, P620; Waring JP, 2003, GASTROINTEST ENDOSC, V58, P317, DOI 10.1067/S0016-5107(03)00001-4; Metzner J, 2009, CURR OPIN ANESTHESIO, V22, P502, DOI 10.1097/ACO.0b013e32832dba50; Imagawa A, 2008, ENDOSCOPY, V40, P905, DOI 10.1055/s-2008-1077641; RAMSAY MAE, 1974, BRIT MED J, V2, P656; Sharma VK, 2007, GASTROINTEST ENDOSC, V66, P27, DOI 10.1016/j.gie.2006.12.040; LOEB JM, 1993, JAMA-J AM MED ASSOC, V270, P1463; LaLuna L, 2001, GASTROINTEST ENDOSC, V53, P289, DOI 10.1067/mge.2001.112192; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Thanvi BR, 2003, POSTGRAD MED J, V79, P650, DOI 10.1136/pmj.79.937.650; Vargo JJ, 2002, GASTROENTEROLOGY, V123, P8, DOI 10.1053/gast.2002.34232; Sipe BW, 2002, GASTROINTEST ENDOSC, V55, P815, DOI 10.1067/mge.2002.124636; PATTERSON KW, 1991, BRIT J ANAESTH, V67, P108, DOI 10.1093/bja/67.1.108; Lichtenstein DR, 2008, GASTROINTEST ENDOSC, V68, P815, DOI 10.1016/j.gie.2008.09.029; CARLSSON U, 1995, ENDOSCOPY, V27, P240, DOI 10.1055/s-2007-1005678; Abraham NS, 2004, AM J GASTROENTEROL, V99, P1692, DOI 10.1111/j.1572-0241.2004.40157.x; Qadeer MA, 2005, CLIN GASTROENTEROL H, V3, P1049, DOI 10.1053/S1542-3565(05)00742-1; MORA CT, 1995, CAN J ANAESTH, V42, P677; McQuaid KR, 2008, GASTROINTEST ENDOSC, V67, P910, DOI 10.1016/j.gie.2007.12.046; Schnider TW, 1999, ANESTHESIOLOGY, V90, P1502, DOI 10.1097/00000542-199906000-00003; Krugliak P, 2000, ENDOSCOPY, V32, P677; LEE MG, 1989, GASTROINTEST ENDOSC, V35, P82, DOI 10.1016/S0016-5107(89)72713-9; Cohen LB, 2006, AM J GASTROENTEROL, V101, P967, DOI 10.1111/j.1572-0241.2006.00500.x; DIPALMA JA, 1995, SOUTHERN MED J, V88, P630, DOI 10.1097/00007611-199506000-00006; Wehrmann T, 2008, SCAND J GASTROENTERO, V43, P368, DOI 10.1080/00365520701679181; Cohen LB, 2007, GASTROENTEROLOGY, V133, P675, DOI 10.1053/j.gastro.2007.06.002; Vargo JJ, 2002, GASTROINTEST ENDOSC, V55, P826, DOI 10.1067/mge.2002.124208; Tohda G, 2006, ENDOSCOPY, V38, P684, DOI 10.1055/s-2006-925374; Paspatis GA, 2008, ENDOSCOPY, V40, P308, DOI 10.1055/s-2007-995346; Garcia RT, 2003, GASTROENTEROLOGY, V125, P1606, DOI 10.1053/S0016-5085(03)01524-5; Kankaria A, 1996, GASTROINTEST ENDOSC, V44, P416, DOI 10.1016/S0016-5107(96)70091-3; Patel S, 2005, AM J GASTROENTEROL, V100, P2689, DOI 10.1111/j.1572-0241.2005.00320.x; Ulmer BJ, 2003, CLIN GASTROENTEROL H, V1, P425, DOI 10.1053/S1542-3565(03)00226-X; Cohen LB, 2010, ALIMENT PHARM THER, V32, P425, DOI 10.1111/j.1365-2036.2010.04352.x; Horiuchi A, 2008, DIGESTION, V78, P20, DOI 10.1159/000151765; Aviv JE, 1997, AM J MED, V103, p74S, DOI 10.1016/S0002-9343(97)00327-6; BARDHAN KD, 1984, BRIT MED J, V288, P1046; BELL GD, 1988, BRIT J CLIN PHARMACO, V26, P595; BERG JC, 1991, ENDOSCOPY, V23, P328, DOI 10.1055/s-2007-1010708; BULLIMORE D W, 1987, Alimentary Pharmacology and Therapeutics, V1, P409; CARTER AS, 1990, ACTA ANAESTH SCAND, V34, P59; Chin K. W., 1994, Annals Academy of Medicine Singapore, V23, P330; Chin N. M., 1992, Singapore Medical Journal, V33, P478; COLE SG, 1983, GASTROINTEST ENDOSC, V29, P219, DOI 10.1016/S0016-5107(83)72588-5; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P3077, DOI 10.1001/jama.263.22.3077; Fukui T, 2007, MINDS MANUAL CONSTRU; Gowing L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002022.pub3; HENNESSY MJ, 1991, PSYCHOPHARMACOLOGY, V103, P545, DOI 10.1007/BF02244257; JANSSEN U, 1989, CLIN PHARMACOL THER, V46, P317; Japan Gastroenterological Endoscopy Society postgraduate education committee, 1999, GUID TREATM DIAB 199, P40; Japan Gastroenterological Endoscopy Society postgraduate education committee, 2006, GRID INT COD JEAC970, P37; Kaneko E, 2004, GASTROENTEROL ENDOSC, V46, P54; Kaneko E, 1995, GASTROINTEST ENDOSC, V37, P642; Kaneko E, 2000, GASTROENTEROL ENDOSC, V42, P308; Kasugai T, 1989, GASTROENTEROL ENDOSC, V31, P2214; Kiriyama S, 2010, J GASTROENTEROL, V45, P831, DOI 10.1007/s00535-010-0222-8; Kotzampassi K, 1997, HELLENIC J GASTROENT, V10, P64; Lightdale JR, 2006, PEDIATRICS, V117, P1170; Maurer WG, 2010, DIGESTION, V82, P87, DOI 10.1159/000285505; McGloy RF, 1995, ACTA ANAESTH SCAND, V39, P35; MEISEL M, 1994, ANN FR ANESTH, V13, P579, DOI 10.1016/S0750-7658(05)80703-8; Miller RD, 2000, ANESTHESIA, P348; Naylor CD, 1998, NEW ENGL J MED, V338, P1918, DOI 10.1056/NEJM199806253382612; PATTERSON KW, 1995, J CLIN ANESTH, V7, P136, DOI 10.1016/0952-8180(94)00042-3; Riphaus A, 2009, ENDOSCOPY, V41, P787, DOI 10.1055/s-0029-1215035; Stoelting RK, 1999, PHARM PHYSL ANESTHET; Takrouri M S, 1988, Middle East J Anaesthesiol, V9, P529; The Japanese Society of Anesthesiologists, 2012, GUID US AN DRUGS ASS; Waye JD, 2000, GASTROINTEST ENDOSC, V51, P768, DOI 10.1016/S0016-5107(00)70104-0; Whitwam J G, 1995, Acta Anaesthesiol Scand Suppl, V108, P15; Yoshino J, 2010, GASTROENTEROL ENDOSC, V52, P95; Yoshizawa T, 2003, GASTROINTEST ENDOSC, V58, P523; Yuksel O, 2007, EUR J GASTROEN HEPAT, V19, P1002	81	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	MAY	2015	27	4					435	449		10.1111/den.12464		15	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG1KL	WOS:000353031400002		
J	Tanaka, M				Tanaka, Masao			Current roles of endoscopy in the management of intraductal papillary mucinous neoplasm of the pancreas	DIGESTIVE ENDOSCOPY			English	Review						endoscopic retrograde cholangiopancreatography; endoscopic ultrasonography; epithelial subtype; intraductal papillary mucinous neoplasm; pancreatic cancer	INTERNATIONAL CONSENSUS GUIDELINES; INVASIVE DUCTAL CARCINOMA; FINE-NEEDLE-ASPIRATION; JUICE CYTOLOGY; PERORAL PANCREATOSCOPY; FOLLOW-UP; CYSTIC NEOPLASMS; REMNANT PANCREAS; RISK-ASSESSMENT; INTESTINAL-TYPE	Intraductal papillary mucinous neoplasm (IPMN) of the pancreas is characterized by intraductal papillary proliferation of mucin-producing epithelial cells that exhibit various degrees of dysplasia. IPMN is classified into four histological subtypes (gastric, intestinal, pancreatobiliary, and oncocytic) according to its histomorphological and immunohistochemical characteristics. Endoscopic retrograde cholangiopancreatography plays a crucial role in the evaluation of these features of IPMN. Endoscopic ultrasonography (EUS) has proven to be more sensitive than computed tomography or magnetic resonance imaging for early detection of malignancy. The present review addresses the current roles of endoscopy and related techniques in the management of IPMN. The particular focus is on diagnosing IPMN and malignancy within IPMN, detecting pancreatic cancer concomitant with IPMN, differentiating the epithelial subtypes of IPMN, determining the optimal strategy for the management of branch duct IPMN, and discussing innovative endoscopic technology related to IPMN. The disadvantages of endoscopic examinations of IPMN and different attitudes toward EUS-guided fine-needle aspiration for IPMN between Japan (negative) and other countries (active) are also discussed.	[Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 8128582, Japan	Tanaka, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	masaotan@med.kyushu-u.ac.jp					Poley JW, 2009, AM J GASTROENTEROL, V104, P2175, DOI 10.1038/ajg.2009.276; Sadakari Y, 2010, SURGERY, V147, P812, DOI 10.1016/j.surg.2009.11.011; Genevay M, 2011, ANN SURG, V254, P977, DOI 10.1097/SLA.0b013e3182383118; Kanno A, 2010, J GASTROENTEROL, V45, P952, DOI 10.1007/s00535-010-0238-0; Tada M, 2006, CLIN GASTROENTEROL H, V4, P1265, DOI 10.1016/j.cgh.2006.07.013; Tanno S, 2010, PANCREATOLOGY, V10, P173, DOI 10.1159/000231982; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Yamaguchi K, 1997, INT J PANCREATOL, V22, P227; Hibi Y, 2007, PANCREAS, V34, P197, DOI 10.1097/MPA.0b013e31802dea0; Hirooka Y, 2003, J GASTROEN HEPATOL, V18, P1323, DOI 10.1046/j.1440-1746.2003.03040.x; Yopp AC, 2011, ANN SURG, V253, P968, DOI 10.1097/SLA.0b013e318214bcb4; Konda VJA, 2013, ENDOSCOPY, V45, P1006, DOI 10.1055/s-0033-1344714; Ohno E, 2009, ANN SURG, V249, P628, DOI 10.1097/SLA.0b013e3181a189a8; Shi CJ, 2009, CLIN CANCER RES, V15, P7737, DOI 10.1158/1078-0432.CCR-09-0004; Ohtsuka T, 2012, AM J SURG, V204, P44, DOI 10.1016/j.amjsurg.2011.04.007; Bartsch DK, 2013, FAM CANCER, V12, P89, DOI 10.1007/s10689-012-9582-y; Miura T, 2010, DIGEST ENDOSC, V22, P119, DOI 10.1111/j.1443-1661.2010.00926.x; Maguchi H, 2011, PANCREAS, V40, P364, DOI 10.1097/MPA.0b013e31820a5975; Uehara H, 2008, GUT, V57, P1561, DOI 10.1136/gut.2007.145631; Nakata K, 2011, PANCREAS, V40, P581, DOI 10.1097/MPA.0b013e318214fa86; Tanaka M, 1997, GASTROINTEST ENDOSC, V46, P447, DOI 10.1016/S0016-5107(97)70039-7; Hara T, 2013, ANN SURG, V257, P1103, DOI 10.1097/SLA.0b013e318281b824; Yamaguchi K, 2005, PANCREATOLOGY, V5, P416, DOI 10.1159/000086555; Ohno E, 2012, PANCREAS, V41, P855, DOI 10.1097/MPA.0b013e3182480c44; Kang MJ, 2013, PANCREAS, V42, P959, DOI 10.1097/MPA.0b013e31827cddbc; Furukawa T, 2005, VIRCHOWS ARCH, V447, P794, DOI 10.1007/s00428-005-0039-7; Hirono S, 2012, ANN SURG, V255, P517, DOI 10.1097/SLA.0b013e3182444231; Uehara H, 2011, J GASTROENTEROL, V46, P657, DOI 10.1007/s00535-010-0343-0; Yamaguchi K, 2002, PANCREATOLOGY, V2, P484, DOI 10.1159/000064716; Mino-Kenudson M, 2011, GUT, V60, P1712, DOI 10.1136/gut.2010.232272; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Nakai Y, 2012, J PHYSIOL PHARMACOL, V63, P577; Yamaguchi T, 2005, CANCER, V104, P2830, DOI 10.1002/cncr.21565; Ohtsuka T, 2013, J HEPATO-BIL-PAN SCI, V20, P356, DOI 10.1007/s00534-012-0541-7; Tanno S, 2010, PANCREAS, V39, P36, DOI 10.1097/MPA.0b013e3181b91cd0; Ingkakul T, 2010, ANN SURG, V251, P70, DOI 10.1097/SLA.0b013e3181c5ddc3; Yamao K, 2011, PANCREAS, V40, P67, DOI 10.1097/MPA.0b013e3181f749d3; Yoon WJ, 2014, ENDOSCOPY, V46, P382, DOI 10.1055/s-0034-1364937; Jones WB, 2014, AM SURGEON, V80, P746; D'Onofrio M, 2013, J ULTRAS MED, V32, P647; Dumonceau Jean-Marc, 2014, Endoscopy, V46, P799, DOI 10.1055/s-0034-1377875; Ideno N, 2013, ANN SURG, V258, P141, DOI 10.1097/SLA.0b013e31828cd008; Iglesias-Garcia J, 2011, Minerva Gastroenterol Dietol, V57, P205; Ikeuchi N, 2010, WORLD J GASTROENTERO, V16, P1890, DOI 10.3748/wjg.v16.i15.1890; Kamata K, 2014, ENDOSCOPY, V46, P22, DOI 10.1055/s-0033-1353603; Kitano M, 2011, DIGEST ENDOSC, V23, P46, DOI 10.1111/j.1443-1661.2011.01146.x; Mikata R, 2013, J GASTROENTEROL, V48, P866, DOI 10.1007/s00535-012-0684-y; Monzen M, 2013, PANCREATOLOGY, V13, P369, DOI 10.1016/j.pan.2013.06.003; Mori Y, 2014, SURGERY, V155, P67, DOI 10.1016/j.surg.2013.06.059; Nagayoshi Y, 2014, J HEPATO-BIL-PAN SCI, V21, P410, DOI 10.1002/jhbp.44; Ohashi K, 1982, PROG DIG ENDOSC, V20, P348; Ohashi K, 1980, PROG DIG ENDOSC, V17, P261; Ohtsuka T, 2014, WORLD J SURG, V38, P2994, DOI 10.1007/s00268-014-2684-y; Ono J, 2011, CYTOJOURNAL, V8, DOI 10.4103/1742-6413.90084; Pitman MB, 2008, PANCREATOLOGY, V8, P277, DOI 10.1159/000134276; Sai JK, 2009, GASTROINTEST ENDOSC, V69, P434, DOI 10.1016/j.gie.2008.04.050; Sakamoto H, 2009, WORLD J GASTROENTERO, V15, P5489, DOI 10.3748/wjg.15.5489; Tamura Koji, 2013, JOP, V14, P450, DOI 10.6092/1590-8577/1494; Tanaka M, 2011, NAT REV GASTRO HEPAT, V8, P56, DOI 10.1038/nrgastro.2010.193; Tanaka M, 2014, INTRADUCTAL PAPILLAR	60	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	MAY	2015	27	4					450	457		10.1111/den.12434		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG1KL	WOS:000353031400003		
J	Ara, N; Iijima, K; Maejima, R; Kondo, Y; Kusaka, G; Hatta, W; Uno, K; Asano, N; Koike, T; Imatani, A; Shimosegawa, T				Ara, Nobuyuki; Iijima, Katsunori; Maejima, Ryuhei; Kondo, Yutaka; Kusaka, Gen; Hatta, Waku; Uno, Kaname; Asano, Naoki; Koike, Tomoyuki; Imatani, Akira; Shimosegawa, Tooru			Prospective analysis of risk for bleeding after endoscopic biopsy without cessation of antithrombotics in Japan	DIGESTIVE ENDOSCOPY			English	Article						antithrombotic; biopsy; bleeding; complication; endoscopy	ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROMES; ANTICOAGULATED PATIENTS; ATRIAL-FIBRILLATION; RANDOMIZED-TRIALS; STROKE PREVENTION; ISCHEMIC-STROKE; ASPIRIN; THERAPY; DISEASE	Background and AimIn Japan, after the revision of the gastrointestinal endoscopic guidelines for patients taking antithrombotics, endoscopic biopsies were permitted while continuing antithrombotic treatment. However, the risk of bleeding after the biopsy with or without cessation of antithrombotics has not been fully evaluated because bleeding events are very rare. The aim of this prospective study was to evaluate the risk for bleeding after upper gastrointestinal biopsy without cessation of antithrombotics. MethodsConsecutive patients who underwent upper gastrointestinal endoscopic biopsy from December 2011 to March 2014 were enrolled in this study. Antithrombotic medication and its cessation status was checked at enrollment. To confirm bleeding events associated with biopsy, medical examination at the hospital or direct confirmation by telephone was done within 1 month after the biopsy. ResultsAmong the 3758 patients who underwent endoscopic biopsies, 394 patients (10.5%) were medicated with antithrombotics, and 286 of them (72.6% of the total antithrombotics users) did not undergo cessation. Bleeding after the biopsy occurred in six cases (0.15%, 95% CI; 0.09%approximate to 0.22%), but there was only one case that had continued taking antithrombotics. The incidence of bleeding after biopsy was not significantly higher in the patients who had continued taking antithrombotics compared with the others (0.35% vs 0.14%, P=0.38). ConclusionThis prospective study showed that continuation of antithrombotics did not increase the bleeding risk after upper gastrointestinal endoscopic biopsy.	[Ara, Nobuyuki; Iijima, Katsunori; Maejima, Ryuhei; Kondo, Yutaka; Kusaka, Gen; Hatta, Waku; Uno, Kaname; Asano, Naoki; Koike, Tomoyuki; Imatani, Akira; Shimosegawa, Tooru] Tohoku Univ Hosp, Div Gastroenterol, Sendai, Miyagi 9808574, Japan	Ara, N (reprint author), Tohoku Univ Hosp, Div Gastroenterol, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	nobuara@med.tohoku.ac.jp					Witt DM, 2012, ARCH INTERN MED, V172, P1484, DOI 10.1001/archinternmed.2012.4261; Uchiyama S, 2009, J STROKE CEREBROVASC, V18, P482, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.010; Hallas J, 2006, BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; Boustiere C, 2011, ENDOSCOPY, V43, P445, DOI 10.1055/s-0030-1256317; Blacker DJ, 2003, NEUROLOGY, V61, P964; Keeling D, 2011, BRIT J HAEMATOL, V154, P311, DOI 10.1111/j.1365-2141.2011.08753.x; Wahl MJ, 1998, ARCH INTERN MED, V158, P1610, DOI 10.1001/archinte.158.15.1610; Sung JJY, 2010, ANN INTERN MED, V152, P1, DOI 10.7326/0003-4819-152-1-201001050-00179; Yousfi M, 2004, AM J GASTROENTEROL, V99, P1785, DOI 10.1111/j.1572-0241.2004.30368.x; Sieg A, 2001, GASTROINTEST ENDOSC, V53, P620, DOI 10.1067/mge.2001.114422; Sawhney MS, 2008, ENDOSCOPY, V40, P115, DOI 10.1055/s-2007-966959; CHOUDARI CP, 1994, GUT, V35, P464, DOI 10.1136/gut.35.4.464; Veitch AM, 2008, GUT, V57, P1322, DOI 10.1136/gut.2007.142497; Yasue H, 1999, AM J CARDIOL, V83, P1308, DOI 10.1016/S0002-9149(99)00091-0; Sibon I, 2004, NEUROLOGY, V62, P1187; Fujimoto K, 2014, DIGEST ENDOSC, V26, P1, DOI 10.1111/den.12183; De Caterina R, 2012, J AM COLL CARDIOL, V59, P1413, DOI 10.1016/j.jacc.2012.02.008; Broderick JP, 2011, STROKE, V42, P2509, DOI 10.1161/STROKEAHA.110.611905; Hussain N, 2007, ALIMENT PHARM THERAP, V25, P579, DOI 10.1111/j.1365-2036.2006.03225.x; ASoP C, 2009, GASTROINTEST ENDOSC, V70, P1060; Baigent C, 2009, LANCET, V373, P1849, DOI DOI 10.1016/S0140-6736(09)60503-1; Becker RC, 2009, AM J GASTROENTEROL, V104, P2903, DOI 10.1038/ajg.2009.667; Buresly K, 2005, ARCH INTERN MED, V165, P784, DOI 10.1001/archinte.165.7.784; Gerson LB, 2010, GASTROINTEST ENDOSC, V71, P1211, DOI 10.1016/j.gie.2009.12.054; Hankey GJ, 2000, STROKE, V31, P1779; Murasaki Kagari, 2011, Nihon Rinsho, V69 Suppl 9, P567; Ono S, 2011, J GASTROEN HEPATOL, V26, P1434, DOI 10.1111/j.1440-1746.2011.06761.x; Ono S, 2009, J GASTROENTEROL, V44, P1185, DOI 10.1007/s00535-009-0127-6; Ono S, 2012, J GASTROENTEROL, V47, P770, DOI 10.1007/s00535-012-0538-7; Sarkis F, 2013, ENDOSCOPY, V45, P75, DOI 10.1055/s-0032-1325866; Uchiyama S, 2014, CEREBROVASC DIS, V37, P296, DOI 10.1159/000360811; Yamashita K, 2014, ENDOSCOPY, V46, P538, DOI 10.1055/s-0034-1365408; Yusuf S, 2001, NEW ENGL J MED, V345, P494	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	MAY	2015	27	4					458	464		10.1111/den.12407		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG1KL	WOS:000353031400004		
J	Maehata, Y; Esaki, M; Nakamura, S; Hirahashi, M; Ueki, T; Iida, M; Kitazono, T; Matsumoto, T				Maehata, Yuji; Esaki, Motohiro; Nakamura, Shotaro; Hirahashi, Minako; Ueki, Takashi; Iida, Mitsuo; Kitazono, Takanari; Matsumoto, Takayuki			Risk of cancer in the rectal remnant after ileorectal anastomosis in patients with familial adenomatous polyposis: Single center experience	DIGESTIVE ENDOSCOPY			English	Article						cancer in the rectal remnant; congenital hypertrophy of the retinal pigment epithelium; familial adenomatous polyposis; ileal pouch-anal anastomosis; ileorectal anastomosis	POUCH-ANAL ANASTOMOSIS; COLI GARDNERS-SYNDROME; APC GENE-MUTATIONS; SECONDARY PROCTECTOMY; SURGICAL-TREATMENT; COLORECTAL-CANCER; NATURAL-HISTORY; PHENOTYPE; CHOICE; MANIFESTATIONS	Background and AimWe aimed to evaluate the long-term risk of cancer in the rectal remnant in patients with familial adenomatous polyposis after ileorectal anastomosis. MethodsCumulative incidence and clinicopathological characteristics of cancer in the rectal remnant were retrospectively investigated in 27 patients with familial adenomatous polyposis who had undergone ileorectal anastomosis. ResultsDuring the follow-up period ranging from 3.0 to 35.0 years (median, 21.1 years), cancer in the rectal remnant developed in 10 patients. Cumulative risk of cancer in the rectal remnant 30 years after surgery was 57%. Five patients had metastases and three patients died of cancer in the rectal remnant after proctectomy. There was a trend towards a higher incidence of cancer in the rectal remnant in patients with small-intestinal adenoma and congenital hypertrophy of the retinal pigment epithelium. Multivariate analysis revealed that the ocular lesion was an independent risk factor associated with cancer in the rectal remnant. ConclusionSubtotal colectomy with ileorectal anastomosis does not seem to be an appropriate prophylactic surgery in patients with familial adenomatous polyposis.	[Maehata, Yuji; Esaki, Motohiro; Kitazono, Takanari] Kyushu Univ, Dept Med & Clin Sci, Grad Sch Med Sci, Fukuoka 812, Japan; [Hirahashi, Minako] Kyushu Univ, Dept Anat Pathol, Grad Sch Med Sci, Fukuoka 812, Japan; [Ueki, Takashi] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan; [Iida, Mitsuo] Kyushu Cent Hosp, Mutual Aid Assoc, Publ Sch Teachers, Fukuoka, Japan; [Nakamura, Shotaro; Matsumoto, Takayuki] Iwate Med Univ, Sch Med, Dept Internal Med, Div Gastroenterol, Morioka, Iwate 0208505, Japan	Matsumoto, T (reprint author), Iwate Med Univ, Sch Med, Dept Internal Med, Div Gastroenterol, Uchimaru 19-1, Morioka, Iwate 0208505, Japan.	tmatsumo@iwate-med.ac.jp					Soravia C, 1999, DIS COLON RECTUM, V42, P1028, DOI 10.1007/BF02236696; Bulow C, 2000, GASTROENTEROLOGY, V119, P1454, DOI 10.1053/gast.2000.20180; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Vasen HFA, 2008, GUT, V57, DOI 10.1136/gut.2007.136127; Matsumoto T, 2006, J GASTROEN HEPATOL, V21, P251, DOI 10.1111/j.1440-1746.2006.04181.x; IWAMA T, 1993, ANN SURG, V217, P101, DOI 10.1097/00000658-199302000-00002; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Aziz O, 2006, BRIT J SURG, V93, P407, DOI 10.1002/bjs.5276; Rajaratnam SG, 2011, INT J COLORECTAL DIS, V26, P1365, DOI 10.1007/s00384-011-1274-9; Ficari F, 2000, BRIT J CANCER, V82, P348, DOI 10.1054/bjoc.1999.0925; Galiatsatos P, 2006, AM J GASTROENTEROL, V101, P385, DOI 10.1111/j.1572-0241.2006.00375.x; IIDA M, 1985, GASTROENTEROLOGY, V89, P1021; Scheenstra R, 2003, GUT, V52, P898, DOI 10.1136/gut.52.6.898; Bertario L, 2000, ANN SURG, V231, P538, DOI 10.1097/00000658-200004000-00013; Campos FG, 2009, J GASTROINTEST SURG, V13, P129, DOI 10.1007/s11605-008-0606-8; CASPARI R, 1994, LANCET, V343, P629, DOI 10.1016/S0140-6736(94)92634-4; Debinski HS, 1996, GASTROENTEROLOGY, V110, P1028, DOI 10.1053/gast.1996.v110.pm8612989; Douma KFL, 2010, COLORECTAL DIS, V12, P1198, DOI 10.1111/j.1463-1318.2009.02008.x; Enomoto M, 2000, JPN J CLIN ONCOL, V30, P82, DOI 10.1093/jjco/hyd017; Giardiello FM, 1997, GUT, V40, P521; HAMILTON SR, 1992, CANCER, V69, P1589, DOI 10.1002/1097-0142(19920315)69:6+<1589::AID-CNCR2820691314>3.0.CO;2-A; Heinimann K, 2001, CANCER RES, V61, P7616; IIDA M, 1988, CANCER, V61, P605, DOI 10.1002/1097-0142(19880201)61:3<605::AID-CNCR2820610331>3.0.CO;2-L; JAGELMAN DG, 1991, WORLD J SURG, V15, P47; Jang YS, 1997, DIS COLON RECTUM, V40, P312, DOI 10.1007/BF02050421; Koskenvuo L, 2014, INT J COLORECTAL DIS, V29, P225, DOI 10.1007/s00384-013-1796-4; Matsumoto T, 2002, AM J GASTROENTEROL, V97, P180; Matsumoto T, 2008, GASTROINTEST ENDOSC, V68, P911, DOI 10.1016/j.gie.2008.02.067; Matsumoto T, 2000, AM J GASTROENTEROL, V95, P557; MATSUMOTO T, 1994, CANCER, V74, P12, DOI 10.1002/1097-0142(19940701)74:1<12::AID-CNCR2820740104>3.0.CO;2-9; Nieuwenhuis MH, 2009, DIS COLON RECTUM, V52, P1259, DOI 10.1007/DCR.0b013e3181a0d33b; Saito Y, 2002, ENDOSCOPY, V34, P421, DOI 10.1055/s-2002-25288; Sinha A, 2010, BRIT J SURG, V97, P1710, DOI 10.1002/bjs.7202; Valanzano R, 2007, J SURG ONCOL, V95, P28, DOI 10.1002/jso.20672; Vasen HFA, 2001, GUT, V49, P231, DOI 10.1136/gut.49.2.231	35	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	MAY	2015	27	4					471	478		10.1111/den.12414		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG1KL	WOS:000353031400006		
J	Bapaye, A; Itoi, T; Kongkam, P; Dubale, N; Mukai, S				Bapaye, Amol; Itoi, Takao; Kongkam, Pradermchai; Dubale, Nachiket; Mukai, Shuntaro			New fully covered large-bore wide-flare removable metal stent for drainage of pancreatic fluid collections: Results of a multicenter study	DIGESTIVE ENDOSCOPY			English	Article						covered metallic stent; EUS guided transmural drainage; pancreatic fluid collection; pseudocyst; walled off necrosis	GUIDED TRANSMURAL DRAINAGE; RANDOMIZED-TRIAL; PSEUDOCYSTS; EUS; NECROSECTOMY; NECROSIS	Background and AimEndoscopic transmural drainage (ETMD) of peripancreatic fluid collections (PFC) is an effective alternative to surgical drainage. Conventional drainage using plastic stents has its limitations. A wide-bore short-length wide flange fully covered self-expandable metallic stent (FCSEMS) has recently been developed. The present study evaluates the efficacy of this new FCSEMS for ETMD of PFC. MethodsThis was a retrospective, multicenter study. Patients with PFC undergoing endoscopic ultrasound (EUS)-guided drainage of PFC using specially designed FCSEMS were included. Parameters evaluated were technical success of stent placement, clinical success as defined by resolution of PFC without any further surgical intervention, ability to carry out endoscopic necrosectomy, complications and feasibility of endoscopic stent removal. ResultsTwenty-one PFC in 19 patients were drained using FCSEMS. Technical and clinical success for drainage was seen in all patients (100%). Endoscopic necrosectomy was carried out in seven (33%) PFC. Complications occurred in two patients (10.5%). Stents could be endoscopically removed in all patients (100%). ConclusionsThe new specially designed FCSEMS is safe and effective for drainage of PFC. Necrosectomy can be carried out through the stent. Stent can be removed endoscopically at the end of the treatment period.	[Bapaye, Amol; Dubale, Nachiket] Deenanath Mangeshkar Hosp & Res Ctr, Dept Digest Dis & Endoscopy, Pune 411004, Maharashtra, India; [Itoi, Takao; Mukai, Shuntaro] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan; [Kongkam, Pradermchai] Chulalongkorn Univ, Fac Med, King Chulalongkorn Mem Hosp, Dept Internal Med, Bangkok 10330, Thailand	Bapaye, A (reprint author), Deenanath Mangeshkar Hosp & Res Ctr, Dept Digest Dis & Endoscopy, Pune 411004, Maharashtra, India.	amolbapaye@gmail.com					Seifert H, 2009, GUT, V58, P1260, DOI 10.1136/gut.2008.163733; Varadarajulu S, 2011, GASTROINTEST ENDOSC, V74, P74, DOI 10.1016/j.gie.2011.03.1122; Gardner TB, 2009, GASTROINTEST ENDOSC, V69, P1085, DOI 10.1016/j.gie.2008.06.061; Varadarajulu S, 2013, GASTROENTEROLOGY, V145, P583, DOI 10.1053/j.gastro.2013.05.046; Varadarajulu S, 2008, GASTROINTEST ENDOSC, V68, P649, DOI 10.1016/j.gie.2008.02.057; Varadarajulu S, 2008, GASTROINTEST ENDOSC, V68, P1102, DOI 10.1016/j.gie.2008.04.028; Fabbri C, 2012, ENDOSCOPY, V44, P429, DOI 10.1055/s-0031-1291624; Bakker OJ, 2012, JAMA-J AM MED ASSOC, V307, P1053, DOI 10.1001/jama.2012.276; Gornals JB, 2013, SURG ENDOSC, V27, P1428, DOI 10.1007/s00464-012-2591-y; Itoi T, 2013, J HEPATO-BIL-PAN SCI, V20, P403, DOI 10.1007/s00534-012-0551-5; Yamamoto N, 2013, GASTROINTEST ENDOSC, V77, P809, DOI 10.1016/j.gie.2013.01.009; Penn DE, 2012, GASTROINTEST ENDOSC, V76, P679, DOI 10.1016/j.gie.2012.04.457; Baron TH, 2002, GASTROINTEST ENDOSC, V56, P7, DOI 10.1067/mge.2002.125106; Talreja JP, 2008, GASTROINTEST ENDOSC, V68, P1199, DOI 10.1016/j.gie.2008.06.015; Gardner TB, 2011, GASTROINTEST ENDOSC, V73, P718, DOI 10.1016/j.gie.2010.10.053; Park JJ, 2002, GASTROINTEST ENDOSC, V55, P256, DOI 10.1067/mge.2002.120887; Paul N, 2013, GASTROINTEST ENDOSC, V77, pAB374; Tarantino I, 2009, GASTROINTEST ENDOSC, V69, P1401, DOI 10.1016/j.gie.2008.08.018; Tarantino Ilaria, 2012, World J Gastrointest Endosc, V4, P148, DOI 10.4253/wjge.v4.i4.148	19	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	MAY	2015	27	4					499	504		10.1111/den.12421		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG1KL	WOS:000353031400009		
J	Ohtaka, M; Kobayashi, S; Yoshida, T; Yamaguchi, T; Uetake, T; Sato, T; Hayashi, A; Kanai, M; Yamamoto, T; Hatsushika, K; Masuyama, K; Enomoto, N				Ohtaka, Masahiko; Kobayashi, Shouji; Yoshida, Takashi; Yamaguchi, Tatsuya; Uetake, Tomoyosi; Sato, Tadashi; Hayashi, Akira; Kanai, Mari; Yamamoto, Takanori; Hatsushika, Kyosuke; Masuyama, Keisuke; Enomoto, Nobuyuki			Use of Sato's curved laryngoscope and an insulated-tip knife for endoscopic incisional therapy of esophageal web	DIGESTIVE ENDOSCOPY			English	Article						endoscopic incision; esophageal web; insulated-tip knife (IT-knife); radial incision and cutting; Sato's curved laryngoscope	PLUMMER-VINSON-SYNDROME; RADIAL INCISION; CUTTING METHOD; DILATATION; STRICTURE	We experienced two cases of esophageal web accompanying severe stricture that were treated by endoscopic incisions with an insulated-tip knife (IT-knife). With attention paid to the mucosa at the stricture, the lesion was incised with an IT-knife without complications. Sato's curved laryngoscope was used even in cervical esophageal lesions and an excellent field was secured.	[Ohtaka, Masahiko; Kobayashi, Shouji; Yoshida, Takashi; Yamaguchi, Tatsuya; Uetake, Tomoyosi; Sato, Tadashi; Enomoto, Nobuyuki] Univ Yamanashi, Dept Internal Med 1, Chuo Ku, Kofu, Yamanashi 4093898, Japan; [Hayashi, Akira; Kanai, Mari; Yamamoto, Takanori; Hatsushika, Kyosuke; Masuyama, Keisuke] Univ Yamanashi, Dept Otorhinolaryngol, Chuo Ku, Kofu, Yamanashi 4093898, Japan	Ohtaka, M (reprint author), Univ Yamanashi, Dept Internal Med 1, Chuo Ku, 1110 Shimokato, Kofu, Yamanashi 4093898, Japan.	mohtaka@yamanashi.ac.jp					Muto M, 2012, GASTROINTEST ENDOSC, V75, P965, DOI 10.1016/j.gie.2012.01.012; Lee TH, 2009, GASTROINTEST ENDOSC, V69, P1029, DOI 10.1016/j.gie.2008.07.018; Chao HC, 2008, J PEDIATR SURG, V43, DOI 10.1016/j.jpedsurg.2007.08.059; Demirci Fikret, 2005, Turk J Gastroenterol, V16, P224; Dinler G, 2009, TURKISH J PEDIATR, V51, P384; Enomoto M, 2007, J GASTROEN HEPATOL, V22, P2348, DOI 10.1111/j.1440-1746.2006.03430.x; Itaba S, 2008, Endoscopy, V40 Suppl 2, pE198, DOI 10.1055/s-2008-1077424; Kawakubo H, 2010, STOMACH INTESTINE TO, V45, P265; Minamino H, 2013, DIGEST ENDOSC, V25, P200, DOI 10.1111/j.1443-1661.2012.01348.x; Seo Min Ho, 2011, Gastrointest Endosc, V74, P1142, DOI 10.1016/j.gie.2011.06.037	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	MAY	2015	27	4					522	526		10.1111/den.12334		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG1KL	WOS:000353031400012		
J	Yagi, M; Abe, Y; Sasaki, Y; Nomura, E; Sato, T; Iwano, D; Yoshizawa, K; Sakuta, K; Kanno, N; Nishise, S; Ueno, Y				Yagi, Makoto; Abe, Yasuhiko; Sasaki, Yu; Nomura, Eiki; Sato, Takeshi; Iwano, Daisuke; Yoshizawa, Kazuya; Sakuta, Kazuhiro; Kanno, Nana; Nishise, Syouichi; Ueno, Yoshiyuki			Esophageal carcinoid tumor treated by endoscopic resection	DIGESTIVE ENDOSCOPY			English	Article						carcinoid tumor; endoscopic resection; esophagus; magnifying endoscopy; narrow-band imaging (NBI)		The present report describes a rare case of esophageal carcinoid tumor that was treated by endoscopic resection. A 43-year-old woman underwent esophagogastroduodenoscopy at her family clinic for screening of the upper digestive tract and a small lesion resembling a submucosal tumor was detected in the lower esophagus. A biopsy sample from the lesion was diagnosed as esophageal carcinoid tumor and the patient visited our hospital for detailed examination. The tumor was approximately 3mm in diameter and its surface appeared to be covered with normal squamous epithelium. The tumor had a shiny reddish surface without ulceration or erosion. Magnifying endoscopy with narrow-band imaging showed structures resembling reticular vessels under the epithelium. Endoscopic ultrasonography depicted the tumor as a low-echoic mass within the lamina propria. Computed tomography did not detect the tumor and no metastatic lesions were evident in other organs. With the patient's informed consent, the tumor was resected using endoscopic submucosal dissection, with a sufficient free margin in both the vertical and horizontal directions. Magnifying endoscopic examination showed the resected tumor to have abundant reticular vessels. Finally, the tumor was diagnosed immunopathologically as an esophageal carcinoid tumor (neuroendocrine cell tumor, grade 1), without lymphatic or vascular invasion.	[Yagi, Makoto; Abe, Yasuhiko; Sasaki, Yu; Nomura, Eiki; Sato, Takeshi; Iwano, Daisuke; Yoshizawa, Kazuya; Sakuta, Kazuhiro; Kanno, Nana; Nishise, Syouichi; Ueno, Yoshiyuki] Yamagata Univ, Dept Gastroenterol, Fac Med, Yamagata 9909585, Japan	Abe, Y (reprint author), Yamagata Univ, Dept Gastroenterol, Fac Med, 2-2-2 Iidanishi, Yamagata 9909585, Japan.	y-abe@med.id.yamagata-u.ac.jp					Bosman FT, 2010, WHO CLASSIFICATION T; Lindberg GM, 1997, CANCER, V79, P1476, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1476::AID-CNCR5>3.0.CO;2-9; Nakamura M, 1994, PROGR DIG ENDOSC, V4, P123; Oiya Hideto, 2000, Stomach and Intestine (Tokyo), V35, P971; PARTENSKY C, 1993, CANCER, V72, P2320, DOI 10.1002/1097-0142(19931015)72:8<2320::AID-CNCR2820720806>3.0.CO;2-O; Sato T, 2009, GASTROENTEROL ENDOSC, V51, P3078; SHINOHARA M, 1988, Stomach and Intestine (Tokyo), V23, P279; Tanida S, 1998, J GASTROENTEROL, V33, P541, DOI 10.1007/s005350050129; Wakahama O, 2000, GASTROENTEROL ENDOSC, V42, P1058	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	MAY	2015	27	4					527	530		10.1111/den.12385		4	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG1KL	WOS:000353031400013		
J	Urushidani, S; Kuriyama, A				Urushidani, Seigo; Kuriyama, Akira			Dexmedetomidine versus midazolam for gastrointestinal endoscopy	DIGESTIVE ENDOSCOPY			English	Letter							COLONOSCOPY; SEDATION		[Urushidani, Seigo] Kurashiki Cent Hosp, Dept Emergency Med, Kurashiki, Okayama, Japan; [Kuriyama, Akira] Kurashiki Cent Hosp, Dept Gen Med, Kurashiki, Okayama, Japan	Urushidani, S (reprint author), Kurashiki Cent Hosp, Dept Emergency Med, Kurashiki, Okayama, Japan.						Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Jalowiecki P, 2005, ANESTHESIOLOGY, V103, P269, DOI 10.1097/00000542-200508000-00009; Ayazoglu TA, 2013, REV MED CHILE, V141, P477, DOI 10.4067/S0034-98872013000400009; Nishizawa T, 2015, DIGEST ENDOSC, V27, P8, DOI 10.1111/den.12399	4	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	MAY	2015	27	4					532	533		10.1111/den.12447		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG1KL	WOS:000353031400016		
J	Nishizawa, T; Suzuki, H				Nishizawa, Toshihiro; Suzuki, Hidekazu			Reply to Letter: Dexmedetomidine versus midazolam for gastrointestinal endoscopy	DIGESTIVE ENDOSCOPY			English	Letter							METAANALYSIS		[Nishizawa, Toshihiro] Keio Univ, Sch Med, Div Res & Dev Minimally Invas Treatment, Ctr Canc, Tokyo, Japan; [Nishizawa, Toshihiro; Suzuki, Hidekazu] Keio Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Internal Med, Tokyo, Japan	Nishizawa, T (reprint author), Keio Univ, Sch Med, Div Res & Dev Minimally Invas Treatment, Ctr Canc, Tokyo, Japan.		Suzuki, Hidekazu/J-4396-2013				Qadeer MA, 2005, CLIN GASTROENTEROL H, V3, P1049, DOI 10.1053/S1542-3565(05)00742-1; Nishizawa T, 2015, DIGEST ENDOSC, V27, P8, DOI 10.1111/den.12399; Urushidani S, 2015, DIGEST ENDOSC, V27, P532, DOI 10.1111/den.12447; Wang DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053311	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	MAY	2015	27	4					533	533		10.1111/den.12459		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG1KL	WOS:000353031400017		
J	Hayashi, Y; Miura, Y; Yamamoto, H				Hayashi, Yoshikazu; Miura, Yoshimasa; Yamamoto, Hironori			Pocket-creation method for the safe, reliable, and efficient endoscopic submucosal dissection of colorectal lateral spreading tumors	DIGESTIVE ENDOSCOPY			English	Letter							EN-BLOC RESECTION		[Hayashi, Yoshikazu; Miura, Yoshimasa; Yamamoto, Hironori] Jichi Med Univ, Dept Med, Div Gastroenterol, Shimotsuke, Japan	Hayashi, Y (reprint author), Jichi Med Univ, Dept Med, Div Gastroenterol, Shimotsuke, Japan.						Yamamoto H, 2003, ENDOSCOPY, V35, P690; Hayashi Y, 2014, ENDOSCOPY, V46, pE421, DOI 10.1055/s-0034-1377438	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	MAY	2015	27	4					534	535		10.1111/den.12465		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG1KL	WOS:000353031400019		
J	Beppu, N; Matsubara, N; Kakuno, A; Doi, H; Kamikonya, N; Yamanaka, N; Yanagi, H; Tomita, N				Beppu, Naohito; Matsubara, Nagahide; Kakuno, Ayako; Doi, Hiroshi; Kamikonya, Norihiko; Yamanaka, Naoki; Yanagi, Hidenori; Tomita, Naohiro			Feasibility of Modified Short-Course Radiotherapy Combined With a Chemoradiosensitizer for T3 Rectal Cancer	DISEASES OF THE COLON & RECTUM			English	Article						Rectal cancer; Short-course radiotherapy with delayed surgery; Chemoradiosensitizer	COURSE PREOPERATIVE RADIOTHERAPY; FRACTIONATED STEREOTACTIC RADIOTHERAPY; LOW ANTERIOR RESECTION; MULTICENTRIC PHASE-II; CELL LUNG-CANCER; QUALITY-OF-LIFE; RADIATION-THERAPY; RANDOMIZED-TRIAL; DELAYED SURGERY; NECK-CANCER	BACKGROUND: 5-Fluorouracil-based chemotherapy is considered to be a radiosensitizer; however, conventional short-course radiotherapy combined with chemotherapy is generally thought to not be feasible because of the prevalence of side effects. OBJECTIVE: The aim of this study was to evaluate the feasibility of modified short-course radiotherapy combined with a chemoradiosensitizer for T3 rectal cancer. DESIGN AND SETTINGS: This study was retrospective in nature and used a prospectively collected database. PATIENTS: Patients with T3 rectal cancer located below the peritoneum reflection were selected. INTERVENTIONS: A total dose of 25 Gy of radiotherapy was administered in 10 fractions of 2.5 Gy each for 5 days. Radiotherapy was performed with S-1 as a radiosensitizer from day 1 to day 10. Surgery was targeted to be performed 4 weeks after radiotherapy. MAIN OUTCOME MEASUREMENTS: The morbidity, sphincter-preserving rate, anal function, and long-term outcomes were assessed. RESULTS: All patients (n = 170) completed the radiotherapy regimen and 166 (97.6%) completed the combination regimen with chemotherapy. A total of 149 patients (87.6%) had sphincter-preserving surgery (double stapling technique (DST), 58 patients; intersphincteric resection (ISR), 91 patients), and postoperative complications were relatively mild (anastomotic leakage, 15.4%; intra-abdominal infection, 8.2%). Among those undergoing sphincter preserving surgery, the 5-year local relapse-free survival rate was 94.3% in the DST group, and 89.8% in the ISR group. With respect to the anal function, the Wexner score the first year after stoma closure for the double-stapling technique group was 6 and that for intersphincteric resection was 15; however, the score for the intersphincteric resection group was improved to 8 at 4 years after stoma closure. LIMITATIONS: This study had limitations because it was an uncontrolled, 1-arm, retrospective review with a small sample size. CONCLUSIONS: Modified short-course radiotherapy combined with chemoradiosensitizer is a feasible approach for treating T3 rectal cancer. With the use of the short-course approach, efforts to reduce the incidence of side effects by appropriately prolonging the waiting period enable the administration of combination treatment with short-course radiotherapy and chemotherapy.	[Beppu, Naohito; Matsubara, Nagahide; Tomita, Naohiro] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; [Kakuno, Ayako] Meiwa Hosp, Dept Pathol, Nishinomiya, Hyogo, Japan; [Doi, Hiroshi; Kamikonya, Norihiko] Hyogo Coll Med, Dept Radiol, Nishinomiya, Hyogo 6638501, Japan; [Yamanaka, Naoki; Yanagi, Hidenori] Meiwa Hosp, Dept Surg, Nishinomiya, Hyogo, Japan	Beppu, N (reprint author), Hyogo Coll Med, Dept Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	beppu-n@hyo-med.ac.jp					Kim TH, 2008, ANN SURG ONCOL, V15, P729, DOI 10.1245/s10434-007-9696-x; Coucke PA, 2006, ACTA ONCOL, V45, P1086, DOI 10.1080/02841860600891317; Gerard JP, 2004, J CLIN ONCOL, V22, P2404, DOI 10.1200/JCO.2004.08.170; Marijnen CAM, 2001, J CLIN ONCOL, V19, P1976; [Anonymous], 2006, COMMON TERMINOLOGY C; Shirao K, 2004, CANCER, V100, P2355, DOI 10.1002/cncr.20277; Pettersson D, 2010, BRIT J SURG, V97, P580, DOI 10.1002/bjs.6914; Marijnen CAM, 2005, J CLIN ONCOL, V23, P1847, DOI 10.1200/JCO.2005.05.256; Fokas E, 2013, INT J RADIAT ONCOL, V87, P992, DOI 10.1016/j.ijrobp.2013.09.011; Temple LK, 2009, ANN SURG, V250, P260, DOI 10.1097/SLA.0b013e3181ae330e; Lagerwaard FJ, 2008, INT J RADIAT ONCOL, V70, P685, DOI 10.1016/j.ijrobp.2007.10.053; Ceelen W, 2009, INT J CANCER, V124, P2966, DOI 10.1002/ijc.24247; Rullier E, 2013, DIS COLON RECTUM, V56, P560, DOI 10.1097/DCR.0b013e31827c4a8c; Peeters KCMJ, 2005, J CLIN ONCOL, V23, P6199, DOI 10.1200/JCO.2005.14.779; Pettersson D, 2013, BRIT J SURG, V100, P969, DOI 10.1002/bjs.9117; Rothbarth J, 2001, DIS COLON RECTUM, V44, P67, DOI 10.1007/BF02234823; Roh KW, 2009, INT J RADIAT ONCOL, V74, P1348, DOI 10.1016/j.ijrobp.2008.10.013; Widder J, 2005, BRIT J CANCER, V92, P1209, DOI 10.1038/sj.bjc.6602485; Landry JC, 2013, CANCER-AM CANCER SOC, V119, P1521, DOI 10.1002/cncr.27890; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Minsky BD, 2012, J CLIN ONCOL, V30, P3777, DOI 10.1200/JCO.2012.45.0551; Marechal R, 2012, ANN ONCOL, V23, P1525, DOI 10.1093/annonc/mdr473; Hatfield P, 2009, RADIOTHER ONCOL, V92, P210, DOI 10.1016/j.radonc.2009.04.007; Unger KR, 2010, INT J RADIAT ONCOL, V77, P1411, DOI 10.1016/j.ijrobp.2009.06.070; Pettersson D, 2012, BRIT J SURG, V99, P577, DOI 10.1002/bjs.7796; Doi H, 2013, J RADIAT RES, V54, P1118, DOI 10.1093/jrr/rrt058; Emmertsen KJ, 2012, ANN SURG, V255, P922, DOI 10.1097/SLA.0b013e31824f1c21; Francois Y, 1999, J CLIN ONCOL, V17, P2396; Birgisson H, 2005, J CLIN ONCOL, V23, P8697, DOI 10.1200/JCO-2005.02.9017; Das P, 2010, INT J RADIAT ONCOL, V77, P60, DOI 10.1016/j.ijrobp.2009.04.056; Faria S, 2014, COLORECTAL DIS, V16, pO66, DOI 10.1111/codi.12466; Fokstuen T, 2009, RADIOTHER ONCOL, V93, P293, DOI 10.1016/j.radonc.2009.08.034; Hartley A, 2003, EUR J SURG ONCOL, V29, P155, DOI 10.1053/ejso.2002.1364; Hartley A, 2002, BRIT J SURG, V89, P889, DOI 10.1046/j.1365-2168.2002.02136.x; Inomata M, 2013, JPN J CLIN ONCOL, V43, P321, DOI 10.1093/jjco/hys219; Japanese Society for Cancer of the Colon and Rectum, 2006, GEN RUL CLIN PATH ST; Matsuyama T, 2013, INT J RADIAT ONCOL, V85, P984, DOI 10.1016/j.ijrobp.2012.09.008; Morimoto S, 2012, HEPATO-GASTROENTEROL, V59, P1428, DOI 10.5754/hge11699; Nilsson PJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-279; Park JS, 2007, INT J COLORECTAL DIS, V22, P1319, DOI 10.1007/s00384-007-0335-6; Sadahiro S, 2011, ONCOLOGY-BASEL, V81, P306, DOI 10.1159/000334580; Valentini V, 2006, INT J RADIAT ONCOL, V64, P1129, DOI 10.1016/j.ijrobp.2005.09.017; Wada H, 2013, INT J CLIN ONCOL, V18, P273, DOI 10.1007/s10147-012-0375-y	43	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0012-3706	1530-0358		DIS COLON RECTUM	Dis. Colon Rectum	MAY	2015	58	5					479	487		10.1097/DCR.0000000000000323		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF6CB	WOS:000352643100489		
J	Saito, O				Saito, Osamu			Growth and inequality in the great and little divergence debate: a Japanese perspective	ECONOMIC HISTORY REVIEW			English	Article							INCOME-DISTRIBUTION; TOKUGAWA JAPAN; INDIA; PRICES; WAGES; GLOBALIZATION; POVERTY; ECONOMY; EUROPE; STATE	This article addresses the question of growth and inequality in the great and little divergence trajectories on both sides of Eurasia. A social table constructed for Tokugawa Japan in the 1840s is compared with two cases with high levels of inequality, Stuart England and Mughal India, and the subsequent changes in the three countries are traced to the modern era of the nineteenth and early twentieth centuries. The Japanese pattern in the early modern period can be characterized by comparatively modest growth with a relatively egalitarian distribution of income between the social classes, but the pattern changed during the subsequent half-century to one with an increased tempo of growth and a substantial rise in the level of income inequality. The implications of this finding are discussed in terms of the concept of Smithian growth and are placed in the comparative context of the divergence debate.	Hitotsubashi Univ, Tokyo, Japan	Saito, O (reprint author), Hitotsubashi Univ, Tokyo, Japan.						Akimoto H., 1987, ZEN KOGYOKA JIDAI NO; Alfani G, 2010, J INTERDISCIPL HIST, V40, P513, DOI 10.1162/jinh.2010.40.4.513; Allen R. C., 2005, LIVING STANDARDS NEW, P111; Allen RC, 2001, EXPLOR ECON HIST, V38, P411, DOI 10.1006/exeh.2001.0775; Allen RC, 2011, ECON HIST REV, V64, P8, DOI 10.1111/j.1468-0289.2010.00515.x; Kuznets S, 1955, AM ECON REV, V45, P1; Roy T, 2008, J GLOBAL HIST, V3, P361, DOI 10.1017/S1740022808002763; Bassino JP, 2005, RES ECON HIST, V23, P229; Booth A., 1985, LABOUR ABSORPTION IN; Broadberry S., EXPLORATIONS IN ECON; Chang C.-L., 1962, THE INCOME OF THE CH; Crafts N., 2004, THE CAMBRIDGE ECONOM, V2, P1; Daunton M., 2007, WEALTH AND WELFARE A; Eisei-kyoku [Bureau of Public Health], 1883, TOSHI SEISHI KONIN T; Francks P., 2006, RURAL ECONOMIC DEVEL; Fujino T., 1982, KOKURITSU MINZOKUGAK, V7, P632; Hatton TJ, 1998, OXFORD ECON PAP, V50, P574, DOI 10.1093/oep/50.4.574; Hayami Y., 1973, NIHON NOGYO NO SEICH; Hayami Y., 1969, AGRICULTURE ECONOMIC, P105; King G., 1973, NATURAL AND POLITICA; Kishimoto Mio, 2011, LAW LONG TERM EC CHA, P68; Koseki-kyoku [Bureau of Family Registration], 1882, NIHON ZENKOKU JINKO; Laslett P., 1983, THE WORLD WE HAVE LO; Li B., 2005, LIVING STANDARDS PAS, P55; Li B., 1998, AGRICULTURAL DEVELOP; Lindert P., 2004, GROWING PUBLIC SOCIA, V1; LINDERT PH, 1985, EXPLOR ECON HIST, V22, P341, DOI 10.1016/0014-4983(85)90001-4; Ma D., 2011, LAW LONG TERM EC CHA, P46; Ma D., 2004, AUSTR EC HIST REV, V44, P259, DOI 10.1111/j.1467-8446.2004.00121.x; Maddison A., 2001, THE WORLD ECONOMY A; Maddison A., 1971, CLASS STRUCTURE AND; Maddison A., 2006, THE WORLD ECONOMY HI; Maddison A., 1995, MONITORING THE WORLD; Mathews R. C. O., 1982, BRITISH ECONOMIC GRO; Middleton R., 2004, THE CAMBRIDGE ECONOM, V2, P456; Milanovic B., 2010, ECONOMIC JOURNAL, V121, P255; Minami R, 1998, CAMBRIDGE J ECON, V22, P39; Moriguchi C, 2008, REV ECON STAT, V90, P713, DOI 10.1162/rest.90.4.713; MOSK C, 1978, EXPLOR ECON HIST, V15, P269, DOI 10.1016/0014-4983(78)90011-6; Nakamura T., 1971, ECONOMIC GROWTH IN P; Nishikawa S., 1987, EC STUDIES Q, V38, P323; Nishikawa S, 1977, ATARASHII EDO JIDAIS, P101; Nishikawa S., 2012, CHOSHU NO KEIZAI KOZ; Nishikawa S., 1986, JAPAN IN TRANSITION, P421; NISHIKAWA S, 1978, EXPLOR ECON HIST, V15, P69, DOI 10.1016/0014-4983(78)90038-4; OJHA PD, 1964, AM ECON REV, V54, P711; Ozeki M., 2009, THESIS; Phelps Brown H, 1977, THE INEQUALITY OF PA; Pomeranz K, 2005, LIVING STANDARDS NEW, P23; Pomeranz Kenneth, 2000, GREAT DIVERGENCE; Rath E. C., 2008, EARLY MODERN JAPAN I, V16, P43; Roy T, 2005, RETHINKING ECONOMIC; Roy T, 2007, AUST ECON HIST REV, V47, P73, DOI 10.1111/j.1467-8446.2006.00197.x; Roy T, 2006, THE ECONOMIC HISTORY; Royal Commission on the Distribution of Income and Wealth, 1977, THIRD REPORT ON THE; Saito O., 2007, KEIZAI KENKYU, V58, P289; Saito O, 2010, AUST ECON HIST REV, V50, P240, DOI 10.1111/j.1467-8446.2010.00304.x; Saito O, 2005, LIVING STANDARDS PAS, P77; Saito O, 2009, CONTINUITY CHANGE, V24, P169, DOI 10.1017/S0268416009007061; Saito O, 2014, ROUTL STUD MOD WORLD, V126, P23; Saito O., 2004, THE ECONOMIC HISTORY, V1, P268; Saito O., 2013, LABOUR INTENSIVE IND, P85; Smith A., 1976, AN ENQUIRY INTO THE; Smith T. C., 1988, NATIVE SOURCES OF JA; van Zanden J. L., 2009, THE LONG ROAD TO THE; VANZANDEN JL, 1995, ECON HIST REV, V48, P643, DOI 10.1111/j.1468-0289.1995.tb01437.x; Wataya T., 1959, NIHON SHIHONSHUGI TO, P191; Williamson J. G., 2000, ASIA PACIFIC DYNAMIS, P13; Williamson J. G., 1985, DID BRITISH CAPITALI; Williamson JG, 2002, J ECON HIST, V62, P55	70	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-0117	1468-0289		ECON HIST REV	Econ. Hist. Rev.	MAY	2015	68	2					399	419		10.1111/ehr.12071		21	Economics; History; History Of Social Sciences	Business & Economics; History; Social Sciences - Other Topics	CF4DJ	WOS:000352498500002		
J	Kozak, D; Panigrahi, M; Grabda, M; Shibata, E; Nakamura, T				Kozak, Dmytro; Panigrahi, Mrutyunjay; Grabda, Mariusz; Shibata, Etsuro; Nakamura, Takashi			Ferrocene redox in trihexyl(tetradecyl)phosphonium bis-2,4,4-(trimethylpentyl) phosphinate (Cyphos IL-104)/ethanol at glassy carbon and platinum working electrodes	ELECTROCHIMICA ACTA			English	Article						Cyclic voltammetry; Cyphos IL-104; ethanol; ferrocene; glassy carbon and platinum working; electrodes; silver and platinum reference electrodes	PHOSPHONIUM IONIC LIQUIDS; EXTRACTION; RECOVERY; REMOVAL; ACID	The redox of ferrocen couple (Fc(+)/Fc) in the 1 M Cyphos IL-104/ethanol electrolyte system was studied via cyclic voltammetry under both inert and air atmospheres at room temperature. The anodic and cathodic peak potentials for Fc(+)/Fc were obtained at scan rates of 0.02, 0.1, and 0.2 V/s. The half-potential of Fc(+)/Fc versus a silver quasi-reference electrode (QAg) changed from 0.80969 to 0.84945 V and from 0.79872 to 0.8627 V at the glassy-carbon (GC)- and platinum (Pt)-working electrodes (WE), respectively, demonstrating that it depended on the presence of water from 0.1 to 0.3 wt.% in the 1 M Cyphos IL-104/ethanol electrolyte system. The half-potential of Fc(+)/Fc versus quasi-platinum (QPt) was not changed for both working electrodes and for the same solutions; the differences between the half-potentials of Fc(+)/Fc versus QPt were 0.0022 and 0.00416 V at the GC-and Pt-WEs, respectively. (C) 2015 Elsevier Ltd. All rights reserved.	[Kozak, Dmytro; Panigrahi, Mrutyunjay; Grabda, Mariusz; Shibata, Etsuro; Nakamura, Takashi] Tohoku Univ, IMRAM, Aoba Ku, Sendai, Miyagi 9808577, Japan	Kozak, D (reprint author), Tohoku Univ, IMRAM, Aoba Ku, 1,1 Katahira,2 Chome, Sendai, Miyagi 9808577, Japan.	dm.s.kozak@gmail.com			High Efficiency Rare Elements Extraction Technology Area in the Tohoku Innovative Materials Technology Initiatives for Reconstruction from Ministry of Education, Culture, Sports, Science and Technology in Japan	This study was supported by the High Efficiency Rare Elements Extraction Technology Area in the Tohoku Innovative Materials Technology Initiatives for Reconstruction from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Castillo J, 2014, HYDROMETALLURGY, V141, P89, DOI 10.1016/j.hydromet.2013.11.001; Neves CMSS, 2011, GREEN CHEM, V13, P1517, DOI 10.1039/c1gc15079k; Oliveira FS, 2012, SEP PURIF TECHNOL, V85, P137, DOI 10.1016/j.seppur.2011.10.002; Yu B, 2012, WEAR, V289, P58, DOI 10.1016/j.wear.2012.04.015; Guo L, 2011, J MEMBRANE SCI, V372, P314, DOI 10.1016/j.memsci.2011.02.014; Tsierkezos NG, 2007, J SOLUTION CHEM, V36, P289, DOI 10.1007/s10953-006-9119-9; Regel-Rosocka M, 2012, SEP PURIF TECHNOL, V97, P158, DOI 10.1016/j.seppur.2012.01.035; Martak J, 2007, SEP PURIF TECHNOL, V57, P483, DOI 10.1016/j.seppur.2006.09.013; Liu Y, 2009, IND ENG CHEM RES, V48, P7308, DOI 10.1021/ie900468c; Rabari D, 2013, FLUID PHASE EQUILIBR, V355, P26, DOI 10.1016/j.fluid.2013.06.047; Dharaskar SA, 2014, FUEL PROCESS TECHNOL, V123, P1, DOI 10.1016/j.fuproc.2014.02.001; Ionkin AS, 2014, SOL ENERG MAT SOL C, V124, P39, DOI 10.1016/j.solmat.2014.01.022; Garcia-Chavez LY, 2012, SEP PURIF TECHNOL, V97, P2, DOI 10.1016/j.seppur.2011.11.041; Fraser KJ, 2009, AUST J CHEM, V62, P309, DOI 10.1071/CH08558; Cieszynska A, 2012, HYDROMETALLURGY, V113, P79, DOI 10.1016/j.hydromet.2011.12.006; Cieszynska Anna, 2012, SEP PURIF TECHNOL, V80, P385; Duffy NW, 2006, ELECTROCHEM COMMUN, V8, P892, DOI 10.1016/j.elecom.2006.03.036; Fortuny Agusti, 2012, PROCEDIA ENG, V44, P807; Kalviri HA, 2011, GREEN CHEM, V13, P681, DOI 10.1039/c0gc00851f; Latham JA, 2011, ELECTROCHIM ACTA, V56, P5328, DOI 10.1016/j.electacta.2011.03.142; ousfi Mohamed, 2014, CHEM ENG J, V255, P513; Yang XY, 2012, T NONFERR METAL SOC, V22, P3126, DOI 10.1016/S1003-6326(12)61764-6	22	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	MAY 1	2015	163						41	47		10.1016/j.electacta.2015.02.138		7	Electrochemistry	Electrochemistry	CF4CR	WOS:000352496700006		
J	Sakamoto, T; Matsumura, D; Asazawa, K; Martinez, U; Serov, A; Artyushkova, K; Atanassov, P; Tamura, K; Nishihata, Y; Tanaka, H				Sakamoto, Tomokazu; Matsumura, Daiju; Asazawa, Koichiro; Martinez, Ulises; Serov, Alexey; Artyushkova, Kateryna; Atanassov, Plamen; Tamura, Kazuhisa; Nishihata, Yasuo; Tanaka, Hirohisa			Operando XAFS study of carbon supported Ni, NiZn, and Co catalysts for hydrazine electrooxidation for use in anion exchange membrane fuel cells	ELECTROCHIMICA ACTA			English	Article						Operando XAFS; Anion exchange membrane fuel cells; Hydrazine electrooxidation catalyst	X-RAY-ABSORPTION; OXYGEN REDUCTION REACTION; IN-SITU XANES; CATHODE CATALYSTS; METHANOL; ELECTROCATALYSTS; SPECTROSCOPY; BOROHYDRIDE; PLATINUM; ANODE	Carbon supported Ni, Ni0.87Zn0.13, and Co hydrazine electrooxidation catalysts were synthesized by an impregnation/freeze-drying procedure followed by thermal annealing for use as anode catalyst of direct hydrazine hydrate fuel cells (DHFCs). The cell performance of DHFCs changed significantly when different catalysts were used as anode. Ammonia generation from anode outlet at open circuit voltage (OCV) condition was higher for Co/C than for Ni-based catalysts. To better understand the cause of different performance and selectivity of each anode catalyst, extensive ex-situ and operando characterization was carried out. Operando XAFS measurement of Ni-K and Co-K edge shows the potential dependence of atomic structure of Ni/C, Ni0.87Zn0.13/C, and Co/C during hydrazine electrooxidation reaction. (C) 2015 Elsevier Ltd. All rights reserved.	[Sakamoto, Tomokazu; Asazawa, Koichiro; Tanaka, Hirohisa] Daihatsu Motor Co Ltd, R&D Div, Shiga 5202593, Japan; [Sakamoto, Tomokazu; Asazawa, Koichiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Matsumura, Daiju; Tamura, Kazuhisa; Nishihata, Yasuo] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Sayo, Hyogo 6795148, Japan; [Martinez, Ulises; Serov, Alexey; Artyushkova, Kateryna; Atanassov, Plamen] Univ New Mexico, Dept Chem & Nucl Engn, Ctr Emerging Energy Technol, Albuquerque, NM 87131 USA	Atanassov, P (reprint author), Univ New Mexico, Dept Chem & Nucl Engn, Ctr Emerging Energy Technol, Albuquerque, NM 87131 USA.	plamen@unm.edu	Artyushkova, Kateryna/B-4709-2008	Artyushkova, Kateryna/0000-0002-2611-0422			Sakamoto T, 2013, J POWER SOURCES, V234, P252, DOI 10.1016/j.jpowsour.2013.01.181; Suzuki S, 2012, J POWER SOURCES, V208, P257, DOI 10.1016/j.jpowsour.2012.02.043; Sakamoto T, 2014, J POWER SOURCES, V247, P605, DOI 10.1016/j.jpowsour.2013.08.107; Ren XM, 2000, J POWER SOURCES, V86, P111, DOI 10.1016/S0378-7753(99)00407-3; Serov A, 2012, APPL CATAL B-ENVIRON, V127, P300, DOI 10.1016/j.apcatb.2012.08.040; Lomocso TL, 2011, ELECTROCHIM ACTA, V56, P8551, DOI 10.1016/j.electacta.2011.07.041; Pylypenko S, 2008, ELECTROCHIM ACTA, V53, P7875, DOI 10.1016/j.electacta.2008.05.047; Serov A, 2012, ELECTROCHEM COMMUN, V22, P193, DOI 10.1016/j.elecom.2012.06.023; Robson MH, 2013, ELECTROCHIM ACTA, V90, P656, DOI 10.1016/j.electacta.2012.11.025; Fujiwara N, 2007, J POWER SOURCES, V164, P457, DOI 10.1016/j.jpowsour.2006.10.08; Li ZP, 2004, J POWER SOURCES, V126, P28, DOI 10.1016/j.jpowsour.2003.08.017; Yin WX, 2008, J POWER SOURCES, V182, P520, DOI 10.1016/j.jpowsour.2008.04.028; Ye LQ, 2011, J POWER SOURCES, V196, P956, DOI 10.1016/j.jpowsour.2010.08.089; Yang HD, 2012, RSC ADV, V2, P5038, DOI 10.1039/c2ra01346k; Dixon D, 2012, J PHYS CHEM C, V116, P7587, DOI 10.1021/jp211321u; WATANABE M, 1987, J ELECTROANAL CHEM, V229, P395, DOI 10.1016/0022-0728(87)85156-2; Gyenge E, 2004, ELECTROCHIM ACTA, V49, P965, DOI 10.1016/j.electa.2003.10.008; Yamada K, 2003, J POWER SOURCES, V115, P236, DOI 10.1016/S0378-7753(03)00008-9; Falase A, 2012, ELECTROCHIM ACTA, V66, P295, DOI 10.1016/j.electacta.2012.01.096; Asazawa K, 2007, ANGEW CHEM INT EDIT, V46, P8024, DOI 10.1002/anie.200701334; Granot E, 2012, J POWER SOURCES, V204, P116, DOI 10.1016/j.jpowsour.2011.12.008; Serov A, 2013, ELECTROCHIM ACTA, V109, P433, DOI 10.1016/j.electacta.2013.07.104; Scott FJ, 2010, J PHYS CHEM C, V114, P442, DOI 10.1021/jp908582r; Serov A, 2013, ELECTROCHEM COMMUN, V34, P185, DOI 10.1016/j.elecom.2013.06.003; Brocato S, 2013, ELECTROCHIM ACTA, V87, P361, DOI 10.1016/j.electacta.2012.09.053; Kobayashi M, 2011, J POWER SOURCES, V196, P8346, DOI 10.1016/j.jpowsour.2011.06.062; Serov A, 2010, APPL CATAL B-ENVIRON, V98, P1, DOI 10.1016/j.apcatb.2010.05.005; Tada M, 2007, ANGEW CHEM INT EDIT, V46, P4310, DOI 10.1002/anie.200604732; Martinez U, 2012, PHYS CHEM CHEM PHYS, V14, P5512, DOI 10.1039/c2cp40546f; Qian WM, 2006, J POWER SOURCES, V154, P202, DOI 10.1016/j.jpowsour.2005.12.019; Serov A, 2012, ELECTROCHEM COMMUN, V22, P53, DOI 10.1016/j.elecom.2012.04.029; Melke J, 2010, J PHYS CHEM C, V114, P5914, DOI 10.1021/jp909342w; Serov A, 2012, ELECTROCHIM ACTA, V80, P213, DOI 10.1016/j.electacta.2012.07.008; Ziegelbauer JM, 2008, J PHYS CHEM C, V112, P8839, DOI 10.1021/jp8001564; MUKERJEE S, 1995, J ELECTROCHEM SOC, V142, P1409, DOI 10.1149/1.2048590; Serov A, 2013, J MATER CHEM A, V1, P14384, DOI 10.1039/c3ta13457a; Asazawa K, 2009, J ELECTROCHEM SOC, V156, pB509, DOI 10.1149/1.3082129; Chinchilla J. S., 2011, J AM CHEM SOC, V133, P5425; Guo JS, 2007, J POWER SOURCES, V168, P299, DOI 10.1016/j.jpowsour.2007.02.085; Lewis EA, 2011, ELECTROCHIM ACTA, V56, P8827, DOI 10.1016/j.electacta.2011.07.091; Qingfeng Y., 2010, RARE METALS, V29, P26; Sakamoto T, 2011, CATAL TODAY, V164, P181, DOI 10.1016/j.cattod.2010.11.012; Sakamoto T, 2014, J POWER SOURCES, V252, P35, DOI 10.1016/j.jpowsour.2013.11.108; SCHMIDT TJ, 1999, J ELECTROCHEM COMMUN, V1, P1; Serov A., 2014, ADV ENERGY MAT, V4; Serov A., 2014, ANGEW CHEM INT EDIT, V126, P10504; Shyam B, 2009, J PHYS CHEM C, V113, P19713, DOI 10.1021/jp905383n; Song SQ, 2005, APPL CATAL B-ENVIRON, V55, P65, DOI 10.1016/j.apcatb.2004.05.017; Strasser P, 2008, J COMB CHEM, V10, P216, DOI 10.1021/cc700166p	49	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	MAY 1	2015	163						116	122		10.1016/j.electacta.2015.02.156		7	Electrochemistry	Electrochemistry	CF4CR	WOS:000352496700016		
J	Lee, KM; Tanaka, H; Takahashi, A; Kim, KH; Kawamura, M; Abe, Y; Kawamoto, T				Lee, Kyoung-Moo; Tanaka, Hisashi; Takahashi, Akira; Kim, Kyung Ho; Kawamura, Midori; Abe, Yoshio; Kawamoto, Tohru			Accelerated coloration of electrochromic device with the counter electrode of nanoparticulate Prussian blue-type complexes	ELECTROCHIMICA ACTA			English	Article						Electrochromic device; Nanoparticle; Zinc hexacyanoferrate; Response time; Counter electrode	ACTIVE-MATRIX DISPLAYS; THIN-FILM; CESIUM; IMMOBILIZATION; TRANSITION; CYANIDES; WINDOWS; WATERS; PAPER	Improvement of the color-switching response of an electrochromic device (ECD) is achieved using nanoparticles of Prussian blue (iron hexacyanoferrate, FeHCF-NPs) and of zinc hexacyanoferrate (ZnHCF-NPs) using size-control of ZnHCF-NP by the nanoparticle classification. Using the centrifuge method, ZnHCF is classified into three groups with average particle sizes of 59 nm, 71 nm, and 214 nm. The maximum transmittance contrast Delta T-max of a FeHCF/ZnHCF ECD is blue-to-colorless with -ca. 60%, irrespective of the ZnHCF-NP used. However, the response time for coloration of the ECD with the smallest ZnHCF-NPs is only 13% of that of other ECDs with the largest ZnHCF-NPs, although the response time of the electrode with the smallest ZnHCF-NP electrode remains 65 % and 79 % of the largest case for oxidation and reduction, respectively. Because the applied voltage is limited to avoid the side reaction in the coloration of the ECD, the acceleration of the electrochemical response by the downsizing of ZnHCF-NPs leads the drastic change in the coloration speed. Published by Elsevier Ltd.	[Lee, Kyoung-Moo; Tanaka, Hisashi; Takahashi, Akira; Kawamoto, Tohru] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki 3058565, Japan; [Kim, Kyung Ho; Kawamura, Midori; Abe, Yoshio] Kitami Inst Technol, Dept Mat Sci & Engn, Kitami, Hokkaido 0908507, Japan	Kawamoto, T (reprint author), Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, 1-1-1Higashi, Tsukuba, Ibaraki 3058565, Japan.	tohru.kawamoto@aist.go.jp	Kawamoto, Tohru/B-7145-2008	Kawamoto, Tohru/0000-0002-3984-2980			Kraft A, 2009, SOL ENERG MAT SOL C, V93, P2088, DOI 10.1016/j.solmat.2009.05.010; Ishizaki M, 2012, GREEN CHEM, V14, P1537, DOI 10.1039/c2gc35079c; BUSER HJ, 1977, INORG CHEM, V16, P2704, DOI 10.1021/ic50177a008; KARYAKIN AA, 1995, ANAL CHEM, V67, P2419, DOI 10.1021/ac00110a016; Andersson P, 2002, ADV MATER, V14, P1460, DOI 10.1002/1521-4095(20021016)14:20<1460::AID-ADMA1460>3.0.CO;2-S; Heikenfeld J, 2011, J SOC INF DISPLAY, V19, P129, DOI 10.1889/JSID19.2.129; Hara S, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.104002; Kitajima A, 2014, ENVIRON SCI-PROC IMP, V16, P28, DOI 10.1039/c3em00416c; LAMPERT CM, 1984, SOL ENERG MATER, V11, P1, DOI 10.1016/0165-1633(84)90024-8; Sato O, 1996, SCIENCE, V272, P704, DOI 10.1126/science.272.5262.704; Kuo TH, 2009, SOL ENERG MAT SOL C, V93, P1755, DOI 10.1016/j.solmat.2009.06.003; NEFF VD, 1978, J ELECTROCHEM SOC, V125, P886, DOI 10.1149/1.2131575; KOBAYASHI T, 1984, J ELECTROANAL CHEM, V161, P419, DOI 10.1016/S0022-0728(84)80201-6; Liu X, 2014, BIORESOURCE TECHNOL, V160, P142, DOI 10.1016/j.biortech.2014.01.012; ITAYA K, 1982, J APPL PHYS, V53, P804, DOI 10.1063/1.329997; Cheng KC, 2007, ELECTROCHIM ACTA, V52, P3330, DOI 10.1016/j.electacta.2006.10.012; Hara S, 2007, JPN J APPL PHYS 2, V46, pL945, DOI 10.1143/JJAP.46.L945; Hong SF, 2012, SOL ENERG MAT SOL C, V104, P64, DOI 10.1016/j.solmat.2012.04.032; Shiozaki H, 2008, JPN J APPL PHYS, V47, P1242, DOI 10.1143/JJAP.47.1242; Han FS, 2007, ADV MATER, V19, P3928, DOI 10.1002/adma.200700931; CHI QJ, 1995, ANAL CHIM ACTA, V310, P429, DOI 10.1016/0003-2670(95)00152-P; Fiorito PA, 2005, CHEM COMMUN, P366, DOI 10.1039/b412583e; Ohkoshi S, 2005, COORDIN CHEM REV, V249, P1830, DOI 10.1016/j.ccr.2004.11.015; Andersson P, 2007, ADV FUNCT MATER, V17, P3074, DOI 10.1002/adfm.200601241; Kitajima A, 2012, CHEM LETT, V41, P1473, DOI 10.1246/cl.2012.1473; Granqvist CG, 2000, SOL ENERG MAT SOL C, V60, P201, DOI 10.1016/S0927-0248(99)00088-4; NEFF VD, 1985, J ELECTROCHEM SOC, V132, P1382, DOI 10.1149/1.2114121; ITAYA K, 1986, ACCOUNTS CHEM RES, V19, P162, DOI 10.1021/ar00126a001; Barratt J., 2006, DESIGN MANAGEMENT RE, P25; Bernard MC, 1998, ELECTROCHIM ACTA, V44, P781, DOI 10.1016/S0013-4686(98)00238-2; Chen L.C., 2001, 2 INT M ADV BATT ACC, P6; Gotoh A, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/34/345609; Hong SF, 2010, ELECTROCHIM ACTA, V55, P3966, DOI 10.1016/j.electacta.2010.02.033; KOURIM V, 1964, J INORG NUCL CHEM, V26, P1111, DOI 10.1016/0022-1902(64)80271-2; Lee K. M., 2013, APPL PHYS LETT, V102, P3; Moritomo Y., 2011, APPL PHYS EXPRESS, V4, P3; Nossol E, 2013, SOL ENERG MAT SOL C, V109, P40, DOI 10.1016/j.solmat.2012.10.006; Omura A., 2008, IEICE T ELECTRON, VE91C, P1887; Soutar AM, 2012, SOL ENERG MAT SOL C, V100, P268, DOI 10.1016/j.solmat.2012.01.034; Tajima K, 2008, J APPL PHYS, V103, DOI 10.1063/1.2829816; Urano H, 2004, J MATER CHEM, V14, P2366, DOI 10.1039/b406093h; Vlachopoulos N, 2008, ELECTROCHIM ACTA, V53, P4065, DOI 10.1016/j.electacta.2007.10.011; Wessells C. D., 2011, NATURE COMMUNICATION, V2, P5; YOSHIMURA K, 1995, JPN J APPL PHYS 1, V34, P2440, DOI 10.1143/JJAP.34.2440	44	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	MAY 1	2015	163						288	295		10.1016/j.electacta.2015.02.119		8	Electrochemistry	Electrochemistry	CF4CR	WOS:000352496700037		
J	Osawa, T				Osawa, Takeshi			Importance of Farmland in Urbanized Areas as a Landscape Component for Barn Swallows (Hirundo rustica) Nesting on Concrete Buildings	ENVIRONMENTAL MANAGEMENT			English	Article						Citizen scientist; Green space; Hirundo rustica; Landscape components; Landscape ecology; Station; Urban ecosystems	CITIZEN SCIENCE; LAND-USE; ECOLOGICAL RESEARCH; SPECIES RICHNESS; BIODIVERSITY; COMMUNITIES; POPULATIONS; ABUNDANCE; HABITAT; EUROPE	Urbanization is one of the key factors in the population declines of many species. Conversely, some species may favor urbanized areas. The barn swallow Hirundo rustica is well known to breed in urban areas of Japan, and uses both urban and farmland areas as habitat during the breeding season. Specifically, this species often nests on concrete buildings and feeds in surrounding farmland. Therefore, it was hypothesized that H. rustica is not strongly influenced by heavy urbanization and benefits from farmland areas, even if they are not near its nests. In this study, I evaluated the landscape components around H. rustica nests situated on concrete buildings, focusing on both urbanized and farmland areas. In particular, I explored the occurrence of H. rustica nests at train stations in the Kinki region of Japan. Assisted by 124 citizen scientists, I analyzed the landscape components around the train stations at multiple spatial scales. Results showed that the occurrence of H. rustica nests was negatively influenced by both urbanized land area and road density, whereas nest occurrence was positively influenced by farmland area and river density. These results suggest that H. rustica does not prefer urbanized areas overall, but can rather utilize urbanized areas primarily as nesting spots. Therefore, H. rustica cannot breed in heavily urbanized areas without feeding sites such as farmland or riparian areas.	Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan	Osawa, T (reprint author), Natl Inst Agroenvironm Sci, 3-1-3 Kannondai, Tsukuba, Ibaraki 3058604, Japan.	arosawa@gmail.com			Japan Society for the Promotion of Science [24710038]	I would like to thank Dr. T. Wada and all 124 citizen scientists for joining this study. Especially, Dr. Wada strongly contributed for the management of the citizen scientist activities. I also would like to thank the member of urbanized bird research circle for their valuable support. I also would like to thank Dr. N. Katayama for commenting on an earlier version of this manuscript. Two reviewers and the editor gave me several useful comments and suggestions. This study was partially supported by a grant-in-aid for young scientists (No. 24710038) from the Japan Society for the Promotion of Science.	Ambrosini R, 2002, ECOL LETT, V5, P640, DOI 10.1046/j.1461-0248.2002.00363.x; Ambrosini R, 2010, EVOL ECOL, V24, P491, DOI 10.1007/s10682-009-9321-5; Lepczyk CA, 2008, CONSERV BIOL, V22, P405, DOI 10.1111/j.1523-1739.2008.00881.x; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Balmford A, 2001, SCIENCE, V291, P2616, DOI 10.1126/science.291.5513.2616; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Lehtinen RM, 1999, WETLANDS, V19, P1; Brotons L, 2004, LANDSCAPE ECOL, V19, P663; Salek M, 2010, LANDSCAPE ECOL, V25, P1113, DOI 10.1007/s10980-010-9487-9; Gibbs JP, 2005, ECOL APPL, V15, P1148, DOI 10.1890/03-5408; Cornelis J, 2004, LANDSCAPE URBAN PLAN, V69, P385, DOI 10.1016/j.landurbplan.2003.10.038; Urban MC, 2006, DIVERS DISTRIB, V12, P337, DOI 10.1111/j.1366-9516.2005.00226.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Gruebler MU, 2010, J APPL ECOL, V47, P1340, DOI 10.1111/j.1365-2664.2010.01873.x; Luck GW, 2004, P NATL ACAD SCI USA, V101, P182, DOI 10.1073/pnas.2237148100; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Araujo MB, 2003, GLOBAL ECOL BIOGEOGR, V12, P5, DOI 10.1046/j.1466-822X.2003.00314.x; Conrad CC, 2011, ENVIRON MONIT ASSESS, V176, P273, DOI 10.1007/s10661-010-1582-5; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Schulze CH, 2004, ECOL APPL, V14, P1321, DOI 10.1890/02-5409; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; BRADY RF, 1979, URBAN ECOL, V4, P11, DOI 10.1016/0304-4009(79)90020-2; Alvey Alexis A., 2006, Urban Forestry & Urban Greening, V5, P195, DOI 10.1016/j.ufug.2006.09.003; Antrop M, 2004, LANDSCAPE URBAN PLAN, V67, P9, DOI 10.1016/S0169-2046(03)00026-4; Kuhn I, 2004, EVOL ECOL RES, V6, P749; Ambrosini R, 2002, J APPL ECOL, V39, P524, DOI 10.1046/j.1365-2664.2002.00721.x; Saizen I, 2006, LANDSCAPE URBAN PLAN, V78, P411, DOI 10.1016/j.landurbplan.2005.12.002; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; NEWTON I, 1995, J ANIM ECOL, V64, P675, DOI 10.2307/5848; Miyashita T, 2012, POPUL ECOL, V54, P573, DOI 10.1007/s10144-012-0329-2; Geary M, 2013, IBIS, V155, P792, DOI 10.1111/ibi.12090; Denys C, 1998, OECOLOGIA, V113, P269, DOI 10.1007/s004420050378; Evans KL, 2007, AGR ECOSYST ENVIRON, V122, P267, DOI 10.1016/j.agee.2007.01.015; Freitag A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064079; Khera Neeraj, 2010, Urban Ecosystems, V13, P147, DOI 10.1007/s11252-009-0109-8; Robillard A, 2013, LANDSCAPE ECOL, V28, P201, DOI 10.1007/s10980-012-9828-y; SOULE M E, 1988, Conservation Biology, V2, P75, DOI 10.1111/j.1523-1739.1988.tb00337.x; Sugawara K, 1993, HIRUNDO RUSTICA STUR; Suzuki Hiroyuki, 1998, Strix, V16, P99; Takagawa S, 2012, BIRD RES, V7, pR9; Tsuji M, 2011, LANDSCAPE URBAN PLAN, V103, P318, DOI 10.1016/j.landurbplan.2011.08.005; Turner A., 2006, BARN SWALLOW; van Rensburg BJ, 2002, AM NAT, V159, P566, DOI 10.1086/339464	46	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-152X	1432-1009		ENVIRON MANAGE	Environ. Manage.	MAY	2015	55	5					1160	1167		10.1007/s00267-015-0457-5		8	Environmental Sciences	Environmental Sciences & Ecology	CF6CZ	WOS:000352645600013		
J	Imjongjairak, S; Jommuengbout, P; Karpilanondh, P; Katsuzaki, H; Sakka, M; Kimura, T; Pason, P; Tachaapaikoon, C; Romsaiyud, J; Ratanakhanokchai, K; Sakka, K				Imjongjairak, Siriluck; Jommuengbout, Pattaporn; Karpilanondh, Pirin; Katsuzaki, Hirotaka; Sakka, Makiko; Kimura, Tetsuya; Pason, Patthra; Tachaapaikoon, Chakrit; Romsaiyud, Jariya; Ratanakhanokchai, Khanok; Sakka, Kazuo			Paenibacillus curdlanolyticus B-6 xylanase Xyn10C capable of producing a doubly arabinose-substituted xylose, alpha-L-Araf-(1 -> 2)-[alpha-L-Araf-(1 -> 3)]-D-Xylp, from rye arabinoxylan	ENZYME AND MICROBIAL TECHNOLOGY			English	Article						Xylanase; Paenibacillus curdlanolyticus; Carbohydrate-binding module; Arabinoxylan; Arabinoxylooligosaccharides; Molecular docking	CARBOHYDRATE-BINDING MODULE; STRAIN B-6; ARABINOFURANOHYDROLASE; ENDO-BETA-1,4-XYLANASE; XYLOOLIGOSACCHARIDES; OLIGOSACCHARIDES; PURIFICATION; STREPTOMYCES; SYSTEM; ENZYME	Paenibacillus curdlanolyticus B-6 Xyn10C is a single module xylanase consisting of a glycoside hydrolase family-10 catalytic module. The recombinant enzyme, rXyn10C, was produced by Escherichia coli and characterized. rXyn10C was highly active toward soluble xylans derived from rye, birchwood, and oat spelt, and slightly active toward insoluble wheat arabinoxylan. It hydrolyzed xylooligosaccharides larger than xylotetraose to produce xylotriose, xylobiose, and xylose. When rye arabinoxylan and oat spelt xylan were treated with the enzyme and the hydrolysis products were analyzed by thin layer chromatography (TLC), two unknown hydrolysis products, U1 and U2, were detected in the upper position of xylose on a TLC plate. Electrospray ionization mass spectrometry and enzymatic analysis using Bacillus licheniformis alpha-L-arabinofuranosidase Axh43A indicated that U1 was alpha-L-Araf-(1 -> 2)-[alpha-L-Araf-(1 -> 3)]-D-Xylp and U2 was alpha-L-Araf-(1 -> 2)-D-Xylp, suggesting that rXyn10C had strong activity towarda xylosidic linkage before and after a doubly arabinose-substituted xylose residue and was able to accommodate an alpha-1,2- and alpha-1,3-linked arabinose-substituted xylose unit in both the -1 and +1 subsites. A molecular docking study suggested that rXyn10C could accommodate a doubly arabinose-substituted xylose residue in its catalytic site, at subsite - 1. This is the first report of a xylanase capable of producing alpha-L-Araf-(1 -> 2)-[alpha-L-Araf-(1 -> 3)]-D-Xylp from highly arabinosylated xylan. (C) 2015 Elsevier Inc. All rights reserved.	[Imjongjairak, Siriluck; Pason, Patthra; Ratanakhanokchai, Khanok] King Mongkuts Univ Technol, Sch Bioresources & Technol, Bangkok 10900, Thailand; [Jommuengbout, Pattaporn] Chandrakasem Rajabhat Univ, Fac Sci, Bangkok 10900, Thailand; [Karpilanondh, Pirin] King Mongkuts Univ Technol North Bangkok, Dept Agroind Technol, Bangkok 10800, Thailand; [Katsuzaki, Hirotaka; Sakka, Makiko; Kimura, Tetsuya; Sakka, Kazuo] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan; [Tachaapaikoon, Chakrit] King Mongkuts Univ Technol, Pilot Plant Dev & Training Inst, Bangkok 10150, Thailand; [Romsaiyud, Jariya] Ramkhamhang Univ, Dept Chem, Bangkok 10241, Thailand	Sakka, K (reprint author), Mie Univ, Grad Sch Bioresources, 1577 Kurimamachiya Cho, Tsu, Mie 5148507, Japan.	khanok.rat@kmutt.ac.th; sakka@bio.mie-u.ac.jp			Asian CORE Program from the Japan Society for the Promotion of Science (JSPS); National Research Council of Thailand; Royal Golden Jubilee Ph.D. program of the Thailand Research Fund; King Mongkut's University of Technology Thonburi	This work was supported in part by a grant for the Asian CORE Program from the Japan Society for the Promotion of Science (JSPS), and by a grant from the National Research Council of Thailand. Imjongjairak Siriluck was supported by the Royal Golden Jubilee Ph.D. program of the Thailand Research Fund and King Mongkut's University of Technology Thonburi.	Ali MK, 2001, BIOSCI BIOTECH BIOCH, V65, P41, DOI 10.1271/bbb.65.41; GILBERT HJ, 1993, J GEN MICROBIOL, V139, P187; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Sakka M, 2012, ENZYME MICROB TECH, V51, P193, DOI 10.1016/j.enzmictec.2012.06.003; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Waeonukul R, 2009, J BIOSCI BIOENG, V107, P610, DOI 10.1016/j.jbiosc.2009.01.010; Fujimoto Z, 2004, J BIOL CHEM, V279, P9606, DOI 10.1074/jbc.M312293200; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Boraston AB, 2004, BIOCHEM J, V382, P769; Knudsen KEB, 2010, CEREAL CHEM, V87, P353, DOI 10.1094/CCHEM-87-4-0353; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Barabote RD, 2010, APPL ENVIRON MICROB, V76, P7363, DOI 10.1128/AEM.01326-10; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Rastall RA, 2002, CURR OPIN BIOTECH, V13, P490, DOI 10.1016/S0958-1669(02)00365-8; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Waeonukul R, 2009, J MICROBIOL BIOTECHN, V19, P277, DOI 10.4014/jmb.0804.293; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Kittur FS, 2003, FEBS LETT, V549, P147, DOI 10.1016/S0014-5793(03)00803-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Rantanen H, 2007, CARBOHYD POLYM, V68, P350, DOI 10.1016/j.carbpol.2006.11.022; Britton HTS, 1931, J CHEM SOC, P1456, DOI 10.1039/jr9310001456; Chamock SJ, 1998, J BIOL CHEM, V273, P32187; Di Tommaso Paolo, 2011, Nucleic Acids Res, V39, pW13, DOI 10.1093/nar/gkr245; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; KORMELINK FJM, 1991, APPL MICROBIOL BIOT, V35, P753; KUSAKABE I, 1977, J AGR CHEM SOC JPN, V51, P669; Liu LW, 2011, PROCESS BIOCHEM, V46, P395, DOI 10.1016/j.procbio.2010.07.026; Pason P, 2006, APPL ENVIRON MICROB, V72, P2483, DOI 10.1128/AEM.72.4.2483-2490.2006; Pason P, 2010, APPL MICROBIOL BIOT, V85, P573, DOI 10.1007/s00253-009-2117-2; Pastell H, 2008, CARBOHYD RES, V343, P3049, DOI 10.1016/j.carres.2008.09.013; Puls J, 2006, MACROMOL SYMP, V232, P85, DOI 10.1002/masy.200551410; PULS J, 1993, PORT PR R M, V4, P1; Sakka M, 2011, APPL ENVIRON MICROB, V77, P4260, DOI 10.1128/AEM.00226-11; Schmidt A, 1999, BIOCHEMISTRY-US, V38, P2403, DOI 10.1021/bi982108l; Sudo M, 2010, BIOSCI BIOTECH BIOCH, V74, P2358, DOI 10.1271/bbb.100555; Teleman A, 2002, CARBOHYD RES, V337, P337; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; VanLaere KMJ, 1997, APPL MICROBIOL BIOT, V47, P231; Van Laere KMJ, 1999, APPL MICROBIOL BIOT, V51, P606, DOI 10.1007/s002530051439; Vardakou M, 2005, J MOL BIOL, V352, P1060, DOI 10.1016/j.jmb.2005.07.051; Waeonukul R, 2008, BIOSCI BIOTECH BIOCH, V72, P321, DOI 10.1271/bbb.70333	44	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0141-0229	1879-0909		ENZYME MICROB TECH	Enzyme Microb. Technol.	MAY	2015	72						1	9		10.1016/j.enzmictec.2015.02.002		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CG2HL	WOS:000353095400001		
J	Goncalves, GAL; Takasugi, Y; Jia, LL; Mori, Y; Noda, S; Tanaka, T; Ichinose, H; Kamiya, N				Goncalves, Geisa A. L.; Takasugi, Yusaku; Jia, Lili; Mori, Yutaro; Noda, Shuhei; Tanaka, Tsutomu; Ichinose, Hirofumi; Kamiya, Noriho			Synergistic effect and application of xylanases as accessory enzymes to enhance the hydrolysis of pretreated bagasse	ENZYME AND MICROBIAL TECHNOLOGY			English	Article						Xylanase; Synergism; Lignocellulose; Bioconversion; Biofuel	CLOSTRIDIUM-THERMOCELLUM; THERMOMONOSPORA-FUSCA; ENZYMATIC-HYDROLYSIS; LIGNOCELLULOSE HYDROLYSIS; CELLULASES; CELLULOSOME; BIOMASS; PURIFICATION; EFFICIENCY; CONVERSION	Recently, the new trend in the second-generation ethanol industry is to use mild pretreatments, in order to reduce costs and to keep higher content of hemicellulose in the biomass. Nevertheless, a high enzyme dosage is still required in the conversion of (hemi)cellulose. The interaction between cellulases and xylanases seems to be an effective alternative to reduce enzyme loading in the saccharification process. At first, to evaluate the synergism of xylanases on bagasse degradation, we have produced two xylanases from glycoside hydrolase family 10 (GH10) and three xylanases from glycoside hydrolase family11 (GH11),from two thermophilic organisms, Thermobifida fusca and Clostridium thermocellum, and one mesophilic organism, Streptomyces lividans. Peracetic acid (PAA) pretreated bagasse was used as substrate. The combination of XynZ-C (GH10, from C. thermocellum), and XlnB (GH11, from S. lividans) presented the highest degree of synergy after 6 h (3,62). However, the combination of XynZ-C and Xyn11A (GH11, from T. fusca) resulted in the highest total yield of reducing sugars. To evaluate the synergism between xylanases and cellulases, commercial cellulase preparation from Trichoderma reesei was combined with the selected xylanases, XynZ-C and Xyn11A. About 2-fold increase was observed in the concentration of reducing sugars, when both xylanases, XynZ-C and Xyn11A, were added together with T. reesei cellulases in the reaction mixture. (C) 2015 Elsevier Inc. All rights reserved.	[Goncalves, Geisa A. L.; Takasugi, Yusaku; Jia, Lili; Mori, Yutaro; Kamiya, Noriho] Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Fukuoka 812, Japan; [Noda, Shuhei] RIKEN, Biomass Engn Program, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Tanaka, Tsutomu] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 6578501, Japan; [Ichinose, Hirofumi] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan; [Kamiya, Noriho] Kyushu Univ, Ctr Future Chem, Fukuoka 812, Japan	Kamiya, N (reprint author), 744 Motooka,Nishi Ku, Fukuoka, Japan.	nori_kamiya@mail.cstm.kyushu-u.ac.jp			Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST); China Scholarship Council [201306300044]	This research was supported by the Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST). L. Jia thanks the China Scholarship Council (grant number: 201306300044).	Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Yasuno S, 1997, BIOSCI BIOTECH BIOCH, V61, P1944; Blumer-Schuette SE, 2008, CURR OPIN BIOTECH, V19, P210, DOI 10.1016/j.copbio.2008.04.007; Blum DL, 2000, J BACTERIOL, V182, P1346, DOI 10.1128/JB.182.5.1346-1351.2000; WALKER LP, 1992, BIOTECHNOL BIOENG, V40, P1019, DOI 10.1002/bit.260400905; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; Fox JM, 2013, NAT CHEM BIOL, V9, P356, DOI 10.1038/nchembio.1227; Harris PV, 2014, CURR OPIN CHEM BIOL, V19, P162, DOI 10.1016/j.cbpa.2014.02.015; Andersen N, 2008, ENZYME MICROB TECH, V42, P362, DOI 10.1016/j.enzmictec.2007.11.018; Kumar R, 2013, BIORESOURCE TECHNOL, V130, P372, DOI 10.1016/j.biortech.2012.12.028; Van Dyk JS, 2012, BIOTECHNOL ADV, V30, P1458, DOI 10.1016/j.biotechadv.2012.03.002; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Berlin A, 2007, BIOTECHNOL BIOENG, V97, P287, DOI 10.1002/bit.21238; BAYER EA, 1994, TRENDS BIOTECHNOL, V12, P379, DOI 10.1016/0167-7799(94)90039-6; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Zhang JH, 2011, BIORESOURCE TECHNOL, V102, P9090, DOI 10.1016/j.biortech.2011.06.085; Zhang JH, 2012, BIORESOURCE TECHNOL, V117, P286, DOI 10.1016/j.biortech.2012.04.072; Khan MIM, 2013, J BIOTECHNOL, V168, P403, DOI 10.1016/j.jbiotec.2013.09.010; GREPINET O, 1988, J BACTERIOL, V170, P4576; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Li JB, 2014, BIORESOURCE TECHNOL, V155, P258, DOI 10.1016/j.biortech.2013.12.113; Beaugrand J, 2004, CARBOHYD RES, V339, P2529, DOI 10.1016/j.carres.2004.08.012; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; BIELY P, 1985, TRENDS BIOTECHNOL, V3, P286, DOI 10.1016/0167-7799(85)90004-6; Bissoon S, 2002, SYNERGETIC INTERACTI; BOTHWELL MK, 1993, BIOMASS BIOENERG, V4, P293, DOI 10.1016/0961-9534(93)90088-L; Cannio R, 2004, EXTREMOPHILES, V8, P117, DOI 10.1007/s00792-003-0370-3; Clarke JH, 1997, APPL MICROBIOL BIOT, V48, P177; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Hopwood DA., 1995, GENETIC MANIPULATION; Hu J, 2011, BIOTECHNOL BIOENG, V36, P1; Hu JG, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-112; IRWIN D, 1994, APPL ENVIRON MICROB, V60, P763; Kim JH, 2004, CAN J MICROBIOL, V50, P835, DOI 10.1139/W04-077; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411; Mohanram S., 2013, SUSTAINABLE CHEM PRO, V1, P1; Noda S, 2010, PROTEIN EXPRES PURIF, V73, P198, DOI 10.1016/j.pep.2010.05.011; Sajjad M, 2010, J BIOTECHNOL, V145, P38, DOI 10.1016/j.jbiotec.2009.10.013; Sluiter A, 2004, DETERMINATION ASH BI; Sluiter A, 2004, DETERMINATION EXTRAC; Sluiter A, 2004, BIOMASS ANAL TECHNOL, V2011, P1; Sydenham R, 2014, APPL MICROBIOL BIOT, V98, P3613, DOI 10.1007/s00253-013-5244-8; Zhang JH, 2014, APPL BIOCHEM BIOTECH, V174, P1393, DOI 10.1007/s12010-014-1140-7; Zhang J, 2011, BIOTECHNOL BIOFUELS, V4, P1; Zverlov VV, 2005, MICROBIOL-SGM, V151, P3395, DOI 10.1099/mic.0.28206-0	45	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0141-0229	1879-0909		ENZYME MICROB TECH	Enzyme Microb. Technol.	MAY	2015	72						16	24		10.1016/j.enzmictec.2015.01.007		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CG2HL	WOS:000353095400003		
J	Hoffren-Mikkola, M; Ishikawa, M; Rantalainen, T; Avela, J; Komi, PV				Hoffren-Mikkola, Merja; Ishikawa, Masaki; Rantalainen, Timo; Avela, Janne; Komi, Paavo V.			Neuromuscular mechanics and hopping training in elderly	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Stretch-shortening cycle; Aging; Ultrasound; Electromyography; Tendon; Gastrocnemius medialis	HUMAN ACHILLES-TENDON; SHORTENING CYCLE EXERCISE; PREFERRED WALKING SPEED; ANKLE JOINT STIFFNESS; IN-VIVO; OLDER-ADULTS; HUMAN MUSCLE; MORPHOLOGICAL PROPERTIES; PHYSICAL-ACTIVITY; JUMP PERFORMANCE	The present study examined the effects of repetitive hopping training on muscle activation profiles and fascicle-tendon interaction in the elderly. 20 physically active elderly men were randomly assigned for training (TG) and control groups (CG). TG performed supervised bilateral short contact hopping training with progressively increasing training volume. Measurements were performed before the training period (BEF) as well as after 2 weeks (2 W) and 11 weeks (11 W) of training. During measurements, the gastrocnemius medialis-muscle (GaM) fascicle and its outer Achilles tendon length changes during hopping were examined by ultrasonography together with electromyographic (EMG) activities of calf muscles, kinematics, and kinetics. At 2 W, the ankle joint stiffness was increased by 21.0 +/- A 19.3 % and contact time decreased by 9.4 +/- A 7.8 % in TG. Thereafter, from 2-11 W the jumping height increased 56.2 +/- A 18.1 % in TG. Simultaneously, tendon forces increased 24.3 +/- A 19.0 % but tendon stiffness did not change. GaM fascicles shifted to shorter operating lengths after training without any changes in their length modifications during the contact phase of hopping. Normalized EMG amplitudes during hopping did not change with training. The present study shows that 11 W of hopping training improves the performance of physically active elderly men. This improvement is achieved with shorter GaM operating lengths and, therefore, increased fascicle stiffness and improved tendon utilization after training. Based on these results, hopping training could be recommended for healthy fit elderly to retain and improve rapid force production capacity.	[Hoffren-Mikkola, Merja; Avela, Janne; Komi, Paavo V.] Univ Jyvaskyla, Dept Biol Phys Act, Neuromuscular Res Ctr, SF-40100 Jyvaskyla, Finland; [Ishikawa, Masaki] Osaka Univ Hlth & Sport Sci, Osaka, Japan; [Rantalainen, Timo] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Burwood, Australia	Hoffren-Mikkola, M (reprint author), Univ Jyvaskyla, Dept Biol Phys Act, Neuromuscular Res Ctr, SF-40100 Jyvaskyla, Finland.	merja.hoffren@jyu.fi			Academy of Finland [123757]; Finnish Cultural Foundation's South Ostrobothnia Regional Fund; Osaka University of Health and Sport Sciences; Alfred Deakin Postdoctoral Research Fellowship from Deakin University	The authors acknowledge the valuable contribution of Ms. P. Puttonen and Mr Masanobu Akiyama for help with the data analysis. This study was supported by Grant # 123757 from the Academy of Finland, by Finnish Cultural Foundation's South Ostrobothnia Regional Fund's personal grant for Merja Hoffren-Mikkola and by the research exchange grant of Osaka University of Health and Sport Sciences. Dr Rantalainen was supported by an Alfred Deakin Postdoctoral Research Fellowship from Deakin University during the preparation of the manuscript.	LaRoche DP, 2010, J ELECTROMYOGR KINES, V20, P482, DOI 10.1016/j.jelekin.2009.08.004; Lichtwark GA, 2005, J EXP BIOL, V208, P2845, DOI 10.1242/jeb.01710; Kubo K, 2003, ACTA PHYSIOL SCAND, V178, P25, DOI 10.1046/j.1365-201X.2003.01097.x; Van Cutsem M, 1998, J PHYSIOL-LONDON, V513, P295; Pijnappels M, 2005, J BIOMECH, V38, P627, DOI 10.1016/j.jbiomech.2004.03.029; Karamanidis K, 2005, J EXP BIOL, V208, P3907, DOI 10.1242/jeb.01830; Stenroth L, 2012, J APPL PHYSIOL, V113, P1537, DOI 10.1152/japplphysiol.00782.2012; Beijersbergen CMI, 2013, AGEING RES REV, V12, P618, DOI 10.1016/j.arr.2013.03.001; Andersen JL, 2003, SCAND J MED SCI SPOR, V13, P40, DOI 10.1034/j.1600-0838.2003.00299.x; Chimera NJ, 2004, J ATHL TRAINING, V39, P24; Stosic J, 2011, EUR J APPL PHYSIOL, V111, P3151, DOI 10.1007/s00421-011-1929-9; Taube W, 2012, SCAND J MED SCI SPOR, V22, P671, DOI 10.1111/j.1600-0838.2011.01293.x; Hoffren M, 2011, J ELECTROMYOGR KINES, V21, P483, DOI 10.1016/j.jelekin.2011.01.009; Arampatzis A, 2010, J BIOMECH, V43, P3073, DOI 10.1016/j.jbiomech.2010.08.014; Lichtwark GA, 2005, J EXP BIOL, V208, P4715, DOI 10.1242/jeb.01950; Hortobagyi T, 2000, J ELECTROMYOGR KINES, V10, P117, DOI 10.1016/S1050-6411(99)00026-7; Morse CI, 2004, EUR J APPL PHYSIOL, V92, P219, DOI 10.1007/s00421-004-1056-y; Finni T, 2001, EUR J APPL PHYSIOL, V85, P170, DOI 10.1007/s004210100438; Pijnappels M, 2005, EXP BRAIN RES, V160, P326, DOI 10.1007/s00221-004-2014-y; Kyrolainen H, 2005, SCAND J MED SCI SPOR, V15, P58, DOI 10.1111/j.1600-0838.2004.00390.x; Kubo K, 2007, MED SCI SPORT EXER, V39, P1801, DOI 10.1249/mss.0b013e31813e630a; Hansen P, 2003, J APPL PHYSIOL, V95, P2375, DOI 10.1152/japplphysiol.00503.2003; Kubo K, 2006, SCAND J MED SCI SPOR, V16, P159, DOI 10.1111/j.1600-0838.2005.00450.x; Magnusson SP, 2003, ACTA PHYSIOL SCAND, V177, P185, DOI 10.1046/j.1365-201X.2003.01048.x; AURA O, 1986, INT J SPORTS MED, V7, P137, DOI 10.1055/s-2008-1025751; Reeves ND, 2003, J PHYSIOL-LONDON, V548, P971, DOI 10.1113/jphysiol.2002.035576; Lanza IR, 2003, J APPL PHYSIOL, V95, P2361, DOI 10.1152/japplphysiol.00724.2002; Malatesta D, 2003, J APPL PHYSIOL, V95, P2248, DOI 10.1152/japplphysiol.01106.2002; Newton RU, 2002, MED SCI SPORT EXER, V34, P1367, DOI 10.1097/00005768-200208000-00020; Kubo K, 2001, J PHYSIOL-LONDON, V536, P649, DOI 10.1111/j.1469-7793.2001.0649c.xd; Hunter SK, 2000, J GERONTOL A-BIOL, V55, pB264; Farris DJ, 2012, EUR J APPL PHYSIOL, V112, P653, DOI 10.1007/s00421-011-2019-8; BOSCO C, 1982, ACTA PHYSIOL SCAND, V114, P543, DOI 10.1111/j.1748-1716.1982.tb07022.x; Arampatzis A, 2007, J EXP BIOL, V210, P2743, DOI 10.1242/jeb.003814; Malisoux L, 2006, J APPL PHYSIOL, V100, P771, DOI 10.1152/japplphysiol.01027.2005; Morse CI, 2005, J APPL PHYSIOL, V98, P221, DOI 10.1152/japplphysiol.00774.2004; Finni T, 2003, J APPL PHYSIOL, V95, P829, DOI 10.1152/japplphysiol.00775.2002; RUGG SG, 1990, J BIOMECH, V23, P495, DOI 10.1016/0021-9290(90)90305-M; Barber LA, 2013, EXP GERONTOL, V48, P1147, DOI 10.1016/j.exger.2013.07.007; Kyrolainen H, 2004, EUR J APPL PHYSIOL, V91, P155, DOI 10.1007/s00421-003-0934-z; Kubo K, 2005, CLIN BIOMECH, V20, P291, DOI 10.1016/j.clinbiomech.2004.11.005; Kuitunen S, 2002, MED SCI SPORT EXER, V34, P166, DOI 10.1097/00005768-200201000-00025; Wren TAL, 2001, CLIN BIOMECH, V16, P245, DOI 10.1016/S0268-0033(00)00089-9; Kuitunen S, 2007, SCAND J MED SCI SPOR, V17, P67, DOI 10.1111/j.1600-0838.2005.00506.x; Clark DJ, 2013, EXP GERONTOL, V48, P358, DOI 10.1016/j.exger.2013.01.010; Mian OS, 2006, ACTA PHYSIOL, V186, P127, DOI 10.1111/j.1748-1716.2006.01522.x; Candow DG, 2005, J GERONTOL A-BIOL, V60, P148; Mian OS, 2007, ACTA PHYSIOL, V189, P57, DOI 10.1111/j.1748-1716.2006.01634.x; Flanagan EP, 2008, J STRENGTH COND RES, V22, P1677, DOI 10.1519/JSC.0b013e318182034b; HAKKINEN K, 1983, MED SCI SPORT EXER, V15, P455; Hakkinen K, 1998, J AGING PHYS ACTIV, V6, P232; HAWKINS D, 1990, J BIOMECH, V23, P487, DOI 10.1016/0021-9290(90)90304-L; Hermens H. J., 1999, SENIAM 8 EUROPEAN RE; Hoffren M, 2007, J APPL PHYSIOL, V103, P1276, DOI 10.1152/japplphysiol.00430.2007; Houghton LA, 2013, J STRENGTH COND RES, V27, P1036, DOI 10.1519/JSC.0b013e3182651e7a; KOMI PV, 1987, INT J SPORTS MED, V8, P196, DOI 10.1055/s-2008-1025655; Kubo K, 2012, EUR J APPL PHYSIOL, V112, P2679, DOI 10.1007/s00421-011-2248-x; Kyrolainen H, 1998, MED SCI SPORT EXER, V30, P415; Liu Y, 2003, J APPL PHYSIOL, V94, P2282, DOI 10.1152/japplphysiol.00830.2002; Norris JA, 2007, GAIT POSTURE, V25, P620, DOI 10.1016/j.gaitpost.2006.07.002; Onambele-Pearson GL, 2012, AGE, V34, P427, DOI 10.1007/s11357-011-9248-y; Panizzolo FA, 2013, GAIT POSTURE, V38, P764, DOI 10.1016/j.gaitpost.2013.03.021; Pearson SJ, 2002, MED SCI SPORT EXER, V34, P1199, DOI 10.1097/00005768-200207000-00023; Peltonen J, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-212; Peltonen J, 2012, J EXP BIOL, V215, P3665, DOI 10.1242/jeb.068874; Piirainen JM, 2014, J ELECTROMYOGR KINES, V24, P246, DOI 10.1016/j.jelekin.2014.01.010; Rantalainen T, 2011, EUR J APPL PHYSIOL, V111, P2155, DOI 10.1007/s00421-011-1849-8; Seynnes OR, 2011, SCAND J MED SCI SPOR, V21, P39, DOI 10.1111/j.1600-0838.2011.01340.x; Winter D., 1990, BIOMECHANICS MOTOR C; Yoon S, 2007, INT J SPORTS MED, V28, P66, DOI 10.1055/s-2006-923903; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	71	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	MAY	2015	115	5					863	877		10.1007/s00421-014-3065-9		15	Physiology; Sport Sciences	Physiology; Sport Sciences	CF7FL	WOS:000352721500001		
J	Yasuda, T; Fukumura, K; Iida, H; Nakajima, T				Yasuda, Tomohiro; Fukumura, Kazuya; Iida, Haruko; Nakajima, Toshiaki			Effect of low-load resistance exercise with and without blood flow restriction to volitional fatigue on muscle swelling	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Muscle thickness; Electromyography; Vascular occlusion; Biceps brachii; Metabolite	EXTERNAL LIMB COMPRESSION; VASCULAR OCCLUSION; CONTRACTIONS; PROTEIN; ACTIVATION; STRENGTH; HUMANS; MEN	The effects on muscle swelling were compared between low-load resistance exercise to exhaustion with (BFR) and without blood flow restriction (NBFR). Ten young men [aged 27 (SD 5) years, standing height 1.74 (SD 0.05) m, body mass 70.3 (SD 4.3) kg] performed 20 % of one repetition maximal dumbbell curl exercise to exhaustion (four sets, rest intervals were 30 s for BFR and/or 3 min for NBFR, respectively). One arm was randomly chosen for BFR exercise and the other arm performed NBFR exercise. During the BFR exercise session, an elastic cuff was worn proximally on the testing arm at 160 mmHg. Electromyography (EMG) signals were recorded from surface electrodes placed on the biceps brachii muscle and analyzed for integrated EMG (iEMG). Biceps brachii muscle thickness (MTH) was measured using B-mode ultrasound. The total number of exercise repetitions was greater (p < 0.01) in NBFR (221 +/- A 67 reps) than in BFR (111 +/- A 36 reps). During the exercise session, iEMG for biceps brachii muscles increased (p < 0.01) during BFR and NBFR (3.94 and 4.45 times of baseline value). Immediately after the exercise, MTH sharply increased (p < 0.01) with BFR and NBFR (1.21 and 1.20 times of baseline value). These results demonstrate that both BFR and NBFR exercises lead to pronounced muscle activation and muscle swelling. Low-load resistance exercise to exhaustion is an effective method for promoting muscle swelling regardless of BFR. Furthermore, our data indicate that the increase in muscle swelling for both NBFR and BFR is maintained even 60 min after the exercise.	[Yasuda, Tomohiro; Fukumura, Kazuya; Iida, Haruko; Nakajima, Toshiaki] Univ Tokyo, Grad Sch Med, Dept Ischem Circulatory Physiol, Bunkyo Ku, Tokyo 1138655, Japan	Yasuda, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Ischem Circulatory Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasuda-tomohiro@umin.ac.jp			Japan Ministry of Education, Culture, Sports, Science, and Technology [25750288, 20549604]; Descente Foundation; KAATSU Japan Co., Ltd	The authors thank the participants who participated in this study. We also thank Yusuke Uchida, Seiya Oosumi, Kenji Kinpara, and Shinpei Sugimoto (Okamoto-Ishii Hospital, Shizuoka, Japan). This study was supported, in part, by Grant-in-aid (#25750288 and #20549604 to TY) from the Japan Ministry of Education, Culture, Sports, Science, and Technology, and the Descente Foundation. Our department is funded by KAATSU Japan Co., Ltd.	Abe T, 2005, INT J KAATSU TRAININ, V1, P6, DOI 10.3806/ijktr.1.6; Yasuda T, 2011, EUR J APPL PHYSIOL, V111, P2525, DOI 10.1007/s00421-011-1873-8; Takarada Y, 2000, J APPL PHYSIOL, V88, P2097; Yasuda T, 2008, J SPORT SCI MED, V7, P467; Karabulut M, 2010, EUR J APPL PHYSIOL, V108, P147, DOI 10.1007/s00421-009-1204-5; Yasuda T, 2010, METABOLISM, V59, P1510, DOI 10.1016/j.metabol.2010.01.016; Loenneke JP, 2012, ACTA PHYSIOL HUNG, V99, P400, DOI 10.1556/APhysiol.99.2012.4.4; MORITANI T, 1986, J APPL PHYSIOL, V60, P1179; Yasuda T, 2009, J SPORT SCI, V27, P479, DOI 10.1080/02640410802626567; Loenneke JP, 2012, EUR J APPL PHYSIOL, V112, P1849, DOI 10.1007/s00421-011-2167-x; Fry CS, 2010, J APPL PHYSIOL, V108, P1199, DOI 10.1152/japplphysiol.01266.2009; Loenneke JP, 2012, EUR J APPL PHYSIOL, V112, P2903, DOI 10.1007/s00421-011-2266-8; Abe T, 2006, J APPL PHYSIOL, V100, P1460, DOI 10.1152/japplphysiol.01267.2005; Martin-Hernandez J, 2013, ACTA PHYSIOL HUNG, V100, P411, DOI 10.1556/APhysiol.100.2013.011; Yasuda T, 2010, CLIN PHYSIOL FUNCT I, V30, P338, DOI 10.1111/j.1475-097X.2010.00949.x; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; HAUSSINGER D, 1993, LANCET, V341, P1330, DOI 10.1016/0140-6736(93)90828-5; Mitchell CJ, 2012, J APPL PHYSIOL, V113, P71, DOI 10.1152/japplphysiol.00307.2012; Nosaka K, 2002, J STRENGTH COND RES, V16, P202; Loenneke JP, 2012, MED HYPOTHESES, V78, P151, DOI 10.1016/j.mehy.2011.10.014; de Salles BF, 2009, SPORTS MED, V39, P765, DOI 10.2165/11315230-000000000-00000; Kubo K, 2006, J APPL BIOMECH, V22, P112; Berneis K, 1999, AM J PHYSIOL-ENDOC M, V276, pE188; BIGLANDRITCHIE B, 1986, ACTA PHYSIOL SCAND, V128, P137; Burd NA, 2010, PLOS ONE, V9; Cohen J., 1988, STAT POWER ANAL BEHA, P273; Fahs CA, 2014, CLIN PHYSL FUNCT IMA; Fujita T, 2008, INT J KAATSU TRAININ, V4, P1, DOI 10.3806/ijktr.4.1; Loenneke JP, 2013, FRONT PHYSIOL, V10, P249; Ogasawara R, 2013, INT J CLIN MED, V4, P114; Sato Y, 2005, INT J KAATSU TRAIN R, V1, P1, DOI 10.3806/ijktr.1.1; STULL GA, 1978, MED SCI SPORT EXER, V10, P109; Thiebaud Robert S, 2013, Interv Med Appl Sci, V5, P53, DOI 10.1556/IMAS.5.2013.2.1; Yasuda T, 2012, PLOS ONE, V12; Yasuda T, 2014, SCAND J MED SCI SPOR, V24, P799, DOI 10.1111/sms.12087	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	MAY	2015	115	5					919	926		10.1007/s00421-014-3073-9		8	Physiology; Sport Sciences	Physiology; Sport Sciences	CF7FL	WOS:000352721500006		
J	Matsuo, S; Suzuki, S; Iwata, M; Hatano, G; Nosaka, K				Matsuo, Shingo; Suzuki, Shigeyuki; Iwata, Masahiro; Hatano, Genki; Nosaka, Kazunori			Changes in force and stiffness after static stretching of eccentrically-damaged hamstrings	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Static stretching; Range of motion; Passive stiffness; Stretching-induced force loss; Muscle damage; Delayed onset muscle soreness	HUMAN SKELETAL-MUSCLE; PASSIVE STIFFNESS; PEAK TORQUE; WARM-UP; STRENGTH; EXERCISE; PERFORMANCE; ELECTROMYOGRAPHY; MECHANOMYOGRAPHY; FLEXIBILITY	This study compared responses to static stretching between eccentrically damaged and non-damaged muscles. Twelve young men performed 60 maximum knee flexor eccentric contractions of one leg, and received a 300-s continuous passive static stretching at tolerable intensity without pain to both knee flexors at 2 and 4 days after the eccentric exercise. Range of motion (ROM) and passive stiffness during knee extension, passive torque at onset of pain (PT), maximum voluntary isometric (MVC-ISO) and isokinetic concentric contraction torque (MVC-CON), and visual analogue scale (VAS) for muscle soreness were measured before, immediately after, 60 min, 2 and 4 days after exercise as well as before, immediately after, 20 and 60 min after the stretching. Changes in these variables after eccentric exercise and stretching were compared between limbs. The eccentric exercise decreased MVC-ISO, MVC-CON, ROM and PT, and increased passive stiffness and VAS (p < 0.05), suggesting that muscle damage was induced to the knee flexors. ROM and PT increased after stretching for both limbs; however, the magnitude of the increase was greater (p < 0.05) for the damaged than non-damaged limb. Passive stiffness decreased for both limbs similarly (4-7 %) at immediately after stretching (p < 0.05). Significant decreases in MVC-ISO torque (7-11 %) after stretching were observed only for the non-damaged limb (p < 0.05), but MVC-CON torque did not change after stretching for both limbs. VAS decreased for the exercised limb after stretching (p < 0.05). These results suggest that the static stretching at tolerable intensity without pain produced greater positive effects on damaged than non-damaged muscles.	[Matsuo, Shingo; Suzuki, Shigeyuki; Iwata, Masahiro; Hatano, Genki] Nagoya Univ, Grad Sch Med, Program Phys & Occupat Therapy, Nagoya, Aichi 4618673, Japan; [Matsuo, Shingo; Iwata, Masahiro] Nihon Fukushi Univ, Dept Rehabil, Fac Hlth Sci, Handa, Japan; [Nosaka, Kazunori] Edith Cowan Univ, Sch Exercise & Hlth Sci, Joondalup, WA, Australia	Suzuki, S (reprint author), Nagoya Univ, Grad Sch Med, Program Phys & Occupat Therapy, 1-1-20 Daikominami Higashiku, Nagoya, Aichi 4618673, Japan.	suzuki@met.nagoya-u.ac.jp			A-kit Co., Ltd; Public Advertisement Research Project of Nihon Fukushi University	This work was supported in part by a grant from A-kit Co., Ltd. and the Public Advertisement Research Project of Nihon Fukushi University.	Andersen L L, 2010, Scand J Med Sci Sports, V20, pe162, DOI 10.1111/j.1600-0838.2009.00933.x; Kollock RO, 2010, J ATHL TRAINING, V45, P349, DOI 10.4085/1062-6050-45.4.349; Ford-Smith CD, 2001, ARCH PHYS MED REHAB, V82, P1128, DOI 10.1053/apmr.2001.24291; McHugh MP, 2008, MED SCI SPORT EXER, V40, P566, DOI [10.1249/MSS.0b013e31815d2f8c, 10.1249/mss.0b013e31815d2f8c]; Janecki D, 2011, J SCI MED SPORT, V14, P338, DOI 10.1016/j.jsams.2011.02.005; Cramer JT, 2007, J SPORT SCI, V25, P687, DOI 10.1080/02640410600818416; Chen TC, 2011, EUR J APPL PHYSIOL, V111, P211, DOI 10.1007/s00421-010-1648-7; Magnusson SP, 1996, J PHYSIOL-LONDON, V497, P291; Torres R, 2007, INT J SPORTS MED, V28, P590, DOI 10.1055/s-2007-964865; SMITH CA, 1994, J ORTHOP SPORT PHYS, V19, P12; Magnusson SP, 1998, SCAND J MED SCI SPOR, V8, P65; McHugh MP, 2010, SCAND J MED SCI SPOR, V20, P169, DOI 10.1111/j.1600-0838.2009.01058.x; Andersen LL, 2006, EUR J APPL PHYSIOL, V96, P46, DOI 10.1007/s00421-005-0070-z; Fowles JR, 2000, J APPL PHYSIOL, V89, P1179; Nosaka K, 2001, MED SCI SPORT EXER, V33, P22; Kay AD, 2012, MED SCI SPORT EXER, V44, P154, DOI 10.1249/MSS.0b013e318225cb27; Cramer JT, 2005, EUR J APPL PHYSIOL, V93, P530, DOI 10.1007/s00421-004-1199-x; Magnusson SP, 1997, SCAND J MED SCI SPOR, V7, P195; Blazevich AJ, 2014, J APPL PHYSIOL, V117, P452, DOI 10.1152/japplphysiol.00204.2014; Nakamura M, 2011, J ORTHOP RES, V29, P1759, DOI 10.1002/jor.21445; Nosaka K, 2002, SCAND J MED SCI SPOR, V12, P337, DOI 10.1034/j.1600-0838.2002.10178.x; Blazevich AJ, 2008, MUSCLE NERVE, V38, P1133, DOI 10.1002/mus.21021; Chen CH, 2011, MED SCI SPORT EXER, V43, P491, DOI 10.1249/MSS.0b013e3181f315ad; Simic L, 2013, SCAND J MED SCI SPOR, V23, P131, DOI 10.1111/j.1600-0838.2012.01444.x; Woods K, 2007, SPORTS MED, V37, P1089, DOI 10.2165/00007256-200737120-00006; de Oliveira ALM, 2012, J STRENGTH COND RES, V26, P2174, DOI 10.1519/JSC.0b013e31823b0546; Halbertsma JPK, 1996, ARCH PHYS MED REHAB, V77, P688, DOI 10.1016/S0003-9993(96)90009-X; Johansson PH, 1999, SCAND J MED SCI SPOR, V9, P219; Herbert RD, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004577.pub3; MacIntosh BR, 2005, J APPL PHYSIOL, V98, P1666, DOI 10.1152/japplphysiol.01045.2004; Matsuo S, 2013, J STRENGTH COND RES, V27, P3367, DOI 10.1519/JSC.0b013e318290c26f; Mizuno T, 2013, SCAND J MED SCI SPOR, V23, P23, DOI 10.1111/j.1600-0838.2011.01329.x; Reisman S, 2009, EXP BRAIN RES, V193, P545, DOI 10.1007/s00221-008-1657-5; Ryan ED, 2008, MED SCI SPORT EXER, V40, P1529, DOI 10.1249/MSS.0b013e31817242eb; Shrier I, 2005, PHYSICIAN SPORTSMED, V33, P22, DOI 10.3810/psm.2005.03.61; Siatras TA, 2008, J STRENGTH COND RES, V22, P40, DOI 10.1519/JSC.0b013e31815f970c; Small Katie, 2008, Res Sports Med, V16, P213, DOI 10.1080/15438620802310784; Trajano GS, 2013, J APPL PHYSIOL, V115, P212, DOI 10.1152/japplphysiol.00333.2013	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	MAY	2015	115	5					981	991		10.1007/s00421-014-3079-3		11	Physiology; Sport Sciences	Physiology; Sport Sciences	CF7FL	WOS:000352721500012		
J	Hirano, M; Shindo, M; Mishima, S; Morimura, K; Higuchi, Y; Yamada, Y; Higaki, Y; Kiyonaga, A				Hirano, Masami; Shindo, Munehiro; Mishima, Saki; Morimura, Kazuhiro; Higuchi, Yoshiyasu; Yamada, Yosuke; Higaki, Yasuki; Kiyonaga, Akira			Effects of 2 weeks of low-intensity cycle training with different pedaling rates on the work rate at lactate threshold	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Pedal frequency; Lactate threshold; Aerobic exercise; Short-term training; Near-infrared spectroscopy	NEAR-INFRARED SPECTROSCOPY; SKELETAL-MUSCLE; PHYSIOLOGICAL-RESPONSES; HEMOGLOBIN OXYGENATION; GLUCOSE EFFECTIVENESS; GLYCOGEN DEPLETION; AEROBIC EXERCISE; MILD EXERCISE; ADAPTATIONS; FREQUENCY	This study examined (1) the effects of a single bout of exercise at different pedaling rates on physiological responses, pedal force, and muscle oxygenation, and (2) the effects of 2 weeks of training with different pedaling rates on work rate at lactate threshold (Work(LT)). Sixteen healthy men participated in the study. An incremental exercise test involving pedaling a cycling ergometer at 50 rpm was conducted to assess maximal oxygen consumption and Work(LT). The participants performed constant workload, submaximal exercise tests at Work(LT) intensity with three different pedaling rates (35, 50, and 75 rpm). Oxygen consumption (O-2), blood pressure, heart rate (HR), blood lactate, and pedal force were measured and oxy-hemoglobin/myoglobin concentration (OxyHb/Mb) at vastus lateralis was monitored by near-infrared spectroscopy during exercise. The participants were then randomly assigned to cycling exercise training at Work(LT) in either the low or high frequency pedaling rate (LFTr, 35 rpm or HFTr, 75 rpm) group. Each 60-min training session was performed five times/week. Despite maintaining the same work rate, O-2 and HR were significantly lower at 35 than 75 rpm. Conversely, integrated pedal force was significantly higher at 35 than 75 rpm. Peripheral OxyHb/Mb was significantly lower at 35 than 75 rpm. After 2 weeks of training, Work(LT) normalized to body mass significantly increased in the LFTr, but not the HFTr group. Pedaling rate and the corresponding pedal force and peripheral oxygenation during cycling exercise influence the effect of training at LT on Work(LT).	[Hirano, Masami; Shindo, Munehiro; Mishima, Saki; Morimura, Kazuhiro; Higaki, Yasuki; Kiyonaga, Akira] Fukuoka Univ, Fac Sports & Hlth Sci, Jonan Ku, Fukuoka 8140180, Japan; [Hirano, Masami; Yamada, Yosuke; Higaki, Yasuki; Kiyonaga, Akira] Fukuoka Univ, Cent Res Inst Phys Act, Jonan Ku, Fukuoka 8140180, Japan; [Higuchi, Yoshiyasu] Lab Phys Sci, Chuo Ku, Fukuoka 8100001, Japan; [Yamada, Yosuke] Natl Inst Hlth & Nutr, Shinjuku Ku, Tokyo 1628636, Japan	Hirano, M (reprint author), Fukuoka Univ, Fac Sports & Hlth Sci, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	masami.hrn@gmail.com			Japan Society for the Promotion of Science KAKENHI [19300224, 26750317]; Fukuoka University Institute for Physical Activity, a Technology Scientific Research Budget Basic Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology [A19200049]	We thank the member of the Laboratory of Exercise Physiology Fukuoka University. This work was supported by the Japan Society for the Promotion of Science KAKENHI Grant Number 19300224, 26750317, and the Fukuoka University Institute for Physical Activity, a Technology Scientific Research Budget Basic Research Grant (A19200049 Strategic Research Infrastructure) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The authors thank Prof. Tetsuo Takaishi of Nagoya City University, who provided advice during measurement of NIRS and crank angle data.	Hoppeler H, 2001, J EXP BIOL, V204, P3133; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Villard S, 2005, NEUROSCI LETT, V383, P333, DOI 10.1016/j.neulet.2005.04.047; AHLQUIST LE, 1992, EUR J APPL PHYSIOL O, V65, P360, DOI 10.1007/BF00868141; Faude O, 2009, SPORTS MED, V39, P469, DOI 10.2165/00007256-200939060-00003; Gotshall RW, 1996, INT J SPORTS MED, V17, P17; Goodman JM, 2005, J APPL PHYSIOL, V98, P454, DOI 10.1152/japplphysiol.00258.2004; Matsuo K, 2000, J NEUROPSYCH CLIN N, V12, P465, DOI 10.1176/appi.neuropsych.12.4.465; Tanimoto M, 2006, J APPL PHYSIOL, V100, P1150, DOI 10.1152/japplphysiol.00741.2005; Candotti CT, 2007, SPORT BIOMECH, V6, P31, DOI 10.1080/14763140601058490; Abe T, 2006, J APPL PHYSIOL, V100, P1460, DOI 10.1152/japplphysiol.01267.2005; Nishida Y, 2001, DIABETES CARE, V24, P1008, DOI 10.2337/diacare.24.6.1008; Watanabe A, 2002, NEUROSCI RES, V42, P279, DOI 10.1016/S0168-0102(02)00007-X; Ferreira LF, 2006, EUR J APPL PHYSIOL, V96, P558, DOI 10.1007/s00421-005-0107-3; Hansen EA, 2002, ACTA PHYSIOL SCAND, V176, P185, DOI 10.1046/j.1365-201X.2002.01032.x; BEAVER WL, 1985, J APPL PHYSIOL, V59, P1936; BELARDINELLI R, 1995, MED SCI SPORT EXER, V27, P512; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; BUCHANAN M, 1985, INT J SPORTS MED, V6, P163, DOI 10.1055/s-2008-1025832; Deschenes MR, 2000, AM J PHYSIOL-REG I, V279, pR2229; Green HJ, 2013, EUR J APPL PHYSIOL, V113, P1965, DOI 10.1007/s00421-013-2621-z; Green HJ, 2009, AM J PHYSIOL-REG I, V297, pR593, DOI 10.1152/ajpregu.91035.2008; Green HJ, 2013, EUR J APPL PHYSIOL, V113, P313, DOI 10.1007/s00421-012-2434-5; Hamaoka T, 1996, J APPL PHYSIOL, V81, P1410; Hansen EA, 2004, EUR J APPL PHYSIOL, V91, P435, DOI 10.1007/s00421-003-0997-x; Hirano M, 2014, J PHYS FITNESS SPORT, V3, P269; Homma S, 1996, J Biomed Opt, V1, P418, DOI 10.1117/12.252417; HUGHES EF, 1982, J APPL PHYSIOL, V52, P1598; KIRBY RL, 1992, J APPL PHYSIOL, V72, P1368; KIYONAGA A, 1985, HYPERTENSION, V7, P125; Novak V, 2007, J GERONTOL A-BIOL, V62, P86; ONODERA K., 1976, JPN J PHYS ED, V21, P191; PATTERSON RP, 1983, ERGONOMICS, V26, P659, DOI 10.1080/00140138308963387; PATTERSON RP, 1990, MED SCI SPORT EXER, V22, P512; Rowland T, 2001, INT J SPORTS MED, V22, P405, DOI 10.1055/s-2001-16245; Sakamoto M, 1999, J APPL PHYSIOL, V87, P2305; Shono Naoko, 2002, J Atheroscler Thromb, V9, P78; Sunami Y, 1999, METABOLISM, V48, P984, DOI 10.1016/S0026-0495(99)90194-4; Takaishi T, 2002, MED SCI SPORT EXER, V34, P520, DOI 10.1097/00005768-200203000-00020; Takaishi T, 1996, MED SCI SPORT EXER, V28, P1492, DOI 10.1097/00005768-199612000-00008; Takaishi T, 2002, MED SCI SPORT EXER, V34, P2062, DOI 10.1249/01.MSS.0000039304.91231.76; Tanaka H, 2012, J PHYS FITNESS SPORT, V1, P595; Tokui Masato, 2007, Eur J Appl Physiol, V101, P565, DOI 10.1007/s00421-007-0527-3; VANPRAAGH E, 1992, INT J SPORTS MED, V13, P27, DOI 10.1055/s-2007-1021229; Wang LX, 2005, JPN J PHYS FIT SPORT, V54, P229; Yoshimura E, 2014, OBESITY FACTS, V7, P26, DOI 10.1159/000358576; Yoshimura Eiichi, 2011, Obes Res Clin Pract, V5, pe169, DOI 10.1016/j.orcp.2011.03.003	47	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	MAY	2015	115	5					1005	1013		10.1007/s00421-014-3081-9		9	Physiology; Sport Sciences	Physiology; Sport Sciences	CF7FL	WOS:000352721500014		
J	Potier, L; Roussel, R; Labreuche, J; Marre, M; Cacoub, P; Rother, J; Wilson, PWF; Goto, S; Bhatt, DL; Steg, PG				Potier, Louis; Roussel, Ronan; Labreuche, Julien; Marre, Michel; Cacoub, Patrice; Roether, Joachim; Wilson, Peter W. F.; Goto, Shinya; Bhatt, Deepak L.; Steg, Philippe Gabriel		REACH Investigators	Interaction between diabetes and a high ankle-brachial index on mortality risk	EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY			English	Article						Cardiovascular risk; diabetes; high ankle-brachial index	PERIPHERAL ARTERIAL-DISEASE; COMPRESSIBLE LEG ARTERIES; CARDIOVASCULAR-DISEASE; PRESSURE INDEX; ARM INDEX; ALL-CAUSE; CALCIFICATION; ASSOCIATION; EVENTS; ATHEROSCLEROSIS	Objective Low ankle-brachial index (ABI) is a predictor of increased mortality. The impact of a high ABI on mortality is less studied. Moreover, diabetes is frequently associated with high ABI and, because of specific mechanisms in diabetic vascular diseases, the relationship with prognosis may be unique. Therefore, our aim was to compare mortality in individuals with and without diabetes according to abnormally low and high ABI. Design and methods We studied the association between ABI and all-cause and cardiovascular mortality in 6986 participants from the REACH registry, a cohort of 45 years and older stable outpatients at high cardiovascular risk (2875 (41.1%) with diabetes) followed for 4 years. Results ABI was normal (0.91-1.29) in 49.5%, low (0.9) in 47.5%, and high (1.3) in 2.9% of participants. During follow up, 9.9% of participants died (6.5% from cardiovascular causes). A low ABI was associated with cardiovascular mortality (adjusted hazard ratio, HR, 1.98, 95% CI 1.62-2.41) and all-cause mortality (HR 2.01, 95% CI 1.72-2.36), without heterogeneity according to diabetes. In contrast, high ABI was associated with higher risk of all-cause mortality in individuals with diabetes (HR 2.11, 95% CI 1.16-3.84), but not without diabetes (HR 0.82, 95% CI 0.36-1.85; p-value for interaction 0.07). The trend was similar for cardiovascular mortality (HR 2.13, 95% CI 1.03-4.44 and HR 1.05, 95% CI 0.43-2.59 with and without diabetes, respectively; p-value for interaction 0.24). Conclusions In the REACH registry, low ABI was associated with mortality, similarly in individuals without and with diabetes, whereas the association with high ABI was only observed in patients with diabetes.	[Potier, Louis; Roussel, Ronan; Marre, Michel] Hop Bichat Claude Bernard, Diabetol, F-75018 Paris, France; [Potier, Louis; Roussel, Ronan; Marre, Michel] AP HP, Dept Hosp Univ FIRE, Paris, France; [Potier, Louis; Roussel, Ronan] INSERM, U1138, Res Ctr Cordeliers, Paris, France; [Potier, Louis; Roussel, Ronan; Labreuche, Julien; Marre, Michel; Steg, Philippe Gabriel] Paris Diderot Univ, Paris, France; [Labreuche, Julien; Steg, Philippe Gabriel] INSERM, U1148, Paris, France; [Cacoub, Patrice] Grp Hosp Pitie Salpetriere, AP HP, Dept Internal Med, F-75634 Paris, France; [Roether, Joachim] Asklepios Klin Hamburg Altona, Dept Neurol, Hamburg, Germany; [Wilson, Peter W. F.] Atlanta VA Med Ctr, Atlanta, GA USA; [Wilson, Peter W. F.] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA; [Goto, Shinya] Tokai Univ, Sch Med, Dept Med Cardiol, Isehara, Kanagawa 25911, Japan; [Bhatt, Deepak L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA; [Steg, Philippe Gabriel] Hop Bichat Claude Bernard, Cardiol, F-75018 Paris, France; [Steg, Philippe Gabriel] AP HP, Dept Hosp Univ FIRE, Paris, France; [Steg, Philippe Gabriel] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, NHLI, London, England	Potier, L (reprint author), Hop Bichat Claude Bernard, Dept Diabetol, 46 Rue Henri Huchard, F-75018 Paris, France.	louis.potier@gmail.com			DHU FIRE; Sanofi-Aventis; Bristol-Myers Squibb; Waksman Foundation (Tokyo, Japan)	The REACH Registry is endorsed by the World Heart Federation and supported by the DHU FIRE. The REACH Registry was sponsored by Sanofi-Aventis and Bristol-Myers Squibb, (who have completed their funding) and continues to be sponsored by the Waksman Foundation (Tokyo, Japan).	Aboyans V, 2005, J AM COLL CARDIOL, V46, P815, DOI 10.1016/j.jacc.2005.05.066; Aboyans V, 2012, J AM COLL CARDIOL, V60, P643, DOI 10.1016/j.jacc.2012.02.077; Clark N, 2003, DIABETES CARE, V26, P3333; Aboyans V, 2008, J VASC SURG, V48, P1197, DOI 10.1016/j.jvs.2008.06.005; Olin JW, 2010, J AM COLL CARDIOL, V56, P2147, DOI 10.1016/j.jacc.2010.08.606; Ix JH, 2012, J VASC SURG, V56, P721, DOI 10.1016/j.jvs.2012.02.042; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Papamichael CM, 2000, AM J CARDIOL, V86, P615, DOI 10.1016/S0002-9149(00)01038-9; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; YOUNG MJ, 1993, DIABETOLOGIA, V36, P615, DOI 10.1007/BF00404070; QUIGLEY FG, 1991, CLIN PHYSIOL, V11, P21, DOI 10.1111/j.1475-097X.1991.tb00650.x; EVERHART JE, 1988, DIABETOLOGIA, V31, P16; Ogren M, 2005, EUR J VASC ENDOVASC, V29, P182, DOI 10.1016/j.ejvs.2004.11.013; Potier L, 2011, EUR J VASC ENDOVASC, V41, P110, DOI 10.1016/j.ejvs.2010.09.020; Leng GC, 1996, BRIT MED J, V313, P1440; O'Hare AM, 2006, CIRCULATION, V113, P388, DOI 10.1161/CIRCULATIONAHA.105.570903; NEWMAN AB, 1993, CIRCULATION, V88, P837; Levey AS, 1999, ANN INTERN MED, V130, P461; Arain FA, 2012, J AM COLL CARDIOL, V59, P400, DOI 10.1016/j.jacc.2011.09.055; Clairotte C, 2009, DIABETES CARE, V32, P1231, DOI 10.2337/dc08-2230; Fowkes FGR, 2014, EUR J PREV CARDIOL, V21, P310, DOI 10.1177/2047487313516564; Busch MA, 2009, STROKE, V40, P3700, DOI 10.1161/STROKEAHA.109.559740; Eraso LH, 2012, EUR J PREV CARDIOL; Greenland P, 2000, Circulation, V101, pE16; Hanssen NMJ, 2012, DIABETES CARE, V35, P1731, DOI 10.2337/dc12-0178; MASER RE, 1991, ARTERIOSCLER THROMB, V11, P958; Mostaza JM, 2011, ATHEROSCLEROSIS, V214, P191, DOI 10.1016/j.atherosclerosis.2010.10.020; Quiles Juan, 2011, Int J Cardiol, V151, P84, DOI 10.1016/j.ijcard.2010.04.097; Wilson PWF, 2012, AM J MED, V125, P695, DOI 10.1016/j.amjmed.2012.01.014	29	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2047-4873	2047-4881		EUR J PREV CARDIOL	Eur. J. Prev. Cardiol.	MAY	2015	22	5					615	621		10.1177/2047487314533621		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CF8FQ	WOS:000352791900009		
J	Nagoshi, N; Fehlings, MG				Nagoshi, Narihito; Fehlings, Michael G.			Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to II	EXPERT OPINION ON INVESTIGATIONAL DRUGS			English	Review						basic fibroblast growth factor; clinical trials in Phase II; magnesium; minocycline; Rho protein antagonist; riluzole; spinal cord injury	PROMOTES FUNCTIONAL RECOVERY; CHONDROITIN SULFATE PROTEOGLYCANS; CENTRAL-NERVOUS-SYSTEM; NEURITE OUTGROWTH; SECONDARY INJURY; WHITE-MATTER; NOGO-A; NEUROPROTECTIVE AGENT; CORTICOSPINAL TRACT; CEREBROSPINAL-FLUID	Introduction: Efforts in basic research have clarified mechanisms involved in spinal cord injury (SCI), and resulted in positive findings using experimental treatments including cell transplantation and drug administration preclinically. Based on accumulated results, various clinical trials have begun for human SCI. Areas covered: In this review, the authors focus on five investigational drugs: riluzole, minocycline, Rho protein antagonist, magnesium chloride in polyethylene glycol formulation, and basic fibroblast growth factor. All drugs have established safety and tolerability from Phase I clinical trials, and are now in Phase II. They have been proven to have neuroprotective and/or neuroregenerative effects in animal models of SCI. Expert opinion: To date, diverse drugs have been translated into clinical trials, but none have reached clinical application. A key gap was the lack of reliable biomarkers for SCI to fast-track Phase I/II trials. Furthermore, problems were often due to lack of adequate outcome assessments for both animal models and SCI patients. In order to advance clinical trials more quickly and with greater success, more clinically relevant animal models should be used in basic research. Clinically, it is indispensable to use appropriate outcome measurements and to construct a wide network among clinical centers to validate the efficacy of drugs.	[Nagoshi, Narihito; Fehlings, Michael G.] Univ Hlth Network, Toronto Western Hosp, Krembil Neurosci Ctr, Toronto, ON M5T 2S8, Canada; [Nagoshi, Narihito] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1608582, Japan; [Fehlings, Michael G.] Univ Toronto, Univ Hlth Network, Inst Med Sci, Toronto, ON M5S 1A8, Canada	Fehlings, MG (reprint author), Univ Hlth Network, Toronto Western Hosp, Krembil Neurosci Ctr, Toronto, ON M5T 2S8, Canada.	Michael.Fehlings@uhn.ca			AOSpine North America; AOSpine International; NACTN; Rick Hansen Institute; Ontario Neurotrauma Foundation; Hadassah Medical Organization; BioAxone BioSciences, Inc.; Acorda Therapeutics, Inc.; Asubio Pharmaceuticals, Inc.	The trial for riluzole is supported by AOSpine North America in partnership with AOSpine International, NACTN, the Rick Hansen Institute and the Ontario Neurotrauma Foundation. The trial for minocycline in Canada is supported by the Rick Hansen Institute, and the one in Israel is by Hadassah Medical Organization. The trial for BA-210 is supported by BioAxone BioSciences, Inc. The trial for magnesium chloride is supported by Acorda Therapeutics, Inc. The trial for FGF2 is supported by Asubio Pharmaceuticals, Inc.	Adams M, 2004, SPINAL CORD, V42, P273, DOI 10.1038/sj.sc.3101597; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Fehlings MG, 2012, J NEUROSURG-SPINE, V17, P151, DOI 10.3171/2012.4.AOSPINE1259; Zhang HY, 2013, MOL NEUROBIOL, V48, P452, DOI 10.1007/s12035-013-8432-8; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Kwon BK, 2010, SPINE, V35, pS263, DOI 10.1097/BRS.0b013e3181f3286d; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Grossman RG, 2014, J NEUROTRAUM, V31, P239, DOI 10.1089/neu.2013.2969; Bensimon G, 2002, J NEUROL, V249, P609, DOI 10.1007/s004150200071; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Chen MS, 2000, NATURE, V403, P434; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Agrawal SK, 1996, J NEUROSCI, V16, P545; STYS PK, 1991, ANN NEUROL, V30, P375, DOI 10.1002/ana.410300309; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175; Suzer T, 1999, SPINAL CORD, V37, P480, DOI 10.1038/sj.sc.3100874; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; KOBRINE AI, 1984, J NEUROSURG, V60, P595, DOI 10.3171/jns.1984.60.3.0595; GrandPre T, 2000, NATURE, V403, P439; HAIGNEY MCP, 1992, CIRC RES, V71, P547; Wu YC, 2013, J NEUROTRAUM, V30, P441, DOI 10.1089/neu.2012.2622; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Konomi T, 2012, NEUROIMAGE, V63, P1841, DOI 10.1016/j.neuroimage.2012.08.040; Lord-Fontaine S, 2008, J NEUROTRAUM, V25, P1309, DOI 10.1089/neu.2008.0613; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456; Fujiyoshi K, 2007, J NEUROSCI, V27, P11991, DOI 10.1523/JNEUROSCI.3354-07.2007; Grossman RG, 2012, J NEUROSURG-SPINE, V17, P6, DOI 10.3171/2012.4.AOSPINE1294; Lee SM, 2003, J NEUROTRAUM, V20, P1017, DOI 10.1089/089771503770195867; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; Zhang HY, 2013, CNS NEUROSCI THER, V19, P20, DOI 10.1111/cns.12013; Lee JHT, 2010, EXP NEUROL, V225, P219, DOI 10.1016/j.expneurol.2010.06.018; Dergham P, 2002, J NEUROSCI, V22, P6570; Cho DC, 2011, J KOREAN NEUROSURG S, V49, P83, DOI 10.3340/jkns.2011.49.2.83; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Kwon BK, 2009, J NEUROTRAUM, V26, P1379, DOI 10.1089/neu.2009-0884; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Wilson JR, 2013, CAN MED ASSOC J, V185, P485, DOI 10.1503/cmaj.121206; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; Palmer GC, 2001, CURR DRUG TARGETS, V2, P241, DOI 10.2174/1389450013348335; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Labruyere R, 2010, SPINE, V35, pS259, DOI 10.1097/BRS.0b013e3181f1a979; Raad M, 2012, ELECTROPHORESIS, V33, P3659, DOI 10.1002/elps.201200470; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; Guest JD, 1997, J NEUROSCI RES, V50, P888, DOI 10.1002/(SICI)1097-4547(19971201)50:5<888::AID-JNR24>3.0.CO;2-W; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Lehmann M, 1999, J NEUROSCI, V19, P7537; Fehlings MG, 2011, J NEUROTRAUM, V28, P787, DOI 10.1089/neu.2011.1765; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Pouw MH, 2014, SPINAL CORD, V52, P428, DOI 10.1038/sc.2014.26; Hug A, 2012, INT REV NEUROBIOL, V106, P173, DOI 10.1016/B978-0-12-407178-0.00008-9; Yune TY, 2007, J NEUROSCI, V27, P7751, DOI 10.1523/JNEUROSCI.1661-07.2007; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; [Anonymous], 2013, J SPINAL CORD MED, V36, P170; Wu Y, 2014, NEUROSCIENCE, V265, P302, DOI 10.1016/j.neuroscience.2014.01.059; Teng YD, 1998, EUR J NEUROSCI, V10, P798, DOI 10.1046/j.1460-9568.1998.00100.x; Teng YD, 1997, J NEUROSCI, V17, P4359; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Wilson JR, 2012, SPINAL CORD, V50, P840, DOI 10.1038/sc.2012.59; McKerracher L, 2013, J NEUROTRAUM, V30, P1795, DOI 10.1089/neu.2013.2909; Schwartz G, 2001, J NEUROSURG, V94, P245, DOI 10.3171/spi.2001.94.2.0245; Watzlawick R, 2014, JAMA NEUROL, V71, P91, DOI 10.1001/jamaneurol.2013.4684; Kaptanoglu E, 2003, J CLIN NEUROSCI, V10, P329, DOI 10.1016/S0967-5868(03)00031-6; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Festoff BW, 2006, J NEUROCHEM, V97, P1314, DOI 10.1111/j.1471-4159.2006.03799.x; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; HAIGNEY MCP, 1994, CIRCULATION, V90, P391; Schnell L, 1999, J NEUROPATH EXP NEUR, V58, P245, DOI 10.1097/00005072-199903000-00004; Freund P, 2007, J COMP NEUROL, V502, P644, DOI 10.1002/cne.21321; Teng YD, 1999, J NEUROSCI, V19, P7037; Kwon BK, 2011, J NEUROTRAUM, V28, P1525, DOI 10.1089/neu.2010.1296; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Hayakawa K, 2012, SPINAL CORD, V50, P493, DOI 10.1038/sc.2011.184; Cadotte DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045560; DILLON ST, 1995, METHOD ENZYMOL, V256, P174; Fehlings Michael G, 2014, Neurosurgery, V61 Suppl 1, P36, DOI 10.1227/NEU.0000000000000412; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Forgione N, 2014, WORLD NEUROSURG, V82, pE535, DOI 10.1016/j.wneu.2013.01.009; Gomes-Leal W, 2012, BRAIN BEHAV, V2, P345, DOI 10.1002/brb3.51; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1007/BF03206569; Harrop JS, 2012, J NEUROSURG-SPINE, V17, P230, DOI 10.3171/2012.5.AOSPINE12115; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Hurlbert R John, 2014, Neurosurgery, V61 Suppl 1, P32, DOI 10.1227/NEU.0000000000000393; Kaptanoglu E, 2003, NEUROSURG REV, V26, P283, DOI 10.1007/s10143-003-0272-y; Kuhle J, 2014, J NEUROL NEUROSURG P; Li S, 1999, J Neurosci, V19, pRC16; Saganova K, 2008, NEUROSCI LETT, V433, P246, DOI 10.1016/j.neulet.2008.01.041; SCHANNE FAX, 1979, SCIENCE, V206, P700, DOI 10.1126/science.386513; Schwartz G, 2002, PROG BRAIN RES, V137, P177; Sonmez E, 2013, SPINE, V38, P1253, DOI 10.1097/BRS.0b013e3182895587; Yokobori S., 2013, WORLD NEUROSURG	101	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1354-3784	1744-7658		EXPERT OPIN INV DRUG	Expert Opin. Investig. Drugs	MAY	2015	24	5					645	658		10.1517/13543784.2015.1009629		14	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CF6EF	WOS:000352648800005		
J	Michel, MC; Igawa, Y				Michel, Martin C.; Igawa, Yasuhiko			Therapeutic targets for overactive bladder other than smooth muscle	EXPERT OPINION ON THERAPEUTIC TARGETS			English	Review						afferent nerve; bladder vasculature; overactive bladder; urothelium	LOWER URINARY-TRACT; NERVE GROWTH-FACTOR; BETA-ADRENOCEPTOR AGONISTS; MESSENGER-RNA EXPRESSION; NITRIC-OXIDE SYNTHASE; CYCLOPHOSPHAMIDE-INDUCED CYSTITIS; SPONTANEOUSLY HYPERTENSIVE-RAT; CHRONICALLY ISCHEMIC BLADDER; MUSCARINIC RECEPTOR SUBTYPES; GUINEA-PIG BLADDER	Introduction: For a long time, our concepts of regulation of urinary bladder function in health and disease as well as of the target structures of therapeutics have focused on detrusor smooth muscle cells. However, other structures including urothelium, afferent nerves and bladder blood vessels may also be important in pathophysiology and its treatment. Areas covered: Based on a selective review of literature, we discuss the role of urothelium, afferent nerve fibers and bladder blood vessels in bladder pathophysiology and as targets for treatment. Expert opinion: There is solid evidence now that multiple anatomical structures within the urinary bladder contribute to the regulation of its function and hence may be targets for established and emerging drugs. However, most previous studies have looked at the various target structures in isolation. In contrast, we propose that they should be seen as a network sensing and responding to alterations in the cellular environment or to xenobiotics. Studies are emerging in which the interaction of two of these structures is explored. Major advances in our understanding of bladder function are expected to result from studies integrating multiple such structures but these may be technically challenging and difficult to perform and interpret.	[Michel, Martin C.] Johannes Gutenberg Univ Mainz, Dept Pharmacol, Mainz, Germany; [Igawa, Yasuhiko] Univ Tokyo, Grad Sch Med, Dept Continence Med, Tokyo, Japan	Michel, MC (reprint author), Johannes Gutenberg Univ Mainz, Dept Pharmacol, Mainz, Germany.	marmiche@uni-mainz.de			Allergan; AltheRX; Astellas; Bayer; Pfizer; Deutsche Forschungsgemeinschaft [MI 294/7-2]; European Community [HEALTH-F2-2008-223234]; Asahi-kasei; Kissei; Kyorin; Ono; RaQualia; Taiho; Daiichi-Sankyo; Nippon-Shinyaku; Ministry of Education, Culture, Sport, Science and Technology of the Japanese government [40159588]	MC Michel has received research support, consultant and/or lecturer honoraria in the OAB field from Allergan, AltheRX, Astellas, Bayer and Pfizer. Currently he is an employee of Boehringer Ingelheim. Research in his laboratory has been supported in part by grants from the Deutsche Forschungsgemeinschaft (MI 294/7-2) and Coordination Theme 1 (Health) of the European Community's FP7, Grant agreement number HEALTH-F2-2008-223234. Y Igawa has received research support, consultant and/or lecturer honoraria in the OAB field from Astellas, Asahi-kasei, Kissei, Kyorin, Ono, Pfizer, RaQualia, Taiho, Daiichi-Sankyo and Nippon-Shinyaku. Research in his laboratory has been supported by a Grant-in-Aid for Scientific Research (Grant no. 40159588), from the Ministry of Education, Culture, Sport, Science and Technology of the Japanese government. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Aizawa N, 2014, J UROLOGY, V192, P956, DOI 10.1016/j.juro.2014.04.008; Aizawa N, 2014, NEUROUROL URODYNAM, V33, P734; Aizawa N, 2014, NEUROUROL URODYN; Aizawa N, 2013, EUR UROL SUPPL, V12, pe64; Aizawa N, 2012, NEUROUROL URODYNAM, V31, P148, DOI 10.1002/nau.21212; Aizawa N, 2013, NEUROUROL URODYNAM, V32, P569; Aizawa N, 2013, J UROLOGY, V189, P1580, DOI 10.1016/j.juro.2012.10.060; Aizawa N, 2014, J UROL; Aizawa N, 2014, J UROLOGY, V191, pe138; Andersson KE, 2014, NEUROUROL URODYNAM, V33, P9, DOI 10.1002/nau.22465; Andersson MC, 2008, BRIT J PHARMACOL, V153, P1438, DOI 10.1038/bjp.2008.6; Walden PD, 1997, J UROLOGY, V157, P1032, DOI 10.1016/S0022-5347(01)65136-X; Bschleipfer T, 2007, LIFE SCI, V80, P2303, DOI 10.1016/j.lfs.2007.01.053; Ashton JC, 2014, N-S ARCH PHARMACOL, V387, P301, DOI 10.1007/s00210-013-0948-y; Kurizaki Y, 2011, SCAND J UROL NEPHROL, V45, P15, DOI 10.3109/00365599.2010.515611; Lips KS, 2007, EUR UROL, V51, P1042, DOI 10.1016/j.eururo.2006.10.028; Murakami S, 2007, BJU INT, V99, P669, DOI 10.1111/j.1464-410X.2006.06679.x; Collins VM, 2013, BJU INT, V112, P1018, DOI 10.1111/bju.12266; Otsuka A, 2008, N-S ARCH PHARMACOL, V377, P473, DOI 10.1007/s00210-008-0274-y; Frazier EP, 2005, J PHARMACOL EXP THER, V313, P260, DOI 10.1124/jpet.104.077768; De Laet K, 2006, NEUROUROL URODYNAM, V25, P156, DOI 10.1002/nau.20208; Azadzoi KM, 2011, J UROLOGY, V186, P2115, DOI 10.1016/j.juro.2011.06.047; Arrighi N, 2011, PHARMACOL RES, V64, P420, DOI 10.1016/j.phrs.2011.06.009; Mine S, 2013, UROLOGY, V81, P155, DOI 10.1016/j.urology.2012.09.008; Azadzoi KM, 2004, NEUROUROL URODYNAM, V23, P258, DOI 10.1002/nau.20029; Franken J, 2014, BRIT J PHARMACOL, V171, P2537, DOI 10.1111/bph.12502; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Tully BT, 2009, UROLOGY, V74, P467, DOI 10.1016/j.urology.2009.02.043; Nomiya M, 2013, J UROLOGY, V189, P754, DOI 10.1016/j.juro.2012.07.141; Azadzoi KM, 2007, J UROLOGY, V178, P710, DOI 10.1016/j.juro.2007.03.096; Goi Y, 2013, J UROLOGY, V190, P1116, DOI 10.1016/j.juro.2013.03.110; Minagawa T, 2014, NEUROUROL URODYNAM, V33, P544, DOI 10.1002/nau.22449; Anisuzzaman ASM, 2008, J PHARMACOL SCI, V106, P271, DOI 10.1254/jphs.FP0071435; Hawthorn MH, 2000, BRIT J PHARMACOL, V129, P416, DOI 10.1038/sj.bjp.0703068; Frazier EP, 2008, N-S ARCH PHARMACOL, V377, P449, DOI 10.1007/s00210-007-0208-0; Bohmer T, 2014, N-S ARCH PHARMACOL, V387, P703, DOI 10.1007/s00210-014-0992-2; Chapple CR, 2014, NEUROUROL URODYNAM, V33, P17, DOI 10.1002/nau.22505; Iijima K, 2007, EUR UROL, V52, P842, DOI 10.1016/j.eururo.2007.02.057; Datta SN, 2010, J UROLOGY, V184, P2578, DOI 10.1016/j.juro.2010.07.034; Ochodnicky P, 2011, NEUROUROL URODYNAM, V30, P1227, DOI 10.1002/nau.21022; Jang J, 2006, BJU INT, V98, P435, DOI 10.1111/j.1464-410X.2006.06207.x; Aizawa N, 2011, NEUROUROL URODYNAM, V30, P163, DOI 10.1002/nau.20940; Yoshida M, 2008, J PHARMACOL SCI, V106, P193, DOI 10.1254/jphs.FM0070115; Gillespie JI, 2009, BJU INT, V103, P1324, DOI 10.1111/j.1464-410X.2009.08377.x; Mangera A, 2011, EUR UROL, V60, P784, DOI 10.1016/j.eururo.2011.07.001; Okutsu H, 2010, UROLOGY, V75, P235, DOI 10.1016/j.urology.2009.05.045; Yokoyama O, 2010, WORLD J UROL, V28, P609, DOI 10.1007/s00345-009-0481-2; Kurzrock EA, 2005, J UROLOGY, V173, P281, DOI 10.1097/01.ju.0000141585.17953.fa; Apodaca G, 2007, KIDNEY INT, V72, P1057, DOI 10.1038/sj.ki.5002439; Kershen RT, 2002, J UROLOGY, V168, P121, DOI 10.1016/S0022-5347(05)64843-4; Andersson KE, 2011, EUR UROL, V59, P377, DOI 10.1016/j.eururo.2010.11.040; Mansfield KJ, 2005, BRIT J PHARMACOL, V144, P1089, DOI 10.1038/sj.bjp.0706147; Aizawa N, 2010, NEUROUROL URODYNAM, V29, P771, DOI 10.1002/nau.20826; Martin SA, 2011, WORLD J UROL, V29, P179, DOI 10.1007/s00345-010-0605-8; Birder LA, 2007, NAT CLIN PRACT UROL, V4, P46, DOI 10.1038/ncpuro0672; Aizawa N, 2011, EUR UROL, V59, P264, DOI 10.1016/j.eururo.2010.10.035; Ohlstein EH, 2012, EUR UROL, V62, P834, DOI 10.1016/j.eururo.2012.05.053; Daly DM, 2014, J PHYSIOL-LONDON, V592, P537, DOI 10.1113/jphysiol.2013.262634; Michel MC, 2006, BRIT J PHARMACOL, V147, pS88, DOI 10.1038/sj.bjp.0706619; Nomiya M, 2014, J UROLOGY, V191, P1462, DOI 10.1016/j.juro.2013.10.097; Kuo HC, 2014, EUR UROL, V65, P1117, DOI 10.1016/j.eururo.2014.01.036; Masunaga K, 2010, NEUROUROL URODYNAM, V29, P1320, DOI 10.1002/nau.20838; Tyagi P, 2009, INT BRAZ J UROL, V35, P76, DOI 10.1590/S1677-55382009000100012; Chaiyaprasithi B, 2003, J UROLOGY, V170, P1897, DOI 10.1097/01.ju.0000091870.51841.ae; Patra PB, 2011, J PHARMACOL EXP THER, V338, P392, DOI 10.1124/jpet.111.180885; Greenland JE, 2001, J UROLOGY, V165, P245, DOI 10.1097/00005392-200101000-00072; Chapple CR, 2008, EUR UROL, V54, P543, DOI 10.1016/j.eururo.2008.06.047; Michel MC, 2008, PHARMACOL THERAPEUT, V117, P297, DOI 10.1016/j.pharmthera.2007.12.001; Azadzoi KM, 1999, J UROLOGY, V162, P1768, DOI 10.1016/S0022-5347(05)68236-5; Limberg BJ, 2010, CELL TISSUE RES, V342, P295, DOI 10.1007/s00441-010-1053-x; Andersson KE, 2009, CURR OPIN UROL, V19, P380, DOI 10.1097/MOU.0b013e32832ce8a4; de Groat WC, 2010, NEUROUROL URODYNAM, V29, P63, DOI 10.1002/nau.20761; Nomiya M, 2012, NEUROUROL URODYNAM, V31, P195, DOI 10.1002/nau.21073; Hashitani H, 2012, BRIT J PHARMACOL, V167, P1723, DOI 10.1111/j.1476-5381.2012.02125.x; Smith CP, 2008, NEUROCHEM INT, V52, P1068, DOI 10.1016/j.neuint.2007.11.006; Azadzoi KM, 2010, J UROLOGY, V183, P362, DOI 10.1016/j.juro.2009.08.103; Yoshimura N, 2014, INT J UROL, V21, P18, DOI 10.1111/iju.12308; Azadzoi KM, 1999, J UROLOGY, V161, P1626, DOI 10.1016/S0022-5347(05)68995-1; Nomiya M, 2003, J UROLOGY, V170, P649, DOI 10.1097/01.ju.0000067621.62736.7c; Aizawa N, 2012, EUR UROL, V62, P1165, DOI 10.1016/j.eururo.2012.08.056; Gillespie JI, 2004, BJU INT, V93, P851, DOI 10.1111/j.1464-410X.2004.04727.x; Minagawa T, 2012, BJU INT, V110, pE259, DOI 10.1111/j.1464-410X.2012.11255.x; Shenfeld OZ, 2005, UROLOGY, V65, P181, DOI 10.1016/j.urology.2004.08.055; Cheng JT, 2007, NEUROSCI LETT, V423, P1, DOI 10.1016/j.neulet.2007.05.062; Parsons CL, 2011, BJU INT, V107, P370, DOI 10.1111/j.1464-410X.2010.09843.x; Wuest M, 2005, N-S ARCH PHARMACOL, V372, P203, DOI 10.1007/s00210-005-0015-4; Antunes-Lopes T, 2014, CURR OPIN UROL, V24, P352, DOI 10.1097/MOU.0000000000000064; Aydin M, 2010, BJU INT, V106, P562, DOI 10.1111/j.1464-410X.2009.09156.x; Azadzoi KM, 2008, UROLOGY, V71, P979, DOI 10.1016/j.urology.2007.11.012; Bahadory F, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00148; Barendrecht M. M., 2007, Autonomic & Autacoid Pharmacology, V27, P47, DOI 10.1111/j.1474-8673.2006.00393.x; Birder LA, 2002, J NEUROSCI, V22, P8063; Birder LA, 1998, AM J PHYSIOL-RENAL, V275, pF226; Birder LA, 2013, ACTA PHYSIOL, V207, P123, DOI 10.1111/j.1748-1716.2012.02462.x; Borowsky AD, 2012, J LIPID RES, V53, P1920, DOI 10.1194/jlr.M028084; Braverman AS, 2007, NEUROUROL URODYNAM, V26, P63, DOI 10.1002/nau.20378; Bschleipfer T, 2012, LIFE SCI, V91, P1082, DOI 10.1016/j.lfs.2012.04.007; Bschleipfer T, 2012, LIFE SCI, V91, P1077, DOI 10.1016/j.lfs.2012.05.007; Bschleipfer T, 2015, J UROLOGY, V193, P345, DOI 10.1016/j.juro.2014.08.098; BURNSTOC.G, 1972, BRIT J PHARMACOL, V44, P451; Cecyre B, 2014, N-S ARCH PHARMACOL, V387, P175, DOI 10.1007/s00210-013-0930-8; Cernecka H, 2014, N-S ARCH PHARMACOL, V387, P1117, DOI 10.1007/s00210-014-1039-4; Charrua A, 2014, BJU INT; Chopra B, 2005, J PHYSIOL-LONDON, V562, P859, DOI 10.1113/jphysiol.2004.071159; Daher A, 2004, EUR UROL, V45, P799, DOI 10.1016/j.eururo.2004.01.002; Daly DM, 2010, EUR UROL, V58, P22, DOI 10.1016/j.eururo.2009.12.030; Everaerts W, 2009, N-S ARCH PHARMACOL, V379, P421, DOI 10.1007/s00210-008-0391-7; Fovaeus M, 1999, J UROLOGY, V161, P649, DOI 10.1016/S0022-5347(01)61988-8; Frias B, 2012, BJU INT, V110, pE422, DOI 10.1111/j.1464-410X.2012.11187.x; Gabella G, 1999, Scand J Urol Nephrol Suppl, V201, P32; Ha US, 2011, UROLOGY, V78; Hanna-Mitchell AT, 2015, NEUROUROL URODYNAM, V34, P79, DOI 10.1002/nau.22508; Hanna-Mitchell AT, 2013, AM J PHYSIOL-REG I, V304, pR84, DOI 10.1152/ajpregu.00129.2012; Harmon Erin B, 2005, Cell Commun Signal, V3, P10, DOI 10.1186/1478-811X-3-10; Hernandez M, 2007, NEUROUROL URODYNAM, V26, P578, DOI 10.1002/nau.20368; Inoue S, 2012, BJU INT, V110, pE118, DOI 10.1111/j.1464-410X.2011.10814.x; Ishida T, 1999, JPN J UROL, V90, P564; Ishihama H, 2006, J UROLOGY, V175, P358, DOI 10.1016/S0022-5347(05)00016-9; Johansson R, 2002, J UROLOGY, V168, P2689, DOI 10.1097/01.ju.0000031837.95143.85; Kendig DM, 2013, EUR J PHARMACOL, V720, P355, DOI 10.1016/j.ejphar.2013.10.004; Kim SE, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-81; Klausner AP, 2009, EUR J PHARMACOL, V606, P191, DOI 10.1016/j.ejphar.2009.01.034; Koritsiadis G, 2008, BJU INT, V102, P28; Krause P, 2013, J UROLOGY, V190, P1791, DOI 10.1016/j.juro.2013.05.011; Krege S, 2004, J UROLOGY, V172, P2045, DOI 10.1097/01.ju.0000137938.47097.63; Kullmann FA, 2009, J PHARMACOL EXP THER, V330, P704, DOI 10.1124/jpet.109.155010; Kullmann FA, 2011, NEUROUROL URODYNAM, V30, P144, DOI 10.1002/nau.20965; Kurizaki Y, 2013, NEUROUROL URODYNAM, V32, P88, DOI 10.1002/nau.22278; LEE JG, 1994, J UROLOGY, V151, P1096; Lee WC, 2008, J UROLOGY, V179, P2470, DOI 10.1016/j.juro.2008.01.086; Levin RM, 2000, NEUROUROL URODYNAM, V19, P701, DOI 10.1002/1520-6777(2000)19:6<701::AID-NAU8>3.0.CO;2-W; Lin WY, 2011, WORLD J UROL, V29, P165, DOI 10.1007/s00345-008-0369-6; Liu SH, 1997, N-S ARCH PHARMACOL, V356, P850, DOI 10.1007/PL00005127; MADERSBACHER H, 1995, EUR UROL, V28, P340; McLatchie LM, 2014, BRIT J PHARMACOL, V171, P3394, DOI 10.1111/bph.12682; Michel MC, 2014, EUR UROL, V65, P1125, DOI 10.1016/j.eururo.2014.02.046; Michel MC, 2014, N-S ARCH PHARMACOL, V387, P215, DOI 10.1007/s00210-013-0936-2; Mitterberger Michael, 2007, BJU Int, V99, P831, DOI 10.1111/j.1464-410X.2006.06735.x; Mizuno H, 2010, UROLOGY, V76; Nandigama R, 2010, NEUROSCIENCE, V168, P842, DOI 10.1016/j.neuroscience.2010.04.012; Nishiya Y, 2014, BIOL PHARM BULL, V37, P130; Nomiya M, 2012, NEUROUROL URODYNAM, V31, P185, DOI 10.1002/nau.21191; Ochodnicky P, 2013, PHARMACOL RES, V70, P147, DOI 10.1016/j.phrs.2013.01.010; Ochodnicky P, 2012, BJU INT, V110, pE293, DOI [10.1111/j.1464-410X.2012.011145.x, 10.1111/j.1464-410X.2012.11145]; Okutsu H, 2011, J UROLOGY, V186, P2470, DOI 10.1016/j.juro.2011.07.085; Otsuka A, 2013, LUTS, V5, P173, DOI 10.1111/luts.12007; Pessina F, 2004, N-S ARCH PHARMACOL, V370, P521, DOI 10.1007/s00210-004-0998-2; Pontari MA, 1999, AM J PHYSIOL-REG I, V276, pR407; Propping S, 2009, NEUROUROL URODYNAM, V28, P870; Rapp DE, 2005, EUR UROL, V48, P303, DOI 10.1016/j.eururo.2005.04.019; Sadananda P, 2008, BRIT J PHARMACOL, V153, P1465, DOI 10.1038/bjp.2008.29; Sand C, 2014, J PHARMACOL EXP THER, V348, P25, DOI 10.1124/jpet.113.208025; Sawada N, 2013, EUR UROL, V64, P664, DOI 10.1016/j.eururo.2013.06.043; Takeda M, 2010, LUTS, V2, P51, DOI 10.1111/j.1757-5672.2010.00074.x; Talmont F, 2014, N-S ARCH PHARMACOL, V387, P427, DOI 10.1007/s00210-014-0957-5; Templeman L, 2002, J UROLOGY, V167, P742, DOI 10.1016/S0022-5347(01)69137-7; Tong YC, 2007, J UROLOGY, V178, P1537, DOI 10.1016/j.juro.2007.05.114; Tucci P, 2002, PHARMACOLOGY, V64, P57, DOI 10.1159/000056151; Watterson KR, 2007, FASEB J, V21, P2818, DOI 10.1096/fj.06-7326com; Wyndaele JJ, 2010, NEUROUROL URODYNAM, V29, P56, DOI 10.1002/nau.20776; Xiao ZY, 2014, AM J PHYSIOL-RENAL, V307, pF673, DOI 10.1152/ajprenal.00308.2014; Yokoyama O, 2011, J UROLOGY, V185, P2392, DOI 10.1016/j.juro.2011.02.048; Yokoyama O, 2005, J UROLOGY, V174, P2032, DOI 10.1097/01.ju.0000176793.50410.9e; Yokoyama O, 2006, NEUROUROL URODYNAM, V25, P461, DOI 10.1002/nau.20253; Yoshiyama M, 2001, AM J PHYSIOL-REG I, V280, pR1414; Yu WQ, 2013, N-S ARCH PHARMACOL, V386, P885, DOI 10.1007/s00210-013-0894-8; Yu YB, 2010, BRAIN RES, V1361, P43, DOI 10.1016/j.brainres.2010.09.018; Yu YB, 2013, BRAIN RES, V1490, P83, DOI 10.1016/j.brainres.2012.10.007	168	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1472-8222	1744-7631		EXPERT OPIN THER TAR	Expert Opin. Ther. Targets	MAY	2015	19	5					687	705		10.1517/14728222.2015.1009447		19	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CF9UA	WOS:000352911100009		
J	Ulanova, D; Goo, KS				Ulanova, Dana; Goo, Kian-Sim			Diversity of actinomycetes isolated from subseafloor sediments after prolonged low-temperature storage	FOLIA MICROBIOLOGICA			English	Article							MARINE ACTINOBACTERIA; BACTERIAL-POPULATIONS; SALINISPORA	Subseafloor sediments present an untapped source of novel bacterial species with industrially important bioactivities. Subseafloor core samples collected during the Integrated Ocean Drilling Program Expeditions 315, 316, and 331 and stored in Kochi Core Center at -80 A degrees C for 1 to 4 years were used for cultivation-based study of viable actinomycetes. In total, more than 100 actinomycete-like colonies were isolated from two deep-frozen subseafloor sediment samples. Isolated actinomycetes showed close similarity to known Actinotalea, Dietzia, Gordonia, Isoptericola, Microbacterium, Nocardia, Rhodococcus, Pseudonocardia, Streptomyces, and Tsukamurella species and were halotolerant. Bioactivity assays revealed that two of the isolates were producing potent antibacterial compound(s) and one isolate was having antifungal activity. Our study demonstrated that deep-frozen subseafloor core samples could be a potential source of viable actinomycetes, which may be used in drug discovery.	[Ulanova, Dana] Kochi Univ, Ctr Sci Res, Oceanog Sect, IMT MEXT, Nankoku, Kochi 7838505, Japan; [Goo, Kian-Sim] Kochi Univ, Evaluat & Support Org Young Researchers, Nankoku, Kochi 7838505, Japan	Ulanova, D (reprint author), Kochi Univ, Ctr Sci Res, Oceanog Sect, IMT MEXT, Oko Cho, Nankoku, Kochi 7838505, Japan.	ulanova@kochi-u.ac.jp					Bull AT, 2005, ANTON LEEUW INT J G, V87, P65, DOI 10.1007/s10482-004-6562-8; Kobayashi T, 2008, EXTREMOPHILES, V12, P519, DOI 10.1007/s00792-008-0157-7; Dastager SG, 2013, CURR MICROBIOL, V66, P421, DOI 10.1007/s00284-012-0288-z; Orsi WD, 2013, NATURE, V499, P205, DOI 10.1038/nature12230; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Soina VS, 2004, ASTROBIOLOGY, V4, P345, DOI 10.1089/ast.2004.4.345; Goo KS, 2014, ANTON LEEUW INT J G, V105, P207, DOI 10.1007/s10482-013-0067-2; Abdel-Mageed WM, 2010, ORG BIOMOL CHEM, V8, P2352, DOI 10.1039/c001445a; Ziemert N, 2014, P NATL ACAD SCI USA, V111, pE1130, DOI 10.1073/pnas.1324161111; Berdy J, 2005, J ANTIBIOT, V58, P1; Mills HJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00113; Masui N, 2008, GEOMICROBIOL J, V25, P274, DOI 10.1080/01490450802258154; Jensen PR, 2005, ENVIRON MICROBIOL, V7, P1039, DOI 10.1111/j.1462-2920.2005.00785.x; Maldonado LA, 2009, ANTON LEEUW INT J G, V95, P111, DOI 10.1007/s10482-008-9294-3; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Ward AC, 2006, CURR OPIN MICROBIOL, V9, P279, DOI 10.1016/j.mib.2006.04.004; JENSEN PR, 1991, APPL ENVIRON MICROB, V57, P1102; Chattopadhyay MK, 1997, BIOCHEM BIOPH RES CO, V239, P85, DOI 10.1006/bbrc.1997.7433; Colquhoun JA, 1998, ANTON LEEUW INT J G, V74, P27, DOI 10.1023/A:1001743625912; IIVANAINEN E, 1995, LETT APPL MICROBIOL, V21, P257; IKEDA H, 1988, ANTIMICROB AGENTS CH, V32, P282; Kinoshita M, 2009, P INT OC DRILL PROGR; Lever MA, 2006, GEOMICROBIOL J, V23, P517; Masui N., 2009, SCI DRILL, V8, P35; Mills HJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00049; Moussa M, 2008, BIOTECHNOL BIOENG, V101, P1245, DOI 10.1002/bit.21981; Okazaki T, 2006, ACTINOMYCETOLOGICA, V20, P15, DOI 10.3209/saj.20.15; Pathom-Aree W, 2006, EXTREMOPHILES, V10, P181; Ray B, 1973, CRC Crit Rev Clin Lab Sci, V4, P161, DOI 10.3109/10408367309151556; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Sunga MJ, 2008, J IND MICROBIOL BIOT, V35, P761, DOI 10.1007/s10295-008-0344-7; Takai K., 2011, P INTEGRATED OCEAN D; Yanagawa K, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00327	34	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0015-5632	1874-9356		FOLIA MICROBIOL	Folia Microbiol.	MAY	2015	60	3					211	216		10.1007/s12223-014-0361-z		6	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CF9PI	WOS:000352897000003		
J	Yahaya, N; Sanagi, MM; Mitome, T; Nishiyama, N; Ibrahim, WAW; Nur, H				Yahaya, Noorfatimah; Sanagi, Mohd Marsin; Mitome, Takahito; Nishiyama, Norikazu; Ibrahim, Wan Aini Wan; Nur, Hadi			Dispersive Micro-Solid Phase Extraction Combined with High-Performance Liquid Chromatography for the Determination of Three Penicillins in Milk Samples	FOOD ANALYTICAL METHODS			English	Article						Liquid chromatography; Penicillins; Microextraction; Dispersive micro-solid phase extraction; Mesoporous carbon; Milk	TANDEM MASS-SPECTROMETRY; BETA-LACTAM ANTIBIOTICS; BOVINE-MILK; MESOPOROUS CARBON; WATER SAMPLES; THERMAL-DESORPTION; RESIDUES; ION; MICROEXTRACTION; QUANTIFICATION	A simple, rapid, and environmentally friendly microextraction termed COU-2-D-mu-SPE has been developed for the analysis of three penicillins (i.e., oxacillin, cloxacillin, and dicloxacillin) in milk samples. An ordered mesoporous carbon, COU-2, was synthesized and used as the sorbent in dispersive micro-solid phase for the extraction of selected penicillins prior to high-performance liquid chromatography-ultraviolet detection (HPLC-UV). Several important parameters, namely, pH value, salt addition, desorption solvent, extraction time, desorption time, and amount of COU-2, were investigated and optimized. Under the optimum extraction conditions, the method showed good linearity in the range of 10-5,000 mu g L-1 (r (2) a parts per thousand yenaEuro parts per thousand 0.9994), low limits of detection (2.0-3.3 mu g L-1), acceptable reproducibility (relative standard deviation (RSD) 6.2-8.8 %, n = 9), and satisfactory relative recoveries (80.3-99.5 %) for studied penicillins in milk. The proposed COU-2-D-mu-SPE method has been successfully applied to six commercial milk samples, and the extraction of blank samples indicated that all samples were free from selected penicillin contamination.	[Yahaya, Noorfatimah; Sanagi, Mohd Marsin; Ibrahim, Wan Aini Wan] Univ Teknol Malaysia, Dept Chem, Fac Sci, Utm Johor Bahru 81310, Johor, Malaysia; [Yahaya, Noorfatimah] Univ Sains Malaysia, Adv Med & Dent Inst, Kepala Batas 13200, Pulau Pinang, Malaysia; [Sanagi, Mohd Marsin; Nur, Hadi] Univ Teknol Malaysia, Ibnu Sina Inst Fundamental Sci Studies, Nanotechnol Res Alliance, Utm Johor Bahru 81310, Johor, Malaysia; [Mitome, Takahito; Nishiyama, Norikazu] Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, Toyonaka, Osaka 5608531, Japan	Sanagi, MM (reprint author), Univ Teknol Malaysia, Ibnu Sina Inst Fundamental Sci Studies, Nanotechnol Res Alliance, Utm Johor Bahru 81310, Johor, Malaysia.	marsin@kimia.fs.utm.my	Nur, Hadi/C-9200-2009	Nur, Hadi/0000-0002-4387-431X	Universiti Teknologi Malaysia [R.J130000.7809.4F177]; Ministry of Education Malaysia (MOE) [R.J130000.7809.4F177]; Advanced Medical and Dental Institute, Universiti Sains Malaysia Fellowship Program	The authors wish to thank Universiti Teknologi Malaysia and the Ministry of Education Malaysia (MOE) for financial supports through research grant no. R.J130000.7809.4F177 and sponsorship for N. Yahaya through Advanced Medical and Dental Institute, Universiti Sains Malaysia Fellowship Program.	Oliveira RV, 2007, TALANTA, V71, P1233, DOI 10.1016/j.talanta.2006.06.024; Jank L, 2012, FOOD ADDIT CONTAM A, V29, P497, DOI 10.1080/19440049.2011.604044; Zhu F, 2010, J CHROMATOGR A, V1217, P7848, DOI 10.1016/j.chroma.2010.10.080; Kukusamude C, 2012, TALANTA, V92, P38, DOI 10.1016/j.talanta.2012.01.020; Turnipseed SB, 2008, RAPID COMMUN MASS SP, V22, P1467, DOI 10.1002/rcm.3532; Guo L, 2012, J CHROMATOGR A, V1235, P26, DOI 10.1016/j.chroma.2012.02.068; Sun M, 2013, J CHROMATOGR A, V1300, P173, DOI 10.1016/j.chroma.2013.04.061; Santos SM, 2007, TALANTA, V71, P731, DOI 10.1016/j.talanta.2006.05.049; Marchetti M, 2001, FRESEN J ANAL CHEM, V371, P64, DOI 10.1007/s002160100858; Jimenez-Soto JM, 2012, ANAL CHIM ACTA, V714, P76, DOI 10.1016/j.aca.2011.11.055; See HH, 2010, J CHROMATOGR A, V1217, P1767, DOI 10.1016/j.chroma.2010.01.053; Kantiani L, 2009, TRAC-TREND ANAL CHEM, V28, P729, DOI 10.1016/j.trac.2009.04.005; Benito-Pena E, 2006, ANAL CHIM ACTA, V556, P415, DOI 10.1016/j.aca.2005.09.054; Chung WH, 2013, J CHROMATOGR A, V1307, P34, DOI 10.1016/j.chroma.2013.07.074; Riediker S, 2001, ANAL CHEM, V73, P1614, DOI 10.1021/ac0011383; Zhang XP, 2010, J CHROMATOGR B, V878, P3421, DOI 10.1016/j.jchromb.2010.10.030; Rezende CP, 2012, FOOD ADDIT CONTAM A, V29, P541, DOI 10.1080/19440049.2011.627883; Moradi SE, 2011, CHEM IND CHEM ENG Q, V17, P397, DOI 10.2298/CICEQ110526026M; Bruno F, 2001, J AGR FOOD CHEM, V49, P3463, DOI 10.1021/jf010046r; Jin J, 2009, MICROPOR MESOPOR MAT, V118, P218, DOI 10.1016/j.micromeso.2008.08.030; Dousa M, 2005, J PHARMACEUT BIOMED, V37, P373, DOI 10.1016/j.jpba.2004.10.010; Stolker AAM, 2008, ANAL BIOANAL CHEM, V391, P2309, DOI 10.1007/s00216-008-2168-8; Liang CD, 2008, ANGEW CHEM INT EDIT, V47, P3696, DOI 10.1002/anie.200702046; Bovee TFH, 2009, J CHROMATOGR A, V1216, P8035, DOI 10.1016/j.chroma.2009.03.045; Jung HH, 2010, J CONTROL RELEASE, V147, P84, DOI 10.1016/j.jconrel.2010.06.020; Saaid M, 2009, J CHROMATOGR A, V1216, P5165, DOI 10.1016/j.chroma.2009.04.091; Huang XJ, 2013, J SEP SCI, V36, P907, DOI 10.1002/jssc.201200987; Carretero V, 2008, J CHROMATOGR A, V1209, P162, DOI 10.1016/j.chroma.2008.09.011; Pozo OJ, 2006, J CHROMATOGR A, V1103, P83, DOI 10.1016/j.chroma.2005.10.073; Bailon-Perez ML, 2009, J CHROMATOGR A, V1216, P8355, DOI 10.1016/j.chroma.2009.09.042; De Baere S, 2007, ANAL CHIM ACTA, V586, P319, DOI 10.1016/j.aca.2006.10.036; Freitas A, 2012, FOOD ANAL METHOD, V5, P471, DOI 10.1007/s12161-011-9267-4; Fu SC, 2012, ANAL BIOANAL CHEM, V402, P2209, DOI 10.1007/s00216-011-5681-0; Galan-Cano F, 2011, ANAL METHODS-UK, V3, P991, DOI 10.1039/c1ay05033h; Gramse M, 2005, J AOAC INT, V88, P679; Karageorgou EG, 2011, J SEP SCI, V34, P1893, DOI 10.1002/jssc.201100194; Karageorgou EG, 2012, J SEP SCI, V35, P2599, DOI 10.1002/jssc.201200514; Kukusamude C, 2010, TALANTA, V81, P486, DOI 10.1016/j.talanta.2009.12.029; Maggi L, 2012, FOOD ANAL METHOD, V5, P1047, DOI 10.1007/s12161-011-9342-x; Tsai WH, 2009, J CHROMATOGR A, V1216, P2263; Yahaya N, 2013, J PHARM INNOV, V8, P240, DOI 10.1007/s12247-013-9164-z	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-9751	1936-976X		FOOD ANAL METHOD	Food Anal. Meth.	MAY	2015	8	5					1079	1087		10.1007/s12161-014-9991-7		9	Food Science & Technology	Food Science & Technology	CF6EA	WOS:000352648300001		
J	Harikai, N; Shinomiya, K				Harikai, Naoki; Shinomiya, Kazufusa			Application of an Alkaline and Silica Membrane DNA Extraction Method to Detect Mitochondrial DNA in Foods	FOOD ANALYTICAL METHODS			English	Article						Alkaline sodium dodecyl sulfate lysis; Mitochondrial DNA extraction; beta-Actin; Cytochrome C oxidase subunit I	POLYMERASE-CHAIN-REACTION; SPECIES IDENTIFICATION; NUCLEIC-ACIDS; PURIFICATION; COLUMNS	To improve the efficiency of mitochondrial DNA (mtDNA) extraction from food, a simple method, PrepM, was developed by effectively combining alkaline sodium dodecyl sulfate lysis and DNA binding to a silica membrane. PrepM was evaluated using fresh, cold, and autoclaved rat liver samples and compared with commercial total DNA extraction kits. When PrepM was applied to fresh and cold samples, the DNA yield was low, but the OD260/280 ratio was close to 1.8. The cytochrome C oxidase subunit I (COI) copy number, which is the number of mtDNA copies, per DNA weight and the ratio of COI to beta-actin, which is the ratio of mitochondrial to genomic DNA, were higher with PrepM than with total DNA extraction kits. When PrepM was applied to autoclaved samples, the DNA purity and yield and the COI copy number per DNA weight were relatively high, but the COI to beta-actin ratio was low. PrepM was then applied to shrimp samples, a known allergenic food. Data obtained from cold and autoclaved shrimp samples were similar to data obtained from rat liver samples. When PrepM was applied to food samples spiked with shrimp, the DNA purity was high, but the DNA yield and the mtDNA levels were almost same as those obtained with total DNA extraction kits. We concluded that PrepM has a comparative advantage for sensitive polymerase chain reaction detection of mtDNA sequences in relatively fresh samples, and it has almost the same performance as general total DNA extraction kits with autoclaved and/or complex mixture samples.	[Harikai, Naoki] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Nishinomiya, Hyogo 6638179, Japan; [Harikai, Naoki; Shinomiya, Kazufusa] Nihon Univ, Sch Pharm, Funabashi, Chiba 2748555, Japan	Harikai, N (reprint author), Nihon Univ, Sch Pharm, 7-7-1 Narashinodai, Funabashi, Chiba 2748555, Japan.	harikai.naoki@nihon-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [25860104]; Research Foundation for Pharmaceutical Sciences	We thank Dr. Yuzo Yoshida for advice. This study was financially supported by a grant from the Research Foundation for Pharmaceutical Sciences to N.H. This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 25860104.	Sakai S, 2013, J AGR FOOD CHEM, V61, P5675, DOI 10.1021/jf3033396; Tanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P3131, DOI 10.1271/bbb.70683; Taguchi H, 2011, J AGR FOOD CHEM, V59, P3510, DOI 10.1021/jf103878h; BOOM R, 1990, J CLIN MICROBIOL, V28, P495; Borodina TA, 2003, ANAL BIOCHEM, V321, P135, DOI 10.1016/S0003-2697(03)00403-2; PALVA TK, 1985, FEBS LETT, V192, P267, DOI 10.1016/0014-5793(85)80122-8; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; Melzak KA, 1996, J COLLOID INTERF SCI, V181, P635, DOI 10.1006/jcis.1996.0421; Aslan O, 2009, J ANIM SCI, V87, P57, DOI 10.2527/jas.2008-0995; Lang BF, 2007, NAT PROTOC, V2, P652, DOI 10.1038/nprot.2007.58; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; Quispe-Tintaya W, 2013, BIOTECHNIQUES, V55, P133, DOI 10.2144/000114077; Alexander PJ, 2007, MOL ECOL NOTES, V7, P5, DOI 10.1111/j.1471-8286.2006.01549.x; Dyachenko V, 2008, PARASITOL RES, V102, P811, DOI 10.1007/s00436-007-0855-6; Bellis C, 2003, FORENSIC SCI INT, V134, P99, DOI 10.1016/S0379-0738(03)00128-2; Baker LE, 2001, J FORENSIC SCI, V46, P126; BALANSKY R, 1995, CANCER LETT, V97, P17, DOI 10.1016/0304-3835(95)03943-Q; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bodenhagen D, 1974, J BIOL CHEM, V249, P7991; Burgener M, 1998, Z LEBENSM UNTERS F A, V207, P261, DOI 10.1007/s002170050329; Haider N, 2012, MEAT SCI, V90, P490, DOI 10.1016/j.meatsci.2011.09.013; Kong WJ, 2006, CHINESE MED J-PEKING, V119, P986; Michelini E, 2007, J AGR FOOD CHEM, V55, P7638, DOI 10.1021/jf070902k; Patel AS, 1995, A1804A BECKM INSTR I; Psifidi A, 2010, MOL CELL PROBE, V24, P93, DOI 10.1016/j.mcp.2009.11.001; Watanabe T, 2006, J FOOD BIOCHEM, V30, P215, DOI 10.1111/j.1745-4514.2006.00056.x; WELTER C, 1989, GENE, V83, P169, DOI 10.1016/0378-1119(89)90415-0; Yoshimura T, 2005, J AGR FOOD CHEM, V53, P2060, DOI 10.1021/jf0483265; Zardoya Rafael, 2008, V422, P185, DOI 10.1007/978-1-59745-581-7_12	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-9751	1936-976X		FOOD ANAL METHOD	Food Anal. Meth.	MAY	2015	8	5					1215	1224		10.1007/s12161-014-0002-9		10	Food Science & Technology	Food Science & Technology	CF6EA	WOS:000352648300015		
J	Funatsuki, A; Shiota, K; Takaoka, M; Tamenori, Y				Funatsuki, Atsushi; Shiota, Kenji; Takaoka, Masaki; Tamenori, Yusuke			Forensic analysis of tire rubbers based on their sulfur chemical states	FORENSIC SCIENCE INTERNATIONAL			English	Article						Hit and run accident; Discrimination; Tire rubber; XANES; Sulfur chemical states; Source determination	FINE-STRUCTURE SPECTROSCOPY; QUANTITATIVE-ANALYSIS; STYRENE-BUTADIENE; XANES; SPECIATION; PARTICLES; OXIDATION; SPECTRA; MATTER	The chemical states of sulfur in 11 tires were analyzed using X-ray absorption near-edge structure (XANES) in order to discriminate between various tire rubbers. All tires had peaks around 2471.5 and 2480.5 eV, and the shapes and heights of these peaks differed among tires, suggesting that the sulfur chemical state could be used for discrimination between tire rubbers. Based on t-tests on the results of XANES, 43 of 55 combinations were different at a significance level of 5%. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Funatsuki, Atsushi] Mie Prefectural Police HQ, Forens Sci Lab, Tsu, Mie 5148514, Japan; [Shiota, Kenji; Takaoka, Masaki] Kyoto Univ, Grad Sch Engn, Dept Environm Engn, Nishikyo Ku, Kyoto 6158540, Japan; [Takaoka, Masaki] Kyoto Univ, Grad Sch Global Environm Studies, Dept Global Ecol, Nishikyo Ku, Kyoto 6158540, Japan; [Tamenori, Yusuke] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Funatsuki, A (reprint author), Mie Prefectural Police HQ, Forens Sci Lab, 1-100 Sakaemachi, Tsu, Mie 5148514, Japan.	laboratory@police.pref.mie.jp		Shiota, Kenji/0000-0002-2056-3746	JSPS KAKENHI Grant [26915017]	The synchrotron radiation experiments were performed on beamline 27SU at SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI; proposal no. 2014A1133). This work was supported by JSPS KAKENHI Grant no. 26915017.	Solomon D, 2003, SOIL SCI SOC AM J, V67, P1721; Xia K, 1998, SOIL SCI SOC AM J, V62, P1240; HUFFMAN GP, 1991, ENERG FUEL, V5, P574, DOI 10.1021/ef00028a008; Funatsuki A, 2012, ANAL SCI, V28, P481; Jalilehvand F, 2006, CHEM SOC REV, V35, P1256, DOI 10.1039/b417595f; Farges F., 2009, J PHYS C SER, V190; Funatsuki A, 2014, CHEM LETT, V43, P357, DOI 10.1246/cl.130950; LEE YK, 1989, J ANAL APPL PYROL, V16, P49, DOI 10.1016/0165-2370(89)80035-X; Modrow H, 2001, RUBBER CHEM TECHNOL, V74, P281, DOI 10.5254/1.3544950; Pattanasiriwisawa W, 2008, J SYNCHROTRON RADIAT, V15, P510, DOI 10.1107/S0909049508015173; SAITO T, 1989, J ANAL APPL PYROL, V15, P227, DOI 10.1016/0165-2370(89)85036-3; Sarkissian G, 2007, J FORENSIC SCI, V52, P1050, DOI 10.1111/j.1556-4029.2007.00529.x; SEKIYAMA H, 1986, B CHEM SOC JPN, V59, P575, DOI 10.1246/bcsj.59.575; Taguchi T, 2005, PHYS SCRIPTA, VT115, P205; Takahashi Y, 2006, ENVIRON SCI TECHNOL, V40, P5052, DOI 10.1021/es060497y	15	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	MAY	2015	250						53	56		10.1016/j.forsciint.2015.02.022		4	Medicine, Legal	Legal Medicine	CF3IK	WOS:000352441700009		
J	Hyzewicz, J; Tanihata, J; Kuraoka, M; Ito, N; Miyagoe-Suzuki, Y; Takeda, S				Hyzewicz, Janek; Tanihata, Jun; Kuraoka, Mutsuki; Ito, Naoki; Miyagoe-Suzuki, Yuko; Takeda, Shin'ichi			Low intensity training of mdx mice reduces carbonylation and increases expression levels of proteins involved in energy metabolism and muscle contraction	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						mdx mouse; Oxidative stress; Proteomic; Exercise; Skeletal muscle; Blue Native PAGE	DUCHENNE MUSCULAR-DYSTROPHY; OXIDATIVE STRESS; SKELETAL-MUSCLE; DAMAGE; PATHOLOGY; EXERCISE; DEFICIENCY; PROTEOMICS; OXIDASE; IMPACT	High intensity training induces muscle damage in dystrophin-deficient mdx mice, an animal model for Duchenne muscular dystrophy. However, low intensity training (LIT) rescues the mdx phenotype and even reduces the level of protein carbonylation, a marker of oxidative damage. Until now, beneficial effects of LIT were mainly assessed at the physiological level. We investigated the effects of LIT at the molecular level on 8-week-old wild-type and mdx muscle using 2D Western blot and protein-protein interaction analysis. We found that the fast isoforms of troponin T and myosin binding protein C as well as glycogen phosphorylase were overcarbonylated and downregulated in mdx muscle. Some of the mitochondrial enzymes of the citric acid cycle were overcarbonylated, whereas some proteins of the respiratory chain were downregulated. Of functional importance, ATP synthase was only partially assembled, as revealed by Blue Native PAGE analysis. LIT decreased the carbonylation level and increased the expression of fast isoforms of troponin T and of myosin binding protein C, and glycogen phosphorylase. In addition, it increased the expression of aconitate hydratase and NADH dehydrogenase, and fully restored the ATP synthase complex. Our study demonstrates that the benefits of LIT are associated with lowered oxidative damage as revealed by carbonylation and higher expression of proteins involved in energy metabolism and muscle contraction. Potentially, these results will help to design therapies for DMD based on exercise mimicking drugs. (C) 2015 The Authors. Published by Elsevier Inc.	[Hyzewicz, Janek; Tanihata, Jun; Kuraoka, Mutsuki; Ito, Naoki; Miyagoe-Suzuki, Yuko; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1878502, Japan	Takeda, S (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878502, Japan.	takeda@ncnp.go.jp			Intramural Research Grant for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry [25-5]	We thank E. Kimura, Y. Aoki, T. Nagata, Y. Kasahara, A. Narita, A. Okuyama, and the members of the Department of Molecular Therapy, National Center of Neurology and Psychiatry, for support and useful discussions. We thank the members of the small animal facility, National Center of Neurology and Psychiatry, for technical assistance. We thank C. Broussard and the members of the 3P5 Proteomics Facility, Universite Paris Descartes, Sorbonne Paris Cite, for the work performed on protein identification. We thank B. Raveney of the Department of Immunology, National Center of Neurology and Psychiatry, for English review. We also thank the members of Laboratoire de Biologie Cellulaire du Vieillissement UR4, Universite Paris 6, for support and technical discussions. This work was supported by an Intramural Research Grant (25-5) for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry.	Allen DG, 2010, ADV EXP MED BIOL, V682, P297, DOI 10.1007/978-1-4419-6366-6_17; Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021; Menazza S, 2010, HUM MOL GENET, V19, P4207, DOI 10.1093/hmg/ddq339; Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002; Yang Y, 2007, ELECTROPHORESIS, V28, P2080, DOI 10.1002/elps.200600524; Renjini R, 2012, NEUROCHEM RES, V37, P885, DOI 10.1007/s11064-011-0683-z; Lawler JM, 2011, J PHYSIOL-LONDON, V589, P2161, DOI 10.1113/jphysiol.2011.207456; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Gardan-Salmon D, 2011, EUR J APPL PHYSIOL, V111, P2763, DOI 10.1007/s00421-011-1906-3; Dalle-Donne I, 2005, MASS SPECTROM REV, V24, P55, DOI 10.1002/mas.20006; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x; Aoki Y, 2010, MOL THER, V18, P1995, DOI 10.1038/mt.2010.186; Ge Y, 2003, PROTEOMICS, V3, P1895, DOI 10.1002/pmic.200300561; Kaczor JJ, 2007, FREE RADICAL BIO MED, V43, P145, DOI 10.1016/j.freeradbiomed.2007.04.003; Hayes A, 1998, AM J PHYSIOL-CELL PH, V274, pC1138; Allen DG, 2005, J PHYSIOL-LONDON, V567, P723, DOI 10.1113/jphysiol.2005.091694; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Muller J, 2001, J MUSCLE RES CELL M, V22, P133, DOI 10.1023/A:1010305801236; Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Augusto V, 2004, BRAZ J MORPHOL SCI, V27, P89; Austin S, 2011, FREE RADICAL BIO MED, V51, P2243, DOI 10.1016/j.freeradbiomed.2011.08.036; Baltgalvis KA, 2012, MED SCI SPORT EXER, V44, P1671, DOI 10.1249/MSS.0b013e31825703f0; Baraibar MA, 2011, FREE RADICAL BIO MED, V51, P1522, DOI 10.1016/j.freeradbiomed.2011.06.032; Bayot A., J BIOL CHEM, V285, P11445; Call J. A., MUSCLE NERVE, V42, P871; Carberry S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/691641; Chattopadhyay S., PLOS ONE, V8; Coffey VG, 2006, AM J PHYSIOL-ENDOC M, V290, pE849, DOI 10.1152/ajpendo.00299.2005; Disatnik MH, 2000, MUSCLE NERVE, V23, P784, DOI 10.1002/(SICI)1097-4598(200005)23:5<784::AID-MUS17>3.0.CO;2-Y; Dudley RWR, 2006, AM J PATHOL, V168, P1276, DOI 10.2353/ajpath.2006.050683; Egan B., CELL METAB, V17, P162; Evans N. P., PM R, V1, P755; Godin Richard, 2012, J Physiol, V590, P5487, DOI 10.1113/jphysiol.2012.240390; Gomez-Cabrera M. C., PHYS SPORTSMED, V37, P116; Gomez-Cabrera M. C., FREE RADIC BIOL MED, V44, P126; Gomez-Cabrera MC, 2005, J PHYSIOL-LONDON, V567, P113, DOI 10.1113/jphysiol.2004.080564; Khairallah R. J., SCI SIGNAL, V5, pra56; Khairani A. F., 2014, MED MOL MORPHOL; Kim J. H., 2012, J MUSCLES RES CELL M, V34, P1; Ljubicic V, 2013, FASEB J, V28, P548; Magherini F., J PROTEOMICS, V75, P978, DOI 10.1016/j.jprot.2011.10.017; Martins-Bach A. B., MAGN RESON IMAGING, V30, P1167; Mittal M., 2013, ANTIOXID REDOX SIGN, V20, P1126; Onopiuk M., BIOCH BIOPHYS RES CO, V386, P463; Percival J. M., HUM MOL GENET, V22, P153; Perier C., COLD SPRING HARB PER, V2; Powers S. K., 2010, FREE RADIC BIOL MED, V51, P942, DOI DOI 10.1016/J.FREERADBI0MED.2010.12.009.PMID:21167935; Powers S. K., 2009, EXP PHYSIOL, V95, P1; Radley-Crabb H, 2011, NEUROMUSCULAR DISORD, V22, P170; Raith M., SKELET MUSCLE, V3, P14; Ramadasan-Nair R., 2013, J BIOL CHEM, V289, P485; Seo D. Y., 2014, PFLUGERS ARCH; Shim JY, 2003, YONSEI MED J, V44, P15; Smythe G. M., MUSCLE NERVE, V46, P374; Stapleton DI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091514; Suzuki T., HUM MOV SCI C, V36C, P35; Suzuki Y. J., ANTIOXID REDOX SIGNA, V12, P323; Swamy M., 2006, SCI STKE, V2006, pl4, DOI DOI 10.1126/STKE.3452006PL4.PMID:16868305; Yan L.J., 2010, J CHROMATOGR B, V879, P1308; YASMINEH WG, 1978, CLIN CHEM, V24, P1985; Yokota T., ANN NEUROL, V65, P667	61	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	MAY	2015	82						122	136		10.1016/j.freeradbiomed.2015.01.023		15	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CF8PF	WOS:000352823700011		
J	Khashab, MA; Messallam, AA; Onimaru, M; Teitelbaum, EN; Ujiki, MB; Gitelis, ME; Modayil, RJ; Hungness, ES; Stavropoulos, SN; El Zein, MH; Shiwaku, H; Kunda, R; Repici, A; Minami, H; Chiu, PW; Ponsky, J; Kumbhari, V; Saxena, P; Maydeo, AP; Inoue, H				Khashab, Mouen A.; Messallam, Ahmed A.; Onimaru, Manabu; Teitelbaum, Ezra N.; Ujiki, Michael B.; Gitelis, Matthew E.; Modayil, Rani J.; Hungness, Eric S.; Stavropoulos, Stavros N.; El Zein, Mohamad H.; Shiwaku, Hironari; Kunda, Rastislav; Repici, Alessandro; Minami, Hitomi; Chiu, Philip W.; Ponsky, Jeffrey; Kumbhari, Vivek; Saxena, Payal; Maydeo, Amit P.; Inoue, Haruhiro			International multicenter experience with peroral endoscopic myotomy for the treatment of spastic esophageal disorders refractory to medical therapy (with video)	GASTROINTESTINAL ENDOSCOPY			English	Article							MOTILITY DISORDERS; PRESSURE TOPOGRAPHY; ACHALASIA; POEM; CLASSIFICATION	Background: Limited data exist on the use of peroral endoscopic myotomy (POEM) for therapy of spastic esophageal disorders (SEDs). Objective: To study the efficacy and safety of POEM for the treatment of patients with diffuse esophageal spasm, jackhammer esophagus, or type III (spastic) achalasia. Design: Retrospective study. Setting: International, multicenter, academic institutions. Patients: All patients who underwent POEM for treatment of SEDs refractory to medical therapy at 11 centers were included. Interventions: POEM. Main Outcome Measurements: Eckardt score and adverse events. Results: A total of 73 patients underwent POEM for treatment of SEDs (diffuse esophageal spasm 9, jackhammer esophagus 10, spastic achalasia 54). POEM was successfully completed in all patients, with a mean procedural time of 118 minutes. The mean length of the submucosal tunnel was 19 cm, and the mean myotomy length was 16 cm. A total of 8 adverse events (11%) occurred, with 5 rated as mild, 3 moderate, and 0 severe. The mean length of hospital stay was 3.4 days. There was a significant decrease in Eckardt scores after POEM (6.71 vs 1.13; P = .0001). Overall, clinical response was observed in 93% of patients during a mean follow-up of 234 days. Chest pain significantly improved in 87% of patients who reported chest pain before POEM. Repeat manometry after POEM was available in 44 patients and showed resolution of initial manometric abnormalities in all cases. Limitations: Retrospective design and selection bias. Conclusion: POEM offers a logical therapeutic modality for patients with SEDs refractory to medical therapy. Results from this international study suggest POEM as an effective and safe platform for these patients.	[Khashab, Mouen A.; Messallam, Ahmed A.; El Zein, Mohamad H.; Kumbhari, Vivek; Saxena, Payal] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Onimaru, Manabu; Inoue, Haruhiro] Showa Univ, Northern Yokohama Hosp, Yokohama, Kanagawa, Japan; [Teitelbaum, Ezra N.; Hungness, Eric S.] Northwestern Univ, Chicago, IL 60611 USA; [Ujiki, Michael B.; Gitelis, Matthew E.] North Shore Univ Hlth Syst, Evanston, IL USA; [Modayil, Rani J.; Stavropoulos, Stavros N.] Winthrop Univ Hosp, Mineola, NY 11501 USA; [Shiwaku, Hironari] Fukuoka Univ, Fac Med, Fukuoka 81401, Japan; [Kunda, Rastislav] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; [Repici, Alessandro] Humanitas Res Hosp, Milan, Italy; [Minami, Hitomi] Nagasaki Univ Hosp, Nagasaki, Japan; [Chiu, Philip W.] Chinese Univ Hong Kong, Inst Digest Dis, Shatin, Hong Kong, Peoples R China; [Ponsky, Jeffrey] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Maydeo, Amit P.] Baladota Inst Digest Sci, Bombay, Maharashtra, India	Khashab, MA (reprint author), Johns Hopkins Univ Hosp, Med, 1800 Orleans St,Suite 7125 B, Baltimore, MD 21205 USA.	mkhasha1@jhmi.edu			Cook Medical	M. Khashab is a consultant for Boston Scientific and Olympus America and has received research support from Cook Medical. H. Inoue is a founding member, equity holder, and consultant for Apollo Endosurgery. No other financial relationships relevant to this article were disclosed.	Kurian AA, 2013, GASTROINTEST ENDOSC, V77, P719, DOI 10.1016/j.gie.2012.12.006; Bredenoord AJ, 2012, NEUROGASTROENT MOTIL, V24, P57, DOI 10.1111/j.1365-2982.2011.01834.x; Saxena P, 2013, ENDOSCOPY, V45, P579, DOI 10.1055/s-0032-1326398; von Renteln D, 2012, AM J GASTROENTEROL, V107, P411, DOI 10.1038/ajg.2011.388; Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080; Swanstrom LL, 2011, J AM COLL SURGEONS, V213, P751, DOI 10.1016/j.jamcollsurg.2011.09.001; Pandolfino JE, 2008, GASTROENTEROLOGY, V135, P1526, DOI 10.1053/j.gastro.2008.07.022; Sharata A, 2013, J GASTROINTEST SURG, V17, P1188, DOI 10.1007/s11605-013-2193-6; Sumiyama K, 2007, GASTROINTEST ENDOSC, V65, P688, DOI 10.1016/j.gie.2006.07.030; Roman S, 2012, AM J GASTROENTEROL, V107, P37, DOI 10.1038/ajg.2011.313; Pasricha PJ, 2007, ENDOSCOPY, V39, P761, DOI 10.1055/s-2007-966764; Khashab MA, 2014, GASTROINTEST ENDOSC, V79, P136, DOI 10.1016/j.gie.2013.08.021; Shiwaku H, 2013, GASTROINTEST ENDOSC, V77, P149, DOI 10.1016/j.gie.2012.02.008; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; Maselli R, 2012, ENDOSCOPY, V44, pE285, DOI 10.1055/s-0032-1309924; Kalloo AN, 2004, GASTROINTEST ENDOSC, V60, P114, DOI 10.1016/S0016-5107(04)01309-4; Costamagna G, 2012, DIGEST LIVER DIS, V44, P827, DOI 10.1016/j.dld.2012.04.003; Roman S, 2013, GASTROENTEROL CLIN N, V42, P27, DOI 10.1016/j.gtc.2012.11.002; Ellis Jr FH, 1992, AM J MED, V92, P129; HENDERSON RD, 1983, SURG CLIN N AM, V63, P951; Khashab MA, 2012, GASTROENTEROLOGY, V142, P704, DOI 10.1053/j.gastro.2012.02.022; Khashab MA, 2012, NAT REV GASTRO HEPAT, V8, P565; Leconte M, 2007, BRIT J SURG, V94, P1113, DOI 10.1002/bjs.5761; PATTI MG, 1995, ARCH SURG-CHICAGO, V130, P609; Patti MG, 1995, ARCH SURG, V130, P15; Rohof WO, 2013, GASTROENTEROLOGY, V144, P718, DOI 10.1053/j.gastro.2012.12.027; Rohof WO, 2013, GASTROENTEROLOGY, V144, pe13, DOI DOI 10.1053/J.GASTRO.2012.12.027	27	4	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	MAY	2015	81	5					1170	1177		10.1016/j.gie.2014.10.011		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF6ZV	WOS:000352706600012		
J	Khashab, MA; Baron, TH; Binmoeller, KF; Itoi, T				Khashab, Mouen A.; Baron, Todd H.; Binmoeller, Kenneth F.; Itoi, Takao			EUS-guided gastroenterostomy: a new promising technique in evolution	GASTROINTESTINAL ENDOSCOPY			English	Article							GASTROJEJUNOSTOMY; OBSTRUCTION; TRIAL; STENT		[Khashab, Mouen A.] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Khashab, Mouen A.] Johns Hopkins Med Inst, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Baron, Todd H.] Univ N Carolina, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Binmoeller, Kenneth F.] Calif Pacific Med Ctr, Paul May & Frank Stein Intervent Endoscopy Ctr, San Francisco, CA USA; [Itoi, Takao] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan	Khashab, MA (reprint author), Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA.				Cook Medical	The following authors disclosed financial relationships relative to this publication. Dr Khashab is a consultant for Boston Scientific, Olympus America, and Xlumena, and has received research support from Cook Medical. Dr Baron is a consultant for Boston Scientific, Cook Endoscopy, and W. L. Gore. Dr Binmoeller is the founder and chief medical officer of Xlumena. Dr Itoi is a consultant for Boston Scientific, Xlumena, Fuji Film, and Olympus Medical Systems.	Binmoeller KF, 2012, ENDOSCOPY, V44, P499, DOI 10.1055/s-0032-1309382; DOBERNECK RC, 1987, ARCH SURG-CHICAGO, V122, P827; Jeurnink SM, 2010, GASTROINTEST ENDOSC, V71, P490, DOI 10.1016/j.gie.2009.09.042; van Hooft JE, 2009, GASTROINTEST ENDOSC, V69, P1059, DOI 10.1016/j.gie.2008.07.026; Mehta S, 2006, SURG ENDOSC, V20, P239, DOI 10.1007/s00464-005-0130-9; Fiori E, 2004, ANTICANCER RES, V24, P265; Fritscher-Ravens A, 2002, GASTROINTEST ENDOSC, V56, P737, DOI 10.1067/mge.2002.129084; Binmoeller KF, 2011, ENDOSCOPY, V43, P337, DOI 10.1055/s-0030-1256127; Itoi T, 2013, GASTROINTEST ENDOSC, V78, P934, DOI 10.1016/j.gie.2013.09.025; Teoh AYB, 2014, GASTROINTEST ENDOSC, V80, P1171, DOI 10.1016/j.gie.2014.03.038; Telford JJ, 2004, GASTROINTEST ENDOSC, V60, P916, DOI 10.1016/S0016-5107(04)02228-X; Khashab M, 2013, SURG ENDOSC, V27, P2068, DOI 10.1007/s00464-012-2712-7; Itoi T, 2015, J HEPATO-BIL-PAN SCI, V22, P3, DOI 10.1002/jhbp.148	13	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	MAY	2015	81	5					1234	1236		10.1016/j.gie.2014.12.053		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF6ZV	WOS:000352706600021		
J	Itoi, T; Ikeuchi, N; Tonozuka, R; Mukai, S; Sofuni, A				Itoi, Takao; Ikeuchi, Nobuhito; Tonozuka, Ryosuke; Mukai, Shuntaro; Sofuni, Atsushi			EUS-guided choledochojejunostomy with a lumen-apposing metal stent in a post-Whipple patient	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Itoi, Takao; Ikeuchi, Nobuhito; Tonozuka, Ryosuke; Mukai, Shuntaro; Sofuni, Atsushi] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan	Itoi, T (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan.							0	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	MAY	2015	81	5					1259	1260		10.1016/j.gie.2014.08.033		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF6ZV	WOS:000352706600033		
J	Mukai, S; Itoi, T; Tsuchiya, T; Ishii, K; Tonozuka, R				Mukai, Shuntaro; Itoi, Takao; Tsuchiya, Takayoshi; Ishii, Kentaro; Tonozuka, Ryosuke			Pulsating pseudoaneurysm in a walled-off necrosis	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Mukai, Shuntaro; Itoi, Takao; Tsuchiya, Takayoshi; Ishii, Kentaro; Tonozuka, Ryosuke] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan	Mukai, S (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	MAY	2015	81	5					1262	1262		10.1016/j.gie.2014.08.031		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF6ZV	WOS:000352706600036		
J	Miura, S; Ono, M; Hayashi, T; Ishiwatari, H; Kato, J				Miura, Shogo; Ono, Michihiro; Hayashi, Tsuyoshi; Ishiwatari, Hirotoshi; Kato, Junji			EUS-guided choledochoduodenostomy for cholangitis caused by mucin derived from intraductal papillary-mucinous neoplasms penetrating the bile duct	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Miura, Shogo; Ono, Michihiro; Hayashi, Tsuyoshi; Ishiwatari, Hirotoshi; Kato, Junji] Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Sapporo, Hokkaido, Japan	Miura, S (reprint author), Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Sapporo, Hokkaido, Japan.							0	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	MAY	2015	81	5					1266	1267		10.1016/j.gie.2014.08.036		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF6ZV	WOS:000352706600040		
J	Onda, S; Ogura, T; Sano, T; Imoto, A; Masuda, D; Yamamoto, K; Takeuchi, T; Higuchi, K				Onda, Saori; Ogura, Takeshi; Sano, Tatsushi; Imoto, Akira; Masuda, Daisuke; Yamamoto, Kazuhiro; Takeuchi, Toshihisa; Higuchi, Kazuhide			Successful removal of intrahepatic bile duct stone using a novel basket catheter	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Onda, Saori; Ogura, Takeshi; Sano, Tatsushi; Imoto, Akira; Masuda, Daisuke; Takeuchi, Toshihisa; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Osaka, Japan; [Yamamoto, Kazuhiro] Osaka Med Coll, Dept Pathol, Osaka, Japan	Onda, S (reprint author), Osaka Med Coll, Dept Internal Med 2, Osaka, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	MAY	2015	81	5					1267	1267		10.1016/j.gie.2014.09.005		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF6ZV	WOS:000352706600041		
J	Nakano, A; Hirooka, Y; Watanabe, O; Nakamura, M; Yamamura, T; Ando, T; Goto, H				Nakano, Arihiro; Hirooka, Yoshiki; Watanabe, Osamu; Nakamura, Masanao; Yamamura, Takeshi; Ando, Takafumi; Goto, Hidemi			Challenging EMR for the definite diagnosis of submucosal tumor in the small bowel by using double-balloon endoscopy	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Nakano, Arihiro; Watanabe, Osamu; Nakamura, Masanao; Ando, Takafumi; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan; [Hirooka, Yoshiki; Yamamura, Takeshi] Nagoya Univ Hosp, Dept Endoscopy, Nagoya, Aichi, Japan	Nakano, A (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	MAY	2015	81	5					1273	1274		10.1016/j.gie.2014.08.011		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF6ZV	WOS:000352706600047		
J	Nishiyama, N; Mori, H; Kobara, H; Rafiq, K; Fujihara, S; Ayaki, M; Yachida, T; Goda, Y; Morishita, A; Masaki, T				Nishiyama, Noriko; Mori, Hirohito; Kobara, Hideki; Rafiq, Kazi; Fujihara, Shintaro; Ayaki, Maki; Yachida, Tatsuo; Goda, Yasuhiro; Morishita, Asahiro; Masaki, Tsutomu			Endoscopic management with over-the-scope clips for intestinal bleeding of Behcet's disease	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Nishiyama, Noriko; Mori, Hirohito; Kobara, Hideki; Fujihara, Shintaro; Ayaki, Maki; Yachida, Tatsuo; Goda, Yasuhiro; Morishita, Asahiro; Masaki, Tsutomu] Kagawa Univ, Fac Med, Dept Gastroenterol, Takamatsu, Kagawa 760, Japan; [Nishiyama, Noriko; Mori, Hirohito; Kobara, Hideki; Fujihara, Shintaro; Ayaki, Maki; Yachida, Tatsuo; Goda, Yasuhiro; Morishita, Asahiro; Masaki, Tsutomu] Kagawa Univ, Fac Med, Dept Neurol, Takamatsu, Kagawa 760, Japan; [Rafiq, Kazi] Kagawa Univ, Fac Med, Dept Pharmacol, Takamatsu, Kagawa 760, Japan	Nishiyama, N (reprint author), Kagawa Univ, Fac Med, Dept Gastroenterol, Takamatsu, Kagawa 760, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	MAY	2015	81	5					1275	1276		10.1016/j.gie.2014.09.052		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF6ZV	WOS:000352706600049		
J	Konno, T; Ninomiya, T; Kohno, T; Kikuchi, S; Sawada, N; Kojima, T				Konno, Takumi; Ninomiya, Takafumi; Kohno, Takayuki; Kikuchi, Shin; Sawada, Norimasa; Kojima, Takashi			c-Jun N-terminal kinase inhibitor SP600125 enhances barrier function and elongation of human pancreatic cancer cell line HPAC in a Ca-switch model	HISTOCHEMISTRY AND CELL BIOLOGY			English	Article						JNK; Barrier function; Cell elongation; Ca-switch model; Tight junctions; beta-Catenin; DrebrinE; Human pancreatic cancer cell line	EPITHELIAL-CELLS; SIGNAL-TRANSDUCTION; ADHERENS JUNCTIONS; TIGHT JUNCTIONS; JNK; PROLIFERATION; CARCINOMA; REQUIRES; DREBRIN; BINDING	c-Jun N-terminal kinase (JNK), known as a stress-activated protein kinase, regulates normal epithelial biological processes, including assembly of adherens and tight junctions, and it is involved in the development of several cancers. The JNK inhibitor SP600125 enhances epithelial barrier function through modulation of tight junction molecules in normal human pancreatic epithelial cells. Furthermore, this JNK inhibitor suppresses the growth of human pancreatic cancer cells. However, the effects of SP600125 on the epithelial barrier in human pancreatic cancer cells remain unknown. In the present study, the JNK inhibitor SP600125 markedly enhanced the barrier function and cell elongation of well-differentiated human pancreatic cancer cell line HPAC in a Ca-switch model. The epithelial barrier function induced by SP600125 was regulated by phosphorylated beta-catenin without changes in the tight junction molecules. The cell elongation induced by SP600125 was closely related to the expression of the F-actin-binding protein DrebrinE. These findings suggest that JNK is involved in the regulation of the epithelial barrier function and cell shape during remodeling of pancreatic cancer cells. The JNK inhibitor SP600125 may have potential as a therapeutic drug for pancreatic cancer via induction of differentiation.	[Konno, Takumi; Kohno, Takayuki; Kojima, Takashi] Sapporo Med Univ, Sch Med, Dept Cell Sci, Res Inst Frontier Med, Sapporo, Hokkaido 0608556, Japan; [Ninomiya, Takafumi; Kikuchi, Shin] Sapporo Med Univ, Dept Anat, Sch Med, Sapporo, Hokkaido 0608556, Japan; [Sawada, Norimasa] Sapporo Med Univ, Dept Pathol, Sch Med, Sapporo, Hokkaido 0608556, Japan	Kojima, T (reprint author), Sapporo Med Univ, Sch Med, Dept Cell Sci, Res Inst Frontier Med, S1 W17, Sapporo, Hokkaido 0608556, Japan.	ktakashi@sapmed.ac.jp			Ministry of Education, Culture, Sports Science, and Technology; Ministry of Health, Labour and Welfare of Japan	This work was supported by the Ministry of Education, Culture, Sports Science, and Technology, and the Ministry of Health, Labour and Welfare of Japan.	Yang YM, 2003, CLIN CANCER RES, V9, P391; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; Whatcott Clifford J., 2013, Critical Reviews in Oncogenesis, V18, P135; Ebnet K, 2008, HISTOCHEM CELL BIOL, V130, P1, DOI 10.1007/s00418-008-0418-7; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Lee MH, 2011, FASEB J, V25, P613, DOI 10.1096/fj.10-161380; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Kojima T, 2010, J CELL PHYSIOL, V225, P720, DOI 10.1002/jcp.22273; Takahashi R, 2013, CANCER SCI, V104, P337, DOI 10.1111/cas.12080; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Samak G, 2010, AM J PHYSIOL-GASTR L, V299, pG572, DOI 10.1152/ajpgi.00265.2010; Bazellieres E, 2012, J CELL SCI, V125, P919, DOI 10.1242/jcs.092676; Carrozzino F, 2009, AM J PHYSIOL-CELL PH, V297, pC775, DOI 10.1152/ajpcell.00084.2009; Chen YH, 2002, MOL BIOL CELL, V13, P1227, DOI 10.1091/mbc.01-08-0423; Dun XP, 2010, HISTOL HISTOPATHOL, V25, P533; Ebelt Nancy D, 2013, Genes Cancer, V4, P378, DOI 10.1177/1947601913485413; Gazel A, 2006, J BIOL CHEM, V281, P20530, DOI 10.1074/jbc.M602712200; Gross ND, 2007, CLIN CANCER RES, V13, P5910, DOI 10.1158/1078-0432.CCR-07-0352; Kojima T, 2013, TISSUE BARRIERS, V1, DOI DOI 10.4161/TISB.24894; Naydenov NG, 2009, CELL CYCLE, V8, P2110, DOI 10.4161/cc.8.13.8928; Shibata W, 2008, CANCER RES, V68, P5031, DOI 10.1158/0008-5472.CAN-07-6332; SHIRAO T, 1985, J NEUROCHEM, V44, P1210, DOI 10.1111/j.1471-4159.1985.tb08745.x; Vacca B, 2014, HUM MOL GENET, V23, P2834, DOI 10.1093/hmg/ddt670; VOLBERG T, 1986, J CELL BIOL, V102, P1832, DOI 10.1083/jcb.102.5.1832; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; You H., 2013, TISSUE BARRIERS, V1, DOI [DOI 10.4161/TISB.26845, 10.4161/tisb.26845]	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	MAY	2015	143	5					471	479		10.1007/s00418-014-1300-4		9	Cell Biology; Microscopy	Cell Biology; Microscopy	CF6FL	WOS:000352652300004		
J	Wakisaka, N; Yoshida, S; Kondo, S; Kita, M; Sawada-Kitamura, S; Endo, K; Tsuji, A; Nakanish, Y; Murono, S; Yoshizaki, T				Wakisaka, Naohiro; Yoshida, Shinya; Kondo, Satoru; Kita, Makiko; Sawada-Kitamura, Seiko; Endo, Kazuhira; Tsuji, Akira; Nakanish, Yosuke; Murono, Shigeyuki; Yoshizaki, Tomokazu			Induction of epithelial-mesenchymal transition and loss of podoplanin expression are associated with progression of lymph node metastases in human papillomavirus-related oropharyngeal carcinoma	HISTOPATHOLOGY			English	Article						epithelial-mesenchymal transition; human papillomavirus; lymph node metastasis; oropharyngeal cancer; podoplanin	SQUAMOUS-CELL CARCINOMA; PREDICTS POOR-PROGNOSIS; NECK-CANCER; D2-40 IMMUNOREACTIVITY; TUMOR INVASION; UTERINE CERVIX; BREAST-CANCER; ORAL-CAVITY; HEAD; LYMPHANGIOGENESIS	Aims To examine human papillomavirus (HPV) status, the expression of podoplanin and epithelial-mesenchymal transition (EMT) markers and lymphatic vessel counts (LVC) in oropharyngeal squamous cell carcinoma (OPSCC) tissues, and to evaluate whether these factors were associated with survival and nodal status. Methods and results A total of 53 OPSCC specimens were evaluated for HPV status and expression of proteins such as podoplanin and EMT markers by immunohistochemistry. E-cadherin-negative and vimentin-positive specimens were defined as EMT-positive. Twenty-twoOPSCCs were HPV-positive. There was significant progression of nodal status in patients with HPV-positive tumours (P=0.0475). HPV-positive cases had significantly lower expression of podoplanin (P=0.0016) and were more frequently EMT-positive (P=0.0172). Podoplanin-negative cases and EMT-positive cases showed significantly more advanced nodal status than their respective counterparts (P=0.0082 and P0.0186, respectively). LVC correlated with neither HPV nor nodal status. Multivariate analyses revealed that HPV infection was an independent marker of longer disease-specific survival (P=0.014). Conclusions HPV-positivity in OPSCC was associated with loss of podoplanin expression and with EMT induction, which resulted in progression of nodal status. The mechanisms leading to an improved prognosis in HPV-positive OPSCC patients requires elucidation, as this is inconsistent with the aggressive phenotype with lymph node metastases.	[Wakisaka, Naohiro; Yoshida, Shinya; Kondo, Satoru; Kita, Makiko; Endo, Kazuhira; Tsuji, Akira; Nakanish, Yosuke; Murono, Shigeyuki; Yoshizaki, Tomokazu] Kanazawa Univ, Grad Sch Med Sci, Div Otolaryngol Head & Neck Surg, Kanazawa, Ishikawa 9208640, Japan; [Sawada-Kitamura, Seiko] Kanazawa Univ, Grad Sch Med Sci, Div Human Pathol, Kanazawa, Ishikawa 9208640, Japan	Yoshizaki, T (reprint author), Kanazawa Univ, Grad Sch Med Sci, Div Otolaryngol Head & Neck Surg, Takara Machi 13-1, Kanazawa, Ishikawa 9208640, Japan.	tomoy@med.kanazawa-u.ac.jp			Ministry of Education, Science, Sports, Culture and Technology of Japan [C21592189]	This work was supported by a scientific research grant from the Ministry of Education, Science, Sports, Culture and Technology of Japan (C21592189).	Schache AG, 2011, CLIN CANCER RES, V17, P6262, DOI 10.1158/1078-0432.CCR-11-0388; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Nakamura Y, 2005, BREAST CANCER RES TR, V91, P125, DOI 10.1007/s10549-004-5783-x; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Ito T, 2009, LUNG CANCER, V63, P418, DOI 10.1016/j.lungcan.2008.06.008; Fakhry C, 2008, J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Bono P, 2004, CLIN CANCER RES, V10, P7144, DOI 10.1158/1078-0432.CCR-03-0826; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Nishiwaki M, 2008, J CLIN MICROBIOL, V46, P1161, DOI 10.1128/JCM.00793-07; Suzuki H, 2011, PATHOL RES PRACT, V207, P111, DOI 10.1016/j.prp.2010.11.006; Chuang WY, 2009, HISTOL HISTOPATHOL, V24, P1021; Sun Q, 2013, INT J BIOCHEM CELL B, V45, P513, DOI 10.1016/j.biocel.2012.12.004; Psyrri A, 2008, NAT CLIN PRACT ONCOL, V5, P24, DOI 10.1038/ncponc0984; Klussmann JP, 2003, AM J PATHOL, V162, P747, DOI 10.1016/S0002-9440(10)63871-0; Franchi A, 2004, CANCER, V101, P973, DOI 10.1002/cncr.20454; Kreppel M, 2010, VIRCHOWS ARCH, V456, P473, DOI 10.1007/s00428-010-0915-7; Huber GF, 2011, INT J CANCER, V129, P1404, DOI 10.1002/ijc.25795; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Boulenouar S, 2010, CARCINOGENESIS, V31, P473, DOI 10.1093/carcin/bgp281; Yuan P, 2006, CANCER, V107, P563, DOI 10.1002/cncr.22061; Kim SH, 2007, INT J CANCER, V120, P1418, DOI 10.1002/ijc.22464; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Chao YK, 2012, J SURG ONCOL, V105, P183, DOI 10.1002/jso.22068; Peterziel H, 2012, NEURO-ONCOLOGY, V14, P426, DOI 10.1093/neuonc/nos055; Begum S, 2003, CLIN CANCER RES, V9, P6469; Kyzas PA, 2005, J PATHOL, V206, P170, DOI 10.1002/path.1776; Dumoff KL, 2005, MODERN PATHOL, V18, P97, DOI 10.1038/modpathol.3800269; Laurson J, 2010, CARCINOGENESIS, V31, P918, DOI 10.1093/carcin/bgq027; Worden FP, 2008, J CLIN ONCOL, V26, P3138, DOI 10.1200/JCO.2007.12.7597; Maula SM, 2003, CANCER RES, V63, P1920; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; Nakashima Y, 2013, CANCER SCI, V104, P1718, DOI 10.1111/cas.12286; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Van der Auwera I, 2006, BRIT J CANCER, V95, P1611, DOI 10.1038/sj.bjc.6603445; Wakisaka N, 2012, ORAL ONCOL, V48, P703, DOI 10.1016/j.oraloncology.2012.02.003; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Dumoff KL, 2006, MODERN PATHOL, V19, P708, DOI 10.1038/modpathol.3800580; Goon PKC, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-36; Hellner K, 2009, VIROLOGY, V391, P57, DOI 10.1016/j.virol.2009.05.036; Huber G. F., 2011, BMC CANCER, V11, P211; Joo YH, 2012, HEAD NECK-J SCI SPEC, V34, P10, DOI 10.1002/hed.21697; Lajer CB, 2012, BRIT J CANCER, V106, P1526, DOI 10.1038/bjc.2012.109; Minardi D, 2011, HUM PATHOL, V42, P1596, DOI 10.1016/j.humpath.2010.12.020; Sobin LH, 2009, TNM CLASSIFICATION M, P30	45	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	MAY	2015	66	6					771	780		10.1111/his.12496		10	Cell Biology; Pathology	Cell Biology; Pathology	CF8KZ	WOS:000352809600002		
J	Mimori, T; Kobayashi, S; Tanaka, A; Sasada, S; Yoshida, A; Izumo, T; Sasaki, N; Tsuchida, T; Tsuta, K				Mimori, Tomoyasu; Kobayashi, Saori; Tanaka, Ayako; Sasada, Shinji; Yoshida, Akihiko; Izumo, Takehiro; Sasaki, Naoshi; Tsuchida, Takaaki; Tsuta, Koji			Novel use for an EGFR mutation-specific antibody in discriminating lung adenocarcinoma from reactive pneumocyte hyperplasia	HISTOPATHOLOGY			English	Article						EGFR; immunohistochemistry; lung adenocarcinoma; pneumocyte hyperplasia	EPIDERMAL-GROWTH-FACTOR; FACTOR-RECEPTOR GENE; GROUND-GLASS OPACITY; CLINICAL-IMPLICATIONS; COMPUTED-TOMOGRAPHY; CANCER; P53; EXPRESSION; CT; NODULES	Aims Pulmonary ground-glass nodules (GGNs) are frequently observed. Histopathologically, their presentation can indicate a wide range of disorders from an inflammatory process to malignancy. An accurate diagnosis based on GGNs can sometimes be challenging on small-sized biopsies. Mutations in the EGFR gene are detected in pulmonary adenocarcinomas (ADCs). Immunohistochemical analysis using antibodies that detect specific EGFR mutations has been shown to correlate with mutational status as determined by molecular methods. We hypothesized that these antibodies could be used to discriminate between ADCs and benign pneumocyte hyperplasias. Methods and results Surgically resected, pre-invasive to invasive lung ADC (n=32) and reactive pneumocyte hyperplasia (n=40) tissue samples were probed with antibodies against EGFR mutations, p53, Mouse double minute 2 and 14-3-3 sigma. Of the 32 lung ADC specimens analysed, 12 (38%) were positive using the EGFR mutation-specific antibodies, while no immunoreactivity was observed in reactive pneumocyte hyperplasia specimens. Analyses of receiver operating characteristic curves showed that the highest area under the curve values were associated with the use of EGFR mutation-specific antibodies. In addition, a high concordance rate was observed between surgically resected and corresponding biopsy materials using these antibodies. Conclusions EGFR mutation-specific antibodies can be used to discriminate between lung ADC and benign pneumocyte hyperplasia, even in small-sized biopsies.	[Mimori, Tomoyasu; Kobayashi, Saori; Tanaka, Ayako; Yoshida, Akihiko; Sasaki, Naoshi; Tsuta, Koji] Natl Canc Ctr, Div Pathol, Tokyo 1040045, Japan; [Mimori, Tomoyasu; Kobayashi, Saori; Tanaka, Ayako; Yoshida, Akihiko; Sasaki, Naoshi; Tsuta, Koji] Natl Canc Ctr, Clin Labs, Tokyo 1040045, Japan; [Mimori, Tomoyasu; Tanaka, Ayako; Sasada, Shinji; Izumo, Takehiro; Tsuchida, Takaaki] Natl Inst Canc Res, Div Endoscopy, Resp Endoscopy, Tokyo, Japan	Tsuta, K (reprint author), Natl Canc Ctr, Div Pathol, Chuo Ku, 1-1 Tsukiji 5 Chome, Tokyo 1040045, Japan.	ktsuta@ncc.go.jp			National Cancer Center Research and Development Fund [23-A-2, 23-A-11, 23-A-35, 24-A-1];  [25460446]	This work was supported by the National Cancer Center Research and Development Fund (23-A-2, 23-A-11, 23-A-35, and 24-A-1), and Grant-in-Aid for Scientific Research (C; grant number 25460446). We thank Koh Furuta and Noriko Abe for their excellent technical assistance.	Kozu Y, 2011, LUNG CANCER, V73, P45, DOI 10.1016/j.lungcan.2010.11.003; Lee HY, 2011, J THORAC IMAG, V26, P106, DOI 10.1097/RTI.0b013e3181fbaa64; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Kawahara A, 2010, CLIN CANCER RES, V16, P3163, DOI 10.1158/1078-0432.CCR-09-3239; Tsuta K, 2013, LUNG CANCER, V81, P371, DOI 10.1016/j.lungcan.2013.06.012; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Shigematsu H, 2005, J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Kawahara A, 2012, LUNG CANCER, V78, P39, DOI 10.1016/j.lungcan.2012.07.002; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Aoki T, 2001, RADIOLOGY, V220, P803, DOI 10.1148/radiol.2203001701; Aoki T, 2012, RADIOLOGY, V264, P590, DOI 10.1148/radiol.12111337; Wen YH, 2013, MODERN PATHOL, V26, P1197, DOI 10.1038/modpathol.2013.53; Travis WD, 2005, J CLIN ONCOL, V23, P3279, DOI 10.1200/JCO.2005.15.778; Allo G, 2014, HISTOPATHOLOGY, V64, P826, DOI 10.1111/his.12331; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Takeda Y, 2008, ARCH PATHOL LAB MED, V132, P239, DOI 10.1043/1543-2165(2008)132[239:AOEPOB]2.0.CO;2; Kato Y, 2010, J THORAC ONCOL, V5, P1551, DOI 10.1097/JTO.0b013e3181e9da60; Brandman S, 2011, J THORAC IMAG, V26, P90, DOI 10.1097/RTI.0b013e31821639a9; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Tang XN, 2005, CANCER RES, V65, P7568, DOI 10.1158/0008-5472.CAN-05-1705; Shiba-Ishii A, 2011, INT J CANCER, V129, P2445, DOI 10.1002/ijc.25907; Yoshizawa A, 2013, J THORAC ONCOL, V8, P52, DOI 10.1097/JTO.0b013e3182769aa8; Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Blons H, 2006, AM J SURG PATHOL, V30, P1309, DOI 10.1097/01.pas.0000213285.65907.31; Collins J, 1997, AM J ROENTGENOL, V169, P355; Hojo S, 1998, RESP MED, V92, P184, DOI 10.1016/S0954-6111(98)90093-2; Kobel M, 2012, J PATHOL, V222, P191; Kunitake R, 1998, EUR RESPIR J, V12, P920, DOI 10.1183/09031936.98.12040920; Mills SE, 2007, HISTOLOGY PATHOLOGIS, P493; Mitsudomi Tetsuya, 2006, Int J Clin Oncol, V11, P190, DOI 10.1007/s10147-006-0583-4; Nomori H, 2004, LUNG CANCER-J IASLC, V45, P19, DOI 10.1016/j.lungcan.2004.01.009; Staib F, 2005, CANCER RES, V65, P10255, DOI 10.1158/0008-5472.CAN-05-1714; Xue Q, 2002, PATHOL INT, V52, P103, DOI 10.1046/j.1440-1827.2002.01321.x	35	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	MAY	2015	66	6					816	823		10.1111/his.12516		8	Cell Biology; Pathology	Cell Biology; Pathology	CF8KZ	WOS:000352809600007		
J	Sasaki, M; Yoneda, N; Sawai, Y; Imai, Y; Kondo, F; Fukusato, T; Yoshikawa, S; Kobayashi, S; Sato, Y; Matsui, O; Nakanuma, Y				Sasaki, Motoko; Yoneda, Norihide; Sawai, Yoshiyuki; Imai, Yasuharu; Kondo, Fukuo; Fukusato, Toshio; Yoshikawa, Seiichi; Kobayashi, Satoshi; Sato, Yasunori; Matsui, Osamu; Nakanuma, Yasuni			Clinicopathological characteristics of serum amyloid A-positive hepatocellular neoplasms/nodules arising in alcoholic cirrhosis	HISTOPATHOLOGY			English	Article						alcoholic cirrhosis; focal nodular hyperplasia; glutamine synthetase; hepatocellular carcinoma; inflammatory hepatocellular adenoma; serum amyloid A; serum amyloid A-positive hepatocellular neoplasm/nodule	FOCAL NODULAR HYPERPLASIA; LIVER-CIRRHOSIS; MUTATIONS; ADENOMA; TUMORS; STAT3; CLASSIFICATION; EXPRESSION; CARCINOMA	Aims To characterize serum amyloid A (SAA)-positive hepatocellular neoplasms/nodules arising in alcoholic cirrhosis, which are detected as hypervascular hepatocellular nodules resembling hepatocellular carcinoma on imaging. Methods and results Fifty-three hepatocellular nodules were examined with immunostaining for SAA, glutamine synthetase and glypican-3 in 23 patients (four women and 19 men) with alcoholic cirrhosis. Sixteen nodules were examined with magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid enhancement (EOB-MRI). Somatic mutations in IL6ST, GNAS and STAT3 were examined in 19 nodules. Thirty-six nodules in 18 patients were diagnosed as SAA-positive hepatocellular neoplasms/nodules, and the remaining 17 nodules in eight patients were SAA-negative focal nodular hyperplasia (FNH)-like nodules. SAA-positive hepatocellular neoplasms/nodules showed significantly more extensive sinusoidal dilatation, inflammatory reaction, abnormally thick arteries and cellular atypia than FNH-like nodules (P<0.05). Eight SAA-positive hepatocellular neoplasms/nodules (67%) showed slight hypointensity in the hepatobiliary phase on EOB-MRI, whereas all four FNH-like nodules showed iso-intensity (P<0.05). STAT3 mutations were detected in two of 17 SAA-positive hepatocellular neoplasms/nodules. Conclusions This study showed that approximately two-thirds of hypervascular hepatocellular nodules arising in alcoholic cirrhosis were SAA-positive hepatocellular neoplasms/nodules, which show different findings on the EOB-MRI. STAT3 mutations were detected in 11.8% of SAA-positive hepatocellular neoplasms/nodules, supporting a neoplastic nature.	[Sasaki, Motoko; Yoneda, Norihide; Sato, Yasunori; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med Sci, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan; [Yoneda, Norihide; Kobayashi, Satoshi; Matsui, Osamu] Kanazawa Univ, Grad Sch Med Sci, Dept Radiol, Kanazawa, Ishikawa 9208640, Japan; [Sawai, Yoshiyuki; Imai, Yasuharu] Ikeda Municipal Hosp, Dept Gastroenterol, Osaka, Japan; [Kondo, Fukuo; Fukusato, Toshio] Teikyo Univ, Sch Med, Dept Pathol, Tokyo 173, Japan; [Yoshikawa, Seiichi] Niigata Univ, Grad Sch Med, Dept Gastroenterol, Japan Cine, Niigata, Japan; [Nakanuma, Yasuni] Shizuoka Canc Ctr, Dept Pathol, Shizuoka, Japan	Sasaki, M (reprint author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.	m8sasaki@med.kanazawa-u.ac.jp	Sasaki, Motoko/K-5913-2015	Sasaki, Motoko/0000-0003-2514-760X	Ministry of Education, Culture, Sports and Science and Technology of Japan [21590366]	This study was supported in part by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports and Science and Technology of Japan (21590366).	Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Jerez A, 2012, BLOOD, V120, P3048, DOI 10.1182/blood-2012-06-435297; Sasaki M, 2012, MODERN PATHOL, V25, P1584, DOI 10.1038/modpathol.2012.114; Nakashima O, 2004, J HEPATOL, V41, P992, DOI 10.1016/j.jhep.2004.08.014; Farges O, 2011, GUT, V60, P85, DOI 10.1136/gut.2010.222109; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI [10.1002/hep.22734, 10.1002/hep.227.34]; TERADA T, 1993, VIRCHOWS ARCH A, V422, P247, DOI 10.1007/BF01621809; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Kobayashi S, 2007, J COMPUT ASSIST TOMO, V31, P557, DOI 10.1097/RCT.0b013e3180305bfb; Sasaki M, 2011, HEPATOL RES, V41, P982, DOI 10.1111/j.1872-034X.2011.00851.x; Rebouissou S, 2008, J HEPATOL, V49, P61, DOI 10.1016/j.jhep.2008.03.013; Nault JC, 2012, J HEPATOL, V56, P184, DOI 10.1016/j.jhep.2011.07.018; Yoneda N, 2012, JPN J RADIOL, V30, P777, DOI 10.1007/s11604-012-0115-2; Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237; Sekine S, 2011, CANCER SCI, V102, P1742, DOI 10.1111/j.1349-7006.2011.01990.x; Nault JC, 2013, GASTROENTEROLOGY, V144, P888, DOI 10.1053/j.gastro.2013.02.032; Bioulac-Sage P, 2010, WHO CLASSIFICATION T, P198; DisTommaso L, 2009, J HEPATOL, V50, P746; Kitao A, 2011, RADIOLOGY, V256, P817; Sasaki M, 2013, HISTOL HISTOPATHOL, V28, P1499	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	MAY	2015	66	6					836	845		10.1111/his.12588		10	Cell Biology; Pathology	Cell Biology; Pathology	CF8KZ	WOS:000352809600009		
J	Mizutani, T; Yokoyama, Y; Kokuryo, T; Ebata, T; Igami, T; Sugawara, G; Nagino, M				Mizutani, Tetsushi; Yokoyama, Yukihiro; Kokuryo, Toshio; Ebata, Tomoki; Igami, Tsuyoshi; Sugawara, Gen; Nagino, Masato			Does inchinkoto, a herbal medicine, have hepatoprotective effects in major hepatectomy? A prospective randomized study	HPB			English	Article							RAT-LIVER; KO-TO; BILIARY CANCER; ISCHEMIA-REPERFUSION; EXTENDED HEPATECTOMY; APOPTOSIS; RESECTION; INJURY; COMPLICATIONS; EMBOLIZATIONS	ObjectivesThis randomized clinical trial was designed to investigate whether inchinkoto has a hepatoprotective effect on postoperative outcome after major hepatectomy. MethodsSixty-one patients scheduled for major hepatectomy were randomly assigned to one of two groups in which preoperative inchinkoto was (inchinkoto group, n = 30) or was not (non-inchinkoto group, n = 31) administered. Inchinkoto was administered for at least 7 days before surgery. The primary endpoint was the incidence of post-hepatectomy liver damage. The expression of nuclear factor E2-related factor 2 (Nrf2) and other oxygen stress-related markers in the liver were also determined. ResultsThere was no significant difference in clinical characteristics between the inchinkoto and non-inchinkoto groups. Serum levels in liver function tests and incidences of post-hepatectomy liver failure did not differ significantly between the two groups. However, there was a significantly higher induction of antioxidant factors in the liver, such as Nrf2 protein and heme oxygenase-1 mRNA, after hepatectomy in the inchinkoto group than in the non-inchinkoto group. ConclusionsThe preoperative administration of inchinkoto did not have a significant impact on the overall outcome of major hepatectomy. However, inchinkoto induced the expression of Nrf2 during hepatectomy and may have exerted an antioxidative effect on the liver.	[Mizutani, Tetsushi; Yokoyama, Yukihiro; Kokuryo, Toshio; Ebata, Tomoki; Igami, Tsuyoshi; Sugawara, Gen; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol, Nagoya, Aichi 4668550, Japan	Yokoyama, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	yyoko@med.nagoya-u.ac.jp					Beck-Schimmer B, 2008, ANN SURG, V248, P909, DOI 10.1097/SLA.0b013e31818f3dda; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Yokoyama Y, 2010, BRIT J SURG, V97, P1260, DOI 10.1002/bjs.7084; Ebata T, 2012, DIGEST SURG, V29, P23, DOI 10.1159/000335718; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; FAN ST, 1994, NEW ENGL J MED, V331, P1547, DOI 10.1056/NEJM199412083312303; Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14; Bilzer M, 1999, GASTROENTEROLOGY, V117, P200, DOI 10.1016/S0016-5085(99)70568-8; Yamaguchi T, 1996, BIOCHEM BIOPH RES CO, V223, P129, DOI 10.1006/bbrc.1996.0857; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Muratore A, 2003, BRIT J SURG, V90, P17, DOI 10.1002/bjs.4055; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Rahbari NN, 2011, ANN SURG ONCOL, V18, P3640, DOI 10.1245/s10434-011-1829-6; Yamamoto M, 2000, GASTROENTEROLOGY, V118, P380, DOI 10.1016/S0016-5085(00)70220-4; Fondevila C, 2004, HEPATOLOGY, V40, P1333, DOI 10.1002/hep.20480; Asakawa T, 2012, PEDIATR SURG INT, V28, P379, DOI 10.1007/s00383-011-2974-5; Fisette A, 2012, J CLIN ENDOCR METAB, V97, P217, DOI 10.1210/jc.2011-1598; Hsu YC, 2008, TRANSPL P, V40, P2156, DOI 10.1016/j.transproceed.2008.07.088; Imanishi Y, 2004, J HEPATOL, V41, P242, DOI 10.1016/j.jhep.2004.04.005; Kaiho T, 2008, HEPATO-GASTROENTEROL, V55, P150; Kawai K, 2010, ANN SURG, V251, P692, DOI 10.1097/SLA.0b013e3181d50299; Kobayashi H, 2001, PEDIATR SURG INT, V17, P386, DOI 10.1007/s003830000561; Mase A, 2010, J ETHNOPHARMACOL, V127, P742, DOI 10.1016/j.jep.2009.11.029; Okada K, 2007, AM J PHYSIOL-GASTR L, V292, pG1450, DOI 10.1152/ajpgi.00302.2006; Schulz KF, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c332; Shoda J, 2004, HEPATOLOGY, V39, P167, DOI 10.1002/hep.20003; Takayama Y, 2008, CANCER LETT, V264, P241, DOI 10.1016/j.canlet.2008.01.035; Watanabe S, 2009, HEPATOL RES, V39, P247, DOI 10.1111/j.1872-034X.2008.00453.x; Yamamoto M, 1996, HEPATOLOGY, V23, P552	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1365-182X	1477-2574		HPB	HPB	MAY	2015	17	5					461	469		10.1111/hpb.12384		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF8HJ	WOS:000352796600012		
J	Liu, HC; Qin, JT; Mao, LX; Zhang, ZY				Liu, Hu-Chen; Qin, Jiang-Tao; Mao, Ling-Xiang; Zhang, Zhi-Ying			Personnel Selection Using Interval 2-Tuple Linguistic VIKOR Method	HUMAN FACTORS AND ERGONOMICS IN MANUFACTURING & SERVICE INDUSTRIES			English	Article						Personnel selection; Interval 2-tuple; VIKOR method; Multicriteria group decision making	GROUP DECISION-MAKING; FUZZY ENVIRONMENT; AGGREGATION OPERATORS; REPRESENTATION MODEL; MCDM APPROACH; INFORMATION; TOPSIS; PERFORMANCE; MANAGEMENT; EXTENSION	Personnel selection is a very important activity in the human resource management of an organization. However, in many practical circumstances, due to time pressure and lack of information about candidates, decision makers generally tend to provide linguistic assessments and use different linguistic term sets to express their opinions during the personnel selection process. In this article, the VIKOR method combined with interval 2-tuple linguistic variables is proposed to choose appropriate individuals among candidates in a group decision-making environment. The interval 2-tuple linguistic variable, which comprises two linguistic terms and two real numbers, is more flexible and precise to deal with linguistic information in solving personnel selection problems. To demonstrate the applicability and effectiveness of the proposed interval 2-tuple linguistic VIKOR method, a numerical example of personnel selection in a tertiary care hospital is provided.	[Liu, Hu-Chen] Hefei Univ Technol, Sch Management, Hefei 230009, Peoples R China; [Liu, Hu-Chen] Tokyo Inst Technol, Dept Ind Engn & Management, Tokyo 152, Japan; [Qin, Jiang-Tao] Chongqing Vocat Inst Engn, Sch Min & Environm, Chongqing, Peoples R China; [Mao, Ling-Xiang] Nanjing Univ, Sch Informat Management, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Zhi-Ying] Tongji Univ, Coll Mech Engn, Shanghai 200092, Peoples R China	Zhang, ZY (reprint author), Tongji Univ, Coll Mech Engn, 1239 Siping Rd, Shanghai 200092, Peoples R China.	zyzhang08@tongji.edu.cn			Natural Science Foundation Project of China [70872076]	We express sincere appreciation to the editor and all the anonymous reviewers for their constructive comments and suggestions, which are very helpful in improving the quality of the article. This work was partially supported by the Natural Science Foundation Project of China (No. 70872076).	Balezentis A, 2012, EXPERT SYST APPL, V39, P7961, DOI 10.1016/j.eswa.2012.01.100; Opricovic S, 2007, EUR J OPER RES, V178, P514, DOI 10.1016/j.ejor.2006.01.020; Opricovic S, 2011, EXPERT SYST APPL, V38, P12983, DOI 10.1016/j.eswa.2011.04.097; Wang YL, 2012, EXPERT SYST APPL, V39, P5600, DOI 10.1016/j.eswa.2011.11.057; Liu HC, 2012, EXPERT SYST APPL, V39, P12926, DOI 10.1016/j.eswa.2012.05.031; Ju YB, 2013, APPL MATH MODEL, V37, P3112, DOI 10.1016/j.apm.2012.07.035; Tai WS, 2009, EXPERT SYST APPL, V36, P3483, DOI 10.1016/j.eswa.2008.02.017; Liu HC, 2013, APPL MATH MODEL, V37, P6325, DOI 10.1016/j.apm.2013.01.026; Girubha RJ, 2012, MATER DESIGN, V37, P478, DOI 10.1016/j.matdes.2012.01.022; Kuo MS, 2012, APPL SOFT COMPUT, V12, P476, DOI 10.1016/j.asoc.2011.08.020; Ebrahimnejad S, 2012, APPL MATH MODEL, V36, P4197, DOI 10.1016/j.apm.2011.11.050; Opricovic S, 2004, EUR J OPER RES, V156, P445, DOI [10.1016/S0377-2217(03)00020-1, 10.1016/s0377-2217(03)00020-1]; Zhang HM, 2012, MATH COMPUT MODEL, V56, P27, DOI 10.1016/j.mcm.2012.01.001; Gungor Z, 2009, APPL SOFT COMPUT, V9, P641, DOI 10.1016/j.asoc.2008.09.003; Kelemenis A, 2011, EXPERT SYST APPL, V38, P2774, DOI 10.1016/j.eswa.2010.08.068; Dursun M, 2010, EXPERT SYST APPL, V37, P4324, DOI 10.1016/j.eswa.2009.11.067; Wu HY, 2012, MEASUREMENT, V45, P856, DOI 10.1016/j.measurement.2012.02.009; Herrera-Viedma E, 2004, FUZZY SET SYST, V148, P61, DOI 10.1016/j.fss.2004.03.006; Kelemenis A, 2010, EXPERT SYST APPL, V37, P4999, DOI 10.1016/j.eswa.2009.12.013; Zhang SF, 2011, EXPERT SYST APPL, V38, P11401, DOI 10.1016/j.eswa.2011.03.012; Kuo MS, 2011, EXPERT SYST APPL, V38, P1304, DOI 10.1016/j.eswa.2010.07.003; Lin HT, 2010, COMPUT IND ENG, V59, P937, DOI 10.1016/j.cie.2010.09.004; YAGER RR, 1988, IEEE T SYST MAN CYB, V18, P183, DOI 10.1109/21.87068; Wang WP, 2009, EXPERT SYST APPL, V36, P9759, DOI 10.1016/j.eswa.2009.02.034; Sanayei A, 2010, EXPERT SYST APPL, V37, P24, DOI 10.1016/j.eswa.2009.04.063; Herrera F, 2000, INT J UNCERTAIN FUZZ, V8, P539, DOI 10.1142/S0218488500000381; Boran FE, 2011, HUM FACTOR ERGON MAN, V21, P493, DOI 10.1002/hfm.20252; Canos L, 2008, EUR J OPER RES, V189, P669, DOI 10.1016/j.ejor.2006.01.054; Chen C. T., 2005, P 10 ANN M AS PAC RE, V20; Cristobal JS, 2011, RENEW ENERG, V36, P498; Herrera F, 2000, IEEE T FUZZY SYST, V8, P746, DOI 10.1109/91.890332; Herrera F, 2001, INT J UNCERTAIN FUZZ, V9, P33, DOI 10.1142/S0218488501000971; Herrera F, 2001, IEEE T SYST MAN CY B, V31, P227, DOI 10.1109/3477.915345; Kabak M, 2012, EXPERT SYST APPL, V39, P3516, DOI 10.1016/j.eswa.2011.09.042; KARWOWSKI W, 1986, INT J PROD RES, V24, P129, DOI 10.1080/00207548608919718; Karwowski W., 1990, International Journal of Human-Computer Interaction, V2; Liu HC, 2014, INT J SYST SCI, V45, P2012, DOI 10.1080/00207721.2012.760669; Opricovic S., 1998, THESIS BELGRADE; Yucenur GN, 2012, EXPERT SYST APPL, V39, P3702, DOI 10.1016/j.eswa.2011.09.065; ZADEH LA, 1975, INFORM SCIENCES, V8, P199, DOI 10.1016/0020-0255(75)90036-5; Zeleny M., 1982, MULTIPLE CRITERIA DE; Zhang HM, 2013, APPL MATH MODEL, V37, P4269, DOI 10.1016/j.apm.2012.09.033	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1090-8471	1520-6564		HUM FACTOR ERGON MAN	Hum. Factors Ergonom. Manuf. Serv. Ind.	MAY-JUN	2015	25	3					370	384		10.1002/hfm.20553		15	Engineering, Manufacturing; Ergonomics	Engineering	CF4NX	WOS:000352527700009		
J	Ito, S				Ito, Sadayoshi			In Vitro Study of the Juxtaglomerular Apparatus and Its Implications in the Chronic Kidney Disease	HYPERTENSION			English	Biographical-Item									[Ito, Sadayoshi] Tohoku Univ, Sch Med, Dept Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 9808574, Japan	Ito, S (reprint author), Tohoku Univ, Sch Med, Dept Med, Div Nephrol Endocrinol & Vasc Med,Aoba Ku, 1-1 Seiryo Cyo, Sendai, Miyagi 9808574, Japan.	ishisho@med.tohoku.ac.jp						0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	MAY	2015	65	5					970	U537		10.1161/HYPERTENSIONAHA.114.04365		12	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF4AJ	WOS:000352490400085		
J	Satoh, F; Morimoto, R; Ono, Y; Iwakura, Y; Omata, K; Kudo, M; Takase, K; Seiji, K; Sasamoto, H; Honma, S; Okuyama, M; Yamashita, K; Gomez-Sanchez, CE; Rainey, WE; Arai, Y; Sasano, H; Nakamura, Y; Ito, S				Satoh, Fumitoshi; Morimoto, Ryo; Ono, Yoshikiyo; Iwakura, Yoshitsugu; Omata, Kei; Kudo, Masataka; Takase, Kei; Seiji, Kazumasa; Sasamoto, Hidehiko; Honma, Seijiro; Okuyama, Mitsunobu; Yamashita, Kouwa; Gomez-Sanchez, Celso E.; Rainey, William E.; Arai, Yoichi; Sasano, Hironobu; Nakamura, Yasuhiro; Ito, Sadayoshi			Measurement of Peripheral Plasma 18-Oxocortisol Can Discriminate Unilateral Adenoma From Bilateral Diseases in Patients With Primary Aldosteronism	HYPERTENSION			English	Article						1-(2-(18F)fluoro-3-pyridyl)-4-(2-isopropyl-1-oxo-isoindoline-5-yl)-5-methyl-1H-1,2,3-triazole; hyperaldosteronism	ADRENAL VEIN; DIFFERENTIAL-DIAGNOSIS; MONOCLONAL-ANTIBODIES; 18-HYDROXYCORTISOL; SUBTYPES; 11-BETA-HYDROXYLASE; HYPERALDOSTERONISM; HYPERTENSION; EXPERIENCE; CORTISOL	Adrenal venous sampling is currently the only reliable method to distinguish unilateral from bilateral diseases in primary aldosteronism. In this study, we attempted to determine whether peripheral plasma levels of 18-oxocortisol (18oxoF) and 18-hydroxycortisol could contribute to the clinical differentiation between aldosteronoma and bilateral hyperaldosteronism in 234 patients with primary aldosteronism, including computed tomography (CT) detectable aldosteronoma (n=113) and bilateral hyperaldosteronism (n=121), all of whom underwent CT and adrenal venous sampling. All aldosteronomas were surgically resected and the accuracy of diagnosis was clinically and histopathologically confirmed. 18oxoF and 18-hydroxycortisol were measured using liquid chromatography tandem mass spectrometry. Receiver operating characteristic analysis of 18oxoF discrimination of adenoma from hyperplasia demonstrated sensitivity/specificity of 0.83/0.99 at a cut-off value of 4.7 ng/dL., compared with that based on 18-hydroxycortisol (sensitivity/specificity: 0.62/0.96). 18oxoF levels above 6,1 ng/dL or of aldosterone >32.7 ng/dl were found in 95 of 113 patients with aldosteronoma (84%) but in none of 121 bilateral hyperaldosteronism, 30 of whom harbored CT-detectable unilateral nonfunctioning nodules in their adrenals. In addition, 18oxoF levels below 1.2 ng/dL, the lowest in aldosteronoma, were found 52 of the 121 (43%) patients with bilateral hyperaldosteronism. Further analysis of 27 patients with CT-undetectable micro aldosteronomas revealed that 8 of these 27 patients had CT-detectable contralateral adrenal nodules, the highest values of 18oxoF and aldosterone were 4,8 and 24.5 ng/dL respectively, both below their cut-off levels indicated above. The peripheral plasma 18oxoF concentrations served not only to differentiate aldosteronoma but also could serve to avoid unnecessary surgery for nonfunctioning adrenocortical nodules concurrent with hyperplasia or microadenoma.	[Satoh, Fumitoshi; Morimoto, Ryo; Ono, Yoshikiyo; Iwakura, Yoshitsugu; Omata, Kei; Kudo, Masataka; Ito, Sadayoshi] Tohoku Univ Hosp, Dept Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi, Japan; [Takase, Kei; Seiji, Kazumasa] Tohoku Univ Hosp, Dept Radiol, Sendai, Miyagi, Japan; [Arai, Yoichi] Tohoku Univ Hosp, Dept Urol, Sendai, Miyagi, Japan; [Sasano, Hironobu; Nakamura, Yasuhiro] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan; [Sasamoto, Hidehiko; Honma, Seijiro; Okuyama, Mitsunobu] Aska Pharma Med Co Ltd, Kawasaki, Kanagawa, Japan; [Yamashita, Kouwa] Tohoku Pharmaceut Univ, Div Fac Pharmaceut Sci, Sendai, Miyagi, Japan; [Gomez-Sanchez, Celso E.] Univ Mississippi, Med Ctr, Div Endocrinol, Jackson, MS 39216 USA; [Rainey, William E.] Univ Michigan, Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Satoh, F (reprint author), Tohoku Univ, Grad Sch Med, Dept Med, Div Nephrol Endocrinol & Vasc Med,Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	fsatoh@mail.tains.tohoku.ac.jp			Takeda Science Foundation; National Institutes of Health [DK069950]	Y. Nakamura was partly supported by Takeda Science Foundation. W.E. Rainey was partly supported by grants from the National Institutes of Health (DK069950). The other authors report no conflicts.	Hiraishi K, 2011, ENDOCR J, V58, P543; Mulatero P, 2012, J CLIN ENDOCR METAB, V97, P881, DOI 10.1210/jc.2011-2384; Satoh F, 2007, HYPERTENS RES, V30, P1083, DOI 10.1291/hypres.30.1083; Rossi GP, 2012, J CLIN ENDOCR METAB, V97, P1606, DOI 10.1210/jc.2011-2830; Kempers MJE, 2009, ANN INTERN MED, V151, P329; Rossi GP, 2014, HYPERTENSION, V63, P151, DOI 10.1161/HYPERTENSIONAHA.113.02097; Fallo F, 2011, J HYPERTENS, V29, P1773, DOI 10.1097/HJH.0b013e32834937f3; ULICK S, 1993, J CLIN ENDOCR METAB, V76, P873, DOI 10.1210/jc.76.4.873; Mosso L, 2001, HYPERTENSION, V38, P688; Gomez-Sanchez CE, 2014, MOL CELL ENDOCRINOL, V383, P111, DOI 10.1016/j.mce.2013.11.022; Savard S, 2013, HYPERTENSION, V62, P331, DOI 10.1161/HYPERTENSIONAHA.113.01060; Ono Y, 2014, HYPERTENSION, V64, P438, DOI 10.1161/HYPERTENSIONAHA.113.02944; Yamashita K, 2008, J CHROMATOGR A, V1200, P114, DOI 10.1016/j.chroma.2008.05.034; Young WF, 2004, SURGERY, V136, P1227, DOI 10.1016/j.surg.2004.06.051; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; Mulatero P, 1998, J CLIN ENDOCR METAB, V83, P3996, DOI 10.1210/jc.83.11.3996; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; Ishidoya S, 2011, UROLOGY, V78, P68, DOI 10.1016/j.urology.2010.12.042; Nakamura Y, 2011, J CLIN ENDOCR METAB, V96, pE1272, DOI 10.1210/jc.2010-2785; Freel EM, 2004, J CLIN ENDOCR METAB, V89, P4628, DOI 10.1210/jc.2004-0379; Stowasser M, 2004, MOL CELL ENDOCRINOL, V217, P33, DOI 10.1016/j.mce.2003.10.006; Monticone S, 2012, HYPERTENSION, V59, P840, DOI 10.1161/HYPERTENSIONAHA.111.189548; Nishikawa T, 2011, ENDOCR J, V58, P711; Doi M, 2014, J CLIN ENDOCR METAB, V99, pE257, DOI 10.1210/jc.2013-3279; Iwakura Y, 2014, J CLIN ENDOCR METAB, V99, P1593, DOI 10.1210/jc.2013-2180; Matsuura T, 2008, AM J ROENTGENOL, V191, P402, DOI 10.2214/AJR.07.3338; Mulatero P, 2004, J CLIN ENDOCR METAB, V89, P1045, DOI 10.1210/jc.2003-031337; Omura M, 2006, HYPERTENS RES, V29, P883, DOI 10.1291/hypres.29.883; Phillips JL, 2000, J CLIN ENDOCR METAB, V85, P4526, DOI 10.1210/jc.85.12.4526; Reynolds RM, 2005, EUR J ENDOCRINOL, V152, P903, DOI 10.1530/eje.1.01922; Sasano H, 1990, ENDOCR PATHOL, V1, P94, DOI 10.1007/BF02915624; Stowasser M, 1996, CLIN EXP PHARMACOL P, V23, P591, DOI 10.1111/j.1440-1681.1996.tb02789.x	33	6	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	MAY	2015	65	5					1096	1102		10.1161/HYPERTENSIONAHA.114.04453		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF4AJ	WOS:000352490400106		
J	Morris, BJ; Willcox, BJ; Tranah, GJ; Chen, R; Masaki, KH; He, Q; Willcox, DC; Allsopp, R; Moisyad, S; Poon, LW; Newman, AB; Harris, TB; Cummings, SR; Liu, Y; Parimi, N; Evans, DS; Donlon, TA				Morris, B. J.; Willcox, B. J.; Tranah, G. J.; Chen, R.; Masaki, K. H.; He, Q.; Willcox, D. C.; Allsopp, R.; Moisyad, S.; Poon, L. W.; Newman, A. B.; Harris, T. B.; Cummings, S. R.; Liu, Y.; Parimi, N.; Evans, D. S.; Donlon, T. A.			FOXO3 GENOTYPE INCREASES LIFESPAN BY A MAJOR EFFECT ON CARDIOVASCULAR MORTALITY	HYPERTENSION			English	Meeting Abstract	36th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia (HBPRCA)	NOV 26-28, 2014	Adelaide, AUSTRALIA	High Blood Pressure Res Council Australia					[Morris, B. J.; Chen, R.; Masaki, K. H.; He, Q.; Donlon, T. A.] Kuakini Med Ctr, Dept Res, Honolulu, HI USA; [Morris, B. J.; Masaki, K. H.] Univ Hawaii, John A Burns Sch Med, Dept Geriatr, Honolulu, HI 96822 USA; [Morris, B. J.] Univ Sydney, Sch Med Sci & Bosch Inst, Basic & Clin Genom Lab, Sydney, NSW 2006, Australia; [Tranah, G. J.; Cummings, S. R.; Parimi, N.; Evans, D. S.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Willcox, D. C.] Okinawa Int Univ, Dept Human Welf, Okinawa, Japan; [Allsopp, R.; Moisyad, S.] Univ Hawaii, Inst Biogenesis Res, Honolulu, HI 96822 USA; [Poon, L. W.] Univ Georgia, Inst Gerontol, Athens, GA 30602 USA; [Newman, A. B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Harris, T. B.] NIA, Neurogenet Lab, Intramural Res Program, Bethesda, MD 20892 USA; [Liu, Y.] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	MAY	2015	65	5					E29	E30				2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF4AJ	WOS:000352490400018		
J	Tan, A; Matsunaga, Y				Tan, A.; Matsunaga, Y.			BIOMIMETIC VASCULAR DISEASE MICROCHIPS FOR THERAPEUTIC AND BIOPHARMACEUTICAL RESEARCH	HYPERTENSION			English	Meeting Abstract	36th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia (HBPRCA)	NOV 26-28, 2014	Adelaide, AUSTRALIA	High Blood Pressure Res Council Australia					[Tan, A.; Matsunaga, Y.] Univ Tokyo, Inst Ind Sci, Ctr Int Res Integrat Biomed Syst, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	MAY	2015	65	5					E31	E31				1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF4AJ	WOS:000352490400022		
J	Waddingham, MT; Edgley, AJ; Inagaki, T; Tsuchimochi, H; Kelly, DJ; Yagi, N; Shirai, M; Pearson, JT				Waddingham, M. T.; Edgley, A. J.; Inagaki, T.; Tsuchimochi, H.; Kelly, D. J.; Yagi, N.; Shirai, M.; Pearson, J. T.			CARDIAC ACTIN-MYOSIN CROSS-BRIDGE DYSREGULATION OCCURS EARLY IN THE PATHOGENESIS OF TYPE 2 DIABETIC CARDIOMYOPATHY	HYPERTENSION			English	Meeting Abstract	36th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia (HBPRCA)	NOV 26-28, 2014	Adelaide, AUSTRALIA	High Blood Pressure Res Council Australia					[Waddingham, M. T.; Edgley, A. J.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Inagaki, T.; Tsuchimochi, H.] Natl Cerebral Cardiovasc Ctr, Res Inst, Dept Cardiac Physiol, Suita, Osaka, Japan; [Yagi, N.] Japan Synchrotron Radiat Res Inst, Harima, Hyogo, Japan; [Shirai, M.; Pearson, J. T.] Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia			Tsuchimochi, Hirotsugu/D-8224-2011	Tsuchimochi, Hirotsugu/0000-0001-7591-2520				0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	MAY	2015	65	5					E31	E31				1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF4AJ	WOS:000352490400024		
J	Fujimoto, H; Harada, S				Fujimoto, Hiroshi; Harada, Shingo			Model-Based Range Extension Control System for Electric Vehicles With Front and Rear Driving-Braking Force Distributions	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						Bench test; driving and braking force distribution; electric vehicle (EV); range extension control system (RECS)	DRIVEN	This paper proposes a model-based range extension control system for electric vehicles. The proposed system optimizes the front and rear driving-braking force distributions by considering the slip ratio of the wheels and the motor loss. The optimal distribution depends solely on vehicle acceleration and velocity. Therefore, this system is effective not only at constant speeds but also in acceleration and deceleration modes. Bench tests were conducted for more precise evaluation and to realize experimental results with high reproducibility. The effectiveness of the proposed system was verified through field and bench tests.	[Fujimoto, Hiroshi; Harada, Shingo] Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Energy, Chiba 2778561, Japan	Fujimoto, H (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Energy, Chiba 2778561, Japan.	hfuji@ieee.org			New Energy and Industrial Technology Development Organization (NEDO) of Japan [05A48701d]; Ministry of Education, Culture, Sports, Science and Technology [22246057, 26249061]	Manuscript received March 25, 2014; revised March 30, 2014 and August 24, 2014; accepted October 25, 2014. Date of publication February 11, 2015; date of current version April 8, 2015. This work was supported in part by the Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO) of Japan under Grant 05A48701d and in part by the Ministry of Education, Culture, Sports, Science and Technology under Grant 22246057 and Grant 26249061.	Kang J, 2011, IEEE T VEH TECHNOL, V60, P2987, DOI 10.1109/TVT.2011.2155105; Maeda K, 2012, IEEE VEHICLE POWER, P1286, DOI 10.1109/VPPC.2012.6422490; Shin J, 2014, IEEE T IND ELECTRON, V61, P1179, DOI 10.1109/TIE.2013.2258294; Grbovic PJ, 2012, IEEE T IND ELECTRON, V59, P4511, DOI 10.1109/TIE.2011.2181129; Hsiao TS, 2013, IEEE T VEH TECHNOL, V62, P1378, DOI 10.1109/TVT.2012.2230656; Chopra S, 2013, IEEE T IND ELECTRON, V60, P329, DOI 10.1109/TIE.2011.2182015; Hori Y, 2004, IEEE T IND ELECTRON, V51, P954, DOI 10.1109/TIE.2004.834944; Cao J., 2012, IEEE T POWER ELECTR, V27, P122; Fujimoto H., 2011, P 37 ANN C IEEE IND, P3727; Fujimoto H., 2012, P 38 ANN C IEEE IND, P4244; Fujimoto H, 2012, IEEE VEHICLE POWER, P1292, DOI 10.1109/VPPC.2012.6422491; Harada S., 2013, P 39 ANN C IEEE IND, P6624; Inoue K, 2013, INT C POWER ELECT DR, P1127, DOI 10.1109/PEDS.2013.6527189; Kaido C., 1994, IEEE Translation Journal on Magnetics in Japan, V9, DOI 10.1109/TJMJ.1994.4565966; Montazeri-Gh M, 2013, IEEE T IND ELECTRON, V60, P4546, DOI 10.1109/TIE.2012.2216236; MORIMOTO S, 1994, IEEE T IND ELECTRON, V41, P511, DOI 10.1109/41.315269; Nam K, 2014, IEEE-ASME T MECH, V19, P289, DOI 10.1109/TMECH.2012.2233210; Pacejka H. B., 1992, VEHICLE SYSTEM DYNAM, V21, P1, DOI DOI 10.1080/00423119208969994; Toda H, 2012, IEEE T MAGN, V48, P3060, DOI 10.1109/TMAG.2012.2198619; Yuan XB, 2012, IEEE T VEH TECHNOL, V61, P3365, DOI 10.1109/TVT.2012.2213282	20	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	MAY	2015	62	5					3245	3254		10.1109/TIE.2015.2402634		10	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	CF6ZQ	WOS:000352706000058		
J	Chen, WH; Paik, I				Chen, Wuhui; Paik, Incheon			Toward Better Quality of Service Composition Based on a Global Social Service Network	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						Quality of social link; global social service network; workflow as a service; QoS optimization; service composition	SEMANTIC-WEB SERVICES; CONSTRAINTS; DISCOVERY	Automatic service composition can create new value-added services dynamically and automatically from existing services in an envisioned service-oriented architecture. However, despite considerable progress, web-scale uptake has been significantly less than initially anticipated because of several challenging issues, such as poor scalability, exponentially expanding search time in large search spaces, and the lack of service sociability caused by the isolation of services. In this paper, we propose an innovative methodology for moving from isolated service islands to a global social service network (GSSN) by developing a network model that supports service sociability. First, we propose the construction of a GSSN based on the quality of social links. We then propose an algorithm that maps the GSSN into a service cluster network to reduce the search space, and a quality-driven composition approach that enables exploitation of the service cluster network by providing workflow as a service. Finally, experimental results show that our GSSN-based approach can solve the service composition problem well, improving not only the response time but also the success rate.	[Chen, Wuhui; Paik, Incheon] Univ Aizu, Sch Comp Sci & Engn, Fukushima, Japan	Chen, WH (reprint author), Univ Aizu, Sch Comp Sci & Engn, Fukushima, Japan.	chenwuhui21@gmail.com; paikic@u-aizu.ac.jp					Maamar Z, 2011, IEEE INTERNET COMPUT, V15, P48, DOI 10.1109/MIC.2011.27; Chen WH, 2013, INFORM SYST FRONT, V15, P613, DOI 10.1007/s10796-012-9381-x; [Anonymous], 2009, INT J SEMANT WEB INF; Ardagna D, 2007, IEEE T SOFTWARE ENG, V33, P369, DOI 10.1109/TSE.2007.1011.; Lecue F, 2011, IEEE T KNOWL DATA EN, V23, P942, DOI 10.1109/TKDE.2010.237; Maamar Z, 2011, IEEE INTERNET COMPUT, V15, P90, DOI 10.1109/MIC.2011.49; Cabral L, 2006, LECT NOTES COMPUT SC, V4273, P201; Rao JH, 2006, INFORM SYST, V31, P340, DOI 10.1016/j.is.2005.02.005; Paik I, 2014, IEEE T SERV COMPUT, V7, P82, DOI 10.1109/TSC.2012.33; Zeng LZ, 2004, IEEE T SOFTWARE ENG, V30, P311; Bizer C., 2008, P 17 INT WORLD WID W; Brogi A, 2008, ACM T INTERNET TECHN, V8, DOI 10.1145/1391949.1391953; Gu ZF, 2010, IEEE T SERV COMPUT, V3, P279, DOI 10.1109/TSC.2010.22; Kona S., 2007, P INT C WEB SERV ICW, P150; LECUE F, 2009, P INT SEM WEB C ISWC, V5823, P375; Lecue F, 2010, INT J WEB SERV RES, V7, P41, DOI 10.4018/jwsr.2010100103; Lin K., 2010, SERVICE ORIENTED COM, V4, P157, DOI DOI 10.1007/S11761-010-0063-6; Medjahed B, 2005, IEEE T KNOWL DATA EN, V17, P954, DOI 10.1109/TKDE.2005.101; Milanovic N, 2004, IEEE INTERNET COMPUT, V8, P51, DOI 10.1109/MIC.2004.58; Mokhtar S. B., 2008, INT J SYST SOFTW, V81, P785; Paik I., 2007, P 7 IEEE INT C COMP, P206; Sirin E, 2004, J WEB SEMANT, P377, DOI DOI 10.1016/J.WEBSEM.2004.06.005; Sirin E., 2005, P AAAI FALL S AG SEM, P85; Su S. Y. W., 2005, INT J WEB SERV RES, V2, P48, DOI DOI 10.4018/JWSR.2005100103; Tan W., 2011, P IEEE INT C SERV CO, P632; Wagner F., 2012, P 21 INT C WORLD WID, P969, DOI DOI 10.1145/2187836.2187966; Wei Tan, 2009, IEEE Transactions on Automation Science and Engineering, V6, DOI 10.1109/TASE.2008.916747; Xu B, 2012, SERV ORIENTED COMPUT, V6, P1; Yu T, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232728; Zhang J., 2011, P IEEE INT C SERV CO, P48	30	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	MAY	2015	26	5					1466	1476		10.1109/TPDS.2014.2320748		11	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CF7HX	WOS:000352728200022		
J	Sahu, J; Aijaz, A; Xu, Q; Bharadwaj, PK				Sahu, Jhasaketan; Aijaz, Arshad; Xu, Qiang; Bharadwaj, Parimal K.			A three-dimensional pillared-layer metal-organic framework: Synthesis, structure and gas adsorption studies	INORGANICA CHIMICA ACTA			English	Article						Metal-organic framework; Partially methylated ligand; CO2 gas adsorption	COORDINATION POLYMERS; HYDROGEN STORAGE; CRYSTAL-STRUCTURES; MAGNETIC-PROPERTIES; PERMANENT POROSITY; FUNCTIONAL-GROUPS; GUEST MOLECULES; SINGLE-CRYSTAL; SURFACE-AREA; CO2	A stable 3D MOF, {[Zn-3(L)(3)(DPB)(1.5)]center dot 6DMF center dot H2O}(n) was synthesized using a partially methylated linear rigid linker (LH2) in the presence of the co-linker DPB (1,4-dipyridylbenzene) under solvothermal condition. The complex was found to have channels along the crystallographic a-axis with the pore surfaces aligned with -CH3 groups that resulted in a hydrophobic environment inside the cavity. Thermogravimetric analysis and variable temperature powder X-ray diffraction show high thermal stability of the framework. The solvent molecules in the cavity can be evacuated maintaining the structural integrity of the framework to afford a porous structure. Gas (N-2, CH4, CO2 and H-2) adsorptions were carried out for this MOF. The desolvated framework shows significant CO2 adsorption over N-2 and CH4 at 273 K with an isosteric heat of adsorption of similar to 21 kJ/mol, suggesting a strong interaction of the CO2 molecules with the framework walls. (C) 2015 Elsevier B.V. All rights reserved.	[Sahu, Jhasaketan; Bharadwaj, Parimal K.] Indian Inst Technol, Dept Chem, Kanpur 208016, Uttar Pradesh, India; [Aijaz, Arshad; Xu, Qiang] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan	Bharadwaj, PK (reprint author), Indian Inst Technol, Dept Chem, Kanpur 208016, Uttar Pradesh, India.	pkb@iitk.ac.in	Xu, Qiang/H-4997-2011		Department of Science and Technology, New Delhi, India; CSRF from the SIR	We gratefully acknowledge the financial support received from the Department of Science and Technology, New Delhi, India (to P.K.B.) and SRF from the CSIR to J.S.	Aijaz A, 2009, INORG CHIM ACTA, V362, P4246, DOI 10.1016/j.ica.2009.05.054; Dan-Hardi M, 2012, CHEM MATER, V24, P2486, DOI 10.1021/cm300450x; Li XJ, 2006, INORG CHEM, V45, P1508, DOI 10.1021/ic050999x; Rosi NL, 2003, SCIENCE, V300, P1127, DOI 10.1126/science.1083440; Singh R, 2012, CRYST GROWTH DES, V12, P5025, DOI 10.1021/cg300988a; Sen S, 2012, J AM CHEM SOC, V134, P19432, DOI 10.1021/ja3076378; Li P, 2014, J AM CHEM SOC, V136, P547, DOI 10.1021/ja4129795; Cunha D, 2013, CHEM MATER, V25, P2767, DOI 10.1021/cm400798p; Rowsell JLC, 2005, ANGEW CHEM INT EDIT, V44, P4670, DOI 10.1002/anie.200462786; Kim H, 2009, CHEM-ASIAN J, V4, P886, DOI 10.1002/asia.200900020; Sumida K, 2012, CHEM REV, V112, P724, DOI 10.1021/cr2003272; Hou L, 2008, INORG CHEM, V47, P1346, DOI 10.1021/ic702085x; Deng HX, 2012, SCIENCE, V336, P1018, DOI 10.1126/science.1220131; Hijikata Y, 2013, INORG CHEM, V52, P3634, DOI 10.1021/ic302006x; Singh R, 2013, CRYST GROWTH DES, V13, P3722, DOI 10.1021/cg400756z; Sen S, 2014, DALTON T, V43, P6100, DOI 10.1039/c3dt52977k; Santra A, 2013, INORG CHEM, V52, P7358, DOI [10.1021/ic302645r, 10.1022/ic302645r]; Sahu J, 2013, CRYST GROWTH DES, V13, P2618, DOI 10.1021/cg400376g; Zeng MH, 2014, J AM CHEM SOC, V136, P4680, DOI 10.1021/ja500191r; Das MC, 2009, J AM CHEM SOC, V131, P10942, DOI 10.1021/ja9006035; Zhao YG, 2011, CHEM-EUR J, V17, P5101, DOI 10.1002/chem.201002818; [Anonymous], 1952, INT TABLES XRAY CRYS, VIII; Dinca M, 2007, J AM CHEM SOC, V129, P11172, DOI 10.1021/ja072871f; [Anonymous], 1995, XPREP VERS 5 1; Jung DH, 2006, J PHYS CHEM B, V110, P22987, DOI 10.1021/jp065819z; Seo J, 2009, J AM CHEM SOC, V131, P12792, DOI 10.1021/ja904363b; O'Keeffe M, 2012, CHEM REV, V112, P675, DOI 10.1021/cr200205j; Blatov VA, 2010, CRYSTENGCOMM, V12, P44, DOI 10.1039/b910671e; Aijaz A, 2014, CHEM COMMUN, V50, P6498, DOI 10.1039/c4cc02459a; Yamada T, 2009, J AM CHEM SOC, V131, P6312, DOI 10.1021/ja809352y; Eddaoudi M, 2002, J AM CHEM SOC, V124, P376, DOI 10.1021/ja017154e; Chen BL, 2010, ACCOUNTS CHEM RES, V43, P1115, DOI 10.1021/ar100023y; Blatov VA, 2000, J APPL CRYSTALLOGR, V33, P1193, DOI 10.1107/S0021889800007202; Latroche M, 2006, ANGEW CHEM INT EDIT, V45, P8227, DOI 10.1002/anie.200600105; Suh MP, 2012, CHEM REV, V112, P782, DOI 10.1021/cr200274s; Jiang HL, 2012, J AM CHEM SOC, V134, P14690, DOI 10.1021/ja3063919; Schoedel A, 2013, ANGEW CHEM INT EDIT, V52, P2902, DOI 10.1002/anie.201206042; Pan L, 2004, J AM CHEM SOC, V126, P1308, DOI 10.1021/ja0392871; Wu H, 2009, J AM CHEM SOC, V131, P4995, DOI 10.1021/ja900258t; Ma SQ, 2007, J AM CHEM SOC, V129, P1858, DOI 10.1021/ja067435s; Ahmad M, 2012, CRYST GROWTH DES, V12, P1571, DOI 10.1021/cg201619x; Nagarkar SS, 2013, ANGEW CHEM INT EDIT, V52, P2881, DOI 10.1002/anie.201208885; Luo J, 2007, INORG CHEM, V46, P9021, DOI 10.1021/ic701003z; Aijaz A, 2014, J AM CHEM SOC, V136, P6790, DOI 10.1021/ja5003907; Zhao D, 2011, ACCOUNTS CHEM RES, V44, P123, DOI 10.1021/ar100112y; Vaidhyanathan R, 2010, SCIENCE, V330, P650, DOI 10.1126/science.1194237; Chun H, 2005, CHEM-EUR J, V11, P3521, DOI 10.1002/chem.200401201; Mondal SS, 2014, J AM CHEM SOC, V136, P44, DOI 10.1021/ja410595q; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Zhang M, 2014, J AM CHEM SOC, V136, P7241, DOI 10.1021/ja502643p; Sumida K, 2011, CHEM COMMUN, V47, P1157, DOI 10.1039/c0cc03453c; Schoedel A, 2013, J AM CHEM SOC, V135, P14016, DOI 10.1021/ja406030p; Burtch NC, 2013, J AM CHEM SOC, V135, P7172, DOI 10.1021/ja310770c; [Anonymous], 1999, SAINT VERS 6 02; Bin L., 2014, J AM CHEM SOC, V136, P6207; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Sheldrick G. M., 1997, SHELXL 97 PROGRAM CR; Sheldrick G.M., 1997, SADABS EMPIRICAL ABS; Sheldrick G.M., 1997, SHELXTL REFERENCE MA; Spek A.L., 1999, PLATON; The network topology was evaluated by the program`` TOPOS- 4. 0'', 2006, IUCR COMP COMM NEWSL, V7, P4; Yamada T, 2011, CRYST GROWTH DES, V11, P1798, DOI 10.1021/cg1017278	62	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0020-1693	1873-3255		INORG CHIM ACTA	Inorg. Chim. Acta	MAY 1	2015	430						193	198		10.1016/j.ica.2015.03.011		6	Chemistry, Inorganic & Nuclear	Chemistry	CF6VM	WOS:000352694600025		
J	Fujinami, T; Hamada, D; Matsumoto, N; Sunatsuki, Y; Irie, R				Fujinami, Takeshi; Hamada, Daisuke; Matsumoto, Naohide; Sunatsuki, Yukinari; Irie, Ryo			Synthesis, structure, and spin equilibrium properties of [(FeX2L)-X-III]BPh4 center dot solvents ( X=1-methylimidazole and imidazole; L = N, N'-bis(3-ethoxycarbonylsalicylidene) ethylenediamine)	INORGANICA CHIMICA ACTA			English	Article						Iron(III); Spin crossover; Imidazole; 1-Methyimidazole; N2O2 Schiff-base ligand	QUADRIDENTATE SCHIFF-BASES; IRON(III) COMPLEXES; MAGNETIC-PROPERTIES; THERMAL HYSTERESIS; CRYSTAL-STRUCTURES; CROSSOVER; TRANSITION; STATES; N,N'-BIS(2-HYDROXYACETOPHENYLIDENE)ETHYLENEDIAMINE; BEHAVIOR	Two iron(III) complexes [(FeX2L)-X-III]BPh4 center dot solvents (X = 1-Meim (1), Him (2)) were synthesized and the crystal structures were determined, where H2L = N, N'-bis(3-ethoxycarbonylsalicylidene) ethylenediamine, 1-Meim = 1-methylimidazole, Him = imidazole, BPh4 = tetraphenylborate. Fe-III ion has an octahedral coordination environment by N2O2 donor atoms of equatorial L-2 and N-2 donor atoms of axial imidazoles. Complex 1 is described as isolated molecule, while complex 2 has a hydrogen-bonded cyclic dimer structure constructed by hydrogen-bond between imidazole group and ethoxycarbonyl oxygen via ethanol. Complex 1 is in a high-spin (S = 5/2) state over the whole temperature region 5-300 K, while complex 2 showed a gradual complete spin equilibrium between high and low-spin states at T-1/2 = 192 K. (C) 2015 Elsevier B. V. All rights reserved.	[Fujinami, Takeshi; Hamada, Daisuke; Matsumoto, Naohide; Irie, Ryo] Kumamoto Univ, Grad Sch Sci & Technol, Dept Chem, Kumamoto 8608555, Japan; [Sunatsuki, Yukinari] Okayama Univ, Fac Sci, Dept Chem, Okayama 7008530, Japan	Matsumoto, N (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Dept Chem, Kurokami 2-39-1, Kumamoto 8608555, Japan.	naohide@aster.sci.kumamoto-u.ac.jp			Research Fellowship for Young Scientists of the Japan Society for the Promotion of Science, KAKENHI [00248556]	T. Fujinami was supported by the Research Fellowship for Young Scientists of the Japan Society for the Promotion of Science, KAKENHI 00248556.	MATSUMOTO N, 1984, B CHEM SOC JPN, V57, P3307, DOI 10.1246/bcsj.57.3307; Ross TM, 2010, DALTON T, V39, P149, DOI 10.1039/b913234a; Fujinami T, 2014, INORG CHEM, V53, P2254, DOI 10.1021/ic402947u; Gutlich P, 2000, CHEM SOC REV, V29, P419, DOI 10.1039/b003504l; Halcrow MA, 2008, CHEM SOC REV, V37, P278, DOI 10.1039/b701085k; [Anonymous], 2000, CRYSTALSTRUCTURE 4 0; Koike M, 2013, INORG CHIM ACTA, V399, P185, DOI 10.1016/j.ica.2013.01.021; Weber B, 2008, ANGEW CHEM INT EDIT, V47, P10098, DOI 10.1002/anie.200802806; Bereau V, 2010, DALTON T, V39, P2070, DOI 10.1039/b918235g; KENNEDY BJ, 1987, INORG CHEM, V26, P483, DOI 10.1021/ic00251a003; Real JA, 2005, DALTON T, P2062, DOI 10.1039/b501491c; Zhang ZJ, 2012, DALTON T, V41, P1252, DOI 10.1039/c1dt11370d; Dorbes S, 2005, CHEM COMMUN, P69, DOI 10.1039/b412182a; Floquet S, 2014, POLYHEDRON, V80, P60, DOI 10.1016/j.poly.2014.01.025; Fukukai T, 2005, B CHEM SOC JPN, V78, P1484, DOI 10.1246/bcsj.78.1484; GOODWIN HA, 1976, COORDIN CHEM REV, V18, P293, DOI 10.1016/S0010-8545(00)80430-0; Gutlich P., 2004, TOP CURR CHEM, P233; Hernandez-Molina R, 1998, INORG CHEM, V37, P5102, DOI 10.1021/ic980297q; Kahn O., 1993, MOL MAGNETISM; KONIG E, 1987, PROG INORG CHEM, V35, P527; Mabbs F. E., 1973, MAGNETISM TRANSITION; MAEDA Y, 1986, J CHEM SOC DALTON, P1115, DOI 10.1039/dt9860001115; Matsumoto N., 1984, CHEM LETT, P79; Murakami K., 2013, J CHEM CHEM ENG, V7, P285; NISHIDA Y, 1987, J CHEM SOC DALTON, P1157, DOI 10.1039/dt9870001157; Tanimura K., 2005, B CHEM SOC JPN, V78, P3307; Weber B, 2011, EUR J INORG CHEM, P3193, DOI 10.1002/ejic.201100394; Weber B, 2009, COORDIN CHEM REV, V253, P2432, DOI 10.1016/j.ccr.2008.10.002	28	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0020-1693	1873-3255		INORG CHIM ACTA	Inorg. Chim. Acta	MAY 1	2015	430						239	244		10.1016/j.ica.2015.03.008		6	Chemistry, Inorganic & Nuclear	Chemistry	CF6VM	WOS:000352694600030		
J	Suehiro, W; Matsuura, K				Suehiro, W.; Matsuura, K.			Queen pheromone promotes production of salivary lysozyme by workers in a termite	INSECTES SOCIAUX			English	Article						Evolutionary parsimony; Queen pheromone; Social insects; Multifunctional pheromone; Salivary lysozyme	SCLEROTIUM-FORMING FUNGUS; CUTICULAR HYDROCARBONS; REPRODUCTIVE STATUS; NITROGEN-FIXATION; EGG-PRODUCTION; SEX-PHEROMONE; ANT; RETICULITERMES; RECOGNITION; FORMICIDAE	Social insects have highly elaborated communication systems. In particular, communication via pheromones is important for maintaining complex social roles and behaviors. Brood care is a typical activity that involves pheromonal communication among colony members. In termites, eggs cannot survive without grooming by workers. The workers coat the eggs with their saliva, which contains an antibacterial protein lysozyme that protects the eggs against bacterial pathogens. The more eggs a colony has, the more salivary lysozyme the workers need to produce for egg grooming. However, it is unknown how termite workers regulate their lysozyme production. Here we show that the queen pheromone, which is emitted by both queens and eggs, promotes lysozyme production by workers in the termite Reticulitermes speratus. Exposure to artificial queen pheromone significantly increased the production of salivary lysozyme by workers as well as the artificial addition of eggs. Furthermore, our survey of field colonies revealed clear seasonality in the production of salivary lysozyme. The seasonal pattern of lysozyme production matched well with the seasonal change of the number of eggs per colony. In addition to the known function of the queen pheromone as an inhibitor of neotenic queen differentiation, this study reveals that the same pheromone also acts as a promoter of lysozyme production in workers. We describe a novel function of the multifunctional queen pheromone in termites and provide new insights into the evolutionary parsimony of social insect pheromones.	[Suehiro, W.; Matsuura, K.] Kyoto Univ, Grad Sch Agr, Lab Insect Ecol, Kyoto 6068502, Japan	Matsuura, K (reprint author), Kyoto Univ, Grad Sch Agr, Lab Insect Ecol, Kyoto 6068502, Japan.	kenjijpn@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science [25221206]	We thank Dr. Kazuya Kobayashi and Dr. Toshihisa Yashiro for helpful comments. This work was supported by the Japan Society for the Promotion of Science (No. 25221206).	Blum MS, 1996, ANNU REV ENTOMOL, V41, P353, DOI 10.1146/annurev.en.41.010196.002033; BREZNAK JA, 1973, NATURE, V244, P577, DOI 10.1038/244577a0; TAYASU I, 1994, NATURWISSENSCHAFTEN, V81, P229, DOI 10.1007/s001140050063; Peeters C, 1999, P ROY SOC B-BIOL SCI, V266, P1323; Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; Steiger S, 2011, P ROY SOC B-BIOL SCI, V278, P970, DOI 10.1098/rspb.2010.2285; Bordereau C, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P279, DOI 10.1007/978-90-481-3977-4_11; Monnin T, 1998, ANIM BEHAV, V55, P299, DOI 10.1006/anbe.1997.0601; Goncalves TT, 2010, ACTA ZOOL-STOCKHOLM, V91, P193, DOI 10.1111/j.1463-6395.2009.00398.x; Endler A, 2004, P NATL ACAD SCI USA, V101, P2945, DOI 10.1073/pnas.0308447101; Fujita A, 2001, PHYSIOL ENTOMOL, V26, P116, DOI 10.1046/j.1365-3032.2001.00224.x; Matsuura K, 2010, P NATL ACAD SCI USA, V107, P12963, DOI 10.1073/pnas.1004675107; Robert A, 2004, NATURWISSENSCHAFTEN, V91, P34, DOI 10.1007/s00114-003-0481-9; Ayasse M, 2002, CHEMOECOLOGY OF INSECT EGGS AND EGG DEPOSITION, P117; BAGNERES AG, 1991, J CHEM ECOL, V17, P2397, DOI 10.1007/BF00994590; BENEMANN JR, 1973, SCIENCE, V181, P164, DOI 10.1126/science.181.4095.164; Bordereau C, 2002, INSECT SOC, V49, P209, DOI 10.1007/s00040-002-8303-1; CHAPPELL DJ, 1993, INSECT BIOCHEM MOLEC, V23, P499, DOI 10.1016/0965-1748(93)90058-Z; Clement Jean-Luc, 1998, P126; de Biseau JC, 2004, J INSECT PHYSIOL, V50, P585, DOI 10.1016/j.jinsphys.2004.04.005; D'Ettorre P, 2004, P ROY SOC B-BIOL SCI, V271, P1427, DOI 10.1098/rspb.2004.2742; Heinze J, 2002, BEHAV ECOL SOCIOBIOL, V52, P59, DOI 10.1007/s00265-002-0491-1; Holldobler B., 1990, ANTS; HOWARD RW, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P179; Hussain A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069543; JESSEN K, 1983, INSECT SOC, V30, P123, DOI 10.1007/BF02223863; Liebig J, 2009, BEHAV ECOL SOCIOBIOL, V63, P1799, DOI 10.1007/s00265-009-0807-5; Matsuura K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000813; Matsuura K, 2000, ECOL RES, V15, P405, DOI 10.1046/j.1440-1703.2000.00361.x; Matsuura K, 2009, CURR BIOL, V19, P30, DOI 10.1016/j.cub.2008.11.030; Matsuura K, 2006, P ROY SOC B-BIOL SCI, V273, P1203, DOI 10.1098/rspb.2005.3434; Matsuura K, 2015, ECOL RES, V30, P93, DOI 10.1007/s11284-014-1213-7; Matsuura K, 2007, POPUL ECOL, V49, P179, DOI 10.1007/s10144-006-0030-4; Matsuura K, 2012, J CHEM ECOL, V38, P746, DOI 10.1007/s10886-012-0137-3; MEDNIKOVA T K, 1984, Journal of Evolutionary Biochemistry and Physiology, V20, P93; Nakayama T, 2004, J WOOD SCI, V50, P530, DOI 10.1007/s10086-003-0594-y; Pasteels Jacques M., 1998, P193; POTRIKUS CJ, 1981, P NATL ACAD SCI-BIOL, V78, P4601, DOI 10.1073/pnas.78.7.4601; Tallamy DW, 2005, ANNU REV ENTOMOL, V50, P347, DOI 10.1146/annurev.ento.50.071803.130424; VanderMeer R. K., 1998, PHEROMONE COMMUNICAT; Yamamoto Y, 2011, BIOL LETTERS, V7, P727, DOI 10.1098/rsbl.2011.0353; Yuki M, 2008, ZOOL SCI, V25, P401, DOI 10.2108/zsj.25.401	42	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0020-1812	1420-9098		INSECT SOC	Insect. Soc.	MAY	2015	62	2					193	198		10.1007/s00040-015-0396-4		6	Entomology	Entomology	CF7FQ	WOS:000352722000011		
J	Zhu, YD; Liu, YQ; Qian, YY; Dai, XJ; Yang, L; Chen, J; Guo, SY; Hisamitsu, T				Zhu, Yaodong; Liu, Yanqing; Qian, Yayun; Dai, Xiaojun; Yang, Lin; Chen, Jue; Guo, Shiyu; Hisamitsu, Tadashi			Antimetastatic Effects of Celastrus orbiculatus on Human Gastric Adenocarcinoma by Inhibiting Epithelial-Mesenchymal Transition and NF-kappa B/Snail Signaling Pathway	INTEGRATIVE CANCER THERAPIES			English	Article						Celastrus orbiculatus; gastric cancer; epithelial-mesenchymal transition; antimetastasis; nuclear factor B	HEPATOCELLULAR-CARCINOMA CELLS; CANCER CELLS; METASTASIS; INVASION; INFLAMMATION; APOPTOSIS; SNAIL	Aim of the Study. Celastrus orbiculatus has been used as a folk medicine in China for the treatment of many diseases. In the laboratory, the ethyl acetate extract of Celastrus orbiculatus (COE) displays a wide range of anticancer functions. However, the inhibition of the metastasis mechanism of COE in gastric cancer cells has not been investigated so far. The present study was undertaken to determine if the antimetastatic effects of COE were involved in inhibition of the epithelial-mesenchymal transition (EMT) of human gastric adenocarcinoma SGC-7901 cells. Methods. The adhesion, invasion, and migration of SGC-7901 cells were determined by COE treatment in vitro, using Matrigel-coated plate, transwell membrane chamber, and wound healing models, respectively. In vivo, the growth-inhibiting and antimetastatic effects of COE on the nude mice model of gastric cancer were tested and the mechanisms were explored. The expression of EMT markers and nuclear factor B (NF-B)/Snail signaling pathway were evaluated by using western blotting and immunohistochemistry. Results. Treatment with COE dose-dependently inhibited the proliferation, adhesion, invasion, and migration of SGC-7901 cells in vitro, which was realized by enhancing the expression of E-cadherin and reducing N-cadherin and vimentin expression. Moreover, COE suppressed the activation of NF-B/Snail signaling pathway induced by tumor necrosis factor-. In addition, COE effectively suppressed tumor growth and metastasis in the nude mice model due to reduced expression of N-cadherin, vimentin, NF-B p65, and Snail and increased expression of E-cadherin in the tumor tissues. Conclusion. Our findings provided new evidence that COE is an effective inhibitor of metastatic potential of SGC-7901 cells through suppression of EMT and NF-B/Snail signal pathway. Based on these findings, COE may be considered a novel anticancer agent for the treatment of metastasis in gastric cancer.	[Zhu, Yaodong; Liu, Yanqing; Qian, Yayun; Yang, Lin; Chen, Jue] Yangzhou Univ, Yangzhou 225009, Jiangsu, Peoples R China; [Dai, Xiaojun] Yangzhou Tradit Chinese Med Hosp, Yangzhou, Jiangsu, Peoples R China; [Guo, Shiyu; Hisamitsu, Tadashi] Showa Univ, Tokyo, Japan	Liu, YQ (reprint author), Yangzhou Univ, Coll Med, Inst Combining Chinese Tradit & Western Med, Yangzhou 225009, Jiangsu, Peoples R China.	liuyanqing2014@163.com			National Natural Science Foundation of China [81450051, 81274141]; Jiangsu Provincial Social Development Project [BE2011738]; Natural Science Foundation of Jiangsu Province [BK20141280, BK2012686]; Administration of Traditional Chinese Medicine of Jiangsu Province [LZ11210]; Plans of Colleges and Universities in Jiangsu Province to Postgraduate Research and Innovation [CXLX13-927]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The research was supported by the National Natural Science Foundation of China (No. 81450051, No. 81274141), Jiangsu Provincial Social Development Project (No. BE2011738), the Natural Science Foundation of Jiangsu Province (No. BK20141280, No. BK2012686), Administration of Traditional Chinese Medicine of Jiangsu Province (No. LZ11210), and the Plans of Colleges and Universities in Jiangsu Province to Postgraduate Research and Innovation (No. CXLX13-927).	Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Wu CY, 2013, FITOTERAPIA, V91, P205, DOI 10.1016/j.fitote.2013.09.005; Zhao XN, 2013, FRONT BIOSCI-LANDMRK, V18, P803, DOI 10.2741/4144; Fan YH, 2013, PROTEIN CELL, V4, P176, DOI 10.1007/s13238-013-2084-3; Conteduca V, 2013, INT J ONCOL, V42, P5, DOI 10.3892/ijo.2012.1701; Zhang ZY, 2013, CANCER LETT, V336, P34, DOI 10.1016/j.canlet.2013.04.021; Chen KC, 2013, LIFE SCI, V93, P924, DOI 10.1016/j.lfs.2013.10.004; Li HY, 2013, CELL PHYSIOL BIOCHEM, V32, P448, DOI 10.1159/000354450; Smith A, 2013, ORAL ONCOL, V49, P287, DOI 10.1016/j.oraloncology.2012.10.009; Qian YY, 2012, CHIN J INTEGR MED, V18, P752, DOI 10.1007/s11655-011-0819-7; Sha M, 2014, PHARMACOLOGY, V93, P39, DOI 10.1159/000357683; Lee MY, 2012, AM J TRANSL RES, V4, P1; Rahman R, 2014, WORLD J GASTROENTERO, V20, P4483, DOI 10.3748/wjg.v20.i16.4483; Erstad DJ, 2013, SURG ONCOL CLIN N AM, V22, P705, DOI 10.1016/j.soc.2013.06.011; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Chu S.C., 2013, INTEGR CANC THER, V13, P259; Ge CQ, 2013, J INT MED RES, V41, P284, DOI 10.1177/0300060513476436; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Jeon Hoon, 2011, Natural Product Sciences, V17, P135; Kan JY, 2013, BIOMED RES INT, V2013; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li JJ, 2012, CHIN J NAT MEDICINES, V10, P279, DOI 10.3724/SP.J.1009.2012.00279; Li ZW, 2013, ONCOL REP, V30, P2859, DOI 10.3892/or.2013.2776; Lin J, 2013, INTEGR CANC THER, V13, P240; Ma H, 2013, LIFE SCI J, V10, P2; Shi ZQ, 2014, CRIT REV EUKAR GENE, V24, P39; Shin NR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-521; Wang MR, 2012, ANTICANCER RES, V32, P1213; Wang Y, 2013, CANC HALLM, V1, P38, DOI DOI 10.1166/CH.2013.1004; Watanabe T, 2013, INT J CANCER, V134, P2373; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058915; [昝珂 ZAN Ke], 2007, [中草药, Chinese Traditional and Herbal Drugs], V38, P1455; Zhang H, 2012, J TRADIT CHIN MED, V32, P621	34	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1534-7354	1552-695X		INTEGR CANCER THER	Integr. Cancer Ther.	MAY	2015	14	3					271	281		10.1177/1534735415572880		11	Oncology; Integrative & Complementary Medicine	Oncology; Integrative & Complementary Medicine	CG0TI	WOS:000352982200009		
J	Oh, C; Matsuoka, S				Oh, Chaewoon; Matsuoka, Shunji			The position of the Low Carbon Growth Partnership (LCGP): at the end of Japan's navigation between the Kyoto Protocol and the APP	INTERNATIONAL ENVIRONMENTAL AGREEMENTS-POLITICS LAW AND ECONOMICS			English	Article						East Asia Low Carbon Growth Partnership; Japan; Normative position; Kyoto Protocol; Asia-Pacific Partnership on Clean Development and Climate; Climate change governance	INTERNATIONAL-RELATIONS; POLITICS; GOVERNANCE	A new climate change institutional package, the East Asia Low Carbon Growth Partnership (LCGP), has been recently developed. The LCGP has significant implications because it was initiated by Japan, which has navigated between the Kyoto Protocol (KP) and the Asia-Pacific Partnership on Clean Development and Climate (APP) but ended the navigation by announcing its intention not to participate in the second commitment period of the KP. This paper investigates the position of the LCGP on the spectrum drawn by the KP and the APP using the theoretical ground of normative contestation. Results show that the normative stance of the LCGP is skewed toward the APP; however, the LCGP differentiates itself from the APP by its own functional properties and through its institutional fit with another regional institution, the East Asia Summit. The LCGP puts another complexion on global climate change governance.	[Oh, Chaewoon; Matsuoka, Shunji] Waseda Univ, Grad Sch Asia Pacific Studies, Tokyo, Japan	Oh, C (reprint author), Waseda Univ, Grad Sch Asia Pacific Studies, Tokyo, Japan.	chaewoon.oh@gmail.com			Ministry of Environment of Japan; Design of International Low Carbon Institution in Asia [S-6-3(4)]; Governance Design Research Project [S-6-3]; Asia Low Carbon Society Research Project [S-6]	The authors greatly appreciate the support of Hiro Katsumata in reading and commenting on earlier drafts. Also, the authors greatly appreciate the Ministry of Environment of Japan for research support. This paper was prepared within the project, titled Design of International Low Carbon Institution in Asia (S-6-3(4)), under the Governance Design Research Project (S-6-3) of the Asia Low Carbon Society Research Project (S-6). More details about the project can be found at http://2050.nies.go.jp/index_j.html.	van Asselt H, 2009, INT ENVIRON AGREEM-P, V9, P319, DOI 10.1007/s10784-009-9098-6; [Anonymous], 2011, BLOOMBERG; Finnemore M, 1998, INT ORGAN, V52, P887, DOI 10.1162/002081898550789; Backstrand K, 2008, GLOBAL ENVIRON POLIT, V8, P74, DOI 10.1162/glep.2008.8.3.74; McGee J, 2009, INT ENVIRON AGREEM-P, V9, P213, DOI 10.1007/s10784-009-9101-2; Corbera E, 2009, J INTEGR ENVIRON SCI, V6, P25, DOI 10.1080/15693430802703958; Bernstein S, 2002, POLICY SCI, V35, P203, DOI 10.1023/A:1016158505323; WENDT A, 1992, INT ORGAN, V46, P391; Muller H, 2004, EUR J INT RELAT, V10, P395, DOI 10.1177/1354066104045542; Tiberghien Y, 2007, GLOBAL ENVIRON POLIT, V7, P70, DOI 10.1162/glep.2007.7.4.70; Hopf T, 1998, INT SECURITY, V23, P171, DOI 10.2307/2539267; Biermann F, 2009, GLOBAL ENVIRON POLIT, V9, P14, DOI 10.1162/glep.2009.9.4.14; WENDT A, 1995, INT SECURITY, V20, P71, DOI 10.2307/2539217; APEC, 2012, AS PAC EC COOP FACT; APP, 2012, AS PAC PARTN CLEAN D; APP, 2007, AS PAC PARTN CLEAN D; Bodansky D, 2011, ARIZONA STATE LAW J, V43, P697; EAS, 2011, CHAIRM STAT 6 E AS S; EAS, 2011, CHAIRM STAT EAS FOR; Erni C., 2011, ASEAN CLIMATE CHANGE; Hoffmann M. J., 2007, AMST C HUM DIM GLOB; Hoffmann Matthew J., 2011, CLIMATE GOVERNANCE C; Keidanren, 2011, POL PROP NEW INT FRA; Keidanren, 2011, 1 PROP EN POL OUTL; Kellow A, 2006, AUST J INT AFF, V60, P287, DOI 10.1080/10357710600696183; Kollmuss A, 2008, MAKING SENSE VOLUNTA; KP, 1997, KYOT PROT UN FRAM CO; Lawrence P., 2007, ASIA PACIFIC J ENV L, V10, P183; LCS-RNet, 2012, LCS RNET INT RES NET; LCS-RNet, 2012, SID EV E AS LOW CARB; Mace M. J., 2005, REV EUROPEAN COMMUNI, V14, P225, DOI DOI 10.1111/J.1467-9388.2005.00445.X; McGee J., 2006, GLOBAL CHANGE PEACE, V18, P173, DOI 10.1080/14781150600960230; Mimura Nobuo, 2012, UN FRAM CONV CLIM CH; Ministry of Economy Trade and Industry (METI), 2010, STRAT EN PLAN JAP M; MOEJ, 2011, COP 17 DEC 7 2011; MOFA, 2012, JAP IN BIL OFFS CRED; MOFA, 2012, E AS LOW CARB GROWTH; MOFA, 2011, AFR GREEN GROWTH STR; MOFA, 2011, COP 17 2011, V17; Narine S., 1998, WORLD AFF, V161, P33; Olmstead SM, 2006, AM ECON REV, V96, P35, DOI 10.1257/000282806777212413; Porter G., 2008, NEW FINANCE CLIMATE; Sands P., 1992, REV EUROPEAN COMMUNI, V1, P270, DOI 10.1111/j.1467-9388.1992.tb00046.x; UNFCCC (United Nations Framework Convention on Climate Change), 2009, COP ACC; UNFCCC (United Nations Framework Convention on Climate Change), 2007, BAL ACT PLAN; United Nations Framework Convention on Climate Change (UNFCCC), 2010, CANC AGR; van Asselt H., 2007, CARBON CLIMATE LAW R, V1, P17	47	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-9764	1573-1553		INT ENVIRON AGREEM-P	Int. Environ. Agreem.-Polit. Law Econom.	MAY	2015	15	2					125	140		10.1007/s10784-013-9219-0		16	Economics; Environmental Studies; Law; Political Science	Business & Economics; Environmental Sciences & Ecology; Government & Law	CF6FV	WOS:000352653400003		
J	Kamigawara, K				Kamigawara, Kenji			Comparative typological study of change in global environmental regimes	INTERNATIONAL ENVIRONMENTAL AGREEMENTS-POLITICS LAW AND ECONOMICS			English	Article						Global environmental regimes; Change; Models; E. B. Haas; Knowledge		Many global environmental agreements have shown diverse changes in their long-term implementation. Comparative studies on international regimes are limited, and research on change in such regimes is not well developed. A comparative typological study of change in global environmental regimes is presented in this paper. Ernst B. Haas's "three models of change" is chosen as a framework to explain change in the regimes. The models are (1) incremental growth, (2) turbulent nongrowth, and (3) managed interdependence. They reflect the shift of power balance among member states and their knowledge of policies. The models are applied to five case studies covering the Ramsar, CITES (Convention on International Trade in Endangered Species of Wild Flora and Fauna), Basel, Ozone, and Climate regimes, which have been in effect for over 15 years. The three models help explain diverse changes in those regimes. Five factors, (1) shift of power balance and political leadership, (2) the scope of the regime (narrow or wide), (3) institutional legacy, (4) consensual knowledge and conflict of political value, and (5) learning between rival groups, have made major contribution to the change in those regimes.	Univ Shiga Prefecture, Sch Environm Sci, Hikone, Shiga 5228533, Japan	Kamigawara, K (reprint author), Univ Shiga Prefecture, Sch Environm Sci, 2500 Hassaka Cho, Hikone, Shiga 5228533, Japan.	2t95f6@bma.biglobe.ne.jp					Andersen S. O., 2002, PROTECTING OZONE LAY; Benedick Richard E., 1998, OZONE DIPLOMACY NEW; Boardman R., 1981, INT ORG CONSERVATION; Bolin B, 2007, HISTORY OF THE SCIENCE AND POLITICS OF CLIMATE CHANGE: THE ROLE OF THE INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE, P1, DOI 10.1017/CBO9780511721731; Bonner R., 1993, AT THE HAND OF MAN; Breitmeier H., 2006, ANAL INT ENV REGIMES; Canan Penelope, 2002, OZONE CONNECTIONS EX; CHASEK P., 2006, GLOBAL ENV POLITICS; Curlier M., 2002, ENV REGIME EFFECTIVE, P357; FAO, 2010, FIRFR925EN FAO; HAAS EB, 1980, WORLD POLIT, V32, P357, DOI 10.2307/2010109; Haas Ernst B, 1990, KNOWLEDGE IS POWER; Haas P. M., 1996, KNOWLEDGE POWER INT, P187; Haas P. M., 1995, I EARTH; Hect A., 1995, CLIMATE CHANGE, V29, P371; Holdgate Martin, 1999, GREEN WEB UNION WORL; IISD, 2008, EARTH NEGOTIATIONS B, V17; IISD, 2005, EARTH NEGOTIATIONS B, V17; IISD, 1999, EARTH NEGOTIATIONS B, V17; IISD, 2009, EARTH NEGOTIATIONS B, V12; International Energy Agency (IEA), 2011, CO2 EM FUEL COMB HIG; IUCN, 1964, 8 GEN ASS P; IUCN UNEP & WWF, 1980, WORLD CONS STRAT; Kempel W., 1999, INT NEGOT, V4, P411; Liefferink D., 2005, ENV POLICY EUROPEAN, P49; Miles E.L., 2002, ENV REGIME EFFECTIVE; Mofson P., 2000, ENDANGERED SPECIES T, P107; Oreskes N., 2010, MERCHANTS DOUBT; Parson E.A., 2003, PROTECTING OZONE LAY; Sand P.H., 1997, EUROPEAN J INT LAW, V8, P29; Sharp R, 1997, ORYX, V31, P111, DOI 10.1046/j.1365-3008.1997.d01-99.x; Sikkink Kathryn, 1998, ACTIVISTS BORDERS; Tolba Mostafa K., 1998, GLOBAL ENV DIPLOMACY; TRAFFIC, 1989, TRAFFIC B, V11; TRAFFIC, 1997, TRAFFIC B, V17, P5; Western D., 2002, DUST KILIMANJARO; Wijnstekers Willem, 2001, EVOLUTION CITES; Young O. R., 1999, EFFECTIVENESS INT EN; Young Oran, 2010, I DYNAMICS EMERGENT; Zito A. R., 2000, CREATING ENV POLICY	40	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-9764	1573-1553		INT ENVIRON AGREEM-P	Int. Environ. Agreem.-Polit. Law Econom.	MAY	2015	15	2					179	197		10.1007/s10784-013-9229-y		19	Economics; Environmental Studies; Law; Political Science	Business & Economics; Environmental Sciences & Ecology; Government & Law	CF6FV	WOS:000352653400006		
J	Li, Y; Guo, B; Huang, GF; Shu, PC; Kiriki, H; Kubo, S; Ohno, K; Kawai, T				Li, Yong; Guo, Bei; Huang, Guanfei; Shu, Pengcheng; Kiriki, Hiroaki; Kubo, Shuichi; Ohno, Kazushige; Kawai, Takeshi			Eutectic compound (KNO3/NaNO3:PCM) quasi-encapsulated into SiC-honeycomb for suppressing natural convection of melted PCM	INTERNATIONAL JOURNAL OF ENERGY RESEARCH			English	Article						phase change eutectic compound (PCM); thermal energy storage; SiC-honeycomb; quasi-encapsulated PCM; natural convection	THERMAL-ENERGY STORAGE; PHASE-CHANGE MATERIALS; MOLTEN-SALT; COMPOSITES; PLANT	The phase change eutectic compound, KNO3/NaNO3 (50/50mol%) (phase change material (PCM)), which is used as the thermal energy storage material in the solar thermal power plant, was quasi-encapsulated into the SiC-honeycomb (SCH) for suppressing the natural convection occurring at the liquid state of PCM. The performance of the SCH as the material suppressing natural convection of PCM was investigated experimentally. PCM with three kinds of mixing ratios of SCH of 10%, 20%, and 30%, was prepared and packed in their respective stainless can with oil-flowing pipe in the center, which is called thermal energy storage unit (TESU). Three units were linked together and stacked vertically by the connector at the inlet/outlet oil pipe. The time variation of temperature at the fixed positions inside the TESU in charging/discharging process and temperature gradient in the radial direction inside TESU when PCM was liquid state were investigated. It is concluded that the natural convection is suppressed by mixing the SCH with PCM up to around 30% in weight, because the PCM is quasi-encapsulated into cell holes and porous structures of SCHs. And thus, the heat transfer of the PCM+30%SCH composite is controlled mainly by its thermal conduction, which is also supported through comparison of simulation result with experimental one. And so, we conclude that SCH has a function as the quasi-encapsulating material for suppressing the natural convection of PCM. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Li, Yong; Guo, Bei; Huang, Guanfei; Shu, Pengcheng; Kawai, Takeshi] Xi An Jiao Tong Univ, Sch Energy & Power Engn, Xian 710049, Shaanxi, Peoples R China; [Kiriki, Hiroaki; Kubo, Shuichi; Ohno, Kazushige] IBIDEN Co Ltd, Ogaki, Gifu 5038604, Japan; [Kawai, Takeshi] Kyoto Univ, Res Reactor Inst, Kumatori, Osaka 59004, Japan	Guo, B (reprint author), Xi An Jiao Tong Univ, Sch Energy & Power Engn, 28 Xianning West Rd, Xian 710049, Shaanxi, Peoples R China.	guobei@mail.xjtu.edu.cn; kawai@mail.xjtu.edu.cn					VOLLER VR, 1987, INT J HEAT MASS TRAN, V30, P1709, DOI 10.1016/0017-9310(87)90317-6; Flueckiger SM, 2014, APPL ENERG, V113, P86, DOI 10.1016/j.apenergy.2013.07.004; Pincemin S, 2008, SOL ENERG MAT SOL C, V92, P603, DOI 10.1016/j.solmat.2007.11.010; Agyenim F, 2010, RENEW SUST ENERG REV, V14, P615, DOI 10.1016/j.rser.2009.10.015; Tamme R, 2008, INT J ENERG RES, V32, P264, DOI 10.1002/er.1346; Herrmann U, 2004, ENERGY, V29, P883, DOI 10.1016/S0360-5442(03)00193-2; Peng Q, 2008, INT J ENERG RES, V32, P1164, DOI 10.1002/er.1453; Malekipirbazari M, 2014, INT J ENERG RES, V38, P1492, DOI 10.1002/er.3153; Cingarapu S, 2014, INT J ENERG RES, V38, P51, DOI 10.1002/er.3041; Ehrharts B, 2013, P SOL PACES LAS VEG, P752; Hasse C, 2011, ENERG BUILDINGS, V43, P232, DOI 10.1016/j.enbuild.2010.09.017; Kline S.J., 1953, J MECH ENG, V75, P3; Liao ZR, 2014, SOL ENERGY, V101, P254, DOI 10.1016/j.solener.2014.01.002; Lius M, 2012, RENEW SUST ENERG REV, V16, P2118; Luzzi A, 1999, SOL ENERGY, V66, P91, DOI 10.1016/S0038-092X(98)00108-X; Meis DD, 2011, INT J ENERG RES, V35, P828; Rady MA, 2010, INT J ENERG RES, V34, P333, DOI 10.1002/er.1560; Sars A, 2014, INT J ENERG RES, V38, P1478; Sciacovelli A, 2013, INT J ENERG RES, V37, P1610, DOI 10.1002/er.2974; Siahpushs A, 2008, J HEAT TRANSFER, V130	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0363-907X	1099-114X		INT J ENERG RES	Int. J. Energy Res.	MAY	2015	39	6					789	804		10.1002/er.3293		16	Energy & Fuels; Nuclear Science & Technology	Energy & Fuels; Nuclear Science & Technology	CF4DB	WOS:000352497700006		
J	Tateno, A; Sakayori, T; Kawashima, Y; Higuchi, M; Suhara, T; Mizumura, S; Mintun, MA; Skovronsky, DM; Honjo, K; Ishihara, K; Kumita, S; Suzuki, H; Okubo, Y				Tateno, Amane; Sakayori, Takeshi; Kawashima, Yoshitaka; Higuchi, Makoto; Suhara, Tetsuya; Mizumura, Sunao; Mintun, Mark A.; Skovronsky, Daniel M.; Honjo, Kazuyoshi; Ishihara, Keiichi; Kumita, Shinichiro; Suzuki, Hidenori; Okubo, Yoshiro			Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [F-18]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy	INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						Alzheimer's disease; beta-amyloid; positron emission tomography; brain atrophy; cognitive function	MILD COGNITIVE IMPAIRMENT; STRUCTURAL MRI; DEMENTIA; BRAIN; PET; FLORBETAPIR; MORPHOMETRY; NEUROPATHOLOGY; DIAGNOSIS; PLAQUES	ObjectiveWe compared amyloid positron emission tomography (PET) and magnetic resonance imaging (MRI) in subjects clinically diagnosed with Alzheimer's disease (AD), mild cognitive impairment (MCI), and older healthy controls (OHC) in order to test how these imaging biomarkers represent cognitive decline in AD. MethodsFifteen OHC, 19 patients with MCI, and 19 patients with AD were examined by [F-18]florbetapir PET to quantify the standard uptake value ratio (SUVR) as the degree of amyloid accumulation, by MRI and the voxel-based specific regional analysis system for AD to calculate z-score as the degree of entorhinal cortex atrophy, and by mini-mental state examination (MMSE) and Alzheimer's Disease Assessment Scale-cognitive componentJapanese version (ADAS-Jcog) for cognitive functions. ResultsBoth cutoff values for measuring AD-like levels of amyloid (1.099 for SUVR) and entorhinal cortex atrophy (1.60 for z-score) were well differentially diagnosed and clinically defined AD from OHC (84.2% for SUVR and 86.7% for z-score). Subgroup analysis based on beta-amyloid positivity revealed that z-score significantly correlated with MMSE (r=-0.626, p<0.01) and ADAS-Jcog (r=0.691, p<0.01) only among subjects with beta-amyloid. ConclusionsThis is the first study to compare [F-18]florbetapir PET and MRI voxel-based analysis of entorhinal cortex atrophy for AD. Both [F-18]florbetapir PET and MRI detected changes in AD compared with OHC. Considering that entorhinal cortex atrophy correlated well with cognitive decline only among subjects with beta-amyloid, [F-18]florbetapir PET makes it possible to detect AD pathology in the early stage, whereas MRI morphometry for subjects with beta-amyloid provides a good biomarker to assess the severity of AD in the later stage. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Tateno, Amane; Sakayori, Takeshi; Kawashima, Yoshitaka; Okubo, Yoshiro] Nippon Med Sch, Dept Neuropsychiat, Bunkyo Ku, Tokyo, Japan; [Higuchi, Makoto; Suhara, Tetsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Chiba 260, Japan; [Mizumura, Sunao] Toho Univ, Omori Med Ctr, Dept Radiol, Ota Ku, Tokyo, Japan; [Mintun, Mark A.; Skovronsky, Daniel M.] Avid Radiopharmaceut Inc, Philadelphia, PA 19104 USA; [Honjo, Kazuyoshi; Ishihara, Keiichi] Nippon Med Sch, Clin Imaging Ctr Healthcare, Bunkyo Ku, Tokyo, Japan; [Kumita, Shinichiro] Nippon Med Sch, Dept Radiol, Bunkyo Ku, Tokyo, Japan; [Suzuki, Hidenori] Nippon Med Sch, Dept Pharmacol, Bunkyo Ku, Tokyo, Japan	Okubo, Y (reprint author), Nippon Med Sch, Dept Neuropsychiat, Bunkyo Ku, 1-1-5 Sendagi, Tokyo, Japan.	okubo-y@nms.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japanese government; Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT); Health and Labor Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Ministry of Health, Labor and Welfare, Japanese government	This study was partly supported by a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japanese government (2011-2015); by a grant of Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT) (2008-2012); and by a Health and Labor Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Ministry of Health, Labor and Welfare, Japanese government. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; JOACHIM CL, 1989, AM J PATHOL, V135, P309; Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4; Scheltens P, 2002, LANCET NEUROL, V1, P13, DOI 10.1016/S1474-4422(02)00002-9; Newberg AB, 2012, J NUCL MED, V53, P902, DOI 10.2967/jnumed.111.099606; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; MORRIS JC, 1993, NEUROLOGY, V43, P2412; Ingelsson M, 2004, NEUROLOGY, V62, P925; Kemppainen NM, 2006, NEUROLOGY, V67, P1575, DOI 10.1212/01.wnl.0000240117.55680.0a; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Fleisher AS, 2011, ARCH NEUROL-CHICAGO, V68, P1404, DOI 10.1001/archneurol.2011.150; Choi SR, 2009, J NUCL MED, V50, P1887, DOI 10.2967/jnumed.109.065284; Jack CR, 2002, NEUROLOGY, V58, P750; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; Nagata T, 2011, INT PSYCHOGERIATR, V23, P764, DOI 10.1017/S1041610210002164; Becker JA, 2011, ANN NEUROL, V69, P1032, DOI 10.1002/ana.22333; Shibuya Y, 2013, INT J GERIATR PSYCH, V28, P372, DOI 10.1002/gps.3834; Camus V, 2012, EUR J NUCL MED MOL I, V39, P621, DOI 10.1007/s00259-011-2021-8; Hirata Y, 2005, NEUROSCI LETT, V382, P269, DOI 10.1016/j.neulet.2005.03.038; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; Gosche KM, 2002, NEUROLOGY, V58, P1476; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; Drzezga A, 2009, NEUROLOGY, V72, P1487, DOI 10.1212/WNL.0b013e3181a2e8d0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Homma A, 1992, JPN J GERIATR PSYCHI, V3, P647; Imabayashi E, 2013, BRAIN BEHAV, V3, P487, DOI 10.1002/brb3.146; Maruyama M, 2013, NEURON, V18, P1094; MCKHANN G, 1984, NEUROLOGY, V34, P939; Rinne JO, 2010, J ALZHEIMERS DIS, V19, P291, DOI 10.3233/JAD-2010-1224	31	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6230	1099-1166		INT J GERIATR PSYCH	Int. J. Geriatr. Psychiatr.	MAY	2015	30	5					505	513		10.1002/gps.4173		9	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CF7EO	WOS:000352719200009		
J	Kim, MJ; Park, CG; McKenna, H; Ketefian, S; Park, SH; Klopper, H; Lee, H; Kunaviktikul, W; Gregg, MF; Daly, J; Coetzee, S; Juntasopeepun, P; Murashima, S; Keeney, S; Khan, S				Kim, Mi Ja; Park, Chang Gi; McKenna, Hugh; Ketefian, Shake; Park, So Hyun; Klopper, Hester; Lee, Hyeonkyeong; Kunaviktikul, Wipada; Gregg, Misuzu F.; Daly, John; Coetzee, Siedine; Juntasopeepun, Phanida; Murashima, Sachiyo; Keeney, Sinead; Khan, Shaheen			Quality of nursing doctoral education in seven countries: survey of faculty and students/graduates	JOURNAL OF ADVANCED NURSING			English	Article						doctoral education; evaluation; faculty; global; nursing education; PhD; postgraduate study; quality; students; graduates	SECTIONAL QUESTIONNAIRE SURVEY; DESCRIBING CAPACITY ISSUES; PROGRAMS; STUDENTS; JAPAN; BIAS	AimsThis study aimed to compare the findings of the quality of nursing doctoral education survey across seven countries and discuss the strategic directions for improving quality. BackgroundNo comparative evaluation of global quality of nursing doctoral education has been reported to date despite the rapid increase in the number of nursing doctoral programmes. DesignA descriptive, cross-country, comparative design was employed. MethodsData were collected from 2007-2010 from nursing schools in seven countries: Australia, Japan, Korea, South Africa, Thailand, UK and USA. An online questionnaire was used to evaluate quality of nursing doctoral education except for Japan, where a paper version was used. Korea and South Africa used e-mails quality of nursing doctoral education was evaluated using four domains: Programme, Faculty (referring to academic staff), Resource and Evaluation. Descriptive statistics, correlational and ordinal logistic regression were employed. ResultsA total of 105 deans/schools, 414 faculty and 1149 students/graduates participated. The perceptions of faculty and students/graduates about the quality of nursing doctoral education across the seven countries were mostly favourable on all four domains. The faculty domain score had the largest estimated coefficient for relative importance. As the overall quality level of doctoral education rose from fair to good, the resource domain showed an increased effect. ConclusionsBoth faculty and students/graduates groups rated the overall quality of nursing doctoral education favourably. The faculty domain had the greatest importance for quality, followed by the programme domain. However, the importance of the resource domain gained significance as the overall quality of nursing doctoral education increased, indicating the needs for more attention to resources if the quality of nursing doctoral education is to improve.	[Kim, Mi Ja; Park, Chang Gi] Univ Illinois, Coll Nursing, Chicago, IL USA; [McKenna, Hugh] Univ Ulster, Res & Innovat, Coleraine BT52 1SA, Londonderry, North Ireland; [Ketefian, Shake] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Park, So Hyun] Florida State Univ, Coll Nursing, Tallahassee, FL 32306 USA; [Klopper, Hester] North West Univ, INSINQ Res Unit, Potchefstroom, South Africa; [Lee, Hyeonkyeong] Yonsei Univ, Coll Nursing, Seoul 120749, South Korea; [Kunaviktikul, Wipada] Chiang Mai Univ, Fac Nursing, Chiang Mai, Thailand; [Gregg, Misuzu F.] Kobe City Coll Nursing, Kobe, Hyogo, Japan; [Daly, John] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Daly, John] Univ Technol Sydney, Fac Hlth, Nursing, Sydney, NSW 2007, Australia; [Coetzee, Siedine] North West Univ, Sch Nursing, Potchefstroom, South Africa; [Juntasopeepun, Phanida] Chiang Mai Univ, Chiang Mai, Thailand; [Juntasopeepun, Phanida] Chiang Mai Univ, Fac Nursing, Global & Res Affairs, Chiang Mai, Thailand; [Murashima, Sachiyo] Oita Univ Nursing & Hlth Sci, Oita, Japan; [Keeney, Sinead] Univ Ulster, Inst Nursing & Hlth Res, Coleraine BT52 1SA, Londonderry, North Ireland; [Khan, Shaheen] Univ Illinois, Coll Appl Hlth Sci, Chicago, IL USA	Park, SH (reprint author), Florida State Univ, Coll Nursing, Tallahassee, FL 32306 USA.	spark10@fsu.edu		McKenna, Hugh/0000-0003-4916-6602	Global Korean Nursing Foundation; Academy of International Leadership Development, UIC College of Nursing; research project on University Evaluation and Accreditation by the Japan Ministry of Education, Culture, Sports, Science and Technology; Faculty of Health Sciences, North-West University (Potchefstroom Campus); Thailand Nursing and Midwifery Council; Faculty of Nursing, Chiang Mai University; University of Ulster	This study was supported, in part, by the Global Korean Nursing Foundation and the Academy of International Leadership Development, UIC College of Nursing. The Japanese study was financially supported by the research project on University Evaluation and Accreditation commissioned by the Japan Ministry of Education, Culture, Sports, Science and Technology in 2008. In South Africa, the study was partly supported by the Faculty of Health Sciences, North-West University (Potchefstroom Campus). The Thailand study received grants from the Thailand Nursing and Midwifery Council and the Faculty of Nursing, Chiang Mai University. In the UK, the study was supported by the University of Ulster.	American Association of Colleges of Nursing (AACN), 2013, 2013 DAT DOCT PROGR; American Association of Colleges of Nursing (AACN), 2012, NURS FAC SHORT FACT; American Association of Colleges of Nursing (AACN), 2001, IND QUAL RES FOC DOC; American Association of Colleges of Nursing (AACN), 2013, PHD SUMM; Williams R, 2006, STATA J, V6, P58; JAMES LR, 1982, J APPL PSYCHOL, V67, P219, DOI 10.1037/0021-9010.67.2.219; Minnick AF, 2010, NURS OUTLOOK, V58, P36, DOI 10.1016/j.outlook.2009.10.001; Nagata S, 2012, NURS EDUC TODAY, V32, P361, DOI 10.1016/j.nedt.2011.05.019; Minnick AF, 2013, NURS OUTLOOK, V61, P93, DOI 10.1016/j.outlook.2012.07.011; Schneider B, 1998, J APPL PSYCHOL, V83, P150, DOI 10.1037/0021-9010.83.2.150; JAMES LR, 1984, J APPL PSYCHOL, V69, P85, DOI 10.1037/0021-9010.69.1.85; Arimoto Azusa, 2012, Nurse Educ Today, V32, pe1, DOI 10.1016/j.nedt.2011.06.007; European University Association (EUA), 2013, ACC RES ENV DOCT ED; Greenhalsh L., 2013, U TAKING STEPS GUARA; HEFCE (Health Education Funding Council for England), 2014, RES EXC FRAM; Higher Education Funding Council for England (HEFCE), 2008, RES ASS EX; Hofmann D. A., 2008, ISSUES MULTILEVEL RE; Horiuchi S., 2013, J NURSING SCI S1, V31, P5; International Network for Doctoral Education in Nursing (INDEN), 2012, DIR INT DOCT PROGR; Japan Nursing Association, 2014, STAT DAT NURS SERV J; Kayama M, 2013, J NURS EDUC, V52, P283, DOI 10.3928/01484834-20130320-02; Ketefian Shaké, 2005, Nurs Health Sci, V7, P150, DOI 10.1111/j.1442-2018.2005.00240.x; Kim MJ, 2014, J PROF NURS, V30, P10, DOI 10.1016/j.profnurs.2013.06.005; Kim MJ, 2012, J ADV NURS, V68, P1494, DOI 10.1111/j.1365-2648.2011.05885.x; Kim MJ, 2010, INT J NURS STUD, V47, P295, DOI 10.1016/j.ijnurstu.2009.07.005; Kim MJ, 2006, INT J NURS STUD, V43, P477, DOI 10.1016/j.ijnurstu.2005.07.003; Kjellgren KI, 2005, NURS EDUC TODAY, V25, P316, DOI 10.1016/j.nedt.2005.02.002; Korean Accreditation Board of Nursing Education, 2012, NURS ED ACCR STAND; Matthews D., 2013, TIMES HIGHER ED; McKenna H, 2005, INT J NURS STUD, V42, P245, DOI 10.1016/j.ijnurstu.2005.01.001; McKenna H, 2014, J ADV NURS, V70, P1639, DOI 10.1111/jan.12326; Miki Y, 2012, JPN J NURS SCI, V9, P160, DOI 10.1111/j.1742-7924.2011.00196.x; Nantsupawat R., 2008, THAI J NURSING COUNC, V23, P41; Park H. A., 2013, J NURSING SCI S1, V31, P9; Parr C., 2013, TIMES HIGHER ED; Sarchet P., 2013, ANYONE TEACHING CONT; The Quality Assurance Agency for Higher Education (QAAHE), 2011, DOCT DEGR CHAR; Tilokskulchai F., 2013, J NURSING SCI S1, V31, P20; Wasburn-Moses L, 2008, REM SPEC EDUC, V29, P259, DOI 10.1177/0741932507312014	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-2402	1365-2648		J ADV NURS	J. Adv. Nurs.	MAY	2015	71	5					1098	1109		10.1111/jan.12606		12	Nursing	Nursing	CF8IA	WOS:000352798600013		
J	Tomitaka, Y; Abe, H; Sakurai, T; Tsuda, S				Tomitaka, Y.; Abe, H.; Sakurai, T.; Tsuda, S.			Preference of the vector thrips Frankliniella occidentalis for plants infected with thrips-non-transmissible Tomato spotted wilt virus	JOURNAL OF APPLIED ENTOMOLOGY			English	Article						attraction; tospovirus; western flower thrips	MYZUS-PERSICAE; INSECT VECTORS; HOST-PLANT; TOSPOVIRUS; THYSANOPTERA; BEHAVIOR; PERFORMANCE; HERBIVORE; ACCUMULATION; SPECIFICITY	The effect of a thrips-non-transmissible Tomato spotted wilt virus (TSWV) on insect-host interactions between thrips and Arabidopsis thaliana was analysed. A wild-type TSWV virulent isolate and a TSWV isolate that induces mild symptoms on inoculated plants (TSWV-Mo) were used in this study, and TSWV-Mo isolate was obtained by single local lesion isolation using Petunia x hybrid after several passages on Nicotiana rustica plants. In transmission test, although wild-type TSWV (TSWV-wt) was transmitted by two thrips species (transmission ratio; Frankliniella occidentalis, 25%; Thrips tabaci, 10%; and T.palmi, 0%), none of the thrips transmitted TSWV-Mo. Feeding damage by F.occidentalis in A.thaliana plants was more extensive on TSWV-wt-infected plants than on TSWV-Mo-infected plants, despite comparable preference. Among the markers of plant defences, salicylic acid-regulated genes were upregulated threefold to sixfold by TSWV-wt or TSWV-Mo infection. In contrast, jasmonate-regulated genes and jasmonate/ethylene-regulated genes were not affected by the infections. Pull assays showed that adjacent TSWV-Mo-infected plants were preferred over uninfected plants. In conclusion, our results showed that the transmissibility by thrips of TSWV is not related to preference of vector thrips and suggested that TSWV-Mo-infected plants may be used as attractants for behaviour control of thrips.	[Tomitaka, Y.; Sakurai, T.; Tsuda, S.] NARO Agr Res Ctr, Tsukuba, Ibaraki 3058666, Japan; [Abe, H.] RIKEN BioResource Ctr, Expt Plant Div, Tsukuba, Ibaraki, Japan	Tsuda, S (reprint author), NARO Agr Res Ctr, 3-1-1 Kannondai, Tsukuba, Ibaraki 3058666, Japan.	shinyat@affrc.go.jp					Abe H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-97; Stafford CA, 2011, P NATL ACAD SCI USA, V108, P9350, DOI 10.1073/pnas.1100773108; Belliure B, 2008, OECOLOGIA, V156, P797, DOI 10.1007/s00442-008-1027-9; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Abe H, 2012, PLANT CELL PHYSIOL, V53, P204, DOI 10.1093/pcp/pcr173; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Lee JS, 2011, ARCH VIROL, V156, P725, DOI 10.1007/s00705-011-0935-x; Murai T, 2001, ENTOMOL EXP APPL, V101, P281, DOI 10.1023/A:1019252708938; WIJKAMP I, 1993, PHYTOPATHOLOGY, V83, P986, DOI 10.1094/Phyto-83-986; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Pickett JA, 2014, CURR OPIN BIOTECH, V26, P125, DOI 10.1016/j.copbio.2013.12.006; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Maris PC, 2004, PHYTOPATHOLOGY, V94, P706, DOI 10.1094/PHYTO.2004.94.7.706; Leon-Reyes A, 2009, PLANT PHYSIOL, V149, P1797, DOI 10.1104/pp.108.133926; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; Shrestha A, 2012, ENTOMOL EXP APPL, V145, P260, DOI 10.1111/eea.12011; Nagata T, 2000, PHYTOPATHOLOGY, V90, P454, DOI 10.1094/PHYTO.2000.90.5.454; GERMAN TL, 1992, ANNU REV PHYTOPATHOL, V30, P315, DOI 10.1146/annurev.py.30.090192.001531; Naidu RA, 2008, PLANT PATHOL, V57, P190, DOI 10.1111/j.1365-3059.2007.01707.x; Khan ZR, 2010, J EXP BOT, V61, P4185, DOI 10.1093/jxb/erq229; Sin SH, 2005, P NATL ACAD SCI USA, V102, P5168, DOI 10.1073/pnas.0407354102; Garcia-Cano E, 2006, PHYTOPATHOLOGY, V96, P1263, DOI 10.1094/PHYTO-96-1263; Medina-Ortega KJ, 2009, ENVIRON ENTOMOL, V38, P836, DOI 10.1603/022.038.0337; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; Hodge S, 2008, ENVIRON ENTOMOL, V37, P1573, DOI 10.1603/0046-225X-37.6.1573; van de Wetering F, 1999, ENTOMOL EXP APPL, V93, P105, DOI 10.1046/j.1570-7458.1999.00567.x; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; BAUTISTA RC, 1995, PHYTOPATHOLOGY, V85, P953, DOI 10.1094/Phyto-85-953; Belliure B, 2010, BASIC APPL ECOL, V11, P162, DOI 10.1016/j.baae.2009.09.004; Blanc S, 2011, RECENT ADVANCES IN PLANT VIROLOGY, P103; BLUA MJ, 1994, J CHEM ECOL, V20, P691, DOI 10.1007/BF02059607; Catzivassiliou EK, 1999, PLANT PATHOL, V48, P700; Chaisuekul C, 2005, J ECON ENTOMOL, V98, P2107; RESENDE RD, 1991, J GEN VIROL, V72, P2375; Howe Gregg A., 2008, P7, DOI 10.1007/978-1-4020-8182-8_1; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; Inoue T, 2004, B ENTOMOL RES, V94, P501, DOI 10.1079/BER2004326; Inoue-Nagata AK, 1998, VIROLOGY, V248, P342, DOI 10.1006/viro.1998.9271; Moreno-Delafuente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061543; Mound L. A., 1996, ACTA HORTIC, V431, P298; Ngumbi E, 2007, J CHEM ECOL, V33, P1733, DOI 10.1007/s10886-007-9340-z; Ogada PA, 2013, J APPL ENTOMOL, V137, P488, DOI 10.1111/jen.12023; Pieterse CMJ, 2006, MULTIGENIC AND INDUCED SYSTEMIC RESISTANCE IN PLANTS, P166, DOI 10.1007/0-387-23266-4_8; Qiu WP, 1998, VIROLOGY, V244, P186, DOI 10.1006/viro.1998.9131; Sakurai T, 1998, APPL ENTOMOL ZOOL, V33, P583; Tsuda Shinya, 1993, Annals of the Phytopathological Society of Japan, V59, P626; vandeWetering F, 1996, PHYTOPATHOLOGY, V86, P900; van de Wetering F, 1999, B ENTOMOL RES, V89, P579; Webb S, 1998, RECENT PROGR TOSPOVI, P67; WIJKAMP I, 1995, PHYTOPATHOLOGY, V85, P1069, DOI 10.1094/Phyto-85-1069	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0931-2048	1439-0418		J APPL ENTOMOL	J. Appl. Entomol.	MAY	2015	139	4					250	259		10.1111/jen.12165		10	Entomology	Entomology	CF7HA	WOS:000352725800002		
J	Nakai, Y; Isayama, H; Sasaki, T; Takahara, N; Saito, K; Ishigaki, K; Hamada, T; Mizuno, S; Miyabayashi, K; Yamamoto, K; Mohri, D; Kogure, H; Yamamoto, N; Ijichi, H; Tateishi, K; Tada, M; Koike, K				Nakai, Yousuke; Isayama, Hiroyuki; Sasaki, Takashi; Takahara, Naminatsu; Saito, Kei; Ishigaki, Kazunaga; Hamada, Tsuyoshi; Mizuno, Suguru; Miyabayashi, Koji; Yamamoto, Keisuke; Mohri, Dai; Kogure, Hirofumi; Yamamoto, Natsuyo; Ijichi, Hideaki; Tateishi, Keisuke; Tada, Minoru; Koike, Kazuhiko			The inhibition of renin-angiotensin system in advanced pancreatic cancer: an exploratory analysis in 349 patients	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY			English	Article						Chemotherapy; Gemcitabine; Pancreatic cancer; Renin-angiotensin system; Smoking	CANDESARTAN COMBINATION THERAPY; GEMCITABINE-INDUCED NEUTROPENIA; ERLOTINIB PLUS GEMCITABINE; CELL LUNG-CANCER; PHASE-II TRIAL; CIGARETTE-SMOKING; JAPANESE PATIENTS; RISK-FACTORS; SURVIVAL; MULTICENTER	The role of local renin-angiotensin system (RAS) as a target for the treatment of pancreatic cancer has been increasingly reported, but the addition of candesartan, one of angiotensin system inhibitors (ASIs), to gemcitabine in our prospective trial failed to demonstrate activity against pancreatic cancer. The aim of this study was to explore subgroups that would benefit from the inhibition of RAS by the use of ASIs. Consecutive patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy were retrospectively studied. Hazard ratios (HRs) for overall survival (OS) and progression-free survival (PFS) were estimated by a Cox proportional hazards model. Interactions between the use of ASIs and each subgroup were tested. Between 2001 and 2013, 349 patients received gemcitabine-based chemotherapy for advanced pancreatic cancer; 232 were metastatic, 210 received gemcitabine monotherapy, 108 took ASIs, 166 were never smokers and 188 were diabetic. The median PFS and OS were 4.9 and 11.2 months, respectively. When the effects of the use of ASIs were evaluated by a Cox proportional hazard model, there were two subgroups with P interaction < 0.10 both in PFS and OS: never smokers and gemcitabine monotherapy. HRs for PFS and OS by the inhibition of RAS were 0.71 (P = 0.021) and 0.68 (P = 0.014) in never smokers and 0.70 (P = 0.027) and 0.77 (P = 0.124) in patients receiving gemcitabine monotherapy. The inhibition of RAS in advanced pancreatic cancer might improve clinical outcomes in cases without a history of smoking or in cases receiving gemcitabine monotherapy.	[Nakai, Yousuke; Isayama, Hiroyuki; Sasaki, Takashi; Takahara, Naminatsu; Saito, Kei; Ishigaki, Kazunaga; Hamada, Tsuyoshi; Mizuno, Suguru; Miyabayashi, Koji; Yamamoto, Keisuke; Mohri, Dai; Kogure, Hirofumi; Yamamoto, Natsuyo; Ijichi, Hideaki; Tateishi, Keisuke; Tada, Minoru; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138655, Japan	Isayama, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	isayama-tky@umin.ac.jp					Kanai M, 2009, ANN ONCOL, V20, P1397, DOI 10.1093/annonc/mdp008; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Shimizu K, 2008, J GASTROENTEROL, V43, P823, DOI 10.1007/s00535-008-2249-7; Yadav D, 2009, ARCH INTERN MED, V169, P1035, DOI 10.1001/archinternmed.2009.125; Cote GA, 2011, CLIN GASTROENTEROL H, V9, P266, DOI 10.1016/j.cgh.2010.10.015; O'Malley M, 2013, ONCOLOGY-BASEL, V85, P216, DOI 10.1159/000355107; Nakai Y, 2012, BRIT J CANCER, V106, P1934, DOI 10.1038/bjc.2012.183; Dandona M, 2011, PANCREAS, V40, P931, DOI 10.1097/MPA.0b013e318215a9b1; Mizuno S, 2014, PANCREAS, V43, P1014, DOI 10.1097/MPA.0000000000000158; Nakai Y, 2010, BRIT J CANCER, V103, P1644, DOI 10.1038/sj.bjc.6605955; Khakoo AY, 2008, CANCER RES, V68, P9112, DOI 10.1158/0008-5472.CAN-08-0851; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Bosetti C, 2012, ANN ONCOL, V23, P1880, DOI 10.1093/annonc/mdr541; Zou L, 2014, EUR J CANCER, V50, P193, DOI 10.1016/j.ejca.2013.08.014; Vincenzi B, 2009, EXPERT OPIN BIOL TH, V9, P945, DOI 10.1517/14712590903081694; Yuge K, 2012, ANN SURG ONCOL, V19, P3987, DOI 10.1245/s10434-012-2568-z; Miyamoto H, 2004, PANCREAS, V28, P38, DOI 10.1097/00006676-200401000-00006; van Geenen EJM, 2011, AM J GASTROENTEROL, V106, P1161, DOI 10.1038/ajg.2011.43; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Blackford A, 2009, CANCER RES, V69, P3681, DOI 10.1158/0008-5472.CAN-09-0015; Wilop S, 2009, J CANCER RES CLIN, V135, P1429, DOI 10.1007/s00432-009-0587-3; Tsao AS, 2006, CANCER, V106, P2428, DOI 10.1002/cncr.21884; Brand RE, 2009, CLIN GASTROENTEROL H, V7, P1007, DOI 10.1016/j.cgh.2009.06.008; Pelucchi C, 2014, PANCREAS, V43, P47, DOI 10.1097/MPA.0b013e3182a7c74b; Anderson MA, 2012, AM J GASTROENTEROL, V107, P1730, DOI 10.1038/ajg.2012.288; Ager EI, 2008, CARCINOGENESIS, V29, P1675, DOI 10.1093/carcin/bgn171; Olson SH, 2010, INT J CANCER, V127, P2412, DOI 10.1002/ijc.25240; Burris HA, 1997, J CLIN ONCOL, V15, P2403; Faehling M, 2010, ONCOLOGY-BASEL, V78, P249, DOI 10.1159/000315731; Keizman D, 2014, ONCOLOGIST, V19, P51, DOI 10.1634/theoncologist.2012-0335; Kim ST, 2012, ONCOLOGY-BASEL, V83, P354, DOI 10.1159/000337979; Kuno A, 2003, GASTROENTEROLOGY, V124, P1010, DOI 10.1053/gast.2003.50147; Masamune A, 2013, SCAND J GASTROENTERO, V48, P602, DOI 10.3109/00365521.2013.777776; Nakai Y, 2009, ONCOLOGY-BASEL, V77, P300, DOI 10.1159/000259616; Nakai Y, 2013, INVEST NEW DRUG, V31, P1294, DOI 10.1007/s10637-013-9972-5; Nakai Y, 2012, CANCER SCI, V103, P1489, DOI 10.1111/j.1349-7006.2012.02311.x; Nakai Y, 2014, CANCER CHEMOTH PHARM, V74, P911, DOI 10.1007/s00280-014-2563-0; Okusaka T, 2011, CANCER SCI, V102, P425, DOI 10.1111/j.1349-7006.2010.01810.x; Olson P, 2009, SCIENCE, V324, P1400, DOI 10.1126/science.1175940	40	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-5216	1432-1335		J CANCER RES CLIN	J. Cancer Res. Clin. Oncol.	MAY	2015	141	5					933	939		10.1007/s00432-014-1873-2		7	Oncology	Oncology	CF9CR	WOS:000352859700015		
J	Fujiwara, T; Kato, N; Sanders, MR				Fujiwara, Takeo; Kato, Noriko; Sanders, Matthew R.			Effectiveness of Group Positive Parenting Program (Triple P) in Changing Child Behavior, Parenting Style, and Parental Adjustment: An Intervention Study in Japan (vol 20, pg 804, 2011)	JOURNAL OF CHILD AND FAMILY STUDIES			English	Correction									[Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Setagaya Ku, Tokyo 1578535, Japan; [Kato, Noriko] Natl Inst Publ Hlth, Dept Hlth Promot, Wako, Saitama 3510197, Japan; [Sanders, Matthew R.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia	Fujiwara, T (reprint author), Natl Res Inst Child Hlth & Dev, Dept Social Med, Setagaya Ku, Tokyo 1578535, Japan.	tfujiwara@nch.go.jp					Fujiwara T, 2011, J CHILD FAM STUD, V20, P804, DOI 10.1007/s10826-011-9448-1	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1062-1024	1573-2843		J CHILD FAM STUD	J. Child Fam. Stud.	MAY	2015	24	5					1526	1526		10.1007/s10826-015-0163-1		1	Family Studies; Psychology, Developmental; Psychiatry	Family Studies; Psychology; Psychiatry	CF7MT	WOS:000352741300035		
J	Shinomiya, K; Tokura, K; Kimura, E; Takai, M; Harikai, N; Yoshida, K; Yanagidaira, K; Ito, Y				Shinomiya, Kazufusa; Tokura, Koji; Kimura, Emiru; Takai, Midori; Harikai, Naoki; Yoshida, Kazunori; Yanagidaira, Kazuhiro; Ito, Yoichiro			Design of a coil satellite centrifuge and its performance on counter-current chromatographic separation of 4-methylumbelliferyl sugar derivatives with polar organic-aqueous two-phase solvent systems	JOURNAL OF CHROMATOGRAPHY A			English	Article; Proceedings Paper	8th International Conference on Countercurrent Chromatography (CCC)	JUL 23-25, 2014	Uxbridge, ENGLAND			Counter-current chromatography; Instrumentation; Coil satellite centrifuge; Partition efficiency; Separation of sugar derivatives	PLANET CENTRIFUGE; ROTARY SEALS; APPARATUS; PROTEINS	A new high-speed counter-current chromatograph, named coil satellite centrifuge (CSC), was designed and fabricated in our laboratory. The CSC apparatus produces the satellite motion such that the coiled column simultaneously rotates around the sun axis (the angular velocity, omega(1)), the planet axis (omega(2)) and the satellite axis (the central axis of the column) (omega(3)). In order to achieve this triplicate rotary motion without twisting of the flow tube, the rotation of each axis was determined by the following formula: omega(1) = omega(2) + omega(3). This relation enabled to lay out the flow tube without twisting by the simultaneous rotation of three axes. The flow tube was introduced from the bottom side of the apparatus into the sun axis of the first rotary frame reaching the upper side of the planet axis and connected to the column in the satellite axis. The performance of the apparatus was examined on separation of 4-methylumbelliferyl (MU) sugar derivatives as test samples with organic-aqueous two-phase solvent systems composed of ethyl acetate/1-butanol/water (3:2:5, v/v) for lower phase mobile and (1:4:5, v/v) for upper phase mobile. With lower phase mobile, five 4-MU sugar derivatives including beta-D-cellobioside (Cel), beta-D-glucopyranoside, alpha-D-mannopyranoside, beta-D-fucopyranoside and alpha-L-fucopyranoside (alpha-L-Fuc) were separated with the combined rotation around each axis at counterclockwise (CCW) (omega(1)) - CCW (omega(2)) - CCW (omega(3)) by the flow tube distribution. With upper phase mobile, three 4-MU sugar derivatives including alpha-L-Fuc, beta-D-galactopyranoside and Cel were separated with the combined rotation around each axis at clockwise (CW) (omega(1)) - CW (omega(2)) - CW (omega(3)) by the flow tube distribution. A series of experiments on peak resolution and stationary phase retention revealed that better partition efficiencies were obtained at the flow rate of 0.5 mL/min (column 1) and 0.8 mL/min (column 2) for lower phase mobile and 0.2 mL/min (column 1) and 0.4 mL/min (column 2) for upper phase mobile when using the left-handed multilayer coil (total capacity: 57.0 mL for column 1 and 75.0 mL for column 2) under the rotation speeds of approximately omega(1) =300 rpm, omega(2) = 150 rpm and omega(3) = 150 rpm. (C) 2015 Elsevier B.V. All rights reserved.	[Shinomiya, Kazufusa; Kimura, Emiru; Takai, Midori; Harikai, Naoki] Nihon Univ, Sch Pharm, Funabashi, Chiba 2748555, Japan; [Tokura, Koji; Yoshida, Kazunori; Yanagidaira, Kazuhiro] Nihon Univ, Coll Sci & Technol, Funabashi, Chiba 2748501, Japan; [Ito, Yoichiro] NHLBI, Lab Bioseparat Technol, Biochem & Biophys Ctr, NIH, Bethesda, MD 20892 USA	Shinomiya, K (reprint author), Nihon Univ, Sch Pharm, 7-7-1 Narashinodai, Funabashi, Chiba 2748555, Japan.	shinomiya.kazufusa@nihon-u.ac.jp					Ito Y, 2007, J CHROMATOGR A, V1151, P108, DOI 10.1016/j.chroma.2006.11.078; Shinomiya K, 2006, J CHROMATOGR A, V1104, P245, DOI 10.1016/j.chroma.2005.12.046; Ignatova S, 2010, J CHROMATOGR A, V1217, P34, DOI 10.1016/j.chroma.2009.10.055; Ito Y, 2003, J CHROMATOGR A, V1017, P71, DOI 10.1016/j.chroma.2003.08.011; Ito Y, 2010, CHEM ENG PROCESS, V49, P782, DOI 10.1016/j.cep.2009.08.003; Conway WD, 1990, COUNTERCURRENT CHROM; Guzlek H, 2009, J CHROMATOGR A, V1216, P4181, DOI 10.1016/j.chroma.2009.02.091; ITO Y, 1983, SEPAR SCI TECHNOL, V18, P33; ITO Y, 1988, J CHROMATOGR, V457, P393, DOI 10.1016/S0021-9673(01)82090-2; Ito Y., 1996, HIGH SPEED COUNTERCU; ITO Y, 1987, SEPAR SCI TECHNOL, V22, P1971, DOI 10.1080/01496398708057623; Ito Y, 2003, J LIQ CHROMATOGR R T, V26, P1355, DOI 10.1081/JLC-120021255; ITO Y, 1987, SEPAR SCI TECHNOL, V22, P1989, DOI 10.1080/01496398708057624; Mandava N. B., 1988, COUNTERCURRENT CHROM; Menet J.-M., 1999, COUNTERCURRENT CHROM; Shinomiya K, 1996, J LIQ CHROMATOGR R T, V19, P415, DOI 10.1080/10826079608001225; Shinomiya K, 2013, J CHROMATOGR A, V1322, P74, DOI 10.1016/j.chroma.2013.10.096	17	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0021-9673	1873-3778		J CHROMATOGR A	J. Chromatogr. A	MAY 1	2015	1392						48	55		10.1016/j.chroma.2015.03.011		8	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CG2CG	WOS:000353081900006		
J	Noguchi, H; Charoenraks, T; Takafuji, M; Ihara, H				Noguchi, Hiroki; Charoenraks, Tiraporn; Takafuji, Makoto; Ihara, Hirotaka			Effects of substitution groups of glutamide-derived molecular gels on molecular shape recognition	JOURNAL OF CHROMATOGRAPHY A			English	Article; Proceedings Paper	30th International Symposium on Chromatography (ISC)	SEP 14-18, 2014	Salzburg, AUSTRIA			Molecular gel; Polycyclic aromatic hydrocarbons; pi-pi interaction; Stationary phases, Liquid chromatography	POLYCYCLIC AROMATIC-HYDROCARBONS; PERFORMANCE LIQUID-CHROMATOGRAPHY; IMMOBILIZED ARTIFICIAL MEMBRANES; STATIONARY-PHASE; RP-HPLC; SILICA; RETENTION; LENGTH	We have reported that self-assembling glutamide lipid-grafted porous silica particles show high selectivity towards polycyclic aromatic hydrocarbons (PAHs) and bio-molecules. This enhancement of molecular recognition is brought about by the formation of a highly ordered structure in the glutamide lipid through intermolecular hydrogen bonding. To utilise, for selective separations, the highly oriented structure of glutamide lipids on the silica surface, in this study, we synthesised four glutamide lipids with different substitution groups and studied the separation behaviours of the glutamide lipid-grafted porous silica particles as reversed phase high-performance liquid chromatography (RP-HPLC) stationary phases. According to the HPLC studies, the functional group substitutions and the spacer group connecting the glutamide moiety and silica surface had a noticeable effect on the retention behaviours. Particularly, glutamide lipids with a long spacer group (C10) showed a higher selectivity towards positional (o-/m-/p-terphenyl) and geometrical (cis-/trans-stilbene) isomers. Differential scanning calorimetric and Fourier transform infrared spectroscopic studies suggested that the long spacer group induced the assembled structure of the glutamide lipid on the silica surface. Interestingly, the glutamide lipids with dodecyl groups and benzyl groups showed reverse elution orders towards the length to breadth ratio of PAHs. (C) 2015 Elsevier B.V. All rights reserved.	[Noguchi, Hiroki; Charoenraks, Tiraporn; Takafuji, Makoto] Kumamoto Univ, Dept Appl Chem & Biochem, Kumamoto, Japan; [Ihara, Hirotaka] Kumamoto Univ, Dept Nanosci & Technol, Kumamoto, Japan; [Ihara, Hirotaka] Kumamoto Inst Photoelectro Organ PHOENICS, Kumamoto, Japan	Takafuji, M (reprint author), Kumamoto Univ, Dept Appl Chem & Biochem, Kumamoto, Japan.	takafuji@kumamoto-u.ac.jp; ihara@kumamoto-u.ac.jp					Rahman MM, 2005, ANAL CHEM, V77, P6671, DOI 10.1021/ac050851v; SHENG Q, 1995, J PHYS CHEM-US, V99, P11018, DOI 10.1021/j100027a050; Ong SW, 1996, J CHROMATOGR A, V728, P113, DOI 10.1016/0021-9673(95)00837-3; Xue PC, 2010, LANGMUIR, V26, P6669, DOI 10.1021/la903990m; Yamamoto C, 2002, J AM CHEM SOC, V124, P12583, DOI 10.1021/ja020828g; Kahsay G, 2014, J PHARMACEUT BIOMED, V87, P142, DOI 10.1016/j.jpba.2013.04.015; BERENDSEN GE, 1980, J LIQ CHROMATOGR, V3, P1437, DOI 10.1080/01483918008062788; Chen SH, 1998, ANAL CHEM, V70, P2523, DOI 10.1021/ac971385f; Delaurent C, 1997, CHROMATOGRAPHIA, V45, P355, DOI 10.1007/BF02505584; Gautam UG, 2009, J CHROMATOGR A, V1216, P3571, DOI 10.1016/j.chroma.2008.08.084; Hachisako H, 1999, J CHEM SOC PERK T 2, P2569, DOI 10.1039/a903956b; IHARA H, 1993, ANAL SCI, V9, P711, DOI 10.2116/analsci.9.711; Ihara H, 2002, LANGMUIR, V18, P7120, DOI 10.1021/la025535f; KALISZAN R, 1978, J CHROMATOGR SCI, V16, P246; Morioka K, 2005, POLYM J, V37, P299, DOI 10.1295/polymj.37.299; Ohyama K, 2008, J CHROMATOGR A, V1208, P242, DOI 10.1016/j.chroma.2008.08.121; ONG SW, 1994, J PHYS CHEM-US, V98, P10189, DOI 10.1021/j100091a039; SAKAKI S, 1993, J CHEM SOC FARADAY T, V89, P659, DOI 10.1039/ft9938900659; Su XY, 2007, J CHROMATOGR A, V1154, P132, DOI 10.1016/j.chroma.2007.03.050; Takafuji M, 2005, J CHROMATOGR A, V1074, P223, DOI 10.1016/j.chroma.2005.03.090; Takafuji M, 2012, CHEM LETT, V41, P181, DOI 10.1246/cl.2012.181; Takafuji M, 2009, LANGMUIR, V25, P8428, DOI 10.1021/la804321u; Wise S.A., 1981, J CHROMATOGR SCI, V8, P248; Yang MH, 1996, J CHROMATOGR A, V722, P87, DOI 10.1016/0021-9673(95)00570-6	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0021-9673	1873-3778		J CHROMATOGR A	J. Chromatogr. A	MAY 1	2015	1392						56	62		10.1016/j.chroma.2015.03.013		7	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CG2CG	WOS:000353081900007		
J	Masunaga, H; Higo, Y; Ishii, M; Maruyama, N; Yamazaki, S				Masunaga, Hiroto; Higo, Yuji; Ishii, Mizuo; Maruyama, Noboru; Yamazaki, Shigeo			Selective removal of carbon dioxide contained in the effluent from ion chromatography suppressors using a new non-vacuum device	JOURNAL OF CHROMATOGRAPHY A			English	Article						Ion chromatography for anion analysis; Selective CO2 removal; Gas permeable tubing; CO2 adsorbent; Suppressor; Non-vacuum	ANION CHROMATOGRAPHY; CONDUCTIVITY; SEPARATION; GRADIENT	In this paper, a new CO2 gas removal device optimized to selectively remove CO2 gas contained in the effluent from suppressors used in ion chromatography (IC) under non-vacuum conditions is described. This device consists of a closed vessel equipped with gas permeable tubing (GPT) and a CO2 adsorbent. During operation, the CO2 adsorbent adsorbs CO2 gas in the vessel, creating CO2 partial pressure difference between the inside of the GPT and the vessel. The CO2 gas contained in the effluent being pumped into the GPT is selectively removed from the effluent based on the diffusion of the CO2 associated with the CO2 partial pressure difference. The purpose of this study is to optimize the IC operating conditions with the aim of selectively removing HCO3- (CO32-) contained in the effluent and reducing the electrical conductivity of the effluent under non-vacuum conditions. The electrical conductivity of the effluent and the signal intensity of the water dip is decreased by approximately 25 mu S/cm (from 30 to 5 mu S/cm) and by approximately twentieth, respectively, using the optimized CO2 remover. In addition, the anion detection limit achieved in IC instruments with a CO2 remover is on the order of a few ppb. (C) 2015 Elsevier B.V. All rights reserved.	[Masunaga, Hiroto; Higo, Yuji; Ishii, Mizuo; Maruyama, Noboru] Nichiri Mfg Co Ltd, Yachiyo, Chiba 2760036, Japan; [Yamazaki, Shigeo] Okayama Univ Sci, Dept Appl Sci, Okayama 7000005, Japan	Masunaga, H (reprint author), Nichiri Mfg Co Ltd, 324-5 Takatu, Yachiyo, Chiba 2760036, Japan.	h.masunaga@nichiri-mfg.co.jp					Anderson Jr J.M., 2007, Japan Patent, Application, Patent No. 510912; REIJN JM, 1981, ANAL CHIM ACTA, V123, P229, DOI 10.1016/S0003-2670(01)83175-5; SMALL H, 1975, ANAL CHEM, V47, P1801, DOI 10.1021/ac60361a017; Bose R, 2002, J CHROMATOGR A, V956, P71, DOI 10.1016/S0021-9673(01)01578-3; Dasgupta P.K., 2011, Japan Patent, Patent No. 4890456; Douglas DR, 2002, J CHROMATOGR A, V956, P47, DOI 10.1016/S0021-9673(02)00038-9; Fritz J.S., 1999, ION CHROMATOGRAPHY; Masunaga H, 2014, ANAL SCI, V30, P477; Masunaga H, 2012, ANAL SCI, V28, P1071; Petropavlovskikh V.A., 2006, US, Patent, Application, Patent No. 0024839; Riviello J.M., 2013, US Patent, Application, Patent No. 0312500; Saari-Nordhaus R, 2002, J CHROMATOGR A, V956, P15, DOI 10.1016/S0021-9673(01)01515-1; SeQuant, 2007, PRACT GUID ION CHROM; SHINTANI H, 1987, ANAL CHEM, V59, P802, DOI 10.1021/ac00133a003; SIEMER DD, 1984, ANAL CHEM, V56, P1033, DOI 10.1021/ac00270a037; Squire E.N., 1991, US Patent, Patent No. 5006382; SUNDEN T, 1984, ANAL CHEM, V56, P1085, DOI 10.1021/ac00271a009; Westlake III T.N., 1995, US Patent, Patent No. 5442968	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0021-9673	1873-3778		J CHROMATOGR A	J. Chromatogr. A	MAY 1	2015	1392						69	73		10.1016/j.chroma.2015.03.021		5	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CG2CG	WOS:000353081900009		
J	Wu, XH; Tang, SH; Jin, Y; Wang, SS; Wang, XJ; Hattori, M; Zhang, HL; Wang, ZG				Wu, Xiuhong; Tang, Shuhan; Jin, Yan; Wang, Shanshan; Wang, Xijun; Hattori, Masao; Zhang, Hailong; Wang, Zhigang			Determination of the metabolic profile of gentianine after oral administration to rats by high performance liquid chromatography/electrospray ionization-trap mass spectrometry	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						Gentianine; Metabolite; LC-MS	INFLAMMATORY CYTOKINES; SWERTIA-JAPONICA; CRUDE DRUGS; CONSTITUENTS; ALKALOIDS; PATHWAY; LPS	We investigated the metabolic fate of gentianine after oral administration to Wistar rats for the first time. Liquid chromatography/ion trap mass spectrometry detected four metabolites secogentianoxide, gentiandiol, gentianepoxide and gentianoxide in rat plasma together with the original compound gentianine. The structures of the metabolites were identified by comparing the retention times, as well as MS (mass) and MS/MS (tandem mass) spectra with those of authentic compounds, which were synthesized from gentianine or isolated from the urine. Three of the metabolites, secogentianoxide, gentianepoxide and gentianoxide, are novel compounds. The major in vivo metabolic processes associated with gentianine include N-oxide, epoxidation, dihydroxylation of double bond and hydrolysis of lactone. Gentianine together with the metabolites in plasma were quantified using gentianone as the internal standard. The mean C-max of G0, G1, G2 and G3 are 425.76, 287.56, 188.45 and 85.05 ng/mL, respectively. The mean T-max of G0, G1, G2 and G3 are 1.16, 3.87, 6.23 and 4.28 h, respectively. The mean T-1/2 of G0, G1, G2 and G3 are 5.23, 12.34, 7.78 and 5.64h, respectively. A comprehensive metabolic pathway was proposed. The new metabolites may shed light on clinical efficacy of gentianine. (C) 2015 Elsevier B.V. All rights reserved.	[Wu, Xiuhong; Wang, Shanshan; Wang, Xijun; Wang, Zhigang] Heilongjiang Univ Chinese Med, Dept Pharmaceut Anal, Natl TCM Key Lab Serum Pharmacochem, Harbin 150040, Peoples R China; [Tang, Shuhan; Hattori, Masao; Wang, Zhigang] Toyama Univ, Inst Nat Med, Sugitani, Toyama 9300194, Japan; [Tang, Shuhan; Jin, Yan] Harbin Childrens Hosp, Harbin, Peoples R China; [Zhang, Hailong] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Xian 710061, Shaanxi, Peoples R China	Wang, ZG (reprint author), Heilongjiang Univ Chinese Med, Dept Pharmaceut Anal, Natl TCM Key Lab Serum Pharmacochem, Heping Rd 24, Harbin 150040, Peoples R China.	wangzhigang0513@vip.163.com			National Natural Science Foundation of China [81102896, 81373931]; Innovative Talent Supporting Plan of Heilongjiang University of Chinese Medicine [2010RCD06, 2010RCD07]; Fundamental Research Funds for the Central Universities, China	This study was financially supported by National Natural Science Foundation of China (Grant Nos. 81102896, 81373931) and by Innovative Talent Supporting Plan of Heilongjiang University of Chinese Medicine (Grant Nos. 2010RCD06, 2010RCD07), and by the Fundamental Research Funds for the Central Universities, China.	Kang K, 2008, BIOCHEM PHARMACOL, V75, P1054, DOI 10.1016/j.bcp.2007.10.028; YAMAHARA J, 1991, J ETHNOPHARMACOL, V33, P31, DOI 10.1016/0378-8741(91)90157-9; Frederich M, 2002, J NAT PROD, V65, P1381, DOI 10.1021/np020070e; NOBREGA EM, 1988, J NAT PROD, V51, P962, DOI 10.1021/np50059a025; BISHAY DW, 1978, PLANTA MED, V33, P422; EL-SEDAWY A, 1989, Planta Medica, V55, P147, DOI 10.1055/s-2006-961909; HAYASHI T, 1976, YAKUGAKU ZASSHI, V96, P362; Khan AU, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-121; KUBOTA T, 1962, B CHEM SOC JPN, V35, P1046; Kwak WJ, 2005, BIOL PHARM BULL, V28, P750, DOI 10.1248/bpb.28.750; Li JC, 2005, BIOL PHARM BULL, V28, P534, DOI 10.1248/bpb.28.545; Mansoor Arsala, 1998, Pharmacy and Pharmacology Communications, V4, P229; Tanaka S, 2001, PLANTA MED, V67, P108, DOI 10.1055/s-2001-11514; Vaidya H., 2012, PHYTOTHER RES, V27, P624; Wang AY, 2010, WORLD J GASTROENTERO, V16, P384, DOI 10.3748/wjg.v16.i3.384; Wang ZG, 2012, J ASIAN NAT PROD RES, V14, P176, DOI 10.1080/10286020.2011.631132; YAMAHARA J, 1978, YAKUGAKU ZASSHI, V98, P1446; Yang HL, 2005, J ETHNOPHARMACOL, V98, P31, DOI 10.1016/j.jep.2004.12.015	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	MAY 1	2015	989						98	103		10.1016/j.jchromb.2015.01.007		6	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CG2CB	WOS:000353081400013		
J	Suzuki, Y; Uchiyama, K; Kato, M; Matsuo, K; Nakagawa, T; Kishikawa, H; Kimura, N; Kasanuki, J; Ino, S				Suzuki, Yasuo; Uchiyama, Kan; Kato, Masahisa; Matsuo, Keigo; Nakagawa, Tomoo; Kishikawa, Hiroshi; Kimura, Norio; Kasanuki, Junji; Ino, Soetsu			Potential Utility of a New Ulcerative Colitis Segmental Endoscopic Index Combining Disease Severity and the Extent of Inflammation	JOURNAL OF CLINICAL GASTROENTEROLOGY			English	Article						mucosal healing; segmental endoscopic evaluation; ulcerative colitis; mesalazine	MEDICAL THERAPY; BOWEL-DISEASE; DOUBLE-BLIND; ENEMA; PATCHINESS; MESALAMINE; MESALAZINE; PROCTITIS; ADULTS	Goal: To investigate the potential utility of a new scoring system, the Ulcerative Colitis Segmental Endoscopic Index (UCSEI), which combines measures of disease severity and extent of inflammation. Background: Intestinal mucosal healing (MH) is a new therapeutic goal for ulcerative colitis (UC). Discontinuous lesions are common in UC and endoscopic observation of the entire colon is important. Study: Patients with active mild-to-moderate UC received daily treatment with oral mesalazine (4 g/ d) and mesalazine enemas (1 g/ d) for 8 weeks. Endoscopic evaluations, using the UCSEI and Mayo Endoscopic Score (MES), were performed in 5 colonic segments at baseline and week 8. The UCSEI criteria included erythema, vascular pattern, friability, and erosion/ulcer. The sum of 5 subscores, determined for each segment, was calculated as the UCSEI. Disease activity was also assessed using the UC Disease Activity Index (UCDAI). MH was defined as MES= 0 to 1. Results: Of 58 patients, 51 completed the scheduled endoscopic evaluations. At week 8, the UCDAI score had significantly decreased from 6.63 (baseline) to 2.73 (P < 0.001). The remission and MH rates were 35.3% and 55.3%, respectively. Segmental endoscopic evaluation, using UCSEI, showed that baseline inflammation tended to be more severe in the distal colon. The baseline UCSEI increased with the extent of disease, which was not seen in MES. Improvements in UCSEI were observed, even in the patients without decreases in the MES. Conclusions: UCSEI, reflecting disease severity and extent of inflammation, provides useful information for UC management that is not available with MES.	[Suzuki, Yasuo] Toho Univ, Sakura Med Ctr, Sakura, Chiba 2858741, Japan; [Uchiyama, Kan] Jikei Univ, Kashiwa Hosp, Kashiwa, Chiba, Japan; [Kato, Masahisa] Tsudanuma Cent Gen Hosp, Narashino, Chiba, Japan; [Matsuo, Keigo] Tokatsu Tsujinaka Hosp, Abiko, Chiba, Japan; [Nakagawa, Tomoo] Chiba Univ Hosp, Chiba, Japan; [Kishikawa, Hiroshi] Ichikawa Gen Hosp, Tokyo Dent Coll, Ichikawa, Japan; [Kimura, Norio] Secomed Hosp, Tokyo, Japan; [Kasanuki, Junji] Funabashi Cent Hosp, Social Insurance, Funabashi, Chiba, Japan; [Ino, Soetsu] Narita Red Cross Hosp, Narita, Japan	Suzuki, Y (reprint author), Toho Univ, Sakura Med Ctr, 564-1 Shimoshizu, Sakura, Chiba 2858741, Japan.	yasuo-suzuki@sakura.med.toho-u.ac.jp					Travis SPL, 2012, GUT, V61, P535, DOI 10.1136/gutjnl-2011-300486; Rutter MD, 2004, GUT, V53, P1813, DOI 10.1136/gut.2003.038505; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Hanauer SB, 1998, GASTROENTEROLOGY, V115, P525, DOI 10.1016/S0016-5085(98)70131-3; DHaens G, 1997, AM J GASTROENTEROL, V92, P1275; Kornbluth A, 1997, AM J GASTROENTEROL, V92, P204; Samuel S, 2013, CLIN GASTROENTEROL H, V11, P49, DOI 10.1016/j.cgh.2012.08.003; Safdi M, 1997, AM J GASTROENTEROL, V92, P1867; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Feagan BG, 2005, NEW ENGL J MED, V352, P2499, DOI 10.1056/NEJMoa042982; Loftus EV, 2005, GUT, V54, P91, DOI 10.1136/gut.2004.046615; Moum B, 1999, AM J GASTROENTEROL, V94, P1564; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; Peyrin-Biroulet L, 2011, J CROHNS COLITIS, V5, P477, DOI 10.1016/j.crohns.2011.06.009; HANAUER S, 1993, AM J GASTROENTEROL, V88, P1188; SUTHERLAND LR, 1987, GASTROENTEROLOGY, V92, P1894; BERNSTEIN CN, 1995, GASTROINTEST ENDOSC, V42, P232, DOI 10.1016/S0016-5107(95)70097-8; de Chambrun GP, 2009, NAT REV GASTRO HEPAT, V7, P15; Joo M, 2010, AM J SURG PATHOL, V34, P689, DOI 10.1097/PAS.0b013e3181db84cd; Kim B, 1999, AM J GASTROENTEROL, V94, P3258; Marteau P, 2005, GUT, V54, P960, DOI 10.1136/gut.2004.060103; Meucci G, 2012, INFLAMM BOWEL DIS, V18, P1006, DOI 10.1002/ibd.21838; Mutinga ML, 2001, GASTROENTEROLOGY, V120, pA450; Regueiro M, 2011, INFLAMM BOWEL DIS, V17, P1008, DOI 10.1002/ibd.21445; Sandborn WJ, 2011, ALIMENT PHARM THER, V34, P747, DOI 10.1111/j.1365-2036.2011.04800.x; Shah Siddharth N, 2011, Trop Gastroenterol, V32, P107; Walsh AJ, 2009, GASTROENTEROLOGY, V136; Yang SK, 1999, GASTROINTEST ENDOSC, V49, P743, DOI 10.1016/S0016-5107(99)70293-2	28	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0192-0790	1539-2031		J CLIN GASTROENTEROL	J. Clin. Gastroenterol.	MAY-JUN	2015	49	5					401	406				6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF8FM	WOS:000352791500008		
J	Maeda, H; Kurokawa, T				Maeda, Hideki; Kurokawa, Tatsuo			Regulatory Review Time for Approval of Oncology Drugs in Japan Between 2001 and 2014. Considerations of Changes, Factors That Affect Review Time, and Difference With the United States	JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						drug lag; Japan; oncology; PMDA; regulatory review	CLINICAL DEVELOPMENT; ANTICANCER DRUGS; SYSTEM; TRIALS; AGENCY	In this study, we comprehensively and historically studied the review time of oncology drugs approved by the regulatory authorities in Japan with publicly available information. A total of 120 applications of oncology drugs were approved in Japan between April 2001 and July 2014. The review time peaked with 732.0 days (24.4 months) in 2005, and showed a tendency to decline gradually each year thereafter. After 2012, a significant reduction of the review time was seen in comparison to the median of 13-year median time. In addition, we compared the review time with that in the United States. The median review time lag with the United States was significantly peaked in 2005. After 2005, the review time lag with the FDA has decreased, but lag did not significantly reduce by 2014. We also examined factors influencing the review time in Japan with multiple regression analysis. It was found that the factors related to a use of overseas data and expedited program for accelerating the reviews influenced the direction of shortening the review time. We consider that regulatory authorities in Japan need to keep making efforts to reduce the review time further and eliminate the review time lag with the United States.	[Maeda, Hideki; Kurokawa, Tatsuo] Keio Univ, Grad Sch Pharmaceut Sci, Div Drug Dev & Regulatory Sci, Minato Ku, Tokyo 1058512, Japan; [Maeda, Hideki] Astellas Pharma Inc, Clin Dev Dept, Oncol, Global Dev,Chuo Ku, Tokyo, Japan	Maeda, H (reprint author), Keio Univ, Grad Sch Pharmaceut Sci, Div Drug Dev & Regulatory Sci, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	hideki.maeda@astellas.com					Shimazawa R, 2012, CLIN THER, V34, P2104, DOI 10.1016/j.clinthera.2012.09.004; Asano K, 2013, CLIN PHARMACOL THER, V94, P195, DOI 10.1038/clpt.2013.106; Ishibashi T, 2010, CLIN PHARMACOL THER, V88, P487, DOI 10.1038/clpt.2010.108; Tsuji K, 2010, J CLIN PHARM THER, V35, P289, DOI 10.1111/j.1365-2710.2009.01099.x; Ichimaru K, 2010, CLIN PHARMACOL THER, V88, P454, DOI 10.1038/clpt.2010.190; Uyama Y, 2005, CLIN PHARMACOL THER, V78, P102, DOI 10.1016/j.clpt.2005.04.001; Hartmann M, 2013, CRIT REV ONCOL HEMAT, V87, P112, DOI 10.1016/j.critrevonc.2013.01.004; Ito Y, 2013, ANN ONCOL, V24, P1297, DOI 10.1093/annonc/mdt020; Yonemori K, 2011, INVEST NEW DRUG, V29, P706, DOI 10.1007/s10637-011-9638-0; Molzon JA, 2011, CLIN PHARMACOL THER, V89, P503, DOI 10.1038/clpt.2011.10; Maeda H, 2014, INVEST NEW DRUG, V32, P661, DOI 10.1007/s10637-014-0080-y; Fujiwara Y, 2002, CRIT REV ONCOL HEMAT, V42, P145, DOI 10.1016/S1040-8428(02)00010-0; Gunjan S., 2010, JNCI-J NATL CANCER I, V102, P148; Ishibashi T, 2012, J CLIN PHARM THER, V37, P657, DOI 10.1111/j.1365-2710.2012.01363.x; Maeda H, 2015, ANN ONCOL, V26, P211, DOI 10.1093/annonc/mdu500; Maeda H, 2013, JPN J CLIN ONCOL, V43, P1273, DOI 10.1093/jjco/hyt146; Ministry of Health, 2005, REV GUID CLIN EV MET; Ministry of Health Labour and Welfare, 2012, GUID EST SAF 1 IN HU; Ministry of Health Labour and Welfare, BAS PRINC GLOB CLIN; Morimoto Kazushige, 2011, Yakushigaku Zasshi, V46, P38; Quan H, 2010, PHARM STAT, V9, P110; Sugita T, 2013, GENET BIOSIMILARS IN, V2, P99; Tominaga T, 2011, CLIN PHARMACOL THER, V90, P29, DOI 10.1038/clpt.2011.89; Tsuji K, 2008, NATURE, V32, P851; Vora K, 2014, J PHARM SCI BIOSCI R, V4, P189	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0091-2700	1552-4604		J CLIN PHARMACOL	J. Clin. Pharmacol.	MAY	2015	55	5					481	489		10.1002/jcph.458		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CF5VX	WOS:000352626500001		
J	Wafa, MA; Fukuzawa, K				Wafa, Mahmoud A.; Fukuzawa, K.			Simultaneous effect of alkali activator and water/slag cement ratios on composites properties by full replacement of Portland cement	JOURNAL OF COMPOSITE MATERIALS			English	Article						Municipal slag cement; alkali activator; compressive strength; drying shrinkage; slag composites microstructure	COMPRESSIVE STRENGTH; SLAG MORTARS; MUNICIPAL WASTE; SODIUM-SILICATE; CURING REGIMES; FLY-ASH; CONCRETE; TEMPERATURE; MIXTURES	This paper presents the simultaneous effect of alkali activator and water/slag cement ratios on composites properties by full replacement of Portland cement at different ages under steam curing condition. Twelve mortar composites divided into four different groups were prepared using municipal slag cement and alkali activator of sodium meta-silicate by varying the ratios of alkali activator/slag cement and water/slag cement. The results revealed that the addition of municipal slag cement by full replacement of Portland cement was largely worthwhile for slag mortar composites under steam curing condition. The preparation of the mortars by taking various ratios of alkali activator/slag cement and water/slag cement contributed significantly in improving the compressive strength with an acceptable drying shrinkage to slag composites. Scanning electron microscopic technique was used to analyze the microstructure of slag composites at different ages. The ACI 209 and EC 2 design equations were used to predict the compressive strength.	[Wafa, Mahmoud A.] King Abdulaziz Univ, Dept Civil Engn, Fac Engn Rabigh, Jeddah, Saudi Arabia; [Wafa, Mahmoud A.] Aswan Univ, Dept Civil Engn, Fac Engn, Aswan, Egypt; [Fukuzawa, K.] Ibaraki Univ, Dept Urban & Civil Engn, Hitachi, Ibaraki, Japan	Wafa, MA (reprint author), King Abdulaziz Univ, Dept Civil Engn, Fac Engn Rabigh, Jeddah, Saudi Arabia.	masayed@kau.edu.sa	Mahmoud A., WAFA/I-1627-2012		Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [829-012-D1433]; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (829-012-D1433). The author, therefore, acknowledge with thanks DSR technical and financial support.	Al-Jabri KS, 2011, CONSTR BUILD MATER, V25, P933, DOI 10.1016/j.conbuildmat.2010.06.090; Lin CF, 2006, WASTE MANAGE, V26, P970, DOI 10.1016/j.wasman.2005.09.014; Bakharev T, 1999, CEMENT CONCRETE RES, V29, P113, DOI 10.1016/S0008-8846(98)00170-7; Sajedi F, 2011, CONSTR BUILD MATER, V25, P2036, DOI 10.1016/j.conbuildmat.2010.11.043; Chang JJ, 2003, CEMENT CONCRETE RES, V33, P1005, DOI 10.1016/S0008-8846(02)01096-7; Rehan R, 2005, ENVIRON SCI POLICY, V8, P105, DOI 10.1016/j.envsci.2004.12.006; Tossavainen M, 2007, WASTE MANAGE, V27, P1335, DOI 10.1016/j.wasman.2006.08.002; Hale WM, 2008, CONSTR BUILD MATER, V22, P1990, DOI 10.1016/j.conbuildmat.2007.07.004; Wafa MA, 2010, J REINF PLAST COMP, V29, P3530, DOI 10.1177/0731684410377814; Sajedi F, 2012, CONSTR BUILD MATER, V31, P188, DOI 10.1016/j.conbuildmat.2011.12.056; [Anonymous], 1994, 209R92 ACI; Yang KH, 2008, CONSTR BUILD MATER, V22, P1981, DOI 10.1016/j.conbuildmat.2007.07.003; Sajedi F, 2011, CONSTR BUILD MATER, V25, P30, DOI 10.1016/j.conbuildmat.2010.06.060; Antonio AM, 2008, CEMENT CONCRETE RES, V38, P565; Chee BC, 2012, CONSTR BUILD MATER, V30, P320; Chunlin L, 2011, C ADV ENG PROC ENG, V24, P412; Cinquepalmi MA, 2008, J HAZARD MATER, V151, P585, DOI 10.1016/j.jhazmat.2007.06.026; Fukuzawa K, 2007, PROC MONOGR ENG WATE, P333; Nazari Ali, 2011, J COMPOS MATER, V46, P1079; Pal SC, 2003, CEMENT CONCRETE RES, V33, P1481, DOI 10.1016/S0008-8846(03)00062-0; Sajedi F, 2012, CONSTR BUILD MATER, V36, P549, DOI 10.1016/j.conbuildmat.2012.06.036; Sajedi F, 2010, CONSTR BUILD MATER, V24, P1944, DOI 10.1016/j.conbuildmat.2010.04.006; Serdar A, 2013, COMPOS B, V45, P63; The European Standard, 2004, 1992112004 EN BRIT S; Tomaru K, 2009, P 9 C CONCR BLOCK PA, P1; Tzen-Chin Lee, 2008, Construction and Building Materials, V22, DOI 10.1016/j.conbuildmat.2007.07.030; Tzen-Chin Lee, 2009, Cement and Concrete Research, V39, DOI 10.1016/j.cemconres.2009.02.005; Wafa MA, 2010, J REINF PLAST COMP, V29, P590, DOI 10.1177/0731684408100263; Wafa MA, 2012, J REINF PLAST COMP, V31, P41, DOI 10.1177/0731684411430870; Watcharapong W, 2012, MATER DESIGN, V36, P655; Jun Zhang, 2009, Journal of Composite Materials, V43, DOI 10.1177/0021998309345303; Zivica V, 2007, CONSTR BUILD MATER, V21, P1463, DOI 10.1016/j.conbuildmat.2006.07.002	32	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0021-9983	1530-793X		J COMPOS MATER	J. Compos Mater.	MAY	2015	49	10					1151	1160		10.1177/0021998314531033		10	Materials Science, Composites	Materials Science	CG1HP	WOS:000353024000001		
J	Fujiki, H; Hsiao, C				Fujiki, Hiroshi; Hsiao, Cheng			Disentangling the effects of multiple treatments-Measuring the net economic impact of the 1995 great Hanshin-Awaji earthquake	JOURNAL OF ECONOMETRICS			English	Article						Multiple treatment effects; Panel data; Great Hanshin-Awaji earthquake, natural disaster, measurement without theory	NATURAL DISASTERS; GROWTH; MODEL	We propose a panel data approach to disentangle the impact of "one treatment" from the "other treatment" when the observed outcomes are subject to both treatments. We use the Great Hanshin-Awaji earthquake that took place on January 17, 1995 to illustrate our methodology. We find that there were no persistent earthquake effects. The observed persistent effects are due to structural change in Hyogo prefecture. (C) 2014 Elsevier B.V. All rights reserved.	[Fujiki, Hiroshi] Chuo Univ, Fac Commerce, Tokyo 112, Japan; [Hsiao, Cheng] Univ So Calif, Dept Econ, Los Angeles, CA 90089 USA; [Hsiao, Cheng] Xiamen Univ, WISE, Xiamen, Peoples R China; [Hsiao, Cheng] Natl Tsinghua Univ, Hsinchu, Taiwan	Hsiao, C (reprint author), Univ So Calif, Dept Econ, Los Angeles, CA 90089 USA.	fujiki@tamacc.chuo-u.ac.jp; chsiao@usc.edu			Institute of Monetary Studies; China NSF [71131008]; Bank of Japan	We gratefully acknowledge the research support by the Institute of Monetary Studies, Bank of Japan and China NSF grant # 71131008. We would like to thank Mitsuru Katagiri and Hiroyuki Ooi for assistance in data preparation and preliminary analysis and Qiankun Zhou for computational assistance. We would also like to thank the co-editor, two referees, Toshihiko Hayashi and the participants of the workshops at the Asia-Pacific Institute of Research, Bank of Japan and Tokyo University for helpful comments.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Hsiao C, 2012, J APPL ECONOMET, V27, P705, DOI 10.1002/jae.1230; [Anonymous], 2011, ANN REP KOB PORT; Cavallo E, 2013, REV ECON STAT, V95, P1549, DOI 10.1162/REST_a_00413; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; Horwich G, 2000, ECON DEV CULT CHANGE, V48, P521, DOI 10.1086/452609; Abadie A, 2003, AM ECON REV, V93, P113, DOI 10.1257/000282803321455188; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Skidmore M, 2002, ECON INQ, V40, P664, DOI 10.1093/ei/40.4.664; Heckman JJ, 1998, REV ECON STUD, V65, P261, DOI 10.1111/1467-937X.00044; Ashiya Tsunenori, 2001, KOKUMIN KEIZAI ZASSH, V183, P79; Bai Chong En, 2013, J ECONOMETR IN PRESS; Bai J, 2008, J ECONOMETRICS, V146, P304, DOI 10.1016/j.jeconom.2008.08.010; Becker Gary S., 2005, WALL STREET J E EDIT; DuPont William, 2012, DEP EC WORKING PAPER, V12-4; Fujiki Hiroshi, 2013, 2013E3 BANK JAP I MO; Hallegatte s, 2010, 5507 WORLD BANK; Hayashi Toshihiko, 2011, PHP SHINSYO, P750; HECKMAN JJ, 1985, J ECONOMETRICS, V30, P239, DOI 10.1016/0304-4076(85)90139-3; Okuyama Yasuhide, 2011, LONG RUN EFFECTS DIS; Surowiecki J., 2011, NEW YORKER; Takahashi Akihiko, 1996, DOBOKUKOUGAKU KENKYU, P19; Toyoda Toshihisa, 1997, KOKUMIN KEIZAI ZASSH, V176, P1	26	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0304-4076	1872-6895		J ECONOMETRICS	J. Econom.	MAY	2015	186	1					66	73		10.1016/j.jeconom.2014.10.010		8	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	CF6IY	WOS:000352661600005		
J	Otsu, T; Xu, KL; Matsushita, Y				Otsu, Taisuke; Xu, Ke-Li; Matsushita, Yukitoshi			Empirical likelihood for regression discontinuity design	JOURNAL OF ECONOMETRICS			English	Article						Empirical likelihood; Nonparametric methods; Regression discontinuity design; Treatment effect; Bartlett correction	CONFIDENCE-INTERVALS; IDENTIFICATION; STATISTICS; SIZE; GMM	This paper proposes empirical likelihood based inference methods for causal effects identified from regression discontinuity designs. We consider both the sharp and fuzzy regression discontinuity designs and treat the regression functions as nonparametric. The proposed inference procedures do not require asymptotic variance estimation and the confidence sets have natural shapes, unlike the conventional Wald-type method. These features are illustrated by simulations and an empirical example which evaluates the effect of class size on pupils' scholastic achievements. Furthermore, for the sharp regression discontinuity design, we show that the empirical likelihood statistic admits a higher-order refinement, so-called the Bartlett correction. Bandwidth selection methods are also discussed. (C) 2014 Elsevier B.V. All rights reserved.	[Otsu, Taisuke] Univ London London Sch Econ & Polit Sci, Dept Econ, London WC2A 2AE, England; [Xu, Ke-Li] Texas A&M Univ, Dept Econ, College Stn, TX 77843 USA; [Matsushita, Yukitoshi] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo 1528550, Japan	Otsu, T (reprint author), Univ London London Sch Econ & Polit Sci, Dept Econ, Houghton St, London WC2A 2AE, England.	t.otsu@lse.ac.uk; keli.xu@econmail.tamu.edu			National Science Foundation [SES-0720961]; University of Alberta School of Business through the Canadian utilities faculty award	We would like to thank Li Gan, Timothy Gronberg, Hidehiko Ichimura, Susumu Imai, Steven Lehrer, Qi Li, James MacKinnon, Vadim Marmer, Thanasis Stengos, an associate editor, anonymous referees, and seminar participants at Queen's University, Texas A&M University, University of Guelph, University of Tokyo, SETA 2009 in Kyoto, and FEMES 2009 in Tokyo for helpful comments. Our research is supported by the National Science Foundation under SES-0720961 (Otsu) and University of Alberta School of Business through the Canadian utilities faculty award (Xu).	Angrist JD, 1999, Q J ECON, V114, P533, DOI 10.1162/003355399556061; Fan JQ, 2001, ANN STAT, V29, P153, DOI 10.1214/aos/996986505; Ruppert D, 1997, TECHNOMETRICS, V39, P262, DOI 10.2307/1271131; Baggerly KA, 1998, BIOMETRIKA, V85, P535, DOI 10.1093/biomet/85.3.535; Hahn JY, 2001, ECONOMETRICA, V69, P201, DOI 10.1111/1468-0262.00183; Stock JH, 2000, ECONOMETRICA, V68, P1055, DOI 10.1111/1468-0262.00151; Newey WK, 2004, ECONOMETRICA, V72, P219, DOI 10.1111/j.1468-0262.2004.00482.x; Chen SX, 2006, BIOMETRIKA, V93, P215, DOI 10.1093/biomet/93.1.215; BHATTACHARYA RN, 1978, ANN STAT, V6, P434, DOI 10.1214/aos/1176344134; Imbens GW, 2008, J ECONOMETRICS, V142, P615, DOI 10.1016/j.jeconom.2007.05.001; Fan JQ, 1998, BIOMETRIKA, V85, P645, DOI 10.1093/biomet/85.3.645; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Xu KL, 2009, J ECONOMETRICS, V153, P65, DOI 10.1016/j.jeconom.2009.04.006; Li Q, 2004, STAT SINICA, V14, P485; Chan NH, 2011, ECONOMET THEOR, V27, P154, DOI 10.1017/S0266466610000150; Chen SX, 2000, BIOMETRIKA, V87, P946, DOI 10.1093/biomet/87.4.946; Chen SX, 2002, SCAND J STAT, V29, P89, DOI 10.1111/1467-9469.00273; Davidson R, 1998, MANCH SCH, V66, P1, DOI 10.1111/1467-9957.00086; Fan J., 1996, LOCAL POLYNOMIAL MOD; Hall P., 1992, BOOTSTRAP EDGEWORTH; HOLLAND PW, 1986, J AM STAT ASSOC, V81, P945, DOI 10.2307/2289064; Imbens G., 2009, 14726 NBER; KNAFL G, 1985, J AM STAT ASSOC, V80, P683, DOI 10.2307/2288485; Lemieux T., 2009, WORKING PAPER; Owen A.B., 2001, EMPIRICAL LIKELIHOOD; Porter J, 2003, WORKING PAPER; Rubin D, 1974, J EDUC PSYCHOL, V51, P309; SACKS J, 1978, ANN STAT, V6, P1122, DOI 10.1214/aos/1176344315; THISTLETHWAITE DL, 1960, J EDUC PSYCHOL, V51, P309, DOI 10.1037/h0044319; Trochim W., 2001, INT ENCY SOCIAL BEHA, V19, P12940; Xu KL, 2011, J BUS ECON STAT, V29, P518, DOI 10.1198/jbes.2011.09012	31	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0304-4076	1872-6895		J ECONOMETRICS	J. Econom.	MAY	2015	186	1					94	112		10.1016/j.jeconom.2014.04.023		19	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	CF6IY	WOS:000352661600007		
J	Luque, S; Kanjirakkad, V; Aslanidou, I; Lubbock, R; Rosic, B; Uchida, S				Luque, S.; Kanjirakkad, V.; Aslanidou, I.; Lubbock, R.; Rosic, B.; Uchida, S.			A New Experimental Facility to Investigate Combustor-Turbine Interactions in Gas Turbines With Multiple Can Combustors	JOURNAL OF ENGINEERING FOR GAS TURBINES AND POWER-TRANSACTIONS OF THE ASME			English	Article							HEAT-TRANSFER; FLOWS	This paper describes a new modular experimental facility that was purpose-built to investigate flow interactions between the combustor and first stage nozzle guide vanes (NGVs) of heavy duty power generation gas turbines with multiple can combustors. The first stage turbine NGV is subjected to the highest thermal loads of all turbine components and therefore consumes a proportionally large amount of cooling air that contributes detrimentally to the stage and cycle efficiency. It has become necessary to devise novel cooling concepts that can substantially reduce the coolant air requirement but still allow the turbine to maintain its aerothermal performance. The present work aims to aid this objective by the design and commissioning of a high-speed linear cascade, which consists of two can combustor transition ducts and four first stage NGVs. This is a modular nonreactive air test platform with engine realistic geometries (gas path and near gas path), cooling system, and boundary conditions (inlet swirl, turbulence level, and boundary layer). The paper presents the various design aspects of the high pressure (HP) blow down type facility, and the initial results from a wide range of aerodynamic and heat transfer measurements under highly engine realistic conditions.	[Luque, S.; Kanjirakkad, V.; Aslanidou, I.; Lubbock, R.; Rosic, B.] Univ Oxford, Dept Engn Sci, Osney Thermofluids Lab, Oxford OX2 0ES, England; [Uchida, S.] Mitsubishi Heavy Ind Co Ltd, Takasago Res & Dev Ctr, Takasago, Hyogo 6768686, Japan	Luque, S (reprint author), Univ Oxford, Dept Engn Sci, Osney Thermofluids Lab, Oxford OX2 0ES, England.	sg.luque@gmail.com; v.kanjirakkad@sussex.ac.uk; ioanna.aslanidou@eng.ox.ac.uk; roderick.lubbock@eng.ox.ac.uk; budimir.rosic@eng.ox.ac.uk; sumiu_uchida@mhi.co.jp			Mitsubishi Heavy Industries Ltd.	The authors gratefully acknowledge Mitsubishi Heavy Industries Ltd. for supporting this work and granting permission for publication.	ACARE, 2010, AER AIT TRANSP VIS 2; Barringer MD, 2009, J TURBOMACH, V131, DOI 10.1115/1.2950051; MOFFAT RJ, 1988, EXP THERM FLUID SCI, V1, P3, DOI 10.1016/0894-1777(88)90043-X; Povey T, 2007, J TURBOMACH, V129, P32, DOI 10.1115/1.2370748; Piccini E, 2000, MEAS SCI TECHNOL, V11, P342, DOI 10.1088/0957-0233/11/4/302; Huang Y, 2009, PROG ENERG COMBUST, V35, P293, DOI 10.1016/j.pecs.2009.01.002; Ireland PT, 1999, INT J HEAT FLUID FL, V20, P355, DOI 10.1016/S0142-727X(99)00030-2; [Anonymous], 2005, 9300 ISO; Buttsworth DR, 1998, J ENG GAS TURB POWER, V120, P694, DOI 10.1115/1.2818456; BLAIR MF, 1974, J HEAT TRANS-T ASME, V96, P524; Basol AM, 2012, J ENG GAS TURB POWER, V134, DOI 10.1115/1.4006671; [Anonymous], 2008, J TURBOMACH, DOI 10.1115/1.2752188; Dorney DJ, 1999, INT J TURBO JET ENG, V16, P1; BUTLER TL, 1989, J PROPUL POWER, V5, P64, DOI 10.2514/3.23116; Cardwell ND, 2007, J TURBOMACH, V129, P756, DOI 10.1115/1.2720497; Aslanidou I, 2013, J TURBOMACH, V135, DOI 10.1115/1.4007514; Gillespie D. R. H., 1996, THESIS U OXFORD OXFO; Han J.C., 2013, GAS TURBINE HEAT TRA; Hirsch C., 1993, ADV METHODS CASCADE; Horlock JH, 2001, J ENG GAS TURB POWER, V123, P487, DOI 10.1115/1.1373398; Jacobi S., 2013, THESIS ETH ZURICH; Lakshminarayana B., 1975, ASME, V97, P64; Luque S, 2011, J TURBOMACH, V133, DOI 10.1115/1.4001232; Lynch S. P., 2013, GT201394942 ASME; Mathison RM, 2012, J TURBOMACH, V134, DOI 10.1115/1.4002996; Mazzoni C. M., 2013, GT201394622 ASME; Qureshi I., 2011, GT201146037 ASME; Rosic B, 2012, J TURBOMACH, V134, DOI 10.1115/1.4003023; Schultz D L, 1973, HEAT TRANSFER MEASUR; Thrift AA, 2012, J TURBOMACH, V134, DOI 10.1115/1.4004817; Turrell M. D., 2004, GT200453112 ASME	31	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0742-4795	1528-8919		J ENG GAS TURB POWER	J. Eng. Gas. Turbines Power-Trans. ASME	MAY	2015	137	5							051503	10.1115/1.4028714		9	Engineering, Mechanical	Engineering	CF9CH	WOS:000352858700004		
J	Shibukawa, N; Fukushima, T; Iwasaki, Y; Takada, Y; Murakami, I; Suzuki, T				Shibukawa, Naoki; Fukushima, Takao; Iwasaki, Yoshifumi; Takada, Yoshiaki; Murakami, Itaru; Suzuki, Takashi			An Experimental Investigation of the Influence of Flash-Back Flow on Last Three Stages of Low Pressure Steam Turbines	JOURNAL OF ENGINEERING FOR GAS TURBINES AND POWER-TRANSACTIONS OF THE ASME			English	Article								A shutdown operation of a large size steam turbine could possibly cause flashing phenomena of the pooled drain water in low-pressure heaters. The boiled steam is sometimes in the same amount as the main flow in the case where shutdown is executed during low load conditions, and returns to the steam flow path through the extraction lines. A series of experimental work with a subscale model turbine facility has been carried out to investigate the vibration stress behavior, and the steady and unsteady pressures under the flashing back (FB) conditions. It was observed that the blades of the two stages before the last stage (L-2) and a stage before the last stage (L-1) presented their peak vibration stresses immediately after the flash-back flow reached the turbine. In the meantime, the vibration stresses of the last stage (L-0) blades were reduced for a few tens of seconds. It can be thought that the flash-back flow pushed out the reverse flow region around the L-0 blades and allow the blades to be more stable. A detailed examination with measured data of the L-2 blade explained that, as long as the flash-back flow has small wetness, the blade is excited in its specific vibration modes in larger than eighth harmonic of rotational speed, but once the flash-back flow carries water droplets, the fluid force in random frequencies remarkably increases and excites the blade in less than seventh harmonic range.	[Shibukawa, Naoki] Toshiba Corp Power Syst Co, Rotating Machine Technol R&D Dept, Power & Ind Syst Res & Dev Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Fukushima, Takao] Toshiba Corp Power Syst Co, Int Project Engn Dept, Nucl Energy Syst & Serv Div, Saiwai Ku, Kawasaki, Kanagawa 2128585, Japan; [Iwasaki, Yoshifumi; Takada, Yoshiaki; Murakami, Itaru; Suzuki, Takashi] Toshiba Corp Power Syst Co, Turbine Design & Assembling Dept, Keihin Prod Operat, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Shibukawa, N (reprint author), Toshiba Corp Power Syst Co, Rotating Machine Technol R&D Dept, Power & Ind Syst Res & Dev Ctr, Tsurumi Ku, 2-4 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	naoki.shibukawa@toshiba.co.jp; takao1.fukushima@toshiba.co.jp					Sigg R, 2009, P I MECH ENG A-J POW, V223, P697, DOI 10.1243/09576509JPE826; Gerschutz W., 2005, JOURNAL OF POWER AND, V219, P499; Ikeuchi K., 1982, THERM NUCL POWER, V33, P47; Iwanaga K., 1985, THERM NUCL POWER, V36, P21; Nakamura T., 2009, HITACHI HYORON, V91, P224; Saito E., 2009, INT C POW ENG ICOPE; Segawa K, 2010, TURBOMACHINERY, V38, P20; Shibukawa N., 2011, GT201146368 ASME; TRUCKENMULLER F, 1999, 3 EUR C TURB FLUID D, V1999, P757	9	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0742-4795	1528-8919		J ENG GAS TURB POWER	J. Eng. Gas. Turbines Power-Trans. ASME	MAY	2015	137	5							052601	10.1115/1.4028674		10	Engineering, Mechanical	Engineering	CF9CH	WOS:000352858700016		
J	Andriamanohiarisoamanana, FJ; Sakamoto, Y; Yamashiro, T; Yasui, S; Iwasaki, M; Ihara, I; Tsuji, O; Umetsu, K				Andriamanohiarisoamanana, Fetra J.; Sakamoto, Yushi; Yamashiro, Takaki; Yasui, Seiichi; Iwasaki, Masahiro; Ihara, Ikko; Tsuji, Osamu; Umetsu, Kazutaka			Effects of handling parameters on hydrogen sulfide emission from stored dairy manure	JOURNAL OF ENVIRONMENTAL MANAGEMENT			English	Article						Hydrogen sulfide; Dairy manure; Mixing; Total solids	SWINE WASTE-WATER; CARBON-DIOXIDE; AMMONIA; GAS; SLURRY; ACIDIFICATION; STORAGE; CATTLE; DIET; H2S	Hydrogen sulfide (H2S) emission from liquid manure in the process preceding field application is an important issue in fertigation systems. Given that H2S poses a significant health risk, it is important to determine the effects of different handling parameters on H2S emissions to prevent health risks to farmers. In this study, the effects of total solids (TS; 3, 5, 7, 9, and 11%) and mixing speed (100, 200, 300, and 400 rpm), duration (5, 15, 30, and 60 min), and frequency (one, two, three, and four times a day) on H2S emissions from two different dairy manures were investigated. The results indicate that the quantity of sulfur-containing substrate intake determines the potential of dairy manure to emit H2S because manure from cows fed with concentrate-based feed generates higher amounts of H2S than manure from cows fed with forage-based feed. The (HS)-S-2 concentration increased with TS concentration and reached a maximum of 1133 ppm at a TS of 9%; thereafter, it decreased with further increases in TS concentration. H2S emission increased with mixing speed with a peak concentration of 3996 ppm at 400 rpm. A similar trend was observed for mixing duration. However, there were no significant differences between the amounts H2S emitted at different frequencies of mixing (P > 0.05). The results indicate that mixing speed, duration, and TS are the major determinants of the quantity of H2S emitted from dairy manure. Therefore, to prevent health risks associated with H2S emission from dairy manure, it is recommended that the mixing speed and duration should be kept as low as possible, while a TS concentration of above 9% should be applied during the fertigation of dairy manure. (C) 2015 Elsevier Ltd. All rights reserved.	[Andriamanohiarisoamanana, Fetra J.; Yamashiro, Takaki; Iwasaki, Masahiro; Tsuji, Osamu; Umetsu, Kazutaka] Obihiro Univ Agr & Vet Med, Grad Sch Anim & Food Hyg, Obihiro, Hokkaido 0808555, Japan; [Yasui, Seiichi] Airwater Co Ltd, Sapporo, Hokkaido 0030027, Japan; [Sakamoto, Yushi; Ihara, Ikko] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan	Umetsu, K (reprint author), Obihiro Univ Agr & Vet Med, Grad Sch Anim & Food Hyg, Obihiro, Hokkaido 0808555, Japan.	umetsu@obihiro.ac.jp					Blunden J, 2008, ATMOS ENVIRON, V42, P3277, DOI 10.1016/j.atmosenv.2007.02.026; Le PD, 2005, NUTR RES REV, V18, P3, DOI 10.1079/NRR200592; Wang KY, 2014, BIOSYST ENG, V122, P23, DOI 10.1016/j.biosystemseng.2014.03.002; Ni JQ, 2009, T ASABE, V52, P2013; Castro HF, 2000, FEMS MICROBIOL ECOL, V31, P1, DOI 10.1016/S0168-6496(99)00071-9; Guerrero L, 1999, WATER RES, V33, P3281, DOI 10.1016/S0043-1354(99)00041-X; Ni JQ, 2010, SCI TOTAL ENVIRON, V408, P5917, DOI 10.1016/j.scitotenv.2010.08.031; Ni JQ, 2000, J AGR ENG RES, V77, P53, DOI 10.1006/jaer.2000.0561; Zahn JA, 2001, J ENVIRON QUAL, V30, P635; Hobbs PJ, 1999, J AGR ENG RES, V72, P291, DOI 10.1006/jaer.1998.0372; Dai XR, 2013, J ENVIRON MANAGE, V115, P147, DOI 10.1016/j.jenvman.2012.11.019; Maebashi K, 2011, FORENSIC SCI INT, V207, P91, DOI 10.1016/j.forsciint.2010.09.008; Liu DZ, 2011, ATMOS ENVIRON, V45, P3786, DOI 10.1016/j.atmosenv.2011.04.028; Arogo J, 2000, T ASAE, V43, P1241; Blanes-Vidal V, 2009, BIOSYST ENG, V104, P510, DOI 10.1016/j.biosystemseng.2009.09.008; Blanes-Vidal V, 2012, ATMOS ENVIRON, V54, P408, DOI 10.1016/j.atmosenv.2012.02.046; Chénard L, 2003, J Agric Saf Health, V9, P285; El-Mashad HM, 2005, BIORESOURCE TECHNOL, V96, P531, DOI 10.1016/j.biortech.2004.06.020; Gypsum Association, 1992, TREATM DISP GYPS B 2; Hooser SB, 2000, J VET DIAGN INVEST, V12, P272; Oesterhelweg L, 2008, INT J LEGAL MED, V122, P101, DOI 10.1007/s00414-007-0172-8; Patni N. K., 1991, Applied Engineering in Agriculture, V7, P478; Predicala B, 2008, J HAZARD MATER, V154, P300, DOI 10.1016/j.jhazmat.2007.10.026; Scully H., 2007, RES HYDROGEN SULFIDE; Staley L.M., 1973, CANADIAN AGR ENG, V15, P124; Standard Methods, 2005, STANDARD METHODS EXA; STEVENS RJ, 1993, BIORESOURCE TECHNOL, V45, P13, DOI 10.1016/0960-8524(93)90136-Y; US EPA, 1974, PROC DES MAN SULF CO; Yongsiri C, 2004, J ENVIRON ENG-ASCE, V130, P104, DOI 10.1061/(ASCE)0733-9372(2004)130:1(104)	29	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0301-4797	1095-8630		J ENVIRON MANAGE	J. Environ. Manage.	MAY 1	2015	154						110	116		10.1016/j.jenvman.2015.02.003		7	Environmental Sciences	Environmental Sciences & Ecology	CF6MT	WOS:000352671500013		
J	Nishiumi, N; Mori, A				Nishiumi, Nozomi; Mori, Akira			Distance-dependent switching of anti-predator behavior of frogs from immobility to fleeing	JOURNAL OF ETHOLOGY			English	Article						Anti-predator behavior; Anura; Escape decision; Immobility; Optimal flight initiation distance; Predator-prey interaction	OPTIMAL ESCAPE; PREY; STRATEGIES; PREDATORS; SURVIVAL; SNAKES; FLIGHT; RISK; ANURANS; FIGHT	To avoid predation, many animals are required to appropriately switch between immobility for crypsis and fleeing for escape. We conducted two staged-encounter experiments using a frog and a snake to examine factors that affect the occurrence of immobility and fleeing, and to evaluate the efficiency of them. The first experiment demonstrated that frogs initially exhibit immobility, when snakes are moving at a long distance, and then switch from immobility to fleeing at a shorter distance even when snakes have not detected them. The second experiment demonstrated that snakes at 400-800 mm distance detect only fleeing frogs, whereas snakes at 100 mm or closer detect both immobile and fleeing frogs. Thus, the ability of snakes to detect motionless frogs depends on the distance, and the distance-dependent switching can be considered an adaptive strategy of the frog. However, a previous model predicts that cryptic prey should flee immediately on seeing a predator or not flee until being detected by the predator. To explain this discordance, we propose two factors: engagement of intensive searching mode by predator at short distance and effects of sudden fleeing at close distance. We suggest incorporating them in future theory for better understanding of anti-predator strategy.	[Nishiumi, Nozomi; Mori, Akira] Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan	Nishiumi, N (reprint author), Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan.	nozo@ethol.zool.kyoto-u.ac.jp			MEXT, Japan [A06]; Japan Science Society [26-528]	We thank D. Muramatsu and T. Jono for their advice on statistical analysis and E. Nakajima for kindly reading and improving the manuscript. We also thank N. Fuse and K. Tsujimoto for allowing us to use their computer software for analyzing C-trax data. This work was partially supported by the Global COE Program (A06) and Grants for Biodiversity & Evolution Project of Excellent Graduate Schools to Kyoto University from MEXT, Japan, and the Sasakawa Research Grant (26-528) to Nozomi Nishiumi from the Japan Science Society.	YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; Broom M, 2005, BEHAV ECOL, V16, P534, DOI 10.1093/beheco/ari024; Cooper WE, 1997, HERPETOLOGICA, V53, P464; Cooper WE, 2003, BEHAV ECOL, V14, P288, DOI 10.1093/beheco/14.2.288; BRODIE ED, 1991, ETHOL ECOL EVOL, V3, P73; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; Cooper WE, 2003, ETHOLOGY, V109, P617, DOI 10.1046/j.1439-0310.2003.00912.x; Ford JKB, 2008, MAMMAL REV, V38, P50, DOI 10.1111/j.1365-2907.2008.00118.x; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325; Vallin A, 2005, P ROY SOC B-BIOL SCI, V272, P1203, DOI 10.1098/rspb.2004.3034; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Toledo LF, 2011, ETHOL ECOL EVOL, V23, P1, DOI 10.1080/03949370.2010.534321; Miyatake T, 2009, P R SOC B, V276, P2763, DOI 10.1098/rspb.2009.0558; Caro T., 2005, ANTIPREDATOR DEFENSE; DUCEY PK, 1983, COPEIA, P1036, DOI 10.2307/1445106; Duellman W. E., 1994, BIOL AMPHIBIANS; Edmunds M, 1974, DEFENCE ANIMALS SURV; Endler J.A., 1991, BEHAV ECOLOGY EVOLUT, V3, P169; Gamberale-Stille G, 2009, ANIM BEHAV, V78, P111, DOI 10.1016/j.anbehav.2009.04.015; Goris RC, 2004, GUIDE AMPHIBIANS REP; Kadowaki S, 1996, B TSUKUBA U EXPER FO, V12, P77; Lagos A, 2014, ANIM BEHAV, V97, P221; Maeda N, 1999, FROGS TOADS JAPAN; MARCHISIN A, 1978, J HERPETOL, V12, P151, DOI 10.2307/1563401; MORI A, 1988, Snake, V20, P98; OTA H, 1986, J ETHOL, V4, P69, DOI 10.1007/BF02348254; Shinohara N, 2007, KAGAWA SEIBUTUSU, V34, P97; Siegel S, 1988, NONPARAMETRIC STAT B; Toledo LF, 2007, J ZOOL, V271, P170, DOI 10.1111/j.1469-7998.2006.00195.x; Wasson K, 2005, BEHAV ECOL, V16, P1037, DOI 10.1093/beheco/ari086; WATTIEZ R, 1994, J CHEM ECOL, V20, P1143, DOI 10.1007/BF02059750; Zhang H, 2008, EVOL BIOL, V8, P21	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0289-0771	1439-5444		J ETHOL	J. Ethol.	MAY	2015	33	2					117	124		10.1007/s10164-014-0419-z		8	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CF9CX	WOS:000352860300004		
J	Sasaki, H				Sasaki, Hiroshi			AN APPROACH TO THE OPTION MARKET MODEL BASED ON END-USER NET DEMAND	JOURNAL OF FUTURES MARKETS			English	Article							VOLATILITY RISK PREMIUM; BUYING PRESSURE; STOCHASTIC VOLATILITY; IMPLIED VOLATILITY; CURRENCY OPTIONS; AVERSION; PRICES	In this paper, we study financial option prices and their related topics in terms of demand-pressure effects of options contracts. Deriving equilibrium demand pressures for options, we provide an explicit representation of the pricing kernel in equilibrium between the supply and demand for options, which is a function of those of equilibrium demand pressures. On the basis of the demand-based pricing kernel in equilibrium derived from our model setup, we provide some important implications for empirical evidence that have been provided in recent studies related to option pricing anomalies. (c) 2014 Wiley Periodicals, Inc. Jrl Fut Mark 35:476-503, 2015	Hitotsubashi Univ, Grad Sch Int Corp Strategy, Chiyoda Ku, Tokyo 1018439, Japan	Sasaki, H (reprint author), Hitotsubashi Univ, Grad Sch Int Corp Strategy, Chiyoda Ku, 2-1-2 Hitotsubashi, Tokyo 1018439, Japan.	id10f002@g.hit-u.ac.jp					Ziegler A, 2007, REV FINANC STUD, V20, P859, DOI 10.1093/rfs/hhl023; BREEDEN DT, 1978, J BUS, V51, P621, DOI 10.1086/296025; Carr P, 2009, REV FINANC STUD, V22, P1311, DOI 10.1093/rfs/hhn038; Low BS, 2005, J FINANC QUANT ANAL, V40, P803; Jackwerth JC, 2000, REV FINANC STUD, V13, P433, DOI 10.1093/rfs/13.2.433; Han B, 2008, REV FINANC STUD, V21, P387, DOI 10.1093/rfs/hhm071; Ait-Sahalia Y, 2007, J FINANC ECON, V83, P413, DOI 10.1016/j.jfineco.2005.10.006; Bakshi G, 2003, REV FINANC STUD, V16, P527, DOI 10.1093/rfs/hhg002; Bollen NPB, 2004, J FINANC, V59, P711, DOI 10.1111/j.1540-6261.2004.00647.x; Garleanu N, 2009, REV FINANC STUD, V22, P4259, DOI 10.1093/rfs/hhp005; HESTON SL, 1993, REV FINANC STUD, V6, P327, DOI 10.1093/rfs/6.2.327; Ait-Sahalia Y, 2000, J ECONOMETRICS, V94, P9, DOI 10.1016/S0304-4076(99)00016-0; Rosenberg JV, 2002, J FINANC ECON, V64, P341, DOI 10.1016/S0304-405X(02)00128-9; Green TC, 1999, J FINANC, V54, P1465, DOI 10.1111/0022-1082.00152; Shiu YM, 2010, J DERIV, V17, P54, DOI 10.3905/jod.2010.17.4.054; Cochrane J., 2001, ASSET PRICING; Cochrane J. H., 1992, 1992 NBER MACROECONO; Driessen J., 2007, REV FINANC, V11, P561, DOI 10.1093/rof/rfm024; Kang J, 2008, J FINANC MARK, V11, P36, DOI 10.1016/j.finmar.2007.01.001; MEHRA R, 1985, J MONETARY ECON, V15, P145, DOI 10.1016/0304-3932(85)90061-3	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-7314	1096-9934		J FUTURES MARKETS	J. Futures Mark.	MAY	2015	35	5					476	503		10.1002/fut.21672		28	Business, Finance	Business & Economics	CF5CD	WOS:000352572100004		
J	Hamada, Y; Sairyo, K; Sato, R				Hamada, Y.; Sairyo, K.; Sato, R.			An adjustable device to keep the thumb in opposition and prevent adduction contracture after surgery or injury	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Letter									[Hamada, Y.] Tokushima Prefectural Cent Hosp, Dept Orthoped, Tokushima, Japan; [Sairyo, K.; Sato, R.] Univ Tokushima, Sch Med, Dept Orthoped, Tokushima 770, Japan	Hamada, Y (reprint author), Tokushima Prefectural Cent Hosp, Dept Orthoped, Tokushima, Japan.	handhamada@hotmail.co.jp					Kapandji IA, 1992, J HAND THER, V2, P102	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	MAY	2015	40	4					416	417		10.1177/1753193414546820		2	Orthopedics; Surgery	Orthopedics; Surgery	CF6FD	WOS:000352651500015		
J	Kanaya, K; Wada, T; Yamashita, T				Kanaya, K.; Wada, T.; Yamashita, T.			Arthroscopically assisted osteosynthesis for osteochondral fracture of the triquetrum	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Letter									[Kanaya, K.; Wada, T.; Yamashita, T.] Sapporo Med Univ, Sch Med, Dept Orthoped Surg, Sapporo, Hokkaido, Japan	Kanaya, K (reprint author), Sapporo Med Univ, Sch Med, Dept Orthoped Surg, Sapporo, Hokkaido, Japan.	kkanaya@pop06.odn.ne.jp					LEVY M, 1979, J BONE JOINT SURG BR, V61, P355; Maeda N, 1998, J JPN SOC SURG HAND, V15, P602; Pevny T, 1996, Am J Orthop (Belle Mead NJ), V25, P155; Suzuki T, 2002, J HAND SURG-AM, V27A, P98, DOI 10.1053/jhsu.2002.28944	4	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	MAY	2015	40	4					420	422		10.1177/1753193413508700		3	Orthopedics; Surgery	Orthopedics; Surgery	CF6FD	WOS:000352651500018		
J	Yamamoto, H; Fujita, S				Yamamoto, H.; Fujita, S.			Rupture of the flexor pollicis longus tendon in a child treated by two-stage tendon transfer	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Letter									[Yamamoto, H.; Fujita, S.] Mitsubishi Kyoto Hosp, Dept Orthopaed Surg, Kyoto, Japan	Yamamoto, H (reprint author), Mitsubishi Kyoto Hosp, Dept Orthopaed Surg, Kyoto, Japan.	yamahiroos@hotmail.co.jp					Mcmaster PE, 1933, J BONE JOINT SURG, V15, P705; HERGENROEDER PT, 1982, CLIN ORTHOP RELAT R, P298; Oka Yoshinori, 2000, Tokai Journal of Experimental and Clinical Medicine, V25, P23; PATEL AP, 1966, POSTGRAD MED J, V42, P512	4	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	MAY	2015	40	4					423	424		10.1177/1753193413511577		2	Orthopedics; Surgery	Orthopedics; Surgery	CF6FD	WOS:000352651500020		
J	Inagaki, NF; Inagaki, FF; Kokudo, N; Miyajima, A				Inagaki, Natsuko F.; Inagaki, Fuyuki F.; Kokudo, Norihiro; Miyajima, Atsushi			Use of mouse liver mesothelial cells to prevent postoperative adhesion and promote liver regeneration after hepatectomy	JOURNAL OF HEPATOLOGY			English	Article						Hepatopancreatobiliary surgery; Regenerative medicine; Cell sheet; Liver resection; Transplantation	HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; COLORECTAL METASTASES; REPEAT HEPATECTOMY; COMBINED RESECTION/ABLATION; 3RD HEPATECTOMY; RAT HEPATOCYTES; PODOCALYXIN; FIBRINOLYSIS	Background & Aims: Repeated hepatectomy is widely accepted as one of the most effective curative treatment for recurrent hepatocellular carcinoma or liver metastasis from colorectal cancer. It has, however, two critical issues; postoperative adhesion and decrease of liver regenerative capacity. Postoperative adhesion makes surgical operations technically more demanding, leading to increased mortality and morbidity rates. Although the liver has a remarkable regenerative ability, volume and functional restoration after multiple repeated hepatectomy is not generally complete. So a new procedure that overcomes these two issues is required. We examined if a fetal liver mesothelial cells (FL-MCs) sheet could solve these two clinical issues simultaneously. Methods: We established a novel mouse hepatectomy model that reproduces postoperative adhesion on the resected liver surface. We isolated FL-MCs from mouse fetal liver and prepared a cell sheet. The FL-MCs sheet was then transplanted to the resected liver surface. Results: The FL-MCs sheet effectively prevented postoperative adhesion by expressing PCLP1, one of the transmembrane sialomucin family proteins and by activating the fibrinolytic system. Furthermore, the FL-MCs sheet facilitated liver regeneration by providing growth factors for hepatocytes, allowing quick recovery of liver weight and function. Additionally, we showed that an allogeneic FL-MCs sheet was as effective as a syngeneic cell sheet. Conclusions: We demonstrate that the FL-MCs sheet is able to not only prevent postoperative adhesion but also promote liver regeneration in both syngeneic and allogeneic transplantation, and hence FL-MCs may serve as a potentially useful cell source for regenerative medicine after hepatectomy. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Inagaki, Natsuko F.; Inagaki, Fuyuki F.; Miyajima, Atsushi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Inagaki, Fuyuki F.; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div,Artificial Organ, Tokyo 1130032, Japan	Miyajima, A (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	miyajima@iam.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology - Japan; CREST program of Japan Science and Technology Agency - Japan	This study was supported, in part, by a Grant-in-Aid for Scientific Research by the Ministry of Education, Culture, Sports, Science, and Technology - Japan, and the CREST program of Japan Science and Technology Agency - Japan.	Clavien PA, 2003, ANN SURG, V238, P883; Sulaiman H, 2002, BIOCHEM SOC T, V30, P126; Asahina K, 2011, HEPATOLOGY, V53, P983, DOI 10.1002/hep.24119; Shimizu A, 2014, SURG TODAY, V44, P314, DOI 10.1007/s00595-013-0530-8; DEKAN G, 1991, P NATL ACAD SCI USA, V88, P5398, DOI 10.1073/pnas.88.12.5398; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Kosaka H, 2008, NAT MED, V14, P437, DOI 10.1038/nm1733; Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; ELIAS D, 1993, BRIT J SURG, V80, P1557, DOI 10.1002/bjs.1800801223; Hasegawa K, 2013, J HEPATOL, V58, P724, DOI 10.1016/j.jhep.2012.11.009; Aoki T, 2011, J GASTROINTEST SURG, V15, P1594, DOI 10.1007/s11605-011-1590-y; Adam R, 2003, ANN SURG, V238, P871, DOI 10.1097/01.sla.0000098112.04758.4e; Mise Y, 2010, ANN SURG, V251, P902, DOI 10.1097/SLA.0b013e3181c9868a; Li YC, 2013, P NATL ACAD SCI USA, V110, P2324, DOI 10.1073/pnas.1214136110; Sadamori H, 2013, BRIT J SURG, V100, P122, DOI 10.1002/bjs.8957; Asahina K, 2009, HEPATOLOGY, V49, P998, DOI 10.1002/hep.22721; Takeda T, 2000, MOL BIOL CELL, V11, P3219; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Lesurtel M, 2005, ANN SURG, V242, P814, DOI 10.1097/01.sla.0000189121.35617.d7; Brochhausen C, 2012, J GASTROINTEST SURG, V16, P1256, DOI 10.1007/s11605-011-1819-9; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Minagawa M, 2003, ANN SURG, V238, P703, DOI 10.1097/01.sla.0000094549.11754.e6; Aoki T, 2001, HEPATOL RES, V21, P228, DOI 10.1016/S1386-6346(01)00124-3; Aramaki M, 2000, HEPATO-GASTROENTEROL, V47, P478; Asahina K, 2002, AM J PATHOL, V160, P2191, DOI 10.1016/S0002-9440(10)61167-4; Drixler TA, 2003, BRIT J SURG, V90, P1384, DOI 10.1002/bjs.4275; Holmdahl L, 1996, SURGERY, V119, P701, DOI 10.1016/S0039-6060(96)80196-6; Ivarsson ML, 1998, BRIT J SURG, V85, P1549; Jochheim-Richter A, 2006, DIFFERENTIATION, V74, P167, DOI 10.1111/j.1432-0436.2006.00066.x; Lesurtel M, 2005, ANN SURG, V242, P822; Ochiai K, 2004, LIVER INT, V24, P484, DOI 10.1111/j.1478-3231.2004.0990.x; Okumura N, 2009, J BIOL CHEM, V284, P16553, DOI 10.1074/jbc.M109.011452; Onitsuka I, 2010, GASTROENTEROLOGY, V138, pe6; Saito S, 2006, J SURG RES, V134, P322, DOI 10.1016/j.jss.2006.01.008; Sato H, 1999, EXP CELL RES, V246, P152, DOI 10.1006/excr.1998.4304	40	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	MAY	2015	62	5					1141	1147		10.1016/j.jhep.2014.12.010		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CG2SJ	WOS:000353124800023		
J	Moriya, A; Iwasaki, Y; Ohguchi, S; Yamamoto, K				Moriya, Akio; Iwasaki, Yoshiaki; Ohguchi, Souhei; Yamamoto, Kazuhide			Reply to: "Protective effects of moderate alcohol consumption on fatty liver: A spurious association?''	JOURNAL OF HEPATOLOGY			English	Letter									[Moriya, Akio] Mitoyo Gen Hosp, Dept Med, Kanonji, Japan; [Iwasaki, Yoshiaki] Okayama Univ, Hlth Serv Ctr, Okayama 7008530, Japan; [Iwasaki, Yoshiaki; Yamamoto, Kazuhide] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008530, Japan; [Ohguchi, Souhei] Junpukai Hlth Maintenance Ctr, Okayama, Japan	Iwasaki, Y (reprint author), Okayama Univ, Hlth Serv Ctr, Okayama 7008530, Japan.	yiwasaki@cc.okayama-u.ac.jp					Moriya A, 2015, J HEPATOL, V62, P921, DOI 10.1016/j.jhep.2014.11.025; You M, 2005, HEPATOLOGY, V42, P568, DOI 10.1002/hep.20821; Moriya A, 2011, ALIMENT PHARM THER, V33, P378, DOI 10.1111/j.1365-2036.2010.04520.x; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33	4	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	MAY	2015	62	5					1211	1212				3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CG2SJ	WOS:000353124800035		
J	Morikane, K; Honda, H; Yamagishi, T; Suzuki, S				Morikane, K.; Honda, H.; Yamagishi, T.; Suzuki, S.			Differences in risk factors associated with surgical site infections following two types of cardiac surgery in Japanese patients	JOURNAL OF HOSPITAL INFECTION			English	Article						Surgical site infection; Risk factor; Cardiac surgery	BYPASS GRAFT-SURGERY; CARE SAFETY NETWORK; NOSOCOMIAL INFECTIONS; SURVEILLANCE; INDEX; HOSPITALS; SYSTEM; RATES	Background: Differences in the risk factors for surgical site infection (SSI) following open heart surgery and coronary artery bypass graft surgery are not well described. Aim: To identify and compare risk factors for SSI following open heart surgery and coronary artery bypass graft surgery. Methods: SSI surveillance data on open heart surgery (CARD) and coronary artery bypass graft surgery (CBGB) submitted to the Japan Nosocomial Infection Surveillance (JANIS) system between 2008 and 2010 were analysed. Factors associated with SSI were analysed using univariate modelling analysis followed by multi-variate logistic regression analysis. Non-binary variables were analysed initially to determine the most appropriate category. Findings: The cumulative incidence rates of SSI for CARD and CBGB were 2.6% (151/5895) and 4.1% (160/3884), respectively. In both groups, the duration of the operation and a high American Society of Anesthesiologists' (ASA) score were significant in predicting SSI risk in the model. Wound class was independently associated with SSI in CARD but not in CBGB. Implants, multiple procedures and emergency operations predicted SSI in CARD, but none of these factors predicted SSI in CBGB. Conclusions: There was a remarkable difference in the prediction of risk for SSI between the two types of cardiac surgery. Risk stratification in CARD could be improved by incorporating variables currently available in the existing surveillance systems. Risk index stratification in CBGB could be enhanced by collecting additional variables, because only two of the current variables were found to be significant for the prediction of SSI. (C) 2015 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.	[Morikane, K.] Yamagata Univ Hosp, Div Infect Control & Clin Lab, Yamagata 9909585, Japan; [Honda, H.] Tokyo Metropolitan Tama Med Ctr, Dept Med, Div Infect Dis, Tokyo, Japan; [Yamagishi, T.] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo 1628640, Japan; [Suzuki, S.] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan	Morikane, K (reprint author), Yamagata Univ Hosp, Div Infect Control & Clin Lab, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	morikane-tky@umin.net			Ministry of Health, Labour and Welfare, Japan [H21-Shinko-Ippan-008, H24-Shinko-Ippan-010]	This work was supported by the H21-Shinko-Ippan-008 and H24-Shinko-Ippan-010 grants from the Ministry of Health, Labour and Welfare, Japan.	Roy MC, 1998, INFECT CONT HOSP EP, V19, P229; Mu Y, 2011, INFECT CONT HOSP EP, V32, P970, DOI 10.1086/662016; Bundy JK, 2006, AM J INFECT CONTROL, V34, P114, DOI 10.1016/j.ajic.2005.10.003; Berrios-Torres SI, 2012, INFECT CONT HOSP EP, V33, P463, DOI 10.1086/665313; Russo PL, 2002, INFECT CONT HOSP EP, V23, P372, DOI 10.1086/502068; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160; Talbot TR, 2004, CLIN INFECT DIS, V38, P1378, DOI 10.1086/386334; Mannien J, 2011, J THORAC CARDIOV SUR, V141, P899, DOI 10.1016/j.jtcvs.2010.09.047; Olsen MA, 2002, J THORAC CARDIOV SUR, V124, P136, DOI 10.1067/mtc.2002.122306; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572; NAGACHINTA T, 1987, J INFECT DIS, V156, P967; Harrington G, 2004, INFECT CONT HOSP EP, V25, P472, DOI 10.1086/502424; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Roy MC, 2000, INFECT CONT HOSP EP, V21, P186, DOI 10.1086/501741; Batista R, 2006, INFECT CONT HOSP EP, V27, P802, DOI 10.1086/506394; CRUSE P, 1981, REV INFECT DIS, V3, P734; CULVER DH, 1991, AM J MED, V91, pS152, DOI 10.1016/0002-9343(91)90361-Z; Friedman ND, 2007, INFECT CONT HOSP EP, V28, P1162, DOI 10.1086/519534; Friedman ND, 2007, INFECT CONT HOSP EP, V28, P55, DOI 10.1086/509848; Gaynes RP, 2000, INFECT CONT HOSP EP, V21, P184, DOI 10.1086/501740; HALEY RW, 1985, AM J EPIDEMIOL, V121, P182; Kaye KS, 2005, J INFECT DIS, V191, P1056, DOI 10.1086/428626; Kaye KS, 2001, EMERG INFECT DIS, V7, P57; Morikane K, 2014, INFECT CONT HOSP EP, V35, P660, DOI 10.1086/676438; Public Health England, 2013, SURV SURG SIT INF NH; Vuorisalo S, 1998, INFECT CONT HOSP EP, V19, P240	27	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0195-6701	1532-2939		J HOSP INFECT	J. Hosp. Infect.	MAY	2015	90	1					15	21		10.1016/j.jhin.2014.11.022		7	Infectious Diseases	Infectious Diseases	CF6TF	WOS:000352688400004		
J	Naito, T; Kubono, N; Deguchi, S; Sugihara, M; Itoh, H; Kanayama, N; Kawakami, J				Naito, Takafumi; Kubono, Naoko; Deguchi, Shuhei; Sugihara, Masahisa; Itoh, Hiroaki; Kanayama, Naohiro; Kawakami, Junichi			Amlodipine Passage into Breast Milk in Lactating Women with Pregnancy-Induced Hypertension and Its Estimation of Infant Risk for Breastfeeding	JOURNAL OF HUMAN LACTATION			English	Article						amlodipine; breastfeeding; breast milk; pharmacokinetics; pregnancy-induced hypertension; relative infant dose	PHARMACOKINETIC PROPERTIES; ANTIHYPERTENSIVE DRUGS; NIFEDIPINE; UPDATE	Background: Few clinical reports have been published on amlodipine passage into breast milk in lactating women. Objectives: The aims of this study were to evaluate the plasma concentration of amlodipine and its passage into breast milk in lactating women with pregnancy-induced hypertension and to estimate the risk for breastfeeding infants. Methods: Thirty-one lactating women receiving oral amlodipine once daily for pregnancy-induced hypertension were enrolled. Pre-dose plasma and milk concentrations of amlodipine were determined at day 6 or later after starting the medication. Relative infant dose (RID) as an infant risk for breastfeeding was calculated by dividing the infant dose via milk by the maternal dose. Results: The mean maternal dose of amlodipine was 6.0 mg. The medians of the plasma and milk concentrations of amlodipine were 15.5 and 11.5 ng/mL, respectively. Interindividual variation was observed in the amlodipine dose and body weight-adjusted milk concentrations (interquartile range [IQR], 96.7-205 ng/mL per mg/kg). The median and IQR of the amlodipine concentration ratio of milk to plasma were 0.85 and 0.74 to 1.08, respectively. The medians of infant birth weight and daily amlodipine dose via milk were 2170 g and 4.2 g/kg, respectively. The median of the RID of amlodipine was 4.2% (IQR, 3.1%-7.3%). Conclusion: Lactating women with pregnancy-induced hypertension had higher plasma concentrations of amlodipine during the early postpartum period. Oral amlodipine transferred into breast milk at the same level as that of plasma. However, the RID of amlodipine in most patients was less than 10%.	[Naito, Takafumi; Kubono, Naoko; Kawakami, Junichi] Hamamatsu Univ Sch Med, Dept Hosp Pharm, Hamamatsu, Shizuoka 4313192, Japan; [Deguchi, Shuhei; Sugihara, Masahisa] Sawai Pharmaceut Co Ltd, Dept Biol Res, Osaka, Japan; [Itoh, Hiroaki; Kanayama, Naohiro] Hamamatsu Univ Sch Med, Dept Obstet & Gynecol, Hamamatsu, Shizuoka 4313192, Japan	Naito, T (reprint author), Hamamatsu Univ Sch Med, Dept Hosp Pharm, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	naitou@hama-med.ac.jp			JSPS KAKENHI [22926007, 25928012]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by JSPS KAKENHI Grant Numbers 22926007 and 25928012.	Ahn HK, 2007, HYPERTENS PREGNANCY, V26, P179, DOI 10.1080/10641950701204554; MURDOCH D, 1991, DRUGS, V41, P478, DOI 10.2165/00003495-199141030-00009; Zhu YL, 2014, DRUG METAB DISPOS, V42, P245, DOI 10.1124/dmd.113.055400; Papageorgiou I, 2013, DRUG METAB DISPOS, V41, P281, DOI 10.1124/dmd.112.049015; Anderson GD, 2006, EXPERT OPIN DRUG MET, V2, P947, DOI 10.1517/17425255.2.6.947; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Ghanem FA, 2008, CARDIOVASC THER, V26, P38, DOI 10.1111/j.1527-3466.2007.00036.x; ATKINSON HC, 1990, CLIN PHARMACOKINET, V18, P151; Bennet PN, 1988, DRUGS HUMAN LACTATIO, P325; CLAVIJO GA, 1994, AM J HOSP PHARM, V51, P59; EHRENKRANZ RA, 1989, J PEDIATR-US, V114, P478, DOI 10.1016/S0022-3476(89)80579-7; ELLIOTT JR, 1971, CLIN CHEM, V17, P156; FAULKNER JK, 1986, BRIT J CLIN PHARMACO, V22, P21; Fujiwara T, 2009, J HUM HYPERTENS, V23, P521, DOI 10.1038/jhh.2008.161; Ghuman N, 2009, J CLIN HYPERTENS, V11, P726, DOI 10.1111/j.1751-7176.2009.00186.x; Hale TW, 2012, MEDICATIONS MOTHERS, P7; Marks Jennifer M, 2003, J Pediatr Health Care, V17, P311, DOI 10.1016/S0891-5245(03)00217-7; Nice FJ, 2012, J AM PHARM ASSOC, V52, P86, DOI 10.1331/JAPhA.2012.10139; PENNY WJ, 1989, EUR J CLIN PHARMACOL, V36, P427, DOI 10.1007/BF00558309; Podymow T, 2008, HYPERTENSION, V51, P960, DOI 10.1161/HYPERTENSIONAHA.106.075895; Szucs KA, 2010, BREASTFEED MED, V5, P123, DOI 10.1089/bfm.2009.0076; VANZWIETEN PA, 1994, CLIN CARDIOL, V17, P3; Vasa R, 2013, BREASTFEEDING MED S1, V8, pS15	23	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0890-3344	1552-5732		J HUM LACT	J. Hum. Lact.	MAY	2015	31	2					301	306		10.1177/0890334414560195		6	Nursing; Obstetrics & Gynecology; Pediatrics	Nursing; Obstetrics & Gynecology; Pediatrics	CG0WE	WOS:000352992600017		
J	Sakamoto, Y; Koga, M; Todo, K; Okuda, S; Okada, Y; Kimura, K; Shiokawa, Y; Kamiyama, K; Furui, E; Hasegawa, Y; Kairo, K; Okata, T; Kobayashi, J; Tanaka, E; Yamagami, H; Nagatsuka, K; Minematsu, K; Toyoda, K				Sakamoto, Yuki; Koga, Masatosi; Todo, Kenichi; Okuda, Satoshi; Okada, Yasushi; Kimura, Kazumi; Shiokawa, Yoshiaki; Kamiyama, Kenji; Furui, Eisuke; Hasegawa, Yasuhiro; Kairo, Kazuomi; Okata, Takuya; Kobayashi, Junpei; Tanaka, Eijirou; Yamagami, Hiroshi; Nagatsuka, Kazuyuki; Minematsu, Kazuo; Toyoda, Kazunori		SAMURAI Study Investigators	Relative systolic blood pressure reduction and clinical outcomes in hyperacute intracerebral hemorrhage: the SAMURAI-ICH observational study	JOURNAL OF HYPERTENSION			English	Article						acute intracerebral hemorrhage; antihypertensive therapy; outcome	STROKE ACUTE MANAGEMENT; RISK-FACTOR ASSESSMENT; INTRAVENOUS ANTIHYPERTENSIVE TREATMENT; DIFFUSION; MORTALITY	Background and purpose: Blood pressure lowering is often performed as a part of general acute management in acute intracerebral hemorrhage (ICH) patients. The relationship between relative blood pressure reduction and clinical outcomes is not fully known. Methods: Hyperacute (<3 h from onset) ICH patients with initial SBP more than 180 mmHg were included in the observational study. All patients received intravenous antihypertensive treatment based on a predefined protocol to lower and maintain SBP between 120 and 160 mmHg. The relative SBP reduction was defined as the ratio of SBP reduction to the admission SBP in the first 24 h, and associations between the relative SBP reduction and neurological deterioration (>= 2 points decrease in the Glasgow Coma Scale score or >= 4 increase in the National Institutes of Health Stroke Scale score), hematoma expansion (>33% increase), and unfavorable outcome (modified Rankin scale score 4-6 at 3 months) were assessed with multivariate logistic regression analyses. Results: Of the 211 patients [81 women, median age 65 (interquartile range 58-74) years, and median initial National Institutes of Health Stroke Scale score 13 (8-17)] enrolled, 17 (8%) showed neurological deterioration, 36 (17%) showed hematoma expansion, and 87 (41%) had an unfavorable outcome. On multivariate regression analyses, relative SBP reduction was independently and inversely associated with neurological deterioration (odds ratio 0.053, 95% confidence interval 0.011-0.254 per 10% increment), hematoma expansion (0.289, 0.099-0.841), and unfavorable outcome (0.254, 0.095-0.680) after adjusting for known predictive factors. Conclusion: Insufficient relative SBP reduction after standardized antihypertensive therapy in hyperacute ICH was independently associated with poor clinical outcomes. Aggressive antihypertensive treatment may improve clinical outcomes.	[Sakamoto, Yuki; Okata, Takuya; Kobayashi, Junpei; Tanaka, Eijirou; Minematsu, Kazuo; Toyoda, Kazunori] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan; [Koga, Masatosi] Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, Suita, Osaka 5658565, Japan; [Yamagami, Hiroshi; Nagatsuka, Kazuyuki] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka 5658565, Japan; [Todo, Kenichi] Kobe City Gen Hosp, Stroke Ctr, Dept Neurol, Kobe, Hyogo, Japan; [Okuda, Satoshi] Natl Hosp Org Nagoya Med Ctr, Dept Neurol, Nagoya, Aichi, Japan; [Okada, Yasushi] Natl Hosp Org Kyushu Med Ctr, Dept Cerebrovasc Med, Fukuoka, Japan; [Kimura, Kazumi] Kawasaki Med Univ, Dept Stroke Med, Kurashiki, Okayama, Japan; [Shiokawa, Yoshiaki] Kyorin Univ, Sch Med, Dept Neurosurg, Mitaka, Tokyo 181, Japan; [Shiokawa, Yoshiaki] Kyorin Univ, Sch Med, Stroke Ctr, Mitaka, Tokyo 181, Japan; [Kamiyama, Kenji] Nakamura Mem Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Kamiyama, Kenji] Nakamura Mem Hosp, Stroke Ctr, Sapporo, Hokkaido, Japan; [Furui, Eisuke] Kohnan Hosp, Dept Stroke Neurol, Sendai, Miyagi, Japan; [Hasegawa, Yasuhiro] St Marianna Univ, Sch Med, Dept Neurol, Kawasaki, Kanagawa, Japan; [Kairo, Kazuomi] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Japan	Koga, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	koga@ncvc.go.jp	Toyoda, Kazunori/J-3828-2015; Kobayashi, Junjiro/J-8547-2015	Toyoda, Kazunori/0000-0002-8346-9845; 	Ministry of Health, Labour and Welfare, Japan [H20-Junkanki-Ippan-019, H23-Junkanki-Ippan-010]; National Cerebral and Cardiovascular Center [H24-6-30]	This study was supported in part by a Grant-in-Aid (H20-Junkanki-Ippan-019 and H23-Junkanki-Ippan-010) from the Ministry of Health, Labour and Welfare, Japan and the Intramural Research Fund (H24-6-30) for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center.	DANDAPANI BK, 1995, STROKE, V26, P21; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Garg RK, 2012, STROKE, V43, P67, DOI 10.1161/STROKEAHA.111.629493; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; Fogelholm R, 1997, STROKE, V28, P1396; Bath P, 2003, J HYPERTENS, V21, P665, DOI 10.1097/01.hjh.0000052489.18130.43; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Ohwaki K, 2004, STROKE, V35, P1364, DOI 10.1161/01.STR.0000128795.38283.4b; Qureshi AI, 2007, AM J EMERG MED, V25, P32, DOI 10.1016/j.ajem.2006.07.008; Leira R, 2004, NEUROLOGY, V63, P461; Sakamoto Y, 2013, STROKE, V44, P1846, DOI 10.1161/STROKEAHA.113.001212; Koga M, 2012, J HYPERTENS, V30, P2357, DOI 10.1097/HJH.0b013e328359311b; Kidwell CS, 2001, NEUROLOGY, V57, P1611; Qureshi AI, 2008, CIRCULATION, V118, P176, DOI 10.1161/CIRCULATIONAHA.107.723874; Aries MJH, 2013, STROKE, V44, pE152, DOI 10.1161/STROKEAHA.113.002897; Itabashi R, 2008, J HYPERTENS, V26, P2016, DOI 10.1097/HJH.0b013e32830b896d; Kuwata N, 1995, NEUROSURG REV, V18, P237, DOI 10.1007/BF00383874; Palesch YY, 2012, AM J MED, V125, P718; Qureshi AI, 1999, CRIT CARE MED, V27, P480, DOI 10.1097/00003246-199903000-00021; Qureshi Al, 2012, AM J MED, pe711	21	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0263-6352	1473-5598		J HYPERTENS	J. Hypertens.	MAY	2015	33	5					1069	1073		10.1097/HJH.0000000000000512		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF8FG	WOS:000352790900025		
J	Osada, T; Nagaoka, K; Takahara, M; Yang, XY; Liu, CX; Guo, HT; Choudhury, KR; Hobeika, A; Hartman, Z; Morse, MA; Lyerly, HK				Osada, Takuya; Nagaoka, Koji; Takahara, Masashi; Yang, Xiao Yi; Liu, Cong-Xiao; Guo, Hongtao; Choudhury, Kingshuk Roy; Hobeika, Amy; Hartman, Zachary; Morse, Michael A.; Lyerly, H. Kim			Precision Cancer Immunotherapy: Optimizing Dendritic Cell-based Strategies to Induce Tumor Antigen-specific T-cell Responses Against Individual Patient Tumors	JOURNAL OF IMMUNOTHERAPY			English	Article						dendritic cell; maturation; electroporation; mRNA; cancer vaccine	MESSENGER-RNA ELECTROPORATION; ACUTE MYELOID-LEUKEMIA; IN-VITRO; ZOLEDRONIC ACID; CLINICAL-TRIAL; GM-CSF; MATURATION; MELANOMA; VACCINATION; EXPRESSION	Most dendritic cell (DC)-based vaccines have loaded the DC with defined antigens, but loading with autologos tumor-derived antigens would generate DCs that activate personalized tumor-specific T-cell responses. We hypothesized that DC matured with an optimized combination of reagents and loaded with tumor-derived antigens using a clinically feasible electroporation strategy would induce potent antitumor immunity. We first studied the effects on DC maturation and antigen presentation of the addition of picibanil (OK432) to a combination of zoledronic acid, tumor necrosis factor-alpha, and prostaglandin E2. Using DC matured with the optimized combination, we tested 2 clinically feasible sources of autologous antigen for electroloading, total tumor mRNA or total tumor lysate, to determine which stimulated more potent antigenspecific T cells in vitro and activated more potent antitumor immunity in vivo. The combination of tumor necrosis factor-alpha/prostaglandin E2/zoledronic acid/OK432 generated DC with high expression of maturation markers and antigen-specific T-cell stimulatory function in vitro. Mature DC electroloaded with tumor-derived mRNA [mRNA electroporated dendritic cell (EPDC)] induced greater expansion of antigen-specific T cells in vitro than DC electroloaded with tumor lysate (lysate EPDC). In a therapeutic model of MC38-carcinoembryonic antigen colon cancer-bearing mice, vaccination with mRNA EPDC induced the most efficient anti-carcinoembryonic antigen cellular immune response, which significantly suppressed tumor growth. In conclusion, mature DC electroloaded with tumor-derived mRNA are a potent cancer vaccine, especially useful when specific tumor antigens for vaccination have not been identified, allowing autologous tumor, and if unavailable, allogeneic cell lines to be used as an unbiased source of antigen. Our data support clinical testing of this strategy.	[Osada, Takuya; Yang, Xiao Yi; Liu, Cong-Xiao; Guo, Hongtao; Hobeika, Amy; Hartman, Zachary; Lyerly, H. Kim] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Morse, Michael A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Choudhury, Kingshuk Roy] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Nagaoka, Koji; Takahara, Masashi] MEDINET Co Ltd, Medinet Med Inst, Tokyo, Japan	Osada, T (reprint author), Res DR, 433a MSRB1, Durham, NC 27710 USA.	osada001@mc.duke.edu					LU D, 1994, CANCER GENE THER, V1, P245; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Toes REM, 1999, J EXP MED, V189, P753, DOI 10.1084/jem.189.5.753; Ponsaerts P, 2003, CLIN EXP IMMUNOL, V134, P378, DOI 10.1046/j.1365-2249.2003.02286.x; Boczkowski D, 1996, J EXP MED, V184, P465, DOI 10.1084/jem.184.2.465; Gilboa E, 2004, IMMUNOL REV, V199, P251, DOI 10.1111/j.0105-2896.2004.00139.x; MacAry PA, 2001, P NATL ACAD SCI USA, V98, P3982, DOI 10.1073/pnas.071477498; Rosenberg SA, 2005, J IMMUNOL, V175, P6169; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Kyte JA, 2006, CANCER GENE THER, V13, P905, DOI 10.1038/sj.cgt.7700961; Wilgenhof S, 2011, J IMMUNOTHER, V34, P448, DOI 10.1097/CJI.0b013e31821dcb31; Prins RM, 2013, J IMMUNOTHER, V36, P152, DOI 10.1097/CJI.0b013e3182811ae4; Morse MA, 2013, ANN SURG, V258, P879, DOI 10.1097/SLA.0b013e318292919e; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49; Itoh T, 2003, CANCER IMMUNOL IMMUN, V52, P207, DOI 10.1007/s00262-002-0337-8; LARSEN CP, 1994, J IMMUNOL, V152, P5208; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Van Tendeloo VF, 2010, P NATL ACAD SCI USA, V107, P13824, DOI 10.1073/pnas.1008051107; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Nair SK, 2002, ANN SURG, V235, P540, DOI 10.1097/00000658-200204000-00013; Alfaro C, 2011, J IMMUNOL, V187, P6130, DOI 10.4049/jimmunol.1102209; Kitawaki T, 2011, BRIT J HAEMATOL, V153, P796, DOI 10.1111/j.1365-2141.2010.08490.x; Fiore F, 2007, BLOOD, V110, P921, DOI 10.1182/blood-2006-09-044321; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445; Heiser A, 2002, J CLIN INVEST, V109, P409, DOI 10.1172/JCI14364; Chen YJ, 2009, IMMUNOPHARM IMMUNOT, V31, P499, DOI 10.1080/08923970902814103; Ferlazzo G, 2001, IMMUNOL LETT, V76, P37, DOI 10.1016/S0165-2478(00)00323-0; Grunebach F, 2005, CANCER IMMUNOL IMMUN, V54, P517, DOI 10.1007/s00262-004-0605-x; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; Li YW, 2000, BLOOD, V96, P2828; LIU Y, 1992, Current Opinion in Immunology, V4, P265, DOI 10.1016/0952-7915(92)90075-P; Maecker HT, 2001, CLIN CANCER RES, V7, p902S; Nakahara S, 2003, CANCER RES, V63, P4112; Ponsaerts P, 2002, J IMMUNOL, V169, P1669; Skipper H, 1982, CANC MED, P636; Sousa-Canavez Juliana M, 2008, Genet Vaccines Ther, V6, P2, DOI 10.1186/1479-0556-6-2; Takahara M, 2008, J LEUKOCYTE BIOL, V83, P742, DOI 10.1189/jlb.0307185; Wolfraim LA, 2013, INT IMMUNOPHARMACOL, V15, P488, DOI 10.1016/j.intimp.2013.01.009; Zheng L, 1999, AIDS RES HUM RETROV, V15, P1011, DOI 10.1089/088922299310520	40	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1524-9557	1537-4513		J IMMUNOTHER	J. Immunother.	MAY	2015	38	4					155	164		10.1097/CJI.0000000000000075		10	Oncology; Immunology; Medicine, Research & Experimental	Oncology; Immunology; Research & Experimental Medicine	CG1TV	WOS:000353058300003		
J	Watanabe, M; Takizawa, H; Tamura, M; Nakajima, A; Kurai, D; Ishii, H; Takata, S; Nakamoto, K; Sohara, E; Honda, K; Nakamura, M; Inui, T; Wada, H; Goto, H				Watanabe, Masato; Takizawa, Hajime; Tamura, Masaki; Nakajima, Akira; Kurai, Daisuke; Ishii, Haruyuki; Takata, Saori; Nakamoto, Keitaro; Sohara, Erei; Honda, Koujirou; Nakamura, Masuo; Inui, Toshiya; Wada, Hiroo; Goto, Hajime			Soluble ST2 as a prognostic marker in community-acquired pneumonia	JOURNAL OF INFECTION			English	Article						Suppression of tumorigenicity 2; Biomarker; Infection; Treatment; Severity	RANDOMIZED CONTROLLED-TRIAL; INTERLEUKIN-1 RECEPTOR; DISEASE; CELLS; IL-33; RISK; PROCALCITONIN; INFLAMMATION; EXPRESSION; GUIDELINES	Objectives: Community-acquired pneumonia (CAP) is associated with high mortality when initial treatment fails. Early identification of these patients allows physicians to modify treatments earlier, increasing survival. Methods: Ninety-one hospitalized patients with CAP were studied. Serum soluble ST2 levels were measured at diagnosis and at 3, 7, and 14 days (days 0, 3, 7, and 14) after the initiation of antimicrobial treatment. The predictive value of all-cause in-hospital mortality and the additive effect of soluble ST2 on the pneumonia severity index (PSI) were evaluated. Results: In univariate analysis, high serum levels of soluble ST2 at days 0, 3, 7, and 14 were predictive of death (hazard ratios: 3.1, 10.0, 12.0, and 22.6, respectively). In multivariate analysis, a combination of soluble ST2 at day 3 (above 2700 pg/ml) and PSI were predictive of death with higher accuracy than PSI alone (net reclassification improvement, 0.44; integrated discrimination improvement, 0.17; P = 0.001 for both). Specifically, simultaneous presence of high soluble ST2 (day 3) and a PSI of 5 was suggestive of higher mortality risk than a PSI of 5 alone (mortality 78% vs. 39%, respectively). Conclusions: Soluble ST2 is prognostic indicator of CAP and can add to the predictive value of the PSI. (C) 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.	[Watanabe, Masato; Takizawa, Hajime; Tamura, Masaki; Nakajima, Akira; Kurai, Daisuke; Ishii, Haruyuki; Takata, Saori; Nakamoto, Keitaro; Sohara, Erei; Honda, Koujirou; Nakamura, Masuo; Inui, Toshiya; Wada, Hiroo; Goto, Hajime] Kyorin Univ, Sch Med, Dept Resp Med, Tokyo 1818166, Japan; [Watanabe, Masato] Fukujuji Hosp, Div Resp Med, Japan Anti TB Assoc, Tokyo 2048522, Japan	Watanabe, M (reprint author), Kyorin Univ, Sch Med, Dept Resp Med, 6-20-3 Sinkawa, Mitaka, Tokyo 1818612, Japan.	masato@ks.kyorin-u.ac.jp					Alves JC, 2010, NAT MED, V16, P708, DOI 10.1038/nm.2156; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Roson B, 2004, ARCH INTERN MED, V164, P502, DOI 10.1001/archinte.164.5.502; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Menendez R, 2004, THORAX, V59, P960, DOI 10.1136/thx.2003.017756; Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Yagami A, 2010, J IMMUNOL, V185, P5743, DOI 10.4049/jimmunol.0903818; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P474, DOI 10.1006/bbrc.1997.6810; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Pencina Michael J, 2011, Stat Med, V30, P11, DOI 10.1002/sim.4085; Liu JH, 2010, J IMMUNOL, V184, P5802, DOI 10.4049/jimmunol.0904127; Bergis D, 2013, TRANSL ONCOL, V6, P311, DOI 10.1593/tlo.12418; Menendez R, 2004, CLIN INFECT DIS, V39, P1783, DOI 10.1086/426028; Dieplinger B, 2009, CLIN CHIM ACTA, V409, P33, DOI 10.1016/j.cca.2009.08.010; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Arancibia F, 2000, AM J RESP CRIT CARE, V162, P154; Martinez-Rumayor A, 2008, AM J CLIN PATHOL, V130, P578, DOI 10.1309/WMG2BFRC97MKKQKP; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Moritz DR, 1998, J IMMUNOL, V161, P4866; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Hoogerwerf JJ, 2010, INTENS CARE MED, V36, P630, DOI 10.1007/s00134-010-1773-0; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Bergers G, 1994, EMBO J, V13, P1176; CELIS R, 1988, CHEST, V93, P318, DOI 10.1378/chest.93.2.318; Lee KS, 2013, ANN LAB MED, V33, P45, DOI 10.3343/alm.2013.33.1.45; MACFARLANE JT, 1982, LANCET, V2, P255; Oshikawa K, 2001, RESP MED, V95, P532, DOI 10.1053/rmed.2001.1080; Oshikawa K, 2002, BIOCHEM BIOPH RES CO, V299, P18, DOI 10.1016/S0006-291X(02)02578-0; Society TJR, 2011, NURSING HEALTHCARE A; The Committee for the Guidelines in Management of Respiratory Infection JRS, 2005, JAP RESP SOC GUID MA; Vander Lugt MT, 2013, NEW ENGL J MED, V369, P529; Yin H, 2011, CLIN EXP IMMUNOL, V164, P248, DOI 10.1111/j.1365-2249.2011.04326.x	35	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0163-4453	1532-2742		J INFECTION	J. Infect.	MAY	2015	70	5					474	482		10.1016/j.jinf.2015.02.004		9	Infectious Diseases	Infectious Diseases	CF6XN	WOS:000352700200005		
J	Kimura, S; Akahoshi, Y; Nakano, H; Harada, N; Kameda, K; Ugai, T; Wada, H; Yamasaki, R; Ishihara, Y; Kawamura, K; Sakamoto, K; Ashizawa, M; Sato, M; Terasako-Saito, K; Nakasone, H; Kikuchi, M; Yamazaki, R; Kanda, J; Kako, S; Tanihara, A; Nishida, J; Kanda, Y				Kimura, Shun-ichi; Akahoshi, Yu; Nakano, Hirofumi; Harada, Naonori; Kameda, Kazuaki; Ugai, Tomotaka; Wada, Hidenori; Yamasaki, Ryoko; Ishihara, Yuko; Kawamura, Koji; Sakamoto, Kana; Ashizawa, Masahiro; Sato, Miki; Terasako-Saito, Kiriko; Nakasone, Hideki; Kikuchi, Misato; Yamazaki, Rie; Kanda, Junya; Kako, Shinichi; Tanihara, Aki; Nishida, Junji; Kanda, Yoshinobu			False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation	JOURNAL OF INFECTION			English	Article						False-positive; Aspergillus galactomannan; Allogeneic hematopoietic stem cell transplantation; Kinetics of Aspergillus galactomannan	LINKED-IMMUNOSORBENT-ASSAY; VERSUS-HOST-DISEASE; INVASIVE FUNGAL-INFECTIONS; ENZYME-IMMUNOASSAY; CROSS-REACTIVITY; ANTIGEN-DETECTION; APLASTIC-ANEMIA; RECIPIENTS; GRAFT; HISTOPLASMOSIS	Objectives: We evaluated the incidence of and risk factors for false-positive Aspergillus galactomannan (GM) antigenemia in allogeneic hematopoietic stem cell transplantation (HSCT). We also focused on the GM index value and its kinetics. Methods: Patients who underwent their first allogeneic HSCT at our center between June 2007 and December 2012 were included (n = 172). Episodes of positive GM tests were classified as either "true-positive", which fulfilled the EORTC criteria for proven or probable invasive aspergillosis (IA), or "false-positive", which was not accompanied by clinical findings. The remaining cases were regarded as "inconclusive". Results: The one-year cumulative incidences of IA and positive GM tests were 10.1% and 48.1%, respectively. Among 148 episodes of positive GM tests, 97(65.5%), 23(15.5%), and 28(19.0%) were classified as false-positive, true-positive and inconclusive, respectively. In the first episodes of positive GM tests in each patient (false-positive = 67, others = 30), an increase in the GM value in the first two measurements, neutropenia, and use of anti-mold agents at positive GM episode were associated with a significantly lower possibility of false-positive results according to a multivariate analysis. Conclusions: A false-positive GM test was frequently seen after allogeneic HSCT. An increase in the GM value may increase its positive predictive value. (C) 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.	[Kimura, Shun-ichi; Akahoshi, Yu; Nakano, Hirofumi; Harada, Naonori; Kameda, Kazuaki; Ugai, Tomotaka; Wada, Hidenori; Yamasaki, Ryoko; Ishihara, Yuko; Kawamura, Koji; Sakamoto, Kana; Ashizawa, Masahiro; Sato, Miki; Terasako-Saito, Kiriko; Nakasone, Hideki; Kikuchi, Misato; Yamazaki, Rie; Kanda, Junya; Kako, Shinichi; Tanihara, Aki; Nishida, Junji; Kanda, Yoshinobu] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama 3308503, Japan	Kanda, Y (reprint author), Jichi Med Univ, Saitama Med Ctr, Div Hematol, Omiya Ku, 1-847 Amanuma, Saitama 3308503, Japan.	ycanda-tky@umin.ac.jp					Aceti A, 2008, PEDIATR INFECT DIS J, V27, P769, DOI 10.1097/INF.0b013e31817c0b6e; Oshima K, 2008, AM J HEMATOL, V83, P226, DOI 10.1002/ajh.21087; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; Vergidis P, 2012, TRANSPL INFECT DIS, V14, P213, DOI 10.1111/j.1399-3062.2011.00675.x; Mikulska M, 2012, J ANTIMICROB CHEMOTH, V67, P1746, DOI 10.1093/jac/dks111; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Ansorg R, 1997, MYCOSES, V40, P353; Maertens JA, 2007, CLIN INFECT DIS, V44, P1329, DOI 10.1086/514349; Safdar A, 2011, CLIN INFECT DIS, V53, P798, DOI 10.1093/cid/cir492; Mori Y, 2010, AM J HEMATOL, V85, P449, DOI 10.1002/ajh.21697; Sulahian A, 2001, CANCER, V91, P311, DOI 10.1002/1097-0142(20010115)91:2<311::AID-CNCR1003>3.0.CO;2-3; Oshima K, 2007, J ANTIMICROB CHEMOTH, V60, P350, DOI 10.1093/jac/dkm217; Martin-Rabadan P, 2012, CLIN INFECT DIS, V55, pE22, DOI 10.1093/cid/cis493; Kanda Y, 2013, AM J HEMATOL, V88, P294, DOI 10.1002/ajh.23392; Cummings JR, 2007, DIAGN MICR INFEC DIS, V59, P113, DOI 10.1016/j.diagmicrobio.2007.04.022; Kourkoumpetis TK, 2012, CLIN INFECT DIS, V54, P1322, DOI 10.1093/cid/cis132; SHULMAN HM, 1978, AM J PATHOL, V91, P545; Wheat LJ, 2007, CLIN VACCINE IMMUNOL, V14, P638, DOI 10.1128/CVI.00479-06; Asano-Mori Y, 2008, J ANTIMICROB CHEMOTH, V61, P411, DOI 10.1093/jac/dkm463; Maertens J, 2009, CANCER, V115, P355, DOI 10.1002/cncr.24022; Giacchino M, 2006, J CLIN MICROBIOL, V44, P3432, DOI 10.1128/JCM.00856-06; Greene RE, 2007, CLIN INFECT DIS, V44, P373, DOI 10.1086/509917; Aubry A, 2006, J CLIN MICROBIOL, V44, P389, DOI 10.1128/JCM.44.2.389-394.2006; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Marchetti O, 2012, BONE MARROW TRANSPL, V47, P846, DOI 10.1038/bmt.2011.178; Rimek D, 1999, MYCOSES, V42, P25; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Swanink CMA, 1997, J CLIN MICROBIOL, V35, P257; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Ashizawa M, 2014, INT J HEMATOL, V99, P311, DOI 10.1007/s12185-014-1501-6; Blijlevens N M A, 2002, Transpl Infect Dis, V4, P64, DOI 10.1034/j.1399-3062.2002.00015.x; Dalle F, 2005, J CLIN MICROBIOL, V43, P2929, DOI 10.1128/JCM.43.6.2929-2931.2005; Fisher CE, 2013, CLIN INFECT DIS, V57, P1001, DOI 10.1093/cid/cit393; Gangneux JP, 2002, LANCET, V359, P1251, DOI 10.1016/S0140-6736(02)08238-7; Girmenia C, 2011, MYCOSES, V54, pE883, DOI 10.1111/j.1439-0507.2011.02022.x; Guigue N, 2013, NEW ENGL J MED, V369, P97, DOI 10.1056/NEJMc1210430; Hamaki T, 2001, BONE MARROW TRANSPL, V28, P633, DOI 10.1038/sj.bmt.1703209; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawamura K, 2014, INT J INFECT DIS, V19, P26, DOI 10.1016/j.ijid.2013.09.020; Kawamura K, 2013, TRANSPL INFECT DIS, V15, P457, DOI 10.1111/tid.12118; Koo S, 2010, J CLIN MICROBIOL, V48, P1255, DOI 10.1128/JCM.02281-09; Leeflang MM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007394; Mennink-Kersten MAS, 2005, J CLIN MICROBIOL, V43, P3925, DOI 10.1128/JCM.43.8.3925-3931.2005; Mennink-Kersten MASH, 2004, LANCET, V363, P325, DOI 10.1016/S0140-6736(03)15393-7; Murashige N, 2005, CLIN INFECT DIS, V40, P333, DOI 10.1086/427070; Narreddy S, 2008, J INFECTION, V56, P80, DOI 10.1016/j.jinf.2007.09.013; Oshima K, 2010, BONE MARROW TRANSPL, V45, P781, DOI 10.1038/bmt.2009.213; Racil Z, 2010, EUR J CLIN MICROBIOL, V29, P851, DOI 10.1007/s10096-010-0938-7; Surmont I, 2007, J CLIN MICROBIOL, V45, P1373, DOI 10.1128/JCM.02373-06	51	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0163-4453	1532-2742		J INFECTION	J. Infect.	MAY	2015	70	5					520	540		10.1016/j.jinf.2015.02.012		21	Infectious Diseases	Infectious Diseases	CF6XN	WOS:000352700200011		
J	Kawada, T				Kawada, T.			Statins use and dementia: causality of the association	JOURNAL OF INTERNAL MEDICINE			English	Letter									[Kawada, T.] Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Richardson K, 2013, ANN INTERN MED, V159, P688, DOI 10.7326/0003-4819-159-10-201311190-00007; Wu CK, 2015, J INTERN MED, V277, P343, DOI 10.1111/joim.12262	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0954-6820	1365-2796		J INTERN MED	J. Intern. Med.	MAY	2015	277	5					624	624		10.1111/joim.12312		1	Medicine, General & Internal	General & Internal Medicine	CF8IR	WOS:000352801300013		
J	Adachi, A; Komine, M; Maki, N; Karakawa, M; Murata, S; Ohtsuki, M				Adachi, A.; Komine, M.; Maki, N.; Karakawa, M.; Murata, S.; Ohtsuki, M.			The change in serum concentration of S100A7 correlated to the change in PASI score during the treatment with adalimumab	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Adachi, A.; Komine, M.; Maki, N.; Karakawa, M.; Murata, S.; Ohtsuki, M.] Jichi Med Univ, Dermatol, Shimotsuke, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		220	S38	S38				1	Dermatology	Dermatology	CF8CO	WOS:000352783200221		
J	Bhatia, A; O'Brien, K; Imai, T; Chen, M; Woodley, DT; Udono, H; Li, W				Bhatia, A.; O'Brien, K.; Imai, T.; Chen, M.; Woodley, D. T.; Udono, H.; Li, W.			Secreted heat shock protein-90 alpha (Hsp90 alpha) is essential for skin wound healing	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Bhatia, A.; O'Brien, K.; Chen, M.; Woodley, D. T.; Li, W.] Univ So Calif, Dermatol, Los Angeles, CA USA; [Bhatia, A.; O'Brien, K.; Chen, M.; Woodley, D. T.; Li, W.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Imai, T.; Udono, H.] Chiba Univ, Immunol, Chiba, Japan; [Udono, H.] Grad Sch Med, Chiba, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		500	S85	S85				1	Dermatology	Dermatology	CF8CO	WOS:000352783200500		
J	Cao, W; Li, L; Mii, S; Amoh, Y; Liu, F; Hoffman, RM				Cao, W.; Li, L.; Mii, S.; Amoh, Y.; Liu, F.; Hoffman, R. M.			3D cultures of hair follicles on Gelfoam (R) promote functional recovery of severed peripheral nerves and the spinal cord when transplanted to the injury site	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Cao, W.; Li, L.; Hoffman, R. M.] AntiCancer Inc, San Diego, CA USA; [Cao, W.; Liu, F.] Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China; [Cao, W.; Hoffman, R. M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Mii, S.; Amoh, Y.] Kitasato Univ, Dept Dermatol, Yokohama, Kanagawa, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		691	S119	S119				1	Dermatology	Dermatology	CF8CO	WOS:000352783200691		
J	Denda, S; Kumamoto, J; Takei, K; Goto, M; Nagayama, M; Denda, M				Denda, S.; Kumamoto, J.; Takei, K.; Goto, M.; Nagayama, M.; Denda, M.			Expression of Orai3 correlates with aging-related changes in stress-induced calcium signaling in keratinocytes	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Denda, S.; Goto, M.; Denda, M.] Shiseido Res Ctr, Yokohama, Kanagawa, Japan; [Denda, S.; Kumamoto, J.; Takei, K.; Goto, M.; Nagayama, M.; Denda, M.] Japan Sci & Technol Agcy, Tokyo, Japan; [Kumamoto, J.; Takei, K.; Nagayama, M.] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan			Nagayama, Masaharu/D-6759-2012					0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		377	S65	S65				1	Dermatology	Dermatology	CF8CO	WOS:000352783200377		
J	Fukuda, K; Sugihara, E; Ohta, S; Izuhara, K; Funakoshi, T; Amagai, M; Saya, H				Fukuda, K.; Sugihara, E.; Ohta, S.; Izuhara, K.; Funakoshi, T.; Amagai, M.; Saya, H.			Periostin is a key niche component for melanoma wound metastasis	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Fukuda, K.; Sugihara, E.; Saya, H.] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan; [Fukuda, K.; Funakoshi, T.; Amagai, M.] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Ohta, S.] Saga Med Sch, Dept Lab Med, Saga, Japan; [Izuhara, K.] Saga Med Sch, Dept Biomol Sci, Div Med Biochem, Saga, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		098	S17	S17				1	Dermatology	Dermatology	CF8CO	WOS:000352783200099		
J	Fukumoto, T; Iwasaki, T; Okada, T; Hashimoto, T; Moon, Y; Sakaguchi, M; Fukami, Y; Nishigori, C; Oka, M				Fukumoto, T.; Iwasaki, T.; Okada, T.; Hashimoto, T.; Moon, Y.; Sakaguchi, M.; Fukami, Y.; Nishigori, C.; Oka, M.			High expression of Mcl-1 mediated by MEK-ERK1/2-STAT3 signaling pathway protects melanocytes and melanoma cells against ultraviolet B-induced apoptosis	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Fukumoto, T.; Sakaguchi, M.; Nishigori, C.; Oka, M.] Kobe Univ, Grad Sch Med, Div Dermatol, Dept Internal Related, Kobe, Hyogo 657, Japan; [Iwasaki, T.; Hashimoto, T.; Moon, Y.; Fukami, Y.] Kobe Univ, Grad Sch Med, Dept Biol, Kobe, Hyogo 657, Japan; [Okada, T.] Kobe Univ, Grad Sch Med, Dept Mol & Cellular Biol, Div Biochem, Kobe, Hyogo 657, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		621	S107	S107				1	Dermatology	Dermatology	CF8CO	WOS:000352783200621		
J	Igawa, K; Itoh, Y; Yokozeki, H				Igawa, K.; Itoh, Y.; Yokozeki, H.			A blockade of lysophosphatidic acid - lysophosphatidic acid receptor 1 cascade augments murine allergic skin inflammation	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Igawa, K.; Itoh, Y.; Yokozeki, H.] Tokyo Med & Dent Univ, Dermatol, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		564	S97	S97				1	Dermatology	Dermatology	CF8CO	WOS:000352783200564		
J	Iida, H; Hasegawa, T; Sakamoto, A; Wada, A; Fukai, T; Ikeda, S				Iida, H.; Hasegawa, T.; Sakamoto, A.; Wada, A.; Fukai, T.; Ikeda, S.			Keratinocyte progenitor cells in human subcutaneous adipose tissue	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Iida, H.; Hasegawa, T.; Sakamoto, A.; Wada, A.; Fukai, T.; Ikeda, S.] Juntendo Univ, Grad Sch Med, Dermatol & Allergol, Tokyo, Japan; [Ikeda, S.] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		716	S124	S124				1	Dermatology	Dermatology	CF8CO	WOS:000352783200716		
J	Ikeya, S; Sakabe, J; Tokura, Y				Ikeya, S.; Sakabe, J.; Tokura, Y.			Involvement of AhR-dependent COX-2 generation in the mechanism of antifungal voriconazole-induced, UV-associated skin cancer development	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Ikeya, S.; Sakabe, J.; Tokura, Y.] Hamamatsu Univ Sch Med, Dermatol, Hamamatsu, Shizuoka 4313192, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		588	S101	S101				1	Dermatology	Dermatology	CF8CO	WOS:000352783200588		
J	Ikushima, H				Ikushima, H.			Recognition of melanoma by an innate immune receptor Dectin-1 orchestrates innate immune cells for anti-tumor responses	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Ikushima, H.] Univ Tokyo, Inst Ind Sci, Max Planck, Ctr Integrat Inflammol, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		504	S87	S87				1	Dermatology	Dermatology	CF8CO	WOS:000352783200504		
J	Imanishi, H; Ansell, D; Harries, M; Sepp, N; Biro, T; Tsuruta, D; Ward, CM; Paus, R				Imanishi, H.; Ansell, D.; Harries, M.; Sepp, N.; Biro, T.; Tsuruta, D.; Ward, C. M.; Paus, R.			Human hair follicle epithelial stem cells undergo epithelial-mesenchymal transition (EMT) in primary cicatricial alopecia: Lessons from lichen planopilaris	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Imanishi, H.; Ansell, D.; Harries, M.; Ward, C. M.; Paus, R.] Univ Manchester, Manchester, Lancs, England; [Sepp, N.] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Tsuruta, D.] Osaka City Univ, Osaka 558, Japan; [Biro, T.] Univ Debrecen, H-4012 Debrecen, Hungary								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		666	S115	S115				1	Dermatology	Dermatology	CF8CO	WOS:000352783200666		
J	Inaba, Y; Yoshimasu, T; Kanazawa, N; Furukawa, F				Inaba, Y.; Yoshimasu, T.; Kanazawa, N.; Furukawa, F.			Protective role of mast cells in development of lupus erythematosus-like skin lesions in MRL-lpr/lpr mice	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Inaba, Y.; Kanazawa, N.; Furukawa, F.] Wakayama Med Univ, Dermatol, Wakayama, Japan; [Yoshimasu, T.] Arida Municipal Hosp, Dermatol, Wakayama, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		062	S11	S11				1	Dermatology	Dermatology	CF8CO	WOS:000352783200063		
J	Inozume, I; Yaguchi, T; Kawakami, Y; Shimada, S				Inozume, I.; Yaguchi, T.; Kawakami, Y.; Shimada, S.			Blockade for CD155-TIGIT interaction is an effective therapy for melanoma	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Inozume, I.; Shimada, S.] Univ Yamanashi, Dermatol, Chuo Ku, Yamanashi, Japan; [Yaguchi, T.; Kawakami, Y.] Keio Univ, Div Cellular Signaling, Inst Adv Med Res, Shinjyuku Ku, Tokyo 108, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		002	S1	S1				1	Dermatology	Dermatology	CF8CO	WOS:000352783200003		
J	Kabasawa, M; Sugaya, M; Oka, T; Takahashi, N; Kawaguchi, M; Suga, H; Miyagaki, T; Fujita, H; Asano, Y; Tada, Y; Kadono, T; Sato, S				Kabasawa, M.; Sugaya, M.; Oka, T.; Takahashi, N.; Kawaguchi, M.; Suga, H.; Miyagaki, T.; Fujita, H.; Asano, Y.; Tada, Y.; Kadono, T.; Sato, S.			Decreased IL-21 expression in skin and blood contributes to progression of mycosis fungoides	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Kabasawa, M.; Sugaya, M.; Oka, T.; Takahashi, N.; Kawaguchi, M.; Suga, H.; Miyagaki, T.; Fujita, H.; Asano, Y.; Tada, Y.; Kadono, T.; Sato, S.] Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 113, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		177	S31	S31				1	Dermatology	Dermatology	CF8CO	WOS:000352783200178		
J	Kamata, Y; Sakaguchi, A; Umehara, Y; Tominaga, M; Ogawa, H; Takamori, K				Kamata, Y.; Sakaguchi, A.; Umehara, Y.; Tominaga, M.; Ogawa, H.; Takamori, K.			Effects of H-1-antihistamines on expression of axon guidance molecules in normal human epidermal keratinocytes	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Kamata, Y.; Sakaguchi, A.; Umehara, Y.; Tominaga, M.; Ogawa, H.; Takamori, K.] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Urayasu, Japan; [Takamori, K.] Juntendo Univ, Urayasu Hosp, Dept Dermatol, Urayasu, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		340	S58	S58				1	Dermatology	Dermatology	CF8CO	WOS:000352783200340		
J	Kiatsurayanon, C; Niyonsaba, F; Ushio, H; Ikeda, S; Okumura, K; Ogawa, H				Kiatsurayanon, C.; Niyonsaba, F.; Ushio, H.; Ikeda, S.; Okumura, K.; Ogawa, H.			Angiogenic peptide-30 (AG-30) activates primary human keratinocytes to produce cytokines/chemokines via MrgX receptors	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Kiatsurayanon, C.; Ikeda, S.] Juntendo Univ, Grad Sch Med, Dermatol, Tokyo, Japan; [Kiatsurayanon, C.; Niyonsaba, F.; Ushio, H.; Ikeda, S.; Okumura, K.; Ogawa, H.] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		526	S90	S90				1	Dermatology	Dermatology	CF8CO	WOS:000352783200526		
J	Kobayashi, T; Glatz, M; Horiuchi, K; Doebel, T; Kaplan, D; Kong, HH; Amagai, M; Nagao, K				Kobayashi, T.; Glatz, M.; Horiuchi, K.; Doebel, T.; Kaplan, D.; Kong, H. H.; Amagai, M.; Nagao, K.			Dysbiotic microbiota drives atopic inflammation in Adam17(fl/fl)Sox9-Cre mice	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Kobayashi, T.; Amagai, M.; Nagao, K.] Keio Univ, Sch Med, Dermatol, Tokyo, Japan; [Kobayashi, T.; Glatz, M.; Doebel, T.; Kong, H. H.; Nagao, K.] NCI, Dermatol Branch, NIH, Bethesda, MD 20892 USA; [Horiuchi, K.] Keio Univ, Sch Med, Orthoped Surg, Tokyo, Japan; [Kaplan, D.] Univ Minnesota, Ctr Immunol, Dermatol, Minneapolis, MN USA								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		508	S87	S87				1	Dermatology	Dermatology	CF8CO	WOS:000352783200508		
J	Kubo, A; Hirano, T; Yokouchi, M; Kawasaki, H; Atsugi, T; Amagai, M				Kubo, A.; Hirano, T.; Yokouchi, M.; Kawasaki, H.; Atsugi, T.; Amagai, M.			Tight junction barrier dysfunction induced by epidermis-specific claudin-1 ablation is sufficient to cause dermatitis in mice	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Kubo, A.; Hirano, T.; Yokouchi, M.; Kawasaki, H.; Atsugi, T.; Amagai, M.] Keio Univ, Tokyo, Japan; [Hirano, T.] Maruho Co, Kyoto, Japan; [Atsugi, T.] KOSE Co, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		352	S60	S60				1	Dermatology	Dermatology	CF8CO	WOS:000352783200352		
J	Masashi, M; Yamanishi, H; Matsumoto, Y; Yamamoto, M; Hachiya, Y; Tsuboi, R; Hibino, T				Masashi, M.; Yamanishi, H.; Matsumoto, Y.; Yamamoto, M.; Hachiya, Y.; Tsuboi, R.; Hibino, T.			Epidermis-specific mesotrypsin is involved in corneocyte desquamation and is regulated by an intrinsic inhibitor, serpin B12	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Masashi, M.; Yamanishi, H.; Matsumoto, Y.; Yamamoto, M.; Hachiya, Y.; Hibino, T.] Shiseido, Yokohama, Kanagawa, Japan; [Yamamoto, M.; Tsuboi, R.] Tokyo Med Univ, Dermatol, Tokyo 1608402, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		368	S63	S63				1	Dermatology	Dermatology	CF8CO	WOS:000352783200368		
J	Masuda, H; Kimura, M; Morita, A				Masuda, H.; Kimura, M.; Morita, A.			Photobiology Comparison of the effects of continuous and pulsed-wave light photodynamic therapy	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[Masuda, H.; Kimura, M.] UHIO INC, Tokyo, Japan; [Masuda, H.; Kimura, M.; Morita, A.] Nagoya City Univ, Dept Geriatr & Environm Dermatol, Grad Sch Med Sci, Nagoya, Aichi, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		575	S99	S99				1	Dermatology	Dermatology	CF8CO	WOS:000352783200575		
J	McGuinn, KP; Sasaki, T; Chu, M; Mahoney, MG				McGuinn, K. P.; Sasaki, T.; Chu, M.; Mahoney, M. G.			Fibulin-4 is down-regulated in malignant head and neck SCC	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Investigative-Dermatology	MAY 06-09, 2015	Atlanta, GA	Soc Investigat Dermatol					[McGuinn, K. P.; Chu, M.; Mahoney, M. G.] Thomas Jefferson Univ, Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Sasaki, T.] Oita Univ, Biochem, Oita 87011, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2015	135			1		502	S86	S86				1	Dermatology	Dermatology	CF8CO	WOS:000352783200502		
